PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Paulun, VC; Kawabe, T; Nishida, S; Fleming, RW				Paulun, Vivian C.; Kawabe, Takahiro; Nishida, Shin'ya; Fleming, Roland W.			Seeing liquids from static snapshots	VISION RESEARCH			English	Article						Viscosity; Material perception; Image statistics; Perceptual organization; Object recognition; Shape	IMAGE STATISTICS; SURFACE REFLECTANCE; VISUAL-PERCEPTION; COLOR CONSTANCY; MOTION; ILLUMINATION; LIGHTNESS; GLOSS; SHAPE	Perceiving material properties can be crucial for many tasks such as determining food edibility, or avoiding getting splashed yet the visual perception of materials remains poorly understood. Most previous research has focussed on optical characteristics (e.g., gloss, translucency). Here, however, we show that shape also provides powerful visual cues to material properties. When liquids pour, splash or ooze, they organize themselves into characteristic shapes, which are highly diagnostic of the material's properties. Subjects viewed snapshots of simulated liquids of different viscosities, and rated their similarity. Using maximum likelihood difference scaling (Maloney & Yang, 2003), we reconstructed perceptual scales for perceived viscosity as a function of the physical viscosity of the simulated fluids. The resulting psychometric function revealed a distinct sigmoidal shape, distinguishing runny liquids that flow easily from viscous gels that clump up into piles. A parameter-free model based on 20 simple shape statistics predicted the subjects' data surprisingly well. This suggests that when subjects are asked to compare the viscosity of static snapshots of liquids that differ only in terms of viscosity, they rely primarily on relatively simple measures of shape similarity. (C) 2015 The Authors. Published by Elsevier Ltd.	[Paulun, Vivian C.; Fleming, Roland W.] Univ Giessen, Dept Expt Psychol, D-35394 Giessen, Germany; [Kawabe, Takahiro; Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Otemachi, Japan	Paulun, VC (reprint author), Univ Giessen, Dept Expt Psychol, D-35394 Giessen, Germany.	Vivian.C.Paulun@psychol.uni-giessen.de		Fleming, Roland/0000-0001-5033-5069	DFG International Research Training Group IRTG [1901]; EU Marie Curie Initial Training Network "PRISM" [316746]; MEXT, Japan [22135004]	This work was in part supported by the DFG International Research Training Group IRTG 1901 "The Brain in Action - BrainAct" and by the EU Marie Curie Initial Training Network "PRISM" (FP7-PEOPLE-2012-ITN, Grant Agreement: 316746). S. Nishida was supported by Grant-in-Aid for Scientific Research on Innovative Areas (No. 22135004) from MEXT, Japan.	Kawabe T, 2015, VISION RES, V109, P125, DOI 10.1016/j.visres.2014.07.003; Knoblauch K, 2008, J STAT SOFTW, V25, P1; Boyaci H, 2004, J VISION, V4, P664, DOI 10.1167/4.9.1; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Fleming RW, 2011, PSYCHOL SCI, V22, P812, DOI 10.1177/0956797611408734; Hecht H, 1996, PSYCHON B REV, V3, P61, DOI 10.3758/BF03210741; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; MALONEY LT, 1986, J OPT SOC AM A, V3, P29, DOI 10.1364/JOSAA.3.000029; Feldman J, 2006, P NATL ACAD SCI USA, V103, P18014, DOI 10.1073/pnas.0608811103; Battaglia PW, 2013, P NATL ACAD SCI USA, V110, P18327, DOI 10.1073/pnas.1306572110; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; DZMURA M, 1993, J OPT SOC AM A, V10, P2148, DOI 10.1364/JOSAA.10.002148; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Ho YX, 2006, J VISION, V6, P634, DOI 10.1167/6.5.8; Maloney LT, 2003, J VISION, V3, P573, DOI 10.1167/3.8.5; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Kourtzi Z, 2004, TRENDS COGN SCI, V8, P47, DOI 10.1016/j.tics.2003.12.001; Nusseck M, 2007, APGV 2007: SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, PROCEEDINGS, P27; Barrow H. G., 1978, COMPUTER VISION SYST, P3; Blender, COMPUTER SOFTWARE; Bulthoff H. H., 2005, ACM T APPL PERCEPT, V2, P346, DOI DOI 10.1145/1077399.1077409; MCCLOSKEY M, 1980, SCIENCE, V210, P1139, DOI 10.1126/science.210.4474.1139; Feldman J., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), DOI 10.1109/CVPR.1992.223268; Feldman J., 1995, P IEEE WORKSH ARCH S; Sprote P, 2013, J VISION, V13, DOI 10.1167/13.14.3; GILDEN DL, 1989, J EXP PSYCHOL HUMAN, V15, P372, DOI 10.1037/0096-1523.15.2.372; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; Koffka K., 1935, PRINCIPLES GESTALT P; LEYTON M, 1989, COGNITIVE SCI, V13, P357, DOI 10.1207/s15516709cog1303_2; Leyton M., 1999, SYMMETRY CAUSALITY M; R Development Core Team, 2011, R LANG ENV STAT COMP; Thompson W. B., 2011, VISUAL PERCEPTION CO	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		B		SI		163	174		10.1016/j.visres.2015.01.023		12	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CT5PE	WOS:000362861500002		
J	Sakai, K; Meiji, R; Abe, T				Sakai, Ko; Meiji, Ryoko; Abe, Tetsuya			Facilitatory mechanisms of specular highlights in the perception of depth	VISION RESEARCH			English	Article						Shading; Pop-out; Specular highlights; Search paradigm; Depth discrimination	IMAGE STATISTICS; VISUAL-SEARCH; SHAPE; GLOSS	We investigated whether specular highlights facilitate the perception of shape from shading in a search paradigm and how highlights interact with shading to facilitate this perception. Our results indicated that stimuli containing highlights led to shorter searching time with the dependence on the light source direction (top lights make searching faster), suggesting that highlights indeed facilitate shape-from-shading processing. To examine how highlight processing interacts with shading processing, we tested unnatural stimuli for which the lighting directions for shading and highlights were inconsistent. The results indicated that unnatural highlights (bright spots) placed in a direction inconsistent with the shading either decrease or do not alter searching time. This suggests that highlights may facilitate, and not suppress, shading processing. With more physically plausible highlights generated from image-based lighting, we also observed facilitation with consistent highlights, but no change with inconsistent highlights. Finally, we examined whether highlights indeed work to facilitate depth perception in a discrimination task. The results showed that correct discrimination of depth increases when highlights are added to shading even when their lighting directions are inconsistent. These results indicate that specular highlights facilitate shading processing, and do not suppress it even when the highlights are placed in a direction inconsistent with shading. The results also elucidate the lighting constraints of the visual system. (C) 2015 Elsevier Ltd. All rights reserved.	[Sakai, Ko; Meiji, Ryoko; Abe, Tetsuya] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3058573, Japan	Sakai, K (reprint author), Univ Tsukuba, Dept Comp Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	sakai@cs.tsukuba.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan [25135704]; JSPS KAKENHI [23135503, 26280047]	This work was supported by Grant-in-Aids from the Ministry of Education, Culture, Sports and Technology of Japan (25135704 (Shitsukan)) and JSPS KAKENHI (23135503 and 26280047).	Adelson E. H., 2008, P SPIE HUMAN VISION, V6809; Kawabe T, 2004, PERCEPTION, V33, P601, DOI 10.1068/p3438; Khang BG, 2007, PERCEPTION, V36, P1191, DOI 10.1068/p5807; Nefs HT, 2006, ACTA PSYCHOL, V121, P297, DOI 10.1016/j.actpsy.2005.08.001; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; Phillips F, 1997, J EXP PSYCHOL HUMAN, V23, P1481; WARD GJ, 1992, COMP GRAPH, V26, P265; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; AKS DJ, 1992, PERCEPT PSYCHOPHYS, V52, P63, DOI 10.3758/BF03206760; Norman JF, 2004, PSYCHOL SCI, V15, P565, DOI 10.1111/j.0956-7976.2004.00720.x; Sakai K, 2006, J OPT SOC AM A, V23, P1805, DOI 10.1364/JOSAA.23.001805; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Chacon J, 2004, PERCEPTION, V33, P1499, DOI 10.1068/p5286; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Bulthoff H. H., 1991, COMPUTATIONAL MODELS, P305; Champion R. A., 2007, J VISION, V7, P1, DOI DOI 10.1167/7.13.10; Chen T., 2006, P IEEE COMP SOC C CO, V2, P1825; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Marlow P., 2011, J VISION, V11, P1, DOI DOI 10.1167/11.9.16.; Nefs H. T., 2008, J VISION, V8, P1, DOI DOI 10.1167/8.3.8; Wijntjes MWA, 2012, J VISION, V12, DOI 10.1167/12.2.16; Zucker S. W., 2013, 13065480V1CSCV ARXIV	24	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		B		SI		188	198		10.1016/j.visres.2015.05.001		11	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CT5PE	WOS:000362861500004		
J	Tanaka, M; Horiuchi, T				Tanaka, Midori; Horiuchi, Takahiko			Investigating perceptual qualities of static surface appearance using real materials and displayed images	VISION RESEARCH			English	Article						Materials; Perceptual qualities; Surface perception; Image reproduction	REFLECTANCE PROPERTIES; VISUAL-PERCEPTION; REPRESENTATION; ILLUMINATION; STATISTICS; DISPARITY	Recent experimental evidence supports the idea that human observers are good at recognizing and categorizing materials. Fleming et al. reported that perceptual qualities and material classes are closely related using projected images (Journal of Vision 13(8) (2013) 9). In this paper, we further investigated their findings using real materials and degraded image versions of the same materials. We constructed a real material dataset, as well as four image datasets by varying chromaticity (color vs. gray) and resolution (high vs. low) of the material images. To investigate the fundamental properties of materials' static surface appearance, we used stimuli that lacked shape and saturated color information. We then investigated the relationship between these perceptual qualities and the various types of image representation through psychophysical experiments. Our results showed that the representation method of some materials affected their perceptual qualities. These cases could be classified into the following three types: (1) perceptual qualities decreased by reproducing the materials as images, (2) perceptual qualities decreased by creating gray images, and (3) perceptual qualities such as "Hardness" and "Coldness" tended to increase when the materials were reproduced as low-quality images. Through methods such as principal component analysis and k-means clustering, we found that material categories are more likely to be confused when materials are represented as images, especially gray images. (C) 2014 Elsevier Ltd. All rights reserved.	[Tanaka, Midori; Horiuchi, Takahiko] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan	Horiuchi, T (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba, Japan.	horiuchi@faculty.chiba-u.jp			MEXT, Japan [25135706]	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (No. 25135706) from MEXT, Japan.	Albertazzi L., 2013, HDB EXPT PHENOMENOLO; Liu C, 2010, PROC CVPR IEEE, P239, DOI 10.1109/ICCET.2010.5485248; Muryy AA, 2013, P NATL ACAD SCI USA, V110, P2413, DOI 10.1073/pnas.1212417110; Fleming RW, 2011, PSYCHOL SCI, V22, P812, DOI 10.1177/0956797611408734; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Motoyoshi I, 2012, VISION RES, V53, P30, DOI 10.1016/j.visres.2011.11.010; Zaidi Q, 2011, WIRES COGN SCI, V2, P686, DOI 10.1002/wcs.148; Padilla S, 2008, VISION RES, V48, P1791, DOI 10.1016/j.visres.2008.05.015; Andreopoulos A, 2013, COMPUT VIS IMAGE UND, V117, P827, DOI 10.1016/j.cviu.2013.04.005; Debevec P, 2000, COMP GRAPH, P145; Varma M, 2009, IEEE T PATTERN ANAL, V31, P2032, DOI 10.1109/TPAMI.2008.182; Abe T, 2012, INT C PATT RECOG, P3712; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Jensen HW, 2001, COMP GRAPH, P511; Fleming RW, 2013, J VISION, V13, DOI 10.1167/13.8.9; Dana KJ, 1999, ACM T GRAPHIC, V18, P1, DOI 10.1145/300776.300778; Dalal N, 2005, PROC CVPR IEEE, P886; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Marschner SR, 2005, ACM T GRAPHIC, V24, P727, DOI 10.1145/1073204.1073254; Anderson BL, 2011, CURR BIOL, V21, pR978, DOI 10.1016/j.cub.2011.11.022; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Bulthoff H. H., 2005, ACM T APPL PERCEPT, V2, P346, DOI DOI 10.1145/1077399.1077409; Doerschner K., 2011, CURR BIOL, V21, P1; Dror R. O., 2001, P WORKSH ID OBJ VAR; KOENDERINK JJ, 1987, BIOL CYBERN, V55, P367, DOI 10.1007/BF00318371; Koenderink J. J., 2005, INT J COMPUTER VISIO, V62; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; Pont S. C., 2008, HDB TEXTURE ANAL, P197, DOI 10.1142/9781848161160_0007; Prasad D. K., 2012, INT J IMAGE PROCESS, V6, P441; Sharan L., 2009, J VISION, V9, P784, DOI [10.1167/9.8.784, DOI 10.1167/9.8.784]; Thompson W. B., 2011, VISUAL PERCEPTION CO; Wendt G, 2008, J VISION, V8, DOI 10.1167/8.1.14	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		B		SI		246	258		10.1016/j.visres.2014.11.016		13	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CT5PE	WOS:000362861500010		
J	Nagai, T; Matsushima, T; Koida, K; Tani, Y; Kitazaki, M; Nakauchi, S				Nagai, Takehiro; Matsushima, Toshiki; Koida, Kowa; Tani, Yusuke; Kitazaki, Michiteru; Nakauchi, Shigeki			Temporal properties of material categorization and material rating: visual vs non-visual material features	VISION RESEARCH			English	Article						Material perception; Material category; Surface feature; Psychophysics	SURFACE REFLECTANCE; IMAGE STATISTICS; PERCEPTION; REPRESENTATION; QUALITIES; ACCURACY; TEXTURE; SPEED; GLOSS	Humans can visually recognize material categories of objects, such as glass, stone, and plastic, easily. However, little is known about the kinds of surface quality features that contribute to such material class recognition. In this paper, we examine the relationship between perceptual surface features and material category discrimination performance for pictures of materials, focusing on temporal aspects, including reaction time and effects of stimulus duration. The stimuli were pictures of objects with an identical shape but made of different materials that could be categorized into seven classes (glass, plastic, metal, stone, wood, leather, and fabric). In a pre-experiment, observers rated the pictures on nine surface features, including visual (e.g., glossiness and transparency) and non-visual features (e.g., heaviness and warmness), on a 7-point scale. In the main experiments, observers judged whether two simultaneously presented pictures were classified as the same or different material category. Reaction times and effects of stimulus duration were measured. The results showed that visual feature ratings were correlated with material discrimination performance for short reaction times or short stimulus durations, while nonvisual feature ratings were correlated only with performance for long reaction times or long stimulus durations. These results suggest that the mechanisms underlying visual and non-visual feature processing may differ in terms of processing time, although the cause is unclear. Visual surface features may mainly contribute to material recognition in daily life, while non-visual features may contribute only weakly, if at all. (C) 2014 Elsevier Ltd. All rights reserved.	[Nagai, Takehiro; Matsushima, Toshiki; Tani, Yusuke; Kitazaki, Michiteru; Nakauchi, Shigeki] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan; [Koida, Kowa] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi 4418580, Japan	Nagai, T (reprint author), Yamagata Univ, Dept Informat, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	tnagai@yz.yamagata-u.ac.jp		Nakauchi, Shigeki/0000-0002-4954-6915	KAKENHI [22135005]; CASIO Science Promotion Foundation	We thank two reviewers for their valuable comments to improve this manuscript. This study was supported by KAKENHI 22135005 and CASIO Science Promotion Foundation.	Liu C, 2010, PROC CVPR IEEE, P239, DOI 10.1109/ICCET.2010.5485248; Singh M, 2002, PERCEPTION, V31, P531, DOI 10.1068/p3363; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; Sharan L, 2008, J OPT SOC AM A, V25, P846, DOI 10.1364/JOSAA.25.000846; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Sharan L, 2013, INT J COMPUT VISION, V103, P348, DOI 10.1007/s11263-013-0609-0; Okamoto S, 2013, IEEE T HAPTICS, V6, P81, DOI [10.1109/TOH.2012.32, 10.1109/ToH.2012.32]; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Lee W, 2001, COLOR RES APPL, V26, P469, DOI 10.1002/col.1067; Fleming RW, 2013, J VISION, V13, DOI 10.1167/13.8.9; Yoonessi A, 2010, OPHTHAL PHYSL OPT, V30, P626, DOI 10.1111/j.1475-1313.2010.00722.x; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Wiebel CB, 2013, ATTEN PERCEPT PSYCHO, V75, P954, DOI 10.3758/s13414-013-0436-y; Goda N, 2014, J NEUROSCI, V34, P2660, DOI 10.1523/JNEUROSCI.2593-13.2014; Bulthoff H. H., 2005, ACM T APPL PERCEPT, V2, P346, DOI DOI 10.1145/1077399.1077409; Koida K, MAT PROPERTY J UNPUB; Lederman S. J., 1993, ATTEN PERCEPT PSYCHO, V53, P315; Wolfe JM, 2010, J VISION, V10, DOI 10.1167/10.9.8; Sharan L, 2014, J VISION, V14, DOI 10.1167/14.9.12; Tani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054549; Xiao B, 2014, J VISION, V14, DOI 10.1167/14.3.17	25	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	OCT	2015	115		B		SI		259	270		10.1016/j.visres.2014.12.011		12	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CT5PE	WOS:000362861500011		
J	Gopiraman, M; Deng, D; Babu, SG; Hayashi, T; Karvembu, R; Kim, IS				Gopiraman, Mayakrishnan; Deng, Dian; Babu, Sundaram Ganesh; Hayashi, Takuya; Karvembu, Ramasamy; Kim, Ick Soo			Sustainable and Versatile CuO/GNS Nanocatalyst for Highly Efficient Base Free Coupling Reactions	ACS SUSTAINABLE CHEMISTRY & ENGINEERING			English	Article						Graphene nanosheets; Copper oxide; Coupling reactions; Reusable; Versatile; Sustainable	NANOCRYSTALLINE COPPER(II) OXIDE; SOLVENT-FREE CONDITIONS; TERMINAL ALKYNES; MULTICOMPONENT REACTIONS; GRAPHENE NANOPLATELETS; TRANSFER HYDROGENATION; RAMAN-SPECTROSCOPY; REUSABLE CATALYST; AERIAL OXIDATION; AMINES	A CuO nanoparticles (CuO NPs)/graphene nanosheet (GNS) hybrid was prepared by a very simple method and employed as a nanocatalyst (CuO/GNS) for base free coupling reactions, namely, A(3)-coupling and aza-Michael reactions. TEM shows that CuO NPs of below similar to 35 nm size are homogeneously dispersed on the GNS. Strong adhesion between CuO NPs and GNS was acknowledged by a high Raman I-D/I-G ratio and XPS result. The BET surface area of CuO/GNS was found to be 66.26 m(2) g(-1) The EDS and XPS investigations revealed that the weight percentage and chemical state of Cu in CuO/GNS were 4.46% and +2, respectively. Under mild reaction conditions, CuO/GNS exhibited an outstanding catalytic activity in terms of yield, turnover number (TON) and turnover frequency (TOF) toward A(3)-coupling reaction. A small amount of catalyst (10 mg, 0.7 mol % of Cu) is enough to carry out the reactions with a wide range of substrates. The CuO/GNS is stable, heterogeneous in nature and reusable for at least five times without any significant loses of yield. N-oxidation of tertiary amines was also carried out to explore further the activity of CuO/GNS, and the results are found to be excellent. Versatility of the CuO/GNS was realized from the superior catalytic activity of used CuO/GNS in aza-Michael reaction. Finally, GNS (similar to 95%) and CuO (as CuCl2) were successfully recovered from the used CuO/GNS and confirmed by TEM, Raman, XPS, XRD and SEM-EDS analyses.	[Gopiraman, Mayakrishnan; Deng, Dian; Babu, Sundaram Ganesh; Kim, Ick Soo] Shinshu Univ, Natl Univ Corp, Inst Fiber Engn IFES,ICCER, Nano Fus Technol Res Lab,Div Frontier Fibers, Ueda, Nagano 3868567, Japan; [Hayashi, Takuya] Shinshu Univ, Fac Engn, Nagano 3808553, Japan; [Karvembu, Ramasamy] Natl Inst Technol, Dept Chem, Tiruchchirappalli 620015, Tamil Nadu, India	Karvembu, R (reprint author), Natl Inst Technol, Dept Chem, Tiruchchirappalli 620015, Tamil Nadu, India.	kar@nitt.edu; kim@shinshu-u.ac.jp					Abdollahi-Alibeik M, 2014, RSC ADV, V4, P39759, DOI 10.1039/c4ra04253k; Albaladejo MJ, 2012, EUR J ORG CHEM, P3093, DOI 10.1002/ejoc.201200090; Hosseini-Sarvari M, 2014, NEW J CHEM, V38, P624, DOI 10.1039/c3nj01146a; BOYER JH, 1980, CHEM REV, V80, P495, DOI 10.1021/cr60328a002; Wang B, 2010, J MATER CHEM, V20, P10661, DOI 10.1039/c0jm01941k; Guo HZ, 2013, RSC ADV, V3, P19812, DOI 10.1039/c3ra43341b; Xu C, 2008, J PHYS CHEM C, V112, P19841, DOI 10.1021/jp807989b; Villaverde G, 2012, ACS CATAL, V2, P399, DOI 10.1021/cs200601w; Kantam ML, 2008, TETRAHEDRON LETT, V49, P3083, DOI 10.1016/j.tetlet.2008.03.053; Naeimi H, 2013, APPL ORGANOMET CHEM, V27, P300, DOI 10.1002/aoc.2976; Jung ME, 2000, ORG LETT, V2, P2659, DOI 10.1021/ol0001517; Hayashi Y, 1996, J AM CHEM SOC, V118, P5502, DOI 10.1021/ja960766s; Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757; Lanke SR, 2013, APPL ORGANOMET CHEM, V27, P729, DOI 10.1002/aoc.3071; Peshkov VA, 2012, CHEM SOC REV, V41, P3790, DOI 10.1039/c2cs15356d; Chang GG, 2014, RSC ADV, V4, P20230, DOI 10.1039/c4ra02125h; Si YC, 2008, CHEM MATER, V20, P6792, DOI 10.1021/cm801356a; Mandel S, 2005, BRAIN RES REV, V48, P379, DOI 10.1016/j.brainresrev.2004.12.027; Gopiraman M, 2013, CATAL SCI TECHNOL, V3, P1485, DOI 10.1039/c3cy20735h; Gopiraman M, 2014, ACS CATAL, V4, P2118, DOI 10.1021/cs500460m; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Weinreb O, 2010, PROG NEUROBIOL, V92, P330, DOI 10.1016/j.pneurobio.2010.06.008; Fodor A, 2010, ORG BIOMOL CHEM, V8, P4575, DOI 10.1039/c0ob00224k; Wabnitz TC, 2004, CHEM-EUR J, V10, P484, DOI 10.1002/chem.200305407; Zhu JW, 2010, NANOSCALE, V2, P988, DOI 10.1039/b9nr00414a; Mandal P, 2015, DALTON T, V44, P11444, DOI 10.1039/c5dt01260k; Georgakilas V, 2012, CHEM REV, V112, P6156, DOI 10.1021/cr3000412; Borah BJ, 2014, CATAL SCI TECHNOL, V4, P1047, DOI 10.1039/c3cy00639e; Gopiraman M, 2013, J PHYS CHEM C, V117, P23582, DOI 10.1021/jp402978q; Liu Y, 2013, ACS APPL MATER INTER, V5, P9850, DOI 10.1021/am403136e; Kantam ML, 2009, TETRAHEDRON LETT, V50, P4467, DOI 10.1016/j.tetlet.2009.05.059; Ni ZH, 2008, NANO RES, V1, P273, DOI 10.1007/s12274-008-8036-1; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Dulle J, 2013, GREEN CHEM, V15, P1238, DOI 10.1039/c3gc36607c; Zhang X, 2008, ANGEW CHEM INT EDIT, V47, P4358, DOI 10.1002/anie.200800098; Li JT, 2009, DALTON T, P823, DOI 10.1039/b814321h; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Lo VKY, 2006, ORG LETT, V8, P1529, DOI 10.1021/ol0528641; Wei CM, 2003, J AM CHEM SOC, V125, P9584, DOI 10.1021/ja0359299; Huo X, 2013, J MATER CHEM A, V1, P651, DOI 10.1039/c2ta00485b; Li N, 2010, J NANOSCI NANOTECHNO, V10, P6690, DOI 10.1166/jnn.2010.2516; Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c; Gopiraman M, 2013, CARBON, V62, P135, DOI 10.1016/j.carbon.2013.06.005; Gopiraman M, 2014, CATAL SCI TECHNOL, V4, P2099, DOI 10.1039/c3cy00963g; Zhang YM, 2005, NEW J CHEM, V29, P366, DOI 10.1039/b414060e; Domling A, 2012, CHEM REV, V112, P3083, DOI 10.1021/cr100233r; Fakhri P, 2014, J MOL CATAL A-CHEM, V383, P17, DOI 10.1016/j.molcata.2013.10.027; Tjoa V, 2011, J MATER CHEM, V21, P15593, DOI 10.1039/c1jm12676h; Reddy KM, 2006, TETRAHEDRON LETT, V47, P7563, DOI 10.1016/j.tetlet.2006.08.094; Gopiraman M, 2015, REACT KINET MECH CAT, V115, P759, DOI 10.1007/s11144-015-0861-0; Prasad MR, 2002, J MOL CATAL A-CHEM, V186, P109; Murai T, 2004, J AM CHEM SOC, V126, P5968, DOI 10.1021/ja048627v; Della Pina C., 2007, TOP CATAL, V44, P319; Namitharan K, 2010, EUR J ORG CHEM, P411, DOI 10.1002/ejoc.200901084; Patil MK, 2008, EUR J ORG CHEM, P4440, DOI 10.1002/ejoc.200800359; Pin-Hua L., 2005, CHINESE J CHEM, V23, P1076, DOI DOI 10.1002/CJOC.200591076; Wang M, 2008, EUR J ORG CHEM, P2255, DOI 10.1002/ejoc.200800006	57	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2168-0485			ACS SUSTAIN CHEM ENG	ACS Sustain. Chem. Eng.	OCT	2015	3	10					2478	2488		10.1021/acssuschemeng.5b00542		11	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CT0FF	WOS:000362468600016		
J	Hettiarachchi, CV; Weerasekara, RK; Uekusa, H				Hettiarachchi, Champika V.; Weerasekara, Roshan K.; Uekusa, Hidehiro			Crystalline state photochromism of 3-furylfulgides: impact of size and bond flexibility of the non-aromatic alkylidene group	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article						crystalline state photochromism; 3-furylfulgides; bond flexibility; fatigue resistance	FURYLFULGIDES; CONFORMATION; ANHYDRIDE; FULGIDES	3-Furylfulgides are photochromic compounds showing high thermal stability in their closed forms. However, their photochromic properties in the solid state should be improved further to fabricate molecular devices. Understanding how the size and the flexibility of the non-aromatic alkylidene moiety alter the crystalline state photochromic properties is also important here, as the alkylidene group is directly involved in the photochromic ring closing and opening reactions. The synthesis of four 3-furylfulgides composed of different alkylidene groups (rigid isopropyl, flexible 2-butyl, rigid cyclopentyl and flexible cyclohexyl), their crystal structures and structure-photochromic property correlation in the crystalline state are reported here. Crystallographic data along with reaction cavity volumes calculated using the program CAVITY [Ohashi et al. (1981), J. Am. Chem. Soc. 103, 5805-5812] disclosed that fulgides with flexible groups at the ring closing site have more free volume around the reactive area in the crystal lattice, which can provide more space for the atomic movements in the reaction and flexibility can reduce the strain built up in the closed C-isomers by making conformations. According to UV-vis spectroscopic data, a higher yield of C-isomers and a better fatigue resistance were obtained for the 3-furylfulgide with the largest and flexible cyclohexyl group showing greater photochromic properties in the crystalline state than the fulgide containing the smallest and rigid isopropyl group.	[Hettiarachchi, Champika V.] Univ Peradeniya, Dept Chem, Fac Sci, Peradeniya 20400, Sri Lanka; [Weerasekara, Roshan K.] Univ Peradeniya, Postgrad Inst Sci, Peradeniya 20400, Sri Lanka; [Uekusa, Hidehiro] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, O Okayama, Tokyo 1528551, Japan	Hettiarachchi, CV (reprint author), Univ Peradeniya, Dept Chem, Fac Sci, Peradeniya 20400, Sri Lanka.	champikav@pdn.ac.lk			National Research Council, Sri Lanka [09-22]; JASSO Fellowship, Japan	This work was financially supported by National Research Council Grant 09-22, Sri Lanka and CVH acknowledges JASSO Fellowship, Japan for providing support for XRD analysis.	RAMAMURTHY V, 1987, CHEM REV, V87, P433, DOI 10.1021/cr00078a009; YOKOYAMA Y, 1994, B CHEM SOC JPN, V67, P3297, DOI 10.1246/bcsj.67.3297; Yokoyama Y, 1996, B CHEM SOC JPN, V69, P1605, DOI 10.1246/bcsj.69.1605; [Anonymous], 1983, SOLID STATE ELECT 1; Khedhiri L, 2004, J PHYS CHEM A, V108, P7473, DOI 10.1021/jp048137p; CASADEI MA, 1984, J AM CHEM SOC, V106, P1051, DOI 10.1021/ja00316a039; [Anonymous], 1998, PROCESS AUTO; ALTOMARE A, 1993, J APPL CRYSTALLOGR, V26, P343, DOI 10.1107/S0021889892010331; OHASHI Y, 1981, J AM CHEM SOC, V103, P5805, DOI 10.1021/ja00409a031; Vithana C, 2002, ACTA CRYSTALLOGR B, V58, P986, DOI 10.1107/S0108768102019663; Kawata S, 2000, CHEM REV, V100, P1777, DOI 10.1021/cr980073p; YOKOYAMA Y, 1990, B CHEM SOC JPN, V63, P1607, DOI 10.1246/bcsj.63.1607; Yokoyama Y, 2000, CHEM REV, V100, P1717, DOI 10.1021/cr980070c; Tamai N, 2000, CHEM REV, V100, P1875, DOI 10.1021/cr9800816; Harada J, 2008, J AM CHEM SOC, V130, P7085, DOI 10.1021/ja800353u; Bahajaj A. A., 2007, J PHOTOCH PHOTOBIO A, V19, P182; Darcy P. J., 1981, J CHEM SOC P1, V1, P202; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Glaze A. P., 1992, J CHEM SOC PT2, V2, P591; Heller H. G., 1991, SILICON ORGANICS ELE; Heller H. G., 1981, J CHEM SOC P2, V2, P341; Higashi T., 1995, ABSCOR; Irie M., 1994, PHOTOREACTIVE MAT UL; Molecular Structure Corporation, 1999, TEXSAN; Sheldrick G. M., 2013, SHELXL2013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stobbe H, 1907, BER DTSCH CHEM GES, V40, P3372, DOI 10.1002/cber.190704003111; Strube F, 2011, EUR J ORG CHEM, P1947, DOI 10.1002/ejoc.201001649; YOKOYAMA Y, 1990, CHEM LETT, P263, DOI 10.1246/cl.1990.263; YOSHIOKA Y, 1989, CHEM LETT, P19, DOI 10.1246/cl.1989.19	30	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2052-5206			ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	OCT	2015	71		5				535	542		10.1107/S2052520615015267		8	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CT1HA	WOS:000362547700006		
J	Matsubara, S; Takahashi, H; Baba, Y; Usui, R				Matsubara, Shigeki; Takahashi, Hironori; Baba, Yosuke; Usui, Rie			Inserting the Bakri balloon during cesarean section in patients with a narrow cervix: Nelaton method (Matsubara)	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							PLACENTA PREVIA		[Matsubara, Shigeki; Takahashi, Hironori; Baba, Yosuke; Usui, Rie] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Matsubara S, 2015, ACTA OBSTET GYN SCAN, V94, P910, DOI 10.1111/aogs.12585; Matsubara S, 2014, ACTA OBSTET GYN SCAN, V93, P120, DOI 10.1111/aogs.12241; Matsubara S, 2014, ARCH GYNECOL OBSTET, V290, P613, DOI 10.1007/s00404-014-3380-8; Kondoh E, 2014, J MATERN-FETAL NEO M, V27, P309, DOI 10.3109/14767058.2013.809418; Matsubara S, 2014, EUR J OBSTET GYN R B, V182, P258, DOI 10.1016/j.ejogrb.2014.01.021; Yoong W, 2015, ACTA OBSTET GYN SCAN, V94, P1145, DOI 10.1111/aogs.12670	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	OCT	2015	94	10					1147	1148		10.1111/aogs.12693		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CT0TZ	WOS:000362511300018		
J	Takahashi, Y; Jonas, W; Ransjo-Arvidson, AB; Lidfors, L; Moberg, KU; Nissen, E				Takahashi, Yuki; Jonas, Wibke; Ransjo-Arvidson, Anna-Berit; Lidfors, Lena; Moberg, Kerstin Uvnas; Nissen, Eva			Weight loss and low age are associated with intensity of rooting behaviours in newborn infants	ACTA PAEDIATRICA			English	Article						Breastfeeding behaviour; Infant age; Infant weight loss; Prefeeding behaviour; Rooting behaviour	FEEDING-BEHAVIOR; BREAST; ANALGESIA; OXYTOCIN; SUCKING	Aim: Little is known about the developing breastfeeding behaviour of newborn infants. This study describes infants' prebreastfeeding behaviour during the second day of life and explores possible associations with infant characteristics. Methods: We studied 13 mothers and healthy full-term infants after normal births. At 2448 hours of life, the newborns were placed in skin-to-skin contact with their mothers for breastfeeding and were video-filmed. The order, frequency and duration of predefined infant prefeeding behaviours and suckling were coded and analysed using computer-based video software. Results: Prefeeding behaviours occurred in the following order: rooting, hand to mouth movements, licking of the nipple and hand to breast to mouth movements. The infants started to suckle at a median of one to two minutes. Rooting was the most common behaviour, observed in 12 infants. The duration of rooting movements during the last minute before breastfeeding was inversely related to neonatal age (p = 0.001) and positively related to neonatal weight loss (p = 0.02) after birth. Conclusion: Infants exhibited a distinct sequence of prefeeding behaviours during the second day of life, and our findings suggest that rooting movements were governed by mechanisms involved in the regulation of food intake and weight gain.	[Takahashi, Yuki; Jonas, Wibke; Nissen, Eva] Karolinska Inst, Dept Womens & Childrens Hlth, Div Reprod Hlth, Stockholm, Sweden; [Takahashi, Yuki] Japanese Red Cross Toyota Coll Nursing, Aichi, Japan; [Jonas, Wibke] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Ransjo-Arvidson, Anna-Berit] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lidfors, Lena; Moberg, Kerstin Uvnas] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Moberg, Kerstin Uvnas] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden	Takahashi, Y (reprint author), Japanese Red Cross Toyota Coll Nursing, Aichi, Japan.	y-takahashi@rctoyota.ac.jp; wibke.jonas@ki.se			Vardal Foundation; Swedish Research Council [K 1999-2001 27P-13085, K1999-27XP-13263-01]; Centre for Health Care Sciences, Strategic Research Program for Caring Science; KI Foundations at Karolinska Institutet; Praktikertjanst AB; Scholarship programme of Swedish Institute	We gratefully acknowledge the support received for the study in the form of grants from the Vardal Foundation, the Swedish Research Council (K 1999-2001 27P-13085 and K1999-27XP-13263-01), the Centre for Health Care Sciences, Strategic Research Program for Caring Science and KI Foundations at Karolinska Institutet, Praktikertjanst AB and the Scholarship programme of Swedish Institute.	Algers B, 2007, HORM BEHAV, V52, P78, DOI 10.1016/j.yhbeh.2007.03.022; Lidfors LM, 2010, APPL ANIM BEHAV SCI, V128, P23, DOI 10.1016/j.applanim.2010.09.002; MARCHINI G, 1993, PHYSIOL BEHAV, V54, P1021, DOI 10.1016/0031-9384(93)90318-A; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; Widstrom AM, 2011, ACTA PAEDIATR, V100, P79, DOI 10.1111/j.1651-2227.2010.01983.x; NISSEN E, 1995, ACTA PAEDIATR, V84, P140, DOI 10.1111/j.1651-2227.1995.tb13596.x; Marchini G, 1998, ACTA PAEDIATR, V87, P671, DOI 10.1080/080352598750014094; UVNASMOBERG K, 1993, ARCH DIS CHILD, V68, P46; da Costa SP, 2010, INFANT BEHAV DEV, V33, P61, DOI 10.1016/j.infbeh.2009.11.007; Varendi H, 1997, ACTA PAEDIATR, V86, P985, DOI 10.1111/j.1651-2227.1997.tb15184.x; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; WIDSTROM AM, 1987, ACTA PAEDIATR SCAND, V76, P566, DOI 10.1111/j.1651-2227.1987.tb10522.x; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; Brazelton TB, 1995, NEONATAL BEHAV ASSES, V15, P48; Jonas W, 2008, ARCH WOMEN MENT HLTH, V11, P335, DOI 10.1007/s00737-008-0027-4; Lawrence R, 1999, BREASTFEEDING GUIDE; Matthews M K, 1989, Midwifery, V5, P3; Matthews M K, 1988, Midwifery, V4, P154, DOI 10.1016/S0266-6138(88)80071-8; Ransjo-Arvidson AB, 2001, BIRTH-ISS PERINAT C, V28, P5, DOI 10.1046/j.1523-536x.2001.00005.x; Wiberg B., 1990, 1 POSTPARTUM HOUR DE	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	OCT	2015	104	10					1018	1023		10.1111/apa.13077		6	Pediatrics	Pediatrics	CT0UG	WOS:000362512100020		
J	Sano, K; Akiyama, M; Hoffren-Mikkola, M; Ito, A; Komi, PV; Ishikawa, M				Sano, K.; Akiyama, M.; Hoffren-Mikkola, M.; Ito, A.; Komi, P. V.; Ishikawa, M.			Age-specific neuromuscular interaction during elderly habitual running	ACTA PHYSIOLOGICA			English	Article						ageing; co-activation; locomotion; tendon; ultrasound	SHORTENING CYCLE EXERCISE; MUSCLE-TENDON INTERACTION; TRICEPS SURAE; GASTROCNEMIUS-MUSCLE; OLDER-ADULTS; IN-VIVO; HUMAN LOCOMOTION; ACHILLES-TENDON; SKELETAL-MUSCLE; STRETCH REFLEX	Aim: It has been reported that advancing age causes tendons to become more compliant and fascicles length shorter. This could then lead to enhancement of movement efficiency provided that the elderly adults can activate their muscles in the same way as the younger adults (YOUNG) during dynamic movements. This study was designed to examine the age-specific behaviour of the medial gastrocnemius (MG) fascicles and tendinous tissues together with lower-leg muscle activities when the well-trained elderly runners ran on the treadmill at preferred speeds. Methods: The well-trained 11 elderly subjects (ELD) who have running experiences and 11 YOUNG were recruited as subjects. While ELD were running on the treadmill at their preferred speed, the lengths of the MG fascicles and tendinous tissues (L-fa and L-TT respectively) were measured by ultrasonography together with kinematics and lower-leg muscle activities. Results: Although the behaviour of the MG muscle-tendon unit did not show any significant differences between both groups during the contact, our results showed significant differences in fascicle-tendinous tissue behaviour as well as muscle activities. The L-TT during the entire contact phase was greater in ELD than in YOUNG (P < 0.001). Co-activation of lower-leg muscles from pre-activation to braking phases was higher in ELD than in YOUNG (P < 0.01). The changes of the L-fa during contact were less, and the L-TT shortening was greater in ELD than in YOUNG (P < 0.001). Conclusion: These results imply that ELD cannot activate their muscles similar to YOUNG during running, and those different activities may modify the L-fa to utilize the tendon elasticity effectively.	[Sano, K.; Akiyama, M.; Ito, A.; Ishikawa, M.] Osaka Univ Hlth & Sport Sci, Kumatori, Osaka 5900496, Japan; [Hoffren-Mikkola, M.; Komi, P. V.] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla, Finland; [Komi, P. V.] Univ Jyvaskyla, Likes Res Ctr, Jyvaskyla, Finland	Sano, K (reprint author), Osaka Univ Hlth & Sport Sci, Asashirodai 1-1, Kumatori, Osaka 5900496, Japan.	kanae.04.dec@gmail.com			MEXT/JSPS KAKENHI [26702026]	This work was supported by MEXT/JSPS KAKENHI Grant Number 26702026.	Hoffren M, 2012, EUR J APPL PHYSIOL, V112, P4035, DOI 10.1007/s00421-012-2393-x; Kubo K, 2003, ACTA PHYSIOL SCAND, V178, P25, DOI 10.1046/j.1365-201X.2003.01097.x; Ochala J, 2004, J GERONTOL A-BIOL, V59, P441; NORMAN RW, 1979, ACTA PHYSIOL SCAND, V106, P241, DOI 10.1111/j.1748-1716.1979.tb06394.x; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Ishikawa M, 2008, EXERC SPORT SCI REV, V36, P193, DOI 10.1097/JES.0b013e3181878417; Sano K, 2013, EUR J APPL PHYSIOL, V113, P1395, DOI 10.1007/s00421-012-2559-6; Cronin NJ, 2009, J PHYSIOL-LONDON, V587, P3375, DOI 10.1113/jphysiol.2008.162610; Klass M, 2005, J APPL PHYSIOL, V99, P31, DOI 10.1152/japplphysiol.01426.2004; Hoffren M, 2011, J ELECTROMYOGR KINES, V21, P483, DOI 10.1016/j.jelekin.2011.01.009; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Roos MR, 1999, MUSCLE NERVE, V22, P1094; Ishikawa M, 2007, J APPL PHYSIOL, V103, P1030, DOI 10.1152/japplphysiol.00277.2007; AURA O, 1986, INT J SPORTS MED, V7, P137, DOI 10.1055/s-2008-1025751; Cronin NJ, 2008, J APPL PHYSIOL, V105, P226, DOI 10.1152/japplphysiol.90432.2008; Hasson CJ, 2011, J BIOMECH, V44, P2299, DOI 10.1016/j.jbiomech.2011.05.031; GOLLHOFER A, 1992, EUR J APPL PHYSIOL O, V64, P283, DOI 10.1007/BF00636213; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Fukunaga T, 2002, EXERC SPORT SCI REV, V30, P106, DOI 10.1097/00003677-200207000-00003; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; af Klint R, 2010, J NEUROPHYSIOL, V103, P1262, DOI 10.1152/jn.00852.2009; Hof AL, 2003, J BIOMECH, V36, P1031, DOI 10.1016/S0021-9290(03)00036-8; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341; Morse CI, 2005, J APPL PHYSIOL, V98, P221, DOI 10.1152/japplphysiol.00774.2004; Barber LA, 2013, EXP GERONTOL, V48, P1147, DOI 10.1016/j.exger.2013.07.007; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; HERZOG W, 1991, CLIN BIOMECH, V6, P230, DOI 10.1016/0268-0033(91)90051-Q; Larsen AH, 2008, J ELECTROMYOGR KINES, V18, P568, DOI 10.1016/j.jelekin.2006.12.008; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Jakobi JM, 2002, J APPL PHYSIOL, V93, P457, DOI 10.1152/japplphysiol.00012.2002; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Reeves ND, 2006, EXP PHYSIOL, V91, P483, DOI 10.1113/expphysiol.2005.032896; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; Roos MR, 1997, MUSCLE NERVE, V20, P679; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Hermens H., 1999, EUROPEAN RECOMMENDAT, P122; Hoffren M., 2007, J APPL PHYSIOL, V103, P1030; Kawakami Y., 2000, SKELETAL MUSCLE MECH, P327; KOMI PV, 1987, INT J SPORTS MED, V8, P196, DOI 10.1055/s-2008-1025655; Ishikawa M, 2007, Gait Posture, V25, P380, DOI 10.1016/j.gaitpost.2006.05.002; Power GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048044	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	OCT	2015	215	2					79	88		10.1111/apha.12550		10	Physiology	Physiology	CT6AS	WOS:000362893300003		
J	Kok, GX; Chow, CO; Ishii, H				Kok, Gin-Xian; Chow, Chee-Onn; Ishii, Hiroshi			Improving network coding in wireless ad hoc networks	AD HOC NETWORKS			English	Article						Network coding; Coding-aware routing protocol; Coding conditions	MESH NETWORKS; MECHANISM	Wireless ad hoc networks usually have lower network throughput than wireless infrastructure networks due to the inherent nature of multi-hop communication on a shared channel in wireless ad hoc networks. Network coding is a method that can improve the network throughput by reducing the amount of workload in the network while still ensuring that all user data is transferred. With network coding, a node can improve its transmission efficiency by combining (encoding) several packets together and sending only the resultant encoded packet if the coding conditions are satisfied. In this paper, we propose the Network Coding Routing (NCRT) protocol which consists of a new set of coding conditions, and a new routing metric that takes into consideration both coding opportunities and network workload. Comprehensive simulation studies showed that NCRT gives promising performance. (C) 2015 Elsevier B.V. All rights reserved.	[Kok, Gin-Xian; Chow, Chee-Onn] Univ Malaya, Kuala Lumpur 50603, Malaysia; [Ishii, Hiroshi] Tokai Univ, Profess Grad Sch Embedded Technol, Hiratsuka, Kanagawa 25912, Japan	Kok, GX (reprint author), Univ Malaya, Kuala Lumpur 50603, Malaysia.	xian_kgx@hotmail.com; cochow@um.edu.my; ishii@ishiilab.net			Ministry of Science, Technology and Innovation, Malaysia [01-01-03-SF0782]	This project was supported by the Ministry of Science, Technology and Innovation, Malaysia under the eScienceFund (01-01-03-SF0782). We express our appreciation to the anonymous reviewers for their constructive comments that helped improve the quality of this paper.	Abedi A., 2010, 2010 INT C WIR NETW, P577; Yan Y, 2010, IEEE WIREL COMMUN, V17, P96, DOI 10.1109/MWC.2010.5490984; Le JL, 2010, IEEE T MOBILE COMPUT, V9, P596, DOI 10.1109/TMC.2009.160; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Chachulski S, 2007, ACM SIGCOMM COMP COM, V37, P169, DOI 10.1145/1282427.1282400; Greco C, 2012, IEEE T MULTIMEDIA, V14, P1337, DOI 10.1109/TMM.2012.2195480; Yang YW, 2010, J NETW COMPUT APPL, V33, P422, DOI 10.1016/j.jnca.2010.02.003; Bellalta B, 2014, IEEE COMMUN LETT, V18, P708, DOI 10.1109/LCOMM.2014.022514.140206; Katti S, 2008, IEEE ACM T NETWORK, V16, P497, DOI 10.1109/TNET.2008.923722; Guo B, 2011, IEEE T VEH TECHNOL, V60, P1714, DOI 10.1109/TVT.2011.2121097; Sengupta S, 2010, IEEE ACM T NETWORK, V18, P1158, DOI 10.1109/TNET.2010.2042727; Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Zhang J, 2009, IEEE INFOCOM SER, P181, DOI 10.1109/INFCOM.2009.5061920; Yan Y, 2008, IEEE ICC, P2871, DOI 10.1109/ICC.2008.541; Peng YH, 2013, COMPUT ELECTR ENG, V39, P1822, DOI 10.1016/j.compeleceng.2013.02.007; Han S, 2008, IEEE IPCCC, P93, DOI 10.1109/PCCC.2008.4745146; Vassis D, 2005, IEEE NETWORK, V19, P21, DOI 10.1109/MNET.2005.1453395; Braves R., 2004, P 10 ANN INT C MOB C, P114, DOI DOI 10.1145/1023720.1023732]; De Couto D.S.J., 2003, P 9 ANN INT C MOB CO, P134, DOI 10.1145/938985.939000; Johnson D. B., 2001, MOBILITY SUPPORT MOB, P1; lqbal M. A., 2011, J NETW COMPUT APPL, V34, P1956; Ni B., 2006, 2 IEEE WORKSH WIR ME, P157, DOI DOI 10.1109/WIMESH.2006.288636; Perkins C.E., 1999, P 2 IEEE WORKSH MOB, V2, P90, DOI DOI 10.1109/MCSA.1999.749281]; Sun Jian-zhen, 2010, Journal of China Universities of Posts and Telecommunications, V17, DOI 10.1016/S1005-8885(09)60511-2; Villaseñor-González L., 2007, Ing. invest. y tecnol., V8, P45; Wang X., 2012, IEEE T PARALL DISTR, VXX, P1	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	OCT	2015	33						16	34		10.1016/j.adhoc.2015.04.002		19	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CS7ZB	WOS:000362304400002		
J	Yang, B; Cai, Y; Chen, Y; Jiang, XH				Yang, Bin; Cai, Ying; Chen, Yin; Jiang, Xiaohong			On the exact multicast delay in mobile ad hoc networks with f-cast relay	AD HOC NETWORKS			English	Article						Mobile ad hoc networks; Multicast delay; Two-hop relay; Packet replication	WIRELESS NETWORKS; CAPACITY; MANETS; INFRASTRUCTURE; TRADEOFFS	The study of multicast delay performance in mobile ad hoc networks (MANETs) is critical for supporting future multicast-intensive applications in such networks. Different from available works that mainly focus on the study of asymptotic scaling laws of the multicast delay in MANETs, this paper explores the exact multicast delay achievable in MANETs under a general multicast two-hop relay (M2HR)-(f,g) algorithm with packet replication limit f and multicast fanout g. In such an algorithm, each packet can be replicated up to f distinct relay nodes and it should be delivered to its g destination nodes through either its source node or these relay nodes. We first develop a Markov chain-based theoretical framework to model the complicated packet delivery process under the M2HR-(f, g) algorithm and then determine some basic probabilities related to packet delivery process. With the help of the theoretical framework and related basic packet delivery probabilities, the analytical models are further derived for both the mean value and variance of exact multicast delay. Finally, simulation and numerical results are provided to illustrate the accuracy of the multicast delay models as well as our theoretical findings. (C) 2015 Elsevier B.V. All rights reserved.	[Yang, Bin; Jiang, Xiaohong] Future Univ Hakodate, Sch Syst Informat Sci, Hakodate, Hokkaido 0418655, Japan; [Yang, Bin] Chuzhou Univ, Sch Comp & Informat Engn, Chuzhou 239000, Peoples R China; [Cai, Ying] Beijing Informat Sci & Technol Univ, Beijing Key Lab Internet Culture & Digital Dissem, Beijing 100101, Peoples R China; [Chen, Yin] Keio Univ, Grad Sch Media & Governance, Yokohama, Kanagawa 2528520, Japan	Yang, B (reprint author), Beijing Informat Sci & Technol Univ, Beijing Key Lab Internet Culture & Digital Dissem, Beijing 100101, Peoples R China.	yangbinchi@gmail.com; ycai@bistu.edu.cn; yin@ht.sfc.keio.ac.jp; jiang@fun.ac.jp			NSF of China [61472057]; NSF of Anhui Education Department [KJ2014A179, KJ201313188, KJ2011ZD06]; Chuzhou University [2014qd013, 2013RC005, 2012kj002Z]; Talented Team of Computer System Architecture	This work was supported by the NSF of China Grant 61472057, the NSF of Anhui Education Department Grants KJ2014A179, KJ201313188 and KJ2011ZD06, Chuzhou University Grants 2014qd013, 2013RC005 and 2012kj002Z, and the Talented Team of Computer System Architecture.	Nguyen HL, 2008, AD HOC NETW, V6, P32, DOI 10.1016/j.adhoc.2006.07.005; Kulkarni SR, 2004, IEEE T INFORM THEORY, V50, P1041, DOI 10.1109/TIT.2004.828055; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Cai Y, 2014, WIREL NETW, V20, P525, DOI 10.1007/s11276-013-0617-6; Shakkottai S, 2010, IEEE ACM T NETWORK, V18, P1691, DOI 10.1109/TNET.2010.2050901; Wang XB, 2011, IEEE ACM T NETWORK, V19, P1354, DOI 10.1109/TNET.2011.2109042; Zhang C, 2009, IEEE J SEL AREA COMM, V27, P662, DOI 10.1109/JSAC.2009.090608; Sakarindr P, 2007, IEEE WIREL COMMUN, V14, P8, DOI 10.1109/MWC.2007.4396938; Li Y, 2011, IEEE T VEH TECHNOL, V60, P2224, DOI 10.1109/TVT.2011.2149552; Wang XB, 2012, IEEE T COMMUN, V60, P3023, DOI 10.1109/TCOMM.2012.081512.110535; Zhang JB, 2014, IEEE T MOBILE COMPUT, V13, P1104, DOI 10.1109/TMC.2013.16; Li P, 2012, IEEE T MOBILE COMPUT, V11, P2073, DOI 10.1109/TMC.2011.239; Wang XB, 2011, IEEE T PARALL DISTR, V22, P729, DOI 10.1109/TPDS.2010.126; Li Z, 2013, AD HOC NETW, V11, P29, DOI 10.1016/j.adhoc.2012.04.002; Li P, 2012, IEEE T MOBILE COMPUT, V11, P427, DOI 10.1109/TMC.2011.54; Qian ZZ, 2014, IEEE T PARALL DISTR, V25, P1808, DOI 10.1109/TPDS.2013.79; Kong ZN, 2012, IEEE T INFORM THEORY, V58, P6894, DOI 10.1109/TIT.2012.2208573; Neely MJ, 2005, IEEE T INFORM THEORY, V51, P1917, DOI 10.1109/TIT.2005.847717; Wang WC, 2007, COMPUT NETW, V51, P4303, DOI 10.1016/j.comnet.2007.06.001; Xiang X, 2011, IEEE T MOBILE COMPUT, V10, P544, DOI 10.1109/TMC.2010.176; Franceschetti M, 2007, IEEE T INFORM THEORY, V53, P1009, DOI 10.1109/TIT.2006.890791; Chen Y, 2013, AD HOC NETW, V11, P1122, DOI 10.1016/j.adhoc.2012.12.003; Grinstead C., 1997, INTRO PROBABILITY; Hu C., 2009, MOBIHOC; Jeong J.P., 2013, COMPUT NETW, V57, P662; Li P., 2010, INFOCOM; Liu J., 2012, INFOCOM; Liu JJ, 2011, IEEE T WIREL COMMUN, V10, P2738, DOI 10.1109/TWC.2011.062111.101976; Rodolakis G., 2007, WWIC; Zhou Shan, 2010, INFOCOM	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	OCT	2015	33						71	86		10.1016/j.adhoc.2015.04.005		16	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CS7ZB	WOS:000362304400005		
J	Kobayashi, T; Kondo, T				Kobayashi, Toshimasa; Kondo, Takefumi			The Euclidean distortion of generalized polygons	ADVANCES IN GEOMETRY			English	Article						Distortion; generalized polygons	REGULAR GRAPHS; SPACES; EMBEDDINGS; GIRTH	We determine the Euclidean distortion of finite generalized polygons by means of semidefinite programing.	[Kobayashi, Toshimasa] Setsunan Univ, Fac Sci & Engn, Inst Fundamental Sci, Neyagawa, Osaka 5728508, Japan; [Kondo, Takefumi] Kagoshima Univ, Fac Sci, Dept Math & Comp Sci, Kagoshima 8900065, Japan	Kobayashi, T (reprint author), Setsunan Univ, Fac Sci & Engn, Inst Fundamental Sci, 17-8 Ikeda Nakamachi, Neyagawa, Osaka 5728508, Japan.	kobayashi@mpg.setsunan.ac.jp; takefumi@sci.kagoshima-u.ac.jp			JST; CREST	We would like to thank Professor Shin Nayatani, Professor Hiroyasu Izeki and Tetsu Toyoda for valuable discussions. We are also grateful to Hirotake Kurihara and Takayuki Okuda for helpful comments and interest on this paper. The second author is supported by JST, CREST, "A mathematical challenge to a new phase of material sciences".	Matousek J, 1999, ISRAEL J MATH, V114, P221, DOI 10.1007/BF02785579; Linial N, 2002, GEOM FUNCT ANAL, V12, P380, DOI 10.1007/s00039-002-8251-y; LINIAL N, 1995, COMBINATORICA, V15, P215, DOI 10.1007/BF01200757; Izeki H, 2005, GEOMETRIAE DEDICATA, V114, P147, DOI 10.1007/s10711-004-1843-y; Bannai E., 1984, ALGEBRAIC COMBINATOR, VMR882540 (87m:05001); Biggs N., 1974, ALGEBRAIC GRAPH THEO; BOURGAIN J, 1985, ISRAEL J MATH, V52, P46, DOI 10.1007/BF02776078; Brouwer A. E., 1989, DISTANCE REGULAR GRA; Enflo P., 1969, ARK MAT, V8, P103; Feit W., 1964, J ALGEBRA, V1, P114, DOI DOI 10.1016/0021-8693(64)90028-6; Hughes D. R., 1957, CAN J MATH, V9, P378, DOI 10.4153/CJM-1957-045-0; Linial N, 2000, J COMB THEORY B, V79, P157, DOI 10.1006/jctb.2000.1953; Matousek J., 2002, LECT DISCRETE GEOMET; Ronan M., 2009, LECT BUILDINGS, VMR2560094 (2010i:20002); SOLE P, 1992, J COMB THEORY B, V56, P239, DOI 10.1016/0095-8956(92)90020-X; Vallentin F, 2008, J COMB THEORY B, V98, P95, DOI 10.1016/j.jctb.2007.06.002; Veblen O., 1907, T AM MATH SOC, V8, P379	17	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1615-715X	1615-7168		ADV GEOM	Adv. Geom.	OCT	2015	15	4					499	506		10.1515/advgeom-2015-0023		8	Mathematics	Mathematics	CT0UF	WOS:000362512000009		
J	Kim, HS; Nabi, M; Kimura, I; Shimizu, Y				Kim, Hyung Suk; Nabi, Mohamed; Kimura, Ichiro; Shimizu, Yasuyuki			Computational modeling of flow and morphodynamics through rigid-emergent vegetation	ADVANCES IN WATER RESOURCES			English	Article						Morphodynamics; Large eddy simulation; Sediment transport; Scour; Vegetation	LOCAL SCOUR; NUMERICAL-SIMULATION; COHERENT STRUCTURES; SEDIMENT TRANSPORT; CIRCULAR-CYLINDER; SMALL SPHERE; PARTICLE; PILE; LIFT; HOLE	The flow and bed morphodynamics through rigid, emergent cylinders which are regarded as vegetation are computed using a three-dimensional numerical model by employing a large-eddy simulation approach with a ghost-cell immersed-boundary method. The scour and transport processes are solved using sophisticated sediment transport and morphodynamic models in a physics-based manner. In an infinitely long patch, the vegetation density significantly influences the flow and morphodynamic behavior. Under a low vegetation density, the scour and deposition are similar to those of an isolated cylinder, while there are significant variations at a higher vegetation density. The cylinder-interval variation has a negligible impact on the maximum scour depth, which is similar to that in an isolated cylinder case. In the high-vegetation-density case, a decrease in cylinders in a selected domain decreases the physical realism of the morphodynamic process. The scour and transport processes in a partly vegetated small patch show a significant difference, compared to the long patch. In this case, local and global scours are observed around the small patch and the maximum scour always occurs around the front cylinders (i.e., leading edge). The scour depth increases with a decrease in the cylinder interval, and the computed scour depths and trends agree well with the measured data in the literature. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Hyung Suk] Korea Inst Civil Engn & Bldg Technol, River & Coastal Res Div, Goyang Si 411712, South Korea; [Nabi, Mohamed] Deltares, Deltares Software Ctr, NL-2629 HD Delft, Netherlands; [Kimura, Ichiro; Shimizu, Yasuyuki] Hokkaido Univ, Grad Sch Engn, Div Field Engn Environm, Sapporo, Hokkaido 0608628, Japan	Kim, HS (reprint author), Korea Inst Civil Engn & Bldg Technol, River & Coastal Res Div, 283 Goyangdae Ro, Goyang Si 411712, South Korea.	hskim0824@gmail.com; mohamed.nabi@deltares.nl; i-kimu2@eng.hokudai.ac.jp; yasu@eng.hokudai.ac.jp			Korea Institute of Civil Engineering and Building Technology [2015-0177-1-1]	This study was financially supported by the Korea Institute of Civil Engineering and Building Technology (project: Development of Floodplain Maintenance Technology for Enhancement of Waterfront Values, Project number: 2015-0177-1-1).	Kirkil G, 2009, J HYDRAUL ENG-ASCE, V135, P888, DOI 10.1061/(ASCE)HY.1943-7900.0000101; Kirkil G, 2008, J HYDRAUL ENG-ASCE, V134, P572, DOI 10.1061/(ASCE)0733-9429(2008)134:5(572); Schmeeckle MW, 2003, SEDIMENTOLOGY, V50, P279, DOI 10.1046/j.1365-3091.2003.00555.x; DARGAHI B, 1990, J HYDRAUL ENG-ASCE, V116, P1197, DOI 10.1061/(ASCE)0733-9429(1990)116:10(1197); Khosronejad A, 2012, ADV WATER RESOUR, V37, P73, DOI 10.1016/j.advwatres.2011.09.013; Rominger JT, 2010, J HYDRAUL ENG-ASCE, V136, P994, DOI 10.1061/(ASCE)HY.1943-7900.0000215; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Zhao M, 2010, COAST ENG, V57, P709, DOI 10.1016/j.coastaleng.2010.03.002; SAFFMAN PG, 1965, J FLUID MECH, V22, P385, DOI 10.1017/S0022112065000824; GARCIA M, 1995, EXP FLUIDS, V19, P16, DOI 10.1007/BF00192229; Zong LJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009516; Choi SU, 2004, J HYDRAUL RES, V42, P3, DOI 10.1080/00221686.2004.9641178; Ataie-Ashtiani B, 2006, J HYDRAUL ENG-ASCE, V132, P1100, DOI 10.1061/(ASCE)0733-9429(2006)132:10(1100); Kim HS, 2014, ADV WATER RESOUR, V70, P131, DOI 10.1016/j.advwatres.2014.04.018; Rominger JT, 2011, J FLUID MECH, V680, P636, DOI 10.1017/jfm.2011.199; Liu X, 2008, COAST ENG, V55, P800, DOI 10.1016/j.coastaleng.2008.02.012; Olsen NRB, 1998, J HYDRAUL RES, V36, P579; Liu D, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001042; Stoesser T, 2010, J HYDRAUL ENG-ASCE, V136, P1003, DOI 10.1061/(ASCE)HY.1943-7900.0000153; Nagata N, 2005, J HYDRAUL ENG-ASCE, V131, P1074, DOI 10.1061/(ASCE)0733-9429(2005)131:12(1074); Follett EM, 2012, GEOMORPHOLOGY, V179, P141, DOI 10.1016/j.geomorph.2012.08.006; Lopez F, 1998, WATER RESOUR RES, V34, P2341, DOI 10.1029/98WR01922; Nabi M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011911; Tal M, 2010, EARTH SURF PROC LAND, V35, P1014, DOI 10.1002/esp.1908; MAXEY MR, 1983, PHYS FLUIDS, V26, P883, DOI 10.1063/1.864230; Jang CL, 2007, J HYDRAUL RES, V45, P763; Zong LJ, 2010, GEOMORPHOLOGY, V116, P363, DOI 10.1016/j.geomorph.2009.11.020; Stoesser T, 2009, TRANSPORT POROUS MED, V78, P347, DOI 10.1007/s11242-009-9371-8; Paik J, 2010, J HYDRAUL ENG-ASCE, V136, P981, DOI 10.1061/(ASCE)HY.1943-7900.0000089; Yager EM, 2013, J GEOPHYS RES-EARTH, V118, P1585, DOI 10.1002/jgrf.20085; MCLAUGHLIN JB, 1991, J FLUID MECH, V224, P261, DOI 10.1017/S0022112091001751; Nabi M, 2013, WATER RESOUR RES, V49, P4775, DOI 10.1002/wrcr.20303; Nicolle A, 2011, J FLUID MECH, V679, P1, DOI 10.1017/jfm.2011.77; Roulund A, 2005, J FLUID MECH, V534, P351, DOI [10.1017/S0022112005004507, 10.1017/S002112005004507]; Bennett SJ, 2008, EARTH SURF PROC LAND, V33, P890, DOI 10.1002/esp.1581; Escauriaza C, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001749; HUNT J., 1988, CTRS88; Kirkil SM, 2008, J HYDRAUL ENG, V134, P572; MEI R, 1992, INT J MULTIPHAS FLOW, V18, P145, DOI 10.1016/0301-9322(92)90012-6; Melville BW, 2000, BRIDGE SCOUR; Nabi M, 2013, WATER RESOUR RES, V49, P5930, DOI 10.1002/wrcr.20457; Nifio Y, 1998, HYDROLOG PROCESS, V12, P1197; Nifio Y, 1998, J HYDRAUL ENG, V124, P1014; Raudkivi AJ, 1990, LOOSE BOUNDARY HYDRA; Schmeeckle MW, 2001, WATER RESOUR RES, V37; Shimizu Y., 1994, J HYDROSCIENCE HYDRA, V11, P57; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Summer B.M., 2002, MECH SCOUR MARINE EN, V17; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1494; White BL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005651	50	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1708	1872-9657		ADV WATER RESOUR	Adv. Water Resour.	OCT	2015	84						64	86		10.1016/j.advwatres.2015.07.020		23	Water Resources	Water Resources	CS7ZQ	WOS:000362305900007		
J	Tsukue, R; Okamoto, Y; Yoshino, A; Kunisato, Y; Takagaki, K; Takebayashi, Y; Tanaka, K; Konuma, K; Tsukue, I; Yamawaki, S				Tsukue, Ryotaro; Okamoto, Yasumasa; Yoshino, Atsuo; Kunisato, Yoshihiko; Takagaki, Koki; Takebayashi, Yoshitake; Tanaka, Keisuke; Konuma, Kyohei; Tsukue, Ichiro; Yamawaki, Shigeto			Do Individuals with Alcohol Dependence Show Higher Unfairness Sensitivity? The Relationship Between Impulsivity and Unfairness Sensitivity in Alcohol-Dependent Adults	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Unfairness; Impulsivity; Alcoholic Dependence; Ultimatum Game; Delay Discounting	SOCIAL DECISION-MAKING; DSM-III-R; NICOTINE DEPENDENCE; REWARDS; DELAY; QUESTIONNAIRE; DISORDERS; IQ	BackgroundAlcohol-dependent patients are known to be generally more unfairness sensitive. The ultimatum game (UG) is an experimental task designed to provoke feelings of perceived unfairness. A previous study using the UG has reported more unfairness sensitivity in patients with alcohol dependence than in a nondependent control group; it has been speculated that this increased sensitivity might be due to a difficulty in impulse control. However, the mechanism of this relationship has not been clarified. Therefore, the relationship between unfairness sensitivity in interpersonal relationships and impulsivity was investigated using UG and delay discounting (DD) paradigms. MethodsSubjects were 32 individuals with alcohol dependency and 36 healthy control individuals; both groups performed UG and DD tasks. ResultsParticipants with alcohol dependence rejected monetary offers deemed unfair at a significantly higher rate than did control participants. Moreover, the proportion of accepting unfairness was negatively correlated with impulsivity in patients with alcohol dependence. ConclusionsPerceived unfairness is related to impulsivity in patients with alcohol dependence. These results provide insights concerning the psychopathology of alcohol dependence.	[Tsukue, Ryotaro; Konuma, Kyohei; Tsukue, Ichiro] Senogawa Hosp, Aki, Hiroshima 7390323, Japan; [Okamoto, Yasumasa; Yoshino, Atsuo; Takagaki, Koki; Yamawaki, Shigeto] Hiroshima Univ, Grad Sch Biomed Sci, Dept Psychiat & Neurosci, Div Frontier,Minami Ku, Hiroshima 7348551, Japan; [Kunisato, Yoshihiko] Senshu Univ, Sch Human Sci, Dept Psychol, Kanagawa, Japan; [Takebayashi, Yoshitake] Risk Anal Res Ctr, Inst Stat Math, Tokyo, Japan; [Tanaka, Keisuke] Hyogo Univ Teachers Educ, Career Dev Ctr, Kato, Hyogo, Japan	Tsukue, R (reprint author), Senogawa Hosp, 4-11-13 Nakanohigashi, Aki, Hiroshima 7390323, Japan.	rtsukue@senoriver.com					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Estle SJ, 2006, MEM COGNITION, V34, P914, DOI 10.3758/BF03193437; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Monterosso J, 2012, BIOL PSYCHIAT, V72, P107, DOI 10.1016/j.biopsych.2012.03.012; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Kawakami N, 1999, ADDICT BEHAV, V24, P155, DOI 10.1016/S0306-4603(98)00127-0; Du WJ, 2002, PSYCHOL REC, V52, P479; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Lejuez CW, 2010, ALCOHOL CLIN EXP RES, V34, P1334, DOI 10.1111/j.1530-0277.2010.01217.x; Green L, 2013, J EXP ANAL BEHAV, V100, P269, DOI 10.1002/jeab.45; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; Takahashi T, 2007, NEUROENDOCRINOL LETT, V28, P659; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; Jarmolowicz DP, 2013, DRUG ALCOHOL DEPEN, V131, P320, DOI 10.1016/j.drugalcdep.2012.12.014; Brevers D, 2013, DRUG ALCOHOL DEPEN, V133, P772, DOI 10.1016/j.drugalcdep.2013.08.013; MacKillop J, 2007, J STUD ALCOHOL DRUGS, V68, P785; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Mikami I, 1999, JPN J CANCER RES, V90, P1071; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Madden GJ, 2004, EXP CLIN PSYCHOPHARM, V12, P251, DOI 10.1037/1064-1297.12.4.251; Beck A. T., 1996, BECK DEPRESSION INVE; Conners K, 1994, CONNERS CONTINUOUS P; COSTANTI.AF, 1973, J GENET PSYCHOL, V123, P309; Dickman SJ, 1993, IMPULSIVITY INFORM T; Tanaka SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001333; Gintis Herbert, 2005, MORAL SENTIMENTS MAT; Hiro Hisanori, 1996, Japanese Journal of Alcohol Studies and Drug Dependence, V31, P437; Nelson HE, 1982, NATL ADULT READING T; Thaler R., 1985, MARKET SCI, V4, P199, DOI DOI 10.1287/MKSC.4.3.199	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	OCT	2015	39	10					2016	2021		10.1111/acer.12832		6	Substance Abuse	Substance Abuse	CS9OI	WOS:000362420100017		
J	Takai, T; Izuhara, K				Takai, Toshiro; Izuhara, Kenji			Allergens in modern society: Updated catalogs and future prospects	ALLERGOLOGY INTERNATIONAL			English	Editorial Material							ASTHMA		[Takai, Toshiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Izuhara, Kenji] Saga Med Sch, Div Med Biochem, Dept Biomol Sci, Saga 8498501, Japan	Izuhara, K (reprint author), Saga Med Sch, Div Med Biochem, Dept Biomol Sci, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp					Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Fujimura T, 2015, ALLERGOL INT, V64, P312, DOI 10.1016/j.alit.2015.05.008; Fukutomi Y, 2015, ALLERGOL INT, V64, P321, DOI 10.1016/j.alit.2015.05.007; Shankardass K, 2009, P NATL ACAD SCI USA, V106, P12406, DOI 10.1073/pnas.0812910106; Chen E, 2007, AM J RESP CRIT CARE, V176, P644, DOI 10.1164/rccm.200610-1473OC; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; Chung CH, 2008, ENGL J MED, V358, P1109; Matsuo H, 2015, ALLERGOL INT, V64, P332, DOI 10.1016/j.alit.2015.06.009; Odajima H, 2015, ALLERGOL INT, V64, P364, DOI 10.1016/j.alit.2015.05.006; Stewart GA, 2015, J ALLERGY CLIN IMMUN, V135, P549, DOI 10.1016/j.jaci.2014.12.934; Tabalipa FD, 2015, ALLERGOL INT, V64, P344, DOI 10.1016/j.alit.2015.04.003; Tanimoto H, 2015, CLIN EXP ALLERGY; Woodfolk JA, 2015, ALLERGOL INT, V64, P295, DOI 10.1016/j.alit.2015.06.001; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	15	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					293	294		10.1016/j.alit.2015.08.003		2	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200001		
J	Fujimura, T; Kawamoto, S				Fujimura, Takashi; Kawamoto, Seiji			Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy	ALLERGOLOGY INTERNATIONAL			English	Review						Allergen-specific immunotherapy; Component-resolved diagnosis; Japanese cedar pollinosis; Oral allergy syndrome; Seasonal rhinitis	CRYPTOMERIA-JAPONICA POLLEN; THAUMATIN-LIKE PROTEINS; 2ND MAJOR ALLERGEN; CRY-J-I; SUBLINGUAL IMMUNOTHERAPY; MOLECULAR-CLONING; BIRCH POLLEN; IMMUNOGLOBULIN-E; CYPRESS POLLEN; TOMATO FRUIT	The high prevalence of Japanese cedar pollinosis in Japan is associated with a negative impact on the quality of life of patients, as well as significant loss of productivity among the workforce in early spring, thus representing a serious social problem. Furthermore, the prevalence is increasing, and has risen by more than 10% in this decade. Cry j 1 and Cry j 2 were identified as the major allergens in Japanese cedar pollen (JCP), and in 2004, the existence of other major and minor allergens were revealed by a combination of two-dimensional electrophoresis and immunoblotting analysis. Allergenome analysis identified a chitinase, a lipid transfer protein, a serine protease, and an aspartic protease as novel IgE-reactive allergens in patients with JCP allergy. Thaumatin-like protein (Cry j 3) was shown to be homologous to Jun a 3, a major allergen from mountain cedar pollen. Isoflavone reductase-like protein was also characterized in a study of a JCP cDNA library. The characterization of component allergens is required to clarify the sensitizer or cross-reactive elicitor allergens for component-resolved diagnosis (CRD). Increasing evidence from numerous clinical trials indicates that CRD can be used to design effective allergen-specific immunotherapy. In this review, we summarize the eight characterized JCP allergens and discuss the impact of CRD and characterization of novel allergens on allergen-specific immunotherapy. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Fujimura, Takashi] RIKEN, Inst Phys & Chem Res, Ctr Integrat Med Sci, RIKEN TORII Joint Res Team, Yokohama, Kanagawa, Japan; [Kawamoto, Seiji] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Hiroshima 7398530, Japan	Kawamoto, S (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398530, Japan.	takashi.fujimura@riken.jp; skawa@hiroshima-u.ac.jp	Kawamoto, Seiji/F-3423-2015				Akdis Mübeccel, 2014, World Allergy Organ J, V7, P23, DOI 10.1186/1939-4551-7-23; Di Felice G, 2001, INT ARCH ALLERGY IMM, V125, P280, DOI 10.1159/000053828; Ibrahim ARN, 2010, BIOSCI BIOTECH BIOCH, V74, P504, DOI 10.1271/bbb.90685; Sakaguchi M, 1997, IMMUNOLOGY, V91, P161, DOI 10.1046/j.1365-2567.1997.00255.x; Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Kouzaki H, 2013, AM J RESP CELL MOL, V49, P741, DOI 10.1165/rcmb.2012-0304OC; Fujimura T, 2007, ALLERGY, V62, P547, DOI 10.1111/j.1398-9995.2007.01331.x; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034; Stringari G, 2014, J ALLERGY CLIN IMMUN, V134, P75, DOI 10.1016/j.jaci.2014.01.042; Sone Toshio, 2009, Allergology International, V58, P237, DOI 10.2332/allergolint.08-OA-0027; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Tripodi S, 2012, J ALLERGY CLIN IMMUN, V129, P834, DOI 10.1016/j.jaci.2011.10.045; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Ibrahim ARN, 2010, INT ARCH ALLERGY IMM, V152, P207, DOI 10.1159/000283026; SONE T, 1994, BIOCHEM BIOPH RES CO, V199, P619, DOI 10.1006/bbrc.1994.1273; Abou Chakra O, 2011, INT ARCH ALLERGY IMM, V154, P128, DOI 10.1159/000320227; Fujimura T, 2005, CLIN EXP ALLERGY, V35, P234, DOI 10.1111/j.1365-2222.2005.02167.x; Fujimura T, 2011, CLIN IMMUNOL, V139, P65, DOI 10.1016/j.clim.2010.12.022; Heiss S, 1999, J INVEST DERMATOL, V113, P830, DOI 10.1046/j.1523-1747.1999.00796.x; Vieira T, 2012, ALLERGOL IMMUNOPATH, V40, P172, DOI 10.1016/j.aller.2011.03.013; Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; SAKAGUCHI M, 1990, ALLERGY, V45, P309, DOI 10.1111/j.1398-9995.1990.tb00501.x; Cromwell O, 2011, J ALLERGY CLIN IMMUN, V127, P865, DOI 10.1016/j.jaci.2011.01.047; Kondo Y, 1997, ALLERGY, V52, P455, DOI 10.1111/j.1398-9995.1997.tb01029.x; Breiteneder H, 2004, ALLERGY, V59, P479, DOI 10.1046/j.1398-9995.2003.00421.x; Asero R, 2005, J ALLERGY CLIN IMMUN, V116, P1036, DOI 10.1016/j.jaci.2005.08.019; KOMIYAMA N, 1994, BIOCHEM BIOPH RES CO, V201, P1021, DOI 10.1006/bbrc.1994.1804; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Kondo Y, 2002, CLIN EXP ALLERGY, V32, P590, DOI 10.1046/j.0954-7894.2002.01337.x; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4; Canonica GW, 2007, ALLERGY, V62, P317, DOI 10.1111/j.1398-9995.2006.01312.x; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X; Ball T, 1999, EUR J IMMUNOL, V29, P2026, DOI 10.1002/(SICI)1521-4141(199906)29:06<2026::AID-IMMU2026>3.0.CO;2-2; Saito Y, 2014, P JPN ACAD B-PHYS, V90, P203, DOI 10.2183/pjab.90.203; Aberer W, 2007, J INVEST ALLERG CLIN, V17, P131; Fujimura T, 2004, INT ARCH ALLERGY IMM, V133, P125, DOI 10.1159/000076438; Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151; Futamura N, 2006, TREE PHYSIOL, V26, P51; Grote M, 2001, J ALLERGY CLIN IMMUN, V108, P109, DOI 10.1067/mai.2001.116431; Dreborg S, 2012, INT ARCH ALLERGY IMM, V158, P63, DOI 10.1159/000330649; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288; Murakami D, 2015, ALLERGOL INT, V64, P161, DOI 10.1016/j.alit.2014.10.009; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; HINO K, 1995, J BIOCHEM-TOKYO, V117, P289, DOI 10.1093/jb/117.2.289; Traidl-Hoffmann C, 2002, J ALLERGY CLIN IMMUN, V109, P831, DOI 10.1067/mai.2002.124655; Barlow JL, 2014, CURR OPIN ALLERGY CL, V14, P397, DOI 10.1097/ACI.0000000000000090; Wachholz PA, 2003, CLIN EXP ALLERGY, V33, P1171, DOI 10.1046/j.1365-2222.2003.01765.x; Rossi RE, 2004, INT ARCH ALLERGY IMM, V135, P44, DOI 10.1159/000080042; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Goto Y, 2004, CLIN EXP ALLERGY, V34, P1754, DOI 10.1111/j.1365-2222.2004.02108.x; Yasueda H, 2000, CLIN EXP ALLERGY, V30, P546; Soman KV, 2000, BIOPHYS J, V79, P1601; Kinaciyan T, 2007, J ALLERGY CLIN IMMUN, V119, P937, DOI 10.1016/j.jaci.2006.11.010; Charpin D, 2005, ALLERGY, V60, P293, DOI 10.1111/j.1398-9995.2005.00731.x; Kawamoto S, 2002, CLIN EXP ALLERGY, V32, P1064, DOI 10.1046/j.1365-2222.2002.01405.x; Sastre J, 2010, CLIN EXP ALLERGY, V40, P1442, DOI 10.1111/j.1365-2222.2010.03585.x; Futamura N, 2002, BIOSCI BIOTECH BIOCH, V66, P2495, DOI 10.1271/bbb.66.2495; Moverare R, 2002, ALLERGY, V57, P423, DOI 10.1034/j.1398-9995.2002.13248.x; Araki H, 1960, ARERUGI, V9, P648; Baba K, 2008, PROG MED, V28, P2001; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Fujimura T, 2012, J ALLERGY CAIRO, V2012, DOI DOI 10.1155/2012/381737; Gunawan Hendra, 2008, Allergol Int, V57, P83, DOI 10.2332/allergolint.O-07-507; Horiguchi Shigetoshi, 2008, Arerugi, V57, P558; HORIGUCHI S, 1964, Arerugi, V13, P16; Ibrahim Ahmed Ragaa Nour, 2010, World Allergy Organ J, V3, P262, DOI 10.1097/WOX.0b013e318201d81d; Koyasu S, 2015, NAT IMMUNOL, V16, P133, DOI 10.1038/ni.3080; Marcucci Francesco, 2012, Clin Mol Allergy, V10, P7, DOI 10.1186/1476-7961-10-7; Nishie H, 2012, ISRN DERMATOL, V2012; Noon L, 1911, LANCET, V1, P1572; Okuda M, 2002, JIBI TO RINSYOU, V48, P99; Sawatani M, 1993, Arerugi, V42, P738; Sircar Gaurab, 2014, Methods Mol Biol, V1184, P165, DOI 10.1007/978-1-4939-1115-8_9; Van Vaerenbergh M, 2015, MOL IMMUNOL, V63, P449, DOI 10.1016/j.molimm.2014.09.018; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yasue H, 1996, Arerugi, V45, P416; Yasueda Hiroshi, 1997, Allergology International, V46, P135, DOI 10.2332/allergolint.46.135	79	2	2	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					312	320		10.1016/j.alit.2015.05.008		9	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200004		
J	Fukutomi, Y; Taniguchi, M				Fukutomi, Yuma; Taniguchi, Masami			Sensitization to fungal allergens: Resolved and unresolved issues	ALLERGOLOGY INTERNATIONAL			English	Review						Allergen; Allergy; Cross-reactivity; Fungi; Molecular-based allergy diagnostics	ASPERGILLUS-FUMIGATUS ALLERGENS; RESPIRATORY HEALTH SURVEY; DEPENDENT MANNITOL DEHYDROGENASE; DELAYED-TYPE HYPERSENSITIVITY; YEAST MALASSEZIA-SYMPODIALIS; DAILY ASTHMA SEVERITY; IGE-BINDING PROTEIN; HOUSE-DUST MITE; CANDIDA-ALBICANS; ATOPIC-DERMATITIS	Exposure and sensitization to fungal allergens can promote the development and worsening of allergic diseases. Although numerous species of fungi have been associated with allergic diseases in the literature, the significance of fungi from the genera Alternaria, Cladosporium, Penicillium, Aspergillus, and Malassezia has been well documented. However, it should be emphasized that the contribution of different fungal allergens to allergic diseases is not identical, but species-specific. Alternaria and Cladosporium species are considered to be important outdoor allergens, and sensitization and exposure to species of these genera is related to the development of asthma and rhinitis, as well as epidemics of asthma exacerbation, including life-threatening asthma exacerbation. In contrast, xerophilic species of Penicillium and Aspergillus, excluding Aspergillus fumigatus, are implicated in allergic diseases as indoor allergens. A. fumigatus has a high capacity to colonize the bronchial tract of asthmatic patients, causing severe persistent asthma and low lung function, and sometimes leading to allergic bronchopulmonary aspergillosis. Malassezia are common commensals of healthy skin, although they are also associated with atopic dermatitis, especially on the head and neck, but not with respiratory allergies. Despite its importance in the management of allergic diseases, precise recognition of species-specific IgE sensitization to fungal allergens is often challenging because the majority of fungal extracts exhibit broad cross-reactivity with taxonomically unrelated fungi. Recent progress in gene technology has contributed to the identification of specific and cross-reactive allergen components from different fungal sources. However, data demonstrating the clinical relevance of IgE reactivity to these allergen components are still insufficient. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Fukutomi, Yuma; Taniguchi, Masami] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 2520392, Japan	Fukutomi, Y (reprint author), Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	y-fukutomi@sagamihara-hosp.gr.jp			Health Labour Sciences Research Grant on allergic disease and immunology from the Ministry of Health Labour and Welfare of Japan	The authors would like to thank all those who were involved in data collection and processing; in particular, Dr. Maiko Watanabe, Yoichi Kamata, and Kosuke Takatori from National Institute of Health Science (of Japan) for providing fungal strains, Dr. Katsuhisa Uchida from Teikyo University for providing fungal extracts, Akemi Saito from Sagamihara National Hospital for the fungal cultures, and Yuji Kawakami from FCG Research Institute Inc. for advice on the taxonomic tree of allergenic fungi. This study was partially supported by the Health Labour Sciences Research Grant on allergic disease and immunology from the Ministry of Health Labour and Welfare of Japan.	Agarwal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061105; Minami T, 2015, ALLERGOL INT, V64, P90, DOI 10.1016/j.alit.2014.08.004; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Fernandez C, 2011, CLIN EXP ALLERGY, V41, P649, DOI 10.1111/j.1365-2222.2010.03645.x; Devos SA, 2000, ALLERGY, V55, P1056, DOI 10.1034/j.1398-9995.2000.00782.x; Brodska P, 2014, DERMATITIS, V25, P120, DOI 10.1097/DER.0000000000000040; Yasueda H, 1998, BIOCHEM BIOPH RES CO, V248, P240, DOI 10.1006/bbrc.1998.8944; Kaffenberger BH, 2014, J AM ACAD DERMATOL, V71, P480, DOI 10.1016/j.jaad.2014.04.045; Svejgaard EI, 2004, J EUR ACAD DERMATOL, V18, P445, DOI 10.1111/j.1468-3083.2004.00963.x; Zureik M, 2002, BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411; DOEKES G, 1993, ALLERGY, V48, P394, DOI 10.1111/j.1398-9995.1993.tb00736.x; Thompson GR, 2012, J ALLERGY CLIN IMMUN, V129, P321, DOI 10.1016/j.jaci.2011.11.039; Neukirch C, 1999, J ALLERGY CLIN IMMUN, V103, P709, DOI 10.1016/S0091-6749(99)70247-2; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; STEWART GA, 1993, CLIN EXP ALLERGY, V23, P154, DOI 10.1111/j.1365-2222.1993.tb00311.x; SPORIK RB, 1993, CLIN EXP ALLERGY, V23, P326, DOI 10.1111/j.1365-2222.1993.tb00330.x; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P348, DOI 10.1111/j.1365-2222.2009.03370.x; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Schneider PB, 2006, CLIN EXP ALLERGY, V36, P1513, DOI 10.1111/j.1365-2222.2006.02582.x; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Chowdhary A, 2013, MYCOSES, V56, P1, DOI 10.1111/j.1439-0507.2012.02190.x; Bergamini BM, 2004, ALLERGY, V59, P746, DOI 10.1111/j.1398-9995.2004.00423.x; Crameri R, 2009, MYCOSES, V52, P99, DOI 10.1111/j.1439-0507.2008.01644.x; Gent JF, 2012, ENVIRON RES, V118, P86, DOI 10.1016/j.envres.2012.07.005; Vailes L, 2001, J ALLERGY CLIN IMMUN, V107, P641, DOI 10.1067/mai.2001.114118; Andersson A, 2003, MED MYCOL, V41, P479, DOI 10.1080/13693780310001615367; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Zargari A, 2003, ALLERGY, V58, P306, DOI 10.1034/j.1398-9995.2003.00082.x; Akiyama K, 1996, ALLERGY, V51, P887; Lindborg M, 1999, J INVEST DERMATOL, V113, P156, DOI 10.1046/j.1523-1747.1999.00661.x; Crameri R, 1998, INT IMMUNOL, V10, P1211, DOI 10.1093/intimm/10.8.1211; Bafadhel M, 2014, EUR RESPIR J, V43, P64, DOI 10.1183/09031936.00162912; Burge HA, 2002, J ALLERGY CLIN IMMUN, V110, P544, DOI 10.1067/mai.2002.128674; Jones R, 2011, INDOOR AIR, V21, P156, DOI 10.1111/j.1600-0668.2010.00692.x; Fairs A, 2013, INDOOR AIR, V23, P275, DOI 10.1111/ina.12020; Andersson A, 2004, EUR J BIOCHEM, V271, P1885, DOI 10.1111/j.1432-1033.2004.04098.x; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Chen CH, 2014, CHEST, V146, P123, DOI 10.1378/chest.13-2129; Staubach P, 2009, MYCOSES, V52, P334, DOI 10.1111/j.1439-0507.2008.01601.x; Kosonen J, 2005, EXP DERMATOL, V14, P551, DOI 10.1111/j.0906-6705.2005.00328.x; Hay RJ, 2001, J EUR ACAD DERMATOL, V15, P229, DOI 10.1046/j.1468-3083.2001.00214.x; NERMES M, 1994, CLIN EXP ALLERGY, V24, P318, DOI 10.1111/j.1365-2222.1994.tb00241.x; Menzies D, 2011, ALLERGY, V66, P679, DOI 10.1111/j.1398-9995.2010.02542.x; Canova C, 2013, EUR RESPIR J, V42, P935, DOI 10.1183/09031936.00097412; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775; AKIYAMA K, 1981, CLIN ALLERGY, V11, P343, DOI 10.1111/j.1365-2222.1981.tb01604.x; TANAKA M, 1994, ARCH DERMATOL, V130, P1393, DOI 10.1001/archderm.130.11.1393; Mitsui C, 2012, ALLERGOL INT, V61, P501, DOI 10.2332/allergolint.12-LE-0421; Mari A, 2003, CLIN EXP ALLERGY, V33, P1429, DOI 10.1046/j.1365-2222.2003.01783.x; RANTIOLEHTIMAKI A, 1989, ALLERGY, V44, P18, DOI 10.1111/j.1398-9995.1989.tb00440.x; Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Cazzoletti L, 2007, J ALLERGY CLIN IMMUN, V120, P1360, DOI 10.1016/j.jaci.2007.09.019; Rasool O, 2000, EUR J BIOCHEM, V267, P4355, DOI 10.1046/j.1432-1327.2000.01475.x; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622; Chou H, 2003, ANN ALLERG ASTHMA IM, V90, P248; Asero R, 2001, ANN ALLERG ASTHMA IM, V86, P283; Baxter CG, 2013, CHEST, V143, P1351, DOI 10.1378/chest.12-1363; Chew GL, 2003, ALLERGY, V58, P13, DOI 10.1034/j.1398-9995.2003.00013.x; Garrett MH, 1998, CLIN EXP ALLERGY, V28, P459; Mayser P, 2000, ACTA DERM-VENEREOL, V80, P357, DOI 10.1080/000155500459303; Rosenbaum PF, 2010, J EXPO SCI ENV EPID, V20, P503, DOI 10.1038/jes.2009.27; Zargari A, 1999, J ALLERGY CLIN IMMUN, V103, P877, DOI 10.1016/S0091-6749(99)70433-1; ARRUDA LK, 1990, J EXP MED, V172, P1529, DOI 10.1084/jem.172.5.1529; Bowyer P, 2007, MED MYCOL, V45, P17, DOI 10.1080/13693780600972907; Perzanowski MS, 1998, J ALLERGY CLIN IMMUN, V101, P626; Delfino RJ, 1996, AM J RESP CRIT CARE, V154, P633; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Kurup VP, 2000, CLIN EXP ALLERGY, V30, P988, DOI 10.1046/j.1365-2222.2000.00837.x; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Scalabrin DMF, 1999, J ALLERGY CLIN IMMUN, V104, P1273, DOI 10.1016/S0091-6749(99)70024-2; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; DEUELL B, 1991, J IMMUNOL, V147, P96; Meng J, 2012, CLIN EXP ALLERGY, V42, P1448, DOI 10.1111/j.1365-2222.2012.04001.x; Hamilos Daniel L, 2010, Proc Am Thorac Soc, V7, P245, DOI 10.1513/pats.200909-098AL; Woodfolk JA, 2000, J IMMUNOL, V165, P4379; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Sunyer J, 2000, INT J EPIDEMIOL, V29, P125, DOI 10.1093/ije/29.1.125; Agbetile J, 2012, CLIN EXP ALLERGY, V42, P782, DOI 10.1111/j.1365-2222.2012.03987.x; ARRUDA LK, 1992, J ALLERGY CLIN IMMUN, V89, P1166, DOI 10.1016/0091-6749(92)90301-H; Bousquet PJ, 2010, ANN EPIDEMIOL, V20, P797, DOI 10.1016/j.annepidem.2010.05.012; Mori A, 2007, J ALLERGY CLIN IMMUN, V119, pS44, DOI 10.1016/j.jaci.2006.11.191; VANASSENDELFT AH, 1985, CHEST, V87, P394, DOI 10.1378/chest.87.3.394; Grinn-Gofron A, 2013, INT J BIOMETEOROL, V57, P759, DOI 10.1007/s00484-012-0604-0; Moss RB, 2014, EUR RESPIR J, V43, P1487, DOI 10.1183/09031936.00139513; Neves NA, 2005, CLIN EXP IMMUNOL, V142, P167, DOI 10.1111/j.1365-2249.2005.02891.x; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Arzumanyan VG, 2003, B EXP BIOL MED+, V135, P460, DOI 10.1023/A:1024967426025; Fluckiger S, 2002, EUR J IMMUNOL, V32, P10, DOI 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I; Kazemi-Shirazi L, 2002, INT ARCH ALLERGY IMM, V127, P259, DOI 10.1159/000057742; Simon D, 2013, ALLERGY, V68, P945, DOI 10.1111/all.12157; Bush RK, 2004, J ALLERGY CLIN IMMUN, V113, P227, DOI 10.1016/j.jaci.2003.11.023; Chou H, 1999, INT ARCH ALLERGY IMM, V119, P282, DOI 10.1159/000024205; Cazzoletti L, 2010, INT ARCH ALLERGY IMM, V151, P70, DOI 10.1159/000232572; Woodfolk JA, 1998, J BIOL CHEM, V273, P29489, DOI 10.1074/jbc.273.45.29489; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; Shen HD, 1999, INT ARCH ALLERGY IMM, V119, P259, DOI 10.1159/000024202; SAVOLAINEN J, 1993, CLIN EXP ALLERGY, V23, P332, DOI 10.1111/j.1365-2222.1993.tb00331.x; Falk MHS, 2005, ACTA DERM-VENEREOL, V85, P17, DOI 10.1080/00015550410022276; Asturias JA, 2005, J ALLERGY CLIN IMMUN, V115, P1210, DOI 10.1016/j.jaci.2005.02.012; Escalante MT, 2000, J ALLERGY CLIN IMMUN, V105, P547, DOI 10.1067/mai.2000.104381; Quirce S, 1998, J ALLERGY CLIN IMMUN, V102, P147, DOI 10.1016/S0091-6749(98)70067-3; Dhooria S, 2014, INT J TUBERC LUNG D, V18, P850, DOI 10.5588/ijtld.13.0838; Mayser P, 2006, SKIN PHARMACOL PHYS, V19, P153, DOI 10.1159/000092596; Asero R, 2004, J INVEST ALLERG CLIN, V14, P309; DOEKES G, 1993, ALLERGY, V48, P401, DOI 10.1111/j.1398-9995.1993.tb00737.x; SHIFRINE M, 1963, J GEN MICROBIOL, V32, P263; NakagawaYoshida K, 1997, CHEST, V111, P245, DOI 10.1378/chest.111.1.245; Toyotome T, 2014, CLIN EXP ALLERGY, V44, P450, DOI 10.1111/cea.12260; Kim TY, 1999, CLIN EXP DERMATOL, V24, P226, DOI 10.1046/j.1365-2230.1999.00460.x; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; YOSHIDA K, 1993, ARCH ENVIRON HEALTH, V48, P260; TESHIMA R, 1993, J ALLERGY CLIN IMMUN, V92, P698, DOI 10.1016/0091-6749(93)90013-6; Kurup VP, 2002, INT ARCH ALLERGY IMM, V129, P181, DOI 10.1159/000066780; Faergemann J, 2002, CLIN MICROBIOL REV, V15, P545, DOI 10.1128/CMR.15.4.545-563.2002; KUMAR A, 1993, J ALLERGY CLIN IMMUN, V91, P1024, DOI 10.1016/0091-6749(93)90215-2; Fluckiger S, 2002, INT ARCH ALLERGY IMM, V128, P292, DOI 10.1159/000063862; Mitakakis TZ, 2000, CLIN EXP ALLERGY, V30, P1733, DOI 10.1046/j.1365-2222.2000.00966.x; Hemmann S, 1997, AM J RESP CRIT CARE, V156, P1956; Bundy KW, 2009, ANN ALLERG ASTHMA IM, V103, P26, DOI 10.1016/S1081-1206(10)60139-1; Hemmann S, 1999, J ALLERGY CLIN IMMUN, V104, P601, DOI 10.1016/S0091-6749(99)70330-1; Aden E, 1999, J ALLERGY CLIN IMMUN, V104, P128, DOI 10.1016/S0091-6749(99)70124-7; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Mitakakis TZ, 2001, J ALLERGY CLIN IMMUN, V107, P388, DOI 10.1067/mai.2001.112602; Chou H, 2003, ALLERGY, V58, P1157, DOI 10.1034/j.1398-9995.2003.00275.x; Postigo I, 2011, CLIN EXP ALLERGY, V41, P443, DOI 10.1111/j.1365-2222.2010.03671.x; Crameri R, 2014, ALLERGY, V69, P176, DOI 10.1111/all.12325; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; Lai HY, 2002, INT ARCH ALLERGY IMM, V127, P181, DOI 10.1159/000053862; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356; SHEN HD, 1989, CLIN EXP ALLERGY, V19, P191, DOI 10.1111/j.1365-2222.1989.tb02363.x; WARD GW, 1989, LANCET, V1, P859; Ghannoum M, 2003, J AM ACAD DERMATOL, V48, P189, DOI 10.1067/mjd.2003.109; Mungan D, 2001, ALLERGY, V56, P558, DOI 10.1034/j.1398-9995.2001.056006558.x; Sharpe R, 2014, CLIN EXP ALLERGY, V44, P631, DOI 10.1111/cea.12281; Matsuoka H, 2009, CHEST, V135, P898, DOI 10.1378/chest.08-1783; Miyazaki Y, 2000, INTERNAL MED, V39, P160, DOI 10.2169/internalmedicine.39.160; Kurup VP, 2005, MED MYCOL, V43, pS189, DOI 10.1080/13693780500064763; Elewski BE, 1999, J EUR ACAD DERMATOL, V12, P250, DOI 10.1111/j.1468-3083.1999.tb01039.x; Banerjee B, 1997, J ALLERGY CLIN IMMUN, V99, P821, DOI 10.1016/S0091-6749(97)80017-6; GRAVESEN S, 1979, ALLERGY, V34, P135, DOI 10.1111/j.1398-9995.1979.tb01562.x; DAVIES RR, 1983, CLIN ALLERGY, V13, P309, DOI 10.1111/j.1365-2222.1983.tb02605.x; Twaroch TE, 2012, J ALLERGY CLIN IMMUN, V129, P1148, DOI 10.1016/j.jaci.2011.10.008; Ballmer-Weber BK, 2002, J ALLERGY CLIN IMMUN, V110, P167, DOI 10.1067/mai.2002.125601; Maruyama R, 2003, MYCOSES, V46, P208, DOI 10.1046/j.1439-0507.2003.00864.x; BUSLAU M, 1990, MYCOSES, V33, P90; Lidholm J, 2006, CURR OPIN ALLERGY CL, V6, P234, DOI 10.1097/01.all.0000225166.90768.d6; Crameri R, 1998, INT ARCH ALLERGY IMM, V115, P99, DOI 10.1159/000023889; Cetinkaya Z, 2005, ASIAN PAC J ALLERGY, V23, P87; KIVITY S, 1992, CLIN EXP ALLERGY, V22, P498, DOI 10.1111/j.1365-2222.1992.tb00153.x; Jaakkola MS, 2006, J ALLERGY CLIN IMMUN, V117, P642, DOI 10.1016/j.jaci.2005.11.003; Nasser SM, 2009, CURR ALLERGY ASTHM R, V9, P384, DOI 10.1007/s11882-009-0056-8; Chrdle A, 2012, ANN NY ACAD SCI, V1272, P73, DOI 10.1111/j.1749-6632.2012.06816.x; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Dales RE, 2003, CHEST, V123, P745, DOI 10.1378/chest.123.3.745; PARK HS, 1994, CLIN EXP ALLERGY, V24, P383, DOI 10.1111/j.1365-2222.1994.tb00251.x; Bayrou O, 2005, DERMATOLOGY, V211, P107, DOI 10.1159/000086438; Glaser AG, 2009, ALLERGY, V64, P1144, DOI 10.1111/j.1398-9995.2009.02029.x; Ward GW, 1999, J ALLERGY CLIN IMMUN, V104, P541, DOI 10.1016/S0091-6749(99)70321-0; Woodfolk JA, 2005, CLIN MICROBIOL REV, V18, P30, DOI 10.1128/CMR.18.1.30-43.2005; Limacher A, 2007, J IMMUNOL, V178, P389; Glaser AG, 2006, BIOCHEM J, V396, P41, DOI 10.1042/BJ20051708; AKIYAMA K, 1994, ALLERGY, V49, P778, DOI 10.1111/j.1398-9995.1994.tb02102.x; Woodfolk JA, 1996, J IMMUNOL, V156, P1695; Simon-Nobbe B, 2006, J BIOL CHEM, V281, P16354, DOI 10.1074/jbc.M513638200; KLEINETEBBE J, 1993, CLIN EXP ALLERGY, V23, P211, DOI 10.1111/j.1365-2222.1993.tb00884.x; Vailes LD, 2001, CLIN EXP ALLERGY, V31, P1891, DOI 10.1046/j.1365-2222.2001.00745.x; Ara Katsutoshi, 2004, Allergology International, V53, P369, DOI 10.1111/j.1440-1592.2004.00356.x; Behbod B, 2013, ALLERGY, V68, P1410, DOI 10.1111/all.12254; Bowyer P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-251; Canonica Giorgio Walter, 2013, World Allergy Organ J, V6, P17, DOI 10.1186/1939-4551-6-17; Chowdhary A, 2014, MED MYCOL, V52, P782, DOI 10.1093/mmy/myu047; Corden Julie M., 2003, Aerobiologia, V19, P191, DOI 10.1023/B:AERO.0000006529.51252.2f; Denning David W, 2014, Clin Transl Allergy, V4, P14, DOI 10.1186/2045-7022-4-14; Gent JF, 2002, ENVIRON HEALTH PERSP, V110, pA781; Hoshi Rie, 2011, Arerugi, V60, P207; Kawakami Y, 2014, URBAN PEST MANAG, V4, P65; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P92; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Kustrzeba-Wojcicka I, 2014, CLIN REV ALLERG IMMU, V47, P354, DOI 10.1007/s12016-014-8447-6; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Morita Eishin, 1999, Journal of Dermatology (Tokyo), V26, P282; Nambu Mitsuhiko, 2009, World Allergy Organ J, V2, P208, DOI 10.1097/WOX.0b013e3181ba7daf; Ogawa Haruhiko, 2011, Med Mycol J, V52, P205, DOI 10.3314/mmj.52.205; PLATTSMILLS TAE, 1986, ANN ALLERGY, V56, P454; Platts-Mills TA, 1986, ANN ALLERGY, V56, P70; Randriamanantany ZA, 2010, ALLERGY, V65, P368, DOI 10.1111/j.1398-9995.2009.02210.x; Saenz-de-Santamaria M, 2006, MYCOSES, V49, P91, DOI 10.1111/j.1439-0507.2006.01195.x; Shah A, 2010, Eur Respir Rev, V19, P261, DOI 10.1183/09059180.00009010; Sharpe R., 2015, ALLERGY CLIN IMMUNOL, V135, P110, DOI DOI 10.1016/J.JACI.2014.07.002; Simon-Nobbe Birgit, 2008, Int Arch Allergy Immunol, V145, P58, DOI 10.1159/000107578; Sugita Takashi, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P179; Takatori M, 1994, Arerugi, V43, P1; Zhang E, 2011, J ALLERGY CAIRO, V2011; Zukiewicz-Sobczak W, 2013, ANN AGR ENV MED, V20, P500	195	2	2	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					321	331		10.1016/j.alit.2015.05.007		11	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200005		
J	Matsuo, H; Yokooji, T; Taogoshi, T				Matsuo, Hiroaki; Yokooji, Tomoharu; Taogoshi, Takanori			Common food allergens and their IgE-binding epitopes	ALLERGOLOGY INTERNATIONAL			English	Review						Allergen; Diagnosis; Epitope; Food allergy; Immunoglobulin E	EXERCISE-INDUCED ANAPHYLAXIS; T-CELL EPITOPES; ARA H 2; COWS-MILK ALLERGY; MOLECULAR-WEIGHT-GLUTENIN; MAJOR PEANUT ALLERGEN; COMPONENT-RESOLVED DIAGNOSIS; LIPID TRANSFER PROTEIN; BOVINE SERUM-ALBUMIN; PRU P 3	Food allergy is an adverse immune response to certain kinds of food. Although any food can cause allergic reactions, chicken egg, cow's milk, wheat, shellfish, fruit, and buckwheat account for 75% of food allergies in Japan. Allergen-specific immunoglobulin E (IgE) antibodies play a pivotal role in the development of food allergy. Recent advances in molecular biological techniques have enabled the efficient analysis of food allergens. As a result, many food allergens have been identified, and their molecular structure and IgE-binding epitopes have also been identified. Studies of allergens have demonstrated that IgE antibodies specific to allergen components and/or the peptide epitopes are good indicators for the identification of patients with food allergy, prediction of clinical severity and development of tolerance. In this review, we summarize our current knowledge regarding the allergens and IgE epitopes in the well-researched allergies to chicken egg, cow's milk, wheat, shrimp, and peanut. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Matsuo, Hiroaki; Taogoshi, Takanori] Hiroshima Univ Hosp, Dept Pharmaceut Serv, Hiroshima 7348551, Japan; [Yokooji, Tomoharu] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Pathophysiol & Therapeut, Hiroshima, Japan	Matsuo, H (reprint author), Hiroshima Univ Hosp, Dept Pharmaceut Serv, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hmatsuo@hiroshima-u.ac.jp					Matsumoto N, 2009, PEPTIDES, V30, P1840, DOI 10.1016/j.peptides.2009.07.005; Javaloyes G, 2012, J ALLERGY CLIN IMMUN, V130, P1432, DOI 10.1016/j.jaci.2012.08.038; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Palosuo K, 2001, CLIN EXP ALLERGY, V31, P466, DOI 10.1046/j.1365-2222.2001.01023.x; Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; Chafen JJS, 2010, JAMA-J AM MED ASSOC, V303, P1848, DOI 10.1001/jama.2010.582; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Chatchatee P, 2001, CLIN EXP ALLERGY, V31, P1256, DOI 10.1046/j.1365-2222.2001.01167.x; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Pahr S, 2013, J ALLERGY CLIN IMMUN, V132, P1000, DOI 10.1016/j.jaci.2013.05.016; Restani P, 1998, INT ARCH ALLERGY IMM, V117, P113, DOI 10.1159/000023997; Hiemori M, 2010, BIOSCI BIOTECH BIOCH, V74, P199, DOI 10.1271/bbb.90634; Pahr S, 2012, CLIN EXP ALLERGY, V42, P597, DOI 10.1111/j.1365-2222.2012.03961.x; Meulenbroek LAPM, 2014, INT ARCH ALLERGY IMM, V163, P292, DOI 10.1159/000360733; Brans R, 2012, EUR J DERMATOL, V22, P358, DOI 10.1684/ejd.2012.1712; Kimoto M, 2009, BIOSCI BIOTECH BIOCH, V73, P85, DOI 10.1271/bbb.80485; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Yokooji T, 2013, ALLERGOL INT, V62, P435, DOI 10.2332/allergolint.13-OA-0561; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; Matsuo H, 2004, J BIOL CHEM, V279, P12135, DOI 10.1074/jbc.M311340200; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Chatchatee P, 2001, J ALLERGY CLIN IMMUN, V107, P379, DOI 10.1067/mai.2001.112372; Ricci G, 2013, INT J IMMUNOPATH PH, V26, P263; Wang Y, 2013, J AGR FOOD CHEM, V61, P1573, DOI 10.1021/jf303861p; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Barre A, 2005, BIOCHIMIE, V87, P499, DOI 10.1016/j.biochi.2005.02.011; Constantin C, 2009, ALLERGY, V64, P1030, DOI 10.1111/j.1398-9995.2009.01955.x; FIOCCHI A, 1995, J AM COLL NUTR, V14, P239; Matsuo H, 2005, J IMMUNOL, V175, P8116; Flinterman AE, 2008, J ALLERGY CLIN IMMUN, V121, P737, DOI 10.1016/j.jaci.2007.11.039; Bogh KL, 2012, MOL IMMUNOL, V51, P337, DOI 10.1016/j.molimm.2012.04.002; Shin M, 2013, ALLERGY ASTHMA IMMUN, V5, P96, DOI 10.4168/aair.2013.5.2.96; D'Urbano LE, 2010, CLIN EXP ALLERGY, V40, P1561, DOI 10.1111/j.1365-2222.2010.03568.x; Ebisawa M, 2012, INT ARCH ALLERGY IMM, V158, P71, DOI 10.1159/000330661; Mameri H, 2012, MOL NUTR FOOD RES, V56, P1874, DOI 10.1002/mnfr.201200244; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Mueller GA, 2011, ALLERGY, V66, P878, DOI 10.1111/j.1398-9995.2010.02532.x; Salcedo G, 2011, J INVEST ALLERG CLIN, V21, P81; Takahashi H, 2012, CLIN EXP ALLERGY, V42, P1293, DOI 10.1111/j.1365-2222.2012.04039.x; Ebisawa M, 2012, PEDIAT ALLERG IMM-UK, V23, P573, DOI 10.1111/j.1399-3038.2012.01332.x; Nakajima-Adachi H, 1998, J ALLERGY CLIN IMMUN, V101, P660; Lemon-Mule H, 2008, J ALLERGY CLIN IMMUN, V122, P977, DOI 10.1016/j.jaci.2008.09.007; Matsuo H, 2008, ALLERGY, V63, P233, DOI 10.1111/j.1398-9995.2007.01504.x; Ito K, 2008, ALLERGY, V63, P1536, DOI 10.1111/j.1398-9995.2008.01753.x; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Kobayashi S, 2012, BIOSCI BIOTECH BIOCH, V76, P1182, DOI 10.1271/bbb.120063; Ebisawa M, 2013, PEDIAT ALLERG IMM-UK, V24, P704, DOI 10.1111/pai.12117; Mine Y, 2002, BIOCHEM BIOPH RES CO, V292, P1070, DOI 10.1006/bbrc.2002.6725; Yokooji T, 2014, BIOL PHARM BULL, V37, P1359; Matsuo H, 2010, CONTACT DERMATITIS, V63, P23, DOI 10.1111/j.1600-0536.2010.01741.x; Moreno FJ, 2007, BIOMED PHARMACOTHER, V61, P50, DOI 10.1016/j.biopha.2006.10.005; Berin MC, 2013, J ALLERGY CLIN IMMUN, V131, P14, DOI 10.1016/j.jaci.2012.10.058; Tordesillas L, 2009, MOL IMMUNOL, V46, P722, DOI 10.1016/j.molimm.2008.10.018; Fiocchi A, 2000, NUTRITION, V16, P454, DOI 10.1016/S0899-9007(00)00285-9; Pastorello EA, 2010, INT ARCH ALLERGY IMM, V153, P1, DOI 10.1159/000301573; Hochwallner H, 2010, CLIN EXP ALLERGY, V40, P1809, DOI 10.1111/j.1365-2222.2010.03602.x; Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5; Hochwallner H, 2010, J ALLERGY CLIN IMMUN, V125, P1279, DOI 10.1016/j.jaci.2010.03.007; Suratannon N, 2013, PEDIAT ALLERG IMM-UK, V24, P665, DOI 10.1111/pai.12125; Bouchez-Mahiout I, 2010, INT ARCH ALLERGY IMM, V153, P35, DOI 10.1159/000301577; Tanabe S, 1996, BIOCHEM BIOPH RES CO, V219, P290, DOI 10.1006/bbrc.1996.0225; Sotkovsky P, 2008, PROTEOMICS, V8, P1677, DOI 10.1002/pmic.200700347; Eiwegger T, 2006, CLIN EXP ALLERGY, V36, P1281, DOI 10.1111/j.1365-2222.2006.02565.x; Ayuso R, 2010, J ALLERGY CLIN IMMUN, V125, P1286, DOI 10.1016/j.jaci.2010.03.010; Tosca MA, 2014, CLIN EXP ALLERGY, V44, P1094, DOI 10.1111/cea.12360; Beyer K, 2008, J ALLERGY CLIN IMMUN, V122, P419, DOI 10.1016/j.jaci.2008.06.006; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; Morita E, 2003, J DERMATOL SCI, V33, P99, DOI 10.1016/S0923-1811(03)00156-7; Wal JM, 2001, ALLERGY, V56, P35, DOI 10.1034/j.1398-9995.2001.00911.x; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Constantin C, 2008, J IMMUNOL, V180, P7451; Baar A, 2012, J IMMUNOL, V189, P3018, DOI 10.4049/jimmunol.1200438; Urisu A, 1997, J ALLERGY CLIN IMMUN, V100, P171, DOI 10.1016/S0091-6749(97)70220-3; Cabanos C, 2011, PROTEIN J, V30, P457, DOI 10.1007/s10930-011-9351-z; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Perez-Gordo M, 2012, INT ARCH ALLERGY IMM, V157, P31, DOI 10.1159/000324677; Denery-Papini S, 2011, CLIN EXP ALLERGY, V41, P1478, DOI 10.1111/j.1365-2222.2011.03808.x; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; Ayuso R, 2008, J ALLERGY CLIN IMMUN, V122, P795, DOI 10.1016/j.jaci.2008.07.023; Kondo Yasuto, 2009, Allergology International, V58, P485, DOI 10.2332/allergolint.09-RAI-0136; MATSUDA T, 1983, J AGR FOOD CHEM, V31, P942, DOI 10.1021/jf00119a005; Bauermeister K, 2011, MOL IMMUNOL, V48, P1983, DOI 10.1016/j.molimm.2011.06.216; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; Flinterman AE, 2007, CLIN EXP ALLERGY, V37, P1221, DOI 10.1111/j.1365-2222.2007.02764.x; Caubet JC, 2011, CURR OPIN ALLERGY CL, V11, P210, DOI 10.1097/ACI.0b013e3283464d1b; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Lisson M, 2013, J DAIRY SCI, V96, P5532, DOI 10.3168/jds.2013-6684; Cerecedo I, 2008, J ALLERGY CLIN IMMUN, V122, P589, DOI 10.1016/j.jaci.2008.06.040; Savilahti EM, 2010, J ALLERGY CLIN IMMUN, V125, P1315, DOI 10.1016/j.jaci.2010.03.025; Beyer K, 2005, J ALLERGY CLIN IMMUN, V116, P704, DOI 10.1016/j.jaci.2005.05.007; Busse PJ, 2002, INT ARCH ALLERGY IMM, V129, P93, DOI 10.1159/000065178; Pastorello EA, 2007, INT ARCH ALLERGY IMM, V144, P10, DOI 10.1159/000102609; Battais F, 2005, ALLERGY, V60, P815, DOI 10.1111/j.1398-9995.2005.00795.x; Ando H, 2008, J ALLERGY CLIN IMMUN, V122, P583, DOI 10.1016/j.jaci.2008.06.016; Savilahti EM, 2014, PEDIAT ALLERG IMM-UK, V25, P227, DOI 10.1111/pai.12186; Spuergin P, 1996, ALLERGY, V51, P306, DOI 10.1111/j.1398-9995.1996.tb04614.x; Pacios LF, 2008, MOL IMMUNOL, V45, P2269, DOI 10.1016/j.molimm.2007.11.022; Ahrens B, 2012, CLIN EXP ALLERGY, V42, P1630, DOI 10.1111/cea.12001; Mine Y, 2003, PROTEIN ENG, V16, P747, DOI 10.1093/protein/gzg095; Mizutani K, 2012, BBA-GEN SUBJECTS, V1820, P203, DOI 10.1016/j.bbagen.2011.08.003; Restani P, 2004, ALLERGY, V59, P21, DOI 10.1111/j.1398-9995.2004.00568.x; Cong YJ, 2013, J DAIRY SCI, V96, P6870, DOI 10.3168/jds.2013-6880; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Coales SJ, 2009, RAPID COMMUN MASS SP, V23, P639, DOI 10.1002/rcm.3921; Chruszcz M, 2011, J BIOL CHEM, V286, P39318, DOI 10.1074/jbc.M111.270132; Palacin A, 2010, INT ARCH ALLERGY IMM, V152, P178, DOI 10.1159/000265539; Morita Eishin, 2009, Allergology International, V58, P493, DOI 10.2332/allergolint.09-RAI-0125; Holen E, 2001, CLIN EXP ALLERGY, V31, P952, DOI 10.1046/j.1365-2222.2001.01102.x; Willison LN, 2013, MOL IMMUNOL, V55, P253, DOI 10.1016/j.molimm.2013.02.004; Bernard H, 2015, J ALLERGY CLIN IMMUN, V135, P1267, DOI 10.1016/j.jaci.2014.10.025; Wood RA, 2013, ALLERGY, V68, P803, DOI 10.1111/all.12158; Cong YJ, 2012, J DAIRY SCI, V95, P6307, DOI 10.3168/jds.2012-5543; Matsuo H, 2009, J DERMATOL SCI, V53, P241, DOI 10.1016/j.jdermsci.2008.09.004; Amo A, 2010, J AGR FOOD CHEM, V58, P7453, DOI 10.1021/jf101403h; Pascal M, 2013, CLIN EXP ALLERGY, V43, P116, DOI 10.1111/cea.12014; Tsume Y, 1996, BIOL PHARM BULL, V19, P1332; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024; Ayuso R, 2009, J ALLERGY CLIN IMMUN, V124, P114, DOI 10.1016/j.jaci.2009.04.016; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Quirce S, 2001, ALLERGY, V56, P754, DOI 10.1034/j.1398-9995.2001.056008754.x; Bohle B, 2006, CLIN REV ALLERG IMMU, V30, P97, DOI 10.1385/CRIAI:30:2:97; Tsabouri S, 2012, PEDIAT ALLERG IMM-UK, V23, P608, DOI 10.1111/j.1399-3038.2012.01275.x; Asarnoj A, 2010, ALLERGY, V65, P1189, DOI 10.1111/j.1398-9995.2010.02334.x; Sander I, 2001, J ALLERGY CLIN IMMUN, V107, P907, DOI 10.1067/mai.2001.113761; Vicente-Serrano J, 2007, PEDIATR ALLERGY IMMU, V18, P503, DOI 10.1111/j.1399-3038.2007.00548.x; SUTTON R, 1984, CLIN ALLERGY, V14, P93, DOI 10.1111/j.1365-2222.1984.tb02196.x; Bogh KL, 2014, MOL IMMUNOL, V58, P169, DOI 10.1016/j.molimm.2013.11.014; Dall'Antonia F, 2014, METHODS, V66, P3, DOI 10.1016/j.ymeth.2013.07.024; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Denery-Papini S, 2012, ALLERGY, V67, P1023, DOI 10.1111/j.1398-9995.2012.02860.x; Kleber-Janke T, 2001, J CHROMATOGR B, V756, P295, DOI 10.1016/S0378-4347(01)00088-3; van Boxtel EL, 2008, J AGR FOOD CHEM, V56, P2223, DOI 10.1021/jf072907n; Yokooji T, 2013, BIOCHEM BIOPH RES CO, V438, P61, DOI 10.1016/j.bbrc.2013.07.024; Han N, 2008, ALLERGY, V63, P198, DOI 10.1111/j.1398-9995.2007.01539.x; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Martinez-Botas J, 2013, INT ARCH ALLERGY IMM, V161, P11, DOI 10.1159/000343040; Petersen A, 2012, ALLERGY, V67, P374; Lin J, 2009, CURR OPIN ALLERGY CL, V9, P357, DOI 10.1097/ACI.0b013e32832d05ba; Beretta B, 2001, INT ARCH ALLERGY IMM, V126, P188, DOI 10.1159/000049513; Sander I, 2015, J ALLERGY CLIN IMMUN, V135, P1529, DOI 10.1016/j.jaci.2014.11.021; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Ayuso R, 2012, CLIN EXP ALLERGY, V42, P293, DOI 10.1111/j.1365-2222.2011.03920.x; Jarvinen KM, 2002, J ALLERGY CLIN IMMUN, V110, P293, DOI 10.1067/mai.2002.126080; Leung NYH, 2014, CLIN REV ALLERG IMMU, V46, P180, DOI 10.1007/s12016-012-8336-9; Werfel SJ, 1997, J ALLERGY CLIN IMMUN, V99, P293, DOI 10.1016/S0091-6749(97)70045-9; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Olivieri M, 2013, OCCUP ENVIRON MED, V70, P617, DOI 10.1136/oemed-2012-101112; Matsuo H, 2005, FEBS J, V272, P4431, DOI 10.1111/j.1742-4658.2005.04858.x; Makela MJ, 2014, CLIN EXP ALLERGY, V44, P1420, DOI 10.1111/cea.12393; Gomez-Casado C, 2014, J ALLERGY CLIN IMMUN, V134, P480, DOI 10.1016/j.jaci.2014.03.016; Kohno K, 2013, ALLERGOL INT, V62, P229, DOI 10.2332/allergolint.12-OA-0495; Chinuki Y, 2012, ALLERGOL INT, V61, P529, DOI 10.2332/allergolint.12-RAI-0494; Tanabe S, 2002, BIOCHEM BIOPH RES CO, V293, P1348, DOI 10.1016/S0006-291X(02)00381-9; Shibata R, 2011, ANN ALLERG ASTHMA IM, V107, P337, DOI 10.1016/j.anai.2011.07.013; Yu CJ, 2003, J IMMUNOL, V170, P445; Andersen Maj-Britt Schmidt, 2011, Clin Rev Allergy Immunol, V41, P4, DOI 10.1007/s12016-009-8177-3; Shiomi K, 2008, INT ARCH ALLERGY IMM, V146, P91, DOI 10.1159/000113512; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Jin T, 2009, MOL IMMUNOL, V46, P1796, DOI 10.1016/j.molimm.2009.01.023; Baar A, 2014, J ALLERGY CLIN IMMUN, V133, P585, DOI 10.1016/j.jaci.2013.10.044; Palosuo K, 2001, J ALLERGY CLIN IMMUN, V108, P634, DOI 10.1067/mai.2001.118602; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Jimenez-Saiz R, 2014, MOL NUTR FOOD RES, V58, P614, DOI 10.1002/mnfr.201300442; Matsuo H, 2005, CLIN EXP ALLERGY, V35, P461, DOI 10.1111/j.1365-2222.2005.02213.x; Myrset HR, 2013, INT ARCH ALLERGY IMM, V162, P25, DOI 10.1159/000350791; Hajeb P, 2012, CLIN REV ALLERG IMMU, V42, P365, DOI 10.1007/s12016-011-8284-9; Chatel JM, 2003, INT ARCH ALLERGY IMM, V131, P14, DOI 10.1159/000070429; Urisu A, 2014, ALLERGOL INT, V63, P399, DOI 10.2332/allergolint.14-RAI-0770; Battais F, 2003, CLIN EXP ALLERGY, V33, P962, DOI 10.1046/j.1365-2222.2003.01592.x; Pastorello EA, 2014, ANN ALLERG ASTHMA IM, V112, P386, DOI 10.1016/j.anai.2014.01.012; Sicherer SH, 2013, J ALLER CL IMM-PRACT, V1, P1, DOI 10.1016/j.jaip.2012.10.004; Snegaroff J, 2007, J AGR FOOD CHEM, V55, P9837, DOI 10.1021/jf071432x; Weichel M, 2006, J ALLERGY CLIN IMMUN, V117, P676, DOI 10.1016/j.jaci.2005.11.040; Pascal M, 2015, J ALLER CL IMM-PRACT, V3, P521, DOI 10.1016/j.jaip.2015.02.001; Xia LX, 2010, MOL IMMUNOL, V47, P1808, DOI 10.1016/j.molimm.2010.01.018; Hurlburt BK, 2013, J BIOL CHEM, V288, P36890, DOI 10.1074/jbc.M113.517797; Romano A, 2012, CLIN EXP ALLERGY, V42, P1643, DOI 10.1111/cea.12011; Palacin A, 2007, J ALLERGY CLIN IMMUN, V120, P1132, DOI 10.1016/j.jaci.2007.07.008; Jarvinen KM, 2001, INT ARCH ALLERGY IMM, V126, P111, DOI 10.1159/000049501; Cooke SK, 1997, J IMMUNOL, V159, P2026; Benede S, 2014, J AGR FOOD CHEM, V62, P152, DOI 10.1021/jf404226w; Bublin M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0426-8; Giuffrida M G, 2014, Eur Ann Allergy Clin Immunol, V46, P172; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Hensen Sanne M M, 2014, Methods Mol Biol, V1184, P295, DOI 10.1007/978-1-4939-1115-8_16; Järvinen K-M, 2007, Allergy, V62, P758; Kalyanasundaram A, 2015, EUR FOOD RES TECHNOL, V240, P509, DOI 10.1007/s00217-014-2349-y; Koid AE, 2014, J AGR FOOD CHEM, V62, P206, DOI 10.1021/jf4022509; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Mishra A., 2015, J SCI FOOD AGR; Otsu K, 2015, CLIN EXP ALLERGY, V45, P471, DOI 10.1111/cea.12407; Pahr S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111483; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Price Alexandra, 2015, Dermatitis, V26, P78, DOI 10.1097/DER.0000000000000087; Renand A, 2014, J ALLERGY CLIN IMMUN, V134, P1456, DOI 10.1016/j.jaci.2014.07.048; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054755; Sinha M, 2014, SCI WORLD J, DOI 10.1155/2014/543195; Soh Jian Yi, 2015, Asia Pac Allergy, V5, P17, DOI 10.5415/apallergy.2015.5.1.17; Tanabe S, 2004, J NUTR SCI VITAMINOL, V50, P367; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Untersmayr E, 2008, J ALLERGY CLIN IMMUN, V121, P1301, DOI 10.1016/j.jaci.2008.04.025	206	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					332	343		10.1016/j.alit.2015.06.009		12	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200006		
J	Sekioka, T; Kadode, M; Fujii, M; Kawabata, K; Abe, T; Horiba, M; Kohno, S; Nabe, T				Sekioka, Tomohiko; Kadode, Michiaki; Fujii, Masanori; Kawabata, Kazuhito; Abe, Takashi; Horiba, Michiaki; Kohno, Shigekatsu; Nabe, Takeshi			Expression of CysLT(2) receptors in asthma lung, and their possible role in bronchoconstriction	ALLERGOLOGY INTERNATIONAL			English	Article						Airway smooth muscle; Anti-asthma drugs; CysLT receptors; Cysteinyl leukotrienes; Leukotriene receptor antagonist	CYSTEINYL LEUKOTRIENE RECEPTORS; HUMAN INTRALOBAR AIRWAYS; GUINEA-PIG; PULMONARY INFLAMMATION; PEPTIDE LEUKOTRIENES; ANTAGONIST; CONTRACTIONS; EOSINOPHILS; ICI-204,219; RESPONSES	Background: The expression and functional role of CysLT(2) receptors in asthma have not been clarified. In this study, we evaluated CysLT(2) receptors expression, and effects of CysLT(2)-and CysLT(1/2)-receptor antagonists on antigen-induced bronchoconstriction using isolated lung tissues from both asthma and non-asthma subjects. Methods: CysLT(1) and CysLT(2) receptors expression in asthma and non-asthma lung tissue preparations was examined in immunohistochemistry experiments, and their functional roles in antigen-induced bronchoconstriction were assessed using ONO-6950, a dual CysLT(1/2)-receptor antagonist, montelukast, a CysLT(1) receptor antagonist, and BayCysLT(2)RA, a CysLT(2) receptor-specific antagonist. Results: CysLT(1) receptors were expressed on the bronchial smooth muscle and epithelium, and on alveolar leukocytes in 5 in 5 non-asthma subjects and 2 in 2 asthma subjects. On the other hand, although degrees of CysLT(2) receptors expression were variable among the 5 non-asthma subjects, the expression in the asthma lung was detected on bronchial smooth muscle, epithelium and alveolar leukocytes in 2 in 2 asthma subjects. In the non-asthma specimens, antagonism of CysLT(2) receptors did not affect antigen-induced bronchial contractions, even after pretreatment with the CysLT(1)-receptor specific antagonist, montelukast. However, in the bronchus isolated from one of the 2 asthma subjects, antagonism of CysLT(2) receptors suppressed contractions, and dual antagonism of CysLT(1) and CysLT(2) receptors resulted in additive inhibitory effect on anaphylactic contractions. Conclusions: CysLT(2) receptors were expressed in lung specimens isolated from asthma subjects. Activation of CysLT(2) receptors may contribute to antigen-induced bronchoconstriction in certain asthma population. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Sekioka, Tomohiko; Kadode, Michiaki; Kawabata, Kazuhito] Ono Pharmaceut Co Ltd, Dept Biol & Pharmacol, Discovery Res Labs 2, Osaka, Japan; [Nabe, Takeshi] Setsunan Univ, Fac Pharmaceut Sci, Lab Immunopharmacol, Hirakata, Osaka 5730101, Japan; [Abe, Takashi; Horiba, Michiaki] Ogaki Municipal Hosp, Dept Pneumol, Gifu, Japan; [Sekioka, Tomohiko; Kadode, Michiaki; Fujii, Masanori; Kohno, Shigekatsu; Nabe, Takeshi] Kyoto Pharmaceut Univ, Dept Pharmacol, Kyoto 607, Japan	Nabe, T (reprint author), Setsunan Univ, Fac Pharmaceut Sci, Lab Immunopharmacol, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	t-nabe@pharm.setsunan.ac.jp			Ono Pharmaceutical Co., Ltd., Osaka, Japan	This study was conducted by funds from Ono Pharmaceutical Co., Ltd., Osaka, Japan. We express our sincere gratitude to Dr. Joe Shindo in Ogaki Municipal Hospital (Gifu, Japan), the students in the Department of Pharmacology, Kyoto Pharmaceutical University (Kyoto, Japan), and Mr. Shintaro Nakao and Dr. Atsuto Inoue in Ono Pharmaceutical Co., Ltd, (Osaka, Japan), all of them supported the conduct of this study.	Corrigan C, 2005, J ALLERGY CLIN IMMUN, V115, P316, DOI 10.1016/j.jaci.2004.10.051; Bolla M, 1997, BIOCHEM PHARMACOL, V54, P437, DOI 10.1016/S0006-2952(97)00055-5; YAMAGUCHI T, 1992, AM REV RESPIR DIS, V146, P923; SAMUELSSON B, 1979, PROSTAGLANDINS, V17, P785, DOI 10.1016/0090-6980(79)90052-2; Negri J, 2008, J ALLERGY CLIN IMMUN, V121, P1232, DOI 10.1016/j.jaci.2008.02.007; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Shirasaki H, 2013, ALLERGOL INT, V62, P223, DOI 10.2332/allergolint.12-OA-0490; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Barrett NA, 2012, J IMMUNOL, V189, P4556, DOI 10.4049/jimmunol.1201865; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Lynch KR, 1999, NATURE, V399, P789; Takasaki J, 2000, BIOCHEM BIOPH RES CO, V274, P316, DOI 10.1006/bbrc.2000.3140; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601; Reiss TF, 1996, J ALLERGY CLIN IMMUN, V98, P528, DOI 10.1016/S0091-6749(96)70086-6; BUCKNER CK, 1986, J PHARMACOL EXP THER, V237, P558; NABE T, 1994, PROSTAG LEUKOTR ESS, V51, P163, DOI 10.1016/0952-3278(94)90129-5; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Grossman J, 1997, J ASTHMA, V34, P321, DOI 10.3109/02770909709067222; Kim DC, 2006, J IMMUNOL, V176, P4440; Fujii M, 2005, CHEST, V128, P3148, DOI 10.1378/chest.128.5.3148; Gauvreau GM, 2005, J ALLERGY CLIN IMMUN, V116, P80, DOI 10.1016/j.jaci.2005.03.014; WATANABEKOHNO S, 1992, JPN J PHARMACOL, V60, P209, DOI 10.1254/jjp.60.209; BUCKNER CK, 1990, J PHARMACOL EXP THER, V252, P77; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Harter M, 2004, Search International and National Patent Collections, Patent No. [WO/2004/052839 A1, 2004052839]; HAY DWP, 1987, J PHARMACOL EXP THER, V243, P474; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618	28	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					351	358		10.1016/j.alit.2015.04.008		8	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200008		
J	Nakamura, Y; Hashiba, Y; Endo, J; Furuie, M; Isozaki, A; Yagi, K				Nakamura, Yoichi; Hashiba, Yoko; Endo, Jyunji; Furuie, Masashi; Isozaki, Atsushi; Yagi, Kei-ichi			Elevated exhaled nitric oxide in anaphylaxis with respiratory symptoms	ALLERGOLOGY INTERNATIONAL			English	Article						Anaphylaxis; Asthma; FeNO; Nitric oxide; NOS	SMOKING	Background: Anaphylaxis is a serious type I allergic reaction that occurs suddenly and can result in death, but it is sometimes difficult to differentiate from other diseases, and physicians must rely on symptoms alone for its diagnosis. Meanwhile, fractional exhaled nitric oxide (FeNO) concentration, used in assessing airway inflammation in bronchial asthma, is known to be affected by atopic disposition. The possible role of FeNO measurements was evaluated in patients with anaphylaxis. Methods: FeNO was measured in 52 adult patients (17-78 years old, median age 41.5 years) in whom anaphylaxis occurred. These measurements were made within 24 h after onset and after about one month when the patients were symptom-free. In some of these patients, FeNO was measured a third time, two months or more after onset. Results: The FeNO level in the 52 patients was not significantly different in measurement made within 24 h of onset of anaphylaxis and after one month. However, excluding 9 patients who also had asthma history, the FeNO level in the remaining 43 patients decreased significantly from within 24 h of onset (36.7 +/- 27.5 ppb) to one month later (28.8 +/- 19.5 ppb). Of these 43 patients, this phenomenon was evident in a group that had respiratory symptoms (31 patients), but it was not seen in a group that did not have respiratory symptoms (12 patients). Conclusions: Elevation of FeNO was related to respiratory symptoms observed in anaphylactic patients without asthma. Although the mechanism of increased FeNO level is unclear, its usefulness for diagnosis of anaphylaxis must be examined in prospective studies. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Nakamura, Yoichi; Hashiba, Yoko; Endo, Jyunji; Furuie, Masashi; Isozaki, Atsushi] Yokohama City Minato Red Cross Hosp, Med Ctr Allerg & Immune Dis, Yokohama, Kanagawa 2318682, Japan; [Yagi, Kei-ichi] Yokohama City Minato Red Cross Hosp, Emergency Med Care Ctr, Yokohama, Kanagawa, Japan	Nakamura, Y (reprint author), Yokohama City Minato Red Cross Hosp, Med Ctr Allerg & Immune Dis, Naka Ku, 3-12-1 Shin Yamashita, Yokohama, Kanagawa 2318682, Japan.	nakamura.alle@yokohama.jrc.or.jp					Travers J, 2007, AM J RESP CRIT CARE, V176, P238, DOI 10.1164/rccm.200609-13460C; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Dressel H, 2008, RESP MED, V102, P962, DOI 10.1016/j.rmed.2008.02.012; Sade K, 2007, J INVEST ALLERG CLIN, V17, P379; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Matsunaga Kazuto, 2011, Allergology International, V60, P331, DOI 10.2332/allergolint.10-OA-0277; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Nakamura Yoichi, 2013, Arerugi, V62, P673; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					359	363		10.1016/j.alit.2015.05.005		5	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200009		
J	Odajima, H; Ebisawa, M; Nagakura, T; Fujisawa, T; Akasawa, A; Ito, K; Doi, S; Yamaguchi, K; Katsunuma, T; Kurihara, K; Kondo, N; Sugai, K; Nambu, M; Hoshioka, A; Yoshihara, S; Sato, N; Seko, N; Nishima, S				Odajima, Hiroshi; Ebisawa, Motohiro; Nagakura, Toshikazu; Fujisawa, Takao; Akasawa, Akira; Ito, Komei; Doi, Satoru; Yamaguchi, Koichi; Katsunuma, Toshio; Kurihara, Kazuyuki; Kondo, Naomi; Sugai, Kazuko; Nambu, Mitsuhiko; Hoshioka, Akira; Yoshihara, Shigemi; Sato, Norio; Seko, Noriko; Nishima, Sankei			Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy	ALLERGOLOGY INTERNATIONAL			English	Article						Bronchial asthma; Children; Japanese; Omalizumab; Quality of life	INNER-CITY CHILDREN; QUALITY-OF-LIFE; TO-TREAT ASTHMA; ANTI-IGE; DOSING STRATEGIES; BRONCHIAL-ASTHMA; LUNG-FUNCTION; PHARMACODYNAMICS; ADOLESCENTS; MANAGEMENT	Background: Omalizumab has demonstrated clinical benefits in children with moderate to severe allergic asthma. However, no studies have been performed in Japanese asthmatic children. The aim of this study was to evaluate the efficacy including free IgE suppression and safety of omalizumab in Japanese children with severe allergic asthma. The primary objective was to examine whether omalizumab decreases serum free IgE levels to less than 25 ng/ml (target level of suppression). Methods: Thirty-eight Japanese children (6-15 years) with uncontrolled severe allergic asthma despite inhaled corticosteroids (>200 mu g/day fluticasone propionate or equivalent) and two or more controller therapies received add-on treatment with omalizumab in a 24-week, multicenter, uncontrolled, open-label study. Results: The geometric mean serum free IgE level at 24 weeks was 15.6 ng/mL. Compared with baseline, total asthma symptom scores, daily activity scores and nocturnal sleep scores at 24 weeks were significantly improved. The rates of asthma exacerbation and hospitalization due to asthma were reduced by 69.2% and 78.2%, respectively (p < 0.001), versus baseline. Quality-of-life scores were also significantly improved (p < 0.001). In addition, 11 (28.9%) patients reduced the dose of any asthma controller medications. Thirty-six (94.7%) patients experienced at least one adverse event during the treatment period. All adverse events were mild or moderate in severity and no new safety concerns were detected. No patients discontinued the study. Conclusions: In Japanese children with severe allergic asthma, omalizumab decreased free IgE levels to less than 25 ng/mL. Omalizumab improved asthma control and was well-tolerated, as well. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Odajima, Hiroshi; Nishima, Sankei] Fukuoka Natl Hosp, Dept Pediat, Fukuoka 8111394, Japan; [Ebisawa, Motohiro] Sagamihara Natl Hosp, Clin Res Ctr Allergol & Rheumatol, Dept Allergy, Sagamihara, Kanagawa, Japan; [Nagakura, Toshikazu] Yoga Allergy Clin, Tokyo, Japan; [Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan; [Akasawa, Akira] Tokyo Metropolitan Childrens Med Ctr, Div Allergy, Tokyo, Japan; [Ito, Komei] Aichi Childrens Hlth & Med Ctr, Dept Allergy, Obu, Aichi, Japan; [Doi, Satoru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pediat, Osaka, Japan; [Yamaguchi, Koichi] Fratern Mem Hosp, Dept Pediat, Tokyo, Japan; [Katsunuma, Toshio] Jikei Daisan Hosp, Dept Pediat, Tokyo, Japan; [Kurihara, Kazuyuki] Kanagawa Childrens Med Ctr, Dept Allergy, Yokohama, Kanagawa, Japan; [Kondo, Naomi] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Sugai, Kazuko] Fukuyama Med Ctr, Dept Pediat, Hiroshima, Japan; [Nambu, Mitsuhiko] Tenri Hosp, Dept Pediat, Nara, Japan; [Hoshioka, Akira] Chiba Childrens Hosp, Dept Allergy & Rheumatol, Chiba, Japan; [Yoshihara, Shigemi] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi, Japan; [Sato, Norio; Seko, Noriko] Novartis Pharma KK, Clin Dev, Tokyo, Japan	Odajima, H (reprint author), Fukuoka Natl Hosp, Dept Pediat, Minami Ku, 4-39-1 Yakatabaru, Fukuoka 8111394, Japan.	odaji@mfukuoka2.hosp.go.jp			Novartis Pharma	This clinical phase III study was sponsored by Novartis Pharma.	Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923; Kondo N, 2010, PEDIATR INT, V52, P319, DOI 10.1111/j.1442-200X.2009.03010.x; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2001.120951; Deschildre A, 2013, EUR RESPIR J, V42, P1224, DOI 10.1183/09031936.00149812; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Chipps BE, 2007, J ALLERGY CLIN IMMUN, V119, P1156, DOI 10.1016/j.jaci.2006.12.668; Nopp A, 2010, ALLERGY, V65, P56, DOI 10.1111/j.1398-9995.2009.02144.x; Stelmach I, 2012, QUAL LIFE RES, V21, P1639, DOI 10.1007/s11136-011-0070-x; Casale TB, 1997, J ALLERGY CLIN IMMUN, V100, P110; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Adelroth E, 2000, J ALLERGY CLIN IMMUN, V106, P253, DOI 10.1067/mai.2000.108310; PRESTA LG, 1993, J IMMUNOL, V151, P2623; Sorkness CA, 2013, J ALLER CL IMM-PRACT, V1, P163, DOI 10.1016/j.jaip.2013.01.011; Lowe PJ, 2011, BRIT J CLIN PHARMACO, V72, P306, DOI 10.1111/j.1365-2125.2011.03962.x; Kulus M, 2010, CURR MED RES OPIN, V26, P1285, DOI 10.1185/03007991003771338; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Kelly HW, 2008, PEDIATRICS, V122, pE53, DOI 10.1542/peds.2007-3381; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Slavin RG, 2009, J ALLERGY CLIN IMMUN, V123, P107, DOI 10.1016/j.jaci.2008.09.050; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Hochhaus G, 2003, CURR MED RES OPIN, V19, P491, DOI 10.1185/030079903125002171; Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Nishima Sankei, 2009, Allergology International, V58, P37, DOI 10.2332/allergolint.O-08-550; Chipps BE, 2012, CURR RESPIR CARE REP, V1, P259; Dean BB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-96; Haselkorn T, 2009, J ALLERGY CLIN IMMUN, V124, P895, DOI 10.1016/j.jaci.2009.07.035; Kondo Naomi, 2008, Arerugi, V57, P1022; Miyamoto T, 1994, ARERUGI, V43, P71	30	1	1	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					364	370		10.1016/j.alit.2015.05.006		7	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200010		
J	Yoshihara, S; Kanno, N; Fukuda, H; Arisaka, O; Arita, M; Sekine, K; Yamaguchi, K; Tsuchida, A; Yamada, Y; Watanabe, T; Shimizu, T; Nishikawa, K; Nishimuta, T				Yoshihara, Shigemi; Kanno, Noriko; Fukuda, Hironobu; Arisaka, Osamu; Arita, Masahiko; Sekine, Kunio; Yamaguchi, Koichi; Tsuchida, Akira; Yamada, Yumi; Watanabe, Toru; Shimizu, Toshio; Nishikawa, Kiyoshi; Nishimuta, Toshiyuki		J-TRUST Study Grp	Caregiver treatment satisfaction is improved together with children's asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms	ALLERGOLOGY INTERNATIONAL			English	Article						Asthma symptoms; Budesonide monotherapy; Caregiver treatment satisfaction; JPAC; Pediatric asthma	QUALITY-OF-LIFE; CHILDHOOD ASTHMA; INHALED CORTICOSTEROIDS; REALITY	Background: If asthmatic children cannot obtain sufficient control of their disease, not only do they suffer from asthma symptoms, but the daily life activities of their caregivers are also disrupted. We investigated the effectiveness of an inhaled corticosteroid (ICS) for symptom control in previously ICS-untreated school-aged asthmatic children as well as caregiver treatment satisfaction (CTS). Methods: A multicenter, open-label, single-arm study on 12-week ICS (budesonide Turbuhaler (R)) monotherapy was undertaken in subjects aged 5-15 years with bronchial asthma not treated with ICS during the previous 3 months. At 0, 4, 8, and 12 weeks after start of ICS administration, Japanese Pediatric Asthma Control Program (JPAC) scores, and CTS scores were summated and lung function measured. At weeks 0 and 12, questionnaires on caregiver anxiety were also assessed. Results: Seventy-five patients were enrolled, and 69 assessed. Ninety percent of subjects had been treated with asthma controller medication except ICS before study enrollment. JPAC score and CTS score were improved significantly at weeks 4, 8, and 12 (p < 0.001). With regard to CTS, more than half of caregivers showed a perfect score at weeks 8 and 12. There was a significant correlation between JPAC score and CTS score. Lung function and caregiver anxiety were also improved, and good compliance with treatment was observed during the intervention. Conclusions: If treating ICS-untreated school-aged asthmatic children with uncontrolled symptoms, ICS monotherapy can improve CTS along with improving asthma control. Copyright (C) 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V.	[Yoshihara, Shigemi; Kanno, Noriko; Fukuda, Hironobu; Arisaka, Osamu] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi, Japan; [Kanno, Noriko] Nishikata Hosp, Dept Pediat, Tochigi, Tochigi, Japan; [Arita, Masahiko] Arita Clin Pediat & Pediat Allergy, Hiroshima, Japan; [Sekine, Kunio] Sekine Pediat Clin, Chiba, Japan; [Yamaguchi, Koichi] Fratern Mem Hosp, Dept Pediat, Tokyo, Japan; [Yamada, Yumi] Yamada Gastrointestinal Internal Med & Pediat Cli, Tochigi, Tochigi, Japan; [Watanabe, Toru] Watanabe Pediat Allergy Clin, Sapporo, Hokkaido, Japan; [Shimizu, Toshio] Shimizu Pediat & Allergy Clin, Saitama, Japan; [Nishikawa, Kiyoshi] Nishikawa Clin, Zentsuji, Kagawa, Japan; [Nishimuta, Toshiyuki] Shimoshizu Natl Hosp, Natl Hosp Org, Dept Pediat, Chiba, Japan	Yoshihara, S (reprint author), Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi, Japan.	shigemi@dokkyomed.ac.jp			Japan Allergy Foundation; AstraZeneca KK (Osaka, Japan)	This study was planned by the J-TRUST Study Group and was carried out using research grants from the Japan Allergy Foundation. Assistance in statistical analyses and preparation of the manuscript were provided by Dr. Y. Habara, S. Osaga, and D. Nishiyama (MC&P Co., Ltd., Osaka, Japan). This assistance was funded by AstraZeneca KK (Osaka, Japan).	Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Stelmach I, 2012, QUAL LIFE RES, V21, P1639, DOI 10.1007/s11136-011-0070-x; Dahl R, 2006, RESP MED, V100, P1307, DOI 10.1016/j.rmed.2005.11.020; LORISH CD, 1986, ARTHRITIS RHEUM, V29, P906, DOI 10.1002/art.1780290714; Nishimuta Toshiyuki, 2011, Allergology International, V60, P147, DOI [10.2332/allergolint. 11-RAI-0328, 10.2332/allergolint.11-RAI-0328]; Straub DA, 2005, EUR RESPIR J, V25, P289, DOI 10.1183/09031936.05.00031904; Boulet LP, 1998, CHEST, V113, P587, DOI 10.1378/chest.113.3.587; Kuehni CE, 2002, EUR RESPIR J, V20, P880, DOI 10.1183/09031936.02.00258502; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Takase M, 2013, PEDIATR PULM, V48, P35, DOI 10.1002/ppul.22536; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; Murphy KR, 2003, PEDIATRICS, V112, pE212, DOI 10.1542/peds.112.3.e212; Arioka H, 2005, ALLERGOL INT, V54, P473, DOI 10.2332/allergolint.54.473; Hamasaki Y, 2012, PEDIATR INT, V56, P441; National Institute of Health National Heart Lung and Blood Institute, 2014, GLOB STRAT ASTHM MAN; Nishimuta T, 2008, JPN J PEDIAT ALLERGY, V22, P135; Szefler S, 2000, NEW ENGL J MED, V343, P1054	17	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					371	376		10.1016/j.alit.2015.05.010		6	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200011		
J	Nakai, N; Katoh, N				Nakai, Noriaki; Katoh, Norito			A case of fixed drug eruption caused by loxoprofen sodium hydrate	ALLERGOLOGY INTERNATIONAL			English	Letter							AMOXICILLIN; HYPERSENSITIVITY		[Nakai, Noriaki; Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto 6028566, Japan	Nakai, N (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	nnakai@koto.kpu-m.ac.jp					Mayorga C, 2013, J INVEST ALLERG CLIN, V23, P213; Pichler WJ, 2004, ALLERGY, V59, P809, DOI 10.1111/j.1398-9995.2004.00547.x; Chaabane A, 2013, THERAPIE, V68, P183, DOI 10.2515/therapie/2013027; Amagase K, 2012, J PHARMACOL SCI, V118, P131, DOI 10.1254/jphs.11R03FM; Nakai N, 2013, ALLERGOL INT, V62, P139, DOI 10.2332/allergolint.12-LE-0464; ARIAS J, 1995, CLIN EXP DERMATOL, V20, P339, DOI 10.1111/j.1365-2230.1995.tb01338.x; Gillies M, 2015, CAN MED ASSOC J, V187, pE21, DOI 10.1503/cmaj.140848; Heng YK, 2015, J EUR ACAD DERMATOL, V29, P1539, DOI 10.1111/jdv.12919; Mizuno K, 2007, J ENV DERMATOL CUTAN, V1, P135; Tanaka S, 2007, J ENV DERMATOL CUTAN, V1, P59	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					377	378		10.1016/j.alit.2015.04.007		2	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200012		
J	Kaniwa, N; Ueta, M; Nakamura, R; Okamoto-Uchida, Y; Sugiyama, E; Maekawa, K; Takahashi, Y; Furuya, H; Yagami, A; Matsukura, S; Ikezawa, Z; Matsunaga, K; Sotozono, C; Aihara, M; Kinoshita, S; Saito, Y				Kaniwa, Nahoko; Ueta, Mayumi; Nakamura, Ryosuke; Okamoto-Uchida, Yoshimi; Sugiyama, Emiko; Maekawa, Keiko; Takahashi, Yukitoshi; Furuya, Hirokazu; Yagami, Akiko; Matsukura, Setsuko; Ikezawa, Zenro; Matsunaga, Kayoko; Sotozono, Chie; Aihara, Michiko; Kinoshita, Shigeru; Saito, Yoshiro			Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis	ALLERGOLOGY INTERNATIONAL			English	Letter							SEVERE MUCOSAL INVOLVEMENT; ERYTHEMA MULTIFORME; RISK		[Kaniwa, Nahoko; Nakamura, Ryosuke; Okamoto-Uchida, Yoshimi; Sugiyama, Emiko; Maekawa, Keiko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo 1588501, Japan; [Ueta, Mayumi; Sotozono, Chie; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Shizuoka, Japan; [Furuya, Hirokazu] Kochi Med Sch, Dept Neurol, Kochi, Japan; [Yagami, Akiko; Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi, Japan; [Matsukura, Setsuko; Ikezawa, Zenro; Aihara, Michiko] Yokohama City Univ, Grad Sch Med, Dept Environm Immunodermatol, Yokohama, Kanagawa, Japan	Nakamura, R (reprint author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ryosnak@nihs.go.jp					ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Kaniwa N, 2010, EPILEPSIA, V51, P2461, DOI 10.1111/j.1528-1167.2010.02766.x; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Ueta M, 2015, J ALLERGY CLIN IMMUN, V135, P1538, DOI 10.1016/j.jaci.2014.12.1916; Hashimoto K, 2002, MINISTRY HLTH LABOUR; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Ueta M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04862	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					379	381		10.1016/j.alit.2015.05.002		3	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200013		
J	Ototake, Y; Inomata, N; Sano, S; Takahashi, S; Aihara, M				Ototake, Yasushi; Inomata, Naoko; Sano, Saori; Takahashi, Sanami; Aihara, Michiko			A case of an anaphylactic reaction due to oats in granola	ALLERGOLOGY INTERNATIONAL			English	Letter									[Ototake, Yasushi; Inomata, Naoko; Sano, Saori; Takahashi, Sanami; Aihara, Michiko] Yokohama City Univ, Sch Med, Dept Dermatol, Yokohama, Kanagawa 2360004, Japan	Inomata, N (reprint author), Yokohama City Univ, Sch Med, Dept Dermatol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ninomata@yokohama-cu.ac.jp					Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Boussault P, 2007, ALLERGY, V62, P1251, DOI 10.1111/j.1398-9995.2007.01527.x; Lauriere M, 2006, CONTACT DERMATITIS, V54, P283, DOI 10.1111/j.0105-1873.2006.00830.x; Nagao M, 2008, INT ARCH ALLERGY IMM, V146, P47, DOI 10.1159/000126061; Inuo C, 2013, ANN ALLERG ASTHMA IM, V110, P305, DOI 10.1016/j.anai.2013.01.008; De Paz Arranz S., 2002, Allergy (Copenhagen), V57, P1215, DOI 10.1034/j.1398-9995.2002.23893_7.x; Fukutomi Y, 2010, J ALLERGY CLIN IMMUN, V127, P531; Vansina Sara, 2010, Contact Dermatitis, V63, P169, DOI 10.1111/j.1600-0536.2010.01762.x	8	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					386	387		10.1016/j.alit.2015.06.006		2	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200016		
J	Komatsu-Fujii, T; Ohta, M; Niihara, H; Morita, E				Komatsu-Fujii, Takayoshi; Ohta, Masataka; Niihara, Hiroyuki; Morita, Eishin			Usefulness of rapid measurement of serum thymus and activation-regulated chemokine level in diagnosing drug-induced hypersensitivity syndrome	ALLERGOLOGY INTERNATIONAL			English	Letter							DISEASE-ACTIVITY; EOSINOPHILIA; TARC/CCL17; DRESS		[Komatsu-Fujii, Takayoshi; Ohta, Masataka; Niihara, Hiroyuki; Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Izumo, Shimane 6938501, Japan	Morita, E (reprint author), Shimane Univ, Fac Med, Dept Dermatol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	emorita@med.shimane-u.ac.jp					Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Tamaki K, 2006, J DERMATOL, V33, P300, DOI 10.1111/j.1346-8138.2006.00072.x; Shiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x; Ogawa K, 2013, J DERMATOL SCI, V69, P38, DOI 10.1016/j.jdermsci.2012.10.002; Ogawa K, 2014, BRIT J DERMATOL, V171, P425, DOI 10.1111/bjd.12948	5	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					388	389		10.1016/j.alit.2015.06.007		2	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200017		
J	Tamura, G				Tamura, Gen			Comparison of the aerosol velocity of Respimat (R) soft mist inhaler and seven pressurized metered dose inhalers	ALLERGOLOGY INTERNATIONAL			English	Letter							LUNG DEPOSITION; FLUTICASONE		Airway Inst Sendai Co Ltd, Sendai, Miyagi 9800871, Japan	Tamura, G (reprint author), Airway Inst Sendai Co Ltd, 4-2-11 Hachiman Aoba Ku, Sendai, Miyagi 9800871, Japan.	tamura@airway-sendai.com					Leach CL, 2002, CHEST, V122, P510, DOI 10.1378/chest.122.2.510; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P1497, DOI 10.1164/rccm.200410-1414OC; Newman S, 2006, RESP MED, V100, P375, DOI 10.1016/j.rmed.2005.09.027; Adrian RJ, 2005, EXP FLUIDS, V39, P159, DOI 10.1007/s00348-005-0991-7; Hochrainer D, 2005, J AEROSOL MED, V18, P273, DOI 10.1089/jam.2005.18.273; Donnell D, 2001, DRUG DEV IND PHARM, V27, P111, DOI 10.1081/DDC-100000477; Thorsson L, 2001, BRIT J CLIN PHARMACO, V52, P529, DOI 10.1046/j.0306-5251.2001.01493.x; Tamura Gen, 2009, Arerugi, V58, P790; Tamura G., 2013, KOKYU, V32, P1075; Tamura G, 2012, KOKYU, V31, P1065	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					390	392		10.1016/j.alit.2015.06.012		3	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200018		
J	Numata, T; Ito, T; Egusa, C; Kobayashi, Y; Maeda, T; Tsuboi, R				Numata, Takafumi; Ito, Tomonobu; Egusa, Chizu; Kobayashi, Yuko; Maeda, Tatsuo; Tsuboi, Ryoji			A case of oral allergy syndrome due to star fruit sensitized from atopic hands	ALLERGOLOGY INTERNATIONAL			English	Letter							HYPERSENSITIVITY		[Numata, Takafumi; Ito, Tomonobu; Egusa, Chizu; Kobayashi, Yuko; Maeda, Tatsuo; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Ito, T (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	tomonobu@tokyo-med.ac.jp					FORD SA, 1991, INT ARCH ALLER A IMM, V95, P178; Kondo Y, 1997, ALLERGY, V52, P455, DOI 10.1111/j.1398-9995.1997.tb01029.x; Lucas JSA, 2005, PEDIATR ALLERGY IMMU, V16, P647, DOI 10.1111/j.1399-3038.2005.00330.x; AMLOT PL, 1987, CLIN ALLERGY, V17, P33, DOI 10.1111/j.1365-2222.1987.tb02317.x; Mattila L, 2003, CLIN EXP ALLERGY, V33, P600, DOI 10.1046/j.1365-2222.2003.01661.x; Vlaicu PC, 2011, J INVEST ALLERG CLIN, V21, P236; Auxiliadora-Martins M, 2010, HEART LUNG, V39, P448, DOI 10.1016/j.hrtlng.2009.09.003; Celakovská Jarmila, 2014, Indian J Dermatol, V59, P316, DOI 10.4103/0019-5154.131446; Signate A, 2009, REV NEUROL-FRANCE, V165, P268, DOI 10.1016/j.neurol.2008.06.011; Singh R, 2014, ADV PHARM SCI, V2014	10	0	0	JAPANESE SOCIETY ALLERGOLOGY	TOKYO	MY BLDG 4F, 1-13-3, UENO, TAITO-KU, TOKYO, 110-0005, JAPAN	1323-8930	1440-1592		ALLERGOL INT	Allergol. Int.	OCT	2015	64	4					393	395		10.1016/j.alit.2015.06.011		3	Allergy; Immunology	Allergy; Immunology	CS9LI	WOS:000362412200019		
J	Ogita, M; Miyauchi, K; Tsuboi, S; Shitara, J; Endo, H; Wada, H; Doi, S; Naito, R; Konishi, H; Dohi, T; Kasai, T; Tamura, H; Okazaki, S; Suwa, S; Daida, H				Ogita, Manabu; Miyauchi, Katsumi; Tsuboi, Shuta; Shitara, Jun; Endo, Hirohisa; Wada, Hideki; Doi, Shinichiro; Naito, Ryo; Konishi, Hirokazu; Dohi, Tomotaka; Kasai, Takatoshi; Tamura, Hiroshi; Okazaki, Shinya; Suwa, Satoru; Daida, Hiroyuki			Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Aitery Disease After a First Percutaneous Coronary Intervention	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; MYOCARDIAL-INFARCTION; HEART-DISEASE; ATHEROSCLEROSIS; INFLAMMATION; STATINS; EVENTS; MECHANISMS; RATIONALE	Cardiovascular fisk persists despite intensive low-density lipoprotein cholesterol (LDL-C) reduction using statins. High-density lipoprotein (HDL-C) is inversely associated with coronary artery disease (CAD) that is independent of LDL-C levels. C-reactive protein (CRP) is an established marker of inflammation that can impair the protective function of HDL-C: however, the impact of inflammation on the association between HDL-C and long-term outcomes in patients with CAD under statin therapy remains uncertain. We prospectively enrolled 3,507 consecutive patients with CAD who underwent a first percutaneous coronary intervention (PCI) from 1997 to 2011 at our institution. We stratified 1,682 patients (48%) who had been treated with statin at the time of PCI into 4 groups according to HDL-C levels (cutoffs of 40 and 50 mg/dl for men and women, respectively) and a CRP cutoff of 2 mg/dl: (1) high HDL-C/low CRP, (2) high HDL-C/high CRP, (3) low HDL-C/low CRP, and (4) low HDL-C/high CRP comparing the rates of all-cause death among them. The median follow-up period was 1,985 days (interquartile range 916 to 3,183 days). During this period, 197 patients (11.7%) died because of cardiac death (n = 58), carcinoma (n = 61), stroke (n = 10), and other causes (n = 69). The rates of all-cause death significantly differed among the groups (log-rank test, p <0.0001). In multivariate Cox hazard regression analyses, low HDL-C with high CRP levels remained significantly associated with a higher rate of all-cause death even after adjustment for other co-variates (hazard ratio 2.38, 1.59 to 3.61, p <0.0001). Low HDL-C together with elevated CRP levels is significantly associated with long-term outcomes in patients who received statin therapy after PCI. (C) 2015 Elsevier Inc. All rights reserved.	[Ogita, Manabu; Tsuboi, Shuta; Shitara, Jun; Endo, Hirohisa; Wada, Hideki; Suwa, Satoru] Juntendo Univ, Shizuoka Hosp, Dept Cardiovasc Med, Tokyo, Japan; [Miyauchi, Katsumi; Doi, Shinichiro; Naito, Ryo; Konishi, Hirokazu; Dohi, Tomotaka; Kasai, Takatoshi; Tamura, Hiroshi; Okazaki, Shinya; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	Miyauchi, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	ktmmy@med.juntendo.ac.jp					Brown BG, 2011, AM HEART J, V161, P471, DOI 10.1016/j.ahj.2010.11.017; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Seo SM, 2011, HEART, V97, P1943, DOI 10.1136/hrt.2011.225466; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Brewer HB, 2004, NEW ENGL J MED, V350, P1491, DOI 10.1056/NEJMp048023; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Ota T, 2015, AM J CARDIOL, V115, P411, DOI 10.1016/j.amjcard.2014.11.043; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Ridker PM, 1998, CIRCULATION, V97, P2007; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; GORDON DJ, 1989, CIRCULATION, V79, P8; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Ansell BJ, 2007, AM J CARDIOL, V100, P3; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de la Llera Moya Margarita, 2012, Atherosclerosis, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032; Ross R, 1999, NEW ENGL J MED, V340, P115	24	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	OCT 1	2015	116	7					999	1002		10.1016/j.amjcard.2015.06.036		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9AV	WOS:000362382400001		
J	Kawada, T				Kawada, Tomoyuki			Egg consumption and incident type 2 diabetes: are there any advantages to excessive consumption of eggs?	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Letter							RISK		Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Djousse L, 2010, AM J CLIN NUTR, V92, P422, DOI 10.3945/ajcn.2010.29406; Virtanen JK, 2015, AM J CLIN NUTR, V101, P1088, DOI 10.3945/ajcn.114.104109; Djousse L, 2009, DIABETES CARE, V32, P295, DOI 10.2337/dc08-1271; Zazpe I, 2013, NUTR HOSP, V28, P105, DOI 10.3305/nh.2013.28.1.6124	4	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	OCT	2015	102	4					974	974		10.3945/ajcn.115.116426		1	Nutrition & Dietetics	Nutrition & Dietetics	CS7CO	WOS:000362241900031		
J	Miyake, N; Tsukaguchi, H; Koshimizu, E; Shono, A; Matsunaga, S; Shiina, M; Mimura, Y; Imamura, S; Hirose, T; Okudela, K; Nozu, K; Akioka, Y; Hattori, M; Yoshikawa, N; Kitamura, A; Cheong, HI; Kagami, S; Yamashita, M; Fujita, A; Miyatake, S; Tsurusaki, Y; Nakashima, M; Saitsu, H; Ohashi, K; Imamoto, N; Ryo, A; Ogata, K; Iijima, K; Matsumoto, N				Miyake, Noriko; Tsukaguchi, Hiroyasu; Koshimizu, Eriko; Shono, Akemi; Matsunaga, Satoko; Shiina, Masaaki; Mimura, Yasuhiro; Imamura, Shintaro; Hirose, Tomonori; Okudela, Koji; Nozu, Kandai; Akioka, Yuko; Hattori, Motoshi; Yoshikawa, Norishige; Kitamura, Akiko; Cheong, Hae Il; Kagami, Shoji; Yamashita, Michiaki; Fujita, Atsushi; Miyatake, Satoko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Ohashi, Kenichi.; Imamoto, Naoko; Ryo, Akihide; Ogata, Kazuhiro; Iijima, Kazumoto; Matsumoto, Naomichi			Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CELL-CYCLE; NUCLEOCYTOPLASMIC TRANSPORT; SINGLE NUCLEOPORIN; IN-VITRO; PODOCYTE; GLOMERULOSCLEROSIS; ORGANIZATION; DEPLETION; PROTEINS; GENETICS	The nuclear pore complex (NPC) is a huge protein complex embedded in the nuclear envelope. It has central functions in nucleocytoplasmic transport, nuclear framework, and gene regulation. Nucleoporin 107 kDa (NUP107) is a component of the NPC central scaffold and is an essential protein in all eukaryotic cells. Here, we report on biallelic NUP107 mutations in nine affected individuals who are from five unrelated families and show early-onset steroid-resistant nephrotic syndrome (SRN). These individuals have pathologically focal segmental glomerulosclerosis, a condition that leads to end-stage renal disease with high frequency. NUP107 is ubiquitously expressed, including in glomerular podocytes. Three of four NUP107 mutations detected in the affected individuals hamper NUP107 binding to NUP133 (nucleoporin 133 kDa) and NUP107 incorporation into NPCs in vitro. Zebrafish with nup107 knockdown generated by morpholino oligonucleotides displayed hypoplastic glomerulus structures and abnormal podocyte foot processes, thereby mimicking the pathological changes seen in the kidneys of the SRNS individuals with NUP107 mutations. Considering the unique properties of the podocyte (highly differentiated foot-process architecture and slit membrane and the inability to regenerate), we propose a "podocyte-injury model" as the pathomechanism for SRNS due to biallelic NUP107 mutations.	[Miyake, Noriko; Koshimizu, Eriko; Fujita, Atsushi; Miyatake, Satoko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Tsukaguchi, Hiroyasu] Kansai Med Univ, Dept Internal Med 2, Osaka 5708507, Japan; [Shono, Akemi; Nozu, Kandai; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Matsunaga, Satoko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Dept Microbiol, Yokohama, Kanagawa 2360004, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Mimura, Yasuhiro; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Imamura, Shintaro; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Hirose, Tomonori] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan; [Okudela, Koji; Ohashi, Kenichi.] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Akioka, Yuko; Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo 1628666, Japan; [Yoshikawa, Norishige] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Tokyo 1578535, Japan; [Kitamura, Akiko] Univ Tokushima, Grad Sch, Dept Immunol & Parasitol, Inst Biomed Sci, Tokushima 7708503, Japan; [Cheong, Hae Il] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul 03080, South Korea; [Cheong, Hae Il] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul 03080, South Korea; [Cheong, Hae Il] Seoul Natl Univ, Coll Med, Kidney Res Inst, Med Res Ctr, Seoul 03080, South Korea; [Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Tokushima 7708503, Japan	Tsukaguchi, H (reprint author), Kansai Med Univ, Dept Internal Med 2, Osaka 5708507, Japan.	tsukaguh@hirakata.kmu.ac.jp; naomat@yokohama-cu.ac.jp			Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24118007]; Japan Society for the Promotion of Science; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems from the Japan Science and Technology Agency; Takeda Science Foundation; Osaka Kidney Foundation; Korean Health Technology R&D Project, Ministry of Health Welfare [HI12C0014]; Pfizer Japan; Daiichi Sankyo; Japan Blood Product Organization; Miyarisan Pharmaceutical; AbbVie; CSL Behring; JCR Pharmaceuticals; Teijin Pharma; Chugai Pharmaceutical; Astellas Pharma; Novartis Pharma KK; Asahi Kasei Pharma	We are grateful to all the affected individuals and their families who participated in this study. We also thank our clinical colleagues who supported the participating families: Dr. Makoto Endo (Laboratory of Fish Health Management, Tokyo University of Marine Science and Technology) for morphological evaluation of zebrafish and Ms. Sugimoto, Ms. Takabe, and Mr. Mitsui for technical assistance. This work was supported in part by a grant for Research on Measures for Intractable Diseases, a grant for Comprehensive Research on Disability Health and Welfare, and the Strategic Research Program for Brain Science from the Japan Agency for Medical Research and Development; a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) (24118007) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research (A, B, and C) and for Challenging Exploratory Research from the Japan Society for the Promotion of Science; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program of the Project for Developing Innovation Systems from the Japan Science and Technology Agency; the Takeda Science Foundation; the Osaka Kidney Foundation; and grant HI12C0014 from the Korean Health Technology R&D Project, Ministry of Health & Welfare. K.I. also received grants from Pfizer Japan, Daiichi Sankyo, the Japan Blood Product Organization, Miyarisan Pharmaceutical, AbbVie, CSL Behring, JCR Pharmaceuticals, and Teijin Pharma; and consulting fees from Chugai Pharmaceutical and Astellas Pharma. N.Y. received grants from Novartis Pharma KK and Asahi Kasei Pharma.	Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Banerjee HN, 2010, MOL CELL BIOCHEM, V343, P21, DOI 10.1007/s11010-010-0494-6; Lovric S, 2014, CLIN J AM SOC NEPHRO, V9, P1109, DOI 10.2215/CJN.09010813; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI [10.1093/hmg/ddp328, 10.1093/hmg/ddp/328]; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Bullich G, 2015, EUR J HUM GENET, V23, P1192, DOI 10.1038/ejhg.2014.252; Saleem MA, 2013, PEDIATR NEPHROL, V28, P699, DOI 10.1007/s00467-012-2239-0; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Nagata M, 1998, AM J PATHOL, V153, P1511, DOI 10.1016/S0002-9440(10)65739-2; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Petermann AT, 2002, KIDNEY INT, V61, P40, DOI 10.1046/j.1523-1755.2002.00102.x; Gipson DS, 2009, PEDIATRICS, V124, P747, DOI 10.1542/peds.2008-1559; Mekahli D, 2009, PEDIATR NEPHROL, V24, P1525, DOI 10.1007/s00467-009-1138-5; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Thong KM, 2013, NEPHRON CLIN PRACT, V124, P31, DOI 10.1159/000354716; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738; Sawasaki Tatsuya, 2007, V375, P95; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Kitamura A, 2006, NEPHROL DIAL TRANSPL, V21, P3133, DOI 10.1093/ndt/gfl347; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Endlich N, 2001, J AM SOC NEPHROL, V12, P413; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Trautmann A, 2015, CLIN J AM SOC NEPHRO, V10, P592, DOI 10.2215/CJN.06260614; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Kim JS, 2005, KIDNEY INT, V68, P1275, DOI 10.1111/j.1523-1755.2005.00524.x; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Gonzalez-Aguilera C, 2012, NUCLEUS-PHILA, V3, P340, DOI 10.4161/nucl.21135; Clever M, 2012, NUCLEUS-AUSTIN, V3, P187, DOI 10.4161/nucl.19595; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; McKinney PA, 2001, PEDIATR NEPHROL, V16, P1040; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011; Zagury Alberto, 2013, J Bras Nefrol, V35, P191, DOI 10.5935/0101-2800.20130031; Zheng XF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408997	53	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					555	566		10.1016/j.ajhg.2015.08.013		12	Genetics & Heredity	Genetics & Heredity	CT2FL	WOS:000362617300006		
J	Vukcevic, D; Traherne, JA; Naess, S; Ellinghaus, E; Kamatani, Y; Dilthey, A; Lathrop, M; Karlsen, TH; Franke, A; Moffatt, M; Cookson, W; Trowsdale, J; McVean, G; Sawcer, S; Leslie, S				Vukcevic, Damjan; Traherne, James A.; Naess, Sigrid; Ellinghaus, Eva; Kamatani, Yoichiro; Dilthey, Alexander; Lathrop, Mark; Karlsen, Tom H.; Franke, Andre; Moffatt, Miriam; Cookson, William; Trowsdale, John; McVean, Gil; Sawcer, Stephen; Leslie, Stephen			Imputation of KIR Types from SNP Variation Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASSICAL HLA ALLELES; NK CELL RECEPTORS; DISEASE; SUSCEPTIBILITY; LIGANDS; ERAP1; RISK; LOCI	Large population studies of immune system genes are essential for characterizing their role in diseases, including autoimmune conditions. Of key interest are a group of genes encoding the killer cell immunoglobulin-like receptors (KIRs), which have known and hypothesized roles in autoimmune diseases, resistance to viruses, reproductive conditions, and cancer. These genes are highly polymorphic, which makes typing expensive and time consuming. Consequently, despite their importance, KIRs have been little studied in large cohorts. Statistical imputation methods developed for other complex loci (e.g., human leukocyte antigen [HLA]) on the basis of SNP data provide an inexpensive high-throughput alternative to direct laboratory typing of these loci and have enabled important findings and insights for many diseases. We present KIR*IMP, a method for imputation of KIR copy number. We show that KIR*IMP is highly accurate and thus allows the study of KIRs in large cohorts and enables detailed investigation of the role of KIRs in human disease.	[Vukcevic, Damjan; Leslie, Stephen] Murdoch Childrens Res Inst, Stat Genet, Parkville, Vic 3052, Australia; [Vukcevic, Damjan; Leslie, Stephen] Univ Melbourne, Sch Math & Stat, Parkville, Vic 3010, Australia; [Traherne, James A.; Trowsdale, John] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Traherne, James A.; Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Naess, Sigrid; Karlsen, Tom H.] Univ Oslo, Hosp Rikshosp, Internal Med Res Inst, Dept Canc Med Surg & Transplantat, N-0424 Oslo, Norway; [Naess, Sigrid] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Surg & Transplantat, N-0424 Oslo, Norway; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Kamatani, Yoichiro; Lathrop, Mark] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Kamatani, Yoichiro] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Dilthey, Alexander; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford 0X3 7BN, England; [Lathrop, Mark] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Karlsen, Tom H.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Inst Clin Med, N-0318 Oslo, Norway; [Moffatt, Miriam; Cookson, William] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Sawcer, Stephen] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England	Leslie, S (reprint author), Murdoch Childrens Res Inst, Stat Genet, Parkville, Vic 3052, Australia.	stephen.leslie@mcri.edu.au			Australian National Health and Medical Research Council (NHMRC) [1053756]; Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government of Australia [VR0240]; UK Multiple Sclerosis Society [894/08]; German Ministry of Education and Research (BMBF); Peter Hans Hofschneider Professorship of the "Stiftung Experimentelle Biomedizin" in Zurich; Wellcome Trust; Medical Research Council (MRC); National Institute of Health Cambridge Biomedical Research Centre; Victorian Government's Operational Infrastructure Support Program	We wish to thank Chris Johnson, Wei Jiang, and Jyothi Jayaraman for their contributions to developing the lab-based KIR typing process and data generation, Sandra Maksimovic for assisting with the web-based implementation, Bente Woldseth for technical assistance, and Johannes Hov for helpful discussions. This work was supported by Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship ID 1053756 (S.L.), Victorian Life Sciences Computation Initiative (VLSCI) grant VR0240 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government of Australia (S.L.), UK Multiple Sclerosis Society grant 894/08 (S.S.), the German Ministry of Education and Research (BMBF) program e:Med sysINFLAME (A.F.), the Peter Hans Hofschneider Professorship of the "Stiftung Experimentelle Biomedizin" in Zurich (A.F.), and the Wellcome Trust and Medical Research Council (MRC) with partial funding from the National Institute of Health Cambridge Biomedical Research Centre (J.T. and J.A.T.). Research at the Murdoch Childrens Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program, and further infrastructure support was provided by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at Interfaces." S.L., G.M., and A.D. are founders and partners in Peptide Groove LLP.	Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/nmeth.1785, 10.1038/NMETH.1785]; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Velardi A, 2008, CURR OPIN IMMUNOL, V20, P581, DOI 10.1016/j.coi.2008.07.004; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x; Marsh SGE, 2003, EUR J IMMUNOGENET, V30, P229, DOI 10.1046/j.1365-2370.2003.00383.x; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1023/A:1018054314350; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Vukcevic D, 2011, GENET EPIDEMIOL, V35, P278, DOI 10.1002/gepi.20576; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Bryll R, 2003, PATTERN RECOGN, V36, P1291, DOI 10.1016/S0031-3203(02)00121-8; Carrington M, 2003, THE KIR GENE CLUSTER; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036; Norman PJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003938; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pontikos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-274; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	38	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 1	2015	97	4					593	607		10.1016/j.ajhg.2015.09.005		15	Genetics & Heredity	Genetics & Heredity	CT2FL	WOS:000362617300009		
J	Gao, ZB; Hiroshima, K; Wu, XD; Zhang, JX; Shao, DC; Shao, HJ; Yang, HQ; Yusa, T; Kiyokawa, T; Kobayashi, M; Shinohara, Y; Roe, OD; Zhang, X; Morinaga, K				Gao, Zhibin; Hiroshima, Kenzo; Wu, Xiaodong; Zhang, Jixian; Shao, Dichu; Shao, Huajiang; Yang, Hanqing; Yusa, Toshikazu; Kiyokawa, Takako; Kobayashi, Makio; Shinohara, Yasushi; Roe, Oluf D.; Zhang, Xing; Morinaga, Kenji			Asbestos Textile Production Linked to Malignant Peritoneal and Pleural Mesothelioma in Women: Analysis of 28 Cases in Southeast China	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						asbestos; chrysotile; China; immunohistochemistry; mesothelioma; woman	CAUSE-SPECIFIC MORTALITY; CHRYSOTILE-ASBESTOS; INSULATION WORKERS; CANCER-MORTALITY; EXPOSURE; COHORT; EPIDEMIOLOGY; DIAGNOSIS; CANADA; FIBERS	Background Chrysotile had been used in asbestos textile workshops in Southeast China but a clear relation to mesothelioma is lacking. Methods All patients diagnosed with mesothelioma from 2003 to 2010 at Yuyao People's Hospital were re-evaluated by multiple expert pathologists with immunohistochemistry and asbestos exposure data were collected. Results Of 43 patients with a mesothelioma diagnosis, 19 peritoneal and nine pleural cases were finally diagnosed as mesothelioma. All were females, and the mean age of the patients with peritoneal or pleural mesothelioma was 52.4 and 58.2 years, respectively. All these cases had a history of domestic or occupational exposure to chrysotile. Two-thirds of the patients were from two adjoining towns with multiple small asbestos textile workshops. Contamination of tremolite was estimated to be less than 0.3%. Conclusions This is a report of mesothelioma in women exposed to chrysotile asbestos at home and at work, with an over-representation of peritoneal mesothelioma. (C) 2015 Wiley Periodicals, Inc.	[Gao, Zhibin] Yuyao Peoples Hosp, Dept Pathol, Ningbo 315400, Zhejiang, Peoples R China; [Hiroshima, Kenzo] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Chiba 2768524, Japan; [Wu, Xiaodong; Zhang, Jixian] Yuyao Peoples Hosp, Dept Resp Med, Ningbo 315400, Zhejiang, Peoples R China; [Shao, Dichu] Yuyao Ctr Dis Control & Prevent, Ningbo 315400, Zhejiang, Peoples R China; [Shao, Huajiang] Yuyao Peoples Hosp, Dept Gynecol, Ningbo 315400, Zhejiang, Peoples R China; [Yang, Hanqing] Yuyao Peoples Hosp, Dept Radiol, Ningbo 315400, Zhejiang, Peoples R China; [Yusa, Toshikazu] Chiba Rosai Hosp, Dept Gen Thorac Surg, Chiba 2900003, Japan; [Yusa, Toshikazu] Chiba Rosai Hosp, Asbestos Dis Ctr, Chiba 2900003, Japan; [Kiyokawa, Takako] Jikei Univ, Sch Med, Dept Pathol, Minato Ku, Tokyo, Japan; [Kobayashi, Makio] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; [Shinohara, Yasushi] Natl Inst Occupat Safety & Hlth, Work Environm Res Grp, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; [Roe, Oluf D.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway; [Roe, Oluf D.] Nord Trondelag Hosp Trust, Levanger Hosp, Canc Clin, N-7600 Levanger, Norway; [Roe, Oluf D.] Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Oncol, DK-9000 Aalborg, Denmark; [Zhang, Xing] Zhejiang Acad Med Sci, Hangzhou 310013, Zhejiang, Peoples R China; [Morinaga, Kenji] Environm Restorat & Conservat Agcy Japan, Dept Asbestos Related Hlth Damage Relief, Saiwai Ku, Kawasaki, Kanagawa 2128554, Japan	Hiroshima, K (reprint author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pathol, Owada Shinden 477-96, Chiba 2768524, Japan.	hiroshima.kenzo@twmu.ac.jp			Japan China Medical Association; Norwegian Research Council [218530]	We thank Dr. Norihiko Kohyama for his scientific advice and Mr. Mizuho Karita for technical assistance with the immunohistochemistry investigations. This study was supported partially by a Grant-in-Aid from the Japan China Medical Association (Dr. K Hiroshima) and the Norwegian Research Council ( Dr. OD Roe, Grant no. 218530).	Yano E, 2001, AM J EPIDEMIOL, V154, P538, DOI 10.1093/aje/154.6.538; COGGON D, 1995, OCCUP ENVIRON MED, V52, P775; Yano E, 2009, AM J IND MED, V52, P282, DOI 10.1002/ajim.20675; Reid A, 2014, THORAX, V69, P843, DOI 10.1136/thoraxjnl-2013-204161; Burdorf A, 2007, OCCUP ENVIRON MED, V64, P839, DOI 10.1136/oem.2006.031724; Boffetta P, 2007, ANN ONCOL, V18, P985, DOI 10.1093/annonc/mdl345; Hein MJ, 2007, OCCUP ENVIRON MED, V64, P616, DOI 10.1136/oem.2006.031005; NEWHOUSE ML, 1976, BRIT J IND MED, V33, P147; Tossavainen A, 2000, AM J IND MED, V37, P327, DOI 10.1002/(SICI)1097-0274(200004)37:4<327::AID-AJIM1>3.0.CO;2-1; Egilman D, 2011, AM J IND MED, V54, P153, DOI 10.1002/ajim.20882; Lin SH, 2012, J THORAC ONCOL, V7, P1109, DOI 10.1097/JTO.0b013e3182519a60; Takeshima Y, 2009, LUNG CANCER, V66, P191, DOI 10.1016/j.lungcan.2009.01.011; Cai SX, 2001, IND HEALTH, V39, P75, DOI 10.2486/indhealth.39.75; Hodgson JT, 2000, ANN OCCUP HYG, V44, P565, DOI 10.1016/S0003-4878(00)00045-4; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Wang XR, 2013, CANCER SCI, V104, P245, DOI 10.1111/cas.12060; Goldberg M, 2006, OCCUP ENVIRON MED, V63, P390, DOI 10.1136/oem.2005.023200; Murai Y, 2001, ARCH ENVIRON HEALTH, V56, P84; AKIRA M, 1991, RADIOLOGY, V178, P409; Li L, 2004, BIOMED ENVIRON SCI, V17, P459; Yates DH, 1997, THORAX, V52, P507; Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA; Musk AW, 2011, EUR RESPIR J, V38, P1420, DOI 10.1183/09031936.00000811; SELIKOFF IJ, 1980, CANCER, V46, P2736, DOI 10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L; Tossavainen A, 2001, ANN OCCUP HYG, V45, P145; ELMES PC, 1976, Q J MED, V45, P427; Berry G, 2004, OCCUP ENVIRON MED, V61, pe41; Burgess WA, 1981, ASBESTOS PRODUCTS RE, P152; Churg A, 2004, WHO CLASSIFICATION T, P128; Gibbs A, 2008, ASBESTOS ITS DIS, P190; HILLERDAL G, 1983, BRIT J DIS CHEST, V77, P321, DOI 10.1016/S0007-0971(83)80069-2; IARC, 2012, IARC MON EV CARC R C, V100C, P219; KOHYAMA N, 1991, ANN NY ACAD SCI, V643, P27, DOI 10.1111/j.1749-6632.1991.tb24442.x; Li D, 2004, GLOB ASB C; Neumann V, 2001, INT ARCH OCC ENV HEA, V74, P383; Pavlisko EN, 2014, PATHOLOGY ASBESTOS A, P81; RIBAK J, 1988, BRIT J IND MED, V45, P182; Sandeck HP, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-47; Sebastien P, 1980, IARC SCI PUBL, V1, P237; Sporn T, 2014, PATHOLOGY ASBESTOS A, P1; Sun T, 1997, CHIN J IND HYG OCCUP, V15, P164; WHO, 2014, EL ASB RAL DIS CHRYS, P2; Zhang X, 1998, J JAPAN CHINA MED AS, V13, P14; Zhang X, 2008, J JAPAN CHINA MED AS, V23, P46; Zhang X, 2004, GLOB ASB C; Zielhuis RL, 1977, USAGE ASBESTOS ASBES, P24	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	OCT	2015	58	10					1040	1049		10.1002/ajim.22494		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CT2VW	WOS:000362664000008		
J	Nakamura, T; Ohnuma, T; Hanzawa, R; Takebayashi, Y; Takeda, M; Nishimon, S; Sannohe, T; Katsuta, N; Higashiyama, R; Shibata, N; Arai, H				Nakamura, Toru; Ohnuma, Tohru; Hanzawa, Ryo; Takebayashi, Yuto; Takeda, Mayu; Nishimon, Shohei; Sannohe, Takahiro; Katsuta, Narimasa; Higashiyama, Ryoko; Shibata, Nobuto; Arai, Heii			Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese population	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Article						copy number variants; D-dopachrome tautomerase; glutathione S-transferase; risk factor; schizophrenia	OXIDATIVE STRESS; CARBONYL STRESS; PROJECTS JUSP; SUSCEPTIBILITY; POLYMORPHISM; DELETIONS; GSTM1; FREQUENCY; METAANALYSIS; GENOTYPES	Oxidative-stress, genetic regions of interest (1p13 and 22q11), and common copy number variations (CNVs) may play roles in the pathophysiology of schizophrenia. In the present study, we confirmed associations between schizophrenia and the common CNVs in the glutathione (GSH)-related genes GSTT1, DDTL, and GSTM1 using quantitative real-time polymerase chain reaction analyses of 620 patients with schizophrenia and in 622 controls. No significant differences in GSTT1 copy number distributions were found between patient groups. However, frequencies of characterized CNVs and assumed gain alleles of DDTL and GSTM1 were significantly higher in patients with schizophrenia. In agreement with a previous report, the present data indicate that gains in the CNV alleles DDTL and GSTM1 are genetic risk factors in Japanese patients with schizophrenia, and suggest involvement of micro-inflammation and oxidative stress in the pathophysiology of schizophrenia. (c) 2015 Wiley Periodicals, Inc.	[Nakamura, Toru; Ohnuma, Tohru; Hanzawa, Ryo; Takebayashi, Yuto; Takeda, Mayu; Nishimon, Shohei; Sannohe, Takahiro; Katsuta, Narimasa; Higashiyama, Ryoko; Shibata, Nobuto; Arai, Heii] Juntendo Univ, Fac Med, Dept Psychiat, JUSP, Tokyo 1138421, Japan	Ohnuma, T (reprint author), Juntendo Univ, Fac Med, Dept Psychiat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tohru.oonuma@nifty.ne.jp			Juntendo Institute of Mental Health	Grant sponsor: Juntendo Institute of Mental Health.	Katoh T, 1996, CARCINOGENESIS, V17, P1855, DOI 10.1093/carcin/17.9.1855; Saadat M, 2007, PSYCHIAT RES, V153, P87, DOI 10.1016/j.psychres.2006.03.024; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Grozeva D, 2012, SCHIZOPHR RES, V135, P1, DOI 10.1016/j.schres.2011.11.004; Ohnuma T, 2008, PROG NEURO-PSYCHOPH, V32, P1905, DOI 10.1016/j.pnpbp.2008.07.022; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Rabinovic AD, 1998, J NEUROCHEM, V71, P2071; WAZIRI R, 1983, BRIT J PSYCHIAT, V143, P69, DOI 10.1192/bjp.143.1.69; Buizer-Voskamp JE, 2011, BIOL PSYCHIAT, V70, P655, DOI 10.1016/j.biopsych.2011.02.015; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Rees E, 2014, HUM MOL GENET, V23, P1669, DOI 10.1093/hmg/ddt540; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Gravina P, 2011, PSYCHIAT RES, V187, P454, DOI 10.1016/j.psychres.2010.10.008; Arai M, 2010, ARCH GEN PSYCHIAT, V67, P589, DOI 10.1001/archgenpsychiatry.2010.62; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Raffa M, 2009, PROG NEURO-PSYCHOPH, V33, P1178, DOI 10.1016/j.pnpbp.2009.06.018; Watanabe Y, 2010, SCHIZOPHR RES, V124, P236, DOI 10.1016/j.schres.2010.08.001; Covault J, 2003, BIOTECHNIQUES, V35, P594; Pae CU, 2004, PSYCHIAT GENET, V14, P147, DOI 10.1097/00041444-200409000-00005; Hanzawa R, 2011, PSYCHIAT CLIN NEUROS, V65, P39, DOI 10.1111/j.1440-1819.2010.02157.x; Nafissi S, 2011, PSYCHIAT RES, V187, P314, DOI 10.1016/j.psychres.2010.11.024; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Harada S, 2001, BIOCHEM BIOPH RES CO, V281, P267, DOI 10.1006/bbrc.2001.4347; Marchbanks RM, 2003, SCHIZOPHR RES, V65, P33, DOI 10.1016/S0920-9964(03)00011-2; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Maeshima H, 2007, PROG NEURO-PSYCHOPH, V31, P1410, DOI 10.1016/j.pnpbp.2007.06.009; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Takeda M, 2015, NEUROSCI LETT, V593, P51, DOI [10.1016/j.neulet.2015.03.002, 10.1016/j.neu1et.2015.03.002]; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Arinami T, 2005, AM J HUM GENET, V77, P937, DOI 10.1086/498122; Coggan M, 1998, BIOCHEM J, V334, P617; Hebbring SJ, 2007, HUM MOL GENET, V16, P463, DOI 10.1093/hmg/ddl468; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Ma J, 2010, SCHIZOPHR RES, V119, P273, DOI 10.1016/j.schres.2009.12.017; Raffa M, 2013, GENE, V512, P282, DOI 10.1016/j.gene.2012.10.031; LINDSAY EA, 1995, AM J MED GENET, V57, P514, DOI 10.1002/ajmg.1320570339; Karayiorgou Maria, 1995, Proceedings of the National Academy of Sciences of the United States of America, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kashani Farah Lotfi, 2011, Neuron Glia Biol, V7, P199, DOI 10.1017/S1740925X12000130; Katsuta N, 2014, SCHIZOPHRENIA BULL, V40, P1366, DOI 10.1093/schbul/sbt234; Miyashita M., 2013, SCHIZOPHR B, V40, P1040; Rodriguez-Santiago B, 2010, MOL PSYCHIATR, V15, P1023, DOI 10.1038/mp.2009.53; Yang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09392	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	OCT	2015	168	7					630	636		10.1002/ajmg.b.32347		7	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	CR3GZ	WOS:000361221200013		
J	Ichijo, M; Iwasawa, E; Numasawa, Y; Miki, K; Ishibashi, S; Tomita, M; Tomimitsu, H; Kamata, T; Fujigasaki, H; Shintani, S; Mizusawa, H				Ichijo, M.; Iwasawa, E.; Numasawa, Y.; Miki, K.; Ishibashi, S.; Tomita, M.; Tomimitsu, H.; Kamata, T.; Fujigasaki, H.; Shintani, S.; Mizusawa, H.			Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; HYPERINTENSE VESSELS; HYPERACUTE STROKE; RECOVERY; CIRCULATION; TRIAL; RECANALIZATION; REPERFUSION; ANGIOGRAPHY	BACKGROUND AND PURPOSE: Predicting response to rtPA is essential in the era of endovascular therapy for stroke. The purpose of this study was to elucidate prognostic factors of early neurologic improvement and long-term outcome with respect to the development and reversion of leptomeningeal collaterals in recanalization therapy after acute ischemic stroke. MATERIALS AND METHODS: We analyzed consecutive patients with proximal MCA occlusion treated with rtPA from 2007 to 2012 at 2 hospital stroke centers. All patients routinely underwent brain MR imaging before rtPA. To assess the reversion of collateral signs, we included patients who underwent follow-up MR imaging. We assessed the development and reversion of collaterals by using a combination of 2 MR imaging collateral markers, the hyperintense vessel sign and the posterior cerebral artery laterality sign. Early neurologic improvement was defined as a decrease in the NIHSS score of >= 10 or a score of <= 2 at 24 hours of treatment. RESULTS: Early neurologic improvement was observed in 22 of 48 eligible patients. The development of collaterals at arrival (15/22 versus 9/26, P = .042) was significantly associated with early neurologic improvement. Multivariate analysis adjusting for other variables showed that the development of collaterals at arrival (OR, 4.82; 95% Cl, 1.34-19.98; P = .015) was independently associated with early neurologic improvement. Reversion of collaterals was significantly associated with successful recanalization (P < .001), and multivariate analysis showed that the reversion of collaterals was an independent prognostic factor of long-term functional outcome (OR, 5.07; 95% Cl, 1.38-22.09; P = .013). CONCLUSIONS: Our results indicate that the development of leptomeningeal collaterals plays a crucial role in achieving early neurologic improvement, and reversion of collaterals predicts a favorable outcome via arterial recanalization after rtPA treatment for acute stroke.	[Ichijo, M.; Iwasawa, E.; Numasawa, Y.; Ishibashi, S.; Mizusawa, H.] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Tokyo 1130034, Japan; [Miki, K.] Tokyo Med & Dent Univ, Dept Endovasc Surg, Tokyo 1130034, Japan; [Tomita, M.] Tokyo Med & Dent Univ, Clin Res Ctr, Tokyo 1130034, Japan; [Tomimitsu, H.; Shintani, S.] JA Toride Med Ctr, Dept Neurol, Ibaraki, Japan; [Ichijo, M.; Kamata, T.] Musashino Red Cross Hosp, Dept Neurol, Tokyo, Japan; [Fujigasaki, H.] Metropolitan Bokutoh Hosp, Dept Internal Med, Tokyo, Japan	Ishibashi, S (reprint author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.	t-ishibashi.nuro@tmd.ac.jp					Brown DL, 2004, STROKE, V35, P147, DOI 10.1161/01.STR.000010539.93273.72; Uemura A, 2004, AM J NEURORADIOL, V25, P88; Ichijo M, 2013, STROKE, V44, P512, DOI 10.1161/STROKEAHA.112.674101; Lee KY, 2009, NEUROLOGY, V72, P1134, DOI 10.1212/01.wnl.0000345360.80382.69; Machumpurath B, 2011, CEREBROVASC DIS, V31, P278, DOI 10.1159/000322564; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Muresan IP, 2010, ARCH NEUROL-CHICAGO, V67, P1323, DOI 10.1001/archneurol.2010.265; Felberg RA, 2002, STROKE, V33, P1301, DOI 10.1161/01.STR.0000015556.48283.74; Maeda M, 2001, J MAGN RESON IMAGING, V13, P987, DOI 10.1002/jmri.1142; Schellinger PD, 2005, AM J NEURORADIOL, V26, P618; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; De Silva DA, 2009, STROKE, V40, P2872, DOI 10.1161/STROKEAHA.108.543595; Cipolla MJ, 1997, STROKE, V28, P176; Olindo S, 2012, ARCH NEUROL-CHICAGO, V69, P1462, DOI 10.1001/archneurol.2012.1310; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Alexandrov AV, 2004, STROKE, V35, P449, DOI 10.1161/01.STR.0000113737.58014.B4; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Ribo M, 2011, STROKE, V42, P3465, DOI 10.1161/STROKEAHA.111.623827; Blinzler C, 2011, CEREBROVASC DIS, V31, P185, DOI 10.1159/000321869; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Liu WH, 2012, EUR J RADIOL, V81, P1595, DOI 10.1016/j.ejrad.2011.04.026; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Liu WH, 2011, EUR J RADIOL, V80, P786, DOI 10.1016/j.ejrad.2010.09.043; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Penumbra Pivotal Stroke Trial Investigators, 2009, STROKE, V40, P2761, DOI DOI 10.1161/STR0KEAHA.108.544957; Shinohara Y, 2004, INT J STROKE, V3, P55; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; The Thrombolysis in Myocardial Infarction (TIMI) trial, 1985, NEW ENGL J MED, V312, P932	33	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2015	36	10					1839	1845		10.3174/ajnr.A4384		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CT3IR	WOS:000362700900010		
J	Mori, H; Izawa, T; Tanaka, E				Mori, Hiroki; Izawa, Takashi; Tanaka, Eiji			Smad3 Deficiency Leads to Mandibular Condyle Degradation via the Sphingosine 1-Phosphate (S1P)/S1P(3) Signaling Axis	AMERICAN JOURNAL OF PATHOLOGY			English	Article							GROWTH-FACTOR-BETA; HUMAN OSTEOARTHRITIC CARTILAGE; CHONDROGENIC PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; TGF-BETA; SUBCHONDRAL BONE; TEMPOROMANDIBULAR-JOINT; EXTRACELLULAR-MATRIX; GENE-REGULATION	Temporomandibular joint osteoarthritis is a degenerative disease that is characterized by permanent cartilage destruction. Transforming growth factor (TGF)-beta is one of the most abundant cytokines in the bone matrix and is shown to regulate the migration of osteoprogenitor cells. It is hypothesized that TGF-beta/Smad3 signaling affects cartilage homeostasis by influencing sphingosine 1-phosphate (S1P)/S1P receptor signaling and chondrocyte migration. We therefore investigated the molecular mechanisms by which crosstalk may occur between TGF-beta/Smad3 and S1P/S1P receptor signaling to maintain condylar cartilage and to prevent temporomandibular joint osteoarthritis. Abnormalities in the condylar subchondral bone, including dynamic changes in bone mineral density and microstructure, were observed in Smad3(-/-) mice by microcomputed tomography. Cell-free regions and proteoglycan Loss characterized the cartilage degradation present, and increased numbers of apoptotic chondrocytes and matrix metalloproteinase 13 chondrocytes were also detected. Furthermore, expression of SIP receptor 3 (S1P(3)), but not S1P(1) or S1P(2), was significantly down-regulated in the condylar cartilage of Smad3(-/-) mice. By using RNA interference technology and pharmacologic tools, S1P was found to transactivate Smad3 in an S1P(3)/TGF-beta type II receptor-dependent manner, and S1P(3) was found to be required for TGF-beta-induced migration of chondrocyte cells and downstream signal transduction via Rac1, RhoA, and Cdc42. Taken together, these results indicate that the Smad3/S1P(3) signaling pathway plays an important role in the pathogenesis of temporomandibular joint osteoarthritis.	[Mori, Hiroki; Izawa, Takashi; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan	Izawa, T (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, 3-18-15 Kuramotocho, Tokushima 7708504, Japan.	tizawa@tokushima-u.ac.jp			Ministry of Education, Science, Sport, and Culture of Japan [25713063, 15K15757, 26293436]	Supported by the Ministry of Education, Science, Sport, and Culture of Japan grants-in-aid for scientific research 25713063 (T.I.), 15K15757 (T.I.), and 26293436 (E.T.).	Kim HA, 2001, J RHEUMATOL, V28, P2038; Bismar H, 1999, BONE, V24, P565, DOI 10.1016/S8756-3282(99)00082-4; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI [10.1359/jbmr.080901, 10.1359/JBMR.080901]; Huser CAM, 2006, OSTEOARTHR CARTILAGE, V14, P1002, DOI 10.1016/j.joca.2006.03.012; Yokozeki M, 2003, BIOCHEM BIOPH RES CO, V305, P684, DOI 10.1016/S0006-291X(03)00806-4; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Shen G, 2005, J DENT RES, V84, P691; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Radeke HH, 2005, J IMMUNOL, V174, P2778; Sharif M, 2004, ARTHRITIS RHEUM, V50, P507, DOI 10.1002/art.20020; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; Zhang J, 2013, J DENT RES, V92, P253, DOI 10.1177/0022034512473482; Kim MK, 2006, BIOCHEM BIOPH RES CO, V345, P67, DOI 10.1016/j.bbrc.2006.04.042; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; Scrivani SJ, 2008, NEW ENGL J MED, V359, P2693, DOI 10.1056/NEJMra0802472; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Embree M, 2011, J DENT RES, V90, P1331, DOI 10.1177/0022034511421930; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/i.tem.2007.07.005; Tanaka E, 2008, J DENT RES, V87, P296; Seol D, 2012, ARTHRITIS RHEUM-US, V64, P3626, DOI 10.1002/art.34613; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; MCNEILL C, 1990, J AM DENT ASSOC, V120, P253; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/job.200211089; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260; Gerter R, 2012, MATRIX BIOL, V31, P206, DOI 10.1016/j.matbio.2012.01.007; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Ridley AJ, 2001, J CELL SCI, V114, P2713; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200; Pelletier JP, 2004, BONE, V34, P527, DOI 10.1016/j.bone.2003.11.021; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Jiao K, 2014, J DENT RES, V93, P140, DOI 10.1177/0022034513513034; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Stradner MH, 2008, OSTEOARTHR CARTILAGE, V16, P305, DOI 10.1016/j.joca.2007.06.018; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Xie LQ, 2012, ARTHRITIS RHEUM-US, V64, P1899, DOI 10.1002/art.34370; VONDERMARK K, 1992, ARTHRITIS RHEUM, V35, P806, DOI 10.1002/art.1780350715; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045036	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	OCT	2015	185	10					2742	2756		10.1016/j.ajpath.2015.06.015		15	Pathology	Pathology	CT3HR	WOS:000362698300014		
J	Delgado, ER; Yang, J; So, J; Fanti, M; Leimgruber, S; Kahn, M; Ishitani, T; Shin, D; Wilson, GM; Monga, SP				Delgado, Evan R.; Yang, Jing; So, Juhoon; Fanti, Maura; Leimgruber, Stephanie; Kahn, Michael; Ishitani, Tohru; Shin, Donghun; Wilson, Gabriela Mustata; Monga, Satdarshan P.			Identification and Characterization of a Novel Small-Molecule Inhibitor of beta-Catenin Signaling (vol 184, pg 2111, 2014)	AMERICAN JOURNAL OF PATHOLOGY			English	Correction									[Delgado, Evan R.; Yang, Jing; Fanti, Maura; Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [So, Juhoon; Shin, Donghun] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Fanti, Maura] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Leimgruber, Stephanie] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Fanti, Maura] Univ So Calif, Keck Sch Med, Dept Mol Pharmacol & Toxicol, Sch Pharm, Los Angeles, CA 90033 USA; [Ishitani, Tohru] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Cell Regulat Syst, Fukuoka 812, Japan; [Wilson, Gabriela Mustata] Univ So Indiana, Dept Hlth Serv & Hlth Adm, Evansville, IN 47712 USA	Delgado, ER (reprint author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.						Delgado ER, 2014, AM J PATHOL, V184, P2111, DOI 10.1016/j.ajpath.2014.04.002	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	OCT	2015	185	10					2861	2861				1	Pathology	Pathology	CT3HR	WOS:000362698300024		
J	Shimokaze, T; Saito, E; Akaba, K				Shimokaze, Tomoyuki; Saito, Emi; Akaba, Kazuhiro			Increased Incidence of Late-Onset Circulatory Collapse after Changing Clinical Practice: A Retrospective Investigation of Causative Factors	AMERICAN JOURNAL OF PERINATOLOGY			English	Article						adrenal insufficiency; fentanyl; glucocorticoid; hyponatremia; opioid	LOW-BIRTH-WEIGHT; PRETERM INFANTS; PREMATURE-INFANTS; INSUFFICIENCY; MORPHINE; OUTCOMES; DYSFUNCTION; STRESS; TRIAL; JAPAN	Objective Acute primary profound circulatory failure responsive to glucocorticoid therapy after the first week of age in preterm infants is termed late-onset circulatory collapse (LCC). This study was performed to identify factors that notably increased the incidence of LCC after various management practices were changed. Study Design We retrospectively studied the clinical characteristics of infants (<29 weeks' gestation) before (n = 26) and after (n = 35) implementing the following practice changes: stress reduction, conservative replacement of thyroid hormone, positive antenatal glucocorticoid administration, sedation with fentanyl (<7 days after birth), and hydrocortisone therapy for hypotension. Results After the aforementioned changes, the incidence of LCC increased from 4 to 43%, and that of intraventricular hemorrhage decreased from 42 to 9%. Antenatal glucocorticoids (75 vs. 20%), fentanyl (94 vs. 53%), and hydrocortisone (63 vs. 31%) (<2 weeks of age) were given to infants with LCC and non-LCC. After the practice changes, infants with LCC had lower serum sodium levels than did infants without LCC at 7 to 14 days of age. Conclusion Relative hyponatremia was an early sign of imminent LCC. In addition to adrenal prematurity, the antenatal administration of glucocorticoids and fentanyl, which influence adrenal function, might increase the incidence of LCC.	[Shimokaze, Tomoyuki; Saito, Emi; Akaba, Kazuhiro] Saiseikai Yamagata Hosp, Dept Pediat, Yamagata 9908545, Japan	Shimokaze, T (reprint author), Saiseikai Yamagata Hosp, Dept Pediat, 79-1 Okimachi, Yamagata 9908545, Japan.	tkaze@hotmail.com					Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Davis EP, 2006, J PERINATOL, V26, P147, DOI 10.1038/sj.jp.7211447; Washio Y, 2013, PEDIATR INT, V55, P582, DOI 10.1111/ped.12114; Oltmanns KM, 2005, J INTERN MED, V257, P478, DOI 10.1111/j.1365-2796.2005.01483.x; Toyoshima K, 2013, J FORMOS MED ASSOC, V112, P510, DOI 10.1016/j.jfma.2013.02.011; Nakanishi H, 2010, J PERINATOL, V30, P751, DOI 10.1038/jp.2010.41; Anand KJS, 2004, LANCET, V363, P1673, DOI 10.1016/S0140-6736(04)16251-X; Mussig K, 2007, CLIN ENDOCRINOL, V66, P604, DOI 10.1111/j.1365-2265.2007.02779.x; BALLARD PL, 1980, PEDIATR RES, V14, P122, DOI 10.1203/00006450-198002000-00011; Kawai M, 2012, PEDIATR INT, V54, P177, DOI 10.1111/j.1442-200X.2011.03518.x; Kobayashi S, 2006, TOHOKU J EXP MED, V210, P333, DOI 10.1620/tjem.210.333; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Masumoto K, 2008, PEDIATR RES, V63, P686, DOI 10.1203/PDR.0b013e31816c8fcc; Takizawa F, 2010, PEDIATR INT, V52, pe154, DOI 10.1111/j.1442-200X.2010.03072.x; Hall RW, 2005, PEDIATRICS, V115, P1351, DOI 10.1542/peds.2004-1398; Houshyar H, 2001, J NEUROENDOCRINOL, V13, P862, DOI 10.1046/j.1365-2826.2001.00713.x; Yagasaki H, 2010, J PEDIATR ENDOCR MET, V23, P153; Bellu R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004212.pub3; Choi EJ, 2011, J KOREAN SOC NEONATO, V18, P82; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Efird Meica M, 2005, J Perinatol, V25, P119, DOI 10.1038/sj.jp.7211193; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Lee JA, 2011, J KOREAN SOC NEONATO, V18, P211	23	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0735-1631	1098-8785		AM J PERINAT	Am. J. Perinatol.	OCT	2015	32	12					1169	1176		10.1055/s-0035-1552933		8	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CT3IH	WOS:000362699900013		
J	Moustafa, A; Habara, Y				Moustafa, Amira; Habara, Yoshiaki			Hydrogen sulfide: a novel gaseous signaling molecule and intracellular Ca2+ regulator in rat parotid acinar cells	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						hydrogen sulfide; intracellular Ca2+; ryanodine receptors; nitric oxide; parotid acinar cells	NITRIC-OXIDE SYNTHASE; CYCLIC ADP-RIBOSE; RYANODINE RECEPTORS; SALIVARY-GLANDS; ENDOTHELIAL-CELLS; PANCREATIC ACINAR; SMOOTH-MUSCLE; RELEASE; ACTIVATION; INCREASE	In addition to nitric oxide (NO), hydrogen sulfide (H2S) is recognized as a crucial gaseous messenger that exerts many biological actions in various tissues. An attempt was made to assess the roles and underlying mechanisms of both gases in isolated rat parotid acinar cells. Ductal cells and some acinar cells were found to express NO and H2S synthases. Cevimeline, a muscarinic receptor agonist upregulated endothelial NO synthase in parotid tissue. NO and H2S donors increased the intracellular Ca2+ concentration ([Ca2+](i)). This was not affected by inhibitors of phospholipase C and inositol 1,4,5-trisphosphate receptors, but was decreased by blockers of ryanodine receptors (RyRs), soluble guanylyl cyclase, and protein kinase G. The H2S donor evoked NO production, which was decreased by blockade of NO synthases or phosphoinositide 3-kinase or by hypotaurine, an H2S scavenger. The H2S donor-induced [Ca2+] i increase was diminished by a NO scavenger or the NO synthases blocker. These results suggest that NO and H2S play important roles in regulating [Ca2+] i via soluble guanylyl cyclase-cGMP-protein kinase G-RyRs, but not via inositol 1,4,5-trisphosphate receptors. The effect of H2S may be partially through NO produced via phosphoinositide 3-kinase-Akt-endothelial NO synthase. It was concluded that both gases regulate [Ca2+] i in a synergistic way, mainly via RyRs in rat parotid acinar cells.	[Moustafa, Amira; Habara, Yoshiaki] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Physiol Lab, Sapporo, Hokkaido 0600818, Japan; [Moustafa, Amira] Zagazig Univ, Fac Vet Med, Dept Physiol, Zagazig, Egypt	Habara, Y (reprint author), Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Physiol Lab, Sapporo, Hokkaido 0600818, Japan.	habara@vetmed.hokudai.ac.jp			Goho Life Science International Foundation; F3 project at Hokkaido University	This study was funded in part by Goho Life Science International Foundation and F3 project at Hokkaido University.	Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Rosignoli F, 2002, EUR J PHARMACOL, V439, P27, DOI 10.1016/S0014-2999(02)01375-4; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Ellies M, 2003, ORL J OTO-RHINO-LARY, V65, P140, DOI 10.1159/000072251; Li PL, 2001, AM J PHYSIOL-HEART C, V280, pH208; Miozza V, 2010, ORAL DIS, V16, P801, DOI 10.1111/j.1601-0825.2010.01691.x; Liang GH, 2012, J PHYSIOL-LONDON, V590, P2709, DOI 10.1113/jphysiol.2011.225128; Tritsaris K, 2000, PFLUG ARCH EUR J PHY, V440, P223; Ozawa T, 1997, J MEMBRANE BIOL, V156, P231, DOI 10.1007/s002329900203; Soinila J, 2006, HISTOCHEM CELL BIOL, V125, P717, DOI 10.1007/s00418-005-0123-8; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; Shimomura H, 2004, ARCH ORAL BIOL, V49, P691, DOI 10.1016/j.archoralbio.2004.03.001; Lomniczi A, 1998, NEUROIMMUNOMODULAT, V5, P226, DOI 10.1159/000026342; Alm P, 1997, HISTOCHEM J, V29, P669, DOI 10.1023/A:1026452715555; McGeown JG, 2004, CELL CALCIUM, V35, P613, DOI 10.1016/j.ceca.2004.01.016; Yang YM, 2014, KOREAN J PHYSIOL PHA, V18, P89, DOI 10.4196/kjpp.2014.18.2.89; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Mitsui Y, 2000, ARCH ORAL BIOL, V45, P531, DOI 10.1016/S0003-9969(00)00029-7; Ishikawa Y, 2006, BBA-BIOMEMBRANES, V1758, P1053, DOI 10.1016/j.bbamem.2006.03.026; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077; MacQuaide N, 2010, J PHYSIOL-LONDON, V588, P4731, DOI 10.1113/jphysiol.2010.193375; Looms DK, 2001, BIOCHEM J, V355, P87; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Grossi L, 2009, BIOORG MED CHEM LETT, V19, P6092, DOI 10.1016/j.bmcl.2009.09.030; Konttinen YT, 1997, ARTHRITIS RHEUM, V40, P875, DOI 10.1002/art.1780400515; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Xu X, 1997, CELL CALCIUM, V22, P217, DOI 10.1016/S0143-4160(97)90015-4; Abe K, 1996, J NEUROSCI, V16, P1066; Gerasimova EV, 2013, B EXP BIOL MED+, V155, P11, DOI 10.1007/s10517-013-2067-7; Chen PH, 2014, SCI WORLD J, DOI 10.1155/2014/480387; Takeda I, 2003, RADIAT RES, V159, P465, DOI 10.1667/0033-7587(2003)159[0465:PRONOI]2.0.CO;2; Takai N, 1999, ARCH ORAL BIOL, V44, P745, DOI 10.1016/S0003-9969(99)00064-3; Moustafa A, 2011, NITRIC OXIDE-BIOL CH, V24, P139, DOI 10.1016/j.niox.2011.02.001; Moustafa A, 2014, ANTIOXID REDOX SIGN, V20, P747, DOI 10.1089/ars.2012.5108; Ishikawa Y, 2002, J PHARMACOL EXP THER, V301, P355, DOI 10.1124/jpet.301.1.355; Zucchi R, 1997, PHARMACOL REV, V49, P1; Ta TA, 2006, MOL PHARMACOL, V69, P532, DOI 10.1124/mol.105.019125; Willmott N, 1996, J BIOL CHEM, V271, P3699; Kakizawa S, 2013, CHANNELS, V7, P1, DOI 10.4161/chan.22555; Sugiya H, 2001, CELL CALCIUM, V30, P107, DOI 10.1054/ceca.2001.0218; Kondo K, 2007, TOXICOLOGY, V232, P138; Looms D, 2002, J ORAL PATHOL MED, V31, P569, DOI 10.1034/j.1600-0714.2002.00047.x; Moustafa A, 2014, AM J PHYSIOL-CELL PH, V307, pC1039, DOI 10.1152/ajpcell.00252.2014; Predmore BL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00104	49	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	OCT 1	2015	309	7					C480	C490		10.1152/ajpcell.00147.2015		11	Cell Biology; Physiology	Cell Biology; Physiology	CS7LM	WOS:000362265100005		
J	Tokunaga, T; Shukunami, C; Okamoto, N; Taniwaki, T; Oka, K; Sakamoto, H; Ide, J; Mizuta, H; Hiraki, Y				Tokunaga, Takuya; Shukunami, Chisa; Okamoto, Nobukazu; Taniwaki, Takuya; Oka, Kiyoshi; Sakamoto, Hidetoshi; Ide, Junji; Mizuta, Hiroshi; Hiraki, Yuji			FGF-2 Stimulates the Growth of Tenogenic Progenitor Cells to Facilitate the Generation of Tenomodulin-Positive Tenocytes in a Rat Rotator Cuff Healing Model	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						FGF-2; rotator cuff healing; Scleraxis; Tenomodulin; Sox9; cell proliferation; tenogenic progenitors	MESENCHYMAL STEM-CELLS; SUPRASPINATUS TENDON; ACUTE INJURY; SCLERAXIS; DIFFERENTIATION; PROLIFERATION; EXPRESSION; REPAIR; MATRIX; CARTILAGE	Background: Fibroblast growth factor (FGF)-2 has the potential to enhance tendon-to-bone healing after rotator cuff (RC) injury. Hypothesis: FGF-2 stimulates tenogenic differentiation of progenitors to improve the biomechanical strength and histological appearance of repaired RCs in rats. Study Design: Controlled laboratory study. Methods: Adult male Sprague-Dawley rats (N = 156) underwent unilateral surgery to repair the supraspinatus tendon to insertion sites. The FGF-2-treated group (gelatin hydrogel containing 5 g of FGF-2) and a control group (gelatin hydrogel only) were compared to investigate the effects of FGF-2 at 2, 4, 6, 8, and 12 weeks postoperatively. Biomechanical testing was performed at 6 and 12 weeks. Semiquantitative histological analysis and immunohistochemical analysis for the proliferating cell nuclear antigen (PCNA) were performed, and the expression of tendon-related markers, including Scleraxis (Scx) and Tenomodulin (Tnmd), was monitored by real-time reverse transcription polymerase chain reaction (RT-PCR) and in situ hybridization. SRY-box containing gene 9 (Sox9) expression was monitored by RT-PCR and immunohistochemical analysis. At 2 and 4 weeks, immunohistochemical analysis for mesenchymal stem cell (MSC) markers was also performed. Results: The FGF-2-treated group demonstrated a significant improvement in mechanical strength at 6 and 12 weeks and significantly higher histological scores than the control group at 4 weeks. The average incidence of PCNA-positive cells was significantly higher at 2 and 4 weeks, and more cells expressing MSC markers were detected at the insertion site in the FGF-2-treated group. The expression level of Scx increased significantly in the FGF-2-treated group from 4 to 8 weeks, while the Tnmd level increased significantly from 4 to 12 weeks postoperatively. The localization of Tnmd overlapped with the locations of reparative tissues accompanying collagen fibers with an aligned orientation. Sox9 expression was significantly upregulated at 4 weeks in the FGF-2-treated group. Conclusion: FGF-2 promotes growth of the tenogenic progenitor cells, which participate in tendon-to-bone healing, resulting in biomechanical and histological improvement of the repaired RC. Clinical Relevance: These findings provide clues regarding the clinical development of regenerative repair strategies for RC injury.	[Tokunaga, Takuya; Shukunami, Chisa; Okamoto, Nobukazu; Taniwaki, Takuya; Oka, Kiyoshi; Sakamoto, Hidetoshi; Ide, Junji; Mizuta, Hiroshi; Hiraki, Yuji] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto, Japan	Hiraki, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hiraki@frontier.kyoto-u.ac.jp			Kaken Pharmaceutical Corp.	One or more of the authors has declared the following potential conflict of interest or source of funding: H.M. has received an unrestricted institutional research grant sponsored by Kaken Pharmaceutical Corp. J. I. has received FGF-2 for the study by Kaken Pharmaceutical Corp. This study was partly sponsored by Kaken Pharmaceutical Corp, including financial support to Kumamoto University and providing FGF-2 for the study.	Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0; Scott A, 2011, J ORTHOP RES, V29, P289, DOI 10.1002/jor.21220; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Russell RD, 2014, J BONE JOINT SURG AM, V96A, P265, DOI 10.2106/JBJS.M.00265; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Hee CK, 2011, AM J SPORT MED, V39, P1630, DOI 10.1177/0363546511404942; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI 10.1089/ten.TEA.2009.0100; Mizuta H, 2004, OSTEOARTHR CARTILAGE, V12, P586, DOI 10.1016/j.joca.2004.04.008; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Uezono K, 2014, AM J SPORT MED, V42, P1930, DOI 10.1177/0363546514532338; Ide J, 2009, J SHOULDER ELB SURG, V18, P391, DOI 10.1016/j.jse.2009.01.013; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Yokoya S, 2012, AM J SPORT MED, V40, P1259, DOI 10.1177/0363546512442343; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Anraku Y, 2009, J BONE MINER METAB, V27, P272, DOI 10.1007/s00774-009-0038-x; Thomopoulos S, 2002, J ORTHOPAED RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Wurgler-Hauri CC, 2007, J SHOULDER ELB SURG, V16, p198S, DOI 10.1016/j.jse.2007.04.003; Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dyment NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096113; Liu H, 2014, STEM CELLS, V33, P443; Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289; Tan CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097453	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2015	43	10					2411	2422		10.1177/0363546515597488		12	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CS9WX	WOS:000362445100012		
J	Konda, S; Yanai, T; Sakurai, S				Konda, Shoji; Yanai, Toshimasa; Sakurai, Shinji			Configuration of the Shoulder Complex During the Arm-Cocking Phase in Baseball Pitching	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						scapula; glenohumeral joint; scapular plane; kinematics; biomechanics	3-DIMENSIONAL SCAPULAR KINEMATICS; KINETIC CHAIN; MOTION; JOINT; BIOMECHANICS; ROTATION; ELBOW	Background: The role of the scapula during high-velocity baseball pitching has been described without 3-dimensional kinematic data. It has been speculated that the scapula functions to align the humerus with the spine of the scapula on both the transverse and scapular planes at the end of the arm-cocking phase. Hypothesis: Two hypotheses were formulated: (1) the scapulothoracic protraction angle correlates with the humerothoracic horizontal adduction angle among participants, and (2) the scapulohumeral rhythm of the humerothoracic elevation is not the same as the normal ratio (2:1) observed widely in controlled abductions. Study Design: Descriptive laboratory study. Methods: A total of 20 Japanese professional baseball pitchers were asked to pitch 3 fastballs as they would normally during pitching practice. The 3-dimensional kinematic data of the thorax, scapulae, humeri, and pelvis were recorded using an electromagnetic tracking device operating at 240 Hz. Humerothoracic, scapulothoracic, and glenohumeral joint configurations were determined at the instant of stride-foot contact (SFC) and the end of the arm-cocking phase (MER). Results: The mean (SD) glenohumeral horizontal adduction (-6 degrees 7 degrees) and elevation (85 degrees +/- 10 degrees) angles at the MER indicated that the humerus was positioned almost parallel to the spine of the scapula. The mean scapulothoracic protraction angle (15 degrees +/- 10 degrees) was significantly correlated with the humerothoracic horizontal adduction angle (10 degrees +/- 11 degrees) at the MER (r = 0.76, P < .001) but not at the SFC (r = 0.13, P = .58). The scapulohumeral rhythm (4.2 [+/- 1.9]:1) expressed as the ratio of the glenohumeral elevation angle to the scapulothoracic upward rotation angle at the MER was significantly greater than the normal ratio (2:1) (P < .01). Conclusion: The results supported the hypotheses, providing evidence to corroborate the widely accepted concept that the scapula functions to align the humerus with the spine of the scapula so as to limit the glenohumeral joint configuration within the safe zone at the MER. Clinical Relevance: Disruption of coordination, such as abnormal patterns including SICK scapula (scapular malposition, inferior medial border prominence, coracoid pain, and dyskinesis) and scapular dyskinesis, may result in an abnormal configuration of the glenohumeral joint at the MER.	[Konda, Shoji; Yanai, Toshimasa; Sakurai, Shinji] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Konda, S (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	skonda@caos.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [B-23300236]; Waseda University [2011A-938]	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was partly supported by a Grant-in-Aid for Scientific Research (B-23300236) from the Japan Society for the Promotion of Science and a Waseda University Grant for Special Research Projects (2011A-938).	Kibler WB, 1998, AM J SPORT MED, V26, P325; Meskers CGM, 2007, J BIOMECH, V40, P941, DOI 10.1016/j.jbiomech.2006.02.011; FLEISIG GS, 1995, AM J SPORT MED, V23, P233, DOI 10.1177/036354659502300218; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Meyer KE, 2008, J APPL BIOMECH, V24, P24; Konda S, 2010, MED SCI SPORT EXER, V42, P1745, DOI 10.1249/MSS.0b013e3181d64103; Fleisig GS, 1996, SPORTS MED, V21, P421, DOI 10.2165/00007256-199621060-00004; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; FELTNER M, 1986, INT J SPORT BIOMECH, V2, P235; Ludewig PA, 2002, J APPL BIOMECH, V18, P163; FELTNER ME, 1989, INT J SPORT BIOMECH, V5, P403; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Stodden DF, 2005, J APPL BIOMECH, V21, P44; SAKURAI S, 1993, J APPL BIOMECH, V9, P47; Hamming D, 2012, J BIOMECH, V45, P1161, DOI 10.1016/j.jbiomech.2012.02.003; MATSEN FA, 1991, CLIN SPORT MED, V10, P783; Veeger HEJ, 2000, J BIOMECH, V33, P1711, DOI 10.1016/S0021-9290(00)00141-X; DILLMAN CJ, 1993, J ORTHOP SPORT PHYS, V18, P402; Escamilla RF, 1998, J APPL BIOMECH, V14, P1; Burkhart SS, 2003, ARTHROSCOPY, V19, P641, DOI 10.1016/S0749-8063(03)00389-X; Atwater A E, 1979, Exerc Sport Sci Rev, V7, P43; Escamilla Rafael, 2002, Sports Biomech, V1, P213, DOI 10.1080/14763140208522798; Fleisig G, 2000, EXERCISE SPORT SCI, P563; Ishida K., 2004, INT J SPORT HLTH SCI, V2, P119, DOI 10.5432/ijshs.2.119; Itoi E, 2009, SHOULDER, V1, P208; Konda S, 2011, INT J SPORT HLTH SCI, V9, P26, DOI 10.5432/ijshs.20100033; Kreighbaum E, 1981, BIOMECHANICS QUALITA; Ludewig PM, 2011, JOINT STRUCTURE FUNC, P231; Pink MM, 1996, OPERATIVE TECHNIQUES, P109; Vaughn RE, 1985, BIOMECHANICS SPORTS, V2, P72; Zheng N, 2004, BIOMEDICAL ENG PRINC, P209	31	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2015	43	10					2445	2451		10.1177/0363546515594379		7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CS9WX	WOS:000362445100016		
J	Yoshida, T; Yamashita, K; Watanabe, M; Koshizuka, Y; Kuraya, D; Ogura, M; Asahi, Y; Ono, H; Emoto, S; Mizukami, T; Kobayashi, N; Shibasaki, S; Tomaru, U; Kamachi, H; Matsushita, M; Shiozawa, S; Hirono, S; Todo, S				Yoshida, T.; Yamashita, K.; Watanabe, M.; Koshizuka, Y.; Kuraya, D.; Ogura, M.; Asahi, Y.; Ono, H.; Emoto, S.; Mizukami, T.; Kobayashi, N.; Shibasaki, S.; Tomaru, U.; Kamachi, H.; Matsushita, M.; Shiozawa, S.; Hirono, S.; Todo, S.			The Impact of c-Fos/Activator Protein-1 Inhibition on Allogeneic Pancreatic Islet Transplantation	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							STEROID-FREE IMMUNOSUPPRESSION; CARDIAC ALLOGRAFT SURVIVAL; KAPPA-B INHIBITOR; TRANSCRIPTION FACTOR; SELECTIVE INHIBITOR; NUCLEAR-FACTOR; SINGLE-DONOR; RAT-LIVER; CELLS; REJECTION	Unpreventable allograft rejection is one of the main problems in pancreatic islet transplantation (PIT). Therefore, it is imperative to develop a more effective immunosuppressive strategy. The blockade of transcription factors has been a central part of T celldepleting immunosuppressive therapies, as typified by the use of calcineurin inhibitors. The inhibition of activator protein-1 (AP-1) offers a novel strategy for immunosuppression in PIT, although to date, no reports on the effects of AP-1 inhibition are available. In this study, we investigated the immunosuppressive effects of T-5224, a c-Fos/AP-1-selective inhibitor, on murine T cells activated by alpha CD3+alpha CD28 mAbs. T-5224 inhibited proliferation, CD25 up-regulation, and the production of IL-2 and interferon-gamma. In addition, T-5224 blocked the nuclear translocation of c-Fos/AP-1 in activated murine T cells. In BALB/c (H-2(d))-to-C57BL/6J (H-2(b)) mouse PIT, the 2-week administration of T-5224 prolonged survival of 600 islet allografts in a dose-dependent manner. When combined with a 2-week low-dose tacrolimus, the T-5224 treatment markedly prolonged allograft survival to over 300 days, while the efficacy was indeterminate when transplanted islet allograft mass was reduced to 300. We conclude that the c-Fos/AP-1 inhibition by T-5224 is a potentially attractive strategy for allogeneic PIT.	[Yoshida, T.; Watanabe, M.; Koshizuka, Y.; Kuraya, D.; Ogura, M.; Asahi, Y.; Ono, H.; Emoto, S.; Mizukami, T.; Kobayashi, N.; Shibasaki, S.; Kamachi, H.; Matsushita, M.; Todo, S.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Sapporo, Hokkaido, Japan; [Yamashita, K.] Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Sapporo, Hokkaido, Japan; [Tomaru, U.] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Shiozawa, S.] Kyushu Univ, Beppu Hosp, Dept Med, Beppu, Oita, Japan; [Hirono, S.] Kitasato Univ, Sch Pharm, Lab Phys Chem Drug Design, Tokyo, Japan	Yamashita, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Sapporo, Hokkaido, Japan.	kenchan@med.hokudai.ac.jp; s-todo@st-mary-med.or.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan [233903090]	The authors thank Dr. R. Goto, Dr. K. Wakayama, Dr. M. Zaitsu, Dr. Y. Tsunetoshi, and Ms. R. Igarashi for helping to perform the study. This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to S.T.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#233903090 to K.Y.)	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Holschermann H, 2006, CARDIOVASC RES, V71, P527, DOI 10.1016/j.cardiores.2006.05.021; KORSGREN O, 1989, DIABETES, V38, P510, DOI 10.2337/diabetes.38.4.510; Goronzy JJ, 2004, CURR OPIN RHEUMATOL, V16, P212, DOI 10.1097/00002281-200405000-00008; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; GILL RG, 1989, J IMMUNOL, V143, P2176; Bendfeldt H, 2012, J BIOL CHEM, V287, P18386, DOI 10.1074/jbc.M112.358853; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Izuta S, 2012, BIOTECHNOL LETT, V34, P2175, DOI 10.1007/s10529-012-1022-4; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Avouac J, 2012, ARTHRITIS RHEUM-US, V64, P1642, DOI 10.1002/art.33501; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; YAMAMOTO H, 1990, TRANSPLANTATION, V50, P120, DOI 10.1097/00007890-199007000-00022; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Goto R, 2012, TRANSPLANTATION, V93, P777, DOI 10.1097/TP.0b013e318248ca5f; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; KEYMEULEN B, 1992, DIABETOLOGIA, V35, P719; Koh A, 2010, TRANSPLANTATION, V89, P465, DOI 10.1097/TP.0b013e3181c478fd; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86; Satoh M, 2007, TRANSPLANTATION, V83, P1085, DOI 10.1097/01.tp.0000260161.81775.58; Kyriakis JM, 1999, GENE EXPRESSION, V7, P217; White SA, 2009, LANCET, V373, P1808, DOI 10.1016/S0140-6736(09)60609-7; Nomura M, 2002, TRANSPLANTATION, V73, P1403, DOI 10.1097/00007890-200205150-00008; Drachenberg CB, 1999, TRANSPLANTATION, V68, P396, DOI 10.1097/00007890-199908150-00012; Scott LJ, 2003, DRUGS, V63, P1247, DOI 10.2165/00003495-200363120-00006; Lunsford KE, 2008, AM J TRANSPLANT, V8, P1113, DOI 10.1111/j.1600-6143.2008.02219.x; Toso C, 2006, AM J TRANSPLANT, V6, P1049, DOI 10.1111/j.1600-6143.2006.01303.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shibasaki S, 2012, TRANSPLANTATION, V93, P1229, DOI 10.1097/TP.0b013e3182516c9f; Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Johansen C, 2004, BRIT J DERMATOL, V151, P600, DOI 10.1111/j.1365-2133.2004.06088.x; Kuraya D, 2013, TRANSPLANTATION, V96, P445, DOI 10.1097/TP.0b013e31829b0744; Miyazaki H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-153; Tabata A, 2007, TRANSPLANTATION, V83, P1358, DOI 10.1097/01.tp.0000264196.23944.90; Titus TT, 2003, TRANSPLANTATION, V75, P1317, DOI 10.1097/01.TP.0000064517.98252.00; Watanabe M, 2013, TRANSPLANTATION, V96, P454, DOI 10.1097/TP.0b013e31829b077f	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	OCT	2015	15	10					2565	2575		10.1111/ajt.13338		11	Surgery; Transplantation	Surgery; Transplantation	CT2WJ	WOS:000362665400009		
J	Pandey, BD; Neupane, B; Pandey, K; Tun, MMN; Morita, K				Pandey, Basu Dev; Neupane, Biswas; Pandey, Kishor; Tun, Mya Myat Ngwe; Morita, Kouichi			Detection of Chikungunya Virus in Nepal	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							DENGUE VIRUS; JAPANESE ENCEPHALITIS; INFECTION; COINFECTIONS; FEVER	Chikungunya virus (CHIKV) is an emerging alpha viral disease and a public health problem in South Asia including Nepal in recent years. In this study, sera were collected from patients presenting with fever, headache, muscular pain, fatigue, and joint pain of both upper and lower extremities. A total of 169 serum samples were tested for CHIKV and dengue virus (DENV) by using Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibody using enzyme-linked immunosorbent assay (ELISA) method during August to November 2013. Results showed that 3.6% and 27.8% samples were positive for CHIKV and DENV IgM positive, respectively. Similarly, results of IgG showed 3.0% samples were positive for CHIKV IgG and 29.0% were for DENV IgG positive. Further, a 50% focal reduction neutralization test (FRNT50) was performed to confirm the presence of CHIKV, which demonstrated that 8.9% of CHIKV IgM and/or IgG ELISA positive possessed neutralizing anti-CHIK antibodies. To our knowledge, this is the first report in which the presence of CHIKV is confirmed in Nepalese patients by FRNT50. Basic scientists and clinicians need to consider CHIKV as a differential diagnosis in febrile Nepalese patients, and policy makers should consider appropriate surveillance and actions for control strategies.	[Pandey, Basu Dev] Minist Hlth & Populat, Leprosy Control Div, Dept Hlth Serv, Kathmandu 9045, Nepal; Everest Int Clin & Res Ctr, Kathmandu, Nepal; Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki 852, Japan	Pandey, BD (reprint author), Minist Hlth & Populat, Leprosy Control Div, Dept Hlth Serv, Kathmandu 9045, Nepal.	drbasupandey@gmail.com					Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10; Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746; Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638; Hochedez P, 2006, EMERG INFECT DIS, V12, P1565; BUNDO K, 1985, J VIROL METHODS, V11, P15, DOI 10.1016/0166-0934(85)90120-X; Singh SS, 2008, EPIDEMIOL INFECT, V136, P1277, DOI 10.1017/S0950268807009739; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Dhimal M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003035; Kumar Jairaj C, 2010, Cases J, V3, P6, DOI 10.1186/1757-1626-3-6; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Ngwe Tun MM, 2010, EMERG INFECT DIS, V20, P1378; PAHO, 2015, NUMB REP CAS CHIK FE; Pun SB, 2014, J INFECT DEV COUNTR, V8, P790, DOI 10.3855/jidc.3701	17	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4					697	700		10.4269/ajtmh.15-0092		4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CS8BX	WOS:000362311800006		
J	Gryseels, C; Grietens, KP; Dierickx, S; Xuan, XN; Uk, S; Bannister-Tyrrell, M; Trienekens, S; Ribera, JM; Hausmann-Muela, S; Gerrets, R; D'Alessandro, U; Sochantha, T; Coosemans, M; Erhart, A				Gryseels, Charlotte; Grietens, Koen Peeters; Dierickx, Susan; Xuan, Xa Nguyen; Uk, Sambunny; Bannister-Tyrrell, Melanie; Trienekens, Suzan; Ribera, Joan Muela; Hausmann-Muela, Susanna; Gerrets, Rene; D'Alessandro, Umberto; Sochantha, Tho; Coosemans, Marc; Erhart, Annette			High Mobility and Low Use of Malaria Preventive Measures among the Jarai Male Youth along the Cambodia-Vietnam Border	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOUTHEAST-ASIA; FOREST MALARIA; RISK-FACTORS; RANDOMIZED TRIAL; TREATED HAMMOCK; VECTOR CONTROL; NET COVERAGE; TRANSMISSION; EPIDEMIOLOGY; ELIMINATION	Malaria control along the Vietnam Cambodia border presents a challenge for both countries' malaria elimination targets as the region is forested, inhabited by ethnic minority populations, and potentially characterized by early and outdoor malaria transmission. A mixed methods study assessed the vulnerability to malaria among the Jarai population living on both sides of the border in the provinces of Ratanakiri (Cambodia) and Gia Lai (Vietnam). A qualitative study generated preliminary hypotheses that were quantified in two surveys, one targeting youth (N = 498) and the other household leaders (N = 449). Jarai male youth, especially in Cambodia, had lower uptake of preventive measures (57.4%) and more often stayed overnight in the deep forest (35.8%) compared with the female youth and the adult population. Among male youth, a high-risk subgroup was identified that regularly slept at friends' homes or outdoors, who had fewer bed nets (32.5%) that were torn more often (77.8%). The vulnerability of Jarai youth to malaria could be attributed to the transitional character of youth itself, implying less fixed sleeping arrangements in nonpermanent spaces or non-bed sites. Additional tools such as long-lasting hammock nets could be suitable as they are in line with current practices.	Inst Trop Med, B-2000 Antwerp, Belgium; Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; Nagasaki Univ, Sch Int Hlth Dev, Nagasaki 852, Japan; Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; MRC Unit, Fajara, Gambia; London Sch Hyg & Trop Med, London WC1, England; Univ Antwerp, B-2020 Antwerp, Belgium	Gryseels, C (reprint author), Inst Trop Med, Med Anthropol Unit, Natl Str 155, B-2000 Antwerp, Belgium.	cgryseels@itg.be			Belgian Co-operation (Directorate General for Development Cooperation)	This study was conducted in the framework of the Institutional Collaboration between the National Centre for Malaria Control (CNM) Cambodia and the Institute of Tropical Medicine, Belgium, supported by the Belgian Co-operation (Directorate General for Development Cooperation).	AAA, COD ETH AM ANTHR ASS; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Sanh NH, 2008, AM J TROP MED HYG, V79, P652; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Abe T, 2009, SE ASIAN J TROP MED, V40, P18; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Konradsen F, 2003, AM J TROP MED HYG, V68, P177; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Iwashita H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-176; Erhart A, 2004, AM J TROP MED HYG, V70, P110; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Prothero RM, 1999, SINGAPORE J TROP GEO, V20, P76, DOI 10.1111/1467-9493.00044; Durnez L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-329; Magris M, 2007, TROP MED INT HEALTH, V12, P392, DOI 10.1111/j.1365-3156.2006.01801.x; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Coosemans M, 2006, P INT C HUBS HARB DE, P551; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Kar NP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-265; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Levine R, 2008, ANTHR CHILD DEV; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Morrow M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-85; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Grietens KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029991; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Pongvongsa T, 2012, VIETNAM MALAR J, V11, P262; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3; Tashakkori A, 1998, APPL SOCIAL RES METH; Thang Ngo Duc, 2009, PLoS One, V4, pe7369, DOI 10.1371/journal.pone.0007369; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Van Bortel W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-373; WHO, 2008, MAL GREAT MEK SUBR; Xuan XN, 2010, MALARIA J, V9, P1; Zimmerman R H, 1997, Rev Panam Salud Publica, V2, P18, DOI 10.1590/S1020-49891997000700004	49	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	OCT	2015	93	4					810	818		10.4269/ajtmh.15-0259		9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CS8BX	WOS:000362311800026		
J	Cai, N; Inoue, T; Fujino, K; Ohfuji, H; Yurimoto, H				Cai, Nao; Inoue, Toru; Fujino, Kiyoshi; Ohfuji, Hiroaki; Yurimoto, Hisayoshi			A possible new Al-bearing hydrous Mg-silicate (23 angstrom phase) in the deep upper mantle	AMERICAN MINERALOGIST			English	Article						New hydrous Mg-silicate; 23 angstrom phase; phase A; chlorite; subduction zone; upper mantle	HIGH-PRESSURE STABILITY; TRANSITION ZONE; SYSTEM MGO-SIO2-H2O; CRYSTAL-STRUCTURE; ORTHO-PYROXENE; MAGNESIUM SILICATES; WATER SOLUBILITY; SUBDUCTION ZONES; HIGH-TEMPERATURE; GPA	A new Al-bearing hydrous Mg-silicate that we named as 23 angstrom phase was synthesized at 10 GPa and 1000 degrees C, while also coexisting with diaspore and pyrope in the following system: phase A [Mg7Si2O8(OH)(6)] + Al2O3 + H2O. The chemical composition of this new 23 angstrom phase is Mg11Al2Si4O16(OH)(12), and it contains about 12.1 wt% water. Powder X-ray diffraction and electron diffraction patterns show that this new 23 angstrom phase has a hexagonal structure, with a = 5.1972(2), c = 22.991(4) angstrom, and V = 537.8(2) angstrom(3), and the possible space group is P (6) over bar c2, P6(3)cm, or P6(3)/mcm. The calculated density is 2.761 g/cm(3) accordingly, which was determined by assuming that the formula unit per cell (Z) is 1. This crystal structure is quite unique among mantle minerals in having an extraordinarily long c axis. Several experiments revealed that its stability region is very similar to that of phase A. We further confirmed that this new 23 angstrom phase was stable in the chlorite composition at 10 GPa and 1000 degrees C. The present results indicate that this new 23 angstrom hydrous phase will form in an Al-bearing subducting slab, and transport water together with Al into the deep upper mantle or even into the upper part of the transition zone.	[Cai, Nao; Inoue, Toru; Fujino, Kiyoshi; Ohfuji, Hiroaki] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Cai, N (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	nao@sci.ehime-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26247073]	This work was conducted as a part of a Ph.D. thesis of N. Cai at Ehime University. The authors thank T. Shinmei for his great help in high-pressure experiments and electron microprobe observations. We also appreciate N. Sakamoto for the assistance in SIMS measurements at Hokkaido University, and T. Kuribayashi at Tohoku University for his great comments on this project. The research was supported by a Grant-in-Aid for Scientific Research (A) [KAKENHI] from the Japan Society for the Promotion of Science (JSPS) given to T. Inoue (No. 26247073).	Litasov KD, 2007, EARTH PLANET SC LETT, V262, P620, DOI 10.1016/j.epsl.2007.08.015; Ohtani E, 1997, GEOPHYS RES LETT, V24, P1047, DOI 10.1029/97GL00874; INOUE T, 1995, GEOPHYS RES LETT, V22, P117, DOI 10.1029/94GL02965; Wunder B, 1998, CONTRIB MINERAL PETR, V132, P111, DOI 10.1007/s004100050410; HORIUCHI H, 1979, AM MINERAL, V64, P593; Fockenberg T, 1998, AM MINERAL, V83, P220; Rauch M, 2002, CONTRIB MINERAL PETR, V143, P525, DOI 10.1007/s00410-002-0365-6; KUDOH Y, 1993, PHYS CHEM MINER, V19, P357; Irifune T, 1998, GEOPHYS RES LETT, V25, P203, DOI 10.1029/97GL03572; Okamoto K, 1999, AM MINERAL, V84, P362; Ohtani E, 2001, PHYS EARTH PLANET IN, V124, P105, DOI 10.1016/S0031-9201(01)00192-3; Higo Y, 2001, GEOPHYS RES LETT, V28, P3505, DOI 10.1029/2001GL013194; RINGWOOD AE, 1967, EARTH PLANET SC LETT, V2, P130, DOI 10.1016/0012-821X(67)90114-8; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; GASPARIK T, 1993, J GEOPHYS RES-SOL EA, V98, P4287, DOI 10.1029/92JB02530; Kirby SH, 1996, REV GEOPHYS, V34, P261, DOI 10.1029/96RG01050; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Gemmi M, 2011, EARTH PLANET SC LETT, V310, P422, DOI 10.1016/j.epsl.2011.08.019; YAGI T, 1976, TECTONOPHYSICS, V35, P259, DOI 10.1016/0040-1951(76)90042-1; Komabayashi T, 2006, PHYS EARTH PLANET IN, V156, P89, DOI 10.1016/j.pepi.2006.02.002; STAUDIGEL H, 1977, CONTRIB MINERAL PETR, V61, P187, DOI 10.1007/BF00374367; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; YAMAMOTO K, 1974, J SOLID STATE CHEM, V9, P187, DOI 10.1016/0022-4596(74)90073-5; Chen JH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014429; Mierdel K, 2007, SCIENCE, V315, P364, DOI 10.1126/science.1135422; WUNDER B, 1993, AM MINERAL, V78, P285; KANZAKI M, 1991, PHYS EARTH PLANET IN, V66, P307, DOI 10.1016/0031-9201(91)90085-V; Domanik KJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4133, DOI 10.1016/S0016-7037(96)00241-4; Komabayashi T, 2005, PHYS EARTH PLANET IN, V151, P276, DOI 10.1016/j.pepi.2005.04.002; Bromiley GD, 2002, CONTRIB MINERAL PETR, V142, P714, DOI 10.1007/s00410-001-0318-5; Chen JH, 2011, AM MINERAL, V96, P697, DOI 10.2138/am.2011.3602; Sakurai M, 2014, EARTH PLANET SC LETT, V400, P284, DOI [10.1016/j.epsl.2014.05.041, 10.1016/j.eps1.2014.05.041]; Kurosawa M, 1997, PHYS CHEM MINER, V24, P385, DOI 10.1007/s002690050052; AKAOGI M, 1980, J GEOPHYS RES, V85, P6944, DOI 10.1029/JB085iB12p06944; EGGLETON RA, 1978, GEOCHEM J, V12, P191; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Inoue T, 1998, EARTH PLANET SC LETT, V160, P107, DOI 10.1016/S0012-821X(98)00077-6; SCHMIDT MW, 1994, EARTH PLANET SC LETT, V124, P105, DOI 10.1016/0012-821X(94)00080-8; OHTANI E, 1995, GEOPHYS RES LETT, V22, P2553, DOI 10.1029/95GL02338; Artioli G, 1999, AM MINERAL, V84, P1906; Frost DJ, 1998, J GEOPHYS RES-SOL EA, V103, P7463, DOI 10.1029/98JB00077; Suzuki A, 2000, PHYS CHEM MINER, V27, P689, DOI 10.1007/s002690000120; Gottschalk M, 2000, EUR J MINERAL, V12, P935; Chopin C, 1983, AM J SCI A, V283-a, P72; Fawley A., 1994, CONTRIB MINERAL PETR, V118, P99; Fockenberg T., 1995, BOCHUMER GEOL GEOTEC, V44, P39; LIU LG, 1987, PHYS EARTH PLANET IN, V49, P142, DOI 10.1016/0031-9201(87)90138-5; Miyagi I., 1995, B VOLCANOL SOC JPN, V40, P349; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/ngeo2074, 10.1038/NGEO2074]; YAMAMOTO K, 1977, AM J SCI, V277, P288	51	0	0	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	OCT	2015	100	10					2330	2335		10.2138/am-2015-5148		6	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CT3GG	WOS:000362694600031		
J	Bernabeu, C; Gallardo-Vara, E; Blanco, F; Roque, M; Friedman, SL; Suzuki, T; Botella, LM				Bernabeu, C.; Gallardo-Vara, E.; Blanco, F.; Roque, M.; Friedman, S. L.; Suzuki, T.; Botella, L. M.			Transcription factor KLF6 upregulates gene expression of metaloprotease MMP-14 and soluble endoglin release upon vascular injury	ANGIOGENESIS			English	Meeting Abstract									[Bernabeu, C.; Gallardo-Vara, E.; Blanco, F.; Botella, L. M.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Bernabeu, C.; Gallardo-Vara, E.; Blanco, F.; Botella, L. M.] CIBERER, Madrid 28040, Spain; [Roque, M.] Hosp Clin Barcelona, Inst Torax, Serv Cardiol, Barcelona, Spain; [Friedman, S. L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Suzuki, T.] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-6970	1573-7209		ANGIOGENESIS	Angiogenesis	OCT	2015	18	4				OR56	544	545				2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT3CF	WOS:000362683200063		
J	Terada, A; Ishiguro, T; Komiyama, M; Yamada, O; Morisaki, H				Terada, Aiko; Ishiguro, Tomoya; Komiyama, Masaki; Yamada, Osamu; Morisaki, Hiroko			Clinical features of brain arterivenous malformation and arteriovenous fisutla in hereditary hemorrhagic telagiectasia	ANGIOGENESIS			English	Meeting Abstract									[Terada, Aiko] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; [Ishiguro, Tomoya; Komiyama, Masaki] Osaka City Gen Hosp, Dept Neurointervent, Osaka, Japan; [Yamada, Osamu] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka, Japan; [Morisaki, Hiroko] Natl Cerebral & Cardiovasc Ctr, Dept Biosci & Genet, Suita, Osaka, Japan								0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-6970	1573-7209		ANGIOGENESIS	Angiogenesis	OCT	2015	18	4				P63	564	565				2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CT3CF	WOS:000362683200129		
J	Ishii, J; Uramoto, A; Nagao, Y; Goto, H				Ishii, Junichiro; Uramoto, Akifumi; Nagao, Yoshikazu; Goto, Hisaya			Feeding Solanum glaucophyllum to preparturient multiparous cows prevents postparturient hypocalcemia	ANIMAL SCIENCE JOURNAL			English	Article						1,25dihydroxyvitaminD(3); calcium; Holstein cows; milk fever; Solanum glaucophyllum	BOVINE PARTURIENT PARESIS; 1 ALPHA-HYDROXYCHOLECALCIFEROL; PERIPARTURIENT DAIRY-COWS; MILK FEVER; VITAMIN-D; PARATHYROID-HORMONE; INTESTINAL PHOSPHATE; INORGANIC-PHOSPHATE; CELL-PROLIFERATION; CALCIUM-METABOLISM	Solanum glaucophyllum (SG) contains 1,25-dihydroxyvitamin D-3 (1,25-(OH)(2)D-3) glycosides. We investigated the effect of SG on hypocalcemia in cows. Serum levels of 1,25-(OH)(2)D-3, total calcium and phosphorus dose-relatedly increased after feeding with SG, while serum magnesium and chloride levels fell (P<0.05). We also performed an ethylenediaminetetraacetic acid (EDTA) infusion to induce artificial hypocalcemia. Cows that had been fed 4.0mg/kg body weight of SG daily for 2 weeks had a higher serum concentration of total calcium at the end of EDTA infusion than those not fed SG (P<0.05). In a field trial, multiparous cows were assigned to one of four groups: (1) no SG, (2) 1.3g or (3) 2.6g of SG daily from 14 days before the estimated calving day until 3 days after calving, or (4) a single feed of 35.75g SG at 3 days before the estimated calving day. The concentrations of serum total calcium after the calving in each treatment group were (1) 7.4, (2) 7.9, (3) 8.0 and (4) 8.9mg/dL and higher for (4) than for (1) (P<0.05). The data suggests that feeding a high dose of SG before the calving may maintain higher concentrations of serum calcium after the calving.	[Ishii, Junichiro; Uramoto, Akifumi; Goto, Hisaya] Nippon Formula Feed Mfg Co Ltd, Feed & Livestock Dev Div, Ctr Res & Dev, Motegi, Tochigi 3213621, Japan; [Ishii, Junichiro; Nagao, Yoshikazu] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Anim Prod Sci, Tokyo, Japan; [Ishii, Junichiro; Nagao, Yoshikazu] Utsunomiya Univ, Dept Agr, Univ Farm, Utsunomiya, Tochigi, Japan	Ishii, J (reprint author), Nippon Formula Feed Mfg Co Ltd, Motegi, Tochigi 3213621, Japan.	ishii.junichiro.ws@feed-one.co.jp					ENGSTROM GW, 1987, J DAIRY SCI, V70, P2266; ISHIMI Y, 1990, J BONE MINER RES, V5, P755; GOFF JP, 1986, J DAIRY SCI, V69, P2278, DOI 10.3168/jds.S0022-0302(86)80666-X; Goff JP, 1996, J DAIRY SCI, V79, P378; SACHS M, 1987, J DAIRY SCI, V70, P1671; BOLAND ARD, 1978, CALC TISS RES, V26, P215, DOI 10.1007/BF02013261; BARLET JP, 1979, HORM METAB RES, V11, P57; WITTWER F, 1980, J DAIRY RES, V47, P177; MOATE PJ, 1987, AUST VET J, V64, P73, DOI 10.1111/j.1751-0813.1987.tb09618.x; LAWSON DEM, 1971, NATURE, V230, P228, DOI 10.1038/230228a0; GOFF JP, 1986, J NUTR, V116, P1500; HODNETT DW, 1992, J DAIRY SCI, V75, P485; VOUMARD B, 1984, METAB BONE DIS RELAT, V5, P171, DOI 10.1016/0221-8747(84)90025-0; SANSOM BF, 1971, RES VET SCI, V12, P604; Martin-Tereso J, 2011, J ANIM PHYSIOL AN N, V95, P236, DOI 10.1111/j.1439-0396.2010.01046.x; Taketani Y, 1998, J BIOL CHEM, V273, P14575, DOI 10.1074/jbc.273.23.14575; Jorgensen RJ, 1999, J VET MED A, V46, P389; BAR A, 1985, J DAIRY SCI, V68, P1952, DOI 10.3168/jds.S0022-0302(85)81056-0; BAR A, 1988, J DAIRY SCI, V71, P2723, DOI 10.3168/jds.S0022-0302(88)79865-3; SACHS M, 1987, VET REC, V120, P39; Charbonneau E, 2008, J DAIRY SCI, V91, P1585, DOI 10.3168/jds.2007-0775; Marks J, 2006, EXP PHYSIOL, V91, P531, DOI 10.1113/expphysiol.2005.032516; MATSUI T, 1990, J NUTR SCI VITAMINOL, V36, P99; SMITH VR, 1963, J DAIRY SCI, V46, P223; Goff JP, 2002, J DAIRY SCI, V85, P1427; Yagishita N, 2001, ENDOCRINOLOGY, V142, P5332, DOI 10.1210/en.142.12.5332; Taylor MS, 2008, J DAIRY SCI, V91, P2408, DOI 10.3168/jds.2007-0750; WASSERMAN RH, 1976, SCIENCE, V194, P853, DOI 10.1126/science.982048; JONSSON G, 1978, VET REC, V102, P165; Gimeno EJ, 2000, J VET MED A, V47, P201, DOI 10.1046/j.1439-0442.2000.00279.x; HOVE K, 1983, J DAIRY SCI, V66, P59; Hebert SC, 1997, J EXP BIOL, V200, P295; Thilsing-Hansen T, 2002, J DAIRY SCI, V85, P1855, DOI 10.3168/jds.S0022-0302(02)74259-8; DELUCA HF, 1979, NUTR REV, V37, P161; CURTIS CR, 1983, J AM VET MED ASSOC, V183, P559; MCMURRAY CH, 1980, VET REC, V107, P188; BAR A, 1980, VET REC, V106, P529; ROWLANDS GJ, 1977, J DAIRY RES, V44, P1; Dhiman TR, 1999, J ANIM SCI, V77, P1597; VAGG MJ, 1981, VET REC, V109, P273; PUCHE RC, 1978, CALC TISS RES, V26, P61, DOI 10.1007/BF02013235; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; PONCHON G, 1969, J CLIN INVEST, V48, P2032, DOI 10.1172/JCI106168; ESPARZA MS, 1982, BIOCHIM BIOPHYS ACTA, V719, P633, DOI 10.1016/0304-4165(82)90254-9; BARLET JP, 1975, CR ACAD SCI D NAT, V281, P1497; Ferreira MCD, 1998, AM J PHYSIOL-RENAL, V275, pF198; Huqhes MR, 1977, NATURE, V28, P347; JORGENSE.NA, 1974, J DAIRY SCI, V57, P933; National Research Council, 2001, NUTR REQ DAIR CATTL; Richard JW, 2001, BMC PHYSL, V1, P11; United States Department of Agriculture Animal and Plant Health Inspection Service, 1996, REF 1996 DAIR MAN 1	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	OCT	2015	86	10					869	877		10.1111/asj.12370		9	Agriculture, Dairy & Animal Science	Agriculture	CT1LI	WOS:000362559400001		
J	Oka, A; Iwamoto, E; Tatsuda, K				Oka, Akio; Iwamoto, Eiji; Tatsuda, Ken			Effects of clay on fat necrosis and carcass characteristics in Japanese Black steers	ANIMAL SCIENCE JOURNAL			English	Article						carcass characteristics; clay; fat necrosis; Japanese Black steer	ACID COMPOSITION; TALL FESCUE; ISOPROTHIOLANE; CATTLE; COWS; PERFORMANCE; MINERALS; SERUM	Twenty 10-month-old Japanese Black steers were used to evaluate the effects of clay on fat necrosis and carcass characteristics. Ten steers (Clay group) were fed the clay (50g/day) during 10-30 months of age. The other 10 steers (Control group) were not fed it. There was no significant difference in body weight or average daily gain between the two groups (P>0.05). The occurrence of fat necrotic mass in the Clay group (30%) was lower (P<0.05) than that in the Control group (90%) at slaughter. The size of necrotic masses in the Clay group was smaller (P<0.05) than that in the Control group. There was no significant difference in the marbling score, beef color, Longissimus muscle area or subcutaneous fat thickness between the two groups. These results suggest that the clay prevented the occurrence of fat necrosis and did not affect the carcass characteristics in Japanese Black steers.	[Oka, Akio; Iwamoto, Eiji; Tatsuda, Ken] Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Kasai, Japan	Oka, A (reprint author), Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Agr North Inst, 123 Yasui Wadayama Cho, Asago, Hyogo 6695254, Japan.	akio_oka@pref.hyogo.lg.jp					Abe K, 1979, VITAMINS, V53, P385; Abe K, 1977, VITAMINS, V51, P275; Abe S., 1998, Journal of the Japan Veterinary Medical Association, V51, P187; SHIMADA Y, 1988, JPN J VET SCI, V50, P1017; Queiroz OCM, 2012, J DAIRY SCI, V95, P5901, DOI 10.3168/jds.2011-5287; STUEDEMANN JA, 1985, AM J VET RES, V46, P1990; RUMSEY TS, 1979, J ANIM SCI, V48, P673; MOTOI Y, 1984, JPN J VET SCI, V46, P281; Oka A, 2002, J ANIM SCI, V80, P1005; Williams LB, 2010, INT GEOL REV, V52, P745, DOI 10.1080/00206811003679737; Papaioannou D, 2005, MICROPOR MESOPOR MAT, V84, P161, DOI 10.1016/j.micromeso.2005.05.030; OKA A, 1988, BRIT VET J, V144, P507; SCHELL TC, 1993, J ANIM SCI, V71, P1226; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; LINDEMANN MD, 1993, J ANIM SCI, V71, P171; Katamoto H, 1996, RES VET SCI, V61, P214, DOI 10.1016/S0034-5288(96)90065-X; KATAMOTO H, 1991, J VET MED SCI, V53, P905; Japan Meat Grading Association (JMGA), 1988, NEW BEEF CARC GRAD S; Ministry of Agriculture Forestry and Fisheries, 2013, STAT TABL MUT REL IN; Oka A, 2001, B HYOGO PREFECTURAL, V37, P14; Oka A, 2007, B HYOGO PREFECTURAL, V43, P1; Sakuma H, 2012, JAPANESE J ZOOTECHNI, V83, P291; Shimada Y, 1979, J JPN VET MED ASSOC, V32, P331; Shimada Y., 1978, Journal of the Japan Veterinary Medical Association, V31, P528; Shimada Y., 1977, Journal of the Japan Veterinary Medical Association, V30, P584; Shimada Y., 1979, Journal of the Japan Veterinary Medical Association, V32, P265; Suzuki K, 2013, NIHON CHIKUSAN GAKKA, V84, P375; TANAKA K, 1989, Japanese Journal of Zootechnical Science, V60, P648	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	OCT	2015	86	10					878	883		10.1111/asj.12367		6	Agriculture, Dairy & Animal Science	Agriculture	CT1LI	WOS:000362559400002		
J	Sakai, T; Devkota, NR; Oishi, K; Hirooka, H; Kumagai, H				Sakai, Takashi; Devkota, Naba R.; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime			Evaluation of total mixed ration silage with brewers grains for dairy buffalo in Tarai, Nepal	ANIMAL SCIENCE JOURNAL			English	Article						brewers grain; dairy buffalo; food by-product; total mixed ration silage	COWS; CATTLE; FERMENTATION; FIBER	To investigate the effects of total mixed ration (TMR) silage, which contained brewers grain and rice straw as a substitute for conventional concentrate on feed intake and milk production in middle-to-late lactation buffaloes, four multiparous Murrah buffaloes were assigned to a 3x3 Latin square design experiment. The TMR silage, which had higher neutral and acid detergent fiber contents and digestibility than concentrate (P<0.05) and similar crude protein (CP) and total digestible nutrient (TDN) contents with concentrate were used for the lactation experiment. The treatments were control (CTL) fed concentrate at 0.6% of body weight (BW), and T1 and T2 fed the TMR silage at 0.6 and 1.2% of BW on a dry matter (DM) basis, respectively, with rice straw ad libitum. Daily intakes of DM, CP and TDN, and BW change were higher in T2 than in CTL and T1 (P<0.05). Although milk composition did not differ among the treatments, milk yield (MY) was higher in T2 (P<0.05). There were no significant differences in MY/DM intake and MY/TDN intake among the treatments. The increase of BW and MY in middle-to-late lactation buffaloes might have been due to high TDN intake from supplementary TMR silage.	[Sakai, Takashi; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Devkota, Naba R.] Tribhuvan Univ, Inst Agr & Anim Sci, Rampur, Chitwan, Nepal	Kumagai, H (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto 6068502, Japan.	hkuma@kais.kyoto-u.ac.jp					Abrams SM, 1983, J DAIRY SCI S1, V66, P183; Alexiev AI, 1998, BUFFALO PRODUCTION R, P59; MCCARTHY FD, 1990, ANIM FEED SCI TECH, V28, P29, DOI 10.1016/0377-8401(90)90065-G; MURDOCK FR, 1981, J DAIRY SCI, V64, P1826; Mussatto SI, 2006, J CEREAL SCI, V43, P1, DOI 10.1016/j.jcs.2005.06.001; Paul SS, 2002, J DAIRY RES, V69, P173, DOI [10.1017/S00220299025005423, 10.1017/S0022029902005423]; JOHNSON COLE, 1987, J DAIRY SCI, V70, P98; PATRO BN, 1979, INDIAN J ANIM SCI, V49, P10; Wang F, 2008, J DAIRY SCI, V91, P2380, DOI 10.3168/jds.2007-0821; GRANT RJ, 1974, J ANIM SCI, V39, P423; Armentano L, 1997, J DAIRY SCI, V80, P1416; WEST JW, 1994, J DAIRY SCI, V77, P196; Hayashi Y, 2007, ANIM SCI J, V78, P151, DOI 10.1111/j.1740-0929.2007.00419.x; Cai YM, 1999, J DAIRY SCI, V82, P520; Wanapat M, 2000, ASIAN AUSTRAL J ANIM, V13, P918; KENNEDY PM, 1992, J AGR SCI, V119, P243; STAPLES CR, 1984, J DAIRY SCI, V67, P1214; AOAC, 2000, OFFICIAL METHODS ANA; Barnett AJG, 1951, J BIOCH, V49, P527; CARPINTE.MC, 1969, J SCI FOOD AGR, V20, P677, DOI 10.1002/jsfa.2740201112; Conway E. J., 1962, MICRODIFFUSION ANAL; Food and Agriculture Organization of the United Nations (FAO), 2012, LIV INF; HOMMA H, 1986, Japanese Journal of Zootechnical Science, V57, P336; McDonald P., 1973, CHEMISTRY BIOCHEMIST, P33; National Agriculture and Food Research Organization (NARO), 2010, STAND TABL FEED COMP; NRC, 2001, NUTR REQ DAIR CATTL; Pearson D, 1976, CHEM ANAL FOODS; Prasad J, 1999, PRINCIPLES PRACTICES; Statistical Analysis System (SAS), 1998, SAS STAT US GUID VER; Tyrrell TF, 1965, J DAIRY SCI, V48, P1215; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	OCT	2015	86	10					884	890		10.1111/asj.12374		7	Agriculture, Dairy & Animal Science	Agriculture	CT1LI	WOS:000362559400003		
J	Nakamura, R; Nakamura, F; Fukunaga, S				Nakamura, Ryosuke; Nakamura, Fumio; Fukunaga, Shigeharu			Diverse functions of perlecan in central nervous system cells in vitro	ANIMAL SCIENCE JOURNAL			English	Article						astrocyte; extracellular matrix; HS; neural stem cell; neuron	HEPARAN-SULFATE PROTEOGLYCAN; STEM-CELLS; BASEMENT-MEMBRANE; SPINAL-CORD; NEUROGENESIS; MOLECULE; GROWTH; HIPPOCAMPUS; RECEPTOR; MATRIX	Therapeutic treatment targeting one cell type is considered ineffective in remedying any injury to the central nervous system (CNS). Perlecan, a multi-functional, heparan sulfate proteoglycan, shows diverse effects on distinct cell types, suggesting that it is one of the candidates that can augment the regenerative mechanisms in the injured CNS. Therefore, we examined the functions of perlecan in CNS cells in vitro by using perlecan purified from bovine kidney. Perlecan-coated cell culture plates, unlike their type I/III collagen-coated counterparts, did not inhibit the adhesion of neural stem/progenitor cells (NS/PCs) and neurons. The coated perlecan and the perlecan added to the culture medium suppressed astrocyte proliferation; however, perlecan added to the medium promoted NS/PC proliferation. Neurons were promoted to extend their neurites on the perlecan-coated substrate, and perlecan added to the medium also showed a similar effect. NS/PC proliferation and neurite extension is a major regenerative reaction in CNS injury, whereas excess proliferation of astrocytes cause hypertrophy of glial scars, which repels neurons. Our in vitro study suggests that perlecan is an attractive candidate to promote regenerative mechanisms and to suppress reactions that hamper regenerative processes in cases of CNS injury.	[Nakamura, Ryosuke; Nakamura, Fumio; Fukunaga, Shigeharu] Hokkaido Univ, Res Fac Agr, Lab Anim Byprod Sci, Sapporo, Hokkaido 0608589, Japan	Fukunaga, S (reprint author), Hokkaido Univ, Res Fac Agr, Lab Anim Byprod Sci, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kamui@anim.agr.hokudai.ac.jp					NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Karussis D, 2013, J NEUROL SCI, V324, P1, DOI 10.1016/j.jns.2012.09.031; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Douet V, 2013, CELL PROLIFERAT, V46, P137, DOI 10.1111/cpr.12023; Al-Ahmad AJ, 2011, GLIA, V59, P1822, DOI 10.1002/glia.21227; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9; Walz A, 1997, DEVELOPMENT, V124, P2421; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; RAULO E, 1994, J BIOL CHEM, V269, P12999; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Ahlemeyer B, 2005, J NEUROSCI METH, V149, P110, DOI 10.1016/j.jneumeth.2005.05.022; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Shee WL, 1998, BRAIN RES, V799, P292, DOI 10.1016/S0006-8993(98)00490-9; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Weiss S, 1996, J NEUROSCI, V16, P7599; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; desVellis J, 2012, METHOD MOL BIOL, V814, P49; de Yebenes EG, 1999, J NEUROCHEM, V73, P812, DOI 10.1046/j.1471-4159.1999.0730812.x; Giros A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-29; Lee Seung-Won, 2000, Animal Science Journal, V71, P501; Lo EH, 2005, STROKE J CEREBRAL CI, V36, P189, DOI DOI 10.1161/01.STR.0000153069.96296.FD; Nakamura H, 1992, SHIN SEIKAAGKU JIKKE, V12, P13; Nakamura R, 2014, ANIM SCI J, V85, P262, DOI 10.1111/asj.12116	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	OCT	2015	86	10					904	911		10.1111/asj.12376		8	Agriculture, Dairy & Animal Science	Agriculture	CT1LI	WOS:000362559400006		
J	Kido, J; Nishi, N; Sakaguchi, M; Matsumoto, T				Kido, Jun; Nishi, Natsuko; Sakaguchi, Masami; Matsumoto, Tomoaki			Most cases of cow's milk allergy are able to ingest a partially hydrolyzed formula	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Letter							PROTEIN HYDROLYSATE; AMINO-ACIDS; INFANTS		[Kido, Jun; Nishi, Natsuko; Matsumoto, Tomoaki] Kumamoto Reg Med Ctr, Dept Pediat, Kumamoto, Kumamoto, Japan; [Kido, Jun] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto, Kumamoto, Japan; [Matsumoto, Tomoaki] Kumamoto Univ Hosp, Sakaguchi Childrens Clin, Dept Child Dev, Kumamoto, Kumamoto, Japan; [Sakaguchi, Masami] Aso Spa Hosp, Pediat Div, Aso City, Kumamoto, Japan	Kido, J (reprint author), Kumamoto Reg Med Ctr, Dept Pediat, Kumamoto, Kumamoto, Japan.	matsumoto@a.asospahp.jp					Maggio L, 2005, ACTA PAEDIATR, V94, P75, DOI 10.1080/08035250410023188; Reche M, 2010, PEDIAT ALLERG IMM-UK, V21, P577, DOI 10.1111/j.1399-3038.2010.00991.x; Jin YY, 2011, PEDIAT ALLERG IMM-UK, V22, P688, DOI 10.1111/j.1399-3038.2011.01172.x; Fritsche R, 1997, J ALLERGY CLIN IMMUN, V100, P266, DOI 10.1016/S0091-6749(97)70235-5; Host A, 2002, ANN ALLERG ASTHMA IM, V89, P33; Hernell O, 2003, AM J CLIN NUTR, V78, P296; Pedrosa M, 2006, J INVEST ALLERG CLIN, V16, P351; Hays T, 2005, ARCH PEDIAT ADOL MED, V159, P810, DOI 10.1001/archpedi.159.9.810; Iwamoto H, 2006, ALLERGY PRACT, V26, P466; Malikova NA, 1993, VOP PITANIYA, V1, P26	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	OCT	2015	115	4					330	+		10.1016/j.anai.2015.07.013		4	Allergy; Immunology	Allergy; Immunology	CS8ZW	WOS:000362379500015		
J	Koizumi, M; Miyaji, N; Murata, T; Motegi, K; Miwa, K; Koyama, M; Terauchi, T; Wagatsuma, K; Kawakami, K; Richter, J				Koizumi, Mitsuru; Miyaji, Noriaki; Murata, Taisuke; Motegi, Kazuki; Miwa, Kenta; Koyama, Masamichi; Terauchi, Takashi; Wagatsuma, Kei; Kawakami, Kazunori; Richter, Jens			Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients	ANNALS OF NUCLEAR MEDICINE			English	Article						Bone scan; Skeletal metastasis; Computer-aided diagnosis; BONENAVI version 2.1.7	METASTATIC PROSTATE-CANCER; SCAN INDEX	BONENAVI is a computer-assisted diagnosis system that analyzes bone scintigraphy automatically. We experienced more than a few segmentation errors with the previous BONENAVI version (2.0.5). We have since obtained a revised version (2.1.7) and evaluate it. Bone scans of patients were analyzed by BONENAVI version 2.0.5 and a revised version 2.1.7 with regard to segmentation errors, sensitivity, and specificity. Patients with skeletal metastases from prostate cancer, lung cancer, breast cancer, and other cancers were included in the study as true-positive cases. Patients with no skeletal metastasis (regardless of hot spots), and patients with abnormal bone scans but no skeletal metastasis were included as negative cases. Bone-scan patients were subjected to artificial neural network (ANN) evaluation. Values equal to or above 0.5 were regarded as positive, and those below 0.5 as negative. The patients whose clinical status did not correspond to their ANN scores were assessed for any similarities. The frequency of segmentation errors was statistically significantly reduced when using BONENAVI version 2.1.7. The differences in sensitivity and specificity for the results of version 2.0.5 versus version 2.1.7 were not different, giving a high Cohen's kappa coefficient. In the patients who showed an increased ANN value with version 2.1.7, a few false-positive thoracic lesions were identified. Patients whose ANN value was significantly high with version 2.0.5 showed no tendencies. Revised BONENAVI version 2.1.7 for bone scintigraphy was superior with regard to segmentation errors. However, its sensitivity and specificity were similar to those of version 2.0.5. The false-positive identification of thoracic lesions in revised version 2.1.7 might be subject to remedy.	[Koizumi, Mitsuru; Miyaji, Noriaki; Murata, Taisuke; Motegi, Kazuki; Miwa, Kenta; Koyama, Masamichi; Terauchi, Takashi] Canc Inst Hosp, Dept Nucl Med, Koto Ku, Tokyo 1358550, Japan; [Wagatsuma, Kei] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan; [Kawakami, Kazunori] Fujifilm RI Pharma Co Ltd, Chuo Ku, Tokyo 1040031, Japan; [Richter, Jens] EXINI Diagnost AB, S-22370 Lund, Sweden	Koizumi, M (reprint author), Canc Inst Hosp, Dept Nucl Med, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	mitsuru@jfcr.or.jp					Imbriaco M, 1998, CLIN CANCER RES, V4, P1765; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; Horikoshi H, 2012, ANN NUCL MED, V26, P622, DOI 10.1007/s12149-012-0620-5; Sadik M, 2006, NUCL MED COMMUN, V27, P417, DOI 10.1097/00006231-200605000-00002; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; Meirelles GSP, 2010, CLIN CANCER RES, V16, P6093, DOI 10.1158/1078-0432.CCR-10-1357; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Koizumi M, 2015, ANN NUCL MED, V29, P128; Nakajima K, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-83	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					659	665		10.1007/s12149-015-0988-0		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300001		
J	Yamamoto, T; Kadoya, N; Shirata, Y; Kaneta, T; Koto, M; Umezawa, R; Ishikawa, Y; Kubozono, M; Sugawara, T; Matsushita, H; Abe, K; Takeda, K; Jingu, K				Yamamoto, Takaya; Kadoya, Noriyuki; Shirata, Yuko; Kaneta, Tomohiro; Koto, Masashi; Umezawa, Rei; Ishikawa, Youjirou; Kubozono, Masaki; Sugawara, Toshiyuki; Matsushita, Haruo; Abe, Keiko; Takeda, Ken; Jingu, Keiichi			Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy	ANNALS OF NUCLEAR MEDICINE			English	Article						Stereotactic body radiotherapy; Lung cancer; Prognosis; Corrected SUVmax	POSITRON-EMISSION-TOMOGRAPHY; RADIATION-THERAPY; STRONG PREDICTOR; SBRT; NSCLC	It is known that the partial volume effect and respiratory motion blur affect quantitative parameters such as the maximum standardized uptake value (SUVmax) in FDG-PET, especially in small lesions. The purpose of this study was to assess the prognostic value of corrected SUVmax, which was corrected SUVmax for the partial volume effect and respiratory motion blur, in patients with stage I non-small cell lung cancer (NSCLC) after treatment with stereotactic body radiotherapy (SBRT). Fifty-one patients who were treated with SBRT between 2005 and 2011 in our institute were enrolled. The median tumor diameter was 2.2 cm (range 0.9-3.9 cm). The prescribed dose was typically 48 Gy in 4 fractions, 60 Gy in 8 fractions or 60 Gy in 15 fractions to the isocenter of irradiation fields. Each raw SUVmax was corrected using the recently proposed formula, and the correlations of raw SUVmax and corrected SUVmax with local control rate (LCR) were analyzed retrospectively. Median raw SUVmax before SBRT was 6.4 (range 0.6-22.8). Median corrected SUVmax was 8.0 (range 0.8-22.8), which was significantly increased (p < 0.01). The median follow-up period for survivors was 45.3 months (range 18.5-82.0 months). The 3-year LCR and overall survival rates were 81.8 and 65.2 %, respectively. In univariate analysis, raw SUVmax [per 1 increase; p = 0.02, hazard ratio (HR) 1.20, 95 % confidence interval (CI) 1.03-1.42] was significantly correlated with LCR, but corrected SUVmax did not show a significant correlation with LCR (per 1 increase; p = 0.15, HR 1.07, 95 % CI 0.96-1.19). Other factors significantly correlated with LCR were diagnosis (pathological diagnosis vs. clinical diagnosis; p = 0.04, HR 6.17, 95 % CI 1.08-116) and tumor diameter (per 1 mm increase; p < 0.01, HR 1.33, 95 % CI 1.15-1.61). Tumor diameter was the most significant predictor of LCR after SBRT. Correction for the partial volume effect and respiratory motion blur may weaken the prognostic value of SUVmax.	[Yamamoto, Takaya; Kadoya, Noriyuki; Shirata, Yuko; Umezawa, Rei; Ishikawa, Youjirou; Kubozono, Masaki; Sugawara, Toshiyuki; Matsushita, Haruo; Abe, Keiko; Takeda, Ken; Jingu, Keiichi] Tohoku Univ, Dept Radiat Oncol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kaneta, Tomohiro] Tohoku Univ, Dept Diagnost Radiol, Grad Sch Med, Sendai, Miyagi 9808574, Japan; [Koto, Masashi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan	Jingu, K (reprint author), Tohoku Univ, Dept Radiat Oncol, Grad Sch Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kjingu-jr@rad.med.tohoku.ac.jp					Akamatsu G, 2014, EUR J RADIOL, V83, P226, DOI 10.1016/j.ejrad.2013.09.030; Takeda A, 2011, RADIOTHER ONCOL, V101, P291, DOI 10.1016/j.radonc.2011.08.008; Hoopes DJ, 2007, LUNG CANCER, V56, P229, DOI 10.1016/j.lungcan.2006.12.009; Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Shim SS, 2005, RADIOLOGY, V236, P1011, DOI 10.1148/radiol.2363041310; Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128; Hamamoto Y, 2011, JPN J CLIN ONCOL, V41, P543, DOI 10.1093/jjco/hyq249; Takeda A, 2014, J THORAC ONCOL, V9, P65, DOI 10.1097/JTO.0000000000000031; Kawano T, 2008, J NUCL MED, V49, P1223, DOI 10.2967/jnumed.107.049296; Agarwal M, 2010, EUR J NUCL MED MOL I, V37, P691, DOI 10.1007/s00259-009-1291-x; Aristophanous M, 2012, RADIOTHER ONCOL, V102, P377, DOI 10.1016/j.radonc.2011.12.015; Wiemker R, 2008, INT J COMPUT ASS RAD, V3, P105, DOI 10.1007/s11548-008-0212-y; Clarke K, 2012, RADIOTHER ONCOL, V104, P62, DOI 10.1016/j.radonc.2012.04.019; Yu JM, 2009, INT J RADIAT ONCOL, V75, P1468, DOI 10.1016/j.ijrobp.2009.01.019; Kim H, 2010, J THORAC ONCOL, V5, P526, DOI 10.1097/JTO.0b013e3181cbf622; Ricardi U, 2010, LUNG CANCER, V68, P72, DOI 10.1016/j.lungcan.2009.05.007; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Matsuo Y, 2011, INT J RADIAT ONCOL, V79, P1104, DOI 10.1016/j.ijrobp.2009.12.022; Nehmeh SA, 2002, J NUCL MED, V43, P876; Koto M, 2007, RADIOTHER ONCOL, V85, P429, DOI 10.1016/j.radonc.2007.10.017; Stiles BM, 2013, ANN THORAC SURG, V95, P397, DOI 10.1016/j.athoracsur.2012.07.038; Burdick MJ, 2010, INT J RADIAT ONCOL, V78, P1033, DOI 10.1016/j.ijrobp.2009.09.081; Vesselle H, 2000, CLIN CANCER RES, V6, P3837; Bollineni VR, 2012, INT J RAD ONCOL BIOL, V83; Horne ZD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-41; Kadoya N, 2013, J NUCL MED RAD THER, V4, P162; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Satoh Y, 2014, RADIOLOGY, V270, P275, DOI 10.1148/radiol.13130652; Vu CC, 2013, NUCL MED COMMUN, V34, P959, DOI 10.1097/MNM.0b013e32836491a9	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					666	673		10.1007/s12149-015-0991-5		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300002		
J	Inai, R; Shinya, T; Tada, A; Sato, S; Fujiwara, T; Takeda, K; Kunisada, T; Yanai, H; Ozaki, T; Kanazawa, S				Inai, Ryota; Shinya, Takayoshi; Tada, Akihiro; Sato, Shuhei; Fujiwara, Tomohiro; Takeda, Ken; Kunisada, Toshiyuki; Yanai, Hiroyuki; Ozaki, Toshifumi; Kanazawa, Susumu			Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions	ANNALS OF NUCLEAR MEDICINE			English	Article						Thallium-201 scintigraphy; Malignant bone tumor; Benign bone tumor; Receiver operating characteristic (ROC) analysis; Tumor-to-background contrast (TBC)	SOFT-TISSUE TUMORS; FDG-PET; PREOPERATIVE CHEMOTHERAPY; MUSCULOSKELETAL TUMORS; OSTEOSARCOMA; SARCOMAS; SCANS	This retrospective study aims to evaluate the diagnostic capacity of thallium-201 (201Tl) scintigraphy for differentiating malignant bone tumors from benign bone lesions. Between January 2006 and December 2012, 279 patients with bone lesions (51 malignant and 228 benign) underwent 201Tl scintigraphy before treatment. To evaluate 201Tl uptake, we investigated tumor-to-background contrast (TBC) as well as TBC washout rate (WR). The differences of TBC on early and delayed images and WR were estimated by the Mann-Whitney U test. Receiver operating characteristic (ROC) analyses were used to determine the cut-off TBC values for differentiating malignant bone tumors from benign bone lesions. There were statistically significant differences in median TBC between malignant tumors and benign lesions. These differences occurred for early imaging (1.57 vs. 0.09, p < 0.001) as well as for delayed imaging (0.83 vs. 0.07, p < 0.001). However, there was no statistical difference in WR between malignant tumors and benign lesions (44 vs. 43 %, NS). The chosen TBC cut-off value was 0.68 for early imaging and 0.38 for delayed imaging. Using these cut-off values, the prediction of malignancy had a 77 % sensitivity, 74 % specificity, and 75 % accuracy for early imaging and an 80 % sensitivity, 76 % specificity, and 77 % accuracy for delayed imaging. 201Tl scintigraphy may have the ability to distinguish malignant bone tumors from benign bone lesions.	[Inai, Ryota; Shinya, Takayoshi; Tada, Akihiro; Sato, Shuhei; Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Kita Ku, Okayama, Okayama 7008558, Japan; [Fujiwara, Tomohiro; Takeda, Ken; Kunisada, Toshiyuki; Ozaki, Toshifumi] Okayama Univ Hosp, Dept Orthopaed Surg, Okayama, Okayama 7008558, Japan; [Yanai, Hiroyuki] Okayama Univ Hosp, Dept Pathol, Okayama, Okayama 7008558, Japan	Inai, R (reprint author), Okayama Univ Hosp, Dept Radiol, Kita Ku, 2-5-1 Shikatacho, Okayama, Okayama 7008558, Japan.	mogmog@jb3.so-net.ne.jp					Yamamoto Y, 2011, CLIN NUCL MED, V36, P290, DOI 10.1097/RLU.0b013e31820ade17; Kawakami N, 2011, CLIN NUCL MED, V36, P982, DOI 10.1097/RLU.0b013e3182177407; Taki J, 1997, J NUCL MED, V38, P501; Aoki J, 2003, SKELETAL RADIOL, V32, P133, DOI 10.1007/s00256-002-0586-9; ADLER LP, 1991, J NUCL MED, V32, P1508; AbdelDayem HM, 1997, SEMIN NUCL MED, V27, P355, DOI 10.1016/S0001-2998(97)80008-6; Adalet I, 1996, CLIN NUCL MED, V21, P118, DOI 10.1097/00003072-199602000-00008; Sumiya H, 1998, J NUCL MED, V39, P1600; LIN J, 1995, EUR J NUCL MED, V22, P553; Kunisada T, 1999, CANCER, V86, P949, DOI 10.1002/(SICI)1097-0142(19990915)86:6<949::AID-CNCR9>3.0.CO;2-H; Sugawara Y, 2005, ANN NUCL MED, V19, P461, DOI 10.1007/BF02985573; Bastiaannet E, 2004, CANCER TREAT REV, V30, P83, DOI 10.1016/j.ctrv.2003.07.004; Nishiyama Y, 2000, CLIN NUCL MED, V25, P200, DOI 10.1097/00003072-200003000-00010; Shin DS, 2008, ANN NUCL MED, V22, P603, DOI 10.1007/s12149-008-0151-2; Schulte M, 2000, J NUCL MED, V41, P1695; Dehdashti F, 1996, RADIOLOGY, V200, P243; Imbriaco M, 1997, CANCER, V80, P1507, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1507::AID-CNCR19>3.0.CO;2-9; Aoki J, 2001, RADIOLOGY, V219, P774; MENENDEZ LR, 1993, J BONE JOINT SURG AM, V75A, P526; Abe H, 1997, CLIN NUCL MED, V22, P38, DOI 10.1097/00003072-199701000-00009; ELGAZZAR AH, 1989, NUCL MED COMMUN, V10, P477, DOI 10.1097/00006231-198907000-00004; CALUSER CI, 1994, EUR J NUCL MED, V21, P1198; Fletcher CDM, 2002, PATHOLOGY GENETICS T; Goto Y., 2002, J ARTHROPLASTY, V3, P304; Matsui Ritsuo, 1999, Kaku Igaku, V36, P219; Sato O, 1998, J Orthop Sci, V3, P297, DOI 10.1007/s007760050056; Sumiya H, 2001, Semin Musculoskelet Radiol, V5, P177, DOI 10.1055/s-2001-15677; Terui S, 1994, Ann Nucl Med, V8, P55	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					674	681		10.1007/s12149-015-0990-6		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300003		
J	Suzuki, A; Takeuchi, W; Ishitsu, T; Morimoto, Y; Kobashi, K; Ueno, Y				Suzuki, Atsuro; Takeuchi, Wataru; Ishitsu, Takafumi; Morimoto, Yuichi; Kobashi, Keiji; Ueno, Yuichiro			High-resolution brain SPECT imaging by combination of parallel and tilted detector heads	ANNALS OF NUCLEAR MEDICINE			English	Article						Brain SPECT; Cadmium telluride (CdTe) detector; Collimator	PHOTON-EMISSION-TOMOGRAPHY; 4-PIXEL MATCHED COLLIMATOR; SYSTEM; RECONSTRUCTION; DISEASE	To improve the spatial resolution of brain single-photon emission computed tomography (SPECT), we propose a new brain SPECT system in which the detector heads are tilted towards the rotation axis so that they are closer to the brain. In addition, parallel detector heads are used to obtain the complete projection data set. We evaluated this parallel and tilted detector head system (PT-SPECT) in simulations. In the simulation study, the tilt angle of the detector heads relative to the axis was 45A degrees. The distance from the collimator surface of the parallel detector heads to the axis was 130 mm. The distance from the collimator surface of the tilted detector heads to the origin on the axis was 110 mm. A CdTe semiconductor panel with a 1.4 mm detector pitch and a parallel-hole collimator were employed in both types of detector head. A line source phantom, cold-rod brain-shaped phantom, and cerebral blood flow phantom were evaluated. The projection data were generated by forward-projection of the phantom images using physics models, and Poisson noise at clinical levels was applied to the projection data. The ordered-subsets expectation maximization algorithm with physics models was used. We also evaluated conventional SPECT using four parallel detector heads for the sake of comparison. The evaluation of the line source phantom showed that the transaxial FWHM in the central slice for conventional SPECT ranged from 6.1 to 8.5 mm, while that for PT-SPECT ranged from 5.3 to 6.9 mm. The cold-rod brain-shaped phantom image showed that conventional SPECT could visualize up to 8-mm-diameter rods. By contrast, PT-SPECT could visualize up to 6-mm-diameter rods in upper slices of a cerebrum. The cerebral blood flow phantom image showed that the PT-SPECT system provided higher resolution at the thalamus and caudate nucleus as well as at the longitudinal fissure of the cerebrum compared with conventional SPECT. PT-SPECT provides improved image resolution at not only upper but also at central slices of the cerebrum.	[Suzuki, Atsuro; Takeuchi, Wataru; Ishitsu, Takafumi; Morimoto, Yuichi; Kobashi, Keiji; Ueno, Yuichiro] Hitachi Ltd, Cent Res Lab, Hitachi, Ibaraki 3191221, Japan	Suzuki, A (reprint author), Hitachi Ltd, Cent Res Lab, 2-1 Omika Cho 7 Chome, Hitachi, Ibaraki 3191221, Japan.	atsuro.suzuki.rc@hitachi.com; wataru.takeuchi.rg@hitachi.com; takafumi.ishitsu.bb@hitachi.com; yuichi.morimoto.fb@hitachi.com; keiji.kobashi.xd@hitachi.com; yuichiro.ueno.bv@hitachi.com					Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; KOURIS K, 1993, J NUCL MED, V34, P1778; Wallis JW, 1997, IEEE T MED IMAGING, V16, P118, DOI 10.1109/42.552061; Suzuki A, 2013, PHYS MED BIOL, V58, P2199, DOI 10.1088/0031-9155/58/7/2199; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Tsuchiya K, 2010, ANN NUCL MED, V24, P301, DOI 10.1007/s12149-010-0354-1; ESSER PD, 1984, J NUCL MED, V25, P805; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; POLAK JF, 1984, J NUCL MED, V25, P495; de Jong HWAM, 2001, IEEE T NUCL SCI, V48, P58, DOI 10.1109/23.910833; Suzuki A, 2013, PHYS MED BIOL, V58, P7715, DOI 10.1088/0031-9155/58/21/7715; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Laere KV, 2000, J NUCL MED, V41, P2051	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					682	696		10.1007/s12149-015-0992-4		15	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300004		
J	Ikoma, Y; Sasaki, T; Kimura, Y; Seki, C; Okubo, Y; Suhara, T; Ito, H				Ikoma, Yoko; Sasaki, Takeshi; Kimura, Yasuyuki; Seki, Chie; Okubo, Yoshiro; Suhara, Tetsuya; Ito, Hiroshi			Evaluation of semi-quantitative method for quantification of dopamine transporter in human PET study with F-18-FE-PE2I	ANNALS OF NUCLEAR MEDICINE			English	Article						Positron emission tomography; F-18-FE-PE2I; Binding potential; Standardized uptake value ratio (SUVR); Occupancy	D2-DOPAMINE RECEPTOR OCCUPANCY; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO EVALUATION; HUMAN BRAIN; PARKINSONS-DISEASE; SCHIZOPHRENIC-PATIENTS; KINETIC-ANALYSIS; C-11 RACLOPRIDE; BINDING; RADIOLIGAND	Positron emission tomography (PET) with F-18-FE-PE2I is useful for investigating the function of dopamine transporter, and kinetics of F-18-FE-PE2I could be described by standard two-tissue compartment model (2CM) using plasma input function. In this study, we investigated the feasibility of semi-quantitative methods for estimating binding potential (BPND) and transporter occupancy to shorten the scan period and to reduce the effect of statistical noise on quantitative outcomes using computer simulation and human PET studies with F-18-FE-PE2I. In the simulations, time-activity curves (TACs) for the putamen with a wide range of BPND were generated. In these TACs, BP(ND)s were estimated by standardized uptake value ratio (SUVR) using various integration intervals and the simplified reference tissue model (SRTM) with the cerebellum as reference region, and reduction of BPND assuming transporter occupancy by antipsychotics was calculated from BPND obtained from TACs with various BPND values. These estimates were evaluated by comparison with those of 2CM. In human studies with normal volunteers, BP(ND)s were estimated in the caudate and putamen using SUVR and SRTM with the cerebellar reference region, and compared with BPND by standard 2CM. In the simulations, BPND estimated by SUVR with late time frames and SRTM showed linear correlation with those by 2CM, although the estimates by SUVR were overestimated and affected by the cerebral blood flow as BPND became higher. As for transporter occupancy, SRTM showed higher linearity with 2CM and less effect of statistical noise than the SUVR method. In human studies, BPND by SRTM and SUVR with late time frames showed good correlation with BPND by 2CM. Although SRTM is more reliable than the SUVR method for BPND and occupancy estimation, SUVR using late time frames has the potential to provide practical indices of BPND and occupancy with a shorter scan period.	[Ikoma, Yoko; Sasaki, Takeshi; Kimura, Yasuyuki; Seki, Chie; Suhara, Tetsuya; Ito, Hiroshi] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, Chiba 2638555, Japan; [Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138602, Japan; [Ito, Hiroshi] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima 9601295, Japan	Ikoma, Y (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	ikoma@nirs.go.jp					Rinne JO, 1999, J NEUROL NEUROSUR PS, V67, P737, DOI 10.1136/jnnp.67.6.737; VOLKOW ND, 1993, J NUCL MED, V34, P609; Hirvonen J, 2008, J CEREBR BLOOD F MET, V28, P1059, DOI 10.1038/sj.jcbfm.9600607; Schou M, 2009, BIOORG MED CHEM LETT, V19, P4843, DOI 10.1016/j.bmcl.2009.06.032; Sasaki T, 2012, J NUCL MED, V53, P1065, DOI 10.2967/jnumed.111.101626; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; Varrone A, 2011, J NUCL MED, V52, P132, DOI 10.2967/jnumed.110.077651; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Logan J, 2001, J CEREBR BLOOD F MET, V21, P307; Shetty HU, 2007, EUR J NUCL MED MOL I, V34, P667, DOI 10.1007/s00259-006-0277-1; RINNE JO, 1993, MOVEMENT DISORD, V8, P134, DOI 10.1002/mds.870080203; Ginovart N, 1997, BRAIN, V120, P503, DOI 10.1093/brain/120.3.503; NYBERG S, 1993, PSYCHOPHARMACOLOGY, V110, P265, DOI 10.1007/BF02251280; Seki C, 2010, ANN NUCL MED, V24, P249, DOI 10.1007/s12149-010-0364-z; Jucaite A, 2006, EUR J NUCL MED MOL I, V33, P657, DOI 10.1007/s00259-005-0027-9; Varrone A, 2009, SYNAPSE, V63, P871, DOI 10.1002/syn.20670; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; FARDE L, 1989, J CEREBR BLOOD F MET, V9, P696; Halldin C, 2003, EUR J NUCL MED MOL I, V30, P1220, DOI 10.1007/s00259-003-1212-3; DeLorenzo C, 2009, J CEREBR BLOOD F MET, V29, P1332, DOI 10.1038/jcbfm.2009.49; BROOKS DJ, 1992, ANN NEUROL, V31, P184, DOI 10.1002/ana.410310209; Ito H, 1998, J CEREBR BLOOD F MET, V18, P941; Arakawa R, 2009, J PSYCHIATR RES, V43, P1219, DOI 10.1016/j.jpsychires.2009.04.009; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42; Nakashima Y, 1995, J CEREB BLOOD FLOW M, V15, pS643	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					697	708		10.1007/s12149-015-0993-3		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300005		
J	Harata, S; Isobe, S; Morishima, I; Suzuki, S; Tsuboi, H; Sone, T; Ishii, H; Murohara, T				Harata, Shingo; Isobe, Satoshi; Morishima, Itsuro; Suzuki, Susumu; Tsuboi, Hideyuki; Sone, Takahito; Ishii, Hideki; Murohara, Toyoaki			Application of the newly developed Japanese adenosine normal database for adenosine stress myocardial scintigraphy	ANNALS OF NUCLEAR MEDICINE			English	Article						Adenosine normal database; Japanese Society of Nuclear Medicine normal database; Tc-99m-MIBI	INCREMENTAL PROGNOSTIC VALUE; OPTIMAL MEDICAL THERAPY; PERFUSION SPECT; RISK STRATIFICATION; NUCLEAR CARDIOLOGY; J-ACCESS; QUANTITATION; DISEASE; QUANTIFICATION; TOMOGRAPHY	The currently available Japanese normal database (NDB) in stress myocardial perfusion scintigraphy recommended by the Japanese Society of Nuclear Medicine (JSNM-NDB) is created based on the data from exercise tests. The newly developed adenosine normal database (ADS-NDB) remains to be validated for patients undergoing adenosine stress test. We tested whether the diagnostic accuracy of adenosine stress test is improved by the use of ADS-NDB (Kanazawa University). Of 233 consecutive patients undergoing Tc-99m-MIBI adenosine stress test, 112 patients were tested. The stress/rest myocardial Tc-99m-MIBI single-photon emission computed tomography (SPECT) images were analyzed by AutoQUANT 7.2 with both ADS-NDB and JSNM-NDB. The summed stress score (SSS) and summed difference score (SDS) were calculated. The agreements of the post-stress defect severity between ADS-NDB and JSNM-NDB were assessed using a weighted kappa statistic. In all patients, mean SSSs of all, right coronary artery (RCA), left anterior descending (LAD), and left circumflex (LCx) territories were significantly lower with ADS-NDB than those with JSNM-NDB. Mean SDSs in all, RCA, and LAD territories were significantly lower with ADS-NDB than those with JSNM-NDB. In 28 patients with significant coronary stenosis, the mean SSS in the RCA territory was significantly lower with ADS-NDB than that with JSNM-NDB. In 84 patients without ischemia, both mean SSSs and SDSs in all, RCA, LAD, and LCx territories were significantly lower with ADS-NDB than those with JSNM-NDB. Weighted kappa values of all patients, patients with significant stenosis, and patients without ischemia were 0.89, 0.83, and 0.92, respectively. Differences were observed between results from ADS-NDB and JSNM-NDB. The diagnostic accuracy of adenosine stress myocardial perfusion scintigraphy may be improved by reducing false-positive results.	[Harata, Shingo; Isobe, Satoshi; Suzuki, Susumu; Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Morishima, Itsuro; Tsuboi, Hideyuki; Sone, Takahito] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan	Isobe, S (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sisobe@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Hachamovitch R, 1996, CIRCULATION, V93, P905; Matsumoto N, 2001, J NUCL MED, V42, P687; Nishimura T, 2008, EUR J NUCL MED MOL I, V35, P319, DOI 10.1007/s00259-007-0608-x; Matsuo S, 2008, CIRC J, V72, P611; Ficaro EP, 2007, J NUCL CARDIOL, V14, P455, DOI 10.1016/j.nuclcard.2007.06.006; Hachamovitch R, 1998, CIRCULATION, V97, P535; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Germano G, 2007, J NUCL CARDIOL, V14, P433, DOI 10.1016/j.nuclcard.2007.06.008; Garcia EV, 2007, J NUCL CARDIOL, V14, P420, DOI 10.1016/j.nuclcard.2007.06.009; Knollmann D, 2008, EUR J NUCL MED MOL I, V35, P311, DOI 10.1007/s00259-007-0600-5; GERMANO G, 1995, J NUCL MED, V36, P2138; MESTER J, 1991, EUR J NUCL MED, V18, P184, DOI 10.1007/BF02262729; Sharir T, 2000, J NUCL MED, V41, P720; Nakajima K, 2009, J NUCL CARDIOL, V16, P422, DOI 10.1007/s12350-009-9049-1; Germano G, 2000, J NUCL MED, V41, P712; Nakajima K, 2007, ANN NUCL MED, V21, P505, DOI 10.1007/s12149-007-0059-2; Berman DS, 1995, J AM COLL CARDIOL, V26, P637; Berman DS, 2004, J NUCL CARDIOL, V4, P14; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Leppo JA, 1996, J NUCL CARDIOL, V3, pS22, DOI 10.1016/S1071-3581(96)90204-4; Okuda K, 2013, JAPANESE J NUCL MED, V50, pP187	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	OCT	2015	29	8					730	739		10.1007/s12149-015-0995-1		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1BF	WOS:000362531300008		
J	Akazawa, H; Ueno, Y				Akazawa, Housei; Ueno, Yuko			Control of surface wettability of hydroxyapatite thin films by way of crystal imperfections	APPLIED PHYSICS EXPRESS			English	Article							OSTEOBLAST ADHESION; ION IRRADIATION; MINERALIZATION; DEPOSITION; BEHAVIOR; GROWTH; CHARGE	The wettability of hydroxyapatite (HAp) films can be controlled by process conditions and substrates. C-plane-terminated HAp films on Si(100) substrate were hydrophobic. Only when sputter deposition with Ar was carried out with H2O vapor, followed by solid-phase crystallization at 500-700 degrees C, did highly hydrophilic films with water contact angles between 10 and 20 degrees form. The hydrophilic property was characterized by H2O bending mode signals at 1595 cm(-1) in infrared spectroscopy. Preferentially c- or (310)-plane-oriented epitaxial HAp films on sapphire c-planes were hydrophobic, whereas randomly oriented polycrystalline HAp films on sapphire a-planes were moderately hydrophilic. (C) 2015 The Japan Society of Applied Physics	[Akazawa, Housei] NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Ueno, Yuko] NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Akazawa, H (reprint author), NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	akazawa.housei@lab.ntt.co.jp	Akazawa, Housei/N-1441-2015				Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001; Putkonen M, 2009, THIN SOLID FILMS, V517, P5819, DOI 10.1016/j.tsf.2009.03.013; GRIGOROV GI, 1988, THIN SOLID FILMS, V156, P265, DOI 10.1016/0040-6090(88)90320-3; Paital SR, 2009, ACTA BIOMATER, V5, P2763, DOI 10.1016/j.actbio.2009.03.004; Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060; Elayaraja K, 2011, APPL SURF SCI, V257, P2134, DOI 10.1016/j.apsusc.2010.09.062; Palasantzas G, 2001, ACTA MATER, V49, P3533, DOI 10.1016/S1359-6454(01)00238-5; Aronov D, 2007, J EUR CERAM SOC, V27, P4181, DOI 10.1016/j.jeurceramsoc.2007.02.121; Kim H, 2010, ACTA BIOMATER, V6, P3234, DOI 10.1016/j.actbio.2010.02.031; Akazawa H, 2014, J PHYS CHEM SOLIDS, V75, P94, DOI 10.1016/j.jpcs.2013.08.014; Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069; Zhuang Z, 2013, ACTA BIOMATER, V9, P6732, DOI 10.1016/j.actbio.2013.02.001; Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014; Zhuang Z, 2013, MAT SCI ENG C-MATER, V33, P2534, DOI 10.1016/j.msec.2013.02.035; Akazawa H, 2014, J CRYST GROWTH, V404, P241, DOI 10.1016/j.jcrysgro.2014.07.030; Parau AC, 2012, J OPTOELECTRON ADV M, V14, P1047; Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057; Akazawa H, 2013, APPL SURF SCI, V276, P217, DOI 10.1016/j.apsusc.2013.03.070; Thian ES, 2007, KEY ENG MAT, V330-332, P877; Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023; Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v; Kizuki T, 2003, BIOMATERIALS, V24, P941, DOI 10.1016/S0142-9612(02)00430-1; Dinu M, 2014, KEY ENG MATER, V587, P297, DOI 10.4028/www.scientific.net/KEM.587.297; Dorozhkin SV, 2012, PROG BIOMATER, V1, P1; Dorozhkin S.V., 2011, BIO, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1; KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9; WINTERS HF, 1967, J APPL PHYS, V38, P3928, DOI 10.1063/1.1709043	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							107001	10.7567/APEX.8.107001		4	Physics, Applied	Physics	CS6KM	WOS:000362187500021		
J	Baranwal, AK; Fujikawa, N; Hayat, A; Ogomi, Y; Pandey, SS; Ma, TL; Hayase, S				Baranwal, Ajay Kumar; Fujikawa, Naotaka; Hayat, Azwar; Ogomi, Yuhei; Pandey, Shyam S.; Ma, Tingli; Hayase, Shuzi			Combining novel device architecture and NIR dye towards the fabrication of transparent conductive oxide-less tandem dye sensitized solar cells	APPLIED PHYSICS EXPRESS			English	Article							EFFICIENCY; INJECTION; SILICON	Tandem solar cells with different device architectures utilizing a back contact transparent conductive oxide-less bottom electrode (TCO-less tandem DSSC) that has better control of the optical transmission losses incurred by intermediate TCO layers with flexible Pt/tin-doped indium oxide (ITO)-polyethylene terephthalate film as an intermediate layer are reported. The proposed device architecture suppresses the optical loss to a greater extent (around 30%). Sensitizers were ruthenium-based N719 dye in the top electrode, while the newly synthesized phthalocyanine dye (PC25) corresponding to photon harvesting in the near infrared (NIR) region (up to 900nm) was used in the TCO-less bottom cell. Open circuit voltage (V-oc) >= 1.18V (sum of top cell and bottom cell V-oc) justifies the TCO-less tandem DSSC formation. (C) 2015 The Japan Society of Applied Physics	[Baranwal, Ajay Kumar; Fujikawa, Naotaka; Hayat, Azwar; Ogomi, Yuhei; Pandey, Shyam S.; Ma, Tingli; Hayase, Shuzi] Kyushu Inst Technol, Dept Life Sci & Syst Engn, Div Green Elect, Kitakyushu, Fukuoka 8080196, Japan	Baranwal, AK (reprint author), Kyushu Inst Technol, Dept Life Sci & Syst Engn, Div Green Elect, Kitakyushu, Fukuoka 8080196, Japan.	ajaybarn@gmail.com; hayase@life.kyutech.ac.jp					Fuke N, 2008, J APPL PHYS, V104, DOI 10.1063/1.2975182; Baranwal AK, 2014, RSC ADV, V4, P47735, DOI 10.1039/c4ra07539k; Wenger S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3125432; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Yamaguchi T, 2009, SOL ENERG MAT SOL C, V93, P733, DOI 10.1016/j.solmat.2008.09.021; Durr M, 2004, APPL PHYS LETT, V84, P3397, DOI 10.1063/1.1723685; Qi BY, 2013, PHYS CHEM CHEM PHYS, V15, P8972, DOI 10.1039/c3cp51383a; Choi H, 2015, J POWER SOURCES, V274, P937, DOI 10.1016/j.jpowsour.2014.10.125; Kinoshita T, 2013, NAT PHOTONICS, V7, P535, DOI [10.1038/nphoton.2013.136, 10.1038/NPHOTON.2013.136]; Halme J, 2008, J PHYS CHEM C, V112, P5623, DOI 10.1021/jp711245f; Murayama M, 2008, THIN SOLID FILMS, V516, P2716, DOI 10.1016/j.tsf.2007.04.076; Nattestad A, 2010, NAT MATER, V9, P31, DOI [10.1038/nmat2588, 10.1038/NMAT2588]; Loper P, 2015, PHYS CHEM CHEM PHYS, V17, P1619, DOI 10.1039/c4cp03788j; Bailie CD, 2015, ENERG ENVIRON SCI, V8, P956, DOI 10.1039/c4ee03322a; Yanagida M, 2010, SOL ENERG MAT SOL C, V94, P297, DOI 10.1016/j.solmat.2009.10.002; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Ito S, 2011, SOL ENERGY, V85, P1220, DOI 10.1016/j.solener.2011.02.024; Snaith HJ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045306; Gratzel M, 2006, PROG PHOTOVOLTAICS, V14, P429, DOI 10.1002/pip.712	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							102301	10.7567/APEX.8.102301		3	Physics, Applied	Physics	CS6KM	WOS:000362187500007		
J	Dushenko, S; Higuchi, Y; Ando, Y; Shinjo, T; Shiraishi, M				Dushenko, Sergey; Higuchi, Yukio; Ando, Yuichiro; Shinjo, Teruya; Shiraishi, Masashi			Ferromagnetic resonance and spin pumping efficiency for inverse spin-Hall effect normalization in yttrium-iron-garnet-based systems	APPLIED PHYSICS EXPRESS			English	Article							MAGNETOSTATIC MODES; SEMICONDUCTORS; ORIENTATION; ELECTRONS; FILMS	The inverse spin Hall effect has made its way from being a peculiar phenomenon predicted and discovered in semiconductors more than 30 years ago to being an extremely important effect in modern spintronics. It allows for the detection and conversion of spin current, along with the probing of the spin-orbit interaction of materials. However, the discrepancy between theoretical and experimental results has slowed down the progress of this branch of spintronics and its applications. In this study, we analyzed yttrium-iron-garnet-based systems highly exploited in spin pumping experiments and demonstrated the correct normalization procedure for the inverse spin Hall effect in such systems. (C) 2015 The Japan Society of Applied Physics	[Dushenko, Sergey] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Dushenko, Sergey; Ando, Yuichiro; Shinjo, Teruya; Shiraishi, Masashi] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Higuchi, Yukio] Murata Mfg Co Ltd, Kyoto 6178555, Japan	Shiraishi, M (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	mshiraishi@kuee.kyoto-u.ac.jp	Ando, Yuichiro/J-1611-2012		MEXT KAKENHI Grant (Innovative Area "Nano Spin Conversion Science") [26103003]; Research Grant, Izumi Science and Technology Foundation;  [25630148]	This work was supported by MEXT KAKENHI Grant No. 26103003 (Innovative Area "Nano Spin Conversion Science"), Grant-in-Aid for Challenging Exploratory Research (No. 25630148), and Research Grant, Izumi Science and Technology Foundation. The authors are grateful to Hiroyuki Emoto for his help with sample preparation.	Ando K, 2011, NAT MATER, V10, P655, DOI [10.1038/nmat3052, 10.1038/NMAT3052]; Tang ZY, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.140401; Tsukahara A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235317; BAKUN AA, 1984, JETP LETT+, V40, P1293; Qiu Z, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819460; LAULICHT I, 1991, J APPL PHYS, V70, P2251, DOI 10.1063/1.349417; Dushenko S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.196602; Watanabe S, 2014, NAT PHYS, V10, P308, DOI [10.1038/nphys2901, 10.1038/NPHYS2901]; BARAK J, 1989, J APPL PHYS, V65, P1652, DOI 10.1063/1.343402; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Chen L, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.013002; Kapelrud A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.097602; Vilela-Leao LH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3631683; Mizukami S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.104413; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; DAMON RW, 1961, J PHYS CHEM SOLIDS, V19, P308, DOI 10.1016/0022-3697(61)90041-5; Shikoh E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.127201; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; AVERKIEV NS, 1983, SOV PHYS SEMICOND+, V17, P393; Haidar M., 2015, J APPL PHYS, V117; Ohshima R., 2015, J APPL PHYS, V117; Suhl H., 1957, PHYS CHEM SOLIDS, V1, P209	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							103002	10.7567/APEX.8.103002		4	Physics, Applied	Physics	CS6KM	WOS:000362187500010		
J	Fukumoto, K; Yamada, Y; Koshihara, SY; Onda, K				Fukumoto, Keiki; Yamada, Yuki; Koshihara, Shin-ya; Onda, Ken			Lifetimes of photogenerated electrons on a GaAs surface affected by nanostructural defects	APPLIED PHYSICS EXPRESS			English	Article							TEMPERATURE-GROWN GAAS; BEAM-EPITAXIAL GAAS; CARRIER DYNAMICS; EL2 DEFECT; ABSORPTION; SPECTROSCOPY; MICROSCOPY; DEPENDENCE; EMISSION; CAPTURE	The recombination dynamics of photogenerated carriers on temporal and spatial scales of 100 fs and 100 nm, respectively, on an inhomogeneous GaAs surface with structural defects was investigated using time-resolved photoemission electron microscopy with femtosecond laser pulses. The observed photocarrier lifetimes (T) ranged from subpicoseconds to picoseconds at isolated structural defects and were inversely proportional to the photoemission intensity at each defect. We concluded that T corresponds to the carrier trapping time to midgap defect states and estimated the density of the midgap states at each defect on the basis of the relation between t and the photoemission intensity. (C) 2015 The Japan Society of Applied Physics	[Fukumoto, Keiki; Yamada, Yuki; Koshihara, Shin-ya] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528550, Japan; [Fukumoto, Keiki; Koshihara, Shin-ya] Japan Sci & Technol Agcy, JST CREST, Kawaguchi, Saitama 3320012, Japan; [Onda, Ken] Tokyo Inst Technol, Interact Res Ctr Sci, Yokohama, Kanagawa 2268502, Japan; [Onda, Ken] Japan Sci & Technol Agcy, JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Fukumoto, K (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528550, Japan.		Onda, Ken/H-3389-2014	Onda, Ken/0000-0003-1724-2009			Stohr J, 2000, IBM J RES DEV, V44, P535; McIntosh KA, 1997, APPL PHYS LETT, V70, P354, DOI 10.1063/1.118412; ZAIDI MA, 1992, APPL PHYS LETT, V61, P2452, DOI 10.1063/1.108149; Fukumoto K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864279; Pastor AA, 2012, SEMICONDUCTORS+, V46, P619, DOI 10.1134/S106378261205017X; Stellmacher M, 2000, J APPL PHYS, V88, P6026, DOI 10.1063/1.1285829; LOOK DC, 1990, PHYS REV B, V42, P3578, DOI 10.1103/PhysRevB.42.3578; Fukumoto K, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4893484; BROWN ER, 1995, APPL PHYS LETT, V66, P285, DOI 10.1063/1.113519; Prabhu SS, 1997, APPL PHYS LETT, V70, P2419, DOI 10.1063/1.118890; LIU X, 1995, APPL PHYS LETT, V67, P279, DOI 10.1063/1.114782; Benjamin SD, 1996, APPL PHYS LETT, V68, P2544, DOI 10.1063/1.116178; HALL RN, 1952, PHYS REV, V87, P387, DOI 10.1103/PhysRev.87.387; MANASREH MO, 1990, PHYS REV B, V41, P10272, DOI 10.1103/PhysRevB.41.10272; Wells NP, 2014, J APPL PHYS, V116, DOI 10.1063/1.4892868; Smith PWE, 1997, APPL PHYS LETT, V71, P1156, DOI 10.1063/1.119852; Aeschlimann M, 2010, P NATL ACAD SCI USA, V107, P5329, DOI 10.1073/pnas.0913556107; Nemec H, 2001, J APPL PHYS, V90, P1303, DOI 10.1063/1.1380414; Bourgoin JC, 1999, SOLID STATE ELECTRON, V43, P153, DOI 10.1016/S0038-1101(98)00199-3; GUPTA S, 1991, APPL PHYS LETT, V59, P3276, DOI 10.1063/1.105729; Keil UD, 1996, IEEE J QUANTUM ELECT, V32, P1664, DOI 10.1109/3.535372; GUPTA S, 1992, IEEE J QUANTUM ELECT, V28, P2464, DOI 10.1109/3.159553; HENRY CH, 1977, PHYS REV B, V15, P989, DOI 10.1103/PhysRevB.15.989; CHEN CL, 1991, IEEE ELECTR DEVICE L, V12, P306, DOI 10.1109/55.82069; Luo JK, 1996, J APPL PHYS, V79, P3622, DOI 10.1063/1.361417; Kordos P, 1998, ELECTRON LETT, V34, P119, DOI 10.1049/el:19980039; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Gregory IS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.195201; ATIQUE N, 1995, J APPL PHYS, V77, P1471, DOI 10.1063/1.358895; Loka HS, 1998, IEEE PHOTONIC TECH L, V10, P1733, DOI 10.1109/68.730485; CASEY HC, 1975, J APPL PHYS, V46, P250, DOI 10.1063/1.321330; YAMAMOTO H, 1990, APPL PHYS LETT, V57, P1537, DOI 10.1063/1.103345; Kaminska M., 1987, PHYS SCR, VT19B, P551; Kanasaki J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237401; Kubo A, 2007, J PHYS B-AT MOL OPT, V40, pS259, DOI 10.1088/0953-4075/40/11/S02; Martin G. M., 1986, DEEP CTR SEMICONDUCT; Seebauer EG, 2009, ENG MATER PROCESS, P1; Smith F. W., 1988, IEEE ELECTR DEVICE L, V9, P77	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							101201	10.7567/APEX.8.101201		4	Physics, Applied	Physics	CS6KM	WOS:000362187500002		
J	Inada, M; Yamamoto, H; Gibo, M; Ueda, R; Umezu, I; Tanaka, S; Saitoh, T; Sugimura, A				Inada, Mitsuru; Yamamoto, Hiroshi; Gibo, Manabu; Ueda, Rieko; Umezu, Ikurou; Tanaka, Shukichi; Saitoh, Tadashi; Sugimura, Akira			Crossover from Efros-Shklovskii variable range hopping to nearest-neighbor hopping in silicon nanocrystal random network	APPLIED PHYSICS EXPRESS			English	Article							PULSED-LASER ABLATION; CONDUCTION; FILMS; SI	We investigate how random structure affects the electrical transport of a silicon nanocrystal network. The temperature dependence of conductivity follows G similar to exp[-(T-0/T)(1/2)] between 70 and 160 K. By using T-0 = 5765K obtained by data fitting, the electron localization length is estimated to be 4.1 nm, which corresponds to the mean diameter of silicon nanocrystals. Above 160 K, G follows Arrhenius-like behavior. These temperature dependences are well described by Efros-Shklovskii variable range hopping (ES VRH) with a Coulomb gap and nearest-neighbor hopping (NNH). A crossover between ES VRH and NNH is observed at 160 K. (C) 2015 The Japan Society of Applied Physics	[Inada, Mitsuru; Saitoh, Tadashi] Kansai Univ, Dept Pure & Appl Phys, Fac Engn Sci, Suita, Osaka 5648680, Japan; [Ueda, Rieko; Tanaka, Shukichi] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Kobe, Hyogo 6512492, Japan; [Yamamoto, Hiroshi; Gibo, Manabu; Umezu, Ikurou; Sugimura, Akira] Konan Univ, Dept Phys, Kobe, Hyogo 6588501, Japan	Inada, M (reprint author), Kansai Univ, Dept Pure & Appl Phys, Fac Engn Sci, Suita, Osaka 5648680, Japan.	inada@kansai-u.ac.jp			Kansai University; Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Strategic Project to Support the Formation of Research Bases at Private Universities	This work was partly supported by Kansai University Grant-in-Aid for the Promotion of Advanced Research in a Graduate Course, Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), and "Strategic Project to Support the Formation of Research Bases at Private Universities": Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Umezu I, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832392; Parthasarathy R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076801; Concari SB, 2003, J APPL PHYS, V94, P2417, DOI 10.1063/1.1593215; Matsumoto K, 2005, JPN J APPL PHYS 1, V44, P8742, DOI 10.1143/JJAP.44.8742; Makino T, 2004, APPL PHYS A-MATER, V79, P1391, DOI 10.1007/s00339-004-2788-6; Parthasarathy R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.186807; Yildiz A, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.111203; SUGIMURA A, 1990, JPN J APPL PHYS 2, V29, pL2463; Noguchi Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3605598; Liu H, 2010, ACS NANO, V4, P5211, DOI 10.1021/nn101376u; Umezu I, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045328; Yu D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216802; Rafiq MA, 2006, J APPL PHYS, V100, DOI 10.1063/1.2209808; Romero HE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.156801; Amans D, 2003, J APPL PHYS, V93, P4173, DOI 10.1063/1.1538344; Sharma SK, 2007, SOLID STATE ELECTRON, V51, P1124, DOI 10.1016/j.sse.2007.06.007; Fujii M, 1996, APPL PHYS LETT, V68, P3749, DOI 10.1063/1.115994; EFROS AL, 1975, J PHYS C SOLID STATE, V8, pL49, DOI 10.1088/0022-3719/8/4/003; Efros AL, 1984, ELECT PROPERTIES DOP; Inada M., 2004, MRS P, V832; Lockwood D. J., 1998, LIGHT EMISSION SILIC; Mott N. F., 1968, Journal of Non-Crystalline Solids, V1, DOI 10.1016/0022-3093(68)90002-1	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							105001	10.7567/APEX.8.105001		3	Physics, Applied	Physics	CS6KM	WOS:000362187500016		
J	Kawashima, H; Noguchi, H; Matsumoto, T; Kato, H; Ogura, M; Makino, T; Shirai, S; Takeuchi, D; Yamasaki, S				Kawashima, Hiroyuki; Noguchi, Hitoshi; Matsumoto, Tsubasa; Kato, Hiromitsu; Ogura, Masahiko; Makino, Toshiharu; Shirai, Shozo; Takeuchi, Daisuke; Yamasaki, Satoshi			Electronic properties of diamond Schottky barrier diodes fabricated on silicon-based heteroepitaxially grown diamond substrates	APPLIED PHYSICS EXPRESS			English	Article							SINGLE-CRYSTAL DIAMOND; SURFACE-MORPHOLOGY; EPITAXIAL DIAMOND; FIELD; FILMS	Diamond Schottky barrier diodes (SBDs) were fabricated on silicon-based heteroepitaxially grown diamond substrates. Platinum Schottky metal and boron-doped p-type diamond were used as SBDs. The diodes exhibited good current-voltage (I-V) characteristics. The rectification ratio was over 10(12) at +/- 4 V, and the ideality factor was 1.2. The breakdown voltage estimated at the metal/diamond interface was as high as similar to 1 MV/cm, which is greater than the material limit of silicon (similar to 0.3 MV/cm). This achievement, which does not require the use of single-crystalline diamond substrates, will accelerate the development of the diamond electronic industry. (C) 2015 The Japan Society of Applied Physics	[Kawashima, Hiroyuki; Noguchi, Hitoshi; Matsumoto, Tsubasa; Kato, Hiromitsu; Ogura, Masahiko; Makino, Toshiharu; Takeuchi, Daisuke; Yamasaki, Satoshi] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr ADPERC, Tsukuba, Ibaraki 3058568, Japan; [Kawashima, Hiroyuki; Matsumoto, Tsubasa; Kato, Hiromitsu; Ogura, Masahiko; Makino, Toshiharu; Takeuchi, Daisuke; Yamasaki, Satoshi] AIST, JST, CREST, Tsukuba, Ibaraki 3058568, Japan; [Kawashima, Hiroyuki; Yamasaki, Satoshi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Noguchi, Hitoshi; Shirai, Shozo] Shin Etsu Chem Co Ltd, Adv Funct Mat Res Ctr, Annaka, Gunma 3790195, Japan	Yamasaki, S (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr ADPERC, Tsukuba, Ibaraki 3058568, Japan.	hit_noguchi@shinetsu.jp; s-yamasaki@aist.go.jp					Takeuchi D, 2014, PHYS STATUS SOLIDI A, V211, P2251, DOI 10.1002/pssa.201431167; Yokota Y, 2007, NEW DIAM FRONT C TEC, V17, P211; Silva F, 2009, DIAM RELAT MATER, V18, P683, DOI 10.1016/j.diamond.2009.01.038; Kawarada H, 1998, APPL PHYS LETT, V72, P1878, DOI 10.1063/1.121213; YUGO S, 1991, APPL PHYS LETT, V58, P1036, DOI 10.1063/1.104415; STONER BR, 1992, PHYS REV B, V45, P11067, DOI 10.1103/PhysRevB.45.11067; Umezawa H, 2009, DIAM RELAT MATER, V18, P1196, DOI 10.1016/j.diamond.2009.04.013; Balmer RS, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/36/364221; Umezawa H, 2012, DIAM RELAT MATER, V24, P201, DOI 10.1016/j.diamond.2012.01.011; Stehl C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824330; Mokuno Y, 2008, DIAM RELAT MATER, V17, P415, DOI 10.1016/j.diamond.2007.12.058; Bauer T, 2005, DIAM RELAT MATER, V14, P314, DOI 10.1016/j.diamond.2004.10.028; Yamasaki S, 2014, MRS BULL, V39, P499, DOI 10.1557/mrs.2014.100; Yamada H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868720; JIANG X, 1993, APPL PHYS LETT, V62, P3438, DOI 10.1063/1.109041; Umezawa H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2643374; Ohtsuka K, 1996, JPN J APPL PHYS 2, V35, pL1072; Washiyama S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.095502; Mayr M, 2014, PHYS STATUS SOLIDI A, V211, P2257, DOI 10.1002/pssa.201431210; Schreck M, 2014, MRS BULL, V39, P504, DOI 10.1557/mrs.2014.96; Oyama K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120560; Yaita J, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DH13	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							104103	10.7567/APEX.8.104103		3	Physics, Applied	Physics	CS6KM	WOS:000362187500014		
J	Kimura, Y; Hamaguchi, A; Ikeda, Y; Nagase, T; Naito, H; Takimiya, K; Shiro, T				Kimura, Yu; Hamaguchi, Azusa; Ikeda, Yoshinori; Nagase, Takashi; Naito, Hiroyoshi; Takimiya, Kazuo; Shiro, Takashi			Solution-processed dinaphtho[2,3-b:2 ',3 '-f]thieno[3,2-b]thiophene transistor memory based on phosphorus-doped silicon nanoparticles as a nano-floating gate	APPLIED PHYSICS EXPRESS			English	Article							FIELD-EFFECT TRANSISTORS; ORGANIC TRANSISTORS; PERFORMANCE; STABILITY	High-performance organic field-effect transistor (OFET) memories were developed by a simple solution process using phosphorus-doped silicon nanoparticles (Si NPs) and dinaphtho[2,3-b:2',3'-f]thieno[3,2-b]thiophene (DNTT) precursor-polystyrene (PS) blends. Si NPs were doped with phosphorus to control the ionization potential and functioned as a nano-floating gate. DNTT precursor-PS blends were converted to DNTT/PS layers on a Si NP layer by thermal annealing. The OFET memories clearly exhibited a memory window of 20V and a notably large threshold voltage (V-th) shift of 40V after the application of negative and positive voltages to the gate electrode. (C) 2015 The Japan Society of Applied Physics	[Kimura, Yu; Hamaguchi, Azusa; Ikeda, Yoshinori; Shiro, Takashi] Teijin Ltd, Elect Mat Dev Project, Hino, Tokyo 1918512, Japan; [Nagase, Takashi; Naito, Hiroyoshi] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan; [Nagase, Takashi; Naito, Hiroyoshi] Osaka Prefecture Univ, Res Inst Mol Elect Devices, Sakai, Osaka 5998531, Japan; [Takimiya, Kazuo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Kimura, Y (reprint author), Teijin Ltd, Elect Mat Dev Project, Hino, Tokyo 1918512, Japan.	yuu.kimura@teijin.co.jp; yos.ikeda@teijin.co.jp; naito@pe.osakafu-u.ac.jp	Takimiya, Kazuo/A-5841-2010	Takimiya, Kazuo/0000-0002-6001-1129			Haas S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3183509; Kang M, 2013, ADV FUNCT MATER, V23, P3503, DOI 10.1002/adfm.201203417; Baeg KJ, 2010, ADV FUNCT MATER, V20, P224, DOI 10.1002/adfm.200901677; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Han JH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4860990; Kajimoto K, 2010, PHYSICA E, V42, P2816, DOI 10.1016/j.physe.2009.11.016; She XJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790186; Heremans P, 2011, CHEM MATER, V23, P341, DOI 10.1021/cm102006v; Mushrush M, 2003, J AM CHEM SOC, V125, P9414, DOI 10.1021/ja035143a; Takimiya K, 2011, ADV MATER, V23, P4347, DOI 10.1002/adma.201102007; Zschieschang U, 2011, ORG ELECTRON, V12, P1370, DOI 10.1016/j.orgel.2011.04.018; Kajimoto K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.021601; Zhou Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903243; Moller S, 2003, NATURE, V426, P166, DOI 10.1038/nature02070; Chiruvolu S, 2006, TECH P 2006 NAN C TR, V1, P325; Kajimoto K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DC04; Kambe N., 2008, P IDW 08, P1673; Kimura Y, 2015, ADV MATER, V27, P727, DOI 10.1002/adma.201404052; Kuribara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1721; Liu J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898811; Punchaipetch P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2339562; Sasaki H., 1987, 3 INT PHOT SCI ENG C, P65; Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							101601	10.7567/APEX.8.101601		4	Physics, Applied	Physics	CS6KM	WOS:000362187500004		
J	Kudo, K; Suto, H; Nagasawa, T; Mizushima, K; Sato, R				Kudo, Kiwamu; Suto, Hirofumi; Nagasawa, Tazumi; Mizushima, Koichi; Sato, Rie			Resonant magnetization switching induced by spin-torque-driven oscillations and its use in three-dimensional magnetic storage applications	APPLIED PHYSICS EXPRESS			English	Article							MEMORY; LAYER	Control of magnetization switching is crucial for magnetic storage devices. We numerically show that magnetization switching of a magnetic dot can be induced by using only a spin-torque oscillator (STO). The magnetic-dot magnetization exhibits cooperative dynamics with the STO through dipolar coupling and reverses into a final switched state. This resonant switching occurs under a certain precession chirality and STO frequency range that depend on the magnetic dot's initial direction and intrinsic resonance frequency. We also show that the resonant-switching characteristics are suitable for three-dimensional magnetic storage applications and propose a multi-bit memory cell based on the switching principle. (C) 2015 The Japan Society of Applied Physics	[Kudo, Kiwamu; Suto, Hirofumi; Nagasawa, Tazumi; Mizushima, Koichi; Sato, Rie] Toshiba Co Ltd, Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan	Kudo, K (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan.				Strategic Promotion of Innovative Research and Development from the Japan Science and Technology Agency, JST	The authors would like to thank T. Taniguchi, H. Kubota, S. Okamoto, and N. Kikuchi for useful discussions. This work was supported by Strategic Promotion of Innovative Research and Development from the Japan Science and Technology Agency, JST.	Winkler G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152293; Zeng ZM, 2013, NANOSCALE, V5, P2219, DOI 10.1039/c2nr33407k; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Kudo K, 2014, J APPL PHYS, V116, DOI 10.1063/1.4900536; Khvalkovskiy AV, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/7/074001; Albrecht M, 2005, J APPL PHYS, V97, DOI 10.1063/1.1904705; Sbiaa R, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3273856; Houssameddine D, 2007, NAT MATER, V6, P447, DOI 10.1038/nmat1905; Lavrijsen R, 2013, NATURE, V493, P647, DOI 10.1038/nature11733; Thirion C, 2003, NAT MATER, V2, P524, DOI 10.1038/nmat946; Zhu JG, 2008, IEEE T MAGN, V44, P125, DOI 10.1109/TMAG.2007.911031; Sun ZZ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.132401; Yuan ZM, 2001, J MAGN MAGN MATER, V235, P481, DOI 10.1016/S0304-8853(01)00412-7; Jeong WC, 1999, J APPL PHYS, V85, P4782, DOI 10.1063/1.370480; McFadyen IR, 2006, MRS BULL, V31, P379, DOI 10.1557/mrs2006.97; Barros N, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144418; Igarashi M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3075850; Ishigaki T., 2010, VLSI S TECHN SESS 5, P47; Piramanayagam SN, 2012, J APPL PHYS, V111, DOI 10.1063/1.3678305; Sbiaa R, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3632075; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Suto H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/24/245501; Yang T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4832827; Zhang SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06109	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							103001	10.7567/APEX.8.103001		4	Physics, Applied	Physics	CS6KM	WOS:000362187500009		
J	Kuwahara, Y; Nihey, F; Ohmori, S; Saito, T				Kuwahara, Yuki; Nihey, Fumiyuki; Ohmori, Shigekazu; Saito, Takeshi			Thin-film transistors using DNA-wrapped semiconducting single-wall carbon nanotubes with selected chiralities	APPLIED PHYSICS EXPRESS			English	Article							HIGH-PERFORMANCE; DEPENDENT PERFORMANCE; SEPARATION; CHROMATOGRAPHY; NETWORKS; ORIGAMI	Selected semiconducting chiralities, (7, 5), (7, 6), and (8, 4), of DNA-wrapped single-wall carbon nanotubes (DNA-SWCNTs) were used for thin-film transistors (TFTs). Chirality separation was carried out by ion exchange chromatography (IEX) with the ssDNA of the (TAT)(4) sequence. An on/off ratio of 3.8 x 10(6) with a carrier mobility of 11cm(2)/(V.s) was successfully achieved in the fabricated SWCNT-TFTs. The comparison between the on/off ratios obtained before (10(1)-10(2)) and after IEX (10(4)-10(7)) indicated that the IEX separation process sufficiently improves the performance of SWCNT-TFTs because of the reducing metallic SWCNT pathways in the TFT channel. (C) 2015 The Japan Society of Applied Physics	[Kuwahara, Yuki; Ohmori, Shigekazu; Saito, Takeshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Kuwahara, Yuki; Nihey, Fumiyuki; Ohmori, Shigekazu; Saito, Takeshi] Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058565, Japan; [Nihey, Fumiyuki] NEC Corp Ltd, Smart Energy Res Labs, Tsukuba, Ibaraki 3058501, Japan	Saito, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	takeshi-saito@aist.go.jp			Iketani Science and Technology Foundation; IBEC Innovation Platform; "Nanotechnology Network Japan" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); AIST	This work was supported by Iketani Science and Technology Foundation. Part of this work was conducted at the Nano-Processing Facility, supported by the IBEC Innovation Platform, AIST, and "Nanotechnology Network Japan" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Staii C, 2005, NANO LETT, V5, P1774, DOI 10.1021/nl051261f; Saito T, 2008, J NANOSCI NANOTECHNO, V8, P6153, DOI 10.1166/jnn.2008.SW23; Huang XY, 2005, ANAL CHEM, V77, P6225, DOI 10.1021/ac0508954; Zhang L, 2008, J AM CHEM SOC, V130, P2686, DOI 10.1021/ja7106492; Tang Q, 2014, ACS APPL MATER INTER, V6, P13470, DOI 10.1021/am502311b; Tanaka T, 2009, NANO LETT, V9, P1497, DOI 10.1021/nl8034866; Hu CG, 2005, J PHYS CHEM B, V109, P20072, DOI 10.1021/jp0550457; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Fagan JA, 2014, ADV MATER, V26, P2800, DOI 10.1002/adma.201304873; Subbaiyan NK, 2014, ACS NANO, V8, P1619, DOI 10.1021/nn405934y; Fujii S, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.071601; Zhang L, 2009, J AM CHEM SOC, V131, P2454, DOI 10.1021/ja8096674; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Ohmori S, 2012, RSC ADV, V2, P12408, DOI 10.1039/c2ra22272h; Asada Y, 2010, ADV MATER, V22, P2698, DOI 10.1002/adma.200904006; Moshammer K, 2009, NANO RES, V2, P599, DOI 10.1007/s12274-009-9057-0; Ihara K, 2011, J PHYS CHEM C, V115, P22827, DOI 10.1021/jp2071474; Ohmori S, 2010, J PHYS CHEM C, V114, P10077, DOI 10.1021/jp9120172; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Mangalum A, 2013, J AM CHEM SOC, V135, P2451, DOI 10.1021/ja312191a; Zhao Z, 2013, ORG BIOMOL CHEM, V11, P596, DOI 10.1039/c2ob26942b; Asada Y, 2011, ADV MATER, V23, P4631, DOI 10.1002/adma.201102806; Snow ES, 2003, APPL PHYS LETT, V82, P2145, DOI 10.1063/1.1564291; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Green AA, 2011, ADV MATER, V23, P2185, DOI 10.1002/adma.201100034; Kuwahara Y, 2015, CARBON, V91, P370, DOI 10.1016/j.carbon.2015.05.008; LeMieux MC, 2008, SCIENCE, V321, P101, DOI 10.1126/science.1156588; Palma M, 2013, J AM CHEM SOC, V135, P8440, DOI 10.1021/ja4018072; Zhang M, 2014, ANAL CHEM, V86, P3980, DOI 10.1021/ac5003189; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Ishida M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2901165; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							105101	10.7567/APEX.8.105101		4	Physics, Applied	Physics	CS6KM	WOS:000362187500017		
J	Miyoshi, M; Fujita, S; Egawa, T				Miyoshi, Makoto; Fujita, Shu; Egawa, Takashi			Numerical and experimental analyses on two-dimensional electron mobility in Al(In,Ga)N/AlGaN heterostructures (vol 8, 051003, 2015)	APPLIED PHYSICS EXPRESS			English	Correction									[Miyoshi, Makoto; Fujita, Shu; Egawa, Takashi] Nagoya Inst Technol, Res Ctr Nano Devices & Adv Mat, Nagoya, Aichi 4668555, Japan; [Miyoshi, Makoto; Egawa, Takashi] Nagoya Inst Technol, Innovat Ctr Multibusiness Nitride Semicond, Nagoya, Aichi 4668555, Japan	Miyoshi, M (reprint author), Nagoya Inst Technol, Res Ctr Nano Devices & Adv Mat, Nagoya, Aichi 4668555, Japan.	miyoshi.makoto@nitech.ac.jp					MAKOTO M, 2015, APPL PHYS EXPRESS, V8	1	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							109201	10.7567/APEX.8.109201		1	Physics, Applied	Physics	CS6KM	WOS:000362187500024		
J	Morimoto, M; Koshiba, Y; Misaki, M; Ishida, K				Morimoto, Masahiro; Koshiba, Yasuko; Misaki, Masahiro; Ishida, Kenji			Thermal stability of piezoelectric properties and infrared sensor performance of spin-coated polyurea thin films	APPLIED PHYSICS EXPRESS			English	Article							VAPOR-DEPOSITION POLYMERIZATION; POLY(VINYLIDENE FLUORIDE); TEMPERATURE	We have investigated the temperature dependence of the piezoelectric coefficients and infrared sensor performance of spin-coated thin films of polyundecylurea (PUA11). The piezoelectric coefficients of the PUA11 films remained constant at temperatures above 180 degrees C and these films demonstrated thermal resistance superior to those of poly(vinylidene fluoride/trifluoroethylene) [P(VDF/TrFE)] films. The infrared sensor performance of the PUA11 films was measured after annealing at 125 degrees C for 500 h and was found to have retained 84% of its preannealing level. The thermal stability of the PUA11 films was higher than that of the P(VDF/TrFE) films; moreover, PUA11 is also expected to have superior electrothermal stability. (C) 2015 The Japan Society of Applied Physics	[Morimoto, Masahiro; Koshiba, Yasuko; Misaki, Masahiro; Ishida, Kenji] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Ishida, K (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan.	kishida@crystal.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS); New Energy and Industrial Technology Development Organization (NEDO); JSPS	The authors thank Unitika Ltd. for supplying the polyurea. This work was partly supported by the Japan Society for the Promotion of Science (JSPS), JSPS Fellows, and New Energy and Industrial Technology Development Organization (NEDO).	Kuroda Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.021601; Kanno I, 2003, SENSOR ACTUAT A-PHYS, V107, P68, DOI 10.1016/S0924-4247(03)00234-6; Teo LS, 1997, MACROMOLECULES, V30, P1793, DOI 10.1021/ma961035f; VONMUNCH W, 1993, SENSOR ACTUAT A-PHYS, V37-8, P365, DOI 10.1016/0924-4247(93)80062-L; Muguruma H, 2004, JPN J APPL PHYS 2, V43, pL859, DOI 10.1143/JJAP.43.L859; Koyama D, 2010, APPL ACOUST, V71, P439, DOI 10.1016/j.apacoust.2009.11.009; HATTORI T, 1994, JPN J APPL PHYS 1, V33, P4647, DOI 10.1143/JJAP.33.4647; Feng LQ, 2013, EUR POLYM J, V49, P1811, DOI 10.1016/j.eurpolymj.2013.04.007; Askari F, 2013, KOREAN J CHEM ENG, V30, P2093, DOI 10.1007/s11814-013-0139-z; VONMUNCH W, 1994, SENSOR ACTUAT A-PHYS, V41, P156, DOI 10.1016/0924-4247(94)80105-3; TASHIRO K, 1983, POLYMER, V24, P199, DOI 10.1016/0032-3861(83)90133-7; Tabaru M, 2008, JPN J APPL PHYS, V47, P4044, DOI 10.1143/JJAP.47.4044; WANG H, 1993, J APPL PHYS, V74, P3394, DOI 10.1063/1.354566; WANG XS, 1993, JPN J APPL PHYS 1, V32, P2768, DOI 10.1143/JJAP.32.2768; Hattori T, 1996, J APPL PHYS, V79, P1713, DOI 10.1063/1.360959; TAKAHASHI Y, 1991, J APPL PHYS, V70, P6983, DOI 10.1063/1.349827; Mino T, 2007, JPN J APPL PHYS 1, V46, P6960, DOI 10.1143/JJAP.46.6960; Zhang QQ, 1999, COMPOS PART A-APPL S, V30, P163, DOI 10.1016/S1359-835X(98)00113-4; Yanase T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.041603; KOBAYASHI M, 1975, MACROMOLECULES, V8, P158, DOI 10.1021/ma60044a013; Tajitsu Y, 1996, JPN J APPL PHYS 1, V35, P5199, DOI 10.1143/JJAP.35.5199; Wu S, 2013, ADV MATER, V25, P1734, DOI 10.1002/adma.201204072; Kubono A, 2008, JPN J APPL PHYS, V47, P5553, DOI 10.1143/JJAP.47.5553; FURUKAWA T, 1984, JPN J APPL PHYS 2, V23, pL677, DOI 10.1143/JJAP.23.L677; Morimoto M., POLYMER UNPUB; Morimoto M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DK13; Ohigashi H., 1985, JAPAN J APPL PH S242, V24, P23	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							101501	10.7567/APEX.8.101501		3	Physics, Applied	Physics	CS6KM	WOS:000362187500003		
J	Nakamura, A; Ota, Y; Koike, K; Hidaka, Y; Nishioka, K; Sugiyama, M; Fujii, K				Nakamura, Akihiro; Ota, Yasuyuki; Koike, Kayo; Hidaka, Yoshihide; Nishioka, Kensuke; Sugiyama, Masakazu; Fujii, Katsushi			A 24.4% solar to hydrogen energy conversion efficiency by combining concentrator photovoltaic modules and electrochemical cells	APPLIED PHYSICS EXPRESS			English	Article							WATER ELECTROLYZER; GENERATION; SYSTEMS; STORAGE; PERFORMANCE; PHOTOLYSIS; CONVERTER; DEVICES	The highest efficiency of 24.4% for the solar-to-hydrogen (STH) energy conversion was obtained in an outdoor field test by combining concentrator photovoltaic (CPV) modules with InGaP/GaAs/Ge three-junction cells and polymer-electrolyte electrochemical (EC) cells. The high efficiency was obtained by using the high-efficiency CPV modules (similar to 31% under the present operation conditions) and the direct connection between the CPV modules and the EC cells with an almost optimized number of elements in series. The STH efficiency bottleneck was clarified to be the efficiency of the CPV modules, the over-potential of the EC cells, and matching of the operation point to the maximal-power point of the CPV modules. (C) 2015 The Japan Society of Applied Physics	[Nakamura, Akihiro; Koike, Kayo; Sugiyama, Masakazu] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Ota, Yasuyuki; Hidaka, Yoshihide; Nishioka, Kensuke] Miyazaki Univ, Fac Engn, Dept Appl Phys, Miyazaki 8892192, Japan; [Fujii, Katsushi] Univ Tokyo, Global Solar Plus Initiat, Meguro Ku, Tokyo 1538904, Japan	Sugiyama, M (reprint author), Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan.	sugiyama@ee.t.u-tokyo.ac.jp; k.fujii@rcast.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038			Ager JW, 2015, ENERG ENVIRON SCI, V8, P2811, DOI 10.1039/c5ee00457h; Fujii K, 2013, INT J HYDROGEN ENERG, V38, P14424, DOI 10.1016/j.ijhydene.2013.07.010; BOLTON JR, 1985, NATURE, V316, P495, DOI 10.1038/316495a0; Paul B, 2008, INT J HYDROGEN ENERG, V33, P490, DOI 10.1016/j.ijhydene.2007.10.040; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Licht S, 2001, J PHYS CHEM B, V105, P6281, DOI 10.1021/jp010552j; Shapiro D, 2005, SOL ENERGY, V79, P544, DOI 10.1016/j.solener.2004.10.013; GARCIACONDE AG, 1993, INT J HYDROGEN ENERG, V18, P995, DOI 10.1016/0360-3199(93)90081-K; Garcia-Valverde R, 2008, INT J HYDROGEN ENERG, V33, P5352, DOI 10.1016/j.ijhydene.2008.06.015; Gibson TL, 2010, INT J HYDROGEN ENERG, V35, P900, DOI 10.1016/j.ijhydene.2009.11.074; Garrigos A, 2010, INT J HYDROGEN ENERG, V35, P6123, DOI 10.1016/j.ijhydene.2010.03.131; ESTEVE D, 1982, INT J HYDROGEN ENERG, V7, P711, DOI 10.1016/0360-3199(82)90019-2; Licht S, 2000, J PHYS CHEM B, V104, P8920, DOI 10.1021/jp002083b; Clarke RE, 2009, INT J HYDROGEN ENERG, V34, P2531, DOI 10.1016/j.ijhydene.2009.01.053; Garcia-Valverde R, 2011, INT J HYDROGEN ENERG, V36, P10574, DOI 10.1016/j.ijhydene.2011.05.179; Maeda T, 2012, INT J HYDROGEN ENERG, V37, P4819, DOI 10.1016/j.ijhydene.2011.12.013; Alhumaidan F, 2011, ENERG FUEL, V25, P4217, DOI 10.1021/ef200829x; Hashimoto K, 2002, CORROS SCI, V44, P371, DOI 10.1016/S0010-938X(01)00067-1; Doscher H, 2014, ENERG ENVIRON SCI, V7, P2951, DOI 10.1039/c4ee01753f; Peharz G, 2007, INT J HYDROGEN ENERG, V32, P3248, DOI 10.1016/j.ijhydene.2007.04.036; SIEGEL A, 1988, INT J HYDROGEN ENERG, V13, P659, DOI 10.1016/0360-3199(88)90076-6; FISCHER M, 1986, INT J HYDROGEN ENERG, V11, P495, DOI 10.1016/0360-3199(86)90015-7; Klerke A, 2008, J MATER CHEM, V18, P2304, DOI 10.1039/b720020j; COSTOGUE EN, 1977, SOL ENERGY, V19, P205, DOI 10.1016/0038-092X(77)90060-3; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Solmecke H, 2000, RENEW ENERG, V19, P333, DOI 10.1016/S0960-1481(99)00049-X; Shukla A, 2012, INT J HYDROGEN ENERG, V37, P3719, DOI 10.1016/j.ijhydene.2011.04.107; WEBER MF, 1986, INT J HYDROGEN ENERG, V11, P225, DOI 10.1016/0360-3199(86)90183-7; Hashimoto K, 2001, MAT SCI ENG A-STRUCT, V304, P88, DOI 10.1016/S0921-5093(00)01457-X; Sugiyama M., 2015, P 42 IEEE PHOT SPEC	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							107101	10.7567/APEX.8.107101		4	Physics, Applied	Physics	CS6KM	WOS:000362187500022		
J	Nishitani, H; Ohta, K; Kitano, S; Hamano, R; Inada, M; Shimizu, T; Shingubara, S; Kozuka, H; Saitoh, T				Nishitani, Hiroki; Ohta, Kohei; Kitano, Sosuke; Hamano, Ryosuke; Inada, Mitsuru; Shimizu, Tomohiro; Shingubara, Shoso; Kozuka, Hiromitsu; Saitoh, Tadashi			Band gap tuning of Ni1-xMgxO films by radio-frequency sputter deposition for deep-ultraviolet photodetectors	APPLIED PHYSICS EXPRESS			English	Article							NICMG1-CO SOLID-SOLUTIONS; MGXNI1-XO THIN-FILMS; BLIND; ALGAN; RESPONSIVITY; PHOTODIODES	A deep-ultraviolet photodetector based on a Ni0.52Mg0.48O film was fabricated using a simple radio-frequency sputtering technique and a Ni-Mg composite target. The Ni1-xMgxO band gap can be tuned by adjusting the Mg content, which in turn can be controlled by varying the number of Mg chips on the Ni target. The lattice constant of Ni1-xMgxO linearly depends on the Mg content, whereas the plot of the band gap versus Mg content exhibits bowing. The fabricated photodetector based on the Ni0.52Mg0.48O film operates as a deep-ultraviolet photodetector and shows peak responsivity at a wavelength of 276 nm. (C) 2015 The Japan Society of Applied Physics	[Nishitani, Hiroki; Ohta, Kohei; Kitano, Sosuke; Hamano, Ryosuke; Inada, Mitsuru; Shimizu, Tomohiro; Shingubara, Shoso; Kozuka, Hiromitsu; Saitoh, Tadashi] Kansai Univ, Grad Sch Sci & Engn, Suita, Osaka 5648680, Japan	Nishitani, H (reprint author), Kansai Univ, Grad Sch Sci & Engn, Suita, Osaka 5648680, Japan.	saitoh@kansai-u.ac.jp			Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Strategic Project to Support the Formation of Research Bases at Private Universities	This study was partly supported by the "Strategic Project to Support the Formation of Research Bases at Private Universities": Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Pernot C, 2000, JPN J APPL PHYS 2, V39, pL387, DOI 10.1143/JJAP.39.L387; Deng JK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4769210; Kohama Y, 2014, ADV MATER SCI ENG, DOI 10.1155/2014/120463; Mares JW, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3503634; Tut T, 2005, SOLID STATE ELECTRON, V49, P117, DOI 10.1016/j.sse.2004.07.009; LUETTGEN MR, 1991, J OPT SOC AM A, V8, P1964, DOI 10.1364/JOSAA.8.001964; Ji ZG, 2005, J CRYST GROWTH, V273, P446, DOI 10.1016/j.jcrysgro.2004.09.037; Zhao YM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/9/092007; KUZMIN A, 1995, J PHYS-CONDENS MAT, V7, P9357, DOI 10.1088/0953-8984/7/48/023; Xie XH, 2014, OPT EXPRESS, V22, P246, DOI 10.1364/OE.22.000246; Koide Y, 2005, MATER TRANS, V46, P1965, DOI 10.2320/matertrans.46.1965; Boutwell RC, 2012, THIN SOLID FILMS, V520, P4302, DOI 10.1016/j.tsf.2012.02.065; Wang P, 2013, OPT EXPRESS, V21, P18387, DOI 10.1364/OE.21.018387; Guo YM, 2014, THIN SOLID FILMS, V558, P311, DOI 10.1016/j.tsf.2014.02.072; Li KJ, 2010, OPT EXPRESS, V18, P11713, DOI 10.1364/OE.18.011713; Osinsky A, 1998, APPL PHYS LETT, V72, P742, DOI 10.1063/1.120862; Kwon YH, 2013, THIN SOLID FILMS, V529, P417, DOI 10.1016/j.tsf.2012.06.021; Adivarahan V, 2001, APPL PHYS LETT, V79, P1903, DOI 10.1063/1.1402159; Xu ZY, 2008, IEEE COMMUN MAG, V46, P67, DOI 10.1109/MCOM.2008.4511651; ROESSLER DM, 1967, PHYS REV, V159, P733, DOI 10.1103/PhysRev.159.733; Kuzmin A, 1998, J PHYS-CONDENS MAT, V10, P7937, DOI 10.1088/0953-8984/10/36/004; Rao KV, 2008, J PHYS CHEM SOLIDS, V69, P87, DOI 10.1016/j.jpcs.2007.08.006; Balkanski M, 2000, SEMICONDUCTOR PHYS A; Chen G, 2008, OPT EXPRESS, V16, P15059, DOI 10.1364/OE.16.015059; Li GM, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/38002; Mares JW, 2010, PROC SPIE, V7603, DOI 10.1117/12.841327; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Sun L, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3515903; Suzuki R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574911	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							105801	10.7567/APEX.8.105801		3	Physics, Applied	Physics	CS6KM	WOS:000362187500020		
J	Okano, M; Endo, M; Wakamiya, A; Yoshita, M; Akiyama, H; Kanemitsu, Y				Okano, Makoto; Endo, Masaru; Wakamiya, Atsushi; Yoshita, Masahiro; Akiyama, Hidefumi; Kanemitsu, Yoshihiko			Degradation mechanism of perovskite CH3NH3PbI3 diode devices studied by electroluminescence and photoluminescence imaging spectroscopy	APPLIED PHYSICS EXPRESS			English	Article							ORGANOMETAL HALIDE PEROVSKITES; SENSITIZED SOLAR-CELLS; SPIRO-OMETAD; STATE; EFFICIENCY; RECOMBINATION; SEMICONDUCTORS; CU(IN,GA)SE-2; LAYERS; FILMS	We investigate the degradation behavior of non-sealed perovskite CH3NH3PbI3 diode devices in air at room temperature by means of electroluminescence (EL) and photoluminescence (PL) imaging techniques. From the comparison of these images, we determine that the spatial fluctuation of the EL intensity is mainly due to fluctuations in the luminescence efficiency of the perovskite layer itself. By applying a constant voltage for tens of minutes, the EL intensity decreases gradually. It is observed that the temporal evolution of the EL intensity is governed by the degradation of the perovskite layer and the carrier injection at the interface. (C) 2015 The Japan Society of Applied Physics	[Okano, Makoto; Endo, Masaru; Wakamiya, Atsushi; Kanemitsu, Yoshihiko] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Yoshita, Masahiro; Akiyama, Hidefumi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Yoshita, Masahiro; Akiyama, Hidefumi; Kanemitsu, Yoshihiko] Japan Sci & Technol Agcy, CREST, Uji, Kyoto 6110011, Japan	Kanemitsu, Y (reprint author), Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan.	kanemitu@scl.kyoto-u.ac.jp	Kanemitsu, Yoshihiko/D-2006-2014; Okano, Makoto/F-9311-2011		Sumitomo Electric Industries Group CSR Foundation; JST-CREST	The authors thank Y. Yamada and T. Handa for discussions. This work was supported by The Sumitomo Electric Industries Group CSR Foundation (to M.O. and Y.K.), and JST-CREST (to Y.K.).	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Misra RK, 2015, J PHYS CHEM LETT, V6, P326, DOI 10.1021/jz502642b; Yamada Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032302; Niu GD, 2014, J MATER CHEM A, V2, P705, DOI 10.1039/c3ta13606j; Nguyen WH, 2014, J AM CHEM SOC, V136, P10996, DOI 10.1021/ja504539w; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Snaith HJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424552; Kirchartz T, 2007, THIN SOLID FILMS, V515, P6238, DOI 10.1016/j.tsf.2006.12.105; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Christians JA, 2015, J PHYS CHEM LETT, V6, P2086, DOI 10.1021/acs.jpclett.5b00594; Tan ZK, 2014, NAT NANOTECHNOL, V9, P687, DOI [10.1038/nnano.2014.149, 10.1038/NNANO.2014.149]; HALL RN, 1952, PHYS REV, V87, P387, DOI 10.1103/PhysRev.87.387; Fuyuki T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1978979; Kirchartz T, 2007, J APPL PHYS, V102, DOI 10.1063/1.2817959; Marinova N, 2015, ACS NANO, V9, P4200, DOI 10.1021/acsnano.5b00447; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Ono LK, 2014, J PHYS CHEM LETT, V5, P1374, DOI 10.1021/jz500414m; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Yamada Y, 2015, IEEE J PHOTOVOLT, V5, P401, DOI 10.1109/JPHOTOV.2014.2364115; Deschler F, 2014, J PHYS CHEM LETT, V5, P1421, DOI 10.1021/jz5005285; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Even J, 2015, J PHYS CHEM C, V119, P10161, DOI 10.1021/acs.jpcc.5b00695; Wakamiya A, 2014, CHEM LETT, V43, P711, DOI 10.1246/cl.140074; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Yamada Y, 2015, J AM CHEM SOC, V137, P10456, DOI 10.1021/jacs.5b04503; Xing GC, 2014, NAT MATER, V13, P476, DOI [10.1038/nmat3911, 10.1038/NMAT3911]; Casey H. C., 1978, HETEROSTRUCTURE LASE; Chen SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07836; Jaramillo-Quintero OA, 2015, J PHYS CHEM LETT, V6, P1883, DOI 10.1021/acs.jpclett.5b00732; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; Tvingstedt K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06071	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							102302	10.7567/APEX.8.102302		4	Physics, Applied	Physics	CS6KM	WOS:000362187500008		
J	Takahashi, I; Joonwichien, S; Iwata, T; Usami, N				Takahashi, Isao; Joonwichien, Supawan; Iwata, Taisho; Usami, Noritaka			Seed manipulation for artificially controlled defect technique in new growth method for quasi-monocrystalline Si ingot based on casting	APPLIED PHYSICS EXPRESS			English	Article							MONO-LIKE SILICON; TILT GRAIN-BOUNDARIES; DIRECTIONAL SOLIDIFICATION; MULTICRYSTALLINE SILICON; SOLAR-CELLS; DISLOCATION GENERATION; CRYSTALS	We propose a new growth method for quasi-monocrystalline Si that achieves high-quality ingots and a high yield ratio. This method induces defect regions with compose dislocations surrounded by grain boundaries. These functional defects benefit the crystalline quality through impurity gettering, dislocation-propagation blocking, and stress relaxation with plastic deformation. Functional defect regions were grown from designed seeds and introduced to ingot edges where crystalline Si was disposed because of contamination. Preliminary experimentation demonstrated that functional defects could effectively form from the manipulated seeds. We call this method the Seed Manipulation for Artificially Controlled Defect Technique. (C) 2015 The Japan Society of Applied Physics	[Takahashi, Isao; Joonwichien, Supawan; Iwata, Taisho; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Takahashi, I (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.		Usami, Noritaka/C-1720-2009; Takahashi, Isao/E-8501-2013	Takahashi, Isao/0000-0003-0416-5462			Chen J, 2005, SCRIPTA MATER, V52, P1211, DOI 10.1016/j.scriptamat.2005.03.010; Jouini A, 2012, PROG PHOTOVOLTAICS, V20, P735, DOI 10.1002/pip.1221; Kaden T, 2012, ENRGY PROCED, V27, P103, DOI 10.1016/j.egypro.2012.07.036; Black A, 2012, J CRYST GROWTH, V353, P12, DOI 10.1016/j.jcrysgro.2012.04.033; Autruffe A, 2015, J CRYST GROWTH, V411, P12, DOI 10.1016/j.jcrysgro.2014.10.054; Trempa M, 2012, J CRYST GROWTH, V351, P131, DOI 10.1016/j.jcrysgro.2012.04.035; Usami N, 2010, J APPL PHYS, V107, DOI 10.1063/1.3276219; Ervik T, 2014, ACTA MATER, V67, P199, DOI 10.1016/j.actamat.2013.12.010; Trempa M, 2015, CRYST RES TECHNOL, V50, P124, DOI 10.1002/crat.201400226; KOHYAMA M, 1986, PHYS STATUS SOLIDI B, V138, P387, DOI 10.1002/pssb.2221380202; Kutsukake K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.025505; Oriwol D, 2013, ACTA MATER, V61, P6903, DOI 10.1016/j.actamat.2013.08.002; Trempa M, 2014, J CRYST GROWTH, V405, P131, DOI 10.1016/j.jcrysgro.2014.08.002; Tsoutsouva MG, 2014, J CRYST GROWTH, V401, P397, DOI 10.1016/j.jcrysgro.2013.12.022; Kutsukake K, 2014, IEEE J PHOTOVOLT, V4, P84, DOI 10.1109/JPHOTOV.2013.2281730; Usami N, 2005, JPN J APPL PHYS 2, V44, pL778, DOI 10.1143/JJAP.44.L778; KOHYAMA M, 1987, PHYS STATUS SOLIDI B, V141, P71, DOI 10.1002/pssb.2221410106; Guerrero I, 2014, PROG PHOTOVOLTAICS, V22, P923, DOI 10.1002/pip.2344; Takahashi I, 2015, J APPL PHYS, V117, DOI 10.1063/1.4913855; Kieliba T, 2006, J APPL PHYS, V100, DOI 10.1063/1.2338126; SOPORI BL, 1984, J ELECTROCHEM SOC, V131, P667, DOI 10.1149/1.2115670; Stoddard N., 2007, SOLID STATE PHENOM, V131-133, P1; Takahashi I, 2010, J CRYST GROWTH, V312, P897, DOI 10.1016/j.jcrysgro.2010.01.011; Takahashi I, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DP01; Tsoutsouva MG, 2015, ACTA MATER, V88, P112, DOI 10.1016/j.actamat.2015.01.012	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	OCT	2015	8	10							105501	10.7567/APEX.8.105501		4	Physics, Applied	Physics	CS6KM	WOS:000362187500019		
J	Ogata, A; Atsumi, T; Fukuda, T; Hirabayashi, Y; Inaba, M; Ishiguro, N; Kai, M; Kawabata, D; Kida, D; Kohsaka, H; Matsumura, R; Minota, S; Mukai, M; Sumida, T; Takasugi, K; Tamaki, S; Takeuchi, T; Ueda, A; Yamamoto, K; Yamanaka, H; Yoshifuji, H; Nomura, A				Ogata, Atsushi; Atsumi, Tatsuya; Fukuda, Takaaki; Hirabayashi, Yasuhiko; Inaba, Masaaki; Ishiguro, Naoki; Kai, Motokazu; Kawabata, Daisuke; Kida, Daihei; Kohsaka, Hitoshi; Matsumura, Ryutaro; Minota, Seiji; Mukai, Masaya; Sumida, Takayuki; Takasugi, Kiyoshi; Tamaki, Shigenori; Takeuchi, Tsutomu; Ueda, Atsuhisa; Yamamoto, Kazuhiko; Yamanaka, Hisashi; Yoshifuji, Hajime; Nomura, Akira		Musashi Study Investigators	Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis	ARTHRITIS CARE & RESEARCH			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; INTERLEUKIN-6 RECEPTOR INHIBITION; ANTI-ADALIMUMAB ANTIBODIES; DISEASE-ACTIVITY; IL-6 RECEPTOR; INADEQUATE RESPONSE; CONTROLLED-TRIAL; CLINICAL-TRIALS; DOUBLE-BLIND; SAFETY	Objective. To evaluate the efficacy and safety of switching from intravenous (IV) tocilizumab (TCZ) to subcutaneous (SC) TCZ monotherapy in rheumatoid arthritis patients. Methods. Patients who had completed 24 weeks of TCZ-SC (162 mg/2 weeks) or TCZ-IV (8 mg/kg/4 weeks) monotherapy in the double-blind period of the MUSASHI study were enrolled in an 84-week open-label extension period. All received TCZ-SC (162 mg/2 weeks) monotherapy. Effects of the IV to SC switch were evaluated at week 36 (12 weeks after switching). Results. Overall, 319 patients received >= 1 dose of TCZ-SC during the open-label extension period; 160 switched from TCZ-IV to TCZ-SC (TCZ IV/SC) and 159 continued TCZ-SC (TCZ SC/SC). Disease Activity Score in 28 joints using the erythrocyte sedimentation rate clinical remission rates were 62.5% (100 of 160) for TCZ IV/SC and 50.0% (79 of 158) for TCZ SC/SC at week 24, and were maintained at 62.5% (100 of 160) and 57.0% (90 of 158), respectively, at week 36. In the TCZ IV/SC group, 9% of patients (9 of 100) who had achieved remission at week 24 could not maintain remission at week 36. In TCZ IV/SC patients weighing >= 70 kg, the percentage with a sufficient serum TCZ concentration (>= 1 mu g/ml) decreased from 90.9% (10 of 11) at week 24 to 45.5% (5 of 11) at week 36. Overall safety profiles were similar in TCZ IV/SC and TCZ SC/SC except for mild injection site reactions in TCZ IV/SC. Conclusion. Efficacy is adequately maintained in most patients switching from TCZ-IV (8 mg/kg/4 weeks) to TCZ-SC (162 mg/2 weeks) monotherapy. Patients receiving TCZ-IV can switch to TCZ-SC without serious safety concerns. Clinical efficacy may be reduced after switching in some patients with high body weight.	[Ogata, Atsushi] Osaka Univ, Osaka, Japan; [Atsumi, Tatsuya] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Fukuda, Takaaki] Kurume Univ, Sch Med, Fukuoka, Japan; [Hirabayashi, Yasuhiko] Hikarigaoka Spellman Hosp, Sendai, Miyagi, Japan; [Inaba, Masaaki] Osaka City Univ, Osaka 558, Japan; [Ishiguro, Naoki] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Kai, Motokazu] Natl Hosp Org, Mie Chuo Med Ctr, Tsu, Mie, Japan; [Kawabata, Daisuke; Yoshifuji, Hajime] Kyoto Univ, Kyoto, Japan; [Kida, Daihei] Nagoya Med Ctr, Nagoya, Aichi, Japan; [Kohsaka, Hitoshi] Tokyo Med & Dent Univ, Tokyo, Japan; [Matsumura, Ryutaro] Chiba East Natl Hosp, Natl Hosp Org, Chiba, Japan; [Minota, Seiji] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Mukai, Masaya] Sapporo City Gen Hosp, Sapporo, Hokkaido, Japan; [Sumida, Takayuki] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Takasugi, Kiyoshi] Dogo Spa Hosp, Matsuyama, Ehime, Japan; [Tamaki, Shigenori] Nagoya Rheumatol Clin, Nagoya, Aichi, Japan; [Takeuchi, Tsutomu] Keio Univ, Tokyo, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Tokyo, Japan; [Yamanaka, Hisashi] Tokyo Womens Med Univ, Tokyo, Japan; [Nomura, Akira] Chugai Pharmaceut, Tokyo, Japan	Ogata, A (reprint author), NTT West Osaka Hosp, Div Allergy Rheumatol & Connect Tissue, Tennoji Ku, Osaka 5438922, Japan.	a.ogata@mhc.west.ntt.co.jp			Chugai Pharmaceutical; Actemara	Supported by Chugai Pharmaceutical.; Dr. Ogata has received honoraria (less than $10,000 each) from Pfizer, UCB Japan, GlaxoSmithKline, Ono, Takeda, Mitsubishi Tanabe, and Daiichi Sankyo, and (more than $10,000) from Chugai. Dr. Atsumi has received honoraria (less than $10,000 each) from Ono, Nippon Boehringer Ingelheim, Abbott Japan, Kissei, Dainippon Sumitomo, CSL Behring, Kyowa Hakko Kirin, Merck Sharp & Dohme, and Novo Nordisk, and (more than $10,000 each) from Astellas, Actelion Japan, AbbVie, Eisai, Merck Sharp & Dohme, Asahi Kasei, Otsuka, Daiichi Sankyo, Mitsubishi Tanabe, Takeda, Chugai, Pfizer, Bristol-Myers Squibb, Shionogi, Taisho Toyama, and GlaxoSmithKline. Dr. Fukuda has received honoraria (less than $10,000 each) from Bristol-Myers Squibb, Janssen, AbbVie, Chugai, Takeda, Mitsubishi Tanabe, and Eisai. Dr. Hirabayashi has received honoraria (less than $10,000 each) from Chugai, Takeda, Pfizer, Mitsubishi Tanabe, and Janssen. Dr. Ishiguro has received honoraria (less than $10,000 each) from Eli Lilly Japan, Daiichi Sankyo, Otsuka, Taisho Toyama, Ono, Kaken, UCB Japan, Janssen, Novo Nordisk, Novartis, Bayer, GlaxoSmithKline, Merck Sharp & Dohme, Teijin, Santen, and Pfizer, and (more than $10,000 each) from Chugai, Eisai, AbbVie, Astellas, Takeda, Mitsubishi Tanabe, and Bristol-Myers Squibb. Dr. Kai has received honoraria (less than $10,000 each) from Chugai, Eisai, Mitsubishi Tanabe, and Pfizer. Dr. Kawabata has received honoraria (less than $10,000) from Chugai. Dr. Kida has received honoraria (less than $10,000 each) from Chugai, Bristol-Myers Squibb, Eli Lilly Japan, Asahi Kasei, Pfizer, and Eisai. Dr. Kohsaka has received honoraria (less than $10,000 each) from Chugai, Bristol-Myers Squibb, UCB Japan, Astellas, Nippon Shinyaku, Actelion Japan, Abbott Japan/AbbVie, Pfizer, Kowa, Ono, Asahi Kasei, Japan Blood Products Organization, Mitsubishi Tanabe, Santen, and Teijin. Dr. Minota has received honoraria (less than $10,000 each) from Chugai, UCB Japan, Eisai, Takeda, Asahi Kasei, Santen, Mitsubishi Tanabe, Pfizer, Astellas, AstraZeneca, and Daiichi Sankyo, and receives license fees and royalties for Actemra. Dr. Mukai has received honoraria (less than $10,000 each) from Pfizer, Mitsubishi Tanabe, Janssen, AbbVie, Eisai, Novartis, and Chugai. Dr. Sumida has received honoraria (less than $10,000) from Chugai. Dr. Takasugi has received honoraria (less than $10,000 each) from Mitsubishi Tanabe, Santen, and Pfizer. Dr. Tamaki has received honoraria (less than $10,000 each) from Astellas, Bristol-Myers Squibb, Mitsubishi Tanabe, Takeda, Pfizer, AbbVie, Eisai, Chugai, Santen, Teijin, Taisho Toyama, and Eli Lilly Japan. Dr. Takeuchi has received honoraria (more than $10,000 each) from Astellas, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Mitsubishi Tanabe, Pfizer, Santen, Takeda, Teijin, AbbVie, Asahi Kasei, Taisho Toyama, SymBio, Janssen, AstraZeneca, Eli Lilly Japan, Novartis, and Asahi Kasei Medical. Dr. Ueda has received honoraria (less than $10,000 each) from Chugai, Merck Sharp & Dohme, ViiV Healthcare, Torii, and AbbVie. Dr. Yamamoto has received honoraria (less than $10,000 each) from Astellas, AbbVie, Abbott Japan, Janssen, Asahi Kasei, Santen, Taisho Toyama, Ono, Daiichi Sankyo, Mitsubishi Tanabe, Nippon Shinyaku, Takeda, Johnson & Johnson, Sanofi, Hisamitsu, Dainippon Sumitomo, and Fujifilm, and (more than $10,000 each) from Chugai, Eisai, Pfizer, UCB Japan, and Bristol-Myers Squibb. Dr.; Yamanaka has received honoraria (less than $10,000 each) from Bristol-Myers Squibb, AbbVie, Daiichi Sankyo, Nippon Kayaku, Mitsubishi Tanabe, Pfizer, Takeda, and UCB Japan, and (more than $10,000 each) from Teijin, Chugai, and Astellas. Dr. Yoshifuji has received honoraria (less than $10,000 each) from Mitsubishi Tanabe, Takeda, Pfizer, Chugai, Astellas, and Eisai.	Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; FELSON DT, 1993, ARTHRITIS RHEUM, V36, P729, DOI 10.1002/art.1780360601; Kaneko A, 2012, RHEUMATOL INT, V32, P3631, DOI 10.1007/s00296-011-2256-5; Bartelds GM, 2010, ANN RHEUM DIS, V69, P817, DOI 10.1136/ard.2009.112847; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Stubenrauch K, 2010, CLIN THER, V32, P1597, DOI 10.1016/j.clinthera.2010.07.021; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Ogata A, 2015, J RHEUMATOL, V42, P799, DOI 10.3899/jrheum.140665; Kaine J, 2012, ANN RHEUM DIS, V71, P38, DOI 10.1136/annrheumdis-2011-200344; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Genovese MC, 2008, ARTHRITIS RHEUM, V58, P2968, DOI 10.1002/art.23940; Ogata A, 2014, ARTHRIT CARE RES, V66, P344, DOI 10.1002/acr.22110; Burmester GR, 2014, ANN RHEUM DIS, V73, P69, DOI 10.1136/annrheumdis-2013-203523; Kivitz A, 2014, ARTHRIT CARE RES, V66, P1653, DOI 10.1002/acr.22384; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Pers YM, 2014, RHEUMATOLOGY, V53, P76, DOI 10.1093/rheumatology/ket301	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2151-464X	2151-4658		ARTHRIT CARE RES	Arthritis Care Res.	OCT	2015	67	10					1354	1362		10.1002/acr.22598		9	Rheumatology	Rheumatology	CT2ZJ	WOS:000362675300003		
J	Asai, S; Kojima, T; Oguchi, T; Kaneko, A; Hirano, Y; Yabe, Y; Kanayama, Y; Takahashi, N; Funahashi, K; Hanabayashi, M; Hirabara, S; Yoshioka, Y; Takemoto, T; Terabe, K; Asai, N; Ishiguro, N				Asai, Shuji; Kojima, Toshihisa; Oguchi, Takeshi; Kaneko, Atsushi; Hirano, Yuji; Yabe, Yuichiro; Kanayama, Yasuhide; Takahashi, Nobunori; Funahashi, Koji; Hanabayashi, Masahiro; Hirabara, Shinya; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki			Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan	ARTHRITIS CARE & RESEARCH			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; DOUBLE-BLIND; RADIOGRAPHIC DAMAGE; ORTHOPEDIC-SURGERY; PREDICTIVE FACTORS; PLUS METHOTREXATE; BIOLOGIC THERAPY; AMERICAN-COLLEGE; DISEASE-ACTIVITY; CLINICAL-TRIAL	Objective. To determine the effects of concomitant methotrexate (MTX) on the incidence of large joint replacement resulting from the progression of large joint destruction in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors. Methods. A retrospective cohort study was performed using a multicenter registry. In total, 803 patients with RA who received etanercept or adalimumab were included. The first large joint replacement during treatment with etanercept or adalimumab was used as the outcome variable in predictive analyses. The cumulative incidence of large joint replacement was estimated using Kaplan-Meier curves, and the impact of concomitant MTX on the incidence of large joint replacement was assessed with Cox proportional hazards models. Propensity score matching was used to reduce selection bias. Results. Of all patients, 601 (75%) received concomitant MTX at a median dosage of 8 mg/week (interquartile range 6-8). A total of 49 patients (62 joints) underwent large joint replacement during treatment with etanercept or adalimumab. The incidence of large joint replacement for patients with concomitant MTX was significantly lower than that for patients without MTX (P < 0.001). Multivariate analysis revealed that concomitant MTX independently predicted large joint replacement (hazard ratio 0.36, 95% confidence interval 0.20-0.65). Additionally, propensity score-matched analysis demonstrated that patients with concomitant MTX had a significantly lower incidence of large joint replacement than those without concomitant MTX (P=0.032). Conclusion. Concomitant MTX reduces the incidence of large joint replacement in patients with RA treated with TNF inhibitors.	[Asai, Shuji; Kojima, Toshihisa; Takahashi, Nobunori; Funahashi, Koji; Yoshioka, Yutaka; Takemoto, Toki; Terabe, Kenya; Asai, Nobuyuki; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Oguchi, Takeshi] Anjo Kosei Hosp, Anjo, Japan; [Kaneko, Atsushi] Nagoya Med Ctr, Nagoya, Aichi, Japan; [Hirano, Yuji; Hirabara, Shinya] Toyohashi Municipal Hosp, Toyohashi, Aichi, Japan; [Yabe, Yuichiro] Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Kanayama, Yasuhide] Toyota Kosei Hosp, Toyota, Japan; [Hanabayashi, Masahiro] Ichinomiya Municipal Hosp, Ichinomiya, Japan	Asai, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ku, Nagoya, Aichi 4668550, Japan.	asai@med.nagoya-u.ac.jp			Eisai; Mitsubishi Tanabe; Takeda; Abbott; Bristol-Myers Squibb; Pfizer; Chugai	Dr. S. Asai has received speaking fees (less than $10,000) from Eisai. Dr. Kojima has received speaking fees (less than $10,000 each) from Mitsubishi Tanabe, Takeda, Eisai, Abbott, Bristol-Myers Squibb, and Pfizer, and (more than $10,000) from Chugai. Dr. Kaneko has received speaking fees (less than $10,000 each) from Mitsubishi Tanabe, Takeda, Eisai, Abbott, Bristol-Myers Squibb, and Pfizer, and (more than $10,000) from Chugai. Dr. Hirano has received speaking fees (less than $10,000 each) from Mitsubishi Tanabe, Takeda, Eisai, Abbott, Bristol-Myers Squibb, and Pfizer, and (more than $10,000) from Chugai. Dr. Ishiguro has received speaking fees (less than $10,000 each) from Mitsubishi Tanabe, Takeda, Eisai, Chugai, Abbott, Bristol-Myers Squibb, and Pfizer.	Breedveld FC, 2004, ANN RHEUM DIS, V63, P627, DOI 10.1136/ard.2003.011395; Leon L, 2013, J RHEUMATOL, V40, P1850, DOI 10.3899/jrheum.130118; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Emery P, 2011, ARTHRITIS RHEUM-US, V63, P1200, DOI 10.1002/art.30263; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Wolfe F, 1998, ARTHRITIS RHEUM, V41, P1072, DOI 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G; Louie GH, 2010, ANN RHEUM DIS, V69, P868, DOI 10.1136/ard.2009.112474; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Drossaers-Bakker KW, 2000, RHEUMATOLOGY, V39, P998, DOI 10.1093/rheumatology/39.9.998; Kameda H, 2013, ANN RHEUM DIS, V72, P310, DOI 10.1136/annrheumdis-2012-201804; Kolling C, 2009, ANN RHEUM DIS, V68, P1372, DOI 10.1136/ard.2008.100800; Nikiphorou E, 2014, ARTHRITIS RHEUMATOL, V66, P1081, DOI 10.1002/art.38344; Koike T, 2014, MOD RHEUMATOL, V24, P390, DOI 10.3109/14397595.2013.843760; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv27, DOI 10.1093/rheumatology/kes084; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kapetanovic MC, 2008, ANN RHEUM DIS, V67, P1412, DOI 10.1136/ard.2007.086710; Kameda H, 2011, J RHEUMATOL, V38, P1585, DOI 10.3899/jrheum.110014; Kojima T, 2012, MOD RHEUMATOL, V22, P339, DOI 10.1007/s10165-011-0518-4; Sano H, 2009, MOD RHEUMATOL, V19, P390, DOI 10.1007/s10165-009-0177-x; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Seki E, 2009, CLIN RHEUMATOL, V28, P453, DOI 10.1007/s10067-008-1076-9; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Jamsen E, 2013, ACTA ORTHOP, V84, P331, DOI 10.3109/17453674.2013.810519; Momohara S, 2010, ANN RHEUM DIS, V69, P312, DOI 10.1136/ard.2009.107599; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; Choy EHS, 2001, NEW ENGL J MED, V344, P907; Kuper HH, 1997, BRIT J RHEUMATOL, V36, P855	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2151-464X	2151-4658		ARTHRIT CARE RES	Arthritis Care Res.	OCT	2015	67	10					1363	1370		10.1002/acr.22596		8	Rheumatology	Rheumatology	CT2ZJ	WOS:000362675300004		
J	Watanabe, S; Takahashi, T; Hino, K; Kutsuna, T; Ohnishi, Y; Ishimaru, M; Miura, H				Watanabe, Seiji; Takahashi, Toshiaki; Hino, Kazunori; Kutsuna, Tatsuhiko; Ohnishi, Yoshio; Ishimaru, Masami; Miura, Hiromasa			Short-Term Study of the Outcome of a New Instrument for All-Inside Double-Bundle Anterior Cruciate Ligament Reconstruction	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							3-DIMENSIONAL COMPUTED-TOMOGRAPHY; ANTEROMEDIAL PORTAL TECHNIQUES; BONE TUNNEL ENLARGEMENT; TRANSTIBIAL TECHNIQUE; ACL RECONSTRUCTION; SEMITENDINOSUS TENDON; TIBIAL TUNNEL; FIXATION; RETROCONSTRUCTION; ATTACHMENTS	Purpose: The purpose of this study was to evaluate the short-term clinical results and location of the bone tunnel with a new surgical procedure for all-inside double-bundle anterior cruciate ligament (ACL) reconstruction. Methods: The double-bundle ACL reconstruction procedure was performed in 24 patients (13 male and 11 female patients) with a mean age of 31.0 years. Anterior and posterior tibial translation using an arthrometer (KT-1000; MEDmetric, San Diego, CA) and the Lysholm score were measured before surgery and at a mean of 24.8 months (range, 13 to 45 months) postoperatively. Computed tomography scans were taken to evaluate the bone tunnel positions using 3-dimensional images with the quadrant method for the femoral tunnel and Staubli's technique for the tibial tunnel. Results: Three-dimensional computed tomography scans showed that the anteromedial and posterolateral tunnels were placed in anatomically appropriate positions. Arthrometric measurements showed that the mean side-to-side differences were 5.3 mm (SD, 1.6 mm) preoperatively and 0.05 mm (SD, 0.7 mm) at a mean of 24.8 months postoperatively, indicating a remarkable improvement (P < .00001). The mean Lysholm score was 56.3 points (SD, 14.8 points) preoperatively and 95.5 points (SD, 3.8 points) at final follow-up and was significantly improved after the operation (P < .00001). Conclusions: The all-inside double-bundle ACL reconstruction technique used in this study resulted in the creation of tunnels in an anatomically appropriate position. Short-term clinical follow-up showed improvement in patient-reported outcomes and knee stability. This technique may provide an alternative option for all-inside ACL reconstruction.	[Watanabe, Seiji; Takahashi, Toshiaki; Hino, Kazunori; Kutsuna, Tatsuhiko; Ohnishi, Yoshio; Ishimaru, Masami; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Orthopaed Surg, Toon, Ehime 7910295, Japan	Takahashi, T (reprint author), Ehime Univ, Grad Sch Med Shitsukawa, Dept Orthopaed Surg, Toon, Ehime 7910295, Japan.	takahast@m.ehime-u.ac.jp		Takahashi, Toshiaki/0000-0002-4450-0547	Japanese Foundation for Research and Promotion of Endoscopy	The authors report the following potential conflict of interest or source of funding: S.W. and T.T. receive support from Japanese Foundation for Research and Promotion of Endoscopy. Grant in 2012.	Amis A A, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS2, DOI 10.1007/s001670050215; Smith PA, 2008, ARTHROSCOPY, V24, P1184, DOI 10.1016/j.arthro.2008.06.004; Gadikota HR, 2012, AM J SPORT MED, V40, P882, DOI 10.1177/0363546511434276; Silva A, 2012, KNEE SURG SPORT TR A, V20, P896, DOI 10.1007/s00167-011-1645-3; Tsuda E, 2010, AM J SPORT MED, V38, P698, DOI 10.1177/0363546509351561; Walsh MP, 2009, AM J SPORT MED, V37, P1539, DOI 10.1177/0363546509333013; Edwards A, 2007, KNEE SURG SPORT TR A, V15, P1414, DOI 10.1007/s00167-007-0417-6; Wright RW, 2012, J BONE JOINT SURG AM, V94A, P531, DOI 10.2106/JBJS.K.00733; Giron F, 2007, ARTHROSCOPY, V23, P7, DOI 10.1016/j.arthro.2006.08.008; Tsai AG, 2010, AM J SPORT MED, V38, P263, DOI 10.1177/0363546509348053; Takeda Y, 2013, ARTHROSCOPY, V29, P195, DOI 10.1016/j.arthro.2012.08.020; Sadoghi P, 2011, ARTHROSCOPY, V27, P355, DOI 10.1016/j.arthro.2010.08.015; Bradley JP, 2009, SPORTS MED ARTHROSC, V17, P252, DOI 10.1097/JSA.0b013e3181bf664f; Takahashi T, 2009, ARTHROSCOPY, V25, P212, DOI 10.1016/j.arthro.2008.07.014; Lee YS, 2013, ARCH ORTHOP TRAUM SU, V133, P1121, DOI 10.1007/s00402-013-1780-z; Tompkins M, 2012, AM J SPORT MED, V40, P1313, DOI 10.1177/0363546512443047; Siebold R, 2007, ARTHROSCOPY, V23, P291, DOI 10.1016/j.arthro.2007.01.006; Nebelung W, 1998, ARTHROSCOPY, V14, P810, DOI 10.1016/S0749-8063(98)70015-5; George MS, 2007, CLIN ORTHOP RELAT R, P158, DOI 10.1097/BLO.0b013e31802eb45f; Yagi M, 2002, AM J SPORT MED, V30, P660; Zantop T, 2008, AM J SPORT MED, V36, P65, DOI 10.1177/0363546507308361; Chhabra A, 2006, ARTHROSCOPY, V22, P1107, DOI 10.1016/j.arthro.2006.05.019; Stahelin AC, 1997, ARTHROSCOPY, V13, P773, DOI 10.1016/S0749-8063(97)90019-0; van Eck CF, 2010, ARTHROSCOPY, V26, pS2, DOI 10.1016/j.arthro.2010.03.005; Lubowitz JH, 2010, SPORTS MED ARTHROSC, V18, P20, DOI 10.1097/JSA.0b013e3181bf67ae; Cerulli G, 2011, KNEE SURG SPORT TR A, V19, P829, DOI 10.1007/s00167-010-1371-2; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; Lind M, 2009, ARTHROSCOPY, V25, P1275, DOI 10.1016/j.arthro.2009.06.003; Robert HE, 2013, AM J SPORT MED, V41, P2375, DOI 10.1177/0363546513498989; Fauno P, 2005, ARTHROSCOPY, V21, P1337, DOI 10.1016/j.arthro.2005.08.023; Iriuchishima T, 2010, KNEE SURG SPORT TR A, V18, P1226, DOI 10.1007/s00167-010-1128-y; Marchant MH, 2010, KNEE SURG SPORT TR A, V18, P1059, DOI 10.1007/s00167-009-0952-4; Lubowitz JH, 2013, ARTHROSCOPY, V29, P1195, DOI 10.1016/j.arthro.2013.04.009; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Larson AI, 2012, ARTHROSCOPY, V28, P972, DOI 10.1016/j.arthro.2011.12.015; Heming JF, 2007, AM J SPORT MED, V35, P1708, DOI 10.1177/0363546507304137; Bowers AL, 2011, ARTHROSCOPY, V27, P1511, DOI 10.1016/j.arthro.2011.07.007; McAdams TR, 2008, KNEE SURG SPORT TR A, V16, P818, DOI 10.1007/s00167-008-0554-6; Bernard M, 1997, Am J Knee Surg, V10, P14; Morgan Craig D, 2002, Arthroscopy, V18, pE38; Höher J, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P231, DOI 10.1007/s001670050105; Kim Sung-Gon, 2005, Arthroscopy, V21, P1012; Lubowitz JH, 2006, ARTHROSCOPY, V22; Morgan CD, 1995, OPERATIVE TECHNIQUE; Puddu G, 2005, TECH ORTHOP, V20, P224, DOI 10.1097/01.bto.0000177603.05129.13	45	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	OCT	2015	31	10					1893	1902		10.1016/j.arthro.2015.03.027		10	Orthopedics; Surgery	Orthopedics; Surgery	CS8ZY	WOS:000362379700011		
J	Fukumoto, K; Kajiyama, A; Shimura, S; Taketa, K; Kimura, S; Taguchi, A; Takayama, K; Yakushiji, F; Hayashi, Y				Fukumoto, Kentarou; Kajiyama, Akihiro; Shimura, Shunsuke; Taketa, Koji; Kimura, Shinichiro; Taguchi, Akihiro; Takayama, Kentaro; Yakushiji, Fumika; Hayashi, Yoshio			Development of the Thiol-Selective Solid-Supported Oligoarginine-Conjugating Reagent KSH-2	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						disulfide ligation; octaarginine; peptides; solid-phase synthesis; thiols	PEPTIDES; DELIVERY; CYSTEINE	Arginine-rich, cell-penetrating peptides (CPPs) and oligoarginines are attractive tools for intracellular delivery of various molecules with low membrane permeability. Although a variety of labeling methods have been reported, we report here the design and synthesis of a thiol (SH)-group selective solid-supported octaarginine-conjugating reagent KSH-2. KSH-2 was prepared by two steps including the activation of 3-nitro-2-pyridinesulfenyl (Npys) resin by chlorosulfenylation and the loading of a Cys(tBu)-containing octaarginine unit to form an active disulfide. In model experiments using SH-containing captopril and hexadecapeptide, solid-supported reagent KSH-2 efficiently gave the octaarginine-conjugated products with a high degree of purity by only mixing and filtration. This reagent could be applied to a wide variety of SH-containing molecules for selective oligoarginine conjugation.	[Fukumoto, Kentarou; Kajiyama, Akihiro; Shimura, Shunsuke; Taketa, Koji; Kimura, Shinichiro; Taguchi, Akihiro; Takayama, Kentaro; Yakushiji, Fumika; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Chem, Hachioji, Tokyo 1920392, Japan; [Takayama, Kentaro] Kokusan Chem Co Ltd, Chuo Ku, Tokyo 1030023, Japan	Hayashi, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Med Chem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yhayashi@toyaku.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), KAKENHI [23390029]; Basic Science and Platform Technology Program for Innovative Biological Medicine	This work was supported by the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science and Technology (MEXT), KAKENHI, including a grant-in-Aid for Scientific Research (B) 23390029, and the Basic Science and Platform Technology Program for Innovative Biological Medicine.	Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Fukumoto K, 2012, TETRAHEDRON LETT, V53, P535, DOI 10.1016/j.tetlet.2011.11.089; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082; Ellerby HM, 1999, NAT MED, V5, P1032; BURNS JA, 1991, J ORG CHEM, V56, P2648, DOI 10.1021/jo00008a014; BERNATOWICZ MS, 1986, INT J PEPT PROT RES, V28, P107; Carpino Louis A, 2002, Angew Chem Int Ed Engl, V41, P441, DOI 10.1002/1521-3773(20020201)41:3<441::AID-ANIE441>3.0.CO;2-N; Carpino L. A., 2002, ANGEW CHEM, V114, P457, DOI DOI 10.1002/1521-3757(20020201); Futaki S., 2008, ADV DRUG DELIVERY RE, V60, P447; Garcia-Martin F., 2006, ACS COMB SCI, V8, P213; Kogure K, 2007, J CONTROL RELEASE, V122, P246, DOI 10.1016/j.jconrel.2007.06.018; Langel U., 2006, HDB CELL PENETRATING; MATSUEDA R, 1982, CHEM LETT, P921, DOI 10.1246/cl.1982.921; Taguchi A, 2015, ORG BIOMOL CHEM, V13, P3186, DOI 10.1039/c5ob00030k; UEKI M, 1994, SYNTHESIS-STUTTGART, P21	17	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	OCT	2015	4	10					1030	1033		10.1002/ajoc.201500267		4	Chemistry, Organic	Chemistry	CT1VC	WOS:000362589200005		
J	Nishiyama, J; Makita, Y; Kihara, N				Nishiyama, Junya; Makita, Yoshimasa; Kihara, Nobuhiro			Rapid and Efficient Acylative Active Transport on a Rotaxane	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						active transport; acylation; crown ethers; cyclopentyl; rotaxanes; unidirectional movement	CROWN-ETHER WHEEL; MOLECULAR MOTOR; END-CAP; PSEUDOROTAXANE; AXLE; POLYROTAXANE; MACHINES; RATCHET; DEVICES; MOTION	Biased Brownian movement, a key process of biological molecular motors, was achieved by the neutralization of a rotaxane consisting of a secondary ammonium salt, in which the ammonium group is located next to the terminal group, and crown ether. Active transport occurred kinetically upon fixation of the transient pseudorotaxane by the rapid acylation of the amino group. The bulky terminal group enhanced the biased Brownian movement, although it suppressed the formation of the pseudorotaxane. Efficient active transport was possible when a large excess of acylation agent and triethylamine were used at 0 degrees C with 1.5equivalents of crown ether. The efficiency of active transport increased as the electrophilicity of the acylation agent increased. The highest efficiency of active transport was observed with the cyclopentyl terminal group with one methylene spacer. A simple, two-step, unidirectional transport was carried out using the active transport system based on the cyclopentyl terminal group.	[Nishiyama, Junya; Kihara, Nobuhiro] Kanagawa Univ, Fac Sci, Dept Chem, Hiratsuka, Kanagawa 2591293, Japan; [Makita, Yoshimasa] Osaka Dent Univ, Dept Chem, Hirakata, Osaka 5731121, Japan	Kihara, N (reprint author), Kanagawa Univ, Fac Sci, Dept Chem, Hiratsuka, Kanagawa 2591293, Japan.	kihara@kanagawa-u.ac.jp	Makita, Yoshimasa/L-7660-2015; Iwamoto, Hajime/E-4429-2012	Makita, Yoshimasa/0000-0003-4732-8145; 	Research Institute for Integrated Science, Kanagawa University; MEXT	We are grateful for financial support from a Grant-in-Aid for Joint Research in the Research Institute for Integrated Science, Kanagawa University, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Creation of new fusion materials by integration of highly-ordered nano inorganic materials and ultra-precisely controlled organic polymers).	Kitamura K, 1999, NATURE, V397, P129; Kelly TR, 1998, J ORG CHEM, V63, P3655, DOI 10.1021/jo9723218; Kelly TR, 2000, J AM CHEM SOC, V122, P6935, DOI 10.1021/ja001048f; Nishiyama J, 2015, ORG LETT, V17, P138, DOI 10.1021/ol5031469; Kelly TR, 2007, J AM CHEM SOC, V129, P376, DOI 10.1021/ja066044a; Kihara N, 2007, CHEM LETT, V36, P208, DOI 10.1246/cl.2007.208; Visscher K, 1999, NATURE, V400, P184; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Takata T, 2001, MACROMOLECULES, V34, P5449, DOI 10.1021/ma0016679; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; TRAVIS J, 1995, SCIENCE, V267, P1593, DOI 10.1126/science.267.5204.1593; Baroncini M, 2012, ANGEW CHEM INT EDIT, V51, P4223, DOI 10.1002/anie.201200555; Tachibana Y, 2004, ORG LETT, V6, P4507, DOI 10.1021/ol48135n; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Oku T, 2003, ORG LETT, V5, P4923, DOI 10.1021/ol035831z; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Ashton PR, 1998, J AM CHEM SOC, V120, P2297, DOI 10.1021/ja9731276; Saha S, 2007, CHEM SOC REV, V36, P77, DOI 10.1039/b607187b; Koumura N, 1999, NATURE, V401, P152; FAUCHEUX LP, 1995, PHYS REV LETT, V74, P1504, DOI 10.1103/PhysRevLett.74.1504; Makita Y, 2008, J ORG CHEM, V73, P9245, DOI [10.1021/jo8013726, 10.1021/j08013726]; D'Souza DM, 2010, J AM CHEM SOC, V132, P9465, DOI 10.1021/ja1034683; Tachibana Y, 2006, J ORG CHEM, V71, P5093, DOI 10.1021/jo0601563; Atsumian R. D., 1997, SCIENCE, V276, P917; Atsumian R. D., 1999, BIOPHYS J, V77, P993; Balzani V., 2008, MOL DEVICES MACHINES; Baroncini M., 2012, ANGEW CHEM, V124, P4299; Boyer P. D., 1998, ANGEW CHEM, V110, P2424, DOI 10.1002/(SICI)1521-3757(19980904)110:17<2424::AID-ANGE2424>3.0.CO;2-T; Boyer P. D., 1998, ANGEW CHEM, V110, P2438; Boyer P. D., 1998, ANGEW CHEM INT EDIT, V37, P2296, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2296::AID-ANIE2296>3.0.CO;2-W; Cheng CY, 2015, NAT NANOTECHNOL, V10, P547, DOI [10.1038/nnano.2015.96, 10.1038/NNANO.2015.96]; Credi A, 2014, TOP CURR CHEM, V354, P1, DOI 10.1007/978-3-319-08678-1; Feringa BL, 2011, MOLECULAR SWITCHES, VOL 1, 2ND EDITION, P1, DOI 10.1002/9783527634408; Feynman R. P., 1963, FEYNMAN LECT PHYS, V1; Kelly TR, 2005, TOP CURR CHEM, V262, P1, DOI 10.1007/b105501; Parham AH, 1999, EUR J ORG CHEM, P1233; Ragazzon G, 2015, NAT NANOTECHNOL, V10, P70, DOI [10.1038/nnano.2014.260, 10.1038/NNANO.2014.260]; Sohgawa YH, 2001, CHEM LETT, P774; Sugiyama J, 2007, EUR J ORG CHEM, P4651, DOI 10.1002/ejoc.200700630; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2308, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	OCT	2015	4	10					1056	1064		10.1002/ajoc.201500248		9	Chemistry, Organic	Chemistry	CT1VC	WOS:000362589200011		
J	China, H; Okada, Y; Dohi, T				China, Hideyasu; Okada, Yutaka; Dohi, Toshifumi			The Multiple Reactions in the Monochlorodimedone Assay: Discovery of Unique Dehalolactonizations under Mild Conditions	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						cyclopropanones; dehalolactonization; -haloketo acids; halogenating enzymes; monochlorodimedone assay	RING-CHAIN TAUTOMERISM; HALOGEN SUBSTITUTED 1,3-CYCLOHEXANEDIONES; PHOTOOXIDATIVE OXYLACTONIZATION; BIOLOGICAL HALOGENATION; OXOCARBOXYLIC ACIDS; HYDROGEN-PEROXIDE; MIXED ANHYDRIDE; EFFICIENT; KETONES; BROMOLACTONIZATION	The monochlorodimedone assay has been widely used as an assay of the brominating activity of halogenating enzymes; however, the assumed product was found to spontaneously decompose during the measurement. The decomposition mechanism and systematic error in the assay were explained by five reactions in their multiple reactions. We discovered unique dehalolactonizations of halogenated -keto acids in aqueous solution among many reactions in the assay. Its reaction mechanism was suggested as the cyclization via a cyclopropanone intermediate produced by the intramolecular catalysis of the carboxylate anion.	[China, Hideyasu; Okada, Yutaka] Ritsumeikan Univ, Coll Life Sci, Dept Appl Chem, Shiga 5258577, Japan; [Dohi, Toshifumi] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Pharmaceut Sci, Shiga 5258577, Japan	China, H (reprint author), Ritsumeikan Univ, Coll Life Sci, Dept Appl Chem, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	hchina7a@fc.ritsumei.ac.jp; ygvictor@sk.ritsumei.ac.jp					Mendonca GF, 2009, TETRAHEDRON LETT, V50, P473, DOI 10.1016/j.tetlet.2008.11.045; van Pee KH, 2006, ADV APPL MICROBIOL, V59, P127, DOI 10.1016/S0065-2164(06)59005-7; WHITING JE, 1971, CAN J CHEMISTRY, V49, P3799, DOI 10.1139/v71-635; Lazny R, 2011, TETRAHEDRON LETT, V52, P5680, DOI 10.1016/j.tetlet.2011.08.107; Zhang Z, 2003, CHEM LETT, V32, P966, DOI 10.1246/cl.2003.966; Kirk O, 1999, ANGEW CHEM INT EDIT, V38, P977, DOI 10.1002/(SICI)1521-3773(19990401)38:7<977::AID-ANIE977>3.0.CO;2-8; SCHAMP N, 1967, B SOC CHIM BELG, V76, P400; van Pee KH, 2003, HANDB ENVIRON CHEM, V3, P171; WAKUI T, 1974, B CHEM SOC JPN, V47, P2267, DOI 10.1246/bcsj.47.2267; ITOH N, 1988, EUR J BIOCHEM, V172, P477, DOI 10.1111/j.1432-1033.1988.tb13913.x; Cheng YA, 2012, J AM CHEM SOC, V134, P16492, DOI 10.1021/ja307210n; INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989; Roux MC, 2001, J ORG CHEM, V66, P4304, DOI 10.1021/jo0017234; Wang GW, 2004, ORG PROCESS RES DEV, V8, P18, DOI 10.1021/op0341263; FOHLISCH B, 1986, CHEM BER-RECL, V119, P1661, DOI 10.1002/cber.19861190518; JOHNSON SM, 1968, J AM CHEM SOC, V90, P136, DOI 10.1021/ja01003a024; GREENSPAN FP, 1948, ANAL CHEM, V20, P1061, DOI 10.1021/ac60023a020; Ando K, 2010, ORG LETT, V12, P1460, DOI 10.1021/ol100071d; MURTO J, 1964, ACTA CHEM SCAND, V18, P1043, DOI 10.3891/acta.chem.scand.18-1043; Heard KR, 2013, J MED CHEM, V56, P8339, DOI 10.1021/jm400423p; van Pee KH, 2000, BIOL CHEM, V381, P1; SCHAMP N, 1964, B SOC CHIM BELG, V73, P38; Dicks AP, 2009, GREEN CHEM LETT REV, V2, P9, DOI 10.1080/17518250902820182; Shiina I, 2004, J ORG CHEM, V69, P1822, DOI 10.1021/jo030367x; HAGER LP, 1966, J BIOL CHEM, V241, P1769; Hamann HJ, 2008, CHEM-EUR J, V14, P6849, DOI 10.1002/chem.200800932; Shiina I, 2002, TETRAHEDRON LETT, V43, P7535, DOI 10.1016/S0040-4039(02)01819-1; Murai K, 2010, ANGEW CHEM INT EDIT, V49, P9174, DOI 10.1002/anie.201005409; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; vanPee KH, 1996, ANNU REV MICROBIOL, V50, P375, DOI 10.1146/annurev.micro.50.1.375; Homsi F, 1998, J ORG CHEM, V63, P5255, DOI 10.1021/jo980195h; Yoshimi Y, 2009, ORG LETT, V11, P4652, DOI 10.1021/ol9019277; BECKWITH JR, 1963, J BIOL CHEM, V238, P3091; BECKWITH JR, 1963, J BIOL CHEM, V238, P3086; Rocha GO, 2002, J MOL CATAL A-CHEM, V186, P127, DOI 10.1016/S1381-1169(02)00063-8; Tada N, 2012, GREEN CHEM, V14, P3007, DOI 10.1039/c2gc36238d; Wagner C, 2008, PHYTOCHEMISTRY, V69, P323, DOI 10.1016/j.phytochem.2007.07.020; COREY EJ, 1974, J AM CHEM SOC, V96, P5614, DOI 10.1021/ja00824a073; Murai K, 2012, CHEM-EUR J, V18, P8448, DOI 10.1002/chem.201200647; Tada N, 2013, TETRAHEDRON LETT, V54, P256, DOI 10.1016/j.tetlet.2012.11.014; SCHAMP N, 1964, B SOC CHIM BELG, V73, P81; LIBBY RD, 1982, J BIOL CHEM, V257, P5030; Picard M, 1997, ANGEW CHEM INT EDIT, V36, P1196, DOI 10.1002/anie.199711961; BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Baretta A., 1982, REACTIVE INTERMEDIAT, V2, P527; BEVINAKATTI HS, 1988, J ORG CHEM, V53, P3843, DOI 10.1021/jo00251a034; BOWDEN K, 1973, J CHEM SOC PERK T 2, P1144, DOI 10.1039/p29730001144; BOWDEN K, 1972, J CHEM SOC PERK T 2, P201, DOI 10.1039/p29720000201; BOWDEN K, 1972, J CHEM SOC PERK T 2, P206, DOI 10.1039/p29720000206; Bowden K, 1996, J CHEM SOC PERK T 2, P1921, DOI 10.1039/p29960001921; BOWDEN K, 1971, J CHEM SOC B, P1390, DOI 10.1039/j29710001390; BOWDEN K, 1993, J CHEM SOC PERK T 2, P635, DOI 10.1039/p29930000635; Buechi G., 1973, J ORG CHEM, V38, P4348, DOI DOI 10.1021/JO00964A034; Dean J. A., 1999, LANGES HDB CHEM; FOHLISCH B, 1991, J CHEM RES-S, P134; Goswarni P, 2009, ADV SYNTH CATAL, V351, P1483, DOI 10.1002/adsc.200900138; Griffin B. W., 1991, PEROXIDASES CHEM BIO, V2, P85; BODEN EP, 1985, J ORG CHEM, V50, P2394, DOI 10.1021/jo00213a044; Kende A. S., 1960, ORG REACTIONS, V11, P261; Kim KM, 2004, SYNTHESIS-STUTTGART, P2641, DOI 10.1055/s-2004-831232; Kirk O., 1999, ANGEW CHEM, V111, P1031; March J., 1992, ADV ORGANIC CHEM; McKillop A., 1975, ALIPHATIC CHEM RSC, V3, P132; MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317; MOODY CJ, 1989, J CHEM SOC PERK T 1, P721, DOI 10.1039/p19890000721; Murai K., 2010, ANGEW CHEM, V122, P9360, DOI 10.1002/ange.201005409; NARASAKA K, 1978, CHEM LETT, P885, DOI 10.1246/cl.1978.885; Neidleman S. L., 1986, BIOHALOGENATION PRIN; Picard M., 1997, ANGEW CHEM, V109, P1245, DOI 10.1002/ange.19971091118; Tafazzoli M, 2007, CARBOHYD RES, V342, P2086, DOI 10.1016/j.carres.2007.05.032	70	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	OCT	2015	4	10					1065	1074		10.1002/ajoc.201500210		10	Chemistry, Organic	Chemistry	CT1VC	WOS:000362589200012		
J	Goto, K; Suzuki, T; Tamai, H; Ogawa, J; Imamura, A; Ando, H; Ishida, H; Kiso, M				Goto, Kenta; Suzuki, Tatsuya; Tamai, Hideki; Ogawa, Junya; Imamura, Akihiro; Ando, Hiromune; Ishida, Hideharu; Kiso, Makoto			Total Synthesis and Neuritogenic Activity Evaluation of Ganglioside PNG-2A from the Starfish Protoreaster nodosus	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						ganglioside PNG-2A; glycolipids; neuritogenic activity; sialic acids; total synthesis	SIALIC-ACID; NEURITE OUTGROWTH; STEREOSELECTIVE-SYNTHESIS; GLYCOSYL DONORS; GLYCAN PORTIONS; PART; MEMBRANE; MOIETY; HLG-2; GLYCOSPHINGOLIPIDS	The total synthesis of ganglioside PNG-2A from the starfish Protoreaster nodosus and its neuritogenic activity toward neuron-like cells is described. The unique galactose-enriched glycan moiety, in which an 8-O-methyl sialic acid residue is sandwiched between galactose residues, was constructed through an efficient 8-O-methylation and subsequent di-tert-butylsilylene-assisted -glycosylation at the 4-OH of the sialic acid residue with a Galf(1,3)Gal donor. In vitro biological evaluation in a rat adrenal pheochromocytoma (PC12) cell line revealed that the synthesized PNG-2A potentiated the neurite outgrowth of PC12 cells in the presence of nerve growth factor (NGF).	[Goto, Kenta; Suzuki, Tatsuya; Tamai, Hideki; Ogawa, Junya; Imamura, Akihiro; Ando, Hiromune; Ishida, Hideharu; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu, Gifu 5011193, Japan; [Suzuki, Tatsuya; Tamai, Hideki; Ando, Hiromune; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068501, Japan	Ando, H (reprint author), Gifu Univ, Dept Appl Bioorgan Chem, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.	hando@gifu-u.ac.jp			World Premier International Research Center Initiative (WPI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; MEXT, Japan [22380067, 15H04495, 23688014, 26110704]	The iCeMS is supported by the World Premier International Research Center Initiative (WPI), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was financially supported in part by MEXT, Japan, (Grants-in-Aid for Scientific Research (B) no. 22380067 to M.K. and no. 15H04495 to H.A., and a Grant-in-Aid for Young Scientists (A) no. 23688014 and Grant-in-Aid on Innovative Areas no. 26110704, Deciphering sugar chain-based signals regulating integrative neuronal functions to H.A.). We thank Dr. Tomio Yabe and Ritsuko Hosoda-Yabe for technical guidance related to measuring neurite outgrowth. We also thank Kiyoko Ito for technical assistance.	Ando H., 2005, ANGEW CHEM, V117, P6917, DOI 10.1002/ange.200501608; Nakashima S, 2011, CHEM-EUR J, V17, P588, DOI 10.1002/chem.201002184; Yu B, 2001, TETRAHEDRON LETT, V42, P2405, DOI 10.1016/S0040-4039(01)00157-5; NARASIMHAN R, 1978, BIOCHEM J, V173, P475; ROISEN FJ, 1981, SCIENCE, V214, P577, DOI 10.1126/science.7291999; Burton JW, 1997, J AM CHEM SOC, V119, P7483, DOI 10.1021/ja9709132; FERRARI G, 1983, DEV BRAIN RES, V8, P215, DOI 10.1016/0165-3806(83)90006-8; Tsai YF, 2012, ORG BIOMOL CHEM, V10, P931, DOI 10.1039/c2ob06827c; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Pan K, 2012, MAR DRUGS, V10, P2467, DOI 10.3390/md10112467; Li YT, 2002, J LIPID RES, V43, P1019, DOI 10.1194/jlr.M200010-JLR200; MATSUZAKI Y, 1993, CARBOHYD RES, V242, pC1, DOI 10.1016/0008-6215(93)80049-K; Iwayama Y, 2011, CHEM COMMUN, V47, P9726, DOI 10.1039/c1cc13200h; Ando H, 2005, ANGEW CHEM INT EDIT, V44, P6759, DOI 10.1002/anie.200501608; Rich JR, 2012, ANGEW CHEM INT EDIT, V51, P8640, DOI 10.1002/anie.201204578; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Fuse T, 2006, GLYCOCONJUGATE J, V23, P329, DOI 10.1007/s10719-006-5704-9; Ando H, 2006, CARBOHYD RES, V341, P1522, DOI 10.1016/j.carres.2006.03.017; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; DOHERTY P, 1992, J CELL BIOL, V117, P1093, DOI 10.1083/jcb.117.5.1093; Xu FF, 2014, J ORG CHEM, V79, P797, DOI 10.1021/jo402378a; MASSING U, 1994, CHEM PHYS LIPIDS, V69, P105, DOI 10.1016/0009-3084(94)90032-9; MATSUZAKI Y, 1993, TETRAHEDRON LETT, V34, P1061, DOI 10.1016/S0040-4039(00)77492-2; Imamura A, 2003, TETRAHEDRON LETT, V44, P6725, DOI 10.1016/S0040-4039(03)01647-2; Sogabe S, 2006, TETRAHEDRON LETT, V47, P6603, DOI 10.1016/j.tetlet.2006.07.009; Tamai H, 2015, EUR J ORG CHEM, P5199, DOI 10.1002/ejoc.201500606; ZIMMERMANN P, 1988, J CARBOHYD CHEM, V7, P435, DOI 10.1080/07328308808058935; Imamura A, 2005, ORG LETT, V7, P4415, DOI 10.1021/ol051592z; Shimizu H, 2011, BIOSCI BIOTECH BIOCH, V75, P2079, DOI 10.1271/hbb.110619; ITO Y, 1989, J AM CHEM SOC, V111, P8508, DOI 10.1021/ja00204a028; LEDEEN RW, 1973, J NEUROCHEM, V21, P829, DOI 10.1111/j.1471-4159.1973.tb07527.x; Iwayama Y, 2009, CHEM-EUR J, V15, P4637, DOI 10.1002/chem.200802706; Ando H, 2003, TETRAHEDRON LETT, V44, P6883, DOI 10.1016/S0040-4039(03)01707-6; Tamai H, 2012, ORG LETT, V14, P6342, DOI 10.1021/ol303122w; Morales-Serna JA, 2007, CARBOHYD RES, V342, P1595, DOI 10.1016/j.carres.2007.03.028; Huchel U, 2010, J CARBOHYD CHEM, V29, P61, DOI 10.1080/07328301003597673; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; SKAPER SD, 1985, DEV BRAIN RES, V23, P19, DOI 10.1016/0165-3806(85)90003-3; Saito M, 2001, ARCH BIOCHEM BIOPHYS, V386, P11, DOI 10.1006/abbi.2000.2206; Tamai H, 2011, ANGEW CHEM INT EDIT, V50, P2330, DOI 10.1002/anie.201006035; Hanashima S, 2009, TETRAHEDRON LETT, V50, P6150, DOI 10.1016/j.tetlet.2009.08.071; Hanashima S, 2010, BIOORGAN MED CHEM, V18, P3720, DOI 10.1016/j.bmc.2010.03.062; Imamura A, 2006, CHEM-EUR J, V12, P8862, DOI 10.1002/chem.200600832; Kaneko M, 2007, CHEM PHARM BULL, V55, P462, DOI 10.1248/cpb.55.462; Lee Y.J., 2006, ORG LETT, V8, P3871; Rich J.R., 2012, ANGEW CHEM, V124, P8768; Tamai H., 2011, ANGEW CHEM, V123, P2378; Wennekes T., 2009, ANGEW CHEM, V121, P9006	49	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	OCT	2015	4	10					1160	1171		10.1002/ajoc.201500282		12	Chemistry, Organic	Chemistry	CT1VC	WOS:000362589200023		
J	Fukami, K; Sekiguchi, F; Yasukawa, M; Asano, E; Kasamatsu, R; Ueda, M; Yoshida, S; Kawabata, A				Fukami, Kazuki; Sekiguchi, Fumiko; Yasukawa, Miku; Asano, Erina; Kasamatsu, Ryuji; Ueda, Mai; Yoshida, Shigeru; Kawabata, Atsufumi			Functional upregulation of the H2S/Ca(v)3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells	BIOCHEMICAL PHARMACOLOGY			English	Article						Hydrogen sulfide; T-type calcium channel; Prostate cancer; Neuroendocrine differentiation	K-ATP CHANNELS; HYDROGEN-SULFIDE; CALCIUM-CHANNELS; CA2+ CHANNELS; TUMOR-CELLS; NEUROPATHIC HYPERALGESIA; MECHANICAL HYPERALGESIA; MOLECULAR-MECHANISMS; ACID-PHOSPHATASE; CHROMAFFIN-CELLS	Neuroendocrine-differentiated prostate cancer cells may contribute to androgen-independent proliferation of surrounding cells through Ca2+-dependent secretion of mitogenic factors. Human prostate cancer LNCaP cells, when neuroendocrine-differentiated, overexpress Ca(v)3.2 T-type Ca2+ channels that contribute to Ca2+-dependent secretion. Given evidence for the acceleration of Ca(v)3.2 activity by hydrogen sulfide (H2S), we examined the roles of the H2S/Ca(v)3.2 pathway and then analyzed the molecular mechanisms of the Ca(v)3.2 overexpression in neuroendocrine-differentiated LNCaP cells. LNCaP cells were differentiated by dibutyryl cyclic AMP. Protein levels and T-type Ca2+ channeldependent currents (T-currents) were measured by immunoblotting and whole-cell pacth-clamp technique, respectively. Spontaneous release of prostatic acid phosphatase (PAP) was monitored to evaluate secretory function. The differentiated LNCaP cells exhibited neurite outgrowth, androgenindependent proliferation and upregulation of mitogenic factors, and also showed elevation of Ca(v)3.2 expression or T-currents. Expression of cystathionine-gamma-Iyase (CSE) and cystathionine-beta-synthase (CBS), H2S-forming enzymes, and spontaneous secretion of PAP increased following the differentiation. The augmented T-currents were enhanced by H2S donors and suppressed by inhibitors of CSE, but not CBS. The PAP secretion was reduced by inhibition of CSE or T-type Ca2+ channels. During differentiation, Egr-1 and REST, positive and negative transcriptional regulators for Ca(v)3.2, were upregulated and downregulated, respectively, and Egr-1 knockdown prevented the Ca(v)3.2 overexpression. Our data suggest that, in neuroendocrine-differentiated LNCaP cells, H2S formed by the upregulated CSE promotes the activity of the upregulated Ca(v)3.2, leading to the elevated secretory functions. The overexpression of Ca(v)3.2 appears to involve upregulation of Egr-1 and downregulation of REST. (C) 2015 Elsevier Inc. All rights reserved.	[Fukami, Kazuki; Sekiguchi, Fumiko; Yasukawa, Miku; Asano, Erina; Kasamatsu, Ryuji; Ueda, Mai; Kawabata, Atsufumi] Kindai Univ, Div Pharmacol & Pathophysiol, Fac Pharm, Higashiosaka, Osaka 5778502, Japan; [Yoshida, Shigeru] Kindai Univ, Fac Sci & Engn, Dept Life Sci, Higashiosaka, Osaka 5778502, Japan	Kawabata, A (reprint author), Kindai Univ, Div Pharmacol & Pathophysiol, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	a_smile_bring_up_a_happy_mind9@yahoo.co.jp; fumiko@phar.kindai.ac.jp; raintree.blossom.57@gmail.com; 1111610150f@kindai.ac.jp; cfado303@jtw.zaq.ne.jp; 1211610011n@kindai.ac.jp; physiology@life.kindai.ac.jp; kawabata@phar.kindai.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2014-2018).	Sekiguchi F, 2013, BRIT J PHARMACOL, V168, P734, DOI 10.1111/j.1476-5381.2012.02174.x; Cox ME, 1999, CANCER RES, V59, P3821; Muniyan S, 2014, BBA-REV CANCER, V1846, P88, DOI 10.1016/j.bbcan.2014.04.006; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Jacus MO, 2012, J NEUROSCI, V32, P9374, DOI 10.1523/JNEUROSCI.0068-12.2012; Lin MF, 2001, CELL BIOL INT, V25, P1139, DOI 10.1006/cbir.2001.0794; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Nagasawa K, 2009, J NEUROCHEM, V108, P676, DOI 10.1111/j.1471-4159.2008.05808.x; Gackiere F, 2008, J BIOL CHEM, V283, P10162, DOI 10.1074/jbc.M707159200; Jin RJ, 2004, CANCER RES, V64, P5489, DOI 10.1158/0008-5472.CAN-03-3117; Tang GH, 2005, MOL PHARMACOL, V68, P1757; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nishimura S, 2009, GUT, V58, P762, DOI 10.1136/gut.2008.151910; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Okubo K, 2011, NEUROSCIENCE, V188, P148, DOI 10.1016/j.neuroscience.2011.05.004; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Tarui T, 2010, J NEUROCHEM, V114, P512, DOI 10.1111/j.1471-4159.2010.06774.x; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Zhao KX, 2014, J BIOL CHEM, V289, P20824, DOI 10.1074/jbc.M114.559518; Sitdikova GF, 2010, PFLUG ARCH EUR J PHY, V459, P389, DOI 10.1007/s00424-009-0737-0; Sekiguchi F, 2013, J PHARMACOL SCI, V122, P244, DOI 10.1254/jphs.13R05CP; Sekiguchi F, 2014, BIOCHEM BIOPH RES CO, V445, P225, DOI 10.1016/j.bbrc.2014.01.185; Fukami K, 2015, NITRIC OXIDE-BIOL CH, V46, P50, DOI 10.1016/j.niox.2015.02.001; Takahashi T, 2010, PAIN, V150, P183, DOI 10.1016/j.pain.2010.04.022; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; Okubo K, 2012, BRIT J PHARMACOL, V166, P1738, DOI 10.1111/j.1476-5381.2012.01886.x; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Hill J, 2011, J BIOL CHEM, V286, P42459, DOI 10.1074/jbc.M111.289389; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI [10.2217/fon.09.117, 10.2217/FON.09.117]; Sun Y, 2009, AM J TRANSL RES, V1, P148; van Loo KMJ, 2012, J BIOL CHEM, V287, P15489, DOI 10.1074/jbc.M111.310763; Weiss N, 2012, J BIOL CHEM, V287, P2810, DOI 10.1074/jbc.M111.290882; Yang W, 2005, J PHYSIOL-LONDON, V569, P519, DOI 10.1113/jphysiol.2005.097642; Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; Nagmani R, 2003, BIOCHEM PHARMACOL, V65, P1489, DOI 10.1016/S0006-2952(03)00105-9; Cao QH, 2010, ANTIOXID REDOX SIGN, V12, P1101, DOI 10.1089/ars.2009.2915; DaSilva JO, 2013, PROSTATE, V73, P801, DOI 10.1002/pros.22624; Elies J, 2014, FASEB J, V28, P5376, DOI 10.1096/fj.14-257113; Gackiere F, 2013, BIOL OPEN, V2, P941, DOI 10.1242/bio.20135215; Garcia-Bereguiain MA, 2008, ANTIOXID REDOX SIGN, V10, P31, DOI 10.1089/ars.2007.1656; Guo H, 2012, UROLOGY, V79, P483; Matsunami M, 2012, BRIT J PHARMACOL, V167, P917, DOI 10.1111/j.1476-5381.2012.02060.x; Okubo K, 2012, BRIT J PHARMACOL, V166, P1058, DOI 10.1111/j.1476-5381.2012.01835.x; Surcel C.I., 2015, UROL ONCOL, V33; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Weaver EM, 2015, EUR J PHARMACOL, V749, P20, DOI 10.1016/j.ejphar.2014.12.021; Zhang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037073	56	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	OCT 1	2015	97	3					300	309		10.1016/j.bcp.2015.08.005		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT2HD	WOS:000362621700008		
J	Ogaki, S; Taguchi, K; Maeda, H; Watanabe, H; Ishima, Y; Otagiri, M; Maruyama, T				Ogaki, Shigeru; Taguchi, Kazuaki; Maeda, Hitoshi; Watanabe, Hiroshi; Ishima, Yu; Otagiri, Masaki; Maruyama, Toru			Kupffer cell inactivation by carbon monoxide bound to red blood cells preserves hepatic cytochrome P450 via anti-oxidant and anti-inflammatory effects exerted through the HMGB1/TLR-4 pathway during resuscitation from hemorrhagic shock	BIOCHEMICAL PHARMACOLOGY			English	Article						Carbon monoxide; Hemorrhagic shock; Cytochrome P450; Kupffer cell; Reactive oxygen species; Toll-like receptor-4; High mobility group box-1	ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; METABOLIZING-ENZYMES; RATS; INFLAMMATION; TRANSPORTERS; INHIBITION; HEMOGLOBIN; ACTIVATION; EXPRESSION	Red blood cell (RBC) transfusions for controlling hemorrhaging induce systemic ischemia reperfusion, resulting in a decrease in hepatic cytochrome P450 (CYP) levels. Carbon monoxide (CO), when bound to red blood cells (CO-RBC) has the potential to protect the hepatic CYP protein to produce a resuscitative effect in a hemorrhagic shock rat model. The aim of this study was to investigate the mechanism by which CO-RBC resuscitation from a massive hemorrhage protects against a decrease in hepatic CYP. In the early phase (similar to 1 h) after a hemorrhage and RBC resuscitation, hepatic CYP protein levels were significantly decreased with increasing hepatic free heme levels, but were maintained by a pre-treatment of gadolinium chloride (GdCl3), a Kupffer cell inhibitor, and Trolox, an anti-oxidant agent, as well as CO-RBC resuscitation. Under these conditions, the production of reactive oxygen species (ROS) derived from activated Kupffer cells was increased, but this increase was suppressed by CO-RBC resuscitation. At a late phase (6 similar to 24 h), CYP mRNA levels decreased after hemorrhage and RBC resuscitation, but not in the case of CO-RBC resuscitation. The increases in plasma IL-6 and TNF-alpha levels were decreased by CO-RBC resuscitation via the suppression of the toll-like receptor-4 (TLR-4) and the expression of the high mobility group box-1 (HMGB-1). Hepatic CYP protection after a hemorrhage and CO-RBC resuscitation can be attributed to the inactivation of Kupffer cells, resulting in the suppression of ROS production in the early phase and the suppression of inflammatory cytokine production via the TLR-4/HMGB-1 signal pathway in the late phase. (C) 2015 Elsevier Inc. All rights reserved.	[Ogaki, Shigeru; Maeda, Hitoshi; Watanabe, Hiroshi; Ishima, Yu; Otagiri, Masaki; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto 8620973, Japan; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan; [Watanabe, Hiroshi; Ishima, Yu; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Otagiri, Masaki] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto 8600082, Japan	Maruyama, T (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI 24790159]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (KAKENHI 24790159).	Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Fan J, 2007, J IMMUNOL, V178, P6573; Nace GW, 2013, HEPATOLOGY, V58, P374, DOI 10.1002/hep.26346; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Ogaki S, 2013, DRUG METAB DISPOS, V41, P141, DOI 10.1124/dmd.112.048744; Thelen K, 2009, J PHARM PHARMACOL, V61, P541, DOI 10.1211/jpp/61.05.0002; Ruan YL, 2014, KIDNEY INT, V86, P525, DOI 10.1038/ki.2014.80; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Xue J, 2014, J CLIN INVEST, V124, P437, DOI 10.1172/JCI71362; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Kim TH, 2011, FEBS J, V278, P2307, DOI 10.1111/j.1742-4658.2011.08148.x; Dobashi H, 1999, HEPATOLOGY, V30, P430, DOI 10.1002/hep.510300209; Ogaki S, 2014, J PHARM SCI-US, V103, P2199, DOI 10.1002/jps.24029; Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22; Lee LY, 2011, LIVER TRANSPLANT, V17, P1457, DOI 10.1002/lt.22415; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Riquelme SA, 2015, IMMUNOLOGY, V144, P321, DOI 10.1111/imm.12375; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Gow AJ, 1998, NATURE, V391, P169; Tomiyama K, 2008, HEPATOLOGY, V48, P1608, DOI 10.1002/hep.22482; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Cabrates P, 2007, RESUSCITATION, V75, P124, DOI 10.1016/j.resuscitation.2007.03.010; Czerwinski M, 2015, DRUG METAB DISPOS, V43, P42, DOI 10.1124/dmd.114.060186; Eum HA, 2004, BRIT J PHARMACOL, V142, P35, DOI 10.1038/sj.bjp.0705758; Guan Lian-Yue, 2014, World J Gastrointest Surg, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Izuishi K, 2000, WORLD J SURG, V24, P49; lzuishi K., 2000, WORLD J SURG, V24, P3; Nguyen TV, 2015, DRUG METAB DISPOS, V43, P774, DOI [10.1124/dmd.114.061317, 10.1124/dmd.114.06137]; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	OCT 1	2015	97	3					310	319		10.1016/j.bcp.2015.07.035		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT2HD	WOS:000362621700009		
J	Wu, N; Rathnayaka, T; Kuroda, Y				Wu, Nan; Rathnayaka, Tharangani; Kuroda, Yutaka			Bacterial expression and re-engineering of Gaussia princeps luciferase and its use as a reporter protein	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Review						Bioluminescence imaging; Protein folding; Protein engineering; Protein domain; Disulfide bonds; Bioinformatics; Structure prediction	RENILLA-RENIFORMIS LUCIFERASE; SHORT PEPTIDE TAGS; IN-VIVO; ESCHERICHIA-COLI; BIOLUMINESCENT REPORTER; SECRETED LUCIFERASE; GENE-EXPRESSION; VIBRIO-HARVEYI; DOMAIN LINKERS; LIGHT OUTPUT	Bioluminescence, the generation of visible light in a living organism, is widely observed in nature, and a large variety of bioluminescent proteins have been discovered and characterized. Luciferase is a generic term for bioluminescent enzymes that catalyze the emission of light through the oxidization of a luciferin (also a generic term). Luciferase are not necessarily evolutionary related and do not share sequence or structural similarities. Some luciferases, such as those from fireflies and Renilla, have been thoroughly characterized and are being used in a wide range of applications in bio-imaging. Gaussia luciferase (GLuc) from the marine copepod Gaussia princeps is the smallest known luciferase, and it is attracting much attention as a potential reporter protein. GLuc identification is relatively recent, and its structure and its biophysical properties remain to be fully characterized. Here, we review the bacterial production of natively folded GLuc with special emphasis on its disulfide bond formation and the re-engineering of its bioluminescence properties. We also compare the bioluminescent properties under a strictly controlled in vitro condition of selected GLuc's variants using extensively purified proteins with native disulfide bonds. Furthermore, we discuss and predict the domain structure and location of the catalytic core based on literature and on bioinformatics analysis. Finally, we review some examples of GLuc's emerging use in biomolecular imaging and biochemical assay systems. (C) 2015 Elsevier B.V. All rights reserved.	[Wu, Nan; Rathnayaka, Tharangani; Kuroda, Yutaka] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Kuroda, Y (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	ykuroda@cc.tuat.ac.jp	Kuroda, Yutaka/G-1094-2013		JSPS (KAKENHI) [23651213, 26560432]; Japan Student Services Organization (JASSO)	We thank members of the Kuroda Laboratory for discussion and help with bioinformatics analysis and protein characterization. We are grateful to Professor Russel Hopcroft, University of Alaska-Fairbanks (UAF), for kind permission to reproduce his photograph of Gaussia princeps (Fig. 1; R. Hoperoft copyright), and Patricia McGahan for English proofreading. This work was supported by a JSPS grant-in-aid for scientific research (KAKENHI: 23651213, 26560432). Nan Wu was supported by an honor's scholarship from the Japan Student Services Organization (JASSO).	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006; Li LM, 1998, PLANT MOL BIOL, V36, P275, DOI 10.1023/A:1005941421474; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Gheysens O, 2011, MOL IMAGING BIOL, V13, P1124, DOI 10.1007/s11307-011-0471-9; Li FY, 2012, ANAL CHIM ACTA, V724, P104, DOI 10.1016/j.aca.2012.02.047; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Inouye S, 2008, BIOCHEM BIOPH RES CO, V376, P448, DOI 10.1016/j.bbrc.2008.08.149; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Miyazaki S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-323; Degeling MH, 2013, ANAL CHEM, V85, P3006, DOI 10.1021/ac4003134; Rathnayaka T, 2011, BBA-PROTEINS PROTEOM, V1814, P1775, DOI 10.1016/j.bbapap.2011.09.001; BELAS R, 1982, SCIENCE, V218, P791, DOI 10.1126/science.10636771; Cheng GF, 2007, MOL BIOCHEM PARASIT, V155, P167, DOI 10.1016/j.molbiopara.2007.06.013; Branchini BR, 2005, ANAL BIOCHEM, V345, P140, DOI 10.1016/j.ab.2005.07.015; Suarez-Morales E, 2007, ZOOTAXA, P33; Lee JY, 2008, J NUCL MED, V49, P285, DOI 10.2967/jnumed.107.042507; Kim SB, 2009, ANAL CHEM, V81, P67, DOI 10.1021/ac801658y; Ohmiya Y, 1997, FEBS LETT, V404, P115, DOI 10.1016/S0014-5793(97)00105-1; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Khan MA, 2013, BBA-PROTEINS PROTEOM, V1834, P2107, DOI 10.1016/j.bbapap.2013.06.013; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Tanaka T, 2006, BIOPOLYMERS, V84, P161, DOI 10.1002/hip.20361; Rathnayaka T, 2010, BBA-PROTEINS PROTEOM, V1804, P1902, DOI 10.1016/j.bbapap.2010.04.014; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Kato A, 2007, J MOL BIOL, V372, P737, DOI 10.1016/j.jmb.2007.06.066; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; OLSSON O, 1989, GENE, V81, P335, DOI 10.1016/0378-1119(89)90194-7; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Kato A, 2007, BIOPOLYMERS, V85, P12, DOI 10.1002/bip.20596; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Du JL, 2011, VIRUS RES, V160, P82, DOI 10.1016/j.virusres.2011.05.018; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Donat S, 2012, VIRULENCE, V3, P51, DOI 10.4161/viru.3.1.18799; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI [10.1038/nmeth.1177, 10.1038/NMETH.1177]; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Islam MM, 2012, BBA-PROTEINS PROTEOM, V1824, P1144, DOI 10.1016/j.bbapap.2012.06.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Serganova I, 2009, FASEB J, V23, P2662, DOI 10.1096/fj.08-126920; Huang RM, 2011, MOL IMAGING, V10, P215, DOI 10.2310/7290.2010.00045; Inouye S, 2000, FEBS LETT, V481, P19, DOI 10.1016/S0014-5793(00)01963-3; Loening AM, 2010, NAT METHODS, V7, P5, DOI 10.1038/nmeth0110-05; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Inouye S, 2013, PROTEIN EXPRES PURIF, V88, P150, DOI 10.1016/j.pep.2012.12.006; MCELROY WD, 1947, P NATL ACAD SCI USA, V33, P342, DOI 10.1073/pnas.33.11.342; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Tzertzinis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040099; Wiles S, 2005, APPL ENVIRON MICROB, V71, P3427, DOI 10.1128/AEM.71.7.3427-3432.2005; Zhu WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-29	67	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	OCT	2015	1854	10	A				1392	1399		10.1016/j.bbapap.2015.05.008		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS8AG	WOS:000362307500017		
J	Kulkarni, MR; Islam, MM; Numoto, N; Elahi, M; Mahib, MR; Ito, N; Kuroda, Y				Kulkarni, Manjiri R.; Islam, Monirul M.; Numoto, Nobutaka; Elahi, Montasir; Mahib, Mamunur R.; Ito, Nobutoshi; Kuroda, Yutaka			Structural and biophysical analysis of sero-specific immune responses using epitope grafted Dengue ED3 mutants	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Molecular modeling; Sero-specificity; Epitope residues; ELISA; X-ray crystallography; Immune response	PROTEIN DOMAIN-III; ENVELOPE PROTEIN; CRYSTAL-STRUCTURE; VIRUS TYPE-3; ANTIBODY; GLYCOPROTEIN; BINDING; NEUTRALIZATION; INFECTION; SEQUENCES	Dengue fever is a re-emerging tropical disease and its severe form is caused by cross-reactivity between its four serotypes (DEN1, DEN2, DEN3 and DEN4). The third domain of the viral envelope protein (ED3) contains the two major putative epitopes and is a highly suitable model protein for examining the molecular determinants of a virus' sero-specificity. Here we examine d the sero-specificity and cross-reactivity of the immune response against DEN3 and DEN4 ED3 using six epitope grafted ED3 variants where the surface-exposed epitope residues from DEN3 ED3 were switched to those of DEN4 ED3 and vice versa. We prepared anti-DEN3 and anti-DEN4 ED3 serum by immunizing Swiss albino mice and measured their reactivities against all six grafted mutants. As expected, both sera exhibited strong reactivity against its own serotype's ED3, and little cross-reactivity against their counterpart serotype's ED35. E2 played a major role in the sero-specificity of anti-DEN3 serum, whereas El was important for DEN4 ED3's sero-specificity. Next, the reactivity patterns corroborated our working hypothesis that sero-specificity could be transferred by grafting the surface exposed epitope residues from one serotype to the other. To analyze the above results from a structural viewpoint, we determined the crystal structure of a DEN4 ED3 variant, where E2 was grafted from DEN3 ED3, at 2.78 angstrom resolution and modeled the structures of the five remaining grafted variants by assuming that the overall backbone remained unchanged. The examination of the electrostatic and molecular surfaces of the variants suggested some further rationale for the serospecificity of the immune responses. (C) 2015 Elsevier B.V. All rights reserved.	[Kulkarni, Manjiri R.; Islam, Monirul M.; Elahi, Montasir; Kuroda, Yutaka] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Islam, Monirul M.; Mahib, Mamunur R.] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh; [Numoto, Nobutaka; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Biol Struct, Tokyo 1138510, Japan	Kuroda, Y (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	ykuroda@cc.tuat.ac.jp	Kuroda, Yutaka/G-1094-2013		Joint Usage/Research Program at the Medical Research Institute of Tokyo Medical and Dental University; Japan Society for the Promotion of Science (JSPS) [KAKENHI-15H04359]; JSPS invitation fellowship; Japanese government (Monbukagakusho: MEXT); Photon Factory, KEK (Tsulcuba, Japan) [2013G133, 2015G128]	We are grateful to Drs. Masafumi Yohda and Keiichi Noguchi for advice and support during preliminary X-ray crystallography experiments and to Ms. Patricia McGahan for English proofreading. This study was partly supported by a Joint Usage/Research Program at the Medical Research Institute of Tokyo Medical and Dental University, a Japan Society for the Promotion of Science (JSPS) grant-in-aid for scientific research (KAKENHI-15H04359), a JSPS invitation fellowship to M.M.I., and a Japanese government (Monbukagakusho: MEXT) PhD scholarship to M.R.K. X-ray diffraction data were collected at the Photon Factory, KEK (Tsulcuba, Japan) under project numbers 2013G133 and 2015G128.	Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Rathnayaka T, 2011, BBA-PROTEINS PROTEOM, V1814, P1775, DOI 10.1016/j.bbapap.2011.09.001; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Gromowski GD, 2010, VIROLOGY, V407, P237, DOI 10.1016/j.virol.2010.06.044; ZHAO B, 1986, VIROLOGY, V155, P77, DOI 10.1016/0042-6822(86)90169-8; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Sinha N, 2002, BIOPHYS J, V83, P2946; BLOK J, 1985, J GEN VIROL, V66, P1323, DOI 10.1099/0022-1317-66-6-1323; Kato A, 2007, J MOL BIOL, V372, P737, DOI 10.1016/j.jmb.2007.06.066; OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Islam MM, 2008, P NATL ACAD SCI USA, V105, P15334, DOI 10.1073/pnas.0802699105; Matsui K, 2009, VIROLOGY, V384, P16, DOI 10.1016/j.virol.2008.11.013; Elahi M, 2013, PROTEINS, V81, P1090, DOI 10.1002/prot.24237; Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023; Elahi M, 2014, BBA-PROTEINS PROTEOM, V1844, P585, DOI 10.1016/j.bbapap.2013.12.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Lisova O, 2007, J GEN VIROL, V88, P2387, DOI 10.1099/vir.0.83028-0; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; DeLano W.L, ABSTRACTS PAPERS ACS; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	OCT	2015	1854	10	A				1438	1443		10.1016/j.bbapap.2015.07.004		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS8AG	WOS:000362307500021		
J	Sakurai, K; Nakahata, R; Lee, YH; Kardos, J; Ikegami, T; Goto, Y				Sakurai, Kazumasa; Nakahata, Ryosuke; Lee, Young-Ho; Kardos, Jozsef; Ikegami, Takahisa; Goto, Yuji			Effects of a reduced disulfide bond on aggregation properties of the human IgG1 C(H)3 domain	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						NMR; Aggregation; lmmunoglobulin fold; Disulfide; Calorimetry	IMMUNOGLOBULIN LIGHT-CHAIN; BOVINE BETA-LACTOGLOBULIN; MONOCLONAL-ANTIBODIES; CONSTANT FRAGMENT; STABILITY; FOLD; CONFORMATION; SOLUBILITY; CYSTEINES; PROTEINS	Recombinant human monoclonal antibodies have become important protein-based therapeutics for the treatment of various diseases. An IgG1 molecule, which is now mainly used for antibody preparation, consists of a total of 12 immunoglobulin domains. Each domain has one disulfide bond. The C(H)3 domain is the C-terminal domain of the heavy chain of IgG1. The disulfide bonds of some of the C(H)3 domains are known to be reduced in recombinant human monoclonal antibodies. The lack of intramolecular disulfide bonds may decrease the stability and increase the aggregation propensity of an antibody molecule. To investigate the effects of a reduced disulfide bond in the C(H)3 domain on conformational stability and aggregation propensity, we performed several physicochemical measurements including circular dichroism, differential scanning calorimetty (DSC), and 2D NMR. DSC measurements showed that both the stability and reversibility of the reduced form were lower than those of the oxidized form. In addition, detailed analyses of the thermal denaturation data revealed that, although a dominant fraction of the reduced form retained a stable dimeric structure, some fractions assumed a less-specifically associated oligomeric state between monomers. The results of the present study revealed the characteristic aggregation properties of antibody molecules. (C) 2015 Elsevier B.V. All rights reserved.	[Sakurai, Kazumasa] Kinki Univ, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama 6496493, Japan; [Sakurai, Kazumasa; Nakahata, Ryosuke; Lee, Young-Ho; Ikegami, Takahisa; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kardos, Jozsef] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, MTA ELTE NAP B Neuroimmunol Res Grp, H-1117 Budapest, Hungary	Sakurai, K (reprint author), Kinki Univ, Inst Adv Technol, High Pressure Prot Res Ctr, 930 Nishimitani, Wakayama 6496493, Japan.	sakurai@waka.kindai.ac.jp			JSPS KAKENHI Grant [15076101, 23107719]; Hungarian National Research, Development and Innovation Office Grant [KTIA_NAP_13-2-2014-0017]	We thank Dr. Masazumi Matsumura for his valuable comments and Ms. Miyo Sakai (Institute for Protein Research) for her instructions regarding analytical ultracentrifuge measurements. This work was supported by JSPS KAKENHI Grant Numbers 15076101 and 23107719 (K.S.) and by Hungarian National Research, Development and Innovation Office Grant Number KTIA_NAP_13-2-2014-0017 grant (J.K.).	Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Hasegawa K, 2013, BBA-PROTEINS PROTEOM, V1834, P1624, DOI 10.1016/j.bbapap.2013.04.011; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Latypov RF, 2012, J BIOL CHEM, V287, P1381, DOI 10.1074/jbc.M111.297697; Wang XL, 2009, MABS, V1, P254; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; GOTO Y, 1979, J BIOCHEM-TOKYO, V85, P1427; Pipes GD, 2005, PHARM RES, V22, P1059, DOI 10.1007/s11095-005-5643-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GOTO Y, 1981, J MOL BIOL, V146, P321, DOI 10.1016/0022-2836(81)90391-0; PACE CN, 1988, J BIOL CHEM, V263, P11820; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; Zhang W, 2002, BIOTECHNOL PROGR, V18, P509, DOI 10.1021/bp025511z; Brych SR, 2010, J PHARM SCI-US, V99, P764, DOI 10.1002/jps.21868; Matsuo K, 2009, PROTEINS, V77, P191, DOI 10.1002/prot.22430; Sakurai K, 2002, J BIOL CHEM, V277, P25735, DOI 10.1074/jbc.M203659200; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; SUMI A, 1982, J BIOCHEM-TOKYO, V92, P823; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; LONGWORTH JW, 1976, BIOCHEMISTRY-US, V15, P2953, DOI 10.1021/bi00659a003; Hermeling S, 2004, PHARM RES, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Kim TR, 1997, PROTEIN ENG, V10, P1339, DOI 10.1093/protein/10.11.1339; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; STATES DJ, 1987, J MOL BIOL, V195, P731, DOI 10.1016/0022-2836(87)90192-6; Ohhashi Y, 2002, J BIOCHEM, V131, P45; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fahmer R.L., 2001, BIOTECHNOL GENET ENG, V18, P301; McAuley Arnold, 2008, Protein Sci, V17, P95; Schuck Peter, 2013, Biophysical Reviews, V5, DOI 10.1007/s12551-013-0106-2	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	OCT	2015	1854	10	A				1526	1535		10.1016/j.bbapap.2015.02.020		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS8AG	WOS:000362307500032		
J	Liem, PH; Mu, AF; Kikuta, S; Ohta, K; Kitajima, S; Taketani, S				Pham Hieu Liem; Mu, Anfeng; Kikuta, Shun-ichi; Ohta, Kazushi; Kitajima, Sakihito; Taketani, Shigeru			A simple and highly sensitive method of measuring heme oxygenase activity	BIOLOGICAL CHEMISTRY			English	Article						heme oxygenase; HO activity; HO-1; human cells; Nicotiana tabacum; yeast	BILIRUBIN; PURIFICATION; PROTEIN; LIVER	Heme oxygenase (HO) is a rate-limiting step of heme degradation, which catalyzes the conversion of heme into biliverdin, iron, and CO. HO has been characterized in microorganisms, insects, plants, and mammals. Previously used assays of HO activity were complicated and had low sensitivity. We found that the use of an eel bilirubin-bound fluorescent protein, UnaG, can achieve a highly sensitive and simple assay of HO activity. Using several enzyme sources including human culture cells, homogenates of plant tissues, and recombinant yeast HO, data were successfully obtained. The present method can facilitate the examination of HO in various organisms.	[Pham Hieu Liem; Mu, Anfeng; Kikuta, Shun-ichi; Ohta, Kazushi; Kitajima, Sakihito; Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 6068585, Japan; [Taketani, Shigeru] Kansai Med Univ, Dept Microbiol, Hirakata, Osaka 5731010, Japan; [Pham Hieu Liem] Pham Ngoc Thach Univ Med, Dept Plast & Aesthet Surg, Ho Chi Minh City, Vietnam	Taketani, S (reprint author), Kyoto Inst Technol, Dept Biotechnol, Kyoto 6068585, Japan.	taketani@kit.ac.jp			Ministry of Health, Labor and Welfare of Japan	The authors thank Dr. Atsushi Miyawaki for a kind gift of pcDNA3-UnaG. This study was supported in part by grants from the Ministry of Health, Labor and Welfare of Japan.	BEALE SI, 1984, ARCH BIOCHEM BIOPHYS, V235, P371, DOI 10.1016/0003-9861(84)90210-8; YAMAGUCHI T, 1994, J BIOL CHEM, V269, P24343; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869; Shibahara S, 2003, TOHOKU J EXP MED, V200, P167, DOI 10.1620/tjem.200.167; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; TAKETANI S, 1980, BIOCHEM BIOPH RES CO, V92, P1343, DOI 10.1016/0006-291X(80)90433-7; TAKETANI S, 1989, FEBS LETT, V245, P173, DOI 10.1016/0014-5793(89)80215-7; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Takeda TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10488	12	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	OCT	2015	396	11					1265	1268		10.1515/hsz-2015-0176		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT1OJ	WOS:000362567900010		
J	Avci, E; Hattori, T; Kamiyama, K; Kojima, M; Horade, M; Mae, Y; Arai, T				Avci, Ebubekir; Hattori, Takayuki; Kamiyama, Kazuto; Kojima, Masaru; Horade, Mitsuhiro; Mae, Yasushi; Arai, Tatsuo			Piezo-actuated parallel mechanism for biological cell release at high speed	BIOMEDICAL MICRODEVICES			English	Article						Cell handling; Micro-scale release; Controlled vibration; Micro-manipulation; Piezo actuator		In this paper, a dynamic releasing approach is proposed for high-speed biological cell manipulation. A compact parallel mechanism for grasping and releasing microobjects is used to generate controllable vibration to overcome the strong adhesion forces between the end effector and the manipulated object. To reach the required acceleration of the end effector, which is necessary for the detachment of the target object by overcoming adhesion forces, vibration in the end effector is generated by applying sinusoidal voltage to the PZT actuator of the parallel mechanism. For the necessary acceleration, we focus on the possible range of the frequency of the PZT-actuator-induced vibration, while minimizing the amplitude of the vibration (14 nm) to achieve precise positioning. The effect of the air and liquid environments on the required vibration frequency for successful release is investigated. For the first time, release results of microbeads and biological cells are compared. Release of the biological cells with 100 % success rate suggests that the proposed active release method is an appropriate solution for adhered biological cells during the release task.	[Avci, Ebubekir] Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr Robot Surg, London SW7 2AZ, England; [Hattori, Takayuki; Kamiyama, Kazuto; Kojima, Masaru; Horade, Mitsuhiro; Mae, Yasushi; Arai, Tatsuo] Osaka Univ, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan	Avci, E (reprint author), Univ London Imperial Coll Sci Technol & Med, Hamlyn Ctr Robot Surg, London SW7 2AZ, England.	ebu.avci@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [23106005]	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Bio Assembler" (23106005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Yamahata C, 2008, J MICROELECTROMECH S, V17, P623, DOI 10.1109/JMEMS.2008.922080; Arai F., 1996, P IEEE RSJ INT C INT; Avci E., 2013, P IEEE INT C ROB AUT; Avci E., 2014, P IEEE INT C ROB AUT; Chen B.K., 2009, J MICROELECTROMECH S, V18, P3; Chen T, 2012, INT J ADV ROBOT SYST, V9, DOI 10.5772/51507; Chu H.K., 2012, P IEEE INT C MECH AU; Cross S.E., 2007, NAT NANOTECHNOL, V2, P12; Dejeu J., 2009, ACS APPL MATER INTER, V1, P9; Demaghsi H., 2014, MICROSYST TECHNOL, V20, P12; Ejima T., 2013, P IEEE RSJ INT C INT; Fang Y., 2006, P IEEE RSJ INT C INT; Fearing R.S., 1995, P IEEE RSJ INT C INT; Fuchiwaki O., 2008, P IEEE INT C ROB AUT; Haliyo D.S., 2002, P IEEE INT C ROB AUT; Kim K., 2008, J MICROMECH MICROENG, V18, P5; Leong T.G., 2009, P NATL ACAD SCI USA, V106, P3; Lopez-Walle B., 2008, IEEE T ROBOT, V24, P4; Menguc Y., 2012, ADV FUNCT MATER, V22, P6; Miyazaki H.T., 2000, J APPL PHYS, V88, P6; Rollot Y., 1999, INT J ADHES ADHES, V19, P1; Saito S., 2002, J APPL PHYS, V92, P9; Saito S., 2008, J MICROMECH MICROENG, V18, P10; Sardan O., 2008, NANOTECHNOLOGY, V19, P49; Takahashi K., 2001, J APPL PHYS, V90, P1; Takeuchi M., 2011, P IEEE RSJ INT C INT; Wang H.C., 2014, INT MED, V3, P3; Yabugaki H., 2013, P IEEE INT C ROB AUT; Yuli L., 2014, P IEEE ASME INT C AD; Zesch W., 1997, P IEEE INT C ROB AUT	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	OCT	2015	17	5							98	10.1007/s10544-015-0001-7		10	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CS7QX	WOS:000362281200015		
J	Hasan, A; Paul, A; Memic, A; Khademhosseini, A				Hasan, Anwarul; Paul, Arghya; Memic, Adnan; Khademhosseini, Ali			A multilayered microfluidic blood vessel-like structure	BIOMEDICAL MICRODEVICES			English	Article						Tissue engineering; Microfluidics; Blood vessel; Hydrogel; PDMS; Microfabrication	ENDOTHELIAL GROWTH-FACTOR; GELATIN METHACRYLATE HYDROGELS; GLYCOL) DIACRYLATE HYDROGELS; VASCULAR GRAFTS; IN-VITRO; ANGIOGENESIS; TUBULOGENESIS; MICROVESSELS; COCULTURE; SCAFFOLDS	There is an immense need for tissue engineered blood vessels. However, current tissue engineering approaches still lack the ability to build native blood vessel-like perfusable structures with multi-layered vascular walls. This paper demonstrated a new method to fabricate tri-layer biomimetic blood vessel-like structures on a microfluidic platform using photocrosslinkable gelatin hydrogel. The presented method enables fabrication of physiological blood vessel-like structures with mono-, bi- or tri-layer vascular walls. The diameter of the vessels, the total thickness of the vessel wall and the thickness of each individual layer of the wall were independently controlled. The developed fabrication process is a simple and rapid method, allowing the physical fabrication of the vascular structure in minutes, and the formation of a vascular endothelial cell layer inside the vessels in 3-5 days. The fabricated vascular constructs can potentially be used in numerous applications including drug screening, development of in vitro models for cardiovascular diseases and/or cancer metastasis, and study of vascular biology and mechanobiology.	[Hasan, Anwarul] Amer Univ Beirut, Fac Engn & Architecture, Biomed Engn, Beirut 11072020, Lebanon; [Hasan, Anwarul] Amer Univ Beirut, Fac Engn & Architecture, Dept Mech Engn, Beirut 11072020, Lebanon; [Hasan, Anwarul; Paul, Arghya; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Biomat Innovat Res Ctr,Div Biomed Engn,Dept Med, Cambridge, MA 02139 USA; [Hasan, Anwarul; Paul, Arghya; Khademhosseini, Ali] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Paul, Arghya] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA; [Paul, Arghya; Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia; [Khademhosseini, Ali] Tohoku Univ, World Premier Int Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia	Hasan, A (reprint author), Amer Univ Beirut, Fac Engn & Architecture, Biomed Engn, Beirut 11072020, Lebanon.	mh211@aub.edu.lb; alik@rics.bwh.harvard.edu	Memic, Adnan/I-6138-2013	Memic, Adnan/0000-0003-4639-8168	URB (University Research Board) grant from American University of Beirut, Lebanon; CNRS (National Council for Scientific Research) grant, Lebanon; National Science Foundation [EFRI-1240443]; IMMODGEL [602694]; National Institutes of Health [EB012597, AR057837, DE021468, HL099073, AI105024, AR063745]; National Institute of General Medical Sciences, National Institutes of Health (NIH) [P20GM103638-04]; National Plan for Science, Technology and Innovation (MAARIFAH) by King Abdulaziz City for Science and Technology [12-MED3096-3]	Anwarul Hasan acknowledges the startup grant and the URB (University Research Board) grant from American University of Beirut, Lebanon, and the CNRS (National Council for Scientific Research) grant, Lebanon. Ali Khademhosseini acknowledges funding from the National Science Foundation (EFRI-1240443), IMMODGEL (602694), and the National Institutes of Health (EB012597, AR057837, DE021468, HL099073, AI105024, AR063745). The authors acknowledge the assistance from Gi Seok Jeong in drawing/editing a part of Fig. 1, and scientific/technical discussions with Joe Tien from Boston University. Arghya Paul likes to acknowledge the Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health (NIH), under Award Number P20GM103638-04. Adnan Memic and Ali Khademhosseini would like to thank the National Plan for Science, Technology and Innovation (MAARIFAH) by King Abdulaziz City for Science and Technology, Grant No. 12-MED3096-3 for their support and funding of this project.	Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Saik JE, 2012, CURR VASC PHARMACOL, V10, P331; Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/nmat3357, 10.1038/NMAT3357]; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI 10.1089/ten.TEA.2010.0202; Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109; Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Paul A, 2014, ACS NANO, V8, P8050, DOI 10.1021/nn5020787; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Cao L, 2009, BIOMATERIALS, V30, P4085, DOI 10.1016/j.biomaterials.2009.04.051; Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI 10.1089/ten.TEA.2008.0545; Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022; Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820; Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9; Price GM, 2010, BIOMATERIALS, V31, P6182, DOI 10.1016/j.biomaterials.2010.04.041; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015; Wong KHK, 2010, BIOMATERIALS, V31, P4706, DOI 10.1016/j.biomaterials.2010.02.041; Sadr N, 2011, BIOMATERIALS, V32, P7479, DOI 10.1016/j.biomaterials.2011.06.034; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381; Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Shamloo A, 2012, TISSUE ENG PT A, V18, P320, DOI [10.1089/ten.TEA.2011.0323, 10.1089/ten.tea.2011.0323]; Yeon JH, 2012, LAB CHIP, V12, P2815, DOI 10.1039/c2lc40131b; Barthes J, 2014, BIOMED RES INT, DOI 10.1155/2014/921905; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Du Y., 2008, MICROFLUIDICS BIOL A; Hasan A, 2014, BIOMED RES INT, V2014; Hasan A., 2015, ADV SCI, DOI [10.1002/advs.201500122, DOI 10.1002/ADVS.201500122]; Mendes LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041051; Yoshida H, 2012, ADV FUNCT MATER, V23, P1736	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	OCT	2015	17	5							88	10.1007/s10544-015-9993-2		13	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CS7QX	WOS:000362281200005		
J	Shimba, K; Sakai, K; Takayama, Y; Kotani, K; Jimbo, Y				Shimba, Kenta; Sakai, Koji; Takayama, Yuzo; Kotani, Kiyoshi; Jimbo, Yasuhiko			Recording axonal conduction to evaluate the integration of pluripotent cell-derived neurons into a neuronal network	BIOMEDICAL MICRODEVICES			English	Article						P19 embryonal carcinoma cells; Stem cells; Neuronal networks; Axonal conduction; Microelectrode array	ACTION-POTENTIAL PROPAGATION; CULTURED NEURAL-NETWORKS; CORTICAL NETWORKS; STEM-CELLS; EMBRYONAL CARCINOMA; STIMULATION; TRANSPLANTATION; BRAIN; DIFFERENTIATION; PROGENITORS	Stem cell transplantation is a promising therapy to treat neurodegenerative disorders, and a number of in vitro models have been developed for studying interactions between grafted neurons and the host neuronal network to promote drug discovery. However, methods capable of evaluating the process by which stem cells integrate into the host neuronal network are lacking. In this study, we applied an axonal conduction-based analysis to a co-culture study of primary and differentiated neurons. Mouse cortical neurons and neuronal cells differentiated from P19 embryonal carcinoma cells, a model for early neural differentiation of pluripotent stem cells, were co-cultured in a microfabricated device. The somata of these cells were separated by the co-culture device, but their axons were able to elongate through microtunnels and then form synaptic contacts. Propagating action potentials were recorded from these axons by microelectrodes embedded at the bottom of the microtunnels and sorted into clusters representing individual axons. While the number of axons of cortical neurons increased until 14 days in vitro and then decreased, those of P19 neurons increased throughout the culture period. Network burst analysis showed that P19 neurons participated in approximately 80 % of the bursting activity after 14 days in vitro. Interestingly, the axonal conduction delay of P19 neurons was significantly greater than that of cortical neurons, suggesting that there are some physiological differences in their axons. These results suggest that our method is feasible to evaluate the process by which stem cell-derived neurons integrate into a host neuronal network.	[Shimba, Kenta; Sakai, Koji] Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engn Environm Studies, Bunkyo Ku, Tokyo 1138656, Japan; [Shimba, Kenta] Japan Soc Promot Sci, Tokyo, Japan; [Takayama, Yuzo] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki 3058562, Japan; [Kotani, Kiyoshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Kotani, Kiyoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Jimbo, Yasuhiko] Univ Tokyo, Sch Engn, Dept Precis Engn, Bunkyo Ku, Tokyo 1138656, Japan	Shimba, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engn Environm Studies, Bunkyo Ku, Room 1122,Fac Engn Bldg,14,7-3-1 Hongo, Tokyo 1138656, Japan.	shimba@neuron.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [25-4923, 23240065, 26560202]	This work was partially supported by the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for JSPS Fellows (25-4923) and Grants-in-Aid for Scientific Research (23240065 and 26560202).	Dai JP, 2010, J CELL BIOCHEM, V110, P1457, DOI 10.1002/jcb.22703; Finley MFA, 1996, J NEUROSCI, V16, P1056; Stett A, 1997, PHYS REV E, V55, P1779, DOI 10.1103/PhysRevE.55.1779; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Mukai Y, 2003, ELECTR ENG JPN, V145, P28, DOI 10.1002/eej.10216; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Dworak BJ, 2009, LAB CHIP, V9, P404, DOI 10.1039/b806689b; Kanagasabapathi TT, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036010; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Takayama Y, 2011, ELECTR COMMUN JPN, V94, P9, DOI 10.1002/ecj.10325; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Takayama Y, 2012, BIOSYSTEMS, V107, P1, DOI 10.1016/j.biosystems.2011.08.001; Esposti F, 2009, IEEE T NEUR SYS REH, V17, P364, DOI 10.1109/TNSRE.2009.2022832; Takeuchi A, 2011, LAB CHIP, V11, P2268, DOI 10.1039/c0lc00327a; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; Stock M, 2012, NEUROSCI LETT, V526, P122, DOI 10.1016/j.neulet.2012.08.024; Wang L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026010; Claverol-Tinture E, 2002, J NEUROSCI METH, V117, P13, DOI 10.1016/S0165-0270(02)00043-2; Shlosberg D, 2008, NEUROSCIENCE, V155, P366, DOI 10.1016/j.neuroscience.2008.06.003; Goel A, 2013, J NEUROPHYSIOL, V109, P1824, DOI 10.1152/jn.00612.2012; Voigt T, 1997, EUR J NEUROSCI, V9, P990, DOI 10.1111/j.1460-9568.1997.tb01449.x; Sorensen AT, 2011, EXP NEUROL, V229, P274, DOI 10.1016/j.expneurol.2011.02.008; Jimbo Y, 2003, IEEE T BIO-MED ENG, V50, P241, DOI 10.1109/TBME.2002.805470; Jun SB, 2007, MED BIOL ENG COMPUT, V45, P1015, DOI 10.1007/s11517-007-0218-6; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Nakayama Y, 2014, J NEUROSCI METH, V227, P100, DOI 10.1016/j.jneumeth.2014.02.011; Avaliani N, 2014, STEM CELLS, V32, P3088, DOI 10.1002/stem.1823; Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; Chida K, 2015, EUR J NEUROSCI, V41, P45, DOI 10.1111/ejn.12762; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Illes S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-93; Iwashita M, 2014, DEVELOPMENT, V141, P3793, DOI 10.1242/dev.109637; Kanagasabapathi Thirukumaran T, 2011, Front Neuroeng, V4, P13, DOI 10.3389/fneng.2011.00013; Lewandowska MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118514; Shimba K, 2015, INTEGR BIOL-UK, V7, P64, DOI 10.1039/c4ib00223g; Shimba K., 2012, IEEJ T ELECT INF SYS, V132, P1072; Shimono M., 2014, CEREB CORTEX, DOI [10.1093/cercor/bhu252, DOI 10.1093/CERCOR/BHU252]; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Tonnesen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017560	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	OCT	2015	17	5							94	10.1007/s10544-015-9997-y		10	Engineering, Biomedical; Nanoscience & Nanotechnology	Engineering; Science & Technology - Other Topics	CS7QX	WOS:000362281200011		
J	Gao, GF; Yonezawa, T; Hubbell, K; Dai, GH; Cui, XF				Gao, Guifang; Yonezawa, Tomo; Hubbell, Karen; Dai, Guohao; Cui, Xiaofeng			Inkjet-bioprinted acrylated peptides and PEG hydrogel with human mesenchymal stem cells promote robust bone and cartilage formation with minimal printhead clogging	BIOTECHNOLOGY JOURNAL			English	Article						Bioprinting; Cartilage; Extracellular matrix; Mesenchymal stem cells; Photopolymerization	CHONDROGENIC DIFFERENTIATION; GELATIN METHACRYLATE; TISSUE; SCAFFOLD; REPAIR; TECHNOLOGY; MARROW; KNEE; TRANSPLANTATION; PROLIFERATION	Inkjet bioprinting is one of the most promising additive manufacturing approaches for tissue fabrication with the advantages of high speed, high resolution, and low cost. The limitation of this technology is the potential damage to the printed cells and frequent clogging of the printhead. Here we developed acrylated peptides and co-printed with acrylated poly(ethylene glycol) (PEG) hydrogel with simultaneous photopolymerization. At the same time, the bone marrow-derived human mesenchymal stem cells (hMSCs) were precisely printed during the scaffold fabrication process so the cells were delivered simultaneously with minimal UV exposure. The multiple steps of scaffold synthesis and cell encapsulation were successfully combined into one single step using bioprinting. The resulted peptide-conjugated PEG scaffold demonstrated excellent biocompatibility, with a cell viability of 87.9 +/- 5.3%. Nozzle clogging was minimized due to the low viscosity of the PEG polymer. With osteogenic and chondrogenic differentiation, the bioprinted bone and cartilage tissue demonstrated excellent mineral and cartilage matrix deposition, as well as significantly increased mechanical properties. Strikingly, the bioprinted PEG-peptide scaffold dramatically inhibited hMSC hypertrophy during chondrogenic differentiation. Collectively, bioprinted PEG-peptide scaffold and hMSCs significantly enhanced osteogenic and chondrogenic differentiation for robust bone and cartilage formation with minimal printhead clogging.	[Gao, Guifang] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Hubei, Peoples R China; [Gao, Guifang; Hubbell, Karen; Cui, Xiaofeng] Stemorgan Therapeut, Albany, NY USA; [Yonezawa, Tomo] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Yonezawa, Tomo] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Dai, Guohao; Cui, Xiaofeng] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA	Cui, XF (reprint author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary, Dept Biomed Engn, 110 Eighth St, Troy, NY 12180 USA.	daig@rpi.edu; xfc.cui@gmail.com			NSF [1011796, CBET-1263455, CBET-1350240]; New York Capital Region Research Alliance; R&D Department at Stemorgan Therapeutics	The authors would like to acknowledge M. G. Finn, Kurt Breitenkamp, Lilo Creighton, Vivian Lee, Taylor Dorsey and Diana Kim for constructive suggestions and technical support. This work was partially funded by NSF 1011796, NSF CBET-1263455, CBET-1350240, New York Capital Region Research Alliance grant, and R&D Department at Stemorgan Therapeutics.	Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081; Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073; HARMON JP, 1988, HEWLETT-PACKARD J, V39, P62; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]; Mohebi MM, 2002, J COMB CHEM, V4, P267, DOI 10.1021/cc010075e; [Anonymous], 1997, US Patent, Patent No. 5673069; Cui X, 2011, OSTEOARTHR CARTILAGE, V19, pS47; Cui XF, 2013, BIOTECHNOL LETT, V35, P315, DOI 10.1007/s10529-012-1087-0; Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009; Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x; Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Salinas CN, 2009, J BIOMED MATER RES A, V90A, P456, DOI 10.1002/jbm.a.32112; Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375; Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345; Triffitt JT, 2002, J BIOMED MATER RES, V63, P384, DOI 10.1002/jbm.10260; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Cui XF, 2012, BIOTECHNOL BIOENG, V109, P2357, DOI 10.1002/bit.24488; Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9; Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745; Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k; Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.TEA.2011.0279, 10.1089/ten.tea.2011.0279]; Vaezi M, 2013, INT J ADV MANUF TECH, V67, P1721, DOI 10.1007/s00170-012-4605-2; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291; Cui XF, 2012, BIOTECHNOL BIOENG, V109, P2369, DOI 10.1002/bit.24495; Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385; Cui XF, 2008, NIP24/DIGITAL FABRICATION 2008: 24TH INTERNATIONAL CONFERENCE ON DIGITAL PRINTING TECHNOLOGIES, TECHNICAL PROGRAM AND PROCEEDINGS, P480; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497; Boland T., 2007, P ASME INT C MFG SCI, V2007, P77; Boland T., 2006, J IMAGING SCI TECHN, V2, P86; BUSKIRK WA, 1988, HEWLETT-PACKARD J, V39, P55; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Cui XF, 2014, JOVE-J VIS EXP, DOI 10.3791/51294; Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149; Deitch S., 2008, MATER RES SOC S P, V1094, P52; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Gao GF, 2014, BIOTECHNOL J, V9, P1304, DOI 10.1002/biot.201400305; Hock S. W., 1996, US Patent, Patent No. 5521622; Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379; Mow V. C., 1997, BASIC ORTHOPAEDIC BI; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501; Reichert JC, 2012, SCI TRANSL MED, V4	60	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	OCT	2015	10	10			SI		1568	1577		10.1002/biot.201400635		10	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CT3RP	WOS:000362724900008		
J	Yano, S; Mori, T; Kanda, Y; Kato, J; Nakaseko, C; Fujisawa, S; Tomita, N; Sakai, R; Shono, K; Saitoh, T; Aotsuka, N; Kobayashi, N; Saito, T; Takahashi, S; Kanamori, H; Okamoto, S				Yano, S.; Mori, T.; Kanda, Y.; Kato, J.; Nakaseko, C.; Fujisawa, S.; Tomita, N.; Sakai, R.; Shono, K.; Saitoh, T.; Aotsuka, N.; Kobayashi, N.; Saito, T.; Takahashi, S.; Kanamori, H.; Okamoto, S.		KSGCT	Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma	BONE MARROW TRANSPLANTATION			English	Article							TERM-FOLLOW-UP; NON-HODGKINS-LYMPHOMAS; BONE-MARROW-TRANSPLANTATION; LOW-GRADE; RESPONSE CRITERIA; MULTICENTER TRIAL; RITUXIMAB; THERAPY; CYCLOPHOSPHAMIDE; CHOP	Allogeneic stem cell transplantation (allo-SCT) is a curative option for patients with relapsed follicular lymphoma (FL). Prospective studies of reduced-intensity conditioning (RIC) have revealed that chemosensitivity at allo-SCT is the most reliable predictor of outcome; however, limited data are available for progressive/refractory disease. We report here a retrospective analysis of RIC allo-SCT for patients with FL. The purpose of this study was to elucidate the role of allo-SCT for patients with relapsed/refractory FL. We analyzed 46 patients-11 (24%) transplanted in CR, 6 (13%) transplanted in PR and 29 (63%) with progressive/refractory disease. The estimated 5-year overall survival rate was 71.6% (95% confidence interval (CI), 51.5-84.5%). According to the disease status at transplantation, the 5-year survival rate was 80.7% (95% CI, 37.7-95.4%) in the patients with CR or PR and 66.1% (95% CI, 41.5-82.3%) in those with progressive/refractory disease (P=0.29). There were no differences in relapse/progression and non-relapse mortality between the patients with chemosensitive disease and progressive/refractory disease. Allo-SCT may be a valuable treatment option, even for patients with progressive/refractory FL.	[Yano, S.; Saito, T.] Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, Tokyo 1058461, Japan; [Mori, T.; Kato, J.; Okamoto, S.] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Kanda, Y.] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Nakaseko, C.] Chiba Univ, Grad Sch Med, Div Hematol, Dept Clin Cell Biol, Chiba, Japan; [Fujisawa, S.] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Tomita, N.] Yokohama City Univ, Grad Sch Med, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Sakai, R.] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Shono, K.] Chiba Aoba Municipal Hosp, Dept Hematol, Chiba, Japan; [Saitoh, T.] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Maebashi, Gumma 371, Japan; [Aotsuka, N.] Narita Red Cross Hosp, Dept Hematol, Chiba, Japan; [Kobayashi, N.] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gumma, Japan; [Takahashi, S.] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Mol Therapy, Tokyo, Japan; [Kanamori, H.] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan	Yano, S (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	yano@jikei.ac.jp					Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Pinana JL, 2010, HAEMATOL-HEMATOL J, V95, P1176, DOI 10.3324/haematol.2009.017608; Fisher RI, 2005, J CLIN ONCOL, V23, P7565, DOI 10.1200/JCO.2004.00.9217; Noriega V, 2014, LEUKEMIA RES, V38, P737, DOI 10.1016/j.leukres.2014.03.005; van Besien K, 2003, BLOOD, V102, P3521, DOI 10.1182/blood-2003-04-1205; Robinson SP, 2013, BONE MARROW TRANSPL, V48, P1409, DOI 10.1038/bmt.2013.83; Le Gouill S, 2011, HAEMATOL-HEMATOL J, V96, P1128, DOI 10.3324/haematol.2010.030320; Schouten HC, 2003, J CLIN ONCOL, V21, P3918, DOI 10.1200/JCO.2003.10.023; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Shea T, 2011, BIOL BLOOD MARROW TR, V17, P1395, DOI 10.1016/j.bbmt.2011.01.016; BASTION Y, 1995, BLOOD, V86, P3257; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336; Chan WC, 1997, BLOOD, V89, P3909; SCHOUTEN HC, 1989, BLOOD, V74, P2579; Rohatiner AZS, 2007, J CLIN ONCOL, V25, P2554, DOI 10.1200/JCO.2006.09.8327; Armitage JO, 1998, J CLIN ONCOL, V16, P2780; Tomblyn MR, 2011, BIOL BLOOD MARROW TR, V17, P1051, DOI 10.1016/j.bbmt.2010.11.004; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Ingram W, 2008, BRIT J HAEMATOL, V141, P235, DOI 10.1111/j.1365-2141.2008.07067.x; Herold M, 2007, J CLIN ONCOL, V25, P1986, DOI 10.1200/JCO.2006.06.4618; Khouri IF, 2008, BLOOD, V111, P5530, DOI 10.1182/blood-2008-01-136242; Evens AM, 2013, CANCER-AM CANCER SOC, V119, P3662, DOI 10.1002/cncr.28243; Marcus R, 2008, J CLIN ONCOL, V26, P4579, DOI 10.1200/JCO.2007.13.5376; Vose JM, 2008, BIOL BLOOD MARROW TR, V14, P36, DOI 10.1016/j.bbmt.2007.06.016; Thomson KJ, 2010, J CLIN ONCOL, V28, P3695, DOI 10.1200/JCO.2009.26.9100; Ono Y, 2012, AM J HEMATOL, V87, P929, DOI 10.1002/ajh.23261; Ladetto M, 2008, BLOOD, V111, P4004, DOI 10.1182/blood-2007-10-116749; Fowler N, 2011, J CLIN ONCOL, V29, P3389, DOI 10.1200/JCO.2010.32.1844; Cordonnier C, 2003, ANN INTERN MED, V139, P8; Riihijarvi S, 2011, EUR J HAEMATOL, V86, P124, DOI 10.1111/j.1600-0609.2010.01541.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Fujita M, 2000, PATHOL INT, V50, P696; Sebban C, 2006, BLOOD, V108, P2540, DOI 10.1182/blood-2006-03-013193	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2015	50	10					1299	1305		10.1038/bmt.2015.158		7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CT0PA	WOS:000362497400006		
J	Kudo, K; Muramatsu, H; Yoshida, N; Kobayashi, R; Yabe, H; Tabuchi, K; Kato, K; Koh, K; Takahashi, Y; Hashii, Y; Kawano, Y; Inoue, M; Cho, Y; Sakamaki, H; Kawa, K; Kato, K; Suzuki, R; Kojima, S				Kudo, K.; Muramatsu, H.; Yoshida, N.; Kobayashi, R.; Yabe, H.; Tabuchi, K.; Kato, K.; Koh, K.; Takahashi, Y.; Hashii, Y.; Kawano, Y.; Inoue, M.; Cho, Y.; Sakamaki, H.; Kawa, K.; Kato, K.; Suzuki, R.; Kojima, S.		Japanese Hematopoietic Cell	Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia	BONE MARROW TRANSPLANTATION			English	Article							BONE-MARROW-TRANSPLANTATION; MATCHED SIBLING DONOR; WORKING PARTY; IMMUNOSUPPRESSIVE THERAPY; EUROPEAN GROUP; BLOOD; CYCLOPHOSPHAMIDE; IRRADIATION; ALEMTUZUMAB; FLUDARABINE	The outcome of 55 children with severe aplastic anemia (SAA) who received a second hematopoietic stem cell transplantation (HSCT) was retrospectively analyzed using the registration data of the Japanese Society for Hematopoietic Cell Transplantation. The 5-year overall survival (OS) and failure-free survival (FFS) after the second transplantation were 82.9% (95% confidence interval (CI), 69.7-90.8)) and 81.2% (95% CI, 67.8-89.4), respectively. FFS was significantly better when the interval between the first and second transplantation was >60 days (88.9%; 95% CI, 73.0-95.7) than when it was <= 60 days (61.4%; 95% CI, 33.3-80.5; P = 0.026). All 12 patients who were conditioned with regimens containing fludarabine and melphalan were alive with hematopoietic recovery. These findings justify the recommendation of a second HSCT for children with SAA who have experienced graft failure after first HSCT.	[Kudo, K.] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Muramatsu, H.; Takahashi, Y.; Kojima, S.] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Yoshida, N.; Kato, K.] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Div Pediat Hematol Oncol, Nagoya, Aichi, Japan; [Kobayashi, R.] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Yabe, H.] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan; [Tabuchi, K.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Pediat, Tokyo, Japan; [Kato, K.] Ibaraki Childrens Hosp, Div Pediat Hematol & Oncol, Mito, Ibaraki, Japan; [Koh, K.] Saitama Childrens Med Ctr, Dept Hematol & Oncol, Saitama, Japan; [Hashii, Y.] Osaka Univ Hosp, Dept Pediat, Suita, Osaka, Japan; [Kawano, Y.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima 890, Japan; [Inoue, M.] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Hematol Oncol, Izumi, Japan; [Cho, Y.] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido 060, Japan; [Sakamaki, H.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Kawa, K.] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Japan; [Suzuki, R.] Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, Japan	Kudo, K (reprint author), Fujita Hlth Univ, Sch Med, Dept Pediat, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	kazukok@med.nagoya-u.ac.jp			Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor and Welfare	We thank all participating doctors and patients who were involved in the Japanese Hematopoietic Cell Transplantation Registry. This work was supported in part by a Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor and Welfare.	Horan JT, 2009, BIOL BLOOD MARROW TR, V15, P626, DOI 10.1016/j.bbmt.2009.01.023; Kikuchi A, 2013, BONE MARROW TRANSPL, V48, P657, DOI 10.1038/bmt.2012.205; Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324/haematol.2009.018267; Samarasinghe S, 2012, BRIT J HAEMATOL, V157, P339, DOI 10.1111/j.1365-2141.2012.09066.x; Burroughs LM, 2012, BRIT J HAEMATOL, V158, P120, DOI 10.1111/j.1365-2141.2012.09130.x; Scheinberg P, 2012, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2012.1.292; Yoshimi A, 2008, BIOL BLOOD MARROW TR, V14, P1057, DOI 10.1016/j.bbmt.2008.07.003; Korthof ET, 2013, BONE MARROW TRANSPL, V48, P191, DOI 10.1038/bmt.2012.235; Perez-Albuerne ED, 2008, BRIT J HAEMATOL, V141, P216, DOI [10.1111/j.1365-2141.2008.07030.x, 10.1111/j.1365-2141.2008.07030]; MCCANN SR, 1994, BONE MARROW TRANSPL, V13, P233; Piccin A, 2010, BONE MARROW TRANSPL, V45, P1008, DOI 10.1038/bmt.2009.296; Kojima S, 2002, BLOOD, V100, P799, DOI 10.1182/blood.V100.3.799; Marsh JC, 2014, BONE MARROW TRANSPL, V49, P42, DOI 10.1038/bmt.2013.115; Locasciulli A, 2007, HAEMATOL-HEMATOL J, V92, P11, DOI 10.3324/haematol.10075; Marsh JC, 2011, BLOOD, V118, P2351, DOI 10.1182/blood-2010-12-327536; de Medeiros CR, 2001, BONE MARROW TRANSPL, V28, P941, DOI 10.1038/sj.bmt.1703257; Yamamoto H, 2011, BLOOD, V117, P3240, DOI 10.1182/blood-2010-08-295832; Dufour C, 2014, HAEMATOLOGICA, V99, P1574, DOI 10.3324/haematol.2014.106096; Yoshida N, 2014, HAEMATOLOGICA, V99, P1784, DOI 10.3324/haematol.2014.109355	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2015	50	10					1312	1315		10.1038/bmt.2015.153		4	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CT0PA	WOS:000362497400008		
J	Yaegashi, K; Yamagishi, Y; Uwai, S; Abe, T; Santianez, WJE; Kogame, K				Yaegashi, Kousuke; Yamagishi, Yukimasa; Uwai, Shinya; Abe, Tsuyoshi; Santianez, Wilfred John Eria; Kogame, Kazuhiro			Two species of the genus Acinetospora (Ectocarpales, Phaeophyceae) from Japan: A. filamentosa comb. nov and A. asiatica sp nov.	BOTANICA MARINA			English	Article						Acinetospora asiatica sp nov.; Acinetospora filamentosa comb. nov.; cox1; Ectocarpales; rbcL	BROWN-ALGAE; NORTH-CAROLINA; DNA; PHYLOGENY; SEQUENCES; HISTORY	The brown algal genus Acinetospora is characterised by sparsely branched uniseriate filaments, scattered meristematic zones, short laterals ("crampons") and scattered reproductive organs. The morphology and life history of the generitype A. crinita have been studied repeatedly, and accounts of the species' highly varied reproductive patterns were assumed to be due to the presence of multiple taxa that were reported under this name. Herein, we attempt to contribute to the taxonomy of the genus by conducting morphological and culture studies on 33 Acinetospora samples collected from Japan. We recognised two Acinetospora species and propose to name them A. filamentosa comb. nov. and A. asiatica sp. nov. These two species are distinguished from A. crinita by the absence of monosporangia and plurilocular acinetosporangia/megasporangia. Acinetospora filamentosa and A. asiatica have similar vegetative morphologies but possess different reproductive patterns. The former forms unilocular sporangia on erect filaments and both unilocular sporangia and plurilocular zoidangia on prostrate filaments, while the latter forms plurilocular zoidangia only on both erect and prostrate filaments. Molecular analyses based on rbcL and cox1 genes supported independence of these species.	[Kogame, Kazuhiro] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Yaegashi, Kousuke; Santianez, Wilfred John Eria] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Yamagishi, Yukimasa] Fukuyama Univ, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima 7290292, Japan; [Uwai, Shinya] Niigata Univ, Fac Sci, Dept Environm Sci, Niigata 9502181, Japan; [Abe, Tsuyoshi] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan	Kogame, K (reprint author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan.	kogame@sci.hokudai.ac.jp					Silberfeld T, 2011, EUR J PHYCOL, V46, P361, DOI 10.1080/09670262.2011.628698; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; AMSLER CD, 1985, J PHYCOL, V21, P94; Siemer BL, 1998, J PHYCOL, V34, P1038, DOI 10.1046/j.1529-8817.1998.341038.x; Pedersen PM, 2001, CRYPTOGAMIE ALGOL, V22, P209, DOI 10.1016/S0181-1568(01)01063-7; Kogame K, 1999, PHYCOLOGIA, V38, P496, DOI 10.2216/i0031-8884-38-6-496.1; CLAYTON MN, 1974, AUST J BOT, V22, P743, DOI 10.1071/BT9740743; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; AMSLER CD, 1984, PHYCOLOGIA, V23, P377, DOI 10.2216/i0031-8884-23-3-377.1; Peters AF, 2001, CRYPTOGAMIE ALGOL, V22, P187, DOI 10.1016/S0181-1568(01)01062-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bornet E., 1891, B SOC BOT FRANCE, V38, P353; Cardinal A., 1964, BEIH NOVA HEDWIGIA, V15, P1; De Toni G. B., 1895, SYLLOGE ALGARUM OMNI, VIII, P638; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Harvey W. H., 1841, MANUAL BRIT MARINE A, P229; HOLLENBERG G J, 1971, Phycologia, V10, P11, DOI 10.2216/i0031-8884-10-1-11.1; Kim H.-S., 1994, KOREAN J PHYCOLOGY, V9, P153; Kim H.-S., 2010, ALGAL FLORA OF KOREA, V2, P3; Kitayama T., 1996, MEMOIRS NATL SCI MUS, V29, P223; Knoepffler-Peguy M., 1891, VIE MILIEU A, V24, P43; Konno K., 1974, SCI REP NIGGATA U D, V11, P75; Kornmann P., 1891, HELGOL WISS MEERESUN, V4, P205; Kurogi M., 1950, BOT MAG TOKYO, V63, P233; MULLER DG, 1986, HELGOLANDER MEERESUN, V40, P219; Noda M., 1970, SCI REP NIIGATA U, V7, P27; Nylander JAA, 2004, MRMODELTEST V2 PROGR; Peters AF, 2015, CRYPTOGAMIE ALGOL, V36, P3, DOI 10.7872/crya.v36.iss1.2015.3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauvageau C., 1899, J BOT, V13, P107; Sauvageau C., 1895, J BOT, V9, P274; TANAKA J, 1977, Journal of Japanese Botany, V52, P245; Tatewaki M., 1966, PHYCOLOGIA, V6, P62, DOI 10.2216/i0031-8884-6-1-62.1; Womersley H. B. S., 1987, MARINE BENTHIC FLO 2, P484; Yoshida T., 1998, MARINE ALGAE JAPAN, P1222	35	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0006-8055	1437-4323		BOT MAR	Bot. Marina	OCT	2015	58	5					331	343		10.1515/bot-2015-0051		13	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CS6WA	WOS:000362222600001		
J	Nakano, M; Fujisue, M; Tashima, R; Okumura, Y; Nishiyama, Y; Ohsako, T; Toyozumi, Y; Arima, N; Nishimura, R				Nakano, Masahiro; Fujisue, Mamiko; Tashima, Rumiko; Okumura, Yasuhiro; Nishiyama, Yasuyuki; Ohsako, Tomofumi; Toyozumi, Yasuo; Arima, Nobuyuki; Nishimura, Reiki			Survival time according to the year of recurrence and subtype in recurrent breast cancer	BREAST			English	Article						Breast cancer; Survival after recurrence; Subtype; Disease free interval; Metastatic disease	INTERNATIONAL EXPERT CONSENSUS; POSTMENOPAUSAL WOMEN; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIALS; PRIMARY THERAPY; PHASE-III; TAMOXIFEN; EFFICACY; RECEPTOR; METAANALYSIS	Background: Survival for patients with recurrent breast cancer has improved over time due to the introduction of modern systemic therapy. The aim of this study was to determine the impact of subtype and the year of recurrence on the survival times of recurrent breast cancer. Methods: Between 1979 and 2013, 813 patients who underwent initial treatment for primary breast cancer experienced recurrence. They were divided into two groups based on the year of recurrence; before 2000 and after 2001. Survival after recurrence was compared between these groups based on following criteria; subtypes, disease free interval (DFI), and dominant recurrent site. The median follow-up period after recurrence was 4.3 years. Results: Survival improved significantly in the after 2001 group, and a significant improvement in survival was only seen in the HER2-enriched subtype. Multivariate analysis revealed that DFI, ER, HER2 status, dominant recurrent site and the Ki-67 index value were significant prognostic factors. In the HER2-enriched subtype, the year of recurrence, DFI and dominant recurrent site were significant independent factors. In the other subtypes, these factors were not correlated with survival. Conclusion: Our study revealed that the survival rate of patients with only the HER2-enriched subtype significantly improved after recurrence. To prolong the survival time after recurrence of both luminal and triple negative subtypes, the development of novel targeting therapies to overcome refractory recurrent breast cancer is extremely important. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakano, Masahiro; Fujisue, Mamiko; Okumura, Yasuhiro; Nishiyama, Yasuyuki; Ohsako, Tomofumi; Nishimura, Reiki] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, Kumamoto 8608505, Japan; [Tashima, Rumiko] Kumamoto City Hosp, Dept Surg, Higashi Ku, Kumamoto 8608505, Japan; [Toyozumi, Yasuo; Arima, Nobuyuki] Kumamoto City Hosp, Dept Pathol, Higashi Ku, Kumamoto 8608505, Japan	Nakano, M (reprint author), Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, 1-1-60 Kotoh, Kumamoto 8608505, Japan.	mnakano1020@gmail.com					Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Kaufmann M, 2000, J CLIN ONCOL, V18, P1399; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Aurilio G, 2014, EUR J CANCER, V50, P277, DOI 10.1016/j.ejca.2013.10.004; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI [10.1016/S1470-2045(10)70257-6, 10.1016/S1470.2045(10)70257.6]; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Lee SJ, 2011, CANCER RES TREAT, V43, P89, DOI 10.4143/crt.2011.43.2.89; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Darby S, 2011, LANCET, V378, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Kai Kazuharu, 2006, Int J Clin Oncol, V11, P426, DOI 10.1007/s10147-006-0601-6; Nishimura R, 2014, MOL CLIN ONCOL, V2, P1062; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; Nishimura R, 2013, ONCOLOGY-BASEL, V85, P100, DOI 10.1159/000353099; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Senkus E, 2013, ANN ONCOL, V24, pvi7, DOI DOI 10.1093/ANN0NC/MDT284; Shigematsu H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-118	28	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	OCT	2015	24	5					588	593		10.1016/j.breast.2015.06.003		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CS8ZQ	WOS:000362378800013		
J	Kim, TK; Niklewski, PJ; Martin, JF; Obara, S; Egan, TD				Kim, T. K.; Niklewski, P. J.; Martin, J. F.; Obara, S.; Egan, T. D.			Enhancing a sedation score to include truly noxious stimulation: the Extended Observer's Assessment of Alertness and Sedation (EOAA/S)	BRITISH JOURNAL OF ANAESTHESIA			English	Article						anaesthetics i.v.; propofol; sedation; sedation scale	NITROUS-OXIDE ANESTHESIA; POPULATION PHARMACODYNAMICS; CONTROLLED INFUSION; PROPOFOL; REMIFENTANIL; SURGERY; PHARMACOKINETICS; MODELS; SEVOFLURANE; VOLUNTEERS	Background: Although the Modified Observer's Assessment of Alertness and Sedation (MOAA/S) is frequently used in sedation-related drug and device studies, a major shortcoming is that it does not differentiate between lighter and deeper levels of general anaesthesia because the only noxious stimulus of the MOAA/S is a trapezius squeeze. The primary aim of this investigation was to expand the MOAA/S score to include truly noxious stimulation, thereby extending the dynamic range of the assessment to include sedation states consistent with deeper levels of general anaesthesia. Methods: Twenty healthy volunteers received target controlled infusions of fentanyl (target.0.8 ng ml(-1)) and propofol (starting at 0.5 mu g ml(-1) and gradually increasing to 5 mu g ml(-1)). At each propofol concentration, a MOAA/S score was obtained before and after tetanic electrical stimulation. The tetanic electrical stimulation current was gradually increased until the subject responded or until 50 mA was delivered without a response. A pharmacodynamic model was constructed to characterize the concentration-effect relationship between propofol and the MOAA/S scores. Results: All subjects required a significantly higher propofol concentration to produce unresponsiveness to tetanic electrical stimulation at 50 mA compared with a standardized trapezius squeeze. The pharmacodynamic model adequately characterized the concentration-effect relationship. Conclusions: The Extended Observer's Assessment of Alertness and Sedation (or EOAA/S) extends the range of the widely used MOAA/S score to include truly noxious stimulation, thereby enabling the identification of drug-induced central nervous system depression representative of surgical anaesthesia.	[Kim, T. K.; Obara, S.; Egan, T. D.] Univ Utah, Sch Med, Dept Anesthesiol SOM 3C444, Salt Lake City, UT USA; [Niklewski, P. J.] Pusan Natl Univ, Dept Anesthesia & Pain Med, Busan, South Korea; [Niklewski, P. J.] Ethicon Endo Surg Inc, Cincinnati, OH USA; [Niklewski, P. J.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Obara, S.] Fukushima Med Univ, Sch Med, Dept Anesthesiol, Fukushima 9601295, Japan	Egan, TD (reprint author), Univ Utah, Sch Med, Dept Anesthesiol SOM 3C444, 30 North 1900 East, Salt Lake City, UT USA.	talmage.egan@hsc.utah.edu			Ethicon Endo-Surgery; University of Utah	Ethicon Endo-Surgery; University of Utah Dr K. C. Wong Presidential Endowed Chair Professorship (held by T.D.E.).	Drover DR, 1998, ANESTHESIOLOGY, V89, P869, DOI 10.1097/00000542-199810000-00011; Struys MMRF, 2005, ANESTHESIOLOGY, V103, P730, DOI 10.1097/00000542-200510000-00011; ZBINDEN AM, 1994, ANESTHESIOLOGY, V80, P261, DOI 10.1097/00000542-199402000-00005; Dosani M, 2010, PEDIATR ANESTH, V20, P1001, DOI 10.1111/j.1460-9592.2010.03398.x; LaPierre CD, 2012, ANESTHESIOLOGY, V117, P252, DOI 10.1097/ALN.0b013e31825fb1b2; AUSEMS ME, 1986, ANESTHESIOLOGY, V65, P362, DOI 10.1097/00000542-198610000-00004; Jordan D, 2010, ANESTH ANALG, V111, P1416, DOI 10.1213/ANE.0b013e3181fb919e; Cohen LB, 2008, ALIMENT PHARM THERAP, V27, P597, DOI 10.1111/j.1365-2036.2008.03598.x; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Ropcke H, 2001, ANESTHESIOLOGY, V94, P390; Somma J, 1998, ANESTHESIOLOGY, V89, P1430, DOI 10.1097/00000542-199812000-00021; Manyam SC, 2006, ANESTHESIOLOGY, V105, P267, DOI 10.1097/00000542-200608000-00009; SHAFER SL, 1990, ANESTHESIOLOGY, V73, P1091, DOI 10.1097/00000542-199012000-00005; Pambianco DJ, 2011, GASTROINTEST ENDOSC, V73, P765, DOI 10.1016/j.gie.2010.10.031; GALLA SJ, 1958, ANESTHESIOLOGY, V19, P328, DOI 10.1097/00000542-195805000-00003; YASUDA N, 1991, ANESTH ANALG, V73, P175; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; PETERSENFELIX S, 1993, ANESTHESIOLOGY, V79, P959, DOI 10.1097/00000542-199311000-00014; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Brendel K, 2007, CLIN PHARMACOKINET, V46, P221, DOI 10.2165/00003088-200746030-00003; LaPierre CD, 2011, ANESTH ANALG, V113, P490, DOI 10.1213/ANE.0b013e318210fc45; Bouillon T, 2004, ANESTHESIOLOGY, V100, P240, DOI 10.1097/00000542-200402000-00010; Heyse B, 2012, ANESTHESIOLOGY, V116, P311, DOI 10.1097/ALN.0b013e318242a2ec; Egan TD, 2003, ANESTHESIOLOGY, V99, P1214, DOI 10.1097/00000542-200311000-00031; Smith WD, 1996, ANESTHESIOLOGY, V84, P38, DOI 10.1097/00000542-199601000-00005; Kern SE, 2004, ANESTHESIOLOGY, V100, P1373, DOI 10.1097/00000542-200406000-00007	26	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	OCT	2015	115	4					569	577		10.1093/bja/aev306		9	Anesthesiology	Anesthesiology	CS7ZO	WOS:000362305700014		
J	Terauchi, G; Shinoda, K; Matsumoto, CS; Watanabe, E; Matsumoto, H; Mizota, A				Terauchi, Gaku; Shinoda, Kei; Matsumoto, Celso Soiti; Watanabe, Emiko; Matsumoto, Harue; Mizota, Atsushi			Recovery of photoreceptor inner and outer segment layer thickness after reattachment of rhegmatogenous retinal detachment	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; WHITE DOT SYNDROME; NORMAL EYES; TIPS LINE; VITRECTOMY; MACULA; LENGTH; SURGERY; RESOLUTION; INCREASES	Aims To evaluate the recovery of retinal function and the thicknesses of the photoreceptor inner (IS) and outer segment (OS) layers after a reattachment of a rhegmatogenous retinal detachment (RRD). Methods 49 eyes of 49 patients (mean age, 57.4 +/- 10.3 years) with successfully reattached RRD were retrospectively studied. Spectral-domain optical coherence tomography was used to obtain images of the foveal area, and the thicknesses of the IS and OS were measured before and 1, 3, 6 and 12 months after surgery. The thicknesses of the corresponding structures of the healthy fellow eye served as control. Results The thickness of the IS layer was 20.4 +/- 5.0 mu m and that of the OS layer was 34.4 +/- 9.7 at 1 month after surgery, which was significantly thinner than the IS (28.9 +/- 2.9) and OS (55.4 +/- 5.2) layers of the fellow eyes. The thicknesses gradually increased and were not significantly different from that in the fellow eye at 12 months (IS, 28.4 +/- 4.4 mm and OS, 50.7 +/- 6.6 mm). The IS and OS thicknesses at 1 month after surgery in eyes that had a decimal visual acuity of 1.0 at 6 months were significantly thicker than those in eyes that had a visual acuity of <1.0. Conclusions The increase in the thicknesses of the IS and OS layers of the photoreceptors during the recovery phase of eyes with RRD indicates that the recovery process was slow and gradual. Quantitative analysis of the IS and OS thicknesses may be useful to follow the disease process.	[Terauchi, Gaku; Shinoda, Kei; Matsumoto, Celso Soiti; Watanabe, Emiko; Matsumoto, Harue; Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Tokyo 1730003, Japan; [Matsumoto, Celso Soiti; Matsumoto, Harue] Matsumoto Eye Clin, Tokushima, Japan	Shinoda, K (reprint author), Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1730003, Japan.	shinodak@med.teikyo-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Support of this study was provided by the Research Grants on Sensory and Communicative Disorders from the Ministry of Health, Labor, and Welfare, Japan, and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Gibran SK, 2007, EYE, V21, P1174, DOI 10.1038/sj.eye.6702429; SABATES NR, 1989, AM J OPHTHALMOL, V108, P22; Gharbiya M, 2012, RETINA-J RET VIT DIS, V32, P43, DOI 10.1097/IAE.0b013e3182180114; Schatz P, 2007, RETINA-J RET VIT DIS, V27, P30, DOI 10.1097/01.iae.0000256659.71864.83; Matsumoto H, 2008, AM J OPHTHALMOL, V145, P162, DOI 10.1016/j.ajo.2007.08.024; Kim JH, 2012, INVEST OPHTH VIS SCI, V53, P7316, DOI 10.1167/iovs.12-10155; TANI P, 1981, AM J OPHTHALMOL, V92, P611; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; Park SJ, 2010, INVEST OPHTH VIS SCI, V51, P3673, DOI 10.1167/iovs.09-4169; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Baba T, 2004, GRAEF ARCH CLIN EXP, V242, P576, DOI 10.1007/s00417-004-0884-0; KROLL AJ, 1969, AM J OPHTHALMOL, V67, P117; Shin YU, 2013, GRAEF ARCH CLIN EXP, V251, P2529, DOI 10.1007/s00417-013-2352-1; Wakabayashi T, 2009, OPHTHALMOLOGY, V116, P519, DOI 10.1016/j.ophtha.2008.10.001; Hashimoto Y, 2014, GRAEF ARCH CLIN EXP, V252, P219, DOI 10.1007/s00417-013-2432-2; Wolfensberger TJ, 2004, OPHTHALMOLOGY, V111, P1340, DOI 10.1016/j.ophtha.2003.12.049; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Benson SE, 2006, OPHTHALMOLOGY, V113, P1179, DOI 10.1016/j.ophtha.2006.01.039; Arai R, 2014, GRAEF ARCH CLIN EXP, V252, P1645, DOI 10.1007/s00417-014-2747-7; Hashimoto Y, 2014, ACTA OPHTHALMOL, V92, pe591, DOI 10.1111/aos.12413; Itoh Y, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.023; Rii T, 2012, AM J OPHTHALMOL, V153, P524, DOI 10.1016/j.ajo.2011.08.021; Sugahara Michitaka, 2011, Case Rep Ophthalmol, V2, P116, DOI 10.1159/000327431	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	OCT	2015	99	10					1323	1327		10.1136/bjophthalmol-2014-306252		5	Ophthalmology	Ophthalmology	CT5BJ	WOS:000362821400004		
J	Kamiya, K; Shimizu, K; Igarashi, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga			Effect of femtosecond laser setting on visual performance after small-incision lenticule extraction for myopia	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							REFRACTIVE SURGERY; CONTRAST SENSITIVITY; OPTICAL-QUALITY; SMILE; OUTCOMES; LASIK; PREDICTABILITY; REPEATABILITY; IMPLANTATION; ABERRATIONS	Aim To compare the effect of the two femtosecond laser settings on visual performance after small-incision lenticule extraction (SMILE) for myopia and myopic astigmatism. Methods Forty-four eyes of 22 consecutive patients who underwent SMILE with an energy level of 140 nJ (spot distance 3.0 mu m) in one eye, and with an energy level of 170 nJ (spot distance 4.5 mu m) in the other eye, the eyes being randomly assigned. Preoperatively, 1 week, and 1 and 3 months postoperatively, the values of the modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI) and Optical Quality Analysis System (OQAS) values (OVs) for these eyes were quantitatively assessed using an Optical Quality Analysis System (Visiometrics). Results No significant differences were detected between the two groups in the visual and refractive outcomes, or in the MTF cutoff frequency, the Strehl ratio, the OSI, the OV 100%, the OV 20% or the OV 9% at any time point before or after surgery. Conclusions SMILE with energy settings of 140 and 170 nJ was effective for the correction of myopia and myopic astigmatism. It is indicated that the differences in laser setting (140 nJ, spot distance 3.0 mm vs 170 nJ, spot distance 4.5 mu m) did not significantly affect the optical quality including the intraocular scattering of eyes undergoing SMILE.	[Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa 2520374, Japan	Kamiya, K (reprint author), Kitasato Univ, Sch Med, Dept Ophthalmol, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kamiyak-tky@umin.ac.jp					Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; Hjortdal JO, 2012, J REFRACT SURG, V28, P865, DOI 10.3928/1081597X-20121115-01; Kamiya K, 2014, AM J OPHTHALMOL, V157, P128, DOI 10.1016/j.ajo.2013.08.011; Lin FY, 2014, J REFRACT SURG, V30, P248, DOI 10.3928/1081597X-20140320-03; Vilaseca M, 2009, J REFRACT SURG, V25, P689, DOI 10.3928/1081597X-20090707-03; Kunert KS, 2011, GRAEF ARCH CLIN EXP, V249, P1417, DOI 10.1007/s00417-010-1578-4; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Vilaseca M, 2010, OPTOMETRY VISION SCI, V87, P675, DOI 10.1097/OPX.0b013e3181ea1ad3; Shah R, 2011, J CATARACT REFR SURG, V37, P1636, DOI 10.1016/j.jcrs.2011.03.056; Vestergaard A, 2012, J CATARACT REFR SURG, V38, P2003, DOI 10.1016/j.jcrs.2012.07.021; Agca A, 2014, J OPHTHALMOL, DOI 10.1155/2014/265012; Riau AK, 2013, J REFRACT SURG, V29, P236, DOI 10.3928/1081597X-20130318-02; Serrao S, 2012, J CATARACT REFR SURG, V38, P1453, DOI 10.1016/j.jcrs.2012.05.021; Zeira E, 2003, MOL THER, V8, P342, DOI 10.1016/S1525-0016(03)00184-9; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Kamiya K, 2012, J CATARACT REFR SURG, V38, P1996, DOI 10.1016/j.jcrs.2012.06.052; Sekundo W, 2014, GRAEF ARCH CLIN EXP, V252, P837, DOI 10.1007/s00417-014-2608-4; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Ganesh S, 2014, J REFRACT SURG, V30, P590, DOI 10.3928/1081597X-20140814-02; Kamiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076738; Vestergaard AH, 2014, J CATARACT REFR SURG, V40, P403, DOI 10.1016/j.jcrs.2013.07.053; Xu Y, 2014, OPTOMETRY VISION SCI, V92, P123	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	OCT	2015	99	10					1381	1387		10.1136/bjophthalmol-2015-306717		7	Ophthalmology	Ophthalmology	CT5BJ	WOS:000362821400014		
J	Ueda, K; Kanamori, A; Akashi, A; Matsumoto, Y; Yamada, Y; Nakamura, M				Ueda, Kaori; Kanamori, Akiyasu; Akashi, Azusa; Matsumoto, Yoshiko; Yamada, Yuko; Nakamura, Makoto			Evaluation of the distribution pattern of the circumpapillary retinal nerve fibre layer from the nasal hemiretina	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD SENSITIVITY; CHIASMAL COMPRESSION; BAND ATROPHY; TEMPORAL HEMIANOPIA; AUTOMATED PERIMETRY; GLAUCOMATOUS EYES; DOMAIN; THICKNESS; HISTOLOGY	Background/aims Chiasmal compression affects the crossed nerve fibres originating from the nasal hemiretina, as opposed to the uncrossed fibres from the temporal hemiretina. The objectives were to evaluate circumpapillary retinal nerve fibre layer (cpRNFL) thickness by spectral-domain optical coherence tomography in eyes with band atrophy (BA) accompanying temporal hemianopia due to chiasmal damage and to estimate the distribution pattern of cpRNFL from the nasal hemiretina. Methods This cross-sectional study included 53 eyes with optic neuropathy due to chiasmal lesions and 72 normal eyes. Visual field sensitivity (VFS) was evaluated by standard automated perimetry. Eyes with abnormalities in the nasal visual hemifield were excluded. The structure-function relationships (cpRNFL thickness and VFS in the temporal hemifield) were evaluated in eyes with BA. The base levels composed of only non-neuronal elements and cpRNFL from the temporal hemiretina were estimated in the average and 12 sector-cpRNFL thicknesses using regression analysis. Results The base level in the average cpRNFL thickness was 71.2 mm in eyes with BA, which corresponded to 70% of average thickness of normal controls. However, the estimated base level of 12 sector-cpRNFL thicknesses represented the unique distribution pattern, in which base level-thickness localised at the 1 o'clock and 5 o'clock sectors was extensively reduced, with an even distribution of base levels at other sectors. Conclusions The RNFL originating from the nasal hemiretina is estimated to enter into the optic disc predominantly at the 1 o'clock and 5 o'clock angles.	[Ueda, Kaori; Kanamori, Akiyasu; Akashi, Azusa; Matsumoto, Yoshiko; Yamada, Yuko; Nakamura, Makoto] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 6500017, Japan	Kanamori, A (reprint author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kanaaki@med.kobe-u.ac.jp					UNSOLD R, 1980, ARCH OPHTHALMOL-CHIC, V98, P1637; Monteiro MLR, 2004, BRIT J OPHTHALMOL, V88, P896, DOI 10.1136/bjo.2003.038489; Cho JW, 2010, INVEST OPHTH VIS SCI, V51, P6401, DOI 10.1167/iovs.09-5035; Garvin MK, 2012, INVEST OPHTH VIS SCI, V53, P483, DOI 10.1167/iovs.11-8349; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Monteiro MLR, 2009, INVEST OPHTH VIS SCI, V50, P3535, DOI 10.1167/iovs.08-3093; KUPFER C, 1967, J ANAT, V101, P393; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P8527, DOI 10.1167/iovs.11-8034; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; Kanamori A, 2013, ACTA OPHTHALMOL, V91, pE196, DOI 10.1111/aos.12028; Dichtl A, 1999, GRAEF ARCH CLIN EXP, V237, P474, DOI 10.1007/s004170050264; Takagishi M, 2011, J GLAUCOMA, V20, P383, DOI 10.1097/IJG.0b013e3181efb371; Sihota R, 2006, INVEST OPHTH VIS SCI, V47, P2006, DOI 10.1167/iovs.05-1102; Akashi A, 2014, INVEST OPHTH VIS SCI, V55, P4667, DOI 10.1167/iovs.14-14766; Kanamori A, 2004, OPHTHALMOLOGY, V111, P2278, DOI 10.1016/j.ophtha.2004.05.035; Lee JR, 2010, INVEST OPHTH VIS SCI, V51, P6424, DOI 10.1167/iovs.09-5130; Aptel F, 2010, AM J OPHTHALMOL, V150, P825, DOI 10.1016/j.ajo.2010.06.011; CHACKO LW, 1948, J NEUROL NEUROSUR PS, V11, P211, DOI 10.1136/jnnp.11.3.211; Monteiro MLR, 2007, AM J OPHTHALMOL, V143, P896, DOI 10.1016/j.ajo.2006.11.054; Ferreras A, 2008, INVEST OPHTH VIS SCI, V49, P3018, DOI 10.1167/iovs.08-1775; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Kanamori A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1500, DOI 10.1001/archopht.126.11.1500	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	OCT	2015	99	10					1419	1423		10.1136/bjophthalmol-2014-306100		5	Ophthalmology	Ophthalmology	CT5BJ	WOS:000362821400020		
J	Haruki, T; Miyazaki, D; Inata, K; Sasaki, S; Yamamoto, Y; Kandori, M; Yakura, K; Noguchi, Y; Touge, C; Ishikura, R; Touge, H; Yamagami, S; Inoue, Y				Haruki, Tomoko; Miyazaki, Dai; Inata, Koudai; Sasaki, Shin-ichi; Yamamoto, Yukimi; Kandori, Michiko; Yakura, Keiko; Noguchi, Yumiko; Touge, Chizu; Ishikura, Ryoko; Touge, Hirokazu; Yamagami, Satoru; Inoue, Yoshitsugu			Indoleamine 2,3-dioxygenase 1 in corneal endothelial cells limits herpes simplex virus type 1-induced acquired immune response	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							TRANSCRIPTIONAL NETWORKS; GAMMA-INTERFERON; ANTERIOR SEGMENT; EPITHELIAL-CELLS; INFECTION; INHIBITION; INDOLEAMINE-2,3-DIOXYGENASE; CYTOMEGALOVIRUS; DIOXYGENASE; EXPRESSION	Background Corneal endothelial cells are known to be targets of herpes simplex virus type 1 (HSV-1) infection; however, the pathogenesis of HSV infections of the endothelial cells has not been definitively determined. The purpose of this study was to examine an unrecognised strategy of corneal endothelial cells to protect themselves from HSV-1 infection. Methods Immortalised human corneal endothelial cells (HCEn) were infected with HSV-1. Based on the global transcriptional profile, the expression of indoleamine 2,3-dioxygenase 1 (IDO1) was determined using real-time PCR and western blots. To examine whether IDO1 has any antiviral role, we tested whether viral replication was affected by blocking the activity of IDO1. The immune modulatory role of IDO1 was analysed to determine whether IDO1 might contribute to modulating the recall responses of HSV-1-sensitised CD4(+) T cells. Results IDO1 was strongly expressed in HCEn cells after HSV-1 infection. IDO1 blockade did not significantly restrict viral transcription or replication, arguing against a previously recognised antiviral role for IDO1. When HCEn cells were examined for antigen-presenting function, HSV-1-primed HCEn cells stimulated the proliferation of allogeneic CD4(+) T cells and interleukin 10 (IL-10) secretion. When the recall response to HSV-1 was measured by the mixed lymphocyte reaction, the HCEn-stimulated CD4(+) T cells modulated and limited the recall response. When IDO1 was silenced in HCEn cells, the HCEn-mediated immune modulatory activity and regulatory T-cell activation were reduced. Overexpression of IDO1 promoted immune modulatory activity, which was partly conveyed by IL-10. Conclusions IDO1 induced by HSV-1 infection limits and dampens excessive acquired immune responses in corneal endothelial cells.	[Haruki, Tomoko; Miyazaki, Dai; Inata, Koudai; Sasaki, Shin-ichi; Yamamoto, Yukimi; Kandori, Michiko; Yakura, Keiko; Noguchi, Yumiko; Touge, Chizu; Ishikura, Ryoko; Inoue, Yoshitsugu] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Yonago, Tottori 6838504, Japan; [Touge, Hirokazu] Tottori Univ, Fac Med, Div Med Oncol & Respirol, Yonago, Tottori 6838504, Japan; [Yamagami, Satoru] Univ Tokyo, Grad Sch Med, Corneal Transplantat Sect, Tokyo, Japan	Miyazaki, D (reprint author), Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	dm@grape.med.tottori-u.ac.jp			Japanese Ministry of Education, Science, and Culture [20592076, 21592258, 25462755, 25670734]	This work is supported by Grant-in-Aid 20592076, 21592258, 25462755 and 25670734 for Scientific Research from the Japanese Ministry of Education, Science, and Culture.	Sugita S, 2009, INVEST OPHTH VIS SCI, V50, P263, DOI 10.1167/iovs.08-2536; Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; Kandori M, 2013, JPN J OPHTHALMOL, V57, P497, DOI 10.1007/s10384-013-0268-2; Ryu YH, 2007, INVEST OPHTH VIS SCI, V48, P4148, DOI 10.1167/iovs.05-1336; Liu X, 2009, CURR CANCER DRUG TAR, V9, P938; Beutelspacher SC, 2006, EUR J IMMUNOL, V36, P690, DOI 10.1002/eji.200535238; Miyazaki D, 2011, INVEST OPHTH VIS SCI, V52, P4282, DOI 10.1167/iovs.10-6911; Sugita S, 2011, INVEST OPHTH VIS SCI, V52, P2598, DOI 10.1167/iovs.10-6322; Obojes K, 2005, J VIROL, V79, P7768, DOI 10.1128/JVI.79.12.7768-7776.2005; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Sugioka K, 2005, CURR EYE RES, V30, P863, DOI 10.1080/02713680591005896; Bodaghi B, 1999, J IMMUNOL, V162, P957; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Terasaka Y, 2010, INVEST OPHTH VIS SCI, V51, P2441, DOI 10.1167/iovs.09-4624; Miyazaki D, 2013, AM J PATHOL, V183, P96, DOI 10.1016/j.ajpath.2013.04.006; Hillenaar T, 2009, OPHTHALMOLOGY, V116, P2077, DOI 10.1016/j.ophtha.2009.04.022; Terajima M, 2005, VIRAL IMMUNOL, V18, P722, DOI 10.1089/vim.2005.18.722; Kawano Y, 2003, BLOOD, V101, P532, DOI 10.1182/blood-2002-04-1268; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Adams O, 2004, MICROBES INFECT, V6, P806, DOI 10.1016/j.micinf.2004.04.007; Chen X, 2006, IMMUNOL LETT, V107, P140, DOI 10.1016/j.imlet.2006.08.006; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Sugita S, 2012, BRIT J OPHTHALMOL, V96, P293, DOI 10.1136/bjophthalmol-2011-300769; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Yamada Y, 2010, INVEST OPHTH VIS SCI, V51, P2548, DOI 10.1167/iovs.09-4233; Kakimaru-Hasegawa A, 2008, JPN J OPHTHALMOL, V52, P24, DOI 10.1007/s10384-007-0485-7; Makala LHC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-5; Suzuki Takashi, 2008, Semin Ophthalmol, V23, P235, DOI 10.1080/08820530802111010	28	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	OCT	2015	99	10					1435	1442		10.1136/bjophthalmol-2015-306863		8	Ophthalmology	Ophthalmology	CT5BJ	WOS:000362821400023		
J	Ikoma, N; Ishii, H				Ikoma, Norihisa; Ishii, Hitoshi			Eigenvalue problem for fully nonlinear second-order elliptic PDE on balls, II	BULLETIN OF MATHEMATICAL SCIENCES			English	Article						Eigenvalue problem; Fully nonlinear equation; General boundary conditions; Principal eigenvalues; Higher order eigenvalues	MAXIMUM PRINCIPLE; DIRICHLET PROBLEM; DEGENERATE OPERATORS; 1ST EIGENVALUE; P-LAPLACIAN; EQUATIONS; BIFURCATION; DOMAINS	This is a continuation of Ikoma and Ishii (Ann Inst H Poincar, Anal Non Lin,aire 29:783-812, 2012) and we study the eigenvalue problem for fully nonlinear elliptic operators, positively homogeneous of degree one, on finite intervals or balls. In the multi-dimensional case, we consider only radial eigenpairs. Our eigenvalue problem has a general first-order boundary condition which includes, as a special case, the Dirichlet, Neumann and Robin boundary conditions. Given a nonnegative integer n, we prove the existence and uniqueness, modulo multiplication of the eigenfunction by a positive constant, of an eigenpair whose eigenfunction, as a radial function in the multi-dimensional case, has exactly n zeroes. When an eigenfunction has n zeroes, we call the corresponding eigenvalue of nth order. Furthermore, we establish results concerning comparison of two eigenvalues, characterizations of nth order eigenvalues via differential inequalities, the maximum principle for the boundary value problem in connection with the principal eigenvalue, and existence of a solution having n zeroes, as a radial function in the multi-dimensional case, of the boundary value problem with an inhomogeneous term.	[Ikoma, Norihisa] Kanazawa Univ, Fac Math & Phys, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Ishii, Hitoshi] Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, Tokyo 1698050, Japan	Ishii, H (reprint author), Waseda Univ, Fac Educ & Integrated Arts & Sci, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	ikoma@se.kanazawa-u.ac.jp; hitoshi.ishii@waseda.jp					Amann H., 2005, MATH ESSAYS APPROXIM, P1; ANANE A, 1987, CR ACAD SCI I-MATH, V305, P725; Patrizi S, 2009, NODEA-NONLINEAR DIFF, V16, P79, DOI 10.1007/s00030-008-7042-z; Sirakov B, 2010, ARCH RATION MECH AN, V195, P579, DOI 10.1007/s00205-009-0218-9; BERESTYCKI H, 1977, J DIFFER EQUATIONS, V26, P375, DOI 10.1016/0022-0396(77)90086-9; Birindelli I, 2010, Z ANAL ANWEND, V29, P77, DOI 10.4171/ZAA/1398; Quaas A, 2008, ADV MATH, V218, P105, DOI 10.1016/j.aim.2007.12.002; Birindelli I, 2009, J MATH ANAL APPL, V352, P822, DOI 10.1016/j.jmaa.2008.11.012; Demengel F, 2009, ADV DIFFERENTIAL EQU, V14, P1127; Birindelli I, 2010, J DIFFER EQUATIONS, V249, P1089, DOI 10.1016/j.jde.2010.03.015; Ikoma N, 2012, ANN I H POINCARE-AN, V29, P783, DOI 10.1016/j.anihpc.2012.04.004; Koike S, 2009, J MATH SOC JPN, V61, P723, DOI 10.2969/jmsj/06130723; Felmer P, 2012, NONLINEAR ANAL-THEOR, V75, P6524, DOI 10.1016/j.na.2012.07.029; Busca J, 1999, COMMUN PART DIFF EQ, V24, P2023, DOI 10.1080/03605309908821493; Armstrong SN, 2009, J DIFFER EQUATIONS, V246, P2958, DOI 10.1016/j.jde.2008.10.026; Nadirashvili N, 2012, MATH Z, V270, P331, DOI 10.1007/s00209-010-0799-x; Busca J, 2005, ANN I H POINCARE-AN, V22, P187, DOI 10.1016/j.anihpc.2004.05.004; Esteban MJ, 2010, COMMUN PART DIFF EQ, V35, P1716, DOI 10.1080/03605301003674848; Birindelli I, 2006, ADV DIFFERENTIAL EQU, V11, P91; DELPINO MA, 1991, J DIFFER EQUATIONS, V92, P226, DOI 10.1016/0022-0396(91)90048-E; Birindelli I, 2007, COMMUN PUR APPL ANAL, V6, P335; ESCAURIAZA L, 1993, INDIANA U MATH J, V42, P413, DOI 10.1512/iumj.1993.42.42019; BERESTYCKI H, 1994, COMMUN PUR APPL MATH, V47, P47, DOI 10.1002/cpa.3160470105; Birindelli I., 2007, P 6 AIMS INT C, P110; Birindelli I., 2004, ANN FS TOULOUSE MATH, V13, P261; Caffarelli L, 1995, FULLY NONLINEAR ELLI; CAFFARELLI LA, 1990, ANN MATH, V131, P135, DOI 10.2307/1971510; DANCER EN, 1977, P ROY SOC EDINB A, V76, P283; Fok P., 1996, THESIS UCSB, P82; Fucik S., 1976, CASOPIS PEST MAT, V101, P69; Ishii H., PREPRINT; LIONS PL, 1983, NONLINEAR ANAL-THEOR, V7, P177, DOI 10.1016/0362-546X(83)90081-0	32	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1664-3607	1664-3615		B MATH SCI	Bull. Math. Sci.	OCT	2015	5	3					451	510		10.1007/s13373-015-0071-0		60	Mathematics	Mathematics	CS9TZ	WOS:000362436500002		
J	Li, HK; Morokoshi, Y; Daino, K; Furukawa, T; Kamada, T; Saga, T; Hasegawa, S				Li, Huizi Keiko; Morokoshi, Yukie; Daino, Kazuhiro; Furukawa, Takako; Kamada, Tadashi; Saga, Tsuneo; Hasegawa, Sumitaka			Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting In-111-Trastuzumab for Potential Combination Therapies	CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS			English	Article						Auger electron radioimmunotherapy; Bortezomib; DNA microarray; NF-kappa B	NF-KAPPA-B; GENE-EXPRESSION; CANCER-THERAPY; IONIZING-RADIATION; BREAST-CANCER; CELL-LINES; PHASE-I; ACTIVATION; RADIOSENSITIZATION; RADIORESISTANCE	In-111-labeled trastuzumab modified with nuclear localizing signal (NLS) peptides (In-111-trastuzumab-NLS) efficiently delivers an Auger electron (AE) emitter In-111 into the cell nucleus and is thus a promising radiopharmaceutical in AE radioimmunotherapy (AE-RIT) for targeted killing of HER2-positive cancer. However, further improvement of its therapeutic efficacy is required. In this study, the authors show a transcriptomic approach to identify potential targets for enhancing the cytotoxic effects of In-111-trastuzumab-NLS. They generated two types of In-111-trastuzumab-NLS harboring different numbers of NLS peptides, In-111-trastuzumab-NLS-S and -L. These radioimmunoconjugates (230 and 460kBq) showed a significant higher cytotoxicity to SKBR3 human breast cancer cells overexpressing HER2 compared to In-111-trastuzumab. Microarray analysis revealed that NF-kB-related genes (38 genes) were significantly changed in transcription by In-111 trastuzumab-NLS-L (230kBq) treatment. Quantitative reverse transcription polymerase chain reaction confirmed the microarray data by showing transcriptional alternation of selected NF-B target genes in cells treated with In-111-trastuzumab-NLS-L. Interestingly, bortezomib, a drug known as a NF-B modulator, significantly enhanced the cytotoxicity of In-111-trastuzumab-NLS-L in SKBR3 cells. Taken together, the transcriptome data suggest the possibility that the modulation of NF-kB signaling activity is a molecular signature of In-111-trastuzumab-NLS and coadministration of bortezomib may be efficacious in enhancement of AE-RIT with In-111-trastuzumab-NLS.	[Li, Huizi Keiko; Morokoshi, Yukie; Furukawa, Takako; Saga, Tsuneo; Hasegawa, Sumitaka] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; [Li, Huizi Keiko; Kamada, Tadashi] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Chiba, Japan; [Li, Huizi Keiko; Kamada, Tadashi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan; [Daino, Kazuhiro] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 2638555, Japan	Hasegawa, S (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	shase@nirs.go.jp			JSPS KAKENHI [24390296]; National Institute of Radiological Sciences, Japan	The authors thank Chemicals Evaluation and Research Institute (Tokyo, Japan) for microarray data analysis. This work was supported, in part, by JSPS KAKENHI Grant Number 24390296 and the President's grant from National Institute of Radiological Sciences, Japan.	McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Costantini DL, 2008, CANCER BIOTHER RADIO, V23, P3, DOI 10.1089/cbr.2007.0430; Chen P, 2006, J NUCL MED, V47, P827; Hellweg CE, 2011, RADIAT RES, V175, P424, DOI 10.1667/RR2423.1; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; HUMM JL, 1994, MED PHYS, V21, P1901, DOI 10.1118/1.597227; Roy R, 2013, LEUKEMIA LYMPHOMA, V54, P497, DOI 10.3109/10428194.2012.722215; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI126322; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Costantini DL, 2010, J NUCL MED, V51, P1084, DOI 10.2967/jnumed.109.072389; Costantini DL, 2007, J NUCL MED, V48, P1357, DOI 10.2967/jnumed.106.037937; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Ishigami T, 2007, INT J CANCER, V120, P2262, DOI 10.1002/ijc.22561; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Berenson JR, 2009, CLIN CANCER RES, V15, P1069, DOI 10.1158/1078-0432.CCR-08-1261; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; PRASAD AV, 1994, RADIAT RES, V138, P367, DOI 10.2307/3578685; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; LINSTADT D, 1988, INT J RADIAT ONCOL, V15, P703; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Cornelissen Bart, 2010, Curr Drug Discov Technol, V7, P263, DOI 10.2174/157016310793360657; Kassis AI, 2005, J NUCL MED, V46, p4S; Rae C, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-73	31	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1084-9785	1557-8852		CANCER BIOTHER RADIO	Cancer Biother. Radiopharm.	OCT 1	2015	30	8					349	358		10.1089/cbr.2015.1882		10	Oncology; Medicine, Research & Experimental; Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Research & Experimental Medicine; Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	CS9MM	WOS:000362415200005		
J	Sugimoto, Y; Sada, A; Shimokariya, Y; Monma, F; Ohishi, K; Masuya, M; Nobori, T; Matsui, T; Katayama, N				Sugimoto, Yuka; Sada, Akiko; Shimokariya, Yuji; Monma, Fumihiko; Ohishi, Kohshi; Masuya, Masahiro; Nobori, Tsutomu; Matsui, Toshimitsu; Katayama, Naoyuki			A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia	CANCER GENETICS			English	Article						Myeloproliferative neoplasm with eosinophilia; FOXP1-PDGFRA; Imatinib	IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; ACUTE LYMPHOBLASTIC-LEUKEMIA; IMATINIB; PDGFRA; FOXP1; IDENTIFICATION; PARTNERS; ALPHA	We identified a novel fusion gene, FOXP1-PDGFRA, in a patient with myeloproliferative neoplasm (MPN) with eosinophilia, harboring the chromosome abnormality t(3;4)(p13;q12). The patient responded well to imatinib and has remained in molecular remission for 3 years. This is the seventh fusion gene involving PDGFRA in MPN with eosinophilia. PDGFRA was truncated in its autoinhibitory domain, as in other PDGFRA-related MPNs, and was fused to FOXP1 at its functional forkhead domain. Comparing genomic DNA with mRNA sequences provides the possibility that the splicing process near the breakpoint junction in the FOXP1-PDGFRA fusion gene may use the normal splice donor site for intron 23a of FOXP1 and the cryptic splice acceptor site in exon 12 of PDGFRA. This is the first report to describe the FOXP1-PDGFRA fusion gene in MPN.	[Sugimoto, Yuka; Monma, Fumihiko; Masuya, Masahiro; Katayama, Naoyuki] Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan; [Sada, Akiko] Kobe Univ, Grad Sch Med, Dept Med, Hematol, Kobe, Hyogo 657, Japan; [Shimokariya, Yuji; Nobori, Tsutomu] Mie Univ Hosp, Cent Clin Labs, Tsu, Mie, Japan; [Ohishi, Kohshi] Mie Univ Hosp, Blood Transfus Serv, Tsu, Mie, Japan; [Matsui, Toshimitsu] Nishiwaki Municipal Hosp, Dept Hematol, Nishiwaki, Japan	Sugimoto, Y (reprint author), Mie Univ, Dept Hematol & Oncol, Grad Sch Med, Tsu, Mie 514, Japan.	yuka2@clin.medic.mie-u.ac.jp; n-kata@clin.medic.mie-u.ac.jp					Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Put N, 2011, CANCER GENET-NY, V204, P462, DOI 10.1016/j.cancergen.2011.07.006; MYINT H, 1995, BRIT J HAEMATOL, V90, P462, DOI 10.1111/j.1365-2141.1995.tb05176.x; Curtis CE, 2007, BRIT J HAEMATOL, V138, P77, DOI 10.1111/j.1365-2141.2007.06628.x; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Sada A, 2007, ANN HEMATOL, V86, P855, DOI 10.1007/s00277-007-0357-8; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Stover EH, 2006, P NATL ACAD SCI USA, V103, P8078, DOI 10.1073/pnas.0601192103; Walz C, 2006, GENE CHROMOSOME CANC, V45, P950, DOI 10.1002/gcc.20359; Ernst T, 2011, BRIT J HAEMATOL, V153, P43, DOI 10.1111/j.1365-2141.2010.08457.x; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Score J, 2006, LEUKEMIA, V20, P827, DOI 10.1038/sj.leu.2404154; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Bain BJ, 2008, WHO CLASSIFICATION T, V1, p[68, 70]; Buitenhuis Miranda, 2007, Cancer Res, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2210-7762	2210-7770		CANCER GENET-NY	Cancer Genet.	OCT	2015	208	10					508	512		10.1016/j.cancergen.2015.07.001		5	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	CT2FF	WOS:000362616700005		
J	Yoshimori, M; Takada, H; Imadome, KI; Kurata, M; Yamamoto, K; Koyama, T; Shimizu, N; Fujiwara, S; Miura, O; Arai, A				Yoshimori, Mayumi; Takada, Honami; Imadome, Ken-Ichi; Kurata, Morito; Yamamoto, Kouhei; Koyama, Takatoshi; Shimizu, Norio; Fujiwara, Shigeyoshi; Miura, Osamu; Arai, Ayako			P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases	CANCER MEDICINE			English	Article						Drug resistance; EBV; lymphoproliferative disorders; P-glycoprotein; T-cell lymphoma	EPSTEIN-BARR-VIRUS; GENE-EXPRESSION; L-ASPARAGINASE; MDR1 GENE; DRUG-RESISTANCE; CD40 LIGAND; NK-CELLS; LYMPHOMA; PATHWAY; TRANSPLANTATION	Epstein-Barr virus-positive T-cell lymphoproliferative diseases (EBV-T-LPDs) are rare lymphomas with poor prognosis. Although chemotherapeutic strategies such as CHOP have been often selected, they have exhibited only limited efficacy. To clarify the mechanism of chemoresistance, we examined P-glycoprotein (P-gp) expression. P-gp acts as an energy-dependent efflux pump that excretes drugs from the cytoplasm, resulting in low-intracellular drug concentrations and poor sensitivity to chemotherapy. We examined P-gp expression in EBV-positive cells by immunohistochemistry staining in three patients of EBV-T-LPDs and the expression was detected in all patients. We also examined mdr1 mRNA expression by reverse-transcriptase polymerase-chain reaction (RT-PCR) in EBV-positive tumor cells from these patients and additional three patients. The expression was detected in all examined patients. In five EBV-T-LPDs patients, P-gp function was detected by Rhodamine-123 efflux assay in these cells. The efflux was inhibited by treatment with a P-gp inhibitor, cyclosporine A (CsA). We also examined and detected P-gp expression in EBV-positive T-cell lines SNT8 and SNT16 established from EBV-T-LPDs patients, by RT-PCR and western blotting. The function was also detected by Rhodamine-123 efflux in these cell lines. Inhibition and knock down of P-gp by CsA and siRNA, respectively, enhanced etoposide- and doxorubicin-induced cell death in the EBV-positive T-cell lines. Finally, we infected the T-cell line MOLT4 with EBV, and found that mdr1 mRNA expression and Rhodamine 123 efflux were upregulated after infection. These results indicated that enhanced P-gp expression contributed to the chemoresistance of EBV-T-LPDs.	[Yoshimori, Mayumi; Takada, Honami; Miura, Osamu; Arai, Ayako] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Tokyo, Japan; [Yoshimori, Mayumi; Takada, Honami; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Lab Mol Genet Hematol, Tokyo, Japan; [Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Div Adv Med Virus Infect, Tokyo, Japan; [Kurata, Morito; Yamamoto, Kouhei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Div Med Sci, Tokyo, Japan; [Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan	Arai, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hematol, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan.	ara.hema@tmd.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H24-Nanchi-046]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591375]	This study was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan (H24-Nanchi-046) as well as a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23591375).	Tazzari PL, 2007, LEUKEMIA, V21, P427, DOI 10.1038/sj.leu.2404523; Nagafuji K, 2001, INT J HEMATOL, V74, P447, DOI 10.1007/BF02982090; YAMAGUCHI M, 1995, CANCER, V76, P2351, DOI 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1; Anderton JA, 2011, ONCOGENE, V30, P2037, DOI 10.1038/onc.2010.579; POLITI PM, 1989, MOL PHARMACOL, V35, P271; PASTAN I, 1987, NEW ENGL J MED, V316, P1388; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x; DALTON WS, 1986, CANCER RES, V46, P5125; Ishida F, 2012, CANCER SCI, V103, P1079, DOI 10.1111/j.1349-7006.2012.02251.x; CHAUDHARY PM, 1992, BLOOD, V80, P2735; Tada Y, 2000, CLIN CANCER RES, V6, P4618; MIWA H, 1993, BLOOD, V82, P3445; Sato E, 2008, AM J HEMATOL, V83, P721, DOI 10.1002/ajh.21247; Kawa K, 2011, BONE MARROW TRANSPL, V46, P77, DOI 10.1038/bmt.2010.122; Arai A, 2011, INT J HEMATOL, V93, P602, DOI 10.1007/s12185-011-0831-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto Y, 2003, LEUKEMIA LYMPHOMA, V44, P879, DOI 10.1080/1042819031000067873; Bark H, 2010, CANCER CHEMOTH PHARM, V65, P1131, DOI 10.1007/s00280-009-1121-7; VIRELIZIER JL, 1978, LANCET, V2, P231; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; Mealey KL, 1998, CANCER LETT, V126, P187, DOI 10.1016/S0304-3835(98)00004-4; Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kimura H, 1999, J CLIN MICROBIOL, V37, P132; Shen HL, 2011, EXP HEMATOL, V39, P558, DOI 10.1016/j.exphem.2011.01.013; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Koyama M, 2005, INT J HEMATOL, V82, P437, DOI 10.1532/IJH97.05083; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; Imadome KI, 2003, P NATL ACAD SCI USA, V100, P7836, DOI 10.1073/pnas.1231363100; Darby RAJ, 2011, CURR DRUG METAB, V12, P722; MIKI T, 1994, BLOOD, V83, P217; Ha SY, 2013, PATHOL RES PRACT, V209, P448, DOI 10.1016/j.prp.2013.04.013; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; Arai A, 2002, ONCOGENE, V21, P2641, DOI 10.1038/sj/onc/1205346; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Quintanilla-Martinez L., 2008, EBV POSITIVE T CELL, P278; Yoshimori M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112564	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1494	1504		10.1002/cam4.494		11	Oncology	Oncology	CT4RI	WOS:000362794000004		
J	Chanwimalueang, N; Ekataksin, W; Piyaman, P; Pattanapen, G; Hanboon, BK				Chanwimalueang, Narumon; Ekataksin, Wichai; Piyaman, Parkpoom; Pattanapen, Gedsuda; Hanboon, Borimas K.			Twisting Tourniquet((c)) Technique: introducing Schnogh, a novel device and its effectiveness in treating primary and secondary lymphedema of extremities	CANCER MEDICINE			English	Article						Compression therapy; filariasis; lymphedema; Schnogh; twisting tourniquet; vegan	COMPLEX DECONGESTIVE PHYSIOTHERAPY; CANCER-RELATED LYMPHEDEMA; PREDICTIVE FACTORS; PERIPHERAL EDEMA; LIVER; LYMPHATICS; PRESSURE; EFFICACY; THERAPY; VOLUME	Twisting Tourniquet((c)) or in Thai Schnogh is a new invention for compression therapy of lymphedema. Twisting Tourniquet((c)) Technique (TTT) is totally noninvasive for lymphedema management. After the amazing successful evidence in the first series of 28 patients, we have conducted preliminary studies in lymphedema clinics. It was found that the combination of gradually increasing constriction force by Schnogh until desired pressure was reached and maintained for 15min, followed by a 5-min release, doing repeatedly this compression-decompression for at least 10 sessions a day, can generate acceptable results. The aim of the study was to evaluate the scientific effectiveness and establish a treatment protocol of TTT proposed as a therapeutic approach for clinical management of lymphedema. During 2006-2013, from over 3500 patients, 647 with primary/secondary lymphedema passed inclusion criteria, 307 for upper, and 340 for lower extremity. In the 5-day course of TTT, each day patients underwent 10 sessions of a 15-min compression followed by a 5-min decompression. Vegan diet was encouraged as an adjuvant therapy. Among lymphedema patients whose spectrum of edema severity ranged from mild to gigantic, TTT yielded an average volume reduction rate (VR) at 50.2% and 55.6%, making the average edema reduction volume attained at 463 and 1856mL for upper and lower limb, respectively. The uniformed practice by Schnogh which supports a continual compression-decompression maneuver over 3.5h daily for five consecutive days could induce an average VR at above half of the swelling in extremitiesof 647 patients. Schnogh is therefore effective in clinical management of lymphedema under TTT treatment of fibroblastic interstitium.	[Chanwimalueang, Narumon; Ekataksin, Wichai; Piyaman, Parkpoom; Pattanapen, Gedsuda; Hanboon, Borimas K.] Mahidol Univ, Fac Trop Med, Liver Res Unit, Bangkok, Thailand; [Chanwimalueang, Narumon; Ekataksin, Wichai; Piyaman, Parkpoom] Lymphol Inst Thailand, Lymphedema Day Care Ctr, Nonthaburi 11120, Thailand; [Ekataksin, Wichai] Tateyama Hosp, Tokushukai Overseas Med Cooperat Ctr, Lymphedema Clin, Chiba, Japan	Ekataksin, W (reprint author), Lymphol Inst Thailand, Lymphedema Day Care Ctr, 34-10 M8,Soi YingRuay Niwes,Prashashun Rd, Nonthaburi 11120, Thailand.	ekataksin@gmail.com			Liver Mega Project Phase I under Reverse Brain Drain Grant; National Science and Technology Development Agency NSTDA; Research Project for Technology Transfer of Chronic Lymphedema Treatment Targeting at Medical, Public Health, and Community Personnel in Thailand under the Technology Transfer Grant, Faculty of Tropical Medicine, Mahidol Unversity	Supported in part by Liver Mega Project Phase I under Reverse Brain Drain Grant, the National Science and Technology Development Agency NSTDA, 2004-2006 (to W. E.), and the Research Project for Technology Transfer of Chronic Lymphedema Treatment Targeting at Medical, Public Health, and Community Personnel in Thailand under the Technology Transfer Grant, Faculty of Tropical Medicine, Mahidol Unversity, 2007-2009 (to W. E.). An author, N. C., had been on a study leave granted by her employer the Faculty of Medicine Ramathibodi Hospital, Mahidol University.	Liao SF, 2013, BREAST, V22, P703, DOI 10.1016/j.breast.2012.12.018; HENRIKSEN JH, 1984, LIVER, V4, P221; EKATAKSIN W, 1991, AM J ANAT, V191, P113, DOI 10.1002/aja.1001910202; Liao SF, 2012, GYNECOL ONCOL, V125, P712, DOI 10.1016/j.ygyno.2012.03.017; TRUTMANN M, 1994, ANAT EMBRYOL, V190, P201; SHAW JA, 1982, J BONE JOINT SURG AM, V64, P1148; Mortimer PS, 2004, CLIN MED, V4, P448; Ko DSC, 1998, ARCH SURG-CHICAGO, V133, P452, DOI 10.1001/archsurg.133.4.452; Heath T, 1998, J ANAT, V192, P351, DOI 10.1046/j.1469-7580.1998.19230351.x; Damstra RJ, 2009, J VASC SURG, V49, P1256, DOI 10.1016/j.jvs.2008.12.018; CASLEYSMITH JR, 1994, LYMPHOLOGY, V27, P56; Yamamoto R, 2007, INT J CLIN ONCOL, V12, P463, DOI 10.1007/s10147-007-0715-5; Ramos SM, 1999, AM J SURG, V178, P311, DOI 10.1016/S0002-9610(99)00185-3; Lerner R, 1998, CANCER, V83, P2861, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2861::AID-CNCR39>3.0.CO;2-V; Szuba A, 2000, AM J MED, V109, P296, DOI 10.1016/S0002-9343(00)00503-9; Foldi E, 1998, CANCER, V83, P2833, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3; Ekataksin W, 1999, SEMIN LIVER DIS, V19, P359, DOI 10.1055/s-2007-1007126; BARRETT J E, 1991, P37; Bunnell S., 1956, SURG OF THE HAND; Ekataksin W, 2000, HEPATOLOGY, V32, p402A; Levick J. R., 2003, DIS LYMPHATICS, P44; Yoffey J. M., 1970, LYMPHATIC LYMPH LYMP; Zuther J.E., 2009, LYMPHEDEMA MANAGEMEN	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1514	1524		10.1002/cam4.498		11	Oncology	Oncology	CT4RI	WOS:000362794000006		
J	Harada, H; Miyamoto, K; Yamashita, Y; Taniyama, K; Mihara, K; Nishimura, M; Okada, M				Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Taniyama, Kiyomi; Mihara, Kazuko; Nishimura, Mitsuki; Okada, Morihito			Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer	CANCER MEDICINE			English	Article						Methylation; molecular biomarker; non-small-cell lung cancer; prognosis; protocadherin 10; surgery	CANDIDATE TUMOR-SUPPRESSOR; COLORECTAL-CANCER; HUMAN BREAST; MULTIPLE; FREQUENT; PCDH10; RECURRENCE; GENES; CARCINOMAS; TARGET	Although curative resection is the current treatment of choice for localized non-small-cell lung cancer (NSCLC), patients show a wide spectrum of survival even after complete resection of pathological stage I NSCLC. Thus, identifying molecular biomarkers that help to accurately select patients at high risk of relapse is an important key to improving the treatment strategy. The purpose of this study was to evaluate the prognostic signature of protocadherin 10 (PCDH10) promoter methylation in curatively resected pathological stage I NSCLC. Using methylation-specific polymerase chain reaction assays, methylation of PCDH10 promoter was assessed in cancer tissues of 109 patients who underwent curative resection of pathological stage I NSCLC. Associations between PCDH10 methylation status and disease outcome was analyzed. PCDH10 promoter methylation was detected in 46/109 patients (42.2%). Patients with methylated PCDH10 showed significantly worse recurrence-free, overall, and disease-specific survival compared with those without methylation (P<0.0001, P=0.0004, P=0.0002, respectively). Multivariate Cox proportional hazard regression analysis revealed that adjusted hazard ratios of methylated PCDH10 were 5.159 for recurrence-free, 1.817 for overall, and 5.478 for disease-specific survival (P=0.0005, P=0.1475, P=0.0109, respectively). The pattern of recurrence was not significantly different between patients with and without PCDH10 methylation (P=0.5074). PCDH10 methylation is a potential biomarker that predicts a poor prognosis after curative resection of pathological stage I NSCLC. Assessment of PCDH10 methylation status might assist in patient stratification for determining an appropriate adjuvant treatment and follow-up strategy.	[Harada, Hiroaki; Yamashita, Yoshinori] Kure Med Ctr, Chugoku Canc Ctr, Natl Hosp Org, Dept Surg Res, Kure, Hiroshima 7370023, Japan; [Harada, Hiroaki; Miyamoto, Kazuaki; Yamashita, Yoshinori; Taniyama, Kiyomi; Mihara, Kazuko; Nishimura, Mitsuki] Kure Med Ctr, Chugoku Canc Ctr, Natl Hosp Org, Inst Clin Res, Kure, Hiroshima 7370023, Japan; [Miyamoto, Kazuaki] Higashihiroshima Med Ctr, Natl Hosp Org, Dept Surg, Higashihiroshima, Hiroshima 7390041, Japan; [Okada, Morihito] Hiroshima Univ, Grad Sch Biomed Sci, Res Inst Radiat Biol & Med, Dept Surg Oncol,Minami Ku, Hiroshima, Hiroshima 7348551, Japan	Harada, H (reprint author), 3-1 Aoyama Cho, Kure, Hiroshima 7370023, Japan.	haradah@kure-nh.go.jp			Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Science, Sports, and Technology of Japan; Kyowa Hakko and Daiwa Securities Health Foundation	This work was supported in part by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science; Grants-in-Aid for the Third-term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan; and research funding from Kyowa Hakko and Daiwa Securities Health Foundation.	Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Li Z, 2014, MOL MED REP, V10, P832, DOI 10.3892/mmr.2014.2285; Frank M, 2002, CURR OPIN CELL BIOL, V14, P557, DOI 10.1016/S0955-0674(02)00365-4; Shi DD, 2015, CELL CYCLE, V14, P857, DOI 10.1080/15384101.2015.1004935; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Okada M, 1998, J THORAC CARDIOV SUR, V115, P836, DOI 10.1016/S0022-5223(98)70364-2; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Miyamoto K, 2005, INT J CANCER, V116, P407, DOI 10.1002/ijc.21054; Narayan G, 2009, GENE CHROMOSOME CANC, V48, P983, DOI 10.1002/gcc.20703; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Walter K, 2014, EPIGENOMICS-UK, V6, P59, DOI 10.2217/epi.13.81; Harada H, 2015, ANN THORAC SURG, V99, P1746, DOI 10.1016/j.athoracsur.2014.12.058; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Ushijima T, 2005, CANCER RES, V65, P11; Zhong X, 2013, J CANCER RES CLIN, V139, P485, DOI 10.1007/s00432-012-1353-5; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Harada H, 2013, CANCER-AM CANCER SOC, V119, P792, DOI 10.1002/cncr.27754; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jao TM, 2014, INT J CANCER, V135, P2593, DOI 10.1002/ijc.28899; Tang X, 2013, CANCER BIOMARK, V12, P11; vansRoy F., 2014, NAT REV CANCER, V14, P121	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1536	1546		10.1002/cam4.507		11	Oncology	Oncology	CT4RI	WOS:000362794000008		
J	Matsumoto, A; Hieda, M; Yokoyama, Y; Nishioka, Y; Yoshidome, K; Tsujimoto, M; Matsuura, N				Matsumoto, Ayaka; Hieda, Miki; Yokoyama, Yuhki; Nishioka, Yu; Yoshidome, Katsuhide; Tsujimoto, Masahiko; Matsuura, Nariaki			Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer	CANCER MEDICINE			English	Article						Breast cancer; lamin A; C; LINC complex; nesprin-2; SUN1/2	ENVELOPE; PROTEIN; EXPRESSION; CELLS; PROLIFERATION; CYTOSKELETON; MAINTENANCE; MIGRATION; LYMPHOMA; DISEASE	Cancer cells exhibit a variety of features indicative of atypical nuclei. However, the molecular mechanisms underlying these phenomena remain to be elucidated. The linker of nucleoskeleton and cytoskeleton (LINC) complex, a nuclear envelope protein complex consisting mainly of the SUN and nesprin proteins, connects nuclear lamina and cytoskeletal filaments and helps to regulate the size and shape of the nucleus. Using immunohistology, we found that a nuclear lamina component, lamin A/C and all of the investigated LINC complex components, SUN1, SUN2, and nesprin-2, were downregulated in human breast cancer tissues. In the majority of cases, we observed lower expression levels of these analytes in samples' cancerous regions as compared to their cancer-associated noncancerous regions (in cancerous regions, percentage of tissue samples exhibiting low protein expression: lamin A/C, 85% [n=73]; SUN1, 88% [n=43]; SUN2, 74% [n=43]; and nesprin-2, 79% [n=53]). Statistical analysis showed that the frequencies of recurrence and HER2 expression were negatively correlated with lamin A/C expression (P<0.05), and intrinsic subtype and ki-67 level were associated with nesprin-2 expression (P<0.05). In addition, combinatorial analysis using the above four parameters showed that all patients exhibited reduced expression of at least one of four components despite the tumor's pathological classification. Furthermore, several cultured breast cancer cell lines expressed less SUN1, SUN2, nesprin-2 mRNA, and lamin A/C compared to noncancerous mammary gland cells. Together, these results suggest that the strongly reduced expression of LINC complex and nuclear lamina components may play fundamental pathological functions in breast cancer progression.	[Matsumoto, Ayaka; Hieda, Miki; Yokoyama, Yuhki; Nishioka, Yu; Matsuura, Nariaki] Osaka Univ, Grad Sch Med & Hlth Sci, Suita, Osaka 5650871, Japan; [Nishioka, Yu] Carna Biosci Inc, Present Inst, Kobe, Hyogo, Japan; [Yoshidome, Katsuhide] Osaka Police Hosp, Dept Breast Surg, Osaka, Japan; [Tsujimoto, Masahiko] Osaka Police Hosp, Dept Pathol, Osaka, Japan	Hieda, M (reprint author), Osaka Univ, Grad Sch Med & Hlth Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mikihieda@gmail.com			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MH); and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to MH).	Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Tanaka H, 2012, BIOCHEM BIOPH RES CO, V420, P721, DOI 10.1016/j.bbrc.2012.03.045; Rashmi RN, 2012, NUCLEUS-AUSTIN, V3, P172, DOI 10.4161/nucl.19090; STADELMANN B, 1990, LEUKEMIA RES, V14, P815, DOI 10.1016/0145-2126(90)90076-L; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Tilli CMLJ, 2003, BRIT J DERMATOL, V148, P102, DOI 10.1046/j.1365-2133.2003.05026.x; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Agrelo R, 2005, J CLIN ONCOL, V23, P3940, DOI 10.1200/JCO.2005.11.650; Yokoyama Y, 2013, CANCER SCI, V104, P889, DOI 10.1111/cas.12166; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Lei K, 2012, CURR BIOL, V22, P1609, DOI 10.1016/j.cub.2012.06.043; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Crabbe L, 2012, CELL REP, V2, P1521, DOI 10.1016/j.celrep.2012.11.019; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; BROERS JLV, 1993, AM J PATHOL, V143, P211; Lund E, 2013, GENOME RES, V23, P1580, DOI 10.1101/gr.159400.113; Yang WG, 2013, INT J MOL MED, V32, P805, DOI 10.3892/ijmm.2013.1445; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Isermann P, 2013, CURR BIOL, V23, pR1113, DOI 10.1016/j.cub.2013.11.009; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; vansSteensel B., 2014, NUCLEUS, V5, P124; Wazir U, 2013, CELL MOL BIOL LETT, V18, P595, DOI 10.2478/s11658-013-0109-9; Wu ZR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-8; Yokoyama Y, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3681	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1547	1557		10.1002/cam4.495		11	Oncology	Oncology	CT4RI	WOS:000362794000009		
J	Uchiyama, T; Kawabata, H; Miura, Y; Yoshioka, S; Iwasa, M; Yao, H; Sakamoto, S; Fujimoto, M; Haga, H; Kadowaki, N; Maekawa, T; Takaori-Kondo, A				Uchiyama, Tatsuki; Kawabata, Hiroshi; Miura, Yasuo; Yoshioka, Satoshi; Iwasa, Masaki; Yao, Hisayuki; Sakamoto, Soichiro; Fujimoto, Masakazu; Haga, Hironori; Kadowaki, Norimitsu; Maekawa, Taira; Takaori-Kondo, Akifumi			The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis	CANCER MEDICINE			English	Article						Growth differentiation factor 15; osteoblastic differentiation; primary myelofibrosis	MESENCHYMAL STEM-CELLS; TGF-BETA SUPERFAMILY; EX-VIVO EXPANSION; BONE-MARROW; MULTIPLE-MYELOMA; MORPHOGENETIC PROTEIN; INHIBITORY CYTOKINE-1; STROMAL CELLS; HEL CELLS; EXPRESSION	Growth differentiation factor 15 (GDF15) is a pleiotropic cytokine that belongs to the transforming growth factor- superfamily. Elevated serum concentrations of this cytokine have been reported in patients with various malignancies. To assess the potential roles of GDF15 in hematologic malignancies, we measured its serum levels in patients with these diseases. We found that serum GDF15 levels were elevated in almost all these patients, particularly in patients with primary myelofibrosis (PMF). Immunohistochemical staining of bone marrow (BM) specimens revealed that GDF15 was strongly expressed by megakaryocytes, which may be sources of increased serum GDF15 in PMF patients. Therefore, we further assessed the contribution of GDF15 to the pathogenesis of PMF. Recombinant human (rh) GDF15 enhanced the growth of human BM mesenchymal stromal cells (BM-MSCs), and it enhanced the potential of these cells to support human hematopoietic progenitor cell growth in a co-culture system. rhGDF15 enhanced the growth of human primary fibroblasts, but it did not affect their expression of profibrotic genes. rhGDF15 induced osteoblastic differentiation of BM-MSCs in vitro, and pretreatment of BM-MSCs with rGDF15 enhanced the induction of bone formation in a xenograft mouse model. These results suggest that serum levels of GDF15 in PMF are elevated, that megakaryocytes are sources of this cytokine in BM, and that GDF15 may modulate the pathogenesis of PMF by enhancing proliferation and promoting osteogenic differentiation of BM-MSCs.	[Uchiyama, Tatsuki; Kawabata, Hiroshi; Yoshioka, Satoshi; Sakamoto, Soichiro; Kadowaki, Norimitsu; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan; [Miura, Yasuo; Yoshioka, Satoshi; Iwasa, Masaki; Yao, Hisayuki; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Iwasa, Masaki] Shiga Univ Med Sci, Div Gastroenterol & Hematol, Otsu, Shiga 52021, Japan; [Fujimoto, Masakazu; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan	Kawabata, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Hematol Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	hkawabat@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Cell Science Research Foundation; Takeda Science Foundation	This work was supported in part by grant-in-aids for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. K., T. M., and A. T.-K.). This work was also supported by the Cell Science Research Foundation (Y. M.), and Takeda Science Foundation (Y. M.).	Li N, 2007, EXP HEMATOL, V35, P507, DOI 10.1016/j.exphem.2006.10.015; Kempf T, 2009, CIRC-CARDIOVASC GENE, V2, P286, DOI 10.1161/CIRCGENETICS.108.824870; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; Yao H, 2014, STEM CELLS, V32, P2245, DOI 10.1002/stem.1701; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Wang JC, 2002, BRIT J HAEMATOL, V119, P709, DOI 10.1046/j.1365-2141.2002.03874.x; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Lambrecht S, 2014, ARTHRITIS RHEUMATOL, V66, P418, DOI 10.1002/art.38241; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; Bottner M, 1999, GENE, V237, P105, DOI 10.1016/S0378-1119(99)00309-1; Tarkun P, 2013, EUR J HAEMATOL, V91, P228, DOI 10.1111/ejh.12150; BENEYTOUT JL, 1995, BIOCHEM BIOPH RES CO, V207, P398, DOI 10.1006/bbrc.1995.1201; Wolf D, 2011, CURR CANCER DRUG TAR, V11, P44, DOI 10.2174/156800911793743592; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Hinoi E, 2012, J BONE MINER RES, V27, P938, DOI 10.1002/jbmr.1538; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; Tanno T, 2014, BLOOD, V123, P725, DOI 10.1182/blood-2013-08-524025; Corre J, 2012, CANCER RES, V72, P1395, DOI 10.1158/0008-5472.CAN-11-0188; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Morrish DW, 1996, PLACENTA, V17, P431, DOI 10.1016/S0143-4004(96)90025-9; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2; Wakchoure S, 2009, PROSTATE, V69, P652, DOI 10.1002/pros.20913; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Yoshioka S, 2014, STEM CELLS, V32, P730, DOI 10.1002/stem.1555; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Bock O, 2008, AM J PATHOL, V172, P951, DOI 10.2353/ajpath.2008.071030; Chitteti BR, 2010, J CELL BIOCHEM, V111, P284, DOI 10.1002/jcb.22694; Miura M, 2006, ORAL DIS, V12, P514, DOI 10.1111/j.1601-0825.2006.01300.x; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Tamary H, 2008, BLOOD, V112, P5241, DOI 10.1182/blood-2008-06-165738; Yamaza T, 2009, BLOOD, V113, P2595, DOI 10.1182/blood-2008-10-182246; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; DisRaimondo F., 2001, LEUKEMIA, V15, P976; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Kawabata H, 2012, INTERNAL MED, V51, P917, DOI 10.2169/internalmedicine.51.6978; MARTYRE MC, 1994, BRIT J HAEMATOL, V88, P9, DOI 10.1111/j.1365-2141.1994.tb04970.x; Tarkun P, 2013, ACTA HAEMATOL, V131, P173; Varga J, 1995, Int Rev Immunol, V12, P187, DOI 10.3109/08830189509056712; WHO, 2008, CLASS TUM HAEM LYMPH; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1558	1572		10.1002/cam4.502		15	Oncology	Oncology	CT4RI	WOS:000362794000010		
J	Watanabe, K; Amano, Y; Ishikawa, R; Sunohara, M; Kage, H; Ichinose, J; Sano, A; Nakajima, J; Fukayama, M; Yatomi, Y; Nagase, T; Ohishi, N; Takai, D				Watanabe, Kousuke; Amano, Yosuke; Ishikawa, Rie; Sunohara, Mitsuhiro; Kage, Hidenori; Ichinose, Junji; Sano, Atsushi; Nakajima, Jun; Fukayama, Masashi; Yatomi, Yutaka; Nagase, Takahide; Ohishi, Nobuya; Takai, Daiya			Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer	CANCER MEDICINE			English	Article						Epigenetic repression; histones; lung neoplasms; microRNAs; neoplasm metastasis	COLORECTAL-CANCER; DNA METHYLATION; PROSTATE-CANCER; DOWN-REGULATION; MICRORNAS; GENES; DISRUPTION; EXPRESSION	MicroRNA expression is frequently altered in human cancers, and some microRNAs act as oncogenes or tumor suppressors. MiR-139-5p (denoted thereafter as miR-139) has recently been reported to function as a tumor suppressor in several types of human cancer (hepatocellular carcinoma, colorectal cancer, breast cancer, and gastric cancer), but its function in non-small-cell lung cancer (NSCLC) and the mechanism of its suppression have not been studied in detail. MiR-139 was suppressed frequently in primary NSCLCs. MiR-139 is located within the intron of PDE2A and its expression was significantly correlated with the expression of PDE2A. A chromatin immunoprecipitation assay revealed that miR-139 was epigenetically silenced by histone H3 lysine 27 trimethylation (H3K27me3) of its host gene PDE2A and this process was independent of promoter DNA methylation. Pharmacological inhibition of both histone methylation and deacetylation-induced miR-139 with its host gene PDE2A. Ectopic expression of miR-139 in lung cancer cell lines did not affect the proliferation nor the migration but significantly suppressed the invasion through the extracellular matrix. In primary NSCLCs, decreased expression of miR-139 was significantly associated with distant lymph node metastasis and histological invasiveness (lymphatic invasion and vascular invasion) on both univariate and multivariate analyses. Collectively, these results suggest that H3K27me3-mediated silencing of miR-139 enhances an invasive and metastatic phenotype of NSCLC.	[Watanabe, Kousuke; Amano, Yosuke; Ishikawa, Rie; Sunohara, Mitsuhiro; Kage, Hidenori; Nagase, Takahide; Ohishi, Nobuya] Tokyo Univ Hosp, Dept Resp Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ichinose, Junji; Sano, Atsushi; Nakajima, Jun] Tokyo Univ Hosp, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Fukayama, Masashi] Tokyo Univ Hosp, Dept Pathol, Bunkyo Ku, Tokyo 1138655, Japan; [Yatomi, Yutaka; Takai, Daiya] Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, Tokyo 1138655, Japan	Takai, D (reprint author), Tokyo Univ Hosp, Dept Clin Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	dtakai-ind@umin.ac.jp			Takeda Science Foundation; Japan Society for the Promotion of Science, KAKENHI [23390147, 24659267, 24501339, 24791455]	This work was supported by Takeda Science Foundation, Japan Society for the Promotion of Science, KAKENHI (Grant Numbers: 23390147, 24659267, 24501339, 24791455).	Kitano K, 2011, CANCER SCI, V102, P2126, DOI 10.1111/j.1349-7006.2011.02101.x; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kusakabe M, 2009, BIOCHEM BIOPH RES CO, V390, P1283, DOI 10.1016/j.bbrc.2009.10.137; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Huqun R., 2012, CANCER, V118, P1599; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Sambrook J., 2001, MOL CLONING; Watanabe Kousuke, 2013, Frontiers in Genetics, V4, P275, DOI 10.3389/fgene.2013.00275	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1573	1582		10.1002/cam4.505		10	Oncology	Oncology	CT4RI	WOS:000362794000011		
J	Ping, BQ; Tsuno, S; Wang, XH; Ishihara, Y; Yamashita, T; Miura, K; Miyoshi, F; Shinohara, Y; Matsuki, T; Tanabe, Y; Tanaka, N; Ogawa, T; Shiota, G; Miura, N				Ping, Bingqiong; Tsuno, Satoshi; Wang, Xinhui; Ishihara, Yoshitaka; Yamashita, Taro; Miura, Keigo; Miyoshi, Fuminori; Shinohara, Yuki; Matsuki, Tsutomu; Tanabe, Yoshio; Tanaka, Noriaki; Ogawa, Toshihide; Shiota, Goshi; Miura, Norimasa			Comparative study of F-18-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis	CANCER MEDICINE			English	Article						F-18-FDG; cancer; diagnosis; hTERTmRNA; PET/CTPET/CT	TUMOR-MARKER; BLOOD COLLECTION; LUNG-CANCER; EXOSOMES; PLASMA; STORAGE; MICROVESICLES; METAANALYSIS; DISEASES; QUALITY	We have reported on the clinical usefulness of human telomerase reverse transcriptase (hTERT) mRNA quantification in sera in patients with several cancers. Positron emission tomography-computed tomography (PET/CT) using F-18-fluorodeoxyglucose (FDG) has recently become an excellent modality for detecting cancer. We performed a diagnostic comparative study of FDG-PET/CT and hTERT mRNA quantification in patients with cancer. Four hundred seventy subjects, including 125 healthy individuals and 345 outpatients with cancer who had received medical treatments for cancer in their own or other hospitals, were enrolled. The subjects were diagnosed by FDG-PET/CT, and we measured their serum hTERT mRNA levels using real-time RT-PCR, correlating the quantified values with the clinical course. In this prospective study, we statistically assessed the sensitivity and specificity, and their clinical significance. hTERT mRNA and FDG-PET/CT were demonstrated to be correlated with the clinical parameters of metastasis and recurrence (P<0.001), and of recurrence and tumor number in cancer compared with noncancer patients, respectively. A multivariate analysis showed a significant difference in the detection by FDG-PET/CT, F-18-FDG uptake, the detection by hTERT mRNA, and age. The use of both FDG-PET/CT and hTERT mRNA resulted in a positivity of 94.4% (221/234) for the detection of viable tumor cells. FDG-PET/CT is superior to hTERT mRNA quantification in the early detection of cancer and combinative use of FDG-PET/CT and hTERT mRNA may improve the diagnostic accuracy of cancer.	[Ping, Bingqiong; Tsuno, Satoshi; Wang, Xinhui; Ishihara, Yoshitaka; Yamashita, Taro; Miura, Norimasa] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Pharmacotherapeut, Yonago, Tottori 6838503, Japan; [Miura, Keigo] PEZY Pharma, Yonago, Tottori 6838503, Japan; [Miyoshi, Fuminori; Shinohara, Yuki; Ogawa, Toshihide] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 6838504, Japan; [Matsuki, Tsutomu; Tanabe, Yoshio; Tanaka, Noriaki] Tottori Municipal Hosp, Dept Radiol, Tottori, Tottori 6808501, Japan; [Shiota, Goshi] Tottori Univ, Sch Med, Dept Genet Med & Regenerat Therapeut, Div Mol & Genet Med, Yonago, Tottori 6838503, Japan	Miura, N (reprint author), Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Pharmacotherapeut, 86 Nishicho, Yonago, Tottori 6838503, Japan.	mnmiura@med.tottori-u.ac.jp			Ministry of Education, Science, and Culture [18390208]; Foundation for the Promotion of Cancer Research in Japan	This study was supported by a Grant-in-Aid (18390208) for scientific research from the Ministry of Education, Science, and Culture and the Foundation for the Promotion of Cancer Research in Japan.	Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Kosaka N, 2014, FUTURE ONCOL, V10, P671, DOI [10.2217/fon.13.222, 10.2217/FON.13.222]; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; von Smolinski D, 2005, HISTOCHEM CELL BIOL, V124, P177, DOI 10.1007/s00418-005-0013-0; Schageman J, 2013, BIOMED RES INT, DOI 10.1155/2013/253957; Jin H, 2014, Q J NUCL MED MOL IM, V58, P85; Lin CY, 2012, EUR J RADIOL, V81, P2417, DOI 10.1016/j.ejrad.2011.08.004; Gillio-Meina C, 2013, PEDIATRICS, V131, P754, DOI 10.1542/peds.2012-1181; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Miura N, 2007, ONCOL REP, V17, P541; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tani N, 2007, ANTICANCER RES, V27, P1207; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; KOTTEL RH, 1978, BRIT J CANCER, V38, P280, DOI 10.1038/bjc.1978.199; Osaki M, 2008, BIOMARKERS, V13, P658, DOI 10.1080/13547500802646572 ; Kruse V, 2013, ANN NUCL MED, V27, P97, DOI 10.1007/s12149-012-0664-6; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Hegmans JPJJ, 2008, METHODS MOL BIOL, V484, P97, DOI 10.1007/978-1-59745-398-1_7; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Batagov AO, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-12; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kluetz P., 2000, CLIN POSITRON IMAGIN, V3, P174, DOI 10.1016/S1095-0397(00)00086-8; Krause Berud J, 2013, Recent Results Cancer Res, V187, P351, DOI 10.1007/978-3-642-10853-2_12; Miura N, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-46; O'Driscoll Donnacha, 2007, Cytotechnology, V53, P127, DOI 10.1007/s10616-007-9061-8; Purandare Nilendu C, 2012, Indian J Radiol Imaging, V22, P260, DOI 10.4103/0971-3026.111476; Qin Jianbing, 2013, BMC Res Notes, V6, P380, DOI 10.1186/1756-0500-6-380; Siah A, 2014, J AQUAT ANIM HEALTH, V26, P173, DOI 10.1080/08997659.2014.902874; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Takahashi S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-103; Torrent M, 2009, BBA-BIOMEMBRANES, V1788, P1116, DOI 10.1016/j.bbamem.2009.01.013; Treglia G, 2014, LUNG CANCER, V83, P1, DOI 10.1016/j.lungcan.2013.11.002; Ulger S, 2014, J CANCER RES CLIN, V140, P495, DOI 10.1007/s00432-014-1591-9; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wendler F, 2013, J EXTRACELL VESICLES, V2, P24, DOI [10.3402/jev.v2i0.22390, DOI 10.3402/JEV.V2I0.22390]	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7634			CANCER MED-US	Cancer Med.	OCT	2015	4	10					1603	1611		10.1002/cam4.508		9	Oncology	Oncology	CT4RI	WOS:000362794000015		
J	Kawamoto, H; Latib, A; Ruparelia, N; Miyazaki, T; Sticchi, A; Naganuma, T; Sato, K; Figini, F; Chieffo, A; Carlino, M; Montorfano, M; Colombo, A				Kawamoto, Hiroyoshi; Latib, Azeem; Ruparelia, Neil; Miyazaki, Tadashi; Sticchi, Alessandro; Naganuma, Toru; Sato, Katsumasa; Figini, Filippo; Chieffo, Alaide; Carlino, Mauro; Montorfano, Matteo; Colombo, Antonio			Clinical Outcomes Following Bioresorbable Scaffold Implantation for Bifurcation Lesions: Overall Outcomes and Comparison Between Provisional and Planned Double Stenting Strategy	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						bioresorbable scaffold; coronary bifurcation; provisional stenting; double stenting	PERCUTANEOUS CORONARY INTERVENTION; OPTICAL COHERENCE TOMOGRAPHY; SIROLIMUS-ELUTING STENTS; SIDE BRANCH OCCLUSION; EXPERT CONSENSUS DOCUMENT; MYOCARDIAL-INFARCTION; VASCULAR SCAFFOLD; RANDOMIZED-TRIAL; METALLIC STENT; ABSORB-EXTEND	The aim of this study was to investigate clinical outcomes of patients treated with a provisional stenting (PS) versus a double stenting (DS) strategy for coronary bifurcation lesions with bioresorbable scaffolds (BRS). There are limited data available with regards to outcomes following BRS implantation for bifurcation lesions. A total of 132 bifurcation lesions treated with BRS between 2012 and 2014 were analyzed. Of the total of 132 bifurcation lesions, 10 lesions were treated without crossover stenting. 99 lesions (81%) were treated with a PS strategy and 23 lesions (19%) with a DS strategy. The DS group consisted of patients with a greater number of true bifurcation lesions (PS 52.0% vs. DS 91.3%: P < 0.001). In the PS group, seven lesions (7.1%) were crossed-over to T-stenting. In the DS group, 13 lesions (57%) were treated with BRS to the side branch (SB). A hybrid stenting technique [ BRS to the main branch, and metallic drug-eluting stent (DES) to the SB] was utilized in 10 (43%) lesions. Target lesion revascularization (TLR) rates were 5.5% for PS and 11.2% for DS (P = 50.49) at 1-year follow-up. Definite scaffold thrombosis did not occur at the site of any bifurcation lesion. These findings suggest that BRS implantation for bifurcation lesions is technically feasible. The rates of TLR tended to be higher in the DS group compared to when a PS strategy was employed. Larger studies are eagerly awaited to determine longer-term follow-up of this treatment strategy. (C) 2015 Wiley Periodicals, Inc.	[Kawamoto, Hiroyoshi; Latib, Azeem; Ruparelia, Neil; Miyazaki, Tadashi; Sticchi, Alessandro; Figini, Filippo; Chieffo, Alaide; Carlino, Mauro; Montorfano, Matteo; Colombo, Antonio] Ist Sci San Raffaele, Intervent Cardiol Unit, I-20132 Milan, Italy; [Kawamoto, Hiroyoshi; Latib, Azeem; Ruparelia, Neil; Miyazaki, Tadashi; Figini, Filippo; Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy; [Ruparelia, Neil] Univ London Imperial Coll Sci Technol & Med, London, England; [Kawamoto, Hiroyoshi; Naganuma, Toru] New Tokyo Hosp, Intervent Cardiol Unit, Chiba, Japan; [Sato, Katsumasa] Fukuyama Cardiovasc Hosp, Hiroshima, Japan	Colombo, A (reprint author), EMO GVM Ctr Cuore Columbus, 48 Via M Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it					Abizaid A, 2015, EUROINTERVENTION, V10, P1396, DOI 10.4244/EIJV10I12A243; Chen SL, 2011, J AM COLL CARDIOL, V57, P914, DOI 10.1016/j.jacc.2010.10.023; Lansky AJ, 2010, EUROINTERVENTION, V6, pJ44, DOI 10.4244/EIJV6SUPJA8; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Ormiston JA, 2015, EUROINTERVENTION, V11, P60, DOI 10.4244/EIJY15M02_03; Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297; Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402; Lansky AJ, 2010, CIRC-CARDIOVASC INTE, V3, P602, DOI 10.1161/CIRCINTERVENTIONS.110.959080; Popma JJ, 2009, CIRC-CARDIOVASC INTE, V2, P133, DOI 10.1161/CIRCINTERVENTIONS.108.832048; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Onuma Y, 2011, CIRCULATION, V123, P779, DOI 10.1161/CIRCULATIONAHA.110.971606; Latib A, 2008, JACC-CARDIOVASC INTE, V1, P218, DOI 10.1016/j.jcin.2007.12.008; Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920; Prasad A, 2011, NEW ENGL J MED, V364, P453, DOI 10.1056/NEJMra0912134; Moussa ID, 2014, CATHETER CARDIO INTE, V83, P27, DOI 10.1002/ccd.25135; Guagliumi G, 2013, CATHETER CARDIO INTE, V81, P510, DOI 10.1002/ccd.24374; Mintz GS, 2011, EUROINTERVENTION, V6, P1123, DOI 10.4244/EIJV6I9A195; Ormiston JA, 2015, EUROINTERVENTION, V10, P1169, DOI 10.4244/EIJY14M05_08; Ielasi A, 2014, INT J CARDIOL, V173, P513, DOI 10.1016/j.ijcard.2014.03.061; Muramatsu T, 2013, JACC-CARDIOVASC INTE, V6, P247, DOI 10.1016/j.jcin.2012.10.013; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Erglis A, 2009, CIRC-CARDIOVASC INTE, V2, P27, DOI 10.1161/CIRCINTERVENTIONS.108.804658; Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3; Lassen JF, 2014, EUROINTERVENTION, V10, P545, DOI 10.4244/EIJV10I5A97; Brugaletta S, 2015, JACC-CARDIOVASC INTE, V8, P189, DOI 10.1016/j.jcin.2014.10.005; Parodi G, 2013, EUROINTERVENTION, V9, P936, DOI 10.4244/EIJV9I8A157; Sato K, 2015, JACC-CARDIOVASC INTE, V8, P116, DOI 10.1016/j.jcin.2014.07.029; Serruys PW, 2015, LANCET, V384, P43, DOI 10.1016/S0140-6736(14)61455-0; Song YB, 2014, JACC-CARDIOVASC INTE, V7, P255, DOI 10.1016/j.jcin.2013.11.009; Tamburino C, 2015, EUROINTERVENTION, V10; Vaquerizo B, 2014, EUROINTERVENTION	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	OCT	2015	86	4					644	652		10.1002/ccd.26045		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT4PW	WOS:000362790100011		
J	Miyazaki, T; Latib, A; Colombo, A				Miyazaki, Tadashi; Latib, Azeem; Colombo, Antonio			Provisional Hybrid 2-Stent Strategy Utilizing Bioresorbable Vascular Scaffold and Drug-Eluting Metal Stent: "T-Stenting and Small Protrusion" Technique	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						bioresorbable vascular scaffold (BVS); bifurcation; T-stenting and small protrusion (TAP); kissing balloon inflation; intravascular ultrasound (IVUS); restenosis	CORONARY BIFURCATIONS; EXPERIENCE; REGISTRY; BENCH	We present a case of side-branch restenosis after T-stenting and small protrusion (TAP) technique using a bioresorbable vascular scaffold and a drug-eluting metallic stent. According to intravascular ultrasound imaging findings, the simultaneous balloon deflation after kissing balloon post-dilatation was the likely cause of restenosis. In cases where bifurcation treatment requires the TAP technique, operators should pay particular attention to perform kissing balloon inflation with sequential deflation (main branch first, side branch last). (C) 2015 Wiley Periodicals, Inc.	[Miyazaki, Tadashi; Latib, Azeem; Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy; [Miyazaki, Tadashi; Latib, Azeem; Colombo, Antonio] Ist Sci San Raffaele, Intervent Cardiol Unit, I-20132 Milan, Italy; [Miyazaki, Tadashi] Juntendo Univ, Dept Cardiovasc Med, Tokyo, Japan	Latib, A (reprint author), EMO GVM Ctr Cuore Columbus, 48 Via M Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it					Burzotta F, 2007, CATHETER CARDIO INTE, V70, P75, DOI 10.1002/ccd.21194; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Ruzsa Z, 2013, INT J CARDIOL, V168, pE35, DOI 10.1016/j.ijcard.2013.05.026; Naganuma T, 2013, JACC-CARDIOVASC INTE, V6, P554, DOI 10.1016/j.jcin.2013.01.137; Ormiston JA, 2015, EUROINTERVENTION, V10, P1169, DOI 10.4244/EIJY14M05_08; Hildick-Smith D, 2010, EUROINTERVENTION, V6, P34, DOI 10.4244/; Dzavik V, 2014, JACC-CARDIOVASC INTE, V7, P81, DOI 10.1016/j.jcin.2013.07.013; Kraak RP, 2015, EUROINTERVENTION, V10, P1160, DOI 10.4244/EIJY14M08_08	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	OCT	2015	86	4					682	685		10.1002/ccd.25775		4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT4PW	WOS:000362790100016		
J	Kitano, H; Mamiya, A; Tomomi, I; Shinichiro, K; Chiaki, H				Kitano, Hisataka; Mamiya, Atsushi; Tomomi, Ishikawa; Shinichiro, Kokubun; Chiaki, Hidai			Coagulation factor IX regulates cell migration and adhesion in vitro	CELL BIOLOGY INTERNATIONAL			English	Article						activation peptide; adhesion; coagulation factor; de-adhesion; EGF motif; migration	HEMOPHILIA-B; JUNCTION FORMATION; BINDING; ACTIVATION; MUTATIONS; PATHWAY; GENE; RAP1; UPAR; KEY	Coagulation factor IX is thought to circulate in the blood as an inactive zymogen before being activated in the coagulation process. The effect of coagulation factor IX on cells is poorly understood. This study aimed to evaluate the effects of intact coagulation factor IX and its cleavage fragments on cell behavior. A431 cells (derived from human squamous cell carcinoma), Pro5 cells (derived from mouse embryonic endothelial cells), Cos7 cells, and human umbilical vein endothelial cells were utilized in this study. The effects of coagulation factor IX and its cleavage fragments on cell behavior were investigated in several types of experiments, including wound-healing assays and modified Boyden chamber assays. The effect of coagulation factor IX depended on its processing; full-length coagulation factor IX suppressed cell migration, increased adhesion to matrix, and enhanced intercellular adhesion. In contrast, activated coagulation factor IX enhanced cell migration, suppressed adhesion to matrix, and inhibited intercellular adhesion. An activation peptide that is removed during the coagulation process was found to be responsible for the activity of full-length coagulation factor IX, and the activity of activated coagulation factor IX was localized to an EGF domain of the coagulation factor IX light chain. Full-length coagulation factor IX has a sedative effect on cells, which is counteracted by activated coagulation factor IX in vitro. Thus, coagulation factor IX may play roles before, during, and after the coagulation process.	[Kitano, Hisataka; Mamiya, Atsushi] Nihon Univ, Sch Med, Div Dent Surg, Tokyo, Japan; [Tomomi, Ishikawa; Shinichiro, Kokubun; Chiaki, Hidai] Nihon Univ, Sch Med, Dept Biomed Sci, Div Physiol, Tokyo, Japan	Chiaki, H (reprint author), Nihon Univ, Sch Med, Dept Biomed Sci, Div Physiol, Tokyo, Japan.	hidai.chiaki@nihon-u.ac.jp					LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Gui T, 2002, BLOOD, V100, P153, DOI 10.1182/blood.V100.1.153; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; LAWN RM, 1985, CELL, V42, P405, DOI 10.1016/0092-8674(85)90094-7; Lin HF, 1997, BLOOD, V90, P3962; Kitano H, 2008, MOL BIOTECHNOL, V39, P179, DOI 10.1007/s12033-008-9038-7; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Zogg T, 2009, STRUCTURE, V17, P1669, DOI 10.1016/j.str.2009.10.011; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Hoffman M, 2006, BLOOD, V108, P3053, DOI 10.1182/blood-2006-05-020495; Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w; Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Sabatino DE, 2004, BLOOD, V104, P2767, DOI 10.1182/blood-2004-03-1028; WINSHIP PR, 1991, BRIT J HAEMATOL, V77, P102, DOI 10.1111/j.1365-2141.1991.tb07955.x; Lichtman MA, 2006, WILLIAMS HEMATOLOGY, P1867; Mamiya A, 2012, MOL BIOTECHNOL, V54, P445	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	OCT	2015	39	10					1162	1172		10.1002/cbin.10491		11	Cell Biology	Cell Biology	CT4QE	WOS:000362790900009		
J	Picazarri, K; Nakada-Tsukui, K; Tsuboi, K; Miyamoto, E; Watanabe, N; Kawakami, E; Nozaki, T				Picazarri, Karina; Nakada-Tsukui, Kumiko; Tsuboi, Kumiko; Miyamoto, Eri; Watanabe, Naoko; Kawakami, Eiryo; Nozaki, Tomoyoshi			Atg8 is involved in endosomal and phagosomal acidification in the parasitic protist Entamoeba histolytica	CELLULAR MICROBIOLOGY			English	Article							AUTOPHAGOSOME FORMATION; TRYPANOSOMA-BRUCEI; PROTEOMIC ANALYSIS; MAMMALIAN HOMOLOG; CYSTEINE PROTEASE; LEISHMANIA-MAJOR; CELL-DEATH; PROTEINS; PHAGOCYTOSIS; DEGRADATION	Autophagy is one of two major bulk protein degradation systems and is conserved throughout eukaryotes. The protozoan Entamoeba histolytica, which is a human intestinal parasite, possesses a restricted set of autophagy-related (Atg) proteins compared with other eukaryotes and thus represents a suitable model organism for studying the minimal essential components and ancestral functions of autophagy. E. histolytica possesses two conjugation systems: Atg8 and Atg5/12, although a gene encoding Atg12 is missing in the genome. Atg8 is considered to be the central and authentic marker of autophagosomes, but recent studies have demonstrated that Atg8 is not exclusively involved in autophagy per se, but other fundamental mechanisms of vesicular traffic. To investigate this question in E. histolytica, we studied on Atg8 during the proliferative stage. Atg8 was constitutively expressed in both laboratory-maintained and recently established clinical isolates and appeared to be lipid-modified in logarithmic growth phase, suggesting a role of Atg8 in non-stress and proliferative conditions. These findings are in contrast to those for Entamoeba invadens, in which autophagy is markedly induced during an early phase of differentiation from the trophozoite into the cyst. The repression of Atg8 gene expression in En. histolytica by antisense small RNA-mediated transcriptional gene silencing resulted in growth retardation, delayed endocytosis and reduced acidification of endosomes and phagosomes. Taken together, these results suggest that Atg8 and the Atg8 conjugation pathway have some roles in the biogenesis of endosomes and phagosomes in this primitive eukaryote.	[Picazarri, Karina; Nakada-Tsukui, Kumiko; Tsuboi, Kumiko; Miyamoto, Eri; Kawakami, Eiryo; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Miyamoto, Eri; Watanabe, Naoko] Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan; [Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kawakami, Eiryo] RIKEN, Ctr Integrat Med Sci, Lab Dis Syst Modeling, Tsurumi Ku, Yokohama, Kanagawa, Japan	Nozaki, T (reprint author), Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan.	nozaki@nih.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23117001, 23117005, 14506236, 24590513, 26111524]; Ministry of Health, Labour and Welfare of Japan [H26-Shinkojitsuyoka-ippan-009, H26-Shinkojitsuyoka-ippan-011]	We are grateful to Dr. Dan Sato (Kyoto Institute of Technology) and Dr. Atsushi Furukawa (Hokkaido University) for recombinant production of EhAtg8 and establishment of EhAtg8-gene silenced strain respectively. We are also grateful to Dr. Isei Tanida (Juntendo University) for helpful suggestions. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to T. N. (23117001, 23117005, 14506236) and K.N.-T. (24590513, 26111524), grants for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan (H26-Shinkojitsuyoka-ippan-009 and H26-Shinkojitsuyoka-ippan-011) to T. N.	Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1365-2443.2004.00750.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Meza I, 2004, CELL MOTIL CYTOSKEL, V59, P215, DOI 10.1002/cm.20038; Nakada-Tsukui K, 2012, CELL MICROBIOL, V14, P1299, DOI 10.1111/j.1462-5822.2012.01800.x; Tomlins AM, 2013, AUTOPHAGY, V9, P1540, DOI 10.4161/auto.25832; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Nozaki T, 2006, ARCH MED RES, V37, P277, DOI 10.1016/j.arcmed.2005.09.010; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Herman M, 2008, AUTOPHAGY, V4, P294; Li W, 2012, J CELL BIOL, V197, P27, DOI 10.1083/jcb.201111053; Mitra BN, 2006, EXP PARASITOL, V114, P57, DOI 10.1016/j.exppara.2006.02.009; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; NILSSON JR, 1984, CARLSBERG RES COMMUN, V49, P323, DOI 10.1007/BF02913960; Hellberg A, 2001, CELL MICROBIOL, V3, P13, DOI 10.1046/j.1462-5822.2001.00086.x; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Koopmann R, 2009, AUTOPHAGY, V5, P1085; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Costa Adriana Oliveira, 2006, Revista do Instituto de Medicina Tropical de Sao Paulo, V48, P245, DOI 10.1590/S0036-46652006000500002; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Nakada-Tsukui K, 2010, EXP PARASITOL, V126, P337, DOI 10.1016/j.exppara.2010.04.014; Baisamy L, 2009, J BIOL CHEM, V284, P28232, DOI 10.1074/jbc.M109.054668; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moon EK, 2011, KOREAN J PARASITOL, V49, P103, DOI 10.3347/kjp.2011.49.2.103; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Williams RAM, 2009, AUTOPHAGY, V5, P159; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Haghighi A, 2002, J CLIN MICROBIOL, V40, P4081, DOI 10.1128/JCM.40.11.4081-4090.2002; Mitra BN, 2005, CELL MOTIL CYTOSKEL, V62, P84, DOI 10.1002/cm.20087; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Benchimol M, 1999, BIOL CELL, V91, P165, DOI 10.1016/S0248-4900(99)80039-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Tillack M, 2006, MOL BIOCHEM PARASIT, V149, P58, DOI 10.1016/j.milbiopara.2006.04.009; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; KANEDA Y, 1991, ANN TROP MED PARASIT, V85, P417; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; Liu ML, 2012, EUKARYOT CELL, V11, P494, DOI 10.1128/EC.05296-11; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Field MC, 2011, J CELL BIOL, V193, P963, DOI 10.1083/jcb.201102042; Picazarri K, 2008, METHOD ENZYMOL, V451, P359, DOI 10.1016/S0076-6879(08)03224-2; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P100; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Bracha R, 2006, PLOS PATHOG, V2, P431, DOI 10.1371/journal.ppat.0020048; Matthiesen J., 2013, MBIO, V4, DOI [10.1128/mBio.00072-13, DOI 10.1128/MBI0.00072-13]; Mi-ichi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001263; Sambrook J., 2001, MOL CLONING; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; WHO, 1997, EPIDEMIOL B, V18, P13	77	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	OCT	2015	17	10					1510	1522		10.1111/cmi.12453		13	Cell Biology; Microbiology	Cell Biology; Microbiology	CT4QO	WOS:000362792000010		
J	Uehara, T; Minematsu, K				Uehara, T.; Minematsu, K.		PROMISE-TIA Study Investigators	Final Results of PROMISE TIA Registry: A Nation-Wide Multicenter Cooperative Cohort Study in Japanese Patients with TIA in Acute Setting	CEREBROVASCULAR DISEASES			English	Meeting Abstract									Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; Natl Cerebral & Cardiovasc Ctr, Dept Stroke Rehabil, Suita, Osaka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O05	2	2				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000006		
J	Hoshino, T; Uchiyama, S				Hoshino, T.; Uchiyama, S.			Recurrence of Cardioembolic Stroke after TIA and Transient Neurological Attack before Vertebrovasilar Stroke	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Hoshino, T.; Uchiyama, S.] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan; [Uchiyama, S.] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O07	3	3				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000008		
J	Abe, K				Abe, K.			CADASIL and CARASIL in Asia	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Abe, K.] Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Okayama 7008558, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O11	4	4				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000012		
J	Honda, M; Anda, T				Honda, M.; Anda, T.			Seasonal Variation of Stroke in the Seto Inland Sea Area of Japan	CEREBROVASCULAR DISEASES			English	Meeting Abstract							SUBARACHNOID HEMORRHAGE; TEMPERATURE; POPULATION; MORTALITY; WINTER; ONSET		[Honda, M.; Anda, T.] Shunan Mem Hosp, Dept Neurosurg, Kudamatsu City, Yamaguchi, Japan							TSEMENTZIS SA, 1991, ACTA NEUROCHIR, V111, P80, DOI 10.1007/BF01400492; Passero S, 2000, STROKE, V31, P1538; SUZUKI K, 1987, STROKE, V18, P402; Oberg AL, 2000, AM J EPIDEMIOL, V152, P558, DOI 10.1093/aje/152.6.558; CAPON A, 1992, STROKE, V23, P24; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; SOBEL E, 1987, STROKE, V18, P38; Kawai K, 2001, NEUROL MED-CHIR, V41, P229, DOI 10.2176/nmc.41.229; Turin TC, 2008, STROKE, V39, P745, DOI 10.1161/STROKEAHA.107.495929; Feigin VL, 2001, STROKE, V32, P613; NATSUME K, 1992, INT J BIOMETEOROL, V36, P1, DOI 10.1007/BF01208726; SHINKAWA A, 1990, STROKE, V21, P1262; [Anonymous], 2011, JPN J STROKE, V33, P226; Jakovljevic D, STROKE, V27, P1774; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawai K, 2001, NEUROL MED CHIR TOKY, V41, P236; KNOX EG, 1981, J EPIDEMIOL COMMUN H, V35, P220, DOI 10.1136/jech.35.3.220; Okada K, 1995, JPN J GERIAT, V32, P39; TAKAHASHI E., 1957, HUMAN BIOL, V29, P139; Xu J, 2003, GLOBAL ENV RES JPN, V8, P201	20	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O18	7	8				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000018		
J	Abe, K; Yamashita, T; Nakano, Y; Morihara, R; Ohta, Y; Hishikawa, N				Abe, K.; Yamashita, T.; Nakano, Y.; Morihara, R.; Ohta, Y.; Hishikawa, N.			A New Simple Score (ABS) for Assessing Behavioral and Psychological Symptoms of Dementia	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Abe, K.; Yamashita, T.; Nakano, Y.; Morihara, R.; Ohta, Y.; Hishikawa, N.] Okayama Univ, Grad Sch Med & Dent, Dept Neurol, Okayama 7008558, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O28	11	11				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000028		
J	Fukuma, K; Kajimoto, K; Tanaka, T; Motoyama, R; Yamagami, H; Morita, N; Matsuki, T; Tomari, S; Toyoda, K; Nagatsuka, K				Fukuma, K.; Kajimoto, K.; Tanaka, T.; Motoyama, R.; Yamagami, H.; Morita, N.; Matsuki, T.; Tomari, S.; Toyoda, K.; Nagatsuka, K.			Localizing and Diagnosing Value of Subtraction Peri-Ictal SPECT In Seizure	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Fukuma, K.; Kajimoto, K.; Tanaka, T.; Motoyama, R.; Yamagami, H.; Nagatsuka, K.] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Div Neurol, Suita, Osaka, Japan; [Matsuki, T.; Tomari, S.; Toyoda, K.] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Div Cerebrovasc Med, Suita, Osaka, Japan; [Morita, N.] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O30	12	13				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000030		
J	Ito, S; Ooigawa, H; Ikeda, T; Kikkawa, Y; Nakajima, H; Yamaguchi, Y; Shimohigoshi, W; Teranishi, A; Ikegami, M; Kurita, H				Ito, S.; Ooigawa, H.; Ikeda, T.; Kikkawa, Y.; Nakajima, H.; Yamaguchi, Y.; Shimohigoshi, W.; Teranishi, A.; Ikegami, M.; Kurita, H.			Combined Revascularization for Moyamoya Disease Reduces Ischemic Stroke by Improving Vascular Reserve	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Ito, S.; Ooigawa, H.; Ikeda, T.; Kikkawa, Y.; Nakajima, H.; Yamaguchi, Y.; Shimohigoshi, W.; Teranishi, A.; Ikegami, M.; Kurita, H.] Saitama Int Med Ctr, Saitama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O35	14	14				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000035		
J	Morihara, R; Kono, S; Ota, Y; Yamashita, T; Deguchi, K; Manabe, Y; Takao, Y; Kashihara, K; Kiriyama, H; Abe, K				Morihara, R.; Kono, S.; Ota, Y.; Yamashita, T.; Deguchi, K.; Manabe, Y.; Takao, Y.; Kashihara, K.; Kiriyama, H.; Abe, K.			Thrombolysis with Tissue Plasminogen Activator 3-4.5 h after Acute Ischemic Stroke in 5 Hospital Groups in Japan	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Morihara, R.; Kono, S.; Ota, Y.; Yamashita, T.; Deguchi, K.; Abe, K.] Okayama Univ, Okayama 7008530, Japan; [Manabe, Y.] Okayama Natl Hosp, Med Ctr, Okayama, Japan; [Takao, Y.] Kurashiki Heisei Hosp, Okayama, Japan; [Kashihara, K.] Okayama Kyokuto Hosp, Okayama, Japan; [Kiriyama, H.] Okayama Citizens Hosp, Okayama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O43	17	18				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000043		
J	Nakano, Y; Deguchi, K; Yamashita, T; Morihara, R; Sato, K; Hishikawa, N; Ohta, Y; Higashi, Y; Takao, Y; Abe, K				Nakano, Y.; Deguchi, K.; Yamashita, T.; Morihara, R.; Sato, K.; Hishikawa, N.; Ohta, Y.; Higashi, Y.; Takao, Y.; Abe, K.			High Incidence of Dementia Conversion Than Stroke Recurrence in Post-Stroke Patients of Late Elder Society	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Nakano, Y.; Deguchi, K.; Yamashita, T.; Morihara, R.; Sato, K.; Hishikawa, N.; Ohta, Y.; Abe, K.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008530, Japan; [Higashi, Y.] Kurashiki Heisei Hosp, Dept Neurol, Okayama, Japan; [Takao, Y.] Himeji Cent Hosp, Dept Neurol, Himeji, Hyogo, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O44	18	18				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000044		
J	Yoshimura, S; Todo, K; Terasaki, T; Kamiyama, K; Shiokawa, Y; Okada, Y; Arihiro, S; Yamagami, H; Koga, M; Toyoda, K				Yoshimura, S.; Todo, K.; Terasaki, T.; Kamiyama, K.; Shiokawa, Y.; Okada, Y.; Arihiro, S.; Yamagami, H.; Koga, M.; Toyoda, K.			One-Year Outcome of Anticoagulant Therapy for Acute Ischemic Stroke with Nonvalvular Atrial Fibrillation in the Era of Non-Vitamin K Oral Anticoagulants - SAMURAI-NVAF Study	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yoshimura, S.; Arihiro, S.; Yamagami, H.; Koga, M.; Toyoda, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med & Neurol, Suita, Osaka, Japan; [Todo, K.] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan; [Terasaki, T.] Japanese Red Cross Kumamoto Hosp, Dept Neurol, Kumamoto, Kumamoto, Japan; [Kamiyama, K.] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Shiokawa, Y.] Kyorin Univ, Sch Med, Dept Neurosurg, Mitaka, Tokyo 181, Japan; [Shiokawa, Y.] Kyorin Univ, Sch Med, Stroke Ctr, Mitaka, Tokyo 181, Japan; [Okada, Y.] NHO Kyushu Med Ctr, Dept Neurol & Cerebrovasc Med, Fukuoka, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O45	18	19				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000045		
J	Murao, K; Arakawa, S; Nakashima, H; Kanazawa, Y; Ago, T; Kitazono, T				Murao, K.; Arakawa, S.; Nakashima, H.; Kanazawa, Y.; Ago, T.; Kitazono, T.			Eicosapentaenoic Acid to Arachidonic Acid Ratio in Patients with Acute Ischemic Stroke	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Murao, K.; Arakawa, S.; Nakashima, H.; Kanazawa, Y.] Kyushu Rosai Hosp, Japan Labor Hlth & Welf Org, Dept Cerebrovasc Dis, Fukuoka, Japan; [Ago, T.; Kitazono, T.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O47	19	19				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000047		
J	Yasuda, C; Nakajima, H; Murao, M; Kanazawa, Y; Arakawa, S				Yasuda, C.; Nakajima, H.; Murao, M.; Kanazawa, Y.; Arakawa, S.			Stroke Outcomes after tPA Treatment Within a Time Window of 4.5 Hours	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yasuda, C.; Nakajima, H.; Murao, M.; Kanazawa, Y.; Arakawa, S.] Kyushu Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Cerebrovasc Dis, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O49	20	20				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000049		
J	Kanazawa, Y; Arakawa, S; Nakajima, H; Murao, K; Hagiwara, N; Morioka, T; Ago, T; Kitazono, T				Kanazawa, Y.; Arakawa, S.; Nakajima, H.; Murao, K.; Hagiwara, N.; Morioka, T.; Ago, T.; Kitazono, T.			Arterial Spin Labelling MR Perfusion Imaging for Differential Diagnosis between Stroke and Its Mimics	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Kanazawa, Y.; Ago, T.; Kitazono, T.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Kanazawa, Y.; Arakawa, S.; Nakajima, H.; Murao, K.; Hagiwara, N.; Morioka, T.] Kyushu Rosai Hosp, Japan Labor Hlth & Welf Org, Dept Cerebrovasc Dis, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O51	21	21				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000051		
J	Tomari, S; Yokota, C; Hino, T; Ohyama, S; Toyoda, K; Minematsu, K				Tomari, S.; Yokota, C.; Hino, T.; Ohyama, S.; Toyoda, K.; Minematsu, K.			Stroke Education for Elementary School Children by Emergency Medical Technicians: The Akashi Project	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Tomari, S.; Yokota, C.; Hino, T.; Ohyama, S.; Toyoda, K.; Minematsu, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O55	22	22				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000055		
J	Yokota, C; Ishigami, A; Ohyama, S; Tomari, S; Hino, T; Toyoda, K; Minematsu, K				Yokota, C.; Ishigami, A.; Ohyama, S.; Tomari, S.; Hino, T.; Toyoda, K.; Minematsu, K.			Conducting FAST Message to Parents Through Their Children Using a Manga	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yokota, C.; Ishigami, A.; Ohyama, S.; Tomari, S.; Hino, T.; Toyoda, K.; Minematsu, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O56	23	23				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000056		
J	Tanaka, K; Yamada, T; Torii, T; Yoshimura, T; Takase, KI; Wakata, Y; Murai, H; Nakashima, N; Kira, JI				Tanaka, K.; Yamada, T.; Torii, T.; Yoshimura, T.; Takase, K., I; Wakata, Y.; Murai, H.; Nakashima, N.; Kira, J., I			Factors Associated with Excellent or Extremely Poor Functional Outcomes in Initial Ischemic Stroke with Atrial Fibrillation	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Tanaka, K.; Torii, T.; Murai, H.; Kira, J., I] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Yamada, T.] Fukuoka Saiseikai Gen Hosp, Dept Neurol, Fukuoka, Japan; [Yoshimura, T.] Fukuoka City Hosp, Dept Neurol, Fukuoka, Japan; [Takase, K., I] Iizuka Hosp, Dept Neurol, Iizuka, Fukuoka, Japan; [Wakata, Y.; Nakashima, N.] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka 812, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O67	29	29				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000067		
J	Matsuo, R; Kamouchi, M; Hata, J; Wakisaka, Y; Kuroda, J; Ago, T; Kitazono, T				Matsuo, R.; Kamouchi, M.; Hata, J.; Wakisaka, Y.; Kuroda, J.; Ago, T.; Kitazono, T.		FSR Investigators	Pioglitazone Treatment and Long-Term Post-Stroke Prognosis in Diabetic Patients with Acute Ischemic Stroke - The Fukuoka Stroke Registry	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Matsuo, R.; Hata, J.; Wakisaka, Y.; Kuroda, J.; Ago, T.; Kitazono, T.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Matsuo, R.; Kamouchi, M.] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan; [Kamouchi, M.; Hata, J.; Wakisaka, Y.; Kitazono, T.] Kyushu Univ, Grad Sch Med Sci, Ctr Cohort Studies, Fukuoka 812, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O75	33	33				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000074		
J	Uchiyama, S; Yoon, BW; Wang, Y; Hankey, GJ; Shoamanesh, A; Pater, C; Mundl, H; Berkowitz, SD; Connolly, SJ; Hart, RG				Uchiyama, S.; Yoon, B. W.; Wang, Y.; Hankey, G. J.; Shoamanesh, A.; Pater, C.; Mundl, H.; Berkowitz, S. D.; Connolly, S. J.; Hart, R. G.		NAVIGATE ESUS Asia Pacific	NAVIGATE ESUS: Multicenter, Randomized, Double-Blind, Phase III Trial of Rivaroxaban vs. Aspirin for the Prevention of Recurrent Stroke and Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Uchiyama, S.] Sanno Hosp, Sanno Med Ctr, Tokyo, Japan; [Yoon, B. W.] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Wang, Y.] Beijing Tiantan Hosp, Beijing, Peoples R China; [Hankey, G. J.] Univ Western Australia, Perth, WA 6009, Australia; [Shoamanesh, A.; Connolly, S. J.; Hart, R. G.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Pater, C.] Bayer Healthcare, Leverkusen, Germany; [Mundl, H.] Bayer Healthcare, Wuppertal, Germany; [Berkowitz, S. D.] Bayer Healthcare, Whippany, NJ USA			Hankey, Graeme /H-4968-2014	Hankey, Graeme /0000-0002-6044-7328				0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O77	34	35				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000076		
J	Hosomi, N; Nagai, Y; Aoki, S; Nezu, T; Kitagawa, K; Minematsu, K; Uchiyama, S; Matsumoto, M				Hosomi, N.; Nagai, Y.; Aoki, S.; Nezu, T.; Kitagawa, K.; Minematsu, K.; Uchiyama, S.; Matsumoto, M.		J-STARS Collaborators	Pravastatin Treatment Is More Effective for Preventing Occurrence of Atherothrombotic Infarction When Started Within 6 Months after Initial Stroke: Post-Hoc Analysis of J-STARS	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Hosomi, N.; Aoki, S.; Nezu, T.; Matsumoto, M.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Nagai, Y.] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Kitagawa, K.] Tokyo Womens Med Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Minematsu, K.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Uchiyama, S.] Int Univ Hlth & Welf, Sanno Hosp, Ctr Brain & Cerebral Vessels, Clin Res Ctr, Tokyo, Japan; [Uchiyama, S.] Sanno Med Ctr, Tokyo, Japan							Amarenco P, 2006, NEW ENGL J MED, V355, P549	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		O78	35	35				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000077		
J	Haga, S; Morioka, T; Shimogawa, T; Akiyama, T; Amano, T; Maehara, N; Murao, K; Arakawa, S				Haga, S.; Morioka, T.; Shimogawa, T.; Akiyama, T.; Amano, T.; Maehara, N.; Murao, K.; Arakawa, S.			Arterial Spin-Labeling Perfusion MRI with Dual Post Labeling Delay of 1.5 and 2.5 Seconds Method; A Correlative Study with Acetazolamide IMP SPECT	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Haga, S.; Morioka, T.; Shimogawa, T.; Akiyama, T.; Amano, T.; Maehara, N.] Kyushu Rosai Hosp, Dept Neurosurg, Kitakyushu, Fukuoka, Japan; [Murao, K.; Arakawa, S.] Kyushu Rosai Hosp, Dept Cerebrovasc Dis, Kitakyushu, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P019	43	43				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000095		
J	Ihara, M; Tonomura, S; Tanaka, T; Friedland, R; Kuriyama, N; Nomura, R; Watanabe, Y; Nakano, K; Toyoda, K; Nagatsuka, K				Ihara, M.; Tonomura, S.; Tanaka, T.; Friedland, R.; Kuriyama, N.; Nomura, R.; Watanabe, Y.; Nakano, K.; Toyoda, K.; Nagatsuka, K.			Cerebral Hemorrhage and Microbleeds Associated with Oral cnm-Positive Streptococcus Mutans	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Ihara, M.; Tonomura, S.; Tanaka, T.; Toyoda, K.; Nagatsuka, K.] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan; [Friedland, R.] Univ Louisville, Louisville, KY 40292 USA; [Kuriyama, N.; Watanabe, Y.] Kyoto Prefectural Univ Med, Kyoto, Japan; [Nomura, R.; Nakano, K.] Osaka Univ, Grad Sch Dent, Osaka, Japan							Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P024	45	45				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000099		
J	Teranishi, A; Kikkawa, Y; Yokosako, S; Ikeda, T; Nakashima, H; Ito, S; Yamaguchi, Y; Shimohigoshi, W; Ikegami, M; Kurita, H				Teranishi, A.; Kikkawa, Y.; Yokosako, S.; Ikeda, T.; Nakashima, H.; Ito, S.; Yamaguchi, Y.; Shimohigoshi, W.; Ikegami, M.; Kurita, H.			Acute Ophthalmoplesia Caused by Ruptured Middle Cerebral Artery Aneurysm	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Teranishi, A.; Kikkawa, Y.; Yokosako, S.; Ikeda, T.; Nakashima, H.; Ito, S.; Yamaguchi, Y.; Shimohigoshi, W.; Ikegami, M.; Kurita, H.] Saitama Int Med Ctr, Saitama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P025	45	45				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000100		
J	Matsuo, A; Yoshimura, A; Kanayama, M; Obama, S; Hidaka, T; Ibayashi, S				Matsuo, A.; Yoshimura, A.; Kanayama, M.; Obama, S.; Hidaka, T.; Ibayashi, S.			The Relationship between Home Discharge and Abilities of Toileting Activities in Chronic Stroke Patients in Convalescent Rehabilitation Hospital	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Matsuo, A.; Yoshimura, A.; Kanayama, M.; Ibayashi, S.] Seiai Rehabil Hosp, Fukuoka, Japan; [Obama, S.; Hidaka, T.] St Marys Coll, Sch Nursing, Kurume, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P060	60	61				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000135		
J	Matsushima, H; Hosomi, N; Hara, N; Neshige, S; Yoshimoto, T; Takeshima, S; Shimoe, Y; Takamatsu, K; Kuriyama, M; Matumoto, M				Matsushima, H.; Hosomi, N.; Hara, N.; Neshige, S.; Yoshimoto, T.; Takeshima, S.; Shimoe, Y.; Takamatsu, K.; Kuriyama, M.; Matumoto, M.			ABI and baPWV Are Independent Predictive Factors for a Clinical Outcome in Acute Non-Cardioembolic Stroke	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Matsushima, H.; Hosomi, N.; Matumoto, M.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Hiroshima, Japan; [Hara, N.; Neshige, S.; Yoshimoto, T.; Takeshima, S.; Shimoe, Y.; Takamatsu, K.; Kuriyama, M.] Ota Mem Hosp, Brain Attack Ctr, Dept Neurol, Fukuyama, Hiroshima, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P061	61	61				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000136		
J	Miyazaki, Y; Seguchi, O; Tanaka, T; Hata, H; Yanase, M; Nagatsuka, K; Takahashi, J; Fujita, T; Nakatani, T; Toyoda, K				Miyazaki, Y.; Seguchi, O.; Tanaka, T.; Hata, H.; Yanase, M.; Nagatsuka, K.; Takahashi, J.; Fujita, T.; Nakatani, T.; Toyoda, K.			Management of Intracranial Hemorrhage in Patients with Left Ventricular Assist Devices	CEREBROVASCULAR DISEASES			English	Meeting Abstract							ANTICOAGULATION		[Miyazaki, Y.; Toyoda, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Dis, Suita, Osaka, Japan; [Seguchi, O.; Tanaka, T.; Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Dept Organ Transplantat, Suita, Osaka, Japan; [Yanase, M.; Nagatsuka, K.] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Fujita, T.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Takahashi, J.] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan							Takahashi A, 2010, INT J GERONTOL, V4, P143; Wilson TJ, 2013, J NEUROSURG, V118, P1063, DOI 10.3171/2013.1.JNS121849; Kreuziger LMB, 2015, J THROMB THROMBOLYS, V39, P337, DOI 10.1007/s11239-014-1162-6	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P063	61	62				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000137		
J	Obama, S; Hidaka, T; Nishiguchi, H; Yoshimura, A; Kanayama, M; Ibayashi, S				Obama, S.; Hidaka, T.; Nishiguchi, H.; Yoshimura, A.; Kanayama, M.; Ibayashi, S.			A Study of Nursing Intervention Programs for Apathy Patients - The Effect of Using Games to Enhance Patients' Motivation	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Obama, S.; Hidaka, T.] St Marys Coll, Sch Nursing, Kurume, Fukuoka, Japan; [Nishiguchi, H.] Tokai Univ, Sch Informat & Telecommun Engn, Tokyo 151, Japan; [Yoshimura, A.; Kanayama, M.; Ibayashi, S.] Seiai Rehabil Hosp, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P065	62	62				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000138		
J	Tanaka, T; Ihara, M; Yamagami, H; Toyoda, K; Nagatsuka, K				Tanaka, T.; Ihara, M.; Yamagami, H.; Toyoda, K.; Nagatsuka, K.			Key Factors That Lower Time in Therapeutic Range of Warfarin in Patients with Non-Valvular Atrial Fibrillation	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Tanaka, T.; Ihara, M.; Yamagami, H.; Nagatsuka, K.] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Toyoda, K.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P084	70	70				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000156		
J	Tobinaga, K; Kato, S; Egashira, M; Maeda, R; Hidaka, T; Ishii, M; Ide, M				Tobinaga, K.; Kato, S.; Egashira, M.; Maeda, R.; Hidaka, T.; Ishii, M.; Ide, M.			The Effect of Hybrid-Type Knee-Ankle-Foot Orthosis and Rehabilitative Team Approach on the Toileting Activity in a Person with Cerebellar Vascular Disease	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Tobinaga, K.; Kato, S.; Egashira, M.; Maeda, R.; Ishii, M.; Ide, M.] St Marys Healthcare Ctr, Kurume, Fukuoka, Japan; [Hidaka, T.] St Marys Coll, Sch Nursing, Kurume, Fukuoka, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P087	71	71				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000159		
J	Yamamoto, R; Nakae, Y; Tanaka, F; Johkura, K				Yamamoto, R.; Nakae, Y.; Tanaka, F.; Johkura, K.			D-Dimer and PT-INR in Ischemic Stroke Patients Sufficiently Treated with Warfarin	CEREBROVASCULAR DISEASES			English	Meeting Abstract							ATRIAL-FIBRILLATION; ANTICOAGULATION		[Yamamoto, R.] Hiratsuka Kyosai Hosp, Hiratsuka, Kanagawa, Japan; [Nakae, Y.; Tanaka, F.] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Johkura, K.] Yokohama Brain & Spine Ctr, Yokohama, Kanagawa, Japan							Wakita M, 2002, ANGIOLOGY, V53, P551, DOI 10.1177/000331970205300508; Indredavik B, 2005, J INTERN MED, V258, P133, DOI 10.1111/j.1365-2796.2005.01512.x; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS7, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.003; Inoue Y., 2010, J CLIN NEUROL, V50, P455	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P097	74	75				2	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000168		
J	Yamashita, T; Matsuzono, K; Nakano, Y; Morihara, R; Abe, K				Yamashita, T.; Matsuzono, K.; Nakano, Y.; Morihara, R.; Abe, K.			Cell Transplantation Therapy with Direct Reprogrammed Neuronal Cells for Stroke	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yamashita, T.; Matsuzono, K.; Nakano, Y.; Morihara, R.; Abe, K.] Okayama Univ, Dept Neurol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P098	75	75				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000169		
J	Yoshimura, R; Kawabata, M; Nakanishi, Y; Isii, M; Nakamura, Y; Nakai, K				Yoshimura, R.; Kawabata, M.; Nakanishi, Y.; Isii, M.; Nakamura, Y.; Nakai, K.			Stroke Under Anticoagulants for Atrial Fibrillation in Wakayama	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yoshimura, R.; Kawabata, M.; Nakanishi, Y.; Isii, M.; Nakamura, Y.; Nakai, K.] Minami Wakayama Med Ctr, Dept Neurosurg, Wakayama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P100	75	75				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000170		
J	Yunoki, T; Syoichiro, K; Hisashi, N; Nobuhiko, O; Yasuhiro, M				Yunoki, T.; Syoichiro, K.; Hisashi, N.; Nobuhiko, O.; Yasuhiro, M.			Clinical Evaluation of CKD for rt-PA Intravenous Therapy	CEREBROVASCULAR DISEASES			English	Meeting Abstract									[Yunoki, T.; Syoichiro, K.; Hisashi, N.; Nobuhiko, O.; Yasuhiro, M.] Okayama Med Ctr, Okayama, Japan								0	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	OCT	2015	40			1		P101	76	76				1	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CT0XT	WOS:000362522000171		
J	Okusu, S; Hirano, K; Tokunaga, E; Shibata, N				Okusu, Satoshi; Hirano, Kazuki; Tokunaga, Etsuko; Shibata, Norio			Organocatalyzed Trifluoromethylation of Ketones and Sulfonyl Fluorides by Fluoroform under a Superbase System	CHEMISTRYOPEN			English	Article						fluoroform; organocatalysis; phosphazene base; triflone; trifluoromethylation	NUCLEOPHILIC TRIFLUOROMETHYLATION; MEDICINAL CHEMISTRY; CARBONYL-COMPOUNDS; T-BU-P4 BASE; DEPROTONATIVE FUNCTIONALIZATION; ELECTROGENERATED BASE; ORGANOZINC REAGENTS; EFFICIENT PRECURSOR; 2-PHOTON ABSORPTION; DIRECT CUPRATION	Fluoroform (HCF3, HFC-23) is a side product in the manufacture of polytetrafluoroethylene (Teflon). Despite its attractive properties, taming HCF3 for trifluoromethylation is quite problematic owing to its low acidity and the lability of the naked trifluoromethyl carbanion generated from HCF3. Herein we report the organic-superbase-catalyzed trifluoromethylation of ketones and arylsulfonyl fluorides by HCF3. The reactions were carried out by using a newly developed superbase organocatalyst system consisting of catalytic amounts of P-4-tBu and N(SiMe3)(3). A series of aryl and alkyl ketones were converted into the corresponding -trifluoromethyl carbinols in good yields under the organocatalysis conditions in THF. The superbase organocatalytic system can also be applied to the trifluoromethylation of arylsulfonyl fluorides for biologically important aryl triflones in THF or DMF in good yields. Protonated P-4-tBu, H[P-4-tBu](+), is suggested to be crucial for the catalytic process. This new catalytic methodology using HCF3 is expected to expand the range of synthetic applications of trifluoromethylation.	[Okusu, Satoshi; Hirano, Kazuki; Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Okusu, Satoshi; Hirano, Kazuki; Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Okusu, S (reprint author), Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan; Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency; Pesticide Science Society of Japan	This research was supported financially in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan, the Advanced Catalytic Transformation (ACT-C) from the Japan Science and Technology (JST) Agency, and the Pesticide Science Society of Japan.	Lishchynskyi A, 2013, J ORG CHEM, V78, P11126, DOI 10.1021/jo401423h; Imahori T, 2004, ADV SYNTH CATAL, V346, P1090, DOI 10.1002/adsc.200404076; Imahori T, 2003, J AM CHEM SOC, V125, P8082, DOI 10.1021/ja0342300; Prakash GKS, 2014, ANGEW CHEM INT EDIT, V53, P11575, DOI 10.1002/anie.201406505; Kargbo R, 2007, J AM CHEM SOC, V129, P3846, DOI 10.1021/ja070742t; Koppel IA, 2001, J PHYS CHEM A, V105, P9575, DOI 10.1021/jp012168s; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; SCHWESINGER R, 1987, ANGEW CHEM INT EDIT, V26, P1167, DOI 10.1002/anie.198711671; Mongin O, 2007, CHEM-EUR J, V13, P1481, DOI 10.1002/chem.200600689; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Novak P, 2012, J AM CHEM SOC, V134, P16167, DOI 10.1021/ja307783w; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Porres L, 2004, ORG LETT, V6, P47, DOI 10.1021/ol036041s; Sleebs BE, 2011, J MED CHEM, V54, P1914, DOI 10.1021/jm101596e; FRASER RR, 1985, J ORG CHEM, V50, P3232, DOI 10.1021/jo00217a050; Prakash GKS, 2012, SCIENCE, V338, P1324, DOI 10.1126/science.1227859; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Shibata N, 2008, TETRAHEDRON-ASYMMETR, V19, P2633, DOI 10.1016/j.tetasy.2008.11.011; Cametti M, 2012, CHEM SOC REV, V41, P31, DOI 10.1039/c1cs15084g; Lessene G, 2000, J ELECTROANAL CHEM, V490, P79, DOI 10.1016/S0022-0728(00)00244-8; Kobayashi K, 2009, CHEM-EUR J, V15, P9805, DOI 10.1002/chem.200900556; RAMAIAH P, 1995, ORG SYNTH, V72, P232; Folleas B, 1998, TETRAHEDRON LETT, V39, P2973, DOI 10.1016/S0040-4039(98)00391-8; Novak P, 2012, ANGEW CHEM INT EDIT, V51, P7767, DOI 10.1002/anie.201201613; Zhang Y, 2013, J FLUORINE CHEM, V156, P367, DOI 10.1016/j.jfluchem.2013.07.018; Lishchynskyi A, 2014, CHEM COMMUN, V50, P10237, DOI 10.1039/c4cc04930f; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026; SYMONS EA, 1981, J AM CHEM SOC, V103, P3127, DOI 10.1021/ja00401a034; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h; Kawai H, 2013, ORG BIOMOL CHEM, V11, P1446, DOI 10.1039/c3ob27368g; Large S, 2000, J ORG CHEM, V65, P8848, DOI 10.1021/jo000150s; Naka H, 2008, ADV SYNTH CATAL, V350, P1901, DOI 10.1002/adsc.200800281; Konovalov AI, 2014, J AM CHEM SOC, V136, P13410, DOI 10.1021/ja507564p; Billard T, 2000, ORG LETT, V2, P2101, DOI 10.1021/ol005987o; Araki Y, 2011, ORG BIOMOL CHEM, V9, P78, DOI 10.1039/c0ob00740d; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; El Guesmi N, 2008, ORG BIOMOL CHEM, V6, P4041, DOI 10.1039/b810273b; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; SHONO T, 1991, J ORG CHEM, V56, P2, DOI 10.1021/jo00001a002; Mazloomi Z, 2014, ORG PROCESS RES DEV, V18, P1020, DOI 10.1021/op500109v; Folleas B, 2000, TETRAHEDRON, V56, P275, DOI 10.1016/S0040-4020(99)00951-5; Russell J, 1998, TETRAHEDRON, V54, P13771, DOI 10.1016/S0040-4020(98)00846-1; Barhdadi R, 1998, CHEM COMMUN, P1251, DOI 10.1039/a801406j; Barta K, 2008, ADV SYNTH CATAL, V350, P2013, DOI 10.1002/adsc.200800366; Filler R, 1982, BIOMEDICINAL ASPECTS; Goumont Régis, 2003, Org Biomol Chem, V1, P1741, DOI 10.1039/b302029k; Kobayashi K, 2008, CHEM COMMUN, P3780, DOI 10.1039/b807169a; Kobayashi K, 2006, CHEM COMMUN, P3128, DOI 10.1039/b606056k; Kuhar V. P., 1995, FLUORINE CONTAINING; Langlois B. R., 2003, SYNTHESIS-STUTTGART, P0185; Le Droumaguet C, 2005, CHEM COMMUN, P2802, DOI 10.1039/b502585k; Liang T., 2013, ANGEW CHEM, V125, P8372, DOI DOI 10.1002/ANGE.201206566; Liu X, 2015, CHEM REV, V115, P683, DOI 10.1021/cr400473a; Novak P., 2012, ANGEW CHEM, V124, P7887; Ojima I., 1996, BIOMEDICAL FRONTIERS; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Petrov V. A., 2009, FLUORINATED HETEROCY; Prakash G. K. S., 2014, ANGEW CHEM, V126, P11759; Schwesinger R., 1987, ANGEW CHEM, V99, P1212, DOI 10.1002/ange.19870991134; SHEPPARD WA, 1963, J AM CHEM SOC, V85, P1314, DOI 10.1021/ja00892a021; Shibata N., 2014, Japanese Pat, Patent No. [JP2014091691, 2014091691]; Suzawa K, 2006, CHEM COMMUN, P4850, DOI 10.1039/b611090h; Tarrant P., 1977, PREPARATION REACTION; Terrier F, 2005, J AM CHEM SOC, V127, P5563, DOI 10.1021/ja0436291; Ueno M, 2007, CHEM COMMUN, P2264, DOI 10.1039/b700140a; Ueno M, 2005, EUR J ORG CHEM, P1965, DOI 10.1002/ejoc.200500087; Ueno M, 2006, CHEM COMMUN, P3549, DOI 10.1039/b605807h; Welch J.T., 1991, FLUORINE BIOORGANIC; Xu XH, 2015, CHEM REV, V115, P731, DOI 10.1021/cr500193b; Yagupolskii L. M., 1993, ORGANOFLUORINE COMPO	74	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2191-1363			CHEMISTRYOPEN	ChemistryOpen	OCT	2015	4	5					581	585		10.1002/open.201500160		5	Chemistry, Multidisciplinary	Chemistry	CT3FC	WOS:000362691600004		
J	Beig, MI; Horiuchi, J; Dampney, RAL; Carrive, P				Beig, Mirza I.; Horiuchi, Jouji; Dampney, Roger A. L.; Carrive, Pascal			Both Ox1R and Ox2R orexin receptors contribute to the cardiorespiratory response evoked from the perifornical hypothalamus	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						blood pressure; DORA; heart rate; hypertension; hypocretin; hypothalamus; orexin; respiratory rate; SORA	SPONTANEOUSLY HYPERTENSIVE-RATS; ROSTRAL VENTROLATERAL MEDULLA; SOMATO-SYMPATHETIC REFLEX; ARTERIAL-PRESSURE; CARDIOVASCULAR ACTIONS; SELECTIVE ANTAGONIST; PROTEIN DISTRIBUTION; SOLITARY TRACT; NITRIC-OXIDE; HEART-RATE	Orexin/hypocretin neurons are located in and around the perifornical hypothalamus. Disinhibition of this area in the anaesthetized preparation evokes cardiorespiratory changes that can be reduced to nearly half or more by systemic Almorexant, a dual receptor antagonist of the two known orexin receptors, Ox1R and Ox2R. It is not clear if these reductions result from the blockade of one receptor or both. To determine the contribution of the two receptors, we compared the effects of Almorexant to those of the selective Ox1R antagonist ACT335827 and the selective Ox2R antagonists EMPA and TCS-OX2-29. Bicuculline (20 pmol) was injected in the perifornical hypothalamus of urethane-anaesthetized rats before and after administration of the drugs (all 15 mg/kg, intravenously). The pressor, tachycardic and tachypneic responses to bicuculline were attenuated/reduced by ACT335827 (by 19%, ns; 10%, ns and 24%, P < 0.01, respectively), EMPA (by 35% P < 0.01; 6%, ns; and 26% P < 0.05) and TCS-OX2-29 (by 13%, ns; 10%, ns and 42%, P < 0.001). These reductions represented only a fraction of the reduction after Almorexant (by 43%, P < 0.001; 42%, P < 0.001 and 65% P < 0.001). However, when the selective Ox1R and Ox2R antagonists were given in combination, the reductions were greater and closer to those of Almorexant (ACT335827 + EMPA, by 26%, P < 0.05; 24%, P < 0.05 and 47%, P < 0.001; ACT335827 + TCS-OX2-29, by 40%, P < 0.01; 26%, P < 0.001 and 59%, P < 0.0001). This was particularly clear with the tachypneic response. These results suggest that both orexin receptors contribute to the cardiorespiratory response evoked from the hypothalamus under anaesthesia. They are consistent with our previous study in the conscious animal.	[Beig, Mirza I.; Dampney, Roger A. L.; Carrive, Pascal] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Beig, Mirza I.; Dampney, Roger A. L.; Carrive, Pascal] Toyo Univ, Dept Biomed Engn, Kawagoe, Saitama, Japan; [Dampney, Roger A. L.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Dampney, Roger A. L.] Univ Sydney, Bosch Inst Biomed Res, Sydney, NSW 2006, Australia	Carrive, P (reprint author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	p.carrive@unsw.edu.au			National Health and Medical Research Council of Australia	This work was supported by the National Health and Medical Research Council of Australia. We are very grateful to Dr Francois Jenck and Dr Michel Steiner from Actelion Pharmaceutical for the generous donation of Almorexant and ACT335827.	Steiner MA, 2013, CHEMMEDCHEM, V8, P898, DOI 10.1002/cmdc.201300003; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Furlong TM, 2009, EUR J NEUROSCI, V30, P1603, DOI 10.1111/j.1460-9568.2009.06952.x; van den Pol AN, 1998, J NEUROSCI, V18, P7962; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Shahid IZ, 2011, BRIT J PHARMACOL, V162, P961, DOI 10.1111/j.1476-5381.2010.01102.x; Shih CD, 2007, NEUROSCIENCE, V149, P625, DOI 10.1016/j.neuroscience.2007.07.016; Smith PM, 2007, J NEUROENDOCRINOL, V19, P7, DOI 10.1111/j.1365-2826.2006.01497.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780; Shirasaka T, 2011, J ANESTH, V25, P65, DOI 10.1007/s00540-010-1071-6; de Oliveira CVR, 2003, AM J PHYSIOL-HEART C, V284, pH1369, DOI 10.1152/ajpheart.00877.2002; Cluderay JE, 2002, REGUL PEPTIDES, V104, P131, DOI 10.1016/S0167-0115(01)00357-3; Darwinkel A, 2014, NEUROSCIENCE, V278, P253, DOI 10.1016/j.neuroscience.2014.08.027; Lee YH, 2013, EXP PHYSIOL, V98, P1145, DOI 10.1113/expphysiol.2013.072298; Iigaya K, 2012, AM J PHYSIOL-REG I, V303, pR1011, DOI 10.1152/ajpregu.00263.2012; Gotter AL, 2012, PHARMACOL REV, V64, P389, DOI 10.1124/pr.111.005546; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Huang SC, 2010, J PHARMACOL EXP THER, V334, P522, DOI 10.1124/jpet.110.167791; Yasuda Y, 2003, ANESTH ANALG, V97, P1663, DOI 10.1213/01.ANE.0000089964.85834.EF; Ciriello J, 2013, NEUROSCIENCE, V250, P599, DOI 10.1016/j.neuroscience.2013.07.054; Dutschmann M, 2007, RESP PHYSIOL NEUROBI, V159, P232, DOI 10.1016/j.resp.2007.06.004; Dias MB, 2009, J PHYSIOL-LONDON, V587, P2059, DOI 10.1113/jphysiol.2008.168260; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Li AH, 2013, J PHYSIOL-LONDON, V591, P4237, DOI 10.1113/jphysiol.2013.256271; Malherbe P, 2009, MOL PHARMACOL, V76, P618, DOI 10.1124/mol.109.055152; Ciriello J, 2003, AM J PHYSIOL-REG I, V284, pR1611, DOI 10.1152/ajpregu.00719.2002; Ciriello J, 2003, BRAIN RES, V991, P84, DOI 10.1016/j.brainres.2003.08.008; Lebold TP, 2013, BIOORG MED CHEM LETT, V23, P4761, DOI 10.1016/j.bmcl.2013.06.057; Hirose M, 2003, BIOORG MED CHEM LETT, V13, P4497, DOI 10.1016/j.bmcl.2003.08.038; Malherbe P, 2009, BRIT J PHARMACOL, V156, P1326, DOI 10.1111/j.1476-5381.2009.00127.x; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Backberg M, 2002, EUR J NEUROSCI, V15, P315, DOI 10.1046/j.0953-816x.2001.01859.x; Luong LNL, 2012, NEUROSCIENCE, V202, P209, DOI 10.1016/j.neuroscience.2011.11.073; Dias MB, 2010, RESP PHYSIOL NEUROBI, V170, P96, DOI 10.1016/j.resp.2009.12.002; Shahid IZ, 2012, BRIT J PHARMACOL, V165, P2292, DOI 10.1111/j.1476-5381.2011.01694.x; Antunes VR, 2001, AM J PHYSIOL-REG I, V281, pR1801; Beig MI, 2014, NEUROPHARMACOLOGY C, V89C, P146; Carrive P., 2013, FRONT NEUROSCI, V7, P1; Clifford L, 2015, EXP PHYSIOL, V100, P388, DOI 10.1113/expphysiol.2014.084137; Guyenet PG, 2014, COMPR PHYSIOL, V4, P1511, DOI 10.1002/cphy.c140004; Li AH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00022; Mahler SV, 2014, NAT NEUROSCI, V17, P1298, DOI 10.1038/nn.3810; Morairty SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039131; Paxinos G., 2005, RAT BRAIN STEREOTAXI; Steiner MA, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00165; Xiao F., 2012, NEUROPHARMACOLOGY C, V67C, P16, DOI [10.1016/j.neuropharm.2012.10.021, DOI 10.1016/J.NEUROPHARM.2012.10.021]	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	OCT	2015	42	10					1059	1067		10.1111/1440-1681.12461		9	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CT2PD	WOS:000362644300007		
J	Shrestha, R; Hui, SP; Miura, Y; Yagi, A; Takahashi, Y; Takeda, S; Fuda, H; Chiba, H				Shrestha, Rojeet; Hui, Shu-Ping; Miura, Yusuke; Yagi, Akiko; Takahashi, Yuji; Takeda, Seiji; Fuda, Hirotoshi; Chiba, Hitoshi			Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						intermediate-density lipoprotein; liquid chromato-graphy/mass spectrometry; oxidized triglycerides; triglyceride-rich lipoproteins; very low-density lipoprotein	VERY-LOW-DENSITY; CHOLESTERYL ESTER HYDROPEROXIDES; ORBITRAP MASS-SPECTROMETER; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; LIQUID-CHROMATOGRAPHY; TRIACYLGLYCEROL HYDROPEROXIDES; NONFASTING TRIGLYCERIDES; REMNANT LIPOPROTEINS; RICH LIPOPROTEINS	Background: The role of triglycerides carried in the triglyceride-rich lipoproteins (TRL) in the progression of atherosclerosis is uncertain. Identification of oxidized triglycerides and its possible association with atherosclerosis were largely ignored. Here we applied mass spectrometric approach to detect and identify triglyceride hydroperoxides (TGOOH) in human plasma and lipoproteins. Methods: EDTA plasma was collected from healthy human volunteers (n = 9) after 14-16 h of fasting. Very low-density lipoprotein (VLDL) (d<1.006) and intermediatedensity lipoprotein (IDL) (d=1.006-1.019) were isolated from the plasma (n=6) by sequential ultracentrifugation in KBr, followed by the isolation of LDL and high-density lipoprotein (HDL) using size-exclusion high-performance liquid chromatography (HPLC). Total lipids from the plasma and isolated lipoproteins were extracted, and analyzed for the detection and identification of TGOOH using liquid chromatography/LTQ ion trap Orbitrap mass spectrometry. All the processes, from specimen collection to the mass spectrometric analysis, were carried out at 4 degrees C in the presence of antioxidant to prevent oxidation of lipoproteins. Results: We identified 11 molecular species of TGOOH in either plasma or VLDL and IDL, of which TGOOH-18:1/18:2/16:0, TGOOH-18:1/18:1/16:0, TGOOH-16:0/18:2/16:0, TGOOH-18:1/18:1/18:1, and TGOOH-16:0/20:4/16:0 were most dominant. These TGOOH molecules are carried by TRL but not by LDL and HDL. Mean concentration of TGOOH in plasma, VLDL and IDL were, respectively, 56.1 +/- 25.6, 349.8 +/- 253.6 and 512.5 +/- 173.2 mu mol/mol of triglycerides. Conclusions: This is the first report to identify several molecular species of oxidized triglycerides in TRL. Presence of oxidized triglyceride may contribute to the atherogenicity of TRL. Further work is needed to elucidate the association of the oxidized triglyceride in atherosclerosis.	[Shrestha, Rojeet; Hui, Shu-Ping; Miura, Yusuke; Yagi, Akiko; Takahashi, Yuji; Takeda, Seiji; Fuda, Hirotoshi; Chiba, Hitoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan	Hui, SP (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	keino@hs.hokudai.ac.jp			Regional Innovation Strategy Support Program, Sapporo Health Innovation "Smart-H", of The Ministry of Education, Culture, Sports, Sciences and Technology, Japan; Japan Society for promotion of Sciences, Japan	This work was supported by the Regional Innovation Strategy Support Program, Sapporo Health Innovation "Smart-H", of The Ministry of Education, Culture, Sports, Sciences and Technology, Japan and partly by a Grant-in-Aid for scientific Research from the Japan Society for promotion of Sciences, Japan. A part of this study was presented during annual meeting of American Association of Clinical Chemistry (AACC) and has been recognized as "National Academy of Clinical Biochemistry (NACB) distinguished Abstract Award 2013".	Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Byrdwell WC, 2001, J CHROMATOGR A, V905, P85, DOI 10.1016/S0021-9673(00)00958-4; NouroozZadeh J, 1996, BIOCHEM J, V313, P781; Hui SP, 2003, LIPIDS, V38, P1287, DOI 10.1007/s11745-003-1191-9; Staprans I, 1996, J LIPID RES, V37, P420; Cohn JS, 1999, ARTERIOSCL THROM VAS, V19, P2474; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767; Girotti AW, 1998, J LIPID RES, V39, P1529; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Hui SP, 2012, ANAL BIOANAL CHEM, V403, P1831, DOI 10.1007/s00216-012-5833-x; Suomela JP, 2005, LIPIDS, V40, P437, DOI 10.1007/s11745-005-1402-4; Nakajima K, 2012, CLIN CHIM ACTA, V413, P1077, DOI 10.1016/j.cca.2012.02.026; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P512; Boren J, 2014, CLIN CHIM ACTA, V431, P131, DOI 10.1016/j.cca.2014.01.015; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Hui SP, 2012, ANAL BIOANAL CHEM, V404, P101, DOI 10.1007/s00216-012-6118-0; Staprans I, 1996, ARTERIOSCL THROM VAS, V16, P533; Kusaka T, 1996, J CHROMATOGR A, V730, P1, DOI 10.1016/0021-9673(95)00996-5; Suomela JP, 2004, LIPIDS, V39, P507, DOI 10.1007/s11745-004-1257-8; Hui SP, 2013, ANAL BIOANAL CHEM, V405, P4981, DOI 10.1007/s00216-013-6903-4; WALZEM RL, 1995, P NATL ACAD SCI USA, V92, P7460, DOI 10.1073/pnas.92.16.7460; Mack WJ, 1996, ARTERIOSCL THROM VAS, V16, P697; Suomela JP, 2004, LIPIDS, V39, P639, DOI 10.1007/s11745-004-1277-4; Suomela JP, 2005, LIPIDS, V40, P349, DOI 10.1007/s11745-006-1393-1; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018; Browne RW, 2000, CLIN CHEM, V46, P829; NAITO C, 1993, ANN NY ACAD SCI, V676, P27; AKASAKA K, 1993, J CHROMATOGR-BIOMED, V617, P205, DOI 10.1016/0378-4347(93)80489-Q; Hui SP, 2005, LIPIDS, V40, P515, DOI 10.1007/s11745-005-1412-2; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Havel RJ, 2000, HDB LIPOPROTEIN TEST, P565; Hodis HN, 1997, CIRCULATION, V1997, P95; KRAUSS RM, 1987, LANCET, V2, P62; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Rapaport E, 1993, JAMA-J AM MED ASSOC, V269, P505; Shrestha R, 2014, ANN CLIN BIOCHEM, V51, P662, DOI 10.1177/0004563213516093; Sprecher DL, 1998, AM J CARDIOL, V82, p49U, DOI 10.1016/S0002-9149(98)00953-9; Zaburlini A, 1995, ANAL BIOCHEM, V232, P107	45	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	OCT	2015	53	11					1859	1869		10.1515/cclm-2014-1088		11	Medical Laboratory Technology	Medical Laboratory Technology	CT0TM	WOS:000362510000034		
J	Kanbayashi, T; Saito, F; Matsukawa, T; Oba, H; Hokkoku, K; Hatanaka, Y; Tsuji, S; Sonoo, M				Kanbayashi, Takamichi; Saito, Fumiaki; Matsukawa, Takashi; Oba, Hiroshi; Hokkoku, Keiichi; Hatanaka, Yuki; Tsuji, Shoji; Sonoo, Masahiro			Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4	CLINICAL GENETICS			English	Letter							EIF2B-RELATED DISORDERS; NATURAL-HISTORY; LEUKOENCEPHALOPATHY; GENOTYPE		[Kanbayashi, Takamichi; Saito, Fumiaki; Hokkoku, Keiichi; Hatanaka, Yuki; Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Tokyo 1738605, Japan; [Matsukawa, Takashi; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Oba, Hiroshi] Teikyo Univ, Sch Med, Dept Radiol, Tokyo 173, Japan	Saito, F (reprint author), Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	f-saito@med.teikyo-u.ac.jp					van der Knaap MS, 1999, J CHILD NEUROL, V14, P728, DOI 10.1177/088307389901401108; vanderKnaap MS, 1997, NEUROLOGY, V48, P845; van der Lei HDW, 2010, NEUROLOGY, V75, P1555, DOI 10.1212/WNL.0b013e3181f962ae; Carra-Dalliere C, 2011, REV NEUROL-FRANCE, V167, P802, DOI 10.1016/j.neurol.2011.03.008; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; Fogli A, 2004, NEUROLOGY, V62, P1509	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	OCT	2015	88	4					401	403		10.1111/cge.12554		3	Genetics & Heredity	Genetics & Heredity	CT3BR	WOS:000362681500020		
J	Jimbo, R; Naito, Y; Galli, S; Berner, S; Dard, M; Wennerberg, A				Jimbo, Ryo; Naito, Yoshihito; Galli, Silvia; Berner, Simon; Dard, Michel; Wennerberg, Ann			Biomechanical and Histomorphometrical Evaluation of TiZr Alloy Implants: An in vivo Study in the Rabbit	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						animal study; bone-implant interface; histological analysis	TITANIUM-ZIRCONIUM; TISSUE INTEGRATION; BONE APPOSITION; DENTAL IMPLANTS; SURFACE; DIAMETER	BackgroundClinically, there is a demand for mechanically stronger alloyed implants; however, not much evidence exists with regard to these materials. PurposeTo test the osseointegration property of TiZr1317 implants in a rabbit model. Materials and MethodsHydrophilic titanium-zirconium alloy (TiZr1317) implants with sand-blasted and acid-etched surface (test) and hydrophilic cpTi implants with the same treatment (control) were placed pairwise in the hind limbs (two in each tibia and one in each femur) of 36 Swedish lop-eared rabbits. After 2, 4, and 12 weeks (n=12/time point), the bone samples were subjected to removal torque (RTQ, proximal tibia and femur) and histologic/histomorphometric (distal tibia) testings. ResultsThe control presented significantly higher RTQ than the test at 2 weeks (55 vs 36Ncm). No differences were observed for other time points. The test presented higher mean BIC than the control (19.25 vs 13.89 %) at 4 weeks; however, there were no statistical differences for the following time point tested in vivo.The new bone area was significantly higher for the test at 4 weeks in the marrow areas. ConclusionThe TiZr1317 implants presented comparable biologic outcomes to that of the cpTi implants through a 12-week evaluation period.	[Jimbo, Ryo; Galli, Silvia; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden; [Naito, Yoshihito] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan; [Berner, Simon; Dard, Michel] Inst Straumann AG, Basel, Switzerland; [Dard, Michel] NYU, Coll Dent, Dept Periodont, New York, NY USA	Jimbo, R (reprint author), Malmo Univ, Fac Odontol, Dept Prosthodont, S-20506 Malmo, Sweden.	ryo.jimbo@mah.se			Institut Straumann AG, Basel, Switzerland	This study was fully funded by Institut Straumann AG, Basel, Switzerland. The authors acknowledge Marcel Obrecht for the technical and administrative assistance throughout the study.	ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Al-Nawas B, 2014, J ORAL IMPLANTOL; Anchieta RB, 2014, CLIN IMPLANT DENT R, V16, P913, DOI 10.1111/cid.12061; Mertens C, 2011, CLIN ORAL IMPLAN RES, V22, P1354, DOI 10.1111/j.1600-0501.2010.02123.x; Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J; Ostman PO, 2010, CLIN IMPLANT DENT R, V12, P39, DOI 10.1111/j.1708-8208.2008.00128.x; Buser D, 2004, J DENT RES, V83, P529; Li SJ, 2004, BIOMATERIALS, V25, P2525, DOI 10.1016/j.biomaterials.2003.09.039; Correa DRN, 2014, MAT SCI ENG C-MATER, V34, P354, DOI 10.1016/j.msec.2013.09.032; Johansson CB, 2012, CLIN IMPLANT DENT R, V14, P603, DOI 10.1111/j.1708-8208.2010.00296.x; Wennerberg A, 2013, CLIN ORAL IMPLAN RES, V24, P203, DOI 10.1111/j.1600-0501.2012.02429.x; Thoma DS, 2011, J PERIODONTOL, V82, P1453, DOI 10.1902/jop.2010.100737; Al-Nawas B, 2012, CLIN IMPLANT DENT R, V14, P896, DOI 10.1111/j.1708-8208.2010.00324.x; Saulacic N, 2012, EUR CELLS MATER, V23, P273; Chiapasco M, 2012, CLIN ORAL IMPLAN RES, V23, P1136, DOI 10.1111/j.1600-0501.2011.02296.x; Yamano S, 2011, INT J ORAL MAX IMPL, V26, P1247; Stenport VF, 2008, CLIN IMPLANT DENT R, V10, P191, DOI 10.1111/j.1708-8208.2007.00077.x; Allum SR, 2008, CLIN ORAL IMPLAN RES, V19, P553, DOI 10.1111/j.1600-0501.2007.01395.x; Wen B, 2014, CLIN ORAL IMPLAN RES, V25, P819, DOI 10.1111/clr.12141; Kammerer PW, 2014, CLIN ORAL IMPLAN RES, V25, P774, DOI 10.1111/clr.12175; Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Grandin HM, 2012, MATERIALS, V5, P1348, DOI 10.3390/ma5081348; Welander M, 2008, CLIN ORAL IMPLAN RES, V19, P635, DOI 10.1111/j.1600-0501.2008.01543.x; Veltri M, 2008, CLIN ORAL IMPLAN RES, V19, P1069, DOI 10.1111/j.1600-0501.2008.01531.x; Teixeira ER, 1997, J PROSTHET DENT, V78, P166, DOI 10.1016/S0022-3913(97)70121-5; Sawase T, 2007, CLIN ORAL IMPLAN RES, V18, P680, DOI 10.1111/j.1600-0501.2007.01404.x; Bernhard N., 2009, FORUM IMPLANTOLOGICU, V5, P30; DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231; Quirynen M, 2015, CLIN ORAL IMPLAN RES, V26, P831, DOI 10.1111/clr.12367; Wennerberg A, 2013, CLIN ORAL IMPLAN RES, V25, P1041; Wu AYJ, 2014, IMPLANT DENT, V23, P534, DOI 10.1097/ID.0000000000000108	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	OCT	2015	17			2			E670	E678		10.1111/cid.12305		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS9SZ	WOS:000362433400033		
J	Kaminaka, A; Nakano, T; Ono, S; Kato, T; Yatani, H				Kaminaka, Akihiro; Nakano, Tamaki; Ono, Shinji; Kato, Tokinori; Yatani, Hirofumi			Cone-Beam Computed Tomography Evaluation of Horizontal and Vertical Dimensional Changes in Buccal Peri-Implant Alveolar Bone and Soft Tissue: A 1-Year Prospective Clinical Study	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						abutment design; clinical study; cone beam CT; implants; prei-implant tissue; prospective	FINITE-ELEMENT-ANALYSIS; DENTAL IMPLANT; IN-VITRO; RADIOGRAPHIC EVALUATION; INTERNATIONAL-CONGRESS; EXTRACTION SOCKETS; ABUTMENT INTERFACE; SUBMERGED IMPLANTS; MICROGAP LOCATION; DOG	PurposeThis study evaluated changes in the horizontal and vertical dimensions of the buccal alveolar bone and soft tissue over a 1-year period following implant prosthesis. Materials and MethodsThirty-three participants with no history of guided bone regeneration or soft tissue augmentation underwent dental implant placement with different types of connections. The dimensions of the buccal alveolar bone and soft tissue were evaluated immediately and at 1 year after prosthesis from reconstructions of cross-sectional cone-beam computed tomography images. ResultsThe vertical and horizontal loss of buccal bone and soft tissue around implants with conical connections were lower than around those with external or internal connections. Statistically significant negative correlations were observed between initial horizontal bone thickness and changes in vertical bone and soft tissue height (p<.05), and between initial horizontal soft tissue thickness and the change in vertical soft tissue height (p<.05). ConclusionImplants with a conical connection preserve peri-implant alveolar bone and soft tissue more effectively than other connection types. Furthermore, the initial buccal alveolar bone and soft tissue thickness around the implant platform may influence their vertical dimensional changes at 1 year after implant prosthesis.	[Kaminaka, Akihiro; Nakano, Tamaki; Ono, Shinji; Kato, Tokinori; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka, Japan	Nakano, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	tnakano@dent.osaka-u.ac.jp					Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11; Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x; Becker K, 2012, J CLIN PERIODONTOL, V39, P774, DOI 10.1111/j.1600-051X.2012.01911.x; Poeschl PW, 2013, CLIN ORAL INVEST, V17, P317, DOI 10.1007/s00784-012-0704-6; Chang CL, 2010, INT J ORAL MAX IMPL, V25, P295; Gehrke P, 2008, J ESTHET RESTOR DENT, V20, P375, DOI 10.1111/j.1708-8240.2008.00212.x; Al-Ekrish AA, 2011, DENTOMAXILLOFAC RAD, V40, P67, DOI 10.1259/dmfr/27546065; Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x; Fatemitabar SA, 2010, INT J ORAL MAX IMPL, V25, P499; Brisco J, 2014, BRIT J ORAL MAX SURG, V52, P76, DOI 10.1016/j.bjoms.2013.09.011; Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322; Weng D, 2008, CLIN ORAL IMPLAN RES, V19, P1141, DOI 10.1111/j.1600-0501.2008.01564.x; Linkevicius T, 2009, INT J ORAL MAX IMPL, V24, P712; Grunder U, 2005, INT J PERIODONT REST, V25, P113; Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059; Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x; Loubele M, 2009, EUR J RADIOL, V71, P461, DOI 10.1016/j.ejrad.2008.06.002; Weng D, 2011, INT J ORAL MAX IMPL, V26, P941; Lazzara RJ, 2006, INT J PERIODONT REST, V26, P9; Benavides E, 2012, IMPLANT DENT, V21, P78, DOI 10.1097/ID.0b013e31824885b5; Kim Y, 2005, CLIN ORAL IMPLAN RES, V16, P26, DOI 10.1111/j.1600-0501.2004.01067.x; Luongo R, 2008, INT J PERIODONT REST, V28, P551; Abrahamsson I, 1996, CLIN ORAL IMPLAN RES, V7, P212, DOI 10.1034/j.1600-0501.1996.070303.x; Steinebrunner L, 2005, INT J ORAL MAX IMPL, V20, P875; Kim TS, 2010, J ENDODONT, V36, P1191, DOI 10.1016/j.joen.2010.03.028; Hermann JS, 2001, J PERIODONTOL, V72, P1372, DOI 10.1902/jop.2001.72.10.1372; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Cochran DL, 2009, J PERIODONTOL, V80, P725, DOI 10.1902/jop.2009.080401; Tesmer M, 2009, J PERIODONTOL, V80, P1991, DOI 10.1902/jop.2009.090178; ERICSSON I, 1993, J CLIN PERIODONTOL, V20, P623, DOI 10.1111/j.1600-051X.1993.tb00706.x; Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x; Becker W, 2009, J PERIODONTOL, V80, P347, DOI 10.1902/jop.2009.080286 ; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; Shin YK, 2006, INT J ORAL MAX IMPL, V21, P789; Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Holberg Christof, 2005, J Orofac Orthop, V66, P434, DOI 10.1007/s00056-005-0519-z; Sukovic P, 2003, Orthod Craniofac Res, V6 Suppl 1, P31, DOI 10.1034/j.1600-0544.2003.259.x; Tonetti M S, 1994, Periodontol 2000, V4, P127, DOI 10.1111/j.1600-0757.1994.tb00013.x; Yamanishi Y, 2012, DENT MATER, V28, P26, DOI 10.1016/j.dental.2012.07.160	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	OCT	2015	17			2			E576	E585		10.1111/cid.12286		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS9SZ	WOS:000362433400023		
J	Kuroshima, S; Yasutake, M; Tsuiki, K; Nakano, T; Sawase, T				Kuroshima, Shinichiro; Yasutake, Munenori; Tsuiki, Kotaro; Nakano, Takayoshi; Sawase, Takashi			Structural and Qualitative Bone Remodeling Around Repetitive Loaded Implants in Rabbits	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						anisotropy; bone quality; collagen; dental implant; osseointegration; osteocytes; x-ray diffraction	BIOLOGICAL APATITE CRYSTALLITES; TITANIUM IMPLANTS; OSTEOPOROSIS PREVENTION; TISSUE DIFFERENTIATION; CORTICAL BONE; OSTEOCYTE; MICROSTRUCTURE; ORIENTATION; STRENGTH; THERAPY	BackgroundBone mechanical function is regulated by bone quality and bone mineral density (BMD) that reflect bone strength. The preferential alignment of biological apatite (BAp) c-axis/collagen fibers and osteocytes is a determinant factor of bone quality. However, the effect of mechanical loading on bone quality around dental implants is unclear. PurposeThe aim of this study was to clarify the effects of mechanical loading on osseointegration, bone volume BMD, and bone quality around dental implants. Materials and MethodsTwenty anodized Ti-6Al-4V alloy implants (KYOCERA Co., Kyoto, Japan) were placed in the proximal tibial metaphysis of 10 rabbits. Twelve weeks after surgery, mechanical loading was applied along the long axis of the implant (50N, 3Hz, 1,800cycles, 2 days/week) for 8 weeks. Osseointegration, bone volume, BMD, and bone quality were evaluated using light microscopy, microcomputed tomography, polarized light microscopy, and microbeam X-ray diffractometer. ResultsMechanical loading increased osseointegration, bone volume, and BMD. Bone quality around dental implant was altered with increased osteocyte numbers and the preferential alignment direction and degree of BAp c-axis/collagen fibers. ConclusionsThese findings suggest that mechanical loading effectively induces bone anabolic responses around dental implants. Altered bone quality may upregulate bone strength, contributing to long-term implant stability.	[Kuroshima, Shinichiro; Yasutake, Munenori; Tsuiki, Kotaro; Sawase, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, Nagasaki 8528588, Japan; [Nakano, Takayoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Osaka, Japan	Sawase, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Appl Prosthodont, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	sawase@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [22390368]	The authors thank Dr. Ikuya Watanabe for assistance with analyzing the strain rate. This work was supported by a Grant-in Aid for Science Research (B) from the Japan Society for the Promotion of Science (#22390368). All authors have no conflicts of interest.	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Noyama Y, 2013, BONE, V52, P659, DOI 10.1016/j.bone.2012.11.005; Chambrone L, 2010, J PERIODONTOL, V81, P1367, DOI 10.1902/jop.2010.100176; Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X; Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1; Dougherty G, 1996, MED ENG PHYS, V18, P557, DOI 10.1016/1350-4533(96)00011-2; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Shirota T, 2003, J ORAL MAXIL SURG, V61, P471, DOI 10.1053/joms.2003.50093; Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Torcasio A, 2008, EUR CELLS MATER, V16, P56; Kleerekoper M, 2006, OSTEOPOROSIS INT, V17, P1707, DOI 10.1007/s00198-006-0187-x; WEIJS WA, 1977, ARCH ORAL BIOL, V22, P667, DOI 10.1016/0003-9969(77)90096-6; Bernhardt R, 2012, EUR CELLS MATER, V23, P237; MORIMOTO T, 1985, ARCH ORAL BIOL, V30, P673, DOI 10.1016/0003-9969(85)90154-2; Ohkawa Y, 2008, J ORTHOP SCI, V13, P533, DOI 10.1007/s00776-008-1275-x; SASAKI N, 1989, J BIOMECH, V22, P157, DOI 10.1016/0021-9290(89)90038-9; Peptan AI, 2008, BONE, V42, P432, DOI 10.1016/j.bone.2007.05.014; Chen JH, 2010, J BIOMECH, V43, P108, DOI 10.1016/j.jbiomech.2009.09.016; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; Stokstad E, 2005, SCIENCE, V308, P1580, DOI 10.1126/science.308.5728.1580; Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61; Morioka T, 2012, CRANIO, V30, P32; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Hudieb MI, 2011, J PERIODONTOL, V82, P1061, DOI 10.1902/jop.2010.100237; Kuroshima S, 2013, BONE, V56, P101, DOI 10.1016/j.bone.2013.05.013; Nakano T, 2012, BONE, V51, P741, DOI 10.1016/j.bone.2012.07.003; Yajima A, 2010, J BONE MINER RES, V25, P2374, DOI 10.1002/jbmr.126; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Pazzaglia UE, 2012, J ANAT, V220, P372, DOI 10.1111/j.1469-7580.2012.01477.x; Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Robling AG, 2001, BONE, V29, P105, DOI 10.1016/S8756-3282(01)00488-4; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; JAGGER CJ, 1995, BONE, V16, P309, DOI 10.1016/8756-3282(94)00043-3; Slaets E, 2007, J PERIODONTOL, V78, P510, DOI 10.1902/jop.2007.060183; Bakker AD, 2014, J DENT RES, V93, P394, DOI 10.1177/0022034514522485; BRANEMAR.PI, 1964, ACTA ANAT, V59, P1; Casanova Michele, 2014, Bonekey Rep, V3, P550, DOI 10.1038/bonekey.2014.45; Danckwardt-Lillieström G, 1969, Acta Orthop Scand Suppl, V128, P1; Fyhrie D. P., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P318; Milovanovic P, 2013, ACS NANO; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; NIH, 2001, JAMA-J AM MED ASSOC, V285, P785; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Slotte Christer, 2003, Clin Implant Dent Relat Res, V5, P263, DOI 10.1111/j.1708-8208.2003.tb00209.x; Yang R, 2003, Eur Cell Mater, V6, P57	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	OCT	2015	17			2			E699	E710		10.1111/cid.12318		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS9SZ	WOS:000362433400036		
J	Yamauchi, K; Nogami, S; Tanaka, K; Yokota, S; Shimizu, Y; Kanetaka, H; Takahashi, T				Yamauchi, Kensuke; Nogami, Shinnosuke; Tanaka, Kenko; Yokota, Sou; Shimizu, Yoshinaka; Kanetaka, Hiroyasu; Takahashi, Tetsu			The Effect of Decortication for Periosteal Expansion Osteogenesis Using Shape Memory Alloy Mesh Device	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						decortication; distraction osteogenesis; implant; Ni-Ti; periosteum; shape memory alloy	GUIDED BONE REGENERATION; DISTRACTION OSTEOGENESIS; RIDGE AUGMENTATION; IMPLANTS; GRAFTS; DOGS	BackgroundIn conventional bone grafting technique, decortication procedure enhances the healing process and bone regeneration to reach the grafted site more readily. PurposeThis study evaluates to improve periosteal expansion osteogenesis (PEO) using a shape memory alloy mesh (SMA) device with decortication in a rabbit model. Materials and MethodsThe SMA device was inserted under the periosteum at the forehead and pushed, bent, and attached to the bone surface and fixed with a titanium screw. Twelve rabbits were divided into two groups: PEO without decortication (P group) and with decortication (D group). After 2 weeks, the screw was removed, and the mesh was activated by its own elasticity. Rabbits were sacrificed 5 (P1/D1) and 8 (P2/D2) weeks after operation and histologically and radiographically evaluated. ResultsThe mean activation height was 2.90.5mm. The ratio of new bone volume in the elevated volume was 17.6% in P1, 59.8% in D1 33.4% in P2, and 65.1% in D2. D group had a statistically higher volume of new bone than P group during each period (p<.05). ConclusionPEO with decortication appears to be a promising clinical alternative for bone augmentation and introduces the new concept of dynamic graft and guided bone regeneration (GBR).	[Yamauchi, Kensuke; Nogami, Shinnosuke; Tanaka, Kenko; Yokota, Sou; Shimizu, Yoshinaka; Takahashi, Tetsu] Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Surg, Sendai, Miyagi 9808575, Japan; [Shimizu, Yoshinaka] Tohoku Univ, Grad Sch Dent, Div Oral Pathol, Sendai, Miyagi 9808575, Japan; [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dent, Laison Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan	Yamauchi, K (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Surg, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yamaken@dent.tohoku.ac.jp			JSPS [24792246, 23592995]	This work was supported by JSPS KAKENHI Grant Numbers 24792246, 23592995.	Zakaria O, 2012, J BIOMED MATER RES B, V100B, P882, DOI 10.1002/jbm.b.31944; Greenstein G, 2009, J PERIODONTOL, V80, P175, DOI 10.1902/jop.2009.080309 ; Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291; Triplett RG, 1996, J ORAL MAXIL SURG, V54, P486, DOI 10.1016/S0278-2391(96)90126-3; Sethi A, 2001, INT J ORAL MAX IMPL, V16, P378; Chin M, 1996, J ORAL MAXIL SURG, V54, P45, DOI 10.1016/S0278-2391(96)90303-1; Machtei EE, 2001, J PERIODONTOL, V72, P512, DOI 10.1902/jop.2001.72.4.512; NIJWEIDE PJ, 1986, PHYSIOL REV, V66, P855; Weibull L, 2009, CLIN IMPLANT DENT R, V11, P149, DOI 10.1111/j.1708-8208.2008.00102.x; Kanetaka H, 2010, J CRANIOFAC SURG, V21, P1839, DOI 10.1097/SCS.0b013e3181f43eba; Yamauchi K, 2013, J BIOMED MATER RES B, V101B, P736, DOI 10.1002/jbm.b.32876; Sencimen M, 2007, INT J ORAL MAX SURG, V36, P235, DOI 10.1016/j.ijom.2006.08.016; Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x; Idelsohn S, 2004, J MATER SCI-MATER M, V15, P541, DOI 10.1023/B:JMSM.0000021135.72288.8f; Xie M, 2011, J ORAL MAXIL SURG, V69, P2033, DOI 10.1016/j.joms.2010.10.045; Oda T, 2009, J ORAL MAXIL SURG, V67, P1478, DOI 10.1016/j.joms.2008.06.085; Lethaus B, 2010, J BIOMED MATER RES B, V95B, P126, DOI 10.1002/jbm.b.31691; Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2006.01291.x; Yamauchi K, 2008, J PERIODONTOL, V79, P999, DOI 10.1902/jop.2008.070536 ; Suzuki A, 2006, ANGLE ORTHOD, V76, P1041, DOI 10.2319/083105-306; Buser D, 1995, Int J Periodontics Restorative Dent, V15, P10; Kessler P, 2007, BRIT J ORAL MAX SURG, V45, P284, DOI 10.1016/j.bjoms.2006.09.010; Simion M, 1996, Int J Oral Maxillofac Implants, V11, P735; Garcia-Garcla A, 2005, J ORAL MAXIL SURG, V63, P724, DOI 10.1016/j.joms.2005.01.014; Wang Hom-Lay, 2006, Implant Dent, V15, P8, DOI 10.1097/01.id.0000204762.39826.0f; Yamatuchi K, 2006, INT J ORAL MAX SURG, V35, P493, DOI 10.1016/j.ijom.2006.01.008	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	OCT	2015	17			2			E376	E384		10.1111/cid.12250		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS9SZ	WOS:000362433400004		
J	Kawaguchi, A; Guerra, GG; Duff, JP; Ueta, I; Fukushima, R				Kawaguchi, Atsushi; Guerra, Gonzalo Garcia; Duff, Jonathan P.; Ueta, Ikuya; Fukushima, Ryosuke			Hemodynamic changes in child acute respiratory distress syndrome with airway pressure release ventilation: a case series	CLINICAL RESPIRATORY JOURNAL			English	Article						acute respiratory distress syndrome; airway pressure release ventilation; children; spontaneous breathing	ACUTE LUNG INJURY; VENOUS RETURN; BLOOD-FLOW; PERFUSION; AERATION	BackgroundAirway pressure release ventilation (APRV) is widely used in adult critical care settings. However, information on the use of APRV in the pediatric population is limited. MethodsAll patients admitted to the medical-surgical pediatric intensive care unit with a diagnosis of acute respiratory distress syndrome (ARDS) who received APRV for at least 12h between 2007 and 2009 were reviewed. ResultsThirteen patients with a variety of etiologies of ARDS were included, with a mean weight of 18.215.0kg, a mean age of 68 +/- 57 months and a predicted mortality (based on Pediatric Index of Mortality version 2) of 23.9 +/- 13.8%. Patients were placed on APRV for a median of 4 days (range 1-10 days). There was no change in blood gas parameters after 1h or 12h of APRV when compared with pre-APRV. There was no statistical difference in hemodynamic parameters, including mean arterial blood pressure, central venous blood pressure and heart rate, while the patients were on APRV. ConclusionAPRV could be safely used in pediatric ARDS patients, without significant hemodynamic compromise or side effects.	[Kawaguchi, Atsushi; Guerra, Gonzalo Garcia; Duff, Jonathan P.] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Pediat Crit Care Med, Edmonton, AB T6G 2B7, Canada; [Kawaguchi, Atsushi] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2B7, Canada; [Kawaguchi, Atsushi; Ueta, Ikuya; Fukushima, Ryosuke] Shizuoka Childrens Hosp, Div Pediat Crit Care, Pediat Intens Care Unit, Shizuoka, Japan	Kawaguchi, A (reprint author), Univ Alberta, Pediat Crit Care Med, Pediat, Edmonton, AB T6G 2B7, Canada.	atsushi@ualberta.ca					Hering R, 2002, INTENS CARE MED, V28, P1426, DOI 10.1007/s00134-002-1442-z; Kamath SS, 2010, PEDIATR PULM, V45, P48, DOI 10.1002/ppul.21058; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818; TAKATA M, 1990, J APPL PHYSIOL, V69, P1961; Krishnan J, 2007, PEDIATR PULM, V42, P83, DOI 10.1002/ppul.20550; Demirkol D, 2010, INDIAN J PEDIATR, V77, P1322, DOI 10.1007/s12098-010-0214-y; Erickson S, 2007, PEDIATR CRIT CARE ME, V8, P317, DOI 10.1097/01.PCC.0000269408.64179.FF; Hering R, 2003, ANESTHESIOLOGY, V99, P1137, DOI 10.1097/00000542-200311000-00021; Putensen C, 1999, AM J RESP CRIT CARE, V159, P1241; Roy S, 2012, J TRAUMA ACUTE CARE, V73, P391, DOI 10.1097/TA.0b013e31825c7a82; WILLEPUT R, 1984, J APPL PHYSIOL, V57, P971; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Walsh MA, 2011, CRIT CARE MED, V39, P2599, DOI 10.1097/CCM.0b013e318228297a; Yoshida T, 2009, ANESTH ANALG, V109, P1892, DOI 10.1213/ANE.0b013e3181bbd918; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Schultz TR, 2001, PEDIATR CRIT CARE ME, V2, P243, DOI 10.1097/00130478-200107000-00010	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-6981	1752-699X		CLIN RESPIR J	Clin. Respir. J.	OCT	2015	9	4					423	429		10.1111/crj.12155		7	Respiratory System	Respiratory System	CT1UR	WOS:000362588000007		
J	Asahina, D; Ito, K; Houseworth, JE; Birkholzer, JT; Bolander, JE				Asahina, D.; Ito, K.; Houseworth, J. E.; Birkholzer, J. T.; Bolander, J. E.			Simulating the Poisson effect in lattice models of elastic continua	COMPUTERS AND GEOTECHNICS			English	Article						Discrete methods; Lattice elements; Poisson effect; Elasticity; Stress tensor	NUMERICAL-SIMULATION; PARTICLE MODEL; BRITTLE ROCKS; FRACTURE; FAILURE; DAMAGE; COMPRESSION; COMPOSITES; MECHANICS	Lattice models provide discontinuous approximations of the displacement field over the computational domain, which facilitates the modeling of fracture and other discontinuous phenomena. By discretizing the domain with two-node elements, however, ordinary lattice models cannot simulate the Poisson effect in a local (intra-element) sense, which is problematic for some types of analyses. Furthermore, such methods are limited in the range of Poisson ratio values that can be simulated. We present a new approach to remedy such known, yet underappreciated, shortcomings of lattice models. In this approach, the Poisson effect is modeled through the introduction of fictitious stresses into a regular lattice. Capabilities of the new approach are demonstrated through compressive test simulations of homogeneous and heterogeneous materials. The simulation results are compared with theory and those of continuum finite element models. The comparisons show good agreement for arbitrary Poisson ratios (including nu >= 1/3) with respect to nodal displacement, intra-element stress, and nodal stress. This form of discrete method, supplemented by the proposed fictitious measures of stress, retains the simplicity of collections of two-node elements. (C) 2015 Elsevier Ltd. All rights reserved.	[Asahina, D.; Ito, K.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; [Houseworth, J. E.; Birkholzer, J. T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Bolander, J. E.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	Asahina, D (reprint author), Natl Inst Adv Ind Sci & Technol, Higashi 1-1-1,Cent 7, Tsukuba, Ibaraki 3058567, Japan.	d-asahina@aist.go.jp	Birkholzer, Jens/C-6783-2011				Katsman R, 2005, MECH MATER, V37, P143, DOI 10.1016/j.mechmat.2004.01.004; Schlangen E, 1997, ENG FRACT MECH, V57, P319, DOI 10.1016/S0013-7944(97)00010-6; Liu C, 2013, J GEOPHYS RES-SOL EA, V118, P71, DOI 10.1029/2012JB009615; Asahina D, 2011, CEMENT CONCRETE COMP, V33, P966, DOI 10.1016/j.cemconcomp.2011.01.007; Jing L, 2003, INT J ROCK MECH MIN, V40, P283, DOI 10.1016/S1365-1609(03)00013-3; Potyondy DO, 2004, INT J ROCK MECH MIN, V41, P1329, DOI 10.1016/j.ijrmms.2004.09.011; Tamayo-Mas E, 2014, THEOR APPL FRACT MEC, V69, P90, DOI 10.1016/j.tafmec.2013.11.009; Fang YL, 2013, INT J ROCK MECH MIN, V62, P138, DOI 10.1016/j.ijrmms.2013.05.002; Cusatis G, 2011, CEMENT CONCRETE COMP, V33, P881, DOI 10.1016/j.cemconcomp.2011.02.011; ADLEY MD, 1992, COMPUT STRUCT, V43, P13, DOI 10.1016/0045-7949(92)90075-B; Pan PZ, 2012, COMPUT GEOSCI-UK, V42, P87, DOI 10.1016/j.cageo.2012.02.009; Gercek H, 2007, INT J ROCK MECH MIN, V44, P1, DOI 10.1016/j.ijrmms.2006.04.011; Oliver J, 2002, ENG FRACT MECH, V69, P113, DOI 10.1016/S0013-7944(01)00060-1; Benvenuti E, 2008, INT J NUMER METH ENG, V74, P911, DOI 10.1002/nme.2196; Asahina D, 2014, COMPUT GEOSCI-UK, V65, P13, DOI 10.1016/j.cageo.2013.12.009; Cusatis G, 2003, J ENG MECH-ASCE, V129, P1439, DOI 10.1061/(ASCE)0733-9399; Chiaia B, 1997, ENG FRACT MECH, V57, P301, DOI 10.1016/S0013-7944(97)00011-8; Yoon J, 2007, INT J ROCK MECH MIN, V44, P871, DOI 10.1016/j.ijrmms.2007.01.004; Griffiths DV, 2001, INT J NUMER METH ENG, V50, P1759, DOI 10.1002/nme.99; Hori M, 2005, J MECH PHYS SOLIDS, V53, P681, DOI 10.1016/j.jmps.2004.08.005; Mahabadi OK, 2012, INT J GEOMECH, V12, P676, DOI 10.1061/(ASCE)GM.1943-5622.0000216; Yip M, 2005, COMPUT-AIDED CIV INF, V20, P393, DOI 10.1111/j.1467-8667.2005.00407.x; BAZANT ZP, 1990, J ENG MECH-ASCE, V116, P1686; Bolander JE, 1998, ENG FRACT MECH, V61, P569, DOI 10.1016/S0013-7944(98)00069-1; Bolander JE, 2001, 4 INT C FRACT MECH C, P773; Cundall PA, 1971, P S INT SOC ROCK MEC, V8; Cusatis G, 2010, 7 INT C FRACT MECH C, P529; Fenster SK, 2003, ADV STRENGTH APPL EL; Grassl P, 2015, J MECH PHYS SOLIDS, V75, P104, DOI 10.1016/j.jmps.2014.11.011; Herrmann H. J., 1990, STAT MODELS FRACTURE; Hrennikoff A, 1941, J APPL MECH, V8, P169; Jagota A., 1994, SPRINGER LECT NOTES, V437, P186; KAWAI T, 1978, NUCL ENG DES, V48, P207, DOI 10.1016/0029-5493(78)90217-0; Lisjak A, 2014, INT J ROCK MECH MIN, V65, P96, DOI 10.1016/j.ijrmms.2013.10.006; Munjiza A., 2004, COMBINED FINITE DISC; Munjiza A. A., 2012, COMPUTATIONAL MECH D; Schlangen E., 1992, CEMENT CONCRETE COMP, V14, P105, DOI 10.1016/0958-9465(92)90004-F; Yao C, 2015, COMPUT GEOTECH, V64, P48, DOI 10.1016/j.compgeo.2014.10.012	38	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	OCT	2015	70						60	67		10.1016/j.compgeo.2015.07.013		8	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CT2CN	WOS:000362609700006		
J	Tachibana, S; Kuronuma, Y; Yokota, T; Yamada, K; Moriya, Y; Kami, C				Tachibana, Shunichi; Kuronuma, Yota; Yokota, Tomoyuki; Yamada, Katsumi; Moriya, Yutaka; Kami, Chikara			Effect of hot rolling and cooling conditions on intergranular corrosion behavior in Alloy625 clad steel	CORROSION SCIENCE			English	Article						Alloy; SEM; STEM; XRD; Intergranular corrosion; Segregation	ENVIRONMENTS	The effects of hot rolling and subsequent cooling conditions on intergranular corrosion behavior in Alloy625 clad steel were investigated. Intergranular corrosion resistance of Alloy625 at finishing rolling temperatures (FT) ranging from 800 degrees C to 900 degrees C was almost the same as that of solution treatment. Corrosion rate of 750 degrees C FT increased due to sensitization by precipitations. Corrosion rate also increased at 1000 degrees C FT, but this is not due to sensitization. Preferential corrosion at recrystallized grain boundaries due to an anodic reaction concentration is a possible mechanism. Corrosion rate of Alloy625 which was air-cooled after rolling increased owing to grain boundary segregation. (C) 2015 Elsevier Ltd. All rights reserved.	[Tachibana, Shunichi; Kuronuma, Yota] JFE Steel Corp, Steel Res Lab, Kurashik, Okayamai 7128511, Japan; [Yokota, Tomoyuki; Yamada, Katsumi] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan; [Moriya, Yutaka] JFE Steel Corp, Steel Plate Business Planning Deptartment, Chiyoda Ku, Tokyo 1000011, Japan; [Kami, Chikara] JFE Steel Corp, Steel Res Lab, Kurashiki, Okayama 7128511, Japan	Tachibana, S (reprint author), JFE Steel Corp, Steel Res Lab, Kawasakidori 1 Chome, Kurashik, Okayamai 7128511, Japan.	s-tachibana@jfe-steel.co.jp; y-kuronuma@jfe-steel.co.jp; to-yokota@jfe-steel.co.jp; ka-yamada@jfe-steel.co.jp; y-moriya@jfe-steel.co.jp; c-kami@jfe-steel.co.jp					Pereda B, 2007, ISIJ INT, V47, P860, DOI 10.2355/isijinternational.47.860; MASUDA S, 1988, T IRON STEEL I JPN, V28, P470; [Anonymous], 2008, G28 ASTM; Yin ZF, 2009, CORROS SCI, V51, P1702, DOI 10.1016/j.corsci.2009.04.019; ARMIJO JS, 1968, CORROS SCI, V8, P649, DOI 10.1016/S0010-938X(68)80100-3; [Anonymous], 1986, J MATER ENG, DOI 10.1007/BF02833455; MATSUMOTO K, 1989, TETSU TO HAGANE, V75, P329; Rommerskirchen I, 2008, PROCEEDINGS OF THE 27TH INTERNATIONAL CONFERENCE ON OFFSHORE MECHANICS AND ARCTIC ENGINEERING - 2008, VOL 5, P17; Prohaska M, 2010, CORROS SCI, V52, P1582, DOI 10.1016/j.corsci.2010.01.017; Sahlaoui H, 2002, ACTA MATER, V50, P1383, DOI 10.1016/S1359-6454(01)00444-X; [Anonymous], 2002, A262 ASTM; WILHELM SM, 1986, J PETROL TECHNOL, V38, P1051; Cowan R.L., 1973, ADV CORROS SCI TECH, V3, P293; Ferrer B., 1991, P INT S MET APPL SUP, P217; Floreen G.E., 1994, P INT S MET APPL SUP, P13; Ganesan C.M., 1991, P INT S MET APPL SUP, P663; Harris J.A., 1971, J MET, P45; Hibner E.L., 1988, CORROSION 1988, p324/1; Kain V., 1992, British Corrosion Journal, V27; Kamide H., 2001, CORROS ENG, V50, P811; Kondo J., 1992, P 2 INT OFFSH POL EN, P126; Matsubara H., 1972, TETSU TO HAGANE, V58, P1848; Oouchi C., 1981, TETSU TO HAGANE, V67, P969; Osozawa K., 1978, CORROS ENG, V27, P256; Kumar BS, 2013, CORROS SCI, V70, P55, DOI 10.1016/j.corsci.2012.12.021; Prohaska G., 2011, P NACE CORROSION 201, P1; Reichel T, 2008, PROCEEDINGS OF THE 27TH INTERNATIONAL CONFERENCE ON OFFSHORE MECHANICS AND ARCTIC ENGINEERING - 2008, VOL 5, P179; Smith LM., 2015, ENG CLAD STEEL NIDI, P1; Tachibana S., 2014, P 2014 10 IEEE INT P; Tamehiro H., 1993, P OFFSH MECH ARCT EN, P319; Tanimura M., 1985, 110 NKK, V110, P13; Tomashov N.D., 1969, P 3 INT C MET CORR, V1, P37; Tsuji M., 1988, P 7 INT C OFFSH MECH, P221	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	OCT	2015	99						125	133		10.1016/j.corsci.2015.06.028		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CT2GL	WOS:000362619900010		
J	Liu, JC; Zhang, G; Nagao, S; Jiu, JT; Nogi, M; Sugahara, T; Ma, JS; Suganuma, K				Liu, Jian-Chun; Zhang, Gong; Nagao, Shijo; Jiu, Jin-Ting; Nogi, Masaya; Sugahara, Tohru; Ma, Ju-Sheng; Suganuma, Katsuaki			Metastable pitting and its correlation with electronic properties of passive films on Sn-xZn solder alloys	CORROSION SCIENCE			English	Article						Alloy; Tin; EIS; Potentiostatic; Interfaces; Passive films	LEAD-FREE SOLDERS; CONSTANT-PHASE-ELEMENT; STAINLESS-STEEL; NACL SOLUTION; DISSOLUTION KINETICS; COMPUTER-SIMULATION; CORROSION; TEMPERATURE; ALUMINUM; TIN	The potentiostatically formed passive films on Sn-xZn solder alloys in NaCl solution was investigated by potentiostatic polarization and electrochemical impedance spectroscopy (EIS). Metastable pitting is quantitatively assessed in terms of pit size and frequency, which are found increase with Zn content. EIS results indicate the presence of transport behavior of charge species within the films. The Mott-Schottky analysis reveals that the passive films all behave as a highly disordered n-type semiconductor. The electronic properties of the passive films are greatly associated with metastable pitting susceptibility. The correlation between the stability and the electronic properties of the passive films is discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Liu, Jian-Chun; Zhang, Gong; Ma, Ju-Sheng] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Nagao, Shijo; Jiu, Jin-Ting; Nogi, Masaya; Sugahara, Tohru; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Zhang, G (reprint author), Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.	zhangg@tsinghua.edu.cn			Chinese Scholars Council;  [24226017]	This work was partially supported by Grant-in-Aid for Scientific Research (Grant No. 24226017). The authors wish to thank Mr. M. Ueshima for supplying the pure metals, Dr. H. Koga for his help in apparatus preparation and Dr. H. Cul for his invaluable discussion. Jian-Chun Liu would like to express gratitude to the support from the Chinese Scholars Council.	MULLER IL, 1977, CORROS SCI, V17, P995; Laycock NJ, 2005, CORROS SCI, V47, P3140, DOI 10.1016/j.corsci.2005.07.003; Hirschorn B, 2010, ELECTROCHIM ACTA, V55, P6218, DOI 10.1016/j.electacta.2009.10.065; Schultze JW, 2000, ELECTROCHIM ACTA, V45, P2499, DOI 10.1016/S0013-4686(00)00347-9; Abtew M, 2000, MAT SCI ENG R, V27, P95, DOI 10.1016/S0927-796X(00)00010-3; Boissy C, 2013, ELECTROCHEM COMMUN, V26, P10, DOI 10.1016/j.elecom.2012.09.040; Alves VA, 2002, ELECTROCHIM ACTA, V47, P2081, DOI 10.1016/S0013-4686(02)00077-4; Metikos-Hukovic M, 1999, ELECTROCHIM ACTA, V45, P977, DOI 10.1016/S0013-4686(99)00298-4; Harrington SP, 2008, J ELECTROCHEM SOC, V155, pC381, DOI 10.1149/1.2929819; Maurice V, 2004, NAT MATER, V3, P687, DOI 10.1038/nmat1203; BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/S0022-0728(84)80324-1; Hakiki NE, 2011, CORROS SCI, V53, P2688, DOI 10.1016/j.corsci.2011.05.012; Chung SC, 2000, CORROS SCI, V42, P1249, DOI 10.1016/S0010-938X(99)00129-8; Williams DE, 2010, CORROS SCI, V52, P3702, DOI 10.1016/j.corsci.2010.07.021; SCHMUKI P, 1995, ELECTROCHIM ACTA, V40, P775, DOI 10.1016/0013-4686(94)00341-W; MACDONALD DD, 1992, J ELECTROCHEM SOC, V139, P3434, DOI 10.1149/1.2069096; Chidambaram V, 2009, JOM-US, V61, P59, DOI 10.1007/s11837-009-0089-4; Mohanty US, 2006, CORROS SCI, V48, P662, DOI 10.1016/j.corsci.2005.02.003; Frankel GS, 1998, J ELECTROCHEM SOC, V145, P2186, DOI 10.1149/1.1838615; Suganuma K, 2007, J MATER SCI-MATER EL, V18, P121, DOI 10.1007/s10854-006-9018-2; SCHMUKI P, 1992, J ELECTROCHEM SOC, V139, P1908, DOI 10.1149/1.2069520; Moayed MH, 2006, CORROS SCI, V48, P1004, DOI 10.1016/j.corsci.2005.03.002; Mohanty US, 2008, CORROS SCI, V50, P2437, DOI 10.1016/j.corsci.2008.06.042; Nazeri MFM, 2014, J ALLOY COMPD, V606, P278, DOI 10.1016/j.jallcom.2014.04.034; Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023; Kim YS, 2003, J ALLOY COMPD, V352, P237, DOI 10.1016/S0925-8388(02)01168-4; Hendy SC, 2005, J ELECTROCHEM SOC, V152, pB271, DOI 10.1149/1.1940787; Marcus P, 2008, CORROS SCI, V50, P2698, DOI 10.1016/j.corsci.2008.06.047; KAPUSTA SD, 1980, ELECTROCHIM ACTA, V25, P1625, DOI 10.1016/0013-4686(80)80016-8; Hu J, 2011, J ELECTRON MATER, V40, P1556, DOI 10.1007/s11664-011-1650-9; Chen KI, 2006, J ALLOY COMPD, V416, P98, DOI 10.1016/j.jallcom.2005.08.034; BECK TR, 1984, ELECTROCHIM ACTA, V29, P485, DOI 10.1016/0013-4686(84)87098-X; Macdonald DD, 2011, ELECTROCHIM ACTA, V56, P1761, DOI 10.1016/j.electacta.2010.11.005; Ilevbare GO, 2001, CORROS SCI, V43, P485, DOI 10.1016/S0010-938X(00)00086-X; Suganuma K, 2001, CURR OPIN SOLID ST M, V5, P55, DOI 10.1016/S1359-0286(00)00036-X; Chang TC, 2004, J ELECTROCHEM SOC, V151, pC484, DOI 10.1149/1.1756890; Li DZ, 2008, CORROS SCI, V50, P995, DOI 10.1016/j.corsci.2007.11.025; Escriva-Cerdan C, 2013, ELECTROCHIM ACTA, V111, P552, DOI 10.1016/j.electacta.2013.08.040; NEWMAN RC, 1985, CORROS SCI, V25, P341, DOI 10.1016/0010-938X(85)90112-X; SUZUKI I, 1985, CORROS SCI, V25, P1029, DOI 10.1016/0010-938X(85)90070-8; Macdonald DD, 1998, J ELECTROCHEM SOC, V145, P3141, DOI 10.1149/1.1838777; ARMSTRONG NR, 1976, ANAL CHEM, V48, P741, DOI 10.1021/ac60368a035; GALVELE JR, 1976, J ELECTROCHEM SOC, V123, P464, DOI 10.1149/1.2132857; PRIDE ST, 1994, J ELECTROCHEM SOC, V141, P3028, DOI 10.1149/1.2059275; Laycock NJ, 1997, CORROS SCI, V39, P1771, DOI 10.1016/S0010-938X(97)00049-8; Burstein GT, 2004, CORROS ENG SCI TECHN, V39, P25, DOI 10.1179/147842204225016859; Ningshen S, 2007, CORROS SCI, V49, P481, DOI 10.1016/j.corsci.2006.05.041; Ter-Ovanessian B, 2014, ELECTROCHIM ACTA, V133, P373, DOI 10.1016/j.electacta.2014.04.067; Laycock N.J., 2014, ELECTROCHEM SOC INTE, P67; Laycock NJ, 2001, J ELECTROCHEM SOC, V148, pB264, DOI 10.1149/1.1376119; Liu JC, 2015, CORROS SCI, V92, P263, DOI 10.1016/j.corsci.2014.12.014; Cheng YF, 1999, ELECTROCHIM ACTA, V44, P2947, DOI 10.1016/S0013-4686(99)00011-0; PISTORIUS PC, 1992, PHILOS T ROY SOC A, V341, P531, DOI 10.1098/rsta.1992.0114; Szklarska-Smialowska Z, 1999, CORROS SCI, V41, P1743, DOI 10.1016/S0010-938X(99)00012-8; Xu J, 2014, ACTA MATER, V63, P245, DOI 10.1016/j.actamat.2013.10.040; Yu DQ, 2004, J ALLOY COMPD, V385, P119, DOI 10.1016/j.jallcom.2004.04.129	56	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	OCT	2015	99						154	163		10.1016/j.corsci.2015.06.036		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CT2GL	WOS:000362619900013		
J	Hou, YH; Li, YP; Wang, FL; Zhang, C; Koizumi, Y; Chiba, A				Hou, Yuhang; Li, Yunping; Wang, Fenglin; Zhang, Chen; Koizumi, Yuichiro; Chiba, Akihiko			Influence of Mo concentration on corrosion resistance to HF acid solution of Ni-Co-Cr-Mo alloys with and without Cu	CORROSION SCIENCE			English	Article						Interfaces; Alloy; Acid solutions; Acid corrosion; Cobalt; Nickel	AQUEOUS HYDROFLUORIC-ACID; NI-16CR-15MO ALLOY; TWIP STEELS; BEHAVIOR; MOLYBDENUM; DISSOLUTION; ADDITIONS; ALUMINUM; COPPER	The corrosion resistance of Ni-30Co-16Cr-6Fe-xMo and Ni-30Co-16Cr-6Fe-2Cu-xMo (x= 7-15 wt%) alloys was investigated by immersion tests in 5.2 M HF solution at 100 degrees C. The weight loss of the Ni-30Co-1 6Cr-6Fe-xMo alloys relative to Mo concentration after immersion followed a Boltzmann equation. With decreasing Mo concentration, the Ni-30Co-16Cr-6Fe-xMo alloys first lost the Mo protection of the grain boundaries, then the annealing twin boundaries, and finally the grain matrix. In contrast, decreasing Mo content did not cause a significant increase in Ni-30Co-16Cr-6Fe-2Cu-xMo alloy weight loss, but led to a slightly preferential dissolution of both grain and annealing twin boundaries. Crown Copyright (C) 2015 Published by Elsevier Ltd. All rights reserved.	[Hou, Yuhang; Zhang, Chen] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808577, Japan; [Li, Yunping] Cent S Univ, Dept Mat Sci & Engn, Changsha, Hunan, Peoples R China; [Wang, Fenglin; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Li, YP (reprint author), Cent S Univ, Dept Mat Sci & Engn, Changsha, Hunan, Peoples R China.	lyping@csu.edu.cn			Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was primarily supported by the Regional Innovation Cluster Program 2010 of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aigueperse J., 2000, ULLMANNS ENCY IND CH; Kawamura T, 2006, J POWER SOURCES, V156, P547, DOI 10.1016/j.jpowsour.2005.05.084; Zhang XR, 2013, ELECTROCHIM ACTA, V89, P814, DOI 10.1016/j.electacta.2012.11.029; Zhang C, 2014, CORROS SCI, V89, P81, DOI 10.1016/j.corsci.2014.08.010; Ye HZ, 2008, J MATER PROCESS TECH, V200, P12, DOI 10.1016/j.jmatprotec.2007.10.066; Hou YH, 2014, CORROS SCI, V89, P258, DOI 10.1016/j.corsci.2014.09.004; Hou YH, 2015, CORROS SCI, V90, P133, DOI 10.1016/j.corsci.2014.10.003; Liu SJ, 2007, POLYM TEST, V26, P232, DOI 10.1016/j.polymertesting.2006.10.008; PAWEL SJ, 1994, CORROSION, V50, P963; Li YP, 2015, CORROS SCI, V98, P119, DOI 10.1016/j.corsci.2015.05.024; Zhang XQ, 2014, ELECTROCHIM ACTA, V125, P543, DOI 10.1016/j.electacta.2014.01.143; Tomio A, 2015, CORROS SCI, V98, P391, DOI 10.1016/j.corsci.2015.05.053; CLAYTON CR, 1986, J ELECTROCHEM SOC, V133, P2465, DOI 10.1149/1.2108451; Badawy WA, 1998, ELECTROCHIM ACTA, V44, P693, DOI 10.1016/S0013-4686(98)00180-7; Dieudonne T, 2014, CORROS SCI, V82, P218, DOI 10.1016/j.corsci.2014.01.022; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Bojinov M, 2001, ELECTROCHIM ACTA, V46, P1339, DOI 10.1016/S0013-4686(00)00713-1; NEWMAN RC, 1985, CORROS SCI, V25, P341, DOI 10.1016/0010-938X(85)90112-X; Dieudonne T, 2014, CORROS SCI, V83, P234, DOI 10.1016/j.corsci.2014.02.018; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Critchlow GW, 2006, INT J ADHES ADHES, V26, P577, DOI 10.1016/j.ijadhadh.2005.09.003; Pardo A, 2007, CORROS SCI, V49, P510, DOI 10.1016/j.corsci.2006.06.004; Crook P., 2005, CORROSION NICKEL NIC; Schillmoller C.M., 1968, INC CORROSION ENG B, V5	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	OCT	2015	99						185	193		10.1016/j.corsci.2015.07.004		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CT2GL	WOS:000362619900017		
J	Tahara, H; Furue, Y; Suenaga, C; Sagara, T				Tahara, Hironobu; Furue, Yutaro; Suenaga, Chie; Sagara, Takamasa			A Dialkyl Viologen Ionic Liquid: X-ray Crystal Structure Analysis of Bis(trifluoromethanesulfonyl)imide Salts	CRYSTAL GROWTH & DESIGN			English	Article							IN-SITU CRYSTALLIZATION; IMIDAZOLIUM; ANION; BIS(TRIFLUOROMETHYLSULFONYL)IMIDE; COMPLEXES; TRANSPORT; DESIGN; PHASES; TFSI	An X-ray crystal structure of a viologen type ionic liquid compound, bis(trifluoromethanesulfonyl)imide (TFSI) salt of butyl heptyl viologen [C4VC7 center dot(TFSI)(2)], with a melting point (mp) of 52 degrees C was examined. A cis conformer of TFSI (cis-TFSI), known to be less stable than trans-TFSI, was found in the crystal in a 1:1 coexistence with trans-TFSI. In contrast, all TFSI anions found in dimethylviologen TFSI salts [C1VC1 center dot(TFSI)(2)] were of trans conformation. The lower mp of C4VC7 center dot(TFSI)(2) compared to that of C1VC1.(TFSI)(2) originates in a smaller electrostatic lattice energy and disordered structure of the side chains of C4VC7. Any charge transfer interaction causing a visible region absorption band was not observed in the solids of either C4VC7 center dot(TFSI)(2) (dihedral angle of bipyridinium phi = 37.2 degrees) or C1VC1 center dot(TFSI)(2) (phi = 9 degrees).	[Tahara, Hironobu; Furue, Yutaro; Suenaga, Chie; Sagara, Takamasa] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan	Tahara, H (reprint author), Nagasaki Univ, Grad Sch Engn, 1-14 Bunkyo, Nagasaki 8528521, Japan.	h-tahara@nagasaki-u.ac.jp; sagara@nagasaki-u.ac.jp			JSPS [24810020, 26810052]	This work was financially supported by a Grant-in-Aid for the Murata Science Foundation (H.T.), JSPS Grant-in-Aid for Young Scientists (Start-up) 24810020 (H.T.), and JSPS Grant-in-Aid for Young Scientists (B) 26810052 (H.T.).	Babai A, 2006, INORG CHEM, V45, P4874, DOI 10.1021/ic060414e; Balasubramanian R, 2006, J AM CHEM SOC, V128, P9994, DOI 10.1021/ja0625327; Mudring AV, 2005, ANGEW CHEM INT EDIT, V44, P5485, DOI 10.1002/anie.200501297; Nockemann P, 2008, CRYST GROWTH DES, V8, P1353, DOI 10.1021/cg701187t; Binnemans K, 2005, CHEM REV, V105, P4148, DOI 10.1021/cr0400919; Hardacre C, 2010, PHYS CHEM CHEM PHYS, V12, P1842, DOI 10.1039/b921160h; Izgorodina EI, 2009, CRYST GROWTH DES, V9, P4834, DOI 10.1021/cg900656z; Miura Y, 2010, INORG CHEM, V49, P10032, DOI 10.1021/ic1013363; Bentivoglio G, 2009, J CHEM CRYSTALLOGR, V39, P662, DOI 10.1007/s10870-009-9554-8; Chen XY, 2013, CHEM COMMUN, V49, P1903, DOI 10.1039/c2cc38255e; Babai A, 2006, INORG CHEM, V45, P3249, DOI 10.1021/ic051820l; Jodry JJ, 2004, TETRAHEDRON LETT, V45, P4429, DOI 10.1016/j.tetlet.2004.04.063; Bhowmik PK, 2006, LIQ CRYST, V33, P891, DOI 10.1080/02678290600871598; Hunt PA, 2006, CHEM-EUR J, V12, P6762, DOI 10.1002/chem.200600103; Funasako Y, 2013, DALTON T, V42, P8317, DOI 10.1039/c3dt00084b; Choudhury AR, 2006, CRYSTENGCOMM, V8, P742, DOI 10.1039/b609598d; Patil ML, 2006, ORG LETT, V8, P227, DOI 10.1021/ol052466y; Gunaratne HQN, 2013, AUST J CHEM, V66, P607, DOI 10.1071/CH13054; Hatazawa T, 1996, ANAL CHEM, V68, P597, DOI 10.1021/ac950340g; Causin V, 2009, J MATER CHEM, V19, P9153, DOI 10.1039/b915559g; Dong K, 2012, CHEM-EUR J, V18, P2748, DOI 10.1002/chem.201101645; Fumino K, 2011, PHYS CHEM CHEM PHYS, V13, P14064, DOI 10.1039/c1cp20732f; Katsyuba SA, 2013, J PHYS CHEM B, V117, P9094, DOI 10.1021/jp405255w; Leone AM, 2001, J AM CHEM SOC, V123, P218, DOI 10.1021/ja003332c; Paulechka YU, 2008, J PHYS CHEM B, V112, P15708, DOI 10.1021/jp804607n; Fujii K, 2006, J PHYS CHEM B, V110, P8179, DOI 10.1021/jp0612477; Choudhury AR, 2005, J AM CHEM SOC, V127, P16792, DOI 10.1021/ja055956u; Matsumoto K, 2006, SOLID STATE SCI, V8, P1103, DOI 10.1016/j.solidstatesciences.2005.12.017; Jordao N, 2014, CHEM-EUR J, V20, P3982, DOI 10.1002/chem.201304451; Kavanagh A, 2013, ACS APPL MATER INTER, V5, P55, DOI 10.1021/am3018948; ROSS JH, 1980, J AGR FOOD CHEM, V28, P1026, DOI 10.1021/jf60231a041; Singh RP, 2003, INORG CHEM, V42, P7416, DOI 10.1021/ic034812i; Bodappa N, 2015, J PHYS CHEM C, V119, P1067, DOI 10.1021/jp509931p; Paulechka YU, 2009, J PHYS CHEM B, V113, P9538, DOI 10.1021/jp903702c; Nockemann P, 2008, INORG CHEM, V47, P9987, DOI 10.1021/ic801213z; Holbrey JD, 2004, DALTON T, P2267, DOI 10.1039/b405901h; Hunt PA, 2015, CHEM SOC REV, V44, P1257, DOI 10.1039/c4cs00278d; Zhou Q, 2010, CHEM MATER, V22, P1203, DOI 10.1021/cm902691v; Golding JJ, 1998, CHEM COMMUN, P1593, DOI 10.1039/a802745e; Martinelli A, 2011, J RAMAN SPECTROSC, V42, P522, DOI 10.1002/jrs.2713; Fox PA, 2005, CHEM COMMUN, P3679, DOI 10.1039/b504631a; Holbrey J. D., 2002, IONIC LIQUIDS SYNTHE, P41; Ito-Akita K., 2000, P ELECTROCHEM SOC, V99, P193; Lauw Y, 2012, CRYST GROWTH DES, V12, P2803, DOI 10.1021/c9201592u; Monk P. M. S., 1989, VIOLOGENS PHYSICOCHE; Monk P. M. S., 1995, ELECTROCHROMISM FUND; Shainyan A. B., 2013, CHEM REV, V113, P699; Singh RP, 2003, CHEM COMMUN, P1366, DOI 10.1039/b301968c; Tanabe T., 2007, ORG LETT, V9, P4271	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					4735	4740		10.1021/acs.cgd.5b00645		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800003		
J	Suzuki, Y; Tsukamoto, K; Yoshizaki, I; Miura, H; Fujiwara, T				Suzuki, Yoshihisa; Tsukamoto, Katsuo; Yoshizaki, Izumi; Miura, Hitoshi; Fujiwara, Takahisa			First Direct Observation of Impurity Effects on the Growth Rate of Tetragonal Lysozyme Crystals under Microgravity as Measured by Interferometry	CRYSTAL GROWTH & DESIGN			English	Article							PROTEIN CRYSTALS; 2-DIMENSIONAL NUCLEATION; PURIFICATION; KINETICS; SURFACE	The normal growth rates R and apparent step velocities (lateral growth rates of a spiral hillock) V of tetragonal hen egg-white lysozyme (HEWL) crystals were for the first time measured by Michelson interferometry in the international space station (as part of the Nano Step project) using commercialized HEWL samples containing 1.5% impurities. A significant increase in V under microgravity was confirmed compared to step velocities V-step on the ground, while a decrease in R was also confirmed compared to that in the purified solution under microgravity as expected. Because of exact measurement of growth rates, kinetic analyses of R were conducted as a function of supersaturation, sigma (sigma ln(C/C-e), where C is the concentration; C-e is the solubility), using a spiral growth model and a two-dimensional (2D) -3.5 nucleation growth model. For both models over a wide range of sigma, R in the impure solution was significantly lower than that in the purified solution. The degree of the suppression of impurity effects was also evaluated using the difference in V-p and V-i, where V-p is the apparent step velocity in the purified solution, and V-1, is that in the impure solution. The difference between V-p and V-i was smaller than the difference in step velocities on the ground, V-step,V-p and V-step,V-p where Vs tem is the step velocity in the purified solution, and V-step,V-1 is the step velocity in the impure solution.	[Suzuki, Yoshihisa] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Tsukamoto, Katsuo] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808560, Japan; [Yoshizaki, Izumi] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki 3058505, Japan; [Miura, Hitoshi] Nagoya City Univ, Mizuho Ku, Nagoya, Aichi 4678501, Japan; [Fujiwara, Takahisa] Univ Tokushima, Inst Socioarts & Sci, Tokushima 7708502, Japan	Suzuki, Y (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minamijosanjima, Tokushima 7708506, Japan.	yoshis@tokushima-u.ac.jp			JSPS KAKENHI [24656016, 26390054, 22244066]	The authors wish to thank Professor Gen Sazaki of Hokkaido University for valuable discussion on impurity effects on step intervals of spiral hillocks. The authors also thank Professor Alexander Chernov of Lawrence Livermore National Laboratory for valuable suggestions and discussion. Y.S. was partially supported by JSPS KAKENHI Grant No. 24656016 and 26390054. K.T. was supported by JSPS KAKENHI Grant No. 22244066.	VEKILOV PG, 1992, J CRYST GROWTH, V121, P643, DOI 10.1016/0022-0248(92)90571-Y; Van Driessche AES, 2008, CRYST GROWTH DES, V8, P3623, DOI 10.1021/cg800157t; Thomas BR, 1996, ACTA CRYSTALLOGR D, V52, P776, DOI 10.1107/S090744499600279X; Caylor CL, 1999, PROTEINS, V36, P270, DOI 10.1002/(SICI)1097-0134(19990815)36:3<270::AID-PROT2>3.0.CO;2-N; Liu XY, 1997, J CHEM PHYS, V106, P1870, DOI 10.1063/1.473325; Adawy A, 2015, CRYST GROWTH DES, V15, P1150, DOI 10.1021/cg501455d; Van Driessche AES, 2007, CRYST GROWTH DES, V7, P1980, DOI 10.1021/cg060945d; Van Driessche AES, 2009, CRYST GROWTH DES, V9, P3062, DOI 10.1021/cg8006684; Kurihara K, 1996, J CRYST GROWTH, V166, P904, DOI 10.1016/0022-0248(95)00617-6; Sleutel M, 2012, CRYST GROWTH DES, V12, P2367, DOI 10.1021/cg300024f; Thomas BR, 2000, J CRYST GROWTH, V211, P149, DOI 10.1016/S0022-0248(99)00813-1; Chernov AA, 2001, J CRYST GROWTH, V232, P184, DOI 10.1016/S0022-0248(01)01065-X; BENNEMA P, 1990, J CRYST GROWTH, V102, P547, DOI 10.1016/0022-0248(90)90412-E; Nakada T, 1999, J CRYST GROWTH, V196, P503, DOI 10.1016/S0022-0248(98)00875-6; Iimura Y, 2005, J CRYST GROWTH, V275, P554, DOI 10.1016/j.jcrysgro.2004.11.429; Chernov A A, 1984, MODERN CRYSTALLOGRAP, V3; Fujiwara T., 2015, REV SCI INSTRUM, V86; KONNERT JH, 1994, ACTA CRYSTALLOGR D, V50, P603, DOI 10.1107/S0907444994001988; Space Studies Board National Research Council, 2000, FUT BIOT RES INT SPA, P13; Tsukamoto K., 2015, HDB CRYSTAL GROWTH, P1031; Yoshizaki I., 2013, REV SCI INSTRUM, V84	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					4787	4794		10.1021/acs.cgd.5b00456		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800010		
J	Xiao, X; Wagata, H; Hayashi, F; Onodera, H; Yubuta, K; Zettsu, N; Oishi, S; Teshima, K				Xiao, Xiong; Wagata, Hajime; Hayashi, Fumitaka; Onodera, Hitoshi; Yubuta, Kunio; Zettsu, Nobuyuki; Oishi, Shuji; Teshima, Katsuya			Unique Growth Manner of Li5La3Ta2O12 Crystals from Lithium Hydroxide Flux at Low Temperature	CRYSTAL GROWTH & DESIGN			English	Article							MATERIALS DISCOVERY; LI7LA3ZR2O12; GARNETS; OXIDES; CONDUCTIVITY; SYSTEM; PHASE; TA	Garnet-type Li(5+x)Ln(3)M(2-y)(IV)M(y)(V)O(12+z) (x, y = 0-2, z = 0-1; Ln = La, Pr, Nd; M = Ta, Zr, Nb) compounds are promising Li-ion conducting solid electrolytes, but their growth manner is still unclear. Herein, the analysis of the low-temperature growth of idiomorphic Li5La3Ta2O12 single crystals as a function of holding temperature and time, cooling rate, flux type, and solute concentration revealed a unique growth manner. Li5La3Ta2O12 crystals were grown at 500 degrees C from LiOH flux and transformed into Li7La3Ta2O13 at 700 degrees C. The pseudo-perovskite-type LiLa2TaO6 phase, initially formed during the holding at 500 degrees C, was efficiently transformed into the Li5La3Ta2O12 phase with increasing holding time. The growth of Li5La3Ta2O12 single crystals was independent of the cooling rate but was affected by the kind of flux and solute concentration. A low solute concentration (1 or 5 mol %) was the key to obtain well-dispersed and idiomorphic single crystals. The optimum growth conditions involved a holding temperature of 500 degrees C, a solute concentration of 1 or 5 mol %, and a holding time of 10 h. These findings indicate that formation and growth of Li5La3Ta2O12 single crystals are not only controlled by a general flux growth process but also involve chemical reactions between solutes and LiOH flux. Finally, high-resolution transmission electron microscopy image and selected area diffraction pattern highlighted products with high crystallinity and well-developed {110} and {211} facets.	[Xiao, Xiong] Shinshu Univ, Dept Mat Sci & Engn, Interdisciplinary Grad Sch Sci & Technol, Wakasato, Nagano 3808553, Japan; [Wagata, Hajime; Hayashi, Fumitaka; Onodera, Hitoshi; Zettsu, Nobuyuki; Oishi, Shuji; Teshima, Katsuya] Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Wakasato, Nagano 3808553, Japan; [Zettsu, Nobuyuki; Teshima, Katsuya] Shinshu Univ, Ctr Energy & Environm Sci, Wakasato, Nagano 3808553, Japan; [Yubuta, Kunio] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Teshima, K (reprint author), Shinshu Univ, Fac Engn, Dept Environm Sci & Technol, Wakasato, Nagano 3808553, Japan.	teshima@shinshu-u.ac.jp	HAYASHI, Fumitaka/I-5366-2014	HAYASHI, Fumitaka/0000-0002-4494-739X	Center of Innovation Program, "Global Aqua Innovation Center for Increasing Water-Sustainability and Improving Living Standards in the World" from Japan Science and Technology Agency, JST; Japan Society for the Promotion of Science, JSPS [26630331]	This work was supported by the Center of Innovation Program, "Global Aqua Innovation Center for Increasing Water-Sustainability and Improving Living Standards in the World" from Japan Science and Technology Agency, JST, and the Grant-in-Aid for Challenging Exploratory Research (Research No. 26630331) from the Japan Society for the Promotion of Science, JSPS. We gratefully acknowledge Mr. Tomohiko Yamagami at the Technical Division in Shinshu University for performing the cross-sectional SEM analysis.	Bugaris DE, 2012, ANGEW CHEM INT EDIT, V51, P3780, DOI 10.1002/anie.201102676; Kimijima T, 2015, CRYSTENGCOMM, V17, P3487, DOI 10.1039/c5ce00386e; Cussen EJ, 2007, J SOLID STATE CHEM, V180, P1832, DOI 10.1016/j.jssc.2007.04.007; Roof IP, 2009, J SOLID STATE CHEM, V182, P295, DOI 10.1016/j.jssc.2008.10.032; Tietz F, 2013, SOLID STATE IONICS, V230, P77, DOI 10.1016/j.ssi.2012.10.021; Miara LJ, 2013, CHEM MATER, V25, P3048, DOI 10.1021/cm401232r; FLOOD H, 1947, ACTA CHEM SCAND, V1, P592, DOI 10.3891/acta.chem.scand.01-0592; Mugavero SJ, 2009, J SOLID STATE CHEM, V182, P1950, DOI 10.1016/j.jssc.2009.05.006; Ohta S, 2011, J POWER SOURCES, V196, P3342, DOI 10.1016/j.jpowsour.2010.11.089; Il'ina EA, 2012, J POWER SOURCES, V201, P169, DOI 10.1016/j.jpowsour.2011.10.108; Oishi S, 2004, J AM CHEM SOC, V126, P4768, DOI 10.1021/ja049678v; Mizuno Y, 2013, CRYST GROWTH DES, V13, P479, DOI 10.1021/cg3012348; Cussen EJ, 2006, CHEM COMMUN, P412, DOI 10.1039/b514640b; MAZZA D, 1988, MATER LETT, V7, P205, DOI 10.1016/0167-577X(88)90011-0; Allen JL, 2012, J POWER SOURCES, V206, P315, DOI 10.1016/j.jpowsour.2012.01.131; Galven C, 2011, CHEM MATER, V23, P1892, DOI 10.1021/cm103595x; Xu M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.052301; HYOOMA H, 1988, MATER RES BULL, V23, P1399, DOI 10.1016/0025-5408(88)90264-4; HAYASHI K, 1986, MATER RES BULL, V21, P289, DOI 10.1016/0025-5408(86)90184-4; Thangadurai V, 2004, CHEM MATER, V16, P2998, DOI 10.1021/cm031176d; Murugan R, 2007, ANGEW CHEM INT EDIT, V46, P7778, DOI 10.1002/anie.200701144; Awaka J, 2009, J SOLID STATE CHEM, V182, P2046, DOI 10.1016/j.jssc.2009.05.020	22	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					4863	4868		10.1021/acs.cgd.5b00672		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800018		
J	Takahasi, M; Kozu, M; Sasaki, T; Hu, W				Takahasi, Masamitu; Kozu, Miwa; Sasaki, Takuo; Hu, Wen			Mechanisms Determining the Structure of Gold-Catalyzed GaAs Nanowires Studied by in Situ X-ray Diffraction	CRYSTAL GROWTH & DESIGN			English	Article							III-V NANOWIRES; HETEROSTRUCTURE NANOWIRES; STACKING-FAULTS; ZINC BLENDE; GROWTH; SEMICONDUCTORS; SUPERLATTICES; TRANSISTORS; POLYTYPISM; WHISKERS	The evolution of polytypism during GaAs nanowire growth was investigated by in situ X-ray diffraction. The growth of nanowires was found to start with the formation of zincblende structure, followed by the growth of wurtzite structure. The growth process was well reproduced by a simulation based on a layer-by-layer nucleation model. The good agreement between the measured and simulated results confirms that nucleation costs higher energy for the stackings changing the crystal structure than for those conserving the preceding structure. The transition in prevalent structure can be accounted for by the change of local growth conditions related to the shape of a triple phase line rather than by the change in supersaturation level, which quickly reaches steady state after starting growth.	[Takahasi, Masamitu; Kozu, Miwa; Sasaki, Takuo; Hu, Wen] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Sayo, Hyogo 6795148, Japan; [Takahasi, Masamitu; Kozu, Miwa] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan	Takahasi, M (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, 1-1-1 Koto, Sayo, Hyogo 6795148, Japan.	mtaka@spring8.or.jp			Japan Society for the Promotion of Science [KAKENHI 22360010, 15H01054]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grants KAKENHI 22360010 and 15H01054). The synchrotron experiments were performed at BL11XU of SPring-8 under Proposals 2011A3503, 2011B3503, 2012A3503, and 2012B3503.	Akiyama T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235308; Glas F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146101; Joyce HJ, 2010, NANO LETT, V10, P908, DOI 10.1021/nl903688v; Morral AFI, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837191; Johansson J, 2009, CRYST GROWTH DES, V9, P766, DOI 10.1021/cg800270q; Cirlin GE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035302; Algra RE, 2011, NANO LETT, V11, P1259, DOI 10.1021/nl104267p; Krogstrup P, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3688489; Algra RE, 2011, NANO LETT, V11, P44, DOI 10.1021/nl1023996; Caroff P, 2009, NAT NANOTECHNOL, V4, P50, DOI [10.1038/nnano.2008.359, 10.1038/NNANO.2008.359]; Takahasi M, 2002, JPN J APPL PHYS 1, V41, P6247, DOI 10.1143/JJAP.41.6247; Rosini M, 2010, ACS NANO, V4, P6021, DOI 10.1021/nn1015488; Plissard S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3367746; Karlsson LS, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/48/485717; Johansson J, 2012, ACS NANO, V6, P6142, DOI 10.1021/nn301477x; Algra RE, 2008, NATURE, V456, P369, DOI 10.1038/nature07570; HURLE DTJ, 1995, J CRYST GROWTH, V147, P239, DOI 10.1016/0022-0248(94)00666-0; Shtrikman H, 2009, NANO LETT, V9, P215, DOI 10.1021/nl8027872; Akiyama T, 2007, JPN J APPL PHYS 1, V46, P1783, DOI 10.1143/JJAP.46.1783; Shtrikman H, 2009, NANO LETT, V9, P1506, DOI 10.1021/nl803524s; Mandl B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/14/145603; Krogstrup P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.125505; Mandl B, 2006, NANO LETT, V6, P1817, DOI 10.1021/nl060452v; Dubrovskii VG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235301; Biermanns A, 2014, NANO LETT, V14, P6878, DOI 10.1021/nl502878a; Gamalski AD, 2011, J PHYS CHEM C, V115, P4413, DOI 10.1021/jp1095882; Borg BM, 2010, NANO LETT, V10, P4080, DOI 10.1021/nl102145h; Kriegner D, 2011, NANO LETT, V11, P1483, DOI 10.1021/nl1041512; KOGUCHI M, 1992, JPN J APPL PHYS 1, V31, P2061, DOI 10.1143/JJAP.31.2061; Krogstrup P, 2013, NAT PHOTONICS, V7, P306, DOI [10.1038/nphoton.2013.32, 10.1038/NPHOTON.2013.32]; Harmand JC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2128487; Colombo C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155326; Akopian N, 2010, NANO LETT, V10, P1198, DOI 10.1021/nl903534n; Dubrovskii VG, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035414; Ganjipour B, 2011, NANO LETT, V11, P4222, DOI 10.1021/nl202180b; Mariager SO, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769401; Johansson J, 2010, J PHYS CHEM C, V114, P3837, DOI 10.1021/jp910821e; Dick KA, 2010, NANO LETT, V10, P3494, DOI 10.1021/nl101632a; Zardo I, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245324; Krogstrup P, 2010, NANO LETT, V10, P4475, DOI 10.1021/nl102308k; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Dimakis E, 2011, CRYST GROWTH DES, V11, P4001, DOI 10.1021/cg200568m; HIRUMA K, 1995, J APPL PHYS, V77, P447, DOI 10.1063/1.359026; Motohisa J, 2004, J CRYST GROWTH, V272, P180, DOI 10.1016/j.jcrysgro.2004.08.118; Tomioka K, 2012, NATURE, V488, P189, DOI 10.1038/nature11293; HIRUMA K, 1991, APPL PHYS LETT, V59, P431, DOI 10.1063/1.105453; Oh SH, 2010, SCIENCE, V330, P489, DOI 10.1126/science.1190596; Kohl M, 2015, J SYNCHROTRON RADIAT, V22, P67, DOI 10.1107/S1600577514023480; Krogstrup P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/31/313001; Mariager SO, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115603; Pankoke V, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075455; Panse C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075217; Schroth P, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055504; Spirkoska D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245325; Wen CY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.025503; Wen CY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.195502; Yamashita T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.055003	57	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					4979	4985		10.1021/acs.cgd.5b00915		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800034		
J	Bertrand, A; Carreaud, J; Delaizir, G; Shimoda, M; Duclere, JR; Colas, M; Belleil, M; Comette, J; Hayakawa, T; Genevois, C; Veron, E; Allix, M; Chenu, S; Brisset, F; Thomas, P				Bertrand, Anthony; Carreaud, Julie; Delaizir, Gaelle; Shimoda, Masato; Duclere, Jean-Rene; Colas, Maggy; Belleil, Michel; Comette, Julie; Hayakawa, Tomokatsu; Genevois, Cecile; Veron, Emmanuel; Allix, Mathieu; Chenu, Sebastien; Brisset, Francois; Thomas, Philippe			New Transparent Glass-Ceramics Based on the Crystallization of "Anti-glass" Spherulites in the Bi2O3-Nb2O5-TeO2 System	CRYSTAL GROWTH & DESIGN			English	Article							DIFFERENTIAL THERMAL-ANALYSIS; LITHIUM DISILICATE GLASS; TELLURITE GLASSES; PHASES; LUMINESCENCE; NUCLEATION	The crystallization of the Bi0.5Nb0.5Te3O8 (7.14 Bi2O3-7.14Nb(2)O(5)-85.72TeO(2)) glass composition shows numerous original spherulite-like shape or "droplets" crystalline domains through the bulk. Both SEM-EDS and microprobe measurements demonstrate that both these droplets and the glassy matrix present the same composition. The combination of information obtained from various complementary techniques, electron probe microanalysis, Raman, and SEM-EDS, then leads to the identification of the spherulites as a new Bi0.5Nb0.5Te3O8 "anti-glass" phase. However, the crystallization mechanism is complex since microcracks are observed at the surface of the spherulites in some glass-ceramic materials, suggesting a confined crystal growth. Therefore, the crystallization process appears much different from a homogeneous congruent crystallization. The photoluminescence (PL) properties of the (1 wt %) Er2O3-doped Bi0.5Nb0.5Te3O8 glass-ceramics were investigated during isothermal crystallization of the parent glass at 380 degrees C. The evolution of the PL signal (I-4(13/2) -> I-4(15/2) transition) enables indirect detection of the first steps of crystallization. Moreover, the PL data indicate random nucleation with respect to the location of Er3+ ions, whereas the integrated PL intensity and lifetime values show very comparable evolution trends as a function of the crystallization rate.	[Bertrand, Anthony; Carreaud, Julie; Delaizir, Gaelle; Duclere, Jean-Rene; Colas, Maggy; Comette, Julie; Chenu, Sebastien; Thomas, Philippe] Univ Limoges, Sci Proc Ceram & Traitements Surface, Ctr Europeen Ceram, CNRS,ENSCI,UMR 7315, F-87068 Limoges, France; [Bertrand, Anthony; Carreaud, Julie; Delaizir, Gaelle; Duclere, Jean-Rene; Colas, Maggy; Comette, Julie; Chenu, Sebastien; Thomas, Philippe] Univ Limoges, Labex Sigma Lim, F-87032 Limoges, France; [Shimoda, Masato; Hayakawa, Tomokatsu] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi 4668555, Japan; [Belleil, Michel] Renishaw SAS, F-77447 Marne La Vallee 2, France; [Genevois, Cecile; Veron, Emmanuel; Allix, Mathieu] CNRS, UPR3079, Condit Extremes & Mat Haute Temp & Irradiat, F-45067 Orleans 2, France; [Brisset, Francois] CNRS, UMR 8182, Inst Chim Mol & Mat Orsay, F-91405 Orsay, France	Delaizir, G (reprint author), Univ Limoges, Sci Proc Ceram & Traitements Surface, Ctr Europeen Ceram, CNRS,ENSCI,UMR 7315, F-87068 Limoges, France.	gaelle.delaizir@unilim.fr	Chenu, Sebastien/A-3388-2014; Allix, Mathieu/C-1679-2008	Chenu, Sebastien/0000-0002-5648-9779; Allix, Mathieu/0000-0001-9317-1316	Limousin Regional Council; French state; HOLIGRALE project [ANR-13-B508-0008-01]	We acknowledge Dr. J. Monnier and Dr. E. Leroy from ICMPE for microprobe measurements. We also acknowledge the financial support of the Limousin Regional Council. This work benefited also from financial support from the French state managed by the National Agency of the Research under both the "Future Investments" program referred to as Labex Sigma-Lim (Grant No. ANR-10-LABX-0074-01) and the HOLIGRALE project (Grant No. ANR-13-B508-0008-01).	[Anonymous], 1957, ANAL CHEM; MEUNIER G, 1970, CR ACAD SCI C CHIM, V270, P1987; TROMEL M, 1985, J LESS-COMMON MET, V110, P421, DOI 10.1016/0022-5088(85)90352-2; BURCKHARDT HG, 1983, ACTA CRYSTALLOGR C, V39, P1322, DOI 10.1107/S0108270183008380; VANVLIET JPM, 1989, J PHYS CHEM SOLIDS, V50, P1277, DOI 10.1016/0022-3697(89)90401-0; Berthier T, 2008, J NON-CRYST SOLIDS, V354, P1721, DOI 10.1016/j.jnoncrysol.2007.08.052; HOPPER RW, 1985, J NON-CRYST SOLIDS, V70, P111, DOI 10.1016/0022-3093(85)90098-5; Vigouroux H, 2012, ADV FUNCT MATER, V22, P3985, DOI 10.1002/adfm.201200651; RAY CS, 1990, J AM CERAM SOC, V73, P439, DOI 10.1111/j.1151-2916.1990.tb06532.x; Rocherulle J, 2000, MATER RES BULL, V35, P2353, DOI 10.1016/S0025-5408(00)00465-7; Masson O, 2004, J SOLID STATE CHEM, V177, P2168, DOI 10.1016/j.jssc.2004.03.010; TROMEL M, 1988, J SOLID STATE CHEM, V76, P345, DOI 10.1016/0022-4596(88)90229-0; Lovas GA, 1998, J SOLID STATE CHEM, V135, P175, DOI 10.1006/jssc.1997.7594; Milanese D, 2010, J NON-CRYST SOLIDS, V356, P2378, DOI 10.1016/j.jnoncrysol.2010.03.029; Kumar JS, 2014, J ALLOY COMPD, V617, P108, DOI 10.1016/j.jallcom.2014.07.194; Torres F, 2001, J MATER SCI, V36, P4961, DOI 10.1023/A:1011808926424; Alahrache S, 2013, CHEM MATER, V25, P4017, DOI 10.1021/cm401953d; Rubio-Marcos F, 2012, J MATER CHEM, V22, P9714, DOI 10.1039/c2jm30483j; Monteiro G, 2013, J NON-CRYST SOLIDS, V377, P129, DOI 10.1016/j.jnoncrysol.2012.12.019; OZAWA T, 1971, POLYMER, V12, P150, DOI 10.1016/0032-3861(71)90041-3; Jlassi I, 2012, J LUMIN, V132, P832, DOI 10.1016/j.jlumin.2011.09.013; Ray CS, 1996, J NON-CRYST SOLIDS, V204, P1, DOI 10.1016/0022-3093(96)00401-2; BLASSE G, 1986, J SOLID STATE CHEM, V63, P148, DOI 10.1016/0022-4596(86)90164-7; Berkalne N., 2009, THESIS U LIMOGES LIM; El-Mallawany R. A. H, 2012, TELLURITE GLASSES HD; Granasy L, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011605; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Yen W.M., 2007, PHOSPHOR HDB	28	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					5086	5096		10.1021/acs.cgd.5b01048		11	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800047		
J	Tahara, K; O'Mahony, M; Myerson, AS				Tahara, Kohei; O'Mahony, Marcus; Myerson, Allan S.			Continuous Spherical Crystallization of Albuterol Sulfate with Solvent Recycle System	CRYSTAL GROWTH & DESIGN			English	Article							POLYMERS; INDUSTRY	Spherical crystallization enables the direct preparation of crystal agglomerates of active pharmaceutical ingredients (APIs) with improved crystal handling properties. The continuous spherical crystallization of albuterol sulfate as a model API was developed using a mixed-suspension, mixed-product removal (MSMPR) crystallizer. The application of a solvent recycling system for reuse of the antisolvent in the single-stage MSMPR crystallizer was also demonstrated. Spherical agglomerates of albuterol sulfate were obtained via antisolvent crystallization using the MSMPR crystallizer with water as the solvent and an ethyl acetate/emulsifier (Pluronic L-121) mixture as the antisolvent. Steady-state continuous spherical crystallization was rapidly achieved after 30 min, and a yield of >95% was obtained. The influence of process parameters such as the solvent/antisolvent ratio, emulsifier concentration, residence time, and reactor scale on the properties of the agglomerates formed during the crystallization process was examined. In the MSMPR crystallizer, the desired solvent to antisolvent ratio was maintained by controlling the flow rates of the feed, antisolvent, and recycle stream, and 90% of the mother liquor was recycled during the continuous spherical crystallization of albuterol sulfate by optimizing the rate of each stream.	[Tahara, Kohei; O'Mahony, Marcus; Myerson, Allan S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Tahara, Kohei] Gifu Pharmaceut Univ, Lab Pharmaceut Engn, Gifu 5011196, Japan	Myerson, AS (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.	myerson@mit.edu			DARPA [N66001-11-C-4147]; Yamada Scientific Foundation; New Pharmaceutical Technology and Engineering (NPTE) Foundation	The authors are grateful for the financial support provided by DARPA through Grant N66001-11-C-4147. K.T. was the recipient of a fellowship from Yamada Scientific Foundation and a research grant from the New Pharmaceutical Technology and Engineering (NPTE) Foundation.	Poechlauer P, 2012, ORG PROCESS RES DEV, V16, P1586, DOI 10.1021/op300159y; Kovacic B, 2012, ACTA PHARMACEUT, V62, P1, DOI 10.2478/v10007-012-0010-5; Ferguson S, 2014, CRYST GROWTH DES, V14, P617, DOI 10.1021/cg401491y; Quon JL, 2012, CRYST GROWTH DES, V12, P3036, DOI 10.1021/cg300253a; Shekunov BY, 2000, J CRYST GROWTH, V211, P122, DOI 10.1016/S0022-0248(99)00819-2; Modi SR, 2013, CRYST GROWTH DES, V13, P2824, DOI 10.1021/cg400140a; Eder RJP, 2011, CRYST RES TECHNOL, V46, P227, DOI 10.1002/crat.201000634; Lawton S, 2009, ORG PROCESS RES DEV, V13, P1357, DOI 10.1021/op900237x; Plumb K, 2005, CHEM ENG RES DES, V83, P730, DOI 10.1205/cherd.04359; KAWASHIMA Y, 1989, J PHARM SCI, V78, P68, DOI 10.1002/jps.2600780118; Alvarez AJ, 2010, CRYST GROWTH DES, V10, P2219, DOI 10.1021/cg901496s; Moschou P, 2014, REV CHEM ENG, V30, P127, DOI 10.1515/revce-2013-0041; KAWASHIMA Y, 1982, SCIENCE, V216, P1127, DOI 10.1126/science.216.4550.1127; KAWASHIMA Y, 1991, J PHARM SCI, V80, P472, DOI 10.1002/jps.2600800515; Wong SY, 2012, CRYST GROWTH DES, V12, P5701, DOI 10.1021/cg301221q; DICKINSON E, 1991, ADV COLLOID INTERFAC, V34, P1, DOI 10.1016/0001-8686(91)80045-L; Nocent M, 2001, J PHARM SCI, V90, P1620, DOI 10.1002/jps.1112; Felder R. M., 2008, ELEMENTARY PRINCIPLE; Martinez-Gallegos JF, 2015, CHEM ENG SCI, V134, P36, DOI 10.1016/j.ces.2015.04.047; Myerson A. S., 2002, HDB IND CRYSTALLIZAT; Randolph A., 1971, THEORY PARTICULATE P	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	OCT	2015	15	10					5149	5156		10.1021/acs.cgd.5b01159		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CT2JW	WOS:000362628800054		
J	Yun, MS; Kim, BK; Joo, HT; Yang, EJ; Nishino, S; Chung, KH; Kang, SH; Lee, SH				Yun, Mi Sun; Kim, Bo Kyung; Joo, Hui Tae; Yang, Eun Jin; Nishino, Shigeto; Chung, Kyung Ho; Kang, Sung-Ho; Lee, Sang H.			Regional productivity of phytoplankton in the Western Arctic Ocean during summer in 2010	DEEP-SEA RESEARCH PART II-TOPICAL STUDIES IN OCEANOGRAPHY			English	Article						Phytoplankton; Carbon uptake rates; Nitrogen uptake rates; Warm-core eddy; Arctic	CANADA BASIN; UPTAKE RATES; CHUKCHI SEA; BERING STRAIT; NITROGEN UPTAKE; HAIDA EDDIES; MIXED-LAYER; ICE ALGAE; CARBON; NUTRIENT	Phytoplanlcton production measurements were conducted in the northeast Chukchi Sea and western Canada Basin in the summer season, from 20 July to 10 August 2010, using a C-13-N-15 dual tracer technique. The daily carbon uptake rate in the northeast Chukchi Sea in 2010 was extremely low, with a mean of 29.8 mg C m(-2) d(-1) (SD = 17.6 mg C m(-2) d(-1)). Regional and temporal differences caused the low production rate compared to previous studies in the northeast Chukchi Sea. In the western Canada Basin, the mean daily carbon uptake rate from this study was 20.6 mg m(-2) d(-1), which was influenced by the dominance of small phytoplankton resulting in a low carbon uptake rate in the region. The regionally high nitrate uptake rates compared to ammonium uptake rates in the western Canada Basin can be caused by warm-core eddies, which supply high levels of nitrate to the euphotic zone. Warm-core eddies in the Canada Basin substantially enhanced local phytoplanlcton production and the contribution of large phytoplanlcton. Therefore, the effects of physical forcing events (such as "an" eddy) on the primary production need to be examined further to better understand changes of primary production under ongoing environmental changes in the Arctic Ocean. (C) 2015 Elsevier Ltd. All rights reserved.	[Yun, Mi Sun; Kim, Bo Kyung; Joo, Hui Tae; Lee, Sang H.] Pusan Natl Univ, Dept Oceanog, Busan 609735, South Korea; [Yang, Eun Jin; Chung, Kyung Ho; Kang, Sung-Ho] Korea Polar Res Inst, Dept Polar Ocean Environm, Inchon 406840, South Korea; [Nishino, Shigeto] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan	Lee, SH (reprint author), Pusan Natl Univ, Dept Oceanog, 30 Jangjeon Dong, Busan 609735, South Korea.	sanglee@pusan.ac.kr			Korea-Polar Ocean in Rapid Transition (K-PORT) - Ministry of Oceans and Fisheries, Korea [PM14040]; "Post-Doc. Development Program" of Pusan National University	We thank the captain and crew of the ARAON for their outstanding assistance during the cruise. We are also grateful to Prof. Ho Kyung Ha of the Inha University and Dr. Hyoung Sul La of the Korea Polar Research Institute and Dr. Young Nam Kim of the Korea Marine Environment Management Corporation for providing CTD data and nutrient data. We gratefully acknowledge to Drs. Seung Hyun Son and Hyun- Cheol Kim for providing satellite data. In addition, we are grateful to the anonymous three reviewers who helped us make significant improvements to this manuscript. This work was supported by grants from the Korea-Polar Ocean in Rapid Transition (K-PORT; PM14040) program funded by the Ministry of Oceans and Fisheries, Korea. This study was also financially supported by the "2015 Post-Doc. Development Program" of Pusan National University.	McLaughlin FA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045459; Tremblay JE, 2000, DEEP-SEA RES PT II, V47, P489, DOI 10.1016/S0967-0645(99)00116-2; Cooper LW, 1997, J GEOPHYS RES-OCEANS, V102, P12563, DOI 10.1029/97JC00015; Hill VJ, 2013, PROG OCEANOGR, V110, P107, DOI 10.1016/j.pocean.2012.11.005; Kawaguchi Y, 2012, DEEP-SEA RES PT I, V66, P90, DOI 10.1016/j.dsr.2012.04.006; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Krishfield RA, 2014, J GEOPHYS RES-OCEANS, V119, P1271, DOI 10.1002/2013JC008999; Nishino S, 2013, J GEOPHYS RES-OCEANS, V118, P635, DOI 10.1029/2012JC008234; KING FD, 1979, LIMNOL OCEANOGR, V24, P645; PROBYN TA, 1985, MAR ECOL PROG SER, V22, P249, DOI 10.3354/meps022249; Proshutinsky A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005104; Lee SH, 2005, POLAR BIOL, V28, P190, DOI 10.1007/s00300-004-0676-3; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Muench RD, 2000, J GEOPHYS RES-OCEANS, V105, P23997, DOI 10.1029/2000JC000212; Steele M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005849; Lee SH, 2012, DEEP-SEA RES PT II, V81-84, P18, DOI 10.1016/j.dsr2.2011.06.005; Mizobata K, 2002, PROG OCEANOGR, V55, P65, DOI 10.1016/S0079-6611(02)00070-8; Carmack EC, 2004, MAR ECOL PROG SER, V277, P37, DOI 10.3354/meps277037; Lasternas S, 2010, POLAR BIOL, V33, P1709, DOI 10.1007/s00300-010-0877-x; Crawford WR, 2005, DEEP-SEA RES PT II, V52, P975, DOI 10.1016/j.dsr2.2005.02.011; Yun MS, 2012, POLAR BIOL, V35, P257, DOI 10.1007/s00300-011-1070-6; Nishino S, 2011, J OCEANOGR, V67, P305, DOI 10.1007/s10872-011-0030-7; Lee SH, 2013, CONT SHELF RES, V59, P28, DOI 10.1016/j.csr.2013.04.004; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Jackson JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005265; Lee SH, 2008, ARCTIC, V61, P281; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; MANLEY TO, 1985, J GEOPHYS RES-OCEANS, V90, P4911, DOI 10.1029/JC090iC03p04911; [Anonymous], 2007, GEOPHYS RES LETT, DOI DOI 10.1029/2007GL029703; Cota GF, 1996, MAR ECOL PROG SER, V135, P247, DOI 10.3354/meps135247; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; KOIKE I, 1986, MAR ECOL PROG SER, V30, P105, DOI 10.3354/meps030105; Yun MS, 2014, CONT SHELF RES, V76, P1, DOI 10.1016/j.csr.2014.01.001; Lee SH, 2007, CONT SHELF RES, V27, P2231, DOI 10.1016/j.csr.2007.05.009; SAMBROTTO RN, 1984, SCIENCE, V225, P1147, DOI 10.1126/science.225.4667.1147; Whitney F, 2002, J OCEANOGR, V58, P715, DOI 10.1023/A:1022850508403; COTA GF, 1987, J GEOPHYS RES-OCEANS, V92, P1951, DOI 10.1029/JC092iC02p01951; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; WALSH JJ, 1989, PROG OCEANOGR, V22, P277, DOI 10.1016/0079-6611(89)90006-2; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Lee SH, 2010, POLAR BIOL, V33, P1027, DOI 10.1007/s00300-010-0781-4; Lee SH, 2013, CONT SHELF RES, V68, P43, DOI 10.1016/j.csr.2013.08.008; GARDNER WD, 1995, DEEP-SEA RES PT II, V42, P757, DOI 10.1016/0967-0645(95)00037-Q; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; JONES EP, 1986, J GEOPHYS RES-OCEANS, V91, P759, DOI 10.1029/JC091iC09p10759; Landry M. R., 1998, DEEP SEA RES 2, V45, P2368; Legendre L, 1996, J PLANKTON RES, V19, P263; Mathis JT, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003899; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Nishino S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047885; Parsons T.R., 1984, MANUAL CHEM BIOL MET, V2-xiv, P173; Pickart R.S., 2008, CHINESE J POLAR SCI, V19, P135; Robie W. S., 1992, RESULTS 3 JOINT US U, P123; Sakshaug E., 1980, PHYSL ECOLOGY PHYTOP, P57; SPRINGER AM, 1993, CONT SHELF RES, V13, P575, DOI 10.1016/0278-4343(93)90095-F; RAO DVS, 1984, POLAR BIOL, V3, P191; Yang JY, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005084	59	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0645	1879-0100		DEEP-SEA RES PT II	Deep-Sea Res. Part II-Top. Stud. Oceanogr.	OCT	2015	120				SI		61	71		10.1016/j.dsr2.2014.11.023		11	Oceanography	Oceanography	CT2CX	WOS:000362610700007		
J	Kimura, E; Isogai, S; Hitomi, J				Kimura, Eiji; Isogai, Sumio; Hitomi, Jiro			Integration of vascular systems between the brain and spinal cord in zebrafish	DEVELOPMENTAL BIOLOGY			English	Article						Endothelial cell; Angiogenesis; Flow dynamics; Remodeling; Time-lapse imaging; Multi-photon microscopy	NETWORK FORMATION; INFRARED-LASER; GENE INDUCTION; IN-VIVO; TRUNK; VESSELS; EMBRYOS; MEDAKA; CELLS	Cerebral and spinal vascular systems are organized individually, and they then conjugate at their border, through the integration of basilar artery and vertebral arteries. Zebrafish (Danio rerio) is an ideal organism for studying early vascular development, and the precise procedure of cranial and truncal vascular formation has been previously demonstrated using this model. However, the stepwise process of the integration between the brain and spinal cord has not been clearly elucidated. In this study, we describe the integration of the independent vascular systems for the brain and spinal cord, using transgenic zebrafish expressing enhanced green fluorescent protein in endothelial cells. Initially, basilar artery and primordial hindbrain channels, into which internal carotid arteries supplied blood, were connected with dorsal longitudinal anastomose vessels, via the first intersegmental artery. This initial connection was not influenced by flow dynamics, suggesting that vascular integration in this region is controlled by genetic cues. Vertebral arteries were formed individually as longitudinal vessels beneath the spinal cord, and became integrated with the basilar artery during subsequent remodeling. Furthermore, we confirmed the basal vasculature was well conserved in adult zebrafish. Observations of vascular integration presented herein will contribute to an understanding of regulatory mechanisms behind this process. (C) 2015 Elsevier Inc. All rights reserved.	[Kimura, Eiji; Isogai, Sumio; Hitomi, Jiro] Iwate Med Univ, Dept Anat, Shiwa, Iwate 0283694, Japan	Kimura, E (reprint author), Iwate Med Univ, Dept Anat, 2-1-1 Nishitokuta, Shiwa, Iwate 0283694, Japan.	eijik@iwate-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [18790147, 26460255, 20390054]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1491001]	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) of the Japan Society for the Promotion of Science (JSPS), Grant numbers 18790147; 26460255; and 20390054 (E. K and J. H), and partly supported by a Grant-in-Aid for Strategic Medical Science Research (S1491001, 2014-2018) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (E. K and J. H).	Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Aizawa Y, 1999, ANAT EMBRYOL, V200, P573, DOI 10.1007/s004290050305; Isogai S, 2010, J ANAT, V216, P656, DOI 10.1111/j.1469-7580.2010.01230.x; Cha YR, 2012, DEV CELL, V22, P824, DOI 10.1016/j.devcel.2012.01.011; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Shoji W, 2003, DEVELOPMENT, V130, P3227, DOI 10.1242/dev.00516; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/nmeth.1278, 10.1038/NMETH.1278]; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Kamei M, 2005, ZEBRAFISH, V2, P113, DOI 10.1089/zeb.2005.2.113; Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Kamei M, 2010, METHOD CELL BIOL, V100, P27, DOI 10.1016/B978-0-12-384892-5.00002-5; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Roman BL, 2002, DEVELOPMENT, V129, P3009; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Condon E.D., 1922, CONTRIBUTION EMBRYOL, V68, P47; Crosby E.C., 1982, COMP CORRELATIVE NEU; Evans H.M., 1912, MANUAL HUMAN EMBRYOL, P570; Jin S.W., 2007, DEV BIOL, V307, P29; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; Padget D.H., 1957, CONTRIB EMBRYOL, V247, P81; Padget D.H., 1948, CONTRIBUTION EMBRYOL, V212; Sabin F.R., 1917, CONTRIB EMBRYOL CARN, V18, P61; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Streeter G., 1918, CARNEGIE I WASH PUB, V24, P5; Takase Y., 2014, DEV GROWTH DIFFER, V55, P792; Thoma R., UNTERS HISTOGENESE H; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE	38	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	OCT 1	2015	406	1					40	51		10.1016/j.ydbio.2015.07.015		12	Developmental Biology	Developmental Biology	CS9DE	WOS:000362388500003		
J	Murakami, T				Murakami, Tomoaki			Kallikrein-Kinin System: An Emerging Competitor or Collaborator for VEGF in Diabetic Macular Edema?	DIABETES			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; PERMEABILITY IN-VIVO; VASCULAR-PERMEABILITY; RETINOPATHY; CONTRIBUTES; ACTIVATION; SIGNALS; CELLS		Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Murakami, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	mutomo@kuhp.kyoto-u.ac.jp					AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Otani A, 1998, CIRC RES, V82, P619; Nakamura S, 2011, ARTERIOSCL THROM VAS, V31, P1041, DOI 10.1161/ATVBAHA.111.223594; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Silvestre JS, 2001, CIRC RES, V89, P678, DOI 10.1161/hh2001.097691; Ikeda Y, 2004, CANCER RES, V64, P5178, DOI 10.1158/0008-5472.CAN-03-3589; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; [Anonymous], 2012, NEW ENGL J MED; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Thuringer D, 2002, J BIOL CHEM, V277, P2028, DOI 10.1074/jbc.M109493200; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Kita T, 2015, DIABETES, V64, P3588, DOI 10.2337/db15-0317; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199	20	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	OCT	2015	64	10					3350	3352		10.2337/db15-0746		3	Endocrinology & Metabolism	Endocrinology & Metabolism	CT2IG	WOS:000362624600005		
J	Kita, T; Clermont, AC; Murugesan, N; Zhou, QF; Fujisawa, K; Ishibashi, T; Aiello, LP; Feener, EP				Kita, Takeshi; Clermont, Allen C.; Murugesan, Nivetha; Zhou, Qunfang; Fujisawa, Kimihiko; Ishibashi, Tatsuro; Aiello, Lloyd Paul; Feener, Edward P.			Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema	DIABETES			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-RETINAL BARRIER; NITRIC-OXIDE SYNTHASE; VASCULAR DYSFUNCTION; VITREOUS LEVELS; VISUAL-ACUITY; RETINOPATHY; BREAKDOWN; PROTEOME; DISEASE	This study characterizes the kallikrein-kinin system in vitreous from individuals with diabetic macular edema (DME) and examines mechanisms contributing to retinal thickening and retinal vascular permeability (RVP). Plasma prekallikrein (PPK) and plasma kallikrein (PKal) were increased twofold and 11.0-fold (both P < 0.0001), respectively, in vitreous from subjects with DME compared with those with a macular hole (MH). While the vascular endothelial growth factor (VEGF) level was also increased in DME vitreous, PKal and VEGF concentrations do not correlate (r= 0.266, P = 0.112). Using mass spectrometry-based proteomics, we identified 167 vitreous proteins, including 30 that were increased in DME (fourfold or more, P < 0.001 vs. MH). The majority of proteins associated with DME displayed a higher correlation with PPK than with VEGF concentrations. DME vitreous containing relatively high levels of PKal and low VEGF induced RVP when injected into the vitreous of diabetic rats, a response blocked by bradykinin receptor antagonism but not by bevacizumab. Bradykinin-induced retinal thickening in mice was not affected by blockade of VEGF receptor 2. Diabetes-induced RVP was decreased by up to 78% (P < 0.001) in Klkb1 (PPK)-deficient mice compared with wild-type controls. B2- and B1 receptor-induced RVP in diabetic mice was blocked by endothelial nitric oxide synthase (NOS) and inducible NOS deficiency, respectively. These findings implicate the PKal pathway as a VEGF-independent mediator of DME.	[Kita, Takeshi; Clermont, Allen C.; Murugesan, Nivetha; Zhou, Qunfang; Aiello, Lloyd Paul; Feener, Edward P.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Fujisawa, Kimihiko; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Higashi Ku, Fukuoka 812, Japan; [Aiello, Lloyd Paul] Harvard Univ, Sch Med, Dept Ophthalmol, Beetham Eye Inst, Boston, MA 02115 USA; [Feener, Edward P.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Feener, EP (reprint author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.	edward.feener@joslin.harvard.edu					AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JCI35424, 10.1172/JC135424]; Gao BB, 2008, MOL CELL PROTEOMICS, V7, P2399, DOI 10.1074/mcp.M800104-MCP200; Sonoda S, 2013, INVEST OPHTH VIS SCI, V54, P5367, DOI 10.1167/iovs.13-12382; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Lowry JL, 2013, J BIOL CHEM, V288, P4174, DOI 10.1074/jbc.M112.436022; Li QH, 2010, INVEST OPHTH VIS SCI, V51, P5240, DOI 10.1167/iovs.09-5147; Ma JX, 1996, EXP EYE RES, V63, P19, DOI 10.1006/exer.1996.0087; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Sun JK, 2015, DIABETES, V64, P2560, DOI 10.2337/db14-0782; Kita T, 2007, DIABETES, V56, P1421, DOI 10.2337/db06-1644; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI 10.2735/3505; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Liu J, 2011, NAT MED, V17, P206, DOI 10.1038/nm.2295; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; [Anonymous], 2012, NEW ENGL J MED; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Liu J, 2010, TRANSL STROKE RES, V1, P276, DOI 10.1007/s12975-010-0039-z; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784; Liu J, 2013, INVEST OPHTH VIS SCI, V54, P1086, DOI 10.1167/iovs.12-10537; Funatsu H, 2003, OPHTHALMOLOGY, V110, P1690, DOI 10.1016/S0161-6420(03)00568-2; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Feener EP, 2010, CURR DIABETES REP, V10, P270, DOI 10.1007/s11892-010-0127-1; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Catanzaro O, 2012, PEPTIDES, V34, P349, DOI 10.1016/j.peptides.2012.02.008; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Liu J, 2013, BIOL CHEM, V394, P319, DOI 10.1515/hsz-2012-0316; Bressler SB, 2012, ARCH OPHTHALMOL-CHIC, V130, P1153, DOI 10.1001/archophthalmol.2012.1107; Elman MJ, 2010, OPHTHALMOLOGY, V117, pe35; Farrah T, 2011, MOL CELL PROTEOMICS, V10; Feener EP, 2013, THROMB HAEMOSTASIS, V110, P434, DOI 10.1160/TH13-02-0179; Masuda T, 2015, EUR J PHARMACOL, V749, P161, DOI 10.1016/j.ejphar.2014.10.007; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Pouliot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033864; Sun JK, 2014, JAMA OPHTHALMOL, V132, P1309, DOI 10.1001/jamaophthalmol.2014.2350	49	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	OCT	2015	64	10					3588	3599		10.2337/db15-0317		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CT2IG	WOS:000362624600028		
J	Bednar, KJ; Tsukamoto, H; Kachapati, K; Ohta, S; Wu, YH; Katz, JD; Ascherman, DP; Ridgway, WM				Bednar, Kyle J.; Tsukamoto, Hiroki; Kachapati, Kritika; Ohta, Shoichiro; Wu, Yuehong; Katz, Jonathan D.; Ascherman, Dana P.; Ridgway, William M.			Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody	DIABETES			English	Article							REGULATORY T-CELLS; MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; INCIDENCE TRENDS; INNATE IMMUNITY; LIPOPOLYSACCHARIDE; MICE; INFLAMMATION	Type 1 diabetes (T1D) is currently an incurable disease, characterized by a silent prodromal phase followed by an acute clinical phase, reflecting progressive autoimmune destruction of insulin-producing pancreatic beta-cells. Auto-reactive T cells play a major role in beta-cell destruction, but innate immune cell cytokines and costimulatory molecules critically affect T-cell functional status. We show that an agonistic monoclonal antibody to TLR4/MD-2 (TLR4-Ab) reverses new-onset diabetes in a high percentage of NOD mice. TLR4-Ab induces antigen-presenting cell (APC) tolerance in vitro and in vivo, resulting in an altered cytokine profile, decreased costimulatory molecule expression, and decreased T-cell proliferation in APC:T-cell assays. TLR4-Ab treatment increases T-regulatory cell (Treg) numbers in both the periphery and the pancreatic islet, predominantly expanding the Helios(+)Nrp-1(+)Foxp(3+) Treg subset. TLR4-Ab treatment in the absence of B cells in NOD.scid mice prevents subsequent T cell-mediated disease, further suggesting a major role for APC tolerization in disease protection. Specific stimulation of the innate immune system through TLR4/MD-2, therefore, can restore tolerance in the aberrant adaptive immune system and reverse new-onset T1D, suggesting a novel immunological approach to treatment of T1D in humans.	[Bednar, Kyle J.; Kachapati, Kritika; Wu, Yuehong; Ridgway, William M.] Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45220 USA; [Tsukamoto, Hiroki] Tohoku Univ, Lab Oncol Pharm Practice & Sci, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Ohta, Shoichiro] Saga Med Sch, Dept Lab Med, Saga, Japan; [Katz, Jonathan D.] Cincinnati Childrens Res Fdn, Div Immunobiol, Cincinnati, OH USA; [Ascherman, Dana P.] Univ Miami, Miller Sch Med, Div Rheumatol, Miami, FL 33136 USA	Ridgway, WM (reprint author), Univ Cincinnati, Coll Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45220 USA.	ridgwawm@ucmail.uc.edu			UC2019 Immunology Graduate Student Research Award; Japan Society for the Promotion of Science KAKENHI [26460058]; U.S. Department of Veterans Affairs merit award [BX000827-01A1]; University of Cincinnati Department of Medicine Distinguished Scientific Research Award	K.J.B. was supported by the UC2019 Immunology Graduate Student Research Award. H.T. was supported by Japan Society for the Promotion of Science KAKENHI grant number 26460058. W.M.R. was supported by a U.S. Department of Veterans Affairs merit award grant BX000827-01A1 and by a University of Cincinnati Department of Medicine Distinguished Scientific Research Award.	Lien E, 2009, CURR MOL MED, V9, P52; ROWLEY D, 1956, LANCET, V270, P366; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Nikolic T, 2005, LAB INVEST, V85, P487, DOI 10.1038/labinvest.3700238; HENRICSON BE, 1990, INFECT IMMUN, V58, P2429; Long AE, 2012, DIABETES, V61, P683, DOI 10.2337/db11-0962; Van Parijs L, 2009, J EXP MED, V206, P1207, DOI 10.1084/jem.186.7.11194309r; Kachapati K, 2013, J AUTOIMMUN, V47, P94, DOI 10.1016/j.jaut.2013.09.002; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Bahrun U, 2007, HYBRIDOMA, V26, P393, DOI 10.1089/hyb.2007.0523; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Weaver DJ, 2001, J IMMUNOL, V167, P1461; Matsushita H, 2010, INT IMMUNOL, V22, P739, DOI 10.1093/intimm/dxq062; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Bour-Jordan H, 2004, J CLIN INVEST, V114, P979, DOI 10.1172/JCI200420483; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Caramalho I, 2011, SCAND J IMMUNOL, V74, P585, DOI 10.1111/j.1365-3083.2011.02627.x; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Ohta S, 2006, CLIN VACCINE IMMUNOL, V13, P1131, DOI 10.1128/CVI.00173-06; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Alkanani AK, 2012, DIABETES, V61, P2525, DOI 10.2337/db12-0099; MADONNA GS, 1986, INFECT IMMUN, V52, P6; Katz JD, 2011, CELL MOL LIFE SCI, V68, P2873, DOI 10.1007/s00018-011-0730-6; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Kim HS, 2009, CURR MOL MED, V9, P30; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Dahlen E, 1998, J IMMUNOL, V160, P3585; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Bach JF, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007799; Dessein Rodrigue, 2009, Gastroenterology, V137, P381, DOI 10.1053/j.gastro.2009.05.026; Gulden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075385; Jeker LT, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007807; Prasad Suchitra, 2012, Rev Diabet Stud, V9, P319, DOI 10.1900/RDS.2012.9.319; Trucco Massimo, 2009, Endocrinol Nutr, V56 Suppl 4, P56; Van Parijs Luk, 1997, Journal of Experimental Medicine, V186, P1119; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322	51	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	OCT	2015	64	10					3614	3626		10.2337/db14-1868		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CT2IG	WOS:000362624600030		
J	Akiyama, T; Xin, L; Oda, M; Sharov, AA; Amano, M; Piao, Y; Cadet, JS; Dudekula, DB; Qian, Y; Wang, WD; Ko, SBH; Ko, MSH				Akiyama, Tomohiko; Xin, Li; Oda, Mayumi; Sharov, Alexei A.; Amano, Misa; Piao, Yulan; Cadet, J. Scotty; Dudekula, Dawood B.; Qian, Yong; Wang, Weidong; Ko, Shigeru B. H.; Ko, Minoru S. H.			Transient bursts of Zscan4 expression are accompanied by the rapid derepression of heterochromatin in mouse embryonic stem cells	DNA RESEARCH			English	Article						heterochromatin; pericentromere; embryonic stem cells	PREIMPLANTATION DEVELOPMENT; MAMMALIAN TELOMERES; SATELLITE REPEATS; GENE-EXPRESSION; 2-CELL EMBRYOS; GROUND-STATE; ES CELLS; PLURIPOTENT; TRANSCRIPTION; CULTURE	Mouse embryonic stem cells (mESCs) have a remarkable capacity to maintain normal genome stability and karyotype in culture. We previously showed that infrequent bursts of Zscan4 expression (Z4 events) are important for the maintenance of telomere length and genome stability in mESCs. However, the molecular details of Z4 events remain unclear. Here we show that Z4 events involve unexpected transcriptional derepression in heterochromatin regions that usually remain silent. During a Z4 event, we see rapid derepression and rerepression of heterochromatin leading to a burst of transcription that coincides with transient histone hyperacetylation and DNA demethylation, clustering of pericentromeric heterochromatin around the nucleolus, and accumulation of activating and repressive chromatin remodelling complexes. This heterochromatin-based transcriptional activity suggests that mESCs may maintain their extraordinary genome stability at least in part by transiently resetting their heterochromatin.	[Akiyama, Tomohiko; Oda, Mayumi; Ko, Shigeru B. H.; Ko, Minoru S. H.] Keio Univ, Sch Med, Dept Syst Med, Tokyo 160, Japan; [Akiyama, Tomohiko; Xin, Li; Sharov, Alexei A.; Amano, Misa; Piao, Yulan; Cadet, J. Scotty; Dudekula, Dawood B.; Qian, Yong; Wang, Weidong; Ko, Minoru S. H.] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	Ko, MSH (reprint author), Keio Univ, Sch Med, Dept Syst Med, Tokyo 160, Japan.	ko.minoru@keio.jp	Oda, Mayumi/K-5404-2013	Oda, Mayumi/0000-0001-5102-7076	Keio University Medical Science Fund-The Mitsunada Sakaguchi Laboratory; Takeda Science Foundation; Intramural Research Program of the National Institutes of Health, National Institute on Aging [AG000656, AG000702]	This work was in part supported by the Keio University Medical Science Fund-The Mitsunada Sakaguchi Laboratory, the Takeda Science Foundation, and the Intramural Research Program of the National Institutes of Health (AG000656, AG000702), National Institute on Aging. Funding to pay the Open Access publication charges for this article was provided by the Keio University Medical Science Fund-The Mitsunada Sakaguchi Laboratory.	Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Carone DM, 2013, SEMIN CANCER BIOL, V23, P99, DOI 10.1016/j.semcancer.2012.06.008; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Festuccia N, 2013, CURR OPIN GENET DEV, V23, P504, DOI 10.1016/j.gde.2013.06.003; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Gendrel AV, 2014, ANNU REV CELL DEV BI, V30, P561, DOI 10.1146/annurev-cellbio-101512-122415; Hung SSC, 2013, DNA RES, V20, P391, DOI 10.1093/dnares/dst018; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Ko SBH, 2013, AM J PHYSIOL-GASTR L, V304, pG1103, DOI 10.1152/ajpgi.00299.2012; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Olson LE, 2003, CANCER RES, V63, P6602; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Probst AV, 2008, DIFFERENTIATION, V76, P15, DOI 10.1111/j.1432-0436.2007.00220.x; Akiyama T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002279; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morgani SM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0549; Obeso D, 2014, CHROMOSOMA, V123, P43, DOI 10.1007/s00412-013-0439-4; Stancheva I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002093; Storm MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089821; Suzuki M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r36	59	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	OCT	2015	22	5					307	318		10.1093/dnares/dsv013		12	Genetics & Heredity	Genetics & Heredity	CT5AY	WOS:000362820100001		
J	Amano, T; Jeffries, E; Amano, M; Ko, AC; Yu, H; Ko, MSH				Amano, Tomokazu; Jeffries, Emiko; Amano, Misa; Ko, Akihiro C.; Yu, Hong; Ko, Minoru S. H.			Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures	DNA RESEARCH			English	Article						aneuploidy; Down syndrome; Edwards syndrome; ZSCAN4; human fibroblast cells	PLURIPOTENT STEM-CELLS; MODIFIED MESSENGER-RNA; 2-CELL EMBRYOS; ZSCAN4; GENERATION; TRISOMY-21; DISEASE; GENES	Aneuploidy, an abnormal number of chromosomes, has previously been considered irremediable. Here, we report findings that euploid cells increased among cultured aneuploid cells after exposure to the protein ZSCAN4, encoded by a mammalian-specific gene that is ordinarily expressed in preimplantation embryos and occasionally in stem cells. For footprint-free delivery of ZSCAN4 to cells, we developed ZSCAN4 synthetic mRNAs and Sendai virus vectors that encode human ZSCAN4. Applying the ZSCAN4 biologics to established cultures of mouse embryonic stem cells, most of which had become aneuploid and polyploid, dramatically increased the number of euploid cells within a few days. We then tested the biologics on non-immortalized primary human fibroblast cells derived from four individuals with Down syndrome-the most frequent autosomal trisomy of chromosome 21. Within weeks after ZSCAN4 application to the cells in culture, fluorescent in situ hybridization with a chromosome 21-specific probe detected the emergence of up to 24% of cells with only two rather than three copies. High-resolution G-banded chromosomes further showed up to 40% of cells with a normal karyotype. These findings were confirmed by whole-exome sequencing. Similar results were obtained for cells with the trisomy 18 of Edwards syndrome. Thus a direct, efficient correction of aneuploidy in human fibroblast cells seems possible in vitro using human ZSCAN4.	[Amano, Tomokazu; Jeffries, Emiko; Amano, Misa; Ko, Akihiro C.; Yu, Hong; Ko, Minoru S. H.] Elixirgen LLC, Sci Technol Pk Johns Hopkins, Baltimore, MD 21205 USA; [Ko, Minoru S. H.] Keio Univ, Sch Med, Dept Syst Med, Shinjuku Ku, Tokyo 160, Japan	Ko, MSH (reprint author), Elixirgen LLC, Sci Technol Pk Johns Hopkins, 855 N Wolfe St,Suite 621, Baltimore, MD 21205 USA.	ko.minoru@elixirgen.com			Maryland Stem Cell Research Fund; Elixirgen, LLC.	This work was in part supported by a grant from the Maryland Stem Cell Research Fund. Funding to pay the Open Access publication charges for this article was provided by the Maryland Stem Cell Research Fund and Elixirgen, LLC.	Akiyama T, 2015, DNA RES, V22, P307, DOI 10.1093/dnares/dsv013; Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Jenkins EC, 2010, NEUROBIOL AGING, V31, P765, DOI 10.1016/j.neurobiolaging.2008.06.001; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Inoue M, 2003, J VIROL, V77, P6419, DOI 10.1128/JVI.77.11.6419-6429.2003; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Hung SSC, 2013, DNA RES, V20, P391, DOI 10.1093/dnares/dst018; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Bazrgar M, 2013, STEM CELLS DEV, V22, P2449, DOI 10.1089/scd.2013.0053; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923; Papavassiliou P, 2015, AM J MED GENET A, V167, P26, DOI 10.1002/ajmg.a.36861; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cereda A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-81; Epstein C. J., 1986, CONSEQUENCES CHROMOS; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Liu BB, 2015, EMBO REP, V16, P44, DOI 10.15252/embr.201439583; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Seki S., 2013, SENDAI VIRUS VECTOR, P127; Wiegand M., 2013, SENDAI VIRUS VECTOR, P91	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	OCT	2015	22	5					331	342		10.1093/dnares/dsv016		12	Genetics & Heredity	Genetics & Heredity	CT5AY	WOS:000362820100003		
J	Kawai, M; Higashiura, N; Hayasaki, K; Okamoto, N; Takami, A; Hirakawa, H; Matsushita, K; Azuma, Y				Kawai, Mikihiko; Higashiura, Norie; Hayasaki, Kimie; Okamoto, Naruhei; Takami, Akiko; Hirakawa, Hideki; Matsushita, Kazunobu; Azuma, Yoshinao			Complete genome and gene expression analyses of Asaia bogorensis reveal unique responses to culture with mammalian cells as a potential opportunistic human pathogen	DNA RESEARCH			English	Article						genomics; transcriptome; ubiquinol terminal oxidase; opportunistic pathogen; acetic acid bacteria	ACETIC-ACID BACTERIUM; ESCHERICHIA-COLI; RIBOSOMAL-RNA; GRANULIBACTER-BETHESDENSIS; ACETOBACTER-PASTEURIANUS; GLUCONOBACTER-OXYDANS; UBIQUINOL OXIDASE; SEQUENCE-ANALYSIS; PROTEIN FAMILIES; BINDING-SITE	Asaia bogorensis, a member of acetic acid bacteria (AAB), is an aerobic bacterium isolated from flowers and fruits, as well as an opportunistic pathogen that causes human peritonitis and bacteraemia. Here, we determined the complete genomic sequence of the As. bogorensis type strain NBRC 16594, and conducted comparative analyses of gene expression under different conditions of co-culture with mammalian cells and standard AAB culture. The genome of As. bogorensis contained 2,758 protein-coding genes within a circular chromosome of 3,198,265 bp. There were two complete operons encoding cytochrome bo(3)-type ubiquinol terminal oxidases: cyoABCD-1 and cyoABCD-2. The cyoABCD-1 operon was phylogenetically common to AAB genomes, whereas the cyoABCD-2 operon belonged to a lineage distinctive from the cyoABCD-1 operon. Interestingly, cyoABCD-1 was less expressed under co-culture conditions than under the AAB culture conditions, whereas the converse was true for cyoABCD-2. Asaia bogorensis shared pathogenesis-related genes with another pathogenic AAB, Granulibacter bethesdensis, including a gene coding pathogen-specific large bacterial adhesin and additional genes for the inhibition of oxidation and antibiotic resistance. Expression alteration of the respiratory chain and unique hypothetical genes may be key traits that enable the bacterium to survive under the co-culture conditions.	[Kawai, Mikihiko; Higashiura, Norie; Hayasaki, Kimie; Okamoto, Naruhei; Takami, Akiko; Azuma, Yoshinao] Kindai Univ, Fac Biol Oriented Sci & Technol, Kinokawa, Wakayama, Japan; [Kawai, Mikihiko; Higashiura, Norie; Takami, Akiko] Japan Sci & Technol Agcy JST, Adv Low Carbon Technol Res & Dev Program ALCA, Tokyo, Japan; [Hirakawa, Hideki] Kazusa DNA Inst, Kisarazu, Chiba, Japan; [Matsushita, Kazunobu] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Yamaguchi, Japan	Azuma, Y (reprint author), Kindai Univ, Fac Biol Oriented Sci & Technol, Kinokawa, Wakayama, Japan.	azuma@waka.kindai.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA); Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKEN-HI: 22510222]	This work was financially supported by the Advanced Low Carbon Technology Research and Development Program (ALCA), and a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKEN-HI: 22510222). Funding to pay the Open Access publication charges for this article was provided by the Advanced Low Carbon Technology Research and Development Program (ALCA).	Adachi O, 2003, APPL MICROBIOL BIOT, V60, P643, DOI 10.1007/s00253-002-1155-9; Snyder RW, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.04.042; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Yamada Y, 2000, INT J SYST EVOL MICR, V50, P823; Greenberg DE, 2007, J BACTERIOL, V189, P8727, DOI 10.1128/JB.00793-07; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Holscher T, 2007, MICROBIOL-SGM, V153, P499, DOI 10.1099/mic.0.2006/002196-0; Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Abdel-Hamid AM, 2001, MICROBIOL-SGM, V147, P1483; Alauzet C, 2010, J CLIN MICROBIOL, V48, P3935, DOI 10.1128/JCM.00767-10; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Prust C, 2005, NAT BIOTECHNOL, V23, P195, DOI 10.1038/nbt1062; Tuuminen T, 2007, EUR J CLIN MICROBIOL, V26, P523, DOI 10.1007/s10096-007-0313-5; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Ano Y, 2008, BIOSCI BIOTECH BIOCH, V72, P989, DOI 10.1271/bbb.70740; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; COTTER PA, 1990, J BACTERIOL, V172, P6333; Tuuminen T, 2006, J CLIN MICROBIOL, V44, P3048, DOI 10.1128/JCM.00521-06; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Yamada Y, 2014, INT J SYST EVOL MICR, V64, P1670, DOI 10.1099/ijs.0.054494-0; Greenberg DE, 2006, INT J SYST EVOL MICR, V56, P2609, DOI 10.1099/ijs.0.64412-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Ogino H, 2011, J BACTERIOL, V193, P6997, DOI 10.1128/JB.06158-11; Giongo A, 2010, STAND GENOMIC SCI, V2, P309, DOI 10.4056/sigs.972221; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Kumagai A, 2011, BIOMACROMOLECULES, V12, P2815, DOI 10.1021/bm2005615; Higashiura N, 2014, FEMS MICROBIOL LETT, V351, P9, DOI 10.1111/1574-6968.12357; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Chase JM, 2012, J CLIN IMMUNOL, V32, P1193, DOI 10.1007/s10875-012-9728-6; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ge X., 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00003-13; Illeghems K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-526; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kawai M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00080; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaVerda D, 1999, Infect Dis Obstet Gynecol, V7, P64, DOI 10.1155/S1064744999000137; Matsutani M, 2014, BBA-BIOENERGETICS, V1837, P1810, DOI 10.1016/j.bbabio.2014.05.355; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Saichana N., 2014, BIOTECHNOL ADV, DOI [10.1016/j.biotechadv.2014.1012.1001, DOI 10.1016/J.BIOTECHADV.2014.1012.1001]; Shane J.L., 2014, GENOME ANNOUNC, V2; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617	59	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	OCT	2015	22	5					357	366		10.1093/dnares/dsv018		10	Genetics & Heredity	Genetics & Heredity	CT5AY	WOS:000362820100005		
J	Chen, ZQ; Yang, H; Luo, M; Benton, MJ; Kaiho, K; Zhao, LS; Huang, YG; Zhang, KX; Fang, YH; Jiang, HS; Qiu, H; Li, Y; Tu, CY; Shi, L; Zhang, L; Feng, XQ; Chen, L				Chen, Zhong-Qiang; Yang, Hao; Luo, Mao; Benton, Michael J.; Kaiho, Kunio; Zhao, Laishi; Huang, Yuangeng; Zhang, Kexing; Fang, Yuheng; Jiang, Haishui; Qiu, Huan; Li, Yang; Tu, Chengyi; Shi, Lei; Zhang, Lei; Feng, Xueqian; Chen, Long			Complete biotic and sedimentary records of the Permian-Triassic transition from Meishan section, South China: Ecologically assessing mass extinction and its aftermath	EARTH-SCIENCE REVIEWS			English	Article						Mass extinction; Permian-Triassic; Fossil fragment; Trace fossils; Redox condition; Meishan section	GLOBAL STRATOTYPE SECTION; SHALLOW-MARINE CARBONATES; ZHEJIANG PROVINCE; TRACE FOSSILS; BRACHIOPOD FAUNAS; 2 EPISODES; CONODONT ZONATION; ICHNOFOSSIL ASSEMBLAGES; SEQUENCE STRATIGRAPHY; EROSIONAL TRUNCATION	The Meishan section, South China is the Global Stratotype Section and Point (GSSP) for the Permian-Triassic boundary (PTB), and is also well known for the best record demonstrating the Permian-Triassic mass extinction (PTME) all over the world. This section has also been studied using multidisciplinary approaches to reveal the possible causes for the greatest Phanerozoic biocrisis of life on Earth; many important scenarios interpreting the great dying have been proposed on the basis of data from Meishan. Nevertheless, debates on biotic extinction patterns and possible killers still continue. This paper reviews all fossil and sedimentary records from the Permo-Triassic (P-Tr) transition, based on previously published data and our newly obtained data from Meishan, and assesses ecologically the PTME and its aftermath to determine the biotic response to climatic and environmental extremes associated with the biocrisis. Eight updated conodont zones: Clarkina yini, Clarkina meishanensis, Hindeodus changxingensis, Clarkina taylorae, Hindeodus parvus, Isarcicella staeschei, Isarcicella isarcica, and Clarkina planata zones are proposed for the PTB beds at Meishan. Major turnover in fossil fragment contents and ichnodiversity occurs across the boundary between Bed 24e-5 and Bed 24e-6, suggesting an extinction horizon in a thin stratigraphic interval. The irregular surface in the middle of Bed 27 is re-interpreted as a firmground of Glossifungites ichnofacies rather than the previously proposed submarine dissolution surface or hardground surface. Both fossil fragment contents and ichnodiversity underwent dramatic declines in Beds 25-26a, coinciding with metazoan mass extinction. Fossil fragment content ichnodiversity and all ichnofabric proxies (including burrow size, tiering level, bioturbation level) indicate that the P-Tr ecologic crisis comprises two discrete stages, coinciding with the first and second phases of the PTME in Meishan. Ecologic crisis lagged behind biodiversity decline during the PTME. Pyrite framboid size variations suggest that depositional redox condition was anoxic to euxinic in the latest Changhsingian, became euxinic in Beds 25-26a, turned dysoxic in Bed 27, then varied from euxinic to anoxic through most of the Griesbachian. The similar to 9 degrees C increase in seawater surface temperature from Bed 24e to Bed 27 at Meishan seems to result in dramatic declines in biodiversity and fossil fragment contents in Beds 25-26a, but had little effect on all ecologic proxies. Both metazoans and infauna seem not to have been affected by the pre-extinction anoxic-euxinic condition. The anoxic event associated with the PTME may have occurred in a much shorter period than previously thought and is only recorded in Beds 25-26a at Meishan. Fossil fragment contents, ichnofaunas, ichnofabrics and pyrite framboid size all show that no signs of oceanic acidification and anoxia existed in Bed 27. The early Griesbachian anoxia may have resulted in rarity of ichnofauna and metazoans in the lower Yinkeng Formation, in which the ichnofauna is characterized by small, simple horizontal burrows of Planolites, and metazoan faunas are characterized by low diversity, high abundance, opportunist-dominated communities. The rapid increase of similar to 9 degrees C in sea-surface temperature and a short anoxia or acidification coincided with the first-pulse biocrisis, while a prolonged and widespread anoxia probably due to a long period of high seawater temperate condition may be crucial in mortality of most organisms in the second-pulse PTME. Marine ecosystems started to recover, coupled with environmental amelioration, in the late Griesbachian. (C) 2014 Elsevier BM. All rights reserved.	[Chen, Zhong-Qiang; Yang, Hao; Huang, Yuangeng; Zhang, Kexing; Fang, Yuheng; Jiang, Haishui; Tu, Chengyi; Shi, Lei; Feng, Xueqian; Chen, Long] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Luo, Mao] Univ Western Australia, Sch Earth & Environm, Crawley, WA 3009, Australia; [Benton, Michael J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Kaiho, Kunio] Tohoku Univ, Inst Geol & Paleontol, Sendai, Miyagi 9808578, Japan; [Zhao, Laishi; Qiu, Huan; Li, Yang; Zhang, Lei] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Wuhan 430074, Peoples R China	Chen, ZQ (reprint author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	zhong.qiang.chen@cug.edu.cn			973 Program of China [2011CB808800]; 111 Program of China; Ministry of Education of China; NSFC [41272023]; State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences [GBL11206]; State Key Laboratory of Geological Processes and Mineral Resources, China University of Geosciences [GPMR201302]	We thank J. Tong for help in the field and H.J. Song for discussion on foraminiferal taxonomy of collections from the PTB beds in Meishan. We are also grateful to the Guest Editor Thomas Algeo and two anonymous reviewers for their critical comments and constructive suggestions, which have improved greatly the quality of the paper. This work was supported by the 973 Program of China (2011CB808800), the 111 Program of China, Ministry of Education of China, a NSFC grant (No 41272023), and two research grants from the State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences (GBL11206) and the State Key Laboratory of Geological Processes and Mineral Resources, China University of Geosciences (GPMR201302). It is a contribution to IGCPs 572 and 630.	Kaiho K, 2009, AUST J EARTH SCI, V56, P799, DOI 10.1080/08120090903002615; Yin HF, 2012, EARTH-SCI REV, V115, P163, DOI 10.1016/j.earscirev.2012.08.006; Hubbard SM, 2008, PALAIOS, V23, P223, DOI 10.2110/palo.2006.p06.127r; Knaust D, 1998, GEOL RUNDSCH, V87, P21, DOI 10.1007/s005310050186; Chen ZQ, 2012, GONDWANA RES, V22, P238, DOI 10.1016/j.gr.2011.08.015; Miller MF, 1997, PALAIOS, V12, P391, DOI 10.2307/3515338; Riccardi AL, 2006, GEOCHIM COSMOCHIM AC, V70, P5740, DOI 10.1016/j.gca.2006.08.005; Pemberton SG, 2004, GEOL SOC SPEC PUBL, V228, P29, DOI 10.1144/GSL.SP.2004.228.01.03; Twitchett RJ, 2006, PALAEOGEOGR PALAEOCL, V232, P190, DOI 10.1016/j.palaeo.2005.05.019; Jiang HS, 2014, J EARTH SCI-CHINA, V25, P413, DOI 10.1007/s12583-014-0444-4; Kozur HW, 2007, GLOBAL PLANET CHANGE, V55, P155, DOI 10.1016/j.gloplacha.2006.06.011; Hinojosa JL, 2012, GEOLOGY, V40, P743, DOI 10.1130/G33048.1; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Chen ZQ, 2011, PALAEOGEOGR PALAEOCL, V299, P449, DOI 10.1016/j.palaeo.2010.11.023; Forel MB, 2011, J SYST PALAEONTOL, V9, P455, DOI 10.1080/14772019.2010.526638; Fraiser ML, 2009, AUST J EARTH SCI, V56, P841, DOI 10.1080/08120090903002656; PEMBERTON SG, 1982, SCIENCE, V217, P825, DOI 10.1126/science.217.4562.825; MYROW PM, 1995, PALAIOS, V10, P58, DOI 10.2307/3515007; Brennecka GA, 2011, P NATL ACAD SCI USA, V108, P17631, DOI 10.1073/pnas.1106039108; Algeo TJ, 2011, PALAEOGEOGR PALAEOCL, V308, P65, DOI 10.1016/j.palaeo.2010.07.007; Xie SC, 2007, GEOLOGY, V35, P1083, DOI 10.1130/G24224A.1; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Chen ZQ, 2014, EARTH-SCI REV, V137, P1, DOI 10.1016/j.earscirev.2014.05.007; Perri MC, 2003, COUR FOR SEKENBG, V245, P281; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Tian SF, 2014, J EARTH SCI-CHINA, V25, P64, DOI 10.1007/s12583-014-0400-3; Zhao LS, 2013, PALAIOS, V28, P523, DOI 10.2110/palo.2012.p12-107r; Wang Y, 2014, PALEOBIOLOGY, V40, P113, DOI 10.1666/13022; Song HY, 2013, GLOBAL PLANET CHANGE, V105, P7, DOI 10.1016/j.gloplacha.2012.10.023; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI 10.1038/NGEO1475; Twitchett RJ, 1999, PALAEOGEOGR PALAEOCL, V154, P27, DOI 10.1016/S0031-0182(99)00085-1; Wignall PB, 2007, GEOBIOLOGY, V5, P303, DOI 10.1111/j.1472-4669.2007.00130.x; Payne JL, 2012, ANNU REV EARTH PL SC, V40, P89, DOI 10.1146/annurev-earth-042711-105329; Zonneveld JP, 2010, PALAIOS, V25, P368, DOI 10.2110/palo.2009.p09-135r; Zhang KX, 2007, PALAEOGEOGR PALAEOCL, V252, P4, DOI 10.1016/j.palaeo.2006.11.031; Payne JL, 2006, PALAIOS, V21, P63, DOI 10.2110/palo.2005.p05-12p; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Chen ZQ, 2006, LETHAIA, V39, P79, DOI 10.1080/00241160600581764; He WH, 2005, J PALEONTOL, V79, P209, DOI 10.1666/0022-3360(2005)079<0209:CUPRFF>2.0.CO;2; Zhang H, 2014, LITHOS, V204, P246, DOI 10.1016/j.lithos.2014.02.018; Gorjan P, 2007, CHEM GEOL, V244, P483, DOI 10.1016/j.chemgeo.2007.07.003; Kaiho K, 2006, PALAEOGEOGR PALAEOCL, V239, P396, DOI 10.1016/j.palaeo.2006.02.011; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Song H, 2009, AUST J EARTH SCI, V56, P765, DOI 10.1080/08120090903002599; Sephton MA, 2005, GEOLOGY, V33, P941, DOI 10.1130/G2178.1; Wilson MA, 1998, J PALEONTOL, V72, P769; Algeo TJ, 2011, PALAEOGEOGR PALAEOCL, V308, P1, DOI 10.1016/j.palaeo.2011.01.011; Liang HD, 2002, CHINESE SCI BULL, V47, P1393, DOI 10.1360/02tb9307; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Chen ZQ, 2009, AUST J EARTH SCI, V56, P775, DOI 10.1080/08120090903002607; Algeo TJ, 2010, GEOLOGY, V38, P187, DOI 10.1130/G30483.1; Yin H, 1996, NEWSL STRATIGR, V34, P81; Luo GM, 2008, PALAEOGEOGR PALAEOCL, V264, P176, DOI 10.1016/j.palaeo.2008.04.015; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Huang YF, 2014, PALAEOGEOGR PALAEOCL, V399, P78, DOI 10.1016/j.palaeo.2014.01.030; DROSER ML, 1986, J SEDIMENT PETROL, V56, P558; Chen J, 2010, GLOBAL PLANET CHANGE, V73, P149, DOI 10.1016/j.gloplacha.2010.03.012; Yuan DX, 2014, LITHOS, V204, P220, DOI 10.1016/j.lithos.2014.03.026; Tong JN, 1998, CHINESE SCI BULL, V43, P1350, DOI 10.1007/BF02883680; Crasquin S, 2010, J SYST PALAEONTOL, V8, P331, DOI 10.1080/14772011003784992; Chen ZQ, 2005, ACTA PALAEONTOL POL, V50, P343; Ekdale AA, 2003, PALAEOGEOGR PALAEOCL, V192, P221, DOI 10.1016/S0031-0182(02)00686-7; Luo GM, 2011, PALAEOGEOGR PALAEOCL, V299, P70, DOI 10.1016/j.palaeo.2010.10.035; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; Pruss SB, 2004, PALAIOS, V19, P551, DOI 10.1669/0883-1351(2004)019<0551:ETTFOT>2.0.CO;2; Ekdale AA, 2001, LETHAIA, V34, P119; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; AUSICH WI, 1982, SCIENCE, V216, P173, DOI 10.1126/science.216.4542.173; [Anonymous], 2006, DIZHI XUEBAO; Jiang HS, 2008, LETHAIA, V41, P263, DOI 10.1111/j.1502-3931.2007.00052.x; Dasgupta S, 2012, SEDIMENT GEOL, V269, P69, DOI 10.1016/j.sedgeo.2012.06.004; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; Gao QL, 2013, CHEM GEOL, V360, P41, DOI 10.1016/j.chemgeo.2013.09.020; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578; Wignall PB, 2005, PALAEOGEOGR PALAEOCL, V216, P183, DOI 10.1016/j.palaeo.2004.10.009; Clapham ME, 2011, GEOLOGY, V39, P1059, DOI 10.1130/G32230.1; WIGNALL PB, 1993, PALAEOGEOGR PALAEOCL, V102, P215, DOI 10.1016/0031-0182(93)90068-T; KEIGHLEY DG, 1994, PALAEONTOLOGY, V37, P305; Yin HF, 2001, EPISODES, V24, P102; Algeo TJ, 2010, GEOLOGY, V38, P1023, DOI 10.1130/G31203.1; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Cao CQ, 2009, EARTH PLANET SC LETT, V281, P188, DOI 10.1016/j.epsl.2009.02.012; Beatty TW, 2008, GEOLOGY, V36, P771, DOI 10.1130/G24952A.1; Wignall PB, 2009, GEOL SOC AM BULL, V121, P954, DOI 10.1130/B26424.1; Zhao LS, 2013, GLOBAL PLANET CHANGE, V105, P135, DOI 10.1016/j.gloplacha.2012.09.001; Kosnik MA, 2006, EVOL ECOL RES, V8, P195; Benner JS, 2004, PALAIOS, V19, P543, DOI 10.1669/0883-1351(2004)019<0543:MGILOH>2.0.CO;2; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Shen WJ, 2007, PALAEOGEOGR PALAEOCL, V253, P323, DOI 10.1016/j.palaeo.2007.06.005; Algeo T, 2012, GEOL SOC AM BULL, V124, P1424, DOI 10.1130/B30505.1; Wang C, 2007, PALAEOGEOGR PALAEOCL, V252, P291, DOI 10.1016/j.palaeo.2006.11.048; Song Hai-Jun, 2007, Palaeoworld, V16, P105, DOI 10.1016/j.palwor.2007.05.016; Shen J, 2012, GEOBIOLOGY, V10, P82, DOI 10.1111/j.1472-4669.2011.00306.x; Nicoll RS, 2002, J ASIAN EARTH SCI, V20, P609, DOI 10.1016/S1367-9120(02)00021-4; Knaust D, 2004, GEOL J, V39, P1, DOI 10.1002/gj.941; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Chen ZQ, 2005, PALAEOGEOGR PALAEOCL, V224, P232, DOI 10.1016/j.palaeo.2005.04.014; Luo GM, 2006, SCI CHINA SER D, V49, P337, DOI 10.1007/s11430-006-0337-1; Luo GM, 2010, INT J EARTH SCI, V99, P775, DOI 10.1007/s00531-009-0421-9; Chen ZQ, 2009, NEUES JAHRB GEOL P-A, V254, P315, DOI 10.1127/0077-7749/2009/0020; Reichow MK, 2009, EARTH PLANET SC LETT, V277, P9, DOI 10.1016/j.epsl.2008.09.030; Fraiser ML, 2007, PALAEOGEOGR PALAEOCL, V252, P164, DOI 10.1016/j.palaeo.2006.11.041; Chen J, 2011, PALAEOGEOGR PALAEOCL, V308, P84, DOI 10.1016/j.palaeo.2011.02.019; Cao CQ, 2002, CHINESE SCI BULL, V47, P1125, DOI 10.1360/02tb9252; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Zheng QF, 2013, SCI CHINA EARTH SCI, V56, P956, DOI 10.1007/s11430-013-4602-9; Li J, 2004, NEUES JAHRB GEOL P-M, P427; Mei SL, 1998, PALAEOGEOGR PALAEOCL, V143, P213, DOI 10.1016/S0031-0182(98)00112-6; CLAOUELONG JC, 1991, EARTH PLANET SC LETT, V105, P182, DOI 10.1016/0012-821X(91)90129-6; ELDERFIELD H, 1982, NATURE, V296, P214, DOI 10.1038/296214a0; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Xie SC, 2005, NATURE, V434, P494, DOI 10.1038/nature03396; Chen ZQ, 2010, GLOBAL PLANET CHANGE, V73, P123, DOI 10.1016/j.gloplacha.2010.03.011; SAVRDA CE, 1987, NATURE, V327, P54, DOI 10.1038/327054a0; Huang CJ, 2011, GEOLOGY, V39, P779, DOI 10.1130/G32126.1; Sheldon ND, 2006, PALAEOGEOGR PALAEOCL, V231, P315, DOI 10.1016/j.palaeo.2005.09.001; Jiang HS, 2007, GLOBAL PLANET CHANGE, V55, P39, DOI 10.1016/j.gloplacha.2006.06.007; Chen ZQ, 2002, PALAEONTOLOGY, V45, P149, DOI 10.1111/1475-4983.00231; BROMLEY RG, 1984, SCIENCE, V224, P872, DOI 10.1126/science.224.4651.872; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Kaiho K, 2006, CHEM GEOL, V235, P33, DOI 10.1016/j.chemgeo.2006.06.001; Buatois LA, 2005, PALAIOS, V20, P321, DOI 10.2110/palo.2004.p04.32; Yin HF, 2007, GLOBAL PLANET CHANGE, V55, P1, DOI 10.1016/j.gloplacha.2006.06.005; Jiang HS, 2011, GLOBAL PLANET CHANGE, V77, P103, DOI 10.1016/j.gloplacha.2011.04.003; Cao CQ, 2009, SCI CHINA SER D, V52, P1529, DOI 10.1007/s11430-009-0113-0; [Anonymous], 2001, MANTLE PLUMES THEIR; Savrda CE, 2001, PALAIOS, V16, P294, DOI 10.2307/3515606; Song HJ, 2013, NAT GEOSCI, V6, P52, DOI 10.1038/NGEO1649; Bond DPG, 2010, GEOL SOC AM BULL, V122, P1265, DOI 10.1130/B30042.1; Orchard MJ, 1998, RIV ITAL PALEONTOL S, V104, P341; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Jacobsen ND, 2011, PALAEOGEOGR PALAEOCL, V308, P200, DOI 10.1016/j.palaeo.2010.04.024; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V252, P328, DOI 10.1016/j.palaeo.2006.11.050; XU DY, 1993, PALAEOGEOGR PALAEOCL, V104, P171; Payne JL, 2007, GEOL SOC AM BULL, V119, P771, DOI 10.1130/B26091.1; Chen ZQ, 2006, PALAEOGEOGR PALAEOCL, V236, P321, DOI 10.1016/j.palaeo.2005.11.014; Ausich W.I., 2002, PALAEOBIOLOGY, VII, P384; Bottjer D.J., 1988, GEOL SOC AM ABSTR, V20, pA106; Bottjer David J., 1994, P155; Bottjer D.J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSATG8A.1; Bromley R.G., 1996, TRACE FOSSILS BIOL T; Buatois L.A., 2011, ICHNOLOGY ORGANISMS, P1; Cao C. Q., 1998, PALAEOWORLD, V9, P147; Cao Chang-qun, 2007, Journal of Stratigraphy, V31, P14; Chen J.H., 2004, BIOTIC MASS EXTINCTI, P647; Chen ZQ, 2007, PALAEOGEOGR PALAEOCL, V252, P176, DOI 10.1016/j.palaeo.2006.11.042; Chen ZQ, 2006, GEOL MAG, V143, P301, DOI 10.1017/S0016756806001993; Chen Z.Q, 2014, EARTH SCI R IN PRESS; Erwin D.H., 2006, LIFE EARTH NEARLY EN; Farabegoli E., 2012, EARTH LIFE INT YEAR, P719, DOI DOI 10.1007/978-90-481-3428-1_24; Flugel E, 1982, MICROFACIES ANAL LIM; Gao Q.L, 2014, J EARTH SCI IN PRESS, V26; Gerard J., 2008, ICHNOFABRIC CLASTIC; Gouramanis C, 2003, AUST J EARTH SCI, V50, P811, DOI 10.1111/j.1440-0952.2003.01028.x; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; Hantzschel W., 1975, TREATISE INVERT W S1; He J.W., 1987, J STRATIGR, V11, P194; He J.W., 1981, J STRATIGR, V5, P197; JUMARS PA, 1989, LIFE SCI R, V44, P235; Li WZ, 2008, GEOBIOS-LYON, V41, P307, DOI 10.1016/j.geobios.2007.05.004; Liao Z.-t., 1984, Acta Palaeontologica Sinica, V23, P276; MACEACHERN J.A., 2007, APPL ICHNOLOGY SOC S, V52, P27; MacEachern J.A., 1992, APPL ICHNOLOGY PETRO, V16, P169; Orchard M.J., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P823; Payne J.L., 2004, SCIENCE, V205, P505; Pemberton S.G., 1985, SOC EC PALEONTOLOGIS, V35, P237; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Rindsberg A. K., 2005, ALABAMA PALEONTOLOGI, V1, P121; Rui L, 1988, J STRATIGRAPHY, V12, P48; Savrda C.E., 1992, TRACE FOSSILS PALEON, V5, P172; Seilacher A., 1977, Geological J Special Issue, V9, P289; Seilacher A., 1967, Marine Geology, V5, P413, DOI 10.1016/0025-3227(67)90051-5; Seilacher A, 2007, TRACE FOSSIL ANAL; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; Sepkoski Jr J.J., 1982, MILWAUKEE PUBLIC MUS, V51, P125; Shen YA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1217; Sheng J.Z., 1987, PERMIAN TRIASSIC BOU, V1, P1; SHENG J-Z, 1984, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V21, P133; Shi C., 1987, STRATIGRAPHY PALAEON, V1, P23; Song HJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04132; Twitchett R. J., 2004, SPECIAL PUBLICATION, V228, P395; Williams A, 1997, TREATISE INVERTEBR H, V1, P1; Wu HC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3452; Yang W., 1981, B NANJING I GEOLOGY, V2, P113; Yang Z., 1993, PERMOTRIASSIC EVENTS; Yang Z., 1987, MINISTRY GEOLOGY MIN, V2; Yin H., 1995, DONGWUAN INDOSINIAN; Yin HF, 2014, EARTH-SCI REV, V137, P19, DOI 10.1016/j.earscirev.2013.06.003; Yin H.F., 1992, PERMO TRIASSIC EVENT, P169; Zhang K.X., 2009, ACTA PALAEONTOL SIN, V48, P485; Zhang K.X., 1997, ACTA GEOL SINICA, V71, P90, DOI DOI 10.1111/J.1755-6724.1997.TB00349.X; Zhao J.K., 1981, B NANJING I GEOL PAL, V2, P1; Zhao X.M., 2010, EARTH SCI, V40, P1241	199	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-8252	1872-6828		EARTH-SCI REV	Earth-Sci. Rev.	OCT	2015	149						67	107		10.1016/j.earscirev.2014.10.005		41	Geosciences, Multidisciplinary	Geology	CS9AP	WOS:000362381800005		
J	Hayabuchi, Y; Sakata, M; Kagami, S				Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji			Assessment of the Helical Ventricular Myocardial Band Using Standard Echocardiography Reply	ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES			English	Letter							DEFORMATION; ARRANGEMENT; OVERLOAD; CHILDREN; HEART		[Hayabuchi, Yasunobu; Sakata, Miho; Kagami, Shoji] Univ Tokushima, Dept Pediat, Tokushima 770, Japan	Hayabuchi, Y (reprint author), Univ Tokushima, Dept Pediat, Tokushima 770, Japan.						Anderson RH, 2015, ECHOCARDIOGR-J CARD, V32, P1601, DOI 10.1111/echo.13031; Kocica MJ, 2006, EUR J CARDIO-THORAC, V29, pS21, DOI 10.1016/j.ejcts.2006.03.011; Criscione JC, 2005, EUR J CARDIO-THORAC, V28, P363, DOI 10.1016/j.ejcts.2005.04.015; Buckberg G, 2011, ECHOCARDIOGR-J CARD, V28, P782, DOI 10.1111/j.1540-8175.2011.01448.x; Anderson RH, 2005, EUR J CARDIO-THORAC, V28, P517, DOI 10.1016/j.ejcts.2005.06.043; Hayabuchi Y, 2014, ECHOCARDIOGR-J CARD, V31, P815, DOI 10.1111/echo.12484; Anderson RH, 2008, J THORAC CARDIOV SUR, V136, P10, DOI 10.1016/j.jtcvs.2007.09.083; Hayabuchi Y, 2011, J AM SOC ECHOCARDIOG, V24, P1205, DOI 10.1016/j.echo.2011.06.016; Hayabuchi Y, 2015, EUR HEART J-CARD IMG, V16, P890, DOI 10.1093/ehjci/jev011; Anderson RH, 2006, EUR J CARDIO-THORAC, V30, P689, DOI 10.1016/j.ejcts.2006.06.017; Austin EH, 2007, SEMIN THORAC CARDIOV, V10, P87, DOI 10.1053/j.pcsu.2007.02.001; Hayabuchi Y, 2015, ECHOCARDIOGR-J CARD, V32, P310, DOI 10.1111/echo.12624	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-2822	1540-8175		ECHOCARDIOGR-J CARD	Echocardiography-J. Cardiovasc. Ultrasound Allied Tech.	OCT	2015	32	10					1603	1604		10.1111/echo.13029		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT4BQ	WOS:000362751300026		
J	Will, A; Watanuki, Y; Kikuchi, DM; Sato, N; Ito, M; Callahan, M; Wynne-Edwards, K; Hatch, S; Elliott, K; Slater, L; Takahashi, A; Kitaysky, A				Will, Alexis; Watanuki, Yutaka; Kikuchi, Dale M.; Sato, Nobuhiko; Ito, Motohiro; Callahan, Matt; Wynne-Edwards, Katherine; Hatch, Scott; Elliott, Kyle; Slater, Leslie; Takahashi, Akinori; Kitaysky, Alexander			Feather corticosterone reveals stress associated with dietary changes in a breeding seabird	ECOLOGY AND EVOLUTION			English	Article						Diet composition; foraging behavior; junk-food hypothesis; nutritional stress; rhinoceros auklet	SOUTHEASTERN BERING-SEA; BLACK-LEGGED KITTIWAKES; PLACE FORAGING SEABIRD; JUNK-FOOD HYPOTHESIS; RHINOCEROS AUKLET; LONG-TERM; PREY TYPE; CERORHINCA-MONOCERATA; DEVELOPMENTAL STRESS; RESOURCE-ALLOCATION	Changes in climate and anthropogenic pressures might affect the composition and abundance of forage fish in the world's oceans. The junk-food hypothesis posits that dietary shifts that affect the quality (e.g., energy content) of food available to marine predators may impact their physiological state and consequently affect their fitness. Previously, we experimentally validated that deposition of the adrenocortical hormone, corticosterone, in feathers is a sensitive measure of nutritional stress in seabirds. Here, we use this method to examine how changes in diet composition and prey quality affect the nutritional status of free-living rhinoceros auklets (Cerorhinca monocerata). Our study sites included the following: Teuri Is. Japan, Middleton Is. central Gulf of Alaska, and St. Lazaria Is. Southeast Alaska. In 2012 and 2013, we collected bill loads delivered by parents to feed their chicks (n=758) to document dietary changes. We deployed time-depth-temperature recorders on breeding adults (n=47) to evaluate whether changes in prey coincided with changes in foraging behavior. We measured concentrations of corticosterone in fledgling (n=71) and adult breeders' (n=82) feathers to determine how birds were affected by foraging conditions. We found that seasonal changes in diet composition occurred on each colony, adults dove deeper and engaged in longer foraging bouts when capturing larger prey and that chicks had higher concentrations of corticosterone in their feathers when adults brought back smaller and/or lower energy prey. Corticosterone levels in feathers of fledglings (grown during the breeding season) and those in feathers of adult breeders (grown during the postbreeding season) were positively correlated, indicating possible carryover effects. These results suggest that seabirds might experience increased levels of nutritional stress associated with moderate dietary changes and that physiological responses to changes in prey composition should be considered when evaluating the effect of prey quality on marine predators.	[Will, Alexis; Kitaysky, Alexander] Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries, Hakodate, Hokkaido 0418611, Japan; [Kikuchi, Dale M.; Sato, Nobuhiko; Takahashi, Akinori] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Ito, Motohiro; Takahashi, Akinori] SOKENDAI, Dept Polar Sci, Tachikawa, Tokyo 1908518, Japan; [Callahan, Matt] NOAA, Ted Stevens Res Inst, Juneau, AK USA; [Wynne-Edwards, Katherine] Univ Calgary, Fac Vet Med, Calgary, AB T2N 4N1, Canada; [Wynne-Edwards, Katherine] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Hatch, Scott] Inst Seabird Res & Conservat, Anchorage, AK 99516 USA; [Elliott, Kyle] McGill Univ, Dept Nat Resource Sci, Montreal, PQ H9X 3V9, Canada; [Slater, Leslie] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK 99603 USA	Will, A (reprint author), Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, 311 N Koyukuk Dr, Fairbanks, AK 99775 USA.	awill4@alaska.edu			North Pacific Research Board [GOAIERP: F4181-2]; Institute of Arctic Biology, University of Alaska Fairbanks	This project was made possible primarily by the North Pacific Research Board and also by the Institute of Arctic Biology at the University of Alaska Fairbanks. North Pacific Research Board, (Grant/Award Number: 'GOAIERP: F4181-2', 'Graduate Research Fellowship') Institute of Arctic Biology, University of Alaska Fairbanks, (Grant/Award Number: 'Summer Research Grant').	ALVERSON DL, 1992, REV AQUAT SCI, V6, P203; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Siddon EC, 2013, DEEP-SEA RES PT II, V94, P140, DOI 10.1016/j.dsr2.2012.12.007; Kidawa D, 2015, MAR BIOL RES, V11, P349, DOI 10.1080/17451000.2014.940974; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Takahashi A, 2001, MAR BIOL, V139, P361; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Thompson CW, 2004, AUK, V121, P35, DOI 10.1642/0004-8038(2004)121[0035:PFMSIT]2.0.CO;2; Schrimpf MB, 2012, MAR ECOL PROG SER, V460, P247, DOI 10.3354/meps09750; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Hjernquist B, 2010, BIRD STUDY, V57, P19; SIBLY RM, 1990, ANIM BEHAV, V39, P63, DOI 10.1016/S0003-3472(05)80726-2; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Romano MD, 2006, WATERBIRDS, V29, P407, DOI 10.1675/1524-4695(2006)29[407:TTJHOM]2.0.CO;2; Jackson AC, 2008, J EXP MAR BIOL ECOL, V361, P1, DOI 10.1016/j.jembe.2008.03.007; Rector ME, 2012, GEN COMP ENDOCR, V178, P408, DOI 10.1016/j.ygcen.2012.06.008; Will AP, 2014, J EXP BIOL, V217, P2371, DOI 10.1242/jeb.098533; Sears J, 2008, CONDOR, V110, P709, DOI 10.1525/cond.2008.8531; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; HAMER KC, 1993, J ANIM ECOL, V62, P441, DOI 10.2307/5193; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Harding AMA, 2009, FUNCT ECOL, V23, P348, DOI 10.1111/j.1365-2435.2008.01488.x; WINGFIELD JC, 1975, STEROIDS, V26, P311, DOI 10.1016/0039-128X(75)90077-X; Slater L, 2009, J BIOGEOGR, V36, P465, DOI 10.1111/j.1365-2699.2008.02050.x; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Hirose F, 2012, IBIS, V154, P296, DOI 10.1111/j.1474-919X.2011.01205.x; Watanuki Y, 2012, MAR ECOL PROG SER, V454, P183, DOI 10.3354/meps09627; Welham CVJ, 1997, EVOL ECOL, V11, P399, DOI 10.1023/A:1018480723094; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Takahashi A, 2015, MAR ECOL PROG SER, V525, P229, DOI 10.3354/meps11179; Hedd A, 2009, MAR BIOL, V156, P741, DOI 10.1007/s00227-008-1125-6; Elliott KH, 2008, ANIM BEHAV, V75, P1301, DOI 10.1016/j.anbehav.2007.09.024; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Harding A, 2013, DEEP-SEA RES PT II, V94, P178, DOI 10.1016/j.dsr2.2013.03.013; Kadin M, 2012, MAR ECOL PROG SER, V444, P239, DOI 10.3354/meps09417; Karnovsky NJ, 2011, MAR ECOL PROG SER, V440, P229, DOI 10.3354/meps09351; Watanuki Y, 2009, MAR ECOL PROG SER, V393, P259, DOI 10.3354/meps08264; Dorresteijn I, 2012, MAR ECOL PROG SER, V454, P207, DOI 10.3354/meps09372; Ito M, 2009, MAR ECOL PROG SER, V393, P273, DOI 10.3354/meps08192; MONAGHAN P, 1994, IBIS, V136, P214, DOI 10.1111/j.1474-919X.1994.tb01087.x; Kohl KD, 2015, BIOESSAYS, V37, P701, DOI 10.1002/bies.201400171; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Elliott KH, 2008, MAR ECOL PROG SER, V354, P289, DOI 10.3354/meps07221; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Kitaysky AS, 2001, J COMP PHYSIOL B, V171, P701, DOI 10.1007/s003600100230; Hedd A, 2006, MAR ECOL PROG SER, V309, P263, DOI 10.3354/meps309263; Jodice PGR, 2006, MAR ECOL PROG SER, V325, P267, DOI 10.3354/meps325267; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Schoech SJ, 2011, CURR ZOOL, V57, P514; Ronconi RA, 2008, MAR ECOL PROG SER, V366, P245, DOI 10.3354/meps07529; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Hipfner JM, 2013, J ORNITHOL, V154, P965, DOI 10.1007/s10336-013-0962-3; Barrett RT, 2015, ECOL EVOL, V5, P1306, DOI 10.1002/ece3.1438; Ito M, 2010, AQUAT BIOL, V8, P279, DOI 10.3354/ab00229; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; Benowitz-Fredericks ZM, 2008, DEEP-SEA RES PT II, V55, P1868, DOI 10.1016/j.dsr2.2008.04.007; Boonekamp J. J., 2014, P R SOC B, V281, P2013; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Gaston A. J., 1996, BIRDS N AM ONLINE, DOI [10.2173/bna.212, DOI 10.2173/BNA.212]; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Hovis A., 2012, 1306 AMNWR, P1; Kikuchi D. M., 2015, J AVIAN BIOL, V46; Koren L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032496; Niizuma Yasuaki, 1999, Japanese Journal of Ornithology, V48, P145, DOI 10.3838/jjo.48.145; Spencer K. A., 2007, HORM BEHAV, V51, P23; vansPelt T. I., 1997, COMP BIOCH PHYSL A, V118A, P1393; Young R. C., 2015, ECOSPHERE, V6; Zhou YB, 2015, EUR J WILDLIFE RES, V61, P125, DOI 10.1007/s10344-014-0881-5	72	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	OCT	2015	5	19					4221	4232		10.1002/ece3.1694		12	Ecology	Environmental Sciences & Ecology	CT0YF	WOS:000362523300001		
J	Chen, HY; Kishino, H				Chen, Hungyen; Kishino, Hirohisa			Global pattern of phylogenetic species composition of shark and its conservation priority	ECOLOGY AND EVOLUTION			English	Article						Biodiversity; biogeography; community ecology; ecophylogenetic diversity; phylogenetic skew; shark conservation	BIODIVERSITY HOTSPOTS; MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; DIVERSITY; RICHNESS; COMMUNITIES; CLOCKS	The diversity of marine communities is in striking contrast with the diversity of terrestrial communities. In all oceans, species richness is low in tropical areas and high at latitudes between 20 and 40 degrees. While species richness is a primary metric used in conservation and management strategies, it is important to take into account the complex phylogenetic patterns of species compositions within communities. We measured the phylogenetic skew and diversity of shark communities throughout the world. We found that shark communities in tropical seas were highly phylogenetically skewed, whereas temperate sea communities had phylogenetically diversified species compositions. Interestingly, although geographically distant from one another, tropical sea communities were all highly skewed toward requiem sharks (Carcharhinidae), hammerhead sharks (Sphyrnidae), and whale sharks (Rhincodon typus). Worldwide, the greatest phylogenetic evenness in terms of clades was found in the North Sea and coastal regions of countries in temperate zones, such as the United Kingdom, Ireland, southern Australia, and Chile. This study is the first to examine patterns of phylogenetic diversity of shark communities on a global scale. Our findings suggest that when establishing conservation activities, it is important to take full account of phylogenetic patterns of species composition and not solely use species richness as a target. Protecting areas of high phylogenetic diversity in sharks, which were identified in this study, could form a broader strategy for protecting other threatened marine species.	[Chen, Hungyen] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Chen, Hungyen; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Chen, HY (reprint author), 2-12-4 Fukuura,Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan.	chen@lbm.ab.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25280006]	This work was supported by funding from the Japan Society for the Promotion of Science to HK (grant number 25280006).	Bininda-Emonds ORP, 2000, TRENDS ECOL EVOL, V15, P92, DOI 10.1016/S0169-5347(99)01781-4; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; KENDALL DG, 1949, J ROY STAT SOC B, V11, P230; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; Webb CO, 2002, SYST BIOL, V51, P898, DOI 10.1080/10635150290155944; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Brum FT, 2012, OIKOS, V121, P899, DOI 10.1111/j.1600-0706.2011.19978.x; Knapp S, 2008, ECOL LETT, V11, P1054, DOI 10.1111/j.1461-0248.2008.01217.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; YANG ZB, 1994, J MOL EVOL, V39, P105; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Boyce DG, 2008, MAR ECOL PROG SER, V355, P267, DOI 10.3354/meps07237; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yang ZH, 1997, MOL BIOL EVOL, V14, P717; Chen HY, 2015, MOL ECOL, V24, P759, DOI 10.1111/mec.13064; Davidson L. N. K., 2015, FISH FISH, DOI [10.1111/faf.12119, DOI 10.1111/FAF.12119]; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Dulvy NK, 2014, ELIFE, V2014, P3, DOI DOI 10.7554/ELIFE.00590; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Harvey P. H., 1991, COMP METHOD EVOLUTIO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; JENKINS CN, 2013, P NATL ACAD SCI USA, V110, P2602; Lucifora L. O., 2009, GLOBAL SHARK DISTRIB; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Pienkowski M.W., 1998, J APPL ECOL, V35, P532; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	OCT	2015	5	19					4455	4465		10.1002/ece3.1724		11	Ecology	Environmental Sciences & Ecology	CT0YF	WOS:000362523300020		
J	Kanno, R				Kanno, Ryoji			Towards Development of New Materials and New Electrochemical Devices	ELECTROCHEMISTRY			English	Editorial Material									[Kanno, Ryoji] Comm Battery Technol, Toyota, Japan; [Kanno, Ryoji] Electrochem Soc Japan, Tokyo, Japan								0	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					796	796				1	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800002		
J	Iba, H				Iba, Hideki			Expectation of a Scientific Breakthrough for Realization of a Sustainable Mobile Society	ELECTROCHEMISTRY			English	Article						All-solid Battery; Solid Electrolyte; Lithium-Air Battery; Sodium-ion Battery	SODIUM-ION BATTERIES; NONAQUEOUS LI-O-2 BATTERIES; LIQUID ELECTROLYTES; CARBON SURFACE; AIR BATTERIES; LITHIUM; CATHODE; CONDUCTOR	The development of high energy density devices produces a dramatic improvement in the cruising range of electric vehicles and significantly contributes to realizing a sustainable society. In recent years, innovative batteries, such as all-solid battery, metal-air battery and sodium-ion battery, etc., which are estimated to provide a superior battery performance better than the latest lithium-ion battery, are now being given significant attention. Meanwhile, a number of breakthroughs are required in order to achieve practical use of these innovative batteries. In this paper, we summarized the current research approaches of these innovative batteries. (C) The Electrochemical Society of Japan, All rights reserved.	Toyota Motor Co Ltd, Battery Res Div, Shizuoka 4101193, Japan	Iba, H (reprint author), Toyota Motor Co Ltd, Battery Res Div, 1200 Mishyuku, Shizuoka 4101193, Japan.	hideki_iba@mail.toyota.co.jp					Ogasawara T, 2006, J AM CHEM SOC, V128, P1390, DOI 10.1021/ja056811q; Kawakami Y, 1998, J SOLID STATE ELECTR, V2, P206, DOI 10.1007/s100080050089; Mizuno F, 2013, J POWER SOURCES, V228, P47, DOI 10.1016/j.jpowsour.2012.11.077; Mizuno F, 2011, ELECTROCHEMISTRY, V79, P876, DOI 10.5796/electrochemistry.79.876; Nakayama H, 2015, J POWER SOURCES, V287, P158, DOI 10.1016/j.jpowsour.2015.04.048; Kanno R, 2001, J ELECTROCHEM SOC, V148, pA742, DOI 10.1149/1.1379028; Maekawa H, 2009, J AM CHEM SOC, V131, P894, DOI 10.1021/ja807392k; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Yabuuchi N, 2012, NAT MATER, V11, P512, DOI [10.1038/nmat3309, 10.1038/NMAT3309]; Nose M, 2013, ELECTROCHEM COMMUN, V34, P266, DOI 10.1016/j.elecom.2013.07.004; Kuboki T, 2005, J POWER SOURCES, V146, P766, DOI 10.1016/j.jpowsour.2005.03.082; Ohta N, 2007, ELECTROCHEM COMMUN, V9, P1486, DOI 10.1016/j.elecom.2007.02.008; Mizuno F, 2005, ADV MATER, V17, P918, DOI 10.1002/adma.200401286; Nakanishi S, 2012, ELECTROCHEMISTRY, V80, P783, DOI 10.5796/electrochemistry.80.783; Matsuo M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4716021; Mizuno F, 2010, ELECTROCHEMISTRY, V78, P403; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; Nose M, 2013, J POWER SOURCES, V234, P175, DOI 10.1016/j.jpowsour.2013.01.162; Stramare S, 2003, CHEM MATER, V15, P3974, DOI 10.1021/cm0300516; Nakanishi S, 2012, CARBON, V50, P4794, DOI 10.1016/j.carbon.2012.06.003; Barpanda P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5358; Fujiwara Y., 2015, 39 INT C EXP ADV CER, P124; Gao X., 2015, J MAT CHEM; Hayashi A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1843	24	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					797	802		10.5796/electrochemistry.83.797		6	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800003		
J	Takigawa, M; Maki, H; Mizuhata, M				Takigawa, Masashi; Maki, Hideshi; Mizuhata, Minoru			Coating Current Collector Surface with Ni-Al Layered Double Hydroxide by Liquid Phase Deposition to Reduce Charge-Transfer Resistance	ELECTROCHEMISTRY			English	Article						Layered Double Hydroxide; Liquid Phase Deposition; Ni-MH Secondary Battery; Charge Transfer Resistance	METAL HYDRIDE BATTERY; INDUSTRIAL APPLICATIONS; LDH/C COMPOSITE; THIN-FILMS; ELECTRODE; SUPERCAPACITOR	The direct synthesis of an Ni-Al layered double hydroxide (LDH) as the active material in an Ni-metal hydride secondary battery on an electron-conductive substrate was performed using liquid phase deposition method. A reduction in charge-transfer resistance was achieved by coating a Ni-Al LDH film on a Ni foam surface current collector, as a result of improved adhesion between the current collector and the active material. (C) The Electrochemical Society of Japan, All rights reserved.	[Takigawa, Masashi; Maki, Hideshi; Mizuhata, Minoru] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Mizuhata, M (reprint author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	mizuhata@kobe-u.ac.jp			NEDO project "Development of Safety and Cost Competitive Energy Storage System for Renewable Energy"; Kawasaki Heavy Industry	This study is supported by NEDO project "Development of Safety and Cost Competitive Energy Storage System for Renewable Energy" under collaboration with Kawasaki Heavy Industry. LDH/Ni foam. We would like to appreciate Professor Hiroshi Inoue and Assistant Professor Eiji Higuchi in Osaka Prefecture University for useful discussion.	Feng ZB, 2014, J POWER SOURCES, V266, P22, DOI 10.1016/j.jpowsour.2014.04.145; Beleke AB, 2014, J POWER SOURCES, V247, P572, DOI 10.1016/j.jpowsour.2013.08.001; Maki H, 2013, MATER CHEM PHYS, V141, P445, DOI 10.1016/j.matchemphys.2013.05.043; Maki H, 2014, J PHYS CHEM C, V118, P11964, DOI 10.1021/jp501162a; Takasaki T, 2013, J ALLOY COMPD, V580, pS378, DOI 10.1016/j.jallcom.2013.01.092; Taer E, 2011, ELECTROCHIM ACTA, V56, P10217, DOI 10.1016/j.electacta.2011.09.007; Nohara S, 2006, J POWER SOURCES, V157, P605, DOI 10.1016/j.jpowsour.2005.07.024; Wu JB, 2007, INT J HYDROGEN ENERG, V32, P606, DOI 10.1016/j.ijhydene.2006.06.044; Deki S, 2009, THIN SOLID FILMS, V517, P1546, DOI 10.1016/j.tsf.2008.09.040; Fujita R, 2011, ELECTROCHIM ACTA, V56, P7180, DOI 10.1016/j.electacta.2011.03.146; DELAHAYEVIDAL A, 1987, J APPL ELECTROCHEM, V17, P589, DOI 10.1007/BF01084134; Beleke AB, 2013, J POWER SOURCES, V225, P215, DOI 10.1016/j.jpowsour.2012.10.048; Zhang LJ, 2012, J POWER SOURCES, V199, P395, DOI 10.1016/j.jpowsour.2011.10.056; Gao Z, 2011, CHEM MATER, V23, P3509, DOI 10.1021/cm200975x; Aoi Y, 2007, ELECTROCHIM ACTA, V53, P175, DOI 10.1016/j.electacta.2007.01.033; Bing L, 1999, J POWER SOURCES, V79, P277, DOI 10.1016/S0378-7753(99)00053-1; Deki S., 2007, ECS T, V6, P11, DOI 10.1149/1.2790410; Eang B., 2014, J POWER SOURCES, V246, P747; Inoue I. H., 2010, J POWER SOURCES, V195, P6239; Li Y. W., 2010, J HYDROGEN ENERG, V35, P2540; Nishimura K, 2013, J ALLOY COMPD, V580, pS353, DOI 10.1016/j.jallcom.2013.01.166; Xic L. X., 2012, ELECTROCHIM ACTA, V78, P205	22	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					803	806		10.5796/electrochemistry.83.803		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800004		
J	Hayashi, T; Ishihara, A; Uehara, N; Kohno, Y; Matsuzawa, K; Mitsushima, S; Ota, K				Hayashi, Tomoaki; Ishihara, Akimitsu; Uehara, Naoki; Kohno, Yuji; Matsuzawa, Koichi; Mitsushima, Shigenori; Ota, Ken-ichiro			Kinetic Study of Oxygen Reduction Reaction in Acid Solution Using Titanium Oxide-based Catalysts Prepared from Oxy-titanium Tetra-pyrazino-porphyrazine	ELECTROCHEMISTRY			English	Article						Polymer Electrolyte Fuel Cell; Oxygen Reduction Reaction; Titanium Oxide; Non-platinum Cathode	ELECTRODE	Oxide-based electrocatalysts were investigated as non-platinum cathodes for the oxygen reduction reaction (ORR). Recently, we found that titanium oxide-based compounds produced from oxy-titanium tetra-pyrazino-porphyrazine via oxidation under low oxygen partial pressure exhibited high ORR activity [T. Hayashi et al., ECS Trans., 64(3), 247 (2014)]. However, the mechanism by which the ORR proceeds in the presence of titanium oxide-based catalysts has not yet been analyzed in detail. In this study, the ORR mechanism was investigated based on the Damjanovic model by using a rotating ring disk electrode. The titanium oxide-based catalysts showed high reactivity in the four electron reduction of O-2. (C) The Electrochemical Society of Japan, All rights reserved.	[Hayashi, Tomoaki; Uehara, Naoki; Kohno, Yuji; Matsuzawa, Koichi; Mitsushima, Shigenori; Ota, Ken-ichiro] Yokohama Natl Univ, Green Hydrogen Res Ctr, Yokohama, Kanagawa 2408501, Japan; [Ishihara, Akimitsu; Mitsushima, Shigenori] Yokohama Natl Univ, Inst Adv Sci, Yokohama, Kanagawa 2408501, Japan	Ishihara, A (reprint author), Yokohama Natl Univ, Inst Adv Sci, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	a-ishi@ynu.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); MEXT Program for Promoting the Reform of National Universities	The authors thank ORIENT CHEMICAL INDUSTRIES CO., LTD for supplying oxy-titanium tetra-pyrazino-porphyrazine (TiOTPPz) and the New Energy and Industrial Technology Development Organization (NEDO) for financial support. The Institute of Advanced Sciences (IAS) in YNU is supported by the MEXT Program for Promoting the Reform of National Universities.	Hayashi T, 2014, ECS TRANSACTIONS, V64, P247, DOI 10.1149/06403.0247ecst; Ishihara A, 2013, J PHYS CHEM C, V117, P18837, DOI 10.1021/jp405247m; Ono K, 2013, ELECTROCHIM ACTA, V97, P58, DOI 10.1016/j.electacta.2013.02.070; HSUEH KL, 1983, J ELECTROANAL CHEM, V153, P79, DOI 10.1016/S0022-0728(83)80007-2; DAMJANOV.A, 1966, J CHEM PHYS, V45, P4057, DOI 10.1063/1.1727457; Uehara N., ELECTROCHIM AC UNPUB	6	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					807	809		10.5796/electrochemistry.83.807		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800005		
J	Usui, H; Sakata, T; Shimizu, M; Sakaguchi, H				Usui, Hiroyuki; Sakata, Takuma; Shimizu, Masahiro; Sakaguchi, Hiroki			Electrochemical Na-insertion/Extraction Properties of Sn-P Anodes	ELECTROCHEMISTRY			English	Article						Tin Phosphide; Na-ion Battery Anode; Mechanical Alloying; Ionic Liquid Electrolyte	IONIC LIQUID ELECTROLYTES; THICK-FILM ANODES; GAS-DEPOSITION; ELECTRODES; BATTERIES; MECHANISM; SN4P3	Thick-film electrodes of tin phosphides, Sn4P3 and SnP3, were prepared using a mechanical alloying method followed by a gas-deposition method, and were evaluated as Na-ion battery anodes in an organic electrolyte and ionic liquid electrolytes. The Sn4P3 electrode showed a better cycling performance in the organic electrolyte compared with the SnP3 electrode and an Sn electrode. The performance of the Sn4P3 electrode was further improved by using ionic liquid electrolytes because of a uniformly formed surface layer and resulting uniform sodiation/desodiation reactions on the electrode. (C) The Electrochemical Society of Japan, All rights reserved.	[Usui, Hiroyuki; Sakata, Takuma; Shimizu, Masahiro; Sakaguchi, Hiroki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan; [Usui, Hiroyuki; Sakata, Takuma; Shimizu, Masahiro; Sakaguchi, Hiroki] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan	Sakaguchi, H (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Minami, Tottori 6808552, Japan.	sakaguch@chem.tottori-u.ac.jp	Shimizu, Masahiro/A-5059-2014; Usui, Hiroyuki/C-1168-2009	Shimizu, Masahiro/0000-0003-1084-7486; Usui, Hiroyuki/0000-0002-1156-0340	Japan Society for the Promotion of Science (JSPS) KAKENHI [24350094, 2611485]	This work has been partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant-in-Aid for Scientific Research (B) (Grant Number 24350094) and Grant-in-Aid for JSPS Fellows (No. 2611485).	Yabuuchi N, 2014, CHEMELECTROCHEM, V1, P580, DOI 10.1002/celc.201300149; Qian JF, 2014, NANO LETT, V14, P1865, DOI 10.1021/nl404637q; Shimizu M, 2015, J PHYS CHEM C, V119, P2975, DOI 10.1021/jp5121965; Kim Y, 2014, ADV MATER, V26, P4139, DOI 10.1002/adma.201305638; Komaba S, 2012, ELECTROCHEM COMMUN, V21, P65, DOI 10.1016/j.elecom.2012.05.017; Shimizu M, 2015, J ALLOY COMPD, V640, P440, DOI 10.1016/j.jallcom.2015.03.171; Usui H, 2012, CHEM LETT, V41, P521, DOI 10.1246/cl.2012.521; Usui H, 2013, J POWER SOURCES, V235, P29, DOI 10.1016/j.jpowsour.2013.01.188; Jang JY, 2015, J MATER CHEM A, V3, P8332, DOI 10.1039/c5ta00724k; Shimizu M, 2014, J POWER SOURCES, V248, P378, DOI 10.1016/j.jpowsour.2013.09.046; Usui H, 2015, ACS APPL MATER INTER, V7, P6567, DOI 10.1021/am508670z; Usui H, 2011, J POWER SOURCES, V196, P3911, DOI 10.1016/j.jpowsour.2010.12.027; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Sakaguchi H, 2007, ELECTROCHEM SOLID ST, V10, pJ146, DOI 10.1149/1.2772409; Ding CS, 2014, J POWER SOURCES, V269, P124, DOI 10.1016/j.jpowsour.2014.06.033	15	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					810	812		10.5796/electrochemistry.83.810		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800006		
J	Morimoto, H; Higuchi, D; Tobishima, S				Morimoto, Hideyuki; Higuchi, Daiki; Tobishima, Shin-ichi			Characteristics of High-capacity SiO-C Anodes Containing Olivine-type LiMgPO4 Compounds for Lithium Secondary Batteries	ELECTROCHEMISTRY			English	Article						Lithium Battery Anode; SiO; Olivine-type Compound; Thermal Stability	ION BATTERIES; ELECTROLYTE; PERFORMANCE; COMPOSITE; CELLS	The anode properties of carbon-coated SiO (SiO-C) electrode materials containing a small amount of olivine-type LiMgPO4 powder as the additive were investigated in a lithium cell. The 2 wt% LiMgPO4 (LMP)-containing SiO-C anode exhibited a high charge/discharge capacity of 1500 mAh g(-1) (versus SiO) and good cycle performance. In addition, the high-rate discharge performance was improved by the addition of LMP. The thermal stability of the electrode material was studied by differential scanning calorimetry (DSC). The thermal stability of the SiO-C anode material was improved by the addition of LMP powder. (C) The Electrochemical Society of Japan, All rights reserved.	[Morimoto, Hideyuki; Higuchi, Daiki; Tobishima, Shin-ichi] Gunma Univ, Div Environm Engn Sci, Grad Sch Sci & Technol, Gunma 3768515, Japan	Morimoto, H (reprint author), Gunma Univ, Div Environm Engn Sci, Grad Sch Sci & Technol, Gunma 3768515, Japan.	hmorimoto@gunma-u.ac.jp					Morimoto H, 2012, J POWER SOURCES, V211, P66, DOI 10.1016/j.jpowsour.2012.03.044; Lv PP, 2015, J POWER SOURCES, V274, P542, DOI 10.1016/j.jpowsour.2014.10.077; Inose T, 2006, J POWER SOURCES, V161, P550, DOI 10.1016/j.jpowsour.2006.03.053; Yuan QF, 2014, ELECTROCHIM ACTA, V115, P16, DOI 10.1016/j.electacta.2013.10.106; Yamada M, 2013, J POWER SOURCES, V225, P221, DOI 10.1016/j.jpowsour.2012.10.046; Yamamura H, 2013, J POWER SOURCES, V232, P264, DOI 10.1016/j.jpowsour.2013.01.038; Morimoto H, 2001, ELECTROCHEM SOLID ST, V4, pA16, DOI 10.1149/1.1339239; Morimoto H, 2012, ELECTROCHEMISTRY, V80, P812, DOI 10.5796/electrochemistry.80.812; Nagao Y, 2004, J ELECTROCHEM SOC, V151, pA1572, DOI 10.1149/1.1787173; Netz A, 2003, J POWER SOURCES, V119, P95, DOI 10.1016/S0378-7753(03)00132-0; BESENHARD JO, 1986, SOLID STATE IONICS, V18-9, P823, DOI 10.1016/0167-2738(86)90270-5; Wang J, 2011, J POWER SOURCES, V196, P4811, DOI 10.1016/j.jpowsour.2011.01.053; Yamaki J, 2002, SOLID STATE IONICS, V148, P241, DOI 10.1016/S0167-2738(02)00060-7; Kim JH, 2011, J ELECTROANAL CHEM, V661, P245, DOI 10.1016/j.jelechem.2011.08.010; Yamada M., 2011, J ELECTROCHEM SOC, pA417	15	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					813	816		10.5796/electrochemistry.83.813		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800007		
J	Hamazaki, M; Ishihara, A; Kohno, Y; Matsuzawa, K; Mitsushima, S; Ota, K				Hamazaki, Makoto; Ishihara, Akimitsu; Kohno, Yuji; Matsuzawa, Koichi; Mitsushima, Shigenori; Ota, Ken-ichiro			Durability of Titanium-niobium Oxides Mixed with Ti4O7 as Non-precious-and Carbon-free Cathodes for PEFCs in H2SO4 at 80 degrees C	ELECTROCHEMISTRY			English	Article						Polymer Electrolyte Fuel Cell; Titanium-niobium Oxides; Non-precious- and Carbon-free Cathodes; Durability		To develop durable cathodes, their durability in acidic media at 80 degrees C, which is close to the operation temperature of present polymer electrolyte fuel cells, must be evaluated. We attempted to use a Ti4O7 rod as the substrate, and it was observed to be more suitable than a glassy carbon rod because of its higher electrochemical stability. We evaluated the durability of titanium-niobium oxides mixed with Ti4O7 powder (TixNbyOz+Ti4O7) as a non-precious- and carbon-free cathode in 0.1 mol dm(-3) H2SO4 at 80 degrees C. We successfully demonstrated that the TixNbyOz+Ti4O7 did not deteriorate during start-stop and load cycle tests when a Ti4O7 rod substrate was employed. (C) The Electrochemical Society of Japan, All rights reserved.	[Hamazaki, Makoto; Kohno, Yuji; Matsuzawa, Koichi; Mitsushima, Shigenori; Ota, Ken-ichiro] Yokohama Natl Univ, Green Hydrogen Res Ctr, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Ishihara, Akimitsu; Mitsushima, Shigenori] Yokohama Natl Univ, Inst Adv Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Ishihara, A (reprint author), Yokohama Natl Univ, Inst Adv Sci, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	a-ishi@ynu.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); MEXT Program for Promoting the Reform of National Universities	The authors thank the New Energy and Industrial Technology Development Organization (NEDO) for financial support. The Institute of Advanced Sciences (IAS) in YNU is supported by the MEXT Program for Promoting the Reform of National Universities.	Walsh FC, 2010, ELECTROCHIM ACTA, V55, P6342, DOI 10.1016/j.electacta.2010.05.011; Fuel Cell Commercialization Conference of Japan (FCCJ), PROP DEV TARG RES DE; Ishihara A., ELECTROCHIM AC UNPUB	3	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					817	819		10.5796/electrochemistry.83.817		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800008		
J	Mizuno, Y; Matsuda, Y; Suzuki, K; Yonemura, M; Hirayama, M; Kanno, R				Mizuno, Yoshifumi; Matsuda, Yasuaki; Suzuki, Kota; Yonemura, Masao; Hirayama, Masaaki; Kanno, Ryoji			Synthesis, Crystal Structure, and Electrochemical Properties of Li1.2+xMn0.3Co0.2Ni0.3O2 (x > 0) for Lithium-ion Battery Cathodes	ELECTROCHEMISTRY			English	Article						Li-rich Layered Rock Salt; High-pressure Synthesis; Neutron Diffraction; Rietveld Analysis	ELECTRODES; PERFORMANCE; OXIDES	Li1.2+xMn0.3Co0.2Ni0.3O2 (x = 0, 0.2, 0.4) with a Li-rich layered rock salt type structure were synthesized by a high-pressure method. kietveld analysis using neutron diffraction data elucidated that the Li atoms were located at the octahedral sites in the Li and transitional metal (TM) layers. Furthermore, additional Li was detected at the tetrahedral site in the TM layer for the x = 0.4 sample. The tetrahedral Li caused vacancies at the neighboring TM sites and a structural distortion of the (Li,M)O-6 octahedra. The x = 0.4 sample exhibited larger and smaller charge and discharge capacities of 388 and 135 mAh g(-1) at the first cycle, respectively, than the x = 0.2 sample (296 and 151 mAh g(-1)). The structural modification caused by the introduction of the tetragonal Li affects the initial activation process of the Li-rich layered rock salt type electrodes. (C) The Electrochemical Society of Japan, All rights reserved.	[Mizuno, Yoshifumi; Matsuda, Yasuaki; Suzuki, Kota; Hirayama, Masaaki; Kanno, Ryoji] Tokyo Inst Technol, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yonemura, Masao] High Energy Accelerator Res Org, Inst Mat Struct Sci, Neutron Sci Lab, Tsukuba, Ibaraki 3050801, Japan	Hirayama, M (reprint author), Tokyo Inst Technol, Dept Elect Chem, Midori Ku, G1-1,4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	hirayama@echem.titech.ac.jp	Hirayama, Masaaki/B-5781-2011	Hirayama, Masaaki/0000-0003-4804-4208	RISING project of the New Energy and Industrial Technology Development Organization (NEDO), Japan	This study was supported financially by the RISING project of the New Energy and Industrial Technology Development Organization (NEDO), Japan. The authors thank Material Analysis Suzukake-dai Center, Technical Department, Tokyo Institute of Technology, for ICP-AES analyses.	Jiang M, 2009, CHEM MATER, V21, P2733, DOI 10.1021/cm900279u; Xu B, 2011, ENERG ENVIRON SCI, V4, P2223, DOI 10.1039/c1ee01131f; Fell CR, 2013, CHEM MATER, V25, P1621, DOI 10.1021/cm4000119; Thackeray MM, 2005, J MATER CHEM, V15, P2257, DOI 10.1039/b417616m; Boulineau A, 2009, CHEM MATER, V21, P4216, DOI 10.1021/cm900998n; Numata K, 1999, SOLID STATE IONICS, V117, P257, DOI 10.1016/S0167-2738(98)00417-2; Thackeray MM, 2007, J MATER CHEM, V17, P3112, DOI 10.1039/b702425h; Johnson CS, 2008, CHEM MATER, V20, P6095, DOI 10.1021/cm801245r; Ohzuku T, 2011, J MATER CHEM, V21, P10179, DOI 10.1039/c0jm04325g; Oishi R, 2009, NUCL INSTRUM METH A, V600, P94, DOI 10.1016/j.nima.2008.11.056; Ito A, 2008, J POWER SOURCES, V183, P344, DOI 10.1016/j.jpowsour.2008.04.086; Matsuda Y, 2014, SOLID STATE IONICS, V262, P88, DOI 10.1016/j.ssi.2013.10.052; Martha SK, 2012, J POWER SOURCES, V199, P220, DOI 10.1016/j.jpowsour.2011.10.019; Chang HS, 2014, J POWER SOURCES, V252, P1, DOI 10.1016/j.jpowsour.2013.11.050; Armstrong AR, 2006, J AM CHEM SOC, V128, P8694, DOI 10.1021/ja062027+; Kim JM, 2004, ELECTROCHIM ACTA, V49, P3573, DOI 10.1016/j.electacta.2004.03.025; JIA YQ, 1991, J SOLID STATE CHEM, V95, P184, DOI 10.1016/0022-4596(91)90388-X; Lu ZH, 2001, ELECTROCHEM SOLID ST, V4, pA191, DOI 10.1149/1.1407994	18	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					820	823		10.5796/electrochemistry.83.820		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800009		
J	Hirayama, H; Tachikawa, N; Yoshii, K; Watanabe, M; Katayama, Y				Hirayama, Hirotsugu; Tachikawa, Naoki; Yoshii, Kazuki; Watanabe, Masayoshi; Katayama, Yasushi			Ionic Conductivity and Viscosity of Solvate Ionic Liquids Composed of Glymes and Excess Lithium Bis(Trifluoromethylsulfonyl)Amide	ELECTROCHEMISTRY			English	Article						Ionic Liquid; Lithium Batteries; Concentrated Electrolytes; Mass Transport	SALT MOLTEN COMPLEX; ELECTROLYTES; BATTERIES; STABILITY; MECHANISM; GRAPHITE	Ionic conductivity and viscosity of lithium bis(trifluoromethylsulfonyl)amide (LiTFSA)-glyme solvate ionic liquids with the mole fraction of LiTFSA from 50.0 to 54.5 mol% were investigated at 298-323 K. The ionic conductivity of the solvate ionic liquids was found to be inversely proportional to the viscosity, as expected from Walden's rule. The ionic conductivity of the solvate ionic liquid decreased with increasing the mole fraction of LiTFSA, probably due to formation of a bulky lithium species, [Li(TFSA)(2)](-), which forms at the compositions of more than 50 mol% of LiTFSA. (C) The Electrochemical Society of Japan, All rights reserved.	[Hirayama, Hirotsugu; Tachikawa, Naoki; Yoshii, Kazuki; Katayama, Yasushi] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Yokohama, Kanagawa 2408501, Japan	Katayama, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	katayama@applc.keio.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)	This work was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST). The authors also thank Nippon Nyukazai and Solvay for supplying reagents.	Serizawa N, 2013, J ELECTROCHEM SOC, V160, pA1529, DOI 10.1149/2.085309jes; Moon H, 2014, J PHYS CHEM C, V118, P20246, DOI 10.1021/jp506772f; Sato T, 2004, J POWER SOURCES, V138, P253, DOI 10.1016/j.jpowsour.2004.06.027; Jeong SK, 2003, ELECTROCHEM SOLID ST, V6, pA13, DOI 10.1149/1.1526781; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; Yoshida K, 2011, J PHYS CHEM C, V115, P18384, DOI 10.1021/jp206881t; Ueno K, 2015, PHYS CHEM CHEM PHYS, V17, P8248, DOI 10.1039/c4cp05943c; Tachikawa N, 2011, CHEM COMMUN, V47, P8157, DOI 10.1039/c1cc12415c; Tachikawa N, 2010, ELECTROCHEMISTRY, V78, P349; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Park JW, 2011, J POWER SOURCES, V196, P2264, DOI 10.1016/j.jpowsour.2010.09.067; Xu K, 2004, CHEM REV, V104, P4303, DOI 10.1021/cr030203g; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Yamada Y, 2014, J AM CHEM SOC, V136, P5039, DOI 10.1021/ja412807w; Shirai A, 2008, ANAL SCI, V24, P1291, DOI 10.2116/analsci.24.1291; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Jeong SK, 2008, ELECTROCHEM COMMUN, V10, P635, DOI 10.1016/j.elecom.2008.02.006; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Brouillette D, 1998, J SOLUTION CHEM, V27, P151, DOI 10.1023/A:1022609407560; Watanabe M., 2012, J. P. Patent, Patent No. 109223; Yamada Y., 2013, CHEM COMMUN, V49; Yamada Y., 2009, J PHYS CHEM C, V113; Yamada Y., 2010, J PHYS CHEM C, V114	23	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					824	827		10.5796/electrochemistry.83.824		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800010		
J	Okada, D; Nakano, F; Uematsu, K; Okawa, H; Itadani, A; Toda, K; Sato, M				Okada, Dai; Nakano, Fumiya; Uematsu, Kazuyoshi; Okawa, Hirokazu; Itadani, Atsushi; Toda, Kenji; Sato, Mineo			Improvement of High Rate Performances for Ti-Doped Li3V2(PO4)(3) Cathode Materials	ELECTROCHEMISTRY			English	Article						Li3V2(PO4)(3); Ti Doping; Ionic Conductivity; Carbon Coating	RECHARGEABLE LITHIUM BATTERIES; ION BATTERIES; LI3SC2(PO4)(3); CAPACITY; PHASE	Ti-doped lithium vanadium(III) phosphate cathode materials, Li3-2x(V1-xTix)(2)(PO4)(3), were prepared by a solid state reaction. The Ti-doped samples exhibited that the gamma-phase is stabilized at room temperature by substituting Ti for V sites at more than x = 0.10. The discharge capacity of the doped samples at a 60C rate was found to be much higher than that for the non doped sample. This improved performance found for the doped cathodes was attributed to the increase in ionic conductivity given by the transition of alpha- to gamma-phase via Ti substitution. (C) The Electrochemical Society of Japan, All rights reserved.	[Okada, Dai; Nakano, Fumiya; Itadani, Atsushi; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Nishi Ku, Niigata 9502181, Japan; [Okawa, Hirokazu] Akita Univ, Fac Engn & Resource Sci, Dept Earth Sci & Technol, Akita 0108052, Japan	Sato, M (reprint author), Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Nishi Ku, 8050 Ikarashi 2 No Cho, Niigata 9502181, Japan.	msato@eng.niigata-u.ac.jp					Suzuki T, 1997, SOLID STATE IONICS, V104, P27, DOI 10.1016/S0167-2738(97)00404-9; Tang AP, 2008, J APPL ELECTROCHEM, V38, P1453, DOI 10.1007/s10800-008-9589-0; Han DW, 2014, CHEM MATER, V26, P3644, DOI 10.1021/cm500509q; Huang H, 2002, ADV MATER, V14, P1525, DOI 10.1002/1521-4095(20021104)14:21<1525::AID-ADMA1525>3.0.CO;2-3; Yin SC, 2003, J AM CHEM SOC, V125, P326, DOI 10.1021/ja028973h; Xia Y, 2011, MATER SCI ENG B-ADV, V176, P633, DOI 10.1016/j.mseb.2011.02.006; Suzuki T, 1998, SOLID STATE IONICS, V113, P89, DOI 10.1016/S0167-2738(98)00279-3; Deng C, 2011, J PHYS CHEM C, V115, P15048, DOI 10.1021/jp201686g; Masquelier C, 1998, J SOLID STATE CHEM, V135, P228, DOI 10.1006/jssc.1997.7629; Sato M, 2000, SOLID STATE IONICS, V135, P137, DOI 10.1016/S0167-2738(00)00292-7	10	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					828	830		10.5796/electrochemistry.83.828		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800011		
J	Uemura, S; Furuyama, T; Masuda, T; Tsushima, S; Imanishi, N; Hirai, S				Uemura, Suguru; Furuyama, Tomoaki; Masuda, Tetsutaro; Tsushima, Shoji; Imanishi, Nobuyuki; Hirai, Shuichiro			In-situ Three-dimensional Visualization of Precipitation Behavior in a Porous Air Electrode for Aqueous Lithium-air Battery	ELECTROCHEMISTRY			English	Article						Lithium-air Battery; Precipitation; Soft X-ray; Porous Electrode	CONDUCTING GLASS-CERAMICS; FUEL-CELL	The aqueous lithium-air battery is receiving considerable research attention because of its high theoretical energy density; however, discharge products tend to precipitate and inhibit the chemical reaction in the battery. To clarify the precipitation mechanism, the precipitated discharge products in a carbon-based porous air electrode were visualized three-dimensionally by oblique soft X-ray computed tomography. As a result, precipitation of the discharge products was observed clearly. The precipitate did not dissolve entirely and bubbles emerged in the air electrode during the charging process. This indicates that the charge/discharge products degrade the cycling performance of the aqueous lithium-air battery. (C) The Electrochemical Society of Japan, All rights reserved.	[Uemura, Suguru; Furuyama, Tomoaki; Masuda, Tetsutaro; Tsushima, Shoji; Hirai, Shuichiro] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528550, Japan; [Imanishi, Nobuyuki] Mie Univ, Dept Chem, Fac Engn, Tsu, Mie 5148507, Japan	Uemura, S (reprint author), Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	uemura@mech.titech.ac.jp					Zhang T, 2008, J ELECTROCHEM SOC, V155, pA965, DOI 10.1149/1.2990717; Girishkumar G, 2010, J PHYS CHEM LETT, V1, P2193, DOI 10.1021/jz1005384; Deevanhxay P, 2013, J POWER SOURCES, V230, P38, DOI 10.1016/j.jpowsour.2012.11.140; Deevanhxay P, 2014, ELECTROCHIM ACTA, V135, P68, DOI 10.1016/j.electacta.2014.04.144; Zhang T, 2010, CHEM COMMUN, V46, P1661, DOI 10.1039/b920012f; Stevens P, 2010, ECS TRANSACTIONS, V28, P1, DOI 10.1149/1.3506336; Matsui M., 2013, 224 ECS M, P411; Zhang T, 2011, ELECTROCHEM SOLID ST, V14, pA45, DOI 10.1149/1.3545964	8	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					831	833		10.5796/electrochemistry.83.831		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800012		
J	Nagai, H; Kataoka, K; Akimoto, J; Sotokawa, T; Kumashiro, Y				Nagai, Hideaki; Kataoka, Kunimitsu; Akimoto, Junji; Sotokawa, Tomoyuki; Kumashiro, Yoshimasa			Electrochemical Property of Particle-size Controlled H2Ti12O25 as a Negative Electrode Material for Lithium-ion Battery	ELECTROCHEMISTRY			English	Article						H2Ti12O25; Lithium-ion Battery; Negative Electrode; Particle-size	EXCHANGE SYNTHESIS; CRYSTAL-STRUCTURE; INSERTION	We have successfully prepared the particle-size controlled H2Ti12O25 by soft chemical synthetic technique using the ball-milled and annealed Na2Ti3O7 as a starting compound. In this synthetic route, we first prepared the particle-size controlled Na2Ti3O7 by ball-milling and subsequent annealing at 873-1073K. Then, H2Ti3O7 was prepared by Na+/H+ ion-exchange reaction using HCl solution, and H2Ti12O25 was synthesized by heating H2Ti3O7 at 533 K. The initial discharge capacity of the H2Ti12O25 sample thus obtained was achieved to be 255 mAhg(-1), which was higher than those previously reported for H2Ti12O25 samples, while initial irreversible capacity also increased together with the amounts of smaller particles. (C) The Electrochemical Society of Japan, All rights reserved.	[Nagai, Hideaki; Kataoka, Kunimitsu; Akimoto, Junji] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Sotokawa, Tomoyuki; Kumashiro, Yoshimasa] Ishihara Sangyo Kaisha Ltd, Yokaichi, Mie 5100842, Japan	Nagai, H (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	hideaki-nagai@aist.go.jp					Kataoka K, 2011, CHEM MATER, V23, P2344, DOI 10.1021/cm103678e; Kataoka K, 2013, SOLID STATE IONICS, V252, P109, DOI 10.1016/j.ssi.2013.07.012; Kataoka K, 2013, INORG CHEM, V52, P13861, DOI 10.1021/ic401144k; Takami N, 2011, J ELECTROCHEM SOC, V158, pA725, DOI 10.1149/1.3574037; IZAWA H, 1982, J PHYS CHEM-US, V86, P5023, DOI 10.1021/j100222a036; Akimoto J, 2013, J POWER SOURCES, V244, P679, DOI 10.1016/j.jpowsour.2012.12.035; Akimoto J, 2011, J ELECTROCHEM SOC, V158, pA546, DOI 10.1149/1.3562207; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592	8	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					834	836		10.5796/electrochemistry.83.834		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800013		
J	Haruta, M; Masuo, Y; Moriyasu, T; Tomita, A; Sakakibara, C; Kamei, A; Hirota, M; Takenaka, T; Doi, T; Inaba, M				Haruta, Masakazu; Masuo, Yuta; Moriyasu, Takashi; Tomita, Akira; Sakakibara, Chihiro; Kamei, Akika; Hirota, Masato; Takenaka, Toshio; Doi, Takayuki; Inaba, Minoru			Cycle Performances of Si-flake-powder Anodes in Lithium Salt-tetraglyme Complex Electrolytes	ELECTROCHEMISTRY			English	Article						Silicon Anode; Flake Powder; Tetraglyme; Silicon-sulfur Battery	LI-ION BATTERIES; NEGATIVE ELECTRODES; THIN FLAKES; SILICON	Charge and discharge properties of amorphous Si nano-flake powder (Si Leaf Powder (R), Si-LP) in lithium bis(trifluoromethanesulfonyl)amide-tetraglyme complex electrolyte, [Li(G4)][TFSA], were investigated for use as an anode in silicon-sulfur battery. Though a high reversible capacity (2,300-2,700 mAh g(-1)) was obtained initially in [Li(G4)][TFSA], the overpotential gradually increased upon cycling. The increase in overpotential was reduced by dilution with 1,1,2,2-tetrafluoroethyl-2,2,3,3-tetrafluoropropyl ether. The addition of fluoroethylene carbonate (FEC) further reduced the overpotential and improved cycleability. Electrochemical impedance spectroscopy analysis revealed that the observed improvements in charge and discharge characteristics are due to the formation of solid electrolyte interface layer with a high ionic-conductivity in the presence of FEC. (C) The Electrochemical Society of Japan, All rights reserved.	[Haruta, Masakazu; Masuo, Yuta; Moriyasu, Takashi; Doi, Takayuki; Inaba, Minoru] Doshisha Univ, Depertment Mol Chem & Biochem, Kyoto 6100321, Japan; [Tomita, Akira; Sakakibara, Chihiro; Kamei, Akika; Hirota, Masato; Takenaka, Toshio] Oike & Co Ltd, Minami Ku, Kyoto 6018121, Japan	Haruta, M (reprint author), Doshisha Univ, Depertment Mol Chem & Biochem, Kyoto 6100321, Japan.	mharuta@mail.doshisha.ac.jp			Japan science and technology agency (JST-ALCA); Ministry of Education, Culture, Sports, Science, and Technology of Japan [25820335]	This research was supported by advanced low carbon technology research and development program from Japan science and technology agency (JST-ALCA), and a Grant-in-Aid for Scientific Research (No. 25820335) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BOUKAMP BA, 1981, J ELECTROCHEM SOC, V128, P725, DOI 10.1149/1.2127495; Saito M, 2011, J POWER SOURCES, V196, P6637, DOI 10.1016/j.jpowsour.2011.02.042; Wu H, 2012, NANO TODAY, V7, P414, DOI 10.1016/j.nantod.2012.08.004; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; McMillan R, 1999, J POWER SOURCES, V81, P20, DOI 10.1016/S0378-7753(98)00201-8; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; Huggins RA, 1999, J POWER SOURCES, V81, P13, DOI 10.1016/S0378-7753(99)00124-X; Kasavajjula U, 2007, J POWER SOURCES, V163, P1003, DOI 10.1016/j.jpowsour.2006.09.084; Saito M, 2012, SOLID STATE IONICS, V225, P506, DOI 10.1016/j.ssi.2011.12.016; Choi NS, 2006, J POWER SOURCES, V161, P1254, DOI 10.1016/j.jpowsour.2006.05.049; Larcher D, 2007, J MATER CHEM, V17, P3759, DOI 10.1039/b705421c; Guo JC, 2011, ELECTROCHIM ACTA, V56, P3981, DOI 10.1016/j.electacta.2011.02.014; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Okubo T, 2014, SOLID STATE IONICS, V262, P39, DOI 10.1016/j.ssi.2013.09.014; Etacheri V, 2012, LANGMUIR, V28, P965, DOI 10.1021/la203712s; Hatchard TD, 2004, J ELECTROCHEM SOC, V151, pA838, DOI 10.1149/1.1739217; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421	17	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					837	839		10.5796/electrochemistry.83.837		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800014		
J	Nishibori, E; Shibata, T; Kobayashi, W; Moritomo, Y				Nishibori, Eiji; Shibata, Takayuki; Kobayashi, Wataru; Moritomo, Yutaka			Bonding Nature of LiCoO2 by Topological Analysis of Electron Density from X-ray Diffraction	ELECTROCHEMISTRY			English	Article						Quantitative Evaluation of Bonding Nature; Electron Density; Topological Analysis; Synchrotron Radiation X-ray Diffraction	REFINEMENT; CRYSTALS; SPRING-8; DIAMOND	Electron density distributions of LiCoO2 have been determined by Maximum Entropy method (MEM) and multipole modeling from synchrotron x-ray powder diffraction data. The localization of Co-3d electrons was clearly visualized in the deformation MEM density. An electron density by multipole modeling was investigated by the Bader's topological analysis to reveal bonding characteristics and interactions between the constituted atoms. (C) The Electrochemical Society of Japan, All rights reserved.	[Nishibori, Eiji; Shibata, Takayuki; Kobayashi, Wataru; Moritomo, Yutaka] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Nishibori, Eiji; Moritomo, Yutaka] Univ Tsukuba, Ctr Integrated Res Fundamental Sci & Engn CiRfSE, Tsukuba, Ibaraki 3058571, Japan	Nishibori, E (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	nishibori.eiji.ga@u.tsukuba.ac.jp			 [25600148]	This work was supported by G Grant-in-Aid for Challenging Exploratory Research (No. 25600148). We thank Dr. Kato for experimental help at SPing-8 BL44B2. The synchrotron radiation experiments were performed at BL44B2 in SPring-8 with the approval of RIKEN (Proposal No. 20140077).	Tanaka H, 2002, J APPL CRYSTALLOGR, V35, P282, DOI 10.1107/S002188980200050X; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; HANSEN NK, 1978, ACTA CRYSTALLOGR A, V34, P909, DOI 10.1107/S0567739478001886; Ohno A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064119; Nishibori E, 2007, ACTA CRYSTALLOGR A, V63, P43, DOI 10.1107/S0108767306047210; MIZUSHIMA K, 1980, MATER RES BULL, V15, P783, DOI 10.1016/0025-5408(80)90012-4; McKinnon JJ, 2004, ACTA CRYSTALLOGR B, V60, P627, DOI 10.1107/S0108768104020300; Bindzus N, 2014, ACTA CRYSTALLOGR A, V70, P39, DOI 10.1107/S2053273313026600; Kato K, 2010, AIP CONF PROC, V1234, P875, DOI 10.1063/1.3463354; Nishibori E, 2008, ACTA CRYSTALLOGR D, V64, P237, DOI 10.1107/S0907444907065663; SAKA T, 1986, ACTA CRYSTALLOGR A, V42, P469, DOI 10.1107/S0108767386098860; ORMAN HJ, 1984, ACTA CRYSTALLOGR C, V40, P12, DOI 10.1107/S0108270184002833; Bader R. F. W., 1994, ATOMS MOL QUANTUM TH; Nishibori E., 2015, SOL STAT SC IN PRESS; Svendsen H, 2010, ACTA CRYSTALLOGR A, V66, P458, DOI 10.1107/S0108767310014236; Takahashi Y, 2007, J SOLID STATE CHEM, V180, P313, DOI 10.1016/j.jssc.2006.10.018; Volkov A., 2006, XD2006 COMPUTER PROG	17	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					840	842		10.5796/electrochemistry.83.840		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800015		
J	Yoshida, S; Masuo, Y; Shibata, D; Haruta, M; Doi, T; Inaba, M				Yoshida, Shuhei; Masuo, Yuta; Shibata, Daisuke; Haruta, Masakazu; Doi, Takayuki; Inaba, Minoru			Li Pre-doping of Amorphous Silicon Electrode in Li-Naphthalene Complex Solutions	ELECTROCHEMISTRY			English	Article						Amorphous Silicon Electrode; Irreversible Capacity; Pre-doping; Li-naphthalene Complex	SI THIN FLAKES; NEGATIVE ELECTRODE; ION BATTERIES; CHEMICAL METHOD; LITHIUM	To compensate a large initial irreversible capacity (Q(irr)) of silicon electrode, a novel Li pre-doping technique using Li-naphthalene complex/tetrahydrofuran solutions was developed. Li was successfully doped to amorphous silicon nano-flake particles, and the doping level of Li was easily controlled by adjusting naphthalene concentration. A large Q(irr) of the pristine electrode (1200 mAh g(-1)) was almost completely compensated after pre-doped in 0.1 mol dm(-3) Li-naphthalene solution for 1 h. In addition, no harmful effects of pre-doping on cycleability were observed. (C) The Electrochemical Society of Japan, All rights reserved.	[Yoshida, Shuhei; Shibata, Daisuke] DENSO CORP, Kariya, Aichi 4488661, Japan; [Yoshida, Shuhei; Masuo, Yuta; Haruta, Masakazu; Doi, Takayuki; Inaba, Minoru] Doshisha Univ, Kyoto 6100321, Japan	Yoshida, S (reprint author), DENSO CORP, 1-1 Showa, Kariya, Aichi 4488661, Japan.	SYUUHEI_YOSHIDA@denso.co.jp					Saito M, 2011, J POWER SOURCES, V196, P6637, DOI 10.1016/j.jpowsour.2011.02.042; Key B, 2009, J AM CHEM SOC, V131, P9239, DOI 10.1021/ja8086278; Tabuchi T, 2005, J POWER SOURCES, V146, P507, DOI 10.1016/j.jpowsour.2005.03.100; Abe T, 1997, J POWER SOURCES, V68, P216, DOI 10.1016/S0378-7753(96)02554-2; Saito M, 2012, SOLID STATE IONICS, V225, P506, DOI 10.1016/j.ssi.2011.12.016; Nakai K, 2010, ELECTROCHEMISTRY, V78, P438; Okubo T, 2014, SOLID STATE IONICS, V262, P39, DOI 10.1016/j.ssi.2013.09.014; Hatchard TD, 2004, J ELECTROCHEM SOC, V151, pA838, DOI 10.1149/1.1739217; Iwanari D., 2012, 53 BATT S JAP	9	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					843	845		10.5796/electrochemistry.83.843		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800016		
J	Tachikawa, N; Furuya, R; Yoshii, K; Watanabe, M; Katayama, Y				Tachikawa, Naoki; Furuya, Ryota; Yoshii, Kazuki; Watanabe, Masayoshi; Katayama, Yasushi			Deposition and Dissolution of Lithium through Lithium Phosphorus Oxynitride Thin Film in Lithium Bis(trifluoromethylsulfonyl)amide-Glyme Solvate Ionic Liquid	ELECTROCHEMISTRY			English	Article						Solid Electrolyte Interphase; Ionic Liquid; Lithium Batteries; LiPON	SOLID-ELECTROLYTE INTERPHASE; SALT MOLTEN COMPLEX; ELECTROCHEMICAL-BEHAVIOR; CYCLING EFFICIENCY; BATTERIES; STABILITY; CATHODES; INTERFACE; MECHANISM; SITU	The deposition and dissolution of Li at a Ni electrode coated with lithium phosphorus oxynitride (LiPON) thin film were investigated in lithium bis(trifluoromethylsulfonyl)amide-glyme solvate ionic liquid. The LiPON thin film was able to suppress the irreversible decomposition of the solvate ionic liquid. The cathodic deposition of Li and anodic dissolution of the deposited Li occurred on the Ni electrode through the UPON thin film. These results suggest that the LiPON thin film plays a role as an artificial solid electrolyte interphase film between the Ni electrode and the solvate ionic liquid. (C) The Electrochemical Society of Japan, All rights reserved.	[Tachikawa, Naoki; Furuya, Ryota; Yoshii, Kazuki; Katayama, Yasushi] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Katayama, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	katayama@applc.keio.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)	This work was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST). The authors also thank Nippon Nyukazai and Solvay for supplying reagents.	Serizawa N, 2013, J ELECTROCHEM SOC, V160, pA1529, DOI 10.1149/2.085309jes; Kim Y, 2011, ELECTROCHIM ACTA, V56, P6573, DOI 10.1016/j.electacta.2011.03.070; Moon H, 2014, J PHYS CHEM C, V118, P20246, DOI 10.1021/jp506772f; Le Van-Jodin L, 2013, SOLID STATE IONICS, V253, P151, DOI 10.1016/j.ssi.2013.09.031; Sagane F, 2013, J POWER SOURCES, V225, P245, DOI 10.1016/j.jpowsour.2012.10.026; Kim Y, 2013, J ELECTROCHEM SOC, V160, pA3113, DOI 10.1149/2.017305jes; Li JC, 2013, ADV ENERGY MATER, V3, P1275, DOI 10.1002/aenm201300378; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; Yoshida K, 2011, J PHYS CHEM C, V115, P18384, DOI 10.1021/jp206881t; Choi KH, 2010, J POWER SOURCES, V195, P8317, DOI 10.1016/j.jpowsour.2010.06.102; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Tachikawa N, 2011, CHEM COMMUN, V47, P8157, DOI 10.1039/c1cc12415c; Howlett PC, 2004, ELECTROCHEM SOLID ST, V7, pA97, DOI 10.1149/1.1664051; PELED E, 1979, J ELECTROCHEM SOC, V126, P2047, DOI 10.1149/1.2128859; Wang B, 1996, J ELECTROCHEM SOC, V143, P3203, DOI 10.1149/1.1837188; Tatara R, 2013, CHEM LETT, V42, P1053, DOI 10.1246/cl.130420; BATES JB, 1993, J POWER SOURCES, V43, P103, DOI 10.1016/0378-7753(93)80106-Y; Zhu YL, 2009, ELECTROCHIM ACTA, V54, P7502, DOI 10.1016/j.electacta.2009.07.088; Bates JB, 2000, SOLID STATE IONICS, V135, P33, DOI 10.1016/S0167-2738(00)00327-1; Yu XH, 1997, J ELECTROCHEM SOC, V144, P524, DOI 10.1149/1.1837443; Pappenfus TM, 2004, J ELECTROCHEM SOC, V151, pA209, DOI 10.1149/1.1635384; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Matsumoto H, 2005, J POWER SOURCES, V146, P45, DOI 10.1016/j.jpowsour.2005.03.103; Katayama Y, 2003, ELECTROCHEMISTRY, V71, P1033; AURBACH D, 1994, ELECTROCHIM ACTA, V39, P51, DOI 10.1016/0013-4686(94)85010-0; Li JC, 2014, ACS APPL MATER INTER, V6, P10083, DOI 10.1021/am5009419; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Furuya R, 2014, ECS TRANSACTIONS, V64, P453, DOI 10.1149/06404.0453ecst; Iriyama Y, 2006, J ELECTROCHEM SOC, V153, pA821, DOI 10.1149/1.2178647; Jeon EJ, 2001, J ELECTROCHEM SOC, V148, pA318, DOI 10.1149/1.1354609; Park YS, 2010, J ELECTROCHEM SOC, V157, pA850, DOI 10.1149/1.3430090	32	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					846	848		10.5796/electrochemistry.83.846		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800017		
J	Nakata, A; Fukuda, K; Murayama, H; Tanida, H; Yamane, T; Arai, H; Uchimoto, Y; Sakurai, K; Ogumi, Z				Nakata, Akiyoshi; Fukuda, Katsutoshi; Murayama, Haruno; Tanida, Hajime; Yamane, Tomokazu; Arai, Hajime; Uchimoto, Yoshiharu; Sakurai, Kenji; Ogumi, Zempachi			Operando X-ray Fluorescence Imaging for Zinc-based Secondary Batteries	ELECTROCHEMISTRY			English	Article						Zinc-based Secondary Batteries; X-ray Fluorescence Imaging; Operando Analysis	ANODIC-DISSOLUTION; ALKALINE-SOLUTIONS; ELECTRODE; GROWTH; MORPHOLOGY; REDUCTION; DENDRITE	Zinc-based secondary aqueous batteries are promising candidates as innovative batteries for their high energy density and high safety. Their limited cycle life is chiefly due to the morphology changes of the zinc electrode and thus tracking the zinc distribution during electrochemical processes is indispensable for clarifying the deterioration mechanism of the zinc electrode. We here report the zinc distribution near the electrode in a millimeter scale on zinc reduction and oxidation observed by operand X-ray fluorescence imaging with a high time resolution. The zinc dendritic growth and its dissolution behavior is discussed based on the obtained zinc distribution images. (C) The Electrochemical Society of Japan, All rights reserved.	[Nakata, Akiyoshi; Fukuda, Katsutoshi; Murayama, Haruno; Tanida, Hajime; Yamane, Tomokazu; Arai, Hajime; Ogumi, Zempachi] Kyoto Univ, Off Soc Acad Collaborat Innovat, Uji, Kyoto 6110011, Japan; [Uchimoto, Yoshiharu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Sakurai, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Nakata, A (reprint author), Kyoto Univ, Off Soc Acad Collaborat Innovat, Uji, Kyoto 6110011, Japan.	nakata@saci.kyoto-u.ac.jp			RISING project of NEDO in Japan	This work was financially supported by the RISING project of NEDO in Japan. The synchrotron radiation experiments were performed with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2012A7602). The authors thank Ms. Y. Miyamoto for her contributions to sample preparation and electrochemical evaluation.	Nakata A, 2015, ELECTROCHIM ACTA, V166, P82, DOI 10.1016/j.electacta.2015.03.076; MCLARNON FR, 1991, J ELECTROCHEM SOC, V138, P645, DOI 10.1149/1.2085653; MOSHTEV RV, 1978, J APPL ELECTROCHEM, V8, P213, DOI 10.1007/BF00616424; SATO Y, 1971, J ELECTROCHEM SOC, V118, P1269, DOI 10.1149/1.2408303; Beck F, 2000, ELECTROCHIM ACTA, V45, P2467, DOI 10.1016/S0013-4686(00)00344-3; Hsu PC, 2008, J ELECTROCHEM SOC, V155, pD400, DOI 10.1149/1.2894189; Pei PC, 2014, APPL ENERG, V128, P315, DOI 10.1016/j.apenergy.2014.04.095; BOCKRIS JO, 1973, J ELECTROCHEM SOC, V120, P30, DOI 10.1149/1.2403396; BASS K, 1991, J POWER SOURCES, V35, P333, DOI 10.1016/0378-7753(91)80117-G; Arise I, 2006, J ELECTROCHEM SOC, V153, pA69, DOI 10.1149/1.2131819; DIRKSE TP, 1981, J ELECTROCHEM SOC, V128, P1412, DOI 10.1149/1.2127654; Eba H., 2003, PHOTON FACTORY ACT B, P173	12	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					849	851		10.5796/electrochemistry.83.849		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800018		
J	Ishizaki, R; Lin, L; Fukui, M				Ishizaki, Ryu; Lin, Lei; Fukui, Masahiro			An Accurate SOC Estimation Method for Lithium-ion Batteries which Considers Thermal Variation	ELECTROCHEMISTRY			English	Article						Lithium-ion Battery; State of Charge; Karman Filter; Temperature Dependency		This paper discusses an SOC estimation system for lithium ion batteries based on the extended Kalman filter. The accuracy of the estimation is strongly dependent on accuracy of the battery model. We have newly formulated the equivalent circuit model that covers temperature and SOC dependencies. As the result, the error rate of the estimation has been improved significantly. The experimental results show that the new SOC estimation system derives very accurate results for wide range of temperature. (C) The Electrochemical Society of Japan, All rights reserved.	[Ishizaki, Ryu; Lin, Lei; Fukui, Masahiro] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan	Fukui, M (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	mfukui@se.ritsumei.ac.jp					Plett GL, 2004, J POWER SOURCES, V134, P262, DOI 10.1016/j.jpowsour.2004.02.032; Baronti F., 2011, APPL ELECT, P1; Chen M., 2011, IEEE T ENERGY CONVER, V21, P2; Chenglin L., 2009, IEEE VEH POW PROP C, P1662; Chnglin L., 2010, AS PAC POW EN ENG C, P1; Dai H., 2006, IEEE INT C VEH EL SA, P342; Grewal M. S., 1987, KALMAN FILTERING; Lin L., 2014, IEEE VEH POW PROP C, P1; Pei F, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P8314; Wu G., 2008, IEEE VEH POW PROP C, P1	10	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					852	854		10.5796/electrochemistry.83.852		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800019		
J	Baba, C; Kawaguchi, K; Morimitsu, M				Baba, Chika; Kawaguchi, Kenji; Morimitsu, Masatsugu			Charge-discharge Performance and Energy Density of MH/Air Secondary Battery using A(2)B(7) Type Hydrogen Storage Alloys	ELECTROCHEMISTRY			English	Article						MH/Air Secondary Battery; Hydrogen Storage Alloy; High Energy Density; High Current Density Operation	LI/AIR BATTERIES; AIR ELECTRODE; OPERATION; SYSTEM; DESIGN	The charge-discharge performance and the energy density of a metal hydride/air secondary battery using A(2)B(7) type hydrogen storage alloys were studied. The MH/air secondary battery showed a high energy density more than 750 Wh/L or 100 Wh/kg, which is higher than the theoretical energy density of lithium ion secondary batteries. A high current discharge up to 1100 mA (83 mA cm(-2)) was demonstrated with no plugging of the positive electrode by discharge products. The results indicated that the MH/air secondary battery is one of the most promising candidates for next generation of energy storage devices to a wide range of applications such as electric vehicles and home energy storage systems. (C) The Electrochemical Society of Japan, All rights reserved.	[Baba, Chika; Morimitsu, Masatsugu] Doshisha Univ, Dept Sci Environm & Math Modeling, Kyoto 6100394, Japan; [Kawaguchi, Kenji] Doshisha Univ, Org Res Initiat & Dev, Kyoto 6100394, Japan; [Morimitsu, Masatsugu] Doshisha Univ, Dept Environm Syst Sci, Kyoto 6100394, Japan	Kawaguchi, K (reprint author), Doshisha Univ, Org Res Initiat & Dev, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	kkawaguc@mail.doshisha.ac.jp			"Advanced Low Carbon Technology Research and Development Program (ALCA)" of Japan Science and Technology Agency (JST)	This work was financially supported by "Advanced Low Carbon Technology Research and Development Program (ALCA)" of Japan Science and Technology Agency (JST). The authors also acknowledge FDK CORPORATION for supplying the negative electrode.	Yang SH, 2002, J POWER SOURCES, V112, P162, DOI 10.1016/S0378-7753(02)00370-1; Deiss E, 2002, ELECTROCHIM ACTA, V47, P3995, DOI 10.1016/S0013-4686(02)00316-X; Hasegawa S, 2009, J POWER SOURCES, V189, P371, DOI 10.1016/j.jpowsour.2008.08.009; Xiao J, 2010, J ELECTROCHEM SOC, V157, pA487, DOI 10.1149/1.3314375; Wang YG, 2010, J POWER SOURCES, V195, P358, DOI 10.1016/j.jpowsour.2009.06.109; Williford RE, 2009, J POWER SOURCES, V194, P1164, DOI 10.1016/j.jpowsour.2009.06.005; Zhang X, 2004, J POWER SOURCES, V128, P331, DOI 10.1016/j.jpowsour.2003.09.058; Cohn G, 2009, ELECTROCHEM COMMUN, V11, P1916, DOI 10.1016/j.elecom.2009.08.015; Morimitsu M, 2010, ELECTROCHEMISTRY, V78, P493; Morimitsu M., 2006, ECOINDUSTRY, V11, P71; Morimitsu M., 2011, RECENT DEV TECHNOLOG, P136; Tsuchinaga Y., 2010, 51 BATT S JAP NAG	12	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					855	857		10.5796/electrochemistry.83.855		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800020		
J	Okada, D; Sugiki, T; Uematsu, K; Itadani, A; Toda, K; Sato, M; Yamaguchi, T; Arimitsu, N; Nishikawa, S				Okada, Dai; Sugiki, Takuma; Uematsu, Kazuyoshi; Itadani, Atsushi; Toda, Kenji; Sato, Mineo; Yamaguchi, Togo; Arimitsu, Nozomi; Nishikawa, Shogo			Electrochemical Properties of LiFePO4 Cathode Materials Coated with Newly Developed Carbon Black	ELECTROCHEMISTRY			English	Article						LiFePO4; Carbon Coating; Carbon Black CB1; Polystylene	RECHARGEABLE LITHIUM BATTERIES; PERFORMANCE	A new type of carbon black CB1 was developed, by Asahi Carbon Co., Ltd., for usage of a lithium-ion battery (LIB). Compared with commercially available acetylene black, CB1 in which the network structure of carbon is developed has a relatively larger specific surface area. Therefore, CB1 dispersed in LiFePO4 precursors by planetary ball milling inhibited LiFePO4 primary particles' growth during calcination process. Charge/discharge performance was improved by coexistence of CB1 with polystyrene (PS) carbon layers deposited on LiFePO4 particle surfaces, compared to the performance for the LiFePO4 sample covered with carbon layers derived from only PS. (C) The Electrochemical Society of Japan, All rights reserved.	[Okada, Dai; Sugiki, Takuma; Itadani, Atsushi; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Nishi Ku, Niigata 9502181, Japan; [Yamaguchi, Togo; Arimitsu, Nozomi; Nishikawa, Shogo] Asahi Carbon Co Ltd, R&D Dept, Niigata 9500883, Japan	Sato, M (reprint author), Niigata Univ, Dept Chem & Chem Engn, Fac Engn, Nishi Ku, 8050 Ikarashi 2 No Cho, Niigata 9502181, Japan.	msato@eng.niigata-u.ac.jp					Yamada A, 2001, J ELECTROCHEM SOC, V148, pA224, DOI 10.1149/1.1348257; Dominko R, 2005, J ELECTROCHEM SOC, V152, pA607, DOI 10.1149/1.1860492; Nakano H, 2008, J ELECTROCHEM SOC, V155, pA909, DOI 10.1149/1.2988048; Morgan D, 2002, CHEM MATER, V14, P4684, DOI 10.1021/cm020348o; Masquelier C, 1998, J SOLID STATE CHEM, V135, P228, DOI 10.1006/jssc.1997.7629; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Konarova M, 2010, J POWER SOURCES, V195, P3661, DOI 10.1016/j.jpowsour.2009.11.147; Long Y, 2014, ELECTROCHIM ACTA, V117, P105, DOI 10.1016/j.electacta.2013.11.106; Wagemaker M, 2008, CHEM MATER, V20, P6313, DOI 10.1021/cm801781k	9	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					858	860		10.5796/electrochemistry.83.858		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800021		
J	Ogihara, N; Kishida, Y				Ogihara, Nobuhiro; Kishida, Yoshihiro			Improvement in the Electrochemical Properties of Intercalated Metal-Organic Framework Electrode Materials by Controlling Crystal Growth	ELECTROCHEMISTRY			English	Article						Intercalated Metal-organic Framework; Organic Dicarboxylate Dilithium; Negative Electrode	ION BATTERIES	The growth of the crystal surface of an intercalated metal-organic framework (iMOF) electrode material, 2,6-naphtalnene dicarboxylate dilithium, which forms an organic-inorganic layered structure, was controlled by selecting the solvent species during synthesis. The crystals synthesized under an aqueous solution exhibited a small reversible capacity because the crystal plane in the horizontal direction relative to the layered structure, grew dominantly and exhibited poor lithium intercalation kinetics. In contrast, the crystals synthesized under methanol exhibited a large reversible capacity because the crystal planes in the vertical direction relative to the layered structure were dominant and exhibited favorable lithium intercalation kinetics. (C) The Electrochemical Society of Japan, All rights reserved.	[Ogihara, Nobuhiro; Kishida, Yoshihiro] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Ogihara, N (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	ogihara@mosk.tytlabs.co.jp					Yasuda T, 2014, CHEM COMMUN, V50, P11565, DOI 10.1039/c4cc05344c; Wang CL, 2015, J AM CHEM SOC, V137, P3124, DOI 10.1021/jacs.5b00336; Fedele L, 2014, J ELECTROCHEM SOC, V161, pA46, DOI 10.1149/2.013401jes; Banerjee D, 2009, CRYST GROWTH DES, V9, P2500, DOI 10.1021/cg8014157; Renault S, 2013, CHEM COMMUN, V49, P1945, DOI 10.1039/c3cc39065a; Ogihara N, 2014, ANGEW CHEM INT EDIT, V53, P11467, DOI 10.1002/anie.201405139; Wang LP, 2015, ELECTROCHIM ACTA, V173, P235, DOI 10.1016/j.electacta.2015.05.067; Fujii K., 2011, NIHON KESSHO GAKKAIS, V53, P170; Ogihara N., 2014, 17 INT M LITH BATT, P320; Roisnel T, 2001, MATER SCI FORUM, V378-3, P118	10	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					861	863		10.5796/electrochemistry.83.861		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800022		
J	Ishida, T; Nakata, S; Tsujimoto, S; Yamada, H; Katakura, K				Ishida, Tomoya; Nakata, Shigenori; Tsujimoto, Shoko; Yamada, Hirohisa; Katakura, Katsumi			Electrochemical Behaviors of Zn Anode in Carbonate-based Aqueous Solutions	ELECTROCHEMISTRY			English	Article						Zinc Electrodes; Conc. Carbonate Aqueous Solution; Metal Secondary Batteries; Dendrite Formation	DENDRITE FORMATION; ZINC; INHIBITORS; BATTERY	Electrochemical behaviors of Zn in various concentrations of K2CO3 and KOH containing 5M K2CO3 (M = mol dm(-3)) aqueous solutions (carbonate-based electrolytes) have been investigated. The electrochemical reactions of Zn in diluted K2CO3 and KOH containing 5 M K2CO3 were suppressed while they were activated in concentrated K2CO3. In the point of view of the ratio of the cathodic charge (q(c) to the anodic q(a) and Zn oxidation current, 0.5M KOH containing 5 M K2CO3 showed the best performance among all examined electrolytes. The dendritic growth of Zn was not observed during redox cycles in the carbonate-based electrolytes. (C) The Electrochemical Society of Japan, All rights reserved.	[Ishida, Tomoya; Nakata, Shigenori; Tsujimoto, Shoko; Yamada, Hirohisa; Katakura, Katsumi] Nara Coll, Natl Inst Technol, Nara 6391080, Japan	Katakura, K (reprint author), Nara Coll, Natl Inst Technol, 22 Yata Yamatokoriyama, Nara 6391080, Japan.	katakura@chem.nara-k.ac.jp			Adaptable and Seamless Technology Transfer Program through target-driven RD, JST [AS242Z01801M]; Gigaku Innovation Promotion Center, Nagaoka University of Technology; Nakanishi Scholarship Foundation	This research is partially supported by Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST, No. AS242Z01801M, Gigaku Innovation Promotion Center, Nagaoka University of Technology, and Nakanishi Scholarship Foundation.	Lan CJ, 2007, ELECTROCHIM ACTA, V52, P5407, DOI 10.1016/j.electacta.2007.02.063; ADLER TC, 1993, J ELECTROCHEM SOC, V140, P289, DOI 10.1149/1.2221039; DIGGLE JW, 1969, J ELECTROCHEM SOC, V116, P1503, DOI 10.1149/1.2411588; MCLARNON FR, 1991, J ELECTROCHEM SOC, V138, P645, DOI 10.1149/1.2085653; CONWAY BE, 1987, J ELECTROCHEM SOC, V134, P906, DOI 10.1149/1.2100594; Kan JQ, 1998, J POWER SOURCES, V74, P113, DOI 10.1016/S0378-7753(98)00040-8; Miyazaki K, 2012, ELECTROCHEMISTRY, V80, P725, DOI 10.5796/electrochemistry.80.725; Chen Y, 2013, SURF SCI, V607, P39, DOI 10.1016/j.susc.2012.08.006; Kannangara C. W., 1987, J ELECTROCHEM SOC, V134, P894; Mohamad AA, 2006, J POWER SOURCES, V159, P752, DOI 10.1016/j.jpowsour.2005.10.110; U.S. Geological Survey, 2015, MINERAL COMMODITY SU, V187	11	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					864	866		10.5796/electrochemistry.83.864		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800023		
J	Kanazawa, R; Haruta, M; Doi, T; Inaba, M				Kanazawa, Ryotaro; Haruta, Masakazu; Doi, Takayuki; Inaba, Minoru			Preparation and Charge/Discharge Characteristics of Carbon-modified Ramsdellite TiO2 as a High Potential Anode	ELECTROCHEMISTRY			English	Article						Ramsdellite TiO2; High Potential Anode; Carbon Coating; Carbon Nanotubes	LITHIUM-ION BATTERIES; STRAIN INSERTION MATERIAL; NEGATIVE ELECTRODE; LI4/3TI5/3O4; IMPROVEMENT; CAPACITY; STORAGE	Carbon-modified ramsdellite titanium dioxide, TiO2(R), was prepared without using metallic Ti powder, and its charge and discharge properties was investigated as an anode of lithium ion batteries. Carbon sources (citric acid and multi-walled carbon nanotubes) were added in the calcination process to obtain a LiTi2O4 precursor. The carbon addition was indispensable to obtain stoichiometric LiTi2O4 as a precursor and the resulting Li+-free TiO2(R). The carbon-modified TiO2(R) had a round shape and a smaller particle size of 0.5-1.5 mu m. The discharge capacity and rate-capability were improved by carbon modification due to an enhancement of the electronic conductivity and a reduction of the lithium-ion diffusion path. (C) The Electrochemical Society of Japan, All rights reserved.	[Kanazawa, Ryotaro; Haruta, Masakazu; Doi, Takayuki; Inaba, Minoru] Doshisha Univ, Dept Mol Chem & Biochem, Fac Sci & Engn, Kyoto 6100321, Japan	Haruta, M (reprint author), Doshisha Univ, Dept Mol Chem & Biochem, Fac Sci & Engn, Kyoto 6100321, Japan.	mharuta@mail.doshisha.ac.jp			TEYCA Corporation, Japan	This work was supported by TEYCA Corporation, Japan.	Koudriachova MV, 2008, CHEM PHYS LETT, V458, P108, DOI 10.1016/j.cplett.2008.04.024; Ronci F, 2002, J PHYS CHEM B, V106, P3082, DOI 10.1021/jp013240p; Soares A, 2012, J POWER SOURCES, V208, P440, DOI 10.1016/j.jpowsour.2011.12.013; Kuhn A, 2007, J POWER SOURCES, V174, P421, DOI 10.1016/j.jpowsour.2007.06.147; Villevieille C, 2010, ELECTROCHIM ACTA, V55, P7080, DOI 10.1016/j.electacta.2010.06.052; Ng SH, 2006, ANGEW CHEM INT EDIT, V45, P6896, DOI 10.1002/anie.200601676; Zaghib K, 1999, J POWER SOURCES, V81, P300, DOI 10.1016/S0378-7753(99)00209-8; Rui XH, 2009, ELECTROCHIM ACTA, V54, P3374, DOI 10.1016/j.electacta.2009.01.011; Saito M, 2012, J ELECTROCHEM SOC, V159, pA49, DOI 10.1149/2.051201jes; Inaba M, 2009, J POWER SOURCES, V189, P580, DOI 10.1016/j.jpowsour.2008.10.001; Murota Y, 2010, ELECTROCHEMISTRY, V78, P431; Gover RKB, 1999, J ELECTROCHEM SOC, V146, P4348, DOI 10.1149/1.1392641; Saito M, 2013, J POWER SOURCES, V244, P50, DOI 10.1016/j.jpowsour.2013.04.070; Kuhn A, 2001, J POWER SOURCES, V92, P221, DOI 10.1016/S0378-7753(00)00530-9; Furuya Y, 2014, ELECTROCHIM ACTA, V136, P266, DOI 10.1016/j.electacta.2014.05.107; COLBOW KM, 1989, J POWER SOURCES, V26, P397, DOI 10.1016/0378-7753(89)80152-1; Jiang CH, 2007, J POWER SOURCES, V166, P239, DOI 10.1016/j.jpowsour.2007.01.004; SCROSATI B, 1995, NATURE, V373, P557, DOI 10.1038/373557a0; AKIMOTO J, 1994, J SOLID STATE CHEM, V113, P27, DOI 10.1006/jssc.1994.1337; Chen CH, 2001, J ELECTROCHEM SOC, V148, pA102, DOI 10.1149/1.1344523; Kang JW, 2011, J ELECTROCHEM SOC, V158, pA59, DOI 10.1149/1.3518420; Kosugi S., 2008, TOSHIBA REV, V63, P54; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592	23	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					867	869		10.5796/electrochemistry.83.867		3	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800024		
J	Matsuda, Y; Matsui, M; Sanda, T; Takashi, Y; Imanishi, N				Matsuda, Yasuaki; Matsui, Masaki; Sanda, Takahiro; Takashi, Yusuke; Imanishi, Nobuyuki			Low Temperature Synthesis of High Crystalline Spinel Oxides: LiNi1/2Mn3/2O4	ELECTROCHEMISTRY			English	Article						Li-ion Battery; Spinel Oxide; Morphology Change; Octahedral-shaped Particle	SECONDARY LITHIUM BATTERIES; CATHODE MATERIALS; ION BATTERIES; LINI0.5MN1.5O4; P4(3)32; NI; ME	The crystal growth process of LiNi1/2Mn3/2O4 was investigated and the octahedral shaped LiNi1/2Mn3/2O4 was successfully synthesized by a low temperature synthesis. The morphology change was accelerated by the spinel-rocksalt phase transformation caused by the oxygen loss. After re-oxidation, high crystalline LiNi1/2Mn3/2O4 with octahedral morphology was obtained. High crystalline LiNi1/2Mn3/2O4 with the particle size of 1-3 mu m was obtained by the low temperature synthesis controlling the oxygen partial pressure. High crystalline LiNi1/2Mn3/2O4 crystallized at 850 degrees C exhibited an initial charge capacity of 145 mAh g(-1) and an initial discharge capacity of 137 mAh g(-1) with a plateau at 4.7V, and 90% of cycle retention after 100 cycles at 60 degrees C. Microparticulation of high crystalline LiNi1/2Mn3/2O4 enhanced the discharge capacity. (C) The Electrochemical Society of Japan, All rights reserved.	[Matsuda, Yasuaki; Matsui, Masaki; Sanda, Takahiro; Takashi, Yusuke; Imanishi, Nobuyuki] Mie Univ, Dept Chem, Tsu, Mie 5148507, Japan; [Matsui, Masaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Matsuda, Y (reprint author), Mie Univ, Dept Chem, 1577 Kurimamachiya, Tsu, Mie 5148507, Japan.	matsuda@chem.mie-u.ac.jp	Matsui, Masaki/O-6645-2015	Matsui, Masaki/0000-0003-1499-7457			Kawai H, 1999, ELECTROCHIM ACTA, V45, P315, DOI 10.1016/S0013-4686(99)00213-3; Ariyoshi K, 2011, J ELECTROCHEM SOC, V158, pA281, DOI 10.1149/1.3531965; Song J, 2012, CHEM MATER, V24, P3101, DOI 10.1021/cm301825h; Liu GQ, 2013, J POWER SOURCES, V243, P260, DOI 10.1016/j.jpowsour.2013.05.189; Terada Y, 2001, J SOLID STATE CHEM, V156, P286, DOI 10.1006/jssc.2000.8990; Wang LP, 2011, SOLID STATE IONICS, V193, P32, DOI 10.1016/j.ssi.2011.04.007; Nakayama M, 2014, J PHYS CHEM C, V118, P27245, DOI 10.1021/jp509232m; Zhong QM, 1997, J ELECTROCHEM SOC, V144, P205, DOI 10.1149/1.1837386; Amine K, 1996, J ELECTROCHEM SOC, V143, P1607, DOI 10.1149/1.1836686; Hirayama M, 2010, J AM CHEM SOC, V132, P15268, DOI 10.1021/ja105389t; Kunduraci M, 2007, J POWER SOURCES, V165, P359, DOI 10.1016/j.jpowsour.2006.11.051; Ohzuku T, 1999, J POWER SOURCES, V81, P90, DOI 10.1016/S0378-7753(99)00246-3; Amine K, 1997, J POWER SOURCES, V68, P604, DOI 10.1016/S0378-7753(96)02590-6; Idcmoto Y., 2003, J POWER SOURCES, V125, P119; Karim A., 2013, PHYS REV B, V87; Kim JH, 2004, CHEM MATER, V16, P906, DOI 10.1021/cm035050s; Ohzuku T, 2001, CHEM LETT, P1270	17	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					870	873		10.5796/electrochemistry.83.870		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800025		
J	Matsui, M; Deguchi, S; Kuwata, H; Imanishi, N				Matsui, Masaki; Deguchi, Shotaro; Kuwata, Hiroko; Imanishi, Nobuyuki			In-operando FTIR Spectroscopy for Composite Electrodes of Lithium-ion Batteries	ELECTROCHEMISTRY			English	Article						In-operando Spectroscopy; FTIR; Solid Electrolyte Interphase; Electrolyte Decomposition	ATOMIC-FORCE MICROSCOPY; SURFACE-LAYER FORMATION; THIN-FILM ELECTRODES; PROPYLENE CARBONATE; DYNAMIC-BEHAVIOR; SITU; ELECTROLYTES; SYSTEMS; IDENTIFICATION; DEPOSITION	Electrolyte decomposition processes on cathode and anode active materials significantly affect to the cycle life and the calendar life of lithium-ion batteries. Here we designed a new in-operando FTIR spectroscopy cell to investigate the decomposition process of the electrolyte solutions. The cell is compatible with various cathodes and anodes for lithium-ion batteries and the charging-discharging rate can be increased up to 1C. In the case of the conventional cathode active material LiMn2O4, the in-operando spectra shows adsorption and solvation process of the electrolyte solvent molecules, while no clear evidence of the electrolyte oxidation process is observed. On the other hand, the solid electrolyte interphase (SEI) layer formation processes on graphite anodes are clearly observed. Hence, we think the new measurement technique should be a powerful tool for the development of electrolyte additives. (C) The Electrochemical Society of Japan, All rights reserved.	[Matsui, Masaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Matsui, Masaki; Deguchi, Shotaro; Kuwata, Hiroko; Imanishi, Nobuyuki] Mie Univ, Dept Chem, Tsu, Mie 5148507, Japan	Matsui, M (reprint author), Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	matsui@chem.mie-u.ac.jp	Matsui, Masaki/O-6645-2015	Matsui, Masaki/0000-0003-1499-7457	Japan Science and Technology Agency PRESTO [1347486]	This research was supported by Japan Science and Technology Agency PRESTO (Grant ID: 1347486).	KANAMURA K, 1995, J ELECTROCHEM SOC, V142, P340, DOI 10.1149/1.2044000; Aurbach D, 1997, J ELECTROCHEM SOC, V144, P3355, DOI 10.1149/1.1838018; KANAMURA K, 1994, J ELECTROCHEM SOC, V141, P2379, DOI 10.1149/1.2055129; Akita Y, 2013, J POWER SOURCES, V239, P175, DOI 10.1016/j.jpowsour.2013.03.134; Matsui M, 2008, J POWER SOURCES, V177, P184, DOI 10.1016/j.jpowsour.2007.10.078; Horiba T, 2014, P IEEE, V102, P939, DOI 10.1109/JPROC.2014.2319832; AURBACH D, 1988, J ELECTROCHEM SOC, V135, P1863, DOI 10.1149/1.2096170; PELED E, 1979, J ELECTROCHEM SOC, V126, P2047, DOI 10.1149/1.2128859; Matsui M, 2012, J POWER SOURCES, V210, P60, DOI 10.1016/j.jpowsour.2012.02.042; Kanamura K, 1997, J ELECTROCHEM SOC, V144, P1900, DOI 10.1149/1.1837718; Mogi R, 2002, J ELECTROCHEM SOC, V149, pA1578, DOI 10.1149/1.1516770; KANAMURA K, 1995, J ELECTROCHEM SOC, V142, P1383, DOI 10.1149/1.2048586; Joho F, 2000, ELECTROCHIM ACTA, V45, P3589, DOI 10.1016/S0013-4686(00)00480-1; Moller KC, 2003, J POWER SOURCES, V119, P561, DOI 10.1016/S0378-7753(03)00289-1; Cohen YS, 2000, J PHYS CHEM B, V104, P12282, DOI 10.1021/jp002526b; AURBACH D, 1987, J ELECTROCHEM SOC, V134, P1611, DOI 10.1149/1.2100722; BESENHARD JO, 1995, J POWER SOURCES, V54, P228, DOI 10.1016/0378-7753(94)02073-C; AURBACH D, 1993, J ELECTROCHEM SOC, V140, pL1, DOI 10.1149/1.2056119; AURBACH D, 1993, J ELECTROCHEM SOC, V140, pL155, DOI 10.1149/1.2221034; Matsui M, 2010, J ELECTROCHEM SOC, V157, pA121, DOI 10.1149/1.3262622	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					874	878		10.5796/electrochemistry.83.874		5	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800026		
J	Idemoto, Y; Sera, Y; Ishida, N; Kitamura, N				Idemoto, Yasushi; Sera, Yusuke; Ishida, Naoya; Kitamura, Naoto			Average and Local Crystal Structure and Electronic Structure of 0.4Li(2)MnO(3)-0.6LiMn(1/3)Ni(1/3)Co(1/3)O(2) Using First-principles Calculations and Neutron Beam and Synchrotron X-Ray Sources	ELECTROCHEMISTRY			English	Article						Li-ion Battery; Local Structure; Density Functional Theory; Pair Distribution Function	TOTAL-ENERGY CALCULATIONS; LI-ION BATTERIES; WAVE BASIS-SET; CATHODE MATERIAL; HIGH-VOLTAGE; LITHIUM; PERFORMANCE; WIEN2K	The average and local crystal structures, and the electronic structure of 0.4Li(2)MnO(3)-0.6LiMn(1/3)Ni(1/3)Co(1/3)O(2) were investigated using a combination of a pair distribution function (PDF) analysis and first-principles calculations. A Rietveld analysis showed that the sample had a Li2MnO3-type structure (space group: C2/m) and that Ni and Co existed at two sites, 49 and 2b, in the transition metal layer. Based on the maximum entropy method using synchrotron X-ray diffraction data, and first-principles calculations, it was determined that the covalencies between 2b and 8j sites in the transition metal layer, and between 2c and 8j sites in the lithium layer, were relatively low. In addition, based on the average length of bonds between transition metal and oxygen ions in the local structure determined by a PDF analysis using synchrotron X-ray and neutron total scattering data, and the ionic radius, the valence of Mn, Ni and Co in this material before charging was tetravalent, between divalent and trivalent, and trivalent, respectively. These results were consistent with the valence obtained from the density of states calculated by the WIEN2k code. (C) The Electrochemical Society of Japan, All rights reserved.	[Idemoto, Yasushi; Sera, Yusuke; Ishida, Naoya; Kitamura, Naoto] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Idemoto, Yasushi; Ishida, Naoya; Kitamura, Naoto] Tokyo Univ Sci, Res Inst Sci & Technol, Div Ecosyst Res, Noda, Chiba 2788510, Japan	Idemoto, Y (reprint author), Tokyo Univ Sci, Fac Sci & Technol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	idemoto@rs.noda.tus.ac.jp			JSPS KAKENHI Grant [25420718]	This work was supported in part by JSPS KAKENHI Grant Number 25420718. We are deeply grateful for the cooperation of Dr. Jungen Kim and Dr. Shinji Kohara of JASRI with regard to synchrotron X-ray diffraction and total scattering (SPring-8). We are also very appreciative for the cooperation of Prof. Toru Ishigaki, Dr. Akinori Hoshikawa of Ibaraki University, Prof. Toshiya Otomo of KEK for the neutron diffraction and total scattering analyses.	Tran N, 2008, CHEM MATER, V20, P4815, DOI 10.1021/cm070435m; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Thackeray MM, 2005, J MATER CHEM, V15, P2257, DOI 10.1039/b417616m; Momma K, 2013, POWDER DIFFR, V28, P184, DOI 10.1017/S088571561300002X; STROBEL P, 1988, J SOLID STATE CHEM, V75, P90, DOI 10.1016/0022-4596(88)90305-2; Idemoto Y, 2015, ELECTROCHIM ACTA, V153, P399, DOI 10.1016/j.electacta.2014.12.002; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Farrow CL, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/33/335219; Oishi R, 2009, NUCL INSTRUM METH A, V600, P94, DOI 10.1016/j.nima.2008.11.056; Ito A, 2008, J POWER SOURCES, V183, P344, DOI 10.1016/j.jpowsour.2008.04.086; Kim JS, 2004, CHEM MATER, V16, P1996, DOI 10.1021/cm0306461; Schwarz K, 2002, COMPUT PHYS COMMUN, V147, P71, DOI 10.1016/S0010-4655(02)00206-0; Schwarz K, 2003, COMP MATER SCI, V28, P259, DOI 10.1016/S0927-0256(03)00112-5; Breger J, 2005, J SOLID STATE CHEM, V178, P2575, DOI 10.1016/j.jssc.2005.05.027; Kumagai N, 2008, ELECTROCHIM ACTA, V53, P5287, DOI 10.1016/j.electacta.2008.01.044; Arunkumar T A, 2007, Chemistry of Materials, V19, DOI 10.1021/cm070389q; Ates MN, 2015, J ELECTROCHEM SOC, V162, pA1236, DOI 10.1149/2.0481507jes; Idemoto Y., J POWER SOURCE UNPUB; lzumi F., 2007, SOLID STATE PHENOM, V130, P15; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					879	884		10.5796/electrochemistry.83.879		6	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800027		
J	Kitajou, A; Kobayashi, E; Okada, S				Kitajou, Ayuko; Kobayashi, Eiji; Okada, Shigeto			Electrochemical Performance of a Novel Cathode material "LiFeOF" for Li-ion Batteries	ELECTROCHEMISTRY			English	Article						LiFeOF; Lithium-ion Batteries; Dry Ball-milling Method	FLUORIDE NANOCOMPOSITES; ELECTRODES; FEOF	Iron-based conversion cathode, FeOF is attractive, because of the low cost and the large specific capacity. However, the synthesis is not easy and it cannot be used as cathode against carbonaceous anode. To overcome these drawbacks, we focused on the LiFeOF phase, which has the same chemical composition as the discharged intermediate product of FeOF cathode. LiFeOF can be easily synthesized from LiF and FeO by the dry ball-milling method at room temperature. The reversible capacity was 292 mAh g(-1) with an average voltage of 2.5V and an energy density over 700 Wh kg(-1), which is higher than that of LiFePO4. In addition, we confirmed the feasibility of LiFeOF cathode against Li4Ti5O12 anode. (C) The Electrochemical Society of Japan, All rights reserved.	[Kitajou, Ayuko; Kobayashi, Eiji; Okada, Shigeto] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Kitajou, A (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	kitajyou@cm.kyushu-u.ac.jp			Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING project) of the New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was financially supported by the Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING project) of the New Energy and Industrial Technology Development Organization (NEDO), Japan. Fe K-edge XANES measurements at BL11 were conducted with help of Dr. Toshihiro Okajima of the Kyushu Synchrotron Light Research Center.	Kim SW, 2012, NANO TODAY, V7, P168, DOI 10.1016/j.nantod.2012.04.004; Yu L, 2010, ELECTROCHIM ACTA, V56, P767, DOI 10.1016/j.electacta.2010.09.103; Badway F, 2003, J ELECTROCHEM SOC, V150, pA1318, DOI 10.1149/1.1602454; Ma RG, 2013, ACS APPL MATER INTER, V5, P892, DOI 10.1021/am302558w; Badway F, 2007, CHEM MATER, V19, P4129, DOI 10.1021/cm070421g; Amatucci GG, 2011, J FLUORINE CHEM, V132, P1086, DOI 10.1016/j.jfluchem.2011.06.033; Pereira N, 2009, J ELECTROCHEM SOC, V156, pA407, DOI 10.1149/1.3106132; Kitajou A, 2013, J POWER SOURCES, V243, P494, DOI 10.1016/j.jpowsour.2013.06.053; Brink FJ, 2000, J SOLID STATE CHEM, V155, P359, DOI 10.1006/jssc.2000.8925; MORZILLI S, 1985, ELECTROCHIM ACTA, V30, P1271, DOI 10.1016/0013-4686(85)85002-7; Zhang S., 2012, J PHYS D, V45, P395	11	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					885	888		10.5796/electrochemistry.83.885		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800028		
J	Matsuyama, T; Deguchi, M; Hayashi, A; Tatsumisago, M; Ozaki, T; Togawa, Y; Mori, S				Matsuyama, Takuya; Deguchi, Minako; Hayashi, Akitoshi; Tatsumisago, Masahiro; Ozaki, Tomoatsu; Togawa, Yoshihiko; Mori, Shigeo			Structure Analyses of Amorphous MoS3 Active Materials in All-solid-state Lithium Batteries	ELECTROCHEMISTRY			English	Article						Molybdenum Sulfide; All-solid-state Lithium Battery; Structure Analyses; Amorphous Electrode	X-RAY PHOTOELECTRON; LI-ION BATTERIES; SECONDARY BATTERIES; ELECTROCHEMICAL PROPERTIES; POSITIVE-ELECTRODE; SULFIDE ELECTRODES; HIGH-CAPACITY; CATHODE; CELLS; SPECTROSCOPY	We have successfully prepared amorphous MOS3 (a-MoS3) by ball milling a mixture of Mo metal and sulfur and investigated structural changes during the charge-discharge processes. The XPS measurements revealed that a-MoS3 should consist of Mo4+, S-2(2-), and S2-. In the XRD profiles of the a-MoS3 electrodes after the initial discharge and charge tests, only the halo patterns due to the amorphous state were observed without crystalline diffraction peaks. The HR-TEM observations of a-MoS3 electrodes during the 1st discharge process revealed that the lattice fringes due to MoS2 layer structure disappeared gradually. However, the lattice fringes like MoS2 were also observed after the 1st charge. The HR-TEM image after the 10th charge did not show the lattice fringes of MoS2. These results of HR-TEM observations suggested that the reversible structural changes of a-MoS3 occurred. (C) The Electrochemical Society of Japan, All rights reserved.	[Matsuyama, Takuya; Deguchi, Minako; Hayashi, Akitoshi; Tatsumisago, Masahiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan; [Ozaki, Tomoatsu] Technol Res Inst Osaka Prefecture, Izumi, Osaka 5941157, Japan; [Togawa, Yoshihiko] Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Naka Ku, Sakai, Osaka 5998570, Japan; [Mori, Shigeo] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Tatsumisago, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-1 Gakuen, Sakai, Osaka 5998531, Japan.	tatsu@chem.osakafu-u.ac.jp			JST ALCA-SPRING project	This research was financially supported by JST ALCA-SPRING project.	Amand M., 2008, NATURE, V451, P652; Zeng ZY, 2011, ANGEW CHEM INT EDIT, V50, P11093, DOI 10.1002/anie.201106004; Morales J, 1996, J ELECTROCHEM SOC, V143, P2847, DOI 10.1149/1.1837117; JACOBSON AJ, 1979, MATER RES BULL, V14, P1437, DOI 10.1016/0025-5408(79)90087-4; Seino Y, 2014, ENERG ENVIRON SCI, V7, P627, DOI 10.1039/c3ee41655k; JACOBSON AJ, 1980, J ELECTROCHEM SOC, V127, P779, DOI 10.1149/1.2129757; Matsuyama T, 2013, J SOLID STATE ELECTR, V17, P2697, DOI 10.1007/s10008-013-2157-5; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Sakuda A, 2014, SOLID STATE IONICS, V262, P143, DOI 10.1016/j.ssi.2013.09.044; MIKI Y, 1995, J POWER SOURCES, V54, P508, DOI 10.1016/0378-7753(94)02136-Q; Manthiram A, 1996, J ELECTROCHEM SOC, V143, pL143, DOI 10.1149/1.1836955; Sakuda A, 2013, ELECTROCHEM COMMUN, V31, P71, DOI 10.1016/j.elecom.2013.03.004; Hayashi A, 2003, ELECTROCHEM COMMUN, V5, P111, DOI 10.1016/S1388-2481(02)00555-6; Weber T, 1996, J PHYS CHEM-US, V100, P14144, DOI 10.1021/jp961204y; Hall JW, 2012, J AM CHEM SOC, V134, P5532, DOI 10.1021/ja301173q; Hayashi A, 2012, CHEM LETT, V41, P886, DOI 10.1246/cl.2012.886; SAKURAI Y, 1987, J POWER SOURCES, V20, P173, DOI 10.1016/0378-7753(87)80108-8; Qian JF, 2012, CHEM COMMUN, V48, P8931, DOI 10.1039/c2cc34388f; Matsuyama T, 2015, J MATER CHEM A, V3, P14142, DOI 10.1039/c5ta02263k; YAMIN H, 1988, J ELECTROCHEM SOC, V135, P1045, DOI 10.1149/1.2095868; Jeon BH, 2002, J POWER SOURCES, V109, P89, DOI 10.1016/S0378-7753(02)00050-2; Park CM, 2010, J MATER CHEM, V20, P1097, DOI 10.1039/b918220a; Isono M, 2010, J POWER SOURCES, V195, P593, DOI 10.1016/j.jpowsour.2009.07.038; Ku JH, 2012, ADV FUNCT MATER, V22, P3658, DOI 10.1002/adfm.201102669; Sakuda A, 2014, ECS ELECTROCHEM LETT, V3, pA79, DOI 10.1149/2.0091407eel; AUBORN JJ, 1987, J ELECTROCHEM SOC, V134, P580, DOI 10.1149/1.2100512; Liang X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6682; RIGA J, 1983, J CHEM SOC PERK T 2, P1545, DOI 10.1039/p29830001545; Tarascon I. J. M., 2001, NATURE, V414, P359; Xu JJ, 2002, ELECTROCHEM SOLID ST, V5, pA152, DOI 10.1149/1.1480137	30	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					889	893		10.5796/electrochemistry.83.889		5	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800029		
J	Funayama, K; Nakamura, T; Kuwata, N; Kawamura, J; Kawada, T; Amezawa, K				Funayama, Keita; Nakamura, Takashi; Kuwata, Naoaki; Kawamura, Junichi; Kawada, Tatsuya; Amezawa, Koji			Effect of Mechanical Stress on Lithium Chemical Potential in Positive Electrodes and Solid Electrolytes for Lithium Ion Batteries	ELECTROCHEMISTRY			English	Article						Mechanical Stress; Lithium Chemical Potential; Electromotive Force; Lithium Ion Batteries	LICOO2	Effects of mechanical stress on lithium chemical potential in electrodes and electrolytes for all-solid-state lithium ion batteries were investigated. Dense film electrodes of LiCoO2 or LiMn2O4 were symmetrically deposited on both surfaces of a plate of various solid state lithium ion conductors, such as Li0.29La0.57TiO3, Li2La3Zr2O12 and Li1+x+yAlx(Ti,Ge)(2-x)SiyP3-yO12. Mechanical stress was applied to the specimen by four points bending tests while measuring electromotive force (EMF) between the two electrodes. EMF proportional to the applied stress was observed. EMF was significantly dependent on the electrode material, but was almost independent of the electrolyte material. These results indicated that lithium chemical potential varied under mechanical stress both in the electrode and electrolyte but the influence of mechanical stress appeared more notably in the electrode than the electrolyte. The lithium chemical potential changes in the electrode and the electrolyte under mechanical stress were discussed based on the idea of local equilibrium. (C) The Electrochemical Society of Japan, All rights reserved.	[Funayama, Keita] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Nakamura, Takashi; Kuwata, Naoaki; Kawamura, Junichi; Amezawa, Koji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kawada, Tatsuya] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Amezawa, K (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	amezawa@tagen.tohoku.ac.jp					Amanieu HY, 2014, MAT SCI ENG A-STRUCT, V593, P92, DOI 10.1016/j.msea.2013.11.044; Takada K, 2013, ACTA MATER, V61, P759, DOI 10.1016/j.actamat.2012.10.034; OHZUKU T, 1994, J ELECTROCHEM SOC, V141, P2972, DOI 10.1149/1.2059267; Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; Pannikkat AK, 1999, ACTA MATER, V47, P3423, DOI 10.1016/S1359-6454(99)00206-2; Zhang H, 2013, SENSOR ACTUAT B-CHEM, V176, P52, DOI 10.1016/j.snb.2012.08.079; Araki W, 2011, SOLID STATE IONICS, V193, P5, DOI 10.1016/j.ssi.2011.04.009; Ichitsubo T, 2011, J MATER CHEM, V21, P2701, DOI 10.1039/c0jm02893b; Beer F. P., 2009, MECH MATER, P208; DURHAM WB, 1987, BER BUNSEN PHYS CHEM, V91, P556; Funayama K., SOLID STATE IO UNPUB	11	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					894	897		10.5796/electrochemistry.83.894		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800030		
J	Harada, R; Aso, K; Hayashi, A; Tatsumisago, M				Harada, Ryo; Aso, Keigo; Hayashi, Akitoshi; Tatsumisago, Masahiro			Preparation of Composites with LiCoPO4 Electrode and LiTi2(PO4)(3) Electrolyte for Bulk-type All-solid-state Lithium Batteries	ELECTROCHEMISTRY			English	Article						All-solid-state Lithium Battery; LiCoPO4; LiTi2(PO4)(3); Composite	GLASS-CERAMIC ELECTROLYTES; CATHODES; CAPACITY	All-solid-state cells with LiCoPO4 (LCP) active material with high redox potential of 4.8V (vs. Li+/Li) were fabricated and the cells operated as a lithium secondary battery at room temperature. The composite electrodes of LCP active material and LiTi2(PO4)(3) (LTP) electrolyte with large contact area were synthesized in the media of oleic acid and paraffin wax by heat treatment at 700 degrees C. The prepared LCP-LTP-Acetylene black (AB) composites were applied to electrochemical cells with a conventional organic liquid electrolyte and a sulfide solid electrolyte. The all-solid-state cells using the positive electrode composed of the LCP-LTP-AB composite and the sulfide electrolyte showed the initial discharge capacity of 50 mAh g(-1) at 4.8V (vs. Li+/Li). The cells using the electrodes without LIP and the sulfide electrolyte were difficult to operate, suggesting that formation of close contacts between LCP and LIP, and additional ion conduction paths to LCP-LTP particles are effective in increasing capacities in all-solid-state cells. (C) The Electrochemical Society of Japan, All rights reserved.	[Harada, Ryo; Aso, Keigo; Hayashi, Akitoshi; Tatsumisago, Masahiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Tatsumisago, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-1 Gakuen, Sakai, Osaka 5998531, Japan.	tatsu@chem.osakafu-u.ac.jp					Nagata K, 2007, J POWER SOURCES, V174, P832, DOI 10.1016/j.jpowsour.2007.06.227; Choi DW, 2010, NANO LETT, V10, P2799, DOI 10.1021/nl1007085; Kobayashi Y, 1999, J POWER SOURCES, V81, P853, DOI 10.1016/S0378-7753(99)00121-4; Takada K, 2001, SOLID STATE IONICS, V139, P241, DOI 10.1016/S0167-2738(01)00688-9; Wolfenstine J, 2005, J POWER SOURCES, V144, P226, DOI 10.1016/j.jpowsour.2004.12.013; Xie J, 2009, J POWER SOURCES, V192, P689, DOI 10.1016/j.jpowsour.2009.03.001; Hayashi A, 2003, ELECTROCHEM COMMUN, V5, P111, DOI 10.1016/S1388-2481(02)00555-6; Sakuda A, 2010, CHEM MATER, V22, P949, DOI 10.1021/cm901819c; Kitaura H, 2007, J ELECTROCHEM SOC, V154, pA725, DOI [10.1149/1.2737349, 10.1146/1.2737349]; Markevich E, 2012, ELECTROCHEM COMMUN, V15, P22, DOI 10.1016/j.elecom.2011.11.014; Tadanaga K, 2003, ELECTROCHEMISTRY, V71, P1192; Rabanal ME, 2006, J POWER SOURCES, V160, P523, DOI 10.1016/j.jpowsour.2005.12.071; Fergus JW, 2010, J POWER SOURCES, V195, P4554, DOI 10.1016/j.jpowsour.2010.01.076; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Sharabi R, 2013, ELECTROCHEM COMMUN, V28, P20, DOI 10.1016/j.elecom.2012.12.001; Tatsumisago M, 2014, INT J APPL GLASS SCI, V5, P226, DOI 10.1111/ijag.12084; Kotobuki M., 2013, INT J ENERGY ENV ENG, V4, P25; Lions J. M., 2002, ELECTROCHEM SOLID ST, V5, pA234; Okumura T, 2014, ELECTROCHEMISTRY, V82, P906, DOI 10.5796/electrochemistry.82.906; Sakuda A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02261	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					898	901		10.5796/electrochemistry.83.898		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800031		
J	Ni, EF; Goto, S; Quan, Z; Sonoyama, N				Ni, Erfu; Goto, Syota; Quan, Zhen; Sonoyama, Noriyuki			Electrochemical Property for the Metal-doped Vanadium Bronze K2V8O21 as a Cathode Material of Lithium Battery	ELECTROCHEMISTRY			English	Article						Vanadium Bronzes; Lithium Intercalation; Structure Change During the Discharge-charge	SECONDARY BATTERIES; THERMAL-STABILITY; LIXV2O5 SYSTEM; ION BATTERIES; TEMPERATURE; ELECTRODES; CELLS; R(3)OVER-BAR-M; PERFORMANCE; VANADATES	Improvement of electrochemical property of K2V8O21, a stable phase of vanadium bronzes, was attempted by redox inactive metal ion doping. From the XRD pattern and lattice parameter change, it was confirmed that Ti and Nb can be exchanged with vanadium until 2 mol%. By doping 1 mol% Nb5+ to K2V8O21, the discharged capacity was improved to 210 mAh/g from 140 mAh/g for non-dope system. In ex-situ XRD measurement, non-dope K2V8O21 became amorphous in the first discharge process. For Nb-doped system, main reflection of K2V8O21 observed after both discharge process and first discharge-charge cycle. The lattice parameter of c axis increased while that of a axis decreased after discharge. Both lattice parameters got back to the initial position after charging process. This result suggests that lithium ions are intercalating into the inter layer part along the c axis during the discharge process. Mechanical mixing active materials with acetylene black was attempted for the further improvement in the electrochemical property. The initial capacity of ball milled Nb-doped K2V8O21 was improved to 315 mAh/g. This result suggests that the capacity of K2V8O21 is determined by the numbers of lithium ion that can be intercalated into the lattice without the destruction of its crystal structure. (C) The Electrochemical Society of Japan, All rights reserved.	[Ni, Erfu; Goto, Syota; Quan, Zhen; Sonoyama, Noriyuki] Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Sonoyama, N (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.	sonoyama@nitech.ac.jp					Tran N, 2008, J ELECTROCHEM SOC, V155, pA384, DOI 10.1149/1.2884859; MURPHY DW, 1979, INORG CHEM, V18, P2800, DOI 10.1021/ic50200a034; Aleksandrova A, 2009, CR ACAD BULG SCI, V62, P453; Zheng ZH, 2002, SOLID STATE IONICS, V148, P317, DOI 10.1016/S0167-2738(02)00068-1; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; OHZUKU T, 1994, J ELECTROCHEM SOC, V141, P2972, DOI 10.1149/1.2059267; MANEV V, 1993, J POWER SOURCES, V44, P561, DOI 10.1016/0378-7753(93)80203-2; COCCIANTELLI JM, 1991, J POWER SOURCES, V34, P103, DOI 10.1016/0378-7753(91)85029-V; Myung ST, 2001, J ELECTROCHEM SOC, V148, pA482, DOI 10.1149/1.1365140; Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; Belharouak I, 2006, J ELECTROCHEM SOC, V153, pA2030, DOI 10.1149/1.2336994; SAKURAI Y, 1988, J ELECTROCHEM SOC, V135, P791, DOI 10.1149/1.2095773; Huang H, 2001, ELECTROCHEM SOLID ST, V4, pA170, DOI 10.1149/1.1396695; WIESENER K, 1987, J POWER SOURCES, V20, P157, DOI 10.1016/0378-7753(87)80106-4; DICKENS PG, 1979, MATER RES BULL, V14, P1295, DOI 10.1016/0025-5408(79)90006-0; Aleksandrova A, 2006, NATO SCI SER II MATH, V223, P479; SAKURAI Y, 1987, J POWER SOURCES, V20, P173, DOI 10.1016/0378-7753(87)80108-8; PISTOIA G, 1990, J ELECTROCHEM SOC, V137, P2365, DOI 10.1149/1.2086945; LOW W, 1956, PHYS REV, V101, P1827, DOI 10.1103/PhysRev.101.1827; DELMAS C, 1994, SOLID STATE IONICS, V69, P257, DOI 10.1016/0167-2738(94)90414-6; Lim S, 2008, ELECTROCHEM COMMUN, V10, P1478, DOI 10.1016/j.elecom.2008.07.028; Tyutyunnik AP, 2005, SOLID STATE SCI, V7, P37, DOI 10.1016/j.solidstatesciences.2004.10.013; Kannan AM, 2002, ELECTROCHEM SOLID ST, V5, pA167, DOI 10.1149/1.1482198; WHITTINGHAM MS, 1976, J ELECTROCHEM SOC, V123, P315, DOI 10.1149/1.2132817; BLEANEY B, 1952, P PHYS SOC LOND A, V65, P667, DOI 10.1088/0370-1298/65/8/111; Boisard A, 2008, IONICS, V14, P433, DOI 10.1007/s11581-007-0198-4; Guilmard M, 2003, CHEM MATER, V15, P4484, DOI 10.1021/cm030340u; Amatucci GG, 1997, SOLID STATE IONICS, V104, P13, DOI 10.1016/S0167-2738(97)00407-4; Momchilov A., 2000, NATO SCI SERIES 3, V85, P559; Ohzuku T, 1995, J ELECTROCHEM SOC, V142, P4033, DOI 10.1149/1.2048458; Subramanya Herle P., 2004, Nature Materials, V3, DOI 10.1038/nmat1063	31	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					902	908		10.5796/electrochemistry.83.902		7	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800032		
J	Hori, H; Okada, S				Hori, Hironobu; Okada, Shigeto			Reconversion Reaction of LiF/Fe Composite Thin Film Cathodes for Lithium-Ion Battery	ELECTROCHEMISTRY			English	Article						Lithium-ion Battery; Iron Fluoride; Reconversion Reaction; Nanocomposite Thin Film	POSITIVE ELECTRODE MATERIALS; CONVERSION CATHODE; FLUORIDE NANOCOMPOSITES; LI; SPECTROSCOPY; MECHANISMS	The reconversion reaction of lithium fluoride (LiF)/iron (Fe) nanocomposite thin film cathodes prepared with the co-deposition method was investigated at room temperature. The LiF: Fe in molar ratio of 1:1 composite thin film was able to be discharged with large capacity of 300 mAh g(-1) after the reconversion reaction on the first charge at 25 degrees C. After the 2nd cycle, it showed relatively stable reversible capacity more than 200 mAh g(-1). The discharge profile with 2V plateau was similar to that of ferrous fluoride (FeF2), and the trace of FeF2 was detected in the fully-charged LiF/Fe nanocomposite thin film by X-ray photoelectron spectroscopy (XPS). These results suggest that the reconversion reaction from LiF/Fe to FeF2 proceeded successfully on the first charge as we expected. (C) The Electrochemical Society of Japan, All rights reserved.	[Hori, Hironobu; Okada, Shigeto] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8168580, Japan	Okada, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Fukuoka 8168580, Japan.	s-okada@cm.kyushu-u.ac.jp			Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING project) of the New Energy and Industrial Technology Development Organization (NEDO)	This work was financially supported by the Research & Development Initiative for Scientific Innovation of New Generation Batteries (RISING project) of the New Energy and Industrial Technology Development Organization (NEDO).	Pohl AH, 2014, ACTA MATER, V68, P179, DOI 10.1016/j.actamat.2014.01.016; Arai H, 1997, J POWER SOURCES, V68, P716, DOI 10.1016/S0378-7753(96)02580-3; Li T, 2012, J POWER SOURCES, V217, P54, DOI 10.1016/j.jpowsour.2012.05.111; Bervas M, 2006, J ELECTROCHEM SOC, V153, pA799, DOI 10.1149/1.2167951; Wang F, 2011, J AM CHEM SOC, V133, P18828, DOI 10.1021/ja206268a; Qiu SR, 2000, PHYS REV LETT, V85, P1492, DOI 10.1103/PhysRevLett.85.1492; Liao P, 2008, CHEM MATER, V20, P454, DOI 10.1021/cm702656k; Carlo SR, 2000, J PHYS CHEM B, V104, P6633, DOI 10.1021/jp0009406; Amatucci GG, 2007, J FLUORINE CHEM, V128, P243, DOI 10.1016/j.jfluchem.2006.11.016; Prakash R, 2010, J MATER CHEM, V20, P1871, DOI [10.1039/b919()97j, 10.1039/b919097j]; Cosandey F, 2012, MICRON, V43, P22, DOI 10.1016/j.micron.2011.05.009; Badway F, 2003, MATER RES SOC SYMP P, V756, P207; Doe RE, 2008, CHEM MATER, V20, P5274, DOI 10.1021/cm801105p; Nishijima M, 2009, J POWER SOURCES, V190, P558, DOI 10.1016/j.jpowsour.2009.01.051; Prakash R, 2011, J POWER SOURCES, V196, P5936, DOI 10.1016/j.jpowsour.2011.03.007; Das B, 2014, J POWER SOURCES, V267, P203, DOI 10.1016/j.jpowsour.2014.05.063; Badway F, 2003, J ELECTROCHEM SOC, V150, pA1209, DOI 10.1149/1.1596162; HAWN DD, 1987, SURF INTERFACE ANAL, V10, P63, DOI 10.1002/sia.740100203	18	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					909	913		10.5796/electrochemistry.83.909		5	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800033		
J	Ikeda, K; Terada, S; Mandai, T; Ueno, K; Dokko, K; Watanabe, M				Ikeda, Kohei; Terada, Shoshi; Mandai, Toshihiko; Ueno, Kazuhide; Dokko, Kaoru; Watanabe, Masayoshi			Lithium-tin Alloy/Sulfur Battery with a Solvate Ionic Liquid Electrolyte	ELECTROCHEMISTRY			English	Article						Lithium-sulfur Batteries; Solvate Ionic Liquids; Tetraglyme; Li-Sn Alloy	LI-SN SYSTEM; COMPLEXES; BEHAVIOR; ISSUES	The electrochemical properties of a mechanochemically synthesized Li22Sn5 electrode in a solvate ionic liquid-based electrolyte were investigated. The electrolyte was composed of lithium bis(trifluoromethanesulfonyl)amide (Li[TFSA]), tetraglyme (G4), and a hydrofluoroether solvent (HFE) in a molar ratio of 1:1:6.2, in which Li+ and G4 formed a 1:1 complex cation of {Li(G4)(+). The Li22Sn5 electrode exhibited an initial discharge capacity of 500 mAhg(-1) in this electrolyte; however, the capacity decreased with increased numbers of charge-discharge cycles. This was attributed to the Li-Sn alloy's volume change in the electrode during the electrochemical reaction. To examine the behavior of the electrode material in a lithium-sulfur battery, a full cell consisting of a Li22Sn5 anode, S cathode, and [Li(G4)][TFSA]/HFE electrolyte was fabricated. The cell was discharged and charged stably without severe side reactions. The dissolution of lithium polysulfides, reaction intermediates with the sulfur cathode, was effectively suppressed in the electrolyte, leading to efficient charge-discharge cycling of the Li22Sn5-S cell. (C) The Electrochemical Society of Japan, All rights reserved.	[Ikeda, Kohei; Terada, Shoshi; Mandai, Toshihiko; Ueno, Kazuhide; Dokko, Kaoru; Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Watanabe, M (reprint author), Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	mwatanab@ynu.ac.jp	Dokko, Kaoru/A-4005-2013	Dokko, Kaoru/0000-0002-9622-4345	Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); KAKENHI from the Japan Society for the Promotion of Science (JSPS) [15H03874, 15K13815]	This study was supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) and by KAKENHI (No. 15H03874 and No. 15K13815) from the Japan Society for the Promotion of Science (JSPS). The authors thank Prof. M. Tatsumisago, Prof. A. Hayashi, and Mr. N. Tanibata (Osaka Prefecture University) for their kind advice in preparing Li<INF>22</INF>Sn<INF>5</INF>.	Dunlap RA, 1999, J ALLOY COMPD, V289, P135, DOI 10.1016/S0925-8388(99)00165-6; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; Mikhaylik YV, 2004, J ELECTROCHEM SOC, V151, pA1969, DOI 10.1149/1.1806394; Ueno K, 2015, PHYS CHEM CHEM PHYS, V17, P8248, DOI 10.1039/c4cp05943c; Angell CA, 2012, FARADAY DISCUSS, V154, P9, DOI 10.1039/c1fd00112d; Yamaki J, 1998, J POWER SOURCES, V74, P219, DOI 10.1016/S0378-7753(98)00067-6; Henderson WA, 2005, CHEM MATER, V17, P2284, DOI 10.1021/cm047881j; Tachikawa N, 2011, CHEM COMMUN, V47, P8157, DOI 10.1039/c1cc12415c; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Ueno K, 2012, J PHYS CHEM B, V116, P11323, DOI 10.1021/jp307378j; WANG JQ, 1986, J ELECTROCHEM SOC, V133, P457, DOI 10.1149/1.2108601; Robert F, 2006, HYPERFINE INTERACT, V167, P797, DOI 10.1007/s10751-006-9360-z; Pappenfus TM, 2004, J ELECTROCHEM SOC, V151, pA209, DOI 10.1149/1.1635384; Robert F, 2007, J SOLID STATE CHEM, V180, P339, DOI 10.1016/j.jssc.2006.10.026; Yoshida K, 2011, J AM CHEM SOC, V133, P13121, DOI 10.1021/ja203983r; Mandai T, 2014, PHYS CHEM CHEM PHYS, V16, P8761, DOI 10.1039/c4cp00461b; Wen JW, 2012, MATER EXPRESS, V2, P197, DOI 10.1166/mex.2012.1075; Tamura T, 2010, CHEM LETT, V39, P753, DOI 10.1246/cl.2010.753; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Beaulieu LY, 2003, J ELECTROCHEM SOC, V150, pA419, DOI 10.1149/1.1556595	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					914	917		10.5796/electrochemistry.83.914		4	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800034		
J	Yamagata, M; Tanaka, K; Tsuruda, Y; Sone, Y; Fukuda, S; Nakasuka, S; Kono, M; Ishikawa, M				Yamagata, Masaki; Tanaka, Kohei; Tsuruda, Yoshihiro; Sone, Yoshitsugu; Fukuda, Seisuke; Nakasuka, Shinichi; Kono, Michiyuki; Ishikawa, Masashi			The First Lithium-ion Battery with Ionic Liquid Electrolyte Demonstrated in Extreme Environment of Space	ELECTROCHEMISTRY			English	Article						Lithium-ion Battery; Ionic Liquids; Bis(fluorosulfonyl)imide; Space Application	GRAPHITE NEGATIVE ELECTRODE; MARS EXPLORATION ROVER; SECONDARY BATTERY; PERFORMANCE; FUTURE; ANODE; SALT; INTERCALATION; LUBRICANT; OPERATION	A prototype lithium-ion battery with a bis(fluorosulfonyl)imide (FSI)-based ionic liquid electrolyte was developed. The prototype was mounted on a demonstration module of the "Hodoyoshi-3" microsatellite, which was successfully launched on June 20, 2014. Qualification tests for space application, including radiation tolerance and vacuum tests, revealed negligible degradation of the ionic liquid-based lithium-ion battery (IL-LIB) cell. According to the flight data, the IL-LIB cell can exist stably in an ultra-high vacuum environment despite its thin and flexible pouch casing without any rigid anti-vacuum reinforcements. Furthermore, the power unit showed the same charge-discharge performance as that predicted by the charge-discharge behavior of an identical cell on the ground, suggesting that the IL-LIB cell maintains performance in high vacuum a microgravity environment. These results prove that LIB cells with FSI-based ionic liquids can be used as a power source for space applications. (C) The Electrochemical Society of Japan, All rights reserved.	[Yamagata, Masaki; Ishikawa, Masashi] Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan; [Yamagata, Masaki; Kono, Michiyuki; Ishikawa, Masashi] IElectrolyte LLC, Grand Front Osaka, Kita Ku, Osaka 5300011, Japan; [Tanaka, Kohei; Sone, Yoshitsugu] Grad Univ Adv Studies, SOKENDAI, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tsuruda, Yoshihiro; Nakasuka, Shinichi] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Sone, Yoshitsugu; Fukuda, Seisuke] Inst Space & Astronaut Sci, JAXA, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Yamagata, M (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	yamagata@kansai-u.ac.jp	Yamagata, Masaki/A-7501-2012	Yamagata, Masaki/0000-0001-7565-8251	Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy	Part of this work, including the installation of the IL-LIB cell in the "Hodoyoshi-3" satellite and its operation in orbit, was supported by the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy.	Van Mierlo J, 2007, FUEL CELLS, V7, P165, DOI 10.1002/fuce.200600052; Zheng HH, 2006, CARBON, V44, P203, DOI 10.1016/j.carbon.2005.07.038; Matsui Y, 2015, J POWER SOURCES, V279, P766, DOI 10.1016/j.jpowsour.2015.01.070; Shkrob IA, 2012, J PHYS CHEM B, V116, P9043, DOI 10.1021/jp302151c; Sone Y, 2007, ELECTROCHEMISTRY, V75, P950; Ratnakumar BV, 2003, J POWER SOURCES, V119, P906, DOI 10.1016/S0378-7753(03)00220-9; Sato T, 2004, J POWER SOURCES, V138, P253, DOI 10.1016/j.jpowsour.2004.06.027; Yamagata M, 2013, ELECTROCHIM ACTA, V110, P181, DOI 10.1016/j.electacta.2013.03.018; Wagner FT, 2010, J PHYS CHEM LETT, V1, P2204, DOI 10.1021/jz100553m; Matsui Y, 2012, ELECTROCHEMISTRY, V80, P808, DOI 10.5796/electrochemistry.80.808; Seki S, 2006, CHEM COMMUN, P544, DOI 10.1039/b514681j; Yamagata M, 2013, ELECTROCHEMISTRY, V81, P857, DOI 10.5796/electrochemistry.81.857; Barnsley MJ, 2004, IEEE T GEOSCI REMOTE, V42, P1512, DOI 10.1109/TGRS.2004.827260; Sugimoto T, 2010, J POWER SOURCES, V195, P6153, DOI 10.1016/j.jpowsour.2010.01.011; Yamagata M, 2013, J POWER SOURCES, V227, P60, DOI 10.1016/j.jpowsour.2012.11.013; Sugimoto T, 2008, J POWER SOURCES, V183, P436, DOI 10.1016/j.jpowsour.2008.05.036; Singh RP, 2006, ANGEW CHEM INT EDIT, V45, P3584, DOI 10.1002/anie.200504236; Chakrapani V, 2011, J PHYS CHEM C, V115, P22048, DOI 10.1021/jp207605w; Smiglak M, 2007, ACCOUNTS CHEM RES, V40, P1182, DOI 10.1021/ar7001304; Shkrob IA, 2011, J PHYS CHEM B, V115, P3872, DOI 10.1021/jp2003062; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Reiter J, 2012, ELECTROCHIM ACTA, V71, P22, DOI 10.1016/j.electacta.2012.03.088; Wakihara M, 2001, MAT SCI ENG R, V33, P109, DOI 10.1016/S0927-796X(01)00030-4; Darcy E, 2007, J POWER SOURCES, V174, P575, DOI 10.1016/j.jpowsour.2007.06.245; Bermudez MD, 2009, MOLECULES, V14, P2888, DOI 10.3390/molecules14082888; Seki S, 2005, ELECTROCHEM SOLID ST, V8, pA577, DOI 10.1149/1.2041330; Uno M, 2011, J POWER SOURCES, V196, P8755, DOI 10.1016/j.jpowsour.2011.06.051; Shkrob IA, 2007, J PHYS CHEM B, V111, P11786, DOI 10.1021/jp073619x; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; Ratnakumar BV, 2006, J POWER SOURCES, V159, P1428, DOI 10.1016/j.jpowsour.2005.11.085; SCROSATI B, 1995, NATURE, V373, P557, DOI 10.1038/373557a0; CARLIN RT, 1994, J ELECTROCHEM SOC, V141, pL21, DOI 10.1149/1.2054823; Chiu Y.-H., 2007, ACM S SERIES IONIC L, VIV, P138; Enokuchi A., 2010, P SOC PHOTO-OPT INS, V7862, DOI 10.II17/12.869499; Galinski M, 2006, ELECTROCHIM ACTA, V51, P5567, DOI 10.1016/j.electacta.2006.03.016; Holzapfel M, 2004, CHEM COMMUN, P2098, DOI 10.1039/b407526a; Kamal F, 2011, APPLICATIONS OF IONIC LIQUIDS IN SCIENCE AND TECHNOLOGY, P447; Koura N, 2001, CHEM LETT, P1320; Maeda K., 2014, GEOSC REM SENS S IGA, P3630, DOI [10.1109/IGARSS. 2014.6947269, DOI 10.1109/IGARSS.2014.6947269]; MEGAHED S, 1994, J POWER SOURCES, V51, P79, DOI 10.1016/0378-7753(94)01956-8; Nadherna M, 2011, J POWER SOURCES, V196, P7700, DOI 10.1016/j.jpowsour.2011.04.033; Naito H., 2012, IEICE TECHNICAL REPO, V111, P9; Pearson C., 2005, 3 RESP SPAC C LOS AN; Punning A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06913; Ratnakumar B. V., 2005, 3 INT EN CONV ENG C; Sane Y., 2007, ELECTROCHEMISTRY, V75, P518; Shiraishi H., 2008, ADV SPACE RES, V42, P386; Smart M. C., 2002, J ELECTROCHEM SOC, V149, pA361; Somers AE, 2013, LUBRICANTS, V1, P3, DOI DOI 10.3390/LUBRICANTS1010003; Vreeke M. S., 1998, J ELECTROCHEM SOC, V145, P3668; Ye CF, 2001, CHEM COMMUN, P2244, DOI 10.1039/b106935g	51	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2015	83	10					918	924		10.5796/electrochemistry.83.918		7	Electrochemistry	Electrochemistry	CT3GS	WOS:000362695800035		
J	Yang, WJ; Hu, JH; Uemura, A; Tetzlaff, F; Augustin, HG; Fischer, A				Yang, Wan-Jen; Hu, Junhao; Uemura, Akiyoshi; Tetzlaff, Fabian; Augustin, Hellmut G.; Fischer, Andreas			Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis	EMBO MOLECULAR MEDICINE			English	Article						angiogenesis; semaphorin; retinopathy of prematurity; Sema3C	ENDOTHELIAL GROWTH-FACTOR; SPROUTING ANGIOGENESIS; VASCULAR DEVELOPMENT; TYROSINE KINASE; CELL-MIGRATION; GLIOMA-CELLS; TUMOR-CELLS; VEGF; CANCER; MICE	Retinopathy of prematurity causes visual impairment due to destructive neoangiogenesis after degeneration of the retinal microvasculature. This study was aimed at analyzing whether local delivery of Semaphorin-3C (Sema3C) suppresses pathological retinal angiogenesis. Sema3C exerted potent inhibiting effects in cellular models of angiogenesis. In an endothelial cell xenotransplantation assay, Sema3C acted primarily on immature microvessels by inducing endothelial cell apoptosis. Intravitreal administration of recombinant Sema3C disrupted endothelial tip cell formation and cell-cell contacts, which led to decreased vascular bed expansion and vessel branching in the growing retinal vasculature of newborn mice, while not affecting mature vessels in the adult retina. Sema3C administration strongly inhibited the formation of pathological pre-retinal vascular tufts during oxygen-induced retinopathy. Mechanistically, Sema3C signaled through the receptors Neuropilin-1 and PlexinD1, which were strongly expressed on vascular tufts, induced VE-cadherin internalization, and abrogated vascular endothelial growth factor (VEGF)-induced activation of the kinases AKT, FAK, and p38MAPK. This disrupted endothelial cell junctions, focal adhesions, and cytoskeleton assembly resulted in decreased cell migration and survival. Thus, this study identified Sema3C as a potent and selective inhibitor of pathological retinal angiogenesis.	[Yang, Wan-Jen; Tetzlaff, Fabian; Fischer, Andreas] German Canc Res Ctr, DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, Heidelberg, Germany; [Yang, Wan-Jen; Augustin, Hellmut G.; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim CBTM, Vasc Biol & Tumor Angiogenesis, Mannheim, Germany; [Hu, Junhao; Augustin, Hellmut G.] German Canc Res Ctr, DKFZ ZMBH Alliance, Vasc Oncol & Metastasis A190, Heidelberg, Germany; [Uemura, Akiyoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Retinal Vasc Biol, Nagoya, Aichi, Japan; [Fischer, Andreas] Heidelberg Univ, Dept Med & Clin Chem, Heidelberg, Germany	Fischer, A (reprint author), German Canc Res Ctr, DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, Heidelberg, Germany.	a.fischer@dkfz-heidelberg.de			Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum; Israel's Ministry of Science, Technology and Space; Deutsche Forschungsgemeinschaft [SFB-TR23]; Deutsche Krebshilfe; endowed Chair from the Aventis Foundation	We thank Iris Moll and Shuntaro Ogura for excellent technical assistance and Prof. Dr. Hans-Peter Hammes (5th Medical Clinic Mannheim, Heidelberg University, Germany) for help with the OIR model. Prof. Dr. Dietmar Vestweber (MPI Munster, Germany) kindly provided the VE-Cadherin-GFP expression vector. This work was supported by grants of the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum and Israel's Ministry of Science, Technology and Space (to A.F.); the Deutsche Forschungsgemeinschaft (SFB-TR23 to A.F. and H.G.A.), and the Deutsche Krebshilfe (to A.F.). HGA is supported by an endowed Chair from the Aventis Foundation.	Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Ruediger T, 2013, CEREB CORTEX, V23, P604, DOI 10.1093/cercor/bhs044; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Reidy K, 2011, PEDIATR NEPHROL, V26, P1407, DOI 10.1007/s00467-011-1769-1; Mutlu FM, 2013, INT J OPHTHALMOL-CHI, V6, P228, DOI 10.3980/j.issn.2222-3959.2013.02.23; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Feiner L, 2001, DEVELOPMENT, V128, P3061; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Brown CB, 2001, DEVELOPMENT, V128, P3071; Parker MW, 2013, J MOL BIOL, V425, P4405, DOI 10.1016/j.jmb.2013.07.017; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Franco M, 2008, EMBO REP, V9, P865, DOI 10.1038/embor.2008.139; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Martin-Satue M, 1999, J SURG ONCOL, V72, P18; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Esselens C, 2010, J BIOL CHEM, V285, P2463, DOI 10.1074/jbc.M109.055129; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Barakat MR, 2009, EXPERT OPIN INV DRUG, V18, P637, DOI [10.1517/13543780902855316 , 10.1517/13543780902855316]; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Maione F, 2012, J CLIN INVEST, V122, P1832, DOI 10.1172/JCI58976; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Gross-Thebing T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0055-7; LesGuelte A, 2012, J CELL SCI, V125, P4137; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Roodink I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-297	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	OCT	2015	7	10					1267	1284				18	Medicine, Research & Experimental	Research & Experimental Medicine	CS9MA	WOS:000362414000006		
J	Kishimoto-Yamada, K; Itioka, T				Kishimoto-Yamada, Keiko; Itioka, Takao			How much have we learned about seasonality in tropical insect abundance since Wolda (1988)?	ENTOMOLOGICAL SCIENCE			English	Review						abundance fluctuations; aseasonality; diapause; life cycles; light trapping; population dynamics; tropical arthropods	LOWLAND DIPTEROCARP FOREST; BORNEAN RAIN-FOREST; FRUIT-FEEDING BUTTERFLIES; PAPUA-NEW-GUINEA; POPULATION-DYNAMICS; PANAMANIAN FOREST; SPECIES-DIVERSITY; SARAWAK; FLUCTUATIONS; COMMUNITY	Seasonal patterns in climatic conditions affect the life cycles and temporal patterns in the abundance of most temperate insect species. In tropical regions where there is no winter season, the situation may be different. For a better understanding of the evolution of seasonal life cycles, and the dynamics affecting temporal patterns in abundance of tropical insect populations and assemblages, it is important to study the life cycles of tropical insects and the presence or absence of seasonality in relation to climatic conditions. By reviewing studies on temporal patterns of abundance, this article examines the patterns of seasonality in adult tropical forest insects and discusses the variation in such patterns in various forest types. Seasonal and aseasonal patterns were found to be common in tropical dry and wet regions, respectively. In wet regions, which lack a distinctive dry season, there exists a wide variety of temporal patterns in addition to aseasonal patterns: distinctively seasonal and supra-annual fluctuations in some insect species. Some of the problems of hidden ecological mechanisms underlying seasonal patterns in abundance are discussed, and the definition of seasonality in temporal patterns of insect abundance at a particular stage in the life cycle is considered. Methodological problems are also discussed.	[Kishimoto-Yamada, Keiko] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Kishimoto-Yamada, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Ito Motomi Lab,Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	kky_kei@yahoo.co.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan [21255004, 23-6333]	This study was partly supported by Grants-in-Aid (no. 21255004 to T.I. and no. 23-6333 to K.K-Y. for JSPS fellows) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan.	Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633; Michel B, 2009, AFR J ECOL, V47, P670, DOI 10.1111/j.1365-2028.2008.01019.x; Itioka T, 2004, J TROP ECOL, V20, P479, DOI 10.1017/S0266467404001658; Devries PJ, 2001, BIOL J LINN SOC, V74, P1, DOI 10.1006/bijl.2001.0571; FRITH D, 1990, BIOTROPICA, V22, P181, DOI 10.2307/2388411; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Raimondo S, 2004, ENVIRON ENTOMOL, V33, P418; Ribeiro DB, 2011, BIOL J LINN SOC, V104, P820, DOI 10.1111/j.1095-8312.2011.01771.x; Noguera FA, 2002, ANN ENTOMOL SOC AM, V95, P617, DOI 10.1603/0013-8746(2002)095[0617:DOTFCC]2.0.CO;2; Grotan V, 2012, J ANIM ECOL, V81, P714, DOI 10.1111/j.1365-2656.2011.01950.x; Kishimoto-Yamada K, 2013, INSECT CONSERV DIVER, V6, P179, DOI 10.1111/j.1752-4598.2012.00201.x; Wolda H, 1996, P K NED AKAD WETENSC, V99, P313; WOLDA H, 1986, ECOLOGY, V67, P426, DOI 10.2307/1938586; MASAKI S, 1980, ANNU REV ENTOMOL, V25, P1, DOI 10.1146/annurev.en.25.010180.000245; GODFRAY HCJ, 1987, NATURE, V327, P144, DOI 10.1038/327144a0; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; DENLINGER DL, 1991, OECOLOGIA, V87, P152, DOI 10.1007/BF00323793; Ichie T, 2004, J TROP ECOL, V20, P697, DOI 10.1017/S0266467404001713; WOLDA H, 1985, J ANIM ECOL, V54, P519, DOI 10.2307/4496; Tidon R, 2006, BIOL J LINN SOC, V87, P233, DOI 10.1111/j.1095-8312.2006.00570.x; WOLDA H, 1981, ECOL ENTOMOL, V6, P99, DOI 10.1111/j.1365-2311.1981.tb00976.x; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239; Itioka T, 2001, ANN ENTOMOL SOC AM, V94, P545, DOI 10.1603/0013-8746(2001)094[0545:SYPFOT]2.0.CO;2; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1; Van Bael SA, 2004, J TROP ECOL, V20, P625, DOI 10.1017/S0266467404001725; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Intachat J, 2001, J TROP ECOL, V17, P411; GODFRAY HCJ, 1989, J ANIM ECOL, V58, P153, DOI 10.2307/4992; Momose K, 1998, AM J BOT, V85, P1477, DOI 10.2307/2446404; Kishimoto-Yamada K, 2008, BIOTROPICA, V40, P600, DOI 10.1111/j.1744-7429.2008.00410.x; Wiwatwitaya D, 2005, ECOL RES, V20, P59, DOI 10.1007/s11284-004-0013-x; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Kato M, 2000, POPUL ECOL, V42, P97, DOI 10.1007/s101440050014; Slaa EJ, 2006, INSECT SOC, V53, P70, DOI 10.1007/s00040-005-0837-6; Burgess ND, 1999, AFR J ECOL, V37, P355, DOI 10.1046/j.1365-2028.1999.00188.x; Yule CM, 1996, ARCH HYDROBIOL, V137, P95; WOLDA H, 1978, AM NAT, V112, P1017, DOI 10.1086/283344; FRITH CB, 1985, AUST J ECOL, V10, P237, DOI 10.1111/j.1442-9993.1985.tb00886.x; TANAKA S, 1987, PHYSIOL ENTOMOL, V12, P213, DOI 10.1111/j.1365-3032.1987.tb00744.x; WOLDA H, 1992, OECOLOGIA, V89, P47, DOI 10.1007/BF00319014; MURALI KS, 1993, OECOLOGIA, V94, P114, DOI 10.1007/BF00317311; Kishimoto-Yamada K, 2010, INSECT CONSERV DIVER, V3, P266, DOI 10.1111/j.1752-4598.2010.00099.x; WOLDA H, 1979, RES POPUL ECOL, V20, P247, DOI 10.1007/BF02512630; Kishimoto-Yamada K, 2009, B ENTOMOL RES, V99, P217, DOI 10.1017/S000748530800624X; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; WOLDA H, 1989, OECOLOGIA, V80, P437, DOI 10.1007/BF00380064; Novotny V, 1998, OECOLOGIA, V115, P514, DOI 10.1007/s004420050549; DYER FC, 1994, INSECT SOC, V41, P129, DOI 10.1007/BF01240473; PERERA PACR, 1988, B ENTOMOL RES, V78, P479; Kumagai T, 2005, AGR FOREST METEOROL, V128, P81, DOI 10.1016/j.agrformet.2004.08.006; Brown VK, 1983, DIAPAUSE LIFE CYCLE; Danks HV, 1987, INSECT DORMANCY ECOL; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Lawrence J.F., 1991, P543; Levings Sally C., 1996, P355; Noerdjito WA, 1999, TROPICS, V8, P409; Orr AG, 1996, MONOG BIOL, V74, P125; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; RICKLEFS RE, 1975, J NEW YORK ENTOMOL S, V83, P19; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1046/j.1095-8312.2002.00016.x; Smythe N, 1996, ECOLOGY TROPICAL FOR, P319; Souza-Silva Marconi, 2001, Neotropical Entomology, V30, P351, DOI 10.1590/S1519-566X2001000300002; Tauber MJ, 1986, SEASONAL ADAPTATIONS; Whitmore TC, 1984, TROPICAL RAIN FOREST; WOLDA H, 1980, J ANIM ECOL, V49, P277, DOI 10.2307/4289; WOLDA H, 1992, STUD NEOTROP FAUNA E, V27, P91, DOI 10.1080/01650529209360870; Wolda H, 1998, SMITHSONIAN CONTRIBU, V590, P1	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					407	419		10.1111/ens.12134		13	Entomology	Entomology	CT0WF	WOS:000362517800001		
J	Aoki, S; Kutsukake, M; Kurosu, U; Yeh, HT; Sano, M; Fukatsu, T				Aoki, Shigeyuki; Kutsukake, Mayako; Kurosu, Utako; Yeh, Hsin-Ting; Sano, Masakazu; Fukatsu, Takema			Nipponaphis species (Aphididae: Hormaphidinae) that form green galls on Distylium racemosum in Japan	ENTOMOLOGICAL SCIENCE			English	Article						gall aphid; life cycle; molecular phylogeny; Nipponaphidini; taxonomy	HEMIPTERA; HOMOPTERA; TAIWAN	Some species of the aphid genus Nipponaphis (Nipponaphidini) form green, globular or fig-shaped galls on the evergreen Distylium racemosum, their primary host. Molecular phylogenetic analyses of aphid samples collected from both their galls and secondary hosts indicated the occurrence of four species in Japan: N. distychii, N. distyliicola, N. loochooensis and N. machilicola. The four species could also be discriminated from one another in morphology. The name N. litseae turned out to be a junior synonym of N. distychii. Galls formed by N. machilicola are reported for the first time in this paper. The life cycles of the four species are briefly reviewed.	[Aoki, Shigeyuki] Rissho Univ, Fac Econ, Tokyo 1418602, Japan; [Kutsukake, Mayako; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Kurosu, Utako] Chuo Univ, Fac Econ, Hachioji, Tokyo, Japan; [Yeh, Hsin-Ting] Natl Taiwan Univ, Coll Bioresources & Agr, Expt Forest, Nantou, Taiwan; [Sano, Masakazu] Okinawa City Municipal Museum, Okinawa, Japan	Aoki, S (reprint author), Rissho Univ, Fac Econ, Shinagawa Ku, 4-2-16 Osaki, Tokyo 1418602, Japan.	oregma@rb3.so-net.ne.jp			Project for the Survey on the Regional Natural Environment	We thank Kiyoyuki Mizusawa, Shino Tamamori, Morio Tsukada and Keigo Uematsu for their help in collecting materials, and Hajimu Takada and Masahisa Miyazaki for literature. One of the authors (M.S.) was supported by a lump-sum subsidy for the promotion of Okinawa (project name: Project for the Survey on the Regional Natural Environment) in fiscal years 2013 and 2014.	Sano M, 2005, J NAT HIST, V39, P337, DOI 10.1080/00222930410001708614; Kutsukake M, 2009, P R SOC B, V276, P1555, DOI 10.1098/rspb.2008.1628; Aoki S, 2013, ENTOMOL SCI, V16, P203, DOI 10.1111/ens.12002; ITO Y, 1983, APPL ENTOMOL ZOOL, V18, P361; Fukatsu T, 2001, MOL PHYLOGENET EVOL, V18, P423, DOI 10.1006/mpev.2000.0887; Kurosu U, 2003, P ROY SOC B-BIOL SCI, V270, pS12, DOI 10.1098/rsbl.2003.0026; KUROSU U, 1995, J ETHOL, V13, P133, DOI 10.1007/BF02352573; Kurosu U, 2008, ZOOL STUD, V47, P191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Aoki Shigeyuki, 2000, Entomological Science, V3, P481; Aoki S., 2010, Psyche: A Journal of Entomology, V2010, P380351, DOI 10.1155/2010/380351; Blackman R. L., 1994, APHIDS WORLDS TREES; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurosu U., 1998, P235; Kurosu Utako, 2009, Psyche (Cambridge), V2009, P1; Kutsukake M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2187; MATSUMUEA S., 1917, Collection of Essays for Mr. Yasushi Nawa, P39; Monzen K, 1954, ANN REP GAKUGEI FACU, V7, P46; Monzen K, 1934, B SCI RES ALUMNI ASS, V9, P13; Moritsu M, 1983, APHIDS JAPAN COLOR; NISHITANI I, 1991, Japanese Journal of Entomology, V59, P577; Pergande Theo, 1906, Entomological News Philadelphia, V17; Shinji O, 1941, MONOGRAPH JAPANESE A; SORIN MASATO, 1966, BULL UNIV OSAKA PREFECT SER BAGRBIOL, V18, P95; Sorin Masato, 2003, Shokubutsu Boeki, V57, P437; Sorin Masato, 2003, Shokubutsu Boeki, V57, P480; Sorin M, 1977, SINRIN BOEKI, V26, P51; Sorin M, 1960, SEITAIKONCHU, V8, P105; Sorin M., 1958, Akitu Kyoto, V7, P89; Sorin M., 1987, P219; Sorin Masato, 1996, Bulletin of Kogakkan University, V35, P235; TACHIKAWA TETSUSABURO, 1963, MEM EHIME UNIV SECT VI [AGR], V9, P1; TAKAHASHI RYOICHI, 1962, BULL UNIV OSAKA PREFECT SER B AGRIC AND BIOL, V13, P1; Takahashi R., 1958, Akitu Kyoto, V7, P87; Takahashi R., 1959, Akitu Kyoto, V8, P47; Takahashi R, 1921, SPECIAL REPORT, V20, P1; Togashi I, 2007, NEW ENTOMOLOGIST, V56, P15; Yoshitomi H, 2014, ROSTRIA, V56, P9; Yukawa J, 1996, INSECT MITE GALLS JA	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					420	434		10.1111/ens.12144		15	Entomology	Entomology	CT0WF	WOS:000362517800002		
J	Nakatani, Y				Nakatani, Yukinobu			Revision of the lygaeid genus Nysius (Heteroptera: Lygaeidae: Orsillinae) of Japan, with description of a new species	ENTOMOLOGICAL SCIENCE			English	Article						cytochrome oxidase subunit I; DNA barcoding; genital structure; key; taxonomy		Japanese species of the lygaeid-orsilline genus Nysius were revised, and five species including a new species, N.hidakai, were recognized. Male and female genitalia of all the species were illustrated, and a key to species of Japanese Nysius was provided. The DNA barcoding information of each species except N.expressus were recorded.	Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan	Nakatani, Y (reprint author), Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	nakatany@affrc.go.jp			JSPS KAKENHI [25292034, 24710038]	I would particularly like to thank the late Syoiti Miyamoto who gave me valuable advice on the study of the group. I am deeply grateful to Tomohide Yasunaga (American Museum of Natural History), who gave me suggestions and encouragement. I express my gratitude to Masahisa Miyazaki (NIAES) who gave us helpful support in this study and thank Mick Webb (BMNH) for his generous permission to examine identified specimens including type series of Nysius species. I appreciate the assistance of Eri Tanaka (NIAES) with DNA experiments. I am indebted to the late Shin Gotoh, Masaaki Tomokuni (NSMT), Toshiya Hirowatari (ELKU), Takeshi Osawa (NIAES), Teruaki Ban (Osaka City) and Ichiro Taniyama (Ise City) for their support in examining materials. This research was in part supported by JSPS KAKENHI Grant Number 25292034 and 24710038.	Nakatani Yukinobu, 2012, Rostria, V54, P51; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Malipatil MB, 2010, ZOOTAXA, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Ashlock PD, 1967, U CALIF PUBL ENTOMOL, V48, P1; Barber HG, 1958, INSECTS MICRONESIA, V7, P173; Distant WL, 1883, T ENTOMOLOGICAL SOC, V1883, P413; Distant WL, 1920, ANN MAGAZINE NATURAL, V9, P143; Esaki T, 1950, ICONOGRAPHIA INSECTO, P179; Hebert HDN, 2003, P ROYAL SOC B, V270, P313; Hidaka T, 1965, ICONOGRAPHIA INSECTO, P85; MATSUMURA S., 1931, 6000 ILLUSTRATED INS; Matsuura Y, 2011, ISME J, V2011, P1; Miyamoto S., 1989, CHECK LIST JAPANESE, VI, P151; Nakatani Y, 2013, FIELD GUIDE JAPANESE, V3, P373; Pericart J., 2001, CATALOGUE HETEROPTER, V4, P35; Vinokurov NN, 1988, OPREDELITEL NASEKOMY, V2, P891; Yasunaga T, 1993, FIELD GUIDE JAPANESE	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					435	441		10.1111/ens.12141		7	Entomology	Entomology	CT0WF	WOS:000362517800003		
J	Liu, XY; Hayashi, F; Yang, D				Liu, Xingyue; Hayashi, Fumio; Yang, Ding			New species of alderfly genus Sialis (Megaloptera: Sialidae) from China and Vietnam, with a key to species of Sialis from Asia	ENTOMOLOGICAL SCIENCE			English	Article						distribution; East Asia; Neuropterida; taxonomy	CORYDALIDAE; PHYLOGENY; INSECTA	The alderfly genus Sialis is the most species-rich group of the family Sialidae. However, discovery of new Sialis species is becoming difficult because of previous good faunal exploration. In this paper, we describe two new Sialis species from the southern part of East Asia, S.australis and S.jiyuni, based on materials from historical and recent collections. These two species are closely related to the insular species S.kumejimae and are among the early diverged species within Sialis. Presently, 32 species of Sialis are recorded from Asia. A key to all the Sialis species from Asia is provided.	[Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Hayashi, Fumio] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan	Liu, XY (reprint author), China Agr Univ, Dept Entomol, Yuanmingyuanxilu 2, Beijing 100193, Peoples R China.	xingyue_liu@yahoo.com			National Natural Science Foundation of China [31322501, 31320103902];  [20-08417]	We thank Mr JI Yun (Beijing) for kindly giving us the specimens and photos. We are also grateful to Mr David Goodger (London) for the loan of specimens. This research was supported by the National Natural Science Foundation of China (Nos. 31322501 and 31320103902) and a grant-in-aid for fellows of the Japan Society for the Promotion of Science (JSPS) relating to the JSPS Postdoctoral Fellowship for Foreign Researchers (No. 20-08417).	Liu XY, 2006, SYST ENTOMOL, V31, P652, DOI 10.1111/j.1365-3113.2006.00346.x; Liu XY, 2009, ZOOTAXA, P64; Aspock U, 2008, SYST ENTOMOL, V33, P97; Liu XY, 2011, ENTOMOL NEWS, V122, P265; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Liu XY, 2006, ZOOTAXA, P23; HAYASHI F, 1995, AQUAT INSECT, V17, P1, DOI 10.1080/01650429509361564; Liu XY, 2006, ENTOMOL SCI, V9, P399, DOI 10.1111/j.1479-8298.2006.00186.x; Liu XY, 2006, ENTOMOL FENNICA, V17, P394; Aspock H, 1980, NEUROPTEREN EUROPAS; Aspoeck Horst, 2001, Denisia, V2, P1; Hayashi Fumio, 1997, Japanese Journal of Entomology, V65, P813; Jung SW, 2012, ENTOMOLOGICAL REB, V28, P3; KUWAYAMA SATORU, 1962, PACIFIC INSECTS, V4, P325; Latreille P. A., 1802, HIST NATURELLE GEN P, V3; Linnaeus C., 1758, SYSTEMA NATURAE REGN; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040345; Liu XY, 2015, CLADISTICS, V31, P18, DOI 10.1111/cla.12071; Okamoto H., 1910, WIENER ENTOMOLOGISCH, V29, P255; Ross HH, 1937, B ILLINOIS NATURAL H, V21, P57; Thomas O, 1925, P BIOL SOC LONDON, V1925, P500; VSHIVKOVA T S, 1985, Entomologicheskoe Obozrenie, V64, P146; Vshivkova TS, 1980, INSECTS MONGOLIA, P283; Vshivkova TS, 1979, SYSTEMATICS ECOLOGY, P78; Vshivkova T.S., 1980, P75; Yang D., 2010, FAUNA SINICA INSECTA, V51	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					452	460		10.1111/ens.12142		9	Entomology	Entomology	CT0WF	WOS:000362517800005		
J	Kim, W; Matsunaga, K; Gyoutoku, N; Matsuo, K; Minami, T; Yukawa, J				Kim, Wanggyu; Matsunaga, Kiyoko; Gyoutoku, Naohisa; Matsuo, Kazunori; Minami, Tsuneo; Yukawa, Junichi			Life history strategy and adult and larval behavior of Macrodiplosis selenis (Diptera: Cecidomyiidae), a species that induces leaf-margin fold galls on deciduous Quercus (Fagaceae)	ENTOMOLOGICAL SCIENCE			English	Article						age structure; gall density; mean crowding; oviposition; parasitoid wasp; spatial distribution	HOST-PLANT PHENOLOGY; MIDGE; SYNCHRONIZATION; LAURACEAE	Life historical, behavioral and ecological traits of Macrodiplosis selenis, which induces leaf-margin fold galls on Quercus serrata, Q.mongolica and Q.dentata (Fagaceae) in Japan and South Korea, were studied. Daily activity and larval development indicate that M.selenis is a diurnal and univoltine gall midge. In April, females lay their eggs both on upper and under surfaces of fresh leaves. The duration of the egg stage varies from 5 to 9 days, depending on daily temperatures. Hatched larvae crawl to the upper surface of the leaf margin, where they start to induce galls. Larvae become full-grown in October, drop to the ground in November and overwinter in cocoons on the ground, while larvae of congeners mature in May and drop to the ground in June. A relatively long period of the second larval stadium from July to October on the host trees seems to be effective for M.selenis in avoiding summer mortalities caused by predation and aridity on the ground and by ectoparasitoids that attack mature larvae or pupae on the host leaves. The spatial distribution pattern of M.selenis leaf galls is contagious and the mean gall density per leaf is significantly correlated with the mean crowding. This study adds new insights of life history strategy and adult and larval behavioral pattern to the ecological knowledge of gall midges, and these kinds of information are essential for further studies of M.selenis population dynamics and interactions with other Quercus-associated herbivores.	[Kim, Wanggyu; Matsuo, Kazunori; Yukawa, Junichi] Kyushu Univ, Fac Agr, Entomol Lab, Fukuoka 8128581, Japan	Kim, W (reprint author), Kyushu Univ, Fac Agr, Entomol Lab, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	kincho3@gmail.com					Alford DV, 2012, PESTS ORNAMENTAL TRE, P398; Tokuda M, 2008, ZOOL SCI, V25, P533, DOI 10.2108/zsj.25.533; Skuhrava M, 1998, US FOR SERV T R NC, V199, P1; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; IWAO S, 1977, Researches on Population Ecology (Tokyo), V18, P243, DOI 10.1007/BF02510851; Yukawa J, 2003, B ENTOMOL RES, V93, P73, DOI 10.1079/BER2002218; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Yukawa J, 2013, ENTOMOL SCI, V16, P400, DOI 10.1111/ens.12024; Kim W, 2014, ZOOTAXA, V3821, P222, DOI 10.11646/zootaxa.3821.2.3; Hinz HL, 1998, ENVIRON ENTOMOL, V27, P1537; Tokuda M, 2012, ENTOMOL SCI, V15, P361, DOI 10.1111/j.1479-8298.2012.00539.x; Yukawa J, 2006, POPUL ECOL, V48, P13, DOI 10.1007/s10144-005-0233-0; Mishima M, 2014, ANN ENTOMOL SOC AM, V107, P789, DOI 10.1603/AN13125; Barnes HF, 1930, P ZOOL SOC LOND, V2, P381; Buhl Peter Neerup, 2001, Entomologiske Meddelelser, V69, P113; Fulmek L., 1968, Beitraege zur Entomologie, V18, P719; Gagne R. J., 1989, PLANT FEEDING GALL M; Iwao S., 1968, Researches on Population Ecology Kyoto University, V10, P1, DOI 10.1007/BF02514729; KOLESIK P, 1993, J APPL ENTOMOL, V116, P371; Nijveldt W. C., 1982, Bulletin of the Kitakyushu Museum of Natural History, V4, P23; Ohno K, 1984, KONTYU, V53, P427; Redfern M., 2002, BRIT PLANT GALLS IDE; ROSKAM J C, 1986, Tijdschrift voor Entomologie, V129, P125; Sato Shinsuke, 2004, Esakia, V44, P13; Skuhrava Marcela, 2006, Entomologiske Meddelelser, V74, P1; SUNOSE T, 1983, Kontyu, V51, P29; Tokuda M, 2004, ANN ENTOMOLOGICAL SO, V97, P954; Tsunekawa A, 2003, SATOYAMA TRADITIONAL, P51; Uechi N, 2006, Galling Arthropods and Their Associates: Ecology and Evolution, P275, DOI 10.1007/4-431-32185-3_24; Yamagishi K., 1980, Esakia, V15, P161; YUKAWA J, 1987, Kontyu, V55, P123; YUKAWA J, 1974, Kontyu, V42, P293; YUKAWA J, 1976, Kontyu, V44, P358; Yukawa J, 1996, INSECT MITE GALLS JA; Yukawa J, 1995, NATURE OF KAGOSHIMA, V21, P15; Yukawa J, 2011, ENTOMOLOGICAL SCI, V15, P81; YUKAWA J, 1976, Kontyu, V44, P159; YUKAWA J, 1988, Kontyu, V56, P365; Yukawa Junichi, 1994, Japanese Journal of Entomology, V62, P709; Yukawa J., 2005, BIOL ECOLOGY EVOLUTI, V1, P273; Yukawa J., 1987, Phytophaga, V1, P121	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					470	478		10.1111/ens.12138		9	Entomology	Entomology	CT0WF	WOS:000362517800007		
J	Noriyuki, S; Osawa, N				Noriyuki, Suzuki; Osawa, Naoya			Geographic variation of color polymorphism in two sibling ladybird species, Harmonia yedoensis and H.axyridis (Coleoptera: Coccinellidae)	ENTOMOLOGICAL SCIENCE			English	Article						body color; generalist; geographical cline; melanism; Mullerian mimicry; specialist	REPRODUCTIVE INTERFERENCE; ADALIA-BIPUNCTATA; THERMAL MELANISM; GENE FLOW; AXYRIDIS; SELECTION; BEETLE; DIVERSITY; EVOLUTION; MIMICRY	Geographical variation of elytra color pattern in two sibling ladybird species, Harmonia yedoensis and H.axyridis (Coleoptera: Coccinellidae), was examined. The two species are distributed sympatrically in central Japan; however, only H.yedoensis and H.axyridis occur in the Ryukyu Islands (southern Japan) and Hokkaido island (northern Japan), respectively. The frequency of elytra color patterns was significantly different between the two species in all sympatric locations and our results were inconsistent with the classical theory on Mullerian mimicry. The most dominant pattern of H.axyridis was the least dominant of H.yedoensis in all sympatric populations. Furthermore, the frequency of the non-melanic form (red ground color with or without black spots) increased towards the south in H.yedoensis. This tendency was in contrast to the known geographical cline in H.axyridis in which the melanic form (black ground color with red spots) was gradually displaced with the non-melanic form northwards in the Japanese archipelago. We discuss possible selective factors including predator avoidance, thermal adaptation and reproductive character displacement, all of which might contribute to the maintenance of the color polymorphism in the two Harmonia species.	[Noriyuki, Suzuki] Rissho Univ, Fac Geoenvironm Sci, Dept Environm Syst, Kumagaya, Saitama 3600194, Japan; [Osawa, Naoya] Kyoto Univ, Grad Sch Agr, Lab Forest Ecol, Kyoto, Japan	Noriyuki, S (reprint author), Rissho Univ, Fac Geoenvironm Sci, Dept Environm Syst, 1700 Magechi, Kumagaya, Saitama 3600194, Japan.	fvgnoriyuki@gmail.com			Japan Society for the Promotion of Science [24-3112, 26840137, 26650154, 20405047, 24255013]	We thank Dr Yasunori Maezono for insect sampling, Dr Yukie Kajita for helpful comments on the manuscript, and staff at the Botanical Garden of Kyoto University and the University of Tokyo Tanashi Forest for permission to collect insects. This study was supported by the Japan Society for the Promotion of Science to S Noriyuki (No. 24-3112, No. 26840137 and No. 26650154) and to N Osawa (No. 20405047 and No. 24255013).	Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Noriyuki S, 2011, ECOL ENTOMOL, V36, P282, DOI 10.1111/j.1365-2311.2011.01270.x; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Forsman A, 2002, EVOLUTION, V56, P349; SLATKIN M, 1973, GENETICS, V75, P733; O'Hara RB, 2005, P ROY SOC B-BIOL SCI, V272, P211, DOI 10.1098/rspb.2004.2929; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; BRAKEFIELD PM, 1985, HEREDITY, V54, P9, DOI 10.1038/hdy.1985.3; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; OSAWA N, 1992, HEREDITY, V69, P297; Tynkkynen K, 2004, J EVOLUTION BIOL, V17, P759, DOI 10.1111/j.1420-9101.2004.00733.x; STEWART LA, 1989, FUNCT ECOL, V3, P165, DOI 10.2307/2389297; Noriyuki S, 2012, J ANIM ECOL, V81, P1077, DOI 10.1111/j.1365-2656.2012.01984.x; Ueno H, 1998, FUNCT ECOL, V12, P757, DOI 10.1046/j.1365-2435.1998.00245.x; Van Gossum H, 2007, ECOSCIENCE, V14, P1, DOI 10.2980/1195-6860(2007)14[1:RIBNDS]2.0.CO;2; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Bezzerides AL, 2007, BEHAV ECOL SOCIOBIOL, V61, P1401, DOI 10.1007/s00265-007-0371-9; Wennersten L, 2012, BIOL REV, V87, P756, DOI 10.1111/j.1469-185X.2012.00231.x; Azuma S, 1996, FIELD GUIDE INSECTS; BRAKEFIELD PM, 1984, J ANIM ECOL, V53, P775, DOI 10.2307/4659; Coyne J. A., 2004, SPECIATION; Komai T, 1956, POPULATION GENETICS, P45; Majerus MEN, 1998, MELANISM EVOLUTION A; Nakagawa K, 1988, ENTOMOL J FUKUI, V2, P37; Nakamura N, 1995, BIRDS LIFE JAPAN COL; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; R Core Team, 2014, R LANG ENV STAT COMP; Ruxton G. D., 2004, AVOIDING ATTACK EVOL; Sasaji H, 1998, NATURAL HIST LADYBIR; Sasaji H., 1977, Memoir of the Faculty of Education Fukui University Series II Natural Science, V27, P1; Sasaji H, 1980, MEMOIRS FACULTY ED 2, V30, P59; Sasaji H, 1983, IDEN, V37, P72; Sasaji H, 1977, KONTYU TO SHIZEN, V12, P4; Shannon CE, 1963, MATH THEORY COMMUNIC; Su W., 2009, ECOLOGICAL ENTOMOLOG, V34, P483; Takahashi Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5468	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					502	508		10.1111/ens.12147		7	Entomology	Entomology	CT0WF	WOS:000362517800010		
J	Matsumoto, K				Matsumoto, Kazuma			Habitat specificity of butterflies along urban environmental gradients in Tama City, Tokyo	ENTOMOLOGICAL SCIENCE			English	Article						biological indicator; disturbance; forest; grassland; human activity; landscape; Lepidoptera	FOREST	Butterfly assemblages were monitored by transect counts in a riverine area along Tamagawa River (RIV), a residential area on the plain (RES1), a residential area on the hill (RES2), the core area of the city (COR), the Tama Experimental Station of Forestry and Forest Products Research Institute (TES) and Tokyo Metropolitan Sakuragaoka Park (MSP) in Tama City, Tokyo, in 2005. The butterfly assemblages in forest-dominated TES and MSP were more species-rich than those in the other areas. The assemblage in the grassland-dominated RIV was characterized by the highest abundance of individuals. Species richness and abundance were lowest in COR. Ordination of the areas by detrended correspondence analysis placed RIV, MSP and TES in increasing order of scores along axis1, and RES1, RES2 and COR had higher scores along axis2 than RIV, TES and MSP. In axis1, grassland species had low scores and forest species high scores; the two groups were generally separated, coinciding with Tanaka's classification. However, the scores for two forest species, Papilio xuthus and Ypthima argus, were low and those for two grassland species, Potanthus flavus and Anthocharis scolymus, were high, challenging the validity of the classification. Most species recorded in this study were seminatural type, with relatively few natural type species, according to Sunose's classification. Most urban type species occurred in several different habitats and were not specific to highly human-dominated RES1, RES2 and COR.	[Matsumoto, Kazuma] Tohoku Res Ctr, Forestry & Forest Prod Res Inst, Morioka, Iwate, Japan	Matsumoto, K (reprint author), Assoc Int Res Initiat Environm Studies, Taito Ku, 1-4-4 Ueno, Tokyo 1100005, Japan.	kazuma@airies.or.jp					SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Lee CM, 2014, ENTOMOL SCI, V17, P293, DOI 10.1111/ens.12062; KITAHARA M, 1994, RES POPUL ECOL, V36, P187, DOI 10.1007/BF02514935; WATANABE M, 1981, RES POPUL ECOL, V23, P74, DOI 10.1007/BF02514094; SPITZER K, 1993, J BIOGEOGR, V20, P109, DOI 10.2307/2845744; Kwon TS, 2010, ENVIRON ENTOMOL, V39, P337, DOI 10.1603/EN09184; Brzustowski J, 1998, RAREFACTION CALCULAT; HIURA I, 1976, Shizenshi-Kenkyu Occasional Papers from the Osaka Museum of Natural History, V1, P95; Hiura I, 1971, SPECIAL B LEPIDOPTER, V5, P73; HIURA I, 1973, Shizenshi-Kenkyu Occasional Papers from the Osaka Museum of Natural History, V1, P51; Imai C, 1995, JAPANESE J ENV ENTOM, V7, P119; Imai C, 1998, JPN J ENV ENTOMOL ZO, V9, P55; Inoue Takenari, 2003, Entomological Science, V6, P151, DOI 10.1046/j.1343-8786.2003.00022.x; Matsumoto K, 2015, J TROP FOR SCI, V27, P47; Mefford M. J., 2006, PC ORD MULTIVARIATE; Nishinaka Yasuaki, 2007, Transactions of the Lepidopterological Society of Japan, V58, P69; Nishinaka Yasuaki, 2006, Transactions of the Lepidopterological Society of Japan, V57, P202; Ozaki K., 2004, Journal of the Japanese Forestry Society, V86, P251; Pielou E. C., 1969, INTRO MATH ECOLOGY; Robinson G.S., 2001, HOSTPLANTS MOTH BUTT; Sunose T, 1998, METHODS STUDY BUTTER, P59; Sunose Tsukasa, 1993, Decline and Conservation of Butterflies in Japan, V2, P83; Sunose T, 1994, DECLINE CONSERVATION, V3, P110; Tanaka B, 1988, SPECIAL B LEPIDOPTER, V6, P527; THOMAS CD, 1991, BIOL CONSERV, V55, P269, DOI 10.1016/0006-3207(91)90032-5; Unno K, 1981, BUTTERFLIES OF JAPAN; Yamamoto M, 1983, J RYUTSU KEIZAI U, V18, P28; Yamamoto M, 2007, J RYUTSU KEIZAI U, V41, P355	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					509	518		10.1111/ens.12146		10	Entomology	Entomology	CT0WF	WOS:000362517800011		
J	Ohba, SY; Ushio, M				Ohba, Shin-ya; Ushio, Masayuki			Effect of water depth on predation frequency by diving beetles on mosquito larvae prey	ENTOMOLOGICAL SCIENCE			English	Article						anti-predatory behavior; Culicidae; Dytiscidae; predator-prey relationship	BEHAVIOR; PLASTICITY; RESPONSES; EVOLUTION	Diving behavior and its frequency may differ among species of mosquito larvae because of differences in predation pressure. The present study aimed to investigate the relationship between water depth and predation frequency on two mosquito species, Culex tritaeniorhynchus (wetland breeder) and Aedes albopictus (container breeder), by the diving beetle Eretes griseus. Culex tritaeniorhynchus spends more time at the surface than A. albopictus, which spends more time thrashing underwater. When intact mosquito larvae of both species were present, the diving beetles consumed almost all A. albopictus larvae (98.3%). After all the A. albopictus larvae had been consumed, the diving beetles began to prey on C. tritaeniorhynchus. In order to compare the effect of position on the predation preference of the diving beetles, equal numbers of both species were heat-killed and allowed to settle on the bottom of the container. When all the dead mosquito larvae had sunk to the bottom of a plastic container, the diving beetles caught both mosquito species at random. These results indicate that mosquito larvae near the surface were eaten less frequently by diving beetles than those at the bottom. The low diving frequency of C.tritaeniorhynchus is regarded as a form of anti-predatory behavior.	[Ohba, Shin-ya; Ushio, Masayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Ohba, Shin-ya] Nagasaki Univ, Fac Educ, Biol Lab, Nagasaki 8528521, Japan	Ohba, SY (reprint author), Nagasaki Univ, Fac Educ, Biol Lab, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	ooba@nagasaki-u.ac.jp			JSPS KAKENHI [25830152]	We thank C Tsurukawa and K Ohashi for providing the mosquitoes and R Murakami for collecting the diving beetles. We also thank Y Ohba for her assistance during this study. This study was supported by JSPS KAKENHI Grant Number 25830152.	Futami K, 2008, J MED ENTOMOL, V45, P1050, DOI 10.1603/0022-2585(2008)45[1050:DBIAGD]2.0.CO;2; Ohba SY, 2012, ECOL ENTOMOL, V37, P410, DOI 10.1111/j.1365-2311.2012.01379.x; Van Buskirk J, 2002, EVOLUTION, V56, P361; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; KOLAR CS, 1993, OECOLOGIA, V95, P210, DOI 10.1007/BF00323492; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; Skelly DK, 2001, OIKOS, V94, P198, DOI 10.1034/j.1600-0706.2001.t01-1-11105.x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; SIH A, 1986, ECOLOGY, V67, P434, DOI 10.2307/1938587; JULIANO SA, 1992, OIKOS, V63, P465, DOI 10.2307/3544974; McIntyre PB, 2004, OECOLOGIA, V141, P130, DOI 10.1007/s00442-004-1652-x; Kesavaraju B, 2007, ECOL ENTOMOL, V32, P262, DOI 10.1111/j.1365-2311.2006.00846.x; Minakawa N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-104; R Core Team, 2014, R LANG ENV STAT COMP; WILLIAMS D. D., 2006, BIOL TEMPORARY WATER	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					519	522		10.1111/ens.12143		4	Entomology	Entomology	CT0WF	WOS:000362517800012		
J	Suetsugu, K				Suetsugu, Kenji			Seed dispersal of the hemiparasitic plant Thesium chinense by Tetramorium tsushimae and Pristomyrmex punctatus	ENTOMOLOGICAL SCIENCE			English	Article						elaiosome; myrmecochory; parasitic plant	MUTUALISM INVOLVING ANTS; HEMI-PARASITIC ANNUALS; SELECTIVE ADVANTAGES; GENUS MELAMPYRUM; GROUND-BEETLES; ECOLOGY; LILIACEAE; RODENTS	Heterotrophic plants normally produce a vast number of dust-like seeds containing minimal energy reserves, which are usually wind dispersed. However, some heterotrophic species have evolved adaptive strategies to use zoochorous seed dispersal. Seed dispersal by ants, known as myrmecochory, is one of the most widespread animal dispersal systems and has been reported in a diverse range of plant taxa. However, the combination of myrmecochory and heterotrophy seems to be very rare. Here I report the discovery of myrmecochory in the hemiparasitic plant Thesium chinense by Tetramorium tsushimae and Pristomyrmex punctatus. Myrmecochory would be an advantageous dispersal system for T.chinense because its fruits are quickly transferred to the ants' nests, which provide a refuge from the seed predator Canthophorus niveimarginatus. Myrmecochory is also potentially beneficial for T.chinense, as the nests of these ants are frequently located close to poaceous plants, which are the preferred hosts.	[Suetsugu, Kenji] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan	Suetsugu, K (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan.	kenji.suetsugu@gmail.com			Japan Society for the Promotion of Science [12J00602]	I thank Drs Makoto Kato and Akira Yamawo for helpful discussions. I also thank Ms Hikari Kitora for identifying the ants. This study was partly supported by a Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant (12J00602).	HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Ohkawara K, 1996, OECOLOGIA, V106, P500, DOI 10.1007/BF00329708; Suetsugu K, 2008, ANN BOT-LONDON, V102, P49, DOI 10.1093/aob/mcn065; ODOWD DJ, 1980, ECOLOGY, V61, P531, DOI 10.2307/1937419; OHARA M, 1987, J ECOL, V75, P1091, DOI 10.2307/2260316; LEAKE JR, 1994, NEW PHYTOL, V127, P171, DOI 10.1111/j.1469-8137.1994.tb04272.x; KUSMENOGLU S, 1989, PHYTOCHEMISTRY, V28, P2601, DOI 10.1016/S0031-9422(00)98048-8; GIBSON W, 1993, OIKOS, V67, P345, DOI 10.2307/3545481; Eriksson O, 2011, PERSPECT PLANT ECOL, V13, P73, DOI 10.1016/j.ppees.2011.02.002; Amico G, 2000, NATURE, V408, P929; Ohnishi YK, 2009, ECOL RES, V24, P1155, DOI 10.1007/s11284-009-0593-6; HEITHAUS ER, 1981, ECOLOGY, V62, P136, DOI 10.2307/1936677; GIBSON W, 1993, OIKOS, V67, P334, DOI 10.2307/3545480; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Kuijt J., 1969, BIOL PARASITIC FLOWE; NAKANISHI H, 1988, Japanese Journal of Ecology (Tokyo), V38, P169; Pilger R, 1935, NATURL PFLANZ, P52; Sernander R, 1906, KGL SVENSK VETENSK, V41, P1; Suetsugu K, 2015, NAT PLANTS, V1, P1, DOI 10.1038/NPLANTS.2015.52	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1343-8786	1479-8298		ENTOMOL SCI	Entomol. Sci.	OCT	2015	18	4					523	526		10.1111/ens.12148		4	Entomology	Entomology	CT0WF	WOS:000362517800013		
J	Iossifova, D				Iossifova, Deljana			Everyday practices of sanitation under uneven urban development in contemporary Shanghai	ENVIRONMENT AND URBANIZATION			English	Article						coexistence; differentiation; sanitation; Shanghai; urban development	HEALTH-CARE; CHINA; CITY	China has seen rapid economic development and urbanization, and this has included the upgrading of traditional sanitation systems. But the speed of this transition raises concerns about the coexistence of diverging sanitation practices and their impact. This paper asks how this coexistence is experienced by low-income urban residents in Shanghai. It is based on field research during four weeks in July 2013, which involved in-depth, open-ended interviews with 20 low-income urban residents. The article concludes that these diverging everyday practices are situated at the core of urban socio-spatial differentiation, inequality, exclusion and discrimination. Particularly affected are rural-to-urban migrants and ageing working-class residents, for whom the lack of access to improved sanitation may be associated with stigmatization and social isolation. Future research should examine how changing sanitation cultures under urban development and diverging sanitation practices in different contexts can affect family ties, social relations and socio-spatial integration. To view an animated video that illustrates the ideas discussed in this paper, please visit https://youtu.be/BPEU_apfoLo	[Iossifova, Deljana] Univ Manchester, Urban Studies, Manchester M13 9PL, Lancs, England; [Iossifova, Deljana] Swiss Fed Inst Technol, Zurich, Switzerland; [Iossifova, Deljana] Univ Westminster, London W1R 8AL, England; [Iossifova, Deljana] United Nations Univ, Inst Adv Study Sustainabil, Tokyo, Japan	Iossifova, D (reprint author), Univ Manchester, Sch Environm Educ & Dev, Humanities Bridgeford St,Oxford Rd, Manchester M13 9PL, Lancs, England.	deljana.iossifova@manchester.ac.uk			University of Manchester; cities@manchester Animated Urbanism initiative	The research was supported by the Research Stimulation Fund, University of Manchester and by the cities@manchester Animated Urbanism initiative.	Amparo Flores, 2009, P WAT ENV FED 2009, P6734; Medilanski E, 2007, ENVIRON MANAGE, V39, P648, DOI 10.1007/s00267-005-0321-0; He SJ, 2007, URBAN AFF REV, V43, P171; Sun XJ, 2011, QUAL LIFE RES, V20, P359, DOI 10.1007/s11136-010-9752-z; Wissink B, 2012, URBAN GEOGR, V33, P161, DOI 10.2747/0272-3638.33.2.161; Wu FL, 2013, URBAN STUD, V50, P1919, DOI 10.1177/0042098012466600; Li ZG, 2013, URBAN GEOGR, V34, P923, DOI 10.1080/02723638.2013.778694; He SJ, 2007, CITIES, V24, P194, DOI 10.1016/j.cities.2006.12.001; Wu QY, 2014, CITIES, V39, P109, DOI 10.1016/j.cities.2014.02.011; CHEUNG LYS, 1980, PUBLIC HEALTH REP, V95, P491; Yang H, 2012, NATURE, V488, P32, DOI 10.1038/488032b; Wu FL, 2010, CITIES, V27, P385, DOI 10.1016/j.cities.2010.06.003; Carl Crow, 1937, CHINESE ARE; Chai Joseph C H, 1997, INT J SOC ECON, V24, P1038; Cheuk-kei Tong, 2009, MUNICIPAL WASTE MANA; Chieko Nakajima, 2008, 20 CENTURY CHINA, V34, P42; Deljana Iossifova, 2015, URBAN GEOGR, V36, P90; Emily Honig, 1992, CREATING CHINESE ETH; Hiram King Franklin, 1911, FARMERS 40 CENTURIES; James Griffiths, 2013, SHANGHAIIST     0321; Jennifer McConville, 2011, URINE DIVERSION DRY; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Ju XT, 2005, SCI CHINA SER C, V48, P965, DOI [10.1007/BF03187135, 10.1360/062005-288]; Kumar Srivastava Vinay, 2014, SOCIAL CHANGE, V44, P275; Lei Xiaoyan, 2011, WR866 RAND; Li Bingqin, 2004, 82 CASEPAPER SCH EC; Liu LJ, 2014, INT J GERONTOL, V8, P31, DOI 10.1016/j.ijge.2013.01.013; Luo Shiming, 2002, UTILIZATION HUMAN EX; Luo WX, 2014, POP STUD-J DEMOG, V68, P305, DOI 10.1080/00324728.2014.934908; McFarlane C, 2014, ANN ASSOC AM GEOGR, V104, P989; Robert Chambers, 1983, RURAL DEV PUTTING LA; Sarah Jewitt, 2014, GEOFORUM, V56, P137; Sarah Jewitt, 2011, PROGR HUMAN GEOGRAPH, V35, P608; Shanghai Municipal Statistics Bureau, 2013, SHANGH STAT YB 2012; Shen Dajun, 2006, ACCESS WATER SANITAT; Tong Hong Mei, 2011, J Cross Cult Gerontol, V26, P349, DOI 10.1007/s10823-011-9150-1; [UNICEF WHO], 2010, PROGR SAN DRINK WAT; UNICEF and World Health Organization, 2013, PROGR SAN DRINK WAT; Wu Fulong, 2009, CITY, V13, P418; Wu Fulong, 2013, RURAL MIGRANTS URBAN	40	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-2478	1746-0301		ENVIRON URBAN	Environ. Urban.	OCT	2015	27	2					541	554		10.1177/0956247815581748		14	Environmental Studies; Urban Studies	Environmental Sciences & Ecology; Urban Studies	CT0MX	WOS:000362491200012		
J	Gunawardhana, LN; Al-Rawas, GA; Kazama, S; Al-Najar, KA				Gunawardhana, Luminda Niroshana; Al-Rawas, Ghazi A.; Kazama, So; Al-Najar, Khalid A.			Assessment of future variability in extreme precipitation and the potential effects on the wadi flow regime	ENVIRONMENTAL MONITORING AND ASSESSMENT			English	Article						Climate change; Weather generator; Frequency analysis; Oman	CLIMATE-CHANGE; ANNUAL MAXIMUM; MODEL; TEMPERATURE; TRENDS; SIMULATIONS; CONSTRAINTS; ENSEMBLE	The objective of this study is to investigate how the magnitude and occurrence of extreme precipitation events are affected by climate change and to predict the subsequent impacts on the wadi flow regime in the Al-Khod catchment area, Muscat, Oman. The tank model, a lumped-parameter rainfall-runoff model, was used to simulate the wadi flow. Precipitation extremes and their potential future changes were predicted using six-member ensembles of general circulation models (GCMs) from the Coupled Model Intercomparison Project Phase 5 (CMIP5). Yearly maxima of the daily precipitation and wadi flow for varying return periods were compared for observed and projected data by fitting the generalized extreme value (GEV) distribution function. Flow duration curves (FDC) were developed and compared for the observed and projected wadi flows. The results indicate that extreme precipitation events consistently increase by the middle of the twenty-first century for all return periods (49-52 %), but changes may become more profound by the end of the twenty-first century (81-101 %). Consequently, the relative change in extreme wadi flow is greater than twofolds for all of the return periods in the late twenty-first century compared to the relative changes that occur in the mid-century period. Precipitation analysis further suggests that greater than 50 % of the precipitation may be associated with extreme events in the future. The FDC analysis reveals that changes in low-to-moderate flows (Q60-Q90) may not be statistically significant, whereas increases in high flows (Q5) are statistically robust (20 and 25 % for the mid-and late-century periods, respectively).	[Gunawardhana, Luminda Niroshana; Al-Rawas, Ghazi A.] Sultan Qaboos Univ, Dept Civil & Architectural Engn, Coll Engn, Muscat 123, Oman; [Kazama, So] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Al-Najar, Khalid A.] Salalah Airport, Dept Meteorol, Civil Aviat & Meteorol, Salalah, Oman	Gunawardhana, LN (reprint author), Sultan Qaboos Univ, Dept Civil & Architectural Engn, Coll Engn, POB 50, Muscat 123, Oman.	luminda@squ.edu.om					Al-Barwani A, 2006, AGR MAR SCI, V11, P55; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Al-Rawas A. G., 2009, J HYDROL, V376, P318; Al-Rawas A. G., 2010, HYDROLOG SCI J, V55, P377; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Moriasi DN, 2007, T ASABE, V50, P885; Stahli M, 2011, ENVIRON MONIT ASSESS, V174, P91, DOI 10.1007/s10661-010-1757-0; Gunawardhana LN, 2014, IAHS-AISH P, V364, P57; Westra S, 2013, J CLIMATE, V26, P3904, DOI 10.1175/JCLI-D-12-00502.1; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Gunasekara NK, 2013, HYDROL EARTH SYST SC, V17, P4429, DOI 10.5194/hess-17-4429-2013; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; Yokoo Y, 2001, J HYDROL, V246, P209, DOI 10.1016/S0022-1694(01)00372-9; JENKINSON AF, 1955, Q J ROY METEOR SOC, V81, P158, DOI 10.1002/qj.49708134804; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Maeda M, 2000, J CONTAM HYDROL, V43, P165, DOI 10.1016/S0169-7722(99)00102-3; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Tureyen OI, 2011, GEOTHERMICS, V40, P50, DOI 10.1016/j.geothermics.2010.10.004; Agarwal A, 2014, J HYDROL, V513, P422, DOI 10.1016/j.jhydrol.2014.03.047; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Cooper VA, 2007, J HYDROL, V334, P455, DOI 10.1016/j.jhydrol.2006.10.036; Demaria EMC, 2013, J HYDROL, V502, P128, DOI 10.1016/j.jhydrol.2013.08.027; Gunawardhana LN, 2012, HYDROL EARTH SYST SC, V16, P1033, DOI 10.5194/hess-16-1033-2012; Cubash U., 2001, PROJECTIONS FUTURE C, P524; Semenov MA, 2002, LARS WG STOCHASTIC W; Sugawara M., 1995, WATER RESOURCES PUBL; Symon C., 2013, IPCC 5 ASS REP, P524	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6369	1573-2959		ENVIRON MONIT ASSESS	Environ. Monit. Assess.	OCT	2015	187	10							626	10.1007/s10661-015-4851-5		19	Environmental Sciences	Environmental Sciences & Ecology	CS7SD	WOS:000362284700021		
J	Weber, R; Schlumpf, M; Nakano, T; Vijgen, J				Weber, Roland; Schlumpf, Margret; Nakano, Takeshi; Vijgen, John			The need for better management and control of POPs stockpiles	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Editorial Material							PERSISTENT ORGANIC POLLUTANTS; CHALLENGE; HCH; EXPOSURE; SITES		[Weber, Roland; Vijgen, John] Int HCH & Pesticides Assoc, DK-2840 Holte, Denmark; [Weber, Roland] POPs Environm Consulting, D-73527 Scjwabisch Gmund, Germany; [Schlumpf, Margret] GREEN Tox GmbH, CH-8057 Zurich, Switzerland; [Nakano, Takeshi] Osaka Univ, Res Ctr Environm Preservat, Osaka, Japan; [Nakano, Takeshi] Hyogo Environm Adv Assoc, Kobe, Hyogo, Japan	Weber, R (reprint author), Int HCH & Pesticides Assoc, Elmevej 14, DK-2840 Holte, Denmark.	roland.weber10@web.de; john.vijgen@ihpa.info					Amirova Z, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-5048-8, DOI 10.1007/S11356-015-5048-8]; Anezaki K, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-2985-6, DOI 10.1007/S11356-014-2985-6]; Torres JPM, 2013, ENVIRON SCI POLLUT R, V20, P1951, DOI 10.1007/s11356-012-1089-4; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Breivik K, 2011, ENVIRON SCI TECHNOL, V45, P9154, DOI 10.1021/es202320c; Weber R, 2013, ENVIRON SCI POLLUT R, V20, P1901, DOI 10.1007/s11356-012-1247-8; Labunska I, 2014, ENVIRON SCI TECHNOL, V48, P5555, DOI 10.1021/es500241m; Scheringer M, 2012, ATMOS POLLUT RES, V3, P383, DOI 10.5094/APR.2012.044; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-4324; Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P7157, DOI 10.1021/es061677a; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Reinmann J, 2010, SCI CHINA CHEM, V53, P1017, DOI 10.1007/s11426-010-0156-2; Wycisk P, 2013, ENVIRON SCI POLLUT R, V20, P1907, DOI 10.1007/s11356-012-0963-4; Vijgen J, 2015, ENVIRON SCI POLLUT R, V22, P4780, DOI 10.1007/s11356-014-3775-x; Babayemi J, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3228-6, DOI 10.1007/S11356-014-3228-6]; Balde C.P., 2015, GLOBAL E WASTE MONIT; Bullerdieck U, 2011, ERGEBNISSE UBERBLICK; Carvalho DF, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3073-7, DOI 10.1007/S11356-014-3073-7]; Croes K, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3437-z, DOI 10.1007/S11356-014-3437-Z]; Funk B-C, 2015, HCB BELASTUNG GORTSC; Galimova EF, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3109-z, DOI 10.1007/S11356-014-3109-Z]; Hoffmeister J, 2011, FALL ENVIO DORTMUNDE, P137; Huang J, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3507-2, DOI 10.1007/S11356-014-3507-2]; IHPA, 2006, 1 IHPA; IHPA, 2013, 12 INT HCH PEST FOR; Kawamoto K, 2014, DIOXIN FORMATION CON, DOI [10.1007/s11356-014-3104-4, DOI 10.1007/S11356-014-3104-4]; Korucu MK, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3924-2, DOI 10.1007/S11356-014-3924-2]; Kurier Der, 2015, HCB SKAND SPRENGT LA; Lysychenko G, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-5184-1, DOI 10.1007/S11356-015-5184-1]; Nie Z, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3801-z, DOI 10.1007/S11356-014-3801-Z]; Pieterse B, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-4739-5, DOI 10.1007/S11356-015-4739-5]; Porta M, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3460-0, DOI 10.1007/S11356-014-3460-0]; Sindiku O, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3266-0, DOI 10.1007/S11356-014-3266-0]; Sindiku O, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-5260-6, DOI 10.1007/S11356-015-5260-6]; Sisto R, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-4690-5, DOI 10.1007/S11356-015-4690-5]; UNEP, 2015, UNEPPOPSCOP7INF9; UNEP, 2010, UNEPPOPSPOPRC613; Van Thuong N, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3946-9, DOI 10.1007/S11356-014-3946-9]; Vetter W, 2014, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-014-3267-z, DOI 10.1007/S11356-014-3267-Z]; Weber R., 2007, CHEMOSPHERE, V67, P109; Wimmerova S, 2015, ENVIRON SCI POLLUT R, DOI [10.1007/s11356-015-5047-9, DOI 10.1007/S11356-015-5047-9]	41	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					14385	14390		10.1007/s11356-015-5162-7		6	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300001		
J	Huang, J; Yu, G; Yamauchi, M; Matsumura, T; Yamazaki, N; Weber, R				Huang, Jun; Yu, Gang; Yamauchi, Makoto; Matsumura, Toru; Yamazaki, Norimasa; Weber, Roland			Congener-specific analysis of polychlorinated naphthalenes (PCNs) in the major Chinese technical PCB formulation from a stored Chinese electrical capacitor	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Polychlorinated naphthalene (PCN); Polychlorinated biphenyls (PCBs); Chinese technical PCB; HRGC/HRMS; Electrical capacitor	ISOMER-SPECIFIC ANALYSIS; DIOXIN-LIKE COMPOUNDS; BIPHENYL PREPARATIONS; RELATIVE POTENCIES; DIBENZOFURANS; RESPONSES	Impurity of polychlorinated naphthalenes (PCNs) in commercial polychlorinated biphenyl (PCB) formulations has been recognized as a relevant source of PCNs in the environment. Congener-specific analysis of most main PCB formulations has been accomplished previously, excluding the Chinese product. The insulating oil in a stored Chinese electric capacitor containing the major Chinese technical formulation "PCB3" was sampled and tested by isotope dilution technology using high-resolution gas chromatography coupled to high-resolution mass spectrometry (HRGC/HRMS). The detected concentration of PCNs in the Chinese PCB oil sample was 1,307.5 mu g/g and therefore significantly higher than that reported in PCB formulations from other countries, as well as that in the transformer oil (ASKAREL Nr 1740) additionally tested in the present study for comparison. Based on the measurement, the total amount of PCNs in Chinese PCB3 oil is estimated to be 7.8 t, which would mean only 0.005 % of global production of PCNs of 150,000 t. The homolog profile is similar to those of PCN in Aroclor 1262 and Clophen A40, where the contributions from hexa-CNs and hepta-CNs are predominant and accounted for similar proportions. The Toxic Equivalent Quantity (TEQ) concentration of dioxin-like PCN congeners is 0.47 mu g TEQ/g, with the dominant contributors of CN-73 and CN-66/67. This TEQ content from PCN is higher than that in most other PCB formulations with the exemption of the Russian Sovol formulation. The total TEQ in the historic 6,000 t of the Chinese PCB3 formulation is estimated to be 2.8 kg TEQ.	[Huang, Jun; Yu, Gang; Weber, Roland] Tsinghua Univ, SKLESPC, BKLEOCC, Sch Environm, Beijing 100084, Peoples R China; [Yamauchi, Makoto; Matsumura, Toru] IDEA Consultants Inc, Shizuoka 4210212, Japan; [Matsumura, Toru; Yamazaki, Norimasa] CSD IDEA Beijing Inst Environm Innovat Co Ltd, Beijing 100084, Peoples R China; [Weber, Roland] POPs Environm Consulting, D-73035 Goppingen, Germany	Huang, J (reprint author), Tsinghua Univ, SKLESPC, BKLEOCC, Sch Environm, Beijing 100084, Peoples R China.	huangjun@tsinghua.edu.cn	Huang, Jun/F-6806-2010; Yu, Gang/H-6354-2013	Huang, Jun/0000-0001-9207-8953; 	National High-Tech Research and Development Program [2013AA06A305]; Tsinghua University Initiative Scientific Research Program [20131089251]	This research was financially supported by the National High-Tech Research and Development Program (No. 2013AA06A305) and Tsinghua University Initiative Scientific Research Program (No. 20131089251).	Bidleman TF, 2010, SCI TOTAL ENVIRON, V408, P2919, DOI 10.1016/j.scitotenv.2009.09.013; Guo L, 2008, CHINESE SCI BULL, V53, P508, DOI 10.1007/s11434-008-0129-4; HANBERG A, 1990, CHEMOSPHERE, V20, P1161, DOI 10.1016/0045-6535(90)90238-O; Liu GR, 2014, CHEMOSPHERE, V94, P1, DOI 10.1016/j.chemosphere.2013.09.021; Huang J, 2011, CHEMOSPHERE, V85, P239, DOI 10.1016/j.chemosphere.2011.06.023; Huang J, 2014, FRONT ENV SCI ENG, V8, P195, DOI 10.1007/s11783-013-0527-y; Kannan K, 1998, ENVIRON SCI TECHNOL, V32, P2507, DOI 10.1021/es980167g; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Yamashita N, 2000, ENVIRON SCI TECHNOL, V34, P4236, DOI 10.1021/es001122u; Abad E, 1999, CHEMOSPHERE, V38, P109, DOI 10.1016/S0045-6535(98)00177-5; Taniyasu S, 2003, ENVIRON POLLUT, V126, P169, DOI 10.1016/S0269-7491(03)00207-0; Imagawa T, 2001, CHEMOSPHERE, V44, P1511, DOI 10.1016/S0045-6535(00)00287-3; Behnisch PA, 2003, ENVIRON INT, V29, P861, DOI 10.1016/S0160-4120(03)00105-3; Blankenship AL, 2000, ENVIRON SCI TECHNOL, V34, P3153, DOI 10.1021/es9914339; Weber R, 2013, ENVIRON SCI POLLUT R, V20, P1901, DOI 10.1007/s11356-012-1247-8; Weber R, 2001, CHEMOSPHERE, V44, P1429, DOI 10.1016/S0045-6535(00)00508-7; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P181, DOI 10.1016/S0048-9697(01)01075-0; Rotander A, 2012, ENVIRON POLLUT, V164, P118, DOI 10.1016/j.envpol.2012.01.035; Noma Y, 2004, ENVIRON SCI TECHNOL, V38, P1675, DOI 10.1021/es035101m; Falandysz J, 1998, ENVIRON POLLUT, V101, P77, DOI 10.1016/S0269-7491(98)00023-2; HAGLUND P, 1993, J CHROMATOGR, V634, P79, DOI 10.1016/0021-9673(93)80314-X; Takasuga T., 2012, ORGANOHALOGEN COMPD, V74, P1437; The People's Republic of China, 2007, CONV PERS ORG POLL; Water Environment Department Planning Division (WEDPD) Environmental Management Bureau Ministry of the Environment Japan, 2003, MAN SURV MAIN IT WAT, P136; Xing Ying, 2005, Chemosphere, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001	26	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					14471	14477		10.1007/s11356-014-3677-y		7	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300009		
J	Anezaki, K; Kannan, N; Nakano, T				Anezaki, Katsunori; Kannan, Narayanan; Nakano, Takeshi			Polychlorinated biphenyl contamination of paints containing polycyclic- and Naphthol AS-type pigments	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Polychlorinated biphenyls; Congeners; Pigments; Dioxazineviolet; Diketopyrrolopyrrole; Naphthol AS; By-product	3,3'-DICHLOROBIPHENYL PCB 11; SOURCE APPORTIONMENT; DELAWARE RIVER; CHICAGO AIR; CONGENERS; SEDIMENTS; AROCLOR; PBDES	This study reports the concentrations and congener partners of polychlorinated biphenyls (PCBs) in commercially available paints. Polycyclic-type pigments containing dioxazine violet (pigment violet (PV) 23, PV37) and diketopyrrolopyrrole (PR254, PR255) were found to contain PCB-56, PCB-77, PCB-40, PCB-5, and PCB-12, and PCB-6, PCB-13, and PCB-15, respectively, as major congeners. Dioxazine violet is contaminated with by-products during synthesis from o-dichlorobenzene, which is used as a solvent during synthesis, and diketopyrrolopyrrole is contaminated with by-products during synthesis from p-chlorobenzonitrile. The concentration of PCBs in paint containing PV23 or PV37 was 0.050-29 mg/kg, and toxic equivalency (TEQ) values ranged 1.1-160 pg-TEQ/g. The concentration of PCBs in paint containing PR254 or PR255 was 0.0019-2.4 mg/kg. Naphthol AS is an azo-type pigment, and PCB-52 was detected in paint containing pigment red (PR) 9 with 2,5-dichloroaniline as its source. PCB-146, PCB-149, and PCB-153 were identified from paint containing PR112 produced from 2,4,5-trichloroaniline, as major congeners. These congeners have chlorine positions similar to aniline, indicating that these congeners are by-products obtained during the synthesis of pigments. The concentrations of PCBs in paints containing PR9 and PR112 were 0.0042-0.43 and 0.0044-3.8 mg/kg, respectively. The corresponding TEQ for PR112 was 0.0039-8.6 pg-TEQ/g.	[Anezaki, Katsunori] Hokkaido Res Org, Inst Environm Sci, Environm & Geol Res Dept, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Kannan, Narayanan] Univ Putra Malaysia, Fac Environm Studies, Serdang 43400, Malaysia; [Nakano, Takeshi] Osaka Univ, Ctr Adv Sci & Innovat, Osaka, Japan	Anezaki, K (reprint author), Hokkaido Res Org, Inst Environm Sci, Environm & Geol Res Dept, Kita Ku, Sapporo, Hokkaido 0600819, Japan.	anezaki@hro.or.jp			JSPS KAKENHI [24710016]	This work was supported by JSPS KAKENHI Grant Number 24710016. We also thank the anonymous reviewers for their helpful comments.	Anezaki K., 2013, ORGANOHALOGEN COMPD, V75, P517; Li YM, 2012, ATMOS ENVIRON, V51, P140, DOI 10.1016/j.atmosenv.2012.01.034; King TL, 2002, MAR POLLUT BULL, V44, P590, DOI 10.1016/S0025-326X(01)00289-2; Hu DF, 2008, ENVIRON SCI TECHNOL, V42, P7873, DOI 10.1021/es801823r; Praipipat P, 2013, ENVIRON SCI TECHNOL, V47, P4277, DOI 10.1021/es400375e; Litten S, 2002, CHEMOSPHERE, V46, P1457, DOI 10.1016/S0045-6535(01)00253-3; Basu I, 2009, ENVIRON SCI TECHNOL, V43, P6488, DOI 10.1021/es900919d; Kamata R, 2009, TOXICOL IN VITRO, V23, P736, DOI 10.1016/j.tiv.2009.03.004; Hu DF, 2010, ENVIRON SCI TECHNOL, V44, P2822, DOI 10.1021/es902413k; Rodenburg LA, 2013, ENVIRON SCI TECHNOL, V47, P3774, DOI 10.1021/es305024p; Rowe AA, 2007, ENVIRON SCI TECHNOL, V41, P1152, DOI 10.1021/es061797i; Du S, 2008, ENVIRON SCI TECHNOL, V42, P4044, DOI 10.1021/es703047a; Arulmozhiraja S, 2005, TOXICOL SCI, V84, P49, DOI 10.1093/toxsci/kfi063; Romano S, 2013, CHEMOSPHERE, V90, P2396, DOI 10.1016/j.chemosphere.2012.10.067; Anezaki K, 2014, ENVIRON SCI POLLUT R, V21, P998, DOI 10.1007/s11356-013-1977-2; Takeuchi S, 2011, TOXICOLOGY, V289, P112, DOI 10.1016/j.tox.2011.08.001; Rodenburg LA, 2010, ENVIRON SCI TECHNOL, V44, P2816, DOI 10.1021/es901155h; SCHULZ DE, 1989, ENVIRON SCI TECHNOL, V23, P852, DOI 10.1021/es00065a015; Buxbaum G, 2005, IND INORGANIC PIGMEN; ETAD-The Ecological and Toxicological Association of Dyes and Organic Pigments Manufacturers, 2011, ETAD POS PRES TRAC P; Faulkner E., 2009, HIGH PERFORMANCE PIG; Frame G.M., 1996, J HIGH RES CHROMATOG, V19, P657, DOI DOI 10.1002/JHRC.1240191202; Herbst W., 2004, IND ORGANIC PIGMENTS; Matsumura C, 2002, J ENV CHEM, V12, P855; Numatal M, 2008, J CHROMATOGR A, V1210, P68, DOI 10.1016/j.chroma.2008.09.038; Shamekhi S. S., 2012, PROG COLOR COLORANTS, V5, P1; Shang HT, 2014, CHEMOSPHERE, V98, P44, DOI 10.1016/j.chemosphere.2013.09.075; Stockholm Convention, 2001, C PLEN AD SIGN STOCK; Takasuga T., 2012, ORGANOHALOGEN COMPD, V74, P1437; Takasuga T, 1995, J ENV CHEM, V5, P647	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					14478	14488		10.1007/s11356-014-2985-6		11	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300010		
J	Kakimoto, K; Nagayoshi, H; Akutsu, K; Konishi, Y; Kajimura, K; Hayakawa, K; Toriba, A				Kakimoto, Kensaku; Nagayoshi, Haruna; Akutsu, Kazuhiko; Konishi, Yoshimasa; Kajimura, Keiji; Hayakawa, Kazuichi; Toriba, Akira			Dechlorane Plus and decabromodiphenyl ether in atmospheric particles of northeast Asian cities	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Dechlorane Plus; Decabromodiphenyl ether; Atmosphere; NortheastAsia; Flame retardant	POLYBROMINATED DIPHENYL ETHERS; CHLORINATED FLAME-RETARDANT; GREAT-LAKES; SOUTH CHINA; AIR; EXPOSURE; ANTARCTICA; INHALATION; SEDIMENTS; CANADA	Atmospheric particles were collected in several cities in Japan (Sapporo, Sagamihara, Kanazawa, and Kitakyushu), Korea (Busan), and China (Beijing) using a high-volume air sampler equipped with a quartz fiber filter. The summer and winter samples were analyzed using gas chromatography-high-resolution mass spectrometry for Dechlorane Plus (DP). Decabromodiphenyl ether (BDE-209) was also analyzed for the samples from Kanazawa and Beijing. DP was detected in all samples. The mean total DP (I DP) pound concentration was highest (6.7 pg/m(3)) and lowest (0.87 pg/m(3)) in the winter samples from Sagamihara and Busan, respectively. The seasonal variation of DP concentrations varied by sampling site in this study. BDE-209 was detected in all the analyzed samples except for one of the Kanazawa winter samples. BDE-209 concentration was considerably higher in Beijing than in Kanazawa. Significant correlations were found between the concentrations of I DP pound and BDE-209 in the winter samples from Kanazawa and in both summer and winter samples from Beijing. This similarity in the atmospheric behavior of DP and BDE-209, especially in winter, is assumed to reflect a common end usage and release mechanism.	[Kakimoto, Kensaku; Nagayoshi, Haruna; Akutsu, Kazuhiko; Konishi, Yoshimasa; Kajimura, Keiji] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan; [Kakimoto, Kensaku; Hayakawa, Kazuichi; Toriba, Akira] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Kakimoto, K (reprint author), Osaka Prefectural Inst Publ Hlth, Higashinari Ku, 1-3-69 Nakamichi, Osaka 5370025, Japan.	knkakimoto@iph.pref.osaka.jp	Kakimoto, Kensaku/E-1561-2015	Kakimoto, Kensaku/0000-0002-0592-3280	Japan Society for the Promotion of Science [26860452]	This work was supported in part by a Grant-in-aid for Young Scientists (B) from the Japan Society for the Promotion of Science (project no. 26860452).	Qi H, 2010, ENVIRON SCI TECHNOL, V44, P2305, DOI 10.1021/es9027106; Crump D, 2011, COMP BIOCHEM PHYS C, V154, P129, DOI 10.1016/j.cbpc.2011.04.005; Wang DG, 2010, ENVIRON SCI TECHNOL, V44, P6608, DOI 10.1021/es101224y; Baek SY, 2013, ATMOS ENVIRON, V64, P40, DOI 10.1016/j.atmosenv.2012.09.015; Moller A, 2010, ENVIRON SCI TECHNOL, V44, P8977, DOI 10.1021/es103047n; Sakiyama T, 2012, BUNSEKI KAGAKU, V61, P745; Yang M, 2013, ENVIRON SCI TECHNOL, V47, P8978, DOI 10.1021/es4022409; Wu B, 2012, ENVIRON SCI TECHNOL, V46, P10758, DOI 10.1021/es301804t; Wu JP, 2010, ENVIRON SCI TECHNOL, V44, P606, DOI 10.1021/es902744b; Siddique S, 2012, ENVIRON INT, V39, P50, DOI 10.1016/j.envint.2011.09.010; Kang JH, 2010, CHEMOSPHERE, V79, P850, DOI 10.1016/j.chemosphere.2010.02.051; Sverko E, 2010, ENVIRON SCI TECHNOL, V44, P574, DOI 10.1021/es9025535; Zhu J, 2007, ENVIRON SCI TECHNOL, V41, P7694, DOI 10.1021/es071716y; Yu ZQ, 2011, ENVIRON POLLUT, V159, P2982, DOI 10.1016/j.envpol.2011.04.024; Moller A, 2012, ENVIRON SCI TECHNOL, V46, P3141, DOI 10.1021/es300138q; Hu GC, 2010, J ENVIRON SCI-CHINA, V22, P1833, DOI 10.1016/S1001-0742(09)60328-4; Zheng J, 2010, ENVIRON SCI TECHNOL, V44, P9298, DOI 10.1021/es103105x; Chen SJ, 2011, ENVIRON POLLUT, V159, P1290, DOI 10.1016/j.envpol.2011.01.026; Zhao Z, 2011, CHEMOSPHERE, V83, P984, DOI 10.1016/j.chemosphere.2011.02.011; Hu JC, 2011, CHEMOSPHERE, V84, P355, DOI 10.1016/j.chemosphere.2011.04.002; Yang M, 2012, ATMOS ENVIRON, V55, P73, DOI 10.1016/j.atmosenv.2012.03.040; Tomy GT, 2007, ENVIRON SCI TECHNOL, V41, P2249, DOI 10.1021/es062781v; Zhang XL, 2011, ENVIRON SCI TECHNOL, V45, P400, DOI 10.1021/es102251s; Kakimoto K, 2014, ECOTOX ENVIRON SAFE, V99, P69, DOI 10.1016/j.ecoenv.2013.10.023; Sun JQ, 2013, SCI TOTAL ENVIRON, V443, P194, DOI 10.1016/j.scitotenv.2012.10.096; Ma WL, 2011, ENVIRON INT, V37, P66, DOI 10.1016/j.envint.2010.07.002; Salamova A, 2011, ENVIRON SCI TECHNOL, V45, P9924, DOI 10.1021/es202762n; Ben YJ, 2013, ENVIRON POLLUT, V173, P176, DOI 10.1016/j.envpol.2012.09.028; Meng XZ, 2007, ENVIRON SCI TECHNOL, V41, P4882, DOI 10.1021/es0701560; Hoh E, 2006, ENVIRON SCI TECHNOL, V40, P1184, DOI 10.1021/es051911h; Qiu XH, 2010, CHEMOSPHERE, V80, P1207, DOI 10.1016/j.chemosphere.2010.06.013; He SJ, 2013, ENVIRON TOXICOL CHEM, V32, P1242, DOI 10.1002/etc.2172; Kakimoto K, 2012, CHEMOSPHERE, V89, P416, DOI 10.1016/j.chemosphere.2012.05.072; Pakalin S., 2007, 22693 EUR EN	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					14600	14605		10.1007/s11356-014-2861-4		6	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300022		
J	Kawamoto, K; Miyata, H				Kawamoto, Katsuya; Miyata, Haruo			Dioxin formation and control in a gasification-melting plant	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Catalytic bag filter; Catalytic decomposition; Dioxin formation; Incineration plant; Gasification and melting process; Surrogate organic halogen compounds	MUNICIPAL WASTE INCINERATORS; DESTRUCTION; DIBENZOFURANS; MANAGEMENT; OPERATION; PCDD/PCDF; JAPAN; POPS; PCDD; GAS	We investigated dioxin formation and removal in a commercial thermal waste treatment plant employing a gasification and melting process that has become widespread in the last decade in Japan. The aim was to clarify the possibility of dioxin formation in a process operation at high temperatures and the applicability of catalytic decomposition of dioxins. Also, the possible use of dioxin surrogate compounds for plant monitoring was further evaluated. The main test parameter was the influence of changes in the amount and type of municipal solid waste (MSW) supplied to the thermal waste treatment plant which from day to day operation is a relevant parameter also from commercial perspective. Here especially, the plastic content on dioxin release was assessed. The following conclusions were reached: (1) disturbance of combustion by adding plastic waste above the capability of the system resulted in a considerable increase in dioxin content of the flue gas at the inlet of the bag house and (2) bag filter equipment incorporating a catalytic filter effectively reduced the gaseous dioxin content below the standard of 0.1 ng toxic equivalency (TEQ)/m(3) (N), by decomposition and partly adsorption, as was revealed by total dioxin mass balance and an increased levels in the fly ash. Also, the possible use of organohalogen compounds as dioxin surrogate compounds for plant monitoring was further evaluated. The levels of these surrogates did not exceed values corresponding to 0.1 ng TEQ/m(3) (N) dioxins established from former tests. This further substantiated that surrogate measurement therefore can well reflect dioxin levels.	[Kawamoto, Katsuya] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama 7008530, Japan; [Miyata, Haruo] Sanki Engn Co Ltd, Chuo Ku, Tokyo 1100015, Japan	Kawamoto, K (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	kkawamoto@okayama-u.ac.jp					Takeda N, 2013, ENVIRON SCI POLLUT R, V20, P2070, DOI 10.1007/s11356-012-1412-0; Weber R, 2001, APPL CATAL B-ENVIRON, V31, P195, DOI 10.1016/S0926-3373(00)00278-2; LIEM AKD, 1991, CHEMOSPHERE, V23, P1675, DOI 10.1016/0045-6535(91)90016-7; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Chang YM, 2009, J HAZARD MATER, V161, P1436, DOI 10.1016/j.jhazmat.2008.04.128; HAGENMAIER H, 1991, CHEMOSPHERE, V23, P1429, DOI 10.1016/0045-6535(91)90167-C; Yoshida H, 2009, J MATER CYCLES WASTE, V11, P229, DOI 10.1007/s10163-008-0235-z; ADDINK R, 1995, ENVIRON SCI TECHNOL, V29, P1425, DOI 10.1021/es00006a002; Weber R, 2013, ENVIRON SCI POLLUT R, V20, P1901, DOI 10.1007/s11356-012-1247-8; Weber R, 1999, APPL CATAL B-ENVIRON, V20, P249, DOI 10.1016/S0926-3373(98)00115-5; Weber R, 2001, CHEMOSPHERE, V44, P1429, DOI 10.1016/S0045-6535(00)00508-7; Scheringer M, 2012, ATMOS POLLUT RES, V3, P383, DOI 10.5094/APR.2012.044; Nakui H, 2011, CHEMOSPHERE, V85, P151, DOI 10.1016/j.chemosphere.2011.06.042; Reinmann J, 2010, SCI CHINA CHEM, V53, P1017, DOI 10.1007/s11426-010-0156-2; Inoue K, 2005, ENVIRON SCI TECHNOL, V39, P5844, DOI 10.1021/es0489745; Watanabe N, 2010, J MATER CYCLES WASTE, V12, P254, DOI 10.1007/s10163-010-0295-8; Yasuda K, 2009, J MATER CYCLES WASTE, V11, P328, DOI 10.1007/s10163-009-0261-5; Babcock-Hitachi KK, 2014, CATALYTIC FABRIC FIL; Holmes SJ, 1994, ORGANOHALOG COMPD, V24, P373; Holmes SJ, 1998, ORGANOHALOG COMPD, V39, P257; Kawamoto K, 2008, SEM THERM WAST TREAT; Kawamoto K, 2003, J EICA, V8, P31; Mabuchi K, 2001, J MATER CYCLES WASTE, V3, P38; Malisch R, 1999, ORGANOHALOGEN COMPD, V43, P265; Petrlik J, 2005, THE EGG REPORT; Pless-Mulloli T, 2001, PCDD PCDF HEAVY META; Reinmann J, 2006, ORGANOHALOGEN COMPD, V68, P852; Watson A, 2001, COMMENTS REPORT ANAL	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					14621	14628		10.1007/s11356-014-3104-4		8	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300024		
J	Eio, EJ; Kawai, M; Niwa, C; Ito, M; Yamamoto, S; Toda, T				Eio, Er Jin; Kawai, Minako; Niwa, Chiaki; Ito, Masato; Yamamoto, Shuichi; Toda, Tatsuki			Biodegradation of bisphenol A by an algal-bacterial system	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Algal-bacterial system; Bacterial consortium; Biodegradation; Bisphenol A; Inhibition; Photosynthetic oxygen	MICROALGA CHLORELLA-SOROKINIANA; ESTROGENIC ACTIVITY; ENVIRONMENTAL FATE; SALICYLATE BIODEGRADATION; AZOSPIRILLUM-BRASILENSE; ALGINATE BEADS; WASTE-WATER; DEGRADATION; GROWTH; PHOTOBIOREACTORS	The degradation of bisphenol A (BPA) by Chlorella sorokiniana and BPA-degrading bacteria was investigated. The results show that BPA was partially removed by a monoculture of C. sorokiniana, but the remaining BPA accounted for 50.2, 56.1, and 60.5 % of the initial BPA concentrations of 10, 20, and 50 mg L-1, respectively. The total algal BPA adsorption and accumulation were less than 1 %. C. sorokiniana-bacterial system effectively removed BPA with photosynthetic oxygen provided by the algae irrespective of the initial BPA concentration. The growth of C. sorokiniana in the algal system was inhibited by BPA concentrations of 20 and 50 mg L-1, but not in the algal-bacterial system. This observation indicates that bacterial growth in the algal-bacterial system reduced the BPA-inhibiting effect on algae. A total of ten BPA biodegradation intermediates were identified by GC-MS. The concentrations of the biodegradation intermediates decreased to a low level at the end of the experiment. The hypothetical carbon mass balance analysis showed that the amounts of oxygen demanded by the bacteria are insufficient for effective BPA degradation. However, adding an external carbon source could compensate for the oxygen shortage. This study demonstrates that the algal-bacterial system has the potential to remove BPA and its biodegradation intermediates.	[Eio, Er Jin] Soka Univ, Grad Sch Engn, Hachioji, Tokyo 1928577, Japan; [Kawai, Minako] Asian Peoples Exchange, Taitou Ku, Tokyo 1100003, Japan; [Kawai, Minako; Niwa, Chiaki; Ito, Masato; Yamamoto, Shuichi; Toda, Tatsuki] Soka Univ, Fac Engn, Dept Environm Engn Symbiosis, Hachioji, Tokyo 1928577, Japan	Eio, EJ (reprint author), Soka Univ, Grad Sch Engn, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	erjin_eio@soka.gr.jp			Ministry of the Environment, Japan [4-1406]	We would like to express our gratitude to Kenji Tsuchiya, Masatoshi Kishi, Yukiko Sasakawa, and Xia Yuan Jun from Soka University, for their assistance in this study. We are grateful to the Hachioji Kitano Wastewater Treatment Plant of Japan for the preparation of the seed sludge. The present study was financially supported by "The Environment Research and Technology Development Fund" from the Ministry of the Environment, Japan (4-1406).	Fischer J, 2010, INT BIODETER BIODEGR, V64, P324, DOI 10.1016/j.ibiod.2010.03.007; Correa-Reyes G, 2007, CHEMOSPHERE, V68, P662, DOI 10.1016/j.chemosphere.2007.02.030; Zhao JM, 2008, J HAZARD MATER, V155, P305, DOI 10.1016/j.jhazmat.2007.11.075; De-Bashan LE, 2008, BIORESOURCE TECHNOL, V99, P4980, DOI 10.1016/j.biortech.2007.09.065; Nishihara T, 2000, J HEALTH SCI, V46, P282; Bahr M, 2011, APPL MICROBIOL BIOT, V90, P1527, DOI 10.1007/s00253-011-3204-8; Li GY, 2012, BIORESOURCE TECHNOL, V114, P224, DOI 10.1016/j.biortech.2012.03.067; Morita M, 2000, APPL BIOCHEM BIOTECH, V87, P203, DOI 10.1385/ABAB:87:3:203; Yamamoto T, 2001, CHEMOSPHERE, V42, P415, DOI 10.1016/S0045-6535(00)00079-5; Ike M, 2002, ENVIRON TOXICOL, V17, P457, DOI 10.1002/tox.10079; Kolvenbach B, 2007, APPL ENVIRON MICROB, V73, P4776, DOI 10.1128/AEM.00329-07; Cousins IT, 2002, HUM ECOL RISK ASSESS, V8, P1107, DOI 10.1080/1080-700291905846; Nguyen LN, 2013, BIORESOURCE TECHNOL, V148, P234, DOI 10.1016/j.biortech.2013.08.142; Borde X, 2003, BIORESOURCE TECHNOL, V86, P293, DOI 10.1016/S0960-8524(02)00074-3; SPIVACK J, 1994, J BIOL CHEM, V269, P7323; Bordel S, 2009, ENVIRON SCI TECHNOL, V43, P3200, DOI 10.1021/es802156e; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; Munoz R, 2003, BIOTECHNOL LETT, V25, P1905, DOI 10.1023/B:BILE.0000003980.96235.fd; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Shibata A, 2006, AQUAT MICROB ECOL, V43, P223, DOI 10.3354/ame043223; Benner R, 2011, BIOGEOCHEMISTRY, V102, P209, DOI 10.1007/s10533-010-9435-4; SOROKIN C, 1958, PLANT PHYSIOL, V33, P109, DOI 10.1104/pp.33.2.109; Nakajima N, 2007, CHEMOSPHERE, V69, P934, DOI 10.1016/j.chemosphere.2007.05.088; Li TT, 2013, BIORESOURCE TECHNOL, V131, P60, DOI 10.1016/j.biortech.2012.11.121; LOBOS JH, 1992, APPL ENVIRON MICROB, V58, P1823; ALEXANDER HC, 1988, ENVIRON TOXICOL CHEM, V7, P19, DOI 10.1897/1552-8618(1988)7[19:BAAAT]2.0.CO;2; Nomiyama K, 2007, ARCH ENVIRON CON TOX, V52, P8, DOI 10.1007/s00244-005-0204-7; Munoz R, 2004, BIOTECHNOL BIOENG, V87, P797, DOI 10.1002/bit.20204; Roh H, 2009, CHEMOSPHERE, V77, P1084, DOI 10.1016/j.chemosphere.2009.08.049; Suzuki T, 2004, ENVIRON SCI TECHNOL, V38, P2389, DOI 10.1021/es030576z; Zhang WW, 2013, APPL MICROBIOL BIOT, V97, P5681, DOI 10.1007/s00253-013-4949-z; Eio EJ, 2014, INT BIODETER BIODEGR, V96, P166, DOI 10.1016/j.ibiod.2014.09.011; Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Hirooka T, 2005, ENVIRON TOXICOL CHEM, V24, P1896, DOI 10.1897/04-259R.1; Gonzalez LE, 2000, APPL ENVIRON MICROB, V66, P1527, DOI 10.1128/AEM.66.4.1527-1531.2000; Yoshihara S, 2001, TOXICOL SCI, V62, P221, DOI 10.1093/toxsci/62.2.221; de-Bashan LE, 2002, WATER RES, V36, P2941, DOI 10.1016/S0043-1354(01)00522-X; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Mohapatra D.P., 2011, J XENOBIOTICS, V1, P9; Oswald W.J., 1988, MICROALGAL BIOTECHNO; LUDWIG HF, 1951, SEWAGE IND WASTES, V23, P1337; Porges N, 1956, BIOL TREATMENT SEWAG, V1; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Zhang W, 2014, ENVIRON TOXICOL, V6, P714	46	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	OCT	2015	22	19					15145	15153		10.1007/s11356-015-4693-2		9	Environmental Sciences	Environmental Sciences & Ecology	CS8IB	WOS:000362329300073		
J	Kanemoto, K; Tsuda, H; Goji, H; Tadokoro, Y; Oshima, T; Tachimori, H; DeToffol, B				Kanemoto, Kousuke; Tsuda, Hisamitsu; Goji, Hiroko; Tadokoro, Yukari; Oshima, Tomohiro; Tachimori, Hisateru; DeToffol, Bertrand			Delusional experience awareness gap between patients and treating doctors - Self-reported EPDS questionnaire	EPILEPSY & BEHAVIOR			English	Article						Psychosis; Screener; Epilepsy; Delusion; EPDS	INTERICTAL PSYCHOSES; PRODROMAL SYMPTOMS; PRIME SCREEN; EPILEPSY; RISK; SCHIZOPHRENIA; POPULATION; PREVALENCE; DISORDERS; PSYCHOPATHOLOGY	Objectives: Although early and rapid recognition of a psychotic trend in patients with epilepsy certainly pay dividends, there is no handy assessment instrument for screening because of multiple intrinsic difficulties such as lack of a standard screener as well as a reliability gap for screeners between help-seeking and general populations. On the other hand, the predominance of positive symptoms at the initial stage of psychosis is a promising aspect of this specific group. The following specific questions were examined. Is there a measurable difference between the assessment of the treating doctor and the real feelings of the patient? How well does the attained score correspond to the clinical diagnosis? Methods: The self-reported Emotions with Persecutory Delusions Scale (EPDS) questionnaire, previously validated in a general population, was used as the assessment tool for psychotic trend in 79 outpatients with epilepsy. Independent from scoring by the patients, the treating doctors also expressed their impressions about the same patients using the same scoring tool. Results: Stepwise multiple regression analysis of the EPDS scores of both doctors and patients revealed that a clinical diagnosis of psychosis was the only independent variable significantly related to EPDS score. Also, there was a significant difference between the EPDS scores of the patients and those of the doctors, in favor of the former. Significance: Clinical diagnosis of psychosis proved to be the most powerful determinant of EPDS score independent from other clinical factors. The awareness gap between doctors and patients based on EPDS score revealed that treating doctors often clearly underestimate the psychotic trend of their patients. Our findings suggest that such simple tests as EPDS, with a narrow focus on attenuated delusional symptoms, may help screen for an early psychotic episode in patients with epilepsy that may otherwise not be diagnosed by their physicians. (C) 2015 Elsevier Inc. All rights reserved.	[Kanemoto, Kousuke; Goji, Hiroko; Tadokoro, Yukari; Oshima, Tomohiro] Aichi Med Univ, Dept Neuropsychiat, Nagoya, Aichi, Japan; [Tsuda, Hisamitsu] Aichi Gakusen Univ, Okazaki, Aichi, Japan; [Tachimori, Hisateru] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [DeToffol, Bertrand] CHU Tours, Tours, France	Kanemoto, K (reprint author), Aichi Med Univ, Dept Neuropsychiat, Yazako Karintata 1-1, Nagakute, Aichi 48011, Japan.	fwkh2919@mb.infoweb.ne.dp					SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; Jarrett M, 2012, SCHIZOPHR RES, V136, P1, DOI 10.1016/j.schres.2012.01.025; Tugendhaft P, 2005, ACTA NEUROL BELG, V105, P14; Owoso A, 2014, COMPR PSYCHIAT, V55, P380, DOI 10.1016/j.comppsych.2013.10.004; Mula M, 2009, EPILEPTIC DISORD, V11, P1, DOI 10.1684/epd.2009.0238; EDEH J, 1987, BRIT J PSYCHIAT, V151, P95, DOI 10.1192/bjp.151.1.95; Bragatti JA, 2010, EPILEPTIC DISORD, V12, P283, DOI 10.1684/epd.2010.0345; TRIMBLE MR, 1990, BRIT J PSYCHIAT, V156, P195, DOI 10.1192/bjp.156.2.195; Barry JJ, 2008, EPILEPSY BEHAV, V13, pS1, DOI [10.1016/j.yebeh.2008.04.005, 10.1016/j.yebeh.20008.04.005]; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703; Kline E, 2014, SCHIZOPHR RES, V158, P11, DOI 10.1016/j.schres.2014.06.036; Kang NI, 2012, PSYCHIAT RES, V198, P501, DOI 10.1016/j.psychres.2012.03.005; Kanemoto K, 2012, THER ADV NEUROL DISO, V5, P321, DOI 10.1177/1756285612454180; van der Gaag M, 2012, SCHIZOPHRENIA BULL, V38, P1180, DOI 10.1093/schbul/sbs105; Koch-Stoecker S, 2002, EPILEPSIA, V43, P19, DOI 10.1046/j.1528-1157.2002.043s2019.x; Kanemoto K, 2001, J NEUROPSYCH CLIN N, V13, P243, DOI 10.1176/appi.neuropsych.13.2.243; Gilliam FG, 2006, LANCET NEUROL, V5, P399, DOI 10.1016/S1474-4422(06)70415-X; Qin P, 2005, BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Swinkels WAM, 2001, EPILEPSY BEHAV, V2, P441, DOI 10.1006/ebeh.2001.0242; Kanemoto K, 2001, EPILEPSIA, V42, P98, DOI 10.1046/j.1528-1157.2001.09000.x; Tadokoro Y, 2007, EPILEPSIA, V48, P2345; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Rietdijk J, 2012, ACTA PSYCHIAT SCAND, V126, P21, DOI 10.1111/j.1600-0447.2012.01839.x; Kobayashi H, 2008, SCHIZOPHR RES, V106, P356, DOI 10.1016/j.schres.2008.08.018; Matsuura M, 2004, SCHIZOPHR RES, V69, P189, DOI 10.1016/S0920-9964(02)00492-9; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Zhang TH, 2014, SCHIZOPHR RES, V152, P391, DOI 10.1016/j.schres.2013.11.039; French P, 2012, PSYCHIAT RES, V200, P911, DOI 10.1016/j.psychres.2012.07.040; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Kline E, 2012, SCHIZOPHR RES, V141, P72, DOI 10.1016/j.schres.2012.07.022; Clancy MJ, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-75; Nissen MA, 2010, PSYCHOL ASSESSMENT, V22, P935; Perez MM, 1980, BRIT J PSYCHIAT, V141, P256; Stanghellini G, 2015, J AFFECT DISORDERS, V15, P171; Tanno Y, 2000, JAPANESE J PSYCHOL, V71, P379; Tsuda H, 2011, JPN J PERS, V19, P245	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2015	51						60	64		10.1016/j.yebeh.2015.06.033		5	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CS7TW	WOS:000362290200011		
J	Ritaccio, A; Matsumoto, R; Morrell, M; Kamada, K; Koubeissi, M; Poeppel, D; Lachaux, JP; Yanagisawa, Y; Hirata, M; Guger, C; Schalk, G				Ritaccio, Anthony; Matsumoto, Riki; Morrell, Martha; Kamada, Kyousuke; Koubeissi, Mohamad; Poeppel, David; Lachaux, Jean-Philippe; Yanagisawa, Yakufumi; Hirata, Masayuki; Guger, Christoph; Schalk, Gerwin			Proceedings of the Seventh International Workshop on Advances in Electrocorticography	EPILEPSY & BEHAVIOR			English	Article						Electrocorticography; Brain-computer interface; Corticocortical evoked potentials; Brain mapping; Seizure termination; Neuroprosthetics; Subdural grid; Functional mapping; Subdural grid; Neurolinguistics	INTRACTABLE PARTIAL EPILEPSY; FUNCTIONAL CONNECTIVITY; ELECTRICAL-STIMULATION; GAMMA ACTIVITY; MOTOR SYSTEM; CORTEX; LANGUAGE; NETWORK; SPEECH; OSCILLATIONS	The Seventh International Workshop on Advances in Electrocorticography (ECoG) convened in Washington, DC, on November 13-14, 2014. Electrocorticography-basecl research continues to proliferate widely across basic science and clinical disciplines. The 2014 workshop highlighted advances in neurolinguistics, brain-computer interface, functional mapping, and seizure termination facilitated by advances in the recording and analysis of the ECoG signal. The following proceedings document summarizes the content of this successful multidisciplinary gathering. (c) 2015 Elsevier Inc.	[Ritaccio, Anthony; Schalk, Gerwin] Albany Med Coll, Albany, NY 12208 USA; [Matsumoto, Riki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Morrell, Martha] NeuroPace Inc, Mountain View, CA USA; [Kamada, Kyousuke] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Koubeissi, Mohamad] George Washington Univ, Washington, DC USA; [Poeppel, David] Max Planck Inst, Frankfurt, Germany; [Poeppel, David] NYU, New York, NY USA; [Lachaux, Jean-Philippe] Univ Lyon 1, CNRS UMR5292, INSERM U1028, Lyon Neurosci Res Ctr, F-69365 Lyon, France; [Yanagisawa, Yakufumi; Hirata, Masayuki] Osaka Univ, Grad Sch Med, Osaka, Japan; [Yanagisawa, Yakufumi] ATR Computat Neurosci Labs, Kyoto, Japan; [Guger, Christoph] Gtec Med Engn GmbH, Schiedlberg, Austria; [Schalk, Gerwin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA	Ritaccio, A (reprint author), Albany Med Coll, Dept Neurol, Albany, NY 12208 USA.	RitaccA@mail.amc.edu			Brain Machine Interface Development and Development of BMI Technologies for Clinical Application from the Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI - Japanese Society for the Promotion of Science [26282165]; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [23100101]; NIH [R01-EB00856, R21-EB006356, P41-EB018783]; U.S. Army Research Office [W911NF-08-1-0216, W911NF-12-1-0109, W911NF-14-1-0440]; Fondazione Neurone	This research was partially supported by a Brain Machine Interface Development and Development of BMI Technologies for Clinical Application grant carried out under the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.K.), by KAKENHI Grant-in-Aid for Scientific Research (26282165) funded by the Japanese Society for the Promotion of Science (K.K.), and through a Health Labour Sciences Research Grant (23100101) from the Ministry of Health, Labour and Welfare, Japan (K.K.).; This research was also partially supported by the NIH [R01-EB00856 (G.S.), R21-EB006356 (G.S.) and P41-EB018783 (G.S.)], the U.S. Army Research Office [W911NF-08-1-0216 (G.S.), W911NF-12-1-0109 (G.S.), W911NF-14-1-0440 (G.S.)J, and Fondazione Neurone (G.S. and A.L.R.).; Part of this work was performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (J.P.L.).	Koubeissi MZ, 2009, EPILEPSY BEHAV, V14, P108, DOI 10.1016/j.yebeh.2008.08.021; Roland J, 2010, EPILEPSY BEHAV, V18, P123, DOI 10.1016/j.yebeh.2010.02.017; Catenoix H, 2013, SEIZURE-EUR J EPILEP, V22, P378, DOI 10.1016/j.seizure.2013.02.008; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Vignal JP, 2007, BRAIN, V130, P88, DOI 10.1093/brain/awl329; Rosa M, 2011, NEUROSIGNALS, V19, P151, DOI 10.1159/000328508; Qian TY, 2013, J NEUROSURG, V119, P26, DOI 10.3171/2013.2.JNS12843; Potes C, 2014, NEUROIMAGE, V97, P188, DOI 10.1016/j.neuroimage.2014.04.045; Yamao Y, 2014, HUM BRAIN MAPP, V35, P4345, DOI 10.1002/hbm.22479; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Maciunas JA, 2010, EPILEPSY RES, V91, P106, DOI 10.1016/j.eplepsyres.2010.07.002; Adrian ED, 1936, J PHYSIOL-LONDON, V88, P127; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Kikuchi T, 2012, CLIN NEUROPHYSIOL, V123, P324, DOI 10.1016/j.clinph.2011.06.011; Matsumoto R, 2012, HUM BRAIN MAPP, V33, P2856, DOI 10.1002/hbm.21407; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; RILEY TL, 1981, NEUROLOGY, V31, P912; Bonini F, 2014, EPILEPSIA, V55, P264, DOI 10.1111/epi.12490; Hirata M, 2011, IEICE T COMMUN, VE94B, P2448, DOI 10.1587/transcom.E94.B.2448; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Sillay KA, 2013, BRAIN STIMUL, V6, P718, DOI 10.1016/j.brs.2013.02.001; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Jiruska P, 2010, BRAIN, V133, P1380, DOI 10.1093/brain/awq070; Brunner P, 2009, EPILEPSY BEHAV, V15, P278, DOI 10.1016/j.yebeh.2009.04.001; Ritaccio A, 2013, EPILEPSY BEHAV, V29, P259, DOI 10.1016/j.yebeh.2013.08.012; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Ramot M, 2012, J NEUROSCI, V32, P10458, DOI 10.1523/JNEUROSCI.0877-12.2012; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Katariwala NM, 2001, NEUROLOGY, V57, P1505; Poeppel D, 2012, COGN NEUROPSYCHOL, V29, P34, DOI 10.1080/02643294.2012.710600; Ossandon T, 2011, J NEUROSCI, V31, P14521, DOI 10.1523/JNEUROSCI.2483-11.2011; Prueckl R, 2013, IEEE ENG MED BIO, P6365, DOI 10.1109/EMBC.2013.6611010; Lachaux JP, 2008, CEREB CORTEX, V18, P443, DOI 10.1093/cercor/bhm085; Brunner P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00005; Embick D, 2015, LANG COGN NEUROSCI, V30, P357, DOI 10.1080/23273798.2014.980750; Genetti M, 2015, CLIN NEUROPHYSIOL, V126, P121, DOI 10.1016/j.clinph.2014.04.007; Gergondet P, 2012, STEERING ROBOT BRAIN, P271; Herff C, 2015, FRONT NEUROSCI, P9; Jerbi Karim, 2010, Front Syst Neurosci, V4, P27, DOI 10.3389/fnsys.2010.00027; Kapeller Christoph, 2014, Front Syst Neurosci, V8, P139, DOI 10.3389/fnsys.2014.00139; Kubanek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053398; Lotte F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00097; Morris S, 2015, IEEE T BIO-MED ENG, V62, P1034, DOI 10.1109/TBME.2014.2329812; Schalk G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00352	48	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2015	51						312	320		10.1016/.yebeh.2015.08.002		9	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CS7TW	WOS:000362290200049		
J	Sasaki, T				Sasaki, Toru			Dickens and the Blacking Factory Revisited	ESSAYS IN CRITICISM			English	Article									Kyoto Univ, Kyoto 6068501, Japan	Sasaki, T (reprint author), Kyoto Univ, Kyoto 6068501, Japan.						Ackroyd Peter, 1991, DICKENS, P88; Allen, 2011, C DICKENS BLACKING F, P94; Sasaki T, 2008, DICKENSIAN, V104, P32; [Anonymous], 2012, RISING GENERATION; Bodenheimer Rosemarie, 2007, KNOWING DICKENS, P19; Carey, 1973, THE VIOLENT EFFIGY, P150; Carrow G. D., 1967, DICKENSIAN, V63, P112; Dickens, 1993, SKETCHES BOZ OTHER E, P540; Douglas-Fairhurst Robert, 2011, BECOMING DICKENS, P38; Forster, 1928, LIFE C DICKENS, P25; Forster John, 1928, LIFE C DICKENS, P3; Forster John, 1928, LIFE C DICKENS, P849; Forster John, 1928, LIFE C DICKENS, P837; Gross John, 1962, DICKENS 20 CENTURY, P49; Hibbert Christopher, 1983, THE MAKING C DICKENS, P53; James Henry, 1971, DICKENS CRITICAL HER, P469; Johnson Edgar, 1953, C DICKENS HIS TRAGED, P165; Marcus, 1985, DICKENS PICKWICK DOM, P121; Nabokov Vladimir, 1975, EUGENE ONEGIN, piii; Slater Michael, 2009, C DICKENS, P581; Storey Graham, 1965, LETT C DICKENS, Vxii, P96; Wilson Angus, 1978, DICKENSIAN, V74, P111; Wilson Edmund, 1997, WOUND BOW, P7	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0014-0856	1471-6852		ESSAYS CRITICISM	Essays Critic.	OCT	2015	65	4					401	420		10.1093/escrit/cgv020		20	Literature	Literature	CT5BV	WOS:000362822900004		
J	Ritter, P; Duray, GZ; Steinwender, C; Soejima, K; Omar, R; Mont, L; Boersma, LVA; Knops, RE; Chinitz, L; Zhang, S; Narasimhan, C; Hummel, J; Lloyd, M; Simmers, TA; Voigt, A; Laager, V; Stromberg, K; Bonner, MD; Sheldon, TJ; Reynolds, D				Ritter, Philippe; Duray, Gabor Z.; Steinwender, Clemens; Soejima, Kyoko; Omar, Razali; Mont, Lluis; Boersma, Lucas V. A.; Knops, Reinoud E.; Chinitz, Larry; Zhang, Shu; Narasimhan, Calambur; Hummel, John; Lloyd, Michael; Simmers, Timothy Alexander; Voigt, Andrew; Laager, Verla; Stromberg, Kurt; Bonner, Matthew D.; Sheldon, Todd J.; Reynolds, Dwight		Micra Transcatheter Pacing Study	Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study	EUROPEAN HEART JOURNAL			English	Article						Transcatheter pacing system; Leadless cardiac pacemaker; Miniaturization	THERAPY; DEVICE; DEFIBRILLATORS; COLLABORATION; COMPLICATIONS; IMPLANTATION; GUIDELINES; INFECTION; SOCIETY; SAFETY	Aims Permanent cardiac pacing is the only effective treatment for symptomatic bradycardia, but complications associated with conventional transvenous pacing systems are commonly related to the pacing lead and pocket. We describe the early performance of a novel self-contained miniaturized pacemaker. Methods and results Patients having Class I or II indication for VVI pacing underwent implantation of a Micra transcatheter pacing system, from the femoral vein and fixated in the right ventricle using four protractible nitinol tines. Prespecified objectives were >85% freedom from unanticipated serious adverse device events (safety) and <2 V 3-month mean pacing capture threshold at 0.24 ms pulse width (efficacy). Patients were implanted (n = 140) from 23 centres in 11 countries (61% male, age 77.0 +/- 10.2 years) for atrioventricular block (66%) or sinus node dysfunction (29%) indications. During mean follow-up of 1.9 +/- 1.8 months, the safety endpoint was met with no unanticipated serious adverse device events. Thirty adverse events related to the system or procedure occurred, mostly due to transient dysrhythmias or femoral access complications. One pericardial effusion without tamponade occurred after 18 device deployments. In 60 patients followed to 3 months, mean pacing threshold was 0.51 +/- 0.22 V, and no threshold was >= 2 V, meeting the efficacy endpoint (P < 0.001). Average R-wave was 16.1 +/- 5.2 mV and impedance was 650.7 +/- 130 ohms. Conclusion Early assessment shows the transcatheter pacemaker can safely and effectively be applied. Long-term safety and benefit of the pacemaker will further be evaluated in the trial.	[Ritter, Philippe] Univ Bordeaux, CHU Bordeaux, Hop Cardiol Haut Leveque, IHU LIRYC, Bordeaux, France; [Duray, Gabor Z.] Hungarian Def Forces, Med Ctr, Clin Electrophysiol Dept Cardiol, Budapest, Hungary; [Steinwender, Clemens] Johannes Kepler Univ Linz, Sch Med, Linz Gen Hosp, Dept Cardiol, A-4040 Linz, Austria; [Soejima, Kyoko] Kyorin Univ Hosp, Dept Cardiol, Tokyo, Japan; [Omar, Razali] Natl Heart Inst, Electrophysiol & Pacing Unit, Kuala Lumpur, Malaysia; [Mont, Lluis] Univ Barcelona, Hosp Clin, Catalonia, Spain; [Boersma, Lucas V. A.] St Antonius Hosp, Nieuwegein, Netherlands; [Knops, Reinoud E.] AMC, Amsterdam, Netherlands; [Chinitz, Larry] NYU, New York, NY USA; [Zhang, Shu] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing 100730, Peoples R China; [Zhang, Shu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Narasimhan, Calambur] CARE Hosp & CARE Fdn, Dept Cardiol, Div Electrophysiol, Hyderabad, Andhra Pradesh, India; [Hummel, John] Ohio State Univ, Columbus, OH 43210 USA; [Lloyd, Michael] Emory Univ Hosp, Atlanta, GA 30322 USA; [Simmers, Timothy Alexander] Catharina Hosp, Eindhoven, Netherlands; [Voigt, Andrew] Univ Pittsburgh, Med Ctr UPMC Presbyterian, Pittsburgh, PA USA; [Laager, Verla; Stromberg, Kurt; Bonner, Matthew D.; Sheldon, Todd J.] Medtronic Plc, Mounds View, MN USA; [Reynolds, Dwight] Univ Oklahoma, Hlth Sci Ctr, OU Med Ctr, Cardiovasc Sect, Oklahoma City, OK USA	Ritter, P (reprint author), Univ Hosp Bordeaux, Dept Electrophysiol & Cardiac Pacing, Ave Magellan, F-33604 Pessac, France.	ritterph@free.fr			Medtronic plc	This work was supported by Medtronic plc as the sponsor of The Micra Transcatheter Pacing Study. Funding to pay the Open Access publication charges for this article was provided by Medtronic plc.	Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Gillis AM, 2012, J AM COLL CARDIOL, V60, P682, DOI 10.1016/j.jacc.2012.06.011; Reddy VY, 2014, CIRCULATION, V129, P1466, DOI 10.1161/CIRCULATIONAHA.113.006987; Udo EO, 2012, HEART RHYTHM, V9, P728, DOI 10.1016/j.hrthm.2011.12.014; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Crossley GH, 2009, J AM COLL CARDIOL, V54, P2012, DOI 10.1016/j.jacc.2009.10.001; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; SHAW DB, 1985, BRIT HEART J, V53, P587; Kirkfeldt RE, 2014, EUR HEART J, V35, P1186, DOI 10.1093/eurheartj/eht511; Coates S, 2000, PACE, V23, P1273, DOI 10.1111/j.1540-8159.2000.tb00943.x; DEBUITLEIR M, 1990, AM J CARDIOL, V65, P999, DOI 10.1016/0002-9149(90)91003-O; Hauser RG, 2007, HEART RHYTHM, V4, P154, DOI 10.1016/j.hrthm.2006.10.009; Johansen JB, 2011, EUR HEART J, V32, P991, DOI 10.1093/eurheartj/ehq497; Ritter P, 2015, EUROPACE, V17, P807, DOI 10.1093/europace/euv026; Senaratne J, 2006, PACE, V29, P1044, DOI 10.1111/j.1540-8159.2006.00497.x; Crossley GH, 2009, PACE, V32, P13, DOI 10.1111/j.1540-8159.2009.02171.x; Epstein AE, 2013, J AM COLL CARDIOL, V61, pE6, DOI 10.1016/j.jacc.2012.11.007; Mallela Venkateswara Sarma, 2004, Indian Pacing Electrophysiol J, V4, P201; Wollmann CG, 2014, PACE, V37, P1198, DOI 10.1111/pace.12390	20	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	OCT 1	2015	36	37					2510	2519		10.1093/eurheartj/ehv214		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT5CG	WOS:000362824500011		
J	Haam, S; Lee, S; Paik, HC; Park, MS; Song, JH; Lim, BJ; Nakao, A				Haam, Seokjin; Lee, Sungsoo; Paik, Hyo Chae; Park, Moo Suk; Song, Joo Han; Lim, Beom Jin; Nakao, Atsunori			The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	34th Annual Meeting and Scientific Session of the International-Society-of-Heart-and-Lung-Transplantation	APR 10-13, 2014	San Diego, CA	Int Soc Heart & Lung Transplantat		Hydrogen; Warm ischaemic injury; Donation after cardiac death; Ex vivo lung perfusion	HEART-BEATING DONORS; TRANSPLANTATION; DONATION; IMPROVES; MODEL; RATS	Lung transplantation is a well-established treatment of end-stage lung disease; however, it is limited by a shortage of donor lungs. To overcome this problem, donation after cardiac death (DCD) and ex vivo lung perfusion (EVLP) are being widely investigated. In this study, the effect of hydrogen gas, a known antioxidant, was investigated on a DCD lung model during EVLP. Ten pigs were randomized into either a control (n = 5) or a hydrogen group (n = 5). After fibrillation by electric shock, no further treatment was administered in order to induce warm ischaemic injury for 1 h. The lungs were then procured, followed by 4 h of EVLP. During EVLP, the lungs were ventilated with room air in the control group, and with 2% hydrogen gas in the hydrogen group. Oxygen capacity (OC), pulmonary vascular resistance (PVR) and peak airway pressure (PAP) were measured every hour, and the expressions of interleukin-1 beta (IL-1 beta), IL-6 (IL-6), IL-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha) were evaluated in lung tissue after EVLP. Pathological evaluations were performed using lung injury severity (LIS) scores and the wet/dry ratio was also measured. The OC in the hydrogen group was higher than in the control group, but the difference was not statistically significant (P = 0.0862). PVR (P = 0.0111) and PAP (P = 0.0189) were statistically significantly lower in the hydrogen group. Compared with the control group, the hydrogen group had a statistically significantly lower expression of IL-1 beta (P = 0.0317), IL-6 (P = 0.0159), IL-8 (P = 0.0195) and TNF-alpha (P = 0.0159). The LIS scores (P = 0.0358) and wet/dry ratios (P = 0.040) were also significantly lower in the hydrogen group. Hydrogen gas inhalation during EVLP improved the function of DCD lungs, which may increase the utilization of DCD lungs.	[Haam, Seokjin; Lee, Sungsoo] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Gangnam Severance Hosp, Seoul 120752, South Korea; [Paik, Hyo Chae] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Severance Hosp, Seoul 120752, South Korea; [Park, Moo Suk; Song, Joo Han] Yonsei Univ, Coll Med, Dept Internal Med, Severance Hosp, Seoul 120752, South Korea; [Lim, Beom Jin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pathol, Seoul 120752, South Korea; [Nakao, Atsunori] Hyogo Coll Med, Dept Emergency Disaster & Crit Care Med, Nishinomiya, Hyogo 6638501, Japan	Paik, HC (reprint author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, 50 Yonsei Ro, Seoul 120752, South Korea.	hcpaik@yuhs.ac					Steen S, 2003, ANN THORAC SURG, V76, P244, DOI 10.1016/S0003-4975(03)00191-7; Dong BM, 2009, AM J TRANSPLANT, V9, P2707, DOI 10.1111/j.1600-6143.2009.02840.x; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Mulloy DP, 2012, J THORAC CARDIOV SUR, V144, P1208, DOI 10.1016/j.jtcvs.2012.07.056; Zheng XF, 2011, CLIN EXP PHARMACOL P, V38, P155, DOI 10.1111/j.1440-1681.2011.05479.x; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Wigfield CH, 2011, CURR OPIN ORGAN TRAN, V16, P462, DOI 10.1097/MOT.0b013e32834a99ac; Inci I, 2008, J HEART LUNG TRANSPL, V27, P1229, DOI 10.1016/j.healun.2008.07.027; George TJ, 2012, J SURG RES, V178, P593, DOI 10.1016/j.jss.2012.06.037; Kawamura T, 2011, SURGERY, V150, P240, DOI 10.1016/j.surg.2011.05.019; Snell GI, 2008, AM J TRANSPLANT, V8, P1282, DOI 10.1111/j.1600-6143.2008.02231.x; Wierup P, 2006, ANN THORAC SURG, V81, P460, DOI 10.1016/j.athoracsur.2005.08.015; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Noda K, 2014, TRANSPLANTATION, V98, P499, DOI 10.1097/TP.0000000000000254; Dark JH, 2008, TRANSPLANTATION, V86, P200, DOI 10.1097/TP.0b013e31817c87b6; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; De Vleeschauwer S, 2009, J HEART LUNG TRANSPL, V28, P380, DOI 10.1016/j.healun.2009.01.010; Sue RD, 2004, J IMMUNOL, V172, P3860; Egan TM, 2006, ANN THORAC SURG, V81, P1205, DOI 10.1016/j.athoracsur.2005.09.034; Cypel M, 2009, SCI TRANSL MED, V1, P4; Fernandez E, 2009, EUR J CARDIO-THORAC, V35, P91; Fernandez E, 2009, EUR J CARDIO-THORAC, V35, P287, DOI 10.1016/j.ejcts.2008.10.030; Mason DP, 2012, ANN THORAC SURG, V94, P11; Mason DP, 2012, ANN THORAC SURG, V94, P406, DOI 10.1016/j.athoracsur.2012.03.059; Pierre AF, 2002, J THORAC CARDIOVASC, V123, P27; Pierre AF, 2002, J THORAC CARDIOV SUR, V123, P421, DOI 10.1067/mtc.2002.120345; Saxena P, 2014, J SURG RES, V192, P642, DOI 10.1016/j.jss.2014.07.063; Wallinder A, 2014, EUR J CARDIO-THORAC, V45, P40, DOI 10.1093/ejcts/ezt250; Wallinder A, 2014, EUR J CARDIO-THORAC, V45, P44	29	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2015	48	4					542	547		10.1093/ejcts/ezv057		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5BL	WOS:000362821600011		
J	Kato, M; Motoki, M; Isaji, T; Suzuki, T; Kawai, Y; Ohkubo, N				Kato, Masaaki; Motoki, Manabu; Isaji, Toshihiko; Suzuki, Takahiro; Kawai, Yusuke; Ohkubo, Nobukazu			Spinal cord injury after endovascular treatment for thoracoabdominal aneurysm or dissection	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Branched stent graft; Endovascular aneurysm repair; Fenestrated stent graft; Spinal cord injury; Thoracoabdominal aortic aneurysm or dissection	CEREBROSPINAL-FLUID DRAINAGE; AORTIC-ANEURYSMS; REPAIR; PARAPLEGIA; RISK; ISCHEMIA	Postoperative spinal cord injury (SCI) is a devastating complication of surgical repair for thoracoabdominal aortic aneurysm or dissection (TAAD), despite the complex reconstruction of inter-costal or lumbar arteries involved in the surgery. As an alternative technique, endovascular thoracoabdominal aneurysm repair (EVTAR) with visceral artery reconstruction has been accepted as a treatment option for severe comorbid patients of TAAD, because there is a permissible frequency of SCI after EVTAR in spite of no reconstruction of inter-costal or lumbar arteries. We report the results of EVTAR at our hospital with a focus on spinal cord injury. We analyzed data from 54 consecutive patients with TAAD (mean age, 74 +/- 9.6 years; 42 men) who underwent EVTAR at our hospital between February 2007 and February 2014. Three types of EVTAR technique were used: fenestrated and/or branched stent graft implantation in 39 patients, a hybrid technique (bypass grafts to visceral arteries and straight stent graft implantation) in 10 patients, and intentional coverage of the coeliac artery and straight stent graft implantation in 5 patients. In all patients, mean systemic blood pressure was maintained at a parts per thousand yen80 mmHg. Opioid use was avoided in the perioperative period. According to the Crawford classification, the graft coverage extent was 9% (5/54) in type I, 11% (6/54) in type II, 39% (21/54) in type III, 22%(12/54) in type IV and 19% (10/54) in type V. In most patients (74%, 40/54), cerebrospinal fluid drainage was done intraoperatively and 1 day postoperatively. Hospital mortality was 5.6% (3/54). No patient developed SCI in the perioperative period. However, in the follow-up period 2 patients developed paraplegia as a consequence of shock caused by an aortic event. With close attention to spinal cord protection, EVTAR may be associated with only a low incidence of SCI in the perioperative period. Therefore, EVTAR is expected to become a promising treatment option for appropriately selected patients with TAAD.	[Kato, Masaaki; Motoki, Manabu; Isaji, Toshihiko; Suzuki, Takahiro; Kawai, Yusuke; Ohkubo, Nobukazu] Morinomiya Hosp, Dept Cardiovasc Surg, Joutou Ku, Osaka 5360025, Japan	Kato, M (reprint author), Morinomiya Hosp, Dept Cardiovasc Surg, Joutou Ku, 2-1-88 Morinomiya, Osaka 5360025, Japan.	mkato3@gmail.com					Eagleton MJ, 2014, J VASC SURG, V59, P89, DOI 10.1016/j.jvs.2013.07.007; ACHER CW, 1994, J VASC SURG, V19, P236; Verzini F, 2014, J CARDIOVASC SURG, V55, P9; CRAWFORD ES, 1991, J VASC SURG, V13, P36; Kouchoukos NT, 2013, J THORAC CARDIOV SUR, V145, pS139, DOI 10.1016/j.jtcvs.2012.11.077; Kakinohana M, 2003, ANESTHESIOLOGY, V98, P862, DOI 10.1097/00000542-200304000-00012; Kuratani T, 2010, EUR J CARDIO-THORAC, V38, P299, DOI 10.1016/j.ejcts.2010.02.013; Svensson LG, 1998, ANN THORAC SURG, V66, P132, DOI 10.1016/S0003-4975(98)00359-2; Shimizu H, 2014, EUR J CARDIO-THORAC, V46, P40, DOI 10.1093/ejcts/ezt574; Guillou M, 2012, J VASC SURG, V56, P65, DOI 10.1016/j.jvs.2012.01.008; Reilly LM, 2012, J VASC SURG, V56, P53, DOI 10.1016/j.jvs.2012.01.006; Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024; Conrad MF, 2011, J VASC SURG, V53, P1195, DOI 10.1016/j.jvs.2010.11.055; Omura A, 2014, J THORAC CARDIOV SUR, V147, P1861, DOI 10.1016/j.jtcvs.2013.06.035; Piazza M, 2012, ANN VASC SURG, V26, P600, DOI 10.1016/j.avsg.2011.11.002; Haulon S, 2010, EUR J VASC ENDOVASC, V39, P171, DOI 10.1016/j.ejvs.2009.11.009; LeMaire Scott A, 2012, Ann Cardiothorac Surg, V1, P286, DOI 10.3978/j.issn.2225-319X.2012.08.16; Moulakakis Konstantinos G, 2012, Ann Cardiothorac Surg, V1, P267, DOI 10.3978/j.issn.2225-319X.2012.08.02; Rutherford RB, 2005, VASCULAR SURG, P1490	19	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2015	48	4					571	577		10.1093/ejcts/ezu497		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5BL	WOS:000362821600016		
J	Shiono, S; Matsutani, N; Okumura, S; Nakajima, J; Horio, H; Kohno, M; Ikeda, N; Kawamura, M				Shiono, Satoshi; Matsutani, Noriyuki; Okumura, Sakae; Nakajima, Jun; Horio, Hirotoshi; Kohno, Mitsutomo; Ikeda, Norihiko; Kawamura, Masafumi		Metastatic Lung Tumor Study Grp Ja	The prognostic impact of lymph-node dissection on lobectomy for pulmonary metastasis	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	28th Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	OCT 11-15, 2014	Milan, ITALY	European Assoc Cardio Thorac Surg		Pulmonary metastasis; Lymph-node dissection; Metastasectomy	RENAL-CELL CARCINOMA; COLORECTAL-CARCINOMA; LUNG METASTASECTOMY; MEDIASTINAL LYMPHADENECTOMY; CANCER; INVOLVEMENT; RESECTION; SURVIVAL; EXPERIENCES; SURGERY	The prevalence and characteristics of lymph-node metastasis have not been thoroughly investigated in patients with pulmonary metastases from various primary neoplasms. The necessity of performing lymph-node dissection with pulmonary metastasectomy is unknown. We retrospectively reviewed the database of the Metastatic Lung Tumor Study Group of Japan. Between November 1980 and June 2013, 4363 patients underwent resection of pulmonary metastases. After selecting for patients who underwent lobectomy, 683 patients (16%) were analysed. The presence of lymph-node metastasis, outcomes and prognoses were investigated. The primary tumour site was colorectal in 350 patients, head and neck in 73 patients, kidney in 41 patients, uterus in 41 patients and bone/soft tissue in 31 patients. The overall 5-year survival rate after pulmonary metastasectomy was 50.1%, and the 10-year survival rate was 36.4%. Lymph-node metastasis was more frequently found in uterine (27%) and head and neck cancers (29%). Five-year survival rates were 53.8% in patients without lymph-node metastasis, 39.4% in patients with hilar lymph-node metastasis and 30.8% in patients with mediastinal lymph-node metastasis. The extent of lymph-node dissection was not related to survival. Univariate analysis revealed that tumour size, the presence of lymph-node metastasis, the presence of multiple lesions, a disease-free interval of 24 months or less and incomplete resection were significant predictors of poor prognosis. Multivariate analysis confirmed these prognostic factors. Retrospective analysis of lobectomy for pulmonary metastasis demonstrated that lymph-node metastasis is a significant prognostic factor predicting poor outcome. Lymph-node sampling or dissection is therefore warranted to predict patient prognosis.	[Shiono, Satoshi] Yamagata Prefectural Cent Hosp, Dept Thorac Surg, Yamagata 9902292, Japan; [Matsutani, Noriyuki; Kawamura, Masafumi] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan; [Okumura, Sakae] Japanese Fdn Canc, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan; [Nakajima, Jun] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan; [Horio, Hirotoshi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Surg, Tokyo, Japan; [Kohno, Mitsutomo] Keio Univ, Sch Med, Dept Gen Thorac Surg, Tokyo, Japan; [Ikeda, Norihiko] Tokyo Med Univ, Dept Surg, Tokyo 1608402, Japan	Shiono, S (reprint author), Yamagata Prefectural Cent Hosp, Dept Thorac Surg, 1800 Oazaaoyagi, Yamagata 9902292, Japan.	sshiono@ypch.gr.jp					Shiono S, 2013, EUR J CARDIO-THORAC, V43, pE13, DOI 10.1093/ejcts/ezs574; Renaud S, 2013, INTERACT CARDIOV TH, V16, P525, DOI 10.1093/icvts/ivs534; Internullo E, 2008, J THORAC ONCOL, V3, P1257, DOI 10.1097/JTO.0b013e31818bd9da; Hamaji M, 2012, ANN THORAC SURG, V94, P1796, DOI 10.1016/j.athoracsur.2012.04.049; Treasure T, 2007, ANN ROY COLL SURG, V89, P744, DOI 10.1308/003588407X232198; Pastorino U, 2003, J THORAC CARDIOV SUR, V126, P1906, DOI 10.1016/S0022-5223(03)00211-3; Szoke T, 2010, INTERACT CARDIOV TH, V10, P694, DOI 10.1510/icvts.2009.213173; Garcia-Yuste M, 2010, J THORAC ONCOL, V5, pS166, DOI 10.1097/JTO.0b013e3181dcf920; Pfannschmidt J, 2006, ANN THORAC SURG, V81, P448, DOI 10.1016/j.athoracsur.2005.08.049; Welter S, 2007, EUR J CARDIO-THORAC, V31, P167, DOI 10.1016/j.ejcts.2006.11.004; Ercan S, 2004, ANN THORAC SURG, V77, P1786, DOI 10.1016/S0003-4975(03)01200-1; Shiono S, 2005, ANN THORAC SURG, V79, P278, DOI 10.1016/j.athoracsur.2004.06.096; Inoue M, 2000, ANN THORAC SURG, V70, P380, DOI 10.1016/S0003-4975(00)01417-X; Loehe F, 2001, ANN THORAC SURG, V72, P225, DOI 10.1016/S0003-4975(01)02615-7; Veronesi G, 2007, J THORAC CARDIOV SUR, V133, P967, DOI 10.1016/j.jtcvs.2006.09.104; Saito Y, 2002, J THORAC CARDIOV SUR, V124, P1007, DOI 10.1067/mtc.2002.125165; Pfannschmidt J, 2002, ANN THORAC SURG, V74, P1653, DOI 10.1016/S0003-4975(02)03803-1; Pfannschmidt J, 2003, J THORAC CARDIOV SUR, V126, P732, DOI 10.1016/S0022-5223(03)000587-7; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Bolukbas S, 2014, ANN THORAC SURG, V97, P1926, DOI 10.1016/j.athoracsur.2014.02.026; Kamiyoshihara M, 1998, ONCOL REP, V5, P453; Kudelin N, 2013, ANN THORAC SURG, V96, P265, DOI 10.1016/j.athoracsur.2013.04.047; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0	24	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2015	48	4					616	621		10.1093/ejcts/ezu533		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5BL	WOS:000362821600026		
J	Furukawa, H; Masaki, H; Tanemoto, K				Furukawa, Hiroshi; Masaki, Hisao; Tanemoto, Kazuo			Late limb embolization of biological glue after repair of aortic dissection	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Limb embolization; Biological glue; Aortic dissection			[Furukawa, Hiroshi; Masaki, Hisao; Tanemoto, Kazuo] Kawasaki Med Univ, Dept Cardiovasc Surg, Kurashiki, Okayama 7010192, Japan	Furukawa, H (reprint author), Kawasaki Med Univ, Dept Cardiovasc Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hfurukawa@med.kawasaki-m.ac.jp						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2015	48	4					633	633		10.1093/ejcts/ezv002		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5BL	WOS:000362821600031		
J	Kimura, T; Nojiri, T; Hosoda, H; Shintani, Y; Inoue, M; Miyazato, M; Okumura, M; Kangawa, K				Kimura, Toru; Nojiri, Takashi; Hosoda, Hiroshi; Shintani, Yasushi; Inoue, Masayoshi; Miyazato, Mikiya; Okumura, Meinoshin; Kangawa, Kenji			Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	23rd European Conference on General Thoracic Surgery	MAY 31-JUN 03, 2015	Lisbon, PORTUGAL			Acute exacerbation; Interstitial lung disease; Lung resection; Lung cancer; Bleomycin; Lipopolysaccharide	IDIOPATHIC PULMONARY-FIBROSIS; DIFFUSE ALVEOLAR DAMAGE; CANCER; INFLAMMATION; PNEUMONIAS; RESECTION; FEATURES; THERAPY; FLUID	Interstitial lung disease (ILD) is sometimes seen in patients with primary lung cancer. Therapeutic interventions for lung cancer patients with ILD sometimes provoke acute exacerbation (AE) of pre-existing lung disease. Although postoperative AE after lung resection is a potentially fatal complication, prophylactic treatments have yet to be established. Prophylaxis for postoperative AE is imperative for thoracic surgeons. However, no animal models for preclinical research into postoperative management and prophylactic interventions for AE of ILD have been developed. The objective of this study was to establish a new mouse model of AE of ILD, for further investigation of prophylactic interventions. C57BL/6 mice were intratracheally administered bleomycin (BLM, 1 mg/kg) or saline on Day 0 to induce pulmonary fibrosis, and lipopolysaccharide (LPS, 0.5 mg/kg) or saline to induce inflammatory stimulation on Day 7. Mice were divided into four groups: control group; LPS group; BLM group and BLM + LPS group. Histological changes and computed tomography (CT) images of the lung, lung water content, oxygen partial pressure (pO(2)) of arterial blood and cell counts and inflammatory cytokine levels in bronchoalveolar lavage fluid (BALF) were assessed on Day 8. Survival rates were also determined. In the BLM + LPS group, chest CT showed diffuse ground-glass opacities, and pO(2) was significantly decreased. The most severe inflammatory reaction was evident in the BLM + LPS group, with increased infiltrating cells on histopathology and increased lung water content. Total cell and neutrophil counts and levels of cytokines such as monocyte chemoattractant protein-1, interleukin-6 and keratinocyte chemoattractant in the BALF were significantly elevated in the BLM + LPS group. These findings mimic human AE of ILD. Furthermore, survival curves demonstrated that the BLM + LPS group had the lowest survival rate among all groups. A new mouse model of AE of ILD was developed. This model represents an attractive experimental method for preclinical research of postoperative management and prophylactic interventions for AE of ILD in lung cancer patients.	[Kimura, Toru; Nojiri, Takashi; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Kimura, Toru; Nojiri, Takashi; Shintani, Yasushi; Inoue, Masayoshi; Okumura, Meinoshin] Osaka Univ, Dept Gen Thorac Surg, Grad Sch Med, Suita, Osaka, Japan; [Hosoda, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan	Kimura, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kimura@thoracic.med.osaka-u.ac.jp					Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/00936.06.00114004; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250; Corte TJ, 2010, RESPIROLOGY, V15, P873, DOI 10.1111/j.1440-1843.2010.01802.x; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Kumar P, 2003, J THORAC CARDIOV SUR, V125, P1321, DOI 10.1016/S0022-5223(03)00028-X; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Antoniou KM, 2013, RESPIRATION, V86, P265, DOI 10.1159/000355485; McDonald B, 2009, INT J CANCER, V125, P1298, DOI 10.1002/ijc.24409; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Haupt W, 1998, DIGEST SURG, V15, P102, DOI 10.1159/000018601; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Rice AJ, 2003, AM J CLIN PATHOL, V119, P709, DOI 10.1309/UVARMDY8FE9FJDKU; Harris JM, 2010, THORAX, V65, P70, DOI 10.1136/thx.2009.121962; Liu F, 2013, J SURG RES, V185, P300, DOI 10.1016/j.jss.2013.05.083; Sato T, 2014, J THORAC CARDIOV SUR, V147, P1604, DOI 10.1016/j.jtcvs.2013.09.050; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Ogino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092710	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2015	48	4					E85	E91		10.1093/ejcts/ezv261		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CT5BL	WOS:000362821600004		
J	Das, J; Das, SK; Hasan, T; Ahmed, S; Ferdous, F; Begum, R; Chisti, MJ; Malek, MA; Mamun, AA; Faruque, ASG				Das, J.; Das, S. K.; Hasan, T.; Ahmed, S.; Ferdous, F.; Begum, R.; Chisti, M. J.; Malek, M. A.; Mamun, A. A.; Faruque, A. S. G.			Childhood malnutrition in households with contemporary siblings: a scenario from urban Bangladesh	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article								This study aimed to determine the effect of the presence of under-5 siblings (>= 1) in a household on childhood malnutrition in urban Bangladesh. During 2000 and 2013, a total of 16 948 under-5 children were enrolled in the Diarrhoeal Disease Surveillance of icddr,b. Under-5 siblings were categorised as >= 1 and none except the child himself. In univariate analysis, the presence of siblings was associated with 1.13 (risk ratios = 1.13; 95% CI: 1.06-1.20) times higher risk of being stunted, 1.17 (1.09-1.25) times for wasted and 1.19 (1.13-1.26) times underweight compared with their peers who did not have siblings. In multivariate analysis, such associations remained significant for stunting (1.08; 1.01-1.15), wasting (1.12; 1.04-1.21) and underweight (1.13, 1.06-1.19) after controlling for possible confounders such as age of child, sex, parental education, maternal employment, family size, wealth quintile and time (year). The presence of under-5 siblings increases the risk of malnutrition in children in urban Bangladesh.	[Das, J.; Das, S. K.; Ahmed, S.; Chisti, M. J.; Malek, M. A.; Faruque, A. S. G.] Int Ctr Diarrhoeal Dis Res, CNFS, Dhaka 1000, Bangladesh; [Das, S. K.; Hasan, T.; Mamun, A. A.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Hasan, T.] BRAC Univ, BRAC Inst Global Hlth, Dhaka, Bangladesh; [Ferdous, F.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Clin Trial & Clin Epidemiol, Tsukuba, Ibaraki 305, Japan; [Begum, R.] Coll Home Econ, Dept Food & Nutr, Dhaka, Bangladesh	Das, SK (reprint author), Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, CNFS, 68 Shaheed Tajuddin, Dhaka 1212, Bangladesh.	sumon@icddrb.org			icddr,b; Government of the People's Republic of Bangladesh through IHP-HNPRP	Hospital surveillance was funded by icddr,b and the Government of the People's Republic of Bangladesh through IHP-HNPRP. icddr,b is also thankful to the Governments of Australia, Bangladesh, Canada, Sweden and the United Kingdom for providing core/unrestricted support.	Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; BIDDULPH J, 1993, J PAEDIATR CHILD H, V29, P12, DOI 10.1111/j.1440-1754.1993.tb00429.x; Barros Aluísio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Das SK, 2013, PLOS ONE, V8, P62029; Farr NM, MASSGENERAL HOSP CHI, P3; Nnamuchi O., 2014, U CHI INT L REV, V11, P103; Onyango AW, 2008, TRANING COURSE CHILD; Raj A, 2014, MATERN CHILD HLTH J, V19, P1; United Nations Children's Fund WHO T W B, 2012, UNICEF WHO WORLD BAN; Urke HB, 2006, SOCIAL DETERMINANTS	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	OCT	2015	69	10					1178	1179		10.1038/ejcn.2015.75		2	Nutrition & Dietetics	Nutrition & Dietetics	CT0RM	WOS:000362504000018		
J	Tsuboi, Y; Honda, K; Bae, YC; Shinoda, M; Kondo, M; Katagiri, A; Echizenya, S; Kamakura, S; Lee, J; Iwata, K				Tsuboi, Y.; Honda, K.; Bae, Y. C.; Shinoda, M.; Kondo, M.; Katagiri, A.; Echizenya, S.; Kamakura, S.; Lee, J.; Iwata, K.			Morphological and functional changes in regenerated primary afferent fibres following mental and inferior alveolar nerve transection	EUROPEAN JOURNAL OF PAIN			English	Article							DORSAL-ROOT GANGLION; SCIATIC-NERVE; NEUROPATHIC PAIN; SODIUM-CHANNELS; WALLERIAN DEGENERATION; AXONAL REGENERATION; SENSORY NEURONS; SPINAL-CORD; RAT; EXPRESSION	Background: It is important to know the mechanisms underlying pain abnormalities associated with inferior alveolar nerve (IAN) regeneration in order to develop the appropriate treatment for orofacial neuropathic pain patients. However, peripheral mechanisms underlying orofacial pain abnormalities following IAN regeneration are not fully understood. Methods: Head withdrawal threshold (HWT), jaw opening reflex (JOR) thresholds, single-fibre recordings of the regenerated mental nerve (MN) fibres, calcitonin gene-related peptide (CGRP), isolectin B4 (IB4), peripherin, neurofilament-200 (NF-200) and transient receptor potential vanilloid 1 (TRPV1) expression in trigeminal ganglion (TG) cells, and electron microscopic (EM) observations of the regenerated MN fibres were studied in MN- and IAN-transected (M-IANX) rats. Results: HWT to mechanical or heat stimulation of the mental skin was significantly lower in M-IANX rats compared with sham rats. Mean conduction velocity of action potentials recorded from MN fibres (n = 124) was significantly slower in M-IANX rats compared with sham rats. The percentage of Fluoro-Gold (FG)-labelled CGRP-, peripherin- or TRPV1-immunoreactive (IR) cells was significantly larger in M-IANX rats compared with that of sham rats, whereas that of FG-labelled IB4- and NF-200-IR cells was significantly smaller in M-IANX rats compared with sham rats. Large-sized myelinated nerve fibres were rarely observed in M-IANX rats, whereas large-sized unmyelinated nerve fibres were frequently observed and were aggregated in the bundles at the distal portion of regenerated axons. Conclusions: These findings suggest that the demyelination of MN fibres following regeneration may be involved in peripheral sensitization, resulting in the orofacial neuropathic pain associated with trigeminal nerve injury.	[Tsuboi, Y.; Honda, K.; Shinoda, M.; Kondo, M.; Katagiri, A.; Echizenya, S.; Kamakura, S.; Iwata, K.] Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan; [Tsuboi, Y.; Shinoda, M.; Kondo, M.; Katagiri, A.; Iwata, K.] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 101, Japan; [Honda, K.] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Tokyo 101, Japan; [Bae, Y. C.] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat, Daegu, South Korea; [Lee, J.] Nihon Univ, Sch Dent, Dept Prosthodont, Tokyo 101, Japan	Iwata, K (reprint author), Nihon Univ, Sch Dent, Dept Physiol, Tokyo 101, Japan.	iwata.kouichi@nihon-u.ac.jp			MEXT; Japanese Society for Promotion of Science [24659832, 24593064, 24592818, 26460708, 26861750]	MEXT-Supported Program for Strategic Research Foundation at Private Universities, 2013-2014, Grant-in-Aid for Challenging Exploratory Research (24659832) from the Japanese Society for Promotion of Science, Grant-in-Aid for Scientific Research (C) (24593064, 24592818 and 26460708) from the Japanese Society for Promotion of Science and a Grant-in-Aid for Young Scientists (B) (26861750) from the Japanese Society for Promotion of Science.	Sugiyama T, 2013, J DENT RES, V92, P1113, DOI 10.1177/0022034513509280; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Yi XN, 2006, NEUROSCI RES, V56, P314, DOI 10.1016/j.neures.2006.07.014; Price TJ, 2006, BRAIN RES, V1112, P146, DOI 10.1016/j.brainres.2006.07.012; Shim S, 2010, EXP NEUROL, V223, P38, DOI 10.1016/j.expneurol.2009.10.001; CARTER RB, 1971, J ANAT, V108, P433; Imai T, 2003, BRAIN RES, V992, P20, DOI 10.1016/j.brainres.2003.08.023; Balkowiec-Iskra E, 2011, NEUROSCIENCE, V180, P322, DOI 10.1016/j.neuroscience.2011.02.028; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; George A, 2004, NEUROSCI LETT, V372, P215, DOI 10.1016/j.neulet.2004.09.075; OHARA S, 1986, LAB INVEST, V54, P213; Atsumi Y, 2000, BRAIN RES, V871, P201, DOI 10.1016/S0006-8993(00)02446-X; Rau KK, 2007, J NEUROPHYSIOL, V97, P2651, DOI 10.1152/jn.00840.2006; DOUGHTY SE, 1991, REGUL PEPTIDES, V35, P59, DOI 10.1016/0167-0115(91)90254-E; Webber CA, 2011, GLIA, V59, P1503, DOI 10.1002/glia.21194; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868; Wang W, 2011, ANAT REC, V294, P1406, DOI 10.1002/ar.21437; Wakisaka S, 2000, ARCH HISTOL CYTOL, V63, P91, DOI 10.1679/aohc.63.91; Davies SL, 2006, EXP NEUROL, V202, P207, DOI 10.1016/j.expneurol.2006.05.035; Ogawa A, 2005, EXP NEUROL, V192, P310, DOI 10.1016/j.expneurol.2004.11.010; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Hitomi S, 2012, NEUROSCI LETT, V513, P95, DOI 10.1016/j.neulet.2012.02.018; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/01.wnr.0000048540.12213.f2; Landry M, 2000, EXP NEUROL, V162, P361, DOI 10.1006/exnr.1999.7329; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Sleeper AA, 2000, J NEUROSCI, V20, P7279; Kqiku L, 2011, CLIN ORAL INVEST, V15, P1013, DOI 10.1007/s00784-010-0459-x; Abdulla FA, 2002, J NEUROPHYSIOL, V88, P2518, DOI 10.1152/jn.00913.2001; MEIRI H, 1985, BRAIN RES, V359, P326, DOI 10.1016/0006-8993(85)91444-1; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Robinson PP, 2004, ARCH ORAL BIOL, V49, P763, DOI 10.1016/j.archoralbio.2004.06.004; Iwata K, 1998, PAIN, V75, P27, DOI 10.1016/S0304-3959(97)00201-7; Lindå Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030; Mitchell K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-94; Nakagawa K., 2010, MOL PAIN, V3, P6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain	OCT	2015	19	9					1258	1266		10.1002/ejp.650		9	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	CT3EZ	WOS:000362691300006		
J	Akahoshi, T; Sugimori, H; Kaku, N; Tokuda, K; Nagata, T; Noda, E; Morita, M; Hashizume, M; Maehara, Y				Akahoshi, T.; Sugimori, H.; Kaku, N.; Tokuda, K.; Nagata, T.; Noda, E.; Morita, M.; Hashizume, M.; Maehara, Y.			Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						DIC; Gastrointestinal surgery; rTM; Sepsis; Panperitonitis	HUMAN SOLUBLE THROMBOMODULIN; PROTEIN; ANTITHROMBIN; THROMBIN; SCORE	Recombinant thrombomodulin (rTM) has been available in Japan since 2008, but there is concern about its association with postoperative hemorrhage. The efficacy and safety of rTM were examined in patients with disseminated intravascular coagulation (DIC) caused by a septic condition after gastrointestinal surgery. Forty-two patients were emergently admitted to the intensive care unit after emergent gastrointestinal surgery in Kyushu University Hospital from May 2008 to April 2013. Of these patients, 22 had DIC (defined as an acute DIC score a parts per thousand yen4). All but three patients received treatment with gabexate mesylate (GM) (n = 9) or rTM (n = 10). The causes of sepsis were peritonitis with colorectal perforation, anastomotic leakage, and intestinal necrosis. Acute DIC score, sepsis-related organ failure assessment score, platelet count, and a variety of biochemical parameters were compared between rTM and GM recipients after treatment administration. There were no significant differences between the groups for any parameter except C-reactive protein levels. The CRP level tended to be lower in the rTM group than in the GM group. Acute DIC score in the rTM group resolved significantly earlier than that in the GM group. No patient stopped the administration of rTM because of postoperative bleeding. rTM may be an effective therapeutic drug for the treatment of septic patients with DIC following emergent gastrointestinal surgery.	[Akahoshi, T.; Nagata, T.; Hashizume, M.] Kyushu Univ, Grad Sch Med Sci, Dept Disaster & Emergency Med, Fukuoka 812, Japan; [Akahoshi, T.; Morita, M.; Maehara, Y.] Kyushu Univ, Emergency & Crit Care Ctr, Fukuoka 812, Japan; [Akahoshi, T.; Sugimori, H.; Kaku, N.; Tokuda, K.; Noda, E.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Akahoshi, T (reprint author), Kyushu Univ, Emergency & Crit Care Ctr, Fukuoka 812, Japan.	a_tom411@yahoo.co.jp					Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Nakahara K, 2013, GUT LIVER, V7, P363, DOI 10.5009/gnl.2013.7.3.363; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; TAMURA Y, 1977, BIOCHIM BIOPHYS ACTA, V484, P417, DOI 10.1016/0005-2744(77)90097-3; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; TAENAKA N, 1983, CRIT CARE MED, V11, P735, DOI 10.1097/00003246-198309000-00013; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; Chin S, 2010, JPN J GASTROENTEROL, V43, P1007; Eguchi Y, 2010, J JPN SOC SURG INFEC, V7, P143; Iba T, 2009, CRIT CARE, V13, DOI 10.1186/cc8210; Kosugi C, 2009, JAEM, V29, P697; Sawano H, 2013, NIHON KYUKYU IGAKUKA, V24, P119; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yada N, 2011, NIHON KYUKYU IGAKUKA, V22, P749	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2015	41	5					531	538		10.1007/s00068-014-0478-4		8	Emergency Medicine	Emergency Medicine	CT0WD	WOS:000362517500010		
J	Iizuka, H; Kagoya, Y; Kataoka, K; Yoshimi, A; Miyauchi, M; Taoka, K; Kumano, K; Yamamoto, T; Hotta, A; Arai, S; Kurokawa, M				Iizuka, Hiromitsu; Kagoya, Yuki; Kataoka, Keisuke; Yoshimi, Akihide; Miyauchi, Masashi; Taoka, Kazuki; Kumano, Keiki; Yamamoto, Takashi; Hotta, Akitsu; Arai, Shunya; Kurokawa, Mineo			Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE MYELOGENOUS LEUKEMIA; SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; HEMATOPOIETIC PROGENITORS; ADULT HEMATOPOIESIS; SOMATIC MUTATIONS; IN-VITRO; THERAPY; GENERATION; THALASSEMIA	Familial platelet disorder with propensity to acute myeloid leukemia (FPD/AML) is an autosomal dominant disease associated with a germline mutation in the RUNX1 gene and is characterized by thrombocytopenia and an increased risk of developing myeloid malignancies. We generated induced pluripotent stem cells (iPSCs) from dermal fibroblasts of a patient with FPD/AML possessing a nonsense mutation R174X in the RUNX1 gene. Consistent with the clinical characteristics of the disease, FPD iPSC-derived hematopoietic progenitor cells were significantly impaired in undergoing megakaryocytic differentiation and subsequent maturation, as determined by colony-forming cell assay and surface marker analysis. Notably, when we corrected the RUNX1 mutation using transcription activator-like effector nucleases in conjunction with a donor plasmid containing normal RUNX1 cDNA sequences, megakaryopoiesis and subsequent maturation were restored in FPD iPSC-derived hematopoietic cells. These findings clearly indicate that the RUNX1 mutation is robustly associated with thrombocytopenia in patients with FPD/AML, and transcription activator-like effector nuclease-mediated gene correction in iPSCs generated from patient-derived cells could provide a promising clinical application for treatment of the disease. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Iizuka, Hiromitsu; Kagoya, Yuki; Kataoka, Keisuke; Yoshimi, Akihide; Miyauchi, Masashi; Taoka, Kazuki; Kumano, Keiki; Arai, Shunya; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Iizuka, Hiromitsu; Kagoya, Yuki; Kataoka, Keisuke; Yoshimi, Akihide; Miyauchi, Masashi; Taoka, Kazuki; Kumano, Keiki; Arai, Shunya; Kurokawa, Mineo] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 724, Japan; [Hotta, Akitsu] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Hotta, Akitsu] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan; [Hotta, Akitsu] Japan Sci & Technol Agcy JST, PRESTO, Tokyo, Japan	Kurokawa, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Arepally G, 1998, BLOOD, V92, P2600; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI [10.1172/JCI35700, 10.1172/JC135700]; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Lu M, 2009, EXP HEMATOL, V37, P924, DOI 10.1016/j.exphem.2009.05.007; Owen CJ, 2008, BLOOD, V112, P4639, DOI 10.1182/blood-2008-05-156745; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Cesana D, 2014, MOL THER, V22, P774, DOI 10.1038/mt.2014.3; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Wang YX, 2009, CELL RES, V19, P1120, DOI 10.1038/cr.2009.100; Kirito K, 2008, HAEMATOL-HEMATOL J, V93, P155, DOI 10.3324/haematol.12050; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Wang YX, 2012, CELL RES, V22, P637, DOI 10.1038/cr.2012.23; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Narayan AD, 2006, BLOOD, V107, P2180, DOI 10.1182/blood-2005-05-1922; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Sun LS, 2004, BLOOD, V103, P948, DOI 10.1182/blood-2003-07-2299; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Heller PG, 2005, BLOOD, V105, P4664, DOI 10.1182/blood-2005-01-0050; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; GERRARD JM, 1991, BRIT J HAEMATOL, V79, P246, DOI 10.1111/j.1365-2141.1991.tb04529.x; DOWTON SB, 1985, BLOOD, V65, P557; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Preudhomme C, 2009, BLOOD, V113, P5583, DOI 10.1182/blood-2008-07-168260; Song WJ, 1999, NAT GENET, V23, P166; Nishimoto N, 2010, INT J HEMATOL, V92, P194, DOI 10.1007/s12185-010-0612-y; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Satoh Y, 2012, LEUKEMIA, V26, P303, DOI 10.1038/leu.2011.202; Bujis A, 2001, BLOOD, V98, P2856; Hanna I, 2007, SCIENCE, V318, P1920	49	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	OCT	2015	43	10					849	857		10.1016/j.exphem.2015.05.004		9	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CT3GF	WOS:000362694500003		
J	Nii, T; Marumoto, T; Kohara, H; Yamaguchi, S; Kawano, H; Sasaki, E; Kametani, Y; Tani, K				Nii, Takenobu; Marumoto, Tomotoshi; Kohara, Hiroshi; Yamaguchi, Saori; Kawano, Hirotaka; Sasaki, Erika; Kametani, Yoshie; Tani, Kenzaburo			Improved hematopoietic differentiation of primate embryonic stem cells by inhibition of the PI3K-AKT pathway under defined conditions	EXPERIMENTAL HEMATOLOGY			English	Article							MARMOSET CALLITHRIX-JACCHUS; COMMON MARMOSET; ENDOTHELIAL-CELLS; BIOMEDICAL-RESEARCH; SIGNALING PATHWAYS; SELF-RENEWAL; ES CELLS; PROGENITORS; GENERATION; CULTURES	Hematopoietic stem/progenitor cells (HSPCs) derived from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have potential therapeutic applications in humans. To assess the safety and efficacy of ESC/iPSC-based therapies, reliable animal models are required prior to their clinical application. The common marmoset (CM) was recently found to be a useful nonhuman primate animal model for drug development and safety assessment. However, a method for the efficient hematopoietic differentiation of CM ESCs has not been established. In this study, we developed a novel and efficient method for differentiating CM ESCs into hematopoietic cells by transiently inhibiting the phosphoinositide 3-kinase (PI3K)-Protein kinase B (AKT) pathway, a critical pathway that maintains the undifferentiated state of CM ESCs during embryoid body (EB) formation. Compared with controls, transient inhibition of the P13K-AKT pathway resulted in a threefold increase in the proportion of enriched CD34(+) cells (p < 0.001) and an increase in the number of hematopoietic colonies on day 8 of CM EB cultures. Moreover, number of blast colonies, number of hematopoietic progenitor cell populations of CD34(+)CD117(+), CD34(+)CD45(+)' and CD43(+)CD45(+) cells, and expression of hematopoietic genes were increased by transient inhibition of the PI3K-AKT pathway. We also demonstrated that the hematopoietic progenitor cell population was increased by inhibition of PI3K in a human system. Our novel and efficient ESC differentiation method might be useful for preclinical research on human hematopoietic disorders and may be efficiently translated to human ESC/iPSC-based regenerative medicine. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nii, Takenobu; Marumoto, Tomotoshi; Kohara, Hiroshi; Yamaguchi, Saori; Kawano, Hirotaka; Tani, Kenzaburo] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Div Mol & Clin Genet, Fukuoka 812, Japan; [Kohara, Hiroshi; Tani, Kenzaburo] Univ Tokyo, Inst Med Sci, Project Div ALA Adv Med Res, Tokyo 1088639, Japan; [Sasaki, Erika] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Kametani, Yoshie] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan	Tani, K (reprint author), Univ Tokyo, Inst Med Sci, Project Div ALA Adv Med Res, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	k-tani@ims.u-tokyo.ac.jp					Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Kurita R, 2006, STEM CELLS, V24, P2014, DOI 10.1634/stemcells.2005-0499; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Hibino H, 1999, BLOOD, V93, P2839; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; Park SW, 2010, BLOOD, V116, P5762, DOI [10.1182/blood-2010-04-280719, 10.1182/blood-201004-280719]; Choi K, 1998, DEVELOPMENT, V125, P725; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Kametani Y, 2009, EXP HEMATOL, V37, P1318, DOI 10.1016/j.exphem.2009.08.003; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Choi KD, 2012, CELL REPORTS, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Lacaud G, 2004, BLOOD, V103, P886, DOI 10.1182/blood-2003-06-2149; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Abbott DH, 2003, COMPARATIVE MED, V53, P339; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Sturgeon CM, 2014, NAT BIOTECHNOL, V32, P554, DOI [10.1038/nbt.2915, 10.1038/nbt.2195]; Bone HK, 2007, J CELL SCI, V120, P1752, DOI 10.1242/jcs.003772; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Fresno Vara JA, 2004, CANC TREAT REV, V30, P193, DOI [10.1016/j.ctrv.2003.07.007, DOI 10.1016/J.CTRV.2003.07.007]; Nii T, 2014, FEBS OPEN BIO, V4, P213, DOI 10.1016/j.fob.2014.02.007; Uenishi G, 2014, STEM CELL REP, V3, P1073, DOI 10.1016/j.stemcr.2014.09.014	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	OCT	2015	43	10					901	911		10.1016/j.exphem.2015.06.001		11	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CT3GF	WOS:000362694500008		
J	Makanae, Y; Ogasawara, R; Sato, K; Takamura, Y; Matsutani, K; Kido, K; Shiozawa, N; Nakazato, K; Fujita, S				Makanae, Yuhei; Ogasawara, Riki; Sato, Koji; Takamura, Yusuke; Matsutani, Kenji; Kido, Kohei; Shiozawa, Naruhiro; Nakazato, Koichi; Fujita, Satoshi			Acute bout of resistance exercise increases vitamin D receptor protein expression in rat skeletal muscle	EXPERIMENTAL PHYSIOLOGY			English	Article							SIGNALING PATHWAY; CELLS; ENDURANCE; MTOR; PROLIFERATION; KINASE; DIFFERENTIATION; ACTIVATION; MECHANISMS; SARCOPENIA	Vitamin D and vitamin D receptor (VDR) are involved in the maintenance of skeletal muscle mass and function. Although resistance exercise is well known to enhance muscle growth and improve muscle function, the effect of resistance exercise on VDR has been unclear. We investigated intramuscular VDR expression in response to an acute bout of resistance exercise or endurance exercise. Male adult Sprague-Dawley rats were subjected to either resistance exercise (isometrically exercised via percutaneous electrical stimulation for five sets of ten 3s contractions, with a 7s interval between contractions and 3min rest intervals between sets) or endurance exercise (treadmill at 25mmin(-1) for 60min). Rats were killed immediately or 1, 3, 6 or 24h after completion of the resistance or endurance exercise, and gastrocnemius muscles were removed. Non-exercised control animals were killed in a basal state (control group). Intramuscular VDR expression was significantly higher immediately after resistance exercise and elevated for 3h after exercise compared with the control group (P<0.05), and the resistance exercise significantly increased phosphorylated ERK1/2 and Mnk1 expression (P<0.05), which may be associated with VDR expression, immediately after exercise. Additionally, intramuscular expression of cytochrome P450 27B1, an enzyme related to vitaminD metabolism, was significantly higher at 1 and 3h after exercise (P<0.05) compared with the control group. In contrast, endurance exercise had no effect on any of the measured proteins. Our results indicate that resistance exercise may be an efficient way to increase intramuscular VDR and related enzyme expression.	[Makanae, Yuhei] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan; [Ogasawara, Riki] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Sato, Koji; Takamura, Yusuke; Matsutani, Kenji; Kido, Kohei; Shiozawa, Naruhiro; Fujita, Satoshi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan; [Nakazato, Koichi] Nippon Sport Sci Univ, Grad Sch Hlth & Sport Sci, Tokyo, Japan	Fujita, S (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, I-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	safujita@fc.ritsumei.ac.jp			JSPS [25282200, 25560379]	This work was supported by JSPS KAKENHI grants 25282200 and 25560379 to S.F.	Ogasawara R, 2014, AM J PHYSIOL-ENDOC M, V306, pE1155, DOI 10.1152/ajpendo.00647.2013; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Langfort J, 1996, COMP BIOCHEM PHYS A, V114, P51, DOI 10.1016/0300-9629(95)02087-X; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; Nakazato K, 2010, MOL NUTR FOOD RES, V54, P364, DOI 10.1002/mnfr.200900145; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Li MM, 2013, TISSUE ENG PT A, V19, P2130, DOI [10.1089/ten.TEA.2012.0308, 10.1089/ten.tea.2012.0308]; Bergman BC, 1999, AM J PHYSIOL-ENDOC M, V277, pE81; Buitrago C, 2001, BBA-MOL CELL RES, V1541, P179, DOI 10.1016/S0167-4889(01)00142-2; PLOUG T, 1990, AM J PHYSIOL, V259, pE778; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99; Gregory CM, 2005, PHYS THER, V85, P358; Henry HL, 2011, BEST PRACT RES CL EN, V25, P531, DOI 10.1016/j.beem.2011.05.003; Burne THJ, 2006, BRAIN RES BULL, V69, P74, DOI 10.1016/j.brainresbull.2005.10.014; Glerup H, 2000, CALCIFIED TISSUE INT, V66, P419, DOI 10.1007/s002230010085; Ogasawara R, 2013, J APPL PHYSIOL, V114, P934, DOI 10.1152/japplphysiol.01161.2012; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320; Gilad LA, 2005, J ENDOCRINOL, V185, P577, DOI 10.1677/joe.1.05770; Ogasawara R, 2013, EUR J APPL PHYSIOL, V113, P975, DOI 10.1007/s00421-012-2511-9; Canadillas S, 2010, AM J PHYSIOL-RENAL, V298, pF1197, DOI 10.1152/ajprenal.00529.2009; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Janssen HCJP, 2002, AM J CLIN NUTR, V75, P611; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Nader GA, 2001, J APPL PHYSIOL, V90, P1936; Ogasawara R, 2013, AM J PHYSIOL-ENDOC M, V305, pE760, DOI 10.1152/ajpendo.00302.2013; Parkington JD, 2004, J APPL PHYSIOL, V97, P243, DOI 10.1152/japplphysiol.01383.2003; Ceglia L, 2013, J CLIN ENDOCR METAB, V98, pE1927, DOI 10.1210/jc.2013-2820; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163; Nakamura Hiroshi, 2003, Journal of Medical and Dental Sciences, V50, P167; Salles J, 2013, MOL NUTR FOOD RES, V57, P2137, DOI 10.1002/mnfr.201300074; Srikuea R, 2012, AM J PHYSIOL-CELL PH, V303, pC396, DOI 10.1152/ajpcell.00014.2012	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	OCT 1	2015	100	10					1168	1176		10.1113/EP085207		9	Physiology	Physiology	CT2PR	WOS:000362646000006		
J	Makino, S; Inagaki, M; Nakagawa, M				Makino, Soichiro; Inagaki, Masahide; Nakagawa, Masaki			Laminar-Turbulence Transition over the Rotor Disk in an Enclosed Rotor-Stator Cavity	FLOW TURBULENCE AND COMBUSTION			English	Article						Rotor-stator cavity; Laminar-turbulence transition; Instability; Large eddy simulation	ROTATING-DISK; FLOW; INSTABILITY	Large eddy simulation (LES) of transitional and turbulent flow are performed for a range of rotational Reynolds numbers, 4 x 10(4) a parts per thousand currency sign R e (omega) = b (2) omega/nu a parts per thousand currency sign 4 x 10(5), in both an enclosed rotor-stator annular and an enclosed rotor-stator cylindrical cavities of aspect ratio G = (b - a)/h = 5, where a and b are, respectively, the inner and outer radii of the rotor disk and h is the distance between the rotor and stator disks. Although it is well-known that the Cross-Flow instability plays an important role in the transition process to turbulence in the rotor boundary-layer, the spiral patterns related to the Streamline-Curvature (S-C) instability became dominant in this study. In addition, the structures due to secondary instability appear in the outward side of the primary spiral patterns. These structures obtained from LES are in agreement with experimental visualizations performed in this study. The results suggest that S-C instability is excited and becomes dominant in the rotor side since the rotor boundary-layer is perturbed by disturbances emanating from the stator side. Subsequently, secondary instabilities result from the interaction of the dominant S-C instability with the main flow. These instabilities seem to be the probable source of laminar-turbulence transition in the rotor boundary-layer for the present case.	[Makino, Soichiro; Inagaki, Masahide; Nakagawa, Masaki] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 48011, Japan	Makino, S (reprint author), Toyota Cent Res & Dev Labs Inc, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	makino@mosk.tytlabs.co.jp					FALLER AJ, 1991, J FLUID MECH, V230, P245, DOI 10.1017/S0022112091000782; Viaud B, 2011, J FLUID MECH, V688, P493, DOI 10.1017/jfm.2011.393; Itoh N, 1996, J FLUID MECH, V317, P129, DOI 10.1017/S0022112096000699; Czarny O, 2002, FLOW TURBUL COMBUST, V69, P51, DOI 10.1023/A:1022471329506; Inagaki M, 2005, J FLUID ENG-T ASME, V127, P1, DOI 10.1115/1.1852479; Launder B, 2010, ANNU REV FLUID MECH, V42, P229, DOI 10.1146/annurev-fluid-121108-145514; CHEAH SC, 1994, EXP THERM FLUID SCI, V9, P445, DOI 10.1016/0894-1777(94)90022-1; Serre E, 2001, J FLUID MECH, V434, P65; Craft T, 2008, FLOW TURBUL COMBUST, V80, P419, DOI 10.1007/s10494-008-9156-0; ITOH M, 1992, EXP THERM FLUID SCI, V5, P359, DOI 10.1016/0894-1777(92)90081-F; Viaud B, 2008, J FLUID MECH, V598, P451, DOI 10.1017/S0022112007009962; KOBAYASHI R, 1980, ACTA MECH, V35, P71, DOI 10.1007/BF01190058; Faller A., 1966, DYNAMICS FLUIDS PLAS, P309; Inagaki M., 1998, T JSME B, V64, P1981; LILLY DK, 1966, J ATMOS SCI, V23, P481, DOI 10.1175/1520-0469(1966)023<0481:OTIOEB>2.0.CO;2; Owen J., 1989, FLOW HEAT TRANSFER R, V1; Severac E, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2759530; TAVENER SJ, 1991, J FLUID MECH, V229, P483, DOI 10.1017/S0022112091003129	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-6184	1573-1987		FLOW TURBUL COMBUST	Flow Turbul. Combust.	OCT	2015	95	2-3			SI		399	413		10.1007/s10494-015-9619-z		15	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CS8UN	WOS:000362364500011		
J	Li, J; Tsubokura, M; Tsunoda, M				Li, Jing; Tsubokura, Makoto; Tsunoda, Masaya			Numerical Investigation of the Flow Around a Golf Ball at Around the Critical Reynolds Number and its Comparison with a Smooth Sphere	FLOW TURBULENCE AND COMBUSTION			English	Article						Golf ball; Sphere; Wake turbulence; Aerodynamics	COHERENT STRUCTURES; COFLOWING JETS; UNIFORM-FLOW; WAKES	The flow over a stationary golf ball has been numerically investigated by conducting large-eddy simulations in the subcritical, critical and supercritical regimes. A direct comparison of features of flow fields was made to a smooth sphere model. Particular attention was paid to the effect that the golf ball dimples have on the development of lateral force and wake structures. In the subcritical regime, the lateral force varies irregularly in time for both the golf ball and the smooth sphere, and the wake structures of these two models appear to be similar, indicating the limited effect of the surface roughness on the flow behaviors in this regime. In the critical regime, both the golf ball and the smooth sphere exhibit a larger magnitude lateral force oscillation compared to the subcritical cases, while the wavelengths of the flow structures show differences between the golf ball and the smooth sphere. In the supercritical regime, both the golf ball and the smooth sphere are subjected to a nonzero lateral force during a long time interval. However, the magnitude of the lateral force acting on the golf ball is much smaller due to the relatively more concentrated and less asymmetric wake structures compared to the smooth sphere.	[Li, Jing] Hokkaido Univ, Grad Sch Engn, Div Mech & Space Engn, Lab Computat Fluid Mech, Sapporo, Hokkaido 0600808, Japan; [Tsubokura, Makoto] Kobe Univ, Grad Sch Syst Informat, Dept Computat Sci,Computat Fluid Dynam Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tsubokura, Makoto] RIKEN, Adv Inst Computat Sci, Complex Phenomena Unified Simulat Res Team, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Tsunoda, Masaya] Sumitomo Rubber Ind Ltd, Res Dept 1, Res & Dev HQ, Chuo Ku, Kobe, Hyogo 6510071, Japan	Tsubokura, M (reprint author), Kobe Univ, Grad Sch Syst Informat, Dept Computat Sci,Computat Fluid Dynam Lab, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	jingli@eis.hokudai.ac.jp; tsubo@tiger.kobe-u.ac.jp; m-tsunoda.az@srigroup.co.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT [RSS21]; Japan Society for the Promotion of Science (JSPS) [26289033]	This work was supported by following grants: "Strategic Programs for Innovative Research" Field No. 4: Industrial Innovations from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)'s "Development and Use of Advanced, High-Performance, General-Purpose Supercomputers Project" and carried out in partnership with the University of Tokyo for the improvement of FrontFlow/red-Aero for High Performance Computing simulation; "Revolutionary Simulation Software (RSS21)" by MEXT for the development of FrontFlow/red; Japan Society for the Promotion of Science (JSPS) Grant-in Aid for Scientific Research (KAKENHI) (B) Number 26289033 for the physical mechanism of surface roughness and its separation. Computational resources were provided by following supercomputer systems: HITACHI SR16000 M1 at Hokkaido University; HITACHI HA8000-tc/HT210 at Kyushu University and Dell PowerEdge R620 at Center for Research on Innovative Simulation Software, Institute of Industrial Science, University of Tokyo.	ACHENBAC.E, 1972, J FLUID MECH, V54, P565, DOI 10.1017/S0022112072000874; ACHENBAC.E, 1974, J FLUID MECH, V62, P209, DOI 10.1017/S0022112074000644; Muto M, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3673571; Beratlis N, 2012, J TURBUL, V13, P1, DOI 10.1080/14685248.2012.676182; BEARMAN PW, 1976, AERONAUT QUART, V27, P112; DAVIES JM, 1949, J APPL PHYS, V20, P821, DOI 10.1063/1.1698540; PERRY AE, 1980, J FLUID MECH, V101, P243, DOI 10.1017/S0022112080001644; PERRY AE, 1984, J FLUID MECH, V141, P197, DOI 10.1017/S002211208400080X; Constantinescu G, 2004, PHYS FLUIDS, V16, P1449, DOI 10.1063/1.1688325; Choi J, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2191848; Wieselsberger C, 1922, PHYS Z, V23, P219; Norman AK, 2011, EXP FLUIDS, V51, P1439, DOI 10.1007/s00348-011-1161-8; Norman AK, 2011, J FLUID MECH, V675, P268, DOI 10.1017/S0022112011000164; TANEDA S, 1978, J FLUID MECH, V85, P187, DOI 10.1017/S0022112078000580; SAKAMOTO H, 1990, J FLUID ENG-T ASME, V112, P386, DOI 10.1115/1.2909415; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; PERRY AE, 1978, J FLUID MECH, V88, P451, DOI 10.1017/S0022112078002207; Norman AK, 2011, EXP FLUIDS, V51, P1031, DOI 10.1007/s00348-011-1126-y; Smith CE, 2010, INT J HEAT FLUID FL, V31, P262, DOI 10.1016/j.ijheatfluidflow.2010.01.002; Hunt J.C.R., 1988, STUDYING TURBULENCE, V2, P193, DOI DOI 10.1017/S002211200800236X; Mehta R. D., 2001, MAT SCI SPORTS, P185; Moin P., 1997, SCI AM, V276, P46, DOI [DOI 10.1038/SCIENTIFICAMERICAN0197-62, 10.1038/scientificamerican0197-62]; Schlichting H., 1955, BOUNDARY LAYER THEOR; Tsubokura M., 2009, 2009010007 SAE; Yun G, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2166454	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-6184	1573-1987		FLOW TURBUL COMBUST	Flow Turbul. Combust.	OCT	2015	95	2-3			SI		415	436		10.1007/s10494-015-9630-4		22	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CS8UN	WOS:000362364500012		
J	Ikushima, S; Zhao, Y; Boeke, JD				Ikushima, Shigehito; Zhao, Yu; Boeke, Jef D.			Development of a Tightly Controlled Off Switch for Saccharomyces cerevisiae Regulated by Camphor, a Low-Cost Natural Product	G3-GENES GENOMES GENETICS			English	Article						CamR; Pseudomonas putida; TetR homolog; Tet system	PROMOTER; GENES; CAMR; TRANSCRIPTION; EXPRESSION; REPRESSOR; PLASMID; OPERON	Here we describe the engineering of a distant homolog of the Tet repressor, CamR, isolated from Pseudomonas putida, that is regulated by camphor, a very inexpensive small molecule (at micromolar concentrations) for use in Saccharomyces cerevisiae. The repressor was engineered by expression from a constitutive yeast promoter, fusion to a viral activator protein cassette, and codon optimization. A suitable promoter responsive to the CamR fusion protein was engineered by embedding a P. putida operator binding sequence within an upstream activating sequence (UAS)-less CYC1 promoter from S. cerevisiae. The switch, named the Camphor-Off switch, activates expression of a reporter gene in camphor-free media and represses it with micromolar concentrations of camphor.	[Ikushima, Shigehito; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Ikushima, Shigehito; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Ikushima, Shigehito] KIRIN Co Ltd, Cent Labs Key Technol, Kanagawa 2360004, Japan; [Zhao, Yu; Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10011 USA; [Zhao, Yu; Boeke, Jef D.] NYU, Langone Med Ctr, Dept Biochem & Mol Pharmacol, New York, NY 10011 USA	Boeke, JD (reprint author), NYU, Langone Med Ctr, Inst Syst Genet, 550 First Ave,MSB 238, New York, NY 10011 USA.	jef.boeke@nyumc.org			DARPA CLIO program [N66001-12-C-4020]	We thank Dr. Leslie Mitchell, Mr. James Martin, Ms. Katrina Caravelli, Ms. Anna Sliva, and the iGEM team of Johns Hopkins University for technical support and for sharing valuable plasmids. This study was supported by the DARPA CLIO program (contract no. N66001-12-C-4020).	Aramaki H, 2011, GENES CELLS, V16, P1200, DOI 10.1111/j.1365-2443.2011.01563.x; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; FUJITA M, 1993, J BACTERIOL, V175, P6953; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440; ARAMAKI H, 1993, J BACTERIOL, V175, P7828; KANEKO Y, 1985, MOL CELL BIOL, V5, P248; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Mao XC, 2002, CURR MICROBIOL, V45, P37, DOI 10.1007/s00284-001-0046-0; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Maya D, 2008, BIOTECHNOL LETT, V30, P979, DOI 10.1007/s10529-008-9647-z; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Gomes-Carneiro MR, 1998, MUTAT RES-GEN TOX EN, V416, P129, DOI 10.1016/S1383-5718(98)00077-1	15	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	OCT 1	2015	5	10					1983	1990		10.1534/g3.114.012765		8	Genetics & Heredity	Genetics & Heredity	CT0SB	WOS:000362505600005		
J	Hendi, SH; Sheykhi, A; Rad, MS; Matsuno, K				Hendi, S. H.; Sheykhi, A.; Rad, M. Sepehri; Matsuno, K.			Slowly rotating dilatonic black holes with exponential form of nonlinear electrodynamics	GENERAL RELATIVITY AND GRAVITATION			English	Article						Slowly rotating black hole; Dilaton gravity; Nonlinear electrodynamics	QUANTUM ELECTRODYNAMICS; STRING THEORY; DIMENSIONS; GRAVITY; FIELD; ENERGY; TENSOR	The generalization of the four-dimensional Kerr-Newman black holes to include the nonlinear electrodynamics has been one of the famous problems in black hole physics. In this paper, we address the effects of the small rotation parameter on the exact black hole solutions of Einstein-dilaton gravity coupled to the exponential. nonlinear electrodynamics. We rind a new stationary black hole solutions of this theory, in the limit of small angular momentum, and in the presence of Liouville-type potential for the dilaton field and an arbitrary value of the dilaton coupling constant. We compute the angular momentum and the gyromagnetic ratio of these rotating dilaton black holes. Interestingly enough, we find that the nonlinearity of the electrodynamics do not affect the angular momentum and the gyromagnetic ratio of the spacetime, while in contrast, the dilaton field can modify the angular momentum as well as the gyromagnetic ratio of the rotating black holes. We rind the gyromagnetic ratio as g = 6/(3 - alpha(2)), where a is the coupling constant of the dilaton and the electrodynamic fields. For a = 0, we arrive at g = 2, which is the gyromagnetic ratio of the Kerr-Newman black holes in four dimensions.	[Hendi, S. H.; Sheykhi, A.] Shiraz Univ, Dept Phys, Coll Sci, Shiraz 71454, Iran; [Hendi, S. H.; Sheykhi, A.] Shiraz Univ, Biruni Observ, Coll Sci, Shiraz 71454, Iran; [Hendi, S. H.; Sheykhi, A.] Res Inst Astrophys & Astron Maragha, Maragha, Iran; [Rad, M. Sepehri] Ctr Funct Connect Seoul, Korea Inst Sci & Technol, Seoul, South Korea; [Matsuno, K.] Osaka City Univ, Dept Math & Phys, Sumiyoshi, Osaka 5588585, Japan	Hendi, SH (reprint author), Shiraz Univ, Dept Phys, Coll Sci, Shiraz 71454, Iran.	hendi@shirazu.ac.ir; asheykhi@shirazu.ac.ir; masoud.alahverdi@gmail.com; matsuno@sci.osaka-cu.ac.ip			CFC grant; Research Institute for Astronomy and Astrophysics of Maragha, Iran	K. M. would like to thank H. Ishihara for fruitful comments. S. H. H. and A. S. thank the Shiraz University Research Council. M. S. is supported by a CFC grant. The works of S. H. H. and A. S. have been supported financially by the Research Institute for Astronomy and Astrophysics of Maragha, Iran.	ABRAMOWITZ M., 1972, HDB MATH FUNCTIONS; Allaverdizadeh M, 2014, INT J MOD PHYS D, V23, DOI 10.1142/S0218271814500321; Anninos D, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/07/030; Blazquez-Salcedo JL, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.024038; HORNE JH, 1992, PHYS REV D, V46, P1340, DOI 10.1103/PhysRevD.46.1340; Roychowdhury D, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.106009; BERGSHOEFF E, 1987, PHYS LETT B, V188, P70, DOI 10.1016/0370-2693(87)90707-6; Gibbons GW, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171102; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; MYERS RC, 1986, ANN PHYS-NEW YORK, V172, P304, DOI 10.1016/0003-4916(86)90186-7; Cvetic M, 1996, NUCL PHYS B, V476, P118, DOI 10.1016/0550-3213(96)00355-0; Allahverdizadeh M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.064034; BROWN JD, 1994, PHYS REV D, V50, P6394, DOI 10.1103/PhysRevD.50.6394; Hendi SH, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.044044; Allahverdizadeh M, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.084049; Brihaye Y, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.105013; Allahverdizadeh M, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.044001; Cambiaso M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.101502; BELINSKY V, 1980, PHYS LETT B, V89, P195, DOI 10.1016/0370-2693(80)90008-8; Kim HC, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.024045; Cvetic M, 1996, PHYS REV D, V54, P2612, DOI 10.1103/PhysRevD.54.2612; Sheykhi A, 2008, PHYS LETT B, V666, P82, DOI 10.1016/j.physletb.2008.06.068; Lee HW, 2010, EUR PHYS J C, V70, P367, DOI 10.1140/epjc/s10052-010-1463-7; de Haro S, 2001, COMMUN MATH PHYS, V217, P595, DOI 10.1007/s002200100381; Sheykhi A, 2010, GEN RELAT GRAVIT, V42, P367, DOI 10.1007/s10714-009-0854-2; Hendi SH, 2014, ADV HIGH ENERGY PHYS, DOI 10.1155/2014/390101; Chong ZW, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.041901; Hendi SH, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.084051; Hendi SH, 2014, INT J MOD PHYS D, V23, DOI 10.1142/S0218271814500953; Ali-Haimoud Y, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.124033; Ghosh T, 2003, CLASSICAL QUANT GRAV, V20, P1403, DOI 10.1088/0264-9381/20/7/311; Aliev AN, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.024011; Hawking SW, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.064005; Sheykhi A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.104019; Roychowdhury D, 2013, PHYS LETT B, V718, P1089, DOI 10.1016/j.physletb.2012.11.019; Sheykhi A, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.104022; Ge XH, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/10/009; Kunz J, 2007, PHYS LETT B, V649, P463, DOI 10.1016/j.physletb.2007.04.030; Chemissany WA, 2007, J HIGH ENERGY PHYS; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; TSEYTLIN AA, 1986, NUCL PHYS B, V276, P391, DOI 10.1016/0550-3213(86)90303-2; Ghosh T, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.087504; Sheykhi A, 2007, INT J MOD PHYS A, V22, P4849, DOI 10.1142/S0217751X07037032; FROLOV VP, 1987, ANN PHYS-LEIPZIG, V44, P371; Pani P, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.087501; Kunz J, 2006, PHYS LETT B, V639, P362, DOI 10.1016/j.physletb.2006.06.066; Cai RG, 1999, MOD PHYS LETT A, V14, P1895, DOI 10.1142/S0217732399001966; Aliev AN, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.104016; Balasubramanian V, 1999, COMMUN MATH PHYS, V208, P413, DOI 10.1007/s002200050764; Heisenberg W, 1936, Z PHYS, V98, P714, DOI 10.1007/BF01343663; Hendi SH, 2010, PROG THEOR PHYS, V124, P493; Yajima H, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.064007; BROWN JD, 1993, PHYS REV D, V47, P1407, DOI 10.1103/PhysRevD.47.1407; GROSS DJ, 1987, NUCL PHYS B, V291, P41, DOI 10.1016/0550-3213(87)90465-2; Aliev AN, 2006, MOD PHYS LETT A, V21, P751, DOI 10.1142/S0217732306019281; STEHLE P, 1966, PHYS REV, V152, P1135, DOI 10.1103/PhysRev.152.1135; Sheykhi A, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.124025; Gibbons GW, 2005, J GEOM PHYS, V53, P49, DOI 10.1016/j.geomphys.2004.05.001; CHAN KCK, 1995, NUCL PHYS B, V447, P441, DOI 10.1016/0550-3213(95)00205-7; Allahverdizadeh M, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.024030; Sheykhi A, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064073; Lombardo DJC, 2005, GEN RELAT GRAVIT, V37, P847, DOI 10.1007/s10714-005-0071-6; Cvetic M, 1996, NUCL PHYS B, V477, P449, DOI 10.1016/0550-3213(96)00391-4; Allahverdizadeh M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.084002; Cai RG, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.126007; Ayzenberg D, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.044066; BIALYNIC.Z, 1970, PHYS REV D, V2, P2341, DOI 10.1103/PhysRevD.2.2341; Cai RG, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/09/115; Chamblin A, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.064018; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Cvetic M, 1999, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/1999/04/024; Delphenich D.H., ARXIVHEPTH0610088; Delphenich D.H., ARXIVHEPTH0309108; Dirac PAM, 1964, LECT QUANTUM MECH; FRADKIN ES, 1985, PHYS LETT B, V163, P123, DOI 10.1016/0370-2693(85)90205-9; Gangopadhyay S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2012)156; Gangopadhyay S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2012)002; GIBBONS GW, 1986, ANN PHYS-NEW YORK, V167, P201, DOI 10.1016/S0003-4916(86)80012-4; Hendi SH, 2013, ANN PHYS-NEW YORK, V333, P282, DOI 10.1016/j.aop.2013.03.008; Hendi SH, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2012)065; Jing JL, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2011)045; Kats Y, 2007, J HIGH ENERGY PHYS; Maldacena J M, 1998, ADV THEOR MATH PHYS, V2, P231, DOI DOI 10.1023/A:1026654312961; Matsaev R., 1987, PHYS LETT B, V193, P205; Riazi N., 2006, INT J THEOR PHYS, V45, P2453, DOI 10.1007/s10773-006-9213-1; Seiberg N., 1999, J HIGH ENERGY PHYS, V9909; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6; Youm D., 1999, Physics Reports, V316, DOI 10.1016/S0370-1573(99)00037-X; Yue R.-H., 2011, GEN RELATIV GRAVIT, V43, P22103	89	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-7701	1572-9532		GEN RELAT GRAVIT	Gen. Relativ. Gravit.	OCT	2015	47	10							117	10.1007/s10714-015-1959-4		14	Astronomy & Astrophysics; Physics, Multidisciplinary; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	CS8UQ	WOS:000362365000009		
J	Imakawa, K; Nakagawa, S; Miyazawa, T				Imakawa, Kazuhiko; Nakagawa, So; Miyazawa, Takayuki			Baton pass hypothesis: successive incorporation of unconserved endogenous retroviral genes for placentation during mammalian evolution	GENES TO CELLS			English	Review							JAAGSIEKTE SHEEP RETROVIRUS; MEMBRANE-PROTEIN SYNCYTIN; OLFACTORY RECEPTOR GENES; ENVELOPE GENE; CELL-FUSION; FUNCTIONAL-CHARACTERIZATION; BETARETROVIRUSES ENJSRVS; CHORIOALLANTOIC PLACENTA; MULTIGENE FAMILIES; IMPRINTED GENE	It is well accepted that numerous RNAs derived from endogenous retroviruses (ERVs) are expressed in mammalian reproductive structures, particularly in the uterus, trophoblast, and placenta. Syncytin 1 and syncytin 2 in humans and syncytin A and syncytin B in mice are membrane proteins originating from Env genes of ERVs. These ERVs are involved in the fusion of trophoblast cells, resulting in multinucleated syncytiotrophoblast formation. Evidence accumulated indicates that syncytin-like fusogenic proteins are expressed in the placenta of rabbits, dogs/cats, ruminant ungulates, tenrecs, and opossums. The syncytin genes so far characterized are known to be endogenized to the host genome only within the past 12-80 million years, more recently than the appearance of mammalian placentas, estimated to be 160-180 million years ago. We speculate that ERVs including syncytin-like gene variants integrated into mammalian genomes in a locus-specific manner have replaced the genes previously responsible for cell fusion. We therefore propose the baton pass' hypothesis, in which multiple successive ERV variants take over' cell-fusion roles, resulting in increased trophoblast cell fusion, morphological variations in placental structures, and enhanced reproductive success in placental mammals.	[Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan; [Nakagawa, So] Tokai Univ, Sch Med, Dept Mol Life Sci, Biomed Informat Lab, Isehara, Kanagawa 2591193, Japan; [Miyazawa, Takayuki] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Lab Signal Transduct, Kyoto 6068507, Japan	Imakawa, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Nakagawa, So/Q-2712-2015	Nakagawa, So/0000-0003-1760-3839			Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Carter AM, 2004, PLACENTA, V25, P218, DOI 10.1016/j.placenta.2003.08.009; Dunlap KA, 2005, BIOL REPROD, V73, P271, DOI 10.1095/biolreprod.105.039776; Nakaya Y, 2013, J VIROL, V87, P10563, DOI 10.1128/JVI.01398-13; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0409509102; WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; ODUOROKELO D, 1983, J REPROD FERTIL, V68, P311; Caceres M, 2006, J HERED, V97, P100, DOI 10.1093/jhered/esj011; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Schubert SW, 2008, J BIOL CHEM, V283, P5460, DOI 10.1074/jbc.M710110200; Pfarrer C, 1999, ANAT EMBRYOL, V199, P63, DOI 10.1007/s004290050210; Kudo Y, 2002, PLACENTA, V23, P536, DOI 10.1053/plac.2002.0839; Freyer C, 2003, J EXP ZOOL PART A, V299A, P59, DOI 10.1002/jez.a.10291; Arnaud F, 2008, CELL MOL LIFE SCI, V65, P3422, DOI 10.1007/s00018-008-8500-9; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Hayward MD, 2007, PATHOLOGY, V39, P406, DOI 10.1080/00313020701444572; Baba K, 2011, J VIROL, V85, P1237, DOI 10.1128/JVI.01234-10; Mi S, 2000, NATURE, V403, P785; Dorniak P, 2013, J ANIM SCI, V91, P1627, DOI 10.2527/jas.2012-5845; Spencer TE, 2003, J VIROL, V77, P749, DOI 10.1128/JVI.77.1.749-753.2003; Nakaya Y, 2014, J VIROL, V88, P6896, DOI 10.1128/JVI.00288-14; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Palmarini M, 2000, J VIROL, V74, P8065, DOI 10.1128/JVI.74.17.8065-8076.2000; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.0.014; Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011; Cornelis G, 2013, P NATL ACAD SCI USA, V110, pE828, DOI 10.1073/pnas.1215787110; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Enders AC, 2006, CELLS TISSUES ORGANS, V183, P141, DOI 10.1159/000095988; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Redelsperger F, 2014, J VIROL, V88, P7915, DOI 10.1128/JVI.00141-14; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Koshi K, 2011, PLACENTA, V32, P493, DOI 10.1016/j.placenta.2011.04.002; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607; Cornelis G, 2012, P NATL ACAD SCI USA, V109, pE432, DOI 10.1073/pnas.1115346109; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Dunlap KA, 2006, PLACENTA, V27, pS135, DOI 10.1016/j.placenta.2005.12.009; Lavialle C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0507; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; KING BF, 1974, AM J ANAT, V140, P405, DOI 10.1002/aja.1001400307; Kudaka W, 2008, PLACENTA, V29, P282, DOI 10.1016/j.placenta.2007.11.009; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Mess A, 2003, J EXP ZOOL PART A, V299A, P78, DOI 10.1002/jez.a.10292; Dewannieux M, 2013, CURR OPIN VIROL, V3, P646, DOI 10.1016/j.coviro.2013.08.005; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Cornelis G, 2014, P NATL ACAD SCI USA, V111, pE4332, DOI 10.1073/pnas.1412268111; Chang C, 2004, BIOL REPROD, V71, P1956, DOI 10.1095/biolreprod.104.033340; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; BHIWGADE DA, 1992, ACTA ANAT, V145, P248; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Muroi Y, 2009, REPRODUCTION, V138, P945, DOI 10.1530/REP-09-0082; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Crocker IP, 2007, PLACENTA, V28, P408, DOI 10.1016/j.placenta.2006.05.009; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Carter A. M., 2014, REPROD DOMESTIC RUMI, P387; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; desParseval N, 2003, J VIROL, V77, P10414; dossReis M, 2012, P ROY SOC LOND B BIO, V279, P3491; Esnault C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003400; Heidmann O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-107; HUGHEE AL, 1992, GENETICS, V132, P863; Nakamura Y., 2011, J MAMM OVA RES, V28, P203, DOI DOI 10.1274/JMOR.28.203; Naruse M, 2014, DEVELOPMENT, V141, P4763, DOI 10.1242/dev.114520; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; WOODING FBP, 1984, AM J ANAT, V170, P233, DOI 10.1002/aja.1001700208	87	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					771	788		10.1111/gtc.12278		18	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800001		
J	Shcherbakova, K; Nakayama, H; Shimamoto, N				Shcherbakova, Ksenia; Nakayama, Hideki; Shimamoto, Nobuo			Role of 100S ribosomes in bacterial decay period	GENES TO CELLS			English	Article							ESCHERICHIA-COLI-CELLS; GREEN FLUORESCENT PROTEIN; MODULATION FACTOR RMF; STATIONARY-PHASE; INCLUSION-BODIES; DEGRADATION; AGGREGATION; TRANSLATION; SENSITIVITY; CHROMOPHORE	Ribosomal proteins S10 and S2 were each fused with GFP to track the fates of these proteins in the stationary growth phase and the following decay period in Escherichia coli. The fused proteins localized mainly in the cytoplasm, and their amounts were proportional to the colony-forming unit. S10-GFP strains that lacked genes responsible for regulating 100S ribosomes and S2-GFP strain that was unable to form 100S both showed shortened stationary phases. This result indicates that these strains exhibit earlier death in the absence of 100S formation (S2-GFP, S10-GFPrmf and S10-GFPhpf) and breakdown (S10-GFPyfiA). Therefore, in addition to the mere presence of 100S, the correct timing of 100S formation and breakdown is required to maintain viability. We propose a model in which 100S acts as a tentative repository of ribosomes that are protected from degradation and provide a source of amino acids in later growth period.	[Shcherbakova, Ksenia; Nakayama, Hideki; Shimamoto, Nobuo] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan	Shimamoto, N (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	nshima@cc.kyoto-su.ac.jp			MEXT [S1101029]; Kyoto Sangyo University; Japan-India Science Cooperative Program	This work was supported by grant S1101029 from MEXT and Kyoto Sangyo University and by the Japan-India Science Cooperative Program. We thank Dr Koreaki Ito of the same university and Dr Akira Wada of Yoshida Biological Laboratory for helpful discussions and Ms Harriet Sallach for reading the manuscript.	CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309; Ito Y, 1999, BIOCHEM BIOPH RES CO, V264, P556, DOI 10.1006/bbrc.1999.1541; KOCH AL, 1955, J BIOL CHEM, V217, P947; Yoshida H, 2002, J BIOCHEM, V132, P983; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Piir K, 2011, EMBO REP, V12, P458, DOI 10.1038/embor.2011.47; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Ueta M, 2005, GENES CELLS, V10, P1103, DOI 10.1111/j.1365-2443.2005.00903.x; TALENS A, 1973, EUR J BIOCHEM, V37, P121, DOI 10.1111/j.1432-1033.1973.tb02966.x; KANE JF, 1988, TRENDS BIOTECHNOL, V6, P95, DOI 10.1016/0167-7799(88)90065-0; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; Pink M, 2010, ELECTROPHORESIS, V31, P593, DOI 10.1002/elps.200900481; SHIMOMURA O, 1979, FEBS LETT, V104, P220, DOI 10.1016/0014-5793(79)80818-2; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; DAHLBERG AE, 1969, J MOL BIOL, V41, P139, DOI 10.1016/0022-2836(69)90131-4; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Izutsu K, 2001, GENES CELLS, V6, P665, DOI 10.1046/j.1365-2443.2001.00457.x; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Agafonov DE, 2001, EMBO REP, V2, P399; DAVIS BD, 1986, J BACTERIOL, V166, P439; Stepanenko OV, 2011, BIOTECHNIQUES, V51, P313, DOI 10.2144/000113765; Kato T, 2010, STRUCTURE, V18, P719, DOI 10.1016/j.str.2010.02.017; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Aiso T, 2005, J BACTERIOL, V187, P1951, DOI 10.1128/JB.187.6.1951-1958.2005; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Baba Tomoya, 2006, Mol Syst Biol, V2; BENHAMID.F, 1966, BIOCHIM BIOPHYS ACTA, V119, P183, DOI 10.1016/0005-2787(66)90049-9; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; MCCARTHY BJ, 1962, BIOCHIM BIOPHYS ACTA, V55, P880; Nakayama H, 2014, J MICROBIOL, V52, P891, DOI 10.1007/s12275-014-4501-6; Yoshida H, 2014, WIRES RNA, V5, P723, DOI 10.1002/wrna.1242	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					789	801		10.1111/gtc.12273		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800002		
J	Uozumi, T; Hamakawa, M; Deno, Y; Nakajo, N; Hirotsu, T				Uozumi, Takayuki; Hamakawa, Masayuki; Deno, Yu-ki; Nakajo, Nobushige; Hirotsu, Takaaki			Voltage-dependent anion channel (VDAC-1) is required for olfactory sensing in Caenorhabditis elegans	GENES TO CELLS			English	Article							NUCLEOTIDE-GATED CHANNEL; BCL-2 FAMILY PROTEINS; RAS-MAPK PATHWAY; C-ELEGANS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; SENSORY NEURONS; HEXOKINASE-II; MITOCHONDRIAL; KINASE	The Ras-MAP kinase signaling pathway plays important roles for the olfactory reception in olfactory neurons in Caenorhabditis elegans. However, given the absence of phosphorylation targets of MAPK in the olfactory neurons, the mechanism by which this pathway regulates olfactory function is unknown. Here, we used proteomic screening to identify the mitochondrial voltage-dependent anion channel VDAC-1 as a candidate target molecule of MAPK in the olfactory system of C.elegans. We found that Amphid Wing C (AWC) olfactory neuron-specific knockdown of vdac-1 caused severe defects in chemotaxis toward AWC-sensed odorants. We generated a new vdac-1 mutant using the CRISPR-Cas9 system, with this mutant also showing decreased chemotaxis toward odorants. This defect was rescued by AWC-specific expression of vdac-1, indicating that functions of VDAC-1 in AWC neurons are essential for normal olfactory reception in C.elegans. We observed that AWC-specific RNAi of vdac-1 reduced AWC calcium responses to odorant stimuli and caused a decrease in the quantity of mitochondria in the sensory cilia. Behavioral abnormalities in vdac-1 knockdown animals might therefore be due to reduction of AWC response, which might be caused by loss of mitochondria in the cilia. Here, we showed that the function of VDAC-1 is regulated by phosphorylation and identified Thr175 as the potential phosphorylation site of MAP kinase.	[Uozumi, Takayuki; Hamakawa, Masayuki; Deno, Yu-ki; Nakajo, Nobushige; Hirotsu, Takaaki] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Nakajo, Nobushige; Hirotsu, Takaaki] Kyushu Univ, Grad Sch Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Hirotsu, Takaaki] Kyushu Univ, Div Appl Med Sensing, Res & Dev Ctr Taste & Odor Sensing, Nishi Ku, Fukuoka 8190395, Japan	Hirotsu, T (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	hirotsu.takaaki.056@m.kyushu-u.ac.jp			JSPS; Senri Life Science Foundation; Inamori Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Health Foundation; Mishima Kaiun Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development [24425, E-4]	We thank the Caenorhabditis Genetic Center (CGC) for providing the strains, A. Miyawaki and T. Nagai for providing YC3.60, and members of our laboratory for study discussion. This research was supported by a JSPS Grant-in-aid for Young Scientists (A), Grant-in-Aid for Scientific Research (C), Senri Life Science Foundation, Inamori Foundation, The Kurata Memorial Hitachi Science and Technology Foundation, The Japan Health Foundation, Mishima Kaiun Memorial Foundation, and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (Type E-4, 24425).	Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Chappell WH, 2011, ONCOTARGET, V2, P135; Rostovtseva T, 1997, BIOPHYS J, V72, P1954; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Martel C, 2013, HEPATOLOGY, V57, P93, DOI 10.1002/hep.25967; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Shimizu S, 1999, NATURE, V399, P483; Chou JH, 2001, GENETICS, V157, P211; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Birnby DA, 2000, GENETICS, V155, P85; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; KOGA M, 1995, MECH DEVELOP, V53, P15, DOI 10.1016/0925-4773(95)00417-3; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ROGALSKI TM, 1982, GENETICS, V102, P725; Manczak M, 2013, J ALZHEIMERS DIS, V37, P679, DOI 10.3233/JAD-130761; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2445.2005.00856.x; Arsenovic PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044038; Martel C, 2014, MITOCHONDRION, V19, P69, DOI 10.1016/j.mito.2014.07.009; Robertson H. M., 2006, PUTATIVE CHEMORECEPT, P1; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Taniguchi G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005136; Uozumi T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00500; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					802	816		10.1111/gtc.12269		15	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800003		
J	Le, HP; Masuda, Y; Tsurimoto, T; Maki, S; Katayama, T; Furukohri, A; Maki, H				Le, Hang Phuong; Masuda, Yuji; Tsurimoto, Toshiki; Maki, Satoko; Katayama, Tsutomu; Furukohri, Asako; Maki, Hisaji			Short CCG repeat in huntingtin gene is an obstacle for replicative DNA polymerases, potentially hampering progression of replication fork	GENES TO CELLS			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI CHROMOSOME; SYNTHESIS IN-VITRO; TRINUCLEOTIDE REPEATS; TRIPLET REPEATS; HUMAN-DISEASE; DEPENDENT INSTABILITY; ENZYMATIC REPLICATION; LEADING-STRAND; III HOLOENZYME	Trinucleotide repeats (TNRs) are highly unstable in genomes, and their expansions are linked to human disorders. DNA replication is reported to be involved in TNR instability, but the current models are insufficient in explaining TNR expansion is induced during replication. Here, we investigated replication fork progression across huntingtin (HTT)-gene-derived fragments using an Escherichia coli oriC plasmid DNA replication system. We found most of the forks to travel smoothly across the HTT fragments even when the fragments had a pathological length of CAG/CTG repeats (approximately 120 repeats). A little fork stalling in the fragments was observed, but it occurred within a short 3-flanking region downstream of the repeats. This region contains another short TNR, (CCG/CGG)(7), and the sense strand containing CCG repeats appeared to impede the replicative DNA polymerase Pol III. Examining the behavior of the human leading and lagging replicative polymerases Pol epsilon (hPol epsilon) and Pol delta (hPol) on this sequence, we found hPol replicating DNA across the CCG repeats but hPol epsilon stalling at the CCG repeats even if the secondary structure is eliminated by a single-stranded binding protein. These findings offer insights into the distinct behavior of leading and lagging polymerases at CCG/CGG repeats, which may be important for understanding the process of replication arrest and genome instability at the HTT gene.	[Le, Hang Phuong; Maki, Satoko; Furukohri, Asako; Maki, Hisaji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Div Syst Biol, Nara 6300192, Japan; [Masuda, Yuji] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Nagoya, Aichi 4648601, Japan; [Masuda, Yuji] Nagoya Univ, Grad Sch Med, Dept Toxicogen, Showa Ku, Nagoya, Aichi 4668550, Japan; [Tsurimoto, Toshiki] Kyushu Univ, Sch Sci, Dept Biol, Fukuoka 8128581, Japan; [Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Furukohri, A (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Div Syst Biol, Nara 6300192, Japan.	furukori@bs.naist.jp	Masuda, Yuji/I-6315-2014		Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan [21870023, 25840009, 25291077, 25131713]	We thank Dr Marc S. Wold (University of Iowa College of Medicine, Iowa City, IA) for providing an RPA expression plasmid, Dr Naoto Arai (Nihon University) for generous gifts of TNR-containing plasmids, Dr Shou Waga for help in the gel retardation analysis, and Dr Hisashi Tatebe for help in the human genome analysis. This work was supported by Grants-in-Aid for Scientific Research KAKENHI [21870023, 25840009 to A.F., 25291077, 25131713 to H.M.] from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; VANDERENDE A, 1985, P NATL ACAD SCI USA, V82, P3954; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Delagoutte E, 2008, J BIOL CHEM, V283, P13341, DOI 10.1074/jbc.M800153200; MITAS M, 1995, BIOCHEMISTRY-US, V34, P12803, DOI 10.1021/bi00039a041; MAKI H, 1988, J BIOL CHEM, V263, P6570; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; Gerhardt J, 2014, MOL CELL, V53, P19, DOI 10.1016/j.molcel.2013.10.029; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Lee JY, 2008, BIOCHEMISTRY-US, V47, P3389, DOI 10.1021/bi702013d; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090; Sugaya Y, 2002, GENES CELLS, V7, P385, DOI 10.1046/j.1365-2443.2002.00527.x; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349.2003; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Schweitzer JK, 1999, GENETICS, V152, P953; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1365-2443.2004.00716.x; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Iyer RR, 2000, J BIOL CHEM, V275, P2174, DOI 10.1074/jbc.275.3.2174; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; MITAS M, 1995, NUCLEIC ACIDS RES, V23, P1050, DOI 10.1093/nar/23.6.1050; Murakami T, 2010, J BIOL CHEM, V285, P34608, DOI 10.1074/jbc.M110.166710; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; FUNNELL BE, 1986, J BIOL CHEM, V261, P5616; Walsh E, 2013, J MOL BIOL, V425, P232, DOI 10.1016/j.jmb.2012.11.016; KANG SM, 1995, J BIOL CHEM, V270, P27014; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Panigrahi GB, 2002, J BIOL CHEM, V277, P13926, DOI 10.1074/jbc.M109761200; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; RECKMANN B, 1985, EUR J BIOCHEM, V152, P633, DOI 10.1111/j.1432-1033.1985.tb09242.x; Wells RD, 1996, J BIOL CHEM, V271, P2875; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Smelkova N, 2001, J BIOL CHEM, V276, P39186, DOI 10.1074/jbc.M104411200; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; HIASA H, 1994, J BIOL CHEM, V269, P6058; desMezer M., 2011, NUCLEIC ACIDS RES, V39, P3852; GACY AM, 1995, CELL, V81, P533; The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					817	833		10.1111/gtc.12275		17	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800004		
J	Fukuda, M; Oyama, Y; Nishitarumizu, A; Omura, M; Nose, K; Deshimaru, M				Fukuda, Masatora; Oyama, Yui; Nishitarumizu, Azusa; Omura, Miki; Nose, Kanako; Deshimaru, Masanobu			Identification of an RNA element for specific coordination of A-to-I RNA editing on HTR2C pre-mRNA	GENES TO CELLS			English	Article							DOUBLE-STRANDED-RNA; 5HT(2C) RECEPTOR; ADAR DEAMINASES; SITE; EXPRESSION; DISORDERS; BRAIN	Adenosine-to-Inosine (A-to-I) RNA editing is an intracellular mechanism in which inosine is specifically substituted against adenosine by the action of adenosine deaminases acting on RNA (ADARs). Serotonin 2C receptor (HTR2C) is encoded through combinatorial A-to-I RNA editing at recoding sites (A - E site) on its pre-mRNA. Although the efficiency of RNA editing at particular sites is known to be critical for modulating the serotonin signaling, the mechanistic details of site-specific editing on HTR2C pre-mRNA are not fully understood. Toward complete understanding of this mechanism, we discovered an RNA element, which coordinates site-specific RNA editing on HTR2C pre-mRNA by an invitro editing assay and secondary structural analysis of mutant HTR2C RNA fragments. Our results showed that HTR2C pre-mRNA forms a characteristic structure, which was restricted by the internal loop and Watson-Crick base-pair interaction on site E, for intrinsic editing. We suggest that the internal loop would contribute toward adjusting the relative distance and/or geometry between the editing sites and the scaffold for ADAR.	[Fukuda, Masatora; Oyama, Yui; Nishitarumizu, Azusa; Omura, Miki; Nose, Kanako; Deshimaru, Masanobu] Fukuoka Univ, Dept Chem, Fac Sci, Jonan Ku, Fukuoka 8140180, Japan	Fukuda, M (reprint author), Fukuoka Univ, Dept Chem, Fac Sci, Jonan Ku, Nanakuma 8-19-1, Fukuoka 8140180, Japan.	masatora@fukuoka-u.ac.jp			Japan Society for the Promotion of Science [23710263]; Central Research Institute of Fukuoka University [151042]	This work was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (No. 23710263) and funds from the Central Research Institute of Fukuoka University (No. 151042).	Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Stephens OM, 2004, CHEM BIOL, V11, P1239, DOI 10.1016/j.chembiol.2004.06.009; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Iwamoto K, 2009, RNA BIOL, V6, P248; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; O'Neil RT, 2012, NEUROBIOL DIS, V45, P8, DOI 10.1016/j.nbd.2011.08.026; Nurpeisov V, 2003, J CLIN MICROBIOL, V41, P3306, DOI 10.1128/JCM.41.7.3306-3311.2003; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Rueter SM, 1999, NATURE, V399, P75; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Niswender CM, 1998, CELL MOL LIFE SCI, V54, P946, DOI 10.1007/s000180050225; Wahlstedt H, 2011, WIRES RNA, V2, P761, DOI 10.1002/wrna.89; Carmel L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002663; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Maas Stefan, 2006, RNA Biol, V3, P1; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Rieder LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3232	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					834	846		10.1111/gtc.12272		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800005		
J	Terawaki, S; Kitano, K; Aoyama, M; Mori, T; Hakoshima, T				Terawaki, Shin-ichi; Kitano, Ken; Aoyama, Miki; Mori, Tomoyuki; Hakoshima, Toshio			MT1-MMP recognition by ERM proteins and its implication in CD44 shedding	GENES TO CELLS			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; HEMOPEXIN-LIKE DOMAIN; RADIXIN FERM DOMAIN; STRUCTURAL BASIS; CELL-MIGRATION; CYTOPLASMIC TAIL; CRYSTALLOGRAPHIC CHARACTERIZATION; 1-MATRIX METALLOPROTEINASE; TUMOR-CELLS; BINDING	Membrane type 1-matrix metalloproteinase (MT1-MMP) is a key enzyme involved in tumor cell invasion by shedding their cell-surface receptor CD44 anchored with F-actin through ezrin/radixin/moesin (ERM) proteins. We found the cytoplasmic tail of MT1-MMP directly binds the FERM domain of radixin, suggesting F-actin-based recruitment of MT1-MMP to CD44 for invasion. Our crystal structure shows that the central region of the MT1-MMP cytoplasmic tail binds subdomain A of the FERM domain, and makes an antiparallel beta-beta interaction with beta 2A-strand. This binding mode is distinct from the previously determined binding mode of CD44 to subdomain C. We showed that radixin simultaneously binds both MT1-MMP and CD44, indicating ERM protein-mediated colocalization of MT1-MMP and its substrate CD44 and anchoring to F-actin. Our study implies that ERM proteins contribute toward accelerated CD44 shedding by MT1-MMP through ERM protein-mediated interactions between their cytoplasmic tails.	[Terawaki, Shin-ichi; Kitano, Ken; Aoyama, Miki; Mori, Tomoyuki; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan	Hakoshima, T (reprint author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Uehara Memorial Foundation, Japan	We thank J. Tsukamoto for technical support in performing the MALDI-TOF MS analysis and the beamline staff of BL38B1 of SPring-8 at Harima for help with the data collection. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area 'Structural Cell Biology' (to T. H. and S. T.) and a Grant-in-Aid for Scientific Research for Young Scientists (to K. K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We also appreciate receipt of a research grant from the Uehara Memorial Foundation, Japan (to T. H.).	Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Hofmann UB, 2003, CANCER RES, V63, P8221; Terawaki SI, 2008, ACTA CRYSTALLOGR F, V64, P911, DOI 10.1107/S1744309108026869; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Sato T, 1997, J CELL SCI, V110, P589; Deschamps AM, 2008, AM J PHYSIOL-HEART C, V294, pH875, DOI 10.1152/ajpheart.00918.2007; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Gingras D, 2008, FEBS LETT, V582, P399, DOI 10.1016/j.febslet.2007.12.029; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Ueno H, 1997, CANCER RES, V57, P2055; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Hamada K, 2000, ACTA CRYSTALLOGR D, V56, P922, DOI 10.1107/S0907444900006363; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.0.CO;2-G; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page-McCaw A., 2007, NAT REV MOL CELL BIO, V8, P21	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					847	859		10.1111/gtc.12276		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800006		
J	Kobashigawa, Y; Amano, S; Yokogawa, M; Kumeta, H; Morioka, H; Inouye, M; Schlessinger, J; Inagaki, F				Kobashigawa, Yoshihiro; Amano, Shinjiro; Yokogawa, Mariko; Kumeta, Hiroyuki; Morioka, Hiroshi; Inouye, Masayori; Schlessinger, Joseph; Inagaki, Fuyuhiko			Structural analysis of the mechanism of phosphorylation of a critical autoregulatory tyrosine residue in FGFR1 kinase domain	GENES TO CELLS			English	Article							GROWTH-FACTOR RECEPTOR; TRANS-PHOSPHORYLATION; CRYSTAL-STRUCTURE; AUTOPHOSPHORYLATION; HADDOCK; SUBSTRATE; INSIGHTS; DOCKING; TARGETS; SYSTEM	Receptor and nonreceptor tyrosine kinases are enzymes that play important roles in regulating signal transduction pathways in a variety of normal cellular process and in many pathological conditions. Ordered phosphorylation is required for receptor tyrosine kinase (RTK) activation, a process mediated by transient dimer formation of the kinase domains. This process is triggered by the tyrosine phosphorylation in the activation loop. Here, we report structural and biochemical analyses of the tyrosine kinase domain interaction of fibroblast growth factor receptor 1 (FGFR1) required for the initial phosphorylation step. On the basis of nuclear magnetic resonance (NMR) analysis and covalent cross-linking experiments, we propose a parallel symmetric dimer model where specific contacts are formed between the N-lobes and C-lobes, respectively, in the FGFR1 kinase domains. Moreover, assignment of the contact sites between two FGFR1 kinase domains are supported by a trans-phosphorylation assay and by mutational analyses. The present report shows the molecular mechanism underlying the control of trans-phosphorylation of a critical auto-regulatory site in FGF receptors' catalytic domain.	[Kobashigawa, Yoshihiro; Amano, Shinjiro; Yokogawa, Mariko; Kumeta, Hiroyuki; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0600810, Japan; [Kobashigawa, Yoshihiro; Morioka, Hiroshi] Kumamoto Univ, Dept Analyt & Biophys Chem, Fac Life Sci, Kumamoto 8620973, Japan; [Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Schlessinger, Joseph] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Inagaki, F (reprint author), Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0600810, Japan.	finagaki@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was partly supported by the Grant-in-Aid for Scientific Research on Innovative Areas (F.I.), by Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (F.I.) and by the Grant-in-Aid for Scientific Research (Y.K. and H.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; DICKENS M, 1992, BIOCHEM BIOPH RES CO, V186, P244, DOI 10.1016/S0006-291X(05)80799-5; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Vajpai N, 2014, BIOMOL NMR ASSIGN, V8, P85, DOI 10.1007/s12104-013-9458-6; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; WEI L, 1995, J BIOL CHEM, V270, P8122; Bae JH, 2010, P NATL ACAD SCI USA, V107, P2866, DOI 10.1073/pnas.0914157107; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Al-Obeidi FA, 1998, BIOPOLYMERS, V47, P197, DOI 10.1002/(SICI)1097-0282(1998)47:3<197::AID-BIP2>3.0.CO;2-H; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Hu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041731; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Murray BW, 2001, BIOCHEMISTRY-US, V40, P10243, DOI 10.1021/bi010959e; Schlessinger J., 2014, COLD SPRING HARB PER, V6	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	OCT	2015	20	10					860	870		10.1111/gtc.12277		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CT4BL	WOS:000362750800007		
J	Shimojima, K; Okumura, A; Hayashi, M; Kondo, T; Inoue, H; Yamamoto, T				Shimojima, Keiko; Okumura, Akihisa; Hayashi, Masaharu; Kondo, Takayuki; Inoue, Haruhisa; Yamamoto, Toshiyuki			CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly	GENOMICS			English	Article						Induced pluripotent stem (iPS) cell; Neuronal migration disorder; PAFAH1B1 (LIS1); TUBA1A; Coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2)	PLURIPOTENT STEM-CELLS; CORTICAL DEVELOPMENT; HUNTINGTONS-DISEASE; TUBA1A MUTATION; CEREBRAL-CORTEX; MIGRATION; MALFORMATIONS; EXPRESSION; EVOLUTION; GENE	The human cerebral cortex is peculiar for a six-layered cellular-sheet structure with convolution, which is a consequence of neuronal migration. Dysfunctions of the pathways contributing to this mechanism typically lead to lissencephaly manifesting smooth brain surfaces. To investigate the unknown mechanism underlying neuronal migration disorders, we generated induced pluripotent stem (iPS) cells from two patients with lissencephaly. Whole gene expression study for iPS cells derived from a patient with a LIS1 deletion showed reduced expression of the coiled-coil-helix-coiled-coil-helix domain containing 2 gene (CHCHD2), which was also confirmed in iPS cells derived from a patient with a TUBA1A mutation. CHCHD2 expression was detected in neuronal cells differentiated from normal iPS cells in a time-dependent manner, as well as in the brain of a fetus at 26-28 week gestational age, suggesting development-dependent expression. Migrating neuronal cells showed CHCHD2 expression, suggesting its functional relevance to neuronal migration. (C) 2015 Elsevier Inc. All rights reserved.	[Shimojima, Keiko] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Shimojima, Keiko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Okumura, Akihisa] Juntendo Univ, Dept Pediat, Tokyo, Japan; [Okumura, Akihisa] Aichi Med Univ, Dept Pediat, Nagakute, Aichi 48011, Japan; [Hayashi, Masaharu] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Tokyo, Japan; [Kondo, Takayuki; Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Kondo, Takayuki; Inoue, Haruhisa] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Precursory Research for Embryonic Science and Technology (PRESTO) program in Japan Science and Technology Agency (JST), Kawaguchi, Japan; Japan Society for the Promotion of Science (JSPS) [24791090]; Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Ministry of Health, Labor and Welfare, Japan; Mother and Child Health Foundation in Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development (AMED); CREST; Program for Intractable Diseases Research utilizing disease-specific iPS cells of the JST; JST; Ministry of Education, Culture, Sports, Science and Technology of Japan (Innovative Area Foundation of Synapse and Neurocircuit Pathology) [22110007]; Mochida Memorial Foundation for Medical and Pharmaceutical Research;  [23110534]	We thank the patients and their families for their cooperation. We acknowledge the RIKEN BRC for providing us iPS cells through the National Bio-Resource Project of the MEXT, Japan. This work was mainly supported by a grant from the Precursory Research for Embryonic Science and Technology (PRESTO) program in Japan Science and Technology Agency (JST), Kawaguchi, Japan. It was partially supported by a Grant-in-Aid for Young Scientists (B) (24791090), Japan Society for the Promotion of Science (JSPS), a grant from the Japan Epilepsy Research Foundation (JERF), and a grant from Kanae Foundation for the promotion of Medical Science in Japan (K.S.). In addition, it was partially supported by a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" (23110534); a Grant-in-Aid of Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan; a grant from the Mother and Child Health Foundation in Japan; and a grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development (AMED) (T.Y.). This research was also funded in part by a grant from CREST; a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan; the Program for Intractable Diseases Research utilizing disease-specific iPS cells of the JST; the grant for Core Center for iPS Cell Research of Research Center Network for Realization of Regenerative Medicine from JST; the Ministry of Education, Culture, Sports, Science and Technology of Japan (Innovative Area Foundation of Synapse and Neurocircuit Pathology [22110007]); and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (H.I.).	Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Filges I, 2011, J MED GENET, V48, P117, DOI 10.1136/jmg.2010.084582; Tian GL, 2010, HUM MOL GENET, V19, P3599, DOI 10.1093/hmg/ddq276; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Seo M, 2010, FASEB J, V24, P464, DOI 10.1096/fj.09-137562; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Shimojima K, 2012, J HUM GENET, V57, P580, DOI 10.1038/jhg.2012.71; Molnar Z, 2011, BRAIN BEHAV EVOLUT, V78, P94, DOI 10.1159/000327325; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Shimojima K, 2010, EPILEPSY RES, V89, P303, DOI 10.1016/j.eplepsyres.2010.02.002; Okumura A, 2010, EARLY HUM DEV, V86, P665, DOI 10.1016/j.earlhumdev.2010.09.001; Okumura A, 2013, BRAIN DEV-JPN, V35, P274, DOI 10.1016/j.braindev.2012.05.006; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Ohnuki M., 2009, CURR PROTOC STEM CEL, V9:A:4A.2; Pramparo T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001331; Shimojima K., 2015, DATA BRIEF IN PRESS; Shimojima Keiko, 2014, BMC Res Notes, V7, P465, DOI 10.1186/1756-0500-7-465; Xia GB, 2013, J MOL NEUROSCI, V51, P237, DOI 10.1007/s12031-012-9930-2; Yahata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025788	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	OCT	2015	106	4					196	203		10.1016/j.ygeno.2015.07.001		8	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	CS9DG	WOS:000362388700002		
J	Murakami, K; Hirano, H; Watanabe, Y; Edahiro, A; Ohara, Y; Yoshida, H; Kim, HY; Takagi, D; Hironaka, S				Murakami, Kohji; Hirano, Hirohiko; Watanabe, Yutaka; Edahiro, Ayako; Ohara, Yuki; Yoshida, Hideyo; Kim, Hunkyung; Takagi, Daisuke; Hironaka, Shouji			Relationship between swallowing function and the skeletal muscle mass of older adults requiring long-term care	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						dysphagia; long-term care; modified water swallowing test; Skeletal Muscle Mass Index; tongue motility	NUTRITIONAL-STATUS; DYSPHAGIA; SARCOPENIA; PEOPLE	AimThe present study investigated the risk factors for dysphagia among older adults who require long-term care, and also examined their systemic decrease in skeletal muscle mass. MethodsWe evaluated 399 people who required long-term care and who were residing in Omori town, Yokote city, Akita prefecture, Japan. We then analyzed data from 255 participants who had complete information available regarding their sex, age, case history (stroke, Parkinson's disease and dementia), Barthel Index, Skeletal Muscle Mass Index, oral function test and modified water swallowing test results. Participants' water swallowing test results were used to create groups with good or poor swallowing function, and a univariate analysis was carried out for each parameter. Parameters with a P-value of <0.25 in the univariate analysis were subsequently included in a multiple logistic regression model as explanatory variables, and good or poor swallowing function were defined as the dependent variables. ResultsAfter adjusting for age and sex, our analysis showed that poor tongue motility (odds ratio 17.23, 95% confidence interval 5.90-50.31, P<0.001) and decreased Skeletal Muscle Mass Index (odds ratio 3.36, 95% confidence interval 1.41-7.99, P=0.006) were significantly correlated with decreased swallowing function. ConclusionsDecreased swallowing function was closely correlated with poor tongue motility, and this finding is similar to those of previous studies. However, the present results also show that decreased Skeletal Muscle Mass Index is a novel risk factor for dysphagia among older adults who require long-term care. Geriatr Gerontol Int 2015; 15: 1185-1192.	[Murakami, Kohji; Takagi, Daisuke; Hironaka, Shouji] Showa Univ, Sch Dent, Div Hyg & Oral Hlth, Dept Special Needs Dent, Tokyo 142, Japan; [Hirano, Hirohiko; Edahiro, Ayako; Yoshida, Hideyo; Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo 1730015, Japan; [Ohara, Yuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Hlth Educ, Tokyo, Japan; [Watanabe, Yutaka] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, Aichi, Japan	Hirano, H (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 32-2 Sakae Cho, Tokyo 1730015, Japan.	hhirano@tmig.or.jp			Comprehensive Research on Aging and Health from Japan Agency for Medical Research and development, AMED [15dk0107004h0003]	This research is partially supported by the Comprehensive Research on Aging and Health (15dk0107004h0003) from Japan Agency for Medical Research and development, AMED.	Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Mithal A, 2013, OSTEOPOROSIS INT, V24, P1555, DOI 10.1007/s00198-012-2236-y; ZENNER PM, 1995, DYSPHAGIA, V10, P27, DOI 10.1007/BF00261276; Ha L, 2010, CLIN NUTR, V29, P567, DOI 10.1016/j.clnu.2010.01.011; Gibson AL, 2008, AM J CLIN NUTR, V87, P332; Tamura F, 2002, DYSPHAGIA, V17, P235, DOI 10.1007/s00455-002-0063-6; Sumi Y, 2009, ARCH GERONTOL GERIAT, V48, P100, DOI 10.1016/j.archger.2007.10.010; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Rofes L, 2010, NEUROGASTROENT MOTIL, V22, P851, DOI 10.1111/j.1365-2982.2010.01521.x; Donini LM, 2003, INT PSYCHOGERIATR, V15, P73, DOI 10.1017/S1041610203008779; Kikutani T, 2013, GERIATR GERONTOL INT, V13, P50, DOI 10.1111/j.1447-0594.2012.00855.x; LEOPOLD NA, 1983, ARCH PHYS MED REHAB, V64, P371; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Rabadi MH, 2008, NEUROLOGY, V71, P1856, DOI 10.1212/01.wnl.0000327092.39422.3c; Miller N, 2006, AGE AGEING, V35, P614, DOI 10.1093/ageing/afl105; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Sheiham A, 2001, J DENT RES, V80, P408; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123; Kakinoki Yasuaki, 2004, Gerodontology, V21, P229, DOI 10.1111/j.1741-2358.2004.00037.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Mizuhashi F, 2010, JPN J GERODONTOL, V24, P374; Okayama H, 2010, JJSDH, V31, P723; Rosenberg IH, 1997, J NUTR, V127, P990; Sato E, 2013, GERIATR GERONTOL INT, V14, P549; Statistics Bureau Japan, STAT HDB JAP 2014	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	OCT	2015	15	10					1185	1192		10.1111/ggi.12572		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CT1HN	WOS:000362549300006		
J	Tsuruta, Y; Kikuchi, K; Tsuruta, Y; Sasaki, Y; Moriyama, T; Itabashi, M; Takei, T; Uchida, K; Akiba, T; Tsuchiya, K; Nitta, K				Tsuruta, Yuki; Kikuchi, Kan; Tsuruta, Yukio; Sasaki, Yuko; Moriyama, Takahito; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Akiba, Takashi; Tsuchiya, Ken; Nitta, Kosaku			Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study	HEMODIALYSIS INTERNATIONAL			English	Article						Endothelial dysfunction; hyperuricemia; hemodialysis; chronic kidney disease; febuxostat	SERUM URIC-ACID; CHRONIC KIDNEY-DISEASE; ALL-CAUSE; CARDIOVASCULAR MORTALITY; GOUTY-ARTHRITIS; RENAL-FUNCTION; RISK-FACTOR; ALLOPURINOL; ASSOCIATION; DYSFUNCTION	Endothelial dysfunction is often found in both hyperuricemia and hemodialysis patients. Recent studies have shown that treating hyperuricemia with allopurinol improves endothelial dysfunction. This study is performed to assess the effect of febuxostat on endothelial dysfunction in hemodialysis patients with hyperuricemia. We randomly assigned 53 hemodialysis patients with hyperuricemia to a febuxostat (10mg daily) group and a control group and measured flow-mediated dilation, serum uric acid (UA) levels, systolic and diastolic blood pressure, malondialdehyde-modified low-density lipoprotein (MDA-LDL), and highly sensitive C-reactive protein (hsCRP) at baseline and at the end of a 4-week study period. Flow-mediated dilation increased from 5.3%+/- 2.4% to 8.9%+/- 3.6% in the febuxostat group but did not change significantly in the control group. Treatment with febuxostat resulted in a significant decrease in serum UA level and a significant decrease in MDA-LDL compared with baseline, but no significant difference was observed in hsCRP level or blood pressure. No significant differences were observed in the control group. Febuxostat improved endothelial dysfunction and reduced serum UA levels and oxidative stress in hemodialysis patients with hyperuricemia.	[Tsuruta, Yuki; Kikuchi, Kan; Tsuruta, Yukio; Sasaki, Yuko; Moriyama, Takahito; Itabashi, Mitsuyo; Takei, Takashi; Uchida, Keiko; Akiba, Takashi; Tsuchiya, Ken; Nitta, Kosaku] Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo 1628666, Japan; [Tsuruta, Yuki] Tokyo Metropolitan Geriatr Hosp, Dept Nephrol & Blood Purificat, Tokyo 173, Japan	Tsuruta, Y (reprint author), Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yuki@kb4.so-net.ne.jp					Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Cohen SD, 2008, J AM SOC NEPHROL, V19, P2204, DOI 10.1681/ASN.2007111256; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Lee SMK, 2009, AM J NEPHROL, V29, P79, DOI 10.1159/000151292; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Culleton BF, 1999, ANN INTERN MED, V131, P7; Keenan RT, 2011, AM J MED, V124, P155, DOI 10.1016/j.amjmed.2010.09.012; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Tsuruta Y, 2014, CLIN RHEUMATOL, V33, P1643, DOI 10.1007/s10067-014-2745-5; El Solh AA, 2006, EUR RESPIR J, V27, P997, DOI 10.1183/09031936.06.00101005; Li X, 2012, J ULTRAS MED, V31, P1783; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Dogan A, 2011, BLOOD PRESSURE, V20, P182, DOI 10.3109/08037051.2010.538977; Yiginer O, 2008, CLIN RES CARDIOL, V97, P334, DOI 10.1007/s00392-007-0636-3; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRUCLATIONAHA.106.651117; Latif W, 2011, CLIN J AM SOC NEPHRO, V6, P2470, DOI 10.2215/CJN.00670111; Ohno I, 2005, INTERNAL MED, V44, P706, DOI 10.2169/internalmedicine.44.706; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Curiel RV, 2012, SEMIN ARTHRITIS RHEU, V42, P166, DOI 10.1016/j.semarthrit.2012.03.013; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Mercuro G, 2004, AM J CARDIOL, V94, P932, DOI 10.1016/j.amjcard.2004.06.032; Tsuruta Y, 2014, INT UROL NEPHROL, V46, P1833, DOI 10.1007/s11255-014-0731-0; Nakaya I, 2011, NEPHROLOGY, V16, P518, DOI 10.1111/j.1440-1797.2011.01446.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Luk AJ, 2009, RHEUMATOLOGY, V48, P804, DOI 10.1093/rheumatology/kep069; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Dubreuil M, 2015, ANN RHEUM DIS, V74, P1368, DOI 10.1136/annrheumdis-2014-205269; Hosoya Tatsuo, 2011, J Clin Rheumatol, V17, pS27, DOI 10.1097/RHU.0b013e31821d36f2; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Shibagaki Y, 2014, HYPERTENS RES, V37, P919, DOI 10.1038/hr.2014.107	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2015	19	4					514	520		10.1111/hdi.12313		7	Urology & Nephrology	Urology & Nephrology	CT1TN	WOS:000362584500021		
J	Furusho, M; Kawazu, M; Takeda, K; Kurachi, E; Nakashima, T; Sagara, R; Hara, T; Mukai, H; Miura, S; Sugawara, K				Furusho, Masahide; Kawazu, Minami; Takeda, Kazuhito; Kurachi, Emiko; Nakashima, Takafumi; Sagara, Rikako; Hara, Takashi; Mukai, Hideyuki; Miura, Shuhei; Sugawara, Koji			Nephrology pre-dialysis care affects the psychological adjustment, not only blood pressure, anemia, and phosphorus control	HEMODIALYSIS INTERNATIONAL			English	Article						Pre-dialysis care; nephrology referral; psychological adjustment; Shontz's stage theory	CHRONIC KIDNEY-DISEASE; MANAGEMENT; PEOPLE	Several studies have suggested that pre-dialysis care is associated with clinical outcomes. However, little has been reported on the influence of pre-dialysis care on the psychological adjustment to dialysis. The purpose of this study was to evaluate the impact of pre-dialysis care on psychological adjustment to dialysis and clinical characteristics. In this cross-sectional study, we enrolled 52 patients who started hemodialysis at our hospital. They were divided into two groups according to the time of referral to our hospital: the early referral group (over 1 year prior to first dialysis: 19 patients, mean age 69.3 +/- 11.1) and the late referral group (within 1 year prior to first dialysis: 33 patients, mean age 72.3 +/- 8.9). We measured the clinical characteristics and evaluated the psychological adjustment to dialysis by Shontz's stage theory. Compared with the late referral group, the early referral group had a significantly better clinical characteristics concerning blood pressure (140.2 +/- 23.7 vs. 156.9 +/- 23.3 mmHg, P = 0.0150), hemoglobin (10.3 +/- 1.5 vs. 9.4 +/- 1.0 g/dL, P = 0.0078), and phosphorus (4.5 +/- 1.5 vs. 5.5 +/- 1.3 mg/dL, P = 0.0166). In addition, psychological adjustment to dialysis evaluated by Shontz's stage theory was significantly better in the early referral group (P = 0.017). Our results indicate that nephrology pre-dialysis care affects not only blood pressure, anemia, and phosphorus control but also the psychological adjustment to dialysis.	[Furusho, Masahide; Kawazu, Minami; Takeda, Kazuhito; Kurachi, Emiko; Nakashima, Takafumi; Sagara, Rikako; Hara, Takashi; Mukai, Hideyuki; Miura, Shuhei; Sugawara, Koji] Iizuka Hosp, Kidney Ctr & Blood Purificat, Div Nephrol, Iizuka, Fukuoka 8208505, Japan	Furusho, M (reprint author), Iizuka Hosp, Kidney Ctr & Blood Purificat, Div Nephrol, 3-83 Yoshio Cho, Iizuka, Fukuoka 8208505, Japan.	mfurushoh2@aih-net.com					McKercher C, 2013, NEPHROLOGY, V18, P585, DOI 10.1111/nep.12138; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jac.2004.12.005; Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Black C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14210; de Goeij MCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093069; Hommel K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-108; Kumar Sushanth, 2012, Nephrourol Mon, V4, P578, DOI 10.5812/numonthly.2232	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2015	19			3	SI		S2	S4		10.1111/hdi.12345		3	Urology & Nephrology	Urology & Nephrology	CT1TL	WOS:000362584300002		
J	Ogata, S; Nishi, S; Wakai, K; Hanafusa, N; Iseki, K; Tsubakihara, Y; Masakane, I				Ogata, Satoshi; Nishi, Shinichi; Wakai, Kenji; Hanafusa, Norio; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Masakane, Ikuto			Institutional factors influencing regional differences in the 1-year survival of dialysis patients	HEMODIALYSIS INTERNATIONAL			English	Article						End-stage renal disease; survival; nurse; dietitian	STAGE RENAL-DISEASE; JAPAN; ERYTHROPOIETIN; MORTALITY; ALTITUDE	There are regional differences in the survival of incident dialysis patients, but few studies have investigated the reasons. We assessed the effect of institutional factors on factors on survival (by both cross-sectional assessment and after a 1-year investigation) in a cohort of the Japanese Society for Dialysis Therapy (JSDT). We investigated 20 institutional factors from 3958 dialysis institution data of the 47 prefectures in Japan in 2005 and the JSDT database of 102,011 patients who commenced dialysis during 2004-2006. Univariate regression analysis between 20 factors and 1-year survival rate, Kaplan-Meier method, log-rank test, and Cox's proportional hazard model between the upper 24 and the lower 23 prefectures of the significant factors were carried out. The age-adjusted 1-year survival rate was 0.832 +/- 0.027. Deaths occurred in 15.0% in 24 upper survival prefectures and 18.7% in 23 lower survival prefectures (P < 0.0001, unadjusted hazard ratio [HR] of death in lower survival prefectures: 1.26, 95% confidence interval [CI]: 1.17-1.40). A total of five factors among males were significantly correlated with 1-year survival according to the univariate regression analysis. Among them, three factors (night-time center/total dialysis center ratio [males: P < 0.0001, age, genders, and presence of diabetes adjusted HR: 0.88, 95% CI: 0.81-0.93], number of full-time dialysis nurses [males: P = 0.0427, 0.94, 0.87-1.00], number of full-time dialysis dietitians [males: P = 0.0084, 0.92, 0.85-0.98], respectively) were significant in Kaplan-Meier analysis, log-rank test, and the Cox's model. Institutional factors were closely related to the survival of incident dialysis patients, and regional differences in the survival may be explained, at least partly, by these factors.	[Ogata, Satoshi; Nishi, Shinichi; Wakai, Kenji; Hanafusa, Norio; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Masakane, Ikuto] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Ogata, S (reprint author), Hiroshima Int Univ, Dept Clin Nutr, 5-1-1 Hirokoshingai, Kure, Hiroshima 7370112, Japan.	satoshiogatajp@yahoo.co.jp					Furumatsu Y, 2010, NEPHROL DIAL TRANSPL, V25, P1930, DOI 10.1093/ndt/gfp738; Usami T, 2000, JAMA-J AM MED ASSOC, V284, P2622, DOI 10.1001/jama.284.20.2622; Ogata S, 2011, CLIN EXP NEPHROL, V15, P405, DOI 10.1007/s10157-010-0400-2; Usami T, 2003, KIDNEY INT, V64, P1445, DOI 10.1046/j.1523-1755.2003.00221.x; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008; Winkelmayer WC, 2009, JAMA-J AM MED ASSOC, V301, P508, DOI 10.1001/jama.2009.84; Lameire N, 2002, NEPHROL DIAL TRANSPL, V17, P1550, DOI 10.1093/ndt/17.9.1550; Furumatsu Y, 2008, NEPHROL DIAL TRANSPL, V23, P984, DOI 10.1093/ndt/gfm705; Ogata S, 2009, HEMODIAL INT, V13, pS8, DOI 10.1111/j.1542-4758.2009.00412.x; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; Collins AJ, 2010, BIOCHEM BIOPH RES CO, V55, pS1; Japan Statistics Bureau, 2008, STAT OBS PREF 2008, P1; Patient Registration Committee, 2009, OV REG DIAL TREATM J; The Japanese Society for Dialysis Therapy, 2006, MEMB LIST DIAL I JAP; The Japanese Society for Dialysis Therapy Tokyo, 2008, LIST SPEC PREF	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2015	19			3	SI		S5	S10		10.1111/hdi.12346		6	Urology & Nephrology	Urology & Nephrology	CT1TL	WOS:000362584300003		
J	Yamashita, AC; Masaki, H; Kobayashi, E; Sukegawa, T				Yamashita, Akihiro C.; Masaki, Hidenori; Kobayashi, Eisuke; Sukegawa, Takeshi			Evaluation of solute penetration across the polysulfone membrane with vitamin E coating	HEMODIALYSIS INTERNATIONAL			English	Article						Vitamin E; alpha-tocopherol; dialysis membrane; antioxidative; coating		Vitamin E (vit E) is coated on polysulfone (PS) dialysis membrane for antioxidative purpose. The membrane, however, has not yet been evaluated from the mass transfer point of view. We investigated this PS membrane with and without vit E coating in vitro ultrafiltration experiments to identify whether or not the coating influences the mass transfer. Dialyzers that included PS membrane with and without vit E coating were investigated. Aqueous test solution of various solutes including vitamin B-12 (VB12, MW1355), chymotrypsin (chymo, MW25000), and albumin (alb, MW66000) was prepared, and normal ultrafiltration experiments were performed at 310 K. Reverse ultrafiltration experiments in which test solution was filtered from outside to inside the hollow fiber were also performed. Sieving coefficients (SC) were computed for evaluation. SC for VB12 was the same regardless of vit E coating; however, chymo was 0.82 +/- 0.01 and 0.86 +/- 0.01, respectively, for the membrane with and without vit E. Thus, it would be understood that vit E coating reduces the pore size of the membrane, resulting the reduced transport of larger solutes. Like other PS membrane, SC for alb was decreased over time regardless of vit E coating. More importantly, although the steady-state SC for alb was almost identical in two membranes, PS without vit E showed much greater decrease for the first 2 h, while that with vit E showed very little decrease over time, which suggested the reduced fouling effect due to vit E coating. All the SC values found in reverse ultrafiltration were higher than those found in normal ultrafiltration; moreover, the degree of increase with chymo was approximately 5%, whereas that with alb was approximately 430%, which may be explained by a new model in which wedge effect is taken into consideration for the membrane transport. Vit E coating not only has antioxidative effect but also reduces the fouling that is usually caused by various proteins.	[Yamashita, Akihiro C.; Masaki, Hidenori] Hosei Univ, Fac Biosci & Appl Chem, Dept Chem Sci & Technol, Koganei, Tokyo 1848584, Japan; [Kobayashi, Eisuke] Asahi Kasei Med Co, Blood Purificat Business Unit, Japanese Operat Div, Prod Mkt Dept 2, Tokyo, Japan; [Sukegawa, Takeshi] Asahi Kasei Med MT Co, Blood Purificat Dev & Planning Dept, Tokyo, Japan	Yamashita, AC (reprint author), Hosei Univ, Fac Biosci & Appl Chem, Dept Chem Sci & Technol, 3-7-2 Kajino Cho, Koganei, Tokyo 1848584, Japan.	yama@hosei.ac.jp			Toroy; Nikkiso; Nippro; Kawasum; Asahi Kasei Medical Companies of Tokyo, Japan; Nikkiso Company of Tokyo, Japan; Asahi-Kasei Medical Company, Tokyo Japan	Grant Funding was provided by Toroy, Nikkiso, Nippro, Kawasum, and Asahi Kasei Medical Companies of Tokyo, Japan. Dr. Yamishita received consulting fees from Nikkiso Company of Tokyo, Japan and Drs. Koboyashi and Sukegawa are employed by Asahi-Kasei Medical Company, Tokyo Japan.	Andrulli S, 2010, NEPHRON CLIN PRACT, V115, pE82, DOI 10.1159/000294281; Sanaka T, 2011, CONTRIB NEPHROL, V173, P30, DOI 10.1159/000328942; Yamashita AC, 2001, AM J KIDNEY DIS, V38, pS217, DOI 10.1053/ajkd.2001.27450; Aoun Bilal, 2010, Saudi J Kidney Dis Transpl, V21, P466; Sanaka T, 1999, Contrib Nephrol, V127, P261; Shimazu T, 1999, Contrib Nephrol, V127, P251	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2015	19			3	SI		S20	S25		10.1111/hdi.12348		6	Urology & Nephrology	Urology & Nephrology	CT1TL	WOS:000362584300005		
J	Kanzaki, G; Tsuboi, N; Haruhara, K; Koike, K; Ogura, M; Shimizu, A; Yokoo, T				Kanzaki, Go; Tsuboi, Nobuo; Haruhara, Kotaro; Koike, Kentaro; Ogura, Makoto; Shimizu, Akira; Yokoo, Takashi			Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease	HYPERTENSION RESEARCH			English	Review						chronic kidney disease; glomerular density; glomerular volume; nephron number	LOW-BIRTH-WEIGHT; GLOMERULAR-FILTRATION-RATE; RENIN-ANGIOTENSIN SYSTEM; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; DIFFERENT CORTICAL ZONES; GDNF HETEROZYGOUS MICE; ADULT-BLOOD PRESSURE; RENAL-DISEASE; AUSTRALIAN ABORIGINES; AFRICAN-AMERICANS	It has been reported that there is substantial variation in the nephron number between individuals. Previous studies using autopsy kidneys have demonstrated that a low nephron number, in relation to a low birth weight, may result in hypertension (HTN) and/or chronic kidney disease (CKD). However, recent studies have revealed that the association between a low nephron number and HTN is not a universal finding. This observation indicates that a low nephron number is unlikely to be the sole factor contributing to an elevated blood pressure. In addition to the nephron number, various genetic and congenital factors may contribute to increased susceptibility to HTN and/or CKD in a complex manner. Acquired factors, including aging, obesity and related metabolic abnormalities, and various causes of renal injury, may additionally promote further nephron loss. Such a vicious cycle may induce HTN and/or CKD via the common mechanisms of renal hemodynamic maladaptation.	[Kanzaki, Go; Tsuboi, Nobuo; Haruhara, Kotaro; Koike, Kentaro; Ogura, Makoto; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Shimizu, Akira] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan	Tsuboi, N (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Japan.	tsuboi-n@jikei.ac.jp			Japan Kidney Foundation Research Fund	Part of this study was supported by the Japan Kidney Foundation Research Fund and a Grant-in-Aid for Scientific Research (C) (N.T.).	Zhang SL, 2004, J AM SOC NEPHROL, V15, P1452, DOI 10.1097/01.ASN.0000130567; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Wakasugi M, 2013, HYPERTENS RES, V36, P328, DOI 10.1038/hr.2012.186; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; Murphy VE, 2007, PLACENTA, V28, P39, DOI 10.1016/j.placenta.2005.12.010; Schreuder MF, 2006, J HYPERTENS, V24, P1337, DOI 10.1097/01.hjh.0000234114.33025.fd; Rothermund L, 2006, J HYPERTENS, V24, P1857, DOI 10.1097/01.hjh.0000242411.50536.b9; Almeida JR, 2005, AM J OBSTET GYNECOL, V192, P945, DOI 10.1016/j.ajog.2004.09.010; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Tsuboi N, 2011, NEPHROL DIAL TRANSPL, V26, P3555, DOI 10.1093/ndt/gfr399; Nuyt AM, 2009, CURR OPIN NEPHROL HY, V18, P144, DOI 10.1097/MNH.0b013e328326092c; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; GUNDERSEN HJG, 1988, APMIS, V96, P379; Ohta Y, 2013, HYPERTENS RES, V36, P172, DOI 10.1038/hr.2012.155; Jones SE, 2006, DIABETOLOGIA, V49, P191, DOI 10.1007/s00125-005-0052-z; Tsuboi N, 2009, NEPHROL DIAL TRANSPL, V24, P892, DOI 10.1093/ndt/gfn572; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Bertram JF, 2001, KIDNEY INT, V59, P792, DOI 10.1046/j.1523-1755.2001.059002792.x; Nelson RG, 1998, AM J EPIDEMIOL, V148, P650; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Rule AD, 2011, MAYO CLIN PROC, V86, P282, DOI 10.4065/mcp.2010.0821; Yosypiv IV, 2005, PEDIATR NEPHROL, V20, P1219, DOI 10.1007/s00467-005-1944-3; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Kett MM, 2011, AM J PHYSIOL-REG I, V300, pR791, DOI 10.1152/ajpregu.00791.2010; Salazar F, 2008, HYPERTENSION, V51, P1184, DOI 10.1161/HYPERTENSIONAHA.107.100750; Abitbol CL, 2009, SEMIN NEPHROL, V29, P445, DOI 10.1016/j.semnephrol.2009.03.019; Beeman SC, 2011, AM J PHYSIOL-RENAL, V300, pF1454, DOI 10.1152/ajprenal.00044.2011; Maka N, 2008, PEDIATR NEPHROL, V23, P55, DOI 10.1007/s00467-007-0641-9; Heilmann M, 2012, NEPHROL DIAL TRANSPL, V27, P100, DOI 10.1093/ndt/gfr273; Kanzaki G, 2013, PATHOL INT, V63, P169, DOI 10.1111/pin.12044; Puelles VG, 2011, CURR OPIN NEPHROL HY, V20, P7, DOI 10.1097/MNH.0b013e3283410a7d; Hoy WE, 2001, KIDNEY INT, V60, P243, DOI 10.1046/j.1523-1755.2001.00792.x; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Li L, 2014, NAT REV NEPHROL, V10, P135, DOI 10.1038/nrneph.2013.273; Ots M, 2004, NEPHROL DIAL TRANSPL, V19, P337, DOI 10.1093/ndt/gfg549; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515; Li S, 2008, KIDNEY INT, V73, P637, DOI 10.1038/sj.ki.5002747; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38; Holtkamp FA, 2011, KIDNEY INT, V80, P282, DOI 10.1038/ki.2011.79; Zimanyi MA, 2004, KIDNEY BLOOD PRESS R, V27, P239, DOI 10.1159/000079868; McNamara BJ, 2008, NEPHROL DIAL TRANSPL, V23, P2576, DOI 10.1093/ndt/gfn039; Nenov VD, 2000, CURR OPIN NEPHROL HY, V9, P85, DOI 10.1097/00041552-200003000-00001; Painter RC, 2005, J AM SOC NEPHROL, V16, P189; Young RJ, 2000, AM J KIDNEY DIS, V36, P481, DOI 10.1053/ajkd.2000.9788; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Hoy WE, 2001, KIDNEY INT, V60, P249, DOI 10.1046/j.1523-1755.2001.00793.x; Hughson MD, 2008, AM J KIDNEY DIS, V52, P18, DOI 10.1053/j.ajkd.2008.03.023; Cullen-McEwen LA, 2001, KIDNEY INT, V60, P31, DOI 10.1046/j.1523-1755.2001.00767.x; Ikezumi Y, 2013, AM J NEPHROL, V38, P149, DOI 10.1159/000353898; Jones SE, 2001, DIABETOLOGIA, V44, P721, DOI 10.1007/s001250051681; SKOV K, 1994, J HYPERTENS, V12, P1373; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Hodgin JB, 2009, CLIN J AM SOC NEPHRO, V4, P71, DOI 10.2215/CJN.01700408; Ruta LAM, 2010, AM J PHYSIOL-RENAL, V298, pF1384, DOI 10.1152/ajprenal.00049.2010; Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; BRENNER BM, 1988, AM J HYPERTENS, V1, P335; Moritz KM, 2003, BIOESSAYS, V25, P212, DOI 10.1002/bies.10240; Zidar N, 1998, NEPHRON, V80, P97, DOI 10.1159/000045141; Koike K, 2011, AM J NEPHROL, V34, P542, DOI 10.1159/000334360; Hughson MD, 2014, NEPHROL DIAL TRANSPL, V29, P1399, DOI 10.1093/ndt/gft480; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Zhang Z, 2009, PEDIATR NEPHROL, V24, P1151, DOI 10.1007/s00467-008-1097-2; Walker KA, 2012, AM J PHYSIOL-RENAL, V303, pF253, DOI 10.1152/ajprenal.00028.2012; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Hoy WE, 1998, LANCET, V352, P1826, DOI 10.1016/S0140-6736(05)79888-3; Hoy WE, 2010, J DEV ORIG HLTH DIS, V1, P216, DOI 10.1017/S204017441000022X; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Gray SP, 2012, CLIN EXP PHARMACOL P, V39, P807, DOI 10.1111/j.1440-1681.2011.05597.x; Samuel T, 2005, J AM SOC NEPHROL, V16, P3102, DOI 10.1681/ASN.2005010123; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Nwagwu MO, 2000, BRIT J NUTR, V83, P79; SHOTAN A, 1994, AM J MED, V96, P451, DOI 10.1016/0002-9343(94)90172-4; McNamara BJ, 2010, NEPHROL DIAL TRANSPL, V25, P1514, DOI 10.1093/ndt/gfq030; Woods LL, 1998, AM J PHYSIOL-REG I, V275, pR1593; Ichihara A, 2004, CONTRIB NEPHROL, V143, P117; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; Beeman SC, 2014, AM J PHYSIOL-RENAL, V306, pF1381, DOI 10.1152/ajprenal.00092.2014; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P333, DOI 10.1007/978-1-61779-851-1_30; Douglas-Denton Rebecca N, 2006, Ethn Dis, V16, pS2; Haruhara K, AM J HYPERTENS; Hokke SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058243; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kemper M J, 2001, Curr Opin Urol, V11, P571, DOI 10.1097/00042307-200111000-00003; Lenihan CR, 2015, J CLIN INVEST, V125, P1311, DOI 10.1172/JCI78885; Luyckx Valerie A, 2011, Rambam Maimonides Med J, V2, pe0061, DOI 10.5041/RMMJ.10061; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127; Tsuboi Nobuo, 2014, Clin Kidney J, V7, P107, DOI 10.1093/ckj/sfu018	107	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					633	641		10.1038/hr.2015.67		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000001		
J	Tamura, K; Kanaoka, T; Kobayashi, R; Ohki, K; Ohsawa, M				Tamura, Kouichi; Kanaoka, Tomohiko; Kobayashi, Ryu; Ohki, Kohji; Ohsawa, Masato			TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation	HYPERTENSION RESEARCH			English	Editorial Material							ANGIOTENSIN-II; MEDIATED HYPERTENSION; OXIDATIVE STRESS; ATHEROSCLEROSIS; RATS; MICE		[Tamura, Kouichi; Kanaoka, Tomohiko; Kobayashi, Ryu; Ohki, Kohji; Ohsawa, Masato] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan	Tamura, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan.	tamukou@med.yokohama-cu.ac.jp					Al-Magableh MR, 2015, HYPERTENS RES, V38, P13, DOI 10.1038/hr.2014.125; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152; Hernanz R, 2015, BRIT J PHARMACOL, V172, P3159, DOI 10.1111/bph.13117; Rehman A, 2010, CURR HYPERTENS REP, V12, P226, DOI 10.1007/s11906-010-0117-3; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Wakui H, 2013, CARDIOVASC RES, V100, P511, DOI 10.1093/cvr/cvt225; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Chen XG, 2013, HYPERTENS RES, V36, P361, DOI 10.1038/hr.2012.204; Nakashima T, 2015, HYPERTENS RES, V38, P649, DOI 10.1038/hr.2015.55; Ozasa Y, 2013, HYPERTENS RES, V36, P859, DOI 10.1038/hr.2013.52; Fukai T, 1999, CIRC RES, V85, P23; Heijnen BFJ, 2014, HYPERTENS RES, V37, P100, DOI 10.1038/hr.2013.99; Dhande I, 2015, HYPERTENS RES, V38, P21, DOI 10.1038/hr.2014.132; Kuwabara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088942; Matsuda S, 2015, J ATHEROSCLER THROMB; De Batista PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104020	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					642	643		10.1038/hr.2015.65		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000002		
J	Nakashima, T; Umemoto, S; Yoshimura, K; Matsuda, S; Itoh, S; Murata, T; Fukai, T; Matsuzaki, M				Nakashima, Tadaaki; Umemoto, Seiji; Yoshimura, Koichi; Matsuda, Susumu; Itoh, Shinichi; Murata, Tomoaki; Fukai, Tohru; Matsuzaki, Masunori			TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase	HYPERTENSION RESEARCH			English	Article						angiotensin II; extracellular superoxide dismutase; Toll-like receptor 4; vascular remodeling	TOLL-LIKE RECEPTORS; MUSCLE-CELL DIFFERENTIATION; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; IN-VIVO; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAY; DEFICIENT MICE	Toll-like receptor 4 (TLR4) and angiotensin II (AngII) induce vascular remodeling through the production of reactive oxygen species (ROS). AngII has also been shown to increase antioxidant enzyme extracellular superoxide dismutase (ecSOD). However, the roles of TLR4 in Ang II-induced ROS production, vascular remodeling and hypertension remain unknown. Mice lacking TLR4 function showed significant inhibition of vascular remodeling in response to chronic AngII infusion, with no impact on blood pressure. The increases in ROS level and NADPH oxidase activity in response to AngII infusion were markedly blunted in TLR4-deficient mice. Similar effects were observed in wild-type (WT) mice treated with a sub-depressor dose of the AT1 receptor antagonist irbesartan, which had no effects on TLR4-deficient mice. Intriguingly, the AngII infusion-induced increases in ecSOD activity and expression were rather enhanced in TLR4-deficient mice compared with WT mice, whereas the expression of the proinflammatory chemokine MCP-1 was decreased. Importantly, AngII-induced vascular remodeling was positively correlated with NADPH oxidase activity, ROS levels and MCP-1 expression levels. Notably, chronic norepinephrine infusion, which elevates blood pressure without increasing ROS production, did not induce significant vascular remodeling in WT mice. Taken together, these findings suggest that ROS elevation is required for accelerating vascular remodeling but not for hypertensive effects in this model. We demonstrated that TLR4 plays a pivotal role in regulating AngII-induced vascular ROS levels by inhibiting the expression and activity of the antioxidant enzyme ecSOD, as well as by activating NADPH oxidase, which enhances inflammation to facilitate the progression of vascular remodeling.	[Nakashima, Tadaaki; Matsuda, Susumu; Itoh, Shinichi; Matsuzaki, Masunori] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Yamaguchi, Japan; [Umemoto, Seiji] Yamaguchi Univ, Clin Res Ctr, Ube, Yamaguchi 7558505, Japan; [Yoshimura, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Yamaguchi, Japan; [Murata, Tomoaki] Yamaguchi Univ, Ctr Sci Res, Inst Expt Anim, Yamaguchi, Japan; [Fukai, Tohru] Univ Illinois, Dept Med & Pharmacol, Ctr Cardiovasc Res, Chicago, IL USA	Umemoto, S (reprint author), Yamaguchi Univ, Clin Res Ctr, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	umemoto@yamaguchi-u.ac.jp			JSPS KAKENHI Grant [18590776, 21590954, 24591115]; 11th New Frontier Project of Yamaguchi University Graduate School of Medicine; Yamaguchi University Hospital; NIH [R01 HL070187]; 1st Research Meeting on Kidney Disease and Hypertension; 3rd Research Meeting on Kidney Disease and Hypertension	We thank Dr Hiroko Yoshino for her critical role in this study and Ms Ishihara, Ms Okamoto and Ms Oishi for their excellent technical assistance. This work was supported in part by JSPS KAKENHI Grant Nos. 18590776, 21590954, and 24591115 to SU, the 11th New Frontier Project of Yamaguchi University Graduate School of Medicine and Yamaguchi University Hospital to SU, the 1st and 3rd Research Meetings on Kidney Disease and Hypertension to SU and HY, and NIH R01 HL070187 to TF, respectively.	Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9; VOGEL SN, 1994, INFECT IMMUN, V62, P4454; Kishi T, 2013, HYPERTENS RES, V36, P845, DOI 10.1038/hr.2013.73; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Su B, 2005, NAT IMMUNOL, V6, P541, DOI 10.1038/ni0605-541; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Umemoto S, 2006, HYPERTENS RES, V29, P179, DOI 10.1291/hypres.29.179; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/01.CIR.0000012489.17433.31; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Kawahara S, 2005, J CARDIOVASC PHARM, V45, P367, DOI 10.1097/01.fjc.0000157454.60939.43; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Shinohara M, 2007, ARTERIOSCL THROM VAS, V27, P2384, DOI 10.1161/ATVBAHA.106.139253; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Dasu MR, 2009, ATHEROSCLEROSIS, V202, P76, DOI 10.1016/j.atherosclerosis.2008.04.010; Qin ZY, 2008, HYPERTENSION, V52, P945, DOI 10.1161/HYPERTENSIONAHA.108.116467; Lv JL, 2009, BIOCHEM BIOPH RES CO, V380, P81, DOI 10.1016/j.bbrc.2009.01.035; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/S0008-6363(95)00088-7; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Fukai T, 1999, CIRC RES, V85, P23; Itoh S, 2002, CIRCULATION, V105, P2288, DOI 10.1161/01.CIR.0000015607.33345.1F; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Welch WJ, 2008, HYPERTENSION, V52, P51, DOI 10.1161/HYPERTENSIONAHA.107.090472; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Umeji K, 2006, AM J PHYSIOL-HEART C, V291, pH2522, DOI 10.1152/ajpheart.01198.2005; Park HS, 2004, J IMMUNOL, V173, P3589; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Jun T, 1996, J HUM HYPERTENS, V10, P305; STRALIN P, 1995, ARTERIOSCL THROM VAS, V15, P2032; Vink A, 2004, CURR OPIN LIPIDOL, V15, P515, DOI 10.1097/00041433-200410000-00004; De Batista PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104020; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085	44	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					649	655		10.1038/hr.2015.55		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000005		
J	Mizuno, A; Miyauchi, K; Nishizaki, Y; Yamazoe, M; Komatsu, I; Asano, T; Mitsuhashi, H; Nishi, Y; Niwa, K; Daida, H				Mizuno, Atsushi; Miyauchi, Katsumi; Nishizaki, Yuji; Yamazoe, Masahiro; Komatsu, Ikki; Asano, Taku; Mitsuhashi, Hirotsugu; Nishi, Yutaro; Niwa, Koichiro; Daida, Hiroyuki			Impact of the augmentation time ratio on direct measurement of central aortic pressure in the presence of coronary artery disease	HYPERTENSION RESEARCH			English	Article						augmentation index (AI); augmentation time ratio; central artery pressure; coronary artery disease (CAD)	BLOOD-PRESSURE; WAVE REFLECTION; SYSTOLIC HYPERTENSION; STIFFNESS; INDEX; MORTALITY; AGE; EFFICACY; DIAMETER; WOMEN	The augmentation index measured by using the central artery pressure is associated with an increased risk of coronary artery disease (CAD). However, no study has examined the role of the time duration of the central artery pressure on CAD. Therefore, we evaluated the relationship between the central blood pressure time duration and the presence of CAD. All patients without a history of revascularization or prior myocardial infarction who underwent an elective coronary angiography at one of the two hospitals from January to September 2013 were analyzed. CAD was defined as a significant stenosis in one of the main coronary branches. The augmentation time ratio was defined as the ratio of the reflection to peak systolic time T2T1 duration divided by the peak systolic time to aortic notch T3T2 duration. We analyzed the relationship between the central pressure waveform (not only augmentation pressure) and the presence of CAD. A total of 146 (57.3%) out of 255 patients had a significant CAD. T2T1 duration was longer in the CAD group than the no CAD group, and the T3T2 duration was shorter in the CAD group than the no CAD group. The augmentation time ratio (T2T1/T3T2) was significantly larger in the CAD group than in the no CAD group. The augmentation index and augmentation pressure were lower in the no CAD group, but this difference was not statistically significant. The augmentation time ratio was an independent factor related to no CAD, especially in patients with a high augmentation index (odds ratio, 2.17; 95% confidence interval, 1.02-4.63). The augmentation time ratio was an independent factor related to the presence of CAD.	[Mizuno, Atsushi; Yamazoe, Masahiro; Komatsu, Ikki; Asano, Taku; Mitsuhashi, Hirotsugu; Nishi, Yutaro; Niwa, Koichiro; Daida, Hiroyuki] St Lukes Int Hosp, Dept Cardiol, Tokyo 1048560, Japan; [Miyauchi, Katsumi; Nishizaki, Yuji] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan	Mizuno, A (reprint author), St Lukes Int Hosp, Dept Cardiol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	atmizu@luke.ac.jp					Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; Ahimastos AA, 2003, J CLIN ENDOCR METAB, V88, P5375, DOI 10.1210/jc.2003-030722; Lewington S, 2002, LANCET, V360, P1903; Janner JH, 2013, EUR J PREV CARDIOL, V20, P1005, DOI 10.1177/2047487312449588; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Sakurai M, 2007, J HYPERTENS, V25, P391, DOI 10.1097/HJH.0b013e3280115b7c; O'Rourke MF, 2005, HYPERTENSION, V45, P652, DOI 10.1161/01.HYP.0000153793.84859.b8; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Kwon BJ, 2013, HYPERTENS RES, V36, P79, DOI 10.1038/hr.2012.143; Chirinos JA, 2011, HYPERTENSION, V57, P1108, DOI 10.1161/HYPERTENSIONAHA.110.166348; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Reymond P, 2012, ANN BIOMED ENG, V40, P742, DOI 10.1007/s10439-011-0443-x; Mitchell GF, 2008, HYPERTENSION, V51, P105, DOI 10.1161/HYPERTENSIONAHA.107.099721; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; EMOND M, 1994, CIRCULATION, V90, P2645; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Austen W G, 1975, Circulation, V51, P5; Kawamoto R, 2014, HYPERTENS RES, V37, P933, DOI 10.1038/hr.2014.108; Kim EJ, 2014, HYPERTENS RES, V37, P50, DOI 10.1038/hr.2013.112; Weber T, 2008, J HYPERTENS, V26, P376	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					684	689		10.1038/hr.2015.53		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000009		
J	Shimamoto, K; Kimoto, M; Matsuda, Y; Asano, K; Kajikawa, M				Shimamoto, Kazuaki; Kimoto, Masafumi; Matsuda, Yoshimi; Asano, Kozue; Kajikawa, Mariko			Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension	HYPERTENSION RESEARCH			English	Article						combination therapy; controlled-release nifedipine; essential hypertension	BLOOD-PRESSURE; COMBINATION THERAPY; GUIDELINES; MANAGEMENT; MORTALITY; DISEASE; COMBI; TRIAL	High-dose calcium channel blocker (CCB) shows strong blood pressure (BP) lowering effect. Currently available of controlled-release (CR) nifedipine 80 mg per day clinical data are limited to monotherapy and short-term or long-term retrospective studies. We report the safety and efficacy results of a 52-week, prospective open-label study, in which Japanese patients with essential hypertension were treated with CR nifedipine [80 mg per day; 40 mg bis in die (BID; twice daily)] in combination with other antihypertensive drugs. The patients with inadequate BP control despite treatment with CR nifedipine (40 mg once daily) in combination with other antihypertensive drugs were enrolled. The primary objective of this study was to assess the long-term safety of CR nifedipine (80 mg per day). Efficacy variables included changes in the mean sitting BP, the target BP achievement rate and the BP response rate. CR nifedipine (80 mg per day) was generally well tolerated, with the most common drug-related treatment-emergent adverse event being tachycardia (6.9% of patients). Serious treatment-emergent adverse events were reported in three (4.2%) patients. By week 52, the mean reductions in sitting systolic and diastolic BP were 19.4 and 13.6 mm Hg, respectively. The target BP achievement and BP response rates after 52 weeks of treatment were 32.4 and 63.4%, respectively. Based on these findings, long-term treatment with CR nifedipine at 40 mg BID in combination with antihypertensive drugs was well tolerated and effective in Japanese patients with essential hypertension.	[Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido 0608556, Japan; [Kimoto, Masafumi] Bayer Yakuhin, Study Management, Clin Operat, Prod Dev, Osaka, Japan; [Matsuda, Yoshimi] Bayer Yakuhin, Clin Stat, Prod Dev, Osaka, Japan; [Asano, Kozue] Bayer Yakuhin, Med Affairs Primary Care, Med Affairs, Osaka, Japan; [Kajikawa, Mariko] Bayer Yakuhin, WHD, Clin Dev GME, Prod Dev, Osaka, Japan	Shimamoto, K (reprint author), Sapporo Med Univ, Chuo Ku, S1 W17, Sapporo, Hokkaido 0608556, Japan.	simamoto@sapmed.ac.jp			Bayer Yakuhin (Osaka, Japan)	This study was funded by Bayer Yakuhin (Osaka, Japan). We are indebted to Prof. Kenjiro Kimura, Prof. Hiromi Rakugi and Prof Yusuke Ohya for the scientific advice. We thank Prof. Naoyuki Hasebe, Prof. Sadayoshi Ito, Prof. Kazuomi Kario, Prof. Yasuaki Dohi, Dr Yuhei Kawano, Prof. Masatsugu Horiuchi and Dr Tsutomu Imaizumi for helpful comments. We thank Rod McNab and Maxwell Chang of inScience Communications, Springer Healthcare and Nicholas D. Smith, PhD, for providing the medical writing assistance, which was funded by Bayer Yakuhin (Osaka, Japan). List of study participants: T Sugiura (Sugiura iin), T Iwai (Sagamino central hospital), H Oda (Oda clinic) and H Yamamoto (Yamamoto clinic).	Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Kobayashi N, 2012, CLIN EXP HYPERTENS, V34, P191, DOI 10.3109/10641963.2011.601377; Mori H, 2006, HYPERTENS RES, V29, P143, DOI 10.1291/hypres.29.143; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; FURBERG CD, 1995, CIRCULATION, V92, P1326; Yokokawa H, 2009, J CLIN HYPERTENS, V11, P333, DOI 10.1111/j.1751-7176.2009.00118.x; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Ohkubo T, 2004, HYPERTENS RES, V27, P755, DOI 10.1291/hypres.27.755; Hasebe N, 2005, J HYPERTENS, V23, P445, DOI 10.1097/00004872-200502000-00028; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Chiang CE, 2008, J HUM HYPERTENS, V22, P441, DOI 10.1038/jhh.2008.17; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Saito I, 2006, HYPERTENS RES, V29, P789, DOI 10.1291/hypres.29.789; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Bayer, HIST BAYER AD; Fujita T, 2006, PROG MED, V22, P2297; Ishii M, 1995, JPN PHARMACOL THER, V23, pS335; Nakamichi N, 1995, JPN PHARM THER S2, V23, ps257; Nakamichi N, 1995, JPN PHARM THER S2, V23, ps241; Shimamoto K, 2014, HYPERTENS RES, V37, P69, DOI 10.1038/hr.2013.80; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Teramoto T, 2010, PROG MED, V30, P1437	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					695	700		10.1038/hr.2015.54		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000011		
J	Hosaka, M; Metoki, H; Satoh, M; Ohkubo, T; Asayama, K; Kikuya, M; Inoue, R; Obara, T; Hirose, T; Imai, Y				Hosaka, Miki; Metoki, Hirohito; Satoh, Michihiro; Ohkubo, Takayoshi; Asayama, Kei; Kikuya, Masahiro; Inoue, Ryusuke; Obara, Taku; Hirose, Takuo; Imai, Yutaka		J-HOME-CARD Study Grp	Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide	HYPERTENSION RESEARCH			English	Article						angiotensin II receptor blockers; candesartan/hydrochlorothiazide combination; home blood pressure measurement randomized controlled trial; stabilization time	HYPERTENSIVE PATIENTS; JAPANESE SOCIETY; SELF-MEASUREMENT; METAANALYSIS; AMLODIPINE; GUIDELINES; THERAPY; BLOCKER	We aimed to evaluate the hypotensive effect and the time to attain the maximal antihypertensive effect (stabilization time) of 8 mg candesartan/6.25 mg hydrochlorothiazide (HCTZ) combination therapy (combination regimen) and therapy with an increased candesartan dose (12 mg; maximum dose regimen) using home blood pressure (BP) measurements. A prospective, multicenter, open-label, randomized, comparative trial was conducted. Essential hypertensive patients who failed to achieve adequate BP control (systolic BP (SBP) <= 135 mm Hg) on 8 mg candesartan alone were randomized to two groups: the combination regimen (n=103) and the maximum dose regimen (n=103). Home morning SBP reduction at 8 weeks after randomization was 11.4 +/- 1.3 mm Hg in the combination regimen and 7.8 +/- 1.2 mm Hg in the maximum dose regimen. The combination regimen provided additional reduction of 4.0 mm Hg (95% confidence interval (CI): 0.8-7.2 mm Hg, P=0.01) in home morning SBP over the maximum dose regimen at 8 weeks after randomization. The maximal antihypertensive effect and stabilization time for home SBP were 9.4 mm Hg and 37.1 days (P<0.0001), respectively, with the combination regimen. The maximum dose regimen decreased home SBP with a very gentle slope, and estimated maximal effect and estimated stabilization time were not significant (P>0.2). The rate of achieving target BP (home morning SBP <135 mm Hg) was significantly higher with the combination regimen than with the maximum dose regimen (52.4 vs. 30.1%, P=0.002). In conclusion, changing from 8 mg candesartan to combination therapy was more effective in reducing home SBP and achieving goal BP more rapidly than increasing the candesartan dose.	[Hosaka, Miki; Asayama, Kei; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 9808575, Japan; [Metoki, Hirohito] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Sendai, Miyagi 9808575, Japan; [Satoh, Michihiro; Obara, Taku] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan; [Ohkubo, Takayoshi; Asayama, Kei] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Kikuya, Masahiro; Obara, Taku] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808575, Japan; [Inoue, Ryusuke] Tohoku Univ, Grad Sch Med, Dept Med Informat, Sendai, Miyagi 9808575, Japan; [Hirose, Takuo] Coll France, CIRB, F-75231 Paris, France	Metoki, H (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	hmetoki@med.tohoku.ac.jp			Nouvelle Place, Japan; Miyagi Kidney Foundation; Takeda Pharmaceutical; Ministry of Education, Culture, Sports, Science and Technology, Japan [23249036, 23390171, 24390084, 24591060, 24790654, 25253059, 25461205, 25461083, 25860156, 26860093]; Health Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, Japan [H23-Junkankitou [Seishuu]-Ippan-005]	The study was designed, conducted and interpreted by the investigators, independently of the sponsors. This study was conducted by the J-HOME-CARD study group. This work was supported by Nouvelle Place, Japan, with an unrestricted grant from the Miyagi Kidney Foundation, which is partly funded by Takeda Pharmaceutical; Grants for Scientific Research (23249036, 23390171, 24390084, 24591060, 24790654, 25253059, 25461205, 25461083, 25860156 and 26860093) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (25.9328 and 25.7756); a Health Labor Sciences Research Grant (H23-Junkankitou [Seishuu]-Ippan-005) from the Ministry of Health, Labor and Welfare, Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Hosohata K, 2007, HYPERTENS RES, V30, P707, DOI 10.1291/hypres.30.707; Metoki H, 2012, J HYPERTENS, V30, P1478, DOI 10.1097/HJH.0b013e328353f1fe; FURBERG CD, 1995, CIRCULATION, V92, P1326; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; LIJNEN P, 1981, BRIT J CLIN PHARMACO, V12, P387; Mori H, 2013, HYPERTENS RES, V36, P202, DOI 10.1038/hr.2012.142; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Chonan K, 2001, BLOOD PRESS MONIT, V6, P203, DOI 10.1097/00126097-200108000-00008; Eguchi K, 2010, BLOOD PRESS MONIT, V15, P308, DOI 10.1097/MBP.0b013e32833f4be7; Katsuya T, 2003, HYPERTENS RES, V26, P521, DOI 10.1291/hypres.26.521; JACKSON G, 1976, LANCET, V2, P1317; Mashima K, 2003, CLIN EXP HYPERTENS, V25, P145, DOI 10.1081/CEH-120019147; Uzu T, 2005, J HYPERTENS, V23, P861, DOI 10.1097/01.hjh.0000163156.37363.47; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Parati G, 2013, HYPERTENS RES, V36, P322, DOI 10.1038/hr.2012.171; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771; Association for the Advancement of Medical Instrumentation, 1987, 101987 ANSIAAMI SP; Obara T, 2010, THER RES, V17, P569; Obara T, 2010, DIAGNOSIS TREATMENT, V98, P1039; Yasu M, 2010, J BLOOD PRESS, V17, P145; Yasu M, 2010, J BLOOD PRESS, V17, P445	26	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	OCT	2015	38	10					701	707		10.1038/hr.2015.64		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CS9VW	WOS:000362442000012		
J	Tsuji, H; Nakata, M; Nakajima, Y; Takei, T; Fujisaki, Y; Yamamoto, T				Tsuji, Hiroshi; Nakata, Mitsuru; Nakajima, Yoshiki; Takei, Tatsuya; Fujisaki, Yoshihide; Yamamoto, Toshihiro			Extraction of Trap Densities in Amorphous In-Ga-Zn-O Thin-Film Transistors by Using Efficient Surface Potential Calculations	IEEE ELECTRON DEVICE LETTERS			English	Article						Thin-film transistor; amorphous In-Ga-Zn-O; trap density; density of states; extraction method; capacitance-voltage measurement; surface potential	FIELD-EFFECT TRANSISTORS; STATES; MODEL	A novel extraction method for trap densities in amorphous In-Ga-Zn-O (a-IGZO) thin-film transistors (TFTs) is developed. In this method, a new calculation procedure for efficiently determining surface potentials (SPs) in the a-IGZO layer is used with low-frequency capacitance-voltage (C-V) measurements. To enhance the computational efficiency of the extraction method, we propose an approximate expression relating the front-side and back-side SPs, so that it is possible to determine SPs without conventionally required calculation steps, such as either meshing the a-IGZO layer or calculating the potential profiles for the entire layer. The extraction method is tested by using low-frequency C-V curves of a self-aligned a-IGZO TFT to minimize the influence of parasitic capacitances and resistances. This method is expected to facilitate the extraction of trap densities, and contribute to characterization and modeling of a-IGZO TFTs.	[Tsuji, Hiroshi; Nakata, Mitsuru; Nakajima, Yoshiki; Takei, Tatsuya; Fujisaki, Yoshihide; Yamamoto, Toshihiro] NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578510, Japan	Tsuji, H (reprint author), NHK Japan Broadcasting Corp, Sci & Technol Res Labs, Tokyo 1578510, Japan.	tsuji.h-hi@nhk.or.jp					Tsuji H, 2014, J DISP TECHNOL, V10, P101, DOI 10.1109/JDT.2013.2294852; SHUR M, 1984, J APPL PHYS, V55, P3831, DOI 10.1063/1.332893; Lee S, 2010, IEEE ELECTR DEVICE L, V31, P231, DOI 10.1109/LED.2009.2039634; Liu F, 2008, IEEE T ELECTRON DEV, V55, P3494, DOI 10.1109/TED.2008.2006544; Jun S, 2013, IEEE ELECTR DEVICE L, V34, P641, DOI 10.1109/LED.2013.2248116; Bae H, 2012, IEEE ELECTR DEVICE L, V33, P1138, DOI 10.1109/LED.2012.2198870; Jeon YW, 2010, IEEE T ELECTRON DEV, V57, P2988, DOI 10.1109/TED.2010.2072926; Fung T.-C., 2009, J APPL PHYS, V106; Kamakura Y., 2007, SIMULATION MODELING, P45; Kimura M., 2008, APPL PHYS LETT, V92; Lee S., 2011, IEEE IEDM DEC; LEROUX T, 1986, SOLID STATE ELECTRON, V29, P47, DOI 10.1016/0038-1101(86)90197-8; Nakata M., 2013, APPL PHYS LETT, V103; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	OCT	2015	36	10					1044	1046		10.1109/LED.2015.2467969		3	Engineering, Electrical & Electronic	Engineering	CS7TJ	WOS:000362288700017		
J	Gu, QY; Kawahara, T; Aoyama, T; Takaki, T; Ishii, I; Takemoto, A; Sakamoto, N				Gu, Qingyi; Kawahara, Tomohiro; Aoyama, Tadayoshi; Takaki, Takeshi; Ishii, Idaku; Takemoto, Ayumi; Sakamoto, Naoaki			LOC-Based High-Throughput Cell Morphology Analysis System	IEEE TRANSACTIONS ON AUTOMATION SCIENCE AND ENGINEERING			English	Article						Cell morphological analysis; high-speed vision; lab-on-a-chip; multi-object feature extraction	RED-BLOOD-CELLS; VISION CHIP; FLOW; MICROCHANNEL; EXTRACTION; PROCESSOR; CYTOMETRY; PLATFORM; SHAPE; SIZE	We present a high-speed vision-based morphological analysis system for fast-flowing cells in a microchannel. Real-time video processing is performed in hardware logic by extracting the moment features and bounding boxes of multiple cells in 512 256-pixel images at 2000 fps. The extracted cell regions are pushed into a first-in-first-out (FIFO) buffer for real-time image-based morphological analysis after being shrunk proportionally to a certain size. By extracting the bounding boxes of the cell regions using hardware logic and shrinking the cell region to a certain size to reduce processing time, our high-speed vision system can perform fast morphological analysis of cells at 500 cells/s in fast microchannel flows. Moreover, snapshots of all passed cells under the microscope are stored for offline verification. The results of real-time experiments conducted to analyze the size, eccentricity, and transparency of sea urchin embryos flowing fast in microchannels verify the efficacy of our vision-based cell analysis system.	[Gu, Qingyi; Aoyama, Tadayoshi; Takaki, Takeshi; Ishii, Idaku] Hiroshima Univ, Dept Syst Cybernet, Hiroshima 7398527, Japan; [Kawahara, Tomohiro] Kyushu Inst Technol, Dept Biol Funct Engn, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Takemoto, Ayumi; Sakamoto, Naoaki] Hiroshima Univ, Dept Math & Life Sci, Grad Sch Sci, Hiroshima 7398511, Japan	Gu, QY (reprint author), Hiroshima Univ, Dept Syst Cybernet, Hiroshima 7398527, Japan.	gu@robotics.hiroshima-u.ac.jp; kawahara@lsse.kyutech.ac.jp; aoyama@robotics.hiroshima-u.ac.jp; takaki@robotics.hiroshima-u.ac.jp; iishii@robotics.hiroshima-u.ac.jp; ayu-takemo@hiroshima-u.ac.jp; naosaka@hi-roshima-u.ac.jp	Ishii, Idaku/D-7393-2011				Tan AP, 2014, LAB CHIP, V14, P522, DOI 10.1039/c3lc50870f; BERNARD TM, 1993, IEEE J SOLID-ST CIRC, V28, P789, DOI 10.1109/4.222178; Komuro T, 2004, IEEE J SOLID-ST CIRC, V39, P265, DOI 10.1109/JSSC.2003.820876; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Fujiwara H, 2009, J BIOMECH, V42, P838, DOI 10.1016/j.jbiomech.2009.01.026; Gu QY, 2013, IEEE T CIRC SYST VID, V23, P30, DOI 10.1109/TCSVT.2012.2202195; Otto O, 2015, NAT METHODS, V12, P199, DOI 10.1038/nmeth.3281; Eklund JE, 1996, IEEE T VLSI SYST, V4, P322, DOI 10.1109/92.532033; Hur SC, 2011, LAB CHIP, V11, P912, DOI [10.1039/c0lc00595a, 10.1039/c01c00595a]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tomaiuolo G, 2009, SOFT MATTER, V5, P3736, DOI 10.1039/b904584h; Tomaiuolo G, 2011, MICROVASC RES, V82, P35, DOI 10.1016/j.mvr.2011.03.004; Ji QQ, 2013, TALANTA, V111, P178, DOI 10.1016/j.talanta.2013.03.004; Lee SA, 2012, LAB CHIP, V12, P2385, DOI 10.1039/c2lc40090a; Nazlibilek S, 2014, MEASUREMENT, V55, P58, DOI 10.1016/j.measurement.2014.04.008; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109; Ishii I, 2012, IEEE T CIRC SYST VID, V22, P105, DOI 10.1109/TCSVT.2011.2158340; Forsyth AM, 2010, MICROVASC RES, V80, P37, DOI 10.1016/j.mvr.2010.03.008; Alyassin MA, 2009, LAB CHIP, V9, P3364, DOI 10.1039/b911882a; Chen SY, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/101536; Gu QY, 2012, IEICE T INF SYST, VE95D, P636, DOI 10.1587/transinf.E95.D.636; Schonbrun E, 2012, LAB CHIP, V12, P268, DOI 10.1039/c1lc20843h; Yusof A, 2011, LAB CHIP, V11, P2447, DOI 10.1039/c1lc20176j; Ishii I, 2010, IEEE INT CONF ROBOT, P1536, DOI 10.1109/ROBOT.2010.5509731; Kobel SA, 2012, LAB CHIP, V12, P2843, DOI 10.1039/c2lc40317j; Ishii I, 2006, IEEE T ELECTRON DEV, V53, P1797, DOI 10.1109/TED.2006.878024; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Esteves T., 2013, LNCS, V7887, P624; Gu Q., 2014, P IEEE INT C ROB AUT, P5848; Gu QY, 2015, IEEE T AUTOM SCI ENG, V12, P204, DOI 10.1109/TASE.2013.2292583; Hirai S., 2005, J ROBOT MECHATRON, V17, P1; Moon I, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.010295; Oosterbroek E., 2003, LAB ON A CHIP MINIAT; Sakuma S, 2014, LAB CHIP, V14, P1135, DOI 10.1039/c3lc51003d; Schoendube J., 2012, MUTAS, P419; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Tse HTK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006559; van Loon MC, 2013, HEARING RES, V298, P17, DOI 10.1016/j.heares.2013.01.013; Zheng Y, 2013, LAB CHIP, V14, P577	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1545-5955	1558-3783		IEEE T AUTOM SCI ENG	IEEE Trans. Autom. Sci. Eng.	OCT	2015	12	4					1346	1356		10.1109/TASE.2015.2462118		11	Automation & Control Systems	Automation & Control Systems	CS8SJ	WOS:000362358500019		
J	Lei, Q; Wu, M; She, JH				Lei, Qi; Wu, Min; She, Jinhua			Online Optimization of Fuzzy Controller for Coke-Oven Combustion Process Based on Dynamic Just-in-Time Learning	IEEE TRANSACTIONS ON AUTOMATION SCIENCE AND ENGINEERING			English	Article						Coke oven; combustion process; differential evolution algorithm; dynamic modeling; just-in-time learning (JITL); variable-universe fuzzy logic (VUFL)	SYSTEM	To guarantee the control performance of a fuzzy control system for the combustion process in a coke oven, the parameters of the fuzzy controller need to be optimized so that the controller can handle large changes in the operating state of the oven. This paper describes an online optimization method for this purpose. In this method, the distance and angle of the trend of the change are used to select data, and just-in-time learning is used to create a dynamic sample base and to build a radial-basis-function neural-network model of the process. A variable-universe fuzzy logic controller controls the process, and an adaptive differential evolution algorithm optimizes the universe parameters. This enables the controller to adapt to changes in the operating state in a timely fashion. Simulation results demonstrate the effectiveness of the method.	[Lei, Qi] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Wu, Min; She, Jinhua] China Univ Geosci, Sch Automat, Wuhan 430074, Hubei, Peoples R China; [She, Jinhua] Tokyo Univ Technol, Sch Engn, Hachioji, Tokyo 1920982, Japan	Wu, M (reprint author), China Univ Geosci, Sch Automat, Wuhan 430074, Hubei, Peoples R China.	leiqi@csu.edu.cn; wumin@cug.edu.cn; she@stf.teu.ac.jp			National Natural Science Foundation of China [61203018]; Hubei Provincial Natural Science Foundation of China [2015CFA010]	This work was supported by the National Natural Science Foundation of China under Grant 61203018 and the Hubei Provincial Natural Science Foundation of China under Grant 2015CFA010.	Yu SW, 2010, EXPERT SYST APPL, V37, P2037, DOI 10.1016/j.eswa.2009.06.074; Ge ZQ, 2008, CONTROL ENG PRACT, V16, P1427, DOI 10.1016/j.conengprac.2008.04.004; Li HX, 2002, SCI CHINA SER E, V45, P213, DOI 10.1360/02ye9026; Daneshwar MA, 2014, J PROCESS CONTR, V24, P249, DOI 10.1016/j.jprocont.2014.01.013; Gao CH, 2011, IEEE T NEURAL NETWOR, V22, P2272, DOI 10.1109/TNN.2011.2175945; Pepona E, 2011, IEEE T CONTR SYST T, V19, P148, DOI 10.1109/TCST.2010.2080680; Uddin MN, 2011, IEEE T IND APPL, V47, P1043, DOI 10.1109/TIA.2010.2103293; Fdez-Riverola F, 2007, EXPERT SYST APPL, V33, P36, DOI 10.1016/j.eswa.2006.04.011; Cao DY, 2011, T NONFERR METAL SOC, V21, P429, DOI 10.1016/S1003-6326(11)60732-2; Pedrycz W, 1997, FUZZY SET SYST, V88, P91, DOI 10.1016/S0165-0114(96)00057-7; Liu M, 2010, IEEE T AUTOM SCI ENG, V7, P645, DOI 10.1109/TASE.2010.2045499; Berkutov N. K., 2007, Steel in Translation, V37, DOI 10.3103/S0967091207050099; Bontempi G, 1999, INT J CONTROL, V72, P643, DOI 10.1080/002071799220830; Jiang G. Z., 2012, SENS TRANSDUCERS, V16, P75; Lei Q., 2008, P 17 WORLD C INT FED; Pedrycz W., 1989, FUZZY CONTROL FUZZY; Yu C. Y., 2009, NISCO TECHNOL MA APR, P44; Yurin N. I., 2011, Steel in Translation, V41, DOI 10.3103/S0967091211110209	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1545-5955	1558-3783		IEEE T AUTOM SCI ENG	IEEE Trans. Autom. Sci. Eng.	OCT	2015	12	4					1535	1540		10.1109/TASE.2015.2461024		6	Automation & Control Systems	Automation & Control Systems	CS8SJ	WOS:000362358500035		
J	Zhao, WJ; Onoye, T; Song, T				Zhao, Wenjun; Onoye, Takao; Song, Tian			Hierarchical Structure-Based Fast Mode Decision for H.265/HEVC	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY			English	Article						Depth prediction; discrete cross difference (DCD); fast mode decision; High Efficiency Video Coding (HEVC); residual check	INTRA PREDICTION ALGORITHM; CU SIZE DECISION; HEVC; COMPLEXITY	The mode decision strategy adopted in the High Efficiency Video Coding test model increases the complexity drastically. In this paper, we present a course of low-complexity fast mode decision algorithms. First, the depth information of the colocated block from a previous frame is used to predict the size of current block. Next, for a certain sized block, the inter-prediction residual is analyzed to determine whether to terminate the mode decision process or to skip unnecessary modes and split the block into smaller sizes. After inter-prediction, a hardware-oriented low-complexity fast intra-mode decision algorithm is proposed. A fast discrete cross difference is adopted to detect the dominant direction of the block. In addition, four simple but efficient early termination strategies are proposed to terminate the rate-distortion optimization process properly. The simulation results show that these proposed algorithms reduce the encoding time by 54.0%-68.4% without incurring any noticeable performance degradation. Hardware synthesis results demonstrate that the proposed fast intra-mode decision algorithm can be easily implemented on a hardware platform with fewer resources consumed.	[Zhao, Wenjun; Onoye, Takao] Osaka Univ, Sch Informat Sci & Technol, Dept Informat Syst Engn, Osaka 5650871, Japan; [Song, Tian] Univ Tokushima, Sch Engn, Dept Elect & Elect Engn, Tokushima 7700855, Japan	Zhao, WJ (reprint author), Osaka Univ, Sch Informat Sci & Technol, Dept Informat Syst Engn, Osaka 5650871, Japan.	wen.jun.zhao@ist.osaka-u.ac.jp; onoye@ist.osaka-u.ac.jp; tiansong@ee.tokushima-u.ac.jp					[Anonymous], 2012, LECT NOTES COMPUTER; [Anonymous], 2012, 2012 PICT COD S PCS; Vanne J, 2012, IEEE T CIRC SYST VID, V22, P1885, DOI 10.1109/TCSVT.2012.2223013; Shi YF, 2013, IEEE INT SYMP CIRC S, P225; Kim J, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON CONSUMER ELECTRONICS (ICCE), P261; Bossen F, 2012, IEEE T CIRC SYST VID, V22, P1685, DOI 10.1109/TCSVT.2012.2221255; Zhao WQ, 2012, COMM COM INF SC, V331, P284; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Chen G, 2013, IEEE INT SYMP CIRC S, P53; [Anonymous], 2010, P IEEE TENCON NOV; Yan SQ, 2012, 8TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS 2012), P225; Cassa MB, 2012, 2012 PICTURE CODING SYMPOSIUM (PCS), P493, DOI 10.1109/PCS.2012.6213262; Zhang MM, 2012, IEEE IMAGE PROC, P221; Zhou CT, 2013, APPL MECH MATER, V303-306, P2107, DOI 10.4028/www.scientific.net/AMM.303-306.2107; Tan HL, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P825; Cheng YL, 2012, COMM COM INF SC, V331, P292; Shen LQ, 2013, IEEE T MULTIMEDIA, V15, P465, DOI 10.1109/TMM.2012.2231060; Cho S, 2013, IEEE T CIRC SYST VID, V23, P1555, DOI 10.1109/TCSVT.2013.2249017; Bjontegaard G., 2001, SG16Q6 ITUT; Choi K., 2012, OPT ENG, V51, P1; da Silva T. L., 2012, P 19 IEEE ICECS DEC, P568; ITU- T, 2013, H265ISOIEC230082 ITU; ITU- T, 2005, H264ISOIEC1449610 IT; JCT- VC, 2013, JCTVCL1002; JCT- VC, 2011, JCTVCG543; JCT- VC, 2011, JCTVCF092; JCT- VC, 2013, JCTVCL1100; JCT- VC, 2011, JCTVCF045; Jiang W., 2012, P CONS EL COMM NETW, V1836- 1840; Kim J. U., 2011, EVID-BASED COMPL ALT, V2011, P8; Kim Y., 2012, P SPIE VIS INF PROCE, V8305; Lee H.S., 2012, OPT ENG, V51, P1; Leng J., 2011, INT C MULT SIGN PROC, V1, P56; Motra A. S., 2012, P SOFTW TEL COMP NET, P1; Shen LQ, 2013, IEEE T CONSUM ELECTR, V59, P207; Sun H., 2012, P IEEE INT C MULT EX, P1085; Tai S., 2012, ADV INTELLIGENT SYST, V21, P393; Wang HJ, 2012, PEM FUEL CELL FAILURE MODE ANALYSIS, P1; Zhang Y., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1155/2012/624520); Zhao H., 2013, P IEEE ISCAS, P45; Zhao L., 2011, ELECT J DIFFERENTIAL, V2011, P1	41	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1051-8215	1558-2205		IEEE T CIRC SYST VID	IEEE Trans. Circuits Syst. Video Technol.	OCT	2015	25	10					1651	1664		10.1109/TCSVT.2015.2395751		14	Engineering, Electrical & Electronic	Engineering	CS8SI	WOS:000362358300008		
J	Ma, YL; Yamao, Y				Ma, Yuelin; Yamao, Yasushi			Spectra-Folding Feedback Architecture for Concurrent Dual-Band Power Amplifier Predistortion	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Analog-to-digital converter (ADC); broad band; carrier aggregation; crossband distortion; dual-band amplifier; dual-band receiver; feedback path; linearizer; long-term evolution (LTE); long-term evolution advanced (LTE-Advanced); predistortion	DIGITAL PREDISTORTION; TRANSMITTERS; LINEARIZATION	This paper proposes a spectra-folding feedback (SFFB) architecture for digital predistortion (DPD) of concurrent dual-band power amplifiers (PAs). Conventional dual-band DPD contains a dual-branch feedback path to receive the PA output signals at respective bands. The proposed architecture, however, is constructed by a single-branch receiving path, so that the hardware expense (such as down converters, filters, or analog-to-digital converters) of the feedback path is significantly reduced. In this architecture, simple modifications are made to the down converter to allow the use of only one analog-to-digital converter. With the proposed signal processing in the baseband, the SFFB DPD can achieve comparative performance as the conventional dual-branch DPD. Experiments were performed using various configurations of LTE/LTE-Advanced (long-term evolution/long-term evolution advanced) signals of up to 80 MHz contiguous bandwidth and carrier spacing of 1 GHz. It is clearly shown by the experimental results that the proposed SFFB DPD can achieve satisfactory linearization performance, with significantly reduced hardware complexity.	[Ma, Yuelin] Toshiba Co Ltd, Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan; [Yamao, Yasushi] Univ Electrocommun, Adv Wireless Commun Res Ctr, Tokyo 1828585, Japan	Ma, YL (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Komukai Toshiba Cho, Kawasaki, Kanagawa 2128582, Japan.	yuelinma1985@gmail.com; yamao@ieee.org			Ministry of Internal Affairs and Communications (MIC) of Japan under the SCOPE Program [135003118]	This work was supported in part by the Ministry of Internal Affairs and Communications (MIC) of Japan under the SCOPE Program 135003118 in 2013-2014.	Akaiwa Y., 1997, INTRO DIGITAL MOBILE; Liu YJ, 2013, IEEE T MICROW THEORY, V61, P281, DOI 10.1109/TMTT.2012.2228216; Rawat K, 2012, IEEE CIRC SYST MAG, V12, P12, DOI 10.1109/MCAS.2011.2181074; Ma YL, 2013, IEEE T MICROW THEORY, V61, P3961, DOI 10.1109/TMTT.2013.2281962; Zhu AD, 2008, IEEE T MICROW THEORY, V56, P1524, DOI 10.1109/TMTT.2008.925211; Roblin P, 2013, IEEE MICROW MAG, V14, P75, DOI 10.1109/MMM.2013.2281297; Ma YL, 2013, IEEE T MICROW THEORY, V61, P4209, DOI 10.1109/TMTT.2013.2288088; Bassam SA, 2012, IEEE T MICROW THEORY, V60, P1990, DOI 10.1109/TMTT.2012.2192745; Bassam SA, 2011, IEEE T MICROW THEORY, V59, P2547, DOI 10.1109/TMTT.2011.2163802; Ma YL, 2011, INT J RF MICROW C E, V21, P589, DOI 10.1002/mmce.20546; Cabarkapa M, 2013, IEEE T MICROW THEORY, V61, P4579, DOI 10.1109/TMTT.2013.2287679; Bassam SA, 2013, IEEE MICROW MAG, V14, P78, DOI 10.1109/MMM.2013.2259399; Pedersen KI, 2011, IEEE COMMUN MAG, V49, P89, DOI 10.1109/MCOM.2011.5783991; Bassam SA, 2011, IEEE MICROW WIREL CO, V21, P685, DOI 10.1109/LMWC.2011.2170669; Ma YL, 2014, IEEE T CIRCUITS-I, V61, P2088, DOI 10.1109/TCSI.2013.2295897; Kim J, 2013, IEEE T MICROW THEORY, V61, P596, DOI 10.1109/TMTT.2012.2229714; Ma YL, 2013, INT J RF MICROW C E, V23, P74, DOI 10.1002/mmce.20653; Cidronali A., 2008, P INT NONL MICR MILL, P127; Evolved Universal Terrestrial Radio Access (E-UTRA), 2010, 36300 3GPP TS; Konagurthu A. S., 2014, RECOMB, V8394, P144; Liu YJ, 2014, IEEE T MICROW THEORY, V62, P2604, DOI 10.1109/TMTT.2014.2360398; Ma Y., 2015, THESIS ELECT COMMUN; Xilinx Inc, 2011, LOGICORE IP PEAK CAN; Yu C., 2014, PROCIEEE MTT S INT M, V1, P1	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	OCT	2015	63	10	1				3164	3174		10.1109/TMTT.2015.2472011		11	Engineering, Electrical & Electronic	Engineering	CS8SE	WOS:000362357900017		
J	Shiina, T; Suzuki, Y; Sasaki, K; Watanabe, S; Taki, M				Shiina, Takeo; Suzuki, Yukihisa; Sasaki, Kensuke; Watanabe, Soichi; Taki, Masao			High-Efficiency Applicator Based on Printed Circuit Board in Millimeter-Wave Region	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Applicator; dosimetry; in vitro; millimeter-wave technology; specific absorption rate (SAR)	IN-VITRO EXPERIMENTS; EXPOSURE; DOSIMETRY; CELLS; PERMITTIVITY; RADIATION; APERTURE; GROWTH; RANGE; GUIDE	The purpose of this study is to develop a novel in vitro millimeter-wave (MMW) applicator for an exposure apparatus that allows high power efficiency with reasonably good homogeneity over a sufficient exposure area, as well as the capability of temperature control in biological samples. The applicator is made of a printed circuit board and has a large and circular (90-mm diameter) exposure area that is fed with MMWs using post-wall waveguide technology. The applicator is designed for the exposure of cells to MMWs at 60 GHz. The proposed applicator has an absorption efficiency of 54%, where the absorption efficiency is defined as the ratio of the total power absorbed in the culture medium to the input power. Its efficiency is higher than those of other apparatuses operating at 60 GHz reported in the literature. Most of the cells (89%) are located within the 5-dB region relative to the average specific absorption rate, which shows reasonably good homogeneity compared with previously reported literature data. The applicator enables efficient temperature control for in vitro experiments to explore unknown and possible nonthermal effects of MMW exposures.	[Shiina, Takeo; Suzuki, Yukihisa; Taki, Masao] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Elect & Elect Engn, Tokyo 1920397, Japan; [Shiina, Takeo; Sasaki, Kensuke; Watanabe, Soichi; Taki, Masao] Natl Inst Informat & Commun Technol, Tokyo 1848795, Japan	Shiina, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Elect & Elect Engn, Tokyo 1920397, Japan.	shiina-takeo@ed.tmu.ac.jp			Ministry of Internal Affairs and Communications of Japan under the Research on Biological Effect Project	This work was supported by the Ministry of Internal Affairs and Communications of Japan under the Research on Biological Effect Project.	GRUNDLER W, 1977, PHYS LETT A, V62, P463, DOI 10.1016/0375-9601(77)90696-X; Schuderer J, 2004, IEEE T MICROW THEORY, V52, P2057, DOI 10.1109/TMTT.2004.832009; Zhadobov M, 2011, INT J MICROW WIREL T, V3, P237, DOI 10.1017/S1759078711000122; Hirokawa J, 1998, IEEE T ANTENN PROPAG, V46, P625, DOI 10.1109/8.668903; Boriskin AV, 2013, IEEE T MICROW THEORY, V61, P2005, DOI 10.1109/TMTT.2013.2255619; Zhao JX, 2005, BIOELECTROMAGNETICS, V26, P481, DOI 10.1002/bem.20121; Zhadobov M, 2008, IEEE T MICROW THEORY, V56, P2998, DOI 10.1109/TMTT.2008.2006797; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P55, DOI 10.1002/bem.20685; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P346, DOI 10.1002/bem.20713; Blumm J, 2010, INT J THERMOPHYS, V31, P1919, DOI 10.1007/s10765-008-0512-z; Pakhomov AG, 1998, BIOELECTROMAGNETICS, V19, P393, DOI 10.1002/(SICI)1521-186X(1998)19:7<393::AID-BEM1>3.0.CO;2-X; Kobayashi Y, 2007, IEICE T ELECTRON, VE90C, P2178, DOI 10.1093/ietele/e90-c.12.2178; Pickard WF, 2010, BIOELECTROMAGNETICS, V31, P140, DOI 10.1002/bem.20539; Samaras T, 2000, PHYS MED BIOL, V45, P2233, DOI 10.1088/0031-9155/45/8/312; Kai T, 2005, IEICE T COMMUN, VE88B, P1298, DOI 10.1093/ietcom/e88-b.3.1298; Ellison WJ, 2007, J PHYS CHEM REF DATA, V36, P1, DOI 10.1063/1.2360986; Ramundo-Orlando A, 2009, BBA-BIOMEMBRANES, V1788, P1497, DOI 10.1016/j.bbamem.2009.04.006; FURIA L, 1986, IEEE T BIO-MED ENG, V33, P993, DOI 10.1109/TBME.1986.325865; Kurogi S., 2010, AS PAC RAD SCI C TOY, P1; Kuster N, 2000, BIOELECTROMAGNETICS, V21, P508, DOI 10.1002/1521-186X(200010)21:7<508::AID-BEM4>3.0.CO;2-F; Maruyama Y., 2002, INT UN RAD SCI 27 GE, P1; Saito H., 2009, INT EL COMP S KYOT J, P317; Shiraga K., 2013, APPL PHYS LETT, V102; Szabo Imre, 2006, Bioelectromagnetics, V27, P233, DOI 10.1002/bem.20202; Yuanfeng She, 2011, IEICE Transactions on Electronics, VE94-C, DOI 10.1587/transele.E94.C.312; Zhao JX, 2012, IEEE T MICROW THEORY, V60, P3608, DOI 10.1109/TMTT.2012.2213829	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	OCT	2015	63	10	1				3311	3318		10.1109/TMTT.2015.2472401		8	Engineering, Electrical & Electronic	Engineering	CS8SE	WOS:000362357900032		
J	Hartono, P; Hollensen, P; Trappenberg, T				Hartono, Pitoyo; Hollensen, Paul; Trappenberg, Thomas			Learning-Regulated Context Relevant Topographical Map	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Context relevance; radial basis function (RBF) network; self-organizing map (SOM); supervised learning; topographical maps	SELF-ORGANIZING MAPS; NONLINEAR DIMENSIONALITY REDUCTION; RELATIONSHIP SOR NETWORK; CLASSIFICATION	Kohonen's self-organizing map (SOM) is used to map high-dimensional data into a low-dimensional representation (typically a 2-D or 3-D space) while preserving their topological characteristics. A major reason for its application is to be able to visualize data while preserving their relation in the high-dimensional input data space as much as possible. Here, we are seeking to go further by incorporating semantic meaning in the low-dimensional representation. In a conventional SOM, the semantic context of the data, such as class labels, does not have any influence on the formation of the map. As an abstraction of neural function, the SOM models bottom-up self-organization but not feedback modulation which is also ubiquitous in the brain. In this paper, we demonstrate a hierarchical neural network, which learns a topographical map that also reflects the semantic context of the data. Our method combines unsupervised, bottom-up topographical map formation with top-down supervised learning. We discuss the mathematical properties of the proposed hierarchical neural network and demonstrate its abilities with empirical experiments.	[Hartono, Pitoyo] Chukyo Univ, Dept Elect & Elect Engn, Nagoya, Aichi 4668666, Japan; [Hollensen, Paul; Trappenberg, Thomas] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 4R2, Canada	Hartono, P (reprint author), Chukyo Univ, Dept Elect & Elect Engn, Nagoya, Aichi 4668666, Japan.	hartono@ieee.org; hollensen@cs.dal.ca; tt@cs.dal.edu			Japan Society for the Promotion of Science [25330419, 26590182]; Natural Sciences and Engineering Research Council of Canada	This work was supported by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 25330419 and Grant 26590182. The work of P. Hollensen and T. Trappenberg was supported by the Natural Sciences and Engineering Research Council of Canada.	Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; CHAPPELL GJ, 1993, NEURAL NETWORKS, V6, P441, DOI 10.1016/0893-6080(93)90011-K; Zhang SJ, 2009, LECT NOTES COMPUT SC, V5631, P469; Sarlin P, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P230, DOI 10.1109/CIDM.2013.6597241; Strickert M, 2005, NEUROCOMPUTING, V64, P39, DOI 10.1016/j.neucom.2004.11.014; Cheung YM, 2007, IEEE T NEURAL NETWOR, V18, P289, DOI 10.1109/TNN.2006.885039; Merkl D, 1998, NEUROCOMPUTING, V21, P61, DOI 10.1016/S0925-2312(98)00032-0; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; POGGIO T, 1990, P IEEE, V78, P1481, DOI 10.1109/5.58326; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yin HJ, 2002, IEEE T NEURAL NETWOR, V13, P237, DOI 10.1109/72.977314; Elwell R, 2011, IEEE T NEURAL NETWOR, V22, P1517, DOI 10.1109/TNN.2011.2160459; ICHIKI H, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P1944, DOI 10.1109/ICNN.1993.298854; Yamakawa T, 1999, IEICE T FUND ELECTR, VE82A, P1674; Kohonen T, 2013, NEURAL NETWORKS, V37, P52, DOI 10.1016/j.neunet.2012.09.018; Soares RGF, 2012, IEEE T NEUR NET LEAR, V23, P1779, DOI 10.1109/TNNLS.2012.2214488; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918; Barreto GA, 2004, IEEE T NEURAL NETWOR, V15, P1244, DOI 10.1109/TNN.2004.832825; HECHTNIELSEN R, 1987, APPL OPTICS, V26, P4979, DOI 10.1364/AO.26.004979; Ultsch A, 1996, IEEE IJCNN, P1622, DOI 10.1109/ICNN.1996.549143; Koga T, 2006, NEURAL NETWORKS, V19, P799, DOI 10.1016/j.neunet.2006.05.008; Trappenberg T, 2009, LECT NOTES COMPUT SC, V5629, P316, DOI 10.1007/978-3-642-02397-2_36; RITTER H, 1989, BIOL CYBERN, V61, P241, DOI 10.1007/BF00203171; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Bengio Yoshua, 2009, Foundations and Trends in Machine Learning, V2, DOI 10.1561/2200000006; Foldiak P., 2002, SPARSE CODING PRIMAT; Goppert J., 1993, P WORKSHOP DESIGN ME, P153; Hagenbuchner M, 2001, ADVANCES IN SELF-ORGANISING MAPS, P21; Hartono P., 2013, P IEEE IJCNN AUG, P160; Hartono P., 2009, P IEEE SMC 2009, P2802; Hinton G., 2003, ADV NEURAL INFORM PR, V15, P833; Kohonen T, 1991, ARTIFICIAL NEURAL NE, VII, P1357; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Koskela T., 1998, INT J KNOWLEDGE BASE, V2, P60; Lecun Y, 1998, P IEEE, V86, P2279; Mondada F., 2009, P 9 C AUT ROB SYST C, V1, P59; Moody J., 1989, Neural Computation, V1, DOI 10.1162/neco.1989.1.2.281; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1, P318; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Sarlin P., 2013, P WORKSH NEW CHALL N; Sarlin P., 2012, NEUROCOMPUTING, V99, P496; Sarlin Peter, 2011, Intelligent Systems in Accounting, Finance and Management, V18, DOI 10.1002/isaf.321; Trappenberg T. P., 2010, FUNDAMENTALS COMPUTA	44	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	OCT	2015	26	10					2323	2335		10.1109/TNNLS.2014.2379275		13	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CS8SM	WOS:000362358800009		
J	Redondo, LMS; Hosseini, H; Novac, B; Yu, XJ				Redondo, Luis M. S.; Hosseini, Hamid; Novac, Bucur; Yu, Xinjie			Special Issue on Selected Papers From EAPPC 2014	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Editorial Material									[Redondo, Luis M. S.] Lisbon Super Engn Inst, P-1959007 Lisbon, Portugal; [Hosseini, Hamid] Kumamoto Univ, Bioelect Dept, Inst Pulsed Power Sci, Kumamoto 8608555, Japan; [Novac, Bucur] Univ Loughborough, Sch Elect Elect & Syst Engn, Loughborough LE11 3TU, Leics, England; [Yu, Xinjie] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China	Redondo, LMS (reprint author), Lisbon Super Engn Inst, P-1959007 Lisbon, Portugal.	lmredondo@deea.isel.ipl.pt; hosseini@kumamoto-u.ac.jp; b.m.novac@lboro.ac.uk; yuxj@tsinghua.edu.cn	Redondo, Luis/A-3078-2009; 	Redondo, Luis/0000-0002-2381-4627				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3358	3358		10.1109/TPS.2015.2477555		1	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800001		
J	Saeki, R; Yasuoka, K				Saeki, Ryo; Yasuoka, Koichi			Generation of Hydrogen Peroxide in Gas Bubbles Using Pulsed Plasma for Advanced Oxidation Processes	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Gas-liquid surface discharge; high-conductivity water; hydrogen peroxide; pulsed plasma	WATER; DISCHARGE; REACTOR	Advanced oxidation process (AOP) is one of the most effective methods of decomposing persistent organic pollutants in water using OH radicals. The O-3/H2O2 method is widely used to form OH radials for AOP; however, this method needs a continuous H2O2 supply. The continuous generation of H2O2 using plasma is appropriate for the O-3/H2O2 method, since plasma is readily available anywhere electricity is. This paper presents suitable conditions for pulsed plasma generation in oxygen bubbles for effective and rapid formation of H2O2. The experimental results show that low-voltage-driven and long pulsewidth plasma is best for H2O2 generation. The highest H2O2 generation rate of 61.8 mg/h and energy yield of 2.1 g/kWh were obtained at 2.5-kV voltage, 4-kHz pulse frequency, and 1-mu s pulsewidth.	[Saeki, Ryo; Yasuoka, Koichi] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Saeki, R (reprint author), Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.	saeki@plasma.ee.titech.ac.jp; yasuoka@ee.titech.ac.jp					Wandell RJ, 2014, IND ENG CHEM RES, V53, P609, DOI 10.1021/ie402766t; Burlica R, 2010, IND ENG CHEM RES, V49, P6342, DOI 10.1021/ie100038g; Yasuoka K, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034009; Lukes P, 2005, J PHYS D APPL PHYS, V38, P4074, DOI 10.1088/0022-3727/38/22/010; Wandell RJ, 2014, IEEE T PLASMA SCI, V42, P1195, DOI 10.1109/TPS.2014.2304183; Njoyim-Tamungang E, 2011, CHEM ENG J, V173, P303, DOI 10.1016/j.cej.2011.07.021; Anpilov AM, 2001, J PHYS D APPL PHYS, V34, P993, DOI 10.1088/0022-3727/34/6/322; STROMGREN T, 1995, MAR ENVIRON RES, V40, P147, DOI 10.1016/0141-1136(94)00143-D; Fakhru'l-Razi Ahmadun, 2009, J Hazard Mater, V170, P530, DOI 10.1016/j.jhazmat.2009.05.044; Locke BR, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034006; Takeuchi N., 2011, PLASMA SOUR SCI TECH, V21; Yoshihara K., 2013, P 19 IEEE PULS POW C, P1	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3440	3444		10.1109/TPS.2015.2424977		5	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800015		
J	Yamamoto, A; Kawano, Y; Nakai, M; Nakagawa, T; Sakugawa, T; Hosseini, H; Akiyama, H				Yamamoto, Akinori; Kawano, Yuzo; Nakai, Mizuki; Nakagawa, Toru; Sakugawa, Takashi; Hosseini, Hamid; Akiyama, Hidenori			Investigation of Gas Flow Dependence of Plasma Jet Produced by Pulsed Power	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Dielectric-barrier discharge; gas flow analysis; plasma jet; pulsed power; Schlieren method	MEDICINE; NEEDLE	Nonthermal plasmas were generated using repetitively operated pulsed power generators, demonstrating the technology's potential in creating discharges relatively easily at atmospheric pressure. Control of plasma jets at atmospheric pressure facilitates a wide range of applications in material modification, medicine, and energy. This paper investigates the effects of gas flow velocity and helium mole fraction on plasma length under dielectric-barrier discharge. Helium gas was used for easy observance of light emission.	[Yamamoto, Akinori; Kawano, Yuzo; Nakai, Mizuki] TAKAGI Co Ltd, Kitakyushu, Fukuoka 8028540, Japan; [Nakagawa, Toru; Sakugawa, Takashi; Hosseini, Hamid; Akiyama, Hidenori] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Yamamoto, A (reprint author), TAKAGI Co Ltd, Kitakyushu, Fukuoka 8028540, Japan.	yamamoto1529@takagi.co.jp; kawano1482@takagi.co.jp; nakai1460@takagi.co.jp; tnakagaw@kumamoto-u.ac.jp; sakugawa@cs.kumamoto-u.ac.jp; hosseini@kumamoto-u.ac.jp; akiyama@cs.kumamoto-u.ac.jp					Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; Foletto M, 2014, IEEE T PLASMA SCI, V42, P2436, DOI 10.1109/TPS.2014.2331393; Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003; Iza F, 2008, PLASMA PROCESS POLYM, V5, P322, DOI 10.1002/ppap.200700162; Sands BL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909084; Lu X, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349475; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Naidis GV, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/40/402001; Zhu WC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/202002; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; Ye RB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2972119; Robert E, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/012003; Bardos L, 2010, THIN SOLID FILMS, V518, P6705, DOI 10.1016/j.tsf.2010.07.044; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Choi JH, 2006, J ELECTROSTAT, V64, P17, DOI 10.1016/j.elstat.2005.04.001; Schutze A, 1998, IEEE T PLASMA SCI, V26, P1685, DOI 10.1109/27.747887; Iseki S., 2010, IEICE TECH REP JPN, V109, P21	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3451	3455		10.1109/TPS.2015.2448132		5	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800017		
J	Ikeda, S; Horioka, K; Okamura, M				Ikeda, Shunsuke; Horioka, Kazuhiko; Okamura, Masahiro			Investigation of the Tail of a Fe Plasma Plume Passing Through Solenoidal Magnetic Field for a Laser Ion Source	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Ion sources; laser ablation; magnetic fields; plasmas	FUSION; BEAM	To control the plasma flux of a laser ion source for a desired beam profile, we investigated the influence of a quasi-static magnetic field generated by a solenoidal coil on the tail of an Fe ablation plasma. We observed that the magnetic field converged the outer plasma and almost did not affect the inner plasma when the plasma drifted through the field region. The convergence points of the outer plasma depended on the longitudinal velocity. The results indicate that diamagnetic current was induced in the outer plasma, and therefore, the outer plasma received the converging force and the magnetic field in the inner region was excluded by the plasma intrusion. The results also mean that we have to consider the magnetic effect on the transverse distribution of plasma flux to minimize the emittance growth and obtain desirable beam optics.	[Ikeda, Shunsuke; Horioka, Kazuhiko] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 2268502, Japan; [Ikeda, Shunsuke] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama 3510198, Japan; [Okamura, Masahiro] Brookhaven Natl Lab, Collider Accelerator Dept, Upton, NY 11973 USA	Ikeda, S (reprint author), Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 2268502, Japan.	ikeda.s.ae@m.titech.ac.jp; khorioka@es.titech.ac.jp; okamura@bnl.gov					ROBERTSON S, 1986, J APPL PHYS, V59, P1765, DOI 10.1063/1.336445; Wolowski J, 2002, LASER PART BEAMS, V20, P113, DOI 10.1017/S0263034602201160; Kwan JW, 2005, IEEE T PLASMA SCI, V33, P1901, DOI 10.1109/TPS.2005.860063; Okamura M, 2014, NUCL INSTRUM METH A, V733, P97, DOI 10.1016/j.nima.2013.10.026; KELLY R, 1988, SURF SCI, V198, P263, DOI 10.1016/0039-6028(88)90483-9; Fournier P, 2000, REV SCI INSTRUM, V71, P924, DOI 10.1063/1.1150347; Sharkov BY, 1998, REV SCI INSTRUM, V69, P1035, DOI 10.1063/1.1148531; KRAFT R, 1987, PHYS FLUIDS, V30, P245, DOI 10.1063/1.866182; Ikeda S., 2014, P IPAC DRESD GERM, P601; Ikeda S., 2012, PLASMA FUSION RES, V7; Ikeda S., 2012, NUCL INSTRUM METH A, V733, P103; Ikeda S, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4833015; Kanesue T., 2014, P IPAC2014; TONON GF, 1972, IEEE T NUCL SCI, VNS19, P172, DOI 10.1109/TNS.1972.4326651	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3456	3460		10.1109/TPS.2015.2421284		5	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800018		
J	Ogasawara, A; Han, JK; Fukunaga, K; Wang, JL; Wang, DY; Namihira, T; Sasaki, M; Akiyama, H; Zhang, PY				Ogasawara, Akihiko; Han, Junkai; Fukunaga, Kengo; Wang, Jinlong; Wang, Douyan; Namihira, Takao; Sasaki, Mitsuru; Akiyama, Hidenori; Zhang, Pengyi			Decomposition of Toluene Using Nanosecond-Pulsed-Discharge Plasma Assisted With Catalysts	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Catalyst; MnOx; nanosecond (ns)-pulsed discharge; ozone; toluene decomposition	VOLATILE ORGANIC-COMPOUNDS; NONTHERMAL PLASMA; AIR-POLLUTION; PHOTOCATALYTIC DEGRADATION; HETEROGENEOUS CATALYSIS; ENERGY EFFICIENCY; FUTURE-PROSPECTS; VOC ABATEMENT; INDOOR AIR; TIO2 FILM	Volatile organic compounds (VOCs) are common air pollutants existing in various atmospheric environments; as they present both acute and chronic effects on the health of a number of different human systems and organs, methods for their efficient removal are essential. To this end, catalysis is being researched to prevent environmental pollution. While catalytic and photocatalytic oxidation, which can eliminate low concentrations of various kinds of VOCs as well as O-3, offer potential to improve indoor air quality, neither is effective in areas with high VOC concentration. To overcome this limitation, many researchers have concentrated on synergetic effects of plasma catalysis, combining the advantages of high-selectivity catalysis and fast ignition and response of a nonthermal plasma. The authors' research group has demonstrated that our nanosecond (ns)-pulsed-discharge plasma decomposes NOx as well as produces O-3 with an energy efficiency higher than that of the reported nonthermal discharges. However, the performance of the ns-pulsed-discharge plasma in VOC decomposition in comparison with or without catalyst has not yet been investigated systematically. Thus, this paper experimentally clarified the combined effects of MnOx catalyst supported by Ni foam on toluene decomposition. The input energy density to our plasma catalysis reactor using a ns-pulsed discharge was 11% of a cited dielectric barrier discharge plasma catalysis when toluene removal ratio reached 100%.	[Ogasawara, Akihiko; Han, Junkai; Fukunaga, Kengo] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Wang, Jinlong; Zhang, Pengyi] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Wang, Douyan; Namihira, Takao; Sasaki, Mitsuru; Akiyama, Hidenori] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Ogasawara, A (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	ogasawara@st.cs.kumamoto-u.ac.jp; hanjunkai0609@st.cs.kumamoto-u.ac.jp; k.fukunaga@st.cs.kumamoto-u.ac.jp; jl-wang11@mails.tsinghua.edu.cn; douyan@cs.kumamoto-u.ac.jp; namihira@cs.kumamoto-u.ac.jp; msasaki@kumamoto-u.ac.jp; akiyama@cs.kumamoto-u.ac.jp; zpy@tsinghua.edu.cn	Zhang, Pengyi/E-3385-2012	Zhang, Pengyi/0000-0003-0344-0071			Ojala S, 2011, TOP CATAL, V54, P1224, DOI 10.1007/s11244-011-9747-1; Fu PF, 2011, THIN SOLID FILMS, V519, P3480, DOI 10.1016/j.tsf.2010.12.245; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; Radhakrishnan R, 2001, J PHYS CHEM B, V105, P4245, DOI 10.1021/jp003246z; Zhang L, 2007, CHINESE J CATAL, V28, P299, DOI 10.1016/S1872-2067(07)60028-X; Fu PF, 2010, APPL CATAL B-ENVIRON, V96, P176, DOI 10.1016/j.apcatb.2010.02.017; Nichipor H, 2012, RADIAT PHYS CHEM, V81, P572, DOI 10.1016/j.radphyschem.2012.01.006; Chen HL, 2009, ENVIRON SCI TECHNOL, V43, P2216, DOI 10.1021/es802679b; Hoeben WFLM, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/5/055202; Han WY, 2004, WATER RES, V38, P4197, DOI 10.1016/j.watres.2004.07.019; [Anonymous], 2014, J PHYS D; Demidyuk V, 2007, PLASMA CHEM PLASMA P, V27, P85, DOI 10.1007/s11090-006-9045-z; Matsumoto T, 2010, IEEE T PLASMA SCI, V38, P2639, DOI 10.1109/TPS.2010.2045903; Byeon JH, 2010, J HAZARD MATER, V175, P417, DOI 10.1016/j.jhazmat.2009.10.022; Van Durme J, 2007, CHEMOSPHERE, V68, P1821, DOI 10.1016/j.chemosphere.2007.03.053; Vandenbroucke AM, 2011, J HAZARD MATER, V195, P30, DOI 10.1016/j.jhazmat.2011.08.060; Kim HH, 2005, IEEE T IND APPL, V41, P206, DOI 10.1109/TIA.2004.840988; Magureanu M, 2011, APPL CATAL B-ENVIRON, V104, P84, DOI 10.1016/j.apcatb.2011.02.025; Kohno H, 1998, IEEE T IND APPL, V34, P953, DOI 10.1109/28.720435; Wang DY, 2010, J ADV OXID TECHNOL, V13, P71; Schiorlin M, 2009, ENVIRON SCI TECHNOL, V43, P9386, DOI 10.1021/es9021816; Fu PF, 2011, APPL CATAL B-ENVIRON, V105, P220, DOI 10.1016/j.apcatb.2011.04.021; Zhu T, 2011, INT J ENVIRON SCI TE, V8, P621, DOI 10.1007/BF03326247; Lou JC, 2009, AEROSOL AIR QUAL RES, V9, P435, DOI 10.4209/aaqr.2009.05.0027; Namihira T, 2003, IEEE T PLASMA SCI, V31, P1091, DOI 10.1109/TPS.2003.818765; Xiao G, 2014, PLASMA CHEM PLASMA P, V34, P1033, DOI 10.1007/s11090-014-9562-0; Huang HB, 2011, J MOL CATAL A-CHEM, V336, P87, DOI 10.1016/j.molcata.2011.01.002; Kim HH, 2004, PLASMA PROCESS POLYM, V1, P91, DOI 10.1002/ppap.200400028; Jiang X, 2015, ANAL METHODS-UK, V7, P400, DOI 10.1039/c4ay02194k; Urashima K, 2000, IEEE T DIELECT EL IN, V7, P602, DOI 10.1109/94.879356; Torres JQ, 2013, CHEMSUSCHEM, V6, P578, DOI 10.1002/cssc.201200809; Guo YF, 2007, CATAL TODAY, V126, P328, DOI 10.1016/j.cattod.2007.06.025; Magureanu M, 2011, ROM J PHYS, V56, P156; Van Durme J, 2008, APPL CATAL B-ENVIRON, V78, P324, DOI 10.1016/j.apcatb.2007.09.035; Magureanu M, 2005, APPL CATAL B-ENVIRON, V61, P12, DOI 10.1016/j.apcath.2005.04.007; Sultana S, 2015, CATALYSTS, V5, P718, DOI 10.3390/catal5020718; Fu PF, 2012, INT J PHOTOENERGY, DOI 10.1155/2012/174862; Vandenbroucke AM, 2012, J ADV OXID TECHNOL, V15, P232; Wang F, 2012, ENVIRON SCI TECHNOL, V46, P4034, DOI 10.1021/es204038j; Araki Y., 2011, Proceedings of the 2011 18th IEEE International Conference on IEEE Pulsed Power (PPC 2011), DOI 10.1109/PPC.2011.6191584; Bahri M, 2014, CLEAN-SOIL AIR WATER, V42, P1667, DOI 10.1002/clen.201300296; Farrauto RJ, 2000, CATAL TODAY, V55, P179, DOI 10.1016/S0920-5861(99)00237-0; Kim HH, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100444; Matsumoto T., 2009, P PULS POW C PPC 09, P1035; Namihira T., 2007, P IEEE 34 INT C PLAS, P435; Parvulescu V. I., 2012, PLASMA CHEM CATALYSI; Penetrante B. M., 1992, NONTHERMAL PLASMA B; Rusu A.O., 2003, ENVIRON ENG MANAG J, V2, P273; Subrahmanyam C, 2006, APPL CATAL B-ENVIRON, V65, P150, DOI 10.1016/j.apcatb.2006.01.006; Tamaribuchi H., 2007, 16 IEEE INT PULS POW, V1, P407; United States Environmental Protection Agency, INTR IND AIR QUAL IA; United States Environmental Protection Agency, HLTH EFF PART MATT; Virtual Center for Environmental Technology Exchange and The Asia-Pacific Economic Cooperation Group, VOL ORG COMP VOCS; Zhang X., 2010, INT J PLASMA ENV SCI, V4, P130	55	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3461	3469		10.1109/TPS.2015.2447273		9	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800019		
J	Sarathi, R; Reddy, RS; Tavarmani, RS; Okamoto, A; Suematsu, H; Selvam, P; Mudali, UK; Kamaraj, M				Sarathi, Ramanujam; Reddy, Ravula Sugunakar; Tavarmani, Rashmi S.; Okamoto, Akira; Suematsu, Hisayuki; Selvam, Parasuraman; Mudali, Uthandi Kamachi; Kamaraj, Muthusamy			Investigation of Nano-Molybdenum Carbide Particle Produced by Wire-Explosion Process	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Log-normal distribution; nano-molybdenum carbide (MoC); optical emission spectroscopy (OES); transmission electron microscopy (TEM); wire-explosion process (WEP); X-ray diffractogram (XRD)	DISCHARGE; ELECTROCATALYST; POWDER	Molybdenum carbide (MoC) nanoparticles were generated by exploding molybdenum conductor in methane gas ambience at different pressures. To enhance the level of carburization, exploding conductor was coated with graphite and paraffin mixtures. Various physico-chemical studies were employed to characterize the produced nano-carbide particles, viz., X-ray diffraction, optical emission spectroscopy, X-ray photoelectron spectroscopy, and transmission electron microscopy. It was deduced from these investigations that the nano-MoC particles produced by a wire explosion process (WEP) are spherical in shape. The size of the particles formed by WEP can be controlled by varying the operating ambience pressure of the methane gas. The particle size produced follows a log-normal distribution. Optical emission results clearly indicates the presence of Mo-I, C-I, and C-II components during WEP. X-ray photoelectron spectroscopy confirms the formation of MoC.	[Sarathi, Ramanujam; Reddy, Ravula Sugunakar; Tavarmani, Rashmi S.] Indian Inst Technol, Dept Elect Engn, Madras 600036, Tamil Nadu, India; [Okamoto, Akira; Suematsu, Hisayuki] Nagaoka Univ Technol, Nagaoka, Niigata 9402137, Japan; [Selvam, Parasuraman] Indian Inst Technol, Natl Ctr Catalysis Res, Dept Chem, Madras 600036, Tamil Nadu, India; [Mudali, Uthandi Kamachi] Indira Gandhi Ctr Atom Res, Kalpakkam 603102, Tamil Nadu, India; [Kamaraj, Muthusamy] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India	Sarathi, R (reprint author), Indian Inst Technol, Dept Elect Engn, Madras 600036, Tamil Nadu, India.	rsarathi@iitm.ac.in; ee10d018@ee.iitm.ac.in; rashmist2@gmail.com; nuts133100@gmail.com; suematsu@nagaokaut.ac.jp; selvam@iitm.ac.in; kamachi@igcar.gov.in; kamaraj@iitm.ac.in					Kim W, 2009, MATER TRANS, V50, P2897, DOI 10.2320/matertrans.M2009297; Guil-Lopez R, 2010, INT J HYDROGEN ENERG, V35, P7881, DOI 10.1016/j.ijhydene.2010.05.044; Sarathi R, 2007, MATER CHARACT, V58, P148, DOI 10.1016/j.matchar.2006.04.014; Antony JK, 2010, J QUANT SPECTROSC RA, V111, P2509, DOI 10.1016/j.jqsrt.2010.07.011; Guil-Lopez R, 2012, J SOLID STATE CHEM, V190, P285, DOI 10.1016/j.jssc.2012.02.021; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; Tkachenko SI, 2004, J PHYS D APPL PHYS, V37, P495, DOI 10.1088/0022-3727/37/3/030; Ishihara S, 2012, MATER LETT, V67, P289, DOI 10.1016/j.matlet.2011.09.087; Vitale G, 2015, CATAL TODAY, V250, P123, DOI 10.1016/j.cattod.2014.05.011; Jiang WH, 1998, IEEE T PLASMA SCI, V26, P1498; Suematsu H, 2003, JPN J APPL PHYS 2, V42, pL1028, DOI 10.1143/JJAP.42.L1028; Khabbaz S, 2013, INT J REFRACT MET H, V41, P402, DOI 10.1016/j.ijrmhm.2013.05.014; Yan ZX, 2014, J MATER CHEM A, V2, P4014, DOI 10.1039/c3ta14251e; Bernhardt I. C., 1994, PARTICLE SIZE ANAL C; Guillen-Villafuerte O, 2012, INT J HYDROGEN ENERG, V37, P7171, DOI 10.1016/j.ijhydene.2011.11.117; Hayt W. H., 1993, ENG CIRCUIT ANAL; Koishi T., 2012, FUNCT MATER LETT, V5; Poole C. P., 2003, INTRO NANOTECHNOLOGY; Rhee Chang Kyu, 2002, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V9, P433; Sedoi VS, 1999, IEEE T PLASMA SCI, V27, P845, DOI 10.1109/27.782248; Sindhu TK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/02/025703; Tokoi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.055001	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3470	3475		10.1109/TPS.2015.2426019		6	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800020		
J	Takaki, K; Nishimura, J; Koide, S; Takahashi, K; Uchino, T				Takaki, Koichi; Nishimura, Junki; Koide, Shoji; Takahashi, Katsuyuki; Uchino, Toshitaka			Decomposition of Ethylene Using Dual-Polarity Pulsed Dielectric Barrier Discharge	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Dielectric barrier discharge (DBD); ethylene (C2H4); oxidization; preservation; transportation	NONTHERMAL PLASMA; STREAMER CORONA; C2F6 REMOVAL; REACTOR; OXIDATION; TIO2; NITROGEN; KINETICS; OXYGEN; SHAPE	Ethylene (C2H4) gas promotes the aging of some kinds of fruits and vegetables such as persimmon, banana, and cucumber. Decomposition of ethylene using nonthermal plasma is effective for keeping freshness of fruits and vegetables in the transportation container. The ethylene was decomposed into gas stream using a dielectric barrier discharge (DBD) reactor driven by dual-polarity pulse generator that consisted of four insulated gate bipolar transistors and a pulse transformer. The output voltage of the pulse generator was 10 kV in amplitude, 1 kilopulse/s in repetition rate, and 50 mu s in rectangular pulsewidth. The 200 ppm ethylene was diluted with dried air and was employed as simulated gas of the transportation container. The gas mixture was fed into the DBD reactor for the evaluation of the decomposition efficiency. The ethylene concentration decreased to less than 1 ppm after the DBD treatment at 30 J/L in input energy. The energy efficiency for ethylene decomposition was around 50 g/kWh and was almost independent of the initial ethylene concentration. The decomposition efficiency increased with increasing oxygen content of the background gas. The byproducts were analyzed by a Fourier transform infrared spectrometer. The results showed that the H2O and CO2 were mainly produced after the decomposition of the ethylene by the DBD plasma.	[Takaki, Koichi; Nishimura, Junki] Iwate Univ, Dept Elect & Elect Engn, Morioka, Iwate 0208551, Japan; [Koide, Shoji] Iwate Univ, Dept Agrobiosci, Morioka, Iwate 0208551, Japan; [Takahashi, Katsuyuki] Shishido Electrostat Ltd, Dept Res & Dev, Yokohama, Kanagawa 2240033, Japan; [Uchino, Toshitaka] Kyushu Univ, Div Bioprod Syst Sci, Fukuoka 8190395, Japan	Takaki, K (reprint author), Iwate Univ, Dept Elect & Elect Engn, Morioka, Iwate 0208551, Japan.	takaki@iwate-u.ac.jp; t2314030@iwate-u.ac.jp; shojides@iwate-u.ac.jp; k_takahashi@shishido-esd.co.jp; toshiu@bpes.kyushu-u.ac.jp					Abdelaziz A., 2012, J PHYS D, V45, P1; Abeles F. B., 1992, ETHYLENE PLANT BIOL, P182; Aerts R, 2012, PLASMA PROCESS POLYM, V9, P994, DOI 10.1002/ppap.201100168; Takaki K, 2001, IEEE T PLASMA SCI, V29, P518, DOI 10.1109/27.928950; Takaki K, 2004, IEEE T PLASMA SCI, V32, P32, DOI 10.1109/TPS.2004.823973; Chang MB, 2001, ENVIRON SCI TECHNOL, V35, P1587, DOI 10.1021/es001556p; Orlandini I, 2000, J PHYS D APPL PHYS, V33, P2467, DOI 10.1088/0022-3727/33/19/317; Aerts R, 2013, ENVIRON SCI TECHNOL, V47, P6478, DOI 10.1021/es400405c; Liu CM, 2011, IEEE T PLASMA SCI, V39, P717, DOI 10.1109/TPS.2010.2096434; ELIASSON B, 1987, J PHYS D APPL PHYS, V20, P1421, DOI 10.1088/0022-3727/20/11/010; Maneerat C, 2003, T ASAE, V46, P725; Anglada JM, 1999, CHEM-EUR J, V5, P1809, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1809::AID-CHEM1809>3.0.CO;2-N; Chavadej S, 2007, CHEM ENG J, V132, P345, DOI 10.1016/j.cej.2007.01.030; Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011; Sathiamoorthy G, 1999, IND ENG CHEM RES, V38, P1844, DOI 10.1021/ie980544y; LOWKE JJ, 1995, IEEE T PLASMA SCI, V23, P661, DOI 10.1109/27.467988; Filimonova EA, 2001, PLASMA PHYS REP+, V27, P708, DOI 10.1134/1.1390542; Takaki K, 2004, IEEE T PLASMA SCI, V32, P2175, DOI 10.1109/TPS.2004.837614; CHANG JS, 1991, IEEE T PLASMA SCI, V19, P1152, DOI 10.1109/27.125038; Miura T, 2007, J ADV OXID TECHNOL, V10, P311; Park DR, 1999, J CATAL, V185, P114, DOI 10.1006/jcat.1999.2472; Yamazaki S, 1999, J PHOTOCH PHOTOBIO A, V121, P55, DOI 10.1016/S1010-6030(98)00448-1; ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P1063, DOI 10.1109/27.125031; Hackam R, 2000, IEEE T DIELECT EL IN, V7, P654, DOI 10.1109/94.879361; Horvath G., 2008, J PHYS D, V41; Park K.-S., 2001, 2001013515 SAE, P1; Reichen P., 2011, PLASMA SOUR SCI TECH, V20	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3476	3482		10.1109/TPS.2015.2475753		7	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800021		
J	Sugai, T; Nguyen, PT; Tokuchi, A; Jiang, WH; Minamitani, Y				Sugai, Taichi; Phan Trong Nguyen; Tokuchi, Akira; Jiang, Weihua; Minamitani, Yasushi			The Effect of Flow Rate and Size of Water Droplets on the Water Treatment by Pulsed Discharge in Air	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Flow rate; indigo carmine; pulsed streamer discharge; water treatment	STREAMER CORONA DISCHARGE; APPLIED VOLTAGE; DECOMPOSITION; SPRAY; PLASMA; POWER; DYE	For a water treatment method that sprays waste water droplets into a pulsed discharge space, the effect of the flow rate and size of water droplets was investigated by experiments to investigate the optimum spraying method. Indigo carmine solution was decomposed at the flow rate of water from 3 to 12 L/min and the decomposition amount for energy consumed in a reactor was measured. When the flow rate was 3 L/min, the energy yield was lower because the amount of water passing through the ozone space was little. When the flow rate was from 6 to 12 L/min, the energy yield was similar because the ozone dissolved in water was saturated. Furthermore, the water treatment was performed by water droplets of different sizes. Size of the water droplets was varied by varying the diameter of holes of a nozzle. Two nozzles that have holes of 0.3 or 1.8 mm in diameter were used for the experiment. When the flow rate was same, the variation of size of the water droplets does not affect the energy efficiency. From this result, it is considered that the concentration of ozone and hydroperoxyl radicals in water does not depend on the diameter of water droplets. Above results show that the flow rate needs to be increased until the saturation of ozone for the treatment of high energy yield.	[Sugai, Taichi; Phan Trong Nguyen; Tokuchi, Akira; Jiang, Weihua] Nagaoka Univ Technol, Extreme Energy Dens Inst, Nagaoka, Niigata 9402188, Japan; [Tokuchi, Akira] Pulsed Power Japan Lab, Kusatsu 5250032, Japan; [Minamitani, Yasushi] Yamagata Univ, Yonezawa, Yamagata 9928510, Japan	Sugai, T (reprint author), Nagaoka Univ Technol, Extreme Energy Dens Inst, Nagaoka, Niigata 9402188, Japan.	t_sugai@etigo.nagaokaut.ac.jp; phantrong@etigo.nagaokaut.ac.jp; tokuchi@etigo.nagaokaut.ac.jp; jiang@vos.nagaokaut.ac.jp; minami@yz.yamagata-u.ac.jp					Sugai T, 2013, IEEE T PLASMA SCI, V41, P967, DOI 10.1109/TPS.2013.2251359; Brisset JL, 2012, PLASMA CHEM PLASMA P, V32, P655, DOI 10.1007/s11090-012-9384-x; Kobayashi T, 2010, IEEE T PLASMA SCI, V38, P2675, DOI 10.1109/TPS.2010.2047842; Sugai T, 2012, ELECTR ENG JPN, V180, P1, DOI 10.1002/eej.21273; Akiyama H, 2000, IEEE T DIELECT EL IN, V7, P646, DOI 10.1109/94.879360; Nose T, 2013, IEEE T PLASMA SCI, V41, P112, DOI 10.1109/TPS.2012.2188307; Malik MA, 2010, PLASMA CHEM PLASMA P, V30, P21, DOI 10.1007/s11090-009-9202-2; Sugai T, 2013, IEEE T PLASMA SCI, V41, P2327, DOI 10.1109/TPS.2013.2271319; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Namihira T, 2000, IEEE T PLASMA SCI, V28, P434, DOI 10.1109/27.848102; Nose T, 2013, ELECTR ENG JPN, V183, P10, DOI 10.1002/eej.22284; Minamitani Y, 2008, IEEE T PLASMA SCI, V36, P2586, DOI 10.1109/TPS.2008.2004234; SHARMA AK, 1993, HAZARD WASTE HAZARD, V10, P209, DOI 10.1089/hwm.1993.10.209; Sun B, 1997, J ELECTROSTAT, V39, P189, DOI 10.1016/S0304-3886(97)00002-8	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3493	3499		10.1109/TPS.2015.2450741		7	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800024		
J	Nishida, Y; Chiang, HC; Chen, TC; Konishi, T; Cheng, CZ				Nishida, Yasushi; Chiang, Hsuan-Ching; Chen, Tzu-Ching; Konishi, Takumi; Cheng, Chio-Zong			Hydrogen Production From Hydrocarbons Using Plasma: Effect of Discharge Pulsewidth on Decomposition	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			COx free hydrogen production; electrode length effect; pulsewidth dependence; short pulsewidth dielectric barrier discharge (DBD)	PULSED-POWER; ENERGIES	Hydrogen production in vehicles is underway using plasma discharges working in high pressure conditions of over 1.5 atm. In this system, no production of COx is expected. The original fuel for the system is methane (CH4) or propane (C3H8). For those purposes, mainly dielectric barrier discharge nonthermal plasma system is employed with a high voltage pulse of width 5-30 mu s and a maximum amplitude of 13 kV. The decomposition rate depends on the input pulsewidth; here, a 5-30-mu s width pulse is tried, but each pulse is composed of multiples of fundamental 5-mu s pulse. Up to a 20-mu s width, the decomposition efficiency increases, but above that value, it decreases. The physical phenomena of the pulsewidth dependence depend on the life time of plasma produced by each pulse.	[Nishida, Yasushi; Chiang, Hsuan-Ching; Chen, Tzu-Ching; Cheng, Chio-Zong] Natl Cheng Kung Univ, Inst Space & Plasma Sci, Tainan 70101, Taiwan; [Nishida, Yasushi; Cheng, Chio-Zong] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan; [Konishi, Takumi] Iwate Univ, Dept Elect Engn & Comp Sci, Morioka, Iwate 0208551, Japan	Nishida, Y (reprint author), Natl Cheng Kung Univ, Inst Space & Plasma Sci, Tainan 70101, Taiwan.	nishiday@pssc.ncku.edu.tw; h4595506506@hotmail.com; ching31201@gmail.com; begin082082@yahoo.co.jp; frankcheng@pssc.ncku.edu.tw	Cheng, Chio/K-1005-2014				KERR JA, 1966, CHEM REV, V66, P465, DOI 10.1021/cr60243a001; BENSON SW, 1965, J CHEM EDUC, V42, P502; Brown LF, 2001, INT J HYDROGEN ENERG, V26, P381; Wang DY, 2011, IEEE T DIELECT EL IN, V18, P1091; Mishra LN, 2004, IEEE T PLASMA SCI, V32, P1727, DOI 10.1109/TPS.2004.831591; Wang DY, 2010, IEEE T PLASMA SCI, V38, P2746, DOI 10.1109/TPS.2010.2052369; Martinez SS, 2005, SOL ENERG MAT SOL C, V88, P237, DOI 10.1016/j.solmat.2004.09.022; Matsumoto T., 2008, P 2 EUR PULS POW C V, P1101; Nishida Y, 2014, IEEE T PLASMA SCI, V42, P3674, DOI 10.1109/TPS.2014.2337351; Nishida Y, 2014, IEEE T PLASMA SCI, V42, P3765, DOI 10.1109/TPS.2014.2354695; Nishida Y., 2014, Taiwan Patent, Patent No. [102 111 271, 102111271]; Nishida Y., 2014, Taiwan Patent, Patent No. [100 129 597, 100129597]; Shah R. K., 2007, RECENT TRENDS FUEL C; Zehner O., 2013, IEEE SPECTRUM, P36	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3500	3506		10.1109/TPS.2015.2476369		7	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800025		
J	Takayama, S; Link, G; Sato, M; Jelonnek, J				Takayama, Sadatsugu; Link, Guido; Sato, Motoyasu; Jelonnek, John			Possibility for Iron Production Using High-Power Millimeter Waves	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Application of high-power millimeter waves (mm waves); deoxidization process; microwave (MW) iron production	GYROTRON	Microwave ( MW) technology is a promising alternative to conventional heating. It also resides in the new domain of materials science, namely, microscopic and strong thermal nonequilibrium systems. The application of MWs in the iron industry may be characterized by a high potential for an essential reduction of carbon dioxide emission. A series of experiments has been conducted to prove the effectiveness of rapid and high-purity refinement under an oxygen-containing environment by means of MW application, and achieved highly positive results. That has led to feasibility studies using a compact 30-GHz gyrotron system at the Karlsruhe Institute of Technology. Potential MW effects have been investigated. High-quality pig iron has been made from powder samples of mixed magnetite and carbon by 30-GHz millimeter-wave heating. This paper discusses the experimental results obtained recently and the estimated MW power for the iron production.	[Takayama, Sadatsugu] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Link, Guido; Jelonnek, John] Karlsruhe Inst Technol, D-76131 Karlsruhe, Germany; [Sato, Motoyasu] Chubu Univ, Kasugai, Aichi 4878501, Japan	Takayama, S (reprint author), Natl Inst Fus Sci, Toki, Gifu 5095292, Japan.	takayama.sadatsugu@nifs.ac.jp; guido.link@kit.edu; satomoto@isc.chubu.ac.jp; John.Jelonnek@kit.edu					Link G, 1999, IEEE T PLASMA SCI, V27, P547, DOI 10.1109/27.772284; Nagata K, 2001, ISIJ INT, V41, P1316, DOI 10.2355/isijinternational.41.1316; Sakamoto K, 2007, NAT PHYS, V3, P411, DOI 10.1038/nphys599; Takayama S, 2006, POWDER METALL, V49, P274, DOI 10.1179/174329006X110835; Thumm M, 2007, IEEE T PLASMA SCI, V35, P143, DOI 10.1109/TPS.2007.892144; Tehr L., 1997, DE-PS 19633245C, Patent No. 19633245	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3517	3521		10.1109/TPS.2015.2420682		5	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800028		
J	Gong, SY; Ogura, K; Nomizu, S; Shirai, A; Yamazaki, K; Yambe, K; Kubo, S; Shimozuma, T; Kobayashi, S; Okada, K				Gong, Shaoyan; Ogura, Kazuo; Nomizu, Shintaro; Shirai, Akihiro; Yamazaki, Kosuke; Yambe, Kiyoyuki; Kubo, Shin; Shimozuma, Takashi; Kobayashi, Sakuji; Okada, Kohji			Oscillation-Starting Conditions for Oversized G-Band (140-220 GHz) Backward Wave Oscillator Driven by Weakly Relativistic Electron Beam	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article; Proceedings Paper	5th Euro-Asian Pulsed Power Conference (EAPPC)	SEP 08-12, 2014	Kumamoto, JAPAN			Oversized backward wave oscillator (BWO); rectangular corrugation; slow-wave structure (SWS); starting energy; weakly relativistic electron beam	INSTABILITIES; CURRENTS; ENERGY; LENGTH	An oversized G-band backward wave oscillator (BWO) driven by a weakly relativistic electron beam less than 100 kV is studied. Rectangular corrugations are used as the slow-wave structure (SWS), which have surface waves with upper cutoff frequencies of above 150 GHz [G-band (140-220 GHz)]. In this paper, we examine the starting conditions for intense G-band BWO operation by varying the beam parameters and SWS lengths. It is shown that a starting energy exists for the G-band BWO and that the starting energy is more critical than the starting current in the oversized BWO. Above the starting energy, very intense output powers on the order of 10 kW are obtained. The oscillation-starting condition for such intense operation may play an important role in high-intensity terahertz wave sources.	[Gong, Shaoyan; Ogura, Kazuo; Nomizu, Shintaro; Shirai, Akihiro; Yamazaki, Kosuke; Yambe, Kiyoyuki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Kubo, Shin; Shimozuma, Takashi; Kobayashi, Sakuji; Okada, Kohji] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Gong, SY (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	f12l002a@mail.cc.niigata-u.ac.jp; teogura@eng.niigata-u.ac.jp; yambe@eng.niigata-u.ac.jp					Ogura K, 2013, IEEE T PLASMA SCI, V41, P2729, DOI 10.1109/TPS.2013.2256932; Vlasov AN, 2000, IEEE T PLASMA SCI, V28, P550, DOI 10.1109/27.887671; Aoyama S, 2007, FUSION SCI TECHNOL, V51, P325; Kiuchi Y, 2007, FUSION SCI TECHNOL, V51, P331; BUGAEV SP, 1990, IEEE T PLASMA SCI, V18, P525, DOI 10.1109/27.55924; SWEGLE JA, 1987, PHYS FLUIDS, V30, P1201, DOI 10.1063/1.866269; BUGAEV SP, 1990, IEEE T PLASMA SCI, V18, P518, DOI 10.1109/27.55923; MINAMI K, 1995, IEEE T PLASMA SCI, V23, P124, DOI 10.1109/27.376576; Yambe K, 2013, IEEE T PLASMA SCI, V41, P2781, DOI 10.1109/TPS.2013.2262505; MINAMI K, 1992, J PHYS SOC JPN, V61, P3566, DOI 10.1143/JPSJ.61.3566; Benford J., 1992, HIGH POWER MICROWAVE; Gaponov-Grekhov A. V., 1994, APPL HIGH POWER MICR; Granatstein V. L., 1987, HIGH POWER MICROWAVE; Lifshitz E. M., 1981, PHYSICAL KINETICS, P281; Magori S., 2014, PLASMA FUSION RES, V9; Oe H., 2009, J PLASMA FUSION RES, V8, P1477; Ogura K., 2007, IEEJ T FUNDAM MAT, V127, P681, DOI 10.1541/ieejfms.127.681; Ogura K., 2014, PLASMA FUSION RES, V9; Ogura K., 2004, J PLASMA FUSION RES, V6, P703; Pozar D. M., 1998, MICROWAVE ENG, P706	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	1				3530	3536		10.1109/TPS.2015.2424993		7	Physics, Fluids & Plasmas	Physics	CT4UW	WOS:000362803800031		
J	Jang, J; Nishiyama, H				Jang, Juyong; Nishiyama, Hideya			Discharge Study of Argon DC Arc Jet Assisted by DBD Plasma for Metal Surface Treatment	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Atmospheric-pressure plasmas; discharge property; plasma behavior; surface treatment	THERMAL PLASMA; FILMS; DEPOSITION	An argon dc arc jet assisted by dielectric barrier discharge (DBD) plasma was studied for discharge interaction between two plasmas and metal of plasma surface treatment at atmospheric pressure. While operating conditions of the dc arc jet were retained, DBD plasma was operated by changing the applied DBD voltage amplitudes (V-DBD) between 6 and 12 kV(pp) to investigate the effect of DBD plasma addition to the dc arc jet on the changes of discharge structure and copper surface energy. By igniting the dc arc jet with DBD plasma, a glow plasma column is formed between the dc arc jet tail and the upper region of the DBD reactor, which transfers electrons and ions provided by the dc arc jet. From the correlation between maximum charge quantity (Q(max)) and applied DBD voltage amplitude, the degree of activation of DBD plasma corresponding to the luminescent intensity is proportional to the Q(max). DBD plasma with the dc arc jet has the maximum of Q(max) value at V-DBD = 10 kV(pp), then the dc arc jet assisted by DBD plasma becomes the most active. Based on the discharge property investigation, copper surface energy is effectively increased up to 127% at 10 kVpp using the dc arc jet assisted by DBD plasma, compared with using the dc arc jet alone.	[Jang, Juyong; Nishiyama, Hideya] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan	Jang, J (reprint author), SEMES Co Ltd, Cheonan 31040, South Korea.	ngneerjang@gmail.com; nishiyama@ifs.tohoku.ac.jp			Japan Society for the Promotion of Science for Young Scientists [25-7829]	This work was supported by a Grant-in-Aid for Research Fellowships through the Japan Society for the Promotion of Science for Young Scientists under Contract 25-7829.	Kim H, 2011, J ELECTROCHEM SOC, V158, pH21, DOI 10.1149/1.3511769; Li Q, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698135; BOULOS MI, 1991, IEEE T PLASMA SCI, V19, P1078, DOI 10.1109/27.125032; Kramer NJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/7/075202; Fan CW, 2007, MATER TRANS, V48, P2449, DOI 10.2320/matertrans.MRA2007095; Liu CZ, 2004, MATER CHEM PHYS, V85, P340, DOI 10.1016/j.matchemphys.2004.01.026; Leal-Quiros E, 2004, BRAZ J PHYS, V34, P1587, DOI 10.1590/S0103-97332004000800015; Ortiz-Magan AB, 2010, PLASMA CHEM PLASMA P, V30, P311, DOI 10.1007/s11090-009-9212-0; Kang IJ, 2013, J KOREAN PHYS SOC, V63, P199, DOI 10.3938/jkps.63.199; Meiners A, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/4/045015; Jang J, 2013, J THERM SPRAY TECHN, V22, P974, DOI 10.1007/s11666-013-9941-8; Pipa AV, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737623; Nishikawa H, 2004, VACUUM, V73, P589, DOI 10.1016/j.vacuum.2003.12.074; Martens JB, 1998, SIGNAL PROCESS, V70, P155, DOI 10.1016/S0165-1684(98)00123-6; Becker K. H., 2005, NONEQUILIBRIUM AIR P, P68; Boulos M. I., 1994, THERMAL PLASMAS, V1, P9; enkiewicz M., 2007, J ACHIEVEMENTS MAT M, V24, P137; Hong S.H., 2009, T ELECT ELECT MAT, V10, P71; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Manley T. C., 1943, J ELECTROCHEM SOC, V84, P83, DOI DOI 10.1149/1.3071556; Stachewicz U, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3691186	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	OCT	2015	43	10	2				3688	3694		10.1109/TPS.2015.2471088		7	Physics, Fluids & Plasmas	Physics	CT4UR	WOS:000362803300016		
J	Kawakami, H; Hara, K; Komine, M; Yamamoto, Y				Kawakami, Hiroko; Hara, Kojiro; Komine, Masashi; Yamamoto, Yoshikazu			Production of secoiridoids by adventitious root culture of Swertia japonica	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT			English	Article						Callus induction; Adventitious roots; Secoiridoids; Swertia japonica	AMAROGENTIN; CHIRATA; TISSUES	Swertia japonica is an important Japanese folk medicine used as a remedy for stomach disease, and secoiridoids are the main active constituents. Towards producing secoiridoids using large-scale tissue culture, we investigated the effects of phytohormone conditions on callus induction and redifferentiation of adventitious roots from calli of S. japonica and the associated production of secoiridoids. Here, we report efficient conditions for induction of callus and adventitious roots and confirmed that adventitious roots produced the secoiridoids, swertiamarin, and gentiopicroside. Moreover, redifferentiation of adventitious roots was enhanced when cultured with a low concentration of auxin, while secoiridoid biosynthesis was elevated with a high concentration of cytokinin. In a time course of secoiridoid changes in adventitious roots, maximum secoiridoid production occurred 15 d after redifferentiation of adventitious roots of a 10-d-old culture, suggesting that relatively mature root development may be necessary for the in vitro production of secoiridoids in S. japonica.	[Kawakami, Hiroko; Hara, Kojiro; Komine, Masashi; Yamamoto, Yoshikazu] Akita Prefectural Univ, Grad Sch, Akita 0100195, Japan	Kawakami, H (reprint author), Akita Prefectural Univ, Grad Sch, Kaidobata Nishi 241-438, Akita 0100195, Japan.	D14G001@akita-pu.ac.jp					NISHI T, 1973, BOT MAG TOKYO, V86, P183, DOI 10.1007/BF02489225; Niiho Y, 2006, J NAT MED, V60, P82, DOI 10.1007/s11418-005-0014-2; Rodriguez S, 1998, CURR ORG CHEM, V2, P627; Kikuchi M, 2004, CHEM PHARM BULL, V52, P1210, DOI 10.1248/cpb.52.1210; Wang ZG, 2008, CHEM PHARM BULL, V56, P485, DOI 10.1248/cpb.56.485; Keil M, 2000, PLANTA MED, V66, P452, DOI 10.1055/s-2000-8579; Suryawanshi S, 2006, RAPID COMMUN MASS SP, V20, P3761, DOI 10.1002/rcm.2795; Piatczak E, 2005, PLANT SCI, V168, P431, DOI 10.1016/j.plantsci.2004.08.013; PAWLICKI N, 1995, PLANT SCI, V106, P167, DOI 10.1016/0168-9452(95)04074-5; YAMAHARA J, 1991, J ETHNOPHARMACOL, V33, P31, DOI 10.1016/0378-8741(91)90157-9; ISHIMARU K, 1990, PHYTOCHEMISTRY, V29, P3823, DOI 10.1016/0031-9422(90)85340-L; ISHIMARU K, 1990, PHYTOCHEMISTRY, V29, P1563, DOI 10.1016/0031-9422(90)80122-W; KITAMURA Y, 1988, CHEM PHARM BULL, V36, P1575; Hedhili Sabah, 2007, Phytochemistry Reviews, V6, P341, DOI 10.1007/s11101-006-9021-5; Kimura Y, 2011, FITOTERAPIA, V82, P827, DOI 10.1016/j.fitote.2011.04.008; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; KITAMURA Y, 1987, Shoyakugaku Zasshi, V41, P58; Lloyd G, 1981, P INT PLANT PROP SOC, V30, P421; MIURA H, 1986, Shoyakugaku Zasshi, V40, P40	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1054-5476	1475-2689		IN VITRO CELL DEV-PL	In Vitro Cell. Dev. Biol.-Plant	OCT	2015	51	5					524	529		10.1007/s11627-015-9686-9		6	Plant Sciences; Cell Biology; Developmental Biology	Plant Sciences; Cell Biology; Developmental Biology	CT1BI	WOS:000362531600003		
J	Nagataki, M; Tantrawatpan, C; Agatsuma, T; Sugiura, T; Duenngai, K; Sithithaworn, P; Andrews, RH; Petney, TN; Saijuntha, W				Nagataki, Mitsuru; Tantrawatpan, Chairat; Agatsuma, Takeshi; Sugiura, Tetsuro; Duenngai, Kunyarat; Sithithaworn, Paiboon; Andrews, Ross H.; Petney, Trevor N.; Saijuntha, Weerachai			Mitochondrial DNA sequences of 37 collar-spined echinostomes (Digenea: Echinostomatidae) in Thailand and Lao PDR reveals presence of two species: Echinostoma revolutum and E. miyagawai	INFECTION GENETICS AND EVOLUTION			English	Article						Echinostome; 37 collar-spined; The "revolutum" group; Echinostoma revolutum; Echinostoma miyagawai; Mitochondrial gene	TREMATODA ECHINOSTOMATIDAE; PHYLOGENETIC-RELATIONSHIPS; MORPHOLOGICAL DATA; LIFE-CYCLE; PROVINCE; NUCLEAR; METACERCARIAE; DELIMITATION; BIOLOGY; HUMANS	The "37 collar-spined" or "revolutum" group of echinostomes is recognized as a species complex. The identification of members of this complex by morphological taxonomic characters is difficult and confusing, and hence, molecular analyses are a useful alternative method for molecular systematic studies. The current study examined the genetic diversity of those 37 collar-spined echinostomes which are recognized morphologically as Echinostoma revolutum in Thailand and Lao PDR using the cytochrome c oxidase subunit 1 (CO1) and the NADH dehydrogenase subunit 1 (ND1) sequences. On the basis of molecular investigations, at least two species of 37 collar-spined echinostomes exist in Southeast Asia, namely E. revolutum and Echinostoma miyagawai. The specimens examined in this study, coming from ducks in Thailand and Lao PDR, were compared to isolates from America, Europe and Australia for which DNA sequences are available in public databases. Haplotype analysis detected 6 and 26 haplotypes when comparing the CO1 sequences of E. revolutum and E. miyagawai, respectively, from different geographical isolates from Thailand and Lao PDR. The phylogenetic trees, ND1 haplotype network and genetic differentiation (phi(ST)) analyses showed that E. revolutum were genetically different on a continental scale, i.e. Eurasian and American lineages. (C) 2015 Elsevier B.V. All rights reserved.	[Nagataki, Mitsuru; Agatsuma, Takeshi] Kochi Univ, Kochi Med Sch, Div Environm Hlth Sci, Nankoku, Kochi 7838505, Japan; [Tantrawatpan, Chairat] Thammasat Univ, Div Cell Biol, Dept Preclin Sci, Fac Med, Pathum Thani 12120, Thailand; [Sugiura, Tetsuro] Kochi Univ, Kochi Med Sch, Dept Clin Lab Med, Nankoku, Kochi 7838505, Japan; [Duenngai, Kunyarat] Phetchabun Rajabhat Univ, Fac Sci & Technol, Dept Publ Hlth, Phetchabun 67000, Thailand; [Sithithaworn, Paiboon; Andrews, Ross H.] Khon Kaen Univ, LFCRC, Fac Med, Khon Kaen 40002, Thailand; [Sithithaworn, Paiboon] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen 40002, Thailand; [Andrews, Ross H.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W2 1NY, England; [Petney, Trevor N.] Univ Karlsruhe, Inst Zool Ecol & Parasitol 1, Karlsruhe, Germany; [Saijuntha, Weerachai] Mahasarakham Univ, WRBRI, Maha Sarakham 44150, Thailand; [Andrews, Ross H.; Petney, Trevor N.] Khon Kaen Univ, Cholangiocarcinoma Screening & Care Program, Fac Med, Khon Kaen 40002, Thailand	Saijuntha, W (reprint author), Mahasarakham Univ, WRBRI, Maha Sarakham 44150, Thailand.	weerachai.s@msu.ac.th			Thammasat University; TRF-CHE-MSU [MRG5480009]; Japan Society for the Promotion of Science (JSPS) [L-11566]; Mahasarakham University Development Fund; Deutsche Forschungsgemeinschaft [PE1611/1-3]; National Research Council of Thailand; International Excellence Fund of ASEAN-EU Year of Science, Technology and Innovation	This research was supported by Thammasat University grant to C.T. W.S. was granted by TRF-CHE-MSU (grant no. MRG5480009) and the Japan Society for the Promotion of Science (JSPS) (grant no. L-11566). We would like to thank Mahasarakham University Development Fund to support the budgets for international conference presentation to W.S. Thanks the Deutsche Forschungsgemeinschaft (PE1611/1-3), the National Research Council of Thailand, the International Excellence Fund of ASEAN-EU Year of Science, Technology and Innovation, 2012 for providing funding for cooperative workshops. Thanks to Dr. Wittaya Tawong for BI analysis.	Anh Nguyen Thi Lan, 2010, Vet Parasitol, V169, P391, DOI 10.1016/j.vetpar.2010.01.010; Saijuntha W, 2011, INFECT GENET EVOL, V11, P375, DOI 10.1016/j.meegid.2010.11.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Saijuntha W, 2011, ACTA TROP, V118, P105, DOI 10.1016/j.actatropica.2011.02.014; Georgieva S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-64; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; BOWLES J, 1993, ACTA TROP, V55, P217, DOI 10.1016/0001-706X(93)90079-Q; Morgan JAT, 1998, INT J PARASITOL, V28, P493, DOI 10.1016/S0020-7519(97)00204-X; Tantrawatpan C, 2013, PARASITOL RES, V112, P437, DOI 10.1007/s00436-012-3065-9; Morgan JAT, 1998, PARASITOLOGY, V116, P289, DOI 10.1017/S0031182097002217; Fried B, 2004, ADV PARASIT, V58, P139, DOI 10.1016/S0065-308X(04)58003-X; Chai JY, 2011, KOREAN J PARASITOL, V49, P449, DOI 10.3347/kjp.2011.49.4.449; Chai JY, 2012, KOREAN J PARASITOL, V50, P269, DOI 10.3347/kjp.2012.50.3.269; Detwiler JT, 2010, MOL PHYLOGENET EVOL, V55, P611, DOI 10.1016/j.ympev.2010.01.004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; HUFFMAN JE, 1990, ADV PARASIT, V29, P215, DOI 10.1016/S0065-308X(08)60107-4; Saijuntha W, 2011, PARASITOL RES, V108, P751, DOI 10.1007/s00436-010-2180-8; Sohn WM, 2011, EMERG INFECT DIS, V17, P117, DOI 10.3201/eid1701.100920; Detwiler JT, 2012, J PARASITOL, V98, P1148, DOI 10.1645/GE-3117.1; Toledo R, 2009, ADV PARASIT, V69, P147, DOI 10.1016/S0065-308X(09)69003-5; KANEV I, 1994, SYST PARASITOL, V28, P125, DOI 10.1007/BF00009591; Fried B, 2004, PARASITOL RES, V93, P159, DOI 10.1007/s00436-004-1112-x; Kostadinova A, 2000, SYST PARASITOL, V45, P81, DOI 10.1023/A:1006241610689; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Morgan JAT, 1995, PARASITOLOGY, V111, P609; Kostadinova A, 2003, SYST PARASITOL, V54, P159, DOI 10.1023/A:1022681123340; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bhaibulaya M., 1966, J MEDICAL ASSOCIATIO, V49, P83; Boere G.C., 2006, WATERBIRDS WORLD, P40; Faltynkova A, 2015, SYST PARASITOL, V1, P1; Georgieva S, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0520-8; Kostadinova A., 2005, KEYS TREMATODA, V2, P9; Kostadinova A, 2000, ECHINOSTOMES AS EXPERIMENTAL MODELS FOR BIOLOGICAL RESEARCH, P31; Lan-Anh Nguyen Thi, 2009, Emerg Infect Dis, V15, P540, DOI 10.3201/eid1504.081147; LEE S-H, 1990, Korean Journal of Parasitology, V28, P235; Morgan JAT, 2000, ECHINOSTOMES AS EXPERIMENTAL MODELS FOR BIOLOGICAL RESEARCH, P245; Noikong W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002778; Nylander J.A.A., 2008, MRMODELTEST V2 3 PRO; Radomyos P., 2004, ATLAS MED PARASITOLO, P106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saijuntha W, 2013, KOREAN J PARASITOL, V51, P663, DOI 10.3347/kjp.2013.51.6.663	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2015	35						56	62		10.1016/j.meegid.2015.07.022		7	Infectious Diseases	Infectious Diseases	CT2BQ	WOS:000362607400009		
J	Seto, J; Wada, T; Iwamoto, T; Tamaru, A; Maeda, S; Yamamoto, K; Hase, A; Murakami, K; Maeda, E; Oishi, A; Migita, Y; Yamamoto, T; Ahiko, T				Seto, Junji; Wada, Takayuki; Iwamoto, Tomotada; Tamaru, Aki; Maeda, Shinji; Yamamoto, Kaori; Hase, Atsushi; Murakami, Koichi; Maeda, Eriko; Oishi, Akira; Migita, Yuji; Yamamoto, Taro; Ahiko, Tadayuki			Phylogenetic assignment of Mycobacterium tuberculosis Beijing clinical isolates in Japan by maximum a posteriori estimation	INFECTION GENETICS AND EVOLUTION			English	Article						Phylogeny; Genotype; Maximum a posteriori; Mycobacterium tuberculosis; VNTR	POPULATION-STRUCTURE ANALYSIS; VARIABLE-NUMBER; TANDEM-REPEAT; GENETIC DIVERSITY; FAMILY STRAINS; EAST-ASIA; GENOTYPE; IDENTIFICATION; SPREAD; LOCI	Intra-species phylogeny of Mycobacterium tuberculosis has been regarded as a clue to estimate its potential risk to develop drug-resistance and various epidemiological tendencies. Genotypic characterization of variable number of tandem repeats (VNTR), a standard tool to ascertain transmission routes, has been improving as a public health effort, but determining phylogenetic information from those efforts alone is difficult. We present a platform based on maximum a posteriori (MAP) estimation to estimate phylogenetic information for M. tuberculosis clinical isolates from individual profiles of VNTR types. This study used 1245 M. tuberculosis clinical isolates obtained throughout Japan for construction of an MAP estimation formula. Two MAP estimation formulae, classification of Beijing family and other lineages, and classification of five Beijing sublineages (ST11/26, STK, ST3, and ST25/19 belonging to the ancient Beijing subfamily and modern Beijing subfamily), were created based on 24 loci VNTR (24(Beijing)-VNTR) profiles and phylogenetic information of the isolates. Recursive estimation based on the formulae showed high concordance with their authentic phylogeny by multi-locus sequence typing (MLST) of the isolates. The formulae might further support phylogenetic estimation of the Beijing lineage M. tuberculosis from the VNTR genotype with various geographic backgrounds. These results suggest that MAP estimation can function as a reliable probabilistic process to append phylogenetic information to VNTR genotypes of M. tuberculosis independently, which might improve the usage of genotyping data for control, understanding, prevention, and treatment of TB. (C) 2015 Elsevier B.V. All rights reserved.	[Seto, Junji; Ahiko, Tadayuki] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata, Yamagata 9900031, Japan; [Wada, Takayuki; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 8528523, Japan; [Iwamoto, Tomotada] Kobe Inst Hlth, Dept Microbiol, Chuo Ku, Kobe, Hyogo 6500046, Japan; [Tamaru, Aki] Osaka Prefectural Inst Publ Hlth, Dept Microbiol, Higashinari Ku, Osaka 5370025, Japan; [Maeda, Shinji] Hokkaido Pharmaceut Univ, Sch Pharm, Teine Ku, Sapporo, Hokkaido 0068590, Japan; [Yamamoto, Kaori; Hase, Atsushi] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Tennoji Ku, Osaka 5430026, Japan; [Yamamoto, Kaori; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Murakami, Koichi; Maeda, Eriko; Oishi, Akira] Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Fukuoka 8180135, Japan; [Migita, Yuji] Nagasaki Prefectural Inst Environm Res & Publ Hlt, Dept Microbiol, Nagasaki 8560026, Japan	Seto, J (reprint author), Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, 1-6-6 Tokamachi, Yamagata, Yamagata 9900031, Japan.	setoj@pref.yamagata.jp; twada@nagasaki-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science (JSPS) [24689034]	This work was supported by a grant from the Ministry of Health, Labour and Welfare, Japan (Research on Emerging and Re-emerging Infectious Diseases, Health Sciences Research Grants). This work was also partly supported by a Grant-in-Aid for Young Scientists (A) (24689034) from Japan Society for the Promotion of Science (JSPS).	Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Huyen MNT, 2013, J INFECT DIS, V207, P1516, DOI 10.1093/infdis/jit048; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; WILLCOX WR, 1973, J GEN MICROBIOL, V77, P317; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Hillemann D, 2006, J CLIN MICROBIOL, V44, P302, DOI 10.1128/JCM.44.2.302-306.2006; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Wada T, 2007, J MED MICROBIOL, V56, P1052, DOI 10.1099/jmm.0.46990-0; Wada T, 2012, INFECT GENET EVOL, V12, P1392, DOI 10.1016/j.meegid.2012.04.029; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; LAPAGE SP, 1973, J GEN MICROBIOL, V77, P273; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Wada T, 2013, ELECTROPHORESIS, V34, P1171, DOI 10.1002/elps.201200471; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Wada T, 2009, INFECT GENET EVOL, V9, P921, DOI 10.1016/j.meegid.2009.06.012; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; BASCOMB S, 1973, J GEN MICROBIOL, V77, P291; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Asante-Poku A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092675; De Beer J.L., 2014, EUROSURVEILLANCE, P19; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Lim LKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084487; Lu B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-372; Luo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089726; Maeda Shinji, 2008, Kekkaku, V83, P673; Manning C.D., 2008, INTRO INFORM RETRIEV, P234; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Seto Junji, 2013, Kekkaku, V88, P535; Wada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118495; World Health Organization, 2014, GLOB TUB REP 2014	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2015	35						82	88		10.1016/j.meegid.2015.07.029		7	Infectious Diseases	Infectious Diseases	CT2BQ	WOS:000362607400012		
J	Agbemabiese, CA; Nakagomi, T; Doan, YH; Nakagomi, O				Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Doan, Yen Hai; Nakagomi, Osamu			Whole genomic constellation of the first human G8 rotavirus strain detected in Japan	INFECTION GENETICS AND EVOLUTION			English	Article						Rotavirus; G8; Genotype constellation; Ruminant rotavirus; Phylogenetic analysis; Reassortment	GROUP-A ROTAVIRUS; POLYMERASE-CHAIN-REACTION; G12 HUMAN ROTAVIRUSES; MOLECULAR CHARACTERIZATION; MAMMALIAN ROTAVIRUSES; MONO-REASSORTANT; LAMB ROTAVIRUS; GLOBAL SPREAD; GENOTYPE; BOVINE	Human G8 Rotavirus A (RVA) strains are commonly detected in Africa but are rarely detected in Japan and elsewhere in the world. In this study, the whole genome sequence of the first human G8 RVA strain designated AU109 isolated in a child with acute gastroenteritis in 1994 was determined in order to understand how the strain was generated including the host species origin of its genes. The genotype constellation of AU109 was G8-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2. Phylogenetic analyses of the 11 genome segments revealed that its VP7 and VP1 genes were closely related to those of a Hungarian human G8P[14] RVA strain and these genes shared the most recent common ancestors in 1988 and 1982, respectively. AU109 possessed an NSP2 gene closely related to those of Chinese sheep and goat RVA strains. The remaining eight genome segments were closely related to Japanese human G2P[4] strains which circulated around 1985-1990. Bayesian evolutionary analyses revealed that the NSP2 gene of AU109 and those of the Chinese sheep and goat RVA strains diverged from a common ancestor around 1937. In conclusion, AU109 was generated through genetic reassortment event where Japanese DS-1-like G2P[4] strains circulating around 1985-1990 obtained the VP7, VP1 and NSP2 genes from unknown ruminant G8 RVA strains. These observations highlight the need for comprehensive examination of the whole genomes of RVA strains of less explored host species. (C) 2015 Elsevier B.V. All rights reserved.	[Agbemabiese, Chantal Ama; Nakagomi, Toyoko; Doan, Yen Hai; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan	Nakagomi, O (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	onakagom@nagasaki-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Development, AMED	This study was in part supported by grants-in-aid for scientific research from the Ministry of Health, Labour and Welfare of Japan, as well as a grant from Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Development, AMED.	Pietsch C, 2009, J CLIN MICROBIOL, V47, P3569, DOI 10.1128/JCM.01471-09; Mukherjee A, 2013, J MED VIROL, V85, P537, DOI 10.1002/jmv.23483; Sieg M, 2015, J GEN VIROL, V96, P106, DOI 10.1099/vir.0.069120-0; Nakagomi T, 2013, J GEN VIROL, V94, P1273, DOI 10.1099/vir.0.050625-0; Chen YJ, 2009, VIRUS GENES, V38, P302, DOI 10.1007/s11262-009-0332-7; Pun SB, 2007, EMERG INFECT DIS, V13, P482; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Cunliffe NA, 2009, EMERG INFECT DIS, V15, P87, DOI 10.3201/eid1501.080427; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Drummond AJ, 2002, GENETICS, V161, P1307; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Banyai K, 2010, INFECT GENET EVOL, V10, P1140, DOI 10.1016/j.meegid.2010.05.001; Ghosh S, 2011, J MED VIROL, V83, P367, DOI 10.1002/jmv.21974; Doan YH, 2012, INFECT GENET EVOL, V12, P1202, DOI 10.1016/j.meegid.2012.04.023; Delogu R, 2013, J CLIN MICROBIOL, V51, P1583, DOI 10.1128/JCM.00396-13; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Ianiro G, 2014, INFECT GENET EVOL, V21, P129, DOI 10.1016/j.meegid.2013.10.029; Medici MC, 2008, VIRUS RES, V137, P163, DOI 10.1016/j.virusres.2008.07.005; Ciarlet M, 2008, VIRUS GENES, V37, P250, DOI 10.1007/s11262-008-0257-6; Weinberg GA, 2012, J CLIN MICROBIOL, V50, P1118, DOI 10.1128/JCM.05743-11; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Jere KC, 2014, INFECT GENET EVOL, V21, P58, DOI 10.1016/j.meegid.2013.10.002; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Fukai K, 2004, VIRUS RES, V105, P101, DOI 10.1016/j.virusres.2004.04.016; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Uriarte ELL, 2014, VET MICROBIOL, V171, P189, DOI 10.1016/j.vetmic.2014.03.013; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6; MATSUNO S, 1985, J VIROL, V54, P623; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; Fukai K, 2004, J VET MED SCI, V66, P1413, DOI 10.1292/jvms.66.1413; Nakagomi T, 2009, VACCINE, V27, pF93, DOI 10.1016/j.vaccine.2009.08.067; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Banyai K., 2012, VACCINE, V30, P22; Castello AA, 2006, J CLIN MICROBIOL, V44, P2046, DOI 10.1128/JCM.02436-05; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doan Y.H., 2015, INFECT GENET EVOL; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Estes MK, 2013, FIELDS VIROLOGY, V2, P1347; Gautam R., 2015, INFECT GENET EVOL; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Sasaki E, 2015, J MED VIROL, V87, P694, DOI 10.1002/jmv.24109; World Health Organisation, 2009, WKLY EPIDEMIOL REC, V86, P533	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2015	35						184	193		10.1016/j.meegid.2015.07.033		10	Infectious Diseases	Infectious Diseases	CT2BQ	WOS:000362607400024		
J	Marras, S; Noda, T; Steffensen, JF; Svendsen, MBS; Krause, J; Wilson, ADM; Kurvers, RHJM; Herbert-Read, J; Boswell, KM; Domenici, P				Marras, Stefano; Noda, Takuji; Steffensen, John F.; Svendsen, Morten B. S.; Krause, Jens; Wilson, Alexander D. M.; Kurvers, Ralf H. J. M.; Herbert-Read, James; Boswell, Kevin M.; Domenici, Paolo			Not So Fast: Swimming Behavior of Sailfish during Predator-Prey Interactions using High-Speed Video and Accelerometry	INTEGRATIVE AND COMPARATIVE BIOLOGY			English	Article							ACCELERATION DATA; KILLER WHALES; BLUE MARLIN; FISH; LOCOMOTION; DYNAMICS; PERFORMANCE; KINEMATICS; MOTION; SIZE	Synopsis Billfishes are considered among the fastest swimmers in the oceans. Despite early estimates of extremely high speeds, more recent work showed that these predators (e.g., blue marlin) spend most of their time swimming slowly, rarely exceeding 2 m s(-1). Predator-prey interactions provide a context within which one may expect maximal speeds both by predators and prey. Beyond speed, however, an important component determining the outcome of predator-prey encounters is unsteady swimming (i.e., turning and accelerating). Although large predators are faster than their small prey, the latter show higher performance in unsteady swimming. To contrast the evading behaviors of their highly maneuverable prey, sailfish and other large aquatic predators possess morphological adaptations, such as elongated bills, which can be moved more rapidly than the whole body itself, facilitating capture of the prey. Therefore, it is an open question whether such supposedly very fast swimmers do use high-speed bursts when feeding on evasive prey, in addition to using their bill for slashing prey. Here, we measured the swimming behavior of sailfish by using high-frequency accelerometry and high-speed video observations during predator-prey interactions. These measurements allowed analyses of tail beat frequencies to estimate swimming speeds. Our results suggest that sailfish burst at speeds of about 7 m s(-1) and do not exceed swimming speeds of 10 m s(-1) during predator-prey interactions. These speeds are much lower than previous estimates. In addition, the oscillations of the bill during swimming with, and without, extension of the dorsal fin (i.e., the sail) were measured. We suggest that extension of the dorsal fin may allow sailfish to improve the control of the bill and minimize its yaw, hence preventing disturbance of the prey. Therefore, sailfish, like other large predators, may rely mainly on accuracy of movement and the use of the extensions of their bodies, rather than resorting to top speeds when hunting evasive prey.	[Marras, Stefano; Domenici, Paolo] CNR, IAMC, I-09170 Torregrande, Oristano, Italy; [Noda, Takuji] Kyoto Univ, Grad Sch Informat, Dept Social Informat, Kyoto 6068501, Japan; [Steffensen, John F.; Svendsen, Morten B. S.] Univ Copenhagen, Marine Biol Sect, DK-3000 Helsingor, Denmark; [Krause, Jens; Kurvers, Ralf H. J. M.] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Krause, Jens] Humboldt Univ, Fac Life Sci, D-10115 Berlin, Germany; [Wilson, Alexander D. M.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Herbert-Read, James] Uppsala Univ, Dept Math, S-75106 Uppsala, Sweden; [Boswell, Kevin M.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, North Miami, FL 33181 USA	Marras, S (reprint author), CNR, IAMC, I-09170 Torregrande, Oristano, Italy.	paolo.domenici@cnr.it	Steffensen, John/F-6778-2010; Svendsen, Morten Bo/K-4329-2014; Wilson, Alexander/B-3329-2011; 	Steffensen, John/0000-0002-4477-8039; Svendsen, Morten Bo/0000-0002-4492-3750; Wilson, Alexander/0000-0002-7696-1671; Marras, Stefano/0000-0002-8386-7608	Carlsberg Foundation [2013_01_0729]	This work was supported in part by a Carlsberg Foundation grant # 2013_01_0729 [to J.F.S.].	Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Domenici P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0444; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Lauder GV, 2004, IEEE J OCEANIC ENG, V29, P556, DOI [10.1109/JOE.2004.833219, 10.1109/KOE.833219]; Xiong G, 2014, ZOOLOGY, V117, P269, DOI [10.1016/j.zool.2014.03.002, 10.1016/j.zoo1.2014.03.002]; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; WEBB PW, 1990, T AM FISH SOC, V119, P629, DOI 10.1577/1548-8659(1990)119<0629:LITBOL>2.3.CO;2; McComb DM, 2009, J EXP BIOL, V212, P4010, DOI 10.1242/jeb.032615; Domenici P, 2000, J EXP BIOL, V203, P283; Boswell KM, 2008, N AM J FISH MANAGE, V28, P799, DOI 10.1577/M07-116.1; BLOCK BA, 1992, J EXP BIOL, V166, P267; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Vogel S, 2008, INTEGR COMP BIOL, V48, P702, DOI 10.1093/icb/icn014; Hoolihan JP, 2005, MAR BIOL, V146, P1015, DOI 10.1007/s00227-004-1488-2; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; Sharp NCC, 1997, J ZOOL, V241, P493; Collette BB, 2006, B MAR SCI, V79, P455; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; HEBRANK JH, 1990, J EXP BIOL, V148, P449; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Iosilevskii G, 2008, J R SOC INTERFACE, V5, P329, DOI 10.1098/rsif.2007.1073; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; ROWE DM, 1993, PHILOS T ROY SOC B, V341, P141, DOI 10.1098/rstb.1993.0098; Shadwick RE, 2006, FISH PHYSIOL, V23, P241, DOI 10.1016/S1546-5098(05)23007-8; Bernal Diego, 2010, P436, DOI 10.1201/b10190-15; Blake R. W., 1983, FISH LOCOMOTION; Domenici P, 1997, J EXP BIOL, V200, P1165; Lane FW, 1941, CTRY LIFE, V90, P534; Marras S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072815; Oliver SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067380; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Videler J. J., 1993, FISH SWIMMING; WEBB PW, 1986, CAN J FISH AQUAT SCI, V43, P763	35	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1540-7063	1557-7023		INTEGR COMP BIOL	Integr. Comp. Biol.	OCT	2015	55	4					719	727		10.1093/icb/icv017		9	Zoology	Zoology	CT2YI	WOS:000362672100015		
J	Wu, LJ; Kobayashi, T; Kuramochi, H; Li, YY; Xu, KQ				Wu, Li-Jie; Kobayashi, Takuro; Kuramochi, Hidetoshi; Li, Yu-You; Xu, Kai-Qin			Recovery strategies of inhibition for mesophilic anaerobic sludge treating the de-oiled grease trap waste	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Long-chain fatty acid (LCFA); Grease trap waste (GTW); Mesophilic; Anaerobic digestion; Inhibition; Recovery	CHAIN FATTY-ACIDS; POULTRY SLAUGHTERHOUSE WASTE; CO-DIGESTION; METHANE FERMENTATION; BIODIESEL PRODUCTION; LIPID-CONCENTRATION; CALCIUM ADDITION; ACTIVATED-SLUDGE; GRANULAR SLUDGE; THICKENED WASTE	De-oiled grease trap waste (GTW) could be a feasible substrate for anaerobic digestion. However, due to high concentration of lipid, the long-chain fatty acid (LCFA), as an intermediate in the anaerobic lipid degradation, easily inhibits the anaerobic digestion, resulting in long recovery period. Four recovery strategies: bentonite addition, water dilution, mixing with low LCFA substrate and mixing with inocula, with control test as comparison, were employed in order to accelerate the recovery process of mesophilic anaerobic sludge. Adding bentonite, water dilution with 80% mixing ratio and mixing with active inocula achieved shortening of the recovery process. The whole recovery time took approximately 3.5 months for the control test, as calculated from the beginning to the end of the lag time after de-oiled GTW was readded as F/I ratio of 0.4. At least 10 gl(-1) of bentonite addition was necessary for the fast recovery of the inhibited sludge, with the whole recovery time one month shorter than the control test. 1.5 months could be saved for the whole recovery process when the strategy of water dilution with 80% mixing ratio was considered. The more inocula were mixed with the inhibited sludge, the more the recovery period was lessened. For the strategy of mixing with inocula with the mixing ratio 80%, only 20 days were needed for the whole recovery process. (C) 2015 Elsevier Ltd. All rights reserved.	[Wu, Li-Jie; Li, Yu-You] Tohoku Univ, Grad Sch Engn, Dept Civil & Environm Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kobayashi, Takuro; Kuramochi, Hidetoshi; Xu, Kai-Qin] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Li, Yu-You] Tohoku Univ, Grad Sch Environm Studies, Dept Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Xu, Kai-Qin] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China	Kobayashi, T (reprint author), Natl Inst Environm Studies, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	kobayashi.takuro@nies.go.jp					Aguilar-Garnica E, 2014, CHEM ENG SCI, V117, P396, DOI 10.1016/j.ces.2014.07.006; Angelidaki Irini, 2004, Reviews in Environmental Science and Bio/Technology, V3, P117, DOI 10.1007/s11157-004-2502-3; Sun YF, 2014, WASTE MANAGE, V34, P1025, DOI 10.1016/j.wasman.2013.07.018; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Felizardo P, 2006, WASTE MANAGE, V26, P487, DOI 10.1016/j.wasman.2005.02.025; Nadais MH, 2003, BIOTECHNOL PROGR, V19, P1053, DOI 10.1021/bp0255356; WENG C, 1976, WATER RES, V10, P9, DOI 10.1016/0043-1354(76)90151-2; Beccari M, 1998, WATER SCI TECHNOL, V38, P53, DOI 10.1016/S0273-1223(98)00497-1; Li ZK, 2005, WATER RES, V39, P3109, DOI 10.1016/j.watres.2005.05.021; Nopharatana A, 2007, WASTE MANAGE, V27, P595, DOI 10.1016/j.wasman.2006.04.010; RINZEMA A, 1994, WATER ENVIRON RES, V66, P40; Beccari M, 2001, WATER SCI TECHNOL, V43, P275; Lee DY, 2009, BIORESOURCE TECHNOL, V100, P690, DOI 10.1016/j.biortech.2008.06.056; Salminen EA, 2002, WATER RES, V36, P3175, DOI 10.1016/S0043-1354(02)00010-6; Kobayashi T, 2014, BIORESOURCE TECHNOL, V169, P134, DOI 10.1016/j.biortech.2014.06.071; Silva SA, 2014, BIOMASS BIOENERG, V67, P297, DOI 10.1016/j.biombioe.2014.05.012; Li YY, 2002, WATER SCI TECHNOL, V45, P143; Razaviarani V, 2013, J ENVIRON MANAGE, V123, P26, DOI 10.1016/j.jenvman.2013.03.021; Toba M, 2011, CATAL TODAY, V164, P533, DOI 10.1016/j.cattod.2010.11.049; Martinez EJ, 2012, INT BIODETER BIODEGR, V75, P1, DOI 10.1016/j.ibiod.2012.07.015; Hwu CS, 1998, WATER RES, V32, P1571, DOI 10.1016/S0043-1354(97)00352-7; Wang L, 2013, WATER RES, V47, P3835, DOI 10.1016/j.watres.2013.04.003; Montefrio MJ, 2010, APPL ENERG, V87, P3155, DOI 10.1016/j.apenergy.2010.04.011; Shin H, 2003, WATER SCI TECHNOL, V47, P139; Iasmin M, 2014, WATER RES, V49, P92, DOI 10.1016/j.watres.2013.11.012; Petruy R, 1997, BIORESOURCE TECHNOL, V61, P141, DOI 10.1016/S0960-8524(97)00042-4; Hwu CS, 1997, ENZYME MICROB TECH, V21, P297, DOI 10.1016/S0141-0229(97)00050-1; Kuang Y, 2006, J CHEM TECHNOL BIOT, V81, P1057, DOI 10.1002/jctb.1530; Pereira MA, 2005, BIOTECHNOL BIOENG, V92, P15, DOI 10.1002/bit.20548; Ivanov VN, 2002, APPL BIOCHEM MICRO+, V38, P255, DOI 10.1023/A:1015475425566; Palatsi J, 2009, BIORESOURCE TECHNOL, V100, P4588, DOI 10.1016/j.biortech.2009.04.046; HEUKELEKIAN H, 1958, SEWAGE IND WASTES, V30, P1108; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875; Silvestre G, 2011, BIORESOURCE TECHNOL, V102, P6830, DOI 10.1016/j.biortech.2011.04.019; Wan CX, 2011, WASTE MANAGE, V31, P1752, DOI 10.1016/j.wasman.2011.03.025; Alves MM, 2001, WATER RES, V35, P264, DOI 10.1016/S0043-1354(00)00242-6; Nordell E, 2013, WASTE MANAGE, V33, P2659, DOI 10.1016/j.wasman.2013.08.009; Mouneimne AH, 2004, ENVIRON TECHNOL, V25, P459, DOI 10.1080/09593332508618455; Palatsi J, 2012, WATER RES, V46, P5268, DOI 10.1016/j.watres.2012.07.008; Salminen E, 2000, WATER SCI TECHNOL, V41, P33; Cavaleiro AJ, 2008, BIORESOURCE TECHNOL, V99, P4086, DOI 10.1016/j.biortech.2007.09.005; ANGELIDAKI I, 1990, APPL MICROBIOL BIOT, V33, P469; Cirne DG, 2007, RENEW ENERG, V32, P965, DOI 10.1016/j.renene.2006.04.003; ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808; He X, 2011, ENVIRON SCI TECHNOL, V45, P4385, DOI 10.1021/es2001997; Kim SH, 2010, WATER ENVIRON RES, V82, P267, DOI 10.2175/106143009X442899; Pereira MA, 2004, BIOTECHNOL BIOENG, V88, P502, DOI 10.1002/bit.20278; HANAKI K, 1981, BIOTECHNOL BIOENG, V23, P1591, DOI 10.1002/bit.260230717; APHA, 2012, STANDARD METHODS EXA; Carballa M., 2010, HDB HYDROCARBON LIPI; Hwu C.S., 2001, J CHIN I ENV ENG, V11, P151; KOSTER IW, 1987, BIOL WASTE, V22, P295, DOI 10.1016/0269-7483(87)90116-9; Rinzema A., 1988, THESIS WAGENINGEN AG; ROY F, 1985, APPL ENVIRON MICROB, V49, P702; Sheng J., 2010, MODERN CHEM ENHANCED; WAALER H, 1958, Bull World Health Organ, V19, P783; Hung YT, 2010, HANDB ENVIRON ENG, V11, P743, DOI 10.1007/978-1-60327-031-1_22	57	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	OCT	2015	104						315	323		10.1016/j.ibiod.2015.06.020		9	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CS8AP	WOS:000362308400044		
J	Tran, QNM; Mimoto, H; Nakasaki, K				Quyen Ngoc Minh Tran; Mimoto, Hiroshi; Nakasaki, Kiyohiko			Inoculation of lactic acid bacterium accelerates organic matter degradation during composting	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Composting; Microbial inoculation; Lactic acid bacteria; Pediococcus acidilactici; Paecilomyces sp.	FOOD WASTE; TEMPERATURE; STRAINS; GROWTH; BATCH	In this study, the impact of microbial inoculation upon indigenous microorganisms leading to the acceleration of food waste composting was investigated. The lactic acid bacterium Pediococcus acidilactici TM14 was inoculated into compost raw material composed of rabbit food with the addition of organic acids that simulate food waste. The strain TM14 produced a high concentration of lactic acid in the early stages of composting, whereas composting without inoculation of TM14 accumulated high levels of acetic acid, up to 22 mg g(-1) dry solid of compost, which is detrimental to indigenous microorganisms. The growth of TM14 enhanced the proliferation of fungi having the ability to degrade organic acids, and thus the organic acids contained in the compost material were completely decomposed. Levels of TM14 and the fungi diminished immediately after the increase in composting temperature. However, the fungi modified the environmental conditions allowing for the activity of thermophilic bacteria, which play important roles in composting. In consequence, organic matter degradation in the composting was accelerated. (C) 2015 Published by Elsevier Ltd.	[Quyen Ngoc Minh Tran; Mimoto, Hiroshi; Nakasaki, Kiyohiko] Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, Tokyo 1528550, Japan	Nakasaki, K (reprint author), Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	nakasaki@ide.titech.ac.jp					Sarkar S, 2010, BIORESOURCE TECHNOL, V101, P2892, DOI 10.1016/j.biortech.2009.11.095; Kuok F, 2012, BIORESOURCE TECHNOL, V116, P421, DOI 10.1016/j.biortech.2012.03.106; Hemmi H, 2004, J BIOSCI BIOENG, V97, P119, DOI 10.1263/jbb.97.119; Nakasaki K, 1998, WASTE MANAGE RES, V16, P484, DOI 10.1177/0734242X9801600511; Li ZT, 2013, CHEMOSPHERE, V93, P1247, DOI 10.1016/j.chemosphere.2013.06.064; Ohtaki A, 1998, POLYM DEGRAD STABIL, V61, P499, DOI 10.1016/S0141-3910(97)00238-3; Nakasaki K, 2013, BIORESOURCE TECHNOL, V144, P521, DOI 10.1016/j.biortech.2013.07.005; Wang Q, 2001, PROCESS BIOCHEM, V37, P351, DOI 10.1016/S0032-9592(01)00217-5; Lee JJ, 2004, BIORESOURCE TECHNOL, V93, P21, DOI 10.1016/j.biortech.2003.10.009; Sundberg C, 2011, BIORESOURCE TECHNOL, V102, P2859, DOI 10.1016/j.biortech.2010.10.075; Sampedro I, 2009, PROCESS BIOCHEM, V44, P216, DOI 10.1016/j.procbio.2008.10.016; Sundberg C, 2005, BIODEGRADATION, V16, P205, DOI 10.1007/s10532-004-0628-1; Ke GR, 2010, BIORESOURCE TECHNOL, V101, P7424, DOI 10.1016/j.biortech.2010.04.051; Cheung HNB, 2010, BIORESOURCE TECHNOL, V101, P5925, DOI 10.1016/j.biortech.2010.02.062; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Asano R, 2010, J BIOSCI BIOENG, V110, P419, DOI 10.1016/j.jbiosc.2010.04.006; NAKASAKI K, 1985, APPL ENVIRON MICROB, V50, P1526; GRAY KR, 1971, PROCESS BIOCHEM, V6, P32; Haug R.T., 1993, PRACTICAL HDB COMPOS; Huys G., 2012, LACTIC ACID BACTERIA, P95; Kluczek-Turpeinen B, 2007, INT BIODETER BIODEGR, V59, P283, DOI 10.1016/j.ibiod.2006.09.007; Ray B., 1993, BACTERIOCINS LACTIC, P181; Reinhardt T, 2002, MICROBIOLOGY OF COMPOSTING, P177; Srivastava P.S., 2003, UNDERSTANDING BACTER, P117	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	OCT	2015	104						377	383		10.1016/j.ibiod.2015.07.007		7	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CS8AP	WOS:000362308400051		
J	Fu, XY; Huang, K; Cui, GY; Chen, XM; Li, FS; Zhang, XY; Li, F				Fu, Xiaoyong; Huang, Kui; Cui, Guangyu; Chen, Xuemin; Li, Fusheng; Zhang, Xiaoyu; Li, Fei			Dynamics of bacterial and eukaryotic community associated with stability during vermicomposting of pelletized dewatered sludge	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Earthworms; Pelletized dewatered sludge; Microbial community; Sludge recycling; Vermicomposting	SEWAGE-SLUDGE; MICROBIAL COMMUNITIES; ENZYMATIC-ACTIVITIES; VEGETABLE WASTES; EISENIA-FOETIDA; EARTHWORMS; DIVERSITY; MANURE; SOIL; GUT	This study aimed to investigate the dynamics of bacterial and eukaryotic community associated with stability during vermicomposting of pelletized dewatered sludge (PDS). For this, dewatered sludge was pelletized to the particle sizes of 4.5 mm and 14.5 mm and then vermicomposted for 60 days using earthworms Bimastus parvus. Physicochemical results showed that vermicomposting resulted in the decrements of organic matter, total nitrogen, ammonia-nitrogen and dissolve organic carbon and the increments of electrical conductivity, nitrate-nitrogen and available phosphorous. Principal component analysis of physicochemical and enzymatic characteristics revealed that the active decomposition stage occurred on day 20 and subsequent stable stage began from day 50-60 of vermicomposting. Moreover, the small PDS displayed a fast speed of stabilization than the large one. PCR and denatured gradient gel electrophoresis (DGGE) assay for communities of 165 rDNA and 18S rDNA ascertained that the microbes of the Flavobacteria and the Sphingobacteria and the Cercozoa predominated in vermicomposting system. This study suggests that earthworms combined with the diversified microbes could rapidly stabilize the fresh PDS within 60 days. (C) 2015 Elsevier Ltd. All rights reserved.	[Fu, Xiaoyong; Huang, Kui; Cui, Guangyu; Chen, Xuemin; Zhang, Xiaoyu; Li, Fei] Lanzhou Jiaotong Univ, Sch Environm & Municipal Engn, Lanzhou 730070, Peoples R China; [Huang, Kui; Li, Fusheng] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan	Huang, K (reprint author), Lanzhou Jiaotong Univ, Sch Environm & Municipal Engn, Lanzhou 730070, Peoples R China.	fuxiaoyong7362@foxmail.com; huangk1199@hotmail.com			Natural Science Foundation of China (NSFC) [51168029]	This work was financially supported by the Natural Science Foundation of China (NSFC, 51168029).	Gomez-Brandon M, 2013, BIORESOURCE TECHNOL, V128, P310, DOI 10.1016/j.biortech.2012.10.112; ROSSELLOMORA RA, 1995, APPL ENVIRON MICROB, V61, P702; Ravindran B, 2015, ECOL ENG, V74, P394, DOI 10.1016/j.ecoleng.2014.10.014; Yasir M, 2009, BIORESOURCE TECHNOL, V100, P4396, DOI 10.1016/j.biortech.2009.04.015; Hery M, 2008, ISME J, V2, P92, DOI 10.1038/ismej.2007.66; Wang H, 2013, INT BIODETER BIODEGR, V85, P400, DOI 10.1016/j.ibiod.2013.07.015; Kim JJ, 2013, INT J SYST EVOL MICR, V63, P654, DOI 10.1099/ijs.0.039404-0; Uggetti E, 2010, BIORESOURCE TECHNOL, V101, P2905, DOI 10.1016/j.biortech.2009.11.102; Ren HY, 2007, CHEMOSPHERE, V66, P340, DOI 10.1016/j.chemosphere.2006.04.064; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Hait S, 2011, BIORESOURCE TECHNOL, V102, P2812, DOI 10.1016/j.biortech.2010.10.031; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Kharrazi SM, 2014, INT BIODETER BIODEGR, V92, P41, DOI 10.1016/j.ibiod.2014.04.011; Kizilkaya R, 2014, COMPOST SCI UTIL, V22, P68, DOI 10.1080/1065657X.2014.895454; Zmora-Nahum S, 2005, SOIL BIOL BIOCHEM, V37, P2109, DOI 10.1016/j.soilbio.2005.03.013; Castillo JM, 2013, BIORESOURCE TECHNOL, V146, P345, DOI 10.1016/j.biortech.2013.07.093; Gurtner C, 2000, INT BIODETER BIODEGR, V46, P229, DOI 10.1016/S0964-8305(00)00079-2; Velasco-Velasco J, 2011, BIORESOURCE TECHNOL, V102, P10959, DOI 10.1016/j.biortech.2011.09.047; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07; Sen B, 2009, BIORESOURCE TECHNOL, V100, P804, DOI 10.1016/j.biortech.2008.07.047; Koubova A, 2015, EUR J SOIL BIOL, V68, P42, DOI 10.1016/j.ejsobi.2015.03.004; Yang J, 2014, BIORESOURCE TECHNOL, V154, P94, DOI 10.1016/j.biortech.2013.12.023; Fu XY, 2015, BIORESOURCE TECHNOL, V175, P646, DOI 10.1016/j.biortech.2014.11.007; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; Tao J, 2009, SOIL BIOL BIOCHEM, V41, P898, DOI 10.1016/j.soilbio.2008.12.002; Zhang L, 2014, BIORESOURCE TECHNOL, V163, P112, DOI 10.1016/j.biortech.2014.04.041; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Ndegwa PM, 2001, BIORESOURCE TECHNOL, V76, P107, DOI 10.1016/S0960-8524(00)00104-8; KANDELER E, 1988, BIOL FERT SOILS, V6, P68; Huang K, 2014, BIORESOURCE TECHNOL, V170, P45, DOI 10.1016/j.biortech.2014.07.058; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Jouraiphy A, 2005, INT BIODETER BIODEGR, V56, P101, DOI 10.1016/j.ibiod.2005.06.002; Aira M, 2002, EUR J SOIL BIOL, V38, P7, DOI 10.1016/S1164-5563(01)01116-5; Fernandez-Gomez MJ, 2010, WASTE MANAGE, V30, P2461, DOI 10.1016/j.wasman.2010.07.005; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Suthar S, 2008, ECOL ENG, V33, P210, DOI 10.1016/j.ecoleng.2008.04.004; Gu JD, 2003, INT BIODETER BIODEGR, V52, P69, DOI 10.1016/S0964-8305(02)00177-4; Nikaeen M, 2015, WASTE MANAGE, V39, P104, DOI 10.1016/j.wasman.2015.01.028; Liu J, 2012, BIORESOURCE TECHNOL, V117, P214, DOI 10.1016/j.biortech.2012.04.096; Aira M, 2007, SCI TOTAL ENVIRON, V385, P252, DOI 10.1016/j.scitotenv.2007.06.031; Huang K, 2013, BIORESOURCE TECHNOL, V150, P235, DOI 10.1016/j.biortech.2013.10.006; Gomez-Brandon M, 2008, CHEMOSPHERE, V70, P436, DOI 10.1016/j.chemosphere.2007.06.065; Brown G.G., 1995, SIGNIF REGUL SOIL BI, V170, P209; Dominguez J, 2004, EARTHWORM ECOLOGY, V20, P401; Matsunaga K, 2014, MICROBES ENVIRON, V29, P401, DOI 10.1264/jsme2.ME14112; [宋天顺 Song Tianshun], 2012, [过程工程学报, The Chinese Journal of Process Engineering], V12, P844; Wal A., 2013, FEMS MICROBIOL REV, V37, P477; Wu J.S., 2006, METHOD DETERMINATION, P54	49	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	OCT	2015	104						452	459		10.1016/j.ibiod.2015.07.015		8	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CS8AP	WOS:000362308400060		
J	Hirano, J; Mikami, T				Hirano, Junpei; Mikami, Takehiko			Long-term changes in summer temperature anomaly patterns in Japan since the early 20th century	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						long-term variations; summer; temperature; Japan; circulation field; canonical correlation analysis	SCALE ATMOSPHERIC CIRCULATION; WESTERN PACIFIC; LEPAGE TEST; LATE 1970S; PRECIPITATION; VARIABILITY; CLIMATE; TRENDS; CONNECTION; DEPENDENCE	The relationship between long-term variations in summer temperature in Japan since the early 20th century and the large-scale atmospheric circulation field was analysed. The combined influence of various circulation predictors on temperature variations was analysed via a multicomponent canonical correlation analysis (CCA). The positive phase of the first CCA mode is related to a positive temperature anomaly across Japan, characterized by a weak blocking high over the Okhotsk Sea, and a strong North Pacific subtropical high (NPSH) over Japan. The positive phase of the second CCA mode corresponds to a positive temperature anomaly in southwestern Japan, and a negative anomaly in northern Japan, characterized by an anticyclonic circulation anomaly over eastern China and a cyclonic anomaly over the northwestern Pacific. By investigating the temporal changes in CCA scores, we detected an abrupt increase in the first CCA score in the early 1910s and a long-term increasing trend in the second CCA score since the early 20th century. The abrupt increase in the first CCA score indicates an abrupt increase in temperature throughout Japan. By investigating changes in the circulation field associated with this abrupt warming, we determined that intensification of zonal flow over the Okhotsk Sea was responsible. The increasing trend of the second CCA score indicates an increase in the regional difference in summer temperatures between northern and southwestern Japan. After investigating changes in the circulation field before and after the mid-20th century, we suggest that the southwestward shift of the NPSH and the weakening of anticyclonic circulation anomalies over the northwestern Pacific were responsible for this increase in the regional temperature difference.	[Hirano, Junpei] Natl Res Inst Earth Sci & Disaster Prevent, Ibaraki, Japan; [Mikami, Takehiko] Teikyo Univ, Fac Liberal Arts, Hachioji, Tokyo, Japan	Hirano, J (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	jhirano06@gmail.com					Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0; Chen DL, 2003, GLOBAL PLANET CHANGE, V37, P315, DOI 10.1016/S0921-8181(02)00206-0; Kosaka Y, 2010, J CLIMATE, V23, P5085, DOI 10.1175/2010JCLI3413.1; Yasunaka S, 2006, J METEOROL SOC JPN, V84, P641, DOI 10.2151/jmsj.84.641; LEPAGE Y, 1971, BIOMETRIKA, V58, P213, DOI 10.2307/2334333; Enomoto T, 2003, Q J ROY METEOR SOC, V129, P157, DOI 10.1256/gj.01.211; Wakabayashi S, 2004, J METEOROL SOC JPN, V82, P1577, DOI 10.2151/jmsj.82.1577; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Enomoto T, 2004, J METEOROL SOC JPN, V82, P1019, DOI 10.2151/jmsj.2004.1019; NORTH GR, 1982, MON WEATHER REV, V110, P319, DOI 10.1175/1520-0493(1982)110<0319:TLDOTV>2.0.CO;2; Fujibe F, 2012, J METEOROL SOC JPN, V90, P525, DOI 10.2151/jmsj.2012-406; Sato N, 2007, J CLIMATE, V20, P4982, DOI 10.1175/JCLI4285.1; Inoue T, 2007, J CLIMATE, V20, P4957, DOI 10.1175/JCLI4217.1; Fujibe F, 2009, INT J CLIMATOL, V29, P1811, DOI 10.1002/joc.1822; Fujibe F, 2011, INT J CLIMATOL, V31, P162, DOI 10.1002/joc.2142; Xoplaki E, 2003, CLIM DYNAM, V20, P537, DOI 10.1007/s00382-002-0291-3; Zhao P, 2011, J CLIMATE, V24, P4793, DOI 10.1175/JCLI-D-11-00054.1; YONETANI T, 1993, J METEOROL SOC JPN, V71, P415; Xoplaki E, 2003, CLIM DYNAM, V20, P723, DOI 10.1007/s00382-003-0304-x; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Gong DY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014523; NINOMIYA K, 1985, J METEOROL SOC JPN, V63, P845; Hirano J, 2011, INT J CLIMATOL, V31, P2330, DOI 10.1002/joc.2241; Das L, 2011, ATMOS SCI LETT, V12, P362, DOI 10.1002/asl.350; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; YONETANI T, 1992, J METEOROL SOC JPN, V70, P95; Liu J, 2012, CLIM PAST, V8, P1169, DOI 10.5194/cp-8-1169-2012; ZORITA E, 1992, J CLIMATE, V5, P1097, DOI 10.1175/1520-0442(1992)005<1097:TACASS>2.0.CO;2; Kato H, 1996, J METEOROL SOC JPN, V74, P639; Tachibana Y, 2004, J METEOROL SOC JPN, V82, P1399, DOI 10.2151/jmsj.2004.1399; Zhou TJ, 2009, J CLIMATE, V22, P2199, DOI 10.1175/2008JCLI2527.1; Barnett P, 1987, MON WEATHER REV, V115, P1825; Fujibe F., 2004, GEOGRAPHICAL REV JAP, V77, P119; Fujibe F., 2009, PAP METEOROL GEOPHYS, V63, P43; Fujibe F., 1995, PAP METEOROL GEOPHYS, V46, P35, DOI DOI 10.2467/MRIPAPERS.46.35; He Xuezhao, 2002, Journal of Geographical Sciences, V12, P202; JMA, 2005, UN WEATH REP 2005 RE; JMA, 2012, CLIM CHANG MON REP 2; Kendall MG., 1938, BIOMETRIKA, V30, P1219; Kondo J., 1985, TENKI JAPAN METEOR S, V32, P157; Lo TT, 2008, CLIM DYNAM, V31, P449; MICHAELSEN J, 1987, J CLIM APPL METEOROL, V26, P1589, DOI 10.1175/1520-0450(1987)026<1589:CVISCF>2.0.CO;2; Mikami T., 1975, GEOGR REV JPN, V48, P784; Nagata R, 2010, ANN OCHANOMIZU GEOGR, V50, P99; Nagata R, 2012, GEOGR REV JPN, V85, P508; Nishimori M., 1999, TENKI, V46, P267; RICHMAN MB, 1986, J CLIMATOL, V6, P293; SHABBAR A., 2007, CLIVAR EXCHANGES, V12, P10; Von Storch H., 1999, STAT ANAL CLIMATE RE; Wilks D.S, 1995, INT GEOPHYS SERIES, V59	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	OCT	2015	35	12					3676	3690		10.1002/joc.4241		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT3TY	WOS:000362731000021		
J	Shen, MG; Cong, N; Cao, RY				Shen, Miaogen; Cong, Nan; Cao, Ruyin			Temperature sensitivity as an explanation of the latitudinal pattern of green-up date trend in Northern Hemisphere vegetation during 1982-2008	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						climate change; latitudinal gradient; remote sensing; temperature sensitivity; vegetation spring phenology	CLIMATE-CHANGE; SPRING PHENOLOGY; TIBETAN PLATEAU; FROST DAMAGE; SNOW COVER; NDVI DATA; CHINA; RESPONSES; BUDBURST; MODIS	The vegetation green-up date (GUD) is widely expected to advance to an earlier date in the year in response to increasing spring temperature. However, although it is well known that climatic warming has been more intensive at higher latitudes than at lower latitudes in the Northern Hemisphere, it is not known whether this greater climatic warming at higher latitudes has led to a greater advance of vegetation GUD during the past few decades. We have first determined GUD from the satellite-derived greenness vegetation index for all the vegetated land between 30 and 75 degrees N from 1982 to 2008, and then investigated the latitudinal pattern of the inter-annual trend of GUD and its relation to pre-season temperature. The results show a generally greater GUD advance in lower latitudes, in spite of the faster increase in pre-season temperature in higher latitudes. We find that 88% of the latitudinal variability in the GUD trend can be explained by the sensitivity of the GUD response to pre-season temperature. The GUD change has also resulted in a northward shift of GUD isolines by 1 degrees-4 degrees between 50 and 65 degrees N during the period. These findings highlight the sensitivity of vegetation response to temperature in shaping the spatial pattern of spring phenological change and suggest that temperate ecosystems may experience greater phenological change if the current latitudinal pattern of climatic warming continues.	[Shen, Miaogen; Cong, Nan] Chinese Acad Sci, Key Lab Alpine Ecol & Biodivers, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Shen, Miaogen] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Cao, Ruyin] Natl Inst Environm Studies, Ibaraki, Japan	Cao, RY (reprint author), Natl Inst Environm Studies, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	cao.ruyin@nies.go.jp	Shen, Miaogen/A-8374-2011	Shen, Miaogen/0000-0001-5742-8807	National Natural Science Foundation of China [41201459]; Chinese Academy of Sciences [XDB03030404]; Youth Innovation Promotion Association of CAS; project of early detection and prediction of climate warming based on the long-term monitoring of fragile ecosystems in East Asia - Ministry of Environment, Japan	This study was supported by a grant from the National Natural Science Foundation of China (Grant No.41201459), a grant from the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences (Grant No. XDB03030404), Youth Innovation Promotion Association of CAS, and the project of early detection and prediction of climate warming based on the long-term monitoring of fragile ecosystems in East Asia funded by the Ministry of Environment, Japan. We thank Dr. M. Brown for providing the NDVI data from 1982-2008. The authors declare no conflict of interests.	Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Han LJ, 2014, GLOBAL PLANET CHANGE, V116, P139, DOI 10.1016/j.gloplacha.2014.02.008; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Zou XKK, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003913; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Augspurger CK, 2013, ECOLOGY, V94, P41, DOI 10.1890/12-0200.1; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5; Cong N, 2012, AGR FOREST METEOROL, V165, P104, DOI 10.1016/j.agrformet.2012.06.009; Shen MG, 2011, AGR FOREST METEOROL, V151, P1711, DOI 10.1016/j.agrformet.2011.07.003; Shen MG, 2011, P NATL ACAD SCI USA, V108, pE91, DOI 10.1073/pnas.1018390108; Shen MG, 2014, AGR FOREST METEOROL, V189, P71, DOI 10.1016/j.agrformet.2014.01.003; Han LJ, 2013, INT J CLIMATOL, V33, P1844, DOI 10.1002/joc.3708; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wilczek AM, 2010, PHILOS T R SOC B, V365, P3129, DOI 10.1098/rstb.2010.0128; Wang T, 2014, GLOBAL CHANGE BIOL, V20, P1473, DOI 10.1111/gcb.12509; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Mazer SJ, 2013, AM J BOT, V100, P1381, DOI 10.3732/ajb.1200455; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Han LJ, 2011, GEOMORPHOLOGY, V129, P412, DOI 10.1016/j.geomorph.2011.03.005; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Jeong SJ, 2013, GEOPHYS RES LETT, V40, P359, DOI [10.1029/2012GL054431, 10.1029/2012Gl054431]; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Lee JJ, 2012, ATMOS ENVIRON, V59, P366, DOI 10.1016/j.atmosenv.2012.05.022; Cao RY, 2015, AGR FOREST METEOROL, V200, P9, DOI 10.1016/j.agrformet.2014.09.009; Delbart N, 2006, REMOTE SENS ENVIRON, V101, P52, DOI 10.1016/j.rse.2005.11.012; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Jeong S.-J., 2010, CLIM DYNAM, V37, P821; Jeong SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036583; Lapenis A, 2014, CLIMATIC CHANGE, V122, P723, DOI 10.1007/s10584-013-1010-2; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Shen MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088178; Tucker CJ, 2004, GLOBAL INVENTORY MOD; Zeng HQ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045508; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	OCT	2015	35	12					3707	3712		10.1002/joc.4227		6	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT3TY	WOS:000362731000024		
J	Jang, JH; Harada, H; Shibayama, H; Shimazaki, R; Kim, HJ; Sawada, K; Mitani, K				Jang, Jun Ho; Harada, Hironori; Shibayama, Hirohiko; Shimazaki, Ryutaro; Kim, Hyeoung-Joon; Sawada, Kenichi; Mitani, Kinuko			A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myelodysplastic syndromes; MDS; Darbepoetin alfa; Erythropoiesis-stimulating agent; EPO	COLONY-STIMULATING FACTOR; QUALITY-OF-LIFE; ERYTHROID RESPONSE; PREDICTIVE FACTORS; SCORING SYSTEM; DOUBLE-BLIND; PHASE-II; G-CSF; ANEMIA; ERYTHROPOIETIN	Darbepoetin alfa (DA) is a standard treatment for anemia in lower-risk MDS. However, to date there has been no comparative study to investigate the initial dosage. We, thus, conducted a randomized controlled trial to elucidate the optimal initial dosage of DA. International Prognostic Scoring System low or intermediate-1 risk MDS patients with hemoglobin levels a parts per thousand currency sign9.0 g/dL, serum erythropoietin levels a parts per thousand currency sign500 mIU/mL, and red blood cell transfusion dependency were enrolled. Patients were randomized to receive DA either at 60, 120, or 240 mu g/week for 16 weeks followed by continuous administration with dose adjustment up to 48 weeks. Of 17, 18, and 15 patients in the 60, 120, and 240 mu g DA groups included in the efficacy analysis, 64.7, 44.4, and 66.7 %, respectively, achieved the primary endpoint (major or minor erythroid response), while 17.6, 16.7, and 33.3 % achieved major erythroid responses in the initial 16-week period. No clinically significant safety concerns were identified. DA reduced the transfusion requirements effectively and safely in transfusion-dependent, lower-risk MDS patients. Given the highest achievement rate of the major erythroid response in the 240 mu g group and the absence of dose-dependent adverse events, 240 mu g weekly is the optimal initial dosage.	[Jang, Jun Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematol Oncol, Seoul, South Korea; [Harada, Hironori] Hiroshima Univ Hosp, Dept Hematol & Oncol, Hiroshima, Japan; [Shibayama, Hirohiko] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan; [Shimazaki, Ryutaro] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan; [Kim, Hyeoung-Joon] Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, Jeollanam Do, South Korea; [Sawada, Kenichi] Akita Univ, Akita 010, Japan; [Mitani, Kinuko] Dokkyo Med Univ, Sch Med, Dept Hematol & Oncol, Mibu, Tochigi 3210293, Japan	Mitani, K (reprint author), Dokkyo Med Univ, Sch Med, Dept Hematol & Oncol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	smcjunhojang@gmail.com; kinukom-tky@umin.ac.jp			Kyowa Hakko Kirin Co., Ltd.; Nippon-Shinyaku Co., Ltd.; Novartis Pharma; Celgene K. K.; Chugai Pharmaceutical Co., Ltd.; Bristol-Myers Squibb	Kyowa Hakko Kirin Co., Ltd. sponsored this clinical study and was responsible for medical monitoring and auditing. R. Shimazaki is an employee of and owns stock in Kyowa Hakko Kirin Co., Ltd. J. H. Jang, H. Harada, H. Shibayama, H. J. Kim, and K. Mitani were principle investigators for this trial. HJ Kim and K Mitani were coordinating investigators of this trial and received consulting fees from Kyowa Hakko Kirin Co., Ltd. K. Sawada was the medical adviser of this trial and received consulting fees from Kyowa Hakko Kirin Co., Ltd. H. Harada has received grant from Nippon-Shinyaku Co., Ltd., Novartis Pharma outside the submitted work, and personal fees from Nippon-Shinyaku Co., Ltd., Novartis Pharma, and Celgene K. K. outside the submitted work. H. Shibayama has received personal fee from Kyowa Hakko Kirin Co., Ltd. outside the submitted work. K. Mitani has received grant from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Novartis Pharma, Bristol-Myers Squibb outside the submitted work.	Kelaidi C, 2010, EXPERT OPIN BIOL TH, V10, P605, DOI 10.1517/14712591003709713; Santini V, 2013, BLOOD, V122, P2286, DOI 10.1182/blood-2013-07-512442; Park S, 2010, LEUKEMIA RES, V34, P1430, DOI 10.1016/j.leukres.2010.05.030; [Anonymous], 2011, REVL CAPS 5 MG GUID; Oliva EN, 2010, LEUKEMIA LYMPHOMA, V51, P1007, DOI 10.3109/10428191003728610; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Ross SD, 2007, ONCOLOGIST, V12, P1264, DOI 10.1634/theoncologist.12-10-1264; Thompson JA, 2000, BLOOD, V95, P1175; Musto P, 2005, BRIT J HAEMATOL, V128, P204, DOI 10.1111/j.1365-2141.2004.05288.x; Bowen D, 2006, HAEMATOL-HEMATOL J, V91, P709; Mannone L, 2006, BRIT J HAEMATOL, V133, P513, DOI 10.1111/j.1365-2141.2006.06070.x; Moyo V, 2008, ANN HEMATOL, V87, P527, DOI 10.1007/s00277-008-0450-7; Park S, 2008, BLOOD, V111, P574, DOI 10.1182/blood-2007-06-096370; Gotlib J, 2009, AM J HEMATOL, V84, P15, DOI 10.1002/ajh.21316; [Anonymous], NCCN CLIN PRACT GUID; Gabrilove J, 2008, BRIT J HAEMATOL, V142, P379, DOI 10.1111/j.1365-2141.2008.07181.x; Stasi R, 2005, ANN ONCOL, V16, P1921, DOI 10.1093/annonc/mdi400; Malcovati L, 2006, HAEMATOL-HEMATOL J, V91, P1588; Jadersten M, 2008, J CLIN ONCOL, V26, P3607, DOI 10.1200/JCO.2007.15.4906; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Greenberg P, 1997, BLOOD, V89, P2079; Smith RE, 2008, J CLIN ONCOL, V26, P1040, DOI 10.1200/JCO.2007.14.2885; Villegas A, 2011, CURR MED RES OPIN, V27, P951, DOI 10.1185/03007995.2011.561834; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Giraldo P, 2006, CANCER, V107, P2807, DOI 10.1002/cncr.22343; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Golshayan AR, 2007, BRIT J HAEMATOL, V137, P125, DOI 10.1111/j.1365-2141.2007.06546.x; Casadevall N, 2004, BLOOD, V104, P321, DOI 10.1182/blood-2003-07-2252; AUL C, 1991, LEUKEMIA RES, V15, P571, DOI 10.1016/0145-2126(91)90025-O; Ferrini Pierluigi Rossi, 1998, British Journal of Haematology, V103, P1070; HellstromLindberg E, 1997, BRIT J HAEMATOL, V99, P344, DOI 10.1046/j.1365-2141.1997.4013211.x; HELLSTROMLINDBERG E, 1995, BRIT J HAEMATOL, V89, P67; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; Luksenburg H, 2004, FDA BRIEFING DOCUMEN; Overgaard J, 2009, J CLIN ONCOL, V27, P6007; Patton Jeffrey F, 2005, J Support Oncol, V3, P419	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					401	412		10.1007/s12185-015-1862-5		12	Hematology	Hematology	CT2YU	WOS:000362673700004		
J	Chi, SG; Ikezoe, T				Chi, SungGi; Ikezoe, Takayuki			Disseminated intravascular coagulation in non-Hodgkin lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Disseminated intravascular coagulation; Non-Hodgkin lymphoma; Recombinant thrombomodulin	THROMBOMODULIN; LEUKEMIA	The present study analyzed the incidence and clinical features of disseminated intravascular coagulation (DIC) developed in association with non-Hodgkin lymphoma (NHL). Two hundred thirty-six patients with newly diagnosed NHL were admitted to our institute since Jul. 2008 to Dec. 2014. Coagulation markers were evaluated in 161 of 236 patients at the time of diagnosis. DIC was diagnosed in 18 patients (11.2 %) based on the criteria established by Ministry of Health, Labor, and Welfare of Japan. All of the 18 patients had Ann-Arbor Stage IV advanced disease, and 17 patients were in poor performance status. Liver function panels, such as bilirubin, aminotransferases, serum choline esterase, and albumin levels, were worse in patients with DIC than those without DIC, indicating impaired production of coagulation factors. Importantly, DIC exerts significantly negative impact on prognosis of NHL; median survival of both groups was 176 versus 2430 days. The difference remains significant after statistically adjusting for age, performance status, Ann-Arbor stage, international prognostic index, and liver function panels. Nine of 18 patients with DIC received anti-coagulants, which failed to improve clinical outcome. Nevertheless, early recognition and intervention to DIC state may contribute to improve prognosis of NHL.	[Chi, SungGi; Ikezoe, Takayuki] Kochi Univ, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan	Ikezoe, T (reprint author), Kochi Univ, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan.	ikezoet@kochi-u.ac.jp					Sase T, 2005, THROMB HAEMOSTASIS, V93, P153, DOI 10.1160/TH04-04-0260; Asakura H, 2014, THROMB RES, V133, P364, DOI 10.1016/j.thromres.2013.12.033; Uchiumi H, 2007, INT J HEMATOL, V86, P137, DOI 10.1532/IJH97.06173; Cesarman-Maus G, 2014, THROMB RES, V133, P606, DOI 10.1016/j.thromres.2014.01.020; Ikezoe T, 2014, INT J HEMATOL, V100, P27, DOI 10.1007/s12185-013-1463-0; Sallah S, 2001, THROMB HAEMOSTASIS, V86, P828; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; Colombo R, 2014, CLIN LYMPHOMA MYELOM; Levi M, 2006, TISSUE FACTOR INFECT, P32	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					413	419		10.1007/s12185-015-1854-5		7	Hematology	Hematology	CT2YU	WOS:000362673700005		
J	Shimura, Y; Horiike, S; Tsutsumi, Y; Hatsuse, M; Okano, A; Fuchida, S; Kobayashi, T; Matsumoto, Y; Kuroda, J; Kawata-Iida, E; Uchiyama, H; Uoshima, N; Shimazaki, C; Kaneko, H; Kobayashi, Y; Taniwaki, M				Shimura, Yuji; Horiike, Shigeo; Tsutsumi, Yasuhiko; Hatsuse, Mayumi; Okano, Akira; Fuchida, Shin-ichi; Kobayashi, Tsutomu; Matsumoto, Yosuke; Kuroda, Junya; Kawata-Iida, Eri; Uchiyama, Hitoji; Uoshima, Nobuhiko; Shimazaki, Chihiro; Kaneko, Hiroto; Kobayashi, Yutaka; Taniwaki, Masafumi			The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Dasatinib; LGL; Clonality; Regulatory T cell	CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; REGULATORY T-CELLS; DIAGNOSED CHRONIC-PHASE; 2-YEAR FOLLOW-UP; TYROSINE KINASE; CYTOMEGALOVIRUS REACTIVATION; INHIBITOR DASATINIB; INTERFERON-ALPHA; NK-CELLS	Dasatinib, a 2nd-generation tyrosine kinase inhibitor (TKI), can specifically induce large granular lymphocytes (LGL) in some patients with Philadelphia chromosome (Ph)-positive leukemia. To investigate the properties of the induced LGLs, we performed prospective and longitudinal analyses. From Feb 2011 to Jan 2013, a total of 17 patients with Ph-positive leukemia who were previously untreated or refractory to imatinib were enrolled. T cell receptor (TCR)-gamma/delta gene rearrangements and phenotypic profiles of lymphocytes were examined before and during administration of dasatinib. LGL lymphocytosis was observed in half of the dasatinib-treated cases (LGL+ group), showing a relation to increased achievement of complete cytogenetic response within 6 months. The phenotypes of the increased lymphocytes were revealed to be mostly natural killer cells. In the LGL+ group, clonal TCR-gamma gene rearrangements were frequently detected at diagnosis (six of nine cases) and persisted during therapy, compared with only two of eight in the LGL- group. The proportion of regulatory T cells to CD4+ T cells at diagnosis was lower in the LGL+ compared with the LGL- group (median 4.2 vs. 6.6 %), and this disparity was sustained throughout the therapeutic period. These results demonstrate that immunological condition at diagnosis may affect LGL lymphocytosis in some dasatinib-treated patients.	[Shimura, Yuji; Horiike, Shigeo; Kobayashi, Tsutomu; Matsumoto, Yosuke; Kuroda, Junya; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto 6028566, Japan; [Horiike, Shigeo] Kyoto Prefectural Univ Med, Dept Blood Transfus & Cell Therapy, Kyoto 6028566, Japan; [Tsutsumi, Yasuhiko; Kaneko, Hiroto] Kyoto First Red Cross Hosp, Dept Med, Div Hematol, Kyoto, Japan; [Hatsuse, Mayumi; Okano, Akira; Fuchida, Shin-ichi; Shimazaki, Chihiro] Kyoto Kuramaguchi Med Ctr, Dept Med, Div Hematol, Kyoto, Japan; [Kawata-Iida, Eri; Uchiyama, Hitoji; Uoshima, Nobuhiko; Kobayashi, Yutaka] Kyoto Second Red Cross Hosp, Dept Med, Div Hematol, Kyoto, Japan	Shimura, Y (reprint author), Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kajii Cho 465, Kyoto 6028566, Japan.	yshimura@koto.kpu-m.ac.jp			Bristol-Myers Squibb	Masafumi Taniwaki have received grant from Bristol-Myers Squibb.	Li J, 2010, BLOOD, V115, P3580, DOI 10.1182/blood-2009-10-246991; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Nagata Y, 2010, INT J HEMATOL, V91, P799, DOI 10.1007/s12185-010-0565-1; Powers JJ, 2011, LEUKEMIA LYMPHOMA, V52, P668, DOI 10.3109/10428194.2010.550074; Kumagai T, 2014, INT J HEMATOL, V99, P41, DOI 10.1007/s12185-013-1483-9; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Kreutzman A, 2011, LEUKEMIA, V25, P1587, DOI 10.1038/leu.2011.135; Hayashi Y, 2012, LEUKEMIA LYMPHOMA, V53, P1084, DOI 10.3109/10428194.2011.647017; Kreutzman A, 2010, BLOOD, V116, P772, DOI 10.1182/blood-2009-12-256800; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; OLIVE DM, 1989, J CLIN MICROBIOL, V27, P1238; Sze Daniel M.-Y., 2005, V113, P257, DOI 10.1385/1-59259-916-8:257; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Fujisawa S, 2014, INT J HEMATOL, V99, P141, DOI 10.1007/s12185-013-1470-1; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1039/sj.bjc.6603170; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Tanaka H, 2012, INT J HEMATOL, V96, P308, DOI 10.1007/s12185-012-1132-8; Naylor K, 2005, J IMMUNOL, V174, P7446; Talpaz M, 2013, LEUKEMIA, V27, P803, DOI 10.1038/leu.2012.313; Sasada T, 2003, CANCER, V98, P1089, DOI 10.1002/cncr.11618; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Kim DH, 2009, HAEMATOL-HEMATOL J, V94, P135, DOI 10.3324/haematol.13151; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kreutzman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023022	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					426	433		10.1007/s12185-015-1848-3		8	Hematology	Hematology	CT2YU	WOS:000362673700007		
J	Sugiura, I; Terabe, S; Kinoshita, T; Yamamoto, K; Sawa, M; Ozawa, Y; Atsuta, Y; Suzuki, R; Shimizu, K				Sugiura, Isamu; Terabe, Satomi; Kinoshita, Tomohiro; Yamamoto, Kazuhito; Sawa, Masashi; Ozawa, Yukiyasu; Atsuta, Yoshiko; Suzuki, Ritsuro; Shimizu, Kazuyuki			Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Multiple myeloma; Cyclophosphamide; Recommended dose; CBD regimen	STEM-CELL TRANSPLANTATION; HIGH RESPONSE RATES; INDUCTION TREATMENT; PLUS DEXAMETHASONE; ORAL CYCLOPHOSPHAMIDE; TRIAL; COMBINATION; THALIDOMIDE; THERAPY; LENALIDOMIDE	The present study was conducted to determine the recommended dose (RD) of cyclophosphamide (CPM) in the CBD regimen, a triplet combination of CPM, bortezomib (BTZ), and dexamethasone (Dex), for relapsed and/or refractory multiple myeloma (RRMM). Patients received intravenous CPM on days 1 and 8 at one of three dose levels: 300, 400, or 500 mg/m(2), with dose escalation in a 3 + 3 design. BTZ at 1.3 mg/m(2) was given twice weekly in 3-week cycles, with Dex at 20 mg/m(2) on the day of and day after BTZ. Of 16 patients enrolled, 15 eligible patients were allocated to the study. Dose-limiting toxicities (DLTs) were seen in two patients: one in dose level 1 with increased gamma-GTP and the other in dose level 3 with increased gamma-GTP and ALT. Both patients spontaneously recovered from DLT. Neither therapy-related mortality nor severe adverse events were reported during the study. Therefore, the RD of CPM was determined as 500 mg/m(2). Overall, 2 (13.3 %), 1 (6.7 %), and 8 (53.3 %) patients achieved CR, VGPR, and PR, respectively. The regimen was well tolerated and showed promising activity in patients with RRMM.	[Sugiura, Isamu; Terabe, Satomi] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi 4418570, Japan; [Kinoshita, Tomohiro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Yamamoto, Kazuhito] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Sawa, Masashi] Anjo Kosei Hosp, Dept Hematol, Anjo, Japan; [Ozawa, Yukiyasu] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Atsuta, Yoshiko; Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept Hematopoiet Stem Cell Transplantat Data Mana, Nagoya, Aichi 4648601, Japan; [Shimizu, Kazuyuki] Tokai Cent Hosp, Kakamigahara, Japan	Sugiura, I (reprint author), Toyohashi Municipal Hosp, Div Hematol & Oncol, 50 Hachiken Nishi, Toyohashi, Aichi 4418570, Japan.	i-sugiura@med.email.ne.jp			Center for Supporting Hematology-Oncology Trials (C-SHOT)	This study was supported by the Center for Supporting Hematology-Oncology Trials (C-SHOT). The authors would like to thank Shizuka Kobayashi for assisting as a data manager.	Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Lokhorst HM, 2008, HAEMATOL-HEMATOL J, V93, P124, DOI 10.3324/haematol.11644; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Davies FE, 2007, HAEMATOL-HEMATOL J, V92, P1149, DOI 10.3324/haematol.11228; Palumbo A, 2012, HEMATOL-AM SOC HEMAT, P335, DOI 10.1182/asheducation-2012.1.335; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Reece DE, 2008, J CLIN ONCOL, V26, P4777, DOI 10.1200/JCO.2007.14.2372; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Nooka AK, 2013, CANCER-AM CANCER SOC, V119, P4119, DOI 10.1002/cncr.28325; Sonneveld P, 2013, J CLIN ONCOL, V31, P3279, DOI 10.1200/JCO.2012.48.4626; Kumar S, 2012, BLOOD, V119, P4375, DOI 10.1182/blood-2011-11-395749; Kropff M, 2009, ANN HEMATOL, V88, P1125, DOI 10.1007/s00277-009-0726-6; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Khan ML, 2012, BRIT J HAEMATOL, V156, P326, DOI 10.1111/j.1365-2141.2011.08949.x	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					434	440		10.1007/s12185-015-1846-5		7	Hematology	Hematology	CT2YU	WOS:000362673700008		
J	Tachibana, T; Tanaka, M; Hagihara, M; Kawasaki, R; Yamazaki, E; Koharazawa, H; Taguchi, J; Tomita, N; Fujimaki, K; Sakai, R; Fujita, H; Fujisawa, S; Maruta, A; Ishigatsubo, Y; Kanamori, H				Tachibana, Takayoshi; Tanaka, Masatsugu; Hagihara, Maki; Kawasaki, Rika; Yamazaki, Etsuko; Koharazawa, Hideyuki; Taguchi, Jun; Tomita, Naoto; Fujimaki, Katsumichi; Sakai, Rika; Fujita, Hiroyuki; Fujisawa, Shin; Maruta, Atsuo; Ishigatsubo, Yoshiaki; Kanamori, Heiwa			Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						TBI/CY; Cytarabine; Thiotepa; Stem cell transplantation; Conditioning regimen	BONE-MARROW-TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; CORD BLOOD TRANSPLANTATION; HIGH-DOSE CYTARABINE; CONDITIONING REGIMEN; ADULT PATIENTS; CYTOSINE-ARABINOSIDE; HEMATOLOGIC MALIGNANCIES; RELAPSE; THIOTEPA/CYCLOPHOSPHAMIDE/TBI	A multicenter retrospective study was performed to determine the significance of adding cytarabine (CA) or thiotepa (TT) in the context of total body irradiation (TBI) and cyclophosphamide (CY). A total of 322 patients who underwent allogeneic hematopoietic cell transplantation (HCT) were distributed to the following three groups: TBI/CY (n = 75), TBI/CY/CA (n = 77), and TBI/CY/TT (n = 170). In the TBI/CY/TT group, 164 of patients (96 %) received HCT during the previous year (2000-2005). Multivariate analysis revealed that the TBI/CY/TT group demonstrated a trend of poorer survival rate than the TBI/CY group, [hazard ratio (HR) = 1.49, 95 % confidence interval (CI) 0.99-2.24, P = 0.055] with a higher non-relapse mortality (NRM) (HR = 2.34, 95 % CI 1.35-4.06, P = 0.002) rates, while TBI/CY/CA group demonstrated similar outcomes. Even in the subgroup analyses of disease type or disease risk, the outcomes with intensified conditioning regimens were not superior to those with TBI/CY. In conclusion, although the significant bias has to be carefully considered, the clinical benefit of adding CA or TT to the TBI/CY regimen was not demonstrated.	[Tachibana, Takayoshi; Kawasaki, Rika; Sakai, Rika; Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Tanaka, Masatsugu; Hagihara, Maki; Fujimaki, Katsumichi; Maruta, Atsuo; Kanamori, Heiwa] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan; [Tachibana, Takayoshi; Yamazaki, Etsuko; Tomita, Naoto; Fujita, Hiroyuki; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Koharazawa, Hideyuki; Taguchi, Jun] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan	Tachibana, T (reprint author), Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan.	tcbnt@yokohama-cu.ac.jp			Kanagawa Health Foundation	This work was supported by a grant from the Kanagawa Health Foundation.	Inamoto Y, 2007, BONE MARROW TRANSPL, V39, P25, DOI 10.1038/sj.bmt.1705543; PETERSEN FB, 1988, BONE MARROW TRANSPL, V3, P619; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Rigden JP, 1996, BONE MARROW TRANSPL, V18, P913; RIDDELL S, 1988, J CLIN ONCOL, V6, P576; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Kurosawa S, 2013, BONE MARROW TRANSPL, V48, P529, DOI 10.1038/bmt.2012.172; Fujimaki K, 2008, INTERNAL MED, V47, P379, DOI 10.2169/internalmedicine.47.0598; Mineishi S, 1999, BONE MARROW TRANSPL, V23, P1217, DOI 10.1038/sj.bmt.1701793; TERENZI A, 1990, TRANSPLANTATION, V50, P717; Jillella AP, 1999, BONE MARROW TRANSPL, V23, P1095, DOI 10.1038/sj.bmt.1701786; Mori T, 2013, BIOL BLOOD MARROW TR, V19, P486, DOI 10.1016/j.bbmt.2012.12.007; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; TRIGG ME, 1987, CANCER, V59, P38, DOI 10.1002/1097-0142(19870101)59:1<38::AID-CNCR2820590112>3.0.CO;2-T; Mori T, 2012, AM J HEMATOL, V87, P349, DOI 10.1002/ajh.23109; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; Fujimaki K, 2004, BONE MARROW TRANSPL, V33, P789, DOI 10.1038/sj.bmt.1704451; Zecca M, 1999, J CLIN ONCOL, V17, P1838; Mengarelli A, 2002, HAEMATOLOGICA, V87, P52; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Shigematsu A, 2008, BIOL BLOOD MARROW TR, V14, P568, DOI 10.1016/j.bbmt.2008.02.018; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Konuma T, 2014, BIOL BLOOD MARROW TR, V20, P396, DOI 10.1016/j.bbmt.2013.12.555	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					451	459		10.1007/s12185-015-1836-7		9	Hematology	Hematology	CT2YU	WOS:000362673700010		
J	Nomoto, H; Takami, A; Espinoza, JL; Matsuo, K; Mizuno, S; Onizuka, M; Kashiwase, K; Morishima, Y; Fukuda, T; Kodera, Y; Doki, N; Miyamura, K; Mori, T; Nakao, S; Ohtake, S; Morishita, E				Nomoto, Haruka; Takami, Akiyoshi; Espinoza, J. Luis; Matsuo, Keitaro; Mizuno, Shohei; Onizuka, Makoto; Kashiwase, Koichi; Morishima, Yasuo; Fukuda, Takahiro; Kodera, Yoshihisa; Doki, Noriko; Miyamura, Koichi; Mori, Takehiko; Nakao, Shinji; Ohtake, Shigeki; Morishita, Eriko			A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						THBD; Unrelated donor; Bone marrow transplantation; Single nucleotide variation; Graft-versus-host disease	STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; ALLOGENEIC TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; SOLUBLE THROMBOMODULIN; VASCULAR ENDOTHELIUM; DENDRITIC CELLS; RISK; POLYMORPHISMS; ASSOCIATION	Thrombomodulin, encoded by the THBD gene, is a critical regulator of coagulation and innate immunity. Its gene variant (rs3176123, 2729A > C) in the 3' untranslated region has been reported to be associated with vasculopathies. The present study analyzed the impact of THBD variation on transplant outcomes in a cohort of 317 patients who underwent unrelated HLA-matched bone marrow transplantation (BMT) for hematologic malignancies through the Japan Marrow Donor Program. The donor A/C or C/C genotype vs. the donor A/A genotype resulted in a lower incidence of grades II-IV acute graft-versus-host disease [GVHD; hazard ratio (HR) 0.66; 95 % confidence interval (CI) 0.44-0.99; P = 0.05] according to a multivariate analysis. In patients with grades II-IV acute GVHD, the donor A/C or C/C genotype vs. the donor A/A genotype was associated with significantly better overall survival rates (HR 0.45; 95 % CI 0.21-0.99, P = 0.05), while this effect was absent in other patients. A functional analysis using lymphocytes obtained from healthy individuals revealed that the 2729C allele has a higher level of THBD mRNA than the 2729A allele. These findings suggest the functional relevance of the rs3176123 variation and indicate that higher thrombomodulin expression by individuals with the 2729C allele likely accounts for their decreased risk for acute GVHD development and subsequent mortality.	[Nomoto, Haruka; Mizuno, Shohei; Ohtake, Shigeki; Morishita, Eriko] Kanazawa Univ, Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi] Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, Nagakute, Aichi 4801195, Japan; [Espinoza, J. Luis; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan; [Morishima, Yasuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan; [Doki, Noriko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan	Takami, A (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	haruka84@stu.kanazawa-u.ac.jp; takami-knz@umin.ac.jp; luis@staff.kanazawa-u.ac.jp; keitarom@med.kyushu-u.ac.jp; shohei@aichi-med-u.ac.jp; moni5@mac.com; k-kashiwase@ktks.bbc.jrc.or.jp; ymorisim@aichi-cc.jp; tafukuda@ncc.go.jp; ykodera@river.ocn.ne.jp; n-doki@cick.jp; miyamu@nagoya-1st.jrc.or.jp; tmori@a3.keio.jp; snakao8205@staff.kanazawa-u.ac.jp; sohtake@staff.kanazawa-u.ac.jp; eriko86@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan [24591418, 15K09513]; SENSHIN Medical Research Foundation (Osaka, Japan); Aichi Cancer Research Foundation (Nagoya, Japan); 24th General Assembly of the Japanese Association of Medical Sciences (Nagoya, Japan); Ministry of Health, Labour and Welfare of Japan	We thank all of the Japan Marrow Donor Program (JMDP) transplant teams who provided their valuable assistance in caring for the patients and donors investigated in this study. This study was supported by grants from the Ministry of Health, Labour and Welfare of Japan, the Ministry of Education, Culture, Sports and Technology of Japan (Grant Number 24591418 and 15K09513), the SENSHIN Medical Research Foundation (Osaka, Japan), the Aichi Cancer Research Foundation (Nagoya, Japan), and the 24th General Assembly of the Japanese Association of Medical Sciences (Nagoya, Japan). The funders played no role in the study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Sharfuddin AA, 2009, J AM SOC NEPHROL, V20, P524, DOI 10.1681/ASN.2008060593; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; Hanly AM, 2005, EJSO, V31, P217, DOI 10.1016/j.ejso.2004.11.017; Foley JE, 2005, J IMMUNOL, V175, P5732; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Nurnberger W, 1998, ANN HEMATOL, V76, P61, DOI 10.1007/s002770050364; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Testa S, 1996, BONE MARROW TRANSPL, V18, P383; Willemze AJ, 2009, TRANSPLANTATION, V87, P1096, DOI 10.1097/TP.0b013e31819d340f; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Foley JE, 2008, BIOL BLOOD MARROW TR, V14, P959, DOI 10.1016/j.bbmt.2008.06.007; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Lobato RL, 2011, CIRCULATION, V124, pS143, DOI 10.1161/CIRCULATIONAHA.110.008334; Maeda Y, 2013, INT J HEMATOL, V98, P293, DOI 10.1007/s12185-013-1421-x; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; HOLLER E, 1989, BLOOD, V73, P2018; MARUYAMA I, 1984, J CLIN INVEST, V74, P224, DOI 10.1172/JCI111405; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Espinoza JL, 2013, BIOL BLOOD MARROW TR, V19, P240, DOI 10.1016/j.bbmt.2012.09.014; KRENGER W, 1995, J IMMUNOL, V155, P585; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Andrulis M, 2012, HAEMATOL-HEMATOL J, V97, P1674, DOI 10.3324/haematol.2011.061051; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Sugiyama S, 2007, THROMB RES, V119, P35, DOI 10.1016/j.thromres.2005.12.012; An SH, 2014, J CLIN PHARM THER, V39, P314, DOI 10.1111/jcpt.12143; Inoue Y, 2011, THROMB RES, V127, P603, DOI 10.1016/j.thromres.2010.12.023; Mueller RJ, 2011, HAEMATOL-HEMATOL J, V96, P119, DOI 10.3324/haematol.2010.030288; Navarro A, 2003, J INTERF CYTOK RES, V23, P723, DOI 10.1089/107999003772084833; DUMLER JS, 1989, AM J PATHOL, V135, P1097; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Nakata K, 2013, CLIN IMMUNOL, V146, P104, DOI 10.1016/j.clim.2012.11.009; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Kvasnicka HM, 2003, LEUKEMIA LYMPHOMA, V44, P321, DOI 10.1080/1042819021000035699; Tawara I, 2010, J IMMUNOL, V185, P3866, DOI 10.4049/jimmunol.1001625; Espinoza JL, 2012, HAEMATOL-HEMATOL J, V97, P1295, DOI 10.3324/haematol.2011.058529; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Nomura S, 2011, THROMB HAEMOSTASIS, V105, P1118, DOI 10.1160/TH10-12-0802; Espinoza JL, 2009, HAEMATOL-HEMATOL J, V94, P1427, DOI 10.3324/haematol.2009.008318; Knowles JW, 2007, AM HEART J, V154, P1052, DOI 10.1016/j.ahj.2007.05.021; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Murata H, 2007, BLOOD, V109, P2663, DOI 10.1182/blood-2006-07-033902; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Auro K, 2007, PLOS GENET, V3, P1244, DOI 10.1371/journal.pgen.0030120; Espinoza JL, 2010, ASH ANN M, V116, P221; Ikezoe T, 2015, BONE MARROW TRANSPL, V50, P113, DOI 10.1038/bmt.2014.208; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Liu K, 2011, AM J RESP CRIT CARE, V183, pA3989; Moore Amy, 2012, Int J Mol Epidemiol Genet, V3, P305; Rachakonda SP, 2014, J CLIN ONCOL, V32, P3421, DOI 10.1200/JCO.2013.54.4056; Roeen Z, 2015, CELL IMMUNOL, V293, P34, DOI 10.1016/j.cellimm.2014.11.005; Tanabe T, 2012, TRANSPLANTATION, V93, P709, DOI 10.1097/TP.0b013e31824612b5	59	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					460	470		10.1007/s12185-015-1852-7		11	Hematology	Hematology	CT2YU	WOS:000362673700011		
J	Fujimi, A; Kamihara, Y; Hashimoto, A; Kanisawa, Y; Nakajima, C; Hayasaka, N; Yamada, S; Okuda, T; Minami, S; Ono, K; Iyama, S; Kato, J				Fujimi, Akihito; Kamihara, Yusuke; Hashimoto, Akari; Kanisawa, Yuji; Nakajima, Chisa; Hayasaka, Naotaka; Yamada, Shota; Okuda, Toshinori; Minami, Shinya; Ono, Kaoru; Iyama, Satoshi; Kato, Junji			Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Prolonged thrombocytopenia; Allogeneic hematopoietic stem cell transplantation; Anti-thrombopoietin receptor antibody; Eltrombopag	BONE-MARROW-TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNE THROMBOCYTOPENIA; AUTOANTIBODY; RECOVERY	A 55-year-old female with stage IVA follicular lymphoma in third complete remission underwent allogeneic peripheral blood stem cell transplantation. Neutrophil engraftment was achieved on day +18; however, platelet counts remained below 10 x 10(3)/A mu L, necessitating transfusions twice a week for more than 3 months. Bone marrow showed a decreased number of megakaryocytes with hypolobulated nuclei. No graft versus host disease, viral infection, or disease relapse was observed. Furthermore, severe thrombocytopenia below 5.0 x 10(3)/A mu L refractory to transfusion appeared on day +240 after influenza virus infection. Treatments with intravenous immunoglobulin, romiplostim, and rituximab were administered without any recovery. Subsequently, eltrombopag was initiated on day +443, after which platelet counts rose gradually and continued to rise above 20 x 10(3)/A mu L after 10 weeks of administration. The serum thrombopoietin (TPO) level was markedly elevated, and anti-TPO receptor (TPOR) antibody was detected in the patient's serum. Anti-TPOR antibody may play an important role in some cases of prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation with unknown etiology, and eltrombopag could be a novel therapeutic option for such cases.	[Fujimi, Akihito; Kamihara, Yusuke; Hashimoto, Akari; Kanisawa, Yuji] Oji Gen Hosp, Dept Hematol & Oncol, Tomakomai City 0538506, Japan; [Nakajima, Chisa; Hayasaka, Naotaka; Yamada, Shota; Okuda, Toshinori; Minami, Shinya] Oji Gen Hosp, Dept Gastroenterol, Tomakomai, Japan; [Ono, Kaoru; Iyama, Satoshi; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Fujimi, A (reprint author), Oji Gen Hosp, Dept Hematol & Oncol, 3-4-8 Wakakusa Cho, Tomakomai City 0538506, Japan.	akihito.fujimi@ojihosp.or.jp					Kottaridis PD, 1999, BONE MARROW TRANSPL, V23, P739, DOI 10.1038/sj.bmt.1701651; Reid R, 2012, AM J HEMATOL, V87, P743, DOI 10.1002/ajh.23225; Kim DH, 2006, BONE MARROW TRANSPL, V37, P101, DOI 10.1038/sj.bmt.1705203; Dominietto A, 2001, BRIT J HAEMATOL, V112, P219, DOI 10.1046/j.1365-2141.2001.02468.x; Kuwana M, 2002, ARTHRITIS RHEUM-US, V46, P2148, DOI 10.1002/art.10420; TAANING E, 1994, BRIT J HAEMATOL, V86, P651, DOI 10.1111/j.1365-2141.1994.tb04801.x; Yamazaki R, 2006, BONE MARROW TRANSPL, V38, P377, DOI 10.1038/sj.bmt.1705444; Bielski M, 1998, BONE MARROW TRANSPL, V22, P1071, DOI 10.1038/sj.bmt.1701499; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Kuwana M, 2006, RHEUMATOLOGY, V45, P851, DOI 10.1093/rheumatology/ke1010; Zhang XH, 2011, BIOL BLOOD MARROW TR, V17, P274, DOI 10.1016/j.bbmt.2010.09.007; FEINENDEGEN LE, 1962, P SOC EXP BIOL MED, V111, P177; KLUMPP TR, 1992, MEDICINE, V71, P73; Bolwell B, 2004, BONE MARROW TRANSPL, V33, P419, DOI 10.1038/sj.bmt.1704330; Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; FIRST LR, 1985, BLOOD, V65, P368; Li CZ, 2014, INT J HEMATOL, V100, P529, DOI 10.1007/s12185-014-1660-5; PANZER S, 1989, BRIT J HAEMATOL, V71, P259, DOI 10.1111/j.1365-2141.1989.tb04264.x; Poon Limei Michelle, 2013, Am J Blood Res, V3, P260	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					471	476		10.1007/s12185-015-1806-0		6	Hematology	Hematology	CT2YU	WOS:000362673700012		
J	Higuchi, M; Sasaki, S; Kawadoko, S; Uchiyama, H; Yasui, T; Kamihira, T; Aoki, K; Sasaguri, T; Nakano, R; Uchiyama, A; Muta, T; Ohshima, K				Higuchi, Masakazu; Sasaki, Shoichi; Kawadoko, Shin-ichiro; Uchiyama, Hikaru; Yasui, Takaharu; Kamihira, Takashi; Aoki, Ken-ichi; Sasaguri, Takakazu; Nakano, Ryuji; Uchiyama, Akihiko; Muta, Tsuyoshi; Ohshima, Koichi			Epstein-Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Diffuse large B-cell lymphoma; Epstein-Barr virus; Acute myeloid leukemia; Clonality; Immunoglobulin heavy chain	NON-HODGKINS-LYMPHOMA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; LYMPHOPROLIFERATIVE DISORDERS; MYELODYSPLASTIC SYNDROME; PATIENT; GENE; REMISSION; CANCER	Secondary non-Hodgkin lymphoma following acute myeloid leukemia (AML) is extremely rare. We here describe a unique case involving a patient who developed Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) during complete remission (CR) of AML. A 75-year-old Japanese man was initially diagnosed with AML with maturation (FAB M2), bearing chromosomal translocation t(3,4)(p25;q21). After intensive chemotherapy, bone marrow aspiration revealed normal karyotype, and he achieved CR. Six years and 4 months later, he was still in CR from AML, but developed DLBCL presenting in the terminal ileum. Cytogenetic analysis of the DLBCL cells showed the same translocation as the previous AML. The rearrangements of the immunoglobulin heavy chain genes of the two malignancies were examined using polymerase chain reaction amplification, and the rearrangement patterns were found to differ from each other. Our data thus suggest that, in the present case, the AML and DLBCL arose from a common progenitor cell, as indicated by the clonal abnormality t(3,4)(p25;q21), and that different immunoglobulin heavy chain gene rearrangements occurred during each course of clonal evolution.	[Higuchi, Masakazu; Sasaki, Shoichi; Kawadoko, Shin-ichiro; Kamihira, Takashi; Aoki, Ken-ichi; Muta, Tsuyoshi] Kyushu Hosp, JCHO, Dept Internal Med, Fukuoka, Japan; [Uchiyama, Hikaru; Yasui, Takaharu; Uchiyama, Akihiko] JCHO Kyushu Hosp, Dept Surg, Fukuoka, Japan; [Sasaguri, Takakazu; Nakano, Ryuji] JCHO Kyushu Hosp, Dept Pathol, Fukuoka, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan	Higuchi, M (reprint author), JR Kyushu Hosp, Dept Hematol, Moji Ku, 1-1 Takada 2-Chome, Kitakyushu, Fukuoka 8000031, Japan.	m.higuchi@jrkyushu-hospital.jp					Ahmed Bilal, 2006, Haematologica, V91, pECR55; CHEN CS, 1993, BLOOD, V82, P1080; BLOOM RE, 1985, AM J HEMATOL, V18, P73, DOI 10.1002/ajh.2830180110; Huang Q, 2010, BONE MARROW TRANSPL, V45, P191, DOI 10.1038/bmt.2009.86; Kasahara S, 2011, LEUKEMIA LYMPHOMA, V52, P629, DOI 10.3109/10428194.2011.555024; Chen DB, 2013, INT J HEMATOL, V97, P117, DOI 10.1007/s12185-012-1244-1; BORISCH B, 1992, AM J CLIN PATHOL, V98, P312; Kyoda K, 1997, LEUKEMIA, V11, P803, DOI 10.1038/sj.leu.2400662; KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0; Qiu ZX, 2012, CANCER SCI, V103, P1774, DOI 10.1111/j.1349-7006.2012.02375.x; Ishikawa M, 2007, INT J HEMATOL, V86, P238, DOI 10.1532/IJH97.07054; Weidmann E, 2000, HAEMATOLOGICA, V85, P1024; Thomas X, 1996, ANN HEMATOL, V73, P95, DOI 10.1007/s002770050208; Huang HH, 2009, J INT MED RES, V37, P270; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Moridaira K, 1998, ACTA HAEMATOL-BASEL, V100, P97, DOI 10.1159/000040875; WILLIAMS S, 1979, BRIT MED J, V2, P178; RABAUD C, 1995, J INFECTION, V31, P69, DOI 10.1016/S0163-4453(95)91581-8; Alves MR, 2014, VIRCHOWS ARCH, V465, P321, DOI 10.1007/s00428-014-1629-z; Chakraborty S, 2009, J CLIN ONCOL, V27, P791, DOI 10.1200/JCO.2008.17.1033; GOSSETT TC, 1979, NEW ENGL J MED, V300, P904, DOI 10.1056/NEJM197904193001606; Dojcinov SD, 2011, BLOOD, V117, P4726, DOI 10.1182/blood-2010-12-323238; Ririe MR, 2014, AM J DERMATOPATH, V36, pE125, DOI 10.1097/DAD.0000000000000027; EGUIGUREN JM, 1991, LEUKEMIA, V5, P908; VERSCHUUR A, 1994, BONE MARROW TRANSPL, V14, P467; Schmetzer HM, 1998, CANCER GENET CYTOGEN, V100, P31, DOI 10.1016/S0165-4608(97)00002-2; Xiao ZJ, 2004, LEUKEMIA LYMPHOMA, V45, P1955, DOI 10.1080/10428190310001617240; WITHERSPOON RP, 1989, NEW ENGL J MED, V321, P784, DOI 10.1056/NEJM198909213211203; Nakamura S, 2008, CLASSIFICATION OF TU, V94, P243; Parekh Samir, 2003, Clin Adv Hematol Oncol, V1, P295; Swerdlow S, 2008, WHO CLASSIFICATION T	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					482	487		10.1007/s12185-015-1802-4		6	Hematology	Hematology	CT2YU	WOS:000362673700014		
J	Ishitsuka, K; Murahashi, M; Katsuya, H; Mogi, A; Masaki, M; Kawai, C; Goto, T; Ishizu, M; Ikari, Y; Takamatsu, Y; Ishibashi, H; Nimura, S; Takeshita, M; Tamura, K				Ishitsuka, Kenji; Murahashi, Mutsunori; Katsuya, Hiroo; Mogi, Ai; Masaki, Michio; Kawai, Chisato; Goto, Toshitaka; Ishizu, Masanao; Ikari, Yosuke; Takamatsu, Yasushi; Ishibashi, Hideki; Nimura, Satoshi; Takeshita, Morishige; Tamura, Kazuo			Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Adult T-cell lymphoma/leukemia; CCR4; Mogamulizumab; Colitis; Immune-related adverse event	T-CELL LEUKEMIA/LYMPHOMA; MULTICENTER PHASE-II; RECEPTOR 4 ANTIBODY; LEUKEMIA-LYMPHOMA; MELANOMA; KW-0761; VIRUS; EXPRESSION; PATIENT	A 57-year-old male with acute-type adult T cell leukemia-lymphoma (ATL) developed persistent watery, non-bloody diarrhea at a volume of 2-3 L/day following the administration of the anti-CC chemokine receptor 4 (CCR4) monoclonal antibody, mogamulizumab. An extensive examination revealed the absence of any pathogenic bacteria or parasites in his stool. Biopsied specimens from the colonic mucosa contained many small nests of apoptotic bodies in the colonic glands, which mimicked acute-colonic graft-versus-host disease. Activation of the auto-reactive immune system due to the depletion of regulatory T-cells by mogamulizumab was suspected as causative. Special attention should be paid to the risk of unique immune-related adverse events induced by mogamulizumab.	[Ishitsuka, Kenji; Murahashi, Mutsunori; Katsuya, Hiroo; Mogi, Ai; Masaki, Michio; Kawai, Chisato; Goto, Toshitaka; Ishizu, Masanao; Ikari, Yosuke; Takamatsu, Yasushi; Tamura, Kazuo] Fukuoka Univ, Dept Internal Med, Div Oncol Hematol & Infect Dis, Fukuoka 8140180, Japan; [Ishibashi, Hideki] Fukuoka Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Fukuoka 8140180, Japan; [Nimura, Satoshi; Takeshita, Morishige] Fukuoka Univ, Dept Pathol, Fukuoka 8140180, Japan	Ishitsuka, K (reprint author), Fukuoka Univ, Dept Internal Med, Div Oncol Hematol & Infect Dis, 7-45-1 Nanakuma Jonan, Fukuoka 8140180, Japan.	kenjiishitsuka@fukuoka-u.ac.jp					de Serre NPM, 2009, MODERN PATHOL, V22, P95, DOI 10.1038/modpathol.2008.161; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Ogura M, 2014, J CLIN ONCOL, V32, P1157, DOI 10.1200/JCO.2013.52.0924; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Manousakis G, 2013, MUSCLE NERVE, V48, P440, DOI 10.1002/mus.23830; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Ishida T, 2004, CLIN CANCER RES, V10, P5494, DOI 10.1158/1078-0432.CCR-04-0371; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Bompaire F, 2012, INVEST NEW DRUG, V30, P2407, DOI 10.1007/s10637-011-9787-1; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Kato K, 2013, INT J HEMATOL, V97, P430, DOI 10.1007/s12185-013-1278-z; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Wilgenhof S, 2011, ANN ONCOL, V22, P991, DOI 10.1093/annonc/mdr028; Ishida T, 2013, CANCER SCI, V104, P647, DOI 10.1111/cas.12116; Ishitsuka K, 2014, LANCET ONCOL, V15, pE517, DOI 10.1016/S1470-2045(14)70202-5; Nakano N, 2014, HEPATOL RES, V44, P354, DOI 10.1111/hepr.12117; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					493	497		10.1007/s12185-015-1811-3		5	Hematology	Hematology	CT2YU	WOS:000362673700016		
J	Furukawa, M; Ikeda, K; Ohkawara, H; Saito, S; Takahashi, H; Udea, K; Matsumoto, H; Hashimoto, Y; Ohto, H; Ogawa, K; Takeishi, Y				Furukawa, Miki; Ikeda, Kazuhiko; Ohkawara, Hiroshi; Saito, Shunichi; Takahashi, Hiroshi; Udea, Koki; Matsumoto, Hayato; Hashimoto, Yuko; Ohto, Hitoshi; Ogawa, Kazuei; Takeishi, Yasuchika			Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Peripheral T-cell lymphoma not otherwise specified; Autologous stem cell transplantation; CCR4; Mogamulizumab; Purging	EPSTEIN-BARR-VIRUS; HODGKINS; INFECTION; ANTIBODY; DISEASE; KW-0761	Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), frequently shows a poor outcome. Especially, expressions of CC chemokine receptor 4 (CCR4) and gamma delta T-cell receptor (TCR) are associated with worse prognosis in PTCL-NOS. We here report successful treatment with autologous peripheral blood stem cell transplantation (auto-PBSCT) combined with anti-CCR4 antibody mogamulizumab for a very rare case of CCR4+gamma delta TCR+ PTCL-NOS that coexisted with Hodgkin's lymphoma. PTCL-NOS in this patient progressed to leukemic phase, whereas Hodgkin's lymphoma disappeared with standard chemotherapies within 4 years of the initial diagnosis. Leukemic-phase PTCL-NOS was refractory to several chemotherapies. However, auto-PBSCT following high-dose chemotherapy combined with pre- and post-transplant mogamulizumab, which is a humanized monoclonal antibody to CCR4, provided persistent complete remission of PTCL-NOS, despite residual gamma delta TCR+ in the transplanted stem cell product, suggesting a purging effect of mogamulizumab. At 15 months after transplantation, we also found markedly fewer effector regulatory T cells, which may have contributed to prolonged remission. This case suggests that autologous stem cell transplantation combined with mogamulizumab may have a potential to cure T-cell neoplasms that express CCR4 including leukemic-phase PTCL-NOS.	[Furukawa, Miki; Ikeda, Kazuhiko; Ohkawara, Hiroshi; Takahashi, Hiroshi; Udea, Koki; Matsumoto, Hayato; Ogawa, Kazuei; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Fukushima 9601295, Japan; [Ikeda, Kazuhiko; Saito, Shunichi; Ohto, Hitoshi] Fukushima Med Univ, Dept Transfus & Transplantat Immunol, Fukushima, Japan; [Hashimoto, Yuko] Fukushima Med Univ, Dept Pathol & Diagnost Pathol, Fukushima, Japan	Ikeda, K (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikariga Oka, Fukushima, Fukushima 9601295, Japan.	kazu-ike@fmu.ac.jp					Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Niedobitek G, 2000, J PATHOL, V191, P394; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Ogura M, 2014, J CLIN ONCOL, V32, P1157, DOI 10.1200/JCO.2013.52.0924; Ngoma AM, 2012, INT J HEMATOL, V95, P86, DOI 10.1007/s12185-011-0976-7; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Sanchez S, 2006, ARCH PATHOL LAB MED, V130, P107; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Saito T, 2002, ANN ONCOL, V13, P1792, DOI 10.1093/annonc/mdf293; Ishida T, 2004, CLIN CANCER RES, V10, P5494, DOI 10.1158/1078-0432.CCR-04-0371; Numata A, 2010, BONE MARROW TRANSPL, V45, P311, DOI 10.1038/bmt.2009.165; Pajor L, 2006, HISTOPATHOLOGY, V49, P553, DOI 10.1111/j.1365-2559.2006.02490.x; Chan WC, 1997, BLOOD, V89, P3909; d'Amore F, 2012, J CLIN ONCOL, V30, P3093, DOI 10.1200/JCO.2011.40.2719; Ito A, 2009, J IMMUNOL, V183, P4782, DOI 10.4049/jimmunol.0900699; Ikeda K, 2014, TRANSFUSION, V54, P1235, DOI 10.1111/trf.12437; Gui L, 2014, INT J HEMATOL, V99, P69, DOI 10.1007/s12185-013-1465-y; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Arcaini L, 2015, AM J HEMATOL, V90, P230, DOI 10.1002/ajh.23919; Belhadj K, 2003, BLOOD, V102, P4261, DOI 10.1182/blood-2003-05-1675; Ishida T, 2015, BR J HAEMATOL; Ito Y, 2013, BONE MARROW TRANSPL, V48, P998, DOI 10.1038/bmt.2012.268; Skarbnik Alan P, 2013, Front Oncol, V3, P138, DOI 10.3389/fonc.2013.00138	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					498	505		10.1007/s12185-015-1805-1		8	Hematology	Hematology	CT2YU	WOS:000362673700017		
J	Hashimoto, H; Kitano, S; Ueda, R; Ito, A; Tada, K; Fuji, S; Kim, SW; Yamashita, T; Tomura, D; Nukaya, I; Mineno, J; Fukuda, T; Mori, S; Takaue, Y; Heike, Y				Hashimoto, Hisayoshi; Kitano, Shigehisa; Ueda, Ryosuke; Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Kim, Sung-Won; Yamashita, Takuya; Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi; Fukuda, Takahiro; Mori, Shinichiro; Takaue, Yoichi; Heike, Yuji			Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation (vol 102, pg 101, 2015)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Correction									[Hashimoto, Hisayoshi; Ueda, Ryosuke] Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Kitano, Shigehisa] Natl Canc Ctr, Div Expt Therapeut, Chuo Ku, Tokyo 1040045, Japan; [Kitano, Shigehisa; Tada, Kohei] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Chuo Ku, Tokyo 1040045, Japan; [Ito, Ayumu; Tada, Kohei; Fuji, Shigeo; Kim, Sung-Won; Yamashita, Takuya; Fukuda, Takahiro] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Chuo Ku, Tokyo 1040045, Japan; [Tomura, Daisuke; Nukaya, Ikuei; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Otsu, Shiga 5202193, Japan; [Mori, Shinichiro] St Lukes Int Hosp, Div Hematol & Oncol, Chou Ku, Tokyo 1048560, Japan; [Takaue, Yoichi] St Lukes Int Hosp, Res Planning & Management Dept, Chou Ku, Tokyo 1048560, Japan; [Heike, Yuji] St Lukes Int Univ & Hosp, Immunotherapy & Cell Therapy Serv, Chou Ku, Tokyo 1048560, Japan	Heike, Y (reprint author), St Lukes Int Univ & Hosp, Immunotherapy & Cell Therapy Serv, Chou Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	heiyuji@luke.ac.jp					Hashimoto H, 2015, INT J HEMATOL, V102, P101, DOI 10.1007/s12185-015-1801-5	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					506	506		10.1007/s12185-015-1866-1		1	Hematology	Hematology	CT2YU	WOS:000362673700018		
J	Nomoto, H; Takami, A; Espinoza, JL; Matsuo, K; Mizuno, S; Onizuka, M; Kashiwase, K; Morishima, Y; Fukuda, T; Kodera, Y; Doki, N; Miyamura, K; Mori, T; Nakao, S; Ohtake, S; Morishita, E				Nomoto, Haruka; Takami, Akiyoshi; Espinoza, J. Luis; Matsuo, Keitaro; Mizuno, Shohei; Onizuka, Makoto; Kashiwase, Koichi; Morishima, Yasuo; Fukuda, Takahiro; Kodera, Yoshihisa; Doki, Noriko; Miyamura, Koichi; Mori, Takehiko; Nakao, Shinji; Ohtake, Shigeki; Morishita, Eriko			A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation (vol 102, pg 460, 2015)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Correction									[Nomoto, Haruka; Ohtake, Shigeki; Morishita, Eriko] Kanazawa Univ, Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi; Mizuno, Shohei] Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, Nagakute, Aichi 4801195, Japan; [Espinoza, J. Luis; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Cellular Transplantat Biol, Kanazawa, Ishikawa, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan; [Morishima, Yasuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan; [Doki, Noriko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan	Takami, A (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Hematol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	haruka84@stu.kanazawa-u.ac.jp; takami-knz@umin.ac.jp; luis@staff.kanazawa-u.ac.jp; keitarom@med.kyushu-u.ac.jp; shohei@aichi-med-u.ac.jp; moni5@mac.com; k-kashiwase@ktks.bbc.jrc.or.jp; ymorisim@aichi-cc.jp; tafukuda@ncc.go.jp; ykodera@river.ocn.ne.jp; n-doki@cick.jp; miyamu@nagoya-1st.jrc.or.jp; tmori@a3.keio.jp; snakao8205@staff.kanazawa-u.ac.jp; sohtake@staff.kanazawa-u.ac.jp; eriko86@staff.kanazawa-u.ac.jp					Nomoto H, 2015, INT J HEMATOL, V102, P460, DOI 10.1007/s12185-015-1852-7	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	OCT	2015	102	4					507	508		10.1007/s12185-015-1867-0		2	Hematology	Hematology	CT2YU	WOS:000362673700019		
J	Herrera, F; Shi, G; Leslie, AB; Knopf, P; Ichinnorov, N; Takahashi, M; Crane, PR; Herendeen, PS				Herrera, Fabiany; Shi, Gongle; Leslie, Andrew B.; Knopf, Patrick; Ichinnorov, Niiden; Takahashi, Masamichi; Crane, Peter R.; Herendeen, Patrick S.			A New Voltzian Seed Cone from the Early Cretaceous of Mongolia and Its Implications for the Evolution of Ancient Conifers	INTERNATIONAL JOURNAL OF PLANT SCIENCES			English	Article						Aptian; Albian; conifer; Cretaceous; Cryptomeria; Krassilovia; Mongolia; Swedenborgia; systematics; voltzian	PHYLOGENETIC-RELATIONSHIPS; SP-NOV; PERMIAN PALEOBOTANY; PALEOZOIC CONIFERS; FOSSIL CONIFER; GEN. NOV; CUPRESSACEAE; ANTARCTICA; PALYNOLOGY; RECONSTRUCTION	Premise of research.Abundant fossil and molecular evidence suggests that all extant conifer families were established by the Early Cretaceous. However, the recognition and understanding of the lineages that lead to the evolution of these extant families remain incomplete. Late Paleozoic to Early Mesozoic Voltziales conifersalso known as transitional conifers, usually with multilobed ovuliferous scaleshave been hypothesized to be among the stem lineages of modern crown conifers. This article describes an exquisitely preserved voltzian seed cone from the Aptian-Albian of Mongolia that introduces new taxonomic diversity and morphological data into the complex pattern of conifer evolution.Methodology.Bulk lignite samples collected from the Tevshiin Govi locality were disaggregated in water, cleaned with hydrochloric and hydrofluoric acids, washed, and dried in air. Fossils were examined using LM, SEM, and X-ray microtomography.Pivotal results.Krassilovia mongolica gen. et sp. nov. has seed cones with helically arranged, imbricated, and tightly interlocked bract-scale complexes. Each mature bract-scale complex consists of an inconspicuous bract partially fused to the stalk of a five-lobed scale. Three of the lobes are distal (always pointing away from the cone base), while the other two are proximal (always pointing toward the cone base). Up to five inverted winged seeds are present on the adaxial side of the ovuliferous scales. A systematic review of Late Paleozoic to Early Cretaceous multilobed ovuliferous scalestogether with a morphological cladistic analysissupports the placement of the Mongolian material in a new genus within the voltzian clade of the Voltziales.Conclusions.Krassilovia mongolica provides evidence of the additional diversity of extinct voltzian conifers and shows that some persisted to inhabit forest-moor swamp environments in eastern Asia during the Early Cretaceous. The new fossil taxon also shows novel morphological adaptations of the bract-scale complexes and the cone (i.e., imbrication and interlocking) for the protection of the ovules/seeds that are broadly concurrent with the appearance of new insect and other animal feeding strategies.	[Herrera, Fabiany; Herendeen, Patrick S.] Chicago Bot Garden, Glencoe, IL 60022 USA; [Shi, Gongle] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Shi, Gongle; Crane, Peter R.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Leslie, Andrew B.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02921 USA; [Knopf, Patrick] Bot Garten Rombergpk, D-44225 Dortmund, Germany; [Ichinnorov, Niiden] Mongolian Acad Sci, Inst Paleontol & Geol, Ulaanbaatar, Mongol Peo Rep; [Takahashi, Masamichi] Niigata Univ, Fac Sci, Dept Environm Sci, Nishi Ku, Niigata 9502181, Japan	Herrera, F (reprint author), Chicago Bot Garden, 1000 Lake Cook Rd, Glencoe, IL 60022 USA.	fherrera@chicagobotanic.org			National Science Foundation [DEB-1348456]; Japan Society for the Promotion of Science [21405010, 24405015]	Funding for this work was provided by National Science Foundation grant DEB-1348456 to P. S. Herendeen and P. R. Crane and Grants-in-Aid for Scientific Research (21405010 and 24405015) from the Japan Society for the Promotion of Science to M. Takahashi. We thank T. Gombosuren and O. Nyamsambuu for assistance with fieldwork in Mongolia, I. Glasspool and S. Grant for curatorial assistance, B. Strack for assistance with scanning electron microscopy, and Z.-X. Luo and A. I. Neander for permission and aid with X-ray tomography. We thank C. Thornton, L. Nowack, A. Basey, B. Cooper, D. Bruzzese, and S. Crane for help picking fossil material. We thank S. Mcloughlin and E. Bugdaeva for providing photographic material of related fossil material and I. H. Escapa for comments on an early description of the fossil material. F. Herrera thanks B. Himschoot for constant support. We would also like to thank M. Dunn, G. Hernandez-Castillo, and an anonymous reviewer for their tremendously helpful comments and suggestions.	Anderson HM, 1978, PALAEONTOLOGIA AFRIC, V21, P57; Axsmith BJ, 1998, INT J PLANT SCI, V159, P358, DOI 10.1086/297557; Looy CV, 2014, INT J PLANT SCI, V175, P841, DOI 10.1086/676973; [Anonymous], 1996, PALAEONTOGR ABT B, V293, P1; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Rothwell GW, 2005, TAXON, V54, P733; Yao XL, 1997, AM J BOT, V84, P343, DOI 10.2307/2446008; Schulz C, 2007, ORG DIVERS EVOL, V7, P124, DOI 10.1016/j.ode.2006.03.001; Kusumi J, 2000, AM J BOT, V87, P1480, DOI 10.2307/2656874; Leslie AB, 2013, AM J BOT, V100, P2426, DOI 10.3732/ajb.1300173; Leslie AB, 2011, PALEOBIOLOGY, V37, P587, DOI 10.1666/10049.1; Leslie AB, 2011, P ROY SOC B-BIOL SCI, V278, P3003, DOI 10.1098/rspb.2010.2648; Escapa IH, 2010, INT J PLANT SCI, V171, P560, DOI 10.1086/651948; Bomfleur B, 2011, ANTARCT SCI, V23, P379, DOI 10.1017/S0954102011000241; Graham SA, 2001, GEOL SOC AM BULL, V113, P1560, DOI 10.1130/0016-7606(2001)113<1560:SRATIO>2.0.CO;2; TAKASO T, 1989, AM J BOT, V76, P692, DOI 10.2307/2444416; FLORIN R, 1954, BIOL REV, V29, P367, DOI 10.1111/j.1469-185X.1954.tb01515.x; Erdenetsogt BO, 2009, INT J COAL GEOL, V80, P87, DOI 10.1016/j.coal.2009.08.002; DELEVORYAS T, 1987, REV PALAEOBOT PALYNO, V51, P59, DOI 10.1016/0034-6667(87)90020-0; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Owens JN, 1998, TRENDS PLANT SCI, V3, P479, DOI 10.1016/S1360-1385(98)01337-5; Escapa IH, 2012, AM J BOT, V99, P1058, DOI 10.3732/ajb.1100544; Looy CV, 2007, INT J PLANT SCI, V168, P957, DOI 10.1086/518256; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Bomfleur B, 2013, INT J PLANT SCI, V174, P425, DOI 10.1086/668686; Farjon A, 2003, AM J BOT, V90, P8, DOI 10.3732/ajb.90.1.8; Stevenson RA, 2015, PALEOBIOLOGY, V41, P205, DOI 10.1017/pab.2014.18; Rothwell GW, 2011, REV PALAEOBOT PALYNO, V164, P45, DOI 10.1016/j.revpalbo.2010.11.004; Rothwell GW, 2000, PALAEOGEOGR PALAEOCL, V156, P139, DOI 10.1016/S0031-0182(99)00136-4; Axsmith BJ, 1997, REV PALAEOBOT PALYNO, V96, P71, DOI 10.1016/S0034-6667(96)00050-4; Tomlinson PB, 2002, CAN J BOT, V80, P1250, DOI [10.1139/B02-112, 10.1139/b02-112]; VISSCHER H, 1986, ACTA BOT NEERL, V35, P87; Nichols DJ, 2006, CRETACEOUS RES, V27, P241, DOI 10.1016/j.cretres.2005.11.004; ARCHANGELSKY S, 1987, REV PALAEOBOT PALYNO, V51, P3, DOI 10.1016/0034-6667(87)90016-9; CLEMENTWESTERHOF JA, 1987, REV PALAEOBOT PALYNO, V52, P375, DOI 10.1016/0034-6667(87)90066-2; Clement-Westerhof JA, 1988, ORIGIN EVOLUTION GYM, P298; Farjon A., 2005, MONOGRAPH CUPRESSACE; Florin R, 1938, PALAEONTOGR ABT B, V85, P1; Florin R, 1951, ACTA HORTI BERGIANI, V15, P285; Gradstein F. M., 2012, GEOLOGIC TIME SCALE; Grauvogel-Stamm L, 1978, MEMOIRS SCI GEOLOGIQ; Harris TM, 1935, MEDD GRONL, V112, P3; Hernandez-Castillo GR, 2005, THESIS U ALBERTA EDM; Ichinnorov N, 2003, MONGOLIAN GEOSCIENTI, V22, P12; Ichinnorov N, 2012, 11 S MES TERR EC AUG; Kon'no E, 1961, SCI REP TOHOKU U, V32, P195; Kon'no E, 1944, JAP J GEOL GEOGR, V19, P1; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Krausel R, 1959, SENCKENBERG LETH, V40, P97; Mao K, 2012, P NATL ACAD SCI USA, V109, P77930; Mapes G., 1991, NEUES JB GEOL PAL, V183, P269; Meyen SV, 1997, REV PALAEOBOT PALYNO, V96, P351, DOI 10.1016/S0034-6667(96)00046-2; Miller CN, 1977, BOT REV, V43, P218; Nathorst AG, 1876, KUNGLIGA SVENSKA VET, V14, P1; OISHI SABURO, 1935, PROC IMP ACAD [TOKYO], V11, P438; RETALLACK GJ, 1981, J ROY SOC NEW ZEAL, V11, P167; Roselt G, 1958, WISS Z F SCHILLER U, V5, P75; Schweitzer Hans-Joachim, 1996, Palaeontographica Abteilung B Palaeophytologie, V238, P77; Schweitzer HJ, 1963, PALAEONTOGR ABT B, V113, P1; Shi GL, 2014, INT J PLANT SCI, V175, P911, DOI 10.1086/677651; Stanislavskii FA, 1971, FOSSIL FLORA STRATIG; Stanislavskii FA, 1976, MIDDLE KEUPER FLORA; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Terada K, 2013, MEM FUKUI PREFECT DI, V12, P79; TOWNROW JOHN A., 1967, PAP ROY SOC TASMANIA, V101, P173; Weber R, 1968, ERLANGER GEOL ABH, V72, P1; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2; Zhang W, 1983, B SHENYANG I GEOLOGY, V8, P62	70	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	1058-5893	1537-5315		INT J PLANT SCI	Int. J. Plant Sci.	OCT	2015	176	8					791	809		10.1086/683060		19	Plant Sciences	Plant Sciences	CS8WK	WOS:000362370300007		
J	Simangunsong, GM; Wahyudi, S				Simangunsong, Ganda Marihot; Wahyudi, Sugeng			Effect of bedding plane on prediction blast-induced ground vibration in open pit coal mines	INTERNATIONAL JOURNAL OF ROCK MECHANICS AND MINING SCIENCES			English	Article						Open pit coal mine; Blasting operation; Ground vibration; Peak particle velocity; Incident angle; Number of coal layer	ROCK MASS; ATTENUATION; DAMAGE		[Simangunsong, Ganda Marihot] Inst Teknol Bandung, Dept Min Engn, Bandung 40132, Indonesia; [Wahyudi, Sugeng] Kyushu Univ, Dept Earth Resources Engn, Nishi Ku, Fukuoka 8190395, Japan	Simangunsong, GM (reprint author), Inst Teknol Bandung, Dept Min Engn, JI Ganesa 10, Bandung 40132, Indonesia.	ganda@mining.itb.ac.id					Ambraseys NR, 1968, ROCK MECH ENG PRACTI, P203; Amnieh HB, 2009, SAFETY SCI, V48, P319; Khandelwal M, 2009, INT J ROCK MECH MIN, V46, P1214, DOI 10.1016/j.ijrmms.2009.03.004; Simangunsong GM, 2004, MATER SCI FORUM, V465-466, P175; Yan WM, 2013, INT J ROCK MECH MIN, V59, P160, DOI 10.1016/j.ijrmms.2012.12.005; Wahyudi S, 2011, INT J MIN RECLAM ENV, V25, P69, DOI 10.1080/17480930.2010.509482; Hao H, 2002, ROCK MECH ROCK ENG, V35, P95, DOI 10.1007/s006030200013; Cunningham CVB, 2000, EXPLOSIVES & BLASTING TECHNIQUE, P123; Duvall WT, 1963, VIBRATIONS INSTANTAN, V6151; Hart RD, 1993, COMPREHENSIVE ROCK E, V2, P245; Indian Standard Institute, 1973, ISI B; Langefors U, 1963, MODERN TECHNIQUE ROC; Nicholls HR, 1971, BULLETIN, V656	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1365-1609	1873-4545		INT J ROCK MECH MIN	Int. J. Rock Mech. Min. Sci.	OCT	2015	79						1	8		10.1016/j.ijrmms.2015.08.004		8	Engineering, Geological; Mining & Mineral Processing	Engineering; Mining & Mineral Processing	CT2BG	WOS:000362606400001		
J	Ye, GL; Nishimura, T; Zhang, F				Ye, Guan-lin; Nishimura, Tomohiro; Zhang, Feng			Experimental study on shear and creep behaviour of green tuff at high temperatures	INTERNATIONAL JOURNAL OF ROCK MECHANICS AND MINING SCIENCES			English	Article						Triaxial test; Shear strength; Creep; High temperature; Soft rock	SOFT SEDIMENTARY-ROCK; SUBCRITICAL CRACK-GROWTH; VISCOPLASTIC MODEL; DEFORMATION; FAILURE; STRESS; CLAY	The long-term stability of soft rock under high temperature conditions is very important to the safety of high-level radioactive waste (HLW) disposal. This study presents a series of triaxial compression tests and triaxial creep tests on green tuff in a temperature range of 20-80 degrees C. Repeated tests showed that the influence of temperature was more apparent on the peak strength and creep failure time than on the residual strength and volume change. The thermal effect on creep failure time was significant and became more prominent in higher creep stress. A linear correlation between the creep failure time and the minimum axial steady-strain rate at different temperatures was obtained. A thermal reversion behaviour, in which the peak shear strength and the creep rupture time of soft rocks are not monotonic functions of temperature, was observed. X-ray diffraction analysis showed that neither zeolite reduction nor hydrothermal alteration was the reason for thermal reversion. (C) 2015 Elsevier Ltd. All rights reserved.	[Ye, Guan-lin] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200030, Peoples R China; [Ye, Guan-lin] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, Shanghai 200030, Peoples R China; [Nishimura, Tomohiro; Zhang, Feng] Nagoya Inst Technol, Dept Civil Engn, Nagoya, Aichi, Japan	Ye, GL (reprint author), Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200030, Peoples R China.	ygl@sjtu.edu.cn			National Nature Science Foundation of China [41002097, 41372284]; National Basic Research Program of China (973 Program) [2011CB013800]	Prof. David Muir Wood of University of Dundee is greatly appreciated for the invaluable discussion. The financial supports of National Nature Science Foundation of China (Grant nos. 41002097 and 41372284) and National Basic Research Program of China (973 Program: 2011CB013800) are greatly acknowledged.	Adachi T, 1980, P JSCE, V295, P51; Ye GL, 2007, GEOTECH TEST J, V30, P442; Zhang F, 2005, SOILS FOUND, V45, P65; Brantut N, 2014, J GEOPHYS RES-SOL EA, V119, P1818, DOI 10.1002/2013JB010448; Zhao YS, 2012, INT J ROCK MECH MIN, V52, P132, DOI 10.1016/j.ijrmms.2012.02.011; Hueckel T, 2009, GEOTECHNIQUE, V59, P197, DOI 10.1680/geot.2009.59.3.197; READ MD, 1995, TECTONOPHYSICS, V245, P223, DOI 10.1016/0040-1951(94)00236-3; Mollo S, 2011, GEOPHYS J INT, V186, P1073, DOI 10.1111/j.1365-246X.2011.05097.x; Shibata K, 2007, SOILS FOUND, V47, P1, DOI 10.3208/sandf.47.1; Fujii Y, 1999, INT J ROCK MECH MIN, V36, P323, DOI 10.1016/S0148-9062(99)00024-8; Cekerevac C, 2004, INT J NUMER ANAL MET, V28, P209, DOI 10.1002/nag.332; Cui YJ, 2009, GEOTECHNIQUE, V59, P319, DOI 10.1680/geot.2009.59.4.319; Lightfoot P, 2001, J MATER CHEM, V11, P212, DOI 10.1039/b002950p; Zhang F, 2003, SOILS FOUND, V43, P107; Liao HJ, 2004, INT J ROCK MECH MIN, V41, P423, DOI 10.1016/j.ijrmms.2003.12.020; Ye GL, 2007, SOILS FOUND, V47, P897, DOI 10.3208/sandf.47.897; Heap MJ, 2012, GEOLOGY, V40, P311, DOI 10.1130/G32940.1; HEUZE FE, 1983, INT J ROCK MECH MIN, V20, P3, DOI 10.1016/0148-9062(83)91609-1; MEREDITH PG, 1985, PHYS EARTH PLANET IN, V39, P33, DOI 10.1016/0031-9201(85)90113-X; Nasseri MHB, 2013, INT J ROCK MECH MIN, V61, P212, DOI 10.1016/j.ijrmms.2013.03.004; Ye GL, 2005, SOILS FOUND, V45, P1; Zhang S, 2009, SOILS FOUND, V49, P583, DOI 10.3208/sandf.49.583; ATKINSON BK, 1984, J GEOPHYS RES, V89, P4077, DOI 10.1029/JB089iB06p04077; Campanella R. G., 1968, J SOIL MECH F DIV AM, V94, P709; Heap IVIJ, 2011, EARTH PLANET SC LETT, V307, p71e82; Heap MJ, 2013, SOLID EARTH, V5, P25; Heap MJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039373; Kuntiwattanakul P., 1995, SOILS FOUND, V35, P147; Okada T., 2006, MECH PROPERTIES SE 2; Okada T., 2005, MECH PROPERTIES SE 1; Saito M., 1969, P 7 INT C SOIL MECH, P677; U.S. Department of Energy Office of civilian radioactive waste management, 2002, YUCC MOUNT SCI ENG R; Yagi M., 1993, ISL ARC, V2, P240, DOI 10.1111/j.1440-1738.1993.tb00091.x; Yang C, 1997, INT J ROCK MECH MIN, V34; Zhang S, 2012, INT J PLASTICITY, V34, P93, DOI 10.1016/j.ijplas.2012.01.011	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1365-1609	1873-4545		INT J ROCK MECH MIN	Int. J. Rock Mech. Min. Sci.	OCT	2015	79						19	28		10.1016/j.ijrmms.2015.08.005		10	Engineering, Geological; Mining & Mineral Processing	Engineering; Mining & Mineral Processing	CT2BG	WOS:000362606400003		
J	Moriya, H; Naoi, M; Nakatani, M; van Aswegen, G; Murakami, O; Kgarume, T; Ward, AK; Durrheim, RJ; Philipp, J; Yabe, Y; Kawakata, H; Ogasawara, H				Moriya, Hirokazu; Naoi, Makoto; Nakatani, Masao; van Aswegen, Gerrie; Murakami, Osamu; Kgarume, Thabang; Ward, Anthony K.; Durrheim, Raymond J.; Philipp, Joachim; Yabe, Yasuo; Kawakata, Hironori; Ogasawara, Hiroshi			Delineation of large localized damage structures forming ahead of an active mining front by using advanced acoustic emission mapping techniques	INTERNATIONAL JOURNAL OF ROCK MECHANICS AND MINING SCIENCES			English	Article						Acoustic emission; Gold mine; Mining-induced fracture; Joint hypocenter determination; Double-difference hypocenter relocation	SOUTH-AFRICA; GOLD MINE; INDUCED SEISMICITY; SALT MINE; EARTHQUAKE; STRESS; FAULTS; AFTERSHOCKS; FRACTURE	We applied advanced mapping techniques to 291 230 acoustic emission (AE) events as small as around M 4 that were recorded over 50 days by an ultra-high resolution network close to the active front of a tabular mining stope being advanced northward at 1 km depth in the Cooke 4 Gold Mine in South Africa. We first applied joint hypocenter determination (JHD) to improve absolute locations, and then applied the double-difference relative location algorithm to the JHD output. These steps resolved the seemingly continuous, dense cloud of AEs that extend about 20 m ahead of the stope front into several discrete, steeply dipping tabular clusters a few meters thick and 10-30 m in dip extent, separated by quiet intervals a few meters thick. The clusters have a strike parallel to the stope face and a dip of about 65, resembling commonly observed large shear fractures along the plane of maximum shear (Ortlepp shears). In general, the activity of the clusters changed in similar ways as the stope face advanced, but each cluster remained stationary and the gaps between clusters were impressively quiet. This study demonstrates that high-resolution AE mapping can delineate the formation of large structures of localized damage in the highly stressed intact rock mass ahead of the stope face, a process that may culminate in hazardous seismic events. (C) 2015 Elsevier Ltd. All rights reserved.	[Moriya, Hirokazu] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Naoi, Makoto; Nakatani, Masao] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [van Aswegen, Gerrie] Inst Mine Seismol, Stellenbosch, South Africa; [Murakami, Osamu] Ritsumeikan Univ, Res Org Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Kgarume, Thabang] CSIR, ZA-0001 Pretoria, South Africa; [Ward, Anthony K.] SeismoGen Cc, ZA-2500 Carletonville, South Africa; [Durrheim, Raymond J.] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Philipp, Joachim] Gesell Mat Prufung & Geophys, D-61231 Bad Nauheim, Germany; [Yabe, Yasuo] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kawakata, Hironori; Ogasawara, Hiroshi] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan	Moriya, H (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-04 Aobayama, Sendai, Miyagi 9808579, Japan.	hirokazu@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21246134, 26249137, 21224012]; JST-JICA, SATREPS; MEXT; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This Japanese-South African collaborative research was carried out with the assistance of many gold mines and companies that provided mine seismology technology and services. In particular, we thank Gilbert Morema, Sylvester Morema, Thabang Masakale, Sifiso Khambule, Mike Ward, and Luiz Ribeiro for their daily efforts to maintain and collect the data. A part of this work was supported by Grants-in-Aid for Scientific Research (A) (21246134 and 26249137) and (S) (21224012) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Grant-in-Aid for International Collaborative Research), and by the JST-JICA, SATREPS. This study was also supported by MEXT under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions. RJD acknowledges support from the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation.	Adams GR, 1981, P 22 US S ROCK MECH, P227; RECHES Z, 1994, J GEOPHYS RES-SOL EA, V99, P18159, DOI 10.1029/94JB00115; DOUGLAS A, 1967, NATURE, V215, P47, DOI 10.1038/215047a0; Moriya H, 2006, INT J ROCK MECH MIN, V43, P49, DOI 10.1016/j.ijrmms.2005.04.003; TALEBI S, 1992, INT J ROCK MECH MIN, V29, P25, DOI 10.1016/0148-9062(92)91042-4; YOUNG RP, 1992, PURE APPL GEOPHYS, V139, P697, DOI 10.1007/BF00879959; Kwiatek G, 2010, B SEISMOL SOC AM, V100, P1165, DOI 10.1785/0120090277; Naoi M, 2011, B SEISMOL SOC AM, V101, P2399, DOI 10.1785/0120100346; Young RP, 2000, GEOPHYS RES LETT, V27, P1767, DOI 10.1029/2000GL011547; GAY NC, 1979, GEOL SOC AM BULL, V90, P47, DOI 10.1130/0016-7606(1979)90<47:AOAMFZ>2.0.CO;2; Ogasawara H, 2005, RASIM6: CONTROLLING SEISMIC RISK, P385; Sellers EJ, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000670; Ortlepp WD, 2000, INT J ROCK MECH MIN, V37, P423, DOI 10.1016/S1365-1609(99)00117-3; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Naoi M, 2015, J GEOPHYS RES-SOL EA, V120, P1692, DOI 10.1002/2014JB011165; Yabe Y, 2009, EARTH PLANETS SPACE, V61, pE49; van Aswegen G, 2012, J S AFR I MIN METALL, V112, P729; Becker D, 2010, GEOPHYS J INT, V182, P933, DOI 10.1111/j.1365-246X.2010.04642.x; Naoi M, 2015, TECTONOPHYSICS, V649, P100, DOI 10.1016/j.tecto.2015.02.025; Naoi M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026507; Hayashi K, 1988, PROGR ACOUSTIC EMISS, V4, P265; Horiuchi S, 2011, P IUGG, P3430; Kawakata H, 2011, AGU FALL M SAN FRANC; Lay T, 1995, MODERN GLOBAL SEISMO, P247; NAKATANI M., 2008, SEISMOL RES LETT, V79, P311; Naoi M, 2014, PURE APPL GEOPHYS, V171, P2665, DOI 10.1007/s00024-013-0721-7; Ryder JA, 2002, TXB ROCK MECH TABULA; van Aswegen G., 2013, P 6 INT S ROCK BURST, P1; Wang HL, 2005, INT J ROCK MECH MIN, V43, P1460	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1365-1609	1873-4545		INT J ROCK MECH MIN	Int. J. Rock Mech. Min. Sci.	OCT	2015	79						157	165		10.1016/j.ijrmms.2015.08.018		9	Engineering, Geological; Mining & Mineral Processing	Engineering; Mining & Mineral Processing	CT2BG	WOS:000362606400015		
J	Harrison, CB; Kinugasa, T; Gill, N; Kilding, AE				Harrison, C. B.; Kinugasa, T.; Gill, N.; Kilding, A. E.			Aerobic Fitness for Young Athletes: Combining Game-based and High-intensity Interval Training	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						small-sided games; youth; team sport	SMALL-SIDED GAME; ACUTE PHYSIOLOGICAL-RESPONSES; YOUTH SOCCER PLAYERS; PERCEIVED EXERTION; PHYSICAL-FITNESS; HANDBALL PLAYERS; PERFORMANCE; SPORT; ENDURANCE; EXERCISE	This study compared the effect of game-based training (GT) vs. a mix of game-based training and high-intensity interval training (MT) on physical performance characteristics. 26 young athletes (13.9 +/- 0.3 years) were assigned to either GT (n=13) or MT (n=13) for 6 weeks. Game-based training consisted of 2x8-11min 3 vs. 3 bucketball' SSGs separated by 3min of passive rest twice per week, while MT consisted of one SSGs session and one high-intensity session of 15s runs at 90-95% of the speed reached at the end of the 30-15 intermittent fitness test (V-IFT) interspersed with 15s passive recovery. Peak oxygen uptake (V O-2peak), V-IFT, jump height, and speed were assessed pre- and post-training. Following training, V O-2peak (5.5 +/- 3.3%; ES=large) improved after MT, whereas V-IFT improved after MT (6.6 +/- 3.2%; ES, large) and GT (4.2 +/- 5.5%, ES=small). 5-m sprint improved after GT (ES=small), while 20m sprint and jump height were unchanged. In conclusion, while MT and GT were both effective at increasing performance parameters, greater effects were seen following MT. Therefore, MT should be considered as the preferred training method for improving aerobic power in young athletes.	[Harrison, C. B.; Kilding, A. E.] AUT Univ, Sports Performance Res Inst New Zealand, Auckland 0632, New Zealand; [Kinugasa, T.; Gill, N.] Japan Sports Council, Athlete Pathway Dev Project, Tokyo, Japan	Harrison, CB (reprint author), AUT Univ, Sports Performance Res Inst New Zealand, AUT Millennium, Level 2, Auckland 0632, New Zealand.	hbcraig@gmail.com			VX Sport (New Zealand)	We would like to thanks the players from Westlake Boys High School Sports Institute for their steadfast commitment and effort. We would also like to thank J. Tout from VX Sport (New Zealand) for sponsoring the GPS monitors and software. The results of the present study do not constitute endorsement of the product by the authors or the journal.	Loftin M, 1996, J SPORT MED PHYS FIT, V36, P95; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Lovell TWJ, 2013, INT J SPORT PHYSIOL, V8, P62; Harrison CB, 2013, J STRENGTH COND RES, V27, P2861, DOI 10.1519/JSC.0b013e318280c98d; Armstrong N, 1999, J APPL PHYSIOL, V87, P2230; Owen AL, 2012, J STRENGTH COND RES, V26, P2748, DOI 10.1519/JSC.0b013e318242d2d1; Hoff J, 2002, BRIT J SPORT MED, V36, P218, DOI 10.1136/bjsm.36.3.218; Janz KF, 1997, RES Q EXERCISE SPORT, V68, P1; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Hill-Haas SV, 2009, INT J SPORTS MED, V30, P636, DOI 10.1055/s-0029-1220730; Balabinis CP, 2003, J STRENGTH COND RES, V17, P393; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013c3180304570; Dupont G, 2004, J STRENGTH COND RES, V18, P584; Vanttinen T, 2010, J SPORT SCI MED, V9, P547; Midgley AW, 2006, J SPORT MED PHYS FIT, V46, P1; Dellal A, 2012, J STRENGTH COND RES, V26, P2712, DOI 10.1519/JSC.0b013e31824294c4; Hill-Haas SV, 2009, J STRENGTH COND RES, V23, P111, DOI 10.1519/JSC.0b013e31818efc1a; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311; Hill-Haas S, 2008, J SCI MED SPORT, V11, P487, DOI 10.1016/j.jsams.2007.07.006; Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Buchheit M, 2009, INT J SPORTS MED, V30, P251, DOI 10.1055/s-0028-1105943; Bishop D, 2004, J SPORT MED PHYS FIT, V44, P1; Boyd L, 2010, J SCI MED SPORT, V13, pe14, DOI DOI 10.1016/J.JSAMS.2010.10.491; Gore C, 2000, PHYSL TESTS ELITE AT; Harrison CB, J SPORTS SC IN PRESS, V32, P336; Helgerud J, 2001, MED SCI SPORTS EXERC, V33; Hopkins WG, 2006, SPORTSCIENCE, V10, P46; Reilly T, 2004, J SPORTS SCI, V22, P559	32	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	OCT	2015	36	11					929	934		10.1055/s-0034-1396825		6	Sport Sciences	Sport Sciences	CS9HF	WOS:000362400200010		
J	Shinohara, N; Abe, T				Shinohara, Nobuo; Abe, Takashige			Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma	INTERNATIONAL JOURNAL OF UROLOGY			English	Review						metastasis; molecular targeted therapy; prognostic factor; renal cell carcinoma; risk classification model	ENDOTHELIAL GROWTH-FACTOR; FACTOR-TARGETED THERAPY; PHASE-III TRIAL; C-REACTIVE PROTEIN; TYROSINE KINASE INHIBITORS; INTERFERON-ALPHA; JAPANESE PATIENTS; CYTOREDUCTIVE NEPHRECTOMY; DATABASE CONSORTIUM; KIDNEY CANCER	The introduction of molecular-targeted therapy has made dramatical changes to treatment for metastatic renal cell carcinoma. Currently, there are four vascular endothelial growth factor receptor-tyrosine kinase inhibitors and two mammalian target of rapamycin inhibitors in Japan. For the appropriate clinical use of these molecular-targeted drugs, the identification of prognostic and/or predictive factors in patients who received these drugs is required. Although molecular biological and genetic factors that determine the prognosis of patients with metastatic renal cell carcinoma have been reported, most of these factors are problematic in that the number of patients analyzed was small. In contrast, clinicopathological prognostic factors, including the practice of cytoreductive nephrectomy, pathological findings, metastatic sites and metastasectomy, and abnormal inflammatory response, have been identified by analyzing a relatively large number of patients. Several prognostic classification models that were developed by combining these clinicopathological factors are widely used in not only clinical trials, but also routine clinical practice. However, the quality of these prognostic models is considered to be insufficient regarding prognostic prediction of metastatic renal cell carcinoma patients and, thus, requires further improvements. Recently, basic and clinical studies have been extensively carried out for the identification of promising informative markers and for understanding molecular mechanisms of resistance to molecular-targeted drugs in metastatic renal cell carcinoma patients. The present review considers ongoing translational research efforts on clinicopathological, molecular biological, and genetic prognostic and/or predictive factors for metastatic renal cell carcinoma patients in the era of molecular-targeted therapy, and discusses the clinical implications of these findings.	[Shinohara, Nobuo; Abe, Takashige] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido 0608638, Japan	Shinohara, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	nobuo-s@med.hokudai.ac.jp					Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; De P, 2013, CANCER TREAT REV, V39, P925, DOI 10.1016/j.ctrv.2013.02.006; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Kroeger N, 2013, CANCER-AM CANCER SOC, V119, P2999, DOI 10.1002/cncr.28151; Kavolius JP, 1998, J CLIN ONCOL, V16, P2261; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Funakoshi T, 2014, CANCER TREAT REV, V40, P533, DOI 10.1016/j.ctrv.2013.11.008; Shuch B, 2012, ONCOLOGIST, V17, P46, DOI 10.1634/theoncologist.2011-0227; Shinohara N, 2013, UROL ONCOL-SEMIN ORI, V31, P1276, DOI 10.1016/j.urolonc.2011.08.009; Naito S, 2010, EUR UROL, V57, P317, DOI 10.1016/j.eururo.2008.12.026; Naito S, 2013, UROLOGY, V82, P846, DOI 10.1016/j.urology.2013.06.035; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Beuselinck B, 2014, BJU INT, V114, P81, DOI 10.1111/bju.12494; Kanzaki R, 2011, EUR J CARDIO-THORAC, V39, P167, DOI 10.1016/j.ejcts.2010.05.021; Ljungberg B, 2000, SCAND J UROL NEPHROL, V34, P246; Armstrong AJ, 2012, J CLIN ONCOL, V30, P3402, DOI 10.1200/JCO.2011.40.9631; Beuselinck B, 2011, ANN ONCOL, V22, P794, DOI 10.1093/annonc/mdq554; Thibault C, 2013, CRIT REV ONCOL HEMAT, V88, P123, DOI 10.1016/j.critrevonc.2013.03.003; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Choueiri TK, 2007, CANCER, V110, P543, DOI 10.1002/cncr.22827; Lin PP, 2007, J BONE JOINT SURG AM, V89A, P1794, DOI 10.2106/JBJS.F.00603; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Tran HT, 2012, LANCET ONCOL, V13, P827, DOI 10.1016/S1470-2045(12)70241-3; Assouad J, 2008, EUR J CARDIO-THORAC, V33, P794, DOI 10.1016/j.ejcts.2008.01.045; Linehan WM, 2003, J UROLOGY, V170, P2163, DOI 10.1097/01.ju.0000096060.92397.ed; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Wahlgren T, 2013, BRIT J CANCER, V108, P1541, DOI 10.1038/bjc.2013.119; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Zerbi A, 2008, ANN SURG ONCOL, V15, P1161, DOI 10.1245/s10434-007-9782-0; Procopio G, 2012, BRIT J CANCER, V107, P1227, DOI 10.1038/bjc.2012.327; Flanigan RC, 2004, J UROLOGY, V171, P1071, DOI 10.1097/01.ju.0000110610.61545.ae; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Santoni M, 2014, CANCER METAST REV, V33, P321, DOI 10.1007/s10555-013-9453-5; Pantuck AJ, 2007, CANCER, V109, P2257, DOI 10.1002/cncr.22677; Park JY, 2014, HUM PATHOL, V45, P1437, DOI 10.1016/j.humpath.2014.02.019; Manola J, 2011, CLIN CANCER RES, V17, P5443, DOI 10.1158/1078-0432.CCR-11-0553; Terakawa T, 2013, UROL ONCOL-SEMIN ORI, V31, P493, DOI 10.1016/j.urolonc.2011.02.012; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Keizman D, 2012, EUR J CANCER, V48, P202, DOI 10.1016/j.ejca.2011.09.001; Santoni M, 2013, BRIT J CANCER, V109, P1755, DOI 10.1038/bjc.2013.522; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Hatzaras I, 2012, HPB, V14, P532, DOI 10.1111/j.1477-2574.2012.00495.x; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530; Figlin RA, 2009, CANCER-AM CANCER SOC, V115, P3651, DOI 10.1002/cncr.24438; Ljungberg B, 2013, CURR UROL REP, V14, P19, DOI 10.1007/s11934-012-0293-6; Hida K, 2013, CANCER SCI, V104, P1391, DOI 10.1111/cas.12251; Shinohara N, 2012, CANCER SCI, V103, P1695, DOI 10.1111/j.1349-7006.2012.02351.x; Vogl U, 2006, BRIT J CANCER, V95, P691, DOI 10.1038/sj.bjc.6603327; Tomita Y, 2010, JPN J CLIN ONCOL, V40, P1166, DOI 10.1093/jjco/hyq146; Motzer RJ, 2011, J NATL COMPR CANC NE, V9, P960; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Zurita AJ, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mdr047; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Molina AM, 2011, AM J CLIN ONCOL-CANC, V34, P454, DOI 10.1097/COC.0b013e3181f47aa4; Choueiri TK, 2011, J UROLOGY, V185, P60, DOI 10.1016/j.juro.2010.09.012; Heng DYC, 2014, EUR UROL, V66, P704, DOI 10.1016/j.eururo.2014.05.034; Murthy SC, 2005, ANN THORAC SURG, V79, P996, DOI 10.1016/j.athoracsur.2004.08.034; Ito N, 2007, J CLIN ONCOL, V25, P2785, DOI 10.1200/JCO.2006.09.8897; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Tatokoro M, 2008, J UROLOGY, V180, P515, DOI 10.1016/j.juro.2008.04.025; Golshayan AR, 2009, J CLIN ONCOL, V27, P235, DOI 10.1200/JCO.2008.18.0000; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Eto M, 2013, EUR UROL, V63, P745, DOI 10.1016/j.eururo.2012.09.052; Motzer RJ, 2004, J CLIN ONCOL, V22, P454; Escudier B, 2014, BRIT J CANCER, V110, P2821, DOI 10.1038/bjc.2014.244; Tsao CK, 2013, WORLD J UROL, V31, P1535, DOI 10.1007/s00345-012-1001-3; Cho D, 2007, CLIN GENITOURIN CANC, V5, P379, DOI 10.3816/CGC.2007.n.020; Ruys AT, 2011, ANN SURG ONCOL, V18, P1932, DOI 10.1245/s10434-010-1526-x; Naito S, 2011, BJU INT, V108, P1813, DOI 10.1111/j.1464-410X.2011.10281.x; Yasuda Y, 2013, INT J CLIN ONCOL, V18, P884, DOI 10.1007/s10147-012-0454-0; Pfannschmidt J, 2002, ANN THORAC SURG, V74, P1653, DOI 10.1016/S0003-4975(02)03803-1; Assouad J, 2007, ANN THORAC SURG, V84, P1114, DOI 10.1016/j.athoracsur.2007.04.118; Conti SL, 2014, INT J CANCER, V134, P2245, DOI 10.1002/ijc.28553; Karam JA, 2011, J UROLOGY, V185, P439, DOI 10.1016/j.juro.2010.09.086; Pena C, 2010, CLIN CANCER RES, V16, P4853, DOI 10.1158/1078-0432.CCR-09-3343; Staehler MD, 2010, WORLD J UROL, V28, P543, DOI 10.1007/s00345-010-0560-4; Minardi D, 2013, ANTICANCER RES, V33, P5017; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Motzer RJ, 2008, CANCER, V113, P1552, DOI 10.1002/cncr.23776; Tomita Y, 2011, EUR J CANCER, V47, P2592, DOI 10.1016/j.ejca.2011.07.014; Tsukamoto T, 2011, JPN J CLIN ONCOL, V41, P17, DOI 10.1093/jjco/hyq166; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Porta C, 2010, KIDNEY INT, V77, P809, DOI 10.1038/ki.2009.552; Yuasa T, 2012, BJU INT, V109, P1349, DOI 10.1111/j.1464-410X.2011.10534.x; Sun Y, 2012, JPN J CLIN ONCOL, V42, P836, DOI 10.1093/jjco/hys110; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Heng DYC, 2009, CANCER-AM CANCER SOC, V115, P776, DOI 10.1002/cncr.24051; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Alt AL, 2011, CANCER-AM CANCER SOC, V117, P2873, DOI 10.1002/cncr.25836; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Tzogani K, 2015, ONCOLOGIST, V20, P196, DOI 10.1634/theoncologist.2014-0177; Dabestani S, 2014, LANCET ONCOL, V15, pE549, DOI 10.1016/S1470-2045(14)70235-9; DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32; Escudier Bernard, 2011, Drugs R D, V11, P113, DOI 10.2165/11591240-000000000-00000; Eto M, 2014, CANCER SCI, V105, P1576, DOI 10.1111/cas.12546; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hofmann HS, 2005, EUR UROL, V48, P77, DOI 10.1016/j.eururo.2005.03.004; Hofmann HS, 2005, EUR UROL, V47, P81; Kim T, 2015, CLIN GENITOURIN CANC, V13, P225, DOI 10.1016/j.clgc.2014.12.001; Ko JJ, 2015, LANCET ONCOL, V16, P293, DOI 10.1016/S1470-2045(14)71222-7; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Kroeger N, 2015, EUR UROL, V68, P506, DOI 10.1016/j.eururo.2014.11.054; Kyriakopoulos Christos E, 2015, Clin Genitourin Cancer, V13, pe79, DOI 10.1016/j.clgc.2014.08.011; Motzer RJ, 2013, BRIT J CANCER, V108, P2470, DOI 10.1038/bjc.2013.236; Santoni M, 2015, TARGET ONCOL, V10, P517, DOI 10.1007/s11523-014-0356-3; Satomi Y, 1973, Nihon Hinyokika Gakkai Zasshi, V64, P195; Shinohara N, 2015, CANCER SCI, V106, P618, DOI 10.1111/cas.12646; Tanis PJ, 2009, BRIT J SURG, V96, P579, DOI 10.1002/bjs.6606; Tosoian JJ, 2014, J GASTROINTEST SURG, V18, P542, DOI 10.1007/s11605-013-2278-2	119	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					888	897		10.1111/iju.12858		10	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800001		
J	Kitamura, H; Takahashi, A; Hotta, H; Kato, R; Kunishima, Y; Takei, F; Horita, H; Masumori, N				Kitamura, Hiroshi; Takahashi, Atsushi; Hotta, Hiroshi; Kato, Ryuichi; Kunishima, Yasuharu; Takei, Fumiyasu; Horita, Hiroki; Masumori, Naoya		Sapporo Med Univ Urologic Oncology	Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						aprepitant; chemotherapy-induced nausea and vomiting; emesis; palonosetron; urothelial cancer	HIGH-DOSE CISPLATIN; MODERATELY EMETOGENIC CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PHASE-III; NEUROKININ-1 ANTAGONIST; ANTIEMETIC EFFICACY; RECEPTOR ANTAGONIST; RANDOMIZED-TRIAL; INDUCED EMESIS	ObjectivesTo evaluate the appearance of chemotherapy-induced nausea and vomiting, and to compare the antiemetic efficacy of the triple combination of palonosetron, aprepitant and dexamethasone with that of our old regimen using first-generation 5-hydroxytryptamine 3-receptor antagonists and dexamethasone during gemcitabine and cisplatin chemotherapy in patients with advanced urothelial cancer. MethodsWe carried out a multi-institutional study including 122 patients who received gemcitabine and cisplatin for advanced urothelial cancer between February 2005 and January 2012. Uncontrolled chemotherapy-induced nausea and vomiting events were identified through records of nausea and vomiting, additional infusion, rescue medications, and/or records of food intake. ResultsFirst-generation 5-hydroxytryptamine3-receptor antagonists (ondansetron or granisetron) plus dexamethasone were used for 75 patients (cohort1), and palonosetron with dexamethasone plus aprepitant for 47 patients (cohort2). Patients in cohort2 had significantly higher complete response (defined as no emetic episodes and no rescue medication use) rates than those in cohort1 during the overall phase in the first cycle (85.7% vs 65.3%, P=0.012), and all cycles (78.7% vs 50.7%, P=0.0019) of gemcitabine and cisplatin. Patients in cohort2 were more likely to achieve more favorable chemotherapy-induced nausea and vomiting control; that is, a lower grade of nausea, vomiting or anorexia, lower incidence of rescue therapy required, and shorter time to become chemotherapy-induced nausea- and vomiting-free than patients in cohort1. ConclusionsThe present results show that palonosetron in combination with aprepitant and dexamethasone is more effective to prevent chemotherapy-induced nausea and vomiting in urothelial cancer patients treated with gemcitabine and cisplatin than first-generation 5-hydroxytryptamine3-receptor antagonists plus dexamethasone.	[Kitamura, Hiroshi; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608543, Japan; [Takahashi, Atsushi] Hakodate Goryoukaku Hosp, Dept Urol, Hakodate, Hokkaido, Japan; [Hotta, Hiroshi] Japanese Red Cross Asahikawa Hosp, Dept Urol, Asahikawa, Hokkaido, Japan; [Kato, Ryuichi] Muroran City Gen Hosp, Dept Urol, Muroran, Hokkaido, Japan; [Kunishima, Yasuharu] Obihiro Kyokai Hosp, Dept Urol, Obihiro, Hokkaido, Japan; [Takei, Fumiyasu] Sunagawa City Med Ctr, Dept Urol, Sunagawa, Hokkaido, Japan; [Horita, Hiroki] Saiseikai Otaru Hosp, Dept Urol, Otaru, Hokkaido, Japan	Kitamura, H (reprint author), Sapporo Med Univ, Sch Med, Dept Urol, Chou Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	hkitamu@sapmed.ac.jp			Ministry of Health, Labor and Welfare of Japan [1010387]	This work was supported in part by a Grant-in-Aid for Clinical Cancer Research (H22-Clinical Cancer-026, Project ID: 1010387) from the Ministry of Health, Labor and Welfare of Japan.	Rojas C, 2010, EUR J PHARMACOL, V626, P193, DOI 10.1016/j.ejphar.2009.10.002; Darmani NA, 2011, PHARMACOL BIOCHEM BE, V99, P573, DOI 10.1016/j.pbb.2011.05.025; Longo F, 2011, SUPPORT CARE CANCER, V19, P1159, DOI 10.1007/s00520-010-0930-x; Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Hamada S, 2012, SUPPORT CARE CANCER, V20, P813, DOI 10.1007/s00520-011-1155-3; Gralla RJ, 2005, CANCER, V104, P864, DOI 10.1002/cncr.21222; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Rubenstein EB, 2006, CANCER J, V12, P341, DOI 10.1097/00130404-200609000-00003; Gralla RJ, 1999, J CLIN ONCOL, V17, P2971; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Aapro MS, 2006, ANN ONCOL, V17, P1441, DOI 10.1093/annonc/mdl137; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Eisenberg P, 2003, CANCER, V98, P2473, DOI 10.1002/cncr.11817; Diemunsch P, 2000, DRUGS, V60, P533, DOI 10.2165/00003495-200060030-00002; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Stathis M, 2012, EUR J PHARMACOL, V689, P25, DOI 10.1016/j.ejphar.2012.05.037; Maemondo M, 2009, ANN ONCOL, V20, P1860, DOI 10.1093/annonc/mdp195; Navari RM, 1999, NEW ENGL J MED, V340, P190, DOI 10.1056/NEJM199901213400304; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; Eisenberg P, 2004, ANN ONCOL, V15, P330, DOI 10.1093/annonc/mdh047; Grunberg SM, 2003, EXPERT OPIN PHARMACO, V4, P2297, DOI 10.1517/14656566.4.12.2297; Gralla R, 2003, ANN ONCOL, V14, P1570, DOI 10.1093/annonc/mdg417; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					911	914		10.1111/iju.12842		4	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800004		
J	Kojima, T; Kawai, K; Tsuchiya, K; Abe, T; Shinohara, N; Tanaka, T; Masumori, N; Yamada, S; Arai, Y; Narita, S; Tsuchiya, N; Habuchi, T; Nishiyama, H				Kojima, Takahiro; Kawai, Koji; Tsuchiya, Kunihiko; Abe, Takashige; Shinohara, Nobuo; Tanaka, Toshiaki; Masumori, Naoya; Yamada, Shigeyuki; Arai, Yoichi; Narita, Shintaro; Tsuchiya, Norihiko; Habuchi, Tomonori; Nishiyama, Hiroyuki			Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						chemotherapy; germ cell tumor; neoplasm of testis; poor prognosis; prognostic subgroups	CONSENSUS CLASSIFICATION; SALVAGE CHEMOTHERAPY; INTERMEDIATE-RISK; CANCER; CISPLATIN; IFOSFAMIDE; PACLITAXEL	ObjectivesTo clarify the significance of the International Germ Cell Cancer Collaborative Group classification in the 2000s, especially in intermediate- and poor-prognosis testicular germ cell tumor in Japan. MethodsWe retrospectively analyzed 117 patients with intermediate- and poor-prognosis testicular non-seminomatous germ cell tumor treated at five university hospitals in Japan between 2000 and 2010. Data collected included age, levels of tumor markers, spread to non-pulmonary visceral metastases, treatment details and survival. ResultsThe median follow-up period of all patients was 57months. A total of 50 patients (43%) were classified as having intermediate prognosis, and 67 patients (57%) as poor prognosis according to the International Germ Cell Cancer Collaborative Group classification. As first-line chemotherapy, 92 patients (79%) received bleomycin, etoposide and cisplatin. Of all patients, 74 patients (63%) received second-line chemotherapy. The most commonly used second-line chemotherapy regimens were a combination of taxanes, ifosfamide and platinum in 49 cases (66%). Overall, 33 patients (28%) received third-line chemotherapy. A total of 88 patients (75%) underwent post-chemotherapy surgery. The 5-year overall survival for intermediate (n=50) and poor prognosis (n=67) was 89% and 83% (P=0.21), respectively. In poor prognosis patients, patients with two or more risk factors (any of high lactic dehydrogenase, alpha-fetoprotein and human chorionic gonadotropin levels, and presence of non-pulmonary visceral metastases) had significantly worse survival than those with only one risk factor (71% and 91%, respectively, P=0.01). ConclusionsThe 5-year overall survivals of poor-prognosis testicular non-seminomatous germ cell tumor patients reached 83%. Further stratification of poor-prognosis patients based on a number of risk factors has the potential to further identify those with poorer prognosis.	[Kojima, Takahiro; Kawai, Koji; Nishiyama, Hiroyuki] Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki 3058575, Japan; [Tsuchiya, Kunihiko; Abe, Takashige; Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med Sci, Dept Urol, Sapporo, Hokkaido, Japan; [Tanaka, Toshiaki; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Yamada, Shigeyuki; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan; [Narita, Shintaro; Tsuchiya, Norihiko; Habuchi, Tomonori] Akita Univ, Dept Urol, Akita 010, Japan	Nishiyama, H (reprint author), Univ Tsukuba, Dept Urol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	nishiuro@md.tsukuba.ac.jp			JSPS [24592376, 26462398]	This work was partly supported by JSPS KAKENHI grant number 24592376 and 26462398.	Miki T, 2002, CANCER, V95, P1879, DOI 10.1002/cncr.10918; Shayegan B, 2007, BJU INT, V99, P993, DOI 10.1111/j.1464-410X.2007.06740.x; Kollmannsberger C, 2000, ANN ONCOL, V11, P1115, DOI 10.1023/A:1008333229936; Yamada S, 2013, JPN J CLIN ONCOL, V43, P734, DOI 10.1093/jjco/hyt060; Pentheroudakis G, 2003, BJU INT, V92, P36, DOI 10.1046/j.1464-410X.2003.04261.x; Oechsle K, 2012, J CANCER RES CLIN, V138, P947, DOI 10.1007/s00432-012-1169-3; Miki T, 2014, INT J UROL, V21, pS1, DOI 10.1111/iju.12441; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Shintaku I, 2008, JPN J CLIN ONCOL, V38, P281, DOI 10.1093/jjco/hyn009; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Hanna N, 2014, J CLIN ONCOL, V32, P3085, DOI 10.1200/JCO.2014.56.0896; Kurobe M, 2015, J CANCER RES CLIN, V141, P127, DOI 10.1007/s00432-014-1760-x; Beyer J, 2010, J CLIN ONCOL, V28, P4906, DOI 10.1200/JCO.2009.26.8128; Mead GM, 1997, J CLIN ONCOL, V15, P594; VansDijk MR, 2006, EUR J CANCER, V42, P820; vansDijk MR, 2004, ANN ONCOL, V15, P1400; vansDijk MR, 2004, BRIT J CANCER, V90, P1176	18	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					923	927		10.1111/iju.12844		5	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800008		
J	Nakamura, T				Nakamura, Terukazu			Editorial Comment from Dr Nakamura to Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto, Japan.	teru@koto.kpu-m.ac.jp					Kollmannsberger C, 2000, ANN ONCOL, V11, P1115, DOI 10.1023/A:1008333229936; Kojima T, 2015, INT J UROL, V22, P923, DOI 10.1111/iju.12844; VansDijk MR, 2006, EUR J CANCER, V42, P820; vansDijk MR, 2004, ANN ONCOL, V15, P1400; vansDijk MR, 2004, BRIT J CANCER, V90, P1176	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					928	928		10.1111/iju.12871		1	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800009		
J	Sugiyama, K; Hyodo, Y; Aikawa, A				Sugiyama, Ken; Hyodo, Yoji; Aikawa, Atsushi			Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						ABO-incompatible kidney transplantation; anti-donor blood group antibodies; humoral rejection; rituximab; splenectomy	SINGLE-CENTER EXPERIENCE; PRECONDITIONING REGIMEN; RENAL-TRANSPLANTATION; SPLENECTOMY; ANTI-CD20; ALLOGRAFTS; INFUSIONS; JAPAN	ObjectiveTo assess changes in anti-blood type antibody titers and postoperative outcomes (graft survival and rejection rates) at our center with the use of the immunosuppressant, rituximab, in ABO-incompatible kidney transplants from living donors. Confirming anti-donor blood group antibodies is important for avoiding humoral rejection in ABO-incompatible kidney transplants. Splenectomy has been carried out in our hospital according to Alexandre's policy in order to suppress the production of anti-donor blood group antibodies. However, splenectomy has recently been avoided due to the administration of the immunosuppressant rituximab, which gives satisfactory outcomes. Thus, pre- and postoperative anti-donor blood group antibodies were measured, and the outcomes achieved with rituximab were examined. MethodsA total of 134 cases of ABO-incompatible kidney transplants were carried out at Toho University Omori Medical Center between March 1989 and February 2013. These cases were classified as follows: azathioprine group (n=62 patients); mycophenolate mofetil group (n=33 patients); rituximab group (n=39 patients). The anti-donor blood group antibodies levels (immunoglobulinG and immunoglobulinM) were measured in all groups before antibody removal, immediately before surgery, and 1, 2, 4weeks and 3months after surgery, and then compared. ResultsRates of antibody-mediated rejection, including hyperacute rejection, in the azathioprine, mycophenolate mofetil, and rituximab groups were 32.2%, 18.1% and 7.6%, respectively. Graft survival rates were higher in the mycophenolate mofetil and rituximab groups than in the azathioprine group, but were lower in patients with higher preoperative antibody titers (128-fold higher immunoglobulinG) than in those with lower titers (<128-fold higher immunoglobulinG). In addition, postoperative anti-blood type antibody titers were significantly suppressed in the rituximab group. ConclusionsAdministration of rituximab results in better antibody control than previous protocols including splenectomy, even in the postoperative period during which humoral rejection often occurs. This protocol eliminates the physical invasiveness of pre-transplant splenectomy, and is expected to provide better outcomes in chronic renal failure patients who undergo kidney transplants.	[Sugiyama, Ken] Ota Mem Hosp, Dept Urol, Gunma 3738585, Japan; [Hyodo, Yoji; Aikawa, Atsushi] Toho Univ, Dept Nephrol, Tokyo, Japan	Sugiyama, K (reprint author), Ota Mem Hosp, Dept Urol, 455-1 Ota Shi, Gunma 3738585, Japan.	k.sugiyama@ota-hosp.or.jp					Aikawa Atsushi, 2003, Exp Clin Transplant, V1, P112; Donauer J, 2006, XENOTRANSPLANTATION, V13, P108, DOI 10.1111/j.1399-3089.2006.00293.x; ALEXANDRE GPJ, 1986, TRANSPLANT P, V18, P452; Alkhunaizi AM, 1999, TRANSPLANTATION, V67, P1319, DOI 10.1097/00007890-199905270-00005; Zhou W, 2005, TRANSPLANT P, V37, P1808, DOI 10.1016/j.transproceed.2005.03.129; West LJ, 2006, TRANSPLANTATION, V81, P301, DOI 10.1097/01.tp.0000203829.78700.f3; ALEXANDRE GPJ, 1985, TRANSPLANT P, V17, P138; Tanabe K, 1998, TRANSPLANTATION, V65, P224; ALEXANDRE GPJ, 1987, TRANSPLANT P, V19, P4538; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; BREIMER ME, 1985, TRANSPLANT P, V17, P2640; Gloor JM, 2003, TRANSPLANTATION, V75, P971, DOI 10.1097/01.TP.0000058226.397.32; Koshino K, 2011, TRANSPL P, V43, P2379, DOI 10.1016/j.transproceed.2011.05.031; Sawada T, 2004, CLIN TRANSPLANT, V18, P254, DOI 10.1111/j.1399-0012.2004.00151.x; Shimmura H, 2000, TRANSPLANTATION, V70, P1331, DOI 10.1097/00007890-200011150-00011; Takahashi K, 2006, XENOTRANSPLANTATION, V13, P118, DOI 10.1111/j.1399-3089.2006.00278.x; Kwon O, 2013, TRANSPL P, V45, P1487, DOI 10.1016/j.transproceed.2013.02.046; Sawada T, 2002, TRANSPLANTATION, V74, P1207, DOI 10.1097/01.TP.0000040990.15896.76; Carlos AV, 2004, TRANSPLANTATION, V77, P542; Christopher JS, 2004, AM J TRANSPLANT, V4, P1315; Gunnar T, 2005, AM J TRANSPLANT, V5, P145; Gunnar T, 2003, TRANSPLANTATION, V76, P730; Herwig-Ulf MK, 2003, TRANSPLANTATION, V75, P1341; Philip AC, 2012, TRANSPLANTATION, V94, P152; Takahashi K, 2004, TRANSPLANT P, V36, p193S, DOI 10.1016/j.transproceed.2004.01.070	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					931	936		10.1111/iju.12845		6	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800012		
J	Yoshida, M; Flores, NM; Vietri, J; Lee, M; Murakami, M				Yoshida, Masaki; Flores, Natalia M.; Vietri, Jeffrey; Lee, Matthew; Murakami, Masahiro			Burden of benign prostatic hyperplasia among men in Japan: Patient-reported outcomes among those diagnosed and experiencing symptoms	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						employment; erectile dysfunction; nocturia; prostatic hyperplasia; quality of life	URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; NOCTURIA; HEALTH; IMPACT; COMORBIDITIES; PREVALENCE; SLEEP; FOCUS	ObjectivesTo quantify the burden of benign prostatic hyperplasia among Japanese men according to patient-reported outcomes. A secondary aim was to quantify the incremental burden of nocturia among these men. MethodsSurvey data representative of the Japanese population by age and sex were analyzed (total n=59997). All measures were self-reported, including the revised Medical Outcomes Study 12-Item Short Form Health Survey or the revised Medical Outcomes Study 36-Item Short Form Health Survey, Work Productivity and Activity Impairment questionnaire, and 6-month healthcare use. Men aged 50years were organized into three analysis groups according to diagnosis of benign prostatic hyperplasia and International Prostate Symptom Score total: diagnosed benign prostatic hyperplasia (n=1183); undiagnosed benign prostatic hyperplasia with moderate to severe symptoms (International Prostate Symptom Score total8; n=3141); and controls (no benign prostatic hyperplasia diagnosis and International Prostate Symptom Score total <8; n=9468). Subgroup analyses were carried out according to frequency of nocturia. Generalized linear models adjusted for potential confounders. ResultsRelative to controls, diagnosed and undiagnosed benign prostatic hyperplasia respondents had reduced health-related quality of life, with mean decrements of 3.1points for mental component summary scores, 2.0 for physical component summary scores and 0.05 for health utility scores (all P<0.001). Mean absenteeism, impairment at work and non-work activity impairment among the diagnosed and undiagnosed groups were 1.4-fold those of the control group (P<0.01). Both diagnosed and undiagnosed groups used significantly more healthcare than controls. The outcomes of undiagnosed men were worse than diagnosed patients on many measures. Frequent nocturia (3 voids per night) was associated with worse health-related quality of life. ConclusionsBenign prostatic hyperplasia impacts health-related quality of life, work productivity and healthcare use of Japanese men, with more impact among undiagnosed men experiencing lower urinary tract symptoms and frequent nocturia.	[Yoshida, Masaki] Natl Ctr Geriatr & Gerontol, Obu City, Japan; [Flores, Natalia M.] Kantar Hlth, Los Angeles, CA USA; [Vietri, Jeffrey] Kantar Hlth, I-20121 Milan, Italy; [Lee, Matthew; Murakami, Masahiro] Eli Lilly Japan KK, Kobe, Hyogo, Japan	Vietri, J (reprint author), Kantar Hlth, Hlth Outcomes Practice, Via Paleocapa 7, I-20121 Milan, Italy.	Jeffrey.Vietri@kantarhealth.com					Appell RA, 2008, NEUROUROL URODYNAM, V27, P34, DOI 10.1002/nau.20484; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Araki T, 2004, ACTA MED OKAYAMA, V58, P45; Takao T, 2013, UROLOGY, V82, P189, DOI 10.1016/j.urology.2013.02.024; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Fourcade RO, 2012, WORLD J UROL, V30, P419, DOI 10.1007/s00345-011-0756-2; Azam U, 2001, DRUG AGING, V18, P213, DOI 10.2165/00002512-200118030-00006; Ancoli-Israel S, 2011, SLEEP MED REV, V15, P91, DOI 10.1016/j.smrv.2010.03.002; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x; Liu GG, 2012, VALUE HEALTH, V15, pS65, DOI 10.1016/j.jval.2011.11.012; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Schulman CC, 2005, EUR UROL SUPPL, V4, P1, DOI [10.1016/j.eursup.2004.10.007, 10.1016/j.eursup.2005.04.002]; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe; Breyer BN, 2013, J UROLOGY, V190, P953, DOI 10.1016/j.juro.2013.03.126; Saigal CS, 2005, J UROLOGY, V173, P1309, DOI 10.1097/01.ju.0000152318.79184.6f; Li MK, 2005, BJU INT, V96, P1339, DOI 10.1111/j.1464-410X.2005.05831.x; Yoshimura K, 2009, INT J UROL, V16, P96, DOI 10.1111/j.1442-2042.2008.02185.x; Li MK, 2008, BJU INT, V101, P197, DOI 10.1111/j.1464-410X.2007.07320.x; Robertson C, 2007, BJU INT, V99, P347, DOI 10.1111/j.1464-410X.2007.06609.x; Kupelian V, 2012, EUR UROL, V61, P78, DOI 10.1016/j.eururo.2011.05.065; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1046/j.1464-410X.2003.04527.x; Araki I, 2008, UROL INT, V81, P60, DOI 10.1159/000137642; Boyle P, 1997, EUR UROL SUPPL, V32, P50; Cai Tommaso, 2013, Arch Ital Urol Androl, V85, P184, DOI 10.4081/aiua.2013.4.184; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; Kosinski M, 2008, USERS MANUAL SF 12V2; Maruish M. E. E., 2011, USERS MANUAL SF 36V2	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					949	955		10.1111/iju.12849		7	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800015		
J	Kamei, J; Furuta, A; Akiyama, Y; Niimi, A; Ichihara, K; Fujimura, T; Fukuhara, H; Kume, H; Homma, Y; Igawa, Y				Kamei, Jun; Furuta, Akira; Akiyama, Yoshiyuki; Niimi, Aya; Ichihara, Koji; Fujimura, Tetsuya; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio; Igawa, Yasuhiko			Video-urodynamic effects of mirabegron, a (3)-adrenoceptor agonist, in patients with low-compliance bladder	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						compliance; lower urinary tract dysfunction; mirabegron; urodynamics; vesicoureteral reflux	NEUROGENIC DETRUSOR OVERACTIVITY; BETA(3)-ADRENOCEPTOR AGONISTS; DOUBLE-BLIND; EFFICACY; OXYBUTYNIN; MYELOMENINGOCELE; TOLTERODINE; MANAGEMENT; CHILDREN	ObjectivesTo investigate video-urodynamic effects of mirabegron, a (3)-adrenoceptor agonist, on low-compliance bladder. MethodsWe retrospectively reviewed nine patients (three men, six women, age 17-68years) who had been diagnosed with lower urinary tract dysfunction with low-compliance bladder, and who underwent video-urodynamic study before and during administration of mirabegron 50mg once daily. Urodynamic parameters were compared before and after treatment. ResultsMirabegron treatment significantly increased first desire to void and cystometric capacity with an average increment of 80mL (P=0.027) and 123mL (P=0.005), respectively. Bladder compliance also significantly increased (mean value 8.1mL/cmH(2)O before, 18.2mL/cmH(2)O after, P=0.024). In the six patients who had been taking anticholinergic agents at baseline video-urodynamic study and then switched to mirabegron, mean cystometric capacity and bladder compliance were also increased significantly from 208.3 to 346.8mL (P=0.015) and from 7.2 to 17.5mL/cmH(2)O (P=0.047), respectively. Vesicoureteral reflux grade was improved in three of the four patients who had shown vesicoureteral reflux on cystography before treatment. ConclusionsMirabegron improves cystometric capacity and bladder compliance, and it lowers vesicoureteral reflux grade in patients with low-compliance bladder. Thus, mirabegron might represent a good alternative drug for low-compliance bladder refractory to anticholinergic treatment.	[Kamei, Jun; Akiyama, Yoshiyuki; Ichihara, Koji; Igawa, Yasuhiko] Univ Tokyo, Dept Continence Med, Grad Sch Med, Tokyo 1138655, Japan; [Kamei, Jun; Akiyama, Yoshiyuki; Niimi, Aya; Fujimura, Tetsuya; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo 1138655, Japan; [Furuta, Akira] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan	Igawa, Y (reprint author), Univ Tokyo, Dept Continence Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yigawa-jua@umin.ac.jp			Asahi Kasei; Daiichi-Sankyo; GlaxoSmithKline; Kissei; Ono; Kyorin; Taiho; Pfizer; Nippon Shinyaku; Astellas; RaQualia	YH is a consultant for Astellas and Pfizer, and has received grants from Asahi Kasei, Daiichi-Sankyo, GlaxoSmithKline, Kissei, Ono, Kyorin, Taiho, Pfizer and Nippon Shinyaku, and speaker's honoraria from Astellas, Pfizer, Kyorin, Kissei, Ono, Asahi Kasei, Daiichi-Sankyo, GlaxoSmithKline and Taiho. YI is a consultant for Astellas, Pfizer and Eli Lilly, and has received grants from Astellas, Asahi Kasei, Kissei, Ono, Kyorin, Taiho, RaQualia, Daiichi-Sankyo and Nippon Shinyaku, and speaker's fees from Astellas, Asahi Kasei, Kissei, Kyorin, Taiho, Nippon Shinyaku and Pfizer.	Abrams P, 1984, URODYNAMICS PRINCIPL, P76; Wyndaele JJ, 2011, NEUROUROL URODYNAM, V30, P714, DOI 10.1002/nau.21129; Marte A, 2013, TOXINS, V5, P16, DOI 10.3390/toxins5010016; Watanabe M, 2010, INT J UROL, V17, P931, DOI 10.1111/j.1442-2042.2010.02635.x; Igawa Y, 2013, N-S ARCH PHARMACOL, V386, P177, DOI 10.1007/s00210-012-0824-1; Dmochowski RR, 2010, UROLOGY, V75, P62, DOI 10.1016/j.urology.2009.09.018; Razdan S, 2003, UROLOGY, V61, P893, DOI 10.1016/S0090-4295(02)02518-9; Stohrer M, 2007, EUR UROL, V51, P235, DOI 10.1016/j.eururo.2006.03.016; Cho SY, 2009, NEUROUROL URODYNAM, V28, P1010, DOI 10.1002/nau.20713; Christoph F, 2007, UROL INT, V79, P55, DOI 10.1159/000102915; Andersson KE, 2013, J UROLOGY, V190, P1173, DOI 10.1016/j.juro.2013.02.104; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Khullar V, 2013, EUR UROL, V63, P283, DOI 10.1016/j.eururo.2012.10.016; Yamaguchi O, 2014, BJU INT, V113, P951, DOI 10.1111/bju.12649; Madersbacher S, 1999, NEUROUROL URODYNAM, V18, P3, DOI 10.1002/(SICI)1520-6777(1999)18:1<3::AID-NAU2>3.0.CO;2-4; Klaphajone J, 2005, ARCH PHYS MED REHAB, V86, P2114, DOI 10.1016/j.apmr.2005.06.008; Igawa Y, 1999, BRIT J PHARMACOL, V126, P819, DOI 10.1038/sj.bjp.0702358; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Goessl C, 1998, UROLOGY, V51, P94, DOI 10.1016/S0090-4295(97)00489-5; Nitti VW, 2013, J UROLOGY, V189, P1388, DOI 10.1016/j.juro.2012.10.017; Park WH, 2010, LUTS, V2, P61, DOI 10.1111/j.1757-5672.2010.00076.x; Aizawa N, 2012, EUR UROL, V62, P1165, DOI 10.1016/j.eururo.2012.08.056; Matsukawa Y, 2015, UROLOGY, V85, P786, DOI 10.1016/j.urology.2015.01.002; Ogawa T, 1991, UROL INT S1, V47, P59; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Wada Naoki, 2015, Hinyokika Kiyo, V61, P7	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					956	961		10.1111/iju.12867		6	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800016		
J	Taguchi, K; Hamamoto, S; Okada, A; Mizuno, K; Tozawa, K; Hayashi, Y; Kohri, K; Yasui, T				Taguchi, Kazumi; Hamamoto, Shuzo; Okada, Atsushi; Mizuno, Kentaro; Tozawa, Keiichi; Hayashi, Yutaro; Kohri, Kenjiro; Yasui, Takahiro			First case report of staghorn calculi successfully removed by mini-endoscopic combined intrarenal surgery in a 2-year-old boy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						directional enhanced flow imaging ultrasound technique; endoscopic combined intrarenal surgery; mini-percutaneous nephrolithotomy; pediatric urolithiasis; staghorn calculus	PERCUTANEOUS NEPHROLITHOTOMY; CHILDREN; STONES	Less-invasive therapy for pediatric urolithiasis is available due to the miniaturization of equipment and improved optics; however, surgical treatment strategies, especially for large calculi, remain controversial. We describe here our experience of treating a 2-year-old boy with left renal staghorn calculi with a single session of mini-endoscopic combined intrarenal surgery in the prone split-leg position with pre-ureteral stenting and the directional enhanced flow imaging ultrasound technique. This is the first report of successful pediatric mini-endoscopic combined intrarenal surgery without any major complications. We believe this technique provides an important therapeutic option for large renal calculus in pediatric patients.	[Taguchi, Kazumi; Hamamoto, Shuzo; Okada, Atsushi; Mizuno, Kentaro; Tozawa, Keiichi; Hayashi, Yutaro; Kohri, Kenjiro; Yasui, Takahiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi 4678601, Japan	Hamamoto, S (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hamamo10@med.nagoya-cu.ac.jp					Onal B, 2014, J UROLOGY, V191, P777, DOI 10.1016/j.juro.2013.09.061; Li YD, 2013, J ULTRAS MED, V32, P1291, DOI 10.7863/ultra.32.7.1291; Hamamoto S, 2014, J ENDOUROL, V28, P28, DOI 10.1089/end.2013.0361; Kawahara T, 2012, INT J UROL, V19, P881, DOI 10.1111/j.1442-2042.2012.03046.x; Salerno A, 2013, J PEDIATR SURG, V48, P835, DOI 10.1016/j.jpedsurg.2012.09.058; Hamamoto S, 2014, UROLOGY, V84, P565, DOI 10.1016/j.urology.2014.04.020; Batu F, 2012, NAT REV UROL, V9, P138; De S, 2015, EUR UROL, V67, P125, DOI 10.1016/j.eururo.2014.07.003; Long CJ, 2015, UROL CLIN N AM, V42, P1, DOI 10.1016/j.ucl.2014.09.002; Tasian GE, 2014, J UROLOGY, V192, P1329, DOI 10.1016/j.juro.2014.04.108	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	OCT	2015	22	10					978	980		10.1111/iju.12860		3	Urology & Nephrology	Urology & Nephrology	CT0AT	WOS:000362456800023		
J	Abou El-Hassan, WH; El-Kassar, G; Fujimaki, H; Kitamura, Y; Khater, A				Abou El-Hassan, W. H.; El-Kassar, G.; Fujimaki, H.; Kitamura, Y.; Khater, A.			Assessment Of Cost-Effective Alternatives For Improving Irrigation Systems In The Nile Delta	IRRIGATION AND DRAINAGE			English	Article						irrigation improvement; construction costs; abstraction patterns; water distribution; equity; Egypt		Preliminary studies were conducted to test new design criteria incorporated in the Sefsafa Canal (SC) with the aim of reducing water application costs without sacrificing irrigation performance. For comparison, we also studied the Meet-Yazied Canal (MYC) (which is run without the new techniques). The cost-reduction measures used in this study included reduction of pump discharge rates and the use of electricity instead of diesel. We found that the location of farms along the irrigation canal had little effect on pump operation hours and amount of applied water; instead, crop patterns were the most important factor in this regard. The water use index (WUI), which is the ratio of applied water to required water, was higher in the SC than in the MYC and El-Mesk Canal (MC). Decreasing the pump discharge increased the amount of applied water to meet crop water requirements. During the winter, the WUI values of 1.11-1.16 achieved discharge rates of 70-80 l s(-1) and were considered the optimal values of WUI. Further studies are required to avoid excessive application of water during the summer. The application of new techniques prompted farmers to irrigate their fields at night, thereby reducing water losses and installation and operational costs, and promoting equitable water distribution along the entire irrigation canal and throughout the command area. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Abou El-Hassan, W. H.; El-Kassar, G.] Natl Water Res Ctr, WMRI, Delta Barrage, Egypt; [Fujimaki, H.; Kitamura, Y.] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Khater, A.] Tottori Univ, United Grad Sch Agr Sci, Tottori 680, Japan	Abou El-Hassan, WH (reprint author), Natl Water Res Ctr, WMRI, Delta Barrage, Egypt.	waleed-hassan@live.com			JSPS [24248041]	We would like to express our sincere thanks and appreciation to the Water Management Research Institute, National Water Research Centre and the Ministry of Water Resources and Irrigation, Egypt. This research is supported by the Grant-in-Aid for Scientific Research of JSPS, No. 24248041 led by Professor Tsugihiro Watanabe of Kyoto University.	Abou El Hassans W, 2005, T JSIDRE, V236, P43; Azims R, 2002, IRRIG DRAIN, V16, P15; Depeweg Herman, 1997, Irrigation and Drainage Systems, V11, P299, DOI 10.1023/A:1005827330031; Boss MG, 1980, ICID B, V29, P18; Egypt Water Use Project (EWUP), 1984, FIND EWUP; Elkassars GM, 2008, SCI WATER J NATL WAT, V43, P1; Elshorbagy WE, 2000, WATER RESOUR MANAG, V14, P229, DOI 10.1023/A:1026750104291; Food and Agriculture Organization of the United Nations (FAO), 2005, RAP ASS STUD INT PLA; Hoffmans GJ, 2007, DESIGN OPERATION FAR; International Commission on Irrigation and Drainage (ICID), 1978, ICID B, V27, P91; McDonald & Partners Ltd, 1988, REH IMPR WAT DEL SYS; Ministry of Water Resources and Irrigation (MWRI), 2005, NAT WAT RES PLAN EG; Smiths M, 1992, 46 FAO; Water Management Research Institute (WMRI), 2008, MON EV IRR IMPR PROJ; [Water Management Research Institute (WMRI) Mechanical and Electrical Research Institute (MERI)], 2005, TECHN NOT EL MESK PU; Wichelnss D, 1999, AGR WATER MANAGE, V43, P29; World Bank, 2003, EG IRR IMPR MAN PROJ	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1531-0353	1531-0361		IRRIG DRAIN	Irrig. Drain.	OCT	2015	64	4					454	463		10.1002/ird.1931		10	Agronomy; Water Resources	Agriculture; Water Resources	CT0AY	WOS:000362457300002		
J	Toki, K; Yamai, T; Fukai, K				Toki, Kazue; Yamai, Terumi; Fukai, Kiyoko			Skin temperature changes during a footbath in patients who had had a stroke with consequent sensory impairment	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						footbath; patient who had a stroke; sensory impairment; skin temperature	TRIAL	AimThe objectives of this study were to examine skin temperature changes on the unaffected and affected sides as well as changes in perceived temperature and comfort during a footbath in patients who had had a stroke with consequent sensory impairment. MethodsThe study used a quasi-experimental design in which the results of intervention for patients who had had a stroke and healthy adults were compared. The subjects were 20 patients who had had a stroke with consequent sensory impairment and 20 healthy adults. ResultsBefore the footbath, the skin temperature of the dorsum of the foot on the affected side of the patient who had had a stroke was lower than that of the foot on the unaffected side. Five minutes after the start of the footbath, however, the relationship reversed, with the skin temperature on the affected side increasing in parallel with the water temperature. After the footbath, the dorsum skin temperature on the affected side was again lower than that on the unaffected side. In healthy adults, a difference was found in dorsum skin temperature between the left and right feet. In contrast with patients who had had a stroke, no reversal of the sides was found with the lower and higher temperature. ConclusionUnlike in the healthy adults, the skin temperature of the patients who had had a stroke with consequent sensory impairment was susceptible to changes in the external environment. However, no significant changes in the physiological indices were seen, while perceived temperature and comfort remained at high levels after the footbath.	[Toki, Kazue] Senri Kinran Univ, Fac Nursing, Suita, Osaka 5650873, Japan; [Yamai, Terumi] Baika Womens Univ, Fac Nursing, Ibaraki, Osaka, Japan; [Fukai, Kiyoko] Okayama Univ, Grad Sch Hlth Sci, Okayama, Japan	Toki, K (reprint author), Senri Kinran Univ, Fac Nursing, 5-25-1 Fujishirodai, Suita, Osaka 5650873, Japan.	k-toki@cs.kinran.ac.jp			Ministry of Education [19592519]	This study was supported by the Ministry of Education (Grant-in-Aid for Scientific Research, no. 19592519). The present authors are deeply thankful to all the people who cooperated with this research.	Miwa Chihiro, 2007, Journal of  the Japanese Society of Balneology Climatology and Physical Medicine, V70, P209; Matsumoto S, 2010, INT J BIOMETEOROL, V54, P465, DOI 10.1007/s00484-009-0300-x; Miyazato K, 2010, JPN J NURS SCI, V7, P65, DOI 10.1111/j.1742-7924.2010.00136.x; Liao WC, 2013, INT J NURS STUD, V50, P1607, DOI 10.1016/j.ijnurstu.2013.04.006; Saeki Y, 2000, COMPLEMENT THER MED, V8, P2, DOI 10.1054/ctim.2000.0333; Liao WC, 2005, INT J NURS STUD, V42, P717, DOI 10.1016/j.ijnurstu.2004.11.011; Genta K., 1979, SCI REPORTS SHIGA PR, V20, P112; Goto T., 2012, JAPANESE J NURSING A, V11, P19; Hattori K., 2003, J MED COLL NURSING, V14, P139; Kaneko K., 2009, JAPANESE J NURSING A, V8, P35; Kinoshita A., 2007, CENTRAL JAPAN J ORTH, V50, P87; Miyashita K., 2000, JAPANESE J NURSING E, V4, P1; Morino K., 2002, JAPANESE J BURN INJU, V28, P181; Nakamura R., 2007, STRUCTURE FUNCTION, V5, P61; Nakayama E., 2004, ISHIKAWA J NURSING, V1, P65; Okada J., 2003, KAWASAKI MED WELF JL, V13, P317; Saino T, 2012, J SCH NURS OSAKA PRE, V18, P75; Sung Eun-Jung, 2000, Journal of Physiological Anthropology and Applied Human Science, V19, P21, DOI 10.2114/jpa.19.21; Toki K., 2007, B KOBE CITY COLL NUR, V11, P27; Uebaba Kazuo, 2004, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V67, P119; Xu Feng-Hao, 2003, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V66, P214; Yatuzuka M., 1999, TOYAMA MED J, V12, P54	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	OCT	2015	12	4					276	286		10.1111/jjns.12066		11	Nursing	Nursing	CT1AJ	WOS:000362529100002		
J	Iwata, H; Mori, E; Tsuchiya, M; Sakajo, A; Maehara, K; Ozawa, H; Morita, A; Maekawa, T; Aoki, K; Makaya, M; Tamakoshi, K				Iwata, Hiroko; Mori, Emi; Tsuchiya, Miyako; Sakajo, Akiko; Maehara, Kunie; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko; Aoki, Kyoko; Makaya, Miyuki; Tamakoshi, Koji			Predicting early post-partum depressive symptoms among older primiparous Japanese mothers	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						depression; hospitalization; logistic regression; maternal age; nursing	RANDOMIZED CONTROLLED-TRIAL; POSTNATAL DEPRESSION; MATERNAL AGE; WOMEN; CHILDBIRTH; COHORT; IMPACT; ONSET; BIRTH	AimThe number of older primiparas is increasing in Japan. These women have been shown to be more vulnerable to post-partum depression. This study aimed to identify factors for predicting post-partum depressive symptoms during hospitalization after childbirth in Japanese primiparas aged 35 years and over. MethodsThe present authors used the data of 479 primiparas aged 35 years and over from a prospective cohort study. Data were collected using self-report questionnaires on the day before hospital discharge. The questionnaire consisted of: demographics and background information; depressive symptoms; fatigue; maternal confidence and maternal satisfaction; child-care values; physical symptoms; perceptions of daily life during hospitalization; concerns about child care and daily life; and infant feeding. Additionally, vital records data were obtained from the hospitals. A stepwise logistic regression analysis was performed on the binary outcome variable of depressive symptoms, measured by the Japanese version of the Edinburgh Postnatal Depression Scale. Women who scored 9 or more were considered to be at high risk for post-partum depression. The authors obtained informed consent from all participants and institutional ethics approvals before initiating the study. ResultsThe following six variables reliably predicted the risk of post-partum depression: emergency cesarean section, lower satisfaction with birth experience, higher physical burden in daily life, long-term complications with the newborn, more concerns about newborn caretaking after discharge, and more concerns about one's own life after discharge. ConclusionRecognition of women with these factors will help nurses to identify those at risk for developing post-partum depression and to provide appropriate care during hospitalization after childbirth.	[Iwata, Hiroko; Mori, Emi; Tsuchiya, Miyako; Sakajo, Akiko; Maehara, Kunie; Ozawa, Harumi; Morita, Akiko; Maekawa, Tomoko; Aoki, Kyoko] Chiba Univ, Grad Sch Nursing, Chiba 2608672, Japan; [Makaya, Miyuki] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa 228, Japan; [Tamakoshi, Koji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Mori, E (reprint author), Chiba Univ, Grad Sch Nursing, Chuo Ku, I-8-1 Inohana, Chiba 2608672, Japan.	mori@faculty.chiba-u.jp			Funding Program for the Next Generation World-Leading Research from the Cabinet Office, Japan [LS022]	This study was supported by the Funding Program for the Next Generation World-Leading Research (no. LS022) from the Cabinet Office, Japan.	American Psychiatric Association, 2013, DESK RES DIAGN CRIT; Posmontier B, 2008, JOGNN-J OBST GYN NEO, V37, P722, DOI 10.1111/j.1552-6909.2008.00298.x; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Treacy A, 2006, AM J OBSTET GYNECOL, V195, P760, DOI 10.1016/j.ajog.2006.05.052; Matsumoto K, 2011, J AFFECT DISORDERS, V133, P607, DOI 10.1016/j.jad.2011.04.024; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Kitamura T, 2006, ARCH WOMEN MENT HLTH, V9, P121, DOI 10.1007/s00737-006-0122-3; Bryanton J, 2008, NURS RES, V57, P252, DOI 10.1097/01.NNR.0000313490.56788.cd; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Mori E, 2014, INT J NURS PRACT, V20, P20, DOI 10.1111/ijn.12246; Logsdon MC, 2006, JOGNN-J OBST GYN NEO, V35, P652, DOI 10.1111/J.1552-6909.2006.00087.x; Biro MA, 2012, AUST NZ J OBSTET GYN, V52, P229, DOI 10.1111/j.1479-828X.2012.01427.x; Gamble J, 2005, BIRTH-ISS PERINAT C, V32, P11, DOI 10.1111/j.0730-7659.2005.00340.x; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Satoh A, 2009, JPN J NURS SCI, V6, P27, DOI 10.1111/j.1742-7924.2009.00121.x; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Yoshida K, 2001, PEDIATR INT, V43, P189, DOI 10.1046/j.1442-200x.2001.01370.x; Small R, 2000, BRIT MED J, V321, P1043, DOI 10.1136/bmj.321.7268.1043; Baxter JD, 2014, MIDWIFERY, V30, P194, DOI 10.1016/j.midw.2013.12.013; Carolan Mary, 2004, Contemp Nurse, V18, P133; Chen D., 2006, CHIBA ACAD NURSING S, V12, P76; Hattori R., 2000, J CHILD HLTH, V59, P669; Ichikawa Y., 2008, JAPANESE J MATERNAL, V49, P336; Kitajima H., 2012, J JAPAN SOC PERINATA, V48, P661; Maehara K., 2014, JAPANESE J MATERNAL, V55, P369; Maehara K., 2005, J CHIBA ACAD NURSING, V27, P9; Ministry of Health Labor and Welfare, 2013, DEM SURV FISC YEAR 2; Ministry of Health Labor and Welfare, 2006, DEM SURV FISC YEAR 2; Ministry of Health Labor and Welfare, 2011, VIT STAT; Ministry of Health Labour and Welfare Japan, 2010, VIT STAT; Nakabayashi M., 2006, JAPANESE J MENTAL HL, V46, P655; Niimura M., 2012, WOMENS HLTH SOC J JA, V11, P84; Okano T MM, 1996, ARCH PSYCHIAT DIAGN, V7, P525; Polit D., 1996, DATA ANAL STAT NURSI; Sato M., 2008, B FUKUSHIMA SCH NURS, V10, P31; Shimada M, 2013, NATIONWIDE SURVEY SA; Shindo Y., 2013, MATERNITY NURSING MA; Staehelin K., 2013, SWISS MED WKLY, V143; Sugiura M, 2013, PERINATAL MED, V43, P829; Suzumiya H., 2004, KOUSEI NO SHIHYO, V51, P1; Tsuchiya M, 2015, NURS HEALTH SCI, V17, P71, DOI 10.1111/nhs.12157; Umesaki M., 2013, J JAPAN ACAD PSYCHIA, V22, P39	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	OCT	2015	12	4					297	308		10.1111/jjns.12069		12	Nursing	Nursing	CT1AJ	WOS:000362529100004		
J	Teramoto, C; Matsunaga, A; Nagata, S				Teramoto, Chie; Matsunaga, Atsushi; Nagata, Satoko			Cross-sectional study of social support and psychological distress among displaced earthquake survivors in Japan	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						earthquakes; psychological distress; social support; temporary housing; tsunamis	POSTTRAUMATIC-STRESS-DISORDER; NIIGATA-CHUETSU EARTHQUAKE; MENTAL-HEALTH; WENCHUAN EARTHQUAKE; SICHUAN EARTHQUAKE; ADULT SURVIVORS; SYMPTOMS; FRIENDS; FAMILY; PERFORMANCE	AimThis cross-sectional study aims to explore the relationship between different types and sources of social support and psychological distress by age and sex among survivors living in temporary housing 10 months after the Great East Japan Earthquake. MethodsSelf-reported questionnaires/structured interviews administered from January to March 2012 recorded demographic characteristics, damage involving participants' families, social support, and psychological distress. ResultsData on 296 participants aged 20 years or more from nine temporary housing complexes in Otsuchi were analyzed; K6 scores indicating psychological distress averaged 5.1 (standard deviation, 5.9; range, 0-24). Multiple logistic regression analyses indicated differences among types and sources of social support with regard to psychological distress by age and sex among disaster survivors. For men aged less than 65 years, social support by family was related to lower psychological distress. For women aged 65 years or more, emotional support from family, informational and instrumental support, and social companionship from friends in their own temporary housing complexes were related to less psychological distress. ConclusionDifferences in age and sex were related to different sources of social support in relation to psychological distress. It is necessary to pay more attention to those who lost family members in the disaster, especially men aged less than 65 years. It may also be necessary to support survivors in making friends when they relocate to temporary housing, especially women aged 65 years or more.	[Teramoto, Chie; Matsunaga, Atsushi; Nagata, Satoko] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Community Hlth Nursing, Tokyo 1130033, Japan	Teramoto, C (reprint author), Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Community Hlth Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	cteramoto-tky@umin.ac.jp			Research Institute of Science and Technology for Society of the Japan Science and Technology Agency	This study was conducted as part of a project entitled "Community designs for temporary housing sites in tsunami-stricken areas," funded by a grant from the Research Institute of Science and Technology for Society of the Japan Science and Technology Agency. The authors are grateful to all of the participants for their cooperation and significant contributions as well as the research investigators and staff.	Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Thanakwang K, 2012, AGING MENT HEALTH, V16, P993, DOI 10.1080/13607863.2012.692762; Jones EC, 2011, HUM ORGAN, V70, P33; Kun P, 2009, DEPRESS ANXIETY, V26, P1134, DOI 10.1002/da.20612; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Uscher-Pines L, 2009, DISASTERS, V33, P1, DOI 10.1111/j.1467-7717.2008.01059.x; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Koizumi Y, 2005, PSYCHIAT CLIN NEUROS, V59, P563, DOI 10.1111/j.1440-1819.2005.01415.x; Watanabe C, 2004, J TRAUMA STRESS, V17, P63, DOI 10.1023/B:JOTS.0000014678.79875.30; Oyama Mari, 2012, Environmental Health and Preventive Medicine, V17, P118, DOI 10.1007/s12199-011-0225-y; Cable N, 2013, J EPIDEMIOL COMMUN H, V67, P166, DOI 10.1136/jech-2012-201113; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Ostberg V, 2007, SCAND J PUBLIC HEALT, V35, P197, DOI 10.1080/14034940600813032; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Fukuoka Y, 1997, JPN J PSYCHOL, V68, P403; Disaster prevention Iwate, 2014, DAM SIT; Iwate Prefecture, 2014, TEMP HOUS COMPL GROU; Kawakami N., 2007, PREVALENCE RELATED F; Kwon Y S, 2001, Environ Health Prev Med, V6, P97, DOI 10.1007/BF02897953; Lloyd C., 1995, SOCIAL SUPPORT PSYCH, P41, DOI 10.1017/CBO9780511526749.003; Ministry of Internal Affairs and Communications, 2014, 2010 POP CENS JAP EM; Ministry of Internal Affairs and Communications, 2014, 2010 POP CENS JAP PR; Ministry of Land Infrastructure Transport and Tourism, 2014, TEMP HOUS GROUNDBR C; National Police Agency, 2014, DAM SIT POL COUNT AS; Sakata K., 2012, J PUBLIC HLTH PRACTI, V76, P215; Tohyama T., 1998, J NARA MED ASS, V49, P295; Toyabe S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-230; Tsuji I, 2011, JPN MED J, V4569, P18; vansGriensven F., 2006, JAMA-J AM MED ASSOC, V296, P537	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	OCT	2015	12	4					320	329		10.1111/jjns.12071		10	Nursing	Nursing	CT1AJ	WOS:000362529100006		
J	Kobiyama, A; Suzuki, E; Takayama, Y				Kobiyama, Atsuko; Suzuki, Eiko; Takayama, Yuko			Post-partum anemia and factors that work against alleviation of the anemia	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						anemia; duration of the delivery; post-partum women; self-management skills	IRON STATUS; PREGNANCY; SUPPLEMENTATION; LIFE	AimThis study aimed to clarify conditions of women experiencing post-partum anemia and identify factors that work against the alleviation of anemia. MethodsThis was a retrospective longitudinal study, involving 246 women giving birth at five participating institutions, diagnosed with anemia on day 3 post-partum, and given a blood sample at the medical examination 1 month after the birth. With answers about alleviation of anemia during the 1 month post-partum period as an objective variable, and explanatory variables, multiple logistic regression analysis was performed. The explanatory variables included demographic data of the participants, information about anemia, following the nutrition instruction advice for anemia alleviation, family structure and others assisting the participants, and self-management skills (measured by the Self-Management Skill [SMS] scale). ResultsThe present authors collected 211 valid responses; the average age was 32.6years. The mean hemoglobin values on the 3rd and 30th days post-partum were 9.6 and 12.0g/dL, respectively. One fifth of the participants (21.3%) showed no anemia alleviation. The mean value on the SMS scale was 28.35, and the anemia alleviated group (30.78) was significantly higher than the non-alleviated group (19.38). Results of the multiple logistic regression analysis showed a strong relationship between anemia risk and self-management skills. The absence of anemia alleviation increased 2.51 times as the total score of the SMS decreased 1point. ConclusionThere is an urgent need to develop an intervention program to alleviate post-partum anemia focusing on the low score items because self-management skills strongly affect alleviation improvement.	[Kobiyama, Atsuko; Suzuki, Eiko; Takayama, Yuko] Int Univ Hlth & Welf Grad Sch, Grad Sch Hlth & Welf Sci, Tokyo 1070062, Japan	Kobiyama, A (reprint author), Int Univ Hlth & Welf Grad Sch, Grad Sch Hlth & Welf Sci, Minato Ku, Aoyama Tower,1-3-3 Minamiaoyama, Tokyo 1070062, Japan.	kobiyama@tokyo-med.ac.jp					Abdullahi Hala, 2014, BMC Res Notes, V7, P498, DOI 10.1186/1756-0500-7-498; Allen LH, 2000, AM J CLIN NUTR, V71, P1280; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Singla PN, 1996, ACTA PAEDIATR, V85, P1327, DOI 10.1111/j.1651-2227.1996.tb13919.x; Akase T, 2008, YAKUGAKU ZASSHI, V128, P1081, DOI 10.1248/yakushi.128.1081; GLAZENER CMA, 1995, BRIT J OBSTET GYNAEC, V102, P282, DOI 10.1111/j.1471-0528.1995.tb09132.x; Corwin EJ, 2003, J NUTR, V133, P4139; Farag TH, 2007, AM J TROP MED HYG, V76, P541; Arai K., 1991, JIKEIKAI MED J, V106, P73; Araki T, 2012, LATEST OBSTET ABNORM, V22, P188; Beard JL, 2000, AM J CLIN NUTR, V71, p1288S; Editorial committee of the Japan Society of Perinatal and Neonatal Medicine, 2010, PERINATAL MED, V40, P402; Fujita Y., 2004, CLIN MIDWIFE HDB SUP, V1, P364; Hamada H., 2008, ESSENTIALS PERINATAL, V38, P12; Hokuto H., 1999, KOBE CITY JUNIOR COL, V18, P65; Imanaka M., 2000, JAPANESE J PERINATAL, V19, P101; Inukai T., 1997, JAPANESE J MATERNAL, V38, P62; Ito N., 2005, JAPANESE J MATERNAL, V46, P125; Japan Society of Obstetrics and Gynecology & Japan Association of Obstetricians and Gynecologists, 2008, J OBSTET GYNAECOLOGY, V5, P1; Khalafallah A. A., 2012, BMJ OPEN, V2, P1; Kitahara M., 2005, MEDICATIONS HAEMATOL, P196; Kurokawa H., 2011, PERINATAL CARE, V30, P51; Lone F W, 2004, East Mediterr Health J, V10, P801; Maeda T., 1989, JAPANESE J MATERNAL, V30, P299; Manabe E., 2000, B COLL MED TECHNOLOG, V10, P67; Ministry of Health Labor and Welfare, 2013, HLTH LABOR WELFARE S, V60, P51; Mori E., 2012, STUDY SKILL 2 MATERN, V12, P525; Morimae M., 1994, JAPANESE J MATERNAL, V14, P119; MORTON RE, 1988, J PEDIATR GASTR NUTR, V7, P707, DOI 10.1097/00005176-198809000-00015; Murakami A, 2006, PERINATAL CARE, V25, P28; Otsuka A., 1988, J MIYAZAKI MED ASS, V12, P211; Oumizu Y., 2010, JAPANESE J MATERNAL, V50, P575; Sakamoto M., 2011, B SAITAMA PREFECTURA, V2011, P79; Saotome T., 2006, PERINATAL CARE, V25, P228; Shiraishi M., 2009, MATERNAL HLTH, V50, P148; Takahashi H., 2000, JPN J PUBLIC HLTH, V47, P907; Tanaka N., 2007, JAPANESE J MATERNAL, V47, P60; The Ministry of education, 2012, NOT ENT ACC STAND GE, P1; The Ministry of Health Labor and Welfare Healthy Parents and Children 21 Promotion Committee (Study group of health support for pregnant women through eating), 2006, DIARIO OFICIAL  1127, P26; Toyose E., 1996, MATERNAL HLTH, V37, P64; Tsutsumi C., 2003, CURRENT INFORM MATER, V47, P54; Watanabe H., 2002, J JAPAN SOC OBSTET G, V54, pN73; Yoshikawa H., 2006, REPORT RES NATL PER, P1	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	OCT	2015	12	4					340	353		10.1111/jjns.12073		14	Nursing	Nursing	CT1AJ	WOS:000362529100008		
J	Asazawa, K				Asazawa, Kyoko			Effects of a partnership support program for couples undergoing fertility treatment	JAPAN JOURNAL OF NURSING SCIENCE			English	Article						infertility; partnership; program; psychological distress; quality of life	INFERTILITY-RELATED STRESS; WOMEN; MEN; DEPRESSION; PREVALENCE; QUALITY; ANXIETY; CARE	AimThe study's purpose was to examine the effects of providing a partnership support program. It was designed to improve Japanese couples' partnership, maintain quality of life, decrease psychological distress, and improve marital relationship satisfaction while they underwent infertility treatment that included the possibility of using assisted reproductive technology. MethodsThis quasi-experimental study with a two-group pretest-post-test design used purposive sampling and non-random assignment of 318 consenting Japanese patients from previous phases of assisted reproductive technology fertility treatment who were patients from a fertility clinic in Tokyo, Japan. The intervention group of 152 patients (76 couples) participated in the partnership support program. The comparison group of 166 patients (83 couples) received usual care. Recruitment was age matched. The program provided information and used a participatory-interactive approach to enhance understanding and cooperation in couples undergoing fertility treatment. The main outcome measures were: partnership, FertiQoL, Quality Marriage Index, and psychological distress. ResultsThere were 311 participants (intervention group n=148; comparison group, n=163). The intervention group showed significant improvement in the couples' partnerships and a significant decrease in women's psychological distress using subgroup analysis. ConclusionThe partnership support program provided effective improvement in partnership for the couples, and reduced psychological distress for the women; however, it had less impact for the men. The program was not effective in improving couples' overall quality of life (QOL); however, it was effective in improving the mind-body aspects of the QOL subscale.	[Asazawa, Kyoko] Tokyo Healthcare Univ, Dept Nursing, Tokyo 1528558, Japan	Asazawa, K (reprint author), Tokyo Healthcare Univ, Dept Nursing, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528558, Japan.	k-asazawa@thcu.ac.jp			Japan Academy of Midwifery; Fumiko Yamaji Nursing Research Fund	The author would like to thank the participating patients in this research, as well as the facility staff and research assistants. This research was conducted for the author's doctoral dissertation at St Luke's College of Nursing in 2013. The author also deeply appreciates the valuable advice provided by Professor Akiko Mori, Professor Shigeko Horiuchi, the late Professor Haruo Yanai, Professor Kazuhiro Nakayama, and Dr Sarah E. Porter of St Luke's International University, and Professor Tomohiko Ichikawa of the Department of Urology, Graduate School of Medicine, University of Chiba. This study was supported by a Grant-in-Aid from the Japan Academy of Midwifery and the Fumiko Yamaji Nursing Research Fund.	Akizuki Y., 2009, J JAPAN ACAD MIDWIFE, V23, P271; Anme T., 2004, WHAT IS EMPOWERMENT, P1; Martins MV, 2011, HUM REPROD, V26, P2113, DOI 10.1093/humrep/der157; Wichman CL, 2011, FERTIL STERIL, V95, P717, DOI 10.1016/j.fertnstert.2010.09.043; Domar AD, 2000, HEALTH PSYCHOL, V19, P568, DOI 10.1037//0278-6133.19.6.568; Fassino S, 2002, HUM REPROD, V17, P2986, DOI 10.1093/humrep/17.11.2986; Matsubayashi H, 2004, GEN HOSP PSYCHIAT, V26, P398, DOI 10.1016/j.genhosppsych.2004.05.002; Fisher JRW, 2012, ASIAN J ANDROL, V14, P121, DOI 10.1038/aja.2011.72; Volgsten H, 2008, HUM REPROD, V23, P2056, DOI 10.1093/humrep/den154; Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753; Drosdzol A, 2009, J SEX MED, V6, P3335, DOI 10.1111/j.1743-6109.2009.01355.x; Boivin J, 2011, HUM REPROD, V26, P2084, DOI 10.1093/humrep/der171; Boivin J, 2005, FERTIL STERIL, V83, P1745, DOI 10.1016/j.fertnstert.2004.12.039; BERG BJ, 1991, J BEHAV MED, V14, P11, DOI 10.1007/BF00844765; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Asazawa K., 2013, J JAPAN ACAD NURSING, V33, P14; Asazawa K., 2014, J JAPAN ACAD MIDWIFE, V28, P154; Asazawa K., 2012, J JAPANESE SOC FERTI, V9, P5; Asazawa K, 2015, JPN J NURS SCI, V12, P208, DOI 10.1111/jjns.12061; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen S., 2000, SYNOPTIC PROBLEM RAB, P13; Gomibuchi H., 2002, J FERTILIZATION IMPL, V19, P51; Japan Society of Obstetrics & Gynecology, 2013, 2012 ETH COMM REP HE; Kitamura K., 2001, JAPANESE J FERTILITY, V46, P19; Nakayama M., 2005, PERINATAL MED, V35, P1384; NORTON R, 1983, J MARRIAGE FAM, V45, P141, DOI 10.2307/351302; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Read SC, 2014, PATIENT EDUC COUNS, V94, P390, DOI 10.1016/j.pec.2013.10.025; Schmidt L, 2005, Patient Educ Couns, V59, P252, DOI 10.1016/j.pec.2005.05.013; Shirai C., 2004, SOCIOLOGY INFERTILIT; Shirai C., 2007, JAPANESE J HLTH MED, V18, P25; Yamur Y., 2012, PUBLIC HLTH NURSING, V29, P99; Yasuda T., 2011, METHOD PROGRAM EVALU, P132	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7932	1742-7924		JPN J NURS SCI	Jpn. J. Nurs. Sci.	OCT	2015	12	4					354	366		10.1111/jjns.12074		13	Nursing	Nursing	CT1AJ	WOS:000362529100009		
J	Maehigashi, A; Miwa, K				Maehigashi, Akihiro; Miwa, Kazuhisa			Estimation of trade-off between costs of preprocessing and primary processing	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						epistemic action; external resources; trade-off; cost estimation; preprocessing	INTERACTIVE BEHAVIOR; SOFT CONSTRAINTS; REPRESENTATIONS	When people engage in a task, they often take preliminary actions (preprocessing) to simplify primary processing. Usually, a trade-off is made between the costs of preprocessing and primary processing. We conducted three experiments to find out whether people could adaptively estimate the utility of preprocessing depending on the task situation. The result demonstrated that in performing a high-complexity task, almost all the participants reduced their overall task performance cost by conducting cost-adaptive preprocessing. However, for a low-complexity task, participants tended to conduct preprocessing even though this increased overall task performance cost. Based on these results, we discuss human nature from the viewpoint of the influence of cognitive effort.	[Maehigashi, Akihiro; Miwa, Kazuhisa] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Maehigashi, A (reprint author), Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	mhigashi@cog.human.nagoya-u.ac.jp					Shirouzu H, 2002, COGNITIVE SCI, V26, P469, DOI 10.1207/s15516709cog2604_3; Walsh MM, 2009, COGNITIVE PSYCHOL, V58, P416, DOI 10.1016/j.cogpsych.2008.09.003; RUSSO JE, 1983, J EXP PSYCHOL LEARN, V9, P676; Gray WD, 2004, COGNITIVE SCI, V28, P359, DOI 10.1016/j.cogsci.2003.12.001; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; ZHANG JJ, 1994, COGNITIVE SCI, V18, P87, DOI 10.1016/0364-0213(94)90021-3; Cary M, 2001, J EXP PSYCHOL LEARN, V27, P836, DOI 10.1037/0278-7393.27.3.836; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Kirsh D, 1996, ADAPT BEHAV, V4, P415, DOI 10.1177/105971239600400307; Martin L, 2009, COGNITION INSTRUCT, V27, P370, DOI 10.1080/07370000903221775; Brown J. S., 1989, EDUC RES, V18, P32, DOI DOI 10.3102/0013189X018001032; KIRSH D, 1994, COGNITIVE SCI, V18, P513, DOI 10.1016/0364-0213(94)90007-8; Kirsh David, 2010, AI & Society, V25, DOI 10.1007/s00146-010-0272-8; Lave J., 1984, EVERYDAY COGNITION I, P67; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					269	280		10.1111/jpr.12087		12	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800001		
J	Yamada, Y; Nagai, M				Yamada, Yohei; Nagai, Masayoshi			Positive mood enhances divergent but not convergent thinking	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						positive mood; creativity; divergent thinking; convergent thinking	AFFECT INCREASES; CREATIVITY; THOUGHT; PERFORMANCE; EMOTIONS; BROADEN; MEMORY; TASK	A positive mood enhances creative performance. We examined which type of creativity, divergent or convergent thinking, was enhanced by a positive mood. Half of the participants listened to happy music and thought about happy events (positive group). The other half listened to the Japanese Constitution (neutral group). Participants' emotional valence and arousal were measured before and after mood induction. All participants then engaged in a creative activity involving the generation of new names for rice. The results indicated that the positive group produced more divergent ideas than did the neutral group. On the other hand, the two groups did not differ with respect to the number of convergent ideas that were generated. We suggest that being in a positive mood facilitates flexible thinking and consequently leads to production of unconventional and atypical ideas.	[Yamada, Yohei] Nara Univ Educ, Nara 6308528, Japan; [Nagai, Masayoshi] Aichi Shukutoku Univ, Nagakute, Aichi, Japan	Yamada, Y (reprint author), Nara Univ Educ, Fac Educ, Nara 6308528, Japan.	yamada.yohei@nara-edu.ac.jp					Grawitch MJ, 2003, GROUP DYN-THEOR RES, V7, P41, DOI 10.1037/1089-2699.7.1.41; Phillips LH, 2002, EMOTION, V2, P12, DOI 10.1037/1528-3542.2.1.12; RUBIN DC, 1991, MEM COGNITION, V19, P1, DOI 10.3758/BF03198491; Biss RK, 2011, EMOTION, V11, P1474, DOI 10.1037/a0023855; Marsh RL, 1999, MEM COGNITION, V27, P94, DOI 10.3758/BF03201216; Gilhooly KJ, 2007, BRIT J PSYCHOL, V98, P611, DOI 10.1348/096317907X173421; Dijksterhuis A, 2006, CONSCIOUS COGN, V15, P135, DOI 10.1016/j.concog.2005.04.007; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Dewhurst SA, 2011, PERS INDIV DIFFER, V51, P73, DOI 10.1016/j.paid.2011.03.018; Topolinski S, 2012, EXP PSYCHOL, V59, P302, DOI 10.1027/1618-3169/a000159; Davis MA, 2009, ORGAN BEHAV HUM DEC, V108, P25, DOI 10.1016/j.obhdp.2008.04.001; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037//0022-3514.48.6.1413; Lee CS, 2013, INTELLIGENCE, V41, P306, DOI 10.1016/j.intell.2013.04.008; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Cropley A, 2006, CREATIVITY RES J, V18, P391, DOI 10.1207/s15326934crj1803_13; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037//0022-3514.52.6.1122; Vosburg SK, 1998, CREATIVITY RES J, V11, P165, DOI 10.1207/s15326934crj1102_6; Bass M., 2008, PSYCHOL BULL, V134, P779; Cropley D., 2010, CAMBRIDGE HDB CREATI, P301, DOI DOI 10.1017/CBO9780511763205.019; Guilford J.P., 1967, NATURE HUMAN INTELLI; Chermahini SA, 2012, PSYCHOL RES-PSYCH FO, V76, P634, DOI 10.1007/s00426-011-0358-z; ISEN AM, 1984, J PERS SOC PSYCHOL, V47, P1206, DOI 10.1037/0022-3514.47.6.1206; Kaufmann G, 2003, CREATIVITY RES J, V15, P131, DOI 10.1207/S15326934CRJ152&3_03; Nielsen B. D., 2008, PSYCHOL AESTHET CREA, V2, P131, DOI 10.1037/1931-3896.2.3.131; Runco MA, 2007, CREATIVITY: THEORIES AND THEMES: RESEARCH, DEVELOPMENT, AND PRACTICE, P1; SMITH SM, 1993, MEM COGNITION, V21, P837, DOI 10.3758/BF03202751	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					281	287		10.1111/jpr.12093		7	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800002		
J	Morimoto, H; Shimada, H; Tanaka, H				Morimoto, Hiroshi; Shimada, Hironori; Tanaka, Hideki			Coping orientation and psychological distress in healthcare professionals: The utility of appraising coping acceptability	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						coping orientation; engagement; disengagement; appraisal of coping acceptability; psychological distress; healthcare professionals	BURNOUT; STRESS; STRATEGIES; PHYSICIANS; WORKERS; MODEL	The purpose of this study was to examine interaction effects of healthcare professionals' coping orientation (i.e., engagement versus disengagement) and appraisal of coping acceptability (ACA) on psychological distress, taking into account the individuals' job specificity and the psychological climate in their work environment. A cross-sectional survey was conducted, and Japanese healthcare professionals (N=189; 117 female; mean age: 40.1 +/- 11.2 years) reported the coping strategies that they employed for task-related or interpersonal stressors, their cognitive appraisal of the stressors, their ACA, and the psychological distress evoked by the stressors. The results showed that adding consideration of the ACA to the variable of coping orientation significantly improved predictions of psychological distress for both task and interpersonal stressors. There was no significant interaction between the coping orientation and the use of coping strategies that incorporated the ACA. These results suggest that considering the ACA, in addition to the coping orientation, would be useful for understanding individual differences in the mediators of healthcare professionals' coping in stressful situations.	[Morimoto, Hiroshi; Tanaka, Hideki] Hiroshima Int Univ, Higashihiroshima 7392695, Japan; [Shimada, Hironori] Waseda Univ, Tokyo, Tokyo, Japan	Morimoto, H (reprint author), Hiroshima Int Univ, Fac Psychol, Higashihiroshima 7392695, Japan.	morimoto@he.hirokoku-u.ac.jp					Aiken L. S., 1991, MULTIPLE REGRESSION; Aldwin C M, 1994, STRESS COPING DEV IN; SLAVIN LA, 1991, J COUNS DEV, V70, P156; Morimoto H, 2013, INT J STRESS MANAGE, V20, P1, DOI 10.1037/a0031432; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Geurts S, 1998, J SOC CLIN PSYCHOL, V17, P341, DOI 10.1521/jscp.1998.17.3.341; SCHEIN EH, 1990, AM PSYCHOL, V45, P109, DOI 10.1037//0003-066X.45.2.109; Tyssen R, 2001, J AFFECT DISORDERS, V64, P69, DOI 10.1016/S0165-0327(00)00205-6; STONE AA, 1991, J PERS SOC PSYCHOL, V61, P648, DOI 10.1037//0022-3514.61.4.648; Peiro JM, 2001, PSYCHOL HEALTH, V16, P511, DOI 10.1080/08870440108405524; Morimoto H, 2014, INT J BEHAV MED, V21, P447, DOI 10.1007/s12529-013-9320-3; ASENDORPF JB, 1983, J PERS SOC PSYCHOL, V45, P1334, DOI 10.1037/0022-3514.45.6.1334; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Jain VK, 1996, PSYCHOL REP, V78, P1256; Elliot AJ, 1999, EDUC PSYCHOL, V34, P169, DOI 10.1207/s15326985ep3403_3; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; VITALIANO PP, 1987, J BEHAV MED, V10, P1, DOI 10.1007/BF00845124; Morimoto H, 2015, INT J STRESS MANAGE, V22, P159, DOI 10.1037/a0038484; Suzuki S, 2003, INT J PSYCHOPHYSIOL, V47, P117, DOI 10.1016/S0167-8760(02)00120-4; Dorz S, 2003, PSYCHOL HEALTH, V18, P677, DOI 10.1080/0887044031000141180; TOBIN DL, 1989, COGNITIVE THER RES, V13, P343, DOI 10.1007/BF01173478; Endler NS, 2000, PERS INDIV DIFFER, V29, P951, DOI 10.1016/S0191-8869(99)00246-9; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037//0022-3514.56.2.267; Cohen J., 1988, STAT POWER ANAL BEHA; Edwards R. D., 2014, INT J STRESS MANAGE, V21, P162; Folkman S., 1984, STRESS APPRAISAL COP; Frankenhaeuser M., 1986, DYNAMICS STRESS, P101; Frankenhaeuser M, 1982, Scand J Psychol, VSuppl 1, P158; Hashimoto T., 2000, B GRADUATE SCH ED HU, V47, P89; Hofstede G. H., 1980, CULTURES CONSEQUENCE; Kubo M., 1994, JAPANESE J EXPT SOCI, V34, P33; Morimoto H., 2006, KAWASAKI MED WELF J, V16, P31; Morimoto H., 2010, JOB STRESS RES, V17, P119; Obrist P, 1981, CARDIOVASCULAR PSYCH; Press S. J., 2005, APPL MULTIVARIATE AN; de Rijk AE, 1998, J OCCUP ORGAN PSYCH, V71, P1; Rousseau D., 1990, ORG CLIMATE CULTURE, P153; Sakata K., 2006, JAPANESE ASS IND ORG, V19, P13; Shimomitsu T., 1998, REPORT RES GRANT PRE, P107; Suzuki S., 1998, JAPANESE J BEHAV THE, V24, P85; Suzuki S., 1998, JAPANESE J HLTH PSYC, V11, P15; Suzuki S., 1998, JPN J PSYCHOSOM MED, V38, P597; Suzuki S., 2001, JAPANESE J PSYCHOL, V72, P290; Suzuki S., 1998, HUMAN SCI RES, V7, P113	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					300	312		10.1111/jpr.12090		13	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800004		
J	Nagai, S				Nagai, Satoru			Predictors of help-seeking behavior: Distinction between help-seeking intentions and help-seeking behavior	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						help-seeking; depression; social support; gender	PROFESSIONAL PSYCHOLOGICAL HELP; COLLEGE-STUDENTS ATTITUDES; PLANNED BEHAVIOR; SEX-DIFFERENCES; ADOLESCENTS; DISTRESS; METAANALYSIS; HOPELESSNESS; PERCEPTIONS; COUNSELORS	The overall goals of this research were to: (a) examine whether help-seeking intentions, subjective needs, depressive symptoms, and social support can predict actual help-seeking behavior; and (b) clarify the moderating effects of social support on help-seeking behavior using a longitudinal design. University students (N=370) completed questionnaires that measured social support, subjective needs, depressive symptoms, and help-seeking intentions during Time1, and questionnaires that measured actual help-seeking behavior during Time2. Only subjective needs showed a positive effect on both help-seeking intentions and actual help-seeking behavior. Although depressive symptoms had a negative effect on help-seeking intentions, they had a positive effect on actual help-seeking behavior. Moreover, social support had a positive effect on help-seeking intentions, and moderated the influence of subjective needs on actual help-seeking behavior. Simple slope analysis indicated that subjective needs did not facilitate help-seeking behavior among those with low levels of social support.	[Nagai, Satoru] Rissho Univ, Tokyo 1418602, Japan; [Nagai, Satoru] Rissho Univ, Tokyo, Japan	Nagai, S (reprint author), Rissho Univ, Fac Psychol, Shinagawa Ku, Tokyo 1418602, Japan.	nagai-st@ris.ac.jp					Aiken L. S., 1991, MULTIPLE REGRESSION; OFFER D, 1991, J AM ACAD CHILD PSY, V30, P623, DOI 10.1097/00004583-199107000-00015; FOLKMAN S, 1987, PSYCHOL AGING, V2, P171, DOI 10.1037/0882-7974.2.2.171; Naganuma Y, 2006, PSYCHIAT CLIN NEUROS, V60, P240, DOI 10.1111/j.1440-1819.2006.01492.x; Komiya N, 2000, J COUNS PSYCHOL, V47, P138, DOI 10.1037//0022-0167.47.1.138; Lannin DG, 2013, J COUNS PSYCHOL, V60, P508, DOI 10.1037/a0033789; KARABENICK SA, 1994, J EDUC PSYCHOL, V86, P90, DOI 10.1037/0022-0663.86.1.90; Lopez FG, 1998, J COUNS PSYCHOL, V45, P79, DOI 10.1037/0022-0167.45.1.79; Mizuno H, 1999, JPN J EDUC PSYCHOL, V47, P530; Wilson CJ, 2005, J CLIN PSYCHOL, V61, P1525, DOI 10.1002/jclp.20206; Deane FP, 2001, J CLIN PSYCHOL, V57, P901, DOI 10.1002/jclp.1058.abs; CALHOUN LG, 1974, J CLIN PSYCHOL, V30, P247, DOI 10.1002/1097-4679(197407)30:3<247::AID-JCLP2270300305>3.0.CO;2-M; Vogel DL, 2003, J COUNS PSYCHOL, V50, P351, DOI 10.1037/0022-0167.50.3.351; Nam SK, 2013, PROF PSYCHOL-RES PR, V44, P37, DOI 10.1037/a0029562; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andrews G, 2001, BRIT J PSYCHIAT, V179, P417, DOI 10.1192/bjp.179.5.417; Vogel DL, 2005, J COUNS PSYCHOL, V52, P459, DOI 10.1037/0022-0167.52.4.459; GARLAND AF, 1994, AM J ORTHOPSYCHIAT, V64, P586, DOI 10.1037/h0079573; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Rickwood DJ, 1995, J YOUTH ADOLESCENCE, V24, P685, DOI 10.1007/BF01536951; RICKWOOD DJ, 1994, SOC SCI MED, V39, P563, DOI 10.1016/0277-9536(94)90099-X; Grella CE, 2009, PSYCHIAT SERV, V60, P1068, DOI 10.1176/appi.ps.60.8.1068; Li WJ, 2014, PROF PSYCHOL-RES PR, V45, P163, DOI 10.1037/a0037118; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; CASH TF, 1975, J COUNS PSYCHOL, V22, P273, DOI 10.1037/h0076730; Ryan AM, 2012, J EDUC PSYCHOL, V104, P1122, DOI 10.1037/a0027696; Ploeg J, 1996, CAN J PUBLIC HEALTH, V87, P319; NORCROSS JC, 1986, PSYCHOTHER, V23, P102, DOI 10.1037/h0085577; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Nam SK, 2010, J AM COLL HEALTH, V59, P110, DOI 10.1080/07448481.2010.483714; SAUNDERS SM, 1994, J AM ACAD CHILD PSY, V33, P718, DOI 10.1097/00004583-199406000-00013; Vogel DL, 2005, J COUNS PSYCHOL, V52, P347, DOI 10.1037/0022-0167.52.3.347; Nagai S, 2010, JPN J EDUC PSYCHOL, V58, P46; Sheffield JK, 2004, J YOUTH ADOLESCENCE, V33, P495, DOI 10.1023/B:JOYO.0000048064.31128.c6; Fallon BJ, 1999, AUST J PSYCHOL, V51, P12, DOI 10.1080/00049539908255329; Deane F. P., 1994, BRIT J GUID COUNS, V22, P207, DOI DOI 10.1080/03069889400760211; Delongis A., 1982, HEALTH PSYCHOL, V1, P119, DOI 10.1037/0278-6133.1.2.119; Gross A. E., 1983, NEW DIRECTIONS HELPI, V2, P45; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-81; Hanano N, 2000, J MIYAZAKI PREFECTUR, V1, P66; Hashimoto T, 2015, ANN REPORTS DEP SOCI, V65, pA61; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kimura M., 2004, JAPANESE J COUNSELIN, V37, P260; Nadler A., 1997, SOURCEBOOK SOCIAL SU, P378; Nagai S, 2012, JAPANESE J HLTH PSYC, V25, P83; Radloff I. S., 1977, APPL PSYCH MEAS, V1, P385; Rickwood D., 2005, ADV MENTAL HLTH, V4, P218, DOI DOI 10.5172/JAMH.4.3.218; Rothi D. M., 2006, PASTORAL CARE ED, V24, P4, DOI DOI 10.1111/J.1468-0122.2006.00373.X; Shima N., 1992, JAPANESE J SOCIAL PS, V7, P45; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Short P., 1998, J COUNS PSYCHOL, V45, P1, DOI 10.1037/0022-0167.45.1.58; Takahashi T., 2014, YOKOHAMA J TECHNOLOG, V13, P47; Wilson C. J., 2005, CANADIAN J COUNSELLI, V39, P15	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					313	322		10.1111/jpr.12091		10	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800005		
J	Kawamoto, T				Kawamoto, Tetsuya			Development of Japanese version of the long-term mating orientation scale (LTMO-J)	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						long-term mating orientation; mating strategy; life history theory; test reliability; test validity	INDIVIDUAL-DIFFERENCES; SOCIOSEXUALITY; STRATEGIES; PERSONALITY; ATTACHMENT; PERSPECTIVE; MODEL; SELF; SEX; AGE	The purpose of this study was to validate the 7-item long-term mating orientation scale (LTMO) as translated into Japanese. Two samples of Japanese adults (N=2000; 50.0% male; Mage=40.9 for the first survey; N=300; 54.7% male; Mage=42.4 for the second survey) completed a web-based questionnaire, including the Japanese translation of the LTMO. The results showed that the psychometric properties of the Japanese LTMO scale were comparable to those of the original English version. The scale had adequate reliability based on Cronbach's and McDonald's . Convergent validity was demonstrated by the correlation between the LTMO scores and related variables: human life history strategies, short-term sociosexual orientation, attitude to infidelity, romantic attachment style, and so on. The translated scale provides a valid and reliable instrument in Japanese that measures human mating strategy.	[Kawamoto, Tetsuya] Univ Tokyo, Tokyo 1138654, Japan; [Kawamoto, Tetsuya] Japan Soc Promot Sci, Tokyo, Japan	Kawamoto, T (reprint author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan.	tk5049@p.u-tokyo.ac.jp			JSPS KAKENHI [26-12061]	This research was supported by JSPS KAKENHI Grant Number 26-12061.	Fraley RC, 2011, PSYCHOL ASSESSMENT, V23, P615, DOI 10.1037/a0022898; Bourdage JS, 2007, PERS INDIV DIFFER, V43, P1506, DOI 10.1016/j.paid.2007.04.008; Murray DR, 2013, PERS INDIV DIFFER, V54, P103, DOI 10.1016/j.paid.2012.08.021; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Beall AT, 2014, PERS INDIV DIFFER, V68, P112, DOI 10.1016/j.paid.2014.03.049; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Dunkel CS, 2011, EVOL PSYCHOL-US, V9, P588; Weigold A, 2013, PSYCHOL METHODS, V18, P53, DOI 10.1037/a0031607; Figueredo AJ, 2006, DEV REV, V26, P243, DOI 10.1016/j.dr.2006.02.002; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Hone LSE, 2013, EVOL PSYCHOL-US, V11, P889; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Ten Berge JMF, 2004, PSYCHOMETRIKA, V69, P613; Kawamoto T, 2015, JPN PSYCHOL RES, V57, P254, DOI 10.1111/jpr.12083; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Kanazawa S, 1999, SOC FORCES, V78, P25, DOI 10.2307/3005789; Schmitt DP, 2004, J CROSS CULT PSYCHOL, V35, P367, DOI 10.1177/0022022104266105; Rosseel Y, 2012, J STAT SOFTW, V48, P1; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; Wakabayashi A, 2014, JPN PSYCHOL RES, V56, P211, DOI 10.1111/jpr.12045; BAILEY JM, 1994, J PERS SOC PSYCHOL, V66, P1081, DOI 10.1037/0022-3514.66.6.1081; Bleske-Rechek A, 2009, EVOL PSYCHOL, V7, P179; Brennan K. A., 1998, ATTACHMENT THEORY CL, P46; Costa P., 1992, REVISED NEO PERSONAL; desMiguel A., 2011, J PERS, V79, P563; Geher G., 2007, J SOCIAL EVOLUTIONAR, V1, P18; Holtzman Nicholas S, 2013, Evol Psychol, V11, P1101; Jackson JJ, 2007, EVOL HUM BEHAV, V28, P382, DOI 10.1016/j.evolhumbehav.2007.04.005; Kirkpatrick L. A., 1998, ATTACHMENT THEORY CL, P353; Komura K., 2014, P 78 ANN CONV JAP PS, V18; Makino K., 2011, J BUSINESS ADM INFOR, V19, P41; McArthur R. H., 1967, THEORY ISLAND BIOGEO; Moroi K, 1996, JAPANESE J FAMILY PS, V10, P15; Nakamine S., 2014, P 55 C JAP SOC SOC P, V134; NORTON R, 1983, J MARRIAGE FAM, V45, P141, DOI 10.2307/351302; Ostovich JM, 2004, PERS SOC PSYCHOL B, V30, P1255, DOI 10.1177/0146167204264754; Revelle W., 2014, PSYCH PROCEDURES PER; Schmitt D. P, 2005, HDB EVOLUTIONARY PSY, P851; SHIRAI T, 1994, JPN J PSYCHOL, V65, P54	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					323	336		10.1111/jpr.12092		14	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800006		
J	Umegaki, Y				Umegaki, Yusuke			Effects of contingencies of self-worth and sensitivity to indebtedness on optimistic bias in seeking help for depression	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						help-seeking; optimistic bias; depression; contingencies of self-worth; sensitivity to indebtedness	MENTAL-HEALTH; UNREALISTIC OPTIMISM; COLLEGE-STUDENTS; YOUNG-PEOPLE; ESTEEM; SUSCEPTIBILITY; DETERMINANTS; INTENTIONS; BEHAVIOR; FAMILY	The occurrence of the optimistic bias in seeking help for depressive symptoms has been attributed to the threat-to-self and equity theories. The current study tested the hierarchical relationships between contingencies of self-worth (CSW), self-esteem (SE), sensitivity to indebtedness (SI), and optimistic bias in seeking formal/informal help for depression. An online questionnaire survey was conducted with Japanese university students (n=1000). Results from structural equation modeling analysis revealed the mediating effect of CSW on SE and optimistic bias. SI was positively related to optimistic bias in symptom recognition and informal help-seeking. The results suggest that both CSW and SI are responsible for the occurrence of optimistic bias in seeking help for depression. Cognitive patterns in recognizing personal and others' depressive symptoms and needs for seeking help were discussed.	[Umegaki, Yusuke] Nara Womens Univ, Nara 6308506, Japan	Umegaki, Y (reprint author), Nara Womens Univ, Clin Psychol Course, Nara 6308506, Japan.	y.umegaki@cc.nara-wu.ac.jp					ADAMS JS, 1963, J ABNORM PSYCHOL, V67, P422, DOI 10.1037/h0040968; Aikawa A., 1995, JAPANESE J SOCIAL PS, V11, P63; Naganuma Y, 2006, PSYCHIAT CLIN NEUROS, V60, P240, DOI 10.1111/j.1440-1819.2006.01492.x; Raviv A, 2000, J ADOLESCENCE, V23, P721, DOI 10.1006/jado.2000.0355; WEINSTEIN ND, 1987, J BEHAV MED, V10, P481, DOI 10.1007/BF00846146; Crocker J, 2001, PSYCHOL REV, V108, P593, DOI 10.1037//0033-295X.108.3.593; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037//0033-2909.108.3.480; Crocker J, 2005, CURR DIR PSYCHOL SCI, V14, P200, DOI 10.1111/j.0963-7214.2005.00364.x; Crocker J, 2003, PERS SOC PSYCHOL B, V29, P701, DOI 10.1177/0146167203252881; WALSTER E, 1973, J PERS SOC PSYCHOL, V25, P151, DOI 10.1037/h0033967; Kessler RC, 1998, AM J PSYCHIAT, V155, P62; BECK AT, 1972, POSTGRAD MED, V52, P81; FISHER JD, 1982, PSYCHOL BULL, V91, P27, DOI 10.1037//0033-2909.91.1.27; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; EISENBERGER R, 1987, J PERS SOC PSYCHOL, V53, P743, DOI 10.1037/0022-3514.53.4.743; WEINSTEIN ND, 1982, J BEHAV MED, V5, P441, DOI 10.1007/BF00845372; TESSLER RC, 1972, J PERS SOC PSYCHOL, V21, P318, DOI 10.1037/h0032321; Crocker J, 2003, J PERS SOC PSYCHOL, V85, P894, DOI 10.1037//0022-3514.85.5.894; SchonertReichl KA, 1996, J YOUTH ADOLESCENCE, V25, P705, DOI 10.1007/BF01537450; Spendelow JS, 2010, J GEN PSYCHOL, V137, P190; Rothman AJ, 1996, J APPL SOC PSYCHOL, V26, P1213, DOI 10.1111/j.1559-1816.1996.tb01778.x; Elwy AR, 2011, QUAL HEALTH RES, V21, P1495, DOI 10.1177/1049732311413781; Nagai S, 2010, JPN J EDUC PSYCHOL, V58, P46; ALICKE MD, 1985, J PERS SOC PSYCHOL, V49, P1621, DOI 10.1037/0022-3514.49.6.1621; Pyszczynski T, 2004, PSYCHOL BULL, V130, P425, DOI 10.1037/0033-2909.130.3.425; Beck A. T., 1979, COGNITIVE THERAPY DE; Bramel D, 1968, THEORIES COGNITIVE C, P355; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Feliciano L., 2011, ADULT PSYCHOPATHOLOG, P317; Greenberg M.S., 1980, SOCIAL EXCHANGE ADV, P3, DOI DOI 10.1007/978-1-4613-3087-5_1; Greenberg MS, 1983, NEW DIRECTIONS HELPI, V1, P85; Griffiths KM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-196; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hatfield E., 1983, NEW DIRECTIONS HELPI, V1, P113; NADLER A, 1987, EUR J SOC PSYCHOL, V17, P57, DOI 10.1002/ejsp.2420170106; Nadler A., 1986, ADV EXPT SOCIAL PSYC, V19, P88; Onishi M., 2008, JAPANESE J PERSONALI, V16, P171; Radloff I. S., 1977, APPL PSYCH MEAS, V1, P385; Rickwood D., 2005, AUSTR E J ADV MENTAL, V4, P1; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rothi D. M., 2006, PASTORAL CARE ED, V24, P4, DOI DOI 10.1111/J.1468-0122.2006.00373.X; Schonert-Reichl K. A., 2003, PREVENTION RES, V10, P1; Shepperd JA, 2002, PSYCHOL BELG, V42, P65; Shima S, 1985, CLIN PSYCHIATR, V27, P717; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Uchida Y, 2008, JAPANESE J PSYCHOL, V79, P250, DOI DOI 10.4992/JJPSY.79.250; Umegaki Y., 2014, WEAVING DEPRESSION C, P97; Umegaki Y., 2012, JAPANESE J PSYCHOL, V83, P430; Umegaki Y., 2012, CLIN PSYCHIATR, V54, P287; Yamamoto M., 2001, SHINRI SOKUTEI SHAKU, P199; Yamamoto M., 1982, JAPANESE J ED PSYCHO, V30, P64	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	OCT	2015	57	4					331	U15		10.1111/jpr.12094		17	Psychology, Multidisciplinary	Psychology	CT1IU	WOS:000362552800007		
J	Kasai, A; Harada, T				Kasai, Atsushi; Harada, Takeo			Epimutant Induction as a New Plant Breeding Technology	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						DNA methylation; RNA silencing; transcriptional gene silencing; siRNA long-distance transport	DOUBLE-STRANDED-RNA; TO-CELL MOVEMENT; GENE-EXPRESSION; DNA METHYLATION; SYNTHASE GENE; POTATO; MOBILE; ARABIDOPSIS; SUPPRESSION; INFECTION	A small interfering RNA (siRNA) can be custom-produced in plant cells when a transgene comprising an inverted-repeat sequence is used to form the corresponding double-stranded (ds)RNA. This siRNA induces methylation of the homologous DNA through the RNA-directed DNA methylation (RdDM) pathway. As methylation of the promoter region causes transcriptional gene silencing (TGS), dsRNA for the promoter sequence of a gene can induce TGS of the gene, accompanied by modification of chromatin. Such epigenetic variation provides a novel technique to induce silencing of a target gene. Furthermore, once epigenetic variation has occurred, the siRNA need not be present to maintain the stable repression of transcription even in the subsequent generation. Thus, the induction of epigenetic changes is a potentially new plant-breeding technology to improve crops.	[Kasai, Atsushi; Harada, Takeo] Hirosaki Univ, Fac Agr & Life Sci, Lab Plant Breeding & Genet, Hirosaki, Aomori 0368561, Japan	Harada, T (reprint author), Hirosaki Univ, Fac Agr & Life Sci, Lab Plant Breeding & Genet, Hirosaki, Aomori 0368561, Japan.	tharada@cc.hirosakiu.ac.jp			 [22380003]	This work was supported by the Grant-in-Aid for Scientific Research in Japan (22380003) to T. Harada.	Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Mourrain P, 2007, PLANTA, V225, P365, DOI 10.1007/s00425-006-0366-1; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Cigan AM, 2005, PLANT J, V43, P929, DOI 10.1111/j.1365-313X.2005.02492.x; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Okano Y, 2008, PLANT J, V53, P65, DOI 10.1111/j.1365-313X.2007.03313.x; Otagaki S, 2011, EPIGENETICS-US, V6, P681, DOI 10.4161/epi.6.6.16214; Matsuda Y, 2002, PROTOPLASMA, V220, P51, DOI 10.1007/s00709-002-0027-6; Kanazawa A, 2008, PLANT BIOTECHNOL, V25, P423, DOI 10.5511/plantbiotechnology.25.423; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Liang DC, 2012, PLANT PHYSIOL, V159, P984, DOI 10.1104/pp.112.197129; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Ruiz MT, 1998, PLANT CELL, V10, P937; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; van de Wal MHBJ, 2001, MOL GENET GENOMICS, V265, P1011, DOI 10.1007/s004380100496; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Kanazawa A, 2011, PLANT J, V65, P156, DOI 10.1111/j.1365-313X.2010.04401.x; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; McGarry RC, 2013, TRENDS PLANT SCI, V18, P198, DOI 10.1016/j.tplants.2013.01.004; Bai, 2011, J EXP BOT, V62, P4561; Calarco J. P., CELL, V251, P194; Heilersig H. J., 2006, MOL GEN GENOMICS, V275, P437; Lloret P. G., 2002, PLANT ROOTS HIDDEN H, P127; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Miguel C., J EXP BOT, V62, P3713; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Smet I. D., 2011, NEW PHYTOL, V193, P867; Strpid H., 2013, ELIFE, V2013; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wu R., 2013, PLOS ONE	44	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					301	305				5	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900001		
J	Fukumoto, Y; Suzuki, K; Waki, M; Yasuda, T				Fukumoto, Yasuyuki; Suzuki, Kazuyoshi; Waki, Miyoko; Yasuda, Tomoko			Mitigation Option of Greenhouse Gas Emissions from Livestock Manure Composting	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						nitrification; nitrite-oxidizing bacteria; nitrous oxide	NITROUS-OXIDE EMISSION; PIG MANURE; AMMONIA; N2O; WASTES; CATTLE; SCALE; NH3	Composting of livestock manure is a significant source of greenhouse gases such as nitrous oxide (N2O), but the complexity of the N2O generation pathway hinders efforts to develop effective countermeasures. In this paper, we present one mitigation option for N2O emissions from composting. Nitrite (NO2-) has an important role in N2O generation. It has been observed that significant N2O emissions from composting are induced when NO2- is accumulated during nitrification. Accordingly, in our technique, nitrite-oxidizing bacteria (NOB), as nitrifying bacteria, are added in the middle of composting fermentation to prevent NO2- accumulation. Adding NOB prevents prolonged NO2- accumulation, which had resulted in low N2O emissions. This technique is also cost-effective, because mature compost can be used as an NOB source. Mitigating N2O emissions allows more nitrate nitrogen (NO3-), of high value as fertilizer, to be preserved in the compost product. Moreover, it was confirmed that this technique could be combined with that for NH3 mitigation using chemical reagents. Before actual use, it is necessary to investigate the methods used to determine optimal timing to add NOB source and prevent N2O from being generated from an NO3- reduction.	[Fukumoto, Yasuyuki; Suzuki, Kazuyoshi; Waki, Miyoko; Yasuda, Tomoko] Natl Agr & Food Res Org NARO, Natl Inst Livestock & Grassland Sci, Anim Waste Management & Environm Div, Tsukuba, Ibaraki 3050901, Japan	Fukumoto, Y (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Livestock & Grassland Sci, Anim Waste Management & Environm Div, Tsukuba, Ibaraki 3050901, Japan.	yasuyuki@affrc.go.jp					Jeong YK, 2001, BIORESOURCE TECHNOL, V79, P129, DOI 10.1016/S0960-8524(01)00062-1; He YW, 2001, ENVIRON SCI TECHNOL, V35, P2347, DOI 10.1021/es0011616; Yasuda T, 2009, BIORESOURCE TECHNOL, V100, P1568, DOI 10.1016/j.biortech.2008.09.033; Fukumoto Y, 2006, ENVIRON SCI TECHNOL, V40, P6787, DOI 10.1021/es0611801; Kuroda K, 2004, BIOSCI BIOTECH BIOCH, V68, P286, DOI 10.1271/bbb.68.286; Fukumoto Y, 2009, SOIL SCI PLANT NUTR, V55, P428, DOI 10.1111/j.1747-0765.2009.00376.x; Fukumoto Y, 2003, BIORESOURCE TECHNOL, V89, P109, DOI 10.1016/S0960-8524(03)00060-9; Sommer SG, 2001, EUR J AGRON, V14, P123, DOI 10.1016/S1161-0301(00)00087-3; Fukumoto Y, 2011, BIORESOURCE TECHNOL, V102, P1468, DOI 10.1016/j.biortech.2010.09.089; Jeong YK, 2005, BIORESOURCE TECHNOL, V96, P1, DOI 10.1016/j.biortech.2004.05.028; Petersen SO, 1998, J AGR SCI, V130, P69, DOI 10.1017/S002185969700508X; Czepiel P, 1996, ENVIRON SCI TECHNOL, V30, P2519, DOI 10.1021/es950841j; Blouin M., 1990, CAN J MICROBIOL, V39, P273; Burrows S., 2006, J SCI FOOD AGR, V2, P403; CRUTZEN P. J, 1981, DENITRIFICATION NITR, P17; Fukumoto Y., 2003, AGR ENG INT, V5; IPCC, 2001, 3 IPCC; Osada T., 2000, J MATER CYCLES WASTE, V2, P51, DOI DOI 10.1007/SI0163-999-0018-1; Steinfeld H., 2006, LIV LONG SHAD, P102; Tanahashi T, 2010, JPN J SOIL SCI PLANT, V84, P329	20	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					307	312				6	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900002		
J	Noguchi, M; Ozaki, Y; Azuma, J				Noguchi, Masaki; Ozaki, Yoshihiko; Azuma, Jun-ichi			Recent Progress in Technologies for Enzymatic Peeling of Fruit	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Review						cuticle; emulsifier; persimmon; polygalacturonase; wax	INFUSION; QUALITY; SLICES	Enzymatic peeling of fruit and vegetables is considered superior to conventional peeling methods in terms of minimizing product damage and indeed is expected to improve them. This technology was first proposed for the peeling of citrus fruit and numerous studies on its practical use have been conducted. However, its application to non-citrus fruit and vegetables remains limited. A novel process, including heat treatment prior to enzymatic treatment, is proposed to peel persimmon fruit. Heat treatment induces fine and even cracks on the fruit surface of certain persimmon cultivars, which act as channels via which enzyme solution can enter the peel tissue. Another function of the heat treatment is to inactivate polygalacturonase-inhibiting protein (PGIP), which is inherent in persimmon fruit. Inactivation of PGIP improves the efficiency of enzymatic peeling with exogenous polygalacturonase. Chemical pre-treatments with a food-grade emulsifier solution and a weak basic solution also enhance the permeability of enzyme solution into the peel tissue. These physical and chemical treatments are useful for applying enzymatic peeling to various persimmon cultivars. In future, enzymatic peeling technology is expected to be applied to various agricultural crops as the technology is further refined.	[Noguchi, Masaki] Natl Agr & Food Res Org NARO, NARO Inst Fruit Tree Sci, Plant Physiol & Fruit Chem Div, Tsukuba, Ibaraki 3058605, Japan; [Ozaki, Yoshihiko] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Azuma, Jun-ichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Noguchi, M (reprint author), Natl Agr & Food Res Org NARO, Collaborat & Publ Relat Ctr, Tsukuba, Ibaraki 3058517, Japan.	zhenji@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology	This paper reports the results obtained in the joint project on "City Area Program 2009", "Regional Innovation Cluster Program 2010" and "Regional Innovation Strategy Support Program 2011" sponsored by Ministry of Education, Culture, Sports, Science and Technology.	Adams B., 1991, US Patent, Patent No. 5000967; Murakami Y, 2012, HORTSCIENCE, V47, P1758; Toker I, 2003, LEBENSM-WISS TECHNOL, V36, P215, DOI 10.1016/S0023-6438(02)00203-7; Tsubaki S, 2012, FOOD CHEM, V132, P2135, DOI 10.1016/j.foodchem.2011.12.039; Pretel MT, 2010, ENZYMES IN FRUIT AND VEGETABLE PROCESSING: CHEMISTRY AND ENGINEERING APPLICATIONS, P145, DOI 10.1201/9781420094343-c6; Suutarinen M, 2003, J SCI FOOD AGR, V83, P1556, DOI 10.1002/jsfa.1579; BARMORE CR, 1985, PHYTOPATHOLOGY, V75, P446, DOI 10.1094/Phyto-75-446; Baker RA, 1996, TRENDS FOOD SCI TECH, V7, P279, DOI 10.1016/0924-2244(96)10030-3; Murakami Y, 2012, HORTSCIENCE, V47, P382; Bruemmer J. H., 1981, US Patent, Patent No. 4284651; Gotoh Yukie, 2002, Journal of General Plant Pathology, V68, P57, DOI 10.1007/PL00013054; Lorenzo G. D., 2002, CURR OPIN PLANT BIOL, V5, P295; Matteo A. D., 2006, PHYTOCHEMISTRY, V67, P528, DOI DOI 10.1016/J.PHYTOCHEM.2005.12.025; MCARDLE RN, 1994, FOOD TECHNOL-CHICAGO, V48, P85; Nakanishi H., 2008, JP Patent, Patent No. 4174440; Nalumpang Sarunya, 2002, Journal of General Plant Pathology, V68, P118, DOI 10.1007/PL00013064; Noguchi M., 2013, Nippon Shokuhin Kagaku Kogaku Kaishi = Journal of the Japanese Society for Food Science and Technology, V60, P582, DOI 10.3136/nskkk.60.582; Noguchi M., 2013, JP Patent, Patent No. [2013-243959, 2013243959]; Ozaki Y., 2011, FOOD ENZYME CHEM ITS, P220; Ozaki Y., 2004, JP Patent, Patent No. 3617042; Sakai Y., 2012, JP Patent, Patent No. 4896651	21	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					313	318				6	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900003		
J	Watanabe, Y; Kikuno, H; Asiedu, R; Masunaga, T; Wakatsuki, T				Watanabe, Yoshinori; Kikuno, Hidehiko; Asiedu, Robert; Masunaga, Tsugiyuki; Wakatsuki, Toshiyuki			Comparison of Physicochemical Properties of Soils under Contrasting Land Use Systems in Southwestern Nigeria	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						continuous cultivation; forest restoration; maintain soil fertility; IITA	CONTINUOUS CULTIVATION; MINERALOGICAL COMPOSITION; KAOLINITIC ALFISOL; TROPICAL SOILS; SAVANNA ZONE; WEST-AFRICA; FALLOW; CROP; FERTILITY; CARBON	Soil physicochemical properties were determined for soils under cropland and forest at the headquarters of the International Institute of Tropical Agriculture in Ibadan, Southwestern Nigeria to examine the 30-year effects of different land use on the fertility of five soil series toposequences underlain by a Basement Complex. The cropland had been under cultivation for 30 years, during which mainly maize and yams had been cultivated in rotation with application of chemical fertilizer and intermittent fallow, while the forest had secondary vegetation that had been regenerated during a 30-year period under protection. The findings for cropland indicated an accumulation of available phosphorus and exchangeable potassium, soil compaction and slight depletion of topsoil organic carbon content; and the findings for forest indicated soil acidification and accumulation of exchangeable Ca at the surface soil horizon. These findings suggest the possibility of maintaining soil fertility with a long-term intensive and continuous crop farming system in kaolinitic Alfisol soil over the inland valley toposequences of tropical Africa.	[Watanabe, Yoshinori; Wakatsuki, Toshiyuki] Kinki Univ, Fac Agr, Nara 6318505, Japan; [Kikuno, Hidehiko] Tokyo Univ Agr, Miyako Subtrop Training & Res Farm, Miyakojima, Okinawa 9060103, Japan; [Asiedu, Robert] Int Inst Trop Agr, Ibadan, Nigeria	Wakatsuki, T (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.	wakatuki@life.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS) [19002001]	This work was funded by a Grant-in-Aid for the Specially Promoted Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS Grant-in-Aid No. 19002001 to TW). The authors are very thankful to IITA staff for supporting this study in their fields.	Abe S. S., 2007, Japanese Journal of Tropical Agriculture, V51, P35; Abe S. S., 2007, SOIL SCI PLANT NUTR, V51, P35; Cobo JG, 2002, BIOL FERT SOILS, V36, P87, DOI 10.1007/s00374-002-0496-y; Abe Susumu Shin, 2007, Grassland Science, V53, P33, DOI 10.1111/j.1744-697X.2007.00071.x; Muhr L, 2002, FIELD CROP RES, V78, P197, DOI 10.1016/S0378-4290(02)00135-1; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Egesi CN, 2007, J PHYTOPATHOL, V155, P536, DOI 10.1111/j.1439-0434.2007.01273.x; DETWILER RP, 1986, BIOGEOCHEMISTRY, V2, P67, DOI 10.1007/BF02186966; SANCHEZ PA, 1983, SOIL SCI SOC AM J, V47, P1171; Dijkstra FA, 2002, ECOSYSTEMS, V5, P385, DOI 10.1007/s10021-001-0082-4; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Juo ASR, 1996, PLANT SOIL, V180, P209, DOI 10.1007/BF00015304; Sharma KL, 2009, COMMUN SOIL SCI PLAN, V40, P1436, DOI 10.1080/00103620902818096; ARORA Y, 1982, SOIL SCI SOC AM J, V46, P1212; EWEL JJ, 1986, ANNU REV ECOL SYST, V17, P245; Abe SS, 2006, SOIL SCI PLANT NUTR, V52, P479, DOI 10.1111/j.1747-0765.2006.00060.x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Abe SS, 2009, PEDOSPHERE, V19, P505, DOI 10.1016/S1002-0160(09)60143-0; STUMPE JM, 1991, SOIL SCI SOC AM J, V55, P145; THOMAS ML, 1992, SOIL SCI SOC AM J, V56, P1871; PIERRE WH, 1971, AGRON J, V63, P291; Abe Susumu S., 2009, Grassland Science, V55, P104, DOI 10.1111/j.1744-697X.2009.00146.x; JUO ASR, 1995, PLANT SOIL, V171, P245, DOI 10.1007/BF00010278; Abe SS, 2009, SOIL SCI PLANT NUTR, V55, P514, DOI 10.1111/j.1747-0765.2009.00396.x; Juo ASR, 1995, AGR ECOSYST ENVIRON, V56, P9, DOI 10.1016/0167-8809(95)00635-4; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Vanlauwe B, 2005, PLANT SOIL, V269, P285, DOI 10.1007/s11104-004-0599-3; JUO ASR, 1977, PLANT SOIL, V47, P567, DOI 10.1007/BF00011027; HALL JB, 1979, J ECOL, V67, P321, DOI 10.2307/2259354; Ekleme F., 2004, AGR ECOSYST ENVIRON, V103, P581; IITA, 1979, IITA MAN SER, V1; JAIYEBO E. O., 1964, TROP AGR, V41, P129; JAIYEOBA IA, 1995, SOIL USE MANAGE, V11, P84, DOI 10.1111/j.1475-2743.1995.tb00501.x; JENKINSON DS, 1977, SOIL SCI SOC AM J, V41, P912; Jolley D, 1977, SOIL SCI SOC AM J, V41, P368; Junge B, 2010, SOIL TILL RES, V110, P211, DOI 10.1016/j.still.2010.07.012; Kang B. T., 1986, SMSS TECHNICAL MONOG, V14, P107; LAL R, 1987, SCIENCE, V236, P1069, DOI 10.1126/science.236.4805.1069; Merckx R., 2001, SSSA SPEC PUBL, V58, P69; Moormann F. R., 1975, IITA TECH B, V3; Sahrawat KL, 2001, SOIL SCI SOC AM J, V58, P225; Sanchez P. A., 1997, SSSA SPECIAL PUBLICA, V51, P1; SANCHEZ PA, 1982, SCIENCE, V216, P821, DOI 10.1126/science.216.4548.821; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Smaling E. M. A., 1997, SSSA SPECIAL PUBLICA, V51, P47; Smyth A. J., 1962, SOIL LAND USE CENTRA; Soil Survey Division Staff, 1993, USDA HDB, V18; Soil Survey Staff, 2006, KEYS SOIL TAXONOMY; Van der Kruijs A. C. B. M., 1988, EUR J SOIL SCI, V39, P483	49	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					319	331				13	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900004		
J	Bian, J; Toyota, M; Morokuma, M; Kusutani, A				Bian, Jiabin; Toyota, Masanori; Morokuma, Masahiro; Kusutani, Akihito			Rice Bran Affects Dry-matter Production of Chinese and Japanese Rice Cultivars	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						bleeding rate; growth analysis; light extinction coefficient; the panicle number; type cultivars; root system	LEAF WEIGHT; PHOTOSYNTHESIS; LEAVES; PLANT	The effect of rice bran on dry matter production of different rice cultivars, namely the Chinese panicle weight types and Japanese panicle number types, was evaluated in field conditions, with growth, canopy production structure and the root system determined over a period of 60 days. The treatments consisted of rice cultivars with 1000 kg ha(-1) rice bran without agrochemicals (RB), cultivars with chemical fertilizer and cultivars with herbicide, with the latter serving as a control. The crop growth rate (CGR) and mean leaf area index (mLAI) in RB treatment were lower than that of the control; however, the net assimilation rate (NAR) was higher for all growth stages in this treatment. It was noted that CGR in RB and the control treatment depended greatly on mLAI during the early and middle growth stages, whereas CGR was more dependent on NAR in the late growth stage. Correlation between CGR in middle stage and the extinction coefficient of the canopy (k) at heading was apparent (p < 0.05). NAR in middle stage was positively correlated with mean leaf color and specific leaf weight (SLW). The correlations between NAR in the late stage and bleeding rate per number of primary roots, and per leaf area at maturity was apparent (p < 0.01). Root vitality and NAR were higher in RB treatment. The photosynthesis-related traits after heading in RB treatment were better than the control. Reduction of Delta W in RB treatment as well as the spikelets number (SN) was unapparent. The panicle number type cultivars did not inhibit growth during the early and middle growth stages with the presence of rice bran. The difference between growth, panicle number and weight cultivars was insignificant in the late stage.	[Bian, Jiabin] Tianjin Agr Univ, Coll Agron & Resources & Environm, Tianjin 300384, Peoples R China; [Toyota, Masanori; Kusutani, Akihito] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan; [Morokuma, Masahiro] Kagawa Univ, Fac Agr, Univ Farm, Sanuki, Kagawa 7692304, Japan	Bian, J (reprint author), Tianjin Agr Univ, Coll Agron & Resources & Environm, 22 Jinjing Rd, Tianjin 300384, Peoples R China.	bjb20042001@yahoo.co.jp			Tianjin natural science fund for Scientific Research from the Tianjin Municipal Science and Technology Commission, China [11JCYBJC27100]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [46]; Science&Technology Development Fund of Tianjin Education Commission for Higher Education [20120616]	This research was supported in part by Tianjin natural science fund for Scientific Research (No. 11JCYBJC27100) from the Tianjin Municipal Science and Technology Commission, China. The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (No. 46). This research was supported in part by the Science&Technology Development Fund of Tianjin Education Commission for Higher Education (No. 20120616).	YAMAMOTO Y, 1991, JPN J CROP SCI, V60, P365; BOWES G, 1972, CROP SCI, V12, P77; BARNES DK, 1969, CROP SCI, V9, P421; ISHIHARA K, 1986, JPN J CROP SCI, V55, P458; PEARCE RB, 1969, CROP SCI, V9, P791; DORNHOFF GM, 1970, CROP SCI, V10, P42; Bian J., 2010, NIHONN SAKUMOTSU GAK, V79, P44; Bian J., 2010, NIHONN SAKUMOTSU GAK, V79, P251; CHATTERT.NJ, 1972, CROP SCI, V12, P576; Chiba K., 2001, TOHOKU J CROP SCI, V44, P27; Fukushima Y., 2002, NIHONN SAKUMOTSU GAK, V68, P40; Khan M. A., 1970, IKUSYUGAKU ZASSHI, V20, P344; Kubota F., 1977, NIHON KUSACHI GAKKAI, V23, P101; Kubota F., 1973, NIHON KUSACHI GAKKAI, V19, P201; Kusutani A., 1993, NIHON SAKUMOTSU GAKK, V30, P62; Kusutani A., 1979, NIHON KUSACHI GAKKAI, V25, P16; Lee J. H., 1973, NOGYOU GIJYUTSU KENN, V24, P61; Liu J., 2008, NIHON SAKUMOTSU GAKK, V77, P326; Monsi M., 1953, JAPANESE J BOTANY, V14, P22; Morita S., 2000, ROOT GROWTH ROOT SYS, P194; Morita S., 1999, ROOT RES, V8, P117; Nakazawa F., 1990, NIHON SAKUMOTSU GAKK, V59, P72; OSADA A., 1962, Nihon Sakumotsugaku Kai Kiji = Proceedings of the Crop Science Society of Japan, V30, P220; Qiu B., 1992, NIHON SAKUMOTSU GAKK, V35, P33; Shiotsu F., 2006, NIHON SAKUMOTSU GAKK, V75, P492; Shiotsu F., 2007, NIHON SAKUMOTSU GAKK, V76, P262; Takeda T., 1959, NIHON SAKUMOTSU GAKK, V28, P175	27	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					333	343				11	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900005		
J	Akiyama, Y; Kimura, K; Kubota, A; Fujimori, M; Yamada-Akiyama, H; Takahara, Y; Ueyama, Y				Akiyama, Yukio; Kimura, Kenji; Kubota, Akito; Fujimori, Masahiro; Yamada-Akiyama, Hitomi; Takahara, Yoshinori; Ueyama, Yasufumi			Comparison of Genome Size in Reed Canarygrass (Phalaris arundinacea L.) Exotic and Putative Native Japanese Genotypes by Flow Cytometry	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						invasive plant	NUCLEAR-DNA CONTENT; REFERENCE-STANDARDS; GRASS; ANGIOSPERMS; REDUCTION; EVOLUTION; PLANTS	Reed canarygrass (Phalaris arundinacea L.) is a cool-season perennial grass widely distributed throughout North America, Europe and Asia. P. arundinacea is currently considered a major invasive plant species in the USA. Despite recent concerns that P. arundinacea has become an invasive plant species in Japan, differences between invasive and native Japanese genotypes remain unclear. We used flow cytometry to clarify genome size differences among 14 populations of putative native Japanese P. arundinacea genotypes and three exotic cultivars. The average genome size of the 14 Japanese populations and the three exotic P. arundinacea differed significantly (P < 0.05) and ranged from 4963.90 to 5166.69 Mbp/C. These results implied that the sampled populations included native Japanese genotypes. These populations may be useful in discriminating between invasive and native Japanese P. arundinacea genotypes.	[Akiyama, Yukio; Kubota, Akito; Fujimori, Masahiro] NARO Tohoku Agr Res Ctr, Livestock & Forage Res Div, Morioka, Iwate 0200198, Japan; [Kimura, Kenji; Takahara, Yoshinori] Nagaoka Univ Technol, BioEngn, Nagaoka, Niigata 9402188, Japan; [Yamada-Akiyama, Hitomi] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Ueyama, Yasufumi] Natl Inst Livestock & Grassland Sci, Forage Crop Res Div, Nasushiobara, Tochigi 3292793, Japan	Akiyama, Y (reprint author), NARO Tohoku Agr Res Ctr, Livestock & Forage Res Div, Morioka, Iwate 0200198, Japan.	akky@affrc.go.jp			National Institute of Agrobiological Sciences Genebank, Japan	We would like to express our gratitude to Ms. Setsuko Takahashi, Ms. Sayuri Yamagishi and Messrs. Daisuke Kato, Fumitaka Saitou and Nobuyuki Yoshizawa for their technical assistance. We also thank Dr. Jaroslav Dolezel for kindly providing us with plant standard seeds, and Ms. Yuko Suzuki and Dr. Akinori Oshibe for their assistance in facilitating seed importation. This work was supported by the National Institute of Agrobiological Sciences Genebank, Japan.	Praca-Fontes MM, 2011, PLANT CELL REP, V30, P1183, DOI 10.1007/s00299-011-1026-x; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Akiyama Yukio, 2008, Grassland Science, V54, P89, DOI 10.1111/j.1744-697X.2008.00110.x; Gregory TR, 1999, GENOME RES, V9, P317; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; PRICE HJ, 1980, BOT GAZ, V141, P195, DOI 10.1086/337144; Smarda P, 2008, ANN BOT-LONDON, V101, P421, DOI 10.1093/aob/mcm307; Lavergne S, 2010, ANN BOT-LONDON, V105, P109, DOI 10.1093/aob/mcp271; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Greilhuber J, 2008, ANN BOT-LONDON, V101, P791, DOI 10.1093/aob/mcm250; Suda J, 2010, CYTOM PART A, V77A, P717, DOI 10.1002/cyto.a.20907; MCWILLIAM JR, 1962, AUST J AGR RES, V13, P1, DOI 10.1071/AR9620001; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Lavergne S, 2004, CRIT REV PLANT SCI, V23, P415, DOI 10.1080/07352680490505934; Casler MD, 2009, BIOENERG RES, V2, P165, DOI 10.1007/s12155-009-9043-0; BENNETT MD, 1976, PHILOS T ROY SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Merigliano MF, 1998, NAT AREA J, V18, P223; PFOSSER M, 1995, CYTOMETRY, V21, P387, DOI 10.1002/cyto.990210412; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Bews J. W., 1929, WORLDS GRASSES THEIR, P408; HITCHCOCK A. S., 1935, Manual of the grasses of the United States.; Hokkaido Government, 2010, HOKK BLUE LIST; Hokkaido Government, 2004, HOKK BLUE LIST; Ueyama Y., 2009, ANN REP EXPLOR INTRO, V25, P25; Ueyama Y., 2010, ANN REP EXP INTR PLA, V26, P1	27	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					345	350				6	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900006		
J	Sato, T; Moriwaki, J; Kaneko, S				Sato, Toyozo; Moriwaki, Jouji; Kaneko, Shigeru			Anthracnose Fungi with Curved Conidia, Colletotrichum spp. belonging to Ribosomal Groups 9-13, and Their Host Ranges in Japan	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						beta-tubulin-2; conidial curvature properties; molecular phylogenetic analyses; re-identification; species complex	PRIMER SETS; PHYLOGENIES	Ninety fungal strains with falcate conidia belonging to Colletotrichum spp. classified into the ribosomal groups 9-13 (the RG 9-13 spp.) and preserved at the NIAS Genebank, Japan were re-identified based on molecular phylogenetic analysis of the internal transcribed spacer (ITS) region of the rRNA gene, sequences of the glyceraldehyde 3-phosphate dehydrogenase, chitin synthase 1, histone3, and actin genes, and partial sequences of beta-tubulin-2 (TUB2) genes, or by BLASTN searches with TUB2 gene sequences. Seventy strains were reclassified into nine recently revised species, C. chlorophyti, C. circinans, C. dematium sensu stricto, C. lineola, C. liriopes, C. spaethianum, C. tofieldiae, C. trichellum and C. truncatum, whereas 20 strains were grouped into four unidentified species. RG 9, 10 and 12 corresponded to the C. spaethianum, C. dematium and C. truncatum species complex, respectively, while RG 11 and 13 agreed with C. chlorophyti and C. trichellum, respectively. Phylograms derived from a six-locus analysis and from TUB2 single-locus analysis were very similar to one another with the exception of the association between C. dematium s. str. and C. lineola. Thus, TUB2 partial gene sequences are proposed as an effective genetic marker to differentiate species of RG 9-13 in Japan except for C. dematium s. str. and C. lineola. Thirty-two plant species were identified as new hosts for seven of the species found in this study except for C. circinans and C. trichellum; and two unidentified species. Colletotrichum chlorophyti, C. lineola, C. liriopes, C. spaethianum, and C. truncatum were regarded as polyphagous, whereas C. trichellum and Colletotrichum sp. (Ra), designated tentatively in this study, appeared to have specific pathogenicity to single hosts, Hedera rhombea and Raphanus sativus var. hortensis, respectively. Conidial curvature properties, "outer curvature," "inner curvature" and "height/width ratio" successfully represented conidial shape parameters. Conidial curvature properties of the species in RG 9, 10 and 12 were found to correlate with the species complexes.	[Sato, Toyozo; Kaneko, Shigeru] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan; [Moriwaki, Jouji] Natl Agr & Food Res Org, NARO Kyushu Okinawa Agr Res Ctr, Hort Res Div, Kurume, Fukuoka 8398503, Japan	Sato, T (reprint author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan.	s1043@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	This paper reports results obtained in the NIAS Genebank project sponsored by the Ministry of Agriculture, Forestry and Fisheries, Japan.	Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Crouch JA, 2009, MYCOLOGIA, V101, P717, DOI 10.3852/08-230; Damm U, 2009, FUNGAL DIVERS, V39, P45; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; [Anonymous], 2004, STUDIES MYCOLOGY; Kubota M, 2011, J GEN PLANT PATHOL, V77, P68, DOI 10.1007/s10327-010-0281-y; Tomioka K, 2008, J GEN PLANT PATHOL, V74, P402, DOI 10.1007/s10327-008-0112-6; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323; Guerber JC, 2003, MYCOLOGIA, V95, P872, DOI 10.2307/3762016; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Arx J. A. von, 1981, GENERA FUNGI SPORULA, P315; Arx J. A. von, 1987, PLANT PATHOGENIC FUN, P288; Corda A. K. J., 1831, PILZE DEUTSCHLAND, V3, P41; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Moriwaki Jouji, 2002, Journal of General Plant Pathology, V68, P307, DOI 10.1007/PL00013096; Ohwi J., 1983, NEW FLORA JAPAN, P105; SASAKI K, 1977, T MYCOL SOC JPN, V18, P343; Sato Toyozo, 2005, Journal of General Plant Pathology, V71, P380, DOI 10.1007/s10327-005-0214-3; Sato T., 2008, SHIKOKU SHOKUBUTU BO, V43, P1; Sato T., 2012, CULTURE COLLECT, V28, P121; Sato T, 2014, JARQ-JPN AGR RES Q, V48, P317, DOI 10.6090/jarq.48.317; Sugawara K., 2012, JPN J PHYTOPATHOL, V78, P67; SUTTON B, 1992, CL LIB APPL, P1; Sutton B. C., 1980, COELOMYCETES FUNGI I, P523; TAKIMOTO S., 1934, Ann. phytopath. Soc., V4, P21; The Phytopathological Society of Japan & National Institute of Agrobiological Science, 2012, COMM NAM PLANT DIS J, P1524; Tode H.J., 1790, FUNGI MECKLENBURGENS, V1, P1; von Arx JA, 1957, PHYTOPATHOL Z, V29, P413; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	32	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					351	362				12	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900007		
J	Kudo, R; Masumoto, T; Horikawa, N				Kudo, Ryoji; Masumoto, Takao; Horikawa, Naoki			Modeling of Paddy Water Management with Large Reservoirs in Northeast Thailand and its Application to Climate Change Assessment	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						anthropogenic flow regulation; atmospheric general circulation model; reservoir operation model; water allocation and management model; Monsoon Asia		We developed a water circulation model that incorporates paddy water management, including reservoir operation and water allocation schemes, which is applicable to extensive and well-developed irrigation areas. First, reservoir operation and water allocation and management models were introduced into the water circulation model previously developed by the NIRE. Subsequently, we applied the developed model to assess the impact on irrigation reservoirs of climate change in the Mun River basin of northeast Thailand. As a result, taking into consideration the fluctuation in rainfall, the developed model reproduced the seasonal changes in storage water and water release at two large reservoirs, and monthly diverted water at a major diversion weir. Moreover, introducing the operation of reservoirs and diversion weirs improved the simulation accuracy of river discharges, particularly in dry seasons. According to climate change projections, the impacts of climate change on reservoir operations differed in each reservoir, although the reservoirs are in the same basin. This means that the impacts of climate change on the operation of water-use facilities should be individually assessed. Since the developed model requires only basic information and assumes simple operation rules, this model is useful for assessing impacts on the operation of numerous water-use facilities simultaneously at the macro level.	[Kudo, Ryoji; Horikawa, Naoki] NARO, Natl Inst Rural Engn, Hydraul Engn Res Div, Tsukuba, Ibaraki 3058609, Japan; [Masumoto, Takao] NARO, Natl Inst Rural Engn, Renewable Resources Engn Res Div, Tsukuba, Ibaraki 3058609, Japan	Kudo, R (reprint author), NARO, Natl Inst Rural Engn, Hydraul Engn Res Div, Tsukuba, Ibaraki 3058609, Japan.	rkudo@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries (MAFF), JAPAN	This study was financially supported by the research project "Development of technology for impacts and adaptation of climate change." (Ministry of Agriculture, Forestry and Fisheries (MAFF), JAPAN) and "Impact assessment of climate change impacts on agriculture water use and irrigation facilities in drought and flood periods" (Ministry of Agriculture, Forestry and Fisheries (MAFF), JAPAN). We would particularly like to thank RID, MRC and Mr. Panya of the Hydrology and Water Management Center for the Lower Northeast Region for the field survey and data collection.	Allen R. G., 1998, IRRIG DRAIN; Kiem AS, 2008, HYDROL PROCESS, V22, P1382, DOI 10.1002/hyp.6947; Kusunoki S, 2011, CLIM DYNAM, V37, P2481, DOI 10.1007/s00382-011-1000-x; Masumoto T, 2009, FROM HEADWATERS TO THE OCEAN: HYDROLOGICAL CHANGES AND WATERSHED MANAGEMENT, P195; Eskew EA, 2012, CONSERV BIOL, V26, P504, DOI 10.1111/j.1523-1739.2012.01842.x; Vorosmarty CJ, 1997, AMBIO, V26, P210; McCarthy TK, 2008, HYDROBIOLOGIA, V609, P109, DOI 10.1007/s10750-008-9395-z; Kudo Ryoji, 2012, Transactions of the Japanese Society of Irrigation Drainage and Rural Engineering, V80, P31; Bank of Thailand, 2002, INFLATION REPORT, V4, P22; Chow V.T., 1988, APPL HYDROLOGY, P530; Eastham J., 2008, MEKONG RIVER BASIN W, P131; Forster P., 2012, FOOD SECURITY NCAR F; Hayase Y., 1993, T JAPANESE SOC IRRIG, V165, P75; Horikawa N., 2011, APPL HYDROLOGY, V23, P58; Kitoh A., 2009, HYDROLOGICAL RES LET, V3, P49, DOI DOI 10.3178/HRL.3.49; Li H., 2010, J GEOPHYS RES-ATMOS, V1984-2012, P115, DOI DOI 10.1029/2009JD012882; Ministry of Foreign Affairs of Japan, DEC GREEN MEK IN; MRC, 2009, MRC TECHNICAL PAPPER, V24, P89; Taniguchi T., 2009, Journal of Japan Society of Hydrology and Water Resources, V22, P101, DOI 10.3178/jjshwr.22.101; Taniguchi T., 2009, Journal of Japan Society of Hydrology and Water Resources, V22, P114, DOI 10.3178/jjshwr.22.114; Taniguchi T., 2009, Journal of Japan Society of Hydrology and Water Resources, V22, P126, DOI 10.3178/jjshwr.22.126	21	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					363	376				14	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900008		
J	Sonobe, R; Tani, H; Wang, XF; Kojima, Y; Kobayashi, N				Sonobe, Rei; Tani, Hiroshi; Wang, Xiufeng; Kojima, Yasuhito; Kobayashi, Nobuyuki			Extreme Learning Machine-based Crop Classification using ALOS/PALSAR Images	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						Hokkaido; machine learning; sigma naught	TERRASAR-X DATA; VEGETATION; AREAS	Classification maps are required for agricultural management and the estimation of agricultural disaster compensation. The extreme learning machine (ELM), a newly developed single hidden layer neural network is used as a supervised classifier for remote sensing classifications. In this study, the ELM was evaluated to examine its potential for multi-temporal ALOS/PALSAR images for the classification of crop type. In addition, the k-nearest neighbor algorithm (k-NN), one of the traditional classification methods, was also applied for comparison with the ELM. In the study area, beans, beets, grasses, maize, potato, and winter wheat were cultivated; and these crop types in each field were identified using a data set acquired in 2010. The result of ELM classification was superior to that of k-NN; and overall accuracy was 79.3%. This study highlights the advantages of ALOS/PALSAR images for agricultural field monitoring and indicates the usefulness of regular monitoring using the ALOS-2/PALSAR-2 system.	[Sonobe, Rei] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Tani, Hiroshi; Wang, Xiufeng; Kojima, Yasuhito] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Kobayashi, Nobuyuki] Smart Link Hokkaido, Iwamizawa, Hokkaido 0680034, Japan	Sonobe, R (reprint author), Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan.	reysnb@gmail.com			JSPS KAKENHI Grant [26.5253]	This work was supported by JSPS KAKENHI Grant Number 26.5253. The authors also express their gratitude to the Japan Aerospace Exploration Agency (JAXA) for providing ALOS/PALSAR data.	Foody GM, 2009, INT J REMOTE SENS, V30, P5273, DOI 10.1080/01431160903130937; Bindlish R, 2001, REMOTE SENS ENVIRON, V76, P130, DOI 10.1016/S0034-4257(00)00200-5; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Hirano A, 2013, JARQ-JPN AGR RES Q, V47, P203, DOI 10.6090/jarq.47.203; Kiyono Y, 2011, JARQ-JPN AGR RES Q, V45, P233; Sarker LR, 2011, REMOTE SENS ENVIRON, V115, P968, DOI 10.1016/j.rse.2010.11.010; Sonobe R, 2014, INT J REMOTE SENS, V35, P7898, DOI 10.1080/01431161.2014.978038; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Bargiel D, 2011, REMOTE SENS-BASEL, V3, P859, DOI 10.3390/rs3050859; Hartfield KA, 2013, INT J REMOTE SENS, V34, P6024, DOI 10.1080/01431161.2013.793861; Chakraborty M, 2005, ISPRS J PHOTOGRAMM, V59, P310, DOI 10.1016/j.isprsjprs.2005.05.001; Congalton R. G., 2008, ASSESSING ACCURACY R, P183; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Denoeux F., 1995, IEEE T SYST MAN CYB, V25, P804; Fix E, 1951, 4 USAF SCH AV MED; R core team, R LANG ENV STAT COMP; Sakamoto, 2009, JARQ, V43, P173; Samreth, 2012, JARQ, V46, P187; Sonobe R, 2014, JARQ-JPN AGR RES Q, V48, P471; Sonobe R, 2014, FOREST SYST, V23, P178, DOI 10.5424/fs/2014231-04572; Sonobe R, 2014, JARQ-JPN AGR RES Q, V48, P465; Waisurasingha, 2008, JARQ, V42, P193	22	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					377	381				5	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900009		
J	Nonaka, A; Ono, H				Nonaka, Akihisa; Ono, Hiroshi			Revitalization of Rural Economies though the Restructuring the Self-sufficient Realm - Growth in Small-scale Rapeseed Production in Japan	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						community mill; inducing production effect; local rapeseed production; restoring local production		According to rising social and environmental concerns, the number of small-scale oil mills growing and milling rapeseed has increased over the past decade. This study was undertaken to clarify small-scale rapeseed oil mill production, which is under pressure from mass-produced vegetable oil, and propose the application of this community-based system to developing nations. We analyzed all domestic rapeseed oil mills between 2009 and 2011, and discussed the transition from traditional mills to newly established town office-sponsored mills and its effect on the rural economy. We clarified that small-scale oil mills in rural areas have survived through strong self-sufficient production and have restructured into self-managing local communal businesses. This restructuring of local rapeseed production has had a positive effect on the local community and has revitalized the rural economy. Thus, we concluded that it may be suitable for microcredit in developing nations.	[Nonaka, Akihisa; Ono, Hiroshi] NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan	Nonaka, A (reprint author), NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan.	nonaka@affrc.go.jp					Goto M., 2009, TOHOKU NOUGYOU KEIZA, V27, P14; Goto M., 2008, TOHOKU NOUGYOU KEIZA, V26, P68; Kawate T., 2006, SHOKUHIN KEIZAI KENK, V34, P19; Nonaka A., 2008, JAPANESE J RURAL EC, V80, P33; Nonaka A, 2013, KOKUSAN NATANE NO GE, P1; Nonaka A., 2007, NOUGYOU KEIZAI, V73, P63; Nonaka A., 2011, NOUGYOU KEIEI KENKYU, V48, P66; Ono H., 2011, NOUGYOU KEIZAI KENKY, P184; Ono H., 2011, NOUGYOU KEIEI KENKYU, V49, P121; Sasama Y., 1981, SEIFUN SEIYU GYOU NO; Watanabe T., 2010, TOHOKU NOUGYOU KEIZA, V28, P53	11	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					383	390				8	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900010		
J	Hosomi, A; Isobe, T; Miwa, Y				Hosomi, Akihiro; Isobe, Takeshi; Miwa, Yuka			Shoot Growth and Fruit Production of the 'Masui Dauphine' Variety of Fig (Ficus carica L.) Undergoing Renewal Long Pruning	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						high limb style; leaf-wood ratio; straight-line training		We investigated the shoot growth and fruit production of 'Masui Dauphine' fig trees (Ficus carica L.) with a newly devised "renewal long pruning" method and compared the results with those of conventional short pruning under straight-line training with both normal and high limb styles. This novel pruning method combines long pruning and continuous renewal pruning such that a few dormant shoots remain long and serve both as long mother shoots and as replaceable limbs. In experiments in 2009 and 2010, the shoots sprouted earlier from the renewal long pruning trees than from the short pruning trees. The number of lateral shoots was less in the renewal long pruning trees, indicating the prevention of excess vigour in bearing shoots. Renewal long pruning did not affect total percentage of fruit set; however, it slightly increased fruit set failure in the basal portion of bearing shoots. It potentially induced early maturation and greater enlargement of the fruit. Renewal long pruning was especially useful in high-limb straight-line training because it effectively compensated for disadvantage of this training, such as increasing numbers of lateral shoots and inhibition of fruit enlargement.	[Hosomi, Akihiro; Isobe, Takeshi; Miwa, Yuka] Res Inst Environm Agr & Fisheries, Dept Agr & Food Safety Res, Habikino, Osaka 5830862, Japan	Hosomi, A (reprint author), Res Inst Environm Agr & Fisheries, Dept Agr & Food Safety Res, Habikino, Osaka 5830862, Japan.	hosomi@mbox.kannousuiken-osaka.or.jp			Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries	This study was supported by the Research and Development Projects for Application in Promoting New Policy of Agriculture Forestry and Fisheries.	Hosomi A, 2013, J JPN SOC HORTIC SCI, V82, P215; Yahata D, 2000, J JPN SOC HORTIC SCI, V69, P202; Kawamata M, 2002, J JPN SOC HORTIC SCI, V71, P177; ARAKI H, 1982, J JPN SOC HORTIC SCI, V51, P278; CONDIT IRA J., 1955, HILGARDIA, V23, P323; FORSHEY C. G., 1970, Horticultural Science, V5, P164; Gerber H. J., 2012, ACTA HORTIC, V940, P89; Gonzalez-Rodriguez A. M., 2010, ACTA HORTIC, V872, P333; Hosomi A., 1997, B OSAKA AGR FOR CENT, V33, P24; Kabumoto T, 1986, SPECIAL B HYOGO PREF, P1; Kabumoto T., 1985, KAJUZENSHO UME ICHI, P281; Kabumoto T., 1985, B HYOGO PREFECTURAL, V33, P74; Kanafusa K, 1985, B FUKUOKA AGR RES B, VB-5, P25; Kanato K., 1968, B HORTICULTURAL RES, VA-7, P145	14	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					391	397				7	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900011		
J	Tangjitwattanachai, N; Phaowphaisal, I; Otsuka, M; Sommart, K				Tangjitwattanachai, Natthamon; Phaowphaisal, Ittipon; Otsuka, Makoto; Sommart, Kritapon			Enteric Methane Emission, Energetic Efficiency and Energy Requirements for the Maintenance of Beef Cattle in the Tropics	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						cattle; energy requirements; enteric methane; tropical	BODY-COMPOSITION; MATURE CATTLE; DYNAMIC-MODEL; LEVEL; DIGESTIBILITY; BRAHMAN; STEERS; GRASS; SHEEP; DIETS	This study was conducted to determine the energy balance of beef cattle by indirect animal calorimetry utilizing a ventilated head box respiration system. Fifteen native Thai bulls were randomly allocated to one of three dietary metabolizable energy intake (MEI) levels (1.1 x maintenance, 1.5 x maintenance and 1.9 x maintenance) in a completely randomized design for a 116 day feeding trial. Animals were allocated to individual metabolic cages for the determination of digestibility and energy balance. Heat production was determined from oxygen consumption, carbon dioxide and methane production. The results showed that dry matter, organic matter and crude protein intake were increased (P < 0.01), but digestibility of all nutrients, except neutral detergent fiber, was not significantly affected (P > 0.05) by MEI levels. The energy loss in feces and urine (% of gross energy intake) were not different (P > 0.05); however, enteric methane conversion rate (% of methane energy loss per gross energy intake) and heat energy production loss (% gross energy intake) were linearly decreased (P < 0.01) with increasing MEI levels. Methane conversion rates ranged from 8.4 to 10.0% and appeared to have been underestimated by the Intergovernmental Panel on Climate Change 6.5% default values set for cattle fed low quality crop residues and by-products. The estimate of metabolizable energy requirements for maintenance was measured using linear regression analysis derived for native Thai cattle was 520 kilojoules per kilogram of metabolic body weight per day. Increased dietary intake levels reduced enteric methane emissions in beef cattle fed on tropical feedstuffs. The results of the present study indicated that greater dietary intake feeding strategy in cattle fed above the maintenance level resulted in improved energetic efficiency utilization, and thus improved energy retention because of the reduction of enteric methane energy emission and heat production.	[Tangjitwattanachai, Natthamon; Sommart, Kritapon] Khon Kaen Univ, Dept Anim Sci, Khon Kaen 40002, Thailand; [Phaowphaisal, Ittipon] Khon Kaen Anim Nutr Res & Dev Ctr, Dept Livestock Dev, Khon Kaen 40260, Thailand; [Otsuka, Makoto] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan	Sommart, K (reprint author), Khon Kaen Univ, Dept Anim Sci, Khon Kaen 40002, Thailand.	kritapon@kku.ac.th			Khon Kaen University; Japan International Research Center for Agricultural Sciences; Department of Livestock Development	The authors wish to express their thanks to Khon Kaen University, Japan International Research Center for Agricultural Sciences and Department of Livestock Development for their support of and collaboration in this research project. Acknowledgement is extended to Prof. James A. Will for manuscript preparation.	Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; Sauvant D, 2007, EAAP PUBLIC, P561; Kurihara M, 1999, BRIT J NUTR, V81, P227; Williams CB, 2003, J ANIM SCI, V81, P1371; Ferrell CL, 1998, J ANIM SCI, V76, P647; LIANG JB, 1995, LIVEST PROD SCI, V41, P19, DOI 10.1016/0301-6226(94)00032-3; Tedeschi LO, 2002, J ANIM SCI, V80, P1671; Pittroff W, 2006, LIVEST SCI, V101, P262, DOI 10.1016/j.livprodsci.2005.11.018; SOLIS JC, 1988, J ANIM SCI, V66, P764; Yan T, 2002, ANIM SCI, V75, P141; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Gabel M, 2003, J DAIRY SCI, V86, P3992; Hindrichsen IK, 2003, EAAP PUBLIC, P413; Beauchemin KA, 2006, CAN J ANIM SCI, V86, P401; Ferrell CL, 2008, J ANIM SCI, V86, P2779, DOI 10.2527/jas.20080954; Williams CB, 2003, J ANIM SCI, V81, P1382; Bartlett KS, 2006, J ANIM SCI, V84, P1454; Olson KC, 2008, J ANIM SCI, V86, P1372, DOI 10.2527/jas.2007-0564; O'Mara FP, 1999, ANIM FEED SCI TECH, V81, P167, DOI 10.1016/S0377-8401(99)00082-6; Dawson LER, 1998, J AGR SCI, V131, P477, DOI 10.1017/S0021859698005942; Johnson DE, 1996, ENVIRON MONIT ASSESS, V42, P133, DOI 10.1007/BF00394046; Chuntrakort P, 2014, LIVEST SCI, V161, P80, DOI 10.1016/j.livsci.2014.01.003; Staerfl SM, 2012, AGR ECOSYST ENVIRON, V148, P111, DOI 10.1016/j.agee.2011.11.003; Chaokaur A, 2015, AGR ECOSYST ENVIRON, V199, P225, DOI 10.1016/j.agee.2014.09.014; Luo J, 2004, SMALL RUMINANT RES, V53, P231, DOI 10.1016/j.smallrumres.2004.04.006; KRISHNA G, 1978, INDIAN J ANIM SCI, V48, P366; Chaokaur A, 2007, EAAP PUBLIC, P505; Lassey KR, 2007, AGR FOREST METEOROL, V142, P120, DOI 10.1016/j.agrformet.2006.03.028; AOAC, 1990, OFFICIAL METHODS ANA; Brouwer E., 1965, ENERGY METABOLISM, P441; Chandramoni S, 2000, ANIM FEED SCI TECHNO, V83, P287, DOI 10.1016/S0377-8401(99)00132-7; Gerber P, 2013, TACKLING CLIMATE CHA; IPCC, 2006, GUID NAT GREENH INV, V4; Kearl L. C., 1982, NUTR REQUIREMENTS RU; LOFGREEN GP, 1968, J ANIM SCI, V27, P793; Nimz C. K., 1988, GUIDE CARE USE AGR A; Nitipot P., 2009, 64 JIRCAS, P45; NRC, 2000, NUTR REQ BEEF CATTL; NRC, 1976, NUTR REQ BEEF CATTL; SAS, 1996, SAS US GUID STAT VER; Steinfeld H, 2006, LIVESTOCKS LONG SHAD; Suzuki T, 2008, JARQ-JPN AGR RES Q, V42, P123; Van Soest PJ, 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Woods V. B., 1999, LIVEST PROD SCI, V80, P135; WTSR, 2008, NUTR REQ BEEF CATTL	46	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					399	407				9	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900012		
J	Uchino, H; Watanabe, T; Ramu, K; Sahrawat, KL; Marimuthu, S; Wani, SP; Ito, O				Uchino, Hiroshi; Watanabe, Takeshi; Ramu, Karri; Sahrawat, Kanwar L.; Marimuthu, Subramanian; Wani, Suhas P.; Ito, Osamu			Dynamics of Fertilizer Nitrogen Applied to Sweet Sorghum (Sorghum bicolor (L.) Moench) in the Semi-Arid Tropics	JARQ-JAPAN AGRICULTURAL RESEARCH QUARTERLY			English	Article						N-15-labeled urea; fertilizer application timing; nitrogen recovery efficiency	DIFFERENCE-METHODS; USE EFFICIENCY; STAY-GREEN; RECOVERY; SOIL; SENESCENCE; FIXATION; ALFISOLS; SYSTEMS; FIELD	Although sweet sorghum is in focus as a promising multi-purpose crop in semi-arid tropical regions, information on optimum nitrogen (N) management remains rather limited. To determine and understand the N dynamics in sweet sorghum-soil ecosystem, we evaluated the N recovery of applied fertilizer in the Alfisol field during the 2009 and 2010 rainy seasons. Sweet sorghum was grown under six N rates (0, 30, 60, 90, 120 and 150 kg N ha(-1)) with split application (at 0, 30 and 60 days after sowing) and N concentration and N recovery efficiency (NRE) were measured. In addition, to determine the fate of basal and topdressed N, N-15-labeled urea was applied at each application timing within main plots of 90 kg N ha(-1). There was no significant difference in NRE calculated by the difference method between six N rates and N uptake rose with increasing N rate. The total dry weight and sugar yield increased at rates up to 90 kg N ha(-1) and higher N rates did not significantly affect sorghum productivity. As a total of basal and topdressing applications, 33% of the applied N-15-labeled urea was absorbed by the sorghum plant, while 36 and 30% remained in the soil and unaccounted for, respectively. The NRE calculated by the isotopic method was about 39 and 37% for topdressings at 30 and 60 days after sowing, respectively. The distribution ratio of absorbed N in leaves was higher for basal applications and topdressing at 30 days after sowing, while that in grains was higher for topdressing at 60 days after sowing, compared to the other application timings. In contrast to topdressings, the NRE was very low (13%) for basal N application: about 70% of the basal applied N remained in the soil at the physiological maturity. The results imply that the NRE might be increased by improving the ways in which basal N is applied.	[Uchino, Hiroshi; Watanabe, Takeshi; Ramu, Karri; Sahrawat, Kanwar L.; Wani, Suhas P.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Watanabe, Takeshi] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Marimuthu, Subramanian] Tamil Nadu Agr Univ, Dept Nano Sci & Technol, Coimbatore 641003, Tamil Nadu, India; [Ito, Osamu] United Nations Univ, Inst Adv Study Sustainabil, Shibuya Ku, Tokyo 1500001, Japan	Uchino, H (reprint author), Natl Agr & Food Res Org NARO, Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan.	uchino17@affrc.go.jp			Japan's Ministry of Agriculture, Forestry and Fisheries (MAFF)	This study was part of a research project titled "Development of sustainable soil fertility management for sorghum and sweet sorghum through effective use of biological nitrification inhibition (BNI)" and was funded by a grant from Japan's Ministry of Agriculture, Forestry and Fisheries (MAFF).	Adu-Gyamfi J. J., 1996, DYNAMICS ROOTS NITRO, P453; Raun WR, 1999, AGRON J, V91, P357; Sugihara S, 2010, SOIL SCI PLANT NUTR, V56, P813, DOI 10.1111/j.1747-0765.2010.00516.x; Serrao MG, 2012, COMMUN SOIL SCI PLAN, V43, P2376, DOI 10.1080/00103624.2012.708076; Uchino H, 2013, J PLANT NUTR, V36, P1640, DOI 10.1080/01904167.2013.799190; Harada H, 2000, SOIL SCI PLANT NUTR, V46, P97, DOI 10.1080/00380768.2000.10408766; HAUCK RD, 1976, ADV AGRON, V28, P219, DOI 10.1016/S0065-2113(08)60556-8; Follett RF, 2002, J SOIL WATER CONSERV, V57, P402; VARVEL GE, 1990, AGRON J, V82, P935; AduGyamfi JJ, 1997, NUTR CYCL AGROECOSYS, V48, P197, DOI 10.1023/A:1009788818738; MORAGHAN JT, 1984, PLANT SOIL, V80, P21, DOI 10.1007/BF02232936; Turgut I, 2005, ACTA AGR SCAND B-S P, V55, P236, DOI 10.1080/09064710510029051; Blummel M, 2009, ANIM NUTR FEED TECHN, V9, P1; Stevens WB, 2005, AGRON J, V97, P1046, DOI 10.2134/agronj2003.0313; Harris K, 2007, J EXP BOT, V58, P327, DOI 10.1093/jxb/erl225; Uchino H, 2013, JARQ-JPN AGR RES Q, V47, P65; Yang YM, 2011, NUTR CYCL AGROECOSYS, V90, P379, DOI 10.1007/s10705-011-9439-z; Sanchez AC, 2002, PLANT MOL BIOL, V48, P713, DOI 10.1023/A:1014894130270; MCBEE GG, 1983, CROP SCI, V23, P372; Han LP, 2011, FIELD CROP RES, V120, P230, DOI 10.1016/j.fcr.2010.10.007; Borrell AK, 2000, CROP SCI, V40, P1295; SAHRAWAT KL, 1984, PLANT SOIL, V78, P401, DOI 10.1007/BF02450373; Jia SL, 2011, NUTR CYCL AGROECOSYS, V90, P331, DOI 10.1007/s10705-011-9433-5; Harmsen K, 2003, NJAS-WAGEN J LIFE SC, V50, P321; Burford J. R., 1988, C SOIL FERT FERT MAN, P53; Reddy DD, 2000, BIOL FERT SOILS, V32, P24, DOI 10.1007/s003740000208; Duncan R. R., 1984, SORGHUM ROOT STALK R, P99; MCINTOSH MS, 1983, AGRON J, V75, P153; HARMSEN K, 1988, PLANT SOIL, V105, P55, DOI 10.1007/BF02371143; Pathak, 2013, AGR WATER MANAGE, V118, P12; Prabhakar Pathak, 2013, Agricultural Sciences, V4, P36; Ramu K, 2012, SCI TOTAL ENVIRON, V438, P9, DOI 10.1016/j.scitotenv.2012.08.005; Reddy B. V. S., 2005, International Sorghum and Millets Newsletter, V46, P79; Reddy P. S., 2008, Journal of SAT Agricultural Research, V6, P1; Srinivasa Rao P., 2009, INFORM B, V77; Thorburn P. J., 2007, P INT SOC SUGAR CANE, V26, P302; TOBITA S, 1994, BIOL FERT SOILS, V17, P241, DOI 10.1007/BF00383976; Venkateswarlu, 1978, PANTNAGAR J RES, V3, P36; YAMAGUCHI J, 1991, JARQ-JPN AGR RES Q, V25, P93	39	0	0	JAPAN INT RESEARCH CENTER AGRICULTURAL SCIENCES	IBARAKI	TSUKUBA, IBARAKI, 305-8686, JAPAN	0021-3551			JARQ-JPN AGR RES Q	Jarq - Jpn. Agric. Res. Q.	OCT	2015	49	4					409	418				10	Agriculture, Multidisciplinary	Agriculture	CS6ZL	WOS:000362232900013		
J	Koizumi, H; Uda, S; Fujiwara, K; Tachibana, M; Kojima, K; Nozawa, J				Koizumi, H.; Uda, S.; Fujiwara, K.; Tachibana, M.; Kojima, K.; Nozawa, J.			Crystallization of high-quality protein crystals using an external electric field	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						protein crystallization; external electric fields	WHITE LYSOZYME CRYSTALS; X-RAY-DIFFRACTION; PROSTAGLANDIN D SYNTHASE; GEL-ACUPUNCTURE METHOD; MAGNETIC-FIELD; NUCLEATION RATE; DIELECTRIC-PROPERTIES; CYTOCHROME-C; GROWTH; MICROGRAVITY	The effect of a 20 kHz external electric field on the quality of tetragonal hen egg white (HEW) lysozyme crystals was investigated using X-ray diffraction rocking-curve measurements. The full width at half-maximum was found to be larger for high-order reflections but smaller for low-order reflections. In particular, it was revealed that a large amount of local strain is accumulated in tetragonal HEW lysozyme crystals grown under an applied field at 20 kHz. Comparison with previous results obtained for crystals grown with an applied field at 1 MHz [Koizumi, Uda, Fujiwara, Tachibana, Kojima & Nozawa (2013). J. Appl. Cryst. 46, 25-29] indicated that improvement of the protein crystal quality could be achieved by selection of an appropriate frequency for the applied electric field, which has a significant effect on the growth of the solid.	[Koizumi, H.; Uda, S.; Fujiwara, K.; Nozawa, J.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Tachibana, M.] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Kojima, K.] Yokohama Soei Univ, Dept Educ, Midori Ku, Yokohama, Kanagawa 2260015, Japan	Koizumi, H (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	h_koizumi@imr.tohoku.ac.jp	UDA, Satoshi/B-3728-2011		Ministry of Education, Culture, Sports, Science and Technology of Japan [15K14484]; Photon Factory Program Advisory Committee of KEK [2011G073, 2012G504]	The authors thank Professor M. Saito and Dr S. Nambu at the Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, for X-ray analysis of the lysozyme crystals. This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 15K14484) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. X-ray diffraction rocking-curve measurements were performed at the Photon Factory under the auspices of the Photon Factory Program Advisory Committee of KEK (proposal Nos. 2011G073 and 2012G504).	Al-Haq M. I., 2007, CRYSTALLOGR REV, V13, P29, DOI 10.1080/08893110701421463; Koizumi H, 2010, J CRYST GROWTH, V312, P3503, DOI 10.1016/j.jcrysgro.2010.09.006; Mirkin N, 2008, PROTEINS, V70, P83, DOI 10.1002/prot.21452; LAOGUN AA, 1984, PHYS MED BIOL, V29, P519, DOI 10.1088/0031-9155/29/5/004; Kinoshita T, 2003, ACTA CRYSTALLOGR D, V59, P1333, DOI 10.1107/S0907444903008187; Wakamatsu T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3648114; Otalora F, 2009, PROG BIOPHYS MOL BIO, V101, P26, DOI 10.1016/j.pbiomolbio.2009.12.004; BLAKE CCF, 1962, NATURE, V196, P1173, DOI 10.1038/1961173a0; Koizumi H, 2012, J CRYST GROWTH, V352, P155, DOI 10.1016/j.jcrysgro.2012.03.006; MCPHERSON A, 1993, J PHYS D APPL PHYS, V26, pB104, DOI 10.1088/0022-3727/26/8B/016; Dong J, 1999, ACTA CRYSTALLOGR D, V55, P745, DOI 10.1107/S0907444998016047; Kadowaki A, 2006, CRYST GROWTH DES, V6, P2398, DOI 10.1021/cg050587z; Lin SX, 2000, BIOCHEM BIOPH RES CO, V275, P274, DOI 10.1006/bbrc.2000.3294; Sato T, 2000, ACTA CRYSTALLOGR D, V56, P1079, DOI 10.1107/S0907444900008155; Revalor E, 2010, J CRYST GROWTH, V312, P939, DOI 10.1016/j.jcrysgro.2010.01.006; Mirkin N, 2003, ACTA CRYSTALLOGR D, V59, P1533, DOI 10.1107/S0907444903013027; Garcia-Ruiz JM, 2001, J CRYST GROWTH, V232, P165, DOI 10.1016/S0022-0248(01)01146-0; Wakayama NI, 2003, CRYST GROWTH DES, V3, P17, DOI 10.1021/cg025565g; Wakamatsu T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.048003; Rashkovich LN, 2008, PHYS SOLID STATE+, V50, P631, DOI 10.1134/S1063783408040069; GARCIARUIZ JM, 1994, ACTA CRYSTALLOGR D, V50, P484, DOI 10.1107/S0907444993014350; Sugiyama S, 2012, J AM CHEM SOC, V134, P5786, DOI 10.1021/ja301584y; Koizumi H, 2009, CRYST GROWTH DES, V9, P2420, DOI 10.1021/cg801315p; Maruyama M, 2012, CRYST GROWTH DES, V12, P2856, DOI 10.1021/cg300025b; Hou D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938887; Lubbert D, 2004, ACTA CRYSTALLOGR D, V60, P987, DOI 10.1107/S0907444904005268; Takahashi S, 2010, ACTA CRYSTALLOGR F, V66, P846, DOI 10.1107/S1744309110020828; Perez Y, 2008, CRYST GROWTH DES, V8, P2493, DOI 10.1021/cg800135s; Penkova A, 2005, J CRYST GROWTH, V275, pE1527, DOI 10.1016/j.jcrysgro.2004.11.186; Al-Haq MI, 2007, J APPL CRYSTALLOGR, V40, P199, DOI 10.1107/S0021889806049028; Charron C, 2003, J APPL CRYSTALLOGR, V36, P1482, DOI 10.1107/S0021889803022908; Koizumi H, 2014, CRYST GROWTH DES, V14, P5662, DOI 10.1021/cg500946b; Koizumi H, 2011, LANGMUIR, V27, P8333, DOI 10.1021/la2010985; Lorber B, 1999, J CRYST GROWTH, V204, P357, DOI 10.1016/S0022-0248(99)00184-0; Taleb M, 1999, J CRYST GROWTH, V200, P575, DOI 10.1016/S0022-0248(98)01409-2; PALMER KJ, 1948, J AM CHEM SOC, V70, P906, DOI 10.1021/ja01183a007; Sato M, 2006, MICROGRAVITY SCI TEC, V18, P184, DOI 10.1007/BF02870406; Koizumi H, 2013, J APPL CRYSTALLOGR, V46, P25, DOI 10.1107/S0021889812048716; Hammadi Z, 2007, CRYST GROWTH DES, V7, P1472, DOI 10.1021/cg070108r; Penkova A, 2006, ANN NY ACAD SCI, V1077, P214, DOI 10.1196/annals.1362.048; Vidal O, 1999, J CRYST GROWTH, V196, P559, DOI 10.1016/S0022-0248(98)00917-8; HORDON MJ, 1961, ACTA METALL MATER, V9, P237, DOI 10.1016/0001-6160(61)90073-6; Nanev CN, 2001, J CRYST GROWTH, V232, P285, DOI 10.1016/S0022-0248(01)01169-1; Koizumi H, 2014, AIP CONF PROC, V1618, P265, DOI 10.1063/1.4897724; COLAPIETRO M, 1992, J APPL CRYSTALLOGR, V25, P192, DOI 10.1107/S0021889891011445; Taleb M, 2001, J CRYST GROWTH, V232, P250, DOI 10.1016/S0022-0248(01)01167-8; Koizumi H, 2010, CRYST GROWTH DES, V10, P2591, DOI 10.1021/cg901621x; DELUCAS LJ, 1989, SCIENCE, V246, P651, DOI 10.1126/science.2510297; Moreno A, 2004, J CRYST GROWTH, V264, P438, DOI 10.1016/j.jcrysgro.2004.12.071; Moreno A, 2007, CRYST RES TECHNOL, V42, P231, DOI 10.1002/crat.200610805; Vekilov PG, 1998, J PHYS CHEM B, V102, P5208, DOI 10.1021/jp973123n; SNELL EH, 1995, ACTA CRYSTALLOGR D, V51, P1099, DOI 10.1107/S0907444995012170; Kudryavtsev AB, 2000, J CRYST GROWTH, V219, P102, DOI 10.1016/S0022-0248(00)00602-3; Inaka K, 2011, CRYST GROWTH DES, V11, P2107, DOI 10.1021/cg101370v; Ataka M, 2002, ACTA CRYSTALLOGR D, V58, P1708, DOI 10.1107/S0907444902014415; AYERS JE, 1994, J CRYST GROWTH, V135, P71, DOI 10.1016/0022-0248(94)90727-7; Gavira JA, 2002, ACTA CRYSTALLOGR D, V58, P1653, DOI 10.1107/S0907444902014609; Maeno N., 1988, THE SCIENCE OF ICE; Vekilov PG, 2002, ACTA CRYSTALLOGR D, V58, P1611, DOI 10.1107/S0907444902014312; Yoshikawa S., 2012, ONCOGENE, V32, P27	60	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	OCT	2015	48		5				1507	1513		10.1107/S1600576715015885		7	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CT0QA	WOS:000362500100015		
J	Taguchi, S; Hosokawa, K; Ogawa, Y				Taguchi, Satoshi; Hosokawa, Keisuke; Ogawa, Yasunobu			Three-dimensional imaging of the plasma parameters of a moving cusp aurora	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Cusp aurora; Ion temperature; Electron density; Three-dimensional images	POLAR-CAP PATCHES; ALIGNED CURRENT REGIONS; ELECTRIC-FIELDS; HIGH-LATITUDES; FLUX-TRANSFER; ION UPFLOW; F-REGION; RECONNECTION; TEMPERATURE; IONOSPHERE	During a period of negative IMF B-Z on 13 January 2013, an all-sky imager at Longyearbyen, Svalbard observed a mesoscale aurora moving towards the east-northeast in the cusp, passing through the field of view of the EISCAT Svalbard Radar (ESR) elevation scan. The elevation scans that were being performed at that time have a horizontal coverage of approximately 300 km, at an altitude of 300 km. The plasma data obtained from the elevation scans and the 630-nm aurora emission data from the all-sky imager have shown that ion temperature enhanced 50-60 s earlier than electron density, and that the maximum auroral intensity in the ESR's field of view occurred about 40 s after the electron density enhancement. On the basis of these results we have constructed three-dimensional images of elevated ion temperatures and enhanced electron density associated with the mesoscale moving cusp aurora. The three-dimensional image shows that the enhancement of the ion temperature is prominent in the horizontal area of similar to 160 km x similar to 80 km below an altitude of similar to 300 km, and that this volume forms on the forward side of the enhanced electron density region. We interpret these configurations as being a result of a mesoscale twin-cell convection, which is embedded in the background flow such that the symmetrical axis of the twin-cell is inclined from the background flow direction by several tens of degrees. Our method for visualizing three-dimensional features such as these could be an effective approach to understanding the mesoscale dynamics of the cusp, which is usually located in latitudes that are difficult for the currently-operated radars that permit three-dimensional, simultaneous measurements to investigate. (C) 2015 Elsevier Ltd. All rights reserved.	[Taguchi, Satoshi; Hosokawa, Keisuke] Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan; [Taguchi, Satoshi; Hosokawa, Keisuke] Univ Electrocommun, Ctr Space Sci & Radio Engn, Tokyo 1828585, Japan; [Taguchi, Satoshi] Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan; [Ogawa, Yasunobu] Natl Inst Polar Res, Tokyo 1908518, Japan; [Ogawa, Yasunobu] SOKENDAI Grad Univ Adv Studies, Dept Polar Sci, Hayama, Kanagawa 2400193, Japan	Taguchi, S (reprint author), Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan.	taguchi@kugi.kyoto-u.ac.jp			JSPS KAKENHI [22340143]	We would like to thank T. Aoki of University of Electro-Communications for his maintenance of the all-sky imager. We also thank F. Sigernes and M. Dyrland for their help at the University Centre in Svalbard, Longyearbyen. The assistance of Y. Sagawa, Y. Harano, and K. Sasaki with computational aspects of this research is acknowledged. EISCAT is an international association supported by research organizations in China, Finland, Germany (till end 2011), Japan, Norway, Sweden, and the United Kingdom. OMNI solar wind data were provided through the NASA CDAWeb. This work was supported by JSPS KAKENHI Grant number 22340143.	Hosokawa K, 2013, J GEOPHYS RES-SPACE, V118, P447, DOI 10.1029/2012JA018165; Bahcivan H, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043632; CONRAD JR, 1979, J GEOPHYS RES-SPACE, V84, P811, DOI 10.1029/JA084iA03p00811; Ogawa Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013817; Frey HU, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009861; WAHLUND JE, 1992, J GEOPHYS RES, V97, P3019, DOI 10.1029/91JA02438; SCHUNK RW, 1976, J GEOPHYS RES-SPACE, V81, P3271, DOI 10.1029/JA081i019p03271; Ogawa Y, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009590; SCHUNK RW, 1982, J GEOPHYS RES-SPACE, V87, P5169, DOI 10.1029/JA087iA07p05169; Carlson HC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014087; Davies JA, 2002, ANN GEOPHYS-GERMANY, V20, P781; Taguchi S, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014128; NEWELL PT, 1989, J GEOPHYS RES, V94, P8921, DOI 10.1029/JA094iA07p08921; Hosokawa K, 2013, J GEOPHYS RES-SPACE, V118, P6536, DOI 10.1002/jgra.50577; Kelly JD, 2009, J ATMOS SOL-TERR PHY, V71, P635, DOI 10.1016/j.jastp.2009.01.009; Milan SE, 1999, ANN GEOPHYS-ATM HYDR, V17, P159, DOI 10.1007/s00585-999-0159-5; Mende SB, 2000, SPACE SCI REV, V91, P243, DOI 10.1023/A:1005271728567; Moen J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020129; HAERENDEL G, 1978, J GEOPHYS RES-SPACE, V83, P3195, DOI 10.1029/JA083iA07p03195; FRANKE R, 1982, COMPUT MATH APPL, V8, P273, DOI 10.1016/0898-1221(82)90009-8; Oksavik K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019838; RUSSELL CT, 1978, SPACE SCI REV, V22, P681; Moen J, 2004, ANN GEOPHYS-GERMANY, V22, P1973; Taguchi S, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA018150; LOCKWOOD M, 1989, GEOPHYS RES LETT, V16, P33, DOI 10.1029/GL016i001p00033; SUGIURA M, 1982, GEOPHYS RES LETT, V9, P985, DOI 10.1029/GL009i009p00985; Banks P.M., 1973, AERONOMY A; FASEL GJ, 1995, J GEOPHYS RES-SPACE, V100, P11891, DOI 10.1029/95JA00854; ISHII M, 1992, J GEOPHYS RES, V97, P13877, DOI 10.1029/92JA00110; LOCKWOOD M, 1993, J GEOPHYS RES, V98, P15571, DOI 10.1029/93JA00811; Rees M. H., 1989, PHYS CHEM UPPER ATMO; SANDHOLT PE, 1986, J GEOPHYS RES, V91, P63, DOI 10.1029/JA091iA09p10063; Sandholt PE, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010066; SOUTHWOOD DJ, 1987, J GEOPHYS RES, V92, P3207, DOI 10.1029/JA092iA04p03207; Southwood D.J., 1985, ADV SPACE RES, V5, P7, DOI 10.1016/0273-1177(85)90110-3; STMAURICE JP, 1984, J GEOPHYS RES-SPACE, V89, P987, DOI 10.1029/JA089iA02p00987; STMAURICE JP, 1982, J GEOPHYS RES-SPACE, V87, P7580, DOI 10.1029/JA087iA09p07580; Taguchi S, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015535; TAGUCHI S, 1993, J GEOPHYS RES, V98, P1393, DOI 10.1029/92JA01014	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	OCT	2015	133						98	110		10.1016/j.jastp.2015.08.012		13	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CT2CZ	WOS:000362610900011		
J	Tanaka, Y; Teramoto, H; Inui, M				Tanaka, Yuya; Teramoto, Haruhiko; Inui, Masayuki			Regulation of the Expression of De Novo Pyrimidine Biosynthesis Genes in Corynebacterium glutamicum	JOURNAL OF BACTERIOLOGY			English	Article							OXYGEN-DEPRIVATION CONDITIONS; PYRBI OPERON EXPRESSION; CARBOHYDRATE PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; TRANSCRIPTIONAL ATTENUATION; ACID PRODUCTION; PHOSPHOENOLPYRUVATE; REPRESSION; STRAIN	Expression of pyrimidine de novo biosynthesis is downregulated by an exogenous uracil in many bacteria. In this study, we show that a putative binding motif sequence of PyrR is required for uracil-mediated repression of pyrR-lacZ translational fusion. However, the uracil response was still observed in the strain with the pyrR gene deleted, implying the existence of a uracil response factor other than PyrR which also acts through the PyrR binding loop region. Deletion of rho, encoding the transcription termination factor Rho, resulted in an increase in the expression of pyrR-lacZ. Moreover, the strain with a double deletion of pyrR and rho showed elimination of the uracil-responsive downregulation of the pyrR-lacZ. Therefore, expression of the pyrimidine biosynthetic gene cluster in Corynebacterium glutamicum is controlled by two different mechanisms mediated by PyrR and Rho. IMPORTANCE The pyr genes of C. glutamicum are downregulated in the presence of uracil in culture medium. The mRNA binding regulator PyrR represses the expression of pyr genes, as reported previously. However, the uracil response was still observed in the pyrR deletion strain. Deletion of rho in addition to pyrR deletion results in the elimination of the uracil response. Therefore, we identified the factors that are involved in the uracil response. Involvement of Rho in the regulation of pyrimidine de novo biosynthesis genes has not been reported.	[Tanaka, Yuya; Teramoto, Haruhiko; Inui, Masayuki] Res Inst Innovat Technol Earth, Kyoto, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, Kyoto, Japan.	mmg-lab@rite.or.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was partially supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO).	Lu Y, 1996, J BACTERIOL, V178, P7206; Teramoto H, 2011, J BIOTECHNOL, V154, P114, DOI 10.1016/j.jbiotec.2011.01.016; Inui M, 2007, MICROBIOL-SGM, V153, P2491, DOI 10.1099/mic.0.2006/005587-0; TURNBOUGH CL, 1983, P NATL ACAD SCI-BIOL, V80, P368, DOI 10.1073/pnas.80.2.368; ROLAND KL, 1985, J BACTERIOL, V163, P991; Kotrba P, 2001, BIOCHEM BIOPH RES CO, V289, P1307, DOI 10.1006/bbrc.2001.6116; Lescoute A, 2005, CHEM BIOL, V12, P10, DOI 10.1016/j.chembiol.2005.01.002; Arsene-Ploetze F, 2006, J BACTERIOL, V188, P8607, DOI 10.1128/JB.00985-06; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Tanaka Y, 2011, J BACTERIOL, V193, P349, DOI 10.1128/JB.01123-10; LIU CG, 1994, GENE DEV, V8, P2904, DOI 10.1101/gad.8.23.2904; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Okino S, 2008, APPL MICROBIOL BIOT, V78, P449, DOI 10.1007/s00253-007-1336-7; Takemoto N, 2015, NUCLEIC ACIDS RES, V43, P520, DOI 10.1093/nar/gku1281; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Fields CJ, 2007, J BACTERIOL, V189, P6236, DOI 10.1128/JB.00803-07; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Tanaka Y, 2009, MICROBIOL-SGM, V155, P3652, DOI 10.1099/mic.0.029496-0; NAVRE M, 1983, P NATL ACAD SCI-BIOL, V80, P1207, DOI 10.1073/pnas.80.5.1207; Tanaka Y, 2012, J BACTERIOL, V194, P6527, DOI 10.1128/JB.01635-12; Brinkrolf K, 2008, MICROBIOL-SGM, V154, P1068, DOI 10.1099/mic.0.2007/014001-0; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Kinoshita S, 1957, J GEN APPL MICROBIOL, V3, P193, DOI 10.2323/jgam.3.193; Liebl W, 2005, HDB CORYNEBACTERIUM, P9, DOI 10.1201/9781420039696.pt2; Tanaka Y, 2008, MICROBIOL-SGM, V154, P264, DOI 10.1099/mic.0.2007/008862-0; TURNER RJ, 1994, J BACTERIOL, V176, P3708; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	29	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	OCT	2015	197	20					3307	3316		10.1128/JB.00395-15		10	Microbiology	Microbiology	CT1LA	WOS:000362558600009		
J	Adachi, T; Koba, S; Tsukamoto, S; Watanabe, N; Minoura, Y; Kawamura, M; Asano, T; Kayano, H; Kobayashi, Y				Adachi, Taro; Koba, Shinji; Tsukamoto, Shigeto; Watanabe, Norikazu; Minoura, Yoshino; Kawamura, Mitsuharu; Asano, Taku; Kayano, Hiroyuki; Kobayashi, Youichi			Impact of Obstructive Sleep Apnea on Cardiac Sympathetic Drive in Patients with Congestive Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Adachi, Taro; Koba, Shinji; Tsukamoto, Shigeto; Watanabe, Norikazu; Minoura, Yoshino; Kawamura, Mitsuharu; Asano, Taku; Kayano, Hiroyuki; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP11-1	S170	S170				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100114		
J	Akama, J; Kobayashi, A; Kimishima, Y; Kaneshiro, T; Sakamoto, N; Sugimoto, K; Suzuki, H; Saitoh, SI; Takeishi, Y				Akama, Joh; Kobayashi, Atsushi; Kimishima, Yusuke; Kaneshiro, Takashi; Sakamoto, Nobuo; Sugimoto, Koichi; Suzuki, Hitoshi; Saitoh, Shu-Ichi; Takeishi, Yasuchika			A Case of Takotsubo Cardiomyopathy Complicated by Transient Cataplectic Attack of Upper Limb	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Akama, Joh; Kobayashi, Atsushi; Kimishima, Yusuke; Kaneshiro, Takashi; Sakamoto, Nobuo; Sugimoto, Koichi; Suzuki, Hitoshi; Saitoh, Shu-Ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP10-4	S170	S170				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100112		
J	Akiyama, M; Katahira, S; Kawatsui, S; Fujiwara, H; Kawamoto, S; Fukuda, K; Sugimura, K; Shimokawa, H; Saiki, Y				Akiyama, Masatoshi; Katahira, Shintaro; Kawatsui, Satoshi; Fujiwara, Hideki; Kawamoto, Shunsuke; Fukuda, Koji; Sugimura, Koichiro; Shimokawa, Hiroaki; Saiki, Yoshikatsu			Mechanical Circulatory Support for Acute Fulminant Myocarditis: Retrospective Analysis of a Single Center Experience	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Akiyama, Masatoshi; Katahira, Shintaro; Kawatsui, Satoshi; Fujiwara, Hideki; Kawamoto, Shunsuke; Saiki, Yoshikatsu] Tohoku Univ Hosp, Div Cardiovasc Surg, Sendai, Miyagi, Japan; [Fukuda, Koji; Sugimura, Koichiro; Shimokawa, Hiroaki] Tohoku Univ Hosp, Dept Cardiol, Sendai, Miyagi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD5-4	S155	S155				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100041		
J	Aoki, H; Wakasa, M; Kawal, Y; Kajinami, K				Aoki, Hirofumi; Wakasa, Minoru; Kawal, Yasuyuki; Kajinami, Kouji			Two Cases of Hypertrophic Obstructive Cardiomyopathy Treated with Second Therapy of Percutaneous Transluminal Septal Myocardial Ablation (PTSMA)	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Aoki, Hirofumi; Wakasa, Minoru; Kawal, Yasuyuki; Kajinami, Kouji] Kanazawa Med Univ, Dept Cardiol, Kahoku, Ishikawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD2-2	S153	S154				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100033		
J	Aoki, S; Okumura, T; Sakakibara, M; Sawamura, A; Morimoto, R; Bando, Y; Murohara, T				Aoki, Soichiro; Okumura, Takahiro; Sakakibara, Masaki; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki			The Comparison of the Prognostic Value of Diuretic Response between Heart Failure with Reduced and Preserved Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Aoki, Soichiro; Okumura, Takahiro; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Sakakibara, Masaki] Handa City Hosp, Dept Cardiol, Handa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP26-4	S182	S182				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100176		
J	Arai, H; Fujiwara, T; Nagaoka, E; Oi, K; Mizuno, T				Arai, Hirokuni; Fujiwara, Tatsuki; Nagaoka, Eiki; Oi, Keiji; Mizuno, Tomohiro			What is Optimal Conversion from PCPS to VAD in Acute Cardiogenic Shock?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Arai, Hirokuni; Fujiwara, Tatsuki; Nagaoka, Eiki; Oi, Keiji; Mizuno, Tomohiro] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		JS1-5	S149	S149				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100015		
J	Araki, M; Nagata, Y; Hayashi, A; Tsuda, Y; Otsuji, Y				Araki, Masaru; Nagata, Yasufumi; Hayashi, Atsushi; Tsuda, Yuki; Otsuji, Yutaka			Shunt Closure Improved the Transmitral Flow Pattern in a Patient with Chronic Heart and Renal Failure on Hemodialysis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Araki, Masaru; Nagata, Yasufumi; Hayashi, Atsushi; Tsuda, Yuki; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Dept Internal Med 2, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP34-4	S187	S187				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100201		
J	Awaya, T; Hara, H; Hiroi, Y				Awaya, Toru; Hara, Hisao; Hiroi, Yukio			Adequate PEEP Setting in ASV (Adaptive-Servo Ventilator)	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Awaya, Toru; Hara, Hisao; Hiroi, Yukio] Natl Ctr Global Hlth & Med, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP29-3	S184	S184				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100183		
J	Chung, H; Asanuma, H; Ito, S; Min, KD; Shindo, K; Imazu, M; Fukuda, H; Takahama, H; Asakura, M; Kitakaze, M				Chung, Hyemoon; Asanuma, Hiroshi; Ito, Shin; Min, Kyung-Duk; Shindo, Kazuhiro; Imazu, Miki; Fukuda, Hiroki; Takahama, Hiroko; Asakura, Masanori; Kitakaze, Masafumi			AST-120, an Adsorbent of Uremic Toxins Improved the Cardioprotective Signaling in Pacinginduced Heart Failure Dog	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Chung, Hyemoon; Ito, Shin; Min, Kyung-Duk; Shindo, Kazuhiro; Imazu, Miki; Fukuda, Hiroki; Takahama, Hiroko; Asakura, Masanori; Kitakaze, Masafumi] Natl Cerebral & Cardiocascular Ctr, Clin Res & Dev, Suita, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ, Sch Med, Dept Cardiovasc Med, Kyoto 606, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-1	S197	S197				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100253		
J	Fu, HY; Matsuzaki, T; Okuda, K; Yamato, M; Tsutida, S; Araki, R; Minamino, T; Takata, Y				Fu, Haiying; Matsuzaki, Takashi; Okuda, Keiji; Yamato, Masaki; Tsutida, Shota; Araki, Ryo; Minamino, Tetsuo; Takata, Yasushi			Reduction of ER Stress Ameliorated Doxorubicin-Induced Cardiac Dysfunction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fu, Haiying; Matsuzaki, Takashi; Okuda, Keiji; Yamato, Masaki; Tsutida, Shota; Araki, Ryo; Minamino, Tetsuo; Takata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS6-5	S159	S159				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100058		
J	Fujii, K; Saku, K; Oga, Y; Nishizaki, A; Takehara, T; Akash, T; Kishi, T; Sunagawa, K				Fujii, Kana; Saku, Keita; Oga, Yasuhiro; Nishizaki, Akiko; Takehara, Takako; Akash, Takuya; Kishi, Takuya; Sunagawa, Kenji			Carotid Body Denervation Improves Survival with Sympatho-inhibition in Rats with Hypertensive Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujii, Kana; Oga, Yasuhiro; Nishizaki, Akiko; Takehara, Takako; Akash, Takuya] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Saku, Keita; Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Fukuoka 812, Japan; [Kishi, Takuya] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Collaborat Res Inst Innovat Cardiovasc Dis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-4	S197	S197				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100256		
J	Fujii, T; Murakami, T; Torii, S; Ijichi, T; Nakano, M; Ohno, Y; Nakazawa, G; Sinozaki, N; Yoshimachi, F; Ikari, Y				Fujii, Toshiharu; Murakami, Tsutomo; Torii, Sho; Ijichi, Takeshi; Nakano, Masataka; Ohno, Yohei; Nakazawa, Gaku; Sinozaki, Norihiko; Yoshimachi, Fuminobu; Ikari, Yuji			Clinical Outcomes of Patients with Percutaneous Cardiopulmonary Support	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujii, Toshiharu; Murakami, Tsutomo; Torii, Sho; Ijichi, Takeshi; Nakano, Masataka; Ohno, Yohei; Nakazawa, Gaku; Sinozaki, Norihiko; Yoshimachi, Fuminobu; Ikari, Yuji] Tokai Univ, Sch Med, Dept Cardiovasc Med, Isehara, Kanagawa 25911, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP4-7	S200	S200				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100270		
J	Fujiki, S; Obata, H; Kashimura, T; Tanaka, K; Hanawa, H; Minamino, T				Fujiki, Shinya; Obata, Hiroaki; Kashimura, Takeshi; Tanaka, Komei; Hanawa, Haruo; Minamino, Tohru			Diastolic Wall Strain Predicts Clinical Worsening of Fulminant Myocarditis: Exploratory Findings from Four Case Reports	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujiki, Shinya; Obata, Hiroaki; Kashimura, Takeshi; Tanaka, Komei; Hanawa, Haruo; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP4-5	S164	S165				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100085		
J	Fujin, T; Higo, T; Sakamoto, T; Hiasa, KI; Ide, T				Fujin, Takeo; Higo, Taiki; Sakamoto, Takafumi; Hiasa, Ken-Ichi; Ide, Tomomi			Right-Sided Dominant Heart Failure is a Predictor of Response to Tolvaptan	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujin, Takeo; Higo, Taiki; Sakamoto, Takafumi; Hiasa, Ken-Ichi; Ide, Tomomi] Kyushu Univ Hosp, Dept Cardiovasc Med, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP25-3	S181	S181				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100170		
J	Fujino, N; Hayashi, K; Sakata, K; Konno, T; Yamagishi, M				Fujino, Noboru; Hayashi, Kenshi; Sakata, Kenji; Konno, Tetsuo; Yamagishi, Masakazu			Effect of Olmesartan and Azelnidpine on Plasma B-type Natriuretic Peptide Concentration in Treatment of Hypertension	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujino, Noboru; Hayashi, Kenshi; Sakata, Kenji; Konno, Tetsuo; Yamagishi, Masakazu] Kanazawa Univ, Div Cardiovasc Med, Kanazawa, Ishikawa 9201192, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP7-5	S203	S203				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100286		
J	Fujita, K; Wada, H; Sakakura, K; Fujita, H; Momomura, S				Fujita, Kanna; Wada, Hiroshi; Sakakura, Kenichi; Fujita, Hideo; Momomura, Shin-Ihci			A Case of Destination Therapy for Dilated Cardiomyopathy with Ventricular Assisted Device	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujita, Kanna; Wada, Hiroshi; Sakakura, Kenichi; Fujita, Hideo; Momomura, Shin-Ihci] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP38-2	S190	S190				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100219		
J	Fujita, T; Hata, H; Seguchi, O; Shimahara, Y; Yanase, M; Sato, T; Nakajima, S; Fukushima, N; Nakatani, T; Kobayashi, J				Fujita, Tomoyuki; Hata, Hiroki; Seguchi, Osamu; Shimahara, Yusuke; Yanase, Masanobu; Sato, Takuma; Nakajima, Seiko; Fukushima, Norihide; Nakatani, Takeshi; Kobayashi, Junjiro			Appropriate Use of Left Ventricular Assist Device for Patients in End Stage Heart Failure of INTERMACS Profile 1 and Others	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fujita, Tomoyuki; Hata, Hiroki; Shimahara, Yusuke; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Surg, Suita, Osaka, Japan; [Seguchi, Osamu; Yanase, Masanobu; Sato, Takuma; Nakajima, Seiko; Fukushima, Norihide; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY1-4	S150	S150				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100018		
J	Fukaya, K; Okumura, T; Heraiwa, H; Watanabe, N; Kano, N; Mori, H; Sawamura, A; Morimoto, R; Bando, Y; Murohara, T				Fukaya, Kenji; Okumura, Takahiro; Heraiwa, Hiroaki; Watanabe, Naoki; Kano, Naoaki; Mori, Hiroaki; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki			Electrocardiographic Changes of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fukaya, Kenji; Okumura, Takahiro; Heraiwa, Hiroaki; Watanabe, Naoki; Kano, Naoaki; Mori, Hiroaki; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki] Nagoya Univ Hosp, Dept Cardioligy, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP23-3	S179	S180				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100161		
J	Fukuda, H; Min, KD; Imazu, M; Shindo, K; Ito, S; Tomonaga, T; Minamino, N; Asanuma, H; Asakura, M; Kitakaze, M				Fukuda, Hiroki; Min, Kyung-Duk; Imazu, Miki; Shindo, Kazuhiro; Ito, Shin; Tomonaga, Takeshi; Minamino, Naoto; Asanuma, Hiroshi; Asakura, Masanori; Kitakaze, Masafum			Proteomic Analysis of Failing Hearts: Relationship between Mitochondrial Dysfunction and Left Ventricular Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fukuda, Hiroki; Min, Kyung-Duk; Imazu, Miki; Shindo, Kazuhiro; Ito, Shin; Asakura, Masanori; Kitakaze, Masafum] Natl Cerebral & Cardiovasc Ctr, Clin Res & Dev, Suita, Osaka, Japan; [Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Ibaraki, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Asanuma, Hiroshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-3	S197	S197				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100255		
J	Fukuda, Y; Nakano, Y; Tomomori, S; Matsumura, H; Kawazoe, H; Sairaku, A; Tokuyama, T; Suenari, K; Hidaka, T; Kihara, Y				Fukuda, Yukihiro; Nakano, Yukiko; Tomomori, Syunsuke; Matsumura, Hiroya; Kawazoe, Hiroshi; Sairaku, Akinori; Tokuyama, Takehito; Suenari, Kazuyoshi; Hidaka, Takayuki; Kihara, Yasuki			Neutrophil to Lymphocyte Ratio Predicts Reduced Left Atrial Appendage Wall Velocity in Patients with Paroxysmal Atrial Fibrillation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fukuda, Yukihiro; Nakano, Yukiko; Tomomori, Syunsuke; Matsumura, Hiroya; Kawazoe, Hiroshi; Sairaku, Akinori; Tokuyama, Takehito; Suenari, Kazuyoshi; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP22-2	S178	S178				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100155		
J	Fukuoka, H; Kayano, H; Matsui, T; Kaneko, K; Shouji, M; Toshiba, T; Watanabe, N; Koba, S; Kobayashi, Y				Fukuoka, Hiroto; Kayano, Hiroyuki; Matsui, Taiju; Kaneko, Kyouichi; Shouji, Makoto; Toshiba, Tsutomu; Watanabe, Norikazu; Koba, Shinji; Kobayashi, Youichi			Impact of Continuous Positive Airway Pressure on Left Ventricular Systolic and Diastolic Function in Treated Hypertensives with Sleep Apnea Syndrome	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fukuoka, Hiroto; Kayano, Hiroyuki; Matsui, Taiju; Kaneko, Kyouichi; Shouji, Makoto; Toshiba, Tsutomu; Watanabe, Norikazu; Koba, Shinji; Kobayashi, Youichi] Showa Univ, Dept Med, Div Cardiol, Shinagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP30-4	S184	S185				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100187		
J	Fukushima, S; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Saito, S; Yoshioka, D; Yajima, S; Yoshida, S; Sawa, Y				Fukushima, Satsuki; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Saito, Shunsuke; Yoshioka, Daisuke; Yajima, Shin; Yoshida, Shohei; Sawa, Yoshiki			Surgical Approach for Functional Mitral Regurgitation Associated with Ischaemic Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Fukushima, Satsuki; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Saito, Shunsuke; Yoshioka, Daisuke; Yajima, Shin; Yoshida, Shohei; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS4-6	S157	S158				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100052		
J	Funamoto, M; Sunagawa, Y; Katanasaka, Y; Miyazaki, Y; Imaizumi, A; Asahara, N; Yamakage, H; Wada, H; Hasegawa, K; Morimoto, T				Funamoto, Masafumi; Sunagawa, Yoichi; Katanasaka, Yasufumi; Miyazaki, Yusuke; Imaizumi, Atsushi; Asahara, Noriko; Yamakage, Hazime; Wada, Hiromiti; Hasegawa, Kouzi; Morimoto, Tatsuya			The DDS Curcumin Improved Serum Levels of Arteriosclerotic LDL with Mild COPD Subjects	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Funamoto, Masafumi; Sunagawa, Yoichi; Katanasaka, Yasufumi; Miyazaki, Yusuke; Morimoto, Tatsuya] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Div Mol Med, Shizuoka 4228526, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Asahara, Noriko; Yamakage, Hazime; Wada, Hiromiti; Hasegawa, Kouzi; Morimoto, Tatsuya] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Morimoto, Tatsuya] Shizuoka Prefectural Gen Hosp, Shizuoka, Japan; [Imaizumi, Atsushi] Theravalues Corp, Prote Res Ctr, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP37-5	S190	S190				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100217		
J	Funamoto, M; Sunagawa, Y; Katanasaka, Y; Wada, H; Hasegawa, K; Morimoto, T				Funamoto, Masafumi; Sunagawa, Yoichi; Katanasaka, Yasufumi; Wada, Hiromiti; Hasegawa, Kouzi; Morimoto, Tatsuya			Transcriptional Epigenetic Mechanisms Via Histone Acetylation by p300 during the Development of Cardiomyocyte Hypertrophy and Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Funamoto, Masafumi; Sunagawa, Yoichi; Katanasaka, Yasufumi; Morimoto, Tatsuya] Univ Shizuoka, Div Mol Med, Grad Sch Integrated Pharmaceut & Nutr Sci, Shizuoka 4228526, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Wada, Hiromiti; Hasegawa, Kouzi; Morimoto, Tatsuya] Natl Hosp Org, Clin Res Inst, Kyoto Med Ctr, Kyoto, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Morimoto, Tatsuya] Shizuoka Prefectural Gen Hosp, Shizuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP18-3	S174	S175				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100137		
J	Funatsu, T; Maeda, S; Kainuma, S; Taniguchi, K				Funatsu, Toshihiro; Maeda, Syusaku; Kainuma, Satoshi; Taniguchi, Kazuhiro			Feasibility of Restrictive Annuloplasty with Small Size Rigid Ring for Functional Mitral Regurgitation Associated with Poor Left Ventricular Function	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Funatsu, Toshihiro; Maeda, Syusaku; Kainuma, Satoshi; Taniguchi, Kazuhiro] Osaka Rosai Hosp, Dept Cardiovasc Surg, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP19-1	S175	S175				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100140		
J	Goto, J; Omi, K; Saito, Y; Netu, S; Honda, S; Kikuchi, A; Kiribayashi, N; Sugawara, S				Goto, Jun; Omi, Koki; Saito, Yuji; Netu, Shunsuke; Honda, Shintaro; Kikuchi, Akihiro; Kiribayashi, Nobuyuki; Sugawara, Shigeo			A Case of Fabry Disease with HOCM Like Heart Lesion that Intraventricular Pressure Gradient Decreased by Dual Chamber Pacing	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Goto, Jun; Omi, Koki; Saito, Yuji; Netu, Shunsuke; Honda, Shintaro; Kikuchi, Akihiro; Kiribayashi, Nobuyuki; Sugawara, Shigeo] Nihonkai Gen Hosp, Sakata, Yamagata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP35-3	S188	S188				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100205		
J	Goto, K; Yamane, H; Kobayashi, K; Hagikura, A; Kikuta, Y; Sato, K; Taniguchi, M; Hiramatsu, S; Takebayashi, H; Haruta, S				Goto, Kenji; Yamane, Hiroki; Kobayashi, Kazunari; Hagikura, Arata; Kikuta, Yuetsu; Sato, Katsumasa; Taniguchi, Masahito; Hiramatsu, Shigeki; Takebayashi, Hideo; Haruta, Seiichi			Nutrition Education Based on the Sodium Consumption is Necessary to Improve Dietary Sodium Adherence in Heart Failure Outpatients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Goto, Kenji; Yamane, Hiroki; Kobayashi, Kazunari; Hagikura, Arata; Kikuta, Yuetsu; Sato, Katsumasa; Taniguchi, Masahito; Hiramatsu, Shigeki; Takebayashi, Hideo; Haruta, Seiichi] Fukuyama Cardiovasc Hosp, Fukuyama, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP33-1	S186	S186				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100195		
J	Hachiya, K; Kitada, S; Kikuchi, S; Wakami, K; Ohte, N				Hachiya, Kenta; Kitada, Shuichi; Kikuchi, Shohei; Wakami, Kazuaki; Ohte, Nobuyuki			Prevalence and Short-Time Prognosis of Paradoxical Severe Aortic Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hachiya, Kenta; Kitada, Shuichi; Kikuchi, Shohei; Wakami, Kazuaki; Ohte, Nobuyuki] Nagoya City Univ, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP7-5	S167	S167				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100099		
J	Hagiya, K; Tobaru, T; Mahara, K; Naito, K; Shimizu, J; Takamizawa, I; Iguchi, N; Takanashi, S; Yoshikawa, T; Takayama, M				Hagiya, Kenchi; Tobaru, Tetsuya; Mahara, Keitaro; Naito, Kazuhiro; Shimizu, Jun; Takamizawa, Itaru; Iguchi, Nobuo; Takanashi, Shuichiro; Yoshikawa, Tsutomu; Takayama, Morimasa			A Case of Transcatheter Aortic Valve Implantation in a Patients with Previous Mitral Valve Replacement	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hagiya, Kenchi; Tobaru, Tetsuya; Mahara, Keitaro; Naito, Kazuhiro; Shimizu, Jun; Takamizawa, Itaru; Iguchi, Nobuo; Takanashi, Shuichiro; Yoshikawa, Tsutomu; Takayama, Morimasa] Sakakibara Heart Inst, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP7-2	S167	S167				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100096		
J	Hakui, H; Yamada, T; Morita, T; Tamaki, S; Fukunami, M				Hakui, Hideyuki; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake			Cardiac MIBG Imaging Predicts the Risk of Cardiac-Death in Patients with Chronic Heart Failure Irrespective of Blood-Urea-Nitrogen to Creatinine Ratio	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hakui, Hideyuki; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake] Osaka Gen Med Ctr, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP6-5	S202	S202				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100281		
J	Hamada, T; Kubo, T; Baba, Y; Yamasaki, N; Kitaoka, H				Hamada, Tomoyuki; Kubo, Toru; Baba, Yuichi; Yamasaki, Naohito; Kitaoka, Hiroaki			Predictive Factors of Rehospitalization for Worsening Heart Failure and Cardiac Death within 1 Year in Octogenarians Hospitalized with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hamada, Tomoyuki; Kubo, Toru; Baba, Yuichi; Yamasaki, Naohito; Kitaoka, Hiroaki] Kochi Univ, Kochi Med Sch, Dept Cardiol Neurol & Aging Sci, Kochi 780, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP40-5	S192	S192				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100228		
J	Hanatani, S; Izumiya, Y; Onoue, Y; Kimura, Y; Yamamura, S; Araki, S; Ogawa, H				Hanatani, Shinsuke; Izumiya, Yasuhiro; Onoue, Yoshiro; Kimura, Yuichi; Yamamura, Satoru; Araki, Satoshi; Ogawa, Hisao			Human Epididymis Protein 4 is a Useful Biomarker in Patients with Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hanatani, Shinsuke; Izumiya, Yasuhiro; Onoue, Yoshiro; Kimura, Yuichi; Yamamura, Satoru; Araki, Satoshi; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP44-2	S195	S195				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100244		
J	Hayashi, T; Yamada, S; Iwano, H; Nakabachi, M; Yamada, H; Dohi, K; Seo, Y; Ohte, N; Mikami, T; Tsutsui, H				Hayashi, Taichi; Yamada, Satoshi; Iwano, Hiroyuki; Nakabachi, Masahiro; Yamada, Hirotsugu; Dohi, Kaoru; Seo, Yoshihiro; Ohte, Nobuyuki; Mikami, Taisei; Tsutsui, Hiroyuki			Ratio of Transmitral Early-Diastolic Velocity to Global Longitudinal Strain Accurately Estimates Filling Pressure Regardless of Left Ventricular Hypertrophy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hayashi, Taichi; Yamada, Satoshi; Iwano, Hiroyuki; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Nakabachi, Masahiro] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido 060, Japan; [Yamada, Hirotsugu] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima, Japan; [Dohi, Kaoru] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 514, Japan; [Seo, Yoshihiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan; [Mikami, Taisei] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP1-1	S162	S162				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100070		
J	Hiasa, KI; Fujino, T; Sakamoto, T; Ohtani, K; Mukai, Y; Higo, T; Ide, T				Hiasa, Ken-Ichi; Fujino, Takeo; Sakamoto, Takafumi; Ohtani, Kisho; Mukai, Yasushi; Higo, Taiki; Ide, Tomomi			The FE-K-guided Therapy May Lead a Better Outcome in Heart Failure Treated with Tolvaptan	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hiasa, Ken-Ichi; Fujino, Takeo; Sakamoto, Takafumi; Ohtani, Kisho; Mukai, Yasushi; Higo, Taiki; Ide, Tomomi] Kyushu Univ Hosp, Dept Cardiovasc Med, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP25-2	S181	S181				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100169		
J	Hieda, M; Yasuno, S; Nagaya, N; Fujiwara, R; Kumasaka, R; Arakawa, T; Nakanishi, M; Takaki, H; Goto, Y				Hieda, Michinari; Yasuno, Shinji; Nagaya, Noritoshi; Fujiwara, Reiko; Kumasaka, Reon; Arakawa, Tetsuo; Nakanishi, Michio; Takaki, Hiroshi; Goto, Yoichi			Relationships between Brain Natriuretic Peptide and Left Ventricular End Diastolic Pressure at Rest and during Exercise in Patients after AMI	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hieda, Michinari; Fujiwara, Reiko; Kumasaka, Reon; Arakawa, Tetsuo; Nakanishi, Michio; Takaki, Hiroshi; Goto, Yoichi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Rehabil, Suita, Osaka, Japan; [Yasuno, Shinji] Kyoto Univ, EBM Ctr, Kyoto 6068501, Japan; [Nagaya, Noritoshi] Nagaya Clin, Osaka, Japan; [Takaki, Hiroshi] Takaki Clin, Tsu, Mie, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP24-2	S180	S180				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100164		
J	Higashi, K; Ijuuin, S; Ishikawa, Y; Yamashita, E; Shimokawahara, H; Hiramine, K; Tanoue, K; Tanaka, H; Nuruki, N; Sonoda, M				Higashi, Kensaku; Ijuuin, Shun; Ishikawa, Yusuke; Yamashita, Erika; Shimokawahara, Hiroto; Hiramine, Kiyohisa; Tanoue, Kazuyuki; Tanaka, Hideki; Nuruki, Norihito; Sonoda, Masahiro			Cost-consciousness of Doctors for the Treatment of Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Higashi, Kensaku; Ijuuin, Shun; Ishikawa, Yusuke; Yamashita, Erika; Shimokawahara, Hiroto; Hiramine, Kiyohisa; Tanoue, Kazuyuki; Tanaka, Hideki; Nuruki, Norihito; Sonoda, Masahiro] Natl Hosp Org, Kagoshima Med Ctr, Dept Cardiol 2, Kagoshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP37-4	S190	S190				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100216		
J	Higuchi, R; Tobaru, T; Mahara, K; Naito, K; Shimizu, J; Takamisawa, I; Iguchi, N; Takanashi, S; Toshikawa, T; Takayama, M				Higuchi, Ryosuke; Tobaru, Tetsuya; Mahara, Keitaro; Naito, Kazuhiro; Shimizu, Jun; Takamisawa, Itaru; Iguchi, Nobuo; Takanashi, Shuichiro; Toshikawa, Tsutomu; Takayama, Morimasa			Transcatheter Aortic Valve Implantation to Low-Flow Low-Gradient Aortic Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Higuchi, Ryosuke; Tobaru, Tetsuya; Mahara, Keitaro; Takamisawa, Itaru; Iguchi, Nobuo; Toshikawa, Tsutomu; Takayama, Morimasa] Sakakibara Heart Inst, Dept Cardiol, Tokyo, Japan; [Naito, Kazuhiro; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Tokyo, Japan; [Shimizu, Jun] Sakakibara Heart Inst, Dept Anesthesiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP7-1	S166	S167				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100095		
J	Hirai, M; Iwasaki, Y; Okamura, A; Mimura, A; Tsunoda, F; Ishii, H; Inoue, Y; Shirota, K				Hirai, Masayuki; Iwasaki, Yoichiro; Okamura, Akihiro; Mimura, Asao; Tsunoda, Fumiyo; Ishii, Hiroshige; Inoue, Yoshiaki; Shirota, Kinya			The Impact of Infection Which Has Occurred during Hospitalization of Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hirai, Masayuki; Iwasaki, Yoichiro; Okamura, Akihiro; Mimura, Asao; Tsunoda, Fumiyo; Ishii, Hiroshige; Inoue, Yoshiaki; Shirota, Kinya] Matsue Red Cross Hosp, Dept Cardiol, Matsue, Shimane, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP42-3	S193	S194				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100236		
J	Hirai, T; Tanaka, S; Joho, S; Ohori, T; Asanoi, H; Inoue, H				Hirai, Tadakazu; Tanaka, Shuhei; Joho, Shuji; Ohori, Takashi; Asanoi, Hidetsugu; Inoue, Hiroshi			Effects of Renal Sympathetic Denervation on Nocturnal Sympathetic Tone in Rats with Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hirai, Tadakazu; Tanaka, Shuhei; Joho, Shuji; Ohori, Takashi; Inoue, Hiroshi] Toyama Univ, Dept Internal Med 2, Toyama, Toyama, Japan; [Asanoi, Hidetsugu] Imizu City Hosp, Imizu, Toyama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-6	S198	S198				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100258		
J	Hiraiwa, H; Okumura, T; Kondo, T; Aoki, S; Kato, R; Murohara, T				Hiraiwa, Hiroaki; Okumura, Takahiro; Kondo, Toru; Aoki, Soichiro; Kato, Rinya; Murohara, Toyoaki			The Branched-Chain Amino Acids Level at Discharge is a Useful Prognostic Biomarker in Patients with Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hiraiwa, Hiroaki; Okumura, Takahiro; Kondo, Toru; Aoki, Soichiro; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kato, Rinya] Nagoya Ekisaikai Hosp, Dept Cardiol, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP16-3	S173	S173				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100128		
J	Hiraiwa, H; Yamada, S; Kondo, T; Aoki, S; Okumura, T; Kato, R; Murohara, T				Hiraiwa, Hiroaki; Yamada, Sumio; Kondo, Toru; Aoki, Soichiro; Okumura, Takahiro; Kato, Rinya; Murohara, Toyoaki			The Factors Improve Peak Oxygen Consumption are Different between Heart Failure with Reduced Ejection Fraction and with Preserved Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hiraiwa, Hiroaki; Kondo, Toru; Aoki, Soichiro; Okumura, Takahiro; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4648601, Japan; [Kato, Rinya] Nagoya Ekisaikai Hosp, Dept Cardiol, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP9-1	S168	S168				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100105		
J	Hirasawa, K; Sasaoka, T; Yoshikawa, S; Goya, M; Ashikaga, T; Hirao, K; Fujiwara, T; Mizuno, T; Arai, H; Isobe, M				Hirasawa, Kensuke; Sasaoka, Taro; Yoshikawa, Syunji; Goya, Masahiko; Ashikaga, Takashi; Hirao, Kenzo; Fujiwara, Tatsuki; Mizuno, Tomohiro; Arai, Hirokuni; Isobe, Mitsuaki			Report on Treatment and Outcomes of Fulminant Myocarditis Patients Treated with Cardiopulmonary Support Devices in Our Hospital	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hirasawa, Kensuke; Sasaoka, Taro; Yoshikawa, Syunji; Goya, Masahiko; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Fujiwara, Tatsuki; Mizuno, Tomohiro; Arai, Hirokuni] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD5-3	S155	S155				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100040		
J	Hisatake, S; Kabuki, T; Dobashi, S; Kiuchi, S; Ikeda, T				Hisatake, Shinji; Kabuki, Takayuki; Dobashi, Shintaro; Kiuchi, Shunsuke; Ikeda, Takanori			Serial Changes in Serum ACE 2 and Plasma Ang (1-7) Concentration of Acute Heart Failure Syndrome Patients with Standard Therapy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hisatake, Shinji; Kabuki, Takayuki; Dobashi, Shintaro; Kiuchi, Shunsuke; Ikeda, Takanori] Toho Univ, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-4	S198	S198				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100261		
J	Hitsumoto, T; Ikeda, S; Miyazaki, S; Kadota, H; Shimizu, H; Oshima, K; Hamada, M				Hitsumoto, Tatsuro; Ikeda, Syuntaro; Miyazaki, Sigehiro; Kadota, Hisaki; Shimizu, Hideaki; Oshima, Kiyotaka; Hamada, Mareomi			The Case of Tuberculous Myocarditis Manifested by Extensive Myocardial Calcification	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Hitsumoto, Tatsuro; Ikeda, Syuntaro; Miyazaki, Sigehiro; Kadota, Hisaki; Shimizu, Hideaki; Oshima, Kiyotaka; Hamada, Mareomi] Uwajima City Hosp, Dept Cardiol, Uwajima, Ehime, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP10-5	S170	S170				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100113		
J	Ieda, M				Ieda, Masaki			Direct Cardiac Reprogramming for Regenerative Medicine MASAKI IEDA	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ieda, Masaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo 108, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES5-2	S160	S160				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100065		
J	Iguchi, M; Ogawa, H; Masunaga, N; Ishii, M; Esato, M; Chun, YH; Wada, H; Hasegawa, K; Abe, M; Akao, M				Iguchi, Moritake; Ogawa, Hisashi; Masunaga, Nobutoyo; Ishii, Mitsuru; Esato, Masahiro; Chun, Yeong-Hwa; Wada, Hiromichi; Hasegawa, Koji; Abe, Mrrsuru; Akao, Masaharu			The Impact of Systolic Heart Failure on the Incidence of Stroke in AF Patients: The Fushimi AF Registry	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iguchi, Moritake; Ogawa, Hisashi; Masunaga, Nobutoyo; Ishii, Mitsuru; Abe, Mrrsuru; Akao, Masaharu] Natl Hosp Orgamizat Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Esato, Masahiro; Chun, Yeong-Hwa] Ijinkai Takeda Gen Hosp, Dept Arrhythia, Kyoto, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Orgamizat Kyoto Med Ctr, Dept Translat Res, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS5-6	S158	S158				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100055		
J	Iida, Y; Inomata, T; Kaida, T; Fujita, T; Ikeda, Y; Nabeta, T; Ishii, S; Naruke, T; Koitabashi, T; Ako, J				Iida, Yuichiro; Inomata, Takayuki; Kaida, Toyoji; Fujita, Teppei; Ikeda, Yuki; Nabeta, Takeru; Ishii, Shunsuke; Naruke, Takashi; Koitabashi, Toshimi; Ako, Junya			Impact of Adaptive Servo-Ventilation Support on Physical Exercise in a Patient with Refractory Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iida, Yuichiro; Inomata, Takayuki; Kaida, Toyoji; Fujita, Teppei; Ikeda, Yuki; Nabeta, Takeru; Ishii, Shunsuke; Naruke, Takashi; Koitabashi, Toshimi; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP30-3	S184	S184				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100186		
J	Ikeda, M; Ide, T; Fujino, T; Sunagawa, K				Ikeda, Masataka; Ide, Tomomi; Fujino, Takeo; Sunagawa, Kenji			The Akt-mTOR Axis is a Pivotal Regulator of Eccentric Hypertrophy during Volume Overload	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ikeda, Masataka; Ide, Tomomi; Fujino, Takeo] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat Cardiovasc Homeostasis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA2-5	S147	S147				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100011		
J	Ikeda, N; Tanno, K				Ikeda, Naoko; Tanno, Kaoru			Non-compaction of the Left Ventricular Myocardium and Heart Failure with Reduced EF: Case Report	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ikeda, Naoko; Tanno, Kaoru] Showa Univ, Koto Toyosu Hosp, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP4-5	S200	S200				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100269		
J	Imai, R; Uemura, Y; Miura, A; Mitsuda, T; Ishikawa, S; Koyasu, M; Uchikawa, T; Takemoto, K; Watarai, M				Imai, Ryo; Uemura, Yusuke; Miura, Ayako; Mitsuda, Takayuki; Ishikawa, Shinji; Koyasu, Masayoshi; Uchikawa, Tomohiro; Takemoto, Kenji; Watarai, Masato			Prognostic Value of Red Blood Cell Distribution Width for Patients with Heart Failure with Preserved Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imai, Ryo; Uemura, Yusuke; Miura, Ayako; Mitsuda, Takayuki; Ishikawa, Shinji; Koyasu, Masayoshi; Uchikawa, Tomohiro; Takemoto, Kenji; Watarai, Masato] Anjo Kosei Hosp, Cardiovasc Ctr, Anjo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP26-2	S182	S182				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100174		
J	Imamura, T; Kinugawa, K; Sakata, Y; Miyagawa, S; Sawa, Y; Yamazaki, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Sakata, Yasushi; Miyagawa, Shigeru; Sawa, Yoshiki; Yamazaki, Kenzi; Ono, Minoru			Improved Clinical Course of Autologous Skeletal Myoblast Sheet Transplantation When Compared to a Propensity Score-Matched Cardiac Resynchronization Therapy Population	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 565, Japan; [Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka 565, Japan; [Yamazaki, Kenzi] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Ono, Minoru] Univ Tokyo, Dept Cardiac Surg, Grad Sch Med, Tokyo 1138654, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP20-2	S176	S176				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100145		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Komuro, I				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisule; Hatano, Masaru; Komuro, Issei			Long-Term Adaptive Servo-Ventilator Therapy Prevents Cardiac Death Accompanied by Improved Clinical Outcome	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Nitta, Daisule; Hatano, Masaru; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY3-2	S151	S151				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100022		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Ono, Minoru			Novel Combination Predictors of Biventricular Assist Device Requirement: Pulmonary Vascular Resistance and Right Ventricular Stroke Work Index	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138654, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP38-1	S190	S190				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100218		
J	Imamura, T; Kinugawa, K; Nitta, D; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Ono, Minoru			Pulsatility and Aortic Insufficiency during Left Ventricular Assist Device Treatment	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Nitta, Daisuke; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP38-3	S190	S191				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100220		
J	Imamura, T; Kinugawa, K				Imamura, Teruhiko; Kinugawa, Koichiro			How to Select Adequate Candidates for Each Therapeutic Tool in Patients with Advanced Heart Failure?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY1-1	S150	S150				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100016		
J	Inaba, O; Satoh, Y; Isobe, M; Yamamoto, T; Nagao, K; Takayama, M				Inaba, Osamu; Satoh, Yasuhiro; Isobe, Mitsuaki; Yamamoto, Takeshi; Nagao, Ken; Takayama, Morimasa			Predictive Factors and Immune-related Therapies for Fulminant Myocarditis. Data from Tokyo CCU Network Registry	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Inaba, Osamu; Satoh, Yasuhiro; Isobe, Mitsuaki; Yamamoto, Takeshi; Nagao, Ken; Takayama, Morimasa] Tokyo CCU Network Sci Comm, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD5-1	S154	S154				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100038		
J	Inuzuka, Y; Kishimori, T; Inoue, T; Seki, J; Nishio, S; Takeda, S; Takeuchi, Y; Okada, M; Kosuga, K; Ikeguchi, S				Inuzuka, Yasutaka; Kishimori, Takefumi; Inoue, Takeshi; Seki, Junya; Nishio, Soji; Takeda, Shinsaku; Takeuchi, Yuzo; Okada, Masaharu; Kosuga, Kunihiko; Ikeguchi, Shigeru			Sodium Restriction in Japanese Patients Hospitalized with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Inuzuka, Yasutaka; Kishimori, Takefumi; Inoue, Takeshi; Seki, Junya; Nishio, Soji; Takeda, Shinsaku; Takeuchi, Yuzo; Okada, Masaharu; Kosuga, Kunihiko; Ikeguchi, Shigeru] Shiga Med Ctr Adults, Dept Cardiol, Moriyama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP27-2	S183	S183				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100178		
J	Ishikawa, S; Noma, T; Matsunaga, K; Mantani, K; Takabatake, W; Ishizawa, M; Ishikawa, K; Murakami, K; Ohmori, K; Kohno, M				Ishikawa, Shohei; Noma, Takahisa; Matsunaga, Keiji; Mantani, Kaoru; Takabatake, Wataru; Ishizawa, Makoto; Ishikawa, Kaori; Murakami, Kazushi; Ohmori, Koji; Kohno, Masakazu			Effect of Angiotensin II Receptor Blocker on Cardiac Autonomic Activity in Patients with Chronic Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ishikawa, Shohei; Noma, Takahisa; Matsunaga, Keiji; Mantani, Kaoru; Takabatake, Wataru; Ishizawa, Makoto; Ishikawa, Kaori; Murakami, Kazushi; Ohmori, Koji; Kohno, Masakazu] Kagawa Univ, Dept Cardiorenal Cerebrovasc Med, Fac Med, Takamatsu, Kagawa 760, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP15-4	S172	S172				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100124		
J	Islam, MS; Rahaman, MZ; Uddin, SMN; Tammi, TJ; Sarwar, S; Yokota, K				Islam, Mohammad Safiqul; Rahaman, Md Zahedur; Uddin, S. M. Naim; Tammi, Tanmin Jarana; Sarwar, Shahid; Yokota, Kazushige			Effect of Serum Trace Elements and Macro Minerals on Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Islam, Mohammad Safiqul; Rahaman, Md Zahedur; Uddin, S. M. Naim; Tammi, Tanmin Jarana; Sarwar, Shahid] Noakhali Sci & Technol Univ, Dept Pharm, Sonapur 3814, Noakhali, Bangladesh; [Islam, Mohammad Safiqul; Yokota, Kazushige] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP44-1	S195	S195				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100243		
J	Isomi, M; Muraoka, N; Miyamoto, K; Sadahiro, T; Kojima, H; Haginiwa, S; Akiyama, M; Kuishi, Y; Fukuda, K; Ieda, M				Isomi, Mari; Muraoka, Naoto; Miyamoto, Kazutaka; Sadahiro, Taketaro; Kojima, Hidenori; Haginiwa, Sho; Akiyama, Mizuha; Kuishi, Yuki; Fukuda, Keiichi; Ieda, Masaki			Cardiac Reprogramming into Ventricular-type Myocytes by Transduction of Seven Transcription Factors	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Isomi, Mari; Muraoka, Naoto; Miyamoto, Kazutaka; Sadahiro, Taketaro; Kojima, Hidenori; Haginiwa, Sho; Akiyama, Mizuha; Kuishi, Yuki; Fukuda, Keiichi; Ieda, Masaki] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP36-3	S189	S189				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100210		
J	Isotani, A; Schau, T; Neuss, M; Schoepp, M; Butter, C				Isotani, Akihiro; Schau, Thomas; Neuss, Michael; Schoepp, Maren; Butter, Christian			Therapeutic Effect of Percutaneous Mitral Valve Repair (MitraClip) in Patients with End-Stage Heart Failure (LVEF < 25%)	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Isotani, Akihiro] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Isotani, Akihiro; Schau, Thomas; Neuss, Michael; Schoepp, Maren; Butter, Christian] Heart Ctr Brandenburg, Dept Cardiol, Bernau, Germany								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS4-2	S157	S157				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100048		
J	Itagaki, A; Katou, Y; Suzuki, S; Sakurada, K; Senba, H; Ishii, K; Ishida, C; Uejima, T; Yajima, J; Yamashita, T				Itagaki, Atsunori; Katou, Yuko; Suzuki, Shinya; Sakurada, Koji; Senba, Hiroaki; Ishii, Kaori; Ishida, Chizuru; Uejima, Tokuhisa; Yajima, Junji; Yamashita, Takeshi			Heart Failure Admission in Winter as an Independent Predictor for Early Rehospitalization after Discharge	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Itagaki, Atsunori; Sakurada, Koji] Cardiovasc Inst, Dept Cardiac Rehabil, Tokyo, Japan; [Katou, Yuko; Suzuki, Shinya; Senba, Hiroaki; Uejima, Tokuhisa; Yajima, Junji; Yamashita, Takeshi] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo, Japan; [Ishii, Kaori; Ishida, Chizuru] Cardiovasc Inst, Dept Nursing, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA3-3	S148	S148				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100013		
J	Iuchi, K				Iuchi, Kazuyuki			Clinical Significance of the Intensity of Pulmonary Second Heart Sound in patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iuchi, Kazuyuki] Kamiichi Gen Hosp, Dept Med, Nakaniikawa, Toyama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP7-6	S203	S203				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100287		
J	Iwahana, T; Okada, S; Kobayashi, Y				Iwahana, Togo; Okada, Sho; Kobayashi, Yoshio			A Successful Case of Air Repatriation to Australia Under Intensive Care with Extracorporeal Membrane Oxygenation (ECMO) Support	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwahana, Togo; Okada, Sho; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiol, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP38-4	S191	S191				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100221		
J	Iwahashi, N; Ebina, T; Umemura, S; Kimura, K				Iwahashi, Noriaki; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			The Control of Rapid Atrial Tachyarrhythmia in Patients with Heart Failure with Severely Reduced Ejection Fraction: Usefulness of Landiolol	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwahashi, Noriaki; Ebina, Toshiaki; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa, Japan; [Umemura, Satoshi] Yokohama City Univ Med, Yokohama, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD1-3	S153	S153				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100031		
J	Iwahashi, N; Ebina, T; Umemura, S; Kimura, K				Iwahashi, Noriaki; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			Characteristics of Patients with HFpEF Followed up after a Reperfused First STEMI: The Risk/Benefit of the Administration of Diuretics	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwahashi, Noriaki; Ebina, Toshiaki; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan; [Umemura, Satoshi] Yokohama City Univ Med, Yokohama, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS1-3	S156	S156				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100042		
J	Iwano, H; Kamimura, D; Yamada, S; Tsutsui, H; Little, W				Iwano, Hiroyuki; Kamimura, Daisuke; Yamada, Satoshi; Tsutsui, Hiroyuki; Little, William			Presence of Temporal Non-Uniformity of Early Diastolic Left Ventricular Wall Expansion in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwano, Hiroyuki; Yamada, Satoshi; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Kamimura, Daisuke; Little, William] Univ Mississippi, Med Ctr, Dept Med, University, MS 38677 USA								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP1-3	S162	S162				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100072		
J	Iwasaki, K; Osakada, K; Kawase, Y; Tada, T; Kadota, K; Mitsudo, K				Iwasaki, Keiichiro; Osakada, Kouhei; Kawase, Yuichi; Tada, Takeshi; Kadota, Kazushige; Mitsudo, Kazuaki			Comparison of Patient Characteristics of Acute Heart Failure between Elderly and Younger Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwasaki, Keiichiro; Osakada, Kouhei; Kawase, Yuichi; Tada, Takeshi; Kadota, Kazushige; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-1	S198	S198				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100259		
J	Iwasaki, Y; Watanabe, M; Kobayashi, M; Sakaida, T; Yazaki, Y; Goseki, Y; Yamashina, A				Iwasaki, Yoichi; Watanabe, Masataka; Kobayashi, Masatake; Sakaida, Tomoko; Yazaki, Yoshinao; Goseki, Yoshnari; Yamashina, Akma			The Type Efficiency of Bundle Branch Block for Implantable Cardiac Resynchronization Therapy in Patient with Advanced Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Iwasaki, Yoichi; Watanabe, Masataka; Kobayashi, Masatake; Yazaki, Yoshinao; Goseki, Yoshnari; Yamashina, Akma] Tokyo Med Univ Hosp, Dept Cardiol, Tokyo, Japan; [Sakaida, Tomoko] Tokyo Med Univ Hosp, Dept Med Engn, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP20-4	S176	S177				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100147		
J	Izumiya, Y; Kimura, Y; Onoue, Y; Hanatani, S; Araki, S; Ogawa, H				Izumiya, Yasuhiro; Kimura, Yuichi; Onoue, Yoshiro; Hanatani, Shinsuke; Araki, Satoshi; Ogawa, Hisao			Expression of Let-7 Family microRNAs in Skin Correlates Negatively with Severity of Pulmonary Hypertension in Patients with Systemic Scleroderma	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Izumiya, Yasuhiro; Kimura, Yuichi; Onoue, Yoshiro; Hanatani, Shinsuke; Araki, Satoshi; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto 860, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-1	S200	S200				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100271		
J	Jujo, K; Shiozaki, N; Hagiwara, N				Jujo, Kentaro; Shiozaki, Natsuko; Hagiwara, Nobuhisa			Left Ventricular Systolic Function Affects the Renal Functions after Tolvaptan Treatment in Congestive Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Jujo, Kentaro; Shiozaki, Natsuko; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Jujo, Kentaro] Nishiarai Heart Ctr Hosp, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP25-5	S181	S182				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100172		
J	Kadota, M; Ise, T; Yagi, S; Kusunose, K; Kinoshita, H; Kurobe, H; Yamada, H; Soeki, T; Wakatsuki, T; Sata, M				Kadota, Muneyuki; Ise, Takayuki; Yagi, Shusuke; Kusunose, Kenya; Kinoshita, Hajime; Kurobe, Hirotsugu; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka			Successful Surgical Repair of Aged Sinus Venosus Atrial Septal Defect with Partial Anomalous Pulmonary Venous Connection: A Case Report	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kadota, Muneyuki; Ise, Takayuki; Yagi, Shusuke; Kusunose, Kenya; Yamada, Hirotsugu; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima, Japan; [Kinoshita, Hajime; Kurobe, Hirotsugu] Tokushima Univ Hosp, Dept Cardiovasc Surg, Tokushima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP32-3	S185	S185				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100192		
J	Kaida, T; Inomata, T; Fujita, T; Iida, Y; Ikeda, Y; Nabeta, T; Yanagisawa, T; Maekawa, E; Koitabashi, T; Ako, J				Kaida, Toyoji; Inomata, Takayuki; Fujita, Teppei; Iida, Yuichiro; Ikeda, Yuuki; Nabeta, Takeru; Yanagisawa, Tomoyoshi; Maekawa, Emi; Koitabashi, Toshimi; Ako, Junya			A Case of Dilated Cardiomyopathy and Severe Heart Failure with Repetitive Coma Due to Hepatic Encephalopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kaida, Toyoji; Inomata, Takayuki; Fujita, Teppei; Iida, Yuichiro; Ikeda, Yuuki; Nabeta, Takeru; Yanagisawa, Tomoyoshi; Maekawa, Emi; Koitabashi, Toshimi; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP23-4	S180	S180				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100162		
J	Kamata, S; Richter, M; Kubin, T; Sawa, Y; Walter, T; Kostin, S				Kamata, Sokichi; Richter, Manfred; Kubin, Thomas; Sawa, Yoshiki; Walter, Thomas; Kostin, Sawa			The Role of OSM and Reg3 beta for Dedifferentiation of Atrial Cardiomyocytes in Human Patients with Atrial Fibrillation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kamata, Sokichi; Richter, Manfred; Walter, Thomas] Kerckhoff Clin, Dept Cardiac Surg, Bad Nauheim, Germany; [Kubin, Thomas; Kostin, Sawa] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling, Bad Nauheim, Germany; [Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP22-1	S178	S178				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100154		
J	Kanda, T; Fujita, M; Iida, O; Masuda, M; Okamoto, S; Ishihara, T; Nanto, K; Sbiraki, T; Uematsu, M				Kanda, Takashi; Fujita, Masashi; Iida, Osamu; Masuda, Masaharu; Okamoto, Shin; Ishihara, Takayuki; Nanto, Kiyonori; Sbiraki, Tatsuya; Uematsu, Masaaki			The Accurate Measurement of Pulmonary Vascular Resistance Using Echocardiography in Patients with Mild Left Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kanda, Takashi; Fujita, Masashi; Iida, Osamu; Masuda, Masaharu; Okamoto, Shin; Ishihara, Takayuki; Nanto, Kiyonori; Sbiraki, Tatsuya; Uematsu, Masaaki] Kansai Rosai Hosp, Ctr Cardiovasc, Amagasaki, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP45-2	S196	S196				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100249		
J	Kanno, Y; Yoshihisa, A; Shimizu, T; Takiguchi, M; Yamauchi, H; Sato, T; Suzuki, S; Oikawa, M; Kobayashi, A; Takeishi, Y				Kanno, Yuki; Yoshihisa, Akiomi; Shimizu, Takeshi; Takiguchi, Mai; Yamauchi, Hiroyuki; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Takeishi, Yasuchika			Association of Insomnia with Exercise Capacity in Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kanno, Yuki; Yoshihisa, Akiomi; Shimizu, Takeshi; Takiguchi, Mai; Yamauchi, Hiroyuki; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP11-3	S170	S171				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100116		
J	Kano, N; Okumura, T; Hiraiwa, H; Kondo, T; Watanabe, N; Fukaya, K; Sawamura, A; Morimoto, R; Bando, Y; Murohara, T				Kano, Naoaki; Okumura, Takahiro; Hiraiwa, Hiroaki; Kondo, Toru; Watanabe, Naoki; Fukaya, Kenji; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki			Aspect Ratio of Left Ventricle in Cardiac Magnetic Resonance Predicts a Future Reverse Remodeling in Non-ischemic Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kano, Naoaki; Okumura, Takahiro; Hiraiwa, Hiroaki; Kondo, Toru; Watanabe, Naoki; Fukaya, Kenji; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP45-4	S196	S196				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100251		
J	Kanoh, M; Inai, K; Kogure, T; Shinohara, T; Nakanishi, T; Boku, H				Kanoh, Miki; Inai, Kei; Kogure, Tomohito; Shinohara, Tokuko; Nakanishi, Toshio; Boku, Hitomi			Influence of Pregnancy on Cardiac Function and Hemodynamics in Patients with Ebstein Anomaly	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kanoh, Miki; Inai, Kei; Kogure, Tomohito; Shinohara, Tokuko; Nakanishi, Toshio; Boku, Hitomi] Tokyo Womens Med Univ Hosp, Dept Pediat Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP32-5	S186	S186				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100194		
J	Kashiyama, N; Miyagawa, S; Toda, K; Nakamura, T; Yoshikawa, Y; Fukushima, S; Saito, S; Yoshioka, D; Sawa, Y				Kashiyama, Noriyuki; Miyagawa, Shigeru; Toda, Koichi; Nakamura, Teruya; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki			Indication for Mitral Valve Surgery in Advanced Non-ischemic Dilated Cardiomyopathy: Molecular Biological Analysis in Histone Modification Process in Distressed Cardiomyocytes	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kashiyama, Noriyuki; Miyagawa, Shigeru; Toda, Koichi; Nakamura, Teruya; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP23-5	S180	S180				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100163		
J	Katahira, S; Akiyama, M; Kawatsu, S; Yoshioka, I; Fujiwara, H; Adachi, O; Kumagai, K; Kawamoto, S; Shimokawa, H; Saiki, Y				Katahira, Shintaro; Akiyama, Masatoshi; Kawatsu, Satoshi; Yoshioka, Ichiro; Fujiwara, Hidenori; Adachi, Osamu; Kumagai, Kiichiro; Kawamoto, Shunsuke; Shimokawa, Hiroaki; Saiki, Yoshikatsu			Impact of Temporary LVAD as a Bridge Use in Candidates for Implantable LVAD	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Katahira, Shintaro; Akiyama, Masatoshi; Kawatsu, Satoshi; Yoshioka, Ichiro; Fujiwara, Hidenori; Adachi, Osamu; Kumagai, Kiichiro; Kawamoto, Shunsuke; Saiki, Yoshikatsu] Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Sendai, Miyagi 980, Japan; [Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP8-5	S168	S168				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100104		
J	Kato, M; Okada, T; Kimura, R; Yuge, M; Kawaguchi, T				Kato, Maki; Okada, Takuya; Kimura, Ryo; Yuge, Masaru; Kawaguchi, Takeo			A Difficult Case of Pulmonary Hypertension Caused by Dermatomyositis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kato, Maki; Okada, Takuya; Kimura, Ryo] Odawara Municipal Hosp, Dept Gen Med, Odawara, Kanagawa, Japan; [Yuge, Masaru; Kawaguchi, Takeo] Odawara Municipal Hosp, Dept Cardiol, Odawara, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-4	S200	S201				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100273		
J	Kato, T; Nakane, E; Nohara, R; Inoko, M				Kato, Takao; Nakane, Eisaku; Nohara, Ryuji; Inoko, Moriaki			Mitochondrial Function of the Heart and Leg Muscles, Prognosis, and Cardiac Rehabilitation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kato, Takao] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068501, Japan; [Nakane, Eisaku; Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Osaka, Japan; [Nohara, Ryuji] Hirakata Kohsai Hosp, Hirakata, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY3-3	S151	S151				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100023		
J	Kato, T; Kawamoto, A; Shioi, T; Kimura, T				Kato, Takao; Kawamoto, Akira; Shioi, Tetsuo; Kimura, Takeshi			The Role of Liver in the Context of Metabolism in Congestive Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kato, Takao; Kawamoto, Akira; Shioi, Tetsuo; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068501, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS2-4	S156	S156				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100046		
J	Kawakami, R; Nakada, Y; Ueda, T; Takeda, Y; Kawata, H; Okura, H; Saito, Y				Kawakami, Rika; Nakada, Yasuki; Ueda, Tomoya; Takeda, Yukiji; Kawata, Hiroyuki; Okura, Hiroyuki; Saito, Yoshihiko			Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Patients with Acute Decompensated Heart Failure: A Single-Center Prospective Observational Study	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kawakami, Rika; Nakada, Yasuki; Ueda, Tomoya; Takeda, Yukiji; Kawata, Hiroyuki; Okura, Hiroyuki; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP6-2	S166	S166				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100092		
J	Kawase, T; Shiode, N				Kawase, Tomoharu; Shiode, Nobuo			Usefulness of the Initial Lactate and Lactate Trend for Predicting the Early Mortality of Patients with Acute Heart Failure Syndrome	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kawase, Tomoharu; Shiode, Nobuo] Tsuchiya Gen Hosp, Dept Cardiol, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP16-4	S173	S173				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100129		
J	Kawase, Y; Hata, L; Iwasaki, K; Tada, T; Kadota, K; Mitsudo, K				Kawase, Yuichi; Hata, Leo; Iwasaki, Keiichiro; Tada, Takeshi; Kadota, Kazushige; Mitsudo, Kazuaki			Relation between Hemodynamic Parameters on Admission and Worsening Renal Function in Early Phase in Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kawase, Yuichi; Hata, Leo; Iwasaki, Keiichiro; Tada, Takeshi; Kadota, Kazushige; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP24-5	S180	S181				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100167		
J	Kawasoe, S; Kubozono, T; Miyata, M; Fujita, S; Yamaguchi, T; Torii, H; Ohishi, M				Kawasoe, Shin; Kubozono, Takuro; Miyata, Masaaki; Fujita, Shoji; Yamaguchi, Tsuyoshi; Torii, Hiroyuki; Ohishi, Mitsuru			A Case of Dilated Cardiomyopathy Associated with CD36 Deficiency	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kawasoe, Shin; Kubozono, Takuro; Miyata, Masaaki; Ohishi, Mitsuru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Med & Hypertens, Kagoshima 890, Japan; [Fujita, Shoji; Yamaguchi, Tsuyoshi; Torii, Hiroyuki] Kagoshima Assoc Hosp, Dept Cardiovasc Med, Kagoshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP43-2	S194	S194				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100240		
J	Kikuchi, N; Nunoda, S; Serizawa, N; Suzuki, A; Suzuki, T; Fukushima, K; Momose, M; Shiga, T; Shoda, M; Hagiwara, N				Kikuchi, Noriko; Nunoda, Shinichi; Serizawa, Naoki; Suzuki, Atsushi; Suzuki, Tsuyoshi; Fukushima, Kenji; Momose, Mitsuru; Shiga, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa			The Combination Therapy of Corticosteroid and Mycophenolate Mofetil in a Case of Refractory Cardiac Sarcoidosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kikuchi, Noriko; Nunoda, Shinichi; Serizawa, Naoki; Suzuki, Atsushi; Suzuki, Tsuyoshi; Shiga, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Fukushima, Kenji; Momose, Mitsuru] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-3	S163	S163				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100077		
J	Kikuchi, S; Ikehara, N; Wakami, K; Goto, T; Ohte, N				Kikuchi, Shohei; Ikehara, Noriyuki; Wakami, Kazuaki; Goto, Toshihiko; Ohte, Nobuyuki			Determinants of Exercise Capacity in Patients with Preserved Left Ventricular Ejection Fraction and Reduced Left Ventricular Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kikuchi, Shohei; Ikehara, Noriyuki; Wakami, Kazuaki; Goto, Toshihiko; Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP9-2	S168	S169				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100106		
J	Kimura, Y; Sasaoka, T; Shirai, Y; Ueshima, D; Maejima, Y; Goya, M; Ashikaga, T; Hirao, K; Isobe, M				Kimura, Yayoi; Sasaoka, Taro; Shirai, Yasuhiro; Ueshima, Daisuke; Maejima, Yasuhiro; Goya, Masahiko; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki			Case Report: Successful TAP and Leads Removal for Right Heart Failure Associated with Right Ventricular Infarction and Multiple Ventricular Leads	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kimura, Yayoi] Tokyo Metropolitan Hlth & Med Corp, Toshima Hosp, Dept Cardiol, Tokyo, Japan; [Sasaoka, Taro; Shirai, Yasuhiro; Ueshima, Daisuke; Maejima, Yasuhiro; Goya, Masahiko; Ashikaga, Takashi; Hirao, Kenzo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP20-5	S177	S177				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100148		
J	Kinoshita, H; Dohi, Y; Sada, Y; Kisaka, T; Kotagawa, T; Hidaka, T; Yamamoto, H; Kihara, Y				Kinoshita, Hiroki; Dohi, Yoshihiro; Sada, Yoshiharu; Kisaka, Tomohiko; Kotagawa, Toshiro; Hidaka, Takayuki; Yamamoto, Hideya; Kihara, Yasuki			Prognositic Value of Oscillatory Ventilation during Rest and Exercise in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kinoshita, Hiroki; Dohi, Yoshihiro; Sada, Yoshiharu; Kotagawa, Toshiro; Hidaka, Takayuki; Yamamoto, Hideya; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima 730, Japan; [Kisaka, Tomohiko] Harbor UCLA Med Ctr, Div Resp & Crit Care Physiol & Med, Torrance, CA USA; [Kinoshita, Hiroki; Dohi, Yoshihiro; Sada, Yoshiharu; Kotagawa, Toshiro; Hidaka, Takayuki; Yamamoto, Hideya; Kihara, Yasuki] Hiroshima Univ Hosp, Heart Failure Ctr, Hiroshima, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP29-1	S183	S183				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100181		
J	Kinugawa, K				Kinugawa, Koichiro			How to Determine the Indication of Destination Therapy in Japan	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kinugawa, Koichiro] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD3-1	S154	S154				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100034		
J	Kinugawa, K				Kinugawa, Koichiro			How to Use Intravenous Form of Beta Blocker in Heart Failure Patients?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kinugawa, Koichiro] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo 1138654, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD1-2	S153	S153				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100030		
J	Kishi, T				Kishi, Takuya			Heart Failure is a Dysfunction of Brain Renin Angiotensin-Neuron-Glial Interaction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kishi, Takuya] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Collaborat Res Inst Innovat Cardiovasc Dis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS2-5	S156	S157				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100047		
J	Kishimoto, Y; Nakamura, Y; Kishimoto, S; Harada, S; Obnohara, T; Horie, H; Kurashiki, T; Shiraya, S; Saiki, M; Nishimura, M				Kishimoto, Yuichiro; Nakamura, Yoshinobu; Kishimoto, Satoru; Harada, Shingo; Obnohara, Takeshi; Horie, Hiromu; Kurashiki, Tomohiro; Shiraya, Suguru; Saiki, Munebiro; Nishimura, Motonobu			A Case of Ischemic Cardiomyopathy with Refractory Lethal Arrhythmia Which Successfully Underwent the Implantation of Left Ventricular Assist Device	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kishimoto, Yuichiro; Nakamura, Yoshinobu; Kishimoto, Satoru; Harada, Shingo; Obnohara, Takeshi; Horie, Hiromu; Kurashiki, Tomohiro; Shiraya, Suguru; Saiki, Munebiro; Nishimura, Motonobu] Tottori Univ Hosp, Cardiovasc Surg, Tottori, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP22-5	S179	S179				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100158		
J	Kitada, S; Kikuchi, S; Sonoda, H; Ohte, N				Kitada, Shuichi; Kikuchi, Shohei; Sonoda, Hiroo; Ohte, Nobuyuki			Subclinical Hypothyroidism is a Useful Predictor of Adverse Events in Heart Failure Patients with Reduced Left Ventricular Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kitada, Shuichi; Kikuchi, Shohei; Ohte, Nobuyuki] Nagoya City Univ, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan; [Sonoda, Hiroo] Inabe Gen Hosp, Dept Cardiol, Inabe, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP34-1	S187	S187				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100199		
J	Kitamura, A; Kobayashi, S; Ogawa, M; Izawa, K; Okita, Y				Kitamura, Aki; Kobayashi, Seimi; Ogawa, Masato; Izawa, Kazuhiro; Okita, Yutaka			Efficacy of Evaluating Exercise Tolerance Before and after Cardiac Surgery	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kitamura, Aki; Okita, Yutaka] Kobe Univ Hosp, Dept Cardiovasc Surg, Kobe, Hyogo, Japan; [Kobayashi, Seimi] Kobe Univ, Grad Sch Med, Dept Cardiovasc Med, Kobe, Hyogo 657, Japan; [Ogawa, Masato] Kobe Univ, Grad Sch Med, Dept Rehabil Med, Kobe, Hyogo 657, Japan; [Izawa, Kazuhiro] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP5-2	S165	S165				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100087		
J	Kobayashi, M; Watanabe, M; Iwasaki, Y; Osamura, I; Yumino, D; Yamashina, A				Kobayashi, Masatake; Watanabe, Masataka; Iwasaki, Yoichi; Osamura, Ikuno; Yumino, Dai; Yamashina, Akira			Predictive or Preventive Re-Hospitalization Ability of Home Care Management in Patients with Elderly Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kobayashi, Masatake; Watanabe, Masataka; Iwasaki, Yoichi; Osamura, Ikuno; Yamashina, Akira] Tokyo Med Univ Hosp, Tokyo, Japan; [Yumino, Dai] Yumino Heart Clin, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP40-4	S192	S192				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100227		
J	Kochi, R; Aoki, T; Sugimura, K; Tatebe, S; Miura, M; Yaoita, N; Takahashi, J; Matsumoto, Y; Satou, K; Shimokawa, H				Kochi, Ryuzaburo; Aoki, Tatsuo; Sugimura, Koichiro; Tatebe, Shunsuke; Miura, Masanobu; Yaoita, Nobuhiro; Takahashi, Jun; Matsumoto, Yasuharu; Satou, Kimio; Shimokawa, Hiroaki			Takotsubo Cardiomyopathy in a Case of Recurrent Pheochromocytoma	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kochi, Ryuzaburo] Tohoku Univ Hosp, Resident Ctr, Sendai, Miyagi, Japan; [Aoki, Tatsuo; Sugimura, Koichiro; Tatebe, Shunsuke; Miura, Masanobu; Yaoita, Nobuhiro; Takahashi, Jun; Matsumoto, Yasuharu; Satou, Kimio; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP10-3	S169	S170				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100111		
J	Koide, M; Abe, H; Yasumura, K; Idemoto, A; Shinouchi, K; Miura, H; Date, M; Ueda, Y; Koretsune, Y; Kusuoka, H				Koide, Masao; Abe, Haruhiko; Yasumura, Kaori; Idemoto, Akiko; Shinouchi, Kazuya; Miura, Hiroyuki; Date, Motoo; Ueda, Yasunori; Koretsune, Yukihiro; Kusuoka, Hideo			A Case of Acute Decompensated Heart Failure with Preserved Ejection Fraction Treated by Heart Rate Control	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Koide, Masao; Abe, Haruhiko; Yasumura, Kaori; Idemoto, Akiko; Shinouchi, Kazuya; Miura, Hiroyuki; Date, Motoo; Ueda, Yasunori; Kusuoka, Hideo] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan; [Koretsune, Yukihiro] Osaka Natl Hosp, Inst Clin Reserch, Natl Hosp Org, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP26-3	S182	S182				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100175		
J	Koitabashi, N; Yamamoto, M; Musashi, T; Samejima, M; Iso, T; Imamura, H; Kurabayashi, M				Koitabashi, Norimichi; Yamamoto, Masamichi; Musashi, Takayuki; Samejima, Mai; Iso, Tatsuya; Imamura, Hiromi; Kurabayashi, Masahiko			Cardiac Energetics Re-evaluated by in Vivo Visualization of ATP Levels	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Koitabashi, Norimichi; Musashi, Takayuki; Samejima, Mai; Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Cardiovasc Med, Maebashi, Gumma, Japan; [Yamamoto, Masamichi] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto 6068501, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP18-2	S174	S174				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100136		
J	Komaki, K; Satomi-Kobayasi, S; Tsuboi, Y; Ogawa, M; Izawa, K; Sawa, T; Kitamura, A; Okita, Y; Hirata, KI				Komaki, Kodai; Satomi-Kobayasi, Seimi; Tsuboi, Yasunori; Ogawa, Masato; Izawa, Kazuhiro; Sawa, Takuma; Kitamura, Aki; Okita, Yutaka; Hirata, Ken-Ichi			Safety of Cardiopulmonary Exercise Testing for Assessing Preoperative Exercise Capacity in Japanese Patients with Asymptomatic Aortic Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Komaki, Kodai; Tsuboi, Yasunori; Ogawa, Masato] Kobe Univ Hosp, Div Rehabil Med, Kobe, Hyogo, Japan; [Satomi-Kobayasi, Seimi; Tsuboi, Yasunori; Sawa, Takuma; Hirata, Ken-Ichi] Kobe Univ, Dept Internal Med, Div Cardiovasc Med, Grad Sch Med, Kobe, Hyogo 657, Japan; [Ogawa, Masato; Izawa, Kazuhiro] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan; [Kitamura, Aki; Okita, Yutaka] Kobe Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP17-2	S174	S174				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100132		
J	Komuro, K; Soutome, K; Yokoyama, N; Shibuya, M; Shimazu, K; Takahasi, Y; Kagami, K; Hirose, M; Yonezawa, K; Anzai, T				Komuro, Kaoru; Soutome, Kazuyuki; Yokoyama, Noriko; Shibuya, Misaki; Shimazu, Kyou; Takahasi, Yumi; Kagami, Kazuki; Hirose, Masanori; Yonezawa, Kazuya; Anzai, Teisuke			Change in Renal Perfusion by Treatment of Congestive Heart Failure Using Contrastenhanced Ultrasonography	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Komuro, Kaoru; Shimazu, Kyou; Takahasi, Yumi; Kagami, Kazuki; Hirose, Masanori; Anzai, Teisuke] Hakodate Hosp, Natl Hosp Org, Dept Cardiol, Hakodate, Hokkaido, Japan; [Soutome, Kazuyuki; Yokoyama, Noriko; Shibuya, Misaki] Hakodate Hosp, Natl Hosp Org, Clin Lab, Hakodate, Hokkaido, Japan; [Yonezawa, Kazuya] Hakodate Hosp, Natl Hosp Org, Dept Clin Res, Hakodate, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP45-1	S196	S196				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100248		
J	Kondo, M; Kohno, T; Kohsaka, S; Fukuoka, R; Shiraishi, Y; Sawano, M; Inohara, T; Sano, M; Yoshikawa, T; Fukuda, K				Kondo, Mariko; Kohno, Takashi; Kohsaka, Shun; Fukuoka, Ryoma; Shiraishi, Yasuyuki; Sawano, Mitsuaki; Inohara, Taku; Sano, Motoaki; Yoshikawa, Tsutomu; Fukuda, Keiichi			Increase in the Oxidized Low-density Lipoprotein Level by Sleep-Disordered Breathing and Correlation with Obesity in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kondo, Mariko; Kohno, Takashi; Kohsaka, Shun; Fukuoka, Ryoma; Shiraishi, Yasuyuki; Sawano, Mitsuaki; Inohara, Taku; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Div Cardiol, Tokyo 108, Japan; [Sano, Motoaki; Yoshikawa, Tsutomu] Sakakibara Heart Inst, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP11-4	S171	S171				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100117		
J	Kondo, T; Yamada, T; Morita, T; Tamaki, S; Fukunami, M				Kondo, Takumi; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake			The Modified R(2)CHADS(2) Score Predicts Poor Clinical Outcome Among Chronic Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kondo, Takumi; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake] Osaka Gen Med Ctr, Div Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP15-2	S172	S172				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100122		
J	Kondo, T; Yamada, T; Morita, T; Tamaki, S; Fukunami, M				Kondo, Takumi; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake			High Blood Urea Nitrogen to Creatinine Ratio Predicts Poor Clinical Outcome in CHF Patients with Standard Dose of Furosemide	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kondo, Takumi; Yamada, Takahisa; Morita, Takashi; Tamaki, Shunsuke; Fukunami, Masatake] Osaka Gen Med Ctr, Div Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-2	S204	S204				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100290		
J	Kondo, T; Okumura, T; Watanabe, N; Kano, N; Mori, H; Hukaya, K; Sawamura, A; Morimoto, R; Bando, Y; Murohara, T				Kondo, Toru; Okumura, Takahiro; Watanabe, Naoki; Kano, Naoaki; Mori, Hiroaki; Hukaya, Kenji; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki			The Change of Cardio-Thoracic Ratio and Outcome in Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kondo, Toru; Okumura, Takahiro; Watanabe, Naoki; Kano, Naoaki; Mori, Hiroaki; Hukaya, Kenji; Sawamura, Akinori; Morimoto, Ryota; Bando, Yasuko; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP41-4	S193	S193				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100232		
J	Koyama, T; Watanabe, H; Ito, H				Koyama, Takashi; Watanabe, Hiroyuki; Ito, Hiroshi			Beneficial Effects of Short-Duration ASV Therapy on Albuminuria in Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Koyama, Takashi; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita 010, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP30-1	S184	S184				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100185		
J	Koyama, Y; Shirakawa, T; Yoshitatsu, M; Masai, T				Koyama, Yasushi; Shirakawa, Takashi; Yoshitatsu, Masao; Masai, Takafumi			The Advantage of The Iagnosis and Treatment on Heart Failure by Cardiac CT Imaging as the Second Tools	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Koyama, Yasushi] Sakurabashi Watanabe Hosp, Dept Cadiovasc Imaging Radiol & Cardiol, Osaka, Japan; [Shirakawa, Takashi; Yoshitatsu, Masao] Kansai Rosai Hosp, Dept Cardiovasc Surg, Amagasaki, Hyogo, Japan; [Masai, Takafumi] Sakurabashi Watanabe Hosp, Dept Cardiovasc Surg, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES2-2	S160	S160				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100063		
J	Kubota, R				Kubota, Ryuji			The Efficacy of Long-Term Administration of Tolvaptan for Recurrent Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kubota, Ryuji] Toyota Kosei Hosp, Dept Cardiol, Toyota, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-7	S204	S205				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100295		
J	Kubota, Y; A, K; Y, A; I, Y; M, K; T, Y; Y, M; T, Y; S, W				Kubota, Yoshiaki; A, K.; Y, A.; I, Y.; M, K.; T, Y.; Y, M.; T, Y.; S, W.			Efficacy and Safety of SGLT-2 Inhibitors in Heart Failure Patients with Diabetes Mellitus	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kubota, Yoshiaki; A, K.; Y, A.; I, Y.; M, K.; T, Y.; Y, M.; T, Y.; S, W.] Nippon Med Sch, Dept Cardiol, Tokyo 113, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP7-1	S202	S202				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100282		
J	Kuishi, Y; Akiyama, M; Muraoka, N; Miyamoto, K; Sadahiro, T; Isomi, M; Kojima, H; Haginiwa, S; Fukuda, K; Ieda, M				Kuishi, Yuki; Akiyama, Mizuha; Muraoka, Naoto; Miyamoto, Kazutaka; Sadahiro, Taketaro; Isomi, Mari; Kojima, Hidenori; Haginiwa, Sho; Fukuda, Keiichi; Ieda, Masaki			In Vivo Cardiac Reprogramming by a Single Polycistronic Vector Improves Cardiac Function after Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kuishi, Yuki; Akiyama, Mizuha; Muraoka, Naoto; Miyamoto, Kazutaka; Sadahiro, Taketaro; Isomi, Mari; Kojima, Hidenori; Haginiwa, Sho; Fukuda, Keiichi; Ieda, Masaki] Keio Univ, Sch Med, Dept Cardiol, Shinanomachi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP36-4	S189	S189				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100211		
J	Kunichika, H; Akagawa, E; Kato, T; Shibuya, M; Shiomi, K; Ono, S				Kunichika, Hideki; Akagawa, Eizou; Kato, Takayosi; Shibuya, Masaki; Shiomi, Koutaro; Ono, Shiro			A Case of Adverse Response of Right Ventricular Pacing in Dilated Cardiomyopathy Who Had Fully Recovered Systolic Function	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kunichika, Hideki; Akagawa, Eizou; Kato, Takayosi; Shibuya, Masaki; Shiomi, Koutaro; Ono, Shiro] Saiseikai Yamaguchi Gen Hosp, Dept Cardiovasc Med, Yamaguchi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP20-3	S176	S176				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100146		
J	Kuragaichi, T; Tsuji, S; Miyata, A; Washida, K; Sato, Y				Kuragaichi, Takashi; Tsuji, Shuhei; Miyata, Akihiko; Washida, Koichi; Sato, Yukihito			Usefulness of Dexmedetomidine for Sedation in Patients with End-Stage Heart Failure: A Report of Two Cases	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kuragaichi, Takashi; Tsuji, Shuhei; Miyata, Akihiko; Sato, Yukihito] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiol, Amagasaki, Hyogo, Japan; [Washida, Koichi] Hyogo Kenritsu Amagasaki Hosp, Nursing Dept, Amagasaki, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP8-3	S203	S203				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100288		
J	Kusakawa, Y; Kawata, S; Fukui, K; Kimura, K; Umemura, S				Kusakawa, Yuka; Kawata, Satomi; Fukui, Kazuki; Kimura, Kazuo; Umemura, Satoshi			Effect of Multidisciplinary Heart Failure Conferences on Readmissions in Patients Who Repeat Admissions Due to Chronic Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kusakawa, Yuka; Fukui, Kazuki] Kanagawa Cardiovasc & Resp Ctr, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawata, Satomi] Kanagawa Cardiovasc & Resp Ctr, Dept Nursing, Yokohama, Kanagawa, Japan; [Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 232, Japan; [Umemura, Satoshi] Yokohama City Univ, Sch Med, Dept Cardiorenal Med, Yokohama, Kanagawa 232, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP13-3	S171	S171				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100119		
J	Kusumoto, M; Araki, M; Nagata, Y; Hayashi, A; Tsuda, Y; Otsuji, Y				Kusumoto, Mie; Araki, Masaru; Nagata, Yasufumi; Hayashi, Atsushi; Tsuda, Yuki; Otsuji, Yutaka			Transition from Intravenous Epoprostenol to Intravenous Treprostinil in a Portopulmonary Hypertension Patient with Thrombocytopenia	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Kusumoto, Mie; Araki, Masaru; Nagata, Yasufumi; Hayashi, Atsushi; Tsuda, Yuki; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Interal Med 2, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP34-5	S187	S187				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100202		
J	Maeda, T; Makino, T; Zukeran, T; Kimura, R; Otsuka, T; Oshiro, K				Maeda, Taketoshi; Makino, Takafumi; Zukeran, Takako; Kimura, Ryusuke; Otsuka, Toshiyuki; Oshiro, Koichi			Preoperative Optimal Fluid Management with Tolvaptan in Octogenarian Complicated with Severe Aortic Stenosis and Left Main Trunk Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Maeda, Taketoshi; Makino, Takafumi; Zukeran, Takako; Kimura, Ryusuke; Otsuka, Toshiyuki; Oshiro, Koichi] Ohama Dai Ichi Hosp, Dept Cardiol, Ctr Cardiovasc, Naha, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP19-2	S175	S175				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100141		
J	Maejima, Y; Ito, Y; Tamura, N; Watanabe, R; Isobe, M				Maejima, Yasuhiro; Ito, Yusuke; Tamura, Natsuko; Watanabe, Ryo; Isobe, Mitsuaki			Dipeptidyl Peptidase-4 Suppression Leads to Attenuation of Cardiac Dysfunction Caused by Autoimmune Myocarditis Through Inhibiting Cathepsin-G Activity	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Maejima, Yasuhiro; Ito, Yusuke; Tamura, Natsuko; Watanabe, Ryo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP36-2	S188	S189				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100209		
J	Makabe, S; Watanabe, H; Ito, H				Makabe, Shin; Watanabe, Hiroyuki; Ito, Hiroshi			A Case of Cardiac Amyloidosis Following Familial Mediterranean Fever	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Makabe, Shin; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Akita 010, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP43-4	S194	S194				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100241		
J	Mano, H; Arima, K; Kouno, T; Furuichi, T				Mano, Hiroaki; Arima, Ken; Kouno, Touru; Furuichi, Tomohiro			Diuretic Response in Acute Heart Failure: Effects of Very Low Dose Tolvaptan (1.875 mg) in Old Age Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Mano, Hiroaki; Arima, Ken; Kouno, Touru; Furuichi, Tomohiro] Kasukabe Municipal Hosp, Dept Cardiol, Kasukabe, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-6	S204	S204				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100294		
J	Maruyama, M; Emoto, K; Hondou, S; Kinoshita, M; Kusayama, T; Aburadani, I; Nagata, Y; Usuda, K				Maruyama, Michiro; Emoto, Kenji; Hondou, Syunichirou; Kinoshita, Masaki; Kusayama, Takashi; Aburadani, Isao; Nagata, Yoshiki; Usuda, Kazuo			Influence of Clinical Parameters on Tolvaptan for the Treatment of Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Maruyama, Michiro; Emoto, Kenji; Hondou, Syunichirou; Kinoshita, Masaki; Kusayama, Takashi; Aburadani, Isao; Nagata, Yoshiki; Usuda, Kazuo] Toyama Prefectural Cent Hosp, Dept Internal Med, Div Cardiol, Toyama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP41-5	S193	S193				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100233		
J	Masada, K; Kuratani, T; Maeda, K; Torikai, K; Kudo, T; Ohnishi, T; Ichibori, Y; Nakatani, S; Sakata, Y; Sawa, Y				Masada, Kenta; Kuratani, Toru; Maeda, Koichi; Torikai, Kei; Kudo, Tomoaki; Ohnishi, Toshinari; Ichibori, Yasuhiro; Nakatani, Satoshi; Sakata, Yasushi; Sawa, Yoshiki			The New Treatment Strategy Using Transcatheter Aortic Valve Implication for Decompensated Aortic Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Masada, Kenta; Maeda, Koichi; Torikai, Kei; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Kuratani, Toru; Kudo, Tomoaki] Osaka Univ, Grad Sch Med, Minimally Invas Cardiovasc Med, Suita, Osaka, Japan; [Ohnishi, Toshinari; Ichibori, Yasuhiro; Nakatani, Satoshi; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiol, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA1-3	S146	S146				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100004		
J	Masuda, S; Miyagawa, S; Fukushima, S; Sawa, Y				Masuda, Shigeo; Miyagawa, Shigeru; Fukushima, Satsuki; Sawa, Yoshiki			Tumorigenicity of Human Induced Pluripotent Stem Cells	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Masuda, Shigeo; Miyagawa, Shigeru; Fukushima, Satsuki; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES5-3	S160	S160				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100066		
J	Matsue, Y; Suzuki, M; Torii, S; Yamaguchi, S; Fukamizu, S; Ono, Y; Fujii, H; Kitai, T; Nishioka, T; Sugi, K				Matsue, Yuya; Suzuki, Makoto; Torii, Sho; Yamaguchi, Satoshi; Fukamizu, Seiji; Ono, Yuichi; Fujii, Hiroyuki; Kitai, Takeshi; Nishioka, Toshihiko; Sugi, Kaoru			Clinical Effectiveness of Tolvaptan in Patients with Acute Heart Failure and Renal Dysfunction - AQUAMARINE Study	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsue, Yuya; Suzuki, Makoto] Kameda Med Ctr, Dept Cardiol, Kamogawa, Chiba, Japan; [Torii, Sho] Tokai Univ, Sch Med, Dept Cardiol, Hiratsuka, Kanagawa 25912, Japan; [Yamaguchi, Satoshi] Tomishiro Cent Hosp, Dept Cardiol, Okinawa, Japan; [Fukamizu, Seiji] Tokyo Metropolitan Hiroo Gen Hosp, Dept Cardiol, Tokyo, Japan; [Ono, Yuichi] Ome Municipal Gen Hosp, Dept Cardiol, Tokyo, Japan; [Fujii, Hiroyuki] Yokohama Minami Kyosai Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kitai, Takeshi] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Nishioka, Toshihiko] Saitama Med Univ, Saitama Med Ctr, Dept Cardiol, Saitama, Japan; [Sugi, Kaoru] Toho Univ, Div Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS9-1	S159	S159				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100060		
J	Matsui, S; Nakano, Y; Tomomori, S; Matsumura, H; Kawazoe, H; Tokuyama, T; Sairaku, A; Suenari, K; Hidaka, T; Kihara, Y				Matsui, Shogo; Nakano, Yukiko; Tomomori, Syunsuke; Matsumura, Hiroya; Kawazoe, Hiroshi; Tokuyama, Takehito; Sairaku, Akinori; Suenari, Kazuyoshi; Hidaka, Takayuki; Kihara, Yasuki			A Case of Cardiac Sarcoidosis Which Showed PBC Like Finding in Liver Biopsy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsui, Shogo; Nakano, Yukiko; Tomomori, Syunsuke; Matsumura, Hiroya; Kawazoe, Hiroshi; Tokuyama, Takehito; Sairaku, Akinori; Suenari, Kazuyoshi; Hidaka, Takayuki; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-6	S163	S164				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100080		
J	Matsui, T; Shoji, M; Adachi, T; Koba, S; Kobayashi, Y				Matsui, Taiju; Shoji, Makoto; Adachi, Tarou; Koba, Shinji; Kobayashi, Youichi			Plasma Thrombomodulin Level in Patients with Acute Pulmonary Embolism is Correlated with the Number of Hospitalization Days	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsui, Taiju; Shoji, Makoto; Adachi, Tarou; Koba, Shinji; Kobayashi, Youichi] Showa Univ, Div Cardiol, Dept Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-3	S200	S200				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100272		
J	Matsumoto, H; Kasai, T; Kattel, S; Suda, S; Hiki, M; Takasu, K; Miyazaki, T; Takagi, A; Miyauchi, K; Daida, H				Matsumoto, Hiroki; Kasai, Takatoshi; Kattel, Sharma; Suda, Shoko; Hiki, Masaru; Takasu, Kiyoshi; Miyazaki, Tetsuro; Takagi, Atsutoshi; Miyauchi, Katsumi; Daida, Hiroyuki			Long-Term Outcome of Patients with Acute Decompensated Heart Failure and Elevated Blood Glucose Level on Admission	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsumoto, Hiroki; Kasai, Takatoshi; Kattel, Sharma; Suda, Shoko; Hiki, Masaru; Takasu, Kiyoshi; Miyazaki, Tetsuro; Takagi, Atsutoshi; Miyauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan; [Matsumoto, Hiroki; Kasai, Takatoshi; Suda, Shoko; Miyazaki, Tetsuro] Juntendo Univ, Grad Sch Med, Cardiovasc Resp Sleep Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP16-5	S173	S173				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100130		
J	Matsunaga, Y; Takeuchi, M; Ohata, T; Yoshikawa, Y; Toda, K; Kioka, H; Tsukamoto, Y; Sakata, Y; Sawa, Y				Matsunaga, Yuriko; Takeuchi, Mugiho; Ohata, Toshihiro; Yoshikawa, Yasushi; Toda, Koichi; Kioka, Hidetaka; Tsukamoto, Yasumasa; Sakata, Yasushi; Sawa, Yoshiki			Immunosuppressive Therapy Necessitating Implantation of Biventricular Assist System with Centrifugal Pumps in a Patient with Giant Cell Myocarditis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsunaga, Yuriko; Takeuchi, Mugiho; Ohata, Toshihiro] Suita Tokushukai Gen Hosp, Dept Cardiovasv Surg, Suita, Osaka, Japan; [Yoshikawa, Yasushi; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Kioka, Hidetaka; Tsukamoto, Yasumasa; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiol, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP4-4	S164	S164				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100084		
J	Matsuura, R; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Saito, S; Yoshioka, D; Kuratani, T; Sawa, Y				Matsuura, Ryohei; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasuji; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Kuratani, Toru; Sawa, Yoshiki			Surgical Aortic Valve Replacement for a Critically High Risk Patient in the Era of Transcatheter Aortic Valve Implantation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Matsuura, Ryohei; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasuji; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP7-4	S167	S167				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100098		
J	Minakata, K; Yamazaki, K; Hirao, S; Nishio, H; Nakatsu, T; Sakamoto, K; Uehara, K; Sakaguchi, H; Ikeda, T; Sakata, R				Minakata, Kenji; Yamazaki, Kazuhiro; Hirao, Shingo; Nishio, Hiroomi; Nakatsu, Taro; Sakamoto, Kazuhisa; Uehara, Kyokun; Sakaguchi, Hisashi; Ikeda, Tadashi; Sakata, Ryuzo			Surgical Left Ventricle-Mitral Valve Restoration in Patients with Idiopathic Dilated Cardiomyopathy Who are Not Transplant Candidates	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Minakata, Kenji; Yamazaki, Kazuhiro; Hirao, Shingo; Nishio, Hiroomi; Nakatsu, Taro; Sakamoto, Kazuhisa; Uehara, Kyokun; Sakaguchi, Hisashi; Ikeda, Tadashi; Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto 6068501, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY1-2	S150	S150				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100017		
J	Minamisawa, M; Miura, T; Motoki, H; Ebisawa, S; Okada, A; Izawa, A; Koyama, J; Ikeda, U				Minamisawa, Masatoshi; Miura, Takashi; Motoki, Hirohiko; Ebisawa, Soichiro; Okada, Ayako; Izawa, Atsushi; Koyama, Jun; Ikeda, Uichi			Comparison of Usefulness of SYNTAX Score in Heart Failure Patients with Preserved Ejection Fraction Versus Those with Reduced Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Minamisawa, Masatoshi; Miura, Takashi; Motoki, Hirohiko; Ebisawa, Soichiro; Okada, Ayako; Izawa, Atsushi; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 390, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP9-3	S169	S169				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100107		
J	Miura, M; Sakata, Y; Miyata, S; Tadaki, S; Ushigome, R; Yamauchi, T; Sato, K; Nochioka, K; Takahashi, J; Shimokawa, H				Miura, Masanobu; Sakata, Yasuhiko; Miyata, Satoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Sato, Kenjiro; Nochioka, Kotaro; Takahashi, Jun; Shimokawa, Hiroaki			The Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients with Stable Heart Failure Using Olmesartan (SUPPORT) Trial	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Miura, Masanobu; Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 980, Japan; [Sakata, Yasuhiko; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Sato, Kenjiro; Nochioka, Kotaro; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS9-3	S159	S159				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100061		
J	Miyagawa, S; Toda, K; Nakamura, T; Yoshikawa, Y; Fukushima, S; Saito, S; Yoshioka, D; Domae, K; Sawa, Y				Miyagawa, Shigeru; Toda, Koichi; Nakamura, Teruya; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Domae, Keitaro; Sawa, Yoshiki			Translational Research of iPS Cell Sheet-Based Myocardial Regeneration Therapy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Miyagawa, Shigeru; Toda, Koichi; Nakamura, Teruya; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Domae, Keitaro; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 565, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY1-5	S150	S150				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100019		
J	Miyaji, K; Shakkya, S; Hayakawa, N; Suzuki, H; Kodera, S; Ishiwaki, H; Kushida, S; Kanda, J; Sakuma, Y; Satoh, Y				Miyaji, Kotaro; Shakkya, Sandeep; Hayakawa, Naoki; Suzuki, Hiroki; Kodera, Satoshi; Ishiwaki, Hikaru; Kushida, Shunichi; Kanda, Junji; Sakuma, Yukie; Satoh, Yasunori			Usefulness of Seattle Heart Failure Model in Heart Failure Patients with Reduced Ejection Fraction in the Clinical Settings	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Miyaji, Kotaro; Shakkya, Sandeep; Hayakawa, Naoki; Suzuki, Hiroki; Kodera, Satoshi; Ishiwaki, Hikaru; Kushida, Shunichi; Kanda, Junji] Asahi Gen Hosp, Cardiol, Asahi, Japan; [Sakuma, Yukie] Asahi Gen Hosp, Clin Res Ctr, Asahi, Japan; [Satoh, Yasunori] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP15-1	S171	S171				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100121		
J	Miyazaki, T; Takasu, K; Yatsu, S; Kato, T; Suda, S; Hiki, M; Hiki, M; Kasai, T; Miyauchi, K; Daida, H				Miyazaki, Tetsuro; Takasu, Kiyosi; Yatsu, Shoichiro; Kato, Takao; Suda, Shoko; Hiki, Masaru; Hiki, Makoto; Kasai, Takatoshi; Miyauchi, Katsumi; Daida, Hiroyuki			Successful Treatment of Congestive Heart Failure Due to Severe Aortic Valve Stenosis with Low Dose Tolvaptan in Old Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Miyazaki, Tetsuro; Takasu, Kiyosi; Yatsu, Shoichiro; Kato, Takao; Suda, Shoko; Hiki, Masaru; Hiki, Makoto; Kasai, Takatoshi; Miyauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Tokyo 113, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP19-4	S176	S176				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100143		
J	Mizuakami, T; Ebato, M; Tsujiuchi, M; Nogi, A; Maezawa, H; Ikeda, N; Suzuki, H				Mizuakami, Takuya; Ebato, Mio; Tsujiuchi, Miki; Nogi, Ayaka; Maezawa, Hideyuki; Ikeda, Naoko; Suzuki, Hiroshi			Takotsubo Cardiomyopathy Associated with Complete Atrioventricular Block: A Report of Two Cases	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Mizuakami, Takuya; Ebato, Mio; Tsujiuchi, Miki; Nogi, Ayaka; Maezawa, Hideyuki; Suzuki, Hiroshi] Showa Univ, Dept Cardiol, Fujigaoka Hosp, Tokyo, Japan; [Ikeda, Naoko] Showa Univ, Dept Cardiol, Koto Toyosu Hosp, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP22-4	S179	S179				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100157		
J	Mizuguchi, T; Yamashita, K; Takarada, A				Mizuguchi, Takao; Yamashita, Kentaro; Takarada, Akira			Mortality in Heart Failure Patients Has a Difference by Medical Treatment before Hospitalization	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Mizuguchi, Takao; Yamashita, Kentaro; Takarada, Akira] Hyogo Prefectural Awaji Med Ctr, Sumoto, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP7-4	S203	S203				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100285		
J	Mizuhara, A; Aoki, H				Mizuhara, Akihiro; Aoki, Hiromi			Use of Tolvaptan in Outpatients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Mizuhara, Akihiro] Higashi Washinomiya Hosp, Dept Cardiol & Vasc Surg, Saitama, Japan; [Aoki, Hiromi] Higashi Washinomiya Hosp, Dept Internal Med, Saitama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-4	S204	S204				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100292		
J	Morimoto, T; Hasegawa, K				Morimoto, Tatsuya; Hasegawa, Koji			A Novel Transcriptional Complex that Regulates Hypertrophic Responses in Cardiomyocytes	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Morimoto, Tatsuya] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan; [Morimoto, Tatsuya; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Kyoto, Japan; [Morimoto, Tatsuya] Shizuoka Prefectural Gen Hosp, Shizuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS6-6	S159	S159				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100059		
J	Morita, Y; Morishima, I; Takagi, K; Yoshida, R; Tsuboi, H				Morita, Yasuhiro; Morishima, Itsuro; Takagi, Kensuke; Yoshida, Ruka; Tsuboi, Hideyuki			A Case of Woman with Sub Acute Pulmonary Embolism Whose Pulmonary Hypertension was Rapidly Improved by Edoxaban	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Morita, Yasuhiro; Morishima, Itsuro; Takagi, Kensuke; Yoshida, Ruka; Tsuboi, Hideyuki] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Gifu, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-5	S201	S201				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100274		
J	Mukai, M				Mukai, Mikio			Clinical Feature of Cardiotoxicity Induced by Tyrosine-Kinase Inhibitor in Cancer Treatment	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Mukai, Mikio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES3-4	S160	S160				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100064		
J	Murai, K; Asai, K; Kubota, Y; Tukada, Y; Shimizu, W				Murai, Koji; Asai, Kuniya; Kubota, Yoshiaki; Tukada, Yayoi; Shimizu, Wataru			The Effect of Regular Carvedilol Therapy before Admission for New-onset Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Murai, Koji; Asai, Kuniya; Kubota, Yoshiaki; Tukada, Yayoi; Shimizu, Wataru] Nippon Med Coll Hosp, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP42-5	S194	S194				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100238		
J	Murakawa, T; Yamaguchi, O; Okamoto, K; Sakata, Y; Otsu, K				Murakawa, Tomokazu; Yamaguchi, Osamu; Okamoto, Koji; Sakata, Yasushi; Otsu, Kinya			The Novel Mitophagic Receptor Protein, Bcl2-like Protein 13: New Insights for the Molecular Mechanisms of the Pathogenesis of Heart Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Murakawa, Tomokazu; Yamaguchi, Osamu; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka, Japan; [Otsu, Kinya] Kings Coll London, British Heart Fdn Ctr Excellence, Cardiovasc Div, London WC2R 2LS, England								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA2-4	S147	S147				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100010		
J	Murata, M; Kato, T; Kuwaki, K; Yamamoto, T; Kajimoto, K; Shimada, A; Sato, Y; Shinohara, D; Miyazaki, S; Amano, A				Murata, Mai; Kato, Tomoko; Kuwaki, Kenji; Yamamoto, Taira; Kajimoto, Kan; Shimada, Akie; Sato, Yuichiro; Shinohara, Daisuke; Miyazaki, Suguru; Amano, Atsushi			Discrimination between Ga-67 Scintigraphy and F-FDG PET Findings for the Diagnosis of Cardiac Sarcoidosis and the Evaluation of Inflammatory Activities	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Murata, Mai; Kato, Tomoko; Kuwaki, Kenji; Yamamoto, Taira; Kajimoto, Kan; Shimada, Akie; Sato, Yuichiro; Shinohara, Daisuke; Miyazaki, Suguru; Amano, Atsushi] Juntendo Univ, Sch Med, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP45-5	S196	S196				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100252		
J	Murata, M; Kato, T; Kuwaki, K; Yamamoto, T; Kajimoto, K; Shimada, A; Sato, Y; Shinohara, D; Li, CY; Amano, A				Murata, Mai; Kato, Tomoko; Kuwaki, Kenji; Yamamoto, Taira; Kajimoto, Kan; Shimada, Akie; Sato, Yuichiro; Shinohara, Daisuke; Li, Chiyong; Amano, Atsushi			Pathological Evaluation of Myocardial Tissue Obtained from Heart Failure Patients with and without Reversible Myocardial Function Under Beta-Blocker Therapy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Murata, Mai; Kato, Tomoko; Kuwaki, Kenji; Yamamoto, Taira; Kajimoto, Kan; Shimada, Akie; Sato, Yuichiro; Shinohara, Daisuke; Li, Chiyong; Amano, Atsushi] Juntendo Univ, Sch Med, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP39-3	S191	S191				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100224		
J	Nabeta, T; Inomata, T; Fujita, T; Iida, Y; Ikeda, Y; Ishii, S; Naruke, T; Mizutani, T; Koitabashi, T; Ako, J				Nabeta, Takeru; Inomata, Takayuki; Fujita, Teppei; Iida, Yuichiro; Ikeda, Yuki; Ishii, Syunsuke; Naruke, Takashi; Mizutani, Tomoharu; Koitabashi, Toshimi; Ako, Junya			The Comparison Study of the Midterm Prognosis in Patients with Dilated Cardiomyopathy Last 15 Years	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nabeta, Takeru; Inomata, Takayuki; Fujita, Teppei; Iida, Yuichiro; Ikeda, Yuki; Ishii, Syunsuke; Naruke, Takashi; Mizutani, Tomoharu; Koitabashi, Toshimi; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 228, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP23-2	S179	S179				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100160		
J	Nagai, T; Nagano, N; Sugano, Y; Aiba, T; Kanzaki, H; Kusano, K; Noguchi, T; Yasuda, S; Ogawa, H; Anzai, T				Nagai, Toshiyuki; Nagano, Nobutaka; Sugano, Yasuo; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa			Discontinuation of Corticosteroid Therapy Increases the Risk of Cardiac Mortality Associated with Progression of Left Ventricular Dysfunction in Cardiac Sarcoidosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nagai, Toshiyuki; Nagano, Nobutaka; Sugano, Yasuo; Aiba, Takeshi; Kanzaki, Hideaki; Kusano, Kengo; Noguchi, Teruo; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA1-2	S146	S146				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100003		
J	Nagaoka, E; Mizuno, T; Ooi, K; Hachimaru, T; Kuroki, H; Tasaki, D; Fujiwara, T; Kinoshita, R; Arai, H				Nagaoka, Eiki; Mizuno, Tomohiro; Ooi, Keiji; Hachimaru, Tsuyoshi; Kuroki, Hidehito; Tasaki, Dai; Fujiwara, Tatsuki; Kinoshita, Ryouji; Arai, Hirokuni			Efficacy of Papillary Muscle Relocation against Mitral Valve Complex: Difference Depending on Relocating Direction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nagaoka, Eiki; Mizuno, Tomohiro; Ooi, Keiji; Hachimaru, Tsuyoshi; Kuroki, Hidehito; Tasaki, Dai; Fujiwara, Tatsuki; Kinoshita, Ryouji; Arai, Hirokuni] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS4-4	S157	S157				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100050		
J	Nagata, T; Yasukawa, H; Takahashi, J; Shimozono, K; Nohara, S; Minami, T; Oba, T; Mawatari, K; Sugi, Y; Fukumoto, Y				Nagata, Takanobu; Yasukawa, Hideo; Takahashi, Jinya; Shimozono, Koutatsu; Nohara, Shoichiro; Minami, Tomoko; Oba, Toyoharu; Mawatari, Kazutoshi; Sugi, Yusuke; Fukumoto, Yoshihiro			Change of Transcriptional Profile in Response to Cardiac-Specific Deletion of SOCS3 after Myocardial Ischemia Reperfusion Injury	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nagata, Takanobu; Yasukawa, Hideo; Takahashi, Jinya; Shimozono, Koutatsu; Nohara, Shoichiro; Minami, Tomoko; Oba, Toyoharu; Mawatari, Kazutoshi; Sugi, Yusuke; Fukumoto, Yoshihiro] Kurume Univ, Dept Cardiol, Kurume, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP21-3	S177	S177				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100151		
J	Nakada, Y; Kawakami, R; Nakano, T; Ueda, T; Onoue, K; Takeda, Y; Kawata, H; Okura, H; Saito, Y				Nakada, Yasuki; Kawakami, Rika; Nakano, Tomoya; Ueda, Tomoya; Onoue, Kenji; Takeda, Yukiji; Kawata, Hiroyuici; Okura, Hiroyuki; Saito, Yoshihiko			Prognostic Impact of B-type Natriuretic Peptide Levels and Plasma Renin Activity in Female Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakada, Yasuki; Kawakami, Rika; Nakano, Tomoya; Ueda, Tomoya; Onoue, Kenji; Takeda, Yukiji; Kawata, Hiroyuici; Okura, Hiroyuki; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-6	S198	S199				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100263		
J	Nakagawa, D; Seo, Y; Harimura, Y; Sugano, A; Yamamoto, M; Ishizu, T; Aonuma, K				Nakagawa, Daishi; Seo, Yoshihiro; Harimura, Yoshie; Sugano, Akinori; Yamamoto, Masayoshi; Ishizu, Tomoko; Aonuma, Kazutaka			Diversity of Clinical Courses in Patients with Acute Decompensated Heart Failure and Cold	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakagawa, Daishi; Seo, Yoshihiro; Harimura, Yoshie; Sugano, Akinori; Yamamoto, Masayoshi; Ishizu, Tomoko; Aonuma, Kazutaka] Univ Tsukuba, Inst Clin Med, Cardiovasc Div, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP6-4	S166	S166				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100094		
J	Nakajima, T; Kinugawa, S; Takada, S; Matsumoto, J; Misushima, W; Furihata, T; Tsuda, M; Yokota, T; Matsushima, S; Tsutsui, H				Nakajima, Takayuki; Kinugawa, Shintaro; Takada, Shingo; Matsumoto, Junichi; Misushima, Wataru; Furihata, Takaaki; Tsuda, Masaya; Yokota, Takashi; Matsushima, Shouji; Tsutsui, Hiroyuki			Brain-Derived Neurotrophic Factor Could Regulate Mitochondrial Function in the Skeletal Muscle Through Ampk-Pgc1 alpha Signaling in Heart Failure Mice	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakajima, Takayuki; Kinugawa, Shintaro; Takada, Shingo; Matsumoto, Junichi; Misushima, Wataru; Furihata, Takaaki; Tsuda, Masaya; Yokota, Takashi; Matsushima, Shouji; Tsutsui, Hiroyuki] Hokkaido Univ, Gradiate Sch Med, Depertment Cardiovasc Med, Sapporo, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-2	S197	S197				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100254		
